Citrus Sinensis ID: 035572
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 379 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FMY3 | 341 | Serine/threonine-protein | yes | no | 0.738 | 0.821 | 0.5 | 6e-67 | |
| Q9SV05 | 362 | Serine/threonine-protein | no | no | 0.725 | 0.759 | 0.416 | 4e-57 | |
| Q9SGN7 | 470 | Serine/threonine-protein | no | no | 0.746 | 0.602 | 0.397 | 1e-54 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.741 | 0.313 | 0.392 | 3e-48 | |
| O24585 | 901 | Putative receptor protein | N/A | no | 0.741 | 0.311 | 0.389 | 3e-48 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.720 | 0.400 | 0.347 | 9e-43 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.720 | 0.385 | 0.360 | 1e-42 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.725 | 0.360 | 0.350 | 2e-42 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.717 | 0.379 | 0.350 | 2e-41 | |
| Q9S7D9 | 775 | Serine/threonine-protein | no | no | 0.678 | 0.331 | 0.343 | 3e-41 |
| >sp|Q9FMY3|STPKL_ARATH Serine/threonine-protein kinase-like protein At5g23170 OS=Arabidopsis thaliana GN=At5g23170 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 254 bits (650), Expect = 6e-67, Method: Compositional matrix adjust.
Identities = 157/314 (50%), Positives = 201/314 (64%), Gaps = 34/314 (10%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGD---HKILAIKRASTNGFE 59
+ FDY++LV A + FS S+LIGKGSHG VYKA+L H D D +++AIK S+
Sbjct: 2 KEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALL--HHQDVDETRQRVVAIKTPSSLSPS 59
Query: 60 VLQ-------DNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLL 112
+ +KKL NEI V+SSL +P+ V++F G + KL+
Sbjct: 60 SPSSSSSSKSEQTKKLENEIDVMSSL----PYHPH--VLSFLGHA----------EKKLM 103
Query: 113 VMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172
V+E+MPN SLY LLH +T P W R++IA+QI+ A+ LHE+ IIHRDIKS N
Sbjct: 104 VVEYMPNESLYQLLH---VSTDPLPTWLKRIEIALQIASAVHFLHEHG--IIHRDIKSEN 158
Query: 173 ILFDSKWDAKLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
ILFDS W+AKLADFGLAV D+ PAGTIGYLDP YT P LS K DV+SYGVVL
Sbjct: 159 ILFDSNWEAKLADFGLAVDFGGDKKIRPAPAGTIGYLDPCYTLPENLSMKTDVYSYGVVL 218
Query: 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARC 291
LEI+SCRK ID +R PASI+DWA+PLIKE ++ ++C G G ++L +AARC
Sbjct: 219 LEIVSCRKAIDVSRSPASIVDWAVPLIKEGRIGEICGGGGGGSGVFRGMSLRLLRMAARC 278
Query: 292 VSSEEENRPGIGEI 305
VSS+ E+RP GEI
Sbjct: 279 VSSDVESRPCFGEI 292
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SV05|CCR35_ARATH Serine/threonine-protein kinase-like protein At3g51990 OS=Arabidopsis thaliana GN=At3g51990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 128/307 (41%), Positives = 187/307 (60%), Gaps = 32/307 (10%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F + +L AT F + L+G+GSHGSVYKA++ +A+KR S + ++
Sbjct: 47 FLHRDLESATGGFDINNLLGRGSHGSVYKAVIGSRH-------IAVKRPSKS-----REI 94
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
S++ +NE +LS + R+P + VN G S NS LLV+EFM NGSLYD
Sbjct: 95 SREFHNEFEILSRI-----RSPRF--VNLLGFSADNS------KEPLLVVEFMGNGSLYD 141
Query: 125 LLHNAAAATTPQLG-WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
++H+ + + W R+KIA+QI++A+ LH + IIHRDIKS N+L D +AKL
Sbjct: 142 VIHSDTVLNSGAISSWSKRIKIALQIAKAVHLLHSQETPIIHRDIKSANVLMDKNLNAKL 201
Query: 184 ADFGLAVSESDESSMVQ---PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
DFGLA+ + + V+ PAGT+GYLDP Y +LS K DVFS+G++LLEIIS RK
Sbjct: 202 GDFGLAIRCNVDDQKVKSTPPAGTMGYLDPDYVTADRLSTKTDVFSFGILLLEIISGRKA 261
Query: 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLH-VAARCVSSEEENR 299
ID P+ I+DWA+P+IK K+ + D R+G P ++ +++ L VAA+CV + E R
Sbjct: 262 IDVRYSPSFIVDWAIPMIKRGKIGGIYDPRIGPP--IDVSVRNHLGLVAAKCVRTCREKR 319
Query: 300 PGIGEIL 306
PG+ E++
Sbjct: 320 PGMEEVV 326
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGN7|CCR12_ARATH Serine/threonine-protein kinase-like protein At1g28390 OS=Arabidopsis thaliana GN=At1g28390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 122/307 (39%), Positives = 183/307 (59%), Gaps = 24/307 (7%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F+Y+EL AT FS + +GKGSHG VYKA+L+D + + A+KR + +N
Sbjct: 40 FNYDELAVATNGFSANNFLGKGSHGRVYKAVLDDGKL-----LAAVKRTTITTTVGNNNN 94
Query: 65 S-KKLNNEIRVLSSLQESNKRN-PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL 122
+ +++NEI +LS ++ N YCV + T KLLV+E+MPNG+L
Sbjct: 95 NVSQVDNEIEILSRVRHRWMVNLIGYCVDHRRKT-------------KLLVVEYMPNGTL 141
Query: 123 YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182
+D LH+ ++ + W R+K A+QI+ A+ LH + +IHRDIKS N+L D +A+
Sbjct: 142 HDQLHSRSSLDSRLSSWNRRIKHALQIAIAVHALHTAETQVIHRDIKSCNVLIDGDGNAR 201
Query: 183 LADFGLAV---SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
LADFGLA+ + + PAGT+GYLDP Y P+ L+ K DVFS+G++LLEIIS R+
Sbjct: 202 LADFGLALIGNVDDERLKYTPPAGTLGYLDPSYLAPADLTAKSDVFSFGILLLEIISGRE 261
Query: 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299
ID P+ I+DWA+PLIK +CD ++ + I+++ +AARCV S + R
Sbjct: 262 AIDLNYSPSCIVDWAVPLIKRGDYDAICDLKIKNRPYY-AVIRKLAVMAARCVRSTAKKR 320
Query: 300 PGIGEIL 306
P + E++
Sbjct: 321 PDMLEVV 327
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 121/308 (39%), Positives = 180/308 (58%), Gaps = 27/308 (8%)
Query: 2 AENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL 61
A F YEEL KA + F + ++GKGS VYK +L D T +A+KRA + +
Sbjct: 497 ARVFTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTT------VAVKRAIMSSDK-- 548
Query: 62 QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGS 121
Q NS + E+ +LS L ++ +++ G C G +LLV EFM +GS
Sbjct: 549 QKNSNEFRTELDLLSRLNHAH-------LLSLLGY-CEECG------ERLLVYEFMAHGS 594
Query: 122 LYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND-PMIIHRDIKSTNILFDSKWD 180
L++ LH A QL W RV IA+Q +R I+ LH P +IHRDIKS+NIL D + +
Sbjct: 595 LHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN 654
Query: 181 AKLADFGLAV-SESDESSMVQ--PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237
A++ADFGL++ D S + PAGT+GYLDP Y L+ K DV+S+GV+LLEI+S
Sbjct: 655 ARVADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 714
Query: 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
RK ID + +I++WA+PLIK + + D + P+ +E A+K+++ VA +CV +
Sbjct: 715 RKAIDMHYEEGNIVEWAVPLIKAGDINALLDPVLKHPSEIE-ALKRIVSVACKCVRMRGK 773
Query: 298 NRPGIGEI 305
+RP + ++
Sbjct: 774 DRPSMDKV 781
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 120/308 (38%), Positives = 178/308 (57%), Gaps = 27/308 (8%)
Query: 2 AENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL 61
A+ F YEEL +AT FS+ +GKGS V+K IL D ++A+KRA +
Sbjct: 490 AQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDG------TVVAVKRAIKA--SDV 541
Query: 62 QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGS 121
+ +SK+ +NE+ +LS L ++ N G + S +LLV EFM +GS
Sbjct: 542 KKSSKEFHNELDLLSRLNHAHLLN--------------LLGYCEDGSERLLVYEFMAHGS 587
Query: 122 LYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND-PMIIHRDIKSTNILFDSKWD 180
LY LH +L W RV IA+Q +R I+ LH P +IHRDIKS+NIL D +
Sbjct: 588 LYQHLHGKDPNLKKRLNWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHN 647
Query: 181 AKLADFGLAV-SESDESSMVQ--PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237
A++ADFGL++ +D + + PAGT+GYLDP Y L+ K DV+S+GVVLLEI+S
Sbjct: 648 ARVADFGLSILGPADSGTPLSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSG 707
Query: 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
RK ID + +I++WA+PLIK + + D + P+ +E A+K++ VA +CV +
Sbjct: 708 RKAIDMQFEEGNIVEWAVPLIKAGDIFAILDPVLSPPSDLE-ALKKIASVACKCVRMRGK 766
Query: 298 NRPGIGEI 305
+RP + ++
Sbjct: 767 DRPSMDKV 774
|
Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 9e-43, Method: Compositional matrix adjust.
Identities = 109/314 (34%), Positives = 171/314 (54%), Gaps = 41/314 (13%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F Y+EL + T FS+ L+G+G G VYK +L D + +A+K+ G +
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGRE------VAVKQLKIGGSQ----G 376
Query: 65 SKKLNNEIRVLSSLQESNKRN-PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
++ E+ ++S + + YC+ H +LLV +++PN +L+
Sbjct: 377 EREFKAEVEIISRVHHRHLVTLVGYCISEQH---------------RLLVYDYVPNNTLH 421
Query: 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWDAK 182
LH A P + W RV++A +R I LHE+ P IIHRDIKS+NIL D+ ++A
Sbjct: 422 YHLH---APGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEAL 478
Query: 183 LADFGLA--VSESDESSMVQP--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238
+ADFGLA E D ++ V GT GY+ P Y KLS+K DV+SYGV+LLE+I+ R
Sbjct: 479 VADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGR 538
Query: 239 KPIDAARDPA--SIIDWALPL----IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCV 292
KP+D ++ S+++WA PL I+ E+ ++ D R+G F+ G + +M+ AA CV
Sbjct: 539 KPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGK-NFIPGEMFRMVEAAAACV 597
Query: 293 SSEEENRPGIGEIL 306
RP + +++
Sbjct: 598 RHSAAKRPKMSQVV 611
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 112/311 (36%), Positives = 174/311 (55%), Gaps = 38/311 (12%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F YEELVKAT FSQ L+G+G G VYK IL D +++A+K+ G +
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDG------RVVAVKQLKIGGGQ----G 414
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
++ E+ LS + + +V+ G C + G+ +LL+ +++ N LY
Sbjct: 415 DREFKAEVETLSRIHHRH-------LVSIVG-HC-----ISGD-RRLLIYDYVSNNDLYF 460
Query: 125 LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWDAKL 183
LH + L W RVKIA +R + LHE+ P IIHRDIKS+NIL + +DA++
Sbjct: 461 HLHGEKSV----LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARV 516
Query: 184 ADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+DFGLA D ++ + + GT GY+ P Y + KL++K DVFS+GVVLLE+I+ RKP+
Sbjct: 517 SDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 576
Query: 242 DAAR--DPASIIDWALPL----IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSE 295
D ++ S+++WA PL I+ E+ + D ++G ++E + +M+ A CV
Sbjct: 577 DTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLG-GNYVESEMFRMIEAAGACVRHL 635
Query: 296 EENRPGIGEIL 306
RP +G+I+
Sbjct: 636 ATKRPRMGQIV 646
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 110/314 (35%), Positives = 173/314 (55%), Gaps = 39/314 (12%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ 62
E F YEELV AT FS L+G+G G VYK +L D +++A+K+ G +
Sbjct: 416 ELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDE------RVVAVKQLKIGGGQ--- 466
Query: 63 DNSKKLNNEIRVLSSLQESNKRN-PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGS 121
++ E+ +S + N + YC+ + +LL+ +++PN +
Sbjct: 467 -GDREFKAEVDTISRVHHRNLLSMVGYCI---------------SENRRLLIYDYVPNNN 510
Query: 122 LYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWD 180
LY LH AA TP L W RVKIA +R + LHE+ P IIHRDIKS+NIL ++ +
Sbjct: 511 LYFHLH---AAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFH 567
Query: 181 AKLADFGLAVSESDESSMVQP--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238
A ++DFGLA D ++ + GT GY+ P Y + KL++K DVFS+GVVLLE+I+ R
Sbjct: 568 ALVSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 627
Query: 239 KPIDAARDPA--SIIDWALPLI----KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCV 292
KP+DA++ S+++WA PL+ + E+ + D ++G ++ + +M+ AA C+
Sbjct: 628 KPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGR-NYVGVEMFRMIEAAAACI 686
Query: 293 SSEEENRPGIGEIL 306
RP + +I+
Sbjct: 687 RHSATKRPRMSQIV 700
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 109/311 (35%), Positives = 172/311 (55%), Gaps = 39/311 (12%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F+YEEL +AT FS++ L+G+G G V+K +L + + + + +K S+ G
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGK---EVAVKQLKEGSSQG------- 391
Query: 65 SKKLNNEIRVLSSLQESNKRN-PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
++ E+ ++S + + YC+ + + +LLV EF+PN +L
Sbjct: 392 EREFQAEVGIISRVHHRHLVALVGYCIAD---------------AQRLLVYEFVPNNTLE 436
Query: 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWDAK 182
LH P + W +R+KIA+ ++ + LHEN +P IIHRDIK++NIL D K++AK
Sbjct: 437 FHLHGKG---RPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAK 493
Query: 183 LADFGLAVSESDESSMVQP--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ADFGLA SD ++ V GT GYL P Y + KL++K DVFS+GVVLLE+I+ R+P
Sbjct: 494 VADFGLAKIASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRP 553
Query: 241 IDAARDPA--SIIDWALPLIKE----EKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSS 294
ID A S++DWA PL+ + V D ++ + + + +M+ AA CV S
Sbjct: 554 IDVNNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLN-NEYDKEEMARMVACAAACVRS 612
Query: 295 EEENRPGIGEI 305
RP + ++
Sbjct: 613 TAPRRPRMDQV 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 105/306 (34%), Positives = 164/306 (53%), Gaps = 49/306 (16%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
A+ F EL AT F + +G+GS+G VYKA+L D + +A+KRA N +
Sbjct: 504 FAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQ------VAVKRA--NAATI 555
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
+ N+++ E+ +L +++ N +VN G S +LLV E+MP+G
Sbjct: 556 IHTNTREFETELEILCNIRHCN-------IVNLLGYSTEMG-------ERLLVYEYMPHG 601
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH-ENDPMIIHRDIKSTNILFDSKW 179
+L+D LH+ + L W R+KIAMQ ++ ++ LH E +P IIH D+KS+N+L DS+W
Sbjct: 602 TLHDHLHSGFSP----LSWSLRIKIAMQTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEW 657
Query: 180 DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
A++ADFGL S +N L K DV+ +GVVLLEI++ RK
Sbjct: 658 VARVADFGLVTS---------------------SNEKNLDIKRDVYDFGVVLLEILTGRK 696
Query: 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299
D DP I++W +P+I+E K + D+ + LP +E +K + VA CV + +
Sbjct: 697 RYDRDCDPPEIVEWTVPVIREGKAAAIVDTYIALPRNVEPLLK-LADVAELCVREDPNQQ 755
Query: 300 PGIGEI 305
P + E+
Sbjct: 756 PTMSEL 761
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 379 | ||||||
| 255576237 | 367 | Protein kinase APK1B, chloroplast precur | 0.912 | 0.942 | 0.536 | 1e-100 | |
| 224129644 | 299 | predicted protein [Populus trichocarpa] | 0.754 | 0.956 | 0.622 | 4e-96 | |
| 225448164 | 361 | PREDICTED: serine/threonine-protein kina | 0.841 | 0.883 | 0.502 | 3e-87 | |
| 351720676 | 337 | serine/threonine protein kinase [Glycine | 0.741 | 0.833 | 0.550 | 3e-78 | |
| 449435124 | 333 | PREDICTED: serine/threonine-protein kina | 0.749 | 0.852 | 0.482 | 1e-73 | |
| 297739550 | 323 | unnamed protein product [Vitis vinifera] | 0.762 | 0.894 | 0.454 | 5e-72 | |
| 297812459 | 328 | hypothetical protein ARALYDRAFT_489173 [ | 0.791 | 0.914 | 0.470 | 1e-68 | |
| 63146804 | 346 | putative serine/threonine protein kinase | 0.751 | 0.823 | 0.486 | 3e-65 | |
| 63146744 | 346 | putative serine/threonine protein kinase | 0.751 | 0.823 | 0.483 | 4e-65 | |
| 15237244 | 341 | serine/threonine-protein kinase-like pro | 0.738 | 0.821 | 0.5 | 4e-65 |
| >gi|255576237|ref|XP_002529012.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223531552|gb|EEF33382.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 371 bits (952), Expect = e-100, Method: Compositional matrix adjust.
Identities = 212/395 (53%), Positives = 262/395 (66%), Gaps = 49/395 (12%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
MAE FDY+ELVKATESFS S L+GKGSHGSVYK +L ++KILAIK++S V
Sbjct: 1 MAE-FDYQELVKATESFSPSSLVGKGSHGSVYKGVLVQ-----ENKILAIKKSSIGIDHV 54
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNS--NKLLVMEFMP 118
DNSKKL NEI VLSSL+ P+ +++F GTS + +KLLVMEFMP
Sbjct: 55 FNDNSKKLENEISVLSSLR------PSPYIISFLGTSSSKENEKEKMMIMSKLLVMEFMP 108
Query: 119 NGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
NGSL DLLH A A + WP RV+IA+QI++AIQ LHE P++IHRDIKS N+LFDS
Sbjct: 109 NGSLQDLLHAAKAPPS----WPKRVEIALQIAKAIQFLHEGKPLVIHRDIKSANVLFDSN 164
Query: 179 WDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
W+AKLAD+GLAVS D S+ QPAGTIGY+DP YT PSKLS K DVFSYGVVLLEI
Sbjct: 165 WNAKLADYGLAVSRVDSSTSSHQASQPAGTIGYMDPSYTIPSKLSTKNDVFSYGVVLLEI 224
Query: 235 ISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVS 293
IS RK ID R P S+++WA+PLI +E L ++CD+R+GL P F+EG I+ +L+VAARCVS
Sbjct: 225 ISGRKAIDVNRSPTSVVEWAVPLILKEGLMEICDTRIGLPPPFIEGTIRHLLYVAARCVS 284
Query: 294 SEEENRPGIGEILMGC----SCFFVDHHHHHHHHHVERVRLIPL--WIMSLWGSTKIRQK 347
S EENRP IG+I+M SC VERVR+ P WI + IR++
Sbjct: 285 SNEENRPSIGDIVMAMGMNNSCL------------VERVRVAPTSSWIGLIRSLMAIRRQ 332
Query: 348 KGANNKFPCSQ--------KKMMILREILAVIELK 374
+ KF + K ++LREILA I +K
Sbjct: 333 RKLARKFHVQKGGDYSDISKGKILLREILADITIK 367
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224129644|ref|XP_002328767.1| predicted protein [Populus trichocarpa] gi|222839065|gb|EEE77416.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 191/307 (62%), Positives = 227/307 (73%), Gaps = 21/307 (6%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
FDY+ELVKAT SFS SRL+GKGSHGSVYK LE++ K++AIK++S V DN
Sbjct: 9 FDYKELVKATGSFSPSRLLGKGSHGSVYKGTLEEN------KLVAIKKSSVGSDHVSIDN 62
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS-GSVDGNSNKLLVMEFMPNGSLY 123
SKKL NEI VLSSL ES V+NF GT+ + S N+LLVME+MP GSL+
Sbjct: 63 SKKLENEICVLSSLGESPY------VINFLGTTRDDDHYSTCKEKNRLLVMEYMPYGSLH 116
Query: 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
DLLH AT P WP RV+IA+QI+RAIQ LHE P++IHRDIKS N+LFD W AKL
Sbjct: 117 DLLH--VDATPP--SWPKRVEIAIQIARAIQFLHEGKPLVIHRDIKSANVLFDLNWKAKL 172
Query: 184 ADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
ADFGLAV D SS QPAGTIGYLDP YT PSKLS K DVFSYGVVLLEI+SC+K
Sbjct: 173 ADFGLAVLRVDSSSSPDHETQPAGTIGYLDPCYTTPSKLSTKNDVFSYGVVLLEIVSCQK 232
Query: 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299
ID +R PASI+DWA+PLI++++L +VCDSR+ LPTFMEG IK +L+VA+RCVS +EENR
Sbjct: 233 AIDVSRLPASIVDWAVPLIEKQRLMEVCDSRIALPTFMEGTIKHLLYVASRCVSCKEENR 292
Query: 300 PGIGEIL 306
P I EI+
Sbjct: 293 PSISEIV 299
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448164|ref|XP_002264141.1| PREDICTED: serine/threonine-protein kinase-like protein At5g23170-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 328 bits (840), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 181/360 (50%), Positives = 244/360 (67%), Gaps = 41/360 (11%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
M + FDY+EL +AT+ FS + LIGKGSHG VYK L+D K++AIK+ S G ++
Sbjct: 3 MIKEFDYKELEEATQGFSPTHLIGKGSHGLVYKGALQDG------KLVAIKKPSP-GLQI 55
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
L+DN+K ++NEI +LSSL E NPN +++ GTS D NK+LVME MPNG
Sbjct: 56 LRDNTK-IDNEISMLSSLPE----NPN--IISLLGTSH------DSAMNKVLVMELMPNG 102
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180
SL+DLLH +TTP WP R+ +AMQI+RA+Q LHE P+++HRDIKS NILFDS+W+
Sbjct: 103 SLHDLLH---VSTTPP-TWPQRLGMAMQIARAVQFLHEEKPLVVHRDIKSANILFDSEWN 158
Query: 181 AKLADFGLAVSESDE------SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
AKLADFGLAV +++ S+ QPAGTIGYLDP YT PSKLS K DVFS+GVVLLE+
Sbjct: 159 AKLADFGLAVRKNENIDHSRVDSLSQPAGTIGYLDPCYTTPSKLSTKNDVFSFGVVLLEV 218
Query: 235 ISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSS 294
IS K ID +R I++WA+PLIK++++++VCDSR LP MEG I+ +L VAARCVSS
Sbjct: 219 ISTSKVIDLSRTRTHIVEWAIPLIKKDRIKEVCDSRTELPMCMEGTIRHILRVAARCVSS 278
Query: 295 EEENRPGIGEILMGCSCFFVDHHHHHHHHHVERVRLIPLWIMSLWGSTKIRQKKGANNKF 354
E+ RP + +I++ H ++RVR +P+W L IR+ + + ++F
Sbjct: 279 REDLRPSMQQIIIDID----------KHRSIDRVR-VPIWSSLLESVVLIRRGRRSASRF 327
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351720676|ref|NP_001238464.1| serine/threonine protein kinase [Glycine max] gi|223452294|gb|ACM89475.1| serine/threonine protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 298 bits (763), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 173/314 (55%), Positives = 215/314 (68%), Gaps = 33/314 (10%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
FDYEE+VKATE+F+ R+IGKGSHG VYK +L + D +A+K+ S G E L DN
Sbjct: 6 FDYEEVVKATENFNPRRIIGKGSHGMVYKGVLFN-----DRLQVAVKKPS-EGLESLHDN 59
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
SK L NEIRVLSSL+ES P+ VVN GTS N + KL+VME MPNGSL+D
Sbjct: 60 SK-LENEIRVLSSLRES----PH--VVNLLGTSSYN------DHKKLIVMELMPNGSLHD 106
Query: 125 LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
LLH A TT WP RV+IAMQI+RA+Q LHE ++IHRDIKS+NILFDS W+AKLA
Sbjct: 107 LLHGHANKTT----WPKRVEIAMQIARAVQFLHE--AVVIHRDIKSSNILFDSHWNAKLA 160
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
DFGLAV PAGTIGY+DP YT P KLS K D+FS+GVVLLEIIS RK ID
Sbjct: 161 DFGLAVKGGLSEPGPAPAGTIGYIDPCYTTPDKLSTKNDIFSFGVVLLEIISGRKAIDVC 220
Query: 245 RDPASIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIG 303
+ PASI++ + ++L++ CD+R+ L P +M G++ ++L AARCVS EE RP G
Sbjct: 221 KTPASIVE---RVKTSDELKEFCDTRMPLPPNYMVGSVTRLLSFAARCVSLNEEERPWAG 277
Query: 304 EILMG----CSCFF 313
E++MG +CFF
Sbjct: 278 EVVMGMEMELNCFF 291
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435124|ref|XP_004135345.1| PREDICTED: serine/threonine-protein kinase-like protein At1g28390-like [Cucumis sativus] gi|449503287|ref|XP_004161927.1| PREDICTED: serine/threonine-protein kinase-like protein At1g28390-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 283 bits (723), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 150/311 (48%), Positives = 206/311 (66%), Gaps = 27/311 (8%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
M E F+Y++L+ AT+ FS +RLIGKGSHG VYKAIL+D+ +++A+K+ +
Sbjct: 1 MIELFEYQQLLYATDGFSSTRLIGKGSHGWVYKAILDDN------RVVAVKKPLS----- 49
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
+ + K++NE RVL SL+ P+ VVNF GT+ + NKLLVMEFMPNG
Sbjct: 50 -ETHYSKVDNEARVLLSLR------PSPLVVNFLGTTFDSPS----YKNKLLVMEFMPNG 98
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180
SL DLL A P W R+ I QI+RA+ LH+ +P++IHRDIK+ NILFDS WD
Sbjct: 99 SLRDLLLQPVLAPVPTTSWHRRLHIITQIARAVCFLHQANPIVIHRDIKAENILFDSNWD 158
Query: 181 AKLADFGLAVSESDESSMV-----QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
KLADFGLAVS+ + +PAGTIGYLDP YT SKLS K DVFS+GVV+LE+I
Sbjct: 159 LKLADFGLAVSDEGDGKSTRIIGRKPAGTIGYLDPSYTTASKLSTKSDVFSFGVVVLEVI 218
Query: 236 SCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSE 295
S RK +D ++ PASI++WA PLI++ K + + D R+ LP + E +++++ +A RCV +E
Sbjct: 219 SGRKAMDISKSPASIVEWARPLIEQNKFQGIYDERMTLPKWAERRLRKVVELAGRCVCAE 278
Query: 296 EENRPGIGEIL 306
RP + EI+
Sbjct: 279 PGMRPSMAEIV 289
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739550|emb|CBI29732.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 277 bits (709), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 161/354 (45%), Positives = 218/354 (61%), Gaps = 65/354 (18%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
M + FDY+EL +AT+ FS + LIGKGSHG VYK L+D K++AIK+ S G ++
Sbjct: 1 MIKEFDYKELEEATQGFSPTHLIGKGSHGLVYKGALQDG------KLVAIKKPSP-GLQI 53
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
L+DN+K ++NEI +LSSL E NPN +++ GTS D NK+LVME MPNG
Sbjct: 54 LRDNTK-IDNEISMLSSLPE----NPN--IISLLGTSH------DSAMNKVLVMELMPNG 100
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180
SL+DLLH +TTP WP R+ +AMQI+RA+Q LHE P+++HRDI
Sbjct: 101 SLHDLLH---VSTTPPT-WPQRLGMAMQIARAVQFLHEEKPLVVHRDIN----------- 145
Query: 181 AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
QPAGTIGYLDP YT PSKLS K DVFS+GVVLLE+IS K
Sbjct: 146 -------------------QPAGTIGYLDPCYTTPSKLSTKNDVFSFGVVLLEVISTSKV 186
Query: 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300
ID +R I++WA+PLIK++++++VCDSR LP MEG I+ +L VAARCVSS E+ RP
Sbjct: 187 IDLSRTRTHIVEWAIPLIKKDRIKEVCDSRTELPMCMEGTIRHILRVAARCVSSREDLRP 246
Query: 301 GIGEILMGCSCFFVDHHHHHHHHHVERVRLIPLWIMSLWGSTKIRQKKGANNKF 354
+ +I++ H ++RVR +P+W L IR+ + + ++F
Sbjct: 247 SMQQIIIDID----------KHRSIDRVR-VPIWSSLLESVVLIRRGRRSASRF 289
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297812459|ref|XP_002874113.1| hypothetical protein ARALYDRAFT_489173 [Arabidopsis lyrata subsp. lyrata] gi|297319950|gb|EFH50372.1| hypothetical protein ARALYDRAFT_489173 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 266 bits (680), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 160/340 (47%), Positives = 209/340 (61%), Gaps = 40/340 (11%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDH-KILAIK-----RASTN 56
+ FDY++L T+ FS S+LIGKGSHG VYKA+L H D H +++AIK S +
Sbjct: 2 KEFDYDKLFTVTDRFSHSKLIGKGSHGYVYKALLHHHNHDDKHQRVVAIKAPSSLSLSLS 61
Query: 57 GFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEF 116
+ +KKL NEI V+SSL +P+ V++F G + KL+V+EF
Sbjct: 62 SSSSKSEQTKKLENEINVMSSL----PYHPH--VLSFLGHA----------EKKLMVVEF 105
Query: 117 MPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176
MPNGSL+ LLH +A P W R++IA+QI+ A+ LHE IIHRDIKS N+LFD
Sbjct: 106 MPNGSLHQLLHVSA---DPLPTWLKRIEIALQIASAVHFLHEQG--IIHRDIKSENVLFD 160
Query: 177 SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
S W+AKLADFGLAV + PAGTIGYLDP YT P LS K DV+SYGVVLLEI+S
Sbjct: 161 SNWEAKLADFGLAVDLGGGKTRPAPAGTIGYLDPCYTLPENLSMKTDVYSYGVVLLEIVS 220
Query: 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEE 296
CRK ID +R P+SI+DWA+PLIKE ++ ++C G G ++L +AARCVSS+
Sbjct: 221 CRKAIDVSRSPSSIVDWAVPLIKEGRIGEICGGGGGGSAVFRGMNLRLLRMAARCVSSDV 280
Query: 297 ENRPGIGEILMG-CSCFFVDHHHHHHHHHVERVRLIPLWI 335
E+RP GEI +C E ++ +PLWI
Sbjct: 281 ESRPCFGEITTEIVACL------------AEPLKSLPLWI 308
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|63146804|emb|CAI23733.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 255 bits (651), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 158/325 (48%), Positives = 206/325 (63%), Gaps = 40/325 (12%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGD--HKILAIKRASTNGFEV 60
+ FDY++LV A + FS S+LIGKGSHG VYKA+L HQ D + +++AIK S+
Sbjct: 2 KEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALLH-HQDDDETRRRVVAIKTPSSLSLSP 60
Query: 61 L------------QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNS 108
+ +KKL NEI V+SSL +P+ V++F G +
Sbjct: 61 SSPSSPSSSSSSKSEQTKKLENEINVMSSL----PYHPH--VLSFLGHA----------E 104
Query: 109 NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168
KL+++E+MPNGSL+ LLH +T P W R++IA+QI+ A+ LHE+ IIHRDI
Sbjct: 105 KKLMIVEYMPNGSLHQLLH---VSTDPLPTWLKRIEIALQIASAVHFLHEHG--IIHRDI 159
Query: 169 KSTNILFDSKWDAKLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSY 227
KS NILFDS W+AKLADFGLAV D+ PAGTIGYLDP YT P LS K DV+SY
Sbjct: 160 KSENILFDSNWEAKLADFGLAVDFGGDKKIRPAPAGTIGYLDPCYTLPENLSMKTDVYSY 219
Query: 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHV 287
GVVLLEI+SCRK ID +R PASI+DWA+PLIKE ++ ++C G G ++L +
Sbjct: 220 GVVLLEIVSCRKAIDVSRSPASIVDWAVPLIKEGRIGEICGGGGGGSGVFRGMSLRLLRM 279
Query: 288 AARCVSSEEENRPGIGEI---LMGC 309
AARCVSS+ E+RP GEI +M C
Sbjct: 280 AARCVSSDVESRPCFGEITAEIMAC 304
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|63146744|emb|CAI23749.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146747|emb|CAI23693.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146777|emb|CAI23713.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146780|emb|CAI23715.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146789|emb|CAI23723.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146801|emb|CAI23731.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 254 bits (650), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 157/325 (48%), Positives = 205/325 (63%), Gaps = 40/325 (12%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGD--HKILAIKRASTNGFEV 60
+ FDY++LV A + FS S+LIGKGSHG VYKA+L HQ D + +++AIK S+
Sbjct: 2 KEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALLH-HQDDDETRRRVVAIKTPSSLSLSP 60
Query: 61 L------------QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNS 108
+ +KKL NEI V+SSL +P+ V++F G +
Sbjct: 61 SSPSSPSSSSSSKSEQTKKLENEINVMSSL----PYHPH--VLSFLGHA----------E 104
Query: 109 NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168
KL+++E+MPNGSL+ LLH +T P W R++IA+QI+ A+ LHE +IHRDI
Sbjct: 105 KKLMIVEYMPNGSLHQLLH---VSTDPLPTWLKRIEIALQIASAVHFLHEQG--VIHRDI 159
Query: 169 KSTNILFDSKWDAKLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSY 227
KS NILFDS W+AKLADFGLAV D+ PAGTIGYLDP YT P LS K DV+SY
Sbjct: 160 KSENILFDSNWEAKLADFGLAVEFGGDKKIRPAPAGTIGYLDPCYTLPENLSMKTDVYSY 219
Query: 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHV 287
GVVLLEI+SCRK ID +R PASI+DWA+PLIKE ++ ++C G G ++L +
Sbjct: 220 GVVLLEIVSCRKAIDVSRSPASIVDWAVPLIKEGRIGEICGGGGGGSGVFRGMSLRLLRM 279
Query: 288 AARCVSSEEENRPGIGEI---LMGC 309
AARCVSS+ E+RP GEI +M C
Sbjct: 280 AARCVSSDVESRPCFGEITAEIMAC 304
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15237244|ref|NP_197708.1| serine/threonine-protein kinase-like protein [Arabidopsis thaliana] gi|75334091|sp|Q9FMY3.1|STPKL_ARATH RecName: Full=Serine/threonine-protein kinase-like protein At5g23170 gi|10177806|dbj|BAB11172.1| serine/threonine protein kinase-like protein [Arabidopsis thaliana] gi|26449406|dbj|BAC41830.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|28950913|gb|AAO63380.1| At5g23170 [Arabidopsis thaliana] gi|63146738|emb|CAI23689.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146741|emb|CAI23691.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146762|emb|CAI23703.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146783|emb|CAI23717.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146807|emb|CAI23735.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146810|emb|CAI23737.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146816|emb|CAI23739.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|63146825|emb|CAI23745.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332005746|gb|AED93129.1| serine/threonine-protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 254 bits (650), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 157/314 (50%), Positives = 201/314 (64%), Gaps = 34/314 (10%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGD---HKILAIKRASTNGFE 59
+ FDY++LV A + FS S+LIGKGSHG VYKA+L H D D +++AIK S+
Sbjct: 2 KEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALL--HHQDVDETRQRVVAIKTPSSLSPS 59
Query: 60 VLQ-------DNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLL 112
+ +KKL NEI V+SSL +P+ V++F G + KL+
Sbjct: 60 SPSSSSSSKSEQTKKLENEIDVMSSL----PYHPH--VLSFLGHA----------EKKLM 103
Query: 113 VMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172
V+E+MPN SLY LLH +T P W R++IA+QI+ A+ LHE+ IIHRDIKS N
Sbjct: 104 VVEYMPNESLYQLLH---VSTDPLPTWLKRIEIALQIASAVHFLHEHG--IIHRDIKSEN 158
Query: 173 ILFDSKWDAKLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
ILFDS W+AKLADFGLAV D+ PAGTIGYLDP YT P LS K DV+SYGVVL
Sbjct: 159 ILFDSNWEAKLADFGLAVDFGGDKKIRPAPAGTIGYLDPCYTLPENLSMKTDVYSYGVVL 218
Query: 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARC 291
LEI+SCRK ID +R PASI+DWA+PLIKE ++ ++C G G ++L +AARC
Sbjct: 219 LEIVSCRKAIDVSRSPASIVDWAVPLIKEGRIGEICGGGGGGSGVFRGMSLRLLRMAARC 278
Query: 292 VSSEEENRPGIGEI 305
VSS+ E+RP GEI
Sbjct: 279 VSSDVESRPCFGEI 292
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 379 | ||||||
| TAIR|locus:2166761 | 341 | AT5G23170 [Arabidopsis thalian | 0.836 | 0.929 | 0.443 | 1.1e-64 | |
| TAIR|locus:2083815 | 362 | AT3G51990 [Arabidopsis thalian | 0.630 | 0.660 | 0.424 | 1.6e-47 | |
| TAIR|locus:2183835 | 433 | AT5G11020 [Arabidopsis thalian | 0.601 | 0.526 | 0.365 | 2.5e-43 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.530 | 0.556 | 0.427 | 4.1e-43 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.511 | 0.284 | 0.406 | 5.1e-42 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.514 | 0.255 | 0.394 | 9.7e-42 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.519 | 0.278 | 0.382 | 2.4e-41 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.527 | 0.423 | 0.360 | 2.2e-40 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.538 | 0.51 | 0.378 | 4.6e-40 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.519 | 0.450 | 0.372 | 5.8e-40 |
| TAIR|locus:2166761 AT5G23170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
Identities = 156/352 (44%), Positives = 212/352 (60%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDH-KILAIKRASTNGFEVL 61
+ FDY++LV A + FS S+LIGKGSHG VYKA+L D +++AIK S+
Sbjct: 2 KEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALLHHQDVDETRQRVVAIKTPSSLSPSSP 61
Query: 62 QDNSKKLNNEIRVLSS---LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMP 118
+S + + + L + + S +P+ V++F G + KL+V+E+MP
Sbjct: 62 SSSSSSKSEQTKKLENEIDVMSSLPYHPH--VLSFLGHA----------EKKLMVVEYMP 109
Query: 119 NGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
N SLY LLH +T P W R++IA+QI+ A+ LHE+ IIHRDIKS NILFDS
Sbjct: 110 NESLYQLLH---VSTDPLPTWLKRIEIALQIASAVHFLHEHG--IIHRDIKSENILFDSN 164
Query: 179 WDAKLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237
W+AKLADFGLAV D+ PAGTIGYLDP YT P LS K DV+SYGVVLLEI+SC
Sbjct: 165 WEAKLADFGLAVDFGGDKKIRPAPAGTIGYLDPCYTLPENLSMKTDVYSYGVVLLEIVSC 224
Query: 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
RK ID +R PASI+DWA+PLIKE ++ ++C G G ++L +AARCVSS+ E
Sbjct: 225 RKAIDVSRSPASIVDWAVPLIKEGRIGEICGGGGGGSGVFRGMSLRLLRMAARCVSSDVE 284
Query: 298 NRPGIGEILMGC-SCFFVDXXXXXXXXXVERVRLIPLWIMSLWGSTKIRQKK 348
+RP GEI +C E ++ +PLW+ L K++++K
Sbjct: 285 SRPCFGEITAEIVACL------------AEPLKSLPLWMSVLRRVVKLKRRK 324
|
|
| TAIR|locus:2083815 AT3G51990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 1.6e-47, P = 1.6e-47
Identities = 112/264 (42%), Positives = 164/264 (62%)
Query: 48 LAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGN 107
+A+KR S + ++ S++ +NE +LS + R+P + VN G S NS
Sbjct: 83 IAVKRPSKS-----REISREFHNEFEILSRI-----RSPRF--VNLLGFSADNS------ 124
Query: 108 SNKLLVMEFMPNGSLYDLLHNAAAATTPQLG-WPNRVKIAMQISRAIQCLHENDPMIIHR 166
LLV+EFM NGSLYD++H+ + + W R+KIA+QI++A+ LH + IIHR
Sbjct: 125 KEPLLVVEFMGNGSLYDVIHSDTVLNSGAISSWSKRIKIALQIAKAVHLLHSQETPIIHR 184
Query: 167 DIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ---PAGTIGYLDPGYTNPSKLSKKVD 223
DIKS N+L D +AKL DFGLA+ + + V+ PAGT+GYLDP Y +LS K D
Sbjct: 185 DIKSANVLMDKNLNAKLGDFGLAIRCNVDDQKVKSTPPAGTMGYLDPDYVTADRLSTKTD 244
Query: 224 VFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQ 283
VFS+G++LLEIIS RK ID P+ I+DWA+P+IK K+ + D R+G P ++ +++
Sbjct: 245 VFSFGILLLEIISGRKAIDVRYSPSFIVDWAIPMIKRGKIGGIYDPRIGPP--IDVSVRN 302
Query: 284 MLH-VAARCVSSEEENRPGIGEIL 306
L VAA+CV + E RPG+ E++
Sbjct: 303 HLGLVAAKCVRTCREKRPGMEEVV 326
|
|
| TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 2.5e-43, Sum P(2) = 2.5e-43
Identities = 91/249 (36%), Positives = 149/249 (59%)
Query: 62 QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGS 121
+D +K+ +E+ +LS LQ +PN +++ G S ++ + +V E MPN S
Sbjct: 176 EDAAKEFKSEVEILSKLQ-----HPN--IISLLGYSTNDTA-------RFIVYELMPNVS 221
Query: 122 LYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWD 180
L LH ++ + + WP R+KIA+ ++R ++ LHE+ P IIHRD+KS+NIL DS ++
Sbjct: 222 LESHLHGSSQGSA--ITWPMRMKIALDVTRGLEYLHEHCHPAIIHRDLKSSNILLDSNFN 279
Query: 181 AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
AK++DFGLAV + ++ + +GT+GY+ P Y +L++K DV+++GVVLLE++ +KP
Sbjct: 280 AKISDFGLAVVDGPKNKNHKLSGTVGYVAPEYLLNGQLTEKSDVYAFGVVLLELLLGKKP 339
Query: 241 ID--AARDPASIIDWALPLIKEE-KLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
++ A + SII WA+P + + KL V D + T + Q+ VA CV E
Sbjct: 340 VEKLAPGECQSIITWAMPYLTDRTKLPSVIDPAIK-DTMDLKHLYQVAAVAILCVQPEPS 398
Query: 298 NRPGIGEIL 306
RP I ++L
Sbjct: 399 YRPLITDVL 407
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 392 (143.0 bits), Expect = 4.1e-43, Sum P(2) = 4.1e-43
Identities = 92/215 (42%), Positives = 132/215 (61%)
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNA----AAATTPQLGWPNRVKIAMQISRAIQCLHE 158
SVDGNS ++LV EF NGSL+D+LH A P L W RVKIA+ +R ++ LHE
Sbjct: 131 SVDGNS-RILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGAARGLEYLHE 189
Query: 159 N-DPMIIHRDIKSTNIL-FDSKWDAKLADFGLAVSESDESSMVQPA---GTIGYLDPGYT 213
+P +IHRDIKS+N+L FD+ AK+ADF L+ D ++ + GT GY P Y
Sbjct: 190 KANPHVIHRDIKSSNVLIFDNDV-AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
Query: 214 NPSKLSKKVDVFSYGVVLLEIISCRKPIDAA--RDPASIIDWALPLIKEEKLRQVCDSRV 271
+LS K DV+S+GVVLLE+++ RKP+D R S++ WA P + E+K++Q DSR+
Sbjct: 249 MTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDSRL 308
Query: 272 GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
G + A+ ++ VAA CV E + RP + ++
Sbjct: 309 G-GDYPPKAVAKLAAVAALCVQYEADFRPNMSIVV 342
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 376 (137.4 bits), Expect = 5.1e-42, Sum P(2) = 5.1e-42
Identities = 85/209 (40%), Positives = 129/209 (61%)
Query: 109 NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRD 167
++LLV +++PN +L+ LH A P + W RV++A +R I LHE+ P IIHRD
Sbjct: 407 HRLLVYDYVPNNTLHYHLH---APGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRD 463
Query: 168 IKSTNILFDSKWDAKLADFGLA--VSESDESSMVQPA--GTIGYLDPGYTNPSKLSKKVD 223
IKS+NIL D+ ++A +ADFGLA E D ++ V GT GY+ P Y KLS+K D
Sbjct: 464 IKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKAD 523
Query: 224 VFSYGVVLLEIISCRKPIDAARD--PASIIDWALPL----IKEEKLRQVCDSRVGLPTFM 277
V+SYGV+LLE+I+ RKP+D ++ S+++WA PL I+ E+ ++ D R+G F+
Sbjct: 524 VYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLG-KNFI 582
Query: 278 EGAIKQMLHVAARCVSSEEENRPGIGEIL 306
G + +M+ AA CV RP + +++
Sbjct: 583 PGEMFRMVEAAAACVRHSAAKRPKMSQVV 611
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 365 (133.5 bits), Expect = 9.7e-42, Sum P(2) = 9.7e-42
Identities = 82/208 (39%), Positives = 129/208 (62%)
Query: 108 SNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHR 166
+ +LL+ +++PN +LY LH AA TP L W RVKIA +R + LHE+ P IIHR
Sbjct: 497 NRRLLIYDYVPNNNLYFHLH---AAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 553
Query: 167 DIKSTNILFDSKWDAKLADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSKKVDV 224
DIKS+NIL ++ + A ++DFGLA D ++ + + GT GY+ P Y + KL++K DV
Sbjct: 554 DIKSSNILLENNFHALVSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDV 613
Query: 225 FSYGVVLLEIISCRKPIDAARD--PASIIDWALPLIKE----EKLRQVCDSRVGLPTFME 278
FS+GVVLLE+I+ RKP+DA++ S+++WA PL+ E+ + D ++G ++
Sbjct: 614 FSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGR-NYVG 672
Query: 279 GAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ +M+ AA C+ RP + +I+
Sbjct: 673 VEMFRMIEAAAACIRHSATKRPRMSQIV 700
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 354 (129.7 bits), Expect = 2.4e-41, Sum P(2) = 2.4e-41
Identities = 81/212 (38%), Positives = 127/212 (59%)
Query: 104 VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPM 162
+ G+ +LL+ +++ N LY LH + L W RVKIA +R + LHE+ P
Sbjct: 441 ISGD-RRLLIYDYVSNNDLYFHLHGEKSV----LDWATRVKIAAGAARGLAYLHEDCHPR 495
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSK 220
IIHRDIKS+NIL + +DA+++DFGLA D ++ + + GT GY+ P Y + KL++
Sbjct: 496 IIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTE 555
Query: 221 KVDVFSYGVVLLEIISCRKPIDAARD--PASIIDWALPLIKE----EKLRQVCDSRVGLP 274
K DVFS+GVVLLE+I+ RKP+D ++ S+++WA PLI E+ + D ++G
Sbjct: 556 KSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLG-G 614
Query: 275 TFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
++E + +M+ A CV RP +G+I+
Sbjct: 615 NYVESEMFRMIEAAGACVRHLATKRPRMGQIV 646
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 364 (133.2 bits), Expect = 2.2e-40, Sum P(2) = 2.2e-40
Identities = 75/208 (36%), Positives = 128/208 (61%)
Query: 104 VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPM 162
V+G + ++LV +F+ NG+L +H +P L W R+ I + +++ + LHE +P
Sbjct: 218 VEG-AYRMLVYDFVDNGNLEQWIHGDVGDVSP-LTWDIRMNIILGMAKGLAYLHEGLEPK 275
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSK 220
++HRDIKS+NIL D +W+AK++DFGLA ESS V + GT GY+ P Y L++
Sbjct: 276 VVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNE 335
Query: 221 KVDVFSYGVVLLEIISCRKPIDAARDPA--SIIDWALPLIKEEKLRQVCDSRVGLPTFME 278
K D++S+G++++EII+ R P+D +R +++DW ++ + +V D ++ P +
Sbjct: 336 KSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSK 395
Query: 279 GAIKQMLHVAARCVSSEEENRPGIGEIL 306
A+K++L VA RCV + RP +G I+
Sbjct: 396 -ALKRVLLVALRCVDPDANKRPKMGHII 422
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 362 (132.5 bits), Expect = 4.6e-40, Sum P(2) = 4.6e-40
Identities = 81/214 (37%), Positives = 127/214 (59%)
Query: 102 GSVDGNSNKLLVMEFMPNGSLYDLLH--NAAAATTPQLGWPNRVKIAMQISRAIQCLHEN 159
G NS+KLLV EFM NG L + L+ N + + P+L W R++IA++ ++ ++ LHE
Sbjct: 148 GYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWETRMRIAVEAAKGLEYLHEQ 207
Query: 160 -DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNP 215
P +IHRD KS+NIL D ++AK++DFGLA SD++ + GT GY+ P Y
Sbjct: 208 VSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSDKAGGHVSTRVLGTQGYVAPEYALT 267
Query: 216 SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS--IIDWALP-LIKEEKLRQVCDSRVG 272
L+ K DV+SYGVVLLE+++ R P+D R ++ WALP L +K+ + D +
Sbjct: 268 GHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLVSWALPQLADRDKVVDIMDPTLE 327
Query: 273 LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ + Q+ +AA CV +E + RP + +++
Sbjct: 328 -GQYSTKEVVQVAAIAAMCVQAEADYRPLMADVV 360
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 5.8e-40, Sum P(2) = 5.8e-40
Identities = 76/204 (37%), Positives = 124/204 (60%)
Query: 108 SNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHR 166
S ++LV E++ NG+L LH +P L W R+KIA+ ++ + LHE +P ++HR
Sbjct: 214 SQRMLVYEYIDNGNLEQWLHGDVGPVSP-LTWDIRMKIAIGTAKGLAYLHEGLEPKVVHR 272
Query: 167 DIKSTNILFDSKWDAKLADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSKKVDV 224
D+KS+NIL D KW+AK++DFGLA E+S V + GT GY+ P Y + L++ DV
Sbjct: 273 DVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDV 332
Query: 225 FSYGVVLLEIISCRKPIDAARDPA--SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIK 282
+S+GV+L+EII+ R P+D +R P +++DW ++ + +V D ++ A+K
Sbjct: 333 YSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSP-PPRALK 391
Query: 283 QMLHVAARCVSSEEENRPGIGEIL 306
+ L V RC+ + RP +G+I+
Sbjct: 392 RALLVCLRCIDLDSSKRPKMGQII 415
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 379 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G G+VY A D +T K +AIK E ++L EI +L L
Sbjct: 1 LGEGGFGTVYLA--RDKKTG---KKVAIKIIK---KEDSSSLLEELLREIEILKKLN--- 49
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+PN +V +G + ++ LVME+ GSL DLL +L
Sbjct: 50 --HPN--IVKLYG-------VFEDENHLYLVMEYCEGGSLKDLLKE----NEGKLSEDEI 94
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD-AKLADFGLAVSESDESSMVQP 201
++I +QI ++ LH N IIHRD+K NIL DS KLADFGL+ + + S+++
Sbjct: 95 LRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152
Query: 202 -AGTIGYLDP-GYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
GT Y+ P S+K D++S GV+L E+ +
Sbjct: 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 4e-36
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 53/292 (18%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G+GS G VY A D +T K++AIK + ++ + +++ EI++L L
Sbjct: 5 EKLGEGSFGKVYLAR--DKKT---GKLVAIKVIK---KKKIKKDRERILREIKILKKL-- 54
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
++PN +V + + + LVME+ G L+DLL + +
Sbjct: 55 ---KHPN--IVRLYD-VFEDEDKL------YLVMEYCEGGDLFDLLKKRGRLSEDEAR-- 100
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
QI A++ LH I+HRD+K NIL D KLADFGLA +
Sbjct: 101 ---FYLRQILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT 155
Query: 201 PAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
GT Y+ P GY K VD++S GV+L E+++ + P +
Sbjct: 156 FVGTPEYMAPEVLLGKGY------GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK-- 207
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I + K P + I+++L + E R E L
Sbjct: 208 --KIGKPKPPFPPPEWDISPEAKD-LIRKLLVK-------DPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 92/304 (30%), Positives = 124/304 (40%), Gaps = 63/304 (20%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL---NNEIR 73
+ R +G GS G+VYKA H+ G KI+A+K + + SKK EIR
Sbjct: 1 YELLRKLGSGSFGTVYKAK---HKGTG--KIVAVKI-----LKKRSEKSKKDQTARREIR 50
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
+L L N +V + LVME+ G L+D L
Sbjct: 51 ILRRLSHPN-------IVRLIDAFEDKD-------HLYLVMEYCEGGDLFDYLSRG---- 92
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSE 192
L KIA+QI R ++ LH N IIHRD+K NIL D K+ADFGLA
Sbjct: 93 -GPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLL 149
Query: 193 SDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
SS+ GT Y+ P GY KVDV+S GV+L E+++ + P
Sbjct: 150 KSSSSLTTFVGTPWYMAPEVLLGGNGYG------PKVDVWSLGVILYELLTGKPPF---- 199
Query: 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGA---IKQMLHVAARCVSSEEENRPGI 302
I L LI+ + + E A IK+ L+ + RP
Sbjct: 200 -SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNK-------DPSKRPTA 251
Query: 303 GEIL 306
EIL
Sbjct: 252 EEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+++ L+G+GS GSVY A+ +D G +++A+K + ++ + L EIR+L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKD---TG--ELMAVKSVELS--GDSEEELEALEREIRIL 53
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
SSLQ +PN +V ++G+ + + +E++ GSL LL P
Sbjct: 54 SSLQ-----HPN--IVRYYGSERDEE-----KNTLNIFLEYVSGGSLSSLLKKFGKLPEP 101
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD- 194
+ K QI + LH N I+HRDIK NIL DS KLADFG A D
Sbjct: 102 VIR-----KYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154
Query: 195 --ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT ++ P + + D++S G ++E+ + + P
Sbjct: 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKIL-AIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +G+G+ G VYK L+ G K+ A+K + E ++ E R++ L
Sbjct: 4 GKKLGEGAFGEVYKGKLK--GKGGKKKVEVAVKTLKEDASEQQI---EEFLREARIMRKL 58
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+PN VV G C + +VME+M G L L P+L
Sbjct: 59 D-----HPN--VVKLLG-VCTEEEPL------YIVMEYMEGGDLLSYLRK----NRPKLS 100
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+ + A+QI+R ++ L + IHRD+ + N L K++DFGL+ D+
Sbjct: 101 LSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 158
Query: 199 VQPAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240
+ G I ++ P K + K DV+S+GV+L EI + +P
Sbjct: 159 RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+GS G VYK H+ G KI A+K+ +G E + K+L E++ L S +
Sbjct: 9 LGQGSSGVVYKVR---HKPTG--KIYALKKIHVDGDE---EFRKQLLRELKTLRSCE--- 57
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+P VV +G + G + +V+E+M GSL DLL P L
Sbjct: 58 --SPY--VVKCYGAFYKE-GEIS------IVLEYMDGGSLADLLKKVGKIPEPVLA---- 102
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPA 202
IA QI + + LH IIHRDIK +N+L +SK + K+ADFG +S+ E+++ Q
Sbjct: 103 -YIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFG--ISKVLENTLDQCN 158
Query: 203 ---GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259
GT+ Y+ P S D++S G+ LLE + P P +
Sbjct: 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFF----- 209
Query: 260 EEKLRQVCDSRVGLPTFMEGAIKQML-HVAARCVSSEEENRPGIGEIL 306
E ++ +CD P+ + C+ + + RP E+L
Sbjct: 210 -ELMQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +G+G+ G VYK L +G +A+K + + ++ ++ E ++ L
Sbjct: 5 KKLGEGAFGEVYKGTL-KGDGEGTETKVAVKTLKEGAS-----EEEREEFLEEASIMKKL 58
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+PN +V G C + +V E+MP G L D L +L
Sbjct: 59 S-----HPN--IVRLLGV-CTQGEPL------YIVTEYMPGGDLLDFLRK----HGEKLT 100
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDES 196
+ +++A+QI++ ++ L + +HRD+ + N L K++DFGL+ + E D
Sbjct: 101 LKDLLQMALQIAKGMEYLESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY 158
Query: 197 SMVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIIS-CRKP 240
G L + P K + K DV+S+GV+L EI + +P
Sbjct: 159 RK----RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKIL-AIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79
+ +G+G+ G VYK L+ ++ A+K + E ++ E R++ L
Sbjct: 5 KKLGEGAFGEVYKGTLK--GKGDGKEVEVAVKTLKEDASE---QQIEEFLREARIMRKLD 59
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+PN +V G C + ++VME+MP G L D L L
Sbjct: 60 -----HPN--IVKLLG-VCTEEEPL------MIVMEYMPGGDLLDYLRKNRPKE---LSL 102
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
+ + A+QI+R ++ L + IHRD+ + N L K++DFGL+ D+
Sbjct: 103 SDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160
Query: 200 QPAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240
G I ++ P K + K DV+S+GV+L EI + +P
Sbjct: 161 VKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 66/300 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IGKGS G VY ++DG K+ +K + + + NE+++L L
Sbjct: 6 KQIGKGSFGKVYLVR---RKSDG--KLYVLKEIDLSNMS--EKEREDALNEVKILKKL-- 56
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP----Q 136
+PN ++ ++ S + +VME+ G L + P Q
Sbjct: 57 ---NHPN--IIKYYE-------SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ 104
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESD 194
+ + +Q+ A++ LH I+HRDIK NI S KL DFG++ +S +
Sbjct: 105 I-----LDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157
Query: 195 E--SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
+ ++V GT YL P Y + K D++S G VL E+ + + P + +
Sbjct: 158 DLAKTVV---GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFE-GEN 207
Query: 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ I + + + + + + +L + E RP I +IL
Sbjct: 208 LLELAL----KILKGQYPPI---PSQYSSELRNLVSSLL-------QKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-26
Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
F IGKG G VYKA K +AIK ++ +K+ NEI++L
Sbjct: 2 FEILEKIGKGGFGEVYKAR-----HKRTGKEVAIKVIKLES----KEKKEKIINEIQILK 52
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT-P 135
++PN +V ++G S +VMEF GSL DLL + T
Sbjct: 53 KC-----KHPN--IVKYYG-------SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES 98
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
Q+ + ++ + ++ LH N IIHRDIK+ NIL S + KL DFGL+ SD
Sbjct: 99 QIA-----YVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233
+ GT ++ P N K D++S G+ +E
Sbjct: 152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN--NEIRV 74
F + +GKGS+GSVYK + D++ A+K ++ + NEIR+
Sbjct: 2 FKVLKKLGKGSYGSVYKV-----KRLSDNQFYALKEVDLG----SMSQKEREDAVNEIRI 52
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
L+S VN +DGN KL +VME+ P G L +
Sbjct: 53 LAS-------------VNHPNIISYKEAFLDGN--KLCIVMEYAPFGDLSKAISKRKKKR 97
Query: 134 TP---QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
Q W +I +Q+ R +Q LHE I+HRD+KS NIL + K+ D G++
Sbjct: 98 KLIPEQEIW----RIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISK 151
Query: 191 SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ Q GT Y+ P S K D++S G +L E+ + P +A
Sbjct: 152 VLKKNMAKTQ-IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
LIG+G+ G VYK + + GD +AIK+ S ++ K + EI +L +L+
Sbjct: 7 LIGRGAFGVVYKGL---NLETGD--FVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHP 59
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP- 140
N +V + G S S S+ +++E+ NGSL ++ +P
Sbjct: 60 N-------IVKYIG-SIETSDSL------YIILEYAENGSLRQIIKKFG-------PFPE 98
Query: 141 NRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
+ V + + Q+ + + LHE +IHRDIK+ NIL KLADFG+A +D S
Sbjct: 99 SLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156
Query: 200 -QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT ++ P S S D++S G ++E+++ P
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 28/223 (12%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ +G+G+ G VYK L+ DG +A+K + E + K E RV+ L
Sbjct: 1 KKLGEGAFGEVYKGKLKG--KDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKL-- 53
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN----AAAATTPQ 136
+PN VV G C + LV+E+M G L D L +
Sbjct: 54 ---GHPN--VVRLLGV-CTEEEPL------YLVLEYMEGGDLLDYLRKSRPVFPSPEKST 101
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
L + + A+QI++ ++ L +HRD+ + N L K++DFGL+ D+
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159
Query: 197 SMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ G I ++ P + K DV+S+GV+L EI +
Sbjct: 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G+ G VYKA + G K +AIK+ + + N + + NEI ++
Sbjct: 27 IGEGASGEVYKAT---DRATG--KEVAIKK-----MRLRKQNKELIINEILIMKDC---- 72
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL-HNAAAATTPQLGWPN 141
++PN +V+++ S +VME+M GSL D++ N PQ+ +
Sbjct: 73 -KHPN--IVDYYD-------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-- 120
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE----SS 197
+ ++ + ++ LH + +IHRDIKS NIL KLADFG A + E +S
Sbjct: 121 ---VCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175
Query: 198 MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
+V GT ++ P KVD++S G++ +E+
Sbjct: 176 VV---GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.5 bits (241), Expect = 2e-22
Identities = 79/302 (26%), Positives = 117/302 (38%), Gaps = 40/302 (13%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
S+ R +G+GS G VY A D K++A+K + E ++ EI++L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--------DRKLVALKVLAKK-LESKSKEVERFLREIQIL 51
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
+SL Y + LVME++ GSL DLL
Sbjct: 52 ASLNHPPNIVKLYDFFQD-------------EGSLYLVMEYVDGGSLEDLLKKIG--RKG 96
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLAVSESD 194
L + I QI A++ LH IIHRDIK NIL D KL DFGLA D
Sbjct: 97 PLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154
Query: 195 ESSMVQPA-------GTIGYLDP---GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
S GT GY+ P + + S D++S G+ L E+++ P +
Sbjct: 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-G 213
Query: 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304
+S L +I E + P+ E K + + ++ + +NR
Sbjct: 214 EKNSSATSQTLKIILELPTPSLASPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
Query: 305 IL 306
L
Sbjct: 272 DL 273
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 42/232 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F +G+GS+GSVYKAI H+ G +++AIK + +++ EI +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAI---HKETG--QVVAIKVVPVEE------DLQEIIKEISI 51
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L +P +V ++G S N++ +VME+ GS+ D++ T
Sbjct: 52 LK-----QCDSPY--IVKYYG-------SYFKNTDLWIVMEYCGAGSVSDIMK----ITN 93
Query: 135 PQLGWPNRVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
L +IA Q + ++ LH N IHRDIK+ NIL + + AKLADFG VS
Sbjct: 94 KTL---TEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFG--VS 146
Query: 192 ESDESSMVQPAGTIG---YLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+M + IG ++ P + K D++S G+ +E+ + P
Sbjct: 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-22
Identities = 71/247 (28%), Positives = 108/247 (43%), Gaps = 39/247 (15%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
D+E L K IGKGS G V+K + + D ++ A+K+ + +
Sbjct: 1 DFEILNK----------IGKGSFGVVFKVVRKA-----DKRVYAMKQIDLSKMNRREREE 45
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
+E RVL+ L + +Y + + S G N +VME+ NG L+ L
Sbjct: 46 AI--DEARVLAKL------DSSYIIRYY------ESFLDKGKLN--IVMEYAENGDLHKL 89
Query: 126 LHNAAAATTPQLG-WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
L P+ W + +QI + LH I+HRDIKS N+ D+ + K+
Sbjct: 90 LKMQRGRPLPEDQVW----RFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIG 143
Query: 185 DFGLAVSESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
D G+A SD ++ GT YL P ++K DV++ GVVL E + + P DA
Sbjct: 144 DLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
Query: 244 ARDPASI 250
A I
Sbjct: 204 NNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79
+ +G+G G V D D + +A+K + +G E + EI +L +L
Sbjct: 9 IKQLGEGHFGKVELCRY-DPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLD 64
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
N +V + G G + L+ME++P+GSL D L Q+
Sbjct: 65 HEN-------IVKYKGVC-----EKPGGRSLRLIMEYLPSGSLRDYLQR----HRDQINL 108
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESS 197
+ + QI + + L IHRD+ + NIL +S+ K++DFGLA + E +
Sbjct: 109 KRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
Query: 198 MVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239
V+ G I + P SK S DV+S+GV L E+ +
Sbjct: 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 71/234 (30%), Positives = 113/234 (48%), Gaps = 35/234 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI-RVLSSLQES 81
+G G+ G V K + H+ G KI+A+K + + ++ + +I R L L +
Sbjct: 9 LGAGNSGVVSKVL---HRPTG--KIMAVKT-------IRLEINEAIQKQILRELDILHKC 56
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-TPQLGWP 140
N +P +V F+G + N+G + + ME+M GSL +L LG
Sbjct: 57 N--SPY--IVGFYG-AFYNNGDI------SICMEYMDGGSLDKILKEVQGRIPERILG-- 103
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
KIA+ + + + LHE IIHRD+K +NIL +S+ KL DFG VS +S+ +
Sbjct: 104 ---KIAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFG--VSGQLVNSLAK 157
Query: 201 P-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA-SIID 252
GT Y+ P + S K D++S G+ L+E+ + R P DP I +
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-21
Identities = 69/250 (27%), Positives = 103/250 (41%), Gaps = 47/250 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIRVLSSLQES 81
+GKGS G V +D K+ A+K ++++ + E +LS +
Sbjct: 1 LGKGSFGKVLLVRKKD-----TGKLYAMK--VLKKKKIIKRKEVEHTLTERNILSRI--- 50
Query: 82 NKRNPNYCVVN----FHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
+P +V F KL LV+E+ P G L+ L +
Sbjct: 51 --NHPF--IVKLHYAFQ------------TEEKLYLVLEYAPGGELFSHLSKEGRFSEE- 93
Query: 137 LGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESD 194
R + A +I A++ LH II+RD+K NIL D+ KL DFGLA S+
Sbjct: 94 -----RARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
S GT YL P K VD +S GV+L E+++ + P A D I +
Sbjct: 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY-AEDRKEIYE-- 203
Query: 255 LPLIKEEKLR 264
I ++ LR
Sbjct: 204 --KILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 47/227 (20%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKR-ASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
IG+G+HG V+KA D +T + +A+K+ A + + + + EI+ L + Q
Sbjct: 8 IGEGAHGIVFKAK--DRETG---ETVALKKVALRRLEGGIPNQALR---EIKALQACQ-- 57
Query: 82 NKRNPNYCVVNF-----HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
+P VV HG+ +LVME+MP L ++L +
Sbjct: 58 ---HPY--VVKLLDVFPHGSGF------------VLVMEYMP-SDLSEVLRDEERPLPEA 99
Query: 137 LGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV--SES 193
VK + + + +H N I+HRD+K N+L + K+ADFGLA SE
Sbjct: 100 Q-----VKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152
Query: 194 DESSMVQPAGTIGYLDPG--YTNPSKLSKKVDVFSYGVVLLEIISCR 238
+ T Y P Y K VD+++ G + E+++
Sbjct: 153 EPRLYSHQVATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 52/238 (21%)
Query: 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-LQDNS----KKLNNEIR 73
+ IG G+ G VY A+ D +++A+K E+ +QDN K++ +E++
Sbjct: 4 RGNKIGGGTFGKVYTAVNLD-----TGELMAVK-------EIRIQDNDPKTIKEIADEMK 51
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLV-MEFMPNGSLYDLLHNAAAA 132
VL L ++PN +V ++G V+ + K+ + ME+ G+L +LL +
Sbjct: 52 VLELL-----KHPN--LVKYYG--------VEVHREKVYIFMEYCSGGTLEELLEHGRIL 96
Query: 133 TTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
V +Q+ + LH + I+HRDIK NI D KL DFG AV
Sbjct: 97 -------DEHVIRVYTLQLLEGLAYLHSH--GIVHRDIKPANIFLDHNGVIKLGDFGCAV 147
Query: 191 SESDESSMVQP-----AGTIGYLDPGYTNPSKLSKK---VDVFSYGVVLLEIISCRKP 240
+ ++ + AGT Y+ P K D++S G V+LE+ + ++P
Sbjct: 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 39/274 (14%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-KKLNNEIRVL 75
F R+IGKG+ G V D + K+ A+K N + ++ S + + NE R+L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTK-----KMFAMK--YMNKQKCVEKGSVRNVLNERRIL 54
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL-YDLLHNAAAATT 134
L +P +VN + N LV++ + G L Y L +
Sbjct: 55 QEL-----NHP--FLVNLWYSFQ-------DEENMYLVVDLLLGGDLRYHLSQKVKFSEE 100
Query: 135 PQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
+VK + +I A++ LH IIHRDIK NIL D + + DF +A +
Sbjct: 101 -------QVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151
Query: 194 DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253
++ +GT GY+ P S VD +S GV E + ++P +I D
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS--RTIRDQ 209
Query: 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHV 287
I+ ++ T AI ++L
Sbjct: 210 ----IRAKQETADVLYPATWSTEAIDAINKLLER 239
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 81/316 (25%), Positives = 127/316 (40%), Gaps = 71/316 (22%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
DYE L IGKGS G+V K ++DG KIL K + + +
Sbjct: 1 DYEVLET----------IGKGSFGTVRKVR---RKSDG--KILVWKEID---YGNMTEKE 42
Query: 66 KK-LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLY 123
K+ L +E+ +L L+ N +V ++ +D ++ L +VME+ G L
Sbjct: 43 KQQLVSEVNILRELKHPN-------IVRYYDRI------IDRSNQTLYIVMEYCEGGDLA 89
Query: 124 DLLHNAAAATTP---QLGWPNRVKIAMQISRAIQCLH---ENDPMIIHRDIKSTNILFDS 177
L+ + W +I Q+ A+ H + ++HRD+K NI D+
Sbjct: 90 QLIQKCKKERKYIEEEFIW----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA 145
Query: 178 KWDAKLADFGLAVSESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ KL DFGLA +SS + GT Y+ P N +K D++S G ++ E+ +
Sbjct: 146 NNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205
Query: 237 CRKPIDAAR--DPASIIDWA----LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAAR 290
P A AS I +P +L +V IK ML+V
Sbjct: 206 LSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEV--------------IKSMLNVDP- 250
Query: 291 CVSSEEENRPGIGEIL 306
+ RP E+L
Sbjct: 251 ------DKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRAS-TNGFEVLQDNSKKLNNEIRVLSSLQ 79
L+G GS GSVY+ + D DGD A+K S + + Q+ K+L EI +LS LQ
Sbjct: 6 ELLGSGSFGSVYEGLNLD---DGD--FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
N +V + GT R ++ + +E +P GSL LL + P +
Sbjct: 61 HPN-------IVQYLGTE-REEDNLY------IFLELVPGGSLAKLLKKYGSFPEPVIRL 106
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
R QI ++ LH+ + +HRDIK NIL D+ KLADFG+A + S
Sbjct: 107 YTR-----QILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159
Query: 200 QPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKP 240
G+ ++ P D++S G +LE+ + + P
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 43/228 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F+ IGKGS G VYKAI D +T+ +++AIK E +D + + EI+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAI--DKRTN---QVVAIKVID---LEEAEDEIEDIQQEIQF 52
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
LS + + ++G S S ++ME+ GS DLL
Sbjct: 53 LSQCRSPY-------ITKYYG-------SFLKGSKLWIIMEYCGGGSCLDLL-------- 90
Query: 135 PQLGWPNRVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ G + IA ++ ++ LHE IHRDIK+ NIL + D KLADFG++
Sbjct: 91 -KPGKLDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSGQ 147
Query: 192 ESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
+ S V GT ++ P S +K D++S G+ +E+
Sbjct: 148 LTSTMSKRNTFV---GTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 70/224 (31%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIRVLSSLQES 81
I KG++G V+ A ++ GD I AIK ++++ N + E +LS Q
Sbjct: 1 ISKGAYGRVFLAK---KKSTGD--IYAIK--VIKKADMIRKNQVDQVLTERDILSQAQ-- 51
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+P VV + S G N LVME++P G L LL N + L
Sbjct: 52 ---SPY--VVKLYY-------SFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDV 94
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---------VSE 192
+I A++ LH N IIHRD+K NIL DS KL DFGL+
Sbjct: 95 ARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
DE + GT Y+ P SK VD +S G +L E +
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS------KKLNNEI 72
+ +L+G+G+ G VY + D T + LA+K+ + D+ L EI
Sbjct: 6 RGKLLGQGAFGRVY--LCYDVDTG---RELAVKQVPFD-----PDSPETKKEVNALECEI 55
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++L +LQ ++R +V ++G R+ ++ + ME+MP GS+ D L A
Sbjct: 56 QLLKNLQ--HER-----IVQYYGCL-RDDETLS------IFMEYMPGGSVKDQLKAYGAL 101
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG----L 188
T K QI ++ LH N MI+HRDIK NIL DS + KL DFG L
Sbjct: 102 TETVTR-----KYTRQILEGVEYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154
Query: 189 AVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
S + M GT ++ P + +K DV+S G ++E+++ + P
Sbjct: 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 3e-18
Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 70/242 (28%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRAST----NGFEVLQDNSKKLNNEIRVLSSL 78
IG+G++G VYKA ++ G +++A+K+ GF + + + EI++L L
Sbjct: 7 IGEGTYGQVYKAR---NKKTG--ELVALKKIRMENEKEGFPIT---AIR---EIKLLQKL 55
Query: 79 QESNKRNPNYCVVNFHG--TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-TTP 135
R+PN +V TS GS+ +V E+M + L LL + T
Sbjct: 56 -----RHPN--IVRLKEIVTSKGK-GSI------YMVFEYMDH-DLTGLLDSPEVKFTES 100
Query: 136 QLGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
Q +K Q+ +Q LH N I+HRDIK +NIL ++ KLADFGLA +
Sbjct: 101 Q------IKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152
Query: 195 ESSMVQPAGTIGYLDPGYTN--------PSKL-------SKKVDVFSYGVVLLEIISCRK 239
+S YTN P +L +VD++S G +L E+ K
Sbjct: 153 RNS------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GK 199
Query: 240 PI 241
PI
Sbjct: 200 PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
+GKG+ GSV + Q D +++A+K+ + E L+D + EI +L SLQ
Sbjct: 11 QLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHSTAEHLRDFER----EIEILKSLQHD 65
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
N +V + G C ++G N LVME++P GSL D L +L
Sbjct: 66 N-------IVKYKGV-CYSAG----RRNLRLVMEYLPYGSLRDYLQKHRE----RLDHRK 109
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESSMV 199
+ A QI + ++ L +HRD+ + NIL +S+ K+ DFGL + + E V
Sbjct: 110 LLLYASQICKGMEYLGSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167
Query: 200 QPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ G I + P SK S DV+S+GVVL E+ +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 46/289 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R++GKG+ G A L D ++ K N + + + NEI +LS LQ
Sbjct: 6 RVLGKGAFGE---ATLYRRTEDD--SLVVWKE--VNLTRLSEKERRDALNEIVILSLLQH 58
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
N ++ ++ ++ L+ ME+ G+LYD + +
Sbjct: 59 PN-------IIAYYN-------HFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFE 99
Query: 141 NRVKIAM--QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+ + QI A+ +H+ I+HRDIK+ NI KL DFG++ E SM
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157
Query: 199 VQPA-GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPL 257
+ GT Y+ P K + K D+++ G VL E+++ ++ DA ++
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------ 211
Query: 258 IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ V + + + + ++H + + E RP E+L
Sbjct: 212 ------KIVQGNYTPVVSVYSSELISLVH---SLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 73/294 (24%), Positives = 127/294 (43%), Gaps = 45/294 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRAS--TNGFEVLQDNSKKLNNEIRVLSSL 78
+ +G G+ S Y+A + ++A+K+ + N ++ + L EIR+++ L
Sbjct: 6 QQLGTGAFSSCYQA-----RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ ++ G +C D + N L +E+M GS+ LL A +
Sbjct: 61 NHPH-------IIRMLGATCE-----DSHFN--LFVEWMAGGSVSHLLSKYGAFKEAVI- 105
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLAVSESDESS 197
+ Q+ R + LHEN IIHRD+K N+L DS ++ADFG A + + +
Sbjct: 106 ----INYTEQLLRGLSYLHEN--QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159
Query: 198 MV-----QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
Q GTI ++ P + + DV+S G V++E+ + + P +A +
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK-----HS 214
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
L LI + S P+ E + V RC+ + E+RP E+L
Sbjct: 215 NHLALIFK------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 55/244 (22%), Positives = 90/244 (36%), Gaps = 47/244 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
++IG+GS +V A ++ K AIK + + K + E VL+ L
Sbjct: 7 KIIGEGSFSTVVLAKEKETN-----KEYAIKILDKR-QLIKEKKVKYVKIEKEVLTRL-- 58
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+P ++ + T N V+E+ PNG L + + +
Sbjct: 59 --NGHPG--IIKLYYT-------FQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF- 106
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
A +I A++ LH IIHRD+K NIL D K+ DFG A SS
Sbjct: 107 ----YAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 201 PA---------------------GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
GT Y+ P N K D+++ G ++ ++++ +
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 240 PIDA 243
P
Sbjct: 221 PFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-17
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 49/223 (21%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---EIRVLSSL 78
IGKG G V + +A+K L+D+S E V+++L
Sbjct: 13 TIGKGEFGDVMLGDYRG-------QKVAVK--------CLKDDSTAAQAFLAEASVMTTL 57
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ N +V G + GN +V E+M GSL D L + A +
Sbjct: 58 RHPN-------LVQLLGVV------LQGN-PLYIVTEYMAKGSLVDYLRSRGRAV---IT 100
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
++ A+ + ++ L E + +HRD+ + N+L AK++DFGLA S
Sbjct: 101 LAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156
Query: 199 VQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIIS 236
G L +T P K S K DV+S+G++L EI S
Sbjct: 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 66/232 (28%), Positives = 118/232 (50%), Gaps = 40/232 (17%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-----LNNEIRVLS 76
LIG GS GSVY + + + G+ ++A+K+ + K+ L EI +L
Sbjct: 7 LIGSGSFGSVYLGM---NASSGE--LMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTP 135
LQ N +V + G+S +++ L + +E++P GS+ LL+N A
Sbjct: 62 ELQHEN-------IVQYLGSSL--------DADHLNIFLEYVPGGSVAALLNNYGAFEET 106
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL-----AV 190
+ N V+ QI + + LH IIHRDIK NIL D+K K++DFG+ A
Sbjct: 107 LV--RNFVR---QILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159
Query: 191 SESDESSMVQPA--GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
S S +++ +P+ G++ ++ P + ++K D++S G +++E+++ + P
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 2e-15
Identities = 66/240 (27%), Positives = 102/240 (42%), Gaps = 57/240 (23%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE----- 71
+ + +G+G++G VYKA D +T +I+A+K+ +L+NE
Sbjct: 1 YEKLEKLGEGTYGVVYKAR--DKKTG---EIVALKKI-------------RLDNEEEGIP 42
Query: 72 ---IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLH 127
+R +S L+E +PN +V V KL LV E+ L L
Sbjct: 43 STALREISLLKELK--HPN--IVKLL--------DVIHTERKLYLVFEYCDM-DLKKYLD 89
Query: 128 NAAAATTPQLGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186
+P L +K I Q+ R + H + I+HRD+K NIL + KLADF
Sbjct: 90 KRPGPLSPNL-----IKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADF 142
Query: 187 GLA-VSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
GLA + T+ Y P G + S VD++S G + E+I+ KP+
Sbjct: 143 GLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH---YSTAVDIWSVGCIFAEMIT-GKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 57/236 (24%), Positives = 108/236 (45%), Gaps = 27/236 (11%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+ + R++G+G+ G V+ + D K++ IK+ + +D NE +VL
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKA-----DQKLVIIKQIPVEQ--MTKDERLAAQNECQVLK 54
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
L N ++ ++ + ++VME+ P G+L + + + +
Sbjct: 55 LLSHPN-------IIEYYENFLEDKAL-------MIVMEYAPGGTLAEYIQKRCNSLLDE 100
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS-KWDAKLADFGLAVSESDE 195
+ +QI A+ +H +I+HRD+K+ NIL D K K+ DFG++ S +
Sbjct: 101 ---DTILHFFVQILLALHHVHTK--LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251
S GT Y+ P ++K D+++ G VL E+ S ++ +AA PA ++
Sbjct: 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 54/172 (31%), Positives = 80/172 (46%), Gaps = 39/172 (22%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRAS---TNGFEVLQDNSKKLNNEIRVLSSLQ 79
IG G++G VYKA D T +++AIK + FE++Q EI +L
Sbjct: 11 IGSGTYGDVYKAR--DIATG---ELVAIKVIKLEPGDDFEIIQ-------QEISMLKEC- 57
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLH-NAAAATTPQL 137
R+PN +V + G+ R +KL +VME+ GSL D+ + Q+
Sbjct: 58 ----RHPN--IVAYFGSYLRR--------DKLWIVMEYCGGGSLQDIYQVTRGPLSELQI 103
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+ + + + + LHE IHRDIK NIL D KLADFG++
Sbjct: 104 AY-----VCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 44/225 (19%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK--LNNEIRVLSSLQE 80
IG+G+ G+VY AI D T + +AIK+ + LQ KK + NEI V+
Sbjct: 27 IGQGASGTVYTAI--DVATGQE---VAIKQMN------LQQQPKKELIINEILVMREN-- 73
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGW 139
++PN +VN+ +S V ++L +VME++ GSL D++ T +
Sbjct: 74 ---KHPN--IVNY-----LDSYLV---GDELWVVMEYLAGGSLTDVV------TETCMDE 114
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG----LAVSESDE 195
+ + +A++ LH N +IHRDIKS NIL KL DFG + +S
Sbjct: 115 GQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
S+MV GT ++ P KVD++S G++ +E++ P
Sbjct: 173 STMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 81/307 (26%), Positives = 130/307 (42%), Gaps = 57/307 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKR--ASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G+G++G V K + T I+A+KR A+ N E K+L ++ + S++
Sbjct: 9 LGRGAYGVVDK--MRHVPTG---TIMAVKRIRATVNSQE-----QKRLLMDLDI--SMRS 56
Query: 81 SNKRNPNYCV--VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ C V F+G R G V + ME M + SL L
Sbjct: 57 VD------CPYTVTFYGALFR-EGDV------WICMEVM-DTSLDKFYKKV---YDKGLT 99
Query: 139 WPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
P + KIA+ I +A++ LH +IHRD+K +N+L + KL DFG++ D
Sbjct: 100 IPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSK----KVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
+ AG Y+ P NP K K DV+S G+ ++E+ + R P D+ + P
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---- 214
Query: 253 WALPLIKEEKLRQVC-DSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311
++L+QV + LP E + +C+ + RP E+L
Sbjct: 215 --------QQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HP 262
Query: 312 FFVDHHH 318
FF H
Sbjct: 263 FFELHLS 269
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F++ IGKGS G V+K I D++T +++AIK E +D + + EI V
Sbjct: 4 ELFTKLERIGKGSFGEVFKGI--DNRT---QQVVAIK---IIDLEEAEDEIEDIQQEITV 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
LS V ++G+ + + KL ++ME++ GS DLL
Sbjct: 56 LSQCDSPY-------VTKYYGSYLKGT--------KLWIIMEYLGGGSALDLL------- 93
Query: 134 TPQLGWPNRVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+ G + +IA +I + + LH IHRDIK+ N+L + D KLADFG+A
Sbjct: 94 --RAGPFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 191 SESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+D GT ++ P S K D++S G+ +E+ P
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 36/252 (14%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRV 74
+ + LIG+G++G+VY+ H G +++A+K T +V + E+ +
Sbjct: 3 YQRLELIGRGAYGAVYRGK---HVPTG--RVVALKIINLDTPDDDV-----SDIQREVAL 52
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
LS L++S N + ++G G ++ME+ GS+ L+ A
Sbjct: 53 LSQLRQSQPPN----ITKYYG--SYLKGP-----RLWIIMEYAEGGSVRTLM-KAGPIAE 100
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ I ++ A++ +H+ +IHRDIK+ NIL + + KL DFG+A +
Sbjct: 101 KYIS-----VIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153
Query: 195 ESSMVQP-AGTIGYLDPGY-TNPSKLSKKVDVFSYGVVLLEIISCRKP---IDAARDPAS 249
SS GT ++ P T K D++S G+ + E+ + P +DA R
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
Query: 250 IIDWALPLIKEE 261
I P +++
Sbjct: 214 IPKSKPPRLEDN 225
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 35/174 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN----NEIRVLS 76
+ +G+G++ VYKA D +T +I+AIK+ + +D +N EI++L
Sbjct: 6 KKLGEGTYAVVYKA--RDKETG---RIVAIKKIKLGERKEAKDG---INFTALREIKLLQ 57
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
L+ N ++ + N N LV EFM L ++ + + TP
Sbjct: 58 ELKHPN-------IIGLL-----DVFGHKSNIN--LVFEFME-TDLEKVIKDKSIVLTPA 102
Query: 137 LGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+K + R ++ LH N I+HRD+K N+L S KLADFGLA
Sbjct: 103 -----DIKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 71/229 (31%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79
SRL G+G+ GSV K L++ I A+K +T+ LQ K++ E+ + S +
Sbjct: 7 SRL-GEGAGGSVTKCRLKNTGM-----IFALKTITTDPNPDLQ---KQILRELEINKSCK 57
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+V ++G S S G + ME+ GSL D ++ ++G
Sbjct: 58 SPY-------IVKYYGAFLDESSSSIG-----IAMEYCEGGSL-DSIYKKVKKRGGRIGE 104
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-ESDESSM 198
KIA + + + LH IIHRDIK +NIL K KL DFG VS E S
Sbjct: 105 KVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFG--VSGELVNSLA 160
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
GT Y+ P S DV+S G+ LLE+ R P +P
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 41/246 (16%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRAS--TNGFEVLQDNSKKLNNEIRV 74
+++ ++GKG++G+VY + Q ++A+K+ T+ + +KL E+ +
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQ------LIAVKQVELDTSNVLAAEKEYEKLQEEVDL 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L SL+ N +V + GT C + ++ + MEF+P GS+ +L+
Sbjct: 56 LKSLKHVN-------IVQYLGT-CLDDNTIS------IFMEFVPGGSISSILNRFGPLPE 101
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----- 189
P K QI + LH N ++HRDIK N++ KL DFG A
Sbjct: 102 PVF-----CKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154
Query: 190 ----VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
+ S+ + GT ++ P N S +K D++S G + E+ + + P+ A+
Sbjct: 155 VGLHGTHSNMLKSMH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-ASM 211
Query: 246 DPASII 251
D + +
Sbjct: 212 DRLAAM 217
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 68/237 (28%), Positives = 114/237 (48%), Gaps = 41/237 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---E 71
++ +L+G+G+ G VY + D T + LA+K+ + Q+ SK++N E
Sbjct: 2 VNWRLGKLLGRGAFGEVY--LCYDADTGRE---LAVKQVPFD--PDSQETSKEVNALECE 54
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAA 130
I++L +L+ +V ++G C D KL + +E+MP GS+ D L A
Sbjct: 55 IQLLKNLRHDR-------IVQYYG--CLR----DPEEKKLSIFVEYMPGGSIKDQL-KAY 100
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG--- 187
A T + + QI + + LH N MI+HRDIK NIL DS + KL DFG
Sbjct: 101 GALTENV----TRRYTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASK 154
Query: 188 ----LAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ +S + S+ GT ++ P + +K DV+S ++E+++ + P
Sbjct: 155 RIQTICMSGTGIKSV---TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 34/184 (18%)
Query: 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72
T F +IG+G++G VYKA H+ G +++AIK ++++D +++ E
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKAR---HKKTG--QLVAIKI-----MDIIEDEEEEIKEEY 53
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAA 131
+L SN N + F+G + + GN ++L LVME GS+ DL+
Sbjct: 54 NILRKY--SNHPN----IATFYGAFIKKNPP--GNDDQLWLVMELCGGGSVTDLVKGL-- 103
Query: 132 ATTPQLGWPNRVK------IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
R+K I + R + LHEN +IHRDIK NIL + KL D
Sbjct: 104 -----RKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVD 156
Query: 186 FGLA 189
FG++
Sbjct: 157 FGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 52/234 (22%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG G+ VY AI + + +AIKR E Q + +L E++ +S N
Sbjct: 9 IGVGATAVVYAAICLPNN-----EKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
VV ++ S V ++L LVM ++ GSL D++ ++ P+ G
Sbjct: 61 -------VVKYYT-----SFVVG---DELWLVMPYLSGGSLLDIMKSS----YPRGGLDE 101
Query: 142 RVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+ IA ++ + ++ LH N IHRDIK+ NIL K+ADFG++ S +D
Sbjct: 102 AI-IATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158
Query: 199 VQPA-----GTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ GT ++ P GY K D++S+G+ +E+ + P
Sbjct: 159 TRKVRKTFVGTPCWMAPEVMEQVHGYD------FKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 76/257 (29%), Positives = 109/257 (42%), Gaps = 60/257 (23%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
DYE L K +G+G+ G VYKA G +++A+K+ +L N
Sbjct: 9 DYEILGK----------LGEGTFGEVYKAR---QIKTG--RVVALKK-------ILMHNE 46
Query: 66 KKL-----NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
K EI++L L+ N V S R GSV +V +M +
Sbjct: 47 KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV------YMVTPYM-DH 99
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179
L LL N + T +++K M Q+ I LHEN I+HRDIK+ NIL D++
Sbjct: 100 DLSGLLENPSVKLTE-----SQIKCYMLQLLEGINYLHEN--HILHRDIKAANILIDNQG 152
Query: 180 DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN--------PSKL-------SKKVDV 224
K+ADFGLA + G G YTN P +L + VD+
Sbjct: 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRK--YTNLVVTRWYRPPELLLGERRYTTAVDI 210
Query: 225 FSYGVVLLEIISCRKPI 241
+ G V E+ + R+PI
Sbjct: 211 WGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 45/227 (19%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNEIRVLSSL 78
++G+G++G V K + T +I+AIK F+ +D+ K E++VL L
Sbjct: 8 VVGEGAYGVVLKC--RNKAT---GEIVAIK-----KFKESEDDEDVKKTALREVKVLRQL 57
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
R+ N +VN + R G + LV E++ +L +LL + P
Sbjct: 58 -----RHEN--IVNLK-EAFRRKGRL------YLVFEYVER-TLLELLEASPGGLPPDA- 101
Query: 139 WPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDE 195
V+ + Q+ +AI H ++ IIHRDIK NIL KL DFG A +
Sbjct: 102 ----VRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155
Query: 196 SSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCR 238
S + T Y P G TN K VDV++ G ++ E++
Sbjct: 156 SPLTDYVATRWYRAPELLVGDTN---YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 77/255 (30%), Positives = 112/255 (43%), Gaps = 54/255 (21%)
Query: 13 ATESFSQ---SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN 69
A +S S+ IG G+ G+VYK I H+ G ++ A+K N + ++ +++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVI---HRPTG--RLYALKVIYGNHEDTVR---RQIC 120
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
EI +L + +PN VV H D N +++EFM GSL
Sbjct: 121 REIEILRDVN-----HPN--VVKCHDM-------FDHNGEIQVLLEFMDGGSL----EGT 162
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG-- 187
A L +A QI I LH I+HRDIK +N+L +S + K+ADFG
Sbjct: 163 HIADEQFLA-----DVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 188 --LAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKV------DVFSYGVVLLEIISCRK 239
LA + +S V GTI Y+ P N + L+ D++S GV +LE R
Sbjct: 216 RILAQTMDPCNSSV---GTIAYMSPERIN-TDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271
Query: 240 PIDAARDPASIIDWA 254
P R DWA
Sbjct: 272 PFGVGRQG----DWA 282
|
Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 60/233 (25%), Positives = 111/233 (47%), Gaps = 43/233 (18%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK------LNNEIRVL 75
LIGKG++G VY A+ + T G+ ++A+K+ + +S++ L +EI L
Sbjct: 8 LIGKGTYGRVYLAL---NVTTGE--MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
L N +V + G + +E++P GS+ L
Sbjct: 63 KDLDHLN-------IVQYLG--FET-----TEEYLSIFLEYVPGGSIGSCLRTYGR-FEE 107
Query: 136 QLGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----- 189
QL V+ Q+ + LH I+HRD+K+ N+L D+ K++DFG++
Sbjct: 108 QL-----VRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDD 160
Query: 190 VSESDESSMVQPAGTIGYLDPG--YTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ ++D++ +Q G++ ++ P ++ S KVD++S G V+LE+ + R+P
Sbjct: 161 IYDNDQNMSMQ--GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 5e-14
Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F++ IGKGS G V+K I D++T K++AIK E +D + + EI V
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGI--DNRT---QKVVAIKIID---LEEAEDEIEDIQQEITV 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
LS V ++G+ +++ KL ++ME++ GS DLL
Sbjct: 56 LSQCDSPY-------VTKYYGSYLKDT--------KLWIIMEYLGGGSALDLLEPGPLDE 100
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
T I +I + + LH IHRDIK+ N+L + KLADFG+A +
Sbjct: 101 T------QIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLT 152
Query: 194 DESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
D GT ++ P S K D++S G+ +E+ P
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 54/297 (18%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
IG+G+ G+V K + + T I+A+KR + V + K+L ++ V+ +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGT-----IMAVKRIRST---VDEKEQKRLLMDLDVVMRSSDC 62
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG--SLYDLLHNAAAATTPQ--L 137
P +V F+G R +G+ + ME M Y ++ + P+ L
Sbjct: 63 ----PY--IVKFYGALFR-----EGDC--WICMELMDISLDKFYKYVYEVLKSVIPEEIL 109
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS 197
G KIA+ +A+ L E + IIHRD+K +NIL D + KL DFG++ D +
Sbjct: 110 G-----KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
Query: 198 MVQPAGTIGYLDPGYTNPSKLSK---KVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
+ AG Y+ P +PS + DV+S G+ L E+ + + P W
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK---------WN 214
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIK-----QMLHVAARCVSSEEENRPGIGEIL 306
++L QV G P + + + ++ C+ +E RP E+L
Sbjct: 215 SVF---DQLTQVVK---GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 44/127 (34%), Positives = 67/127 (52%), Gaps = 7/127 (5%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+V E+M GSL D L + +L P V +A QI+ + L + IHRD+ +
Sbjct: 78 IVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAAR 132
Query: 172 NILFDSKWDAKLADFGLA-VSESDESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYGV 229
NIL K+ADFGLA + E DE + + A I + P N + + K DV+S+G+
Sbjct: 133 NILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGI 192
Query: 230 VLLEIIS 236
+L EI++
Sbjct: 193 LLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 49/230 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G++G VYKA D T +I+AIK+ FE +R + L+E N
Sbjct: 7 IGEGTYGVVYKA--RDKLTG---EIVAIKKIKL-RFESEGIP----KTALREIKLLKELN 56
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+PN ++ V + L LV EFM + LY L+ + Q G P
Sbjct: 57 --HPN--IIKLL--------DVFRHKGDLYLVFEFM-DTDLYKLIKDR------QRGLPE 97
Query: 142 -RVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
+K + Q+ + + H + I+HRD+K N+L +++ KLADFGLA S
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155
Query: 200 QP--------AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
A + D GY+ VD++S G + E++S R+P+
Sbjct: 156 THYVVTRWYRAPELLLGDKGYS------TPVDIWSVGCIFAELLS-RRPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 30/224 (13%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
+G GS G V + E + G +A+K + + L D E ++ SL
Sbjct: 2 KLGDGSFGVVRRG--EWSTSGGKVIPVAVKCLKS---DKLSDIMDDFLKEAAIMHSLDHE 56
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
N ++ +G V ++V E P GSL D L A
Sbjct: 57 N-------LIRLYG--------VVLTHPLMMVTELAPLGSLLDRLRKDALGHFL---IST 98
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL--AVSESDESSMV 199
A+QI+ ++ L IHRD+ + NIL S K+ DFGL A+ ++++ ++
Sbjct: 99 LCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156
Query: 200 QPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240
+ + P S DV+ +GV L E+ + +P
Sbjct: 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 23/193 (11%)
Query: 111 LLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170
++ E+M NGSL D L +L + +A QI+ + + + IHRD+++
Sbjct: 76 YIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRA 130
Query: 171 TNILFDSKWDAKLADFGLA-VSESDESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYG 228
NIL K+ADFGLA + E +E + + A I + P N + K DV+S+G
Sbjct: 131 ANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 190
Query: 229 VVLLEIISC-RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHV 287
++L EI++ R P +P I + E R + +++ +
Sbjct: 191 ILLTEIVTYGRIPYPGMTNPEVIQNL------ERGYRMPRP---------DNCPEELYEL 235
Query: 288 AARCVSSEEENRP 300
C + E RP
Sbjct: 236 MRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F++ IGKGS G VYK I ++ + ++AIK E +D + + EI V
Sbjct: 4 ELFTKLERIGKGSFGEVYKGI-DNRTKE----VVAIKIID---LEEAEDEIEDIQQEITV 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
LS + ++G+ + + KL ++ME++ GS DLL
Sbjct: 56 LSQCDSPY-------ITRYYGSYLKGT--------KLWIIMEYLGGGSALDLLKPGPLEE 100
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
T I +I + + LH IHRDIK+ N+L + D KLADFG+A +
Sbjct: 101 T------YIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
Query: 194 DESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
D GT ++ P S K D++S G+ +E+ P
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 56/275 (20%)
Query: 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDH-KI-LAIKRASTNGFEVLQDNSKK 67
++K TE + +++G G+ G+VYK + +G+ KI +AIK + ++ S K
Sbjct: 3 ILKETE-LEKIKVLGSGAFGTVYKGVW---IPEGEKVKIPVAIK-------VLREETSPK 51
Query: 68 LNNEI----RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
N EI V++S+ + VV G +S L+ + MP G L
Sbjct: 52 ANKEILDEAYVMASVDHPH-------VVRLLGICL--------SSQVQLITQLMPLGCLL 96
Query: 124 DLLHNAAAATTPQ--LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
D + N Q L W +QI++ + L E ++HRD+ + N+L +
Sbjct: 97 DYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHV 148
Query: 182 KLADFGLA-VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC- 237
K+ DFGLA + + DE G I ++ + K DV+SYGV + E+++
Sbjct: 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFG 208
Query: 238 RKPIDA--ARDPASIIDWALPLIKEEKLRQ--VCD 268
KP + A + + L K E+L Q +C
Sbjct: 209 AKPYEGIPAVEIPDL------LEKGERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL-QDNSKKLNNEIRVLSSLQ 79
+ +G GS G V + K A+K S +++ + + NE R+L S+
Sbjct: 7 KTLGTGSFGRVMLVRHKGSG-----KYYALKILSKA--KIVKLKQVEHVLNEKRILQSI- 58
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
R+P +VN +G S +SN LVME++P G L+ L + P
Sbjct: 59 ----RHPF--LVNLYG-------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV--- 102
Query: 140 PNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+ A Q+ A++ LH D I++RD+K N+L DS K+ DFG A +
Sbjct: 103 ---ARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157
Query: 199 VQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEII 235
+ GT YL P GY K VD ++ G+++ E++
Sbjct: 158 L--CGTPEYLAPEIILSKGYG------KAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 77/273 (28%), Positives = 119/273 (43%), Gaps = 68/273 (24%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-- 80
IG+G++G VY+A D + +I+A+K+ V DN + + +SSL+E
Sbjct: 15 IGEGTYGIVYRA--RDTTSG---EIVALKK-------VRMDNER----DGIPISSLREIT 58
Query: 81 --SNKRNPNYCVVNFHGTSCRNSGSVDGNS--NKLLVMEFMPNGSLYDLLHNAAAA-TTP 135
N R+PN +V V G + LVME+ L LL N +
Sbjct: 59 LLLNLRHPN--IVELKEV-------VVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES 108
Query: 136 QLGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSES 193
Q VK + +Q+ R +Q LHEN IIHRD+K +N+L K K+ADFGLA
Sbjct: 109 Q------VKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160
Query: 194 DESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
M T+ Y P G T + +D+++ G +L E+++ KP+ +
Sbjct: 161 PAKPMTPKVVTLWYRAPELLLGCTT---YTTAIDMWAVGCILAELLA-HKPLLPGKSEIE 216
Query: 250 IID-------------W----ALPLIKEEKLRQ 265
+D W LPL+ + L +
Sbjct: 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK 249
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 40/228 (17%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-LQDNSKKLNNEIRVLSSLQES 81
+GKG++GSVYK + H+ G +A+K E+ L+ + K N I L L ++
Sbjct: 9 LGKGNYGSVYKVL---HRPTG--VTMAMK-------EIRLELDESKFNQIIMELDILHKA 56
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+P +V+F+G + G+V + ME+M GSL D L+ AT G P
Sbjct: 57 V--SPY--IVDFYG-AFFIEGAV------YMCMEYMDAGSL-DKLYAGGVATE---GIPE 101
Query: 142 RV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
V +I + + ++ L E + IIHRD+K TN+L + KL DFG VS + +S+
Sbjct: 102 DVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFG--VSGNLVASLA 158
Query: 200 QP-AGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ G Y+ P G + + DV+S G+ +LE+ R P
Sbjct: 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 50/299 (16%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK----LNNE 71
++ + +L+G+G+ G VY + D T + LA K+ F+ + K L E
Sbjct: 3 NWRRGKLLGQGAFGRVY--LCYDVDTGRE---LAAKQVQ---FDPESPETSKEVSALECE 54
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
I++L +LQ +V ++G C + ME+MP GS+ D L A
Sbjct: 55 IQLLKNLQHER-------IVQYYG--CLRD---RAEKTLTIFMEYMPGGSVKDQLKAYGA 102
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG---- 187
T K QI + LH N MI+HRDIK NIL DS + KL DFG
Sbjct: 103 LTESVTR-----KYTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKR 155
Query: 188 LAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
L + + GT ++ P + +K DV+S G ++E+++ + P
Sbjct: 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215
Query: 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
A+I A + LP+ + + L C+ E +RP E+L
Sbjct: 216 AAIFKIATQPTNPQ-----------LPSHISEHARDFL----GCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 80/298 (26%), Positives = 120/298 (40%), Gaps = 56/298 (18%)
Query: 21 RLIGKGSHGSVYKAILE--DHQTDGDHKILAIKR-ASTNGFEVLQDNSKKLNNEIRVLSS 77
R++G+G G K L D DG +++A+K G Q N+ EI +L +
Sbjct: 10 RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKT 62
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATTP 135
L N +V + G C + G L+ME++P GSL D L H A
Sbjct: 63 LYHEN-------IVKYKG--CCSEQ---GGKGLQLIMEYVPLGSLRDYLPKHKLNLA--- 107
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSES 193
QL + A QI + LH IHRD+ + N+L D+ K+ DFGLA V E
Sbjct: 108 QL-----LLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
Query: 194 DESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEII-------SCRKPIDAA 244
E V+ G + + +K S DV+S+GV L E++ S K +
Sbjct: 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220
Query: 245 RDPASIIDWALPLIK--EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300
P + LI+ E +R C ++ + C +E + RP
Sbjct: 221 IGPKQGQMTVVRLIELLERGMRLPCPKNCPQ---------EVYILMKNCWETEAKFRP 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG+GS G +Y L ++D +H + IK V + + K E+ +L+ ++
Sbjct: 6 KKIGEGSFGKIY---LAKAKSDSEHCV--IKEIDLTKMPVKEKEASK--KEVILLAKMKH 58
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL---HNAAAATTPQL 137
N +V F S N +VME+ G L + + L
Sbjct: 59 PN-------IVTFFA-------SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD-AKLADFGLAVSESDES 196
W +QIS ++ +H D I+HRDIKS NI AKL DFG+A +D
Sbjct: 105 SW------FVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156
Query: 197 SMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ GT YL P + K D++S G VL E+ + + P +
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 43/228 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G+ G VYKA H+ G A K E L+D EI +LS
Sbjct: 13 LGDGAFGKVYKA---QHKETG--LFAAAKIIQIESEEELEDFMV----EIDILSEC---- 59
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVM-EFMPNGSLYDL-LHNAAAATTPQLGWP 140
++PN +V + NKL ++ EF G+L + L T PQ+ +
Sbjct: 60 -KHPN--IVGLYEAYF--------YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY- 107
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
+ Q+ A+ LH + +IHRD+K+ NIL D KLADFG VS ++S++ +
Sbjct: 108 ----VCRQMLEALNFLHSH--KVIHRDLKAGNILLTLDGDVKLADFG--VSAKNKSTLQK 159
Query: 201 PAGTIG---YLDPGYTNPSKLSK-----KVDVFSYGVVLLEIISCRKP 240
IG ++ P K D++S G+ L+E+ P
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 75/307 (24%), Positives = 117/307 (38%), Gaps = 55/307 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E + R +G+GS G VY+ + + +AIK + N +++ + LN E V
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK--TVNENASMRERIEFLN-EASV 62
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAA 132
+ N ++ VV G V L+VME M G L L A
Sbjct: 63 MKEF------NCHH-VVRLLGV-------VSTGQPTLVVMELMAKGDLKSYLRSRRPEAE 108
Query: 133 TTPQLGWPNRVKI---AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
P LG P K A +I+ + L +HRD+ + N + K+ DFG+
Sbjct: 109 NNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMT 166
Query: 190 --VSESDESSMVQPAGT----IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ E+D + G + ++ P + K DV+S+GVVL E+ +
Sbjct: 167 RDIYETD---YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA----- 218
Query: 244 ARDPASIIDWALP---LIKEEKLRQVCDSRV-GLPTFMEGAIKQMLHVAARCVSSEEENR 299
P L EE L+ V D LP E ++L + C + R
Sbjct: 219 ----------EQPYQGLSNEEVLKFVIDGGHLDLP---ENCPDKLLELMRMCWQYNPKMR 265
Query: 300 PGIGEIL 306
P EI+
Sbjct: 266 PTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 39/234 (16%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ + + IG+GS G KAIL + DG K + I + S ++ S+K E+
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKE----REESRK---EVA 51
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
VLS++ ++PN +V + S + N N +VM++ G LY ++
Sbjct: 52 VLSNM-----KHPN--IVQY-------QESFEENGNLYIVMDYCEGGDLYKKINAQRGVL 97
Query: 134 TPQ---LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA- 189
P+ L W ++ +A++ H +D I+HRDIKS NI KL DFG+A
Sbjct: 98 FPEDQILDWFVQICLALK--------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 190 VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
V S GT YL P + K D+++ G VL E+ + + +A
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 40/129 (31%), Positives = 60/129 (46%), Gaps = 5/129 (3%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
LVM M G L ++N P+ + A QI ++ LH+ I++RD+K
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPE---ARAIFYAAQIICGLEHLHQRR--IVYRDLKPE 124
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
N+L D + +++D GLAV + AGT GY+ P VD F+ G L
Sbjct: 125 NVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTL 184
Query: 232 LEIISCRKP 240
E+I+ R P
Sbjct: 185 YEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDP 161
G+ +N + MEFM GSL + LG KIA+ + + L+ N
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY-NVH 123
Query: 162 MIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP-AGTIGYLDPGYTNPSKLSK 220
I+HRDIK +NIL +S+ KL DFG VS +S+ GT Y+ P K +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFG--VSGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 221 KVDVFSYGVVLLEIISCRKPI-------DAARDPASIIDWALPLIKEE 261
K DV+S G+ ++E+ + P D DP I+D +++E
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 51/232 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKR----ASTNGFEV--LQDNSKKLNNEIRVLS 76
I +G++G VY+A D +T +I+A+K+ GF + L+ EI +L
Sbjct: 13 IEEGTYGVVYRA--RDKKTG---EIVALKKLKMEKEKEGFPITSLR--------EINILL 59
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTP 135
LQ N VV GS N +K+ +VME++ + L L+ T
Sbjct: 60 KLQHPNIVTVKEVVV----------GS---NLDKIYMVMEYVEH-DLKSLM-----ETMK 100
Query: 136 QLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-ES 193
Q + VK M Q+ + LH+N I+HRD+K++N+L +++ K+ DFGLA S
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
Query: 194 DESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
Q T+ Y P G + S +D++S G + E+++ +KP+
Sbjct: 159 PLKPYTQLVVTLWYRAPELLLG---AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---EIRVLSS 77
+L+G+G+ G VY + D T + LA+K+ + + SK++N EI++L +
Sbjct: 8 KLLGQGAFGRVY--LCYDADTGRE---LAVKQVQFDPES--PETSKEVNALECEIQLLKN 60
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L +V ++G C D L + ME MP GS+ D L + A T
Sbjct: 61 LLHER-------IVQYYG--CLR----DPMERTLSIFMEHMPGGSIKDQLKSYGALTENV 107
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG----LAVSE 192
K QI + LH N MI+HRDIK NIL DS + KL DFG L
Sbjct: 108 TR-----KYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ M GT ++ P + +K D++S G ++E+++ + P
Sbjct: 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 74/294 (25%), Positives = 115/294 (39%), Gaps = 56/294 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
IGKG+ G VYK +L+ T+ +A+K T + D +K E +L
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTE-----VAVK---TCRSTLPPDLKRKFLQEAEILK---- 47
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH-NAAAATTPQLGW 139
+PN +V G C + +VME +P GSL L T +L
Sbjct: 48 -QYDHPN--IVKLIGV-CVQKQPI------YIVMELVPGGSLLTFLRKKKNRLTVKKL-- 95
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
+ M + A + IHRD+ + N L K++DFG++ E V
Sbjct: 96 -----LQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150
Query: 200 QPAGT----IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255
G I + P N + + + DV+SYG++L E S+ D
Sbjct: 151 S-DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF-------------SLGDTPY 196
Query: 256 PLIKEEKLRQVCDS--RVGLPTFMEGAIKQ-MLHVAARCVSSEEENRPGIGEIL 306
P + ++ R+ +S R+ P I + ML C + + ENRP EI
Sbjct: 197 PGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQ----CWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 43/130 (33%), Positives = 63/130 (48%), Gaps = 4/130 (3%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
LVM M G L ++N P P QI ++ LH+ II+RD+K
Sbjct: 70 LVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPE 126
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230
N+L D+ + +++D GLAV D S + AGT G++ P + VD F+ GV
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVT 186
Query: 231 LLEIISCRKP 240
L E+I+ R P
Sbjct: 187 LYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 2e-12
Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 44/233 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTD-GDHKILAIKRASTNGFEVLQDNSKK--LNNE 71
+ +++ IG+G+ G+V+ A D + +AIK+ + LQ KK + NE
Sbjct: 19 KKYTRYEKIGQGASGTVFTA------IDVATGQEVAIKQIN------LQKQPKKELIINE 66
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
I V+ L +NPN +VNF S +VME++ GSL D++
Sbjct: 67 ILVMKEL-----KNPN--IVNF-------LDSFLVGDELFVVMEYLAGGSLTDVV----- 107
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
T + + + +A++ LH N +IHRDIKS N+L KL DFG
Sbjct: 108 -TETCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164
Query: 192 ----ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+S S+MV GT ++ P KVD++S G++ +E++ P
Sbjct: 165 ITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 46/238 (19%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN--NEIRV 74
+ + IG+G++G+VYKA D T + +A+K+ L + L+ EI +
Sbjct: 1 YEELAEIGEGAYGTVYKA--RDLNTG---RFVALKKVRVP----LSEEGIPLSTLREIAL 51
Query: 75 LSSLQESNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA 130
L L+ +PN +V HG R + LV E + + L L
Sbjct: 52 LKQLESFE--HPN--IVRLLDVCHG--PRTDRELK----LTLVFEHV-DQDLATYLSKCP 100
Query: 131 AATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
P P +K M Q+ R + LH + I+HRD+K NIL S K+ADFGLA
Sbjct: 101 KPGLP----PETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLA 154
Query: 190 VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
S E ++ T+ Y P Y P VD++S G + E+ R+P+
Sbjct: 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
+IG+G+ G V KA + + DG AIKR +D+ + E+ VL L
Sbjct: 14 VIGEGNFGQVLKARI---KKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKL--- 64
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA-----------A 130
+ ++N G +C + G + L +E+ P+G+L D L + A
Sbjct: 65 ---GHHPNIINLLG-ACEHRGYL------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+T L + A ++R + L + IHRD+ + NIL + AK+ADFGL
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL-- 170
Query: 191 SESDESSMVQPAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
S E + + G + ++ N S + DV+SYGV+L EI+S
Sbjct: 171 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 42/238 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E +IG+G+ G V +A++ + DG AIK E ++ + E+ V
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMI---KKDGLKMNAAIKMLKEFASE---NDHRDFAGELEV 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA--- 131
L L +PN ++N G +C N G + + +E+ P G+L D L +
Sbjct: 56 LCKLGH----HPN--IINLLG-ACENRGYL------YIAIEYAPYGNLLDFLRKSRVLET 102
Query: 132 --------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
T L ++ A ++ +Q L ++ IHRD+ + N+L +K+
Sbjct: 103 DPAFAKEHGTASTLTSQQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKI 160
Query: 184 ADFGLAVSESDESSMVQPAGTIGYLDPGYT-----NPSKLSKKVDVFSYGVVLLEIIS 236
ADFGL+ E V T+G L + N S + K DV+S+GV+L EI+S
Sbjct: 161 ADFGLSRGEE-----VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV---LQDNSKKLNNEIRVLSSL 78
+G G+ G VYK + + +LA+K + + ++ K + + + ++ +
Sbjct: 7 HLGSGAFGCVYKV----RKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFM---PNGSLYDLLHNAAAATT 134
+E R+PN +V ++ T N ++L +VM+ + P G ++ L T
Sbjct: 63 KE-QLRHPN--IVRYYKTFLEN--------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFT 111
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ W I +Q+ A++ LH+ + I+HRD+ NI+ + DFGLA +
Sbjct: 112 EERIW----NIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
ES + GTI Y P +K DV+++G +L ++ + + P
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 7/128 (5%)
Query: 111 LLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170
+V E M GSL + L A L P + +A Q++ + L + IHRD+ +
Sbjct: 77 YIVTELMKYGSLLEYLQGGAGR---ALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAA 131
Query: 171 TNILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYG 228
N+L K+ADFGLA + E + I + P ++ S K DV+S+G
Sbjct: 132 RNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFG 191
Query: 229 VVLLEIIS 236
++L EI++
Sbjct: 192 ILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IGKG G V +L D++ + + IK +T ++ E V++ L+ SN
Sbjct: 14 IGKGEFGDV---MLGDYRGN-KVAVKCIKNDAT---------AQAFLAEASVMTQLRHSN 60
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+V G G + +V E+M GSL D L + + LG
Sbjct: 61 -------LVQLLGVIVEEKGGL------YIVTEYMAKGSLVDYLRSRGRSV---LGGDCL 104
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPA 202
+K ++ + A++ L N+ +HRD+ + N+L AK++DFGL + E+S Q
Sbjct: 105 LKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDT 158
Query: 203 GT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
G + + P K S K DV+S+G++L EI S
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
LVM M G L ++N L + + QI+ I LH D I++RD+K
Sbjct: 70 LVMSLMNGGDLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPE 124
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
N+L D + + +L+D GLAV D ++ Q AGT GY+ P S VD F+ G +
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRV 271
E+++ R P ++ + KEE R+ + V
Sbjct: 185 YEMVAGRTPFKDHKEKVA---------KEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 47/236 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVL 75
R +G+G+ G V+ + + D +++A+K L++ + K E +L
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVK--------TLKETASNDARKDFEREAELL 62
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAA- 132
++ Q N +V F+G C ++V E+M +G L L H AA
Sbjct: 63 TNFQHEN-------IVKFYGV-CTEGDPP------IMVFEYMEHGDLNKFLRSHGPDAAF 108
Query: 133 ------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186
+L ++IA+QI+ + L +HRD+ + N L K+ DF
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDF 166
Query: 187 GLA--VSESD----ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
G++ V +D + P I ++ P K + + DV+S+GVVL EI +
Sbjct: 167 GMSRDVYTTDYYRVGGHTMLP---IRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK--LNNEI 72
+ +++ IG+G+ G+VY AI D T + +AIK+ + LQ KK + NEI
Sbjct: 19 KKYTRFEKIGQGASGTVYTAI--DIATGQE---VAIKQMN------LQQQPKKELIINEI 67
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
V+ +NPN +VN+ S +VME++ GSL D++
Sbjct: 68 LVMRE-----NKNPN--IVNY-------LDSYLVGDELWVVMEYLAGGSLTDVV------ 107
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS- 191
T + + + +A+ LH N +IHRDIKS NIL KL DFG
Sbjct: 108 TETCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
Query: 192 ---ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+S S+MV GT ++ P KVD++S G++ +E++ P
Sbjct: 166 TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-12
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 34/239 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
ES + +G G G V+ A T H +A+K V + E V
Sbjct: 6 ESLKLEKKLGAGQFGEVWMA------TYNKHTKVAVKTMKPGSMSV-----EAFLAEANV 54
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ +LQ +V H + ++ EFM GSL D L + +
Sbjct: 55 MKTLQHDK-------LVKLHAVVTKEP--------IYIITEFMAKGSLLDFLKSDEGSKQ 99
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSES 193
P P + + QI+ + + + + IHRD+++ NIL + K+ADFGLA V E
Sbjct: 100 P---LPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154
Query: 194 DESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKPIDAARDPASI 250
+E + + A I + P N + K DV+S+G++L+EI++ R P +P I
Sbjct: 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 42/232 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK--LNNEI 72
+ +++ IG+G+ G+VY A+ D T + +AI++ + LQ KK + NEI
Sbjct: 20 KKYTRFEKIGQGASGTVYTAM--DVATGQE---VAIRQMN------LQQQPKKELIINEI 68
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
V+ +NPN +VN+ S +VME++ GSL D++
Sbjct: 69 LVMRE-----NKNPN--IVNY-------LDSYLVGDELWVVMEYLAGGSLTDVV------ 108
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS- 191
T + + + +A++ LH N +IHRDIKS NIL KL DFG
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 192 ---ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+S S+MV GT ++ P KVD++S G++ +E+I P
Sbjct: 167 TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
++ E+M GSL D L + ++ P + + QI+ + + + IHRD+++
Sbjct: 78 IITEYMAKGSLLDFLKSDEGG---KVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAA 132
Query: 172 NILFDSKWDAKLADFGLA-VSESDESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYGV 229
N+L K+ADFGLA V E +E + + A I + P N + K DV+S+G+
Sbjct: 133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 192
Query: 230 VLLEIIS 236
+L EI++
Sbjct: 193 LLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 35/225 (15%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
IG G+ G VYK + G ++A+K+ ++ K N+ R+L L
Sbjct: 22 EIGSGTCGQVYKM---RFKKTG--HVMAVKQ--------MRRTGNKEENK-RILMDLDVV 67
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
K + +V +G +S + + ME M + D L Q P
Sbjct: 68 LKSHDCPYIVKCYGYFITDS-------DVFICMELM--STCLDKL-----LKRIQGPIPE 113
Query: 142 RV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
+ K+ + I +A+ L E +IHRD+K +NIL D+ + KL DFG++ D +
Sbjct: 114 DILGKMTVAIVKALHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172
Query: 200 QPAGTIGYLDPGYTNPSKLSKK----VDVFSYGVVLLEIISCRKP 240
+ AG Y+ P +P + K DV+S G+ L+E+ + + P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-11
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
+IG+G+ G V KA + + DG AIKR + D+ + E+ VL L
Sbjct: 2 VIGEGNFGQVLKARI---KKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKL--- 52
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA---------- 131
+PN ++N G +C + G + L +E+ P+G+L D L +
Sbjct: 53 -GHHPN--IINLLG-ACEHRGYL------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 102
Query: 132 -ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+T L + A ++R + L + IHRD+ + NIL + AK+ADFGL+
Sbjct: 103 NSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR 160
Query: 191 SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + ++ N S + DV+SYGV+L EI+S
Sbjct: 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 49/291 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
R++GKGS+G V L H+TDG K L ++ AS K E ++LS
Sbjct: 6 RVVGKGSYGEVS---LVRHRTDGKQYVIKKLNLRNASRR-------ERKAAEQEAQLLSQ 55
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L+ N +V + S +G L +VM F G LY L P+
Sbjct: 56 LKHPN-------IVAYRE-------SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE 101
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
V+ +QI+ A+Q LHE I+HRD+K+ N+ K+ D G+A ++
Sbjct: 102 ---NQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156
Query: 197 SMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255
M GT Y+ P + + K DV++ G + E+ + + + A+D S++
Sbjct: 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLV---- 211
Query: 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I E K LP + ++ + A +S E RP + IL
Sbjct: 212 YRIIEGK----------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN-NEIRVLSSLQ 79
+++GKGS G V A E TD + + +K+ +LQD+ + E RVL+
Sbjct: 1 KVLGKGSFGKVLLA--ELKGTDELYAVKVLKKD-----VILQDDDVECTMTEKRVLAL-- 51
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+ + H SC + VME++ G L + H + +
Sbjct: 52 ---AGKHPF-LTQLH--SCFQT-----KDRLFFVMEYVNGGDL--MFHIQRSGRFDE--- 95
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSESDES 196
P A +I +Q LHE II+RD+K N+L DS+ K+ADFG+ + +
Sbjct: 96 PRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
S GT Y+ P + VD ++ GV+L E+++ + P +
Sbjct: 154 STF--CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 42/127 (33%), Positives = 67/127 (52%), Gaps = 7/127 (5%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+V E+M GSL D L + L PN V +A Q++ + + + IHRD++S
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRA---LKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSA 131
Query: 172 NILFDSKWDAKLADFGLA-VSESDESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYGV 229
NIL K+ADFGLA + E +E + Q A I + P + + K DV+S+G+
Sbjct: 132 NILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 230 VLLEIIS 236
+L E+++
Sbjct: 192 LLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 50/228 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+GS G V I D T + +A+K+ Q + L NE+ ++ Q N
Sbjct: 27 IGEGSTGIV--CIATDKSTG---RQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPN 77
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+V + S V ++L +VMEF+ G+L D++ T ++
Sbjct: 78 -------IVEMYS-----SYLVG---DELWVVMEFLEGGALTDIV------THTRMNEEQ 116
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE----SS 197
+ + + +A+ LH +IHRDIKS +IL S KL+DFG S E S
Sbjct: 117 IATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174
Query: 198 MVQPAGTIGYLDPGYTNPSKLSKK-----VDVFSYGVVLLEIISCRKP 240
+V GT P + P +S+ VD++S G++++E++ P
Sbjct: 175 LV---GT-----PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 22/175 (12%)
Query: 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN 128
N IR L L E N +P +V F+G + + G + + ME M GSL +L
Sbjct: 48 NQIIRELQVLHECN--SPY--IVGFYG-AFYSDGEIS------ICMEHMDGGSLDQVLKE 96
Query: 129 AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL 188
A LG K+++ + R + L E I+HRD+K +NIL +S+ + KL DFG+
Sbjct: 97 AKRIPEEILG-----KVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGV 150
Query: 189 A--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+ + +S +S V GT Y+ P + S + D++S G+ L+E+ R PI
Sbjct: 151 SGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 21/142 (14%)
Query: 111 LLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170
+L+M+++ +G L+DLL + ++ KI Q+ A+ LH+++ IIH DIK
Sbjct: 85 VLIMDYIKDGDLFDLLKKEGKLSEAEV-----KKIIRQLVEALNDLHKHN--IIHNDIKL 137
Query: 171 TNILFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKK-----VDV 224
N+L+D +K L D+GL S GT+ Y +P K+ D
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYF-----SPEKIKGHNYDVSFDW 189
Query: 225 FSYGVVLLEIISCRKPIDAARD 246
++ GV+ E+++ + P D
Sbjct: 190 WAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 45/131 (34%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 114 MEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173
ME M GSL +L A LG KI++ + R + L E I+HRD+K +NI
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKHK-IMHRDVKPSNI 131
Query: 174 LFDSKWDAKLADFGLAVSESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLL 232
L +S+ + KL DFG VS SM GT Y+ P + + + D++S G+ L+
Sbjct: 132 LVNSRGEIKLCDFG--VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 233 EIISCRKPIDA 243
E+ R PI
Sbjct: 190 EMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G G K +L +++ G ++ AIK A G + +D + L E R+ ++
Sbjct: 7 LGRGHFG---KVLLAEYKKTG--ELYAIK-ALKKGDIIARDEVESLMCEKRIF--ETANS 58
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+R+P +VN +C + + VME+ G L +H T P
Sbjct: 59 ERHP--FLVNLF--ACFQT-----EDHVCFVMEYAAGGDLMMHIH------TDVFSEPRA 103
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSESDESSMV 199
V A + +Q LHEN I++RD+K N+L D++ K+ADFGL + D +S
Sbjct: 104 VFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF 161
Query: 200 QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT +L P + ++ VD + GV++ E++ P
Sbjct: 162 --CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G +G VY+ + + + +A+K + EV ++ E V+ ++ N
Sbjct: 14 LGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEV-----EEFLKEAAVMKEIKHPN 63
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+V G R ++ EFM G+L D L +
Sbjct: 64 -------LVQLLGVCTREPPF-------YIITEFMTYGNLLDYLRECNRQEVNAVVL--- 106
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPA 202
+ +A QIS A++ L + + IHRD+ + N L K+ADFGL+ + + + A
Sbjct: 107 LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHA 163
Query: 203 GT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
G I + P +K S K DV+++GV+L EI
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 10/131 (7%)
Query: 112 LVMEFMPNGSLYDLLH-NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170
+V E+M NG L + L T L + + + A++ L N IHRD+ +
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESNG--FIHRDLAA 128
Query: 171 TNILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYG 228
N L K++DFGLA V + +S + + P + S+ S K DV+S+G
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFG 188
Query: 229 VVLLEIISCRK 239
V++ E+ S K
Sbjct: 189 VLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 40/228 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F+ R +G G G V++ + ++ +AIK ++ QD E++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSDDLLKQQD----FQKEVQA 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L L R+ + +++ C V ++ E M GSL L +
Sbjct: 56 LKRL-----RHKH--LISLFAV-CSVGEPV------YIITELMEKGSLLAFLRSPEGQV- 100
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----- 189
L + + +A Q++ + L E + IHRD+ + NIL K+ADFGLA
Sbjct: 101 --LPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156
Query: 190 -VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
V S + + + P + S K DV+S+G++L E+ +
Sbjct: 157 DVYLSSDKKI-----PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 31/169 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G+ GSVY A + +T +++AIK+ F ++ L E++ L L
Sbjct: 7 LGDGTFGSVYLAR--NKET---GELVAIKKMKKK-FYSWEE-CMNLR-EVKSLRKL---- 54
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+PN +V V +++L V E+M G+LY L+ + +
Sbjct: 55 NEHPN--IVKLK--------EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS----ES 99
Query: 142 RVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
++ I QI + + +H++ HRD+K N+L K+ADFGLA
Sbjct: 100 VIRSIIYQILQGLAHIHKHGFF--HRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 55/175 (31%), Positives = 88/175 (50%), Gaps = 22/175 (12%)
Query: 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN 128
N IR L L E N +P +V F+G + + G + + ME M GSL +L
Sbjct: 48 NQIIRELQVLHECN--SPY--IVGFYG-AFYSDGEIS------ICMEHMDGGSLDQVLKK 96
Query: 129 AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL 188
A LG K+++ + + + L E I+HRD+K +NIL +S+ + KL DFG+
Sbjct: 97 AGRIPEQILG-----KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 150
Query: 189 A--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+ + +S +S V GT Y+ P + S + D++S G+ L+E+ R PI
Sbjct: 151 SGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 64/243 (26%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-----LNNEIRVLSS 77
IG+G++G VYKA D T +++A+K+ V DN K+ EI++L
Sbjct: 15 IGEGTYGQVYKA--RDKDTG---ELVALKK-------VRLDNEKEGFPITAIREIKILRQ 62
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNK---LLVMEFMPNGSLYDLLHNAAAATT 134
L N +VN ++D +K LV E+M + L LL + +
Sbjct: 63 LNHRN-------IVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFS 114
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSES 193
+ Q+ + H+ + +HRDIK +NIL ++K KLADFGLA + S
Sbjct: 115 ED----HIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 194 DESSMVQPAGTIGYLDPGYTN--------PSKL-------SKKVDVFSYGVVLLEIISCR 238
+ES YTN P +L +DV+S G +L E+ + +
Sbjct: 169 EESRP-------------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-K 214
Query: 239 KPI 241
KPI
Sbjct: 215 KPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
F L+G G++G VYK H G ++ AIK G D +++ EI +L
Sbjct: 8 FELVELVGNGTYGQVYKG---RHVKTG--QLAAIKVMDVTG-----DEEEEIKQEINMLK 57
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTP 135
+ S+ RN + ++G + + G ++L LVMEF GS+ DL+ N T
Sbjct: 58 --KYSHHRN----IATYYGAFIKKNPP--GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 109
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+ W I +I R + LH++ +IHRDIK N+L + KL DFG++ ++ D
Sbjct: 110 E-EWI--AYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDR 163
Query: 196 SSMVQPA--GTIGYLDPGYT----NP-SKLSKKVDVFSYGVVLLEIISCRKPI 241
+ + GT ++ P NP + K D++S G+ +E+ P+
Sbjct: 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 32/235 (13%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+ IG+G++G V A T +AIK+ S FE Q ++ EI++L
Sbjct: 7 YQNLSYIGEGAYGMVCSAT--HKPTGVK---VAIKKISP--FE-HQTFCQRTLREIKILR 58
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
+ N ++ S + ++ +V E M LY L+ T
Sbjct: 59 RFKHEN-------IIGILDIIR--PPSFESFNDVYIVQELMET-DLYKLIK------TQH 102
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSES 193
L + QI R ++ +H + ++HRD+K +N+L ++ D K+ DFGLA E
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 194 DESS-MVQPAGTIGYLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
D + + + T Y P N +K +D++S G +L E++S R P+ +D
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 70/231 (30%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSK--KLNNEIRV 74
F+ R IG GS G+VY A D +T+ +++AIK+ S +G Q N K + E++
Sbjct: 27 FTDLREIGHGSFGAVYFA--RDVRTN---EVVAIKKMSYSG---KQSNEKWQDIIKEVKF 78
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L ++ N C + H LVME+ GS DLL
Sbjct: 79 LQRIKHPNSIEYKGCYLREH--------------TAWLVMEYCL-GSASDLLEVHKKPL- 122
Query: 135 PQLGWPNRVKIAMQISRAIQCL-HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
V+IA A+Q L + + +IHRDIK+ NIL KLADFG A S
Sbjct: 123 ------QEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 194 DESSMVQPAGTIGYLDPGY---TNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+S V GT ++ P + + KVDV+S G+ +E+ + P+
Sbjct: 177 PANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 17/130 (13%)
Query: 112 LVMEFMPNGSLYDLLHNA--AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169
+VME M G+L + L A + QL ++ ++ ++ ++ L ++HRD+
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLESKK--LVHRDLA 127
Query: 170 STNILFDSKWDAKLADFGLAVSES---DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFS 226
+ NIL AK++DFGLA S D S + + + P K S K DV+S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKHKKFSSKSDVWS 182
Query: 227 YGVVLLEIIS 236
YGV+L E+ S
Sbjct: 183 YGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 72/234 (30%), Positives = 107/234 (45%), Gaps = 48/234 (20%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
F+ R IG GS G+VY A D +T+ +++AIK+ S +G + +++K + I+ +
Sbjct: 17 FTDLREIGHGSFGAVYFA--RDVRTN---EVVAIKKMSYSG----KQSNEKWQDIIKEVR 67
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATT 134
LQ+ N + + G R + LVME+ GS D+L H
Sbjct: 68 FLQQLRHPN----TIEYKGCYLREHTA-------WLVMEYCL-GSASDILEVHKKPL--- 112
Query: 135 PQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
V+IA A+Q L + IHRDIK+ NIL KLADFG A
Sbjct: 113 ------QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA---- 162
Query: 194 DESSMVQPA----GTIGYLDPGY---TNPSKLSKKVDVFSYGVVLLEIISCRKP 240
S+V PA GT ++ P + + KVDV+S G+ +E+ RKP
Sbjct: 163 ---SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 147 MQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL----AVSESDESSMVQPA 202
+Q+ A+ +H +IHRDIKS NIL S KL DFG A + SD+
Sbjct: 150 IQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-C 206
Query: 203 GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
GT Y+ P SKK D+FS GV+L E+++ ++P D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
|
Length = 496 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 53/174 (30%), Positives = 85/174 (48%), Gaps = 24/174 (13%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
F ++G G++G VYK H G ++ AIK +V +D +++ EI +L
Sbjct: 18 FELVEVVGNGTYGQVYKG---RHVKTG--QLAAIKV-----MDVTEDEEEEIKLEINMLK 67
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTP 135
+ S+ RN + ++G + S G+ ++L LVMEF GS+ DL+ N
Sbjct: 68 --KYSHHRN----IATYYGAFIKKSPP--GHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+ W I +I R + LH + +IHRDIK N+L + KL DFG++
Sbjct: 120 E-DWI--AYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 65/241 (26%), Positives = 116/241 (48%), Gaps = 50/241 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG G++G V A+ D +T + +AIK+ +N F+ L D +K++ EI++L L
Sbjct: 6 KPIGSGAYGVVCSAV--DKRTG---RKVAIKKI-SNVFDDLID-AKRILREIKLLRHL-- 56
Query: 81 SNKRNPNYCVVNFHGTSCRN---SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
R+ N ++ + S + ++ +V E M L+ ++ +PQ
Sbjct: 57 ---RHEN--II-----GLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK------SPQP 99
Query: 138 GWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----VSE 192
+ ++ + QI R ++ LH + +IHRD+K +NIL +S D K+ DFGLA E
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 193 SDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
++ + + T Y P YT +D++S G + E+++ RKP+ R
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKA------IDIWSVGCIFAELLT-RKPLFPGR 210
Query: 246 D 246
D
Sbjct: 211 D 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKR-ASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
++G+G++G V K ++ +I+AIK+ + E +++ + + E+++L +L++
Sbjct: 8 VVGEGAYGVVLKCRHKE-----TKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQ 59
Query: 81 SN---------KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
N +R Y V + N L ++E MPNG
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYV------------EKNMLELLEEMPNGVP--------- 98
Query: 132 ATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA- 189
P +V+ + Q+ +AI H+ND I+HRDIK N+L KL DFG A
Sbjct: 99 --------PEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFAR 148
Query: 190 -VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
+SE ++ + T Y P + K VD++S G +L E+
Sbjct: 149 NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+V EFM GSL D L L P V +A QI+ + + + IHRD+++
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAA 131
Query: 172 NILFDSKWDAKLADFGLA-VSESDESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYGV 229
NIL K+ADFGLA + E +E + Q A I + P + + K DV+S+G+
Sbjct: 132 NILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 230 VLLEIIS 236
+L E+++
Sbjct: 192 LLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNE 71
+ + + +G G+ G V+ + + K++AI + + ++NE
Sbjct: 1 DDLERIKTVGTGTFGRVHLV---RDRISEHYYALKVMAIPEV------IRLKQEQHVHNE 51
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
RVL + +P ++ T ++ME++P G L+ L N+
Sbjct: 52 KRVLKEV-----SHP--FIIRLFWTE-------HDQRFLYMLMEYVPGGELFSYLRNSGR 97
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ G + A +I A++ LH + I++RD+K NIL D + KL DFG A
Sbjct: 98 FSN-STG----LFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK 150
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
D + + GT YL P +K VD ++ G+++ E++ P
Sbjct: 151 LRDRTWTL--CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+F Q R++GKG G V Q K+ A K+ + KK E L
Sbjct: 1 TFRQYRVLGKGGFGEVCAC-----QVRATGKMYACKKLE-------KKRIKKRKGESMAL 48
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
+ Q K N + V + +++ LV+ M G L +++ A
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDA--------LCLVLTLMNGGDLKFHIYHMGEAGFE 100
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+ V A +I ++ LH+ I++RD+K NIL D +++D GLAV +
Sbjct: 101 E---GRAVFYAAEICCGLEDLHQE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
++ GT+GY+ P + + D ++ G +L E+I+ + P
Sbjct: 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 17/133 (12%)
Query: 111 LLVMEFMPNGSLYDLL-HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169
+++ E+M NGSL L N T QL V + I+ ++ L E + +HRD+
Sbjct: 81 MIITEYMENGSLDKFLRENDGKFTVGQL-----VGMLRGIASGMKYLSEMN--YVHRDLA 133
Query: 170 STNILFDSKWDAKLADFGLA-VSESDESSMVQPAGTIGYLDPGYTNPS-----KLSKKVD 223
+ NIL +S K++DFGL+ E E++ G I +T P K + D
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR---WTAPEAIAYRKFTSASD 190
Query: 224 VFSYGVVLLEIIS 236
V+S+G+V+ E++S
Sbjct: 191 VWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 82/309 (26%), Positives = 136/309 (44%), Gaps = 61/309 (19%)
Query: 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDH-KI-LAIKRASTNGFEVLQDN-SK 66
++K TE + +++G G+ G+VYK I DG++ KI +AIK VL++N S
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIW---IPDGENVKIPVAIK--------VLRENTSP 50
Query: 67 KLNNEIRVLSSLQESNKRNPNYCVVNFHGT-SCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
K N EI L E+ Y + CR G + S LV + MP G L D
Sbjct: 51 KANKEI-----LDEA------YVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCLLDY 98
Query: 126 L--HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
+ + + L W +QI++ + L E ++HRD+ + N+L S K+
Sbjct: 99 VRENKDRIGSQDLLNW------CVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKI 150
Query: 184 ADFGLA-VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RK 239
DFGLA + + DE+ G I ++ + + + DV+SYGV + E+++ K
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210
Query: 240 PIDA--ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
P D AR+ +++ K E+L Q + + +C + E
Sbjct: 211 PYDGIPAREIPDLLE------KGERLPQPPI-----------CTIDVYMIMVKCWMIDSE 253
Query: 298 NRPGIGEIL 306
RP E++
Sbjct: 254 CRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 38/96 (39%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 145 IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD--ESSMVQPA 202
I + RAIQ LHEN IIHRDIK+ NI + D L DFG A D + A
Sbjct: 187 IERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 203 GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238
GTI P VD++S G+VL E+ +C
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 25/231 (10%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+F Q R++GKG G V Q K+ A KR + KK E L
Sbjct: 1 TFRQYRVLGKGGFGEVCAC-----QVRATGKMYACKRLE-------KKRIKKRKGESMAL 48
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
+ Q K N + V + +++ LV+ M G L ++N P
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDA--------LCLVLTIMNGGDLKFHIYNMG---NP 97
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+ A +I ++ LH + ++RD+K NIL D +++D GLAV +
Sbjct: 98 GFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
S+ GT+GY+ P N + + D + G ++ E+I + P ++
Sbjct: 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 108 SNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166
KL L+++++ G L+ L+ T ++ RV IA +I A+ LH+ II+R
Sbjct: 77 DTKLHLILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIVLALDHLHQLG--IIYR 129
Query: 167 DIKSTNILFDSKWDAKLADFGLA---VSESDESSMVQPAGTIGYLDPGYTN--PSKLSKK 221
DIK NIL DS+ L DFGL+ ++E +E + GTI Y+ P K
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY-SFCGTIEYMAPEVIRGGSGGHDKA 188
Query: 222 VDVFSYGVVLLEIISCRKP--IDAARDPASII 251
VD +S GV+ E+++ P +D ++ S I
Sbjct: 189 VDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 75/262 (28%), Positives = 111/262 (42%), Gaps = 41/262 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNEIRVLSS 77
++IGKGS G K +L ++DG A+K VLQ + KK N I +
Sbjct: 1 KVIGKGSFG---KVLLAKRKSDGS--FYAVK--------VLQKKTILKKKEQNHIMAERN 47
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
+ N ++P +V H S V++++ G L+ L P+
Sbjct: 48 VLLKNLKHP--FLVGLHY-------SFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA 98
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL---AVSESD 194
+ A +++ AI LH + II+RD+K NIL DS+ L DFGL V +
Sbjct: 99 RF-----YAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
+S GT YL P + VD + G VL E++ P +RD + + D
Sbjct: 152 TTSTF--CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQMYDNI 208
Query: 255 L--PL-IKEEKLRQVCDSRVGL 273
L PL + K CD VGL
Sbjct: 209 LHKPLQLPGGKTVAACDLLVGL 230
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 55/224 (24%), Positives = 86/224 (38%), Gaps = 35/224 (15%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDH-KILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
I KG+ GSVY L ++ GD+ I +K++ + ++ + E ++ ES
Sbjct: 4 ISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDM----IAKNQVTNVKAERAIMMIQGES 56
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
P + + S LVME++ G L+ W
Sbjct: 57 ----PYVAKLYY---------SFQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAK 100
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP 201
+ ++ ++ LH+ IIHRDIK N+L D KL DFGL+ + +
Sbjct: 101 --QYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLS-----RNGLENK 151
Query: 202 --AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
GT YL P K D +S G V+ E + P A
Sbjct: 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G+ V KA Q+ K AIK + + Q N+ EI+ L L
Sbjct: 7 IGEGTFSEVLKA-----QSRKTGKYYAIKCMKKHFKSLEQVNNL---REIQALRRLSP-- 56
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+PN ++ D + +L LV E M + +LY+L+ +
Sbjct: 57 --HPN--ILRLIEVL------FDRKTGRLALVFELM-DMNLYELIKGRK-----RPLPEK 100
Query: 142 RVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
RVK M Q+ +++ +H N I HRDIK NIL KLADFG + +
Sbjct: 101 RVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE 157
Query: 201 PAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
T Y P GY P K+D+++ G V EI+S
Sbjct: 158 YISTRWYRAPECLLTDGYYGP-----KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+V E+M GSL D L L P V +A QI+ + + + +HRD+++
Sbjct: 77 IVTEYMSKGSLLDFLK---GEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 131
Query: 172 NILFDSKWDAKLADFGLA-VSESDESSMVQPAG-TIGYLDPGYTNPSKLSKKVDVFSYGV 229
NIL K+ADFGLA + E +E + Q A I + P + + K DV+S+G+
Sbjct: 132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 230 VLLEIIS 236
+L E+ +
Sbjct: 192 LLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 59/191 (30%), Positives = 82/191 (42%), Gaps = 46/191 (24%)
Query: 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSK 66
YE+L K IG+G+ G V+KA +T +I+A+K+ VL +N K
Sbjct: 14 YEKLAK----------IGQGTFGEVFKA--RHKKTK---QIVALKK-------VLMENEK 51
Query: 67 K-----LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNK---LLVMEFMP 118
+ EI++L L+ N VVN CR + N K LV EF
Sbjct: 52 EGFPITALREIKILQLLKHEN-------VVNLIEI-CRTKATP-YNRYKGSFYLVFEFCE 102
Query: 119 NGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
+ L LL N T K+ + + +H N I+HRD+K+ NIL
Sbjct: 103 H-DLAGLLSNKNVKFTL----SEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD 155
Query: 179 WDAKLADFGLA 189
KLADFGLA
Sbjct: 156 GILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 69/240 (28%), Positives = 104/240 (43%), Gaps = 42/240 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE---IRVLSS 77
++IGKGS G V L H+ DG K A+K VLQ + E I +
Sbjct: 1 KVIGKGSFGKVL---LAKHKADG--KFYAVK--------VLQKKAILKKKEQKHIMAERN 47
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
+ N ++P +V H + ++KL V++++ G L+ L + P
Sbjct: 48 VLLKNVKHP--FLVGLHYSF--------QTADKLYFVLDYVNGGELFFHLQRERSFPEP- 96
Query: 137 LGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL---AVSE 192
R + A +I+ A+ LH + II+RD+K NIL DS+ L DFGL +
Sbjct: 97 -----RARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
S +S GT YL P + VD + G VL E++ P +RD A + D
Sbjct: 150 SKTTSTF--CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R +G+G G V + D + D + +A+K E ++ L EI +L +L
Sbjct: 10 RDLGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKP---ESGGNHIADLKKEIEILRNLYH 65
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL-HNAAAATTPQLGW 139
N +V + G C G GN KL +MEF+P+GSL + L N Q
Sbjct: 66 EN-------IVKYKGI-CTEDG---GNGIKL-IMEFLPSGSLKEYLPRNKNKINLKQQ-- 111
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL--AVSESDESS 197
+K A+QI + + L +HRD+ + N+L +S+ K+ DFGL A+ E
Sbjct: 112 ---LKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 198 MVQP--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
V+ + + P SK DV+S+GV L E+++
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 54/236 (22%), Positives = 87/236 (36%), Gaps = 59/236 (25%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE--------------VLQDNSKKL 68
+G+G +G V+ A +D +I+A+KR + + S+ L
Sbjct: 9 VGQGGYGQVFLAKKKD-----TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN 128
+++L + Q+ L ME++P G LL+N
Sbjct: 64 ---VKLLYAFQDDE--------------------------YLYLAMEYVPGGDFRTLLNN 94
Query: 129 AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL 188
+ R +A A+ LHE IHRD+K N L D+ KL DFGL
Sbjct: 95 LGVLSEDH----ARFYMAEMFE-AVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGL 147
Query: 189 AVSE-SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ + +S+V G+ Y+ P VD +S G +L E + P
Sbjct: 148 SKGIVTYANSVV---GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+++GKGS G V+ A L+ G ++ AIK A ++ D+ + E RVLS E
Sbjct: 1 KMLGKGSFGKVFLAELK-----GTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
YC + N VME++ G L + H + + P
Sbjct: 55 HPFLTHLYC-------------TFQTKENLFFVMEYLNGGDL--MFH---IQSCHKFDLP 96
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
A +I +Q LH I++RD+K NIL D+ K+ADFG+ + +M+
Sbjct: 97 RATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMC-----KENMLG 149
Query: 201 PA------GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
A GT Y+ P K + VD +S+GV+L E++ + P
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 47/253 (18%)
Query: 7 YEELVK-------ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE 59
YE++V+ E + ++IG+G+ G V L H++ K+ A+K S FE
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ---LVRHKSS--QKVYAMKLLSK--FE 80
Query: 60 VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPN 119
+++ + E R + + S +C + + +VME+MP
Sbjct: 81 MIKRSDSAFFWEERDIMAFANSPWVVQLFC-------------AFQDDKYLYMVMEYMPG 127
Query: 120 GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179
G L +L+ N P+ W ++ A+ +H +IHRD+K N+L D
Sbjct: 128 GDLVNLMSNY---DVPE-KWAKFY--TAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHG 179
Query: 180 DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLS---------KKVDVFSYGVV 230
KLADFG + + DE+ MV+ +G P Y +P L ++ D +S GV
Sbjct: 180 HLKLADFGTCM-KMDETGMVRCDTAVG--TPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 231 LLEIISCRKPIDA 243
L E++ P A
Sbjct: 237 LFEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN-EIRV 74
F+ ++GKGS G V A E TD + I +K+ V+QD+ + E RV
Sbjct: 1 DFNFLMVLGKGSFGKVMLA--ERKGTDELYAIKILKKDV-----VIQDDDVECTMVEKRV 53
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L+ + P + + H SC + VD VME++ G L +
Sbjct: 54 LALQDK-----PPF-LTQLH--SCFQT--VD---RLYFVMEYVNGGDLMYHIQQVGKFKE 100
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
PQ V A +IS + LH II+RD+K N++ DS+ K+ADFG+
Sbjct: 101 PQ-----AVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153
Query: 195 ESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ + GT Y+ P K VD ++YGV+L E+++ + P D
Sbjct: 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 109 NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168
+LVME G L L + ++ N V++ Q+S ++ L + +HRD+
Sbjct: 68 ALMLVMEMASGGPLNKFL----SGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDL 121
Query: 169 KSTNILFDSKWDAKLADFGL--AVSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDV 224
+ N+L ++ AK++DFGL A+ D + AG + + P N K S + DV
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 225 FSYGVVLLEIISC-RKPIDAARDPASI 250
+SYG+ + E S +KP + P +
Sbjct: 182 WSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+VMEF+ G+L D++ T ++ + + + RA+ LH +IHRDIKS
Sbjct: 96 VVMEFLEGGALTDIV------THTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSD 147
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230
+IL S KL+DFG S E + GT ++ P + +VD++S G++
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 231 LLEIISCRKP 240
++E+I P
Sbjct: 208 VIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 72/298 (24%), Positives = 128/298 (42%), Gaps = 44/298 (14%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSK-KLNNEI 72
+F + IGKG VYKAI D +++A+K+ FE++ ++ EI
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLL-----DGRVVALKKVQI--FEMMDAKARQDCLKEI 53
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAA 131
+L L N V+ + + N N+L +V+E G L ++ +
Sbjct: 54 DLLKQLDHPN-------VIKYLASFIEN--------NELNIVLELADAGDLSRMIKHFKK 98
Query: 132 ATTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
P R K +Q+ A++ +H I+HRDIK N+ + KL D GL
Sbjct: 99 QKRL---IPERTIWKYFVQLCSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLG 153
Query: 190 VSESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248
S +++ GT Y+ P + + + K D++S G +L E+ + + P D
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKM 211
Query: 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
++ L K K+ + CD P + +++ + +RC++ + E RP I +L
Sbjct: 212 NLYS----LCK--KIEK-CDYP---PLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSL 78
+L+GKG+ G K IL + G + + I R EV+ +D E RVL
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQ-- 50
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
N R+P + + + + VME+ G L+ L T
Sbjct: 51 ---NTRHPFLTALKY---------AFQTHDRLCFVMEYANGGELFFHLSRERVFTE---- 94
Query: 139 WPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE-SDES 196
R + +I A++ LH D +++RDIK N++ D K+ DFGL SD +
Sbjct: 95 --ERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 150
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+M GT YL P + + VD + GVV+ E++ R P
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 78/312 (25%), Positives = 126/312 (40%), Gaps = 54/312 (17%)
Query: 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK 67
E L T+++ IGKG++G VYK ++ DG A+ + + D ++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVT---NKKDG-------SLAAVKILDPISDVDEE 64
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH 127
+ E +L SL +PN VV F+G + V G LV+E GS+ +L+
Sbjct: 65 IEAEYNILQSLPN----HPN--VVKFYGMFYKADKLVGGQL--WLVLELCNGGSVTELV- 115
Query: 128 NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
+L I +Q LH N IIHRD+K NIL ++ KL DFG
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 188 LAVSESDESSMVQPAGTIGYLDPGYTNP----------SKLSKKVDVFSYGVVLLEIISC 237
VS S+ ++ ++G P + P + DV+S G+ +E+
Sbjct: 174 --VSAQLTSTRLRRNTSVG--TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL--- 226
Query: 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCD-SRVGLPTFM--EGAIKQMLHVAARCVSS 294
DP PL ++ + R PT + E + H ++C+
Sbjct: 227 -----GDGDP--------PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIK 273
Query: 295 EEENRPGIGEIL 306
+ E RP + +L
Sbjct: 274 DFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R+IGKG G VY L D +DG A+K S N L++ + L I ++
Sbjct: 1 RVIGKGHFGCVYHGTLID--SDGQKIHCAVK--SLNRITDLEEVEQFLKEGI-IMKDFSH 55
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
N V++ G + GS L+V+ +M +G L + + + T +
Sbjct: 56 PN-------VLSLLGICLPSEGS------PLVVLPYMKHGDLRNFIRSETHNPTVK---- 98
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESSM 198
+ + +Q+++ ++ L +HRD+ + N + D + K+ADFGLA + + + S+
Sbjct: 99 DLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156
Query: 199 VQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
G + ++ K + K DV+S+GV+L E+++
Sbjct: 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 59/237 (24%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK---LNNEIRVLSSL 78
++GKG++G VY A Q +AIK E+ + +S+ L+ EI + S L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVR-----IAIK-------EIPERDSRYVQPLHEEIALHSYL 62
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ N +V + GS N + ME +P GSL LL + P
Sbjct: 63 KHRN-------IVQY-------LGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLKD 105
Query: 139 WPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-KLADFGLAVSESDES 196
+ QI ++ LH+N I+HRDIK N+L ++ K++DFG S
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFG----TSKRL 159
Query: 197 SMVQPA-----GTIGYLDP--------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ + P GT+ Y+ P GY P+ D++S G ++E+ + + P
Sbjct: 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA------DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G++G V+KA D + G + +A+KR E + E+ VL L+
Sbjct: 9 IGEGAYGKVFKA--RDLKNGG--RFVALKRVRVQTGE--EGMPLSTIREVAVLRHLE--T 60
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+PN VV C S D + LV E + + L L P
Sbjct: 61 FEHPN--VVRLFDV-CTVS-RTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP----TET 111
Query: 143 VKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP 201
+K M Q+ R + LH + ++HRD+K NIL S KLADFGLA S + ++
Sbjct: 112 IKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 169
Query: 202 AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
T+ Y P S + VD++S G + E+ RKP+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 14/124 (11%)
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAV-SESDESSMVQPAGTIGYLDPGYTNPSKLSKK 221
II+RD+K NIL D + KL DFGL+ S E GT+ Y+ P N ++
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 222 VDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAI 281
D +S+GV++ E+++ P +D ++E + + +++G+P F+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQ-GKD------------RKETMTMILKAKLGMPQFLSPEA 225
Query: 282 KQML 285
+ +L
Sbjct: 226 QSLL 229
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 35/234 (14%)
Query: 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72
A E + SR +G+GS G VY+ I + D +AIK + + + I
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV---------NEAASMRERI 54
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
L+ + N ++ V R G V L++ME M G L L +
Sbjct: 55 EFLNEASVMKEFNCHHVV--------RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 106
Query: 133 T--TPQLGWP---NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
P P +++A +I+ + L+ N +HRD+ + N + + K+ DFG
Sbjct: 107 MENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFG 164
Query: 188 LA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVLLEI 234
+ + E+D G G L + +P L V DV+S+GVVL EI
Sbjct: 165 MTRDIYETDYYR----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IGKG++G V+K + ++ +G +A+ + + D +++ E +L +L +
Sbjct: 26 IGKGTYGKVFKVL---NKKNG-------SKAAVKILDPIHDIDEEIEAEYNILKALSD-- 73
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL----LHNAAAATTPQL 137
+PN VV F+G + N ++L LV+E GS+ DL L P +
Sbjct: 74 --HPN--VVKFYGMYYKKDVK---NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS 197
+ I + +Q LH N IHRD+K NIL ++ KL DFG VS S+
Sbjct: 127 AY-----ILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFG--VSAQLTST 177
Query: 198 MVQPAGTIGYLDPGYTNP----------SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
++ ++G P + P S + DV+S G+ +E+ P+ A P
Sbjct: 178 RLRRNTSVG--TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP 234
Query: 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ + +P L Q P + +C++ + E RP + ++L
Sbjct: 235 MRAL-FKIPRNPPPTLHQ--------PELWSNEFNDFIR---KCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+GS G V A + ++ G K++A+K+ Q + L NE+ ++ Q N
Sbjct: 28 IGEGSTGIVCIATV---KSSG--KLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHEN 78
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
VV + NS V +VMEF+ G+L D++ T ++
Sbjct: 79 -------VVEMY-----NSYLV--GDELWVVMEFLEGGALTDIV------THTRMNEEQI 118
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP- 201
+ + + +A+ LH +IHRDIKS +IL KL+DFG S E +
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176
Query: 202 AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT ++ P + +VD++S G++++E++ P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 60/261 (22%), Positives = 106/261 (40%), Gaps = 65/261 (24%)
Query: 71 EIRVLSSLQESN--------KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL 122
E+++LS L + N +P C++ ME+M NG L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMI----------------------MEYMENGDL 106
Query: 123 ------YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176
+ + A + L + + +A QI+ ++ L + +HRD+ + N L
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVG 164
Query: 177 SKWDAKLADFGLAVS--ESD----ESSMVQP----AGTIGYLDPGYTNPSKLSKKVDVFS 226
+ K+ADFG++ + SD + P A L K + K DV++
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-------KFTTKSDVWA 217
Query: 227 YGVVLLEIIS-CR-KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQM 284
+GV L EI++ CR +P + D +I+ A +++ RQ+ + P K +
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQ-QVIENAGHFFRDDG-RQIY---LPRPP---NCPKDI 269
Query: 285 LHVAARCVSSEEENRPGIGEI 305
+ C +EE+RP EI
Sbjct: 270 YELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 67/225 (29%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNN--EIRVLSSL 78
IG G++G+VYKA D + +A+K R TN ++ L+ E+ +L L
Sbjct: 8 IGVGAYGTVYKA--RDPHSG---HFVALKSVRVQTN------EDGLPLSTVREVALLKRL 56
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ + +PN +V + D + LV E + DL P G
Sbjct: 57 EAFD--HPN--IVRLMDVCA--TSRTDRETKVTLVFEHVDQ----DL--RTYLDKVPPPG 104
Query: 139 WP-NRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
P +K M Q R + LH N I+HRD+K NIL S KLADFGLA S +
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM 162
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
++ T+ Y P S + VD++S G + E+ RKP+
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 44/236 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F + IG G++G VYKA + T I IK F V+Q EI +
Sbjct: 9 EDFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQ-------QEIIM 59
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLV-MEFMPNGSLYDLLHNAAAAT 133
+ + SN +V + G+ R +KL + MEF GSL D+ H +
Sbjct: 60 MKDCKHSN-------IVAYFGSYLRR--------DKLWICMEFCGGGSLQDIYHVTGPLS 104
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
Q+ + +R + + + LH M HRDIK NIL KLADFG VS
Sbjct: 105 ESQIAYVSR-----ETLQGLYYLHSKGKM--HRDIKGANILLTDNGHVKLADFG--VSAQ 155
Query: 194 DESSMVQPAGTIGYLDPGYTNP--SKLSKK------VDVFSYGVVLLEIISCRKPI 241
+++ + IG P + P + + +K D+++ G+ +E+ + P+
Sbjct: 156 ITATIAKRKSFIG--TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 20/133 (15%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+VME+MP G L +L+ N P+ W R A ++ A+ +H IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNY---DIPE-KWA-RFYTA-EVVLALDAIHSMG--FIHRDVKPD 171
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL---------SKKV 222
N+L D KLADFG + + D + MV+ +G P Y +P L ++
Sbjct: 172 NMLLDKSGHLKLADFGTCM-KMDANGMVRCDTAVG--TPDYISPEVLKSQGGDGYYGREC 228
Query: 223 DVFSYGVVLLEII 235
D +S GV L E++
Sbjct: 229 DWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG GS G+VY A ++++A+K+ S +G + + + + E++ L L+ N
Sbjct: 29 IGHGSFGAVYFA-----TNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPN 82
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
C + H LVME+ GS DLL
Sbjct: 83 TIEYKGCYLKEH--------------TAWLVMEYCL-GSASDLLEVHKKPL-------QE 120
Query: 143 VKIAMQISRAIQCL-HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP 201
V+IA A+Q L + + +IHRDIK+ NIL KLADFG A S +S V
Sbjct: 121 VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-- 178
Query: 202 AGTIGYLDPGY---TNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT ++ P + + KVDV+S G+ +E+ RKP
Sbjct: 179 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 43/143 (30%), Positives = 61/143 (42%), Gaps = 16/143 (11%)
Query: 107 NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166
N LVME+ P G L LL+ + + +A ++ AI +H+ +HR
Sbjct: 73 KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA---QFYLA-ELVLAIHSVHQMG--YVHR 126
Query: 167 DIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ--PAGTIGYLDP-------GYTNPSK 217
DIK N+L D KLADFG A + + P GT Y+ P G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK-GT 185
Query: 218 LSKKVDVFSYGVVLLEIISCRKP 240
+ D +S GV+ E+I R P
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 51/189 (26%), Positives = 73/189 (38%), Gaps = 39/189 (20%)
Query: 145 IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGT 204
I QI ++ LH IIHRD+K+ NI + + D G A + + AGT
Sbjct: 162 IEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 205 IGYLDPGYTNPSKLSKKVDVFSYGVVLLEII-------------------SCR------- 238
+ P K + K D++S G+VL E++ SC
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 239 -----KPIDAARDPAS-----IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVA 288
P + RDP S I++A L ++ R C RV LP E + +ML
Sbjct: 280 STLKVHPEEFPRDPGSRLVRGFIEYA-SLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338
Query: 289 ARCVSSEEE 297
A S EE
Sbjct: 339 AAMRPSAEE 347
|
Length = 357 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH-NAAAATTPQLGWPNRVKIAMQISRA 152
H G V + ++V E+M NGSL L + T QL V + I+
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASG 118
Query: 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDESSMVQPAGTIGYLDPG 211
++ L +D +HRD+ + NIL +S K++DFGL+ V E D + G G +
Sbjct: 119 MKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG--GKIPIR 174
Query: 212 YTNPS-----KLSKKVDVFSYGVVLLEIIS 236
+T P K + DV+SYG+V+ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 54/233 (23%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+GKG++G V+KAI D +T +++A+K+ F+ + N+ R + LQE
Sbjct: 15 LGKGAYGIVWKAI--DRRT---KEVVALKKI----FDAFR-NATDAQRTFREIMFLQELG 64
Query: 83 KRNPNYC-VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+PN ++N + + + LV E+M DL H A N
Sbjct: 65 D-HPNIVKLLNVI--------KAENDKDIYLVFEYMET----DL-HAVIRA--------N 102
Query: 142 RVK------IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSES 193
++ I Q+ +A++ +H + +IHRD+K +NIL +S KLADFGLA +SE
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 194 DESS----MVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCR 238
+E+ + T Y P G T + +K VD++S G +L E++ +
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGST---RYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 42/222 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN-EIRVLSSLQES 81
IGKG+ G VY+ +D +I A+K S ++ + + I V + L ES
Sbjct: 1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
P + F S +S+ LV ++M G L+ H + +
Sbjct: 56 ----PFIVGLKF---------SFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSE----D 96
Query: 142 RVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE-SDESSMV 199
R K + ++ A++ LH+ D I++RD+K NIL D+ L DFGL+ + +D +
Sbjct: 97 RAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154
Query: 200 QPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEI 234
GT YL P GYT K VD +S GV++ E+
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYT------KHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE-IRVLSSLQES 81
+G G+ G+V K + + K +A+K +N L +E +R + +Q+
Sbjct: 3 LGSGNFGTVKKGMY---KMKKSEKTVAVKILKN------DNNDPALKDELLREANVMQQL 53
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+ NP Y V R G + S +LVME G L L T N
Sbjct: 54 D--NP-YIV--------RMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEK-----N 96
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP 201
++ Q+S ++ L E + +HRD+ + N+L ++ AK++DFGL+ + + + +
Sbjct: 97 ITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154
Query: 202 AGT----IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + P N K S K DV+S+GV++ E S
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 78/274 (28%), Positives = 123/274 (44%), Gaps = 62/274 (22%)
Query: 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDH-KI-LAIKRASTNGFEVLQDNSKK 67
++K TE F + +++G G+ G+VYK + +G+ KI +AIK E+ + S K
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIK-------ELREATSPK 51
Query: 68 LNNEI----RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
N EI V++S+ + CR G + S L+ + MP G L
Sbjct: 52 ANKEILDEAYVMASVD--------------NPHVCRLLG-ICLTSTVQLITQLMPFGCLL 96
Query: 124 DLL--HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
D + H + L W +QI++ + L E ++HRD+ + N+L +
Sbjct: 97 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHV 148
Query: 182 KLADFGLA-VSESDESSMVQPAGTI--------GYLDPGYTNPSKLSKKVDVFSYGVVLL 232
K+ DFGLA + +DE G + L YT+ S DV+SYGV +
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS------DVWSYGVTVW 202
Query: 233 EIISC-RKPIDAARDPASIIDWALPLIKEEKLRQ 265
E+++ KP D PAS I + L K E+L Q
Sbjct: 203 ELMTFGSKPYDGI--PASEI--SSILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+F R++GKG G V Q K+ A K+ + KK E L
Sbjct: 1 TFRHYRVLGKGGFGEVCAC-----QVRATGKMYACKKLE-------KKRIKKRKGEAMAL 48
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
+ Q K N + V + +++ LV+ M G L ++N
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDA--------LCLVLTLMNGGDLKFHIYNMGNPGFD 100
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+ V A +I+ ++ LH I++RD+K NIL D +++D GLAV +
Sbjct: 101 E---ERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
++ GT+GY+ P + + D + G ++ E+I + P
Sbjct: 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN-EIRVLSSLQ 79
+++GKGS G V A L+ G ++ AIK + VL+D+ + E RVL+
Sbjct: 1 KVLGKGSFGKVMLAELK-----GTNEFFAIKALKKD--VVLEDDDVECTMVERRVLALAW 53
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
E +C + + VME++ G DL+ + ++
Sbjct: 54 EHPFLTHLFC-------------TFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDE-- 95
Query: 140 PNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
R + A +I +Q LH+ II+RD+K N+L D K+ADFG+ +
Sbjct: 96 -ARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152
Query: 199 VQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT Y+ P K ++ VD +S+GV+L E++ + P
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 29/225 (12%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN-NEIRVLSSLQ 79
R++GKGS G V A L++ ++ A+K + +LQD+ + E R+LS +
Sbjct: 1 RVLGKGSFGKVMLARLKE-----SGRLYAVKVLKKD--VILQDDDVECTMTEKRILSLAR 53
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
YC F VMEF+ G L + H + +
Sbjct: 54 NHPFLTQLYCC--FQTPD-----------RLFFVMEFVNGGDL--MFH---IQKSRRFDE 95
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
A +I+ A+ LH+ II+RD+K N+L D + KLADFG+
Sbjct: 96 ARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153
Query: 200 QP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
GT Y+ P VD ++ GV+L E++ P +A
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 56/171 (32%), Positives = 75/171 (43%), Gaps = 34/171 (19%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--KKLN-NEIRVLSSL 78
L+G+GS+G V K H+ G +I+AIK+ F +D+ KK+ EIR+L L
Sbjct: 8 LVGEGSYGMVMKC---KHKETG--QIVAIKK-----FLESEDDKMVKKIAMREIRMLKQL 57
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ N +VN R + LV EF+ + L DL L
Sbjct: 58 RHEN-------LVNLIEV-FRRKKRL------YLVFEFVDHTVLDDLEKYPNG-----LD 98
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
K QI R I+ H ++ IIHRDIK NIL KL DFG A
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH-NAAAATTPQLGWPNRVKIAMQISRA 152
H G V + +++ EFM NG+L L N T QL V + I+
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAG 118
Query: 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDP-G 211
++ L E + +HRD+ + NIL +S K++DFGL+ D++S ++G P
Sbjct: 119 MKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 212 YTNPS-----KLSKKVDVFSYGVVLLEIIS 236
+T P K + DV+SYG+V+ E++S
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G+ GSV K + G +A+K E + K+ E V++ L
Sbjct: 3 LGHGNFGSVVKGVYL--MKSGKEVEVAVKTLKQ---EHIAAGKKEFLREASVMAQLD--- 54
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+ C+V G C+ +LVME P G L L L
Sbjct: 55 ----HPCIVRLIGV-CKGEPL-------MLVMELAPLGPLLKYLKKRREIPVSDL----- 97
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL--AVSESDESSMVQ 200
++A Q++ + L +HRD+ + N+L ++ AK++DFG+ A+ +
Sbjct: 98 KELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 201 PAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
AG + + P N K S K DV+SYGV L E S
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R++G+GS G +A+L H + R + V ++S+K E +L+ ++
Sbjct: 6 RVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRK---EAVLLAKMKH 57
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ---L 137
N +V F S + + + +VME+ G L + P+ L
Sbjct: 58 PN-------IVAF-------KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDES 196
W +Q+ +Q +HE ++HRDIKS NI KL DFG A + S +
Sbjct: 104 QW------FVQMCLGVQHIHEK--RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
GT Y+ P + K D++S G +L E+ + + P A
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 35/229 (15%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
FS R IG GS G+VY A + + +++AIK+ S +G + +++K + I+ +
Sbjct: 17 FSDLREIGHGSFGAVYFA-----RDVRNSEVVAIKKMSYSG----KQSNEKWQDIIKEVR 67
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
LQ+ R+PN + + G R + LVME+ GS DLL
Sbjct: 68 FLQKL--RHPN--TIQYRGCYLREHTA-------WLVMEYCL-GSASDLLEVHKKPL--- 112
Query: 137 LGWPNRVKIAMQISRAIQCL-HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
V+IA A+Q L + + +IHRD+K+ NIL KL DFG A +
Sbjct: 113 ----QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 196 SSMVQPAGTIGYLDPGY---TNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+ V GT ++ P + + KVDV+S G+ +E+ + P+
Sbjct: 169 NXFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 38/238 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN---SKKLNNEIRVLSS 77
++IGKGS G K +L + DG K A+K VLQ ++K I +
Sbjct: 1 KVIGKGSFG---KVLLAKRKLDG--KCYAVK--------VLQKKIVLNRKEQKHIMAERN 47
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
+ N ++P +V H S V++F+ G L+ H + P+
Sbjct: 48 VLLKNVKHP--FLVGLHY-------SFQTTEKLYFVLDFVNGGELF--FHLQRERSFPE- 95
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL---AVSESD 194
P A +I+ A+ LH + I++RD+K NIL DS+ L DFGL +++SD
Sbjct: 96 --PRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
++ GT YL P VD + G VL E++ P RD A + D
Sbjct: 152 TTTTF--CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 44/236 (18%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G G++G V A T K+ AIK+ S F+ +K+ E+R+L +
Sbjct: 21 SPVGSGAYGQVCSAFD----TKTGRKV-AIKKLS-RPFQSAIH-AKRTYRELRLLKHMDH 73
Query: 81 SNKRNPNYCVVN-FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
N +++ F S S++ + LV M L +++ +L
Sbjct: 74 ENV----IGLLDVFTPAS-----SLEDFQDVYLVTHLM-GADLNNIVK------CQKLS- 116
Query: 140 PNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+ ++ + QI R ++ +H IIHRD+K +NI + + K+ DFGLA DE M
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--M 172
Query: 199 VQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
T Y P Y VD++S G ++ E++ K + D
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQ------TVDIWSVGCIMAELL-TGKTLFPGSDH 221
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 62/251 (24%), Positives = 114/251 (45%), Gaps = 35/251 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R+IG+GS+ V L+ +T+ + + +K+ N E + + ++ + E
Sbjct: 1 RVIGRGSYAKVLLVRLK--KTERIYAMKVVKKELVNDDEDI--------DWVQTEKHVFE 50
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+P +V H SC + S V+E++ G L + H P+
Sbjct: 51 QASNHP--FLVGLH--SCFQT-----ESRLFFVIEYVNGGDL--MFHMQRQRKLPE---E 96
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL---AVSESDESS 197
+ + +IS A+ LHE II+RD+K N+L DS+ KL D+G+ + D +S
Sbjct: 97 HARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154
Query: 198 MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID---AARDP-ASIIDW 253
GT Y+ P VD ++ GV++ E+++ R P D ++ +P + D+
Sbjct: 155 TF--CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212
Query: 254 ALPLIKEEKLR 264
+I E+++R
Sbjct: 213 LFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 58/246 (23%), Positives = 106/246 (43%), Gaps = 43/246 (17%)
Query: 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL 68
E+ + F + +G+G+ G VYK L +AIK N +Q +
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR-- 56
Query: 69 NNEIRVLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL- 126
E ++S LQ +PN C++ G ++ E++ +G L++ L
Sbjct: 57 -QEAELMSDLQ-----HPNIVCLL----------GVCTKEQPTCMLFEYLAHGDLHEFLV 100
Query: 127 ----HNAAAATTPQ------LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176
H+ A + L + + IA+QI+ ++ L + +HRD+ + N L
Sbjct: 101 RNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158
Query: 177 SKWDAKLADFGLA--VSESD----ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230
K++DFGL+ + +D +S + P + ++ P K + + D++S+GVV
Sbjct: 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLP---VRWMPPEAILYGKFTTESDIWSFGVV 215
Query: 231 LLEIIS 236
L EI S
Sbjct: 216 LWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 42/131 (32%), Positives = 61/131 (46%), Gaps = 13/131 (9%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVK--IAMQISRAIQCLHENDPMIIHRDIK 169
++EF+ G L+ L A +PN V ++ A + LH D II+RD+K
Sbjct: 95 FLLEFVVGGELFTHLRKAGR-------FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLK 145
Query: 170 STNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229
N+L D+K K+ DFG A D + + GT YL P K VD ++ GV
Sbjct: 146 PENLLLDNKGHVKVTDFGFAKKVPDRTFTL--CGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 230 VLLEIISCRKP 240
+L E I+ P
Sbjct: 204 LLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 40/225 (17%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKI-LAIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78
R IG+G G VY+ + + + KI +A+K +K L
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENE---KIAVAVKTCKN---CTSPSVREKF---------L 55
Query: 79 QES----NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH-NAAAAT 133
QE+ +P+ +V G V + +VME P G L L N +
Sbjct: 56 QEAYIMRQFDHPH--IVKLIG--------VITENPVWIVMELAPLGELRSYLQVNKYSLD 105
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
L + + Q+S A+ L +HRDI + N+L S KL DFGL+
Sbjct: 106 LASL-----ILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
Query: 194 DESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
DES G I ++ P N + + DV+ +GV + EI+
Sbjct: 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 3/97 (3%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP-AGTIG 206
+IS A++ LH+ II+RD+K NIL D++ KL DFGL E ++ GTI
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 207 YLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
Y+ P S K VD +S G ++ ++++ P A
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 7/123 (5%)
Query: 134 TPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VS 191
+PQ + VK+ + QI R ++ LH I+HRDIK N+L +S K+ DFGLA V
Sbjct: 96 SPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153
Query: 192 ESDES-SMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
E DES M Q T Y P S+ + VD++S G + E++ R+ + A+ P
Sbjct: 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQ 212
Query: 250 IID 252
+D
Sbjct: 213 QLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G++G VYKA D T +I+A+K+ + ++ + IR +S L+E N
Sbjct: 7 IGEGTYGVVYKA--RDKLTG---EIVALKK-----IRLETEDEGVPSTAIREISLLKELN 56
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+PN +V V + NKL LV EF+ DL ++ L P
Sbjct: 57 --HPN--IVRLL--------DVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLD-PP 99
Query: 142 RVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+K + Q+ + I H + ++HRD+K N+L D + KLADFGLA
Sbjct: 100 LIKSYLYQLLQGIAYCHSH--RVLHRDLKPQNLLIDREGALKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 49/298 (16%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
++ ++IG G G V++ IL + G ++ + G+ Q +E ++
Sbjct: 6 HITKQKVIGAGEFGEVFRGIL---KMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIM 60
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
H R G V +++ E+M NG+L L + +
Sbjct: 61 GQFS--------------HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS 106
Query: 136 -QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSES 193
QL V + I+ ++ L + + +HRD+ + NIL +S + K++DFGL+ V E
Sbjct: 107 YQL-----VGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159
Query: 194 DESSMVQPAG---TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKPIDAARDPAS 249
D +G I + P K + DV+S+G+V+ E++S +P
Sbjct: 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY-------- 211
Query: 250 IIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
W + E ++ + D R+ P A+ Q++ +C + RP +I+
Sbjct: 212 ---WDMS--NHEVMKAINDGFRLPAPMDCPSAVYQLM---LQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 10/130 (7%)
Query: 113 VMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKST 171
VME+ G L+ L + R + +I A+ LH D +++RD+K
Sbjct: 73 VMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALGYLHSCD--VVYRDLKLE 124
Query: 172 NILFDSKWDAKLADFGLAVSE-SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230
N++ D K+ DFGL SD ++M GT YL P + + VD + GVV
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 231 LLEIISCRKP 240
+ E++ R P
Sbjct: 185 MYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 33/249 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R+IG+GS+ V L+ + +I A+K E++ D+ + ++ + E
Sbjct: 1 RVIGRGSYAKVLLVRLKKND-----QIYAMKVVKK---ELVHDDEDI--DWVQTEKHVFE 50
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
NP +V H SC + S LV+E++ G L + H P+
Sbjct: 51 QASSNP--FLVGLH--SCFQT-----TSRLFLVIEYVNGGDL--MFHMQRQRKLPE---E 96
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL---AVSESDESS 197
+ A +I A+ LHE II+RD+K N+L D+ KL D+G+ + D +S
Sbjct: 97 HARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154
Query: 198 MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI--IDWAL 255
GT Y+ P + VD ++ GV++ E+++ R P D D + D+
Sbjct: 155 TF--CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
Query: 256 PLIKEEKLR 264
+I E+ +R
Sbjct: 213 QVILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 34/236 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNEIRVLSS 77
++IGKGS G K +L H+ + K A+K VLQ + KK I +
Sbjct: 1 KVIGKGSFG---KVLLARHKAE--EKFYAVK--------VLQKKAILKKKEEKHIMSERN 47
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
+ N ++P ++F S V++++ G L+ L P+
Sbjct: 48 VLLKNVKHPFLVGLHF---------SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA 98
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS 197
+ A +I+ A+ LH + I++RD+K NIL DS+ L DFGL + +
Sbjct: 99 RF-----YAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151
Query: 198 MVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
GT YL P + + VD + G VL E++ P +R+ A + D
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 62/233 (26%), Positives = 95/233 (40%), Gaps = 29/233 (12%)
Query: 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72
+S + R +G G+ G VY+ + DGD L + + QD S L E
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYR--GRDGDAVELQVAVKTLPESCSEQDESDFLM-EA 60
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL-HNAAA 131
++S N +V G S + +++E M G L L N
Sbjct: 61 LIMSKFNHQN-------IVRLIGVSFERL-------PRFILLELMAGGDLKSFLRENRPR 106
Query: 132 ATTP-QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD---AKLADFG 187
P L + + A +++ + L EN IHRDI + N L K AK+ADFG
Sbjct: 107 PERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFG 164
Query: 188 LAVSESDESSMVQPAGT----IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+A + +S + G I ++ P + K DV+S+GV+L EI S
Sbjct: 165 MA-RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 39/224 (17%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G G V ++ + A+K V + + +E +L +E N
Sbjct: 1 LGVGGFGRVELVKVKSKN-----RTFALKCVKKRHI-VETGQQEHIFSEKEIL---EECN 51
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+P +V + T ++ + ++ME+ G L+ +L + R
Sbjct: 52 --HPF--IVKLYRTF-KDKKYI------YMLMEYCLGGELWTILRDRGLFDEYT----AR 96
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPA 202
IA + A + LH II+RD+K N+L DS KL DFG A
Sbjct: 97 FYIACVVL-AFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153
Query: 203 GTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT Y+ P GY S VD +S G++L E+++ R P
Sbjct: 154 GTPEYVAPEIILNKGYD----FS--VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQL--GWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169
LV + MP+G L D +H QL W +QI++ + L E ++HRD+
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER--RLVHRDLA 136
Query: 170 STNILFDSKWDAKLADFGLA-VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFS 226
+ N+L S K+ DFGLA + E DE G I ++ + K + + DV+S
Sbjct: 137 ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWS 196
Query: 227 YGVVLLEIISC-RKPIDA 243
YGV + E+++ KP D
Sbjct: 197 YGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 71/297 (23%), Positives = 132/297 (44%), Gaps = 36/297 (12%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
F+ R++GKG GSV +A L+ DG + +A+K + F +S + +R +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLK--SEDGSFQKVAVKMLKADIF-----SSSDIEEFLREAA 53
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP- 135
++E + +PN V+ G S R S + ++++ FM +G L+ L + P
Sbjct: 54 CMKEFD--HPN--VIKLIGVSLR-SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
L V+ + I+ ++ L + IHRD+ + N + + +ADFGL S+
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGL--SKKIY 164
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVLLEIISCRKPIDAARDPASI 250
S G L + L+ V DV+++GV + EI++ + A + + I
Sbjct: 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
Query: 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307
++ LIK +L+Q P +E + +++ +C S E + RP +
Sbjct: 225 YNY---LIKGNRLKQP-------PDCLE-DVYELMC---QCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPA---GT 204
QI A+ +H M HRD+KS NI KL DFG + SD S+ + GT
Sbjct: 177 QIVLALDEVHSRKMM--HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 205 IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
YL P + SKK D++S GV+L E+++ +P
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-08
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 30/222 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+L+GKG+ G K IL + G + + I + + +D E RVL
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEV---IIAKDEVAHTLTESRVLK---- 50
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
N R+P + + S VME++ G L+ L +
Sbjct: 51 -NTRHPFLTSLKY---------SFQTKDRLCFVMEYVNGGELFFHLSRERVFSE------ 94
Query: 141 NRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE-SDESSM 198
+R + +I A+ LH I++RD+K N++ D K+ DFGL +D ++M
Sbjct: 95 DRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT YL P + + VD + GVV+ E++ R P
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 75/293 (25%), Positives = 112/293 (38%), Gaps = 59/293 (20%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
L+GKG+ G V+K L+D +A+K T ++ Q+ K +E R+L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTP------VAVK---TCKEDLPQELKIKFLSEARILKQYDHP 52
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA-AATTPQLGWP 140
N +V G C + +VME +P G L T QL
Sbjct: 53 N-------IVKLIGV-CTQRQPI------YIVMELVPGGDFLSFLRKKKDELKTKQL--- 95
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD--ESSM 198
VK A+ + + L + IHRD+ + N L K++DFG++ E D SS
Sbjct: 96 --VKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS---CRKP---IDAARDPASIID 252
I + P N + S + DV+SYG++L E S C P AR+
Sbjct: 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---- 207
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
E+ R C + + V RC + ENRP E+
Sbjct: 208 -------EKGYRMSCPQKCP---------DDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQ--LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169
LV + P GSL D + + PQ L W +QI++ + L E+ ++HR++
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEEH--RMVHRNLA 136
Query: 170 STNILFDSKWDAKLADFGLA--VSESDESSMVQPAGT-IGYLDPGYTNPSKLSKKVDVFS 226
+ NIL S ++ADFG+A + D+ T I ++ + + + DV+S
Sbjct: 137 ARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWS 196
Query: 227 YGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQ 265
YGV + E++S A P + D L K E+L Q
Sbjct: 197 YGVTVWEMMSYGAEPYAGMRPHEVPDL---LEKGERLAQ 232
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 146 AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP-AGT 204
A +++ A+ LH + +I+RD+K NIL D++ KLADFG+ GT
Sbjct: 102 AAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159
Query: 205 IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
Y+ P + VD ++ GV++ E+++ + P +A
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKI-LAIK---RASTNGFEVLQDNSKKLNNEIRVLS 76
+G G+ G VY+ D G I +A+K + +T+ K+ E ++S
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD------QEKKEFLKEAHLMS 54
Query: 77 SLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
N +PN ++ G N + ++ME M G L L +A
Sbjct: 55 -----NFNHPNIVKLL----------GVCLLNEPQYIIMELMEGGDLLSYLRDARVERFG 99
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDA----KLADFGLA- 189
+ + + + A C++ IHRD+ + N L K +DA K+ DFGLA
Sbjct: 100 PPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
Query: 190 -VSESD----ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ +SD E + P + ++ P K + + DV+S+GV++ EI++
Sbjct: 160 DIYKSDYYRKEGEGLLP---VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 60/286 (20%), Positives = 120/286 (41%), Gaps = 59/286 (20%)
Query: 41 TDGDHKILAIKRASTNGFEVLQDNSKKLN----NEIRVLSSLQESNKRNPNYCVVNFHGT 96
+ G ++ NG + + +N +EI + LQ N +V G
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPN-------IVKLIGL 751
Query: 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCL 156
CR+ L+ E++ +L ++L N L W R KIA+ I++A++ L
Sbjct: 752 -CRS------EKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFL 796
Query: 157 HEN-DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES---DESSMVQPAGTIGYLDPGY 212
H P ++ ++ I+ D K + L L++ D + A Y+ P
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISSA----YVAPET 849
Query: 213 TNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD-PASIIDWALPLIKEEKLRQVCDSRV 271
+++K D++ +G++L+E+++ + P DA SI++WA + C S
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA----------RYCYSDC 899
Query: 272 GLPTFMEGAIK--------QMLHV---AARCVSSEEENRPGIGEIL 306
L +++ +I+ +++ V A C +++ RP ++L
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945
|
Length = 968 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 59/242 (24%), Positives = 112/242 (46%), Gaps = 50/242 (20%)
Query: 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSK 66
YE+L K IG+G++G+V+KA ++ +T H+I+A+KR + D+
Sbjct: 2 YEKLEK----------IGEGTYGTVFKA--KNRET---HEIVALKRVRLD-----DDDEG 41
Query: 67 KLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL 126
++ +R + L+E +N +V + + + LV E+ + L
Sbjct: 42 VPSSALREICLLKELKHKN----IVRLYDV-------LHSDKKLTLVFEYC-DQDLKKYF 89
Query: 127 HNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ P++ VK M Q+ + + H ++ ++HRD+K N+L + + KLAD
Sbjct: 90 DSCNGDIDPEI-----VKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLAD 142
Query: 186 FGLAVS-----ESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRK 239
FGLA + + +V T+ Y P +KL S +D++S G + E+ + +
Sbjct: 143 FGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
Query: 240 PI 241
P+
Sbjct: 199 PL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R+IG+GS+ V L+ +T + + IK+ E++ D+ + ++ + E
Sbjct: 1 RVIGRGSYAKVLLVELK--KTRRIYAMKVIKK------ELVNDDEDI--DWVQTEKHVFE 50
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ +P +V H SC + S V+EF+ G L + H P+
Sbjct: 51 TASNHP--FLVGLH--SCFQT-----ESRLFFVIEFVSGGDL--MFHMQRQRKLPE---E 96
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL---AVSESDESS 197
+ + +IS A+ LHE II+RD+K N+L D++ KL D+G+ + D +S
Sbjct: 97 HARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154
Query: 198 MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242
GT Y+ P VD ++ GV++ E+++ R P D
Sbjct: 155 TF--CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 42/239 (17%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL-NNEIRV 74
+F Q +G+G++ +VYK + +I+A+K E+ D + + IR
Sbjct: 1 NFKQLEKLGEGTYATVYKG-----RNRTTGEIVALK-------EIHLDAEEGTPSTAIRE 48
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
+S ++E ++ N +V H V NKL LV E+M DL
Sbjct: 49 ISLMKEL--KHEN--IVRLH--------DVIHTENKLMLVFEYMDK----DLKKYMDTHG 92
Query: 134 TPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--- 189
PN VK Q+ + I HEN ++HRD+K N+L + + + KLADFGLA
Sbjct: 93 VRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAF 150
Query: 190 -VSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARD 246
+ + S+ V T+ Y P S+ S +D++S G ++ E+I+ R P+ +
Sbjct: 151 GIPVNTFSNEVV---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G+ G+VYKA H +ILA+K + D + +L +I +S L+
Sbjct: 9 LGHGNGGTVYKAY---HLLTR--RILAVK-------VIPLDITVELQKQI--MSELEILY 54
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
K + Y + + N S+ EFM GSL D+ LG
Sbjct: 55 KCDSPYIIGFYGAFFVENRISI--------CTEFMDGGSL-DVYRKIPE---HVLG---- 98
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP- 201
+IA+ + + + L I+HRD+K +N+L +++ KL DFG VS +S+ +
Sbjct: 99 -RIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFG--VSTQLVNSIAKTY 153
Query: 202 AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT Y+ P + + DV+S G+ +E+ R P
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 14/136 (10%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGW---PNRVKIAMQISRAIQCLHENDPMIIHRDI 168
VME++ G DL++ Q+G P+ V A +I+ + LH II+RD+
Sbjct: 78 FVMEYVNGG---DLMYQ-----IQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDL 127
Query: 169 KSTNILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSY 227
K N++ DS+ K+ADFG+ D + GT Y+ P K VD +++
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187
Query: 228 GVVLLEIISCRKPIDA 243
GV+L E+++ + P +
Sbjct: 188 GVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 70/232 (30%), Positives = 100/232 (43%), Gaps = 51/232 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G+ G VYKA Q + A K T E L+D EI +L+S N
Sbjct: 13 LGDGAFGKVYKA-----QNKETGVLAAAKVIDTKSEEELEDYMV----EIDILASCDHPN 63
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDG---NSNKLLVMEFMPNGSLYD-LLHNAAAATTPQLG 138
+V +D +N +++EF G++ +L T PQ+
Sbjct: 64 -------IVKL----------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQI- 105
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
RV + Q A+ LHEN IIHRD+K+ NILF D KLADFG VS + ++
Sbjct: 106 ---RV-VCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFG--VSAKNTRTI 157
Query: 199 VQPAGTIGYLDPGYTNPS----KLSK------KVDVFSYGVVLLEIISCRKP 240
+ IG P + P + SK K DV+S G+ L+E+ P
Sbjct: 158 QRRDSFIG--TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R +G+G+ G V+ A + D ++A+K +D E +L++LQ
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD----FQREAELLTNLQH 66
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAA------- 131
+ +V F+G DG+ ++V E+M +G L L H A
Sbjct: 67 EH-------IVKFYGVC------GDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112
Query: 132 --ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+LG + IA QI+ + L +HRD+ + N L + K+ DFG++
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMS 170
Query: 190 VSESDESSMVQPAG----TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + + G I ++ P K + + DV+S+GV+L EI +
Sbjct: 171 -RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 31/101 (30%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDESSMVQPAGTIG 206
Q+ R ++ +H + ++HRD+K +N+L ++ D K+ DFGLA + M + T
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW 173
Query: 207 YLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
Y P N S+ + +DV+S G + E++ RKP+ +D
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
LV+ F+ G L+ L + R A ++ A++ LH+ + +I+RD+K
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSR----ARFYTA-ELLCALENLHKFN--VIYRDLKPE 122
Query: 172 NILFDSKWDAKLADFGLA---VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYG 228
NIL D + L DFGL + + D+++ GT YL P +K VD ++ G
Sbjct: 123 NILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYLAPELLLGHGYTKAVDWWTLG 180
Query: 229 VVLLEIISCRKP 240
V+L E+++ P
Sbjct: 181 VLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+V E+M NG L + L P +++ + + L IHRD+ +
Sbjct: 76 IVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLESKQ--FIHRDLAAR 129
Query: 172 NILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229
N L D + K++DFGL+ V + + +S V + + P SK S K DV+++GV
Sbjct: 130 NCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGV 189
Query: 230 VLLEIISCRK 239
++ E+ S K
Sbjct: 190 LMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 31/82 (37%), Positives = 42/82 (51%), Gaps = 7/82 (8%)
Query: 107 NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166
+ L+ME++P G + LL T + R IA I AI +H+ IHR
Sbjct: 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEE----TRFYIAETI-LAIDSIHKLG--YIHR 125
Query: 167 DIKSTNILFDSKWDAKLADFGL 188
DIK N+L D+K KL+DFGL
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 25/225 (11%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+F R++GKG G V Q K+ A K+ + + + LN E R+L
Sbjct: 1 TFRHYRVLGKGGFGEVCAC-----QVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRIL 54
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
+ + Y + + LV+ M G L ++N P
Sbjct: 55 EKVNSRFVVSLAY--------------AYETKDALCLVLTIMNGGDLKFHIYNMG---NP 97
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+ A ++ ++ L I++RD+K NIL D + +++D GLAV +
Sbjct: 98 GFDEQRAIFYAAELCCGLEDLQRE--RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
++ GT+GY+ P N K + D + G ++ E+I + P
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 40/226 (17%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G++G VYKA + T + IK + F ++Q EI ++ + N
Sbjct: 17 VGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQ-------QEIFMVKECKHCN 67
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLV-MEFMPNGSLYDLLHNAAAATTPQLGWPN 141
V F R KL + ME+ GSL D+ H + Q+ +
Sbjct: 68 ------IVAYFGSYLSRE---------KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQP 201
R + + + LH M HRDIK NIL D KLADFG+A + +++ +
Sbjct: 113 R-----ETLQGLAYLHSKGKM--HRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKR 163
Query: 202 AGTIG---YLDPGYTNPSK---LSKKVDVFSYGVVLLEIISCRKPI 241
IG ++ P K ++ D+++ G+ +E+ + P+
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 44/141 (31%), Positives = 64/141 (45%), Gaps = 20/141 (14%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+VME+MP G L +L+ N W R A ++ A+ +H IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTA-EVVLALDAIHSMG--FIHRDVKPD 171
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLS---------KKV 222
N+L D KLADFG + + E MV+ +G P Y +P L ++
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVG--TPDYISPEVLKSQGGDGYYGREC 228
Query: 223 DVFSYGVVLLEIISCRKPIDA 243
D +S GV L E++ P A
Sbjct: 229 DWWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 43/232 (18%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G+ G V+ A + + D ++A+K E + + E +L+ LQ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQREAELLTVLQHQH 68
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL----------YDLLHNAAAA 132
+V F+G C + L+V E+M +G L +L
Sbjct: 69 -------IVRFYGV-CTEGRPL------LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 133 TTPQLGWPNRVKIAMQISRA---IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
QL + IA QI+ + LH +HRD+ + N L K+ DFG+
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIGDFGM- 168
Query: 190 VSESDESSMVQPAG-----TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
S S+ G I ++ P K + + D++S+GVVL EI +
Sbjct: 169 -SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 63/301 (20%), Positives = 119/301 (39%), Gaps = 44/301 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + +G+G G V+ A + + +G ++ +K E LQ ++ E+ +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDM 61
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-- 132
L N VV G CR + +++E+ G L L +
Sbjct: 62 FRKLSHKN-------VVRLLGL-CREA------EPHYMILEYTDLGDLKQFLRATKSKDE 107
Query: 133 --TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA- 189
P L +V + QI+ + L +HRD+ + N L S+ + K++ L+
Sbjct: 108 KLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
Query: 190 -VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248
V S+ + + +L P S K DV+S+GV++ E+ + +
Sbjct: 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE--------- 216
Query: 249 SIIDWALP---LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
LP L EE L ++ ++ LP EG ++ + RC + ++RP E+
Sbjct: 217 ------LPFYGLSDEEVLNRLQAGKLELPV-PEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
Query: 306 L 306
+
Sbjct: 270 V 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGY 207
QI R ++ +H ++HRD+K +NIL + D K+ DFGLA +Q GY
Sbjct: 116 QILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLA--------RIQDPQMTGY 165
Query: 208 LDPGYTNP-------SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
+ Y K +VD++S G + E++ KP+ +D
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE-GKPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 47/237 (19%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN-NEIRVL 75
F+ ++GKGS G V A + G ++ AIK + ++QD+ + E RVL
Sbjct: 2 FNFLMVLGKGSFGKVMLA-----ERKGTDELYAIKILKKD--VIIQDDDVECTMVEKRVL 54
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATT 134
+ L P + + H SC + ++L VME++ G DL+++
Sbjct: 55 A-LPG----KPPF-LTQLH--SCFQT------MDRLYFVMEYVNGG---DLMYH-----I 92
Query: 135 PQLG---WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
Q+G P+ V A +I+ + LH II+RD+K N++ D++ K+ADFG+
Sbjct: 93 QQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMC-- 148
Query: 192 ESDESSMVQPA------GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242
+ ++ GT Y+ P K VD +++GV+L E+++ + P D
Sbjct: 149 ---KENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 36/152 (23%)
Query: 112 LVMEFMPNGSLYDLL-HNAAAATT----------------PQLGWPNRVKIAMQISRAIQ 154
L+ E+M G L + L H + A L ++ IA Q++ +
Sbjct: 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144
Query: 155 CLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----------VSESDESSMVQPAGT 204
L E +HRD+ + N L K+ADFGL+ SE+D A
Sbjct: 145 YLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND-------AIP 195
Query: 205 IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
I ++ P ++ + + DV++YGVVL EI S
Sbjct: 196 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 46/180 (25%), Positives = 72/180 (40%), Gaps = 43/180 (23%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN----------EI 72
+G+G++G V KA D T KI+AIK+ ++L E+
Sbjct: 17 LGEGTYGKVEKAY--DTLT---GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 73 RVLSSLQESNKRNPN--YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA 130
++++ ++ N Y +F LVM+ M L ++
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFIN----------------LVMDIM-ASDLKKVVDRKI 114
Query: 131 AATTPQLGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
T Q VK I +QI + LH+ +HRD+ NI +SK K+ADFGLA
Sbjct: 115 RLTESQ------VKCILLQILNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADFGLA 166
|
Length = 335 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 8/127 (6%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
+V EFM NG L + L + + + + + ++ L N IHRD+ +
Sbjct: 76 IVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLERNS--FIHRDLAAR 129
Query: 172 NILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229
N L S K++DFG+ V + + +S + + P N SK S K DV+S+GV
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 230 VLLEIIS 236
++ E+ +
Sbjct: 190 LMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 35/232 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + + IG+G++G VYKA D T+ + +A+K+ + Q++ + IR
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA--RDRVTN---ETIALKK-----IRLEQEDEGVPSTAIRE 51
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+S L+E N +V V LV E++ DL ++
Sbjct: 52 ISLLKEMQHGN----IVRLQDV-------VHSEKRLYLVFEYL------DLDLKKHMDSS 94
Query: 135 PQLGWPNR-VKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-KLADFGLAVS 191
P R +K + QI R I H + ++HRD+K N+L D + +A KLADFGLA +
Sbjct: 95 PDFAKNPRLIKTYLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152
Query: 192 ES-DESSMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPI 241
+ T+ Y P S+ S VD++S G + E+++ +KP+
Sbjct: 153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKR----ASTNGFEVLQDNSKKLNNE 71
+F + IG+G++G VYKA + T +++A+K+ T G +
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKLTG---EVVALKKIRLDTETEGVP---------STA 46
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAA 130
IR +S L+E N +PN +V V NKL LV EF+ + L + +
Sbjct: 47 IREISLLKELN--HPN--IVKLL--------DVIHTENKLYLVFEFL-HQDLKKFMDASP 93
Query: 131 AATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+ P +K + Q+ + + H + ++HRD+K N+L +++ KLADFGLA
Sbjct: 94 LSGIPL----PLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLA 147
Query: 190 VSES-DESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCR 238
+ + T+ Y P K S VD++S G + E+++ R
Sbjct: 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 34/137 (24%), Positives = 65/137 (47%), Gaps = 28/137 (20%)
Query: 113 VMEFMPNGSLYDLLHNA---AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169
V E++P +L ++L A T ++ +Q+ A+ C H I+HRD+K
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGET--------GRLMLQVLDALACAHNQG--IVHRDLK 106
Query: 170 STNILF---DSKWDAKLADFGLA-----VSESDESSMVQPAGTIGYLDPGYTNPSKL--- 218
NI+ + AK+ DFG+ V ++D +++ + +G P Y P +L
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLG--TPTYCAPEQLRGE 164
Query: 219 --SKKVDVFSYGVVLLE 233
+ D++++G++ LE
Sbjct: 165 PVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 11/104 (10%)
Query: 152 AIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPG 211
A+ LH IIHRD+K+ NI D +A L DFG A Q G G L+
Sbjct: 197 ALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE-- 252
Query: 212 YTNPSKLS------KKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
TN +L K D++S G+VL E+ + + +S
Sbjct: 253 -TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 37/137 (27%), Positives = 62/137 (45%), Gaps = 8/137 (5%)
Query: 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDP 161
G S LV EFM +G L D L A + + + + + + L ++
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLR----AQRGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 162 MIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLS 219
+IHRD+ + N L K++DFG+ V + +S + + P + SK S
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 220 KKVDVFSYGVVLLEIIS 236
K DV+S+GV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 48/226 (21%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+++G+G GSV + L Q DG +A+K + ++ + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLS--QDDGSQLKVAVKTMKLDIH-----TYSEIEEFLSEAA 53
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
+++ + +PN V+ G S S+ ++++ FM +G L+ L + P+
Sbjct: 54 CMKDFD--HPN--VMKLIGVCFEAS-SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE 108
Query: 137 -LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
L +K + I+ ++ L + IHRD+ + N + +ADFGL+
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSG 166
Query: 196 SSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVLLEIIS 236
Q G I + + L+ +V DV+++GV + EI +
Sbjct: 167 DYYRQ--GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 46/144 (31%), Positives = 68/144 (47%), Gaps = 23/144 (15%)
Query: 109 NKLLVM-EFMPNGSL-YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166
KL +M EF P G++ +L T PQ+ +V I Q+ A+Q LH IIHR
Sbjct: 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQI----QV-ICRQMLEALQYLHSMK--IIHR 134
Query: 167 DIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP----------S 216
D+K+ N+L D KLADFG VS + ++ + IG P + P +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFG--VSAKNVKTLQRRDSFIG--TPYWMAPEVVMCETMKDT 190
Query: 217 KLSKKVDVFSYGVVLLEIISCRKP 240
K D++S G+ L+E+ P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 29/222 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+L+GKG+ G K IL + G + + I + V +D E RVL
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEV---IVAKDEVAHTLTENRVLQ---- 50
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
N R+P + + S + VME+ G L+ L +
Sbjct: 51 -NSRHPFLTALKY---------SFQTHDRLCFVMEYANGGELFFHLSRERVFSE------ 94
Query: 141 NRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE-SDESSM 198
+R + +I A+ LH ++ +++RD+K N++ D K+ DFGL D ++M
Sbjct: 95 DRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT YL P + + VD + GVV+ E++ R P
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 56/187 (29%), Positives = 81/187 (43%), Gaps = 46/187 (24%)
Query: 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS- 65
YE+L K IG+GS+G V+K ++ G I+AIK+ F +D+
Sbjct: 3 YEKLSK----------IGEGSYGVVFKC---RNRETGQ--IVAIKK-----FVESEDDPV 42
Query: 66 -KKLN-NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSL 122
KK+ EIR+L L+ N +VN V KL LV E+ + L
Sbjct: 43 IKKIALREIRMLKQLKHPN-------LVNLI--------EVFRRKRKLHLVFEYCDHTVL 87
Query: 123 YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182
+L N + KI Q +A+ H+++ IHRD+K NIL + K
Sbjct: 88 NELEKNPRGVPEHLI-----KKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIK 140
Query: 183 LADFGLA 189
L DFG A
Sbjct: 141 LCDFGFA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
++MEF+ G+L D++ + +L + + +A+ LH +IHRDIKS
Sbjct: 95 VLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSD 146
Query: 172 NILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230
+IL KL+DFG S D GT ++ P + + +VD++S G++
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 231 LLEIISCRKP 240
++E++ P
Sbjct: 207 VIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 13/90 (14%)
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW---PNRVKIAMQISRAIQCLHEN 159
S+ +N LVME++ G + LLH G+ VK +++ A+ LH +
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH--------IYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
IIHRD+K N+L ++ KL DFGL+
Sbjct: 124 G--IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 53/231 (22%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 16 SFSQSRLIGKGSHGSVYKA--ILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+F + IG+G VY+A +L D +A+K+ F+++ ++K + I+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLL-------DGVPVALKKVQI--FDLM--DAKARADCIK 51
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+ L++ N +PN V+ ++ + + N+L +V+E G L ++ +
Sbjct: 52 EIDLLKQLN--HPN--VIKYYASFIED--------NELNIVLELADAGDLSRMIKHFKKQ 99
Query: 133 TTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+ P + K +Q+ A++ +H ++HRDIK N+ + KL D GL
Sbjct: 100 ---KRLIPEKTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGR 154
Query: 191 SESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
S +++ GT Y+ P + + + K D++S G +L E+ + + P
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 33/81 (40%), Positives = 43/81 (53%), Gaps = 13/81 (16%)
Query: 112 LVMEFMPNGSLYDLL--HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM-IIHRDI 168
LVME+MP G L +LL + T R IA ++ A+ +H+ + IHRDI
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETA------RFYIA-ELVLALDSVHK---LGFIHRDI 127
Query: 169 KSTNILFDSKWDAKLADFGLA 189
K NIL D+ KLADFGL
Sbjct: 128 KPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+++GKGS G V A L+ G + A+K A ++ D+ + E RVL+ E
Sbjct: 1 KVLGKGSFGKVLLAELK-----GKGEYFAVK-ALKKDVVLIDDDVECTMVEKRVLALAWE 54
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ YC + + VMEF+ G L + + +
Sbjct: 55 NPFLTHLYC-------------TFQTKEHLFFVMEFLNGGDLMFHIQDKG-----RFDLY 96
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----VSESDES 196
A +I +Q LH II+RD+K N++ D K+ADFG+ ++ S
Sbjct: 97 RATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ GT Y+ P K + VD +S+GV+L E++ + P
Sbjct: 155 TF---CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 75/315 (23%), Positives = 133/315 (42%), Gaps = 71/315 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSS--- 77
+ +G+G G V KA + + +A+K +L++N+ +E+R L S
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVK--------MLKENASS--SELRDLLSEFN 55
Query: 78 -LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
L++ N +P+ V+ +G +C G + LL++E+ GSL L +
Sbjct: 56 LLKQVN--HPH--VIKLYG-ACSQDGPL------LLIVEYAKYGSLRSFLRESRKVGPSY 104
Query: 137 LGWPNR-------------------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177
LG + A QISR +Q L E ++HRD+ + N+L
Sbjct: 105 LGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAE 162
Query: 178 KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-----SKKVDVFSYGVVLL 232
K++DFGL+ +E S V+ + G + + L + + DV+S+GV+L
Sbjct: 163 GRKMKISDFGLSRDVYEEDSYVKRSK--GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 220
Query: 233 EIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAAR 290
EI++ +P P I E+L + + R+ P E ++M ++
Sbjct: 221 EIVTL------GGNP-------YPGIAPERLFNLLKTGYRMERP---ENCSEEMYNLMLT 264
Query: 291 CVSSEEENRPGIGEI 305
C E + RP +I
Sbjct: 265 CWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 68/273 (24%), Positives = 111/273 (40%), Gaps = 45/273 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F+ R +G GS G V IL ++ + D +AIKR + + Q + +E ++
Sbjct: 30 EDFNFIRTLGTGSFGRV---ILATYK-NEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKI 84
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L N N +CV N +G S S LV+EF+ G + L
Sbjct: 85 L------NYINHPFCV-NLYG-------SFKDESYLYLVLEFVIGGEFFTFLRRNKR--- 127
Query: 135 PQLGWPNRVKI--AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
+PN V A QI + L + I++RD+K N+L D K+ DFG A +
Sbjct: 128 ----FPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFA--K 179
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
++ GT Y+ P K D ++ G+ + EI+ P A
Sbjct: 180 VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE------- 232
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQML 285
PL+ +K + + + P F++ K ++
Sbjct: 233 ---PLLIYQK---ILEGIIYFPKFLDNNCKHLM 259
|
Length = 340 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 32/80 (40%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 109 NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168
N L+MEF+P G + LL T + + IA + AI +H+ IHRDI
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEE----TQFYIAETV-LAIDSIHQLG--FIHRDI 127
Query: 169 KSTNILFDSKWDAKLADFGL 188
K N+L DSK KL+DFGL
Sbjct: 128 KPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 33/232 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF--EVLQDNSKKLNNEIRVLSSLQE 80
+G+G++G V A + +T + + AIK+ TN F ++L +K+ E+++L +
Sbjct: 8 LGQGAYGIVCSA--RNAETSEEETV-AIKKI-TNVFSKKIL---AKRALRELKLLRHFR- 59
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+N + + G+ + L E M DL + + L
Sbjct: 60 -GHKN----ITCLYDMDIVFPGNFNE---LYLYEELME----ADL--HQIIRSGQPLTDA 105
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-----VSESDE 195
+ QI ++ +H + ++HRD+K N+L ++ + K+ DFGLA +
Sbjct: 106 HFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
Query: 196 SSMVQPAGTIGYLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
M + T Y P + +K +DV+S G +L E++ RKP+ +D
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 68/295 (23%), Positives = 131/295 (44%), Gaps = 42/295 (14%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+F + IG+G VY+A D K +A+K+ FE++ ++K + ++ +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLL-----DRKPVALKKVQI--FEMM--DAKARQDCVKEI 53
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATT 134
L++ N +PN V+ + + + N+L +V+E G L ++
Sbjct: 54 DLLKQLN--HPN--VIKYLDSFIED--------NELNIVLELADAGDLSQMIKYFKKQ-- 99
Query: 135 PQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
+ P R K +Q+ A++ +H ++HRDIK N+ + KL D GL
Sbjct: 100 -KRLIPERTVWKYFVQLCSAVEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
Query: 193 SDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251
S +++ GT Y+ P + + + K D++S G +L E+ + + P D ++
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLF 214
Query: 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+K+ Q CD LPT E +++ + + C+ + + RP IG +
Sbjct: 215 SLC------QKIEQ-CDYP-PLPT--EHYSEKLRELVSMCIYPDPDQRPDIGYVH 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 31/182 (17%)
Query: 63 DNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL 122
+ L +E++++S L + +VN G +C G + L++ E+ G L
Sbjct: 80 SEREALMSELKIMSHL------GNHENIVNLLG-ACTIGGPI------LVITEYCCYGDL 126
Query: 123 YDLLHNAA---AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179
+ L L + +V M + C IHRD+ + N+L
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC--------IHRDLAARNVLLTHGK 178
Query: 180 DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-----SKKVDVFSYGVVLLEI 234
K+ DFGLA ++S+ V L + P + + + DV+SYG++L EI
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNA--RLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 235 IS 236
S
Sbjct: 237 FS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 24/143 (16%)
Query: 112 LVMEFMPNGSLYDLLH-----------NAAAATTPQLGWPNRVKIAMQISRAIQCLHEND 160
+V+E+ +G+L D L + L + V A Q++R ++ L
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152
Query: 161 PMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKL 218
IHRD+ + N+L K+ADFGLA + D T G L + P L
Sbjct: 153 --CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT----TNGRLPVKWMAPEAL 206
Query: 219 SKKV-----DVFSYGVVLLEIIS 236
+V DV+S+GV+L EI +
Sbjct: 207 FDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 36/103 (34%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
LG +A Q+ AI +H IIHRDIK+ N+L + D L DFG A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314
Query: 197 SMVQPAGTIGYLDPGYTN-PSKL-----SKKVDVFSYGVVLLE 233
S G G +D TN P L + VD++S G+V+ E
Sbjct: 315 STPFHYGIAGTVD---TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIRVLSSLQ 79
R +G+G+ G V+ A + + D ++A+K + DN++K + E +L++LQ
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKT-----LKDASDNARKDFHREAELLTNLQ 65
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATTPQL 137
+ +V F+G V+G+ ++V E+M +G L L H A +
Sbjct: 66 HEH-------IVKFYGVC------VEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 138 GWPNRVK------IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
P + IA QI+ + L +HRD+ + N L K+ DFG++
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMS-R 168
Query: 192 ESDESSMVQPAG----TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + + G I ++ P K + + DV+S GVVL EI +
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 45/244 (18%)
Query: 17 FSQSRLI-----GKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--KKLN 69
F + RL+ G+G G V +A E + D + T ++L+DN+ K L
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRP----DQTVTVAVKMLKDNATDKDLA 62
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
+ I + ++ K ++N G C G + +++E+ G+L + L A
Sbjct: 63 DLISEMELMKLIGKHKN---IINLLGV-CTQEGPL------YVIVEYAAKGNLREFLR-A 111
Query: 130 AAATTP------------QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177
P QL + + V A Q++R ++ L IHRD+ + N+L
Sbjct: 112 RRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTE 169
Query: 178 KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVLL 232
K+ADFGLA D + + G L + P L +V DV+S+G+++
Sbjct: 170 DNVMKIADFGLARGVHDIDYYKKTSN--GRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227
Query: 233 EIIS 236
EI +
Sbjct: 228 EIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 7/78 (8%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
L+MEF+P G L +L + R +A + AI+ +H+ IHRDIK
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMA-ECVLAIEAVHKLG--FIHRDIKPD 130
Query: 172 NILFDSKWDAKLADFGLA 189
NIL D KL+DFGL+
Sbjct: 131 NILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 39/179 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G++G VYKA ++ + ++ I K + Q + EI +L L+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELK--- 60
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLH------NAAAATTP 135
+ N VV+ ++ + L+ ++ + +DL A + P
Sbjct: 61 --HEN--VVSLVEVF------LEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIP 106
Query: 136 QLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA----KLADFGLA 189
P+ VK + QI + LH N ++HRD+K NIL + K+ D GLA
Sbjct: 107 ----PSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 31/86 (36%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162
S N L+MEF+P G + LL + + IA + AI +H+
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEA----TQFYIAETV-LAIDAIHQLG-- 121
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGL 188
IHRDIK N+L D+K KL+DFGL
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 35/228 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R +G+GS G VY+ D +A+K + S L I L+
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTV---------NESASLRERIEFLNEASV 62
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
++ V R G V L+VME M +G L L + G P
Sbjct: 63 MKGFTCHHVV--------RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 141 -----NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSES 193
+++A +I+ + L N +HRD+ + N + + K+ DFG+ + E+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYL--NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172
Query: 194 DESSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVLLEIIS 236
D G G L + P L V D++S+GVVL EI S
Sbjct: 173 DYYR----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGY 207
QI R ++ +H D IIHRD+K +N+ + + K+ DFGLA DE M T Y
Sbjct: 128 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWY 183
Query: 208 LDPGYT-NPSKLSKKVDVFSYGVVLLEIISCR 238
P N ++ VD++S G ++ E+++ R
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 55/261 (21%), Positives = 97/261 (37%), Gaps = 50/261 (19%)
Query: 58 FEVLQDNSKKL----NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLV 113
F+ K L NEI+ L + +N ++ +G VD L+
Sbjct: 51 FKKFHKGHKVLIDITENEIKNLRRIDSNN-------ILKIYGFIID---IVDDLPRLSLI 100
Query: 114 MEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE--NDPMIIHRDIKST 171
+E+ G L ++L L + ++ +A+ + + L++ N P ++++ S
Sbjct: 101 LEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSV 152
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPA----GTIGYLDPGYTNP--SKLSKKVDVF 225
+ L + K+ GL E + P + Y N S+ + K D++
Sbjct: 153 SFLVTENYKLKIICHGL------EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206
Query: 226 SYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQML 285
S GVVL EI + + P + I D + KL C P ++
Sbjct: 207 SLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPLDC------PLEIK------- 252
Query: 286 HVAARCVSSEEENRPGIGEIL 306
+ C S + RP I EIL
Sbjct: 253 CIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 143 VKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES-DESSMVQ 200
VKI M Q+ R + H+ I+HRD+K N+L + K + KLADFGLA ++S +
Sbjct: 105 VKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162
Query: 201 PAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEIISCR 238
T+ Y P ++ S +D++ G +L E+ + R
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 6/118 (5%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESSMVQPAGTI 205
+I A++ LH+ II+RDIK NIL DS L DFGL+ E + GTI
Sbjct: 113 EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 206 GYLDPGYT--NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEE 261
Y+ P K VD +S GV++ E+++ P + S + + ++K E
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 46/177 (25%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--------IRV 74
IG+G++G VYK ++ G +I+A+K+ +L +E IR
Sbjct: 8 IGEGTYGVVYKG---RNKKTG--QIVAMKKI-------------RLESEEEGVPSTAIRE 49
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
+S L+E N +V V ++L L+ EF+ DL +
Sbjct: 50 ISLLKELQHPN----IVCLQ--------DVLMQESRLYLIFEFLS----MDLKKYLDSLP 93
Query: 134 TPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
Q VK + QI + I H ++HRD+K N+L D+K KLADFGLA
Sbjct: 94 KGQYMDAELVKSYLYQILQGILFCHSR--RVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 22/139 (15%)
Query: 111 LLVMEFMPNGSLYDLL-----HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165
LLV+EF P G L + L A A L ++A +++ + LH+ D IH
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-----QRMACEVASGLLWLHQAD--FIH 123
Query: 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESSMV---QPAGTIGYLDPGYTN-------P 215
D+ N + K+ D+GLA+ + E + A + +L P P
Sbjct: 124 SDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLP 183
Query: 216 SKLSKKVDVFSYGVVLLEI 234
+KK +++S GV + E+
Sbjct: 184 KDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSESDESSMVQPAGT 204
+I A++ LH+ I++RDIK NIL DS+ L DFGL+ +SE E + GT
Sbjct: 113 EIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-SFCGT 169
Query: 205 IGYLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKP 240
I Y+ P K VD +S G+++ E+++ P
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ F + +G+G+ G VYKA L + Q+ + K +K+A+ G V EI +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGK-YVLKKATEYG-AV----------EIWM 179
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------ 128
++ + PN C +G S LV + +L DL+ +
Sbjct: 180 NERVRRAC---PNSCADFVYGF--LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYN 234
Query: 129 ---AAAATTPQLGWP------NRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFD- 176
L P N++ I QI A+ LH I+HRD+K NI+F
Sbjct: 235 VEPYLLGKVQDL--PKGLERENKIIQTIMRQILFALDGLH--STGIVHRDVKPQNIIFSE 290
Query: 177 SKWDAKLADFGLAVSESDESSMV--QPAGTIGYLDPGYTNP 215
K+ D G A +D + P + LDP Y P
Sbjct: 291 GSGSFKIIDLGAA---ADLRVGINYIPKEFL--LDPRYAAP 326
|
Length = 566 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 39/232 (16%)
Query: 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72
+S+ +IG GS G VY+AI D +AIK+ VLQD K N E+
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEK-----VAIKK-------VLQDPQYK-NREL 110
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSC--RNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA 130
++ +L N N + + +++ T C +N ++ N +VMEF+P + H A
Sbjct: 111 LIMKNL---NHINIIF-LKDYYYTECFKKNEKNIFLN----VVMEFIPQTVHKYMKHYAR 162
Query: 131 -AATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-KLADFG 187
P VK+ + Q+ RA+ +H I HRD+K N+L D KL DFG
Sbjct: 163 NNHALPLF----LVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFG 216
Query: 188 LAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEII 235
A + V + Y P G TN + +D++S G ++ E+I
Sbjct: 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATN---YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 58/257 (22%), Positives = 111/257 (43%), Gaps = 54/257 (21%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
FD K E+ IG G++G V AI D ++ K +AIK+ + F+V
Sbjct: 1 FDVGSRYKPIEN------IGSGAYGVVCSAI--DTRSG---KKVAIKKIP-HAFDVPT-L 47
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNK--LLVMEFMPNGSL 122
+K+ E+++L + N ++ + R+ G K +VM+ M + L
Sbjct: 48 AKRTLRELKILRHFKHDN-------II-----AIRDILRPPGADFKDVYVVMDLMES-DL 94
Query: 123 YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182
+ ++H+ T + + Q+ R ++ +H + +IHRD+K +N+L + + +
Sbjct: 95 HHIIHSDQPLTEEHIRY-----FLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELR 147
Query: 183 LADFGLA---VSESDESS--MVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVV 230
+ DFG+A S E M + T Y P YT +D++S G +
Sbjct: 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYT------TAIDMWSVGCI 201
Query: 231 LLEIISCRKPIDAARDP 247
E++ R+ + ++
Sbjct: 202 FAEMLG-RRQLFPGKNY 217
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 112 LVMEFMPNGSLYDLLHN--------------AAAATTPQLGWPNRVKIAMQISRAIQCLH 157
++ E+M NG L L + A P + + + + +A+QI+ ++ L
Sbjct: 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESD----ESSMVQPAGTIGYLDPG 211
+ +HRD+ + N L K+ADFG++ + D + V P I ++
Sbjct: 156 SLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP---IRWMAWE 210
Query: 212 YTNPSKLSKKVDVFSYGVVLLEIIS-CR-KPIDAARDPASIIDWALPLIKEEKLRQVCDS 269
K + DV+++GV L EI+ C+ +P D +I+ A +++ RQV
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD-EQVIENAGEFFRDQG-RQVYLF 268
Query: 270 RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
R P +G + ML +C S + RP +I
Sbjct: 269 RP--PPCPQGLYELML----QCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 10/119 (8%)
Query: 143 VKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES-DESSMVQ 200
VKI + QI R + H ++HRD+K N+L + + + KLADFGLA ++S +
Sbjct: 106 VKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163
Query: 201 PAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258
T+ Y P S+ S ++D++ G + E+ S R P S ++ L LI
Sbjct: 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-----PGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 61/243 (25%), Positives = 101/243 (41%), Gaps = 55/243 (22%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F +LI G++G+VY L H+ + A+K+ + +L++ +++ E +
Sbjct: 1 EDFETIKLISNGAYGAVY---LVRHKET--RQRFAMKKINKQNL-ILRNQIQQVFVERDI 54
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L+ + NP VV+ S + + +VME++ G LL N A
Sbjct: 55 LTFAE-----NP--FVVSMFC-------SFETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA----- 189
R+ A + A++ LH I+HRD+K N+L S KL DFGL+
Sbjct: 101 DMA----RMYFAETV-LALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153
Query: 190 -----------VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLL 232
++ E Q GT Y+ P GY P VD ++ G++L
Sbjct: 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILY 207
Query: 233 EII 235
E +
Sbjct: 208 EFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 27/79 (34%), Positives = 38/79 (48%), Gaps = 12/79 (15%)
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDP------GYTNPS 216
IIHRD+K +NI+ S K+ DFGLA + M T Y P GY
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY---- 194
Query: 217 KLSKKVDVFSYGVVLLEII 235
+ VD++S G ++ E+I
Sbjct: 195 --KENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 17/94 (18%)
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162
VD + N L+VME++ L D L R + ++ R + LH+
Sbjct: 68 DVDPD-NGLIVMEYIEGELLKDAL------------EEARPDLLREVGRLVGKLHKAG-- 112
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLA-VSESDE 195
I+H D+ ++NI+ DFGL S+ E
Sbjct: 113 IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 17/150 (11%)
Query: 102 GSVDGNSNKLLVMEFMPNGSLYDLL-----HNAAAATTPQ-------LGWPNRVKIAMQI 149
G V ++ E++ G L++ L H+ ++ + L + + IA+QI
Sbjct: 74 GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133
Query: 150 SRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-ESDESSMVQPAG--TIG 206
+ ++ L + +H+D+ + NIL + K++D GL+ S + VQP I
Sbjct: 134 AAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 207 YLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
++ P K S D++S+GVVL EI S
Sbjct: 192 WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 42/225 (18%)
Query: 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQIS 150
V +G R D N ++V E++ G L LH L W ++ +A Q++
Sbjct: 64 VKLYGVCVR-----DEN---IMVEEYVKFGPLDVFLHR--EKNNVSLHW--KLDVAKQLA 111
Query: 151 RAIQCLHENDPMIIHRDIKSTNILF-------DSKWDAKLADFGLAVSESDESSMVQPAG 203
A+ L + ++H ++ NIL KL+D G+ ++ V+
Sbjct: 112 SALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169
Query: 204 TIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEE 261
I N L+ D +S+G LLEI S +P+ + + E+
Sbjct: 170 WIAP--ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL-STLSSS-----------EK 215
Query: 262 KLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ R+ +P ++ ++ +C + + RP IL
Sbjct: 216 ERFYQDQHRLPMPD-----CAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSK-KLNNEIRVLSSLQES 81
IG+G+ G V+ L D+ +A+K E L + K K E R+L
Sbjct: 3 IGRGNFGEVFSGRLR-----ADNTPVAVKSCR----ETLPPDLKAKFLQEARILKQYSHP 53
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
N +V G C + +VME + G L P+L
Sbjct: 54 N-------IVRLIGV-CTQKQPI------YIVMELVQGGDFLTFLRTEG----PRLKVKE 95
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD---ESSM 198
+++ + ++ L IHRD+ + N L K K++DFG++ E D S+
Sbjct: 96 LIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + P N + S + DV+S+G++L E S
Sbjct: 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 140 PNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-S 197
P VK+ + Q+ R + +H+ I+HRD+K N+L + KLADFGLA ++S S +
Sbjct: 102 PENVKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159
Query: 198 MVQPAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEII 235
T+ Y P ++ S +D++ G + +E+I
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 47/243 (19%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKIL----AIKRASTNGFEVLQDNSKKLNN 70
+ F ++IG+G+ G V ++ + KIL +KRA T F ++ + +N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNG 58
Query: 71 EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA 130
+ + +++L + + + NY LVM++ G L LL
Sbjct: 59 DCQWITTLHYAFQ-DENYL---------------------YLVMDYYVGGDLLTLLSKFE 96
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+ R IA ++ AI +H+ +HRDIK N+L D +LADFG +
Sbjct: 97 DRLPEDMA---RFYIA-EMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCL 150
Query: 191 SESDESSMVQPAGTIGYLDPGYTNPS----------KLSKKVDVFSYGVVLLEIISCRKP 240
+ + + VQ + +G P Y +P K + D +S GV + E++ P
Sbjct: 151 KMNQDGT-VQSSVAVG--TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
Query: 241 IDA 243
A
Sbjct: 208 FYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 15/84 (17%)
Query: 109 NKLLVMEFMPNGSLYDLLHNAAAATTPQLG-WPN---RVKIAMQISRAIQCLHENDPMII 164
N VM+++P G + LL +LG + R IA +++ AI+ +H+ I
Sbjct: 75 NLYFVMDYIPGGDMMSLL--------IRLGIFEEDLARFYIA-ELTCAIESVHKMG--FI 123
Query: 165 HRDIKSTNILFDSKWDAKLADFGL 188
HRDIK NIL D KL DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 36/124 (29%), Positives = 56/124 (45%), Gaps = 10/124 (8%)
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
LVME M + +L ++H +L + Q+ I+ LH IIHRD+K +
Sbjct: 103 LVMELM-DANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 152
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
NI+ S K+ DFGLA + M T Y P + VD++S G ++
Sbjct: 153 NIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 232 LEII 235
E++
Sbjct: 213 GELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 18/156 (11%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGT--- 204
Q++R ++ L + +HRD+ + N+L K+ DFGLA +S+ V T
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 205 IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLR 264
+ ++ P + + DV+SYG++L EI S + P I+D K++
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS----LGGTPYPGMIVDSTF----YNKIK 354
Query: 265 QVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300
R+ P + A +++ + +C +SE E RP
Sbjct: 355 S--GYRMAKP---DHATQEVYDIMVKCWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 98 CRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ-LGWPNRVKIAMQISRAIQCL 156
C + +G + ++++ FM +G L+ L + PQ L VK I+ ++ L
Sbjct: 69 CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL 128
Query: 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS 216
IHRD+ + N + + + +ADFGL+ + Q G I + +
Sbjct: 129 SSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ--GRIAKMPVKWIAIE 184
Query: 217 KLSKKV-----DVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRV 271
L+ +V DV+S+GV + EI + + + + I D+ L + +L+Q D
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY---LRQGNRLKQPPDCLD 241
Query: 272 GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
GL + M + C ++RP +
Sbjct: 242 GLYSLM-----------SSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/55 (34%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 140 PNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
+ V++ + Q+ R + H+ ++HRD+K N+L + + KLADFGLA ++S
Sbjct: 102 MHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 52/240 (21%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 23 IGKGSHGSVY-------KAILEDHQTDGDHK--ILAIKRASTNGFEVLQDNSKKLNNEIR 73
+G+G G V+ L + + D + ++A+K + + +++ K EI+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK---EIK 69
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN----- 128
++S L +NPN ++ G + ++ E+M NG L L
Sbjct: 70 IMSRL-----KNPN--IIRLLGVCVSDDPLC-------MITEYMENGDLNQFLSQREIES 115
Query: 129 --AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186
A P + N + +A+QI+ ++ L + +HRD+ + N L + + K+ADF
Sbjct: 116 TFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADF 173
Query: 187 GLA--VSESD----ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239
G++ + D + V P I ++ K + DV+++GV L E+ + C++
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLP---IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 47/243 (19%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKIL----AIKRASTNGFEVLQDNSKKLNN 70
E F ++IG+G+ G V L++ KIL +KRA T F ++ +N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR--EERDVLVNG 58
Query: 71 EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA 130
+ + +++L + +N LVM++ G L LL
Sbjct: 59 DNQWITTLHYA----------------------FQDENNLYLVMDYYVGGDLLTLLSKFE 96
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+ R +A ++ AI +H+ +HRDIK NIL D +LADFG +
Sbjct: 97 DRLPEDMA---RFYLA-EMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCL 150
Query: 191 SESDESSMVQPAGTIGYLDPGYTNPSKLSK----------KVDVFSYGVVLLEIISCRKP 240
++ + VQ + +G P Y +P L + D +S GV + E++ P
Sbjct: 151 KLMEDGT-VQSSVAVG--TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
Query: 241 IDA 243
A
Sbjct: 208 FYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 19/97 (19%)
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAVS---ESDE-------------SSMVQPA---G 203
++HRD+K NIL + + D+G A+ E ++ SSM P G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 204 TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
T Y+ P S+ D+++ GV+L ++++ P
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 47/245 (19%)
Query: 17 FSQSRL-----IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--KKLN 69
FS+ +L +G+G G V A E D D K A T ++L+D++ K L+
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMA--EALGIDKDKP----KEAVTVAVKMLKDDATEKDLS 65
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--- 126
+ + + ++ K ++N G +C G + +++E+ G+L + L
Sbjct: 66 DLVSEMEMMKMIGKHKN---IINLLG-ACTQDGPL------YVIVEYASKGNLREYLRAR 115
Query: 127 --------HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
++ A Q+ + + V Q++R ++ L IHRD+ + N+L
Sbjct: 116 RPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTEN 173
Query: 179 WDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVL 231
K+ADFGLA V+ D T G L + P L +V DV+S+GV++
Sbjct: 174 NVMKIADFGLARDVNNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229
Query: 232 LEIIS 236
EI +
Sbjct: 230 WEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSES 193
QL + + V A Q++R ++ L IHRD+ + N+L K+ADFGLA V
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 194 DESSMVQPAGTIGYLDPGYTNPSKLSKKV-----DVFSYGVVLLEIIS 236
D T G L + P L +V DV+S+GV+L EI +
Sbjct: 188 DYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 12/90 (13%)
Query: 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS 216
H ++ +++RD+K NIL D +++D GLA S + +P ++G GY P
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG--THGYMAPE 165
Query: 217 KLSK------KVDVFSYGVVLLEIISCRKP 240
L K D FS G +L +++ P
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 55/270 (20%), Positives = 96/270 (35%), Gaps = 60/270 (22%)
Query: 52 RASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL 111
RA F ++ S K R + ++R +
Sbjct: 104 RAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIE-------------------AGQASV 144
Query: 112 LVMEFMPNGSLYDLLHNAAAATTPQLG---WPNRVKI------AMQISRAIQCLHENDPM 162
L F P + + PQ W + + + + Q++R ++ L
Sbjct: 145 LFSRFQP--------STSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK-- 194
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKV 222
IHRD+ + NIL K+ DFGLA + V+ L + P + KV
Sbjct: 195 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS--ARLPLKWMAPESIFDKV 252
Query: 223 -----DVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCD-SRVGLPTF 276
DV+S+GV+L EI S + A+ P I+ EE +++ D +R+ P
Sbjct: 253 YTTQSDVWSFGVLLWEIFS----LGASPYPGVQIN-------EEFCQRLKDGTRMRAPEN 301
Query: 277 MEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I +++ C + + RP ++
Sbjct: 302 ATPEIYRIM---LACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 12/90 (13%)
Query: 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS 216
H ++ +++RD+K NIL D +++D GLA S + +P ++G GY P
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG--THGYMAPE 165
Query: 217 KLSKKV------DVFSYGVVLLEIISCRKP 240
L K V D FS G +L +++ P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 140 PNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-S 197
P V++ M Q+ R + +H I+HRD+K N+L + KLADFGLA ++S S +
Sbjct: 102 PYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159
Query: 198 MVQPAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEII 235
T+ Y P + S +D++ G + +E++
Sbjct: 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78
Q RL GKGS G+VY +++D + + ++ +K E+ + + + N E ++LS L
Sbjct: 5 QQRL-GKGSFGTVY--LVKDKKAVAEERLKVLKEIPVG--ELNPNETVQANQEAQLLSKL 59
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL----HNAAAATT 134
+V FH S ++ E+ L L H +
Sbjct: 60 DHP-------AIVKFHA-------SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE 105
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG---LAVS 191
Q+ + +Q+ + +H+ I+HRD+K+ NI F K+ DFG L +
Sbjct: 106 NQV-----CEWFIQLLLGVHYMHQR--RILHRDLKAKNI-FLKNNLLKIGDFGVSRLLMG 157
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
D ++ GT Y+ P K D++S G +L E+
Sbjct: 158 SCDLATTF--TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 32/170 (18%)
Query: 146 AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---------VSESDES 196
+ Q++R ++ L IHRD+ + NIL K+ DFGLA V + D
Sbjct: 179 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256
++ D YT S DV+S+GV+L EI S + A+ P ID
Sbjct: 237 LPLKWMAPESIFDKVYTTQS------DVWSFGVLLWEIFS----LGASPYPGVQID---- 282
Query: 257 LIKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
EE R++ + +R+ P E A ++ + C + E+RP E+
Sbjct: 283 ---EEFCRRLKEGTRMRAP---EYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 16/139 (11%)
Query: 112 LVMEFMPNGSLYDLL-----HNAAAAT------TPQLGWPNRVKIAMQISRAIQCLHEND 160
++ + + L++ L H+ +T L + V I QI+ ++ L +
Sbjct: 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144
Query: 161 PMIIHRDIKSTNILFDSKWDAKLADFGL--AVSESDESS-MVQPAGTIGYLDPGYTNPSK 217
++H+D+ + N+L K + K++D GL V +D M I ++ P K
Sbjct: 145 --VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK 202
Query: 218 LSKKVDVFSYGVVLLEIIS 236
S D++SYGVVL E+ S
Sbjct: 203 FSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 3/76 (3%)
Query: 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGT---IGYLDPGYTNPSKLSK 220
IHRD+ + N+L AK+ DFGLA ++S+ V + ++ P +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 221 KVDVFSYGVVLLEIIS 236
+ DV+SYG++L EI S
Sbjct: 294 QSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIG 206
Q+ R + H ++HRD+K N+L + + + KLADFGLA ++S + T+
Sbjct: 112 QLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 207 YLDPG-YTNPSKLSKKVDVFSYGVVLLEIISCR 238
Y P + S ++D++ G + E+ + R
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 24/143 (16%)
Query: 112 LVMEFMPNGSLYDLL-----------HNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND 160
+++E+ G+L + L +N QL + + V A Q++R ++ L
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 161 PMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKL 218
IHRD+ + N+L K+ADFGLA + D T G L + P L
Sbjct: 161 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT----TNGRLPVKWMAPEAL 214
Query: 219 SKKV-----DVFSYGVVLLEIIS 236
++ DV+S+GV+L EI +
Sbjct: 215 FDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 1/90 (1%)
Query: 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS 216
H + IIHRD+K +NI+ S K+ DFGLA + M T Y P
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 217 KLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
+ VD++S G ++ E+I + D
Sbjct: 201 GYKENVDIWSVGCIMGEMI-KGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 40/149 (26%), Positives = 60/149 (40%), Gaps = 19/149 (12%)
Query: 107 NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166
+N LVM++ G L LL + R +A ++ AI +H+ +HR
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYLA-EMVLAIDSVHQLG--YVHR 126
Query: 167 DIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-------- 218
DIK N+L D +LADFG + VQ +G P Y +P L
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCL-RLLADGTVQSNVAVG--TPDYISPEILQAMEDGKG 183
Query: 219 --SKKVDVFSYGVVLLEIISCRKPIDAAR 245
+ D +S GV + E++ P A
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 146 AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGT- 204
+ Q+++ ++ L IHRD+ + NIL K+ DFGLA + V+
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 205 --IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEK 262
+ ++ P + + DV+S+GV+L EI S + A+ P ID EE
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKID-------EEF 291
Query: 263 LRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
R++ + +R+ P + + Q + C E RP E++
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 30/89 (33%), Positives = 42/89 (47%), Gaps = 13/89 (14%)
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN---RVKIAMQISRAIQCLHEN 159
S N VM+++P G + LL +P R IA +++ A++ +H+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI-------FPEDLARFYIA-ELTCAVESVHKM 120
Query: 160 DPMIIHRDIKSTNILFDSKWDAKLADFGL 188
IHRDIK NIL D KL DFGL
Sbjct: 121 G--FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 11/88 (12%)
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVK--IAMQISRAIQCLHEND 160
S N VM+++P G + LL +P + +++ AI+ +H+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEV-------FPEVLARFYIAELTLAIESVHKMG 121
Query: 161 PMIIHRDIKSTNILFDSKWDAKLADFGL 188
IHRDIK NIL D KL DFGL
Sbjct: 122 --FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 9e-04
Identities = 25/79 (31%), Positives = 38/79 (48%)
Query: 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS 216
H + IIHRD+K +NI+ S K+ DFGLA + M T Y P
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 217 KLSKKVDVFSYGVVLLEII 235
+ VD++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGT---IGYLDPGYTNPSKLSK 220
IHRD+ + NIL K+ DFGLA ++S+ V + ++ P +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 221 KVDVFSYGVVLLEIISC------RKPIDA 243
+ DV+SYG++L EI S P+D+
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 5/100 (5%)
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
R I Q+ A++ +H D +IHRDIK NI + L DFG A+ E
Sbjct: 267 KQTR-AIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 199 VQPA--GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
GT+ P + D++S G++LL+++S
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 38/227 (16%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
+IGKGS+G V AI D T +AIK+ + FE + D ++ L EI++L L
Sbjct: 7 VIGKGSYGVVCSAI--DTHTGEK---VAIKKI-NDVFEHVSDATRILR-EIKLLRLL--- 56
Query: 82 NKRNPNYC-VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT---TPQL 137
R+P+ + + R + +V E M + LH A TP+
Sbjct: 57 --RHPDIVEIKHIMLPPSRRE-----FKDIYVVFELMESD-----LHQVIKANDDLTPE- 103
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDES 196
+ Q+ RA++ +H + + HRD+K NIL ++ K+ DFGLA V+ +D
Sbjct: 104 ---HHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158
Query: 197 SMV---QPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCR 238
+ + T Y P SK + +D++S G + E+++ +
Sbjct: 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGY 207
Q+ R ++ +H IIHRD+K +N+ + + ++ DFGLA DE M T Y
Sbjct: 126 QLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWY 181
Query: 208 LDPGYT-NPSKLSKKVDVFSYGVVLLEII 235
P N ++ VD++S G ++ E++
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 50/238 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G++G VYKA +D + D D+ A+K+ G S EI +L L+ N
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDY---ALKQIEGTGI------SMSACREIALLRELKHPN 59
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATTPQLGWP 140
V++ ++ K+ ++ L+ ++ H A+ A + P
Sbjct: 60 -------VISLQKVFLSHA------DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 141 NRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILF----DSKWDAKLADFGLAVSESD 194
+ + QI I LH N ++HRD+K NIL + K+AD G A
Sbjct: 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFA----- 159
Query: 195 ESSMVQPAGTIGYLDP-----GYTNPSKL------SKKVDVFSYGVVLLEIISCRKPI 241
P + LDP Y P L +K +D+++ G + E+++ +PI
Sbjct: 160 -RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 148 QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGY 207
Q+ + ++ +H IIHRD+K N+ + + K+ DFGLA +S M T Y
Sbjct: 126 QMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA--RQTDSEMTGYVVTRWY 181
Query: 208 LDPGYT-NPSKLSKKVDVFSYGVVLLEIISCR 238
P N ++ VD++S G ++ E+++ +
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 111 LLVMEFMPNGSLYDLLHN--AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168
LLVMEF P G L L + A TP R +A +I+ + LH+N+ IH D+
Sbjct: 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHKNN--FIHSDL 126
Query: 169 KSTNILFDSKWDAKLADFGLAVSESDESSMVQP 201
N L + K+ D+GL+ ++ E V P
Sbjct: 127 ALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 50/238 (21%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G++G VYKA +D + D K A+K+ G S EI +L L+ N
Sbjct: 9 VGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTGI------SMSACREIALLRELKHPN 59
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATTPQLGWP 140
V+ +S K+ ++ L+ ++ H A+ A + P
Sbjct: 60 -------VIALQKVFLSHS------DRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 141 NRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILF----DSKWDAKLADFGLAVSESD 194
+ + QI I LH N ++HRD+K NIL + K+AD G A
Sbjct: 107 RSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFA----- 159
Query: 195 ESSMVQPAGTIGYLDP-----GYTNPSKL------SKKVDVFSYGVVLLEIISCRKPI 241
P + LDP Y P L +K +D+++ G + E+++ +PI
Sbjct: 160 -RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 22/56 (39%), Positives = 29/56 (51%), Gaps = 3/56 (5%)
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL 218
I+HRDIK N+L K+ DFG AV D + + G LDP Y+ P +L
Sbjct: 330 IVHRDIKPENLLVTVDGQVKIIDFGAAV---DMCTGINFNPLYGMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 18/141 (12%)
Query: 112 LVMEFMPNGSLYDLL------HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165
++ E+M NG L L A A + + + +A QI+ ++ L + +H
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVH 153
Query: 166 RDIKSTNILFDSKWDAKLADFGLA--VSESD----ESSMVQPAGTIGYLDPGYTNPSKLS 219
RD+ + N L + K+ADFG++ + D + V P I ++ K +
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMSWESILLGKFT 210
Query: 220 KKVDVFSYGVVLLEIIS-CRK 239
DV+++GV L EI++ C++
Sbjct: 211 TASDVWAFGVTLWEILTLCKE 231
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 58/265 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD--NSKKLNNEIRVLSSL 78
R +G GS+G V+ A+ D D K +A+K+ VL D + K EI+++ L
Sbjct: 11 RPLGCGSNGLVFSAV--DSDCD---KRVAVKKI------VLTDPQSVKHALREIKIIRRL 59
Query: 79 QESNKRNPNYCVVNFH--GTSCRNSGSVDGNSNKL----LVMEFMPNGSLYDLLHNAAAA 132
N V + G S + G+ +L +V E+M L +
Sbjct: 60 DHDN------IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLA- 189
++ M Q+ R ++ +H + ++HRD+K N+ +++ K+ DFGLA
Sbjct: 114 --------EHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
Query: 190 VSESDESSMVQPAGTIGYLDPGYT-----------NPSKLSKKVDVFSYGVVLLEIISCR 238
+ + S GYL G +P+ +K +D+++ G + E+++ +
Sbjct: 164 IVDPHYSHK-------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 239 KPIDAARDPASI--IDWALPLIKEE 261
A + + I ++P+++EE
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREE 241
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 30/122 (24%), Positives = 58/122 (47%), Gaps = 9/122 (7%)
Query: 118 PNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177
P + D L N +P L + + V + Q++ ++ L + +HRD+ + N+L
Sbjct: 221 PERTRRDTLIN----ESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICE 274
Query: 178 KWDAKLADFGLAVSESDESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
K+ DFGLA +S+ + T + ++ P + + DV+S+G++L EI
Sbjct: 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
Query: 235 IS 236
+
Sbjct: 335 FT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 39/195 (20%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-KKLNNEIRV 74
F + +L+GKG G V+ + G K+ A+K E+++ N K++ E +
Sbjct: 2 HFKKIKLLGKGDVGRVFLV-----RLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEI 54
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L++L +P + + S + LVM++ P G L+ LL
Sbjct: 55 LATL-----DHP--FLPTLYA-------SFQTETYLCLVMDYCPGGELFRLLQ-----RQ 95
Query: 135 PQLGWPNRVKI------AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL 188
P + A ++ A++ LH I++RD+K NIL L+DF L
Sbjct: 96 PG----KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDL 149
Query: 189 AVSESDESSMVQPAG 203
+ E V A
Sbjct: 150 SKQSDVEPPPVSKAL 164
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 379 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.01 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.93 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.86 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.86 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.42 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.38 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.87 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| PLN02236 | 344 | choline kinase | 96.75 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.51 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.4 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.33 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.19 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.1 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.93 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.9 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.8 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.45 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.57 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=374.88 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=220.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh---hhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL---QDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
..+.|.+.+.||+|+||.|-+|..+. +++.||||.+++...... ......+.+|+++|++|+||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-----tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~------- 237 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-----TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPN------- 237 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-----cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCC-------
Confidence 45789999999999999999998775 778999999987654321 223445689999999999999
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
||++++. |+..+..||||||++||+|.+.+-..+. +.+..-+.+++|++.|+.|||++| |+|||||
T Consensus 238 IV~~~d~-------f~~~ds~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiK 303 (475)
T KOG0615|consen 238 IVRIKDF-------FEVPDSSYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIK 303 (475)
T ss_pred EEEEeee-------eecCCceEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcC--cccccCC
Confidence 9999977 5667888999999999999999976443 777778999999999999999999 9999999
Q ss_pred CCceEEcCC---CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC---CCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 170 STNILFDSK---WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL---SKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 170 p~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
|+|||+..+ ..+||+|||+|+.....+...+.+||+.|.|||++.+... ..++|+||+||++|-+++|.+||..
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred cceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 999999765 7799999999999988888889999999999999876543 3478999999999999999999987
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
......+.+ ++...++. .|..+..++.+.++||.+||..||++|||++|+|+|....
T Consensus 384 ~~~~~sl~e------------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 384 EYTDPSLKE------------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ccCCccHHH------------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 654432222 23333332 3567888999999999999999999999999999995443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=367.49 Aligned_cols=257 Identities=29% Similarity=0.387 Sum_probs=215.5
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
..+.++.||+|..|+||++.++. +++++|+|.+.... .+...+++.+|+++++..++++ ||.+|+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~-----t~~i~AlK~I~~~~---~~~~~~Qi~rEl~il~~~~spy-------IV~~yg 144 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKP-----TGKIYALKVILLNI---DPALQKQILRELEILRSCQSPY-------IVGFYG 144 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcC-----CCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCC-------eeeEeE
Confidence 45568899999999999998776 67899999995432 2567899999999999999888 999998
Q ss_pred cccccCCCccCCC-ceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCce
Q 035572 96 TSCRNSGSVDGNS-NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNI 173 (379)
Q Consensus 96 ~~~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NI 173 (379)
.+.. ++ .++|+||||.+|||++++...+ ++++.....++.++++||.|||. ++ |+||||||+||
T Consensus 145 aF~~-------~~~~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNl 210 (364)
T KOG0581|consen 145 AFYS-------NGEEISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNL 210 (364)
T ss_pred EEEe-------CCceEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHe
Confidence 8643 44 5999999999999999998643 38899999999999999999995 88 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC-chhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD-PASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~ 252 (379)
|++..|.+||||||.+...... ...+..||..|||||.+.+..|+.++||||||++++|+++|+.||....+ ...+
T Consensus 211 LvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-- 287 (364)
T KOG0581|consen 211 LVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-- 287 (364)
T ss_pred eeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH--
Confidence 9999999999999999776554 55777999999999999999999999999999999999999999977521 1111
Q ss_pred hhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
-+.+..+++. .+..|.. .+++++++++..||+.||.+|||+.|+++|.....
T Consensus 288 -------~~Ll~~Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 288 -------FELLCAIVDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -------HHHHHHHhcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 2234445553 3333322 37899999999999999999999999999965543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=381.57 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=222.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|+..++||+|||+.||++.+.+ ++..||+|++.+... ......+++.+||+|.++|+|+| ||+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-----tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~Hpn-------IV~f~ 84 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-----TGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPN-------IVQFY 84 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-----CCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCc-------EEeee
Confidence 579999999999999999998765 567799998876432 23556788999999999999999 99999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
.+ |++.+++|||.|+|..++|..++++++. +++.+++.+++||+.||.|||+++ |+|||||..|+|
T Consensus 85 ~~-------FEDs~nVYivLELC~~~sL~el~Krrk~-----ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlf 150 (592)
T KOG0575|consen 85 HF-------FEDSNNVYIVLELCHRGSLMELLKRRKP-----LTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLF 150 (592)
T ss_pred eE-------eecCCceEEEEEecCCccHHHHHHhcCC-----CCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhhee
Confidence 87 6889999999999999999999985433 999999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++++.++||+|||+|...... ....+.+|||.|.|||++.....+..+||||+||++|.||.|++||....
T Consensus 151 L~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------- 222 (592)
T KOG0575|consen 151 LNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------- 222 (592)
T ss_pred ecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------
Confidence 999999999999999776644 45566799999999999999999999999999999999999999998753
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.++.+..+....+..|. ..+.++.+||.++|+.||.+|||+++||.|....
T Consensus 223 -----vkety~~Ik~~~Y~~P~---~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 223 -----VKETYNKIKLNEYSMPS---HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred -----HHHHHHHHHhcCccccc---ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 23445555555666665 4458899999999999999999999999998773
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=373.64 Aligned_cols=281 Identities=43% Similarity=0.766 Sum_probs=239.1
Q ss_pred CCCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhc
Q 035572 2 AENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81 (379)
Q Consensus 2 ~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 81 (379)
...|+|++|..+|++|...+.||+|+||.||+|...+ +..||||++...... . ..+|.+|+.++.+++|+
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~------~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~ 131 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD------GTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHP 131 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC------CCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCc
Confidence 3569999999999999999999999999999998764 267999988754321 1 45699999999999999
Q ss_pred cCCCCCceeeeccccccccCCCccCCC-ceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-
Q 035572 82 NKRNPNYCVVNFHGTSCRNSGSVDGNS-NKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN- 159 (379)
Q Consensus 82 ~~~~~~~~iv~~~~~~~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~- 159 (379)
| +|+++|+|.. .+ +.+||+||+++|||.+.+...... .++|..+..|+.++|+||+|||..
T Consensus 132 N-------lv~LlGyC~e-------~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 132 N-------LVKLLGYCLE-------GGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred C-------cccEEEEEec-------CCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCC
Confidence 9 9999999864 33 699999999999999999864322 589999999999999999999985
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCC-CCccccc-CccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD-ESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 237 (379)
.++|+||||||+|||+|++.++||+|||+|+..+. ....... .||.+|+|||+...+..+.++||||||++++|++||
T Consensus 195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg 274 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG 274 (361)
T ss_pred CCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence 44799999999999999999999999999976655 4433333 899999999999999999999999999999999999
Q ss_pred CCCCCCCC--CchhHHHhhhhhhhHHhhhhhccccCCCCcch-HHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 238 RKPIDAAR--DPASIIDWALPLIKEEKLRQVCDSRVGLPTFM-EGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 238 ~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.|.+... ....+..|..+.+....+..++|+.+...... ......+..++.+|++.+|.+||+|.|++...
T Consensus 275 r~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 275 RKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 99987653 33457888888888889999999987633332 25667799999999999999999999987764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=350.58 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=216.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|+++++||+|+||.||++.+.. +++.+|.|.+...... ....+....|+.+|++|+|+| ||+++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~-----~g~l~a~K~i~f~~md--~k~rq~~v~Ei~lLkQL~HpN-------IVqYy 84 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL-----DGKLVALKKIQFGMMD--AKARQDCVKEISLLKQLNHPN-------IVQYY 84 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc-----Ccchhhhhhcchhhcc--HHHHHHHHHHHHHHHhcCCch-------HHHHH
Confidence 469999999999999999998765 7788999999865433 566788999999999999999 99988
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC--CCCeEecCCCCCc
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN--DPMIIHRDIKSTN 172 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~~i~H~dlkp~N 172 (379)
+..+ .++..-++||||||.+|+|.++++..... ...+++++++.++.|++.||.++|+. ..-|.||||||.|
T Consensus 85 ~~~f-----~~~~evlnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaN 158 (375)
T KOG0591|consen 85 AHSF-----IEDNEVLNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPAN 158 (375)
T ss_pred HHhh-----hccchhhHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchh
Confidence 7432 23444599999999999999999987754 44599999999999999999999982 2228999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|+++.+|.+||+|||+++....... ..+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+. +..++
T Consensus 159 IFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L- 236 (375)
T KOG0591|consen 159 IFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSL- 236 (375)
T ss_pred eEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHH-
Confidence 9999999999999999988766544 45668999999999999999999999999999999999999999876 22221
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..++.+...+ |-....++.++..||..|+..||+.||+...++.....
T Consensus 237 -----------~~KI~qgd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 237 -----------CKKIEQGDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----------HHHHHcCCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1222333221 22236678999999999999999999997766665433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=358.59 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=216.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||+||+|+.+. .+..||||.+.+... .....+-+..|+.+|+.++|+| ||.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~-----~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~n-------IV~l 74 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK-----SGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPN-------IVRL 74 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc-----CCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcc-------eeeE
Confidence 4689999999999999999998876 446799999987643 2566788999999999999999 8988
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
.+.+ ..++.+|+|||||.||+|.++++.++ .+++.+++.++.|++.||++||+++ |+||||||+||
T Consensus 75 ~d~~-------~~~~~i~lVMEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNi 140 (429)
T KOG0595|consen 75 LDCI-------EDDDFIYLVMEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNI 140 (429)
T ss_pred EEEE-------ecCCeEEEEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceE
Confidence 8774 56789999999999999999998765 3899999999999999999999999 99999999999
Q ss_pred EEcCC------CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSK------WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|++.+ -.+||+|||+|+.........+.+|++.|||||++...+|+.|+|+||+|+++|++++|+.||......
T Consensus 141 LLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 141 LLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred EeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 99764 458999999999998887778889999999999999999999999999999999999999999865421
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVD 315 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~ 315 (379)
+ .+..+-......|......+..+.+++...++.+|.+|.+..+-+.|.......
T Consensus 221 e-------------L~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 221 E-------------LLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred H-------------HHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1 111122222223444445556677888899999999999888887776554433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=352.10 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=213.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|+++++||+|+||.||.++.++ +++.+|+|++++..+.. ....+....|..+|..++||. ||++
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d-----t~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPF-------iv~l 90 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD-----TGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPF-------IVKL 90 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc-----cCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCc-------Eeee
Confidence 5789999999999999999998764 77899999999876543 355788999999999999876 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+-. |++...+|+|+||+.||.|...|++.+ .+++..++-++..|+.||.|||+.| |+||||||+||
T Consensus 91 ~ys-------FQt~~kLylVld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENI 156 (357)
T KOG0598|consen 91 IYS-------FQTEEKLYLVLDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENI 156 (357)
T ss_pred EEe-------cccCCeEEEEEeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHe
Confidence 644 799999999999999999999998644 3999999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccC-CCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSE-SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|+|.+|+++|+|||+|+.. .......+.+||+.|||||++.+.+|+.++|.||||+++|+|++|.+||.+.+.
T Consensus 157 LLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------ 230 (357)
T KOG0598|consen 157 LLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------ 230 (357)
T ss_pred eecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------
Confidence 9999999999999999744 334445567999999999999999999999999999999999999999988752
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC----ChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP----GIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~e~l~~~~~ 311 (379)
......+...+...++ ...+.++++++.++|+.||++|. ++.++-.|...
T Consensus 231 -------~~~~~~I~~~k~~~~p--~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 231 -------KKMYDKILKGKLPLPP--GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred -------HHHHHHHhcCcCCCCC--ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 2333444444422221 22357899999999999999996 55565555433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=336.94 Aligned_cols=270 Identities=24% Similarity=0.271 Sum_probs=216.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
++.|+.+.++|+|+||.||+|++++ ++++||||++..... ++...+-..+||++|++|+|+| +|++
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~-----TgqIVAIKkF~Esed--d~~VkKIAlREIrmLKqLkH~N-------LVnL 66 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKD-----TGQIVAIKKFVESED--DPVVKKIALREIRMLKQLKHEN-------LVNL 66 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCC-----cccEEEEEeeccCCc--cHHHHHHHHHHHHHHHhcccch-------HHHH
Confidence 4679999999999999999997655 788999999975433 2566777899999999999999 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
...| .....++||+|||+. ++.+-++. ....++...+..+++|++.|+.|+|+++ ++||||||+||
T Consensus 67 iEVF-------rrkrklhLVFE~~dh-TvL~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENI 132 (396)
T KOG0593|consen 67 IEVF-------RRKRKLHLVFEYCDH-TVLHELER----YPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENI 132 (396)
T ss_pred HHHH-------HhcceeEEEeeecch-HHHHHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhhe
Confidence 7664 557899999999954 55555654 2334888899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++.+|.+||||||+|+... +...++.++.|..|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+..+-+++.
T Consensus 133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 99999999999999998776 5666778899999999998776 789999999999999999999999999988777654
Q ss_pred Hhhhh---hhhH--------HhhhhhccccCC----CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALP---LIKE--------EKLRQVCDSRVG----LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~---~~~~--------~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+... ++.. +.+..+.-+.+. +....+..+.-+.+++..||..||++|++-++++.|...
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 43221 1111 011111111111 111234566789999999999999999999999999765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=354.68 Aligned_cols=278 Identities=22% Similarity=0.313 Sum_probs=225.1
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCce
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYC 89 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~ 89 (379)
..+.++|.++++||.|.||.||+|+.+ .++..||||+++..-.. ...---.||+..|++|. |+|
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~-----~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpn------- 70 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSK-----ETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPN------- 70 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeec-----CCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCc-------
Confidence 456889999999999999999999754 47778999999866433 22223479999999998 888
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
||++.+.+. +.+..+|+||||| ..+|.++++.+ ...|++..++.|++||++||+|+|++| ++|||+|
T Consensus 71 iikL~Evi~------d~~~~L~fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlK 137 (538)
T KOG0661|consen 71 IIKLKEVIR------DNDRILYFVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLK 137 (538)
T ss_pred chhhHHHhh------ccCceEeeeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCC
Confidence 888887652 2333999999999 78999999975 345999999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC-CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|+|||+..+..+||+|||+|+........+.++.|+.|.|||++ +.+.|+.+.|+|++|||++|+.+-++.|.+.++.+
T Consensus 138 PENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D 217 (538)
T KOG0661|consen 138 PENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID 217 (538)
T ss_pred hhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence 99999998889999999999988888888899999999999965 56678999999999999999999999999988777
Q ss_pred hHHHhhhhhhhH---------Hhhhhhcccc------CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 249 SIIDWALPLIKE---------EKLRQVCDSR------VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 249 ~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
++..... ++.. ..+...+.-. .++....+.++.++.+++.+|+.+||.+|||+.|+++|.....
T Consensus 218 qi~KIc~-VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 218 QIYKICE-VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHHHH-HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 7655432 2211 1222222221 1222234457789999999999999999999999999977665
Q ss_pred cccC
Q 035572 314 VDHH 317 (379)
Q Consensus 314 ~~~~ 317 (379)
....
T Consensus 297 ~~~~ 300 (538)
T KOG0661|consen 297 GRAS 300 (538)
T ss_pred cccc
Confidence 5443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=353.03 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=217.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
..+|.+++.||+|+|++|++|++++ +++.||||++.++-+ ..+...+.+.+|-.+|.+| .||. |++
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~-----t~keYAiKVl~K~~I-ike~KvkYV~~Ek~~l~~L~~hPg-------ivk 138 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKA-----TGKEYAIKVLDKRYI-IKEKKVKYVTREKEALTQLSGHPG-------IVK 138 (604)
T ss_pred hhhcchhheeccccceeEEEeeecC-----CCceeeHhhhhHHHH-HhhcccchhhHHHHHHHHhhCCCC-------eEE
Confidence 4689999999999999999998876 667899999976543 2355567889999999999 4554 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++-. |.+...+|+|+||+++|+|.++|++.+. |++..++.++.+|+.||+|||++| |+||||||+|
T Consensus 139 Ly~T-------FQD~~sLYFvLe~A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~G--IIHRDlKPEN 204 (604)
T KOG0592|consen 139 LYFT-------FQDEESLYFVLEYAPNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNG--IIHRDLKPEN 204 (604)
T ss_pred EEEE-------eecccceEEEEEecCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhh
Confidence 7655 7889999999999999999999998764 889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC--------------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES--------------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 238 (379)
||+++||+++|+|||.|+...... ...+.+||..|.+||++.....+..+|||+|||++|+|+.|.
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~ 284 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ 284 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC
Confidence 999999999999999996653321 114468999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
+||.+.++.- .+.+++.-.+.+|+ +.++.+.+|+.++|..||.+|+|+++|-+|........
T Consensus 285 PPFra~Neyl-------------iFqkI~~l~y~fp~---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 285 PPFRAANEYL-------------IFQKIQALDYEFPE---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCccccHHH-------------HHHHHHHhcccCCC---CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 9999876432 23333444444444 33478999999999999999999999999976655443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=351.02 Aligned_cols=260 Identities=32% Similarity=0.518 Sum_probs=208.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+...+.+.||+|+||.||+|.++... .||||.+....... ...+.|.+|+.+|++++|+| ||++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~------~vavK~~~~~~~~~--~~~~~f~~E~~il~~l~HpN-------IV~f 104 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTD------VVAVKIISDPDFDD--ESRKAFRREASLLSRLRHPN-------IVQF 104 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCce------eEEEEEecchhcCh--HHHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 344556677999999999999886422 29999998655432 22789999999999999999 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+|.+.. .....+|||||+++|+|.+++... ....+++..+..++.||+.|+.|||++++ |+||||||+||
T Consensus 105 ~G~~~~------~~~~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~Ni 174 (362)
T KOG0192|consen 105 YGACTS------PPGSLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNI 174 (362)
T ss_pred EEEEcC------CCCceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhE
Confidence 998743 122789999999999999999864 23449999999999999999999999986 89999999999
Q ss_pred EEcCCC-CeEEeccccCccCCCC-CcccccCccccccCCCCCC--CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKW-DAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTN--PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~-~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++.++ ++||+|||+++..... .......||+.|||||++. ...++.++||||||+++|||+||+.||..... .+
T Consensus 175 Lv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~ 253 (362)
T KOG0192|consen 175 LVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ 253 (362)
T ss_pred EEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH
Confidence 999997 9999999999776554 2333358999999999999 56899999999999999999999999998765 22
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
..... .....++.+| ..+++.+..++.+||..||.+||++.+++......
T Consensus 254 ~~~~v----------~~~~~Rp~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 254 VASAV----------VVGGLRPPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HHHHH----------HhcCCCCCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 21111 0111222222 33678899999999999999999999998765543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=353.29 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=218.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhh-hcHHHHHHHHHHHHhhh-hccCCCCCce
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-DNSKKLNNEIRVLSSLQ-ESNKRNPNYC 89 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~-~~~~~~~~~~ 89 (379)
...++|.+.+.||+|+||.|+.|.+.. ++..||+|.+......... ...+.+.+|+.+++.++ |+|
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~-----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~Hpn------- 81 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL-----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPN------- 81 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc-----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCC-------
Confidence 346799999999999999999998765 4477999977654221112 45667889999999999 887
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
|++++.. +.....+|+||||+.||+|.+++.+.+ ++.+.+++.+++|++.|++|||++| |+|||||
T Consensus 82 I~~l~ev-------~~t~~~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK 147 (370)
T KOG0583|consen 82 IIRLLEV-------FATPTKIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLK 147 (370)
T ss_pred EeEEEEE-------EecCCeEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCC
Confidence 8887766 456677999999999999999998633 3888999999999999999999999 9999999
Q ss_pred CCceEEcCC-CCeEEeccccCccC-CCCCcccccCccccccCCCCCCCCC-CC-CcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 170 STNILFDSK-WDAKLADFGLAVSE-SDESSMVQPAGTIGYLDPGYTNPSK-LS-KKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 170 p~NIll~~~-~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
|+|||++.+ +++||+|||++... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999999 99999999999877 4666777889999999999999877 75 78999999999999999999998754
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.. ..+..+....+..|.... ++++.+|+.+||..||.+|+|+.+++.|.....
T Consensus 228 ~~-------------~l~~ki~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 228 VP-------------NLYRKIRKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HH-------------HHHHHHhcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 22 223335556666676654 689999999999999999999999998876665
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=353.59 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=213.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...|....+||+|+.|.||.|.... .++.||||++.... +...+-+.+|+.+|+.++|+| ||++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~-----~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~N-------iVnf 335 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS-----TKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPN-------IVNF 335 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc-----CCceEEEEEEEecc----CCchhhhHHHHHHHHhccchH-------HHHH
Confidence 3578889999999999999998765 55679999997653 344677899999999999999 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. .+.+|+||||++||+|.+.+.... +++.+++.+++++++||+|||.+| |+|||||.+||
T Consensus 336 l~Sylv-------~deLWVVMEym~ggsLTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnI 400 (550)
T KOG0578|consen 336 LDSYLV-------GDELWVVMEYMEGGSLTDVVTKTR------MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNI 400 (550)
T ss_pred HHHhcc-------cceeEEEEeecCCCchhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhcc--eeeecccccee
Confidence 877543 478999999999999999997532 899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|.+||+|||+|....... ...+.+||+.|||||++....|++++||||||++++||+.|.+||-..+....+..
T Consensus 401 LL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL 480 (550)
T KOG0578|consen 401 LLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 480 (550)
T ss_pred EeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH
Confidence 99999999999999996655443 56667899999999999999999999999999999999999999987554332211
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.+...+.-.....+++.+.+++.+||+.||++|+++.|+|+|...
T Consensus 481 -------------Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 481 -------------IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred -------------HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 1111111122445678999999999999999999999999999655
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=341.96 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=207.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+|...+.||+|+||.||++.+.+ ++...|||.+...... ..+.+.+|+.+|++++|+| ||++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~-----~g~~~AvK~v~~~~~~----~~~~l~~Ei~iL~~l~~p~-------IV~~ 79 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK-----TGELMAVKSVELEDSP----TSESLEREIRILSRLNHPN-------IVQY 79 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC-----CCcceeeeeeecccch----hHHHHHHHHHHHHhCCCCC-------EEee
Confidence 3568889999999999999998765 3677999998755221 1677999999999999888 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++..... ++ ..+++.|||+++|||.+++...+. .+++..++.+.+|+++||.|||++| |+||||||+||
T Consensus 80 ~G~~~~~----~~-~~~~i~mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~Ni 148 (313)
T KOG0198|consen 80 YGSSSSR----EN-DEYNIFMEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANI 148 (313)
T ss_pred CCccccc----cC-eeeEeeeeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceE
Confidence 9863221 11 368999999999999999987553 3899999999999999999999999 99999999999
Q ss_pred EEcC-CCCeEEeccccCccCCC----CCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCC-CC
Q 035572 174 LFDS-KWDAKLADFGLAVSESD----ESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAA-RD 246 (379)
Q Consensus 174 ll~~-~~~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~-~~ 246 (379)
|++. ++.+||+|||++..... ........||+.|||||++.++ ....++|||||||++.||+||..||... ..
T Consensus 149 Ll~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 149 LLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred EEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 9999 79999999999865542 1223446799999999999853 3345999999999999999999999863 11
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVD 315 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~ 315 (379)
... +..+.... ..|..+..++.+..+++.+|+..||++|||++++|.|.......
T Consensus 229 ~~~-------------~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 229 AEA-------------LLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHH-------------HHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 111 11111111 12344445678899999999999999999999999997665433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=343.68 Aligned_cols=271 Identities=23% Similarity=0.303 Sum_probs=217.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|+.+++||+|.||.||+|++.. ++++||+|+++.+... ........+||.||++|.|+| |+++
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~-----tgkivALKKvr~d~~~--~~~~~t~~REI~ILr~l~HpN-------IikL 181 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLE-----TGKIVALKKVRFDNEK--EGFPITAIREIKILRRLDHPN-------IIKL 181 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecc-----cCcEEEEEEeecccCC--CcchHHHHHHHHHHHhcCCCc-------ccce
Confidence 4678999999999999999998654 7899999999976543 566778899999999999999 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
.+.+... ....+|||+||| .-+|..++.. +.-.|++.++..++.|++.||+|||++| |+|||||.+||
T Consensus 182 ~eivt~~-----~~~siYlVFeYM-dhDL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNi 249 (560)
T KOG0600|consen 182 EEIVTSK-----LSGSIYLVFEYM-DHDLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNI 249 (560)
T ss_pred eeEEEec-----CCceEEEEEecc-cchhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccce
Confidence 7765432 246899999999 5699999975 3344999999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|||.+|.+||+|||+|++..... ..+..+-|..|.|||.+.|. .|+.++|+||.|||+.||++|++.|.+.++..++
T Consensus 250 Lidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 250 LIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred EEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 99999999999999998665443 45667899999999977664 6999999999999999999999999998876665
Q ss_pred HHhhhhhhh---HHhhh--hh-----ccccCC----CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIK---EEKLR--QV-----CDSRVG----LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~---~~~~~--~~-----~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+.. +.. +..+. .+ ..+... +.......+...++|+..+|..||.+|.|+.++|.+...
T Consensus 330 ~kIfk-lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 330 HKIFK-LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred HHHHH-HhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 44322 111 11111 00 000000 011123456789999999999999999999999998766
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=314.09 Aligned_cols=271 Identities=20% Similarity=0.246 Sum_probs=216.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|...++||+|.||.||+|++.. +++.||||+++..... ........+||+.|+.++|+| |+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~-----t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~n-------Ii~Li 67 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE-----TGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPN-------IIELI 67 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC-----CCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcc-------hhhhh
Confidence 578999999999999999998765 6788999999876433 344567899999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. |.+.+.+.||+||+ ..+|+..+++. ...++...+..|+.++++||+|||++. |+||||||.|+|
T Consensus 68 D~-------F~~~~~l~lVfEfm-~tdLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLL 133 (318)
T KOG0659|consen 68 DV-------FPHKSNLSLVFEFM-PTDLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLL 133 (318)
T ss_pred hh-------ccCCCceEEEEEec-cccHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceE
Confidence 65 67788999999999 57999999863 344888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.+|.+||+|||+|+....... ....+-|..|.|||.+-| ..|+..+|+||.||++.||+-|.+-|.+..|-+++..
T Consensus 134 is~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~ 213 (318)
T KOG0659|consen 134 ISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK 213 (318)
T ss_pred EcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence 99999999999999987765443 333478999999997665 4689999999999999999999888888777666654
Q ss_pred hhhhhhh--H---------Hhhhhhc-cccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIK--E---------EKLRQVC-DSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~--~---------~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
....+-. . ..+.++. -+.......+..++.++.||+.+|+.+||.+|+|++|+++|.....
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 4332110 0 1111111 0111112245667788999999999999999999999999966544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=350.15 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=223.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+-|++++.||.|+.|.|-+|.+- .+|+..|||.+.+.. .........+++||-+|+.+.|+| ++.++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~-----~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~Hpn-------Vl~Ly 78 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHA-----ETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPN-------VLRLY 78 (786)
T ss_pred cceeccccccCCCCceehhhhcc-----cccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCC-------eeeee
Confidence 56899999999999999999643 478889999998652 223455788999999999999998 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +++..++|+|.||++||.|.+++-..+. +++.+++.+++||+.|+.|+|..+ |+||||||+|+|
T Consensus 79 dV-------we~~~~lylvlEyv~gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlL 144 (786)
T KOG0588|consen 79 DV-------WENKQHLYLVLEYVPGGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLL 144 (786)
T ss_pred ee-------eccCceEEEEEEecCCchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhh
Confidence 55 6788999999999999999999986554 889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++..+++||+|||+|.....+....+.+|++.|.+||++.+.+| +.++||||.|||||.||||+.||++.+ -
T Consensus 145 Ld~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-i------ 217 (786)
T KOG0588|consen 145 LDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-I------ 217 (786)
T ss_pred hhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-H------
Confidence 99998999999999988888888888899999999999999998 568999999999999999999998432 1
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDHH 317 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~~ 317 (379)
...+.++....+.+|. .+++++++||.+||..||++|+|++||++|.........
T Consensus 218 ------r~LLlKV~~G~f~MPs---~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 218 ------RVLLLKVQRGVFEMPS---NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ------HHHHHHHHcCcccCCC---cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 2234445556666664 445899999999999999999999999999776655443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=347.63 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=217.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+++|-+.+.||+|+||.||+|+.+ .+.++||+|.+.+.... ....+.+.+|+++++.++|+| ||.+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK-----~t~~~vAik~i~K~gr~--~k~l~~l~~ev~i~r~lkHpn-------iv~m 66 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRK-----YTIQVVAIKFIDKSGRN--EKELKNLRQEVRILRSLKHPN-------IVEM 66 (808)
T ss_pred CcchhHHHHhcCCccceeeecccc-----cceeEEEEEEehhcCCc--hHHHHHHHHHHHHHHhcCCcc-------hhhH
Confidence 368999999999999999999644 48899999999876543 456778999999999999999 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. |+...++|+|.||+.| +|..++.+.+. ++++.+..++++++.||.|||+++ |.|||+||.||
T Consensus 67 ~es-------fEt~~~~~vVte~a~g-~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqni 131 (808)
T KOG0597|consen 67 LES-------FETSAHLWVVTEYAVG-DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNI 131 (808)
T ss_pred HHh-------hcccceEEEEehhhhh-hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCccee
Confidence 765 7889999999999965 99999986543 899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc-cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM-VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|.+|+||||+|+.++..... ....|||.|||||.+.+.+|+..+|+|||||++||+.+|++||-... +.
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~- 206 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----IT- 206 (808)
T ss_pred eecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HH-
Confidence 9999999999999999988765543 34469999999999999999999999999999999999999996532 11
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
.....+......+| ...+..+..++..+|..||.+|.|-.+++.|........
T Consensus 207 --------~Lv~~I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 207 --------QLVKSILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred --------HHHHHHhcCCCCCc---ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 11222222333323 366789999999999999999999999999976655443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=318.55 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=214.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|+.++.||.|+||.|.+++.+. ++..+|+|++.+... +.....+...+|..+|+.+.||. ++.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~-----~g~yYAmKvL~k~~v-VklKQveH~~nEk~vL~~v~~PF-------lv~l~ 110 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH-----SGNYYAMKVLDKQKV-VKLKQVEHTHNEKRVLKAVSHPF-------LVKLY 110 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc-----CCceeehhhcCHHHH-HHHHHHHHHhhHHHHHhhccCce-------eEEEE
Confidence 478899999999999999998765 567899999986543 33455677899999999999877 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+.+|+||||++||.|..++++.+. ++++.++-++.||+.||+|||+.+ |++|||||+|||
T Consensus 111 ~t-------~~d~~~lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiL 176 (355)
T KOG0616|consen 111 GT-------FKDNSNLYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLL 176 (355)
T ss_pred Ee-------eccCCeEEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHee
Confidence 65 5778999999999999999999987543 899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+|.+|.+||+|||.|+..... ..+-+|||.|+|||++...+++.++|.||||+++|||+.|.+||...+.
T Consensus 177 lD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------- 246 (355)
T KOG0616|consen 177 LDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------- 246 (355)
T ss_pred eccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------
Confidence 999999999999999887654 4456899999999999999999999999999999999999999987653
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhcccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCS 310 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~ 310 (379)
...+.+++...+..|..+. +++.+|+.++|+.|-.+|. ...+|-.|..
T Consensus 247 -----~~iY~KI~~~~v~fP~~fs---~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 247 -----IQIYEKILEGKVKFPSYFS---SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred -----HHHHHHHHhCcccCCcccC---HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcc
Confidence 3445667777777776654 7899999999999999993 4445555533
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=329.20 Aligned_cols=281 Identities=22% Similarity=0.271 Sum_probs=219.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+...|...+.||.|+||.|+.|.++. +++.||||++...-. ..-..++..+|+++|+.++|+| |+
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~-----t~~~VAIKKi~~~F~--~~~~akRtlRElklLr~~~HeN-------Ii 84 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKR-----TGEKVAIKKILNPFE--NQIDAKRTLRELKLLRHLRHEN-------II 84 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcC-----CCCEeehhhhhhhhh--chHHHHHHHHHHHHHHHhcCCC-------cc
Confidence 456778888999999999999999876 457799999873321 2456788999999999999999 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.+.+.+.. .....-+.+|+|+|+| +.+|.+.++.... ++..-+..+++|++.||.|+|+.+ ++||||||+
T Consensus 85 ~l~di~~p--~~~~~f~DvYiV~elM-etDL~~iik~~~~-----L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPs 154 (359)
T KOG0660|consen 85 GLLDIFRP--PSRDKFNDVYLVFELM-ETDLHQIIKSQQD-----LTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPS 154 (359)
T ss_pred eEEeeccc--ccccccceeEEehhHH-hhHHHHHHHcCcc-----ccHHHHHHHHHHHHHhcchhhccc--ccccccchh
Confidence 66666544 3455678999999999 7899999986432 777788889999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCC---CCcccccCccccccCCCCC-CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSKWDAKLADFGLAVSESD---ESSMVQPAGTIGYLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|+|++.+..+||+|||+|+.... ....+..+.|..|.|||+. ....|+.+.||||+|||+.||++|++-|.+.+..
T Consensus 155 Nll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 155 NLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred heeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 99999999999999999987753 4455677899999999954 5678999999999999999999999999887654
Q ss_pred hhHHHhh----------hhhhhHHhhhhhcc---ccCCC--CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 248 ASIIDWA----------LPLIKEEKLRQVCD---SRVGL--PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~----------~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.++.... ...+........+. ..... ...++...+.+++|+.+||.+||.+|+|++|+|+|....
T Consensus 235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 4332111 11111111111222 22211 123456678999999999999999999999999997665
Q ss_pred cccc
Q 035572 313 FVDH 316 (379)
Q Consensus 313 ~~~~ 316 (379)
....
T Consensus 315 ~~hd 318 (359)
T KOG0660|consen 315 PYHD 318 (359)
T ss_pred hhcC
Confidence 5443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=331.76 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=215.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..+.|++.+.||.|..++||+|+... .+..||||++..+.+. ...+.+.+|+..++.+.||| |++
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPN-------Iv~ 88 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPN-------IVT 88 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCC-------cce
Confidence 46789999999999999999999876 4578999999877654 44789999999999999999 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.. |..+..+|+||+||.+||+.++++..- ...+++..+..+++++++||.|||.+| .+|||||+.|
T Consensus 89 ~~~s-------Fvv~~~LWvVmpfMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgn 156 (516)
T KOG0582|consen 89 YHCS-------FVVDSELWVVMPFMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGN 156 (516)
T ss_pred EEEE-------EEecceeEEeehhhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC--ceeccccccc
Confidence 7765 455789999999999999999998753 334999999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc----c-cccCccccccCCCCC--CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS----M-VQPAGTIGYLDPGYT--NPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~----~-~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
|||+.+|.|||+|||.+......+. . .+..||+.|||||++ ....|+.|+||||||++..||.+|..||....
T Consensus 157 ILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 157 ILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred EEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 9999999999999998754433221 1 455899999999984 34579999999999999999999999998764
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCC-------CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVG-------LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
...-+. ..++..++ ........++.+..++..||+.||++|||++++++|........
T Consensus 237 PmkvLl-------------~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 237 PMKVLL-------------LTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hHHHHH-------------HHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 322221 11111111 11123456678999999999999999999999999976655443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=317.78 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=221.0
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
..++.|++-+.||+|.|+.|+++....+ ++.+++|.+....++ +...+++.+|+.|-+.|+||| |+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~t-----g~~fa~kiin~~k~~--~~~~e~l~rEarIC~~LqHP~-------Iv 73 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTT-----GLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPN-------IV 73 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccc-----hHHHHHHHhhhhhhc--cccHHHHHHHHHHHHhcCCCc-------Ee
Confidence 3478999999999999999999987664 445666666554444 346788999999999999998 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
+++.. +.+.+..|||+|+++|++|..-+-++.. .++..+..+++||+.+|.|+|.+| |||||+||.
T Consensus 74 rL~~t-------i~~~~~~ylvFe~m~G~dl~~eIV~R~~-----ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~ 139 (355)
T KOG0033|consen 74 RLHDS-------IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILEALAYCHSNG--IVHRDLKPE 139 (355)
T ss_pred ehhhh-------hcccceeEEEEecccchHHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChh
Confidence 88876 4667899999999999999887766532 778888899999999999999999 999999999
Q ss_pred ceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 172 NILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 172 NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|+++.. ..-+||+|||+|...+.........|||.|||||++...+|+..+|||+-|++||-|+.|.+||.+.+.
T Consensus 140 nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-- 217 (355)
T KOG0033|consen 140 NLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-- 217 (355)
T ss_pred heeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--
Confidence 999963 334899999999888866666677899999999999999999999999999999999999999988542
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
...+.++....+..+. .++.++++..+|+++||..||.+|+|+.|+|+|......
T Consensus 218 -----------~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 218 -----------HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -----------HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 3445555555555555 778889999999999999999999999999999665443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=340.47 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=214.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...|...++||+|+||.||+|++.. +.+.||+|++..+.. .+..+.+..|+.+|.++++++ |.++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~-----t~k~vAiKii~Le~~---~deIediqqei~~Ls~~~~~~-------it~y 76 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNK-----TKKVVAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPN-------ITEY 76 (467)
T ss_pred ccccccchhccccccceeeeeeecc-----ccceEEEEEechhhc---chhhHHHHHHHHHHHhcCcch-------HHhh
Confidence 3468888999999999999998765 668899999986543 567788999999999999877 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ -.+..++++||||.||++.+.++.... +.+..+.-++++++.||.|||+++ .+|||||+.||
T Consensus 77 ygsy-------l~g~~LwiiMey~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaani 142 (467)
T KOG0201|consen 77 YGSY-------LKGTKLWIIMEYCGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANI 142 (467)
T ss_pred hhhe-------eecccHHHHHHHhcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcc--eecccccccce
Confidence 7664 346789999999999999999975332 467777889999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|+..+|.+||+|||++........ ..+..||+.|||||++....|+.++||||||++++||++|.+|+...+....
T Consensus 143 l~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--- 219 (467)
T KOG0201|consen 143 LLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--- 219 (467)
T ss_pred eEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---
Confidence 999999999999999976655433 3677999999999999988999999999999999999999999987664221
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
..++. ....|.....+++.+.+++..||+.||+.||++.++|+|.....
T Consensus 220 -----------lflIp-k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 220 -----------LFLIP-KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----------EEecc-CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 11111 12224444467889999999999999999999999999976655
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=338.76 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=209.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++++.||+|+||.||+|+-++ +++++|+|++++...- .....+-+..|-.+|....++. ||++
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~-----Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~-------vVKL 206 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKD-----TGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPW-------VVKL 206 (550)
T ss_pred cccchhheeeccccceeEEEEEEcc-----CCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCc-------EEEE
Confidence 4789999999999999999998665 7789999999876432 2455677889999998877666 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+-. |++.+.+||||||++||++..+|...+ .+++..++-++.+++.|+..||+.| ++||||||+|+
T Consensus 207 yYs-------FQD~~~LYLiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNl 272 (550)
T KOG0605|consen 207 YYS-------FQDKEYLYLIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNL 272 (550)
T ss_pred EEE-------ecCCCeeEEEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhhe
Confidence 654 799999999999999999999998644 3899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCC----------------------C--C------------------------cccccCccc
Q 035572 174 LFDSKWDAKLADFGLAVSESD----------------------E--S------------------------SMVQPAGTI 205 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~----------------------~--~------------------------~~~~~~gt~ 205 (379)
|||..|++||+|||+|..... . . .....+|||
T Consensus 273 LiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTP 352 (550)
T KOG0605|consen 273 LIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTP 352 (550)
T ss_pred eecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCc
Confidence 999999999999999831100 0 0 011235999
Q ss_pred cccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcccc--CCCCcchHHHHHH
Q 035572 206 GYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSR--VGLPTFMEGAIKQ 283 (379)
Q Consensus 206 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 283 (379)
.|||||++.+..|+..+|.||||||+||||.|.+||.+.+..+. +.++...+ +..|. ....+.+
T Consensus 353 DYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T-------------~rkI~nwr~~l~fP~-~~~~s~e 418 (550)
T KOG0605|consen 353 DYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET-------------YRKIVNWRETLKFPE-EVDLSDE 418 (550)
T ss_pred cccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHHHhhhccCCC-cCcccHH
Confidence 99999999999999999999999999999999999988764332 22222221 11122 1233488
Q ss_pred HHHHHHhcccCCCCCCCC---hHHHhccccCccccc
Q 035572 284 MLHVAARCVSSEEENRPG---IGEILMGCSCFFVDH 316 (379)
Q Consensus 284 ~~~li~~~l~~dp~~Rps---~~e~l~~~~~~~~~~ 316 (379)
+.|||.+||. ||++|.. ++||-+|........
T Consensus 419 A~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 419 AKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999999999 9999975 888888876655443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=326.43 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=224.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
...+|++.+.||.|.||.|-+|+... .++.||||.++++.+.. ....-.+.+||+||+.|+||+ |+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~-----sgR~VAiKsIrKdkIkd-eqDlvhIRREIeIMSsLNHPh-------II~ 117 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHK-----SGREVAIKSIRKDKIKD-EQDLVHIRREIEIMSSLNHPH-------IIQ 117 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhcc-----CCcEeehhhhhhhhccc-HHHHHHHHHHHHHHhhcCCCc-------eee
Confidence 34689999999999999999997654 67889999999876643 344667899999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++. +|+..+.+.|||||..+|.|.+++..++. +++.+++.+++||.+|+.|+|+++ ++|||||.+|
T Consensus 118 IyE-------VFENkdKIvivMEYaS~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLEN 183 (668)
T KOG0611|consen 118 IYE-------VFENKDKIVIVMEYASGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLEN 183 (668)
T ss_pred hhh-------hhcCCceEEEEEEecCCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhh
Confidence 665 47889999999999999999999987654 999999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||+|+|+++||+|||++..+.......+.+|++-|.+||++++.+| ++.+|.||||++||.|+.|..||++.+
T Consensus 184 ILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------ 257 (668)
T KOG0611|consen 184 ILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------ 257 (668)
T ss_pred eeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------
Confidence 9999999999999999988888888888999999999999999988 568999999999999999999999875
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
....+.++....+..|... .+..-||+.||..||++|-|+.++..|........
T Consensus 258 -------hk~lvrQIs~GaYrEP~~P----SdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 258 -------HKRLVRQISRGAYREPETP----SDASGLIRWMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred -------HHHHHHHhhcccccCCCCC----chHHHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence 2334445555555444433 45678899999999999999999999977665444
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.19 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=217.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|..++.+|+|+||.+++++.+. ..+.+++|.+...... ....+....|+.++++++||| ||.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~-------iv~y 68 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPN-------IVEY 68 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCC-------eeee
Confidence 4789999999999999999997654 5568999999876543 344557899999999999999 9988
Q ss_pred cccccccCCCccCCCc-eEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSN-KLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
.+.+ ..++. ++|||+||+||+|.+.+.+++ ...++++.+..|+.|++.|+.|||++. |+|||||++|
T Consensus 69 ~ds~-------~~~~~~l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~N 136 (426)
T KOG0589|consen 69 KDSF-------EEDGQLLCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCAN 136 (426)
T ss_pred ccch-------hcCCceEEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhh
Confidence 8775 44566 999999999999999999865 344999999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.++.++|+|||+|+...... ...+..||+.||+||.+.+.+|+.++|||||||++|||++-+++|...+- ..+
T Consensus 137 ifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-~~L- 214 (426)
T KOG0589|consen 137 IFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-SEL- 214 (426)
T ss_pred hhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-HHH-
Confidence 999999999999999998887766 66677899999999999999999999999999999999999999987653 222
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..++.... ..+....++.++..++..||+.+|..||++.++|.+...
T Consensus 215 -----------i~ki~~~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l 261 (426)
T KOG0589|consen 215 -----------ILKINRGL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHL 261 (426)
T ss_pred -----------HHHHhhcc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence 22223322 123345567899999999999999999999999998433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=327.53 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=203.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|+..+.||+|+||.||+|.+.. +++.||+|.+....... ......+.+|+.+++.++|++ ++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~-------iv~~~~ 67 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRF-------VVSLAY 67 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec-----CCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCc-------EEEEEE
Confidence 48889999999999999998765 56789999987543221 223356789999999999887 777665
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+.+..++||||+++|+|.+.+.... ...+++..+..++.|++.||+|||+.| |+||||||+|||+
T Consensus 68 ~-------~~~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill 135 (285)
T cd05631 68 A-------YETKDALCLVLTIMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILL 135 (285)
T ss_pred E-------EccCCeEEEEEEecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE
Confidence 5 345678999999999999998886532 234888999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||++.............||..|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--- 212 (285)
T cd05631 136 DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--- 212 (285)
T ss_pred CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---
Confidence 99999999999999765444344455799999999999999999999999999999999999999987543221110
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhcccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCS 310 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~ 310 (379)
....+...... .....+.++.+|+.+||+.||.+||+ ++++++|..
T Consensus 213 ------~~~~~~~~~~~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 213 ------VDRRVKEDQEE---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred ------HHHHhhccccc---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 01111111111 22234578999999999999999997 899998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=336.77 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=203.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
..++|++.++||+|+||.||+|.+........++.||+|.+..... ......+.+|+.++..+ +|+| |+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~n-------iv 74 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLN-------VV 74 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcc-------ee
Confidence 4578999999999999999999865433344567899999874321 23456789999999999 7887 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC---------------------------------------
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--------------------------------------- 132 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--------------------------------------- 132 (379)
++++.+. ...+.+++||||+++|+|.+++......
T Consensus 75 ~~~~~~~------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (338)
T cd05102 75 NLLGACT------KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSR 148 (338)
T ss_pred eEEeEec------CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccc
Confidence 8887653 2345689999999999999999753211
Q ss_pred ------------------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCC
Q 035572 133 ------------------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194 (379)
Q Consensus 133 ------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 194 (379)
....+++.++..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 149 FQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 0123778888999999999999999999 99999999999999999999999999965432
Q ss_pred CCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhcccc
Q 035572 195 ESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSR 270 (379)
Q Consensus 195 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (379)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||............. .. ...
T Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~----~~-------~~~ 295 (338)
T cd05102 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL----KD-------GTR 295 (338)
T ss_pred CcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----hc-------CCC
Confidence 211 122346688999999988899999999999999999997 999997754322221110 00 011
Q ss_pred CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 271 VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. ....+++.+.+++.+||+.||++|||+.++++.
T Consensus 296 ~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~ 330 (338)
T cd05102 296 MR---APENATPEIYRIMLACWQGDPKERPTFSALVEI 330 (338)
T ss_pred CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11 112345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=329.02 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=214.1
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh----------hhhcHHHHHHHHHHHHhhhh
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV----------LQDNSKKLNNEIRVLSSLQE 80 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~~E~~~l~~l~~ 80 (379)
.+.-..|++.+.||+|.||.|-+|++.. +++.||||++.+..... .-...++..+||.+|+++.|
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~-----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV-----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC-----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 3445789999999999999999998654 77899999997654321 11224689999999999999
Q ss_pred ccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC
Q 035572 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND 160 (379)
Q Consensus 81 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 160 (379)
+| ||+++..+-. ...+.+|||+|||..|.+...- ...+.+++.+++.|+++++.||+|||.+|
T Consensus 168 ~n-------VV~LiEvLDD-----P~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg 230 (576)
T KOG0585|consen 168 PN-------VVKLIEVLDD-----PESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG 230 (576)
T ss_pred cC-------eeEEEEeecC-----cccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 98 7877765422 3457999999999888864432 12223899999999999999999999999
Q ss_pred CCeEecCCCCCceEEcCCCCeEEeccccCccCCCC------CcccccCccccccCCCCCCCCC----CCCcCCeehhHHH
Q 035572 161 PMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE------SSMVQPAGTIGYLDPGYTNPSK----LSKKVDVFSYGVV 230 (379)
Q Consensus 161 ~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~i 230 (379)
|+||||||+|+|++++|++||+|||.+...... .......|||.|+|||.+.++. .+.+.||||+||+
T Consensus 231 --iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 231 --IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred --eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 999999999999999999999999998655322 1223458999999999876632 3678999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 231 LLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 231 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
||.|+.|+.||.+.. ..+.+.++....+..|... ++...+.+||.+||..||++|++..++..|..
T Consensus 309 LYCllfG~~PF~~~~-------------~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDF-------------ELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHhhhccCCcccch-------------HHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 999999999997653 2345566777777666543 45688999999999999999999999999977
Q ss_pred Cccccc
Q 035572 311 CFFVDH 316 (379)
Q Consensus 311 ~~~~~~ 316 (379)
......
T Consensus 375 vt~~g~ 380 (576)
T KOG0585|consen 375 VTRDGD 380 (576)
T ss_pred eccCCC
Confidence 665533
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=304.35 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=218.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|-||.||.|+.+. +.-+||+|++-++... ......++.+|++|-+.|+||| |++++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekk-----s~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpn-------ilrlY 88 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKK-----SLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPN-------ILRLY 88 (281)
T ss_pred hhccccccccCCccccEeEeeecc-----CCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCcc-------HHhhh
Confidence 578999999999999999998765 5678999999876643 2456788999999999999999 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
++ |-+....||++||..+|+|...|.... ..++++.....+++|++.||.|+|..+ ++||||||+|+|
T Consensus 89 ~~-------fhd~~riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlL 156 (281)
T KOG0580|consen 89 GY-------FHDSKRIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLL 156 (281)
T ss_pred hh-------eeccceeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhc
Confidence 87 456789999999999999999998633 334888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++..|.+||+|||-+...+ .+...+.+||..|.|||+.++...+..+|+|++|++.||++.|.+||....
T Consensus 157 lg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------- 226 (281)
T KOG0580|consen 157 LGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------- 226 (281)
T ss_pred cCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---------
Confidence 9999999999999997776 555667799999999999999999999999999999999999999998654
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..+.+..+.......| ..++.++.|+|.+||..+|.+|.+..|++.|..
T Consensus 227 ----~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 227 ----HSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ----hHHHHHHHHHccccCC---cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 2334444444455545 455688999999999999999999999999843
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=328.54 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=203.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.++|+| |++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~-------iv~~~ 67 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPF-------IIRLF 67 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCc-------HhhhH
Confidence 479999999999999999998765 4677999998643211 1233567889999999999988 77776
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++| ++||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIl 133 (291)
T cd05612 68 WT-------EHDQRFLYMLMEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENIL 133 (291)
T ss_pred hh-------hccCCeEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeE
Confidence 55 456778999999999999999997543 3888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 134 i~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------ 205 (291)
T cd05612 134 LDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------ 205 (291)
T ss_pred ECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 999999999999998665332 223468999999999998889999999999999999999999997654211
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~ 311 (379)
....+.......+. ..+..+.+++.+||+.||.+||+ +++++.|...
T Consensus 206 -------~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 206 -------IYEKILAGKLEFPR---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred -------HHHHHHhCCcCCCc---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 11122222222232 23567899999999999999995 9999998554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=313.69 Aligned_cols=273 Identities=21% Similarity=0.242 Sum_probs=213.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+.++.|++|+||.||+|.++. +..+||+|+++.+... ....-.-.+||.+|.+++|+| ||.+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~-----t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~N-------IV~vk 141 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKK-----TDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPN-------IVEVK 141 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCC-----cceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCC-------eeeeE
Confidence 579999999999999999998765 6788999999876532 333445689999999999999 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
...+. .+-+.+|||||||+ .+|..++.... ..|...++..++.|++.|++|||.+. |+||||||+|+|
T Consensus 142 EVVvG-----~~~d~iy~VMe~~E-hDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLL 209 (419)
T KOG0663|consen 142 EVVVG-----SNMDKIYIVMEYVE-HDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLL 209 (419)
T ss_pred EEEec-----cccceeeeeHHHHH-hhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhhee
Confidence 65543 33467999999995 69999998754 34899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++..|.+||+|||+|+..+.. ...+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....+++..
T Consensus 210 m~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 210 LSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred eccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 999999999999999877654 334555789999999977654 689999999999999999999999998877766654
Q ss_pred hhhhhhhHHh---hhhh--------cc-ccC---CCCcchH--HHHHHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 253 WALPLIKEEK---LRQV--------CD-SRV---GLPTFME--GAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 253 ~~~~~~~~~~---~~~~--------~~-~~~---~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
+...+ .... +... .. ... .+...+. ..+..-.+|+..+|.+||.+|.|++|.|.|......
T Consensus 290 If~ll-GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 290 IFKLL-GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred HHHHh-CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 43211 1100 0000 00 000 0000111 144778899999999999999999999999766553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.38 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=205.4
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
+.+..-.+.++.++.||+|-||.||.|.++.... ||+|.++.. ....+.|.+|+++|++|+|++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~------vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~----- 262 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTK------VAVKTIKEG-----SMSPEAFLREAQIMKKLRHEK----- 262 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCc------ccceEEecc-----ccChhHHHHHHHHHHhCcccC-----
Confidence 3444445567788999999999999999976432 788877643 334577889999999999999
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
||++++.|. .++.+|||||||+.|+|.++|+.. ....+...+.+.++.||++|++||++++ +||||
T Consensus 263 --lV~l~gV~~-------~~~piyIVtE~m~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRD 328 (468)
T KOG0197|consen 263 --LVKLYGVCT-------KQEPIYIVTEYMPKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRD 328 (468)
T ss_pred --eEEEEEEEe-------cCCceEEEEEecccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC--ccchh
Confidence 999998863 345799999999999999999872 3344888899999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
|-..||||+++..+||+|||+|+........ ....-...|.|||.+..+.++.+|||||||++||||+| |+.|+.+.
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred hhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 9999999999999999999999854433322 22234567999999999999999999999999999999 99999887
Q ss_pred CCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.+.+-+ +.+. .+++.| ..++.++.+++..||..+|++|||++.+...
T Consensus 409 sn~ev~--------------~~le~GyRlp~P---~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~ 457 (468)
T KOG0197|consen 409 SNEEVL--------------ELLERGYRLPRP---EGCPDEVYELMKSCWHEDPEDRPTFETLREV 457 (468)
T ss_pred CHHHHH--------------HHHhccCcCCCC---CCCCHHHHHHHHHHhhCCcccCCCHHHHHHH
Confidence 543321 2222 233333 3467889999999999999999999976643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=332.37 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=205.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.+...... .....+.+.+|+.+++.++|+| |+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~-------iv~~ 83 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKG-----TGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPF-------IVNM 83 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 3689999999999999999998765 5578999998643211 1234567899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+++..|+||||+++++|.+.+.+.. .+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 84 ~~~-------~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NI 149 (329)
T PTZ00263 84 MCS-------FQDENRVYFLLEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENL 149 (329)
T ss_pred EEE-------EEcCCEEEEEEcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHE
Confidence 765 355788999999999999999997532 3788889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 150 ll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------ 221 (329)
T PTZ00263 150 LLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------ 221 (329)
T ss_pred EECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------
Confidence 99999999999999987654322 2347999999999999889999999999999999999999999764321
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCF 312 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~ 312 (379)
.....+.......|.. ++..+.+|+.+||+.||++||+ +++++.|....
T Consensus 222 -------~~~~~i~~~~~~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~ 275 (329)
T PTZ00263 222 -------RIYEKILAGRLKFPNW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275 (329)
T ss_pred -------HHHHHHhcCCcCCCCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence 1112222333333332 3467899999999999999997 79999996654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=337.66 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=209.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
-++|.++++||+|+||.|++|..+. +++.+|||.+++..+- ..+..+..+.|..|++... +
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il-~~d~Ve~~~~EkrI~~la~--~----------- 427 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDIL-QRDEVESLMCEKRIFELAN--R----------- 427 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeecccee-ccccHHHHHHHHHHHHHhc--c-----------
Confidence 4689999999999999999998775 5678999999987553 3567888999999999886 1
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
|+++..++..|++..++|.||||+.||++..+.+ ...+++..++-|+..++.||.|||++| |++||||.+||
T Consensus 428 HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNi 499 (694)
T KOG0694|consen 428 HPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNL 499 (694)
T ss_pred CCeEeecccccccCCeEEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhhe
Confidence 3333444455899999999999999999544443 233999999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|+|.+|.+||+|||+++-.- ......+.+||+.|||||++.+..|+.++|.|||||++||||.|..||.+.+.
T Consensus 500 LLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------ 573 (694)
T KOG0694|consen 500 LLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------ 573 (694)
T ss_pred EEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------
Confidence 99999999999999996544 55667788999999999999999999999999999999999999999998763
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhcccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~ 310 (379)
++.+..++...+..|.. ++.+...+++++|+.+|++|..+ ++|..|..
T Consensus 574 -------ee~FdsI~~d~~~yP~~---ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 574 -------EEVFDSIVNDEVRYPRF---LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred -------HHHHHHHhcCCCCCCCc---ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence 33444444444444444 45889999999999999999876 45555533
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=330.15 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=198.5
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.++. +++.||+|.++..... .......+.+|+.+++.++|++ |+.+++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~-------i~~~~~~---- 63 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPF-------LTALKYS---- 63 (323)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCC-------CCCEEEE----
Confidence 469999999999998764 5678999998743211 1234567789999999999988 6665554
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
+...+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 64 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~ 133 (323)
T cd05571 64 ---FQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGH 133 (323)
T ss_pred ---EEcCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCC
Confidence 455788999999999999999997532 3889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhh
Q 035572 181 AKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 259 (379)
+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .+
T Consensus 134 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~--------- 203 (323)
T cd05571 134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KL--------- 203 (323)
T ss_pred EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HH---------
Confidence 99999999865322 22233456999999999999999999999999999999999999999764321 11
Q ss_pred HHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCcc
Q 035572 260 EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCFF 313 (379)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~~ 313 (379)
...+.......| ...++++.+++.+||+.||++|| ++.++++|.....
T Consensus 204 ---~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 204 ---FELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred ---HHHHHcCCCCCC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 111122222222 23457899999999999999999 8999999876533
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=313.32 Aligned_cols=281 Identities=22% Similarity=0.268 Sum_probs=215.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...|+.+++||+|+||.||+|+.+. +++.||+|+++.+..+ +.......+|+.+|+.|+|+|+ |+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~-----~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~------iv~L 76 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR-----TGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANH------IVRL 76 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec-----CCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcc------eEEE
Confidence 5678889999999999999998775 5688999999876432 2345667899999999999874 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+..... +.....+++|+||+ ..+|.+++....... ..++...+..+++||+.||+|||+++ |+||||||+||
T Consensus 77 ~dv~~~~~~-~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNl 151 (323)
T KOG0594|consen 77 HDVIHTSNN-HRGIGKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNL 151 (323)
T ss_pred Eeeeeeccc-ccccceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceE
Confidence 777654322 33445899999999 789999998755321 34667889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++++|.+||+|||+|+... +........+|..|.|||++-+. .|+...||||+||++.||+++++-|.+..+.+++.
T Consensus 152 Li~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~ 231 (323)
T KOG0594|consen 152 LISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF 231 (323)
T ss_pred EECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999999999997665 33345666899999999988776 78999999999999999999999998887755554
Q ss_pred HhhhhhhhHH---hhhh---hccccCCCCcc---------hHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 252 DWALPLIKEE---KLRQ---VCDSRVGLPTF---------MEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~---~~~~---~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
....- +... .+.. ..+.....+.. .+...++..+++.+||+.+|.+|.|++.++.|.....
T Consensus 232 ~If~~-lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 232 RIFRL-LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred HHHHH-cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 43221 1111 1111 11111111111 1112247899999999999999999999999955443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=324.42 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=201.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.++. +++.+|+|++...... ....+.+.+|+.+++.++|+| |++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 66 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-----TKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQEN-------IVELK 66 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-----CCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCcc-------ccchh
Confidence 479999999999999999998765 5567999998754322 344567889999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +..++..++||||++++++..+... ...+++..++.++.|++.||.|||+.| ++||||||+||+
T Consensus 67 ~~-------~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil 132 (287)
T cd07848 67 EA-------FRRRGKLYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLL 132 (287)
T ss_pred hh-------EecCCEEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence 65 3556789999999988766654432 223888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|++||...........
T Consensus 133 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 133 ISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred EcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999997654322 22334689999999999888899999999999999999999999987554332211
Q ss_pred hhh--hhhhHHhhhh---------hccccCCCCc-----chHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WAL--PLIKEEKLRQ---------VCDSRVGLPT-----FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~--~~~~~~~~~~---------~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .......... ........+. .....+..+.+|+.+||+.||++|||++++++|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 100 0000000000 0000000000 1123467899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=335.03 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=213.0
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
++|...++....++.||.|+.|.||+|+.+ ++.||||+++. .-+.+|+-|++|+|+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-------netVAVKKV~e-----------lkETdIKHLRkLkH~N----- 173 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-------NETVAVKKVRE-----------LKETDIKHLRKLKHPN----- 173 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-------CceehhHHHhh-----------hhhhhHHHHHhccCcc-----
Confidence 466777788888999999999999999874 35699998762 2357899999999999
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+.+.+.| .....+|||||||..|-|..+|+..+. +.......|..+|+.|+.|||.+. |+|||
T Consensus 174 --II~FkGVC-------tqsPcyCIiMEfCa~GqL~~VLka~~~-----itp~llv~Wsk~IA~GM~YLH~hK--IIHRD 237 (904)
T KOG4721|consen 174 --IITFKGVC-------TQSPCYCIIMEFCAQGQLYEVLKAGRP-----ITPSLLVDWSKGIAGGMNYLHLHK--IIHRD 237 (904)
T ss_pred --eeeEeeee-------cCCceeEEeeeccccccHHHHHhccCc-----cCHHHHHHHHHHhhhhhHHHHHhh--Hhhhc
Confidence 99988876 456889999999999999999986443 777778899999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||.-||||+.+..+||+|||.++.....++...+.||..|||||++...+.+.|+|||||||+|||||||..||..-+..
T Consensus 238 LKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 238 LKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred cCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 99999999999999999999998777767777789999999999999999999999999999999999999999776543
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVD 315 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~ 315 (379)
..+.. +-...+. ...+..++..+.-|+++||+-.|.+||++.+++.|.......
T Consensus 318 AIIwG-------------VGsNsL~-LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 318 AIIWG-------------VGSNSLH-LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred eeEEe-------------ccCCccc-ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 22110 0001111 112355678899999999999999999999999997665433
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=318.65 Aligned_cols=279 Identities=21% Similarity=0.294 Sum_probs=216.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.+=.|...+++|+|+||.||+|+... +.+.||||+.-.+. +.-.+|+++|+.+.|+| ||+
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~--------r~knrEl~im~~l~HpN-------IV~ 81 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDK--------RYKNRELQIMRKLDHPN-------IVR 81 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCC--------CcCcHHHHHHHhcCCcC-------eee
Confidence 34468889999999999999999875 35779999986442 23358999999999999 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+.-++....+. +.-...+||||+ ..+|.++++.... .+..++...++-+.+||++||+|||+.| |+||||||+|
T Consensus 82 L~~~f~~~~~~--d~~~lnlVleym-P~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqN 155 (364)
T KOG0658|consen 82 LLYFFSSSTES--DEVYLNLVLEYM-PETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQN 155 (364)
T ss_pred EEEEEEecCCC--chhHHHHHHHhc-hHHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChhe
Confidence 77776554332 345677899999 4799999986432 2344778888999999999999999999 9999999999
Q ss_pred eEEcC-CCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDS-KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+|+|. +|.+||||||.|+.........+..-|+.|.|||.+-+ ..|+.+.||||.||++.||+-|++-|.+.+..+++
T Consensus 156 lLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL 235 (364)
T KOG0658|consen 156 LLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL 235 (364)
T ss_pred EEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH
Confidence 99995 59999999999988877777777889999999996654 57999999999999999999999999987766665
Q ss_pred HHhhhhhh--hHHhhhhhccc-------cCCCCc----chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcccccC
Q 035572 251 IDWALPLI--KEEKLRQVCDS-------RVGLPT----FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDHH 317 (379)
Q Consensus 251 ~~~~~~~~--~~~~~~~~~~~-------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~~ 317 (379)
...+..+- ..+.+..+... ...... .....+++..+|+.++|+++|.+|.++.|++.|.........
T Consensus 236 ~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 236 VEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 54432211 11111111111 111111 234456899999999999999999999999999766554443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=324.99 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=200.7
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
++.||+|+||.||+|.+.... ..++.||+|.+..............+.+|+.+++.++|+| |+++++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-------iv~~~~~--- 68 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA--DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF-------IVDLIYA--- 68 (323)
T ss_pred CceeeecCCeEEEEEEEcccC--CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCc-------hhceeeE---
Confidence 368999999999999865422 3678899999875432222334466789999999999988 7776655
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+..++..|+||||+++++|.+.+...+ .+.+..+..++.|++.||.|||++| |+||||||+|||++.++
T Consensus 69 ----~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~ 137 (323)
T cd05584 69 ----FQTGGKLYLILEYLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQG 137 (323)
T ss_pred ----EecCCeEEEEEeCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCC
Confidence 355678999999999999999997533 3778888899999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---------- 207 (323)
T cd05584 138 HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---------- 207 (323)
T ss_pred CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------
Confidence 9999999998643222 22333469999999999998889999999999999999999999997654211
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
....+.......|.. .++.+.+++.+||+.||++|| ++.+++.|....
T Consensus 208 ---~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~ 260 (323)
T cd05584 208 ---TIDKILKGKLNLPPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260 (323)
T ss_pred ---HHHHHHcCCCCCCCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence 122222233333332 347789999999999999999 899999986543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=328.42 Aligned_cols=262 Identities=20% Similarity=0.253 Sum_probs=205.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|+++..... .......+.+|+.++..++|++ |++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~-------iv~~~ 67 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-----TGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEW-------LVKLL 67 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCC-------CccEE
Confidence 479999999999999999998765 4567999998743211 1234567889999999999888 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+..|+||||++|++|.+++.... .+++..++.++.|++.||.|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil 133 (333)
T cd05600 68 YA-------FQDDEYLYLAMEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFL 133 (333)
T ss_pred EE-------EEcCCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEE
Confidence 55 355778999999999999999997532 3788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .
T Consensus 134 ~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-i 210 (333)
T cd05600 134 IDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN-L 210 (333)
T ss_pred ECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH-H
Confidence 99999999999999865543 22344799999999999988999999999999999999999999976543221111 0
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
. ........ .........++.++.+++.+||..+|.+||++.+++.|.....
T Consensus 211 ~------~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 211 K------YWKETLQR-PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred H------hccccccC-CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 0 00000100 0001111234678999999999999999999999999965543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=325.53 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=218.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv 91 (379)
..+.|++.+.||+|.||.||+|+.+. +++.+|+|.+.+..... ......+.+|+.+|+++. |+| +|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~-----tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpn-------iv 99 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS-----TGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPN-------IV 99 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC-----CCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCC-------EE
Confidence 45689999999999999999998876 46779999998664321 124578999999999998 888 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.+++. +++.+.+++|||+|.||.|.+.+.+. .+++..+..++.|++.++.|||+.| ++||||||+
T Consensus 100 ~l~~~-------~e~~~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpE 164 (382)
T KOG0032|consen 100 QLKDA-------FEDPDSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPE 164 (382)
T ss_pred EEEEE-------EEcCCeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHH
Confidence 88876 57788999999999999999999875 2899999999999999999999999 999999999
Q ss_pred ceEEcCC----CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSK----WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|+|+... +.+|++|||++............+||+.|+|||+....+|+..+||||+|+++|.|++|.+||.+....
T Consensus 165 N~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 165 NLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred HeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 9999633 579999999998887766677789999999999999999999999999999999999999999887643
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.... .+....+.. ...+..++..+.+++.+||..||.+|+|+.++|+|..
T Consensus 245 ~~~~-------------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 245 EIFL-------------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHH-------------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 3322 233332222 3356677899999999999999999999999999843
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=328.31 Aligned_cols=272 Identities=21% Similarity=0.290 Sum_probs=200.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|++.. +++.||+|.+...... .....++.+|+.+++.++|+| |+++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn-------iv~~~~ 66 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKINDVFEH--VSDATRILREIKLLRLLRHPD-------IVEIKH 66 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEechhhcc--chhHHHHHHHHHHHHhCCCCC-------Eeeecc
Confidence 58999999999999999998764 5577999998643211 233457889999999999998 888777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+.... ..+....|+||||+ +++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||+
T Consensus 67 ~~~~~~--~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll 136 (338)
T cd07859 67 IMLPPS--RREFKDIYVVFELM-ESDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILA 136 (338)
T ss_pred eEeccC--CCCCceEEEEEecC-CCCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE
Confidence 653211 12334689999999 579999987532 3889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 176 DSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....
T Consensus 137 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~ 216 (338)
T cd07859 137 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216 (338)
T ss_pred CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 999999999999986542221 1233469999999998765 6789999999999999999999999976543221
Q ss_pred HHHhhh----------hhhhHH---hhhhhccccCC--CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWAL----------PLIKEE---KLRQVCDSRVG--LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~----------~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+..... ..+... ........... .....+..++.+.+++.+||+.||++|||++|+++|...
T Consensus 217 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 217 LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 110000 000000 00001111111 011122345678999999999999999999999998554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=312.47 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=220.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++++.||.|.-|+||+|.+.. +.+.+|+|++.++.... .+...+...|-+||+.+.||- +.++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPF-------lPTL 142 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPF-------LPTL 142 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCc-------cchh
Confidence 3578889999999999999998776 45889999998765543 455788899999999999775 5555
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+.. |+.++..|+|||||+||+|..+++++ +...+++..++-++..++.||+|||-.| ||+|||||+||
T Consensus 143 Ya~-------fet~~~~cl~meyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENI 210 (459)
T KOG0610|consen 143 YAS-------FETDKYSCLVMEYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENI 210 (459)
T ss_pred hhe-------eeccceeEEEEecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCccee
Confidence 544 78899999999999999999999874 5566999999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCC---------------------------------C-C-----------------------
Q 035572 174 LFDSKWDAKLADFGLAVSESD---------------------------------E-S----------------------- 196 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~---------------------------------~-~----------------------- 196 (379)
||-++|++.|+||.++..... . .
T Consensus 211 LvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~ 290 (459)
T KOG0610|consen 211 LVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGA 290 (459)
T ss_pred EEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCc
Confidence 999999999999998732100 0 0
Q ss_pred cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcc
Q 035572 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTF 276 (379)
Q Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (379)
.....+||-.|+|||++.+...+.++|.|+||+.+|||+.|..||.+.+. ++.+.+++...+..|..
T Consensus 291 RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-------------~~Tl~NIv~~~l~Fp~~ 357 (459)
T KOG0610|consen 291 RSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-------------KETLRNIVGQPLKFPEE 357 (459)
T ss_pred cccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-------------hhhHHHHhcCCCcCCCC
Confidence 01123589999999999999999999999999999999999999999875 44556666666666665
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCC----hHHHhccccCccccc
Q 035572 277 MEGAIKQMLHVAARCVSSEEENRPG----IGEILMGCSCFFVDH 316 (379)
Q Consensus 277 ~~~~~~~~~~li~~~l~~dp~~Rps----~~e~l~~~~~~~~~~ 316 (379)
. .++..+.|||+++|..||++|.. +.||=+|........
T Consensus 358 ~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 358 P-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred C-cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 4 66789999999999999999998 999998876655444
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=320.08 Aligned_cols=274 Identities=23% Similarity=0.293 Sum_probs=201.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh---hccCCCCCceee
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ---ESNKRNPNYCVV 91 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~~~~~~~~iv 91 (379)
++|++.+.||+|+||.||+|.+... .++.||+|.++..... ......+.+|+.+++.++ |+| |+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpn-------iv 67 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPN-------VV 67 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC----CCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCC-------cc
Confidence 4799999999999999999986432 3467999988754322 223345677888887774 666 78
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+... ........++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.| |+||||||+
T Consensus 68 ~~~~~~~~~--~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~ 139 (290)
T cd07862 68 RLFDVCTVS--RTDRETKLTLVFEHV-DQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQ 139 (290)
T ss_pred eEEEEEecc--cCCCCCcEEEEEccC-CCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHH
Confidence 777765321 123456789999999 47999998753 2234888999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|||++.++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|++||.+..+...+.
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 219 (290)
T cd07862 140 NILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 219 (290)
T ss_pred HEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 99999999999999999976554444445578999999999988889999999999999999999999998765543322
Q ss_pred Hhhhhhh--hHHhhhh-------hcccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLI--KEEKLRQ-------VCDSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~--~~~~~~~-------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... ....+.. ..... ..........+..+.+++.+||+.||++|||+.|+++|.
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp 288 (290)
T cd07862 220 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288 (290)
T ss_pred HHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence 2111000 0000000 00000 000011123456788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=323.01 Aligned_cols=270 Identities=21% Similarity=0.285 Sum_probs=200.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+.+++.++|+| ++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------iv~~ 68 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHAN-------IVLL 68 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC-----CCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCC-------cCeE
Confidence 5789999999999999999998764 567799999875432 223456788999999999988 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+ +++|.+++... ...+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 69 ~~~~-------~~~~~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Ni 134 (303)
T cd07869 69 HDII-------HTKETLTLVFEYV-HTDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNL 134 (303)
T ss_pred EEEE-------ecCCeEEEEEECC-CcCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHE
Confidence 6653 4567899999999 57888888653 223788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|+++++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+.....
T Consensus 135 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 214 (303)
T cd07869 135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214 (303)
T ss_pred EECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence 9999999999999998654322 22234568999999998765 457889999999999999999999998765543322
Q ss_pred HhhhhhhhHH---hhhh------hccccC--CCCcchH------HHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 252 DWALPLIKEE---KLRQ------VCDSRV--GLPTFME------GAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~~~---~~~~------~~~~~~--~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.......... .+.. ...... ..+.... ..+..+.+|+.+||+.||++|||+.|+++|....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 215 ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 2211111000 0000 000000 0011000 1235688999999999999999999999986553
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=331.37 Aligned_cols=276 Identities=23% Similarity=0.267 Sum_probs=214.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCcee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCV 90 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~i 90 (379)
.+.-+|++.++||+|+||.|-+|.+.. +++.||||+++.. .....+-..|+.+|..|+ |.+..+ +.+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~-----T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~--~n~ 250 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHK-----TGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDK--YNI 250 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecC-----CCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCC--eeE
Confidence 344589999999999999999999876 6678999999865 456777889999999998 433333 338
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
|+++++ |...+++|||+|.+ +.+|.++++... ...++...++.++.||+.||.+||+.| |+|+||||
T Consensus 251 Vrm~d~-------F~fr~HlciVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKP 317 (586)
T KOG0667|consen 251 VRMLDY-------FYFRNHLCIVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKP 317 (586)
T ss_pred EEeeec-------cccccceeeeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCh
Confidence 888877 45679999999999 789999999754 344999999999999999999999999 99999999
Q ss_pred CceEEcC--CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 171 TNILFDS--KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 171 ~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
+||||.+ ...+||+|||+|......-. +..-++.|.|||++.|.+|+.+.||||||||+.||++|.+.|.+.+..+
T Consensus 318 ENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 318 ENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred hheeeccCCcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 9999973 34799999999987765433 6688999999999999999999999999999999999988888877655
Q ss_pred hHHHhhh-----------------hhhhH-H---------------------hhhhhccccCCCC-c------chH-HHH
Q 035572 249 SIIDWAL-----------------PLIKE-E---------------------KLRQVCDSRVGLP-T------FME-GAI 281 (379)
Q Consensus 249 ~~~~~~~-----------------~~~~~-~---------------------~~~~~~~~~~~~~-~------~~~-~~~ 281 (379)
++..... ..... . ............| . ... ..-
T Consensus 396 Ql~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~ 475 (586)
T KOG0667|consen 396 QLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADD 475 (586)
T ss_pred HHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccH
Confidence 4422111 00000 0 0000000111111 1 111 234
Q ss_pred HHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 282 KQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 282 ~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
..+.+++.+||.+||.+|+|+.+++.|......
T Consensus 476 ~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 476 KLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred HHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 578999999999999999999999999877643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=324.49 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=197.3
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+.. +++.||+|.+..... ........+.+|+.+++.++|++ ++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~-------iv~~~~~---- 63 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPF-------LTSLKYS---- 63 (328)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCC-------CcceEEE----
Confidence 468999999999998764 567899999875322 12344567889999999999887 6665544
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
+...+..|+||||+++|+|.+.+... ..+++.++..++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 64 ---~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~ 133 (328)
T cd05593 64 ---FQTKDRLCFVMEYVNGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGH 133 (328)
T ss_pred ---EEcCCEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCc
Confidence 45678899999999999999988653 23889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhh
Q 035572 181 AKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 259 (379)
+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... .
T Consensus 134 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~--------- 203 (328)
T cd05593 134 IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-L--------- 203 (328)
T ss_pred EEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-H---------
Confidence 99999999865322 222334569999999999998899999999999999999999999997653211 1
Q ss_pred HHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 260 EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
...+.......|. ..+.++.+++.+||+.||++|| ++.++++|...
T Consensus 204 ---~~~~~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 204 ---FELILMEDIKFPR---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred ---HHHhccCCccCCC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 1111222222232 3457899999999999999997 89999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=322.07 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=197.0
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||+|+||.||+|.+.. +++.||+|.+...... .......+.+|+.+++.++|+| |+++++.
T Consensus 1 lg~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~-------iv~~~~~------ 61 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-----TQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPF-------IVPLKFS------ 61 (312)
T ss_pred CCcCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCc-------EeceeeE------
Confidence 7999999999998764 5677999998643211 1334567889999999999988 7777655
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
+.+.+..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++| |+||||||+|||++.++.++
T Consensus 62 -~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~k 133 (312)
T cd05585 62 -FQSPEKLYLVLAFINGGELFHHLQREG-----RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIA 133 (312)
T ss_pred -EecCCeEEEEEcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEE
Confidence 355788999999999999999997532 3888999999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHH
Q 035572 183 LADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEE 261 (379)
Q Consensus 183 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 261 (379)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 134 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------------- 200 (312)
T cd05585 134 LCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------------- 200 (312)
T ss_pred EEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------------
Confidence 9999998653322 22334569999999999999999999999999999999999999997653211
Q ss_pred hhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC---ChHHHhccccCc
Q 035572 262 KLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP---GIGEILMGCSCF 312 (379)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~~~~~~ 312 (379)
....+.......+ ...++.+.+++.+||+.||.+|| ++.+++.|....
T Consensus 201 ~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 201 MYRKILQEPLRFP---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred HHHHHHcCCCCCC---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 1122222222223 23457899999999999999997 578999986544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.50 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=205.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|+++..... .......+.+|+.++..++|++ +++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~-------i~~~~ 67 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-----TGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPW-------IVKLY 67 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-----CCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCC-------ccchh
Confidence 479999999999999999998765 5678999998743221 1234567899999999999888 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++..|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIl 133 (350)
T cd05573 68 YS-------FQDEEHLYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNIL 133 (350)
T ss_pred hh-------eecCCeEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeE
Confidence 55 45678899999999999999999764 23888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC------------------------------cccccCccccccCCCCCCCCCCCCcCCe
Q 035572 175 FDSKWDAKLADFGLAVSESDES------------------------------SMVQPAGTIGYLDPGYTNPSKLSKKVDV 224 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 224 (379)
++.++.++|+|||++....... ......||+.|+|||++.+..++.++||
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 213 (350)
T cd05573 134 IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213 (350)
T ss_pred ECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceee
Confidence 9999999999999986544332 2233469999999999999999999999
Q ss_pred ehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-
Q 035572 225 FSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG- 301 (379)
Q Consensus 225 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps- 301 (379)
|||||++|+|++|+.||......... ..+.. .....|... .+++++.+++.+||. ||.+||+
T Consensus 214 wSlG~il~ell~g~~Pf~~~~~~~~~-------------~~i~~~~~~~~~p~~~-~~~~~~~~li~~ll~-dp~~R~~s 278 (350)
T cd05573 214 WSLGVILYEMLYGFPPFYSDTLQETY-------------NKIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGS 278 (350)
T ss_pred EecchhhhhhccCCCCCCCCCHHHHH-------------HHHhccCCcccCCCCC-CCCHHHHHHHHHHcc-ChhhcCCC
Confidence 99999999999999999876522111 11111 111222211 146789999999998 9999999
Q ss_pred hHHHhccccCc
Q 035572 302 IGEILMGCSCF 312 (379)
Q Consensus 302 ~~e~l~~~~~~ 312 (379)
++++++|....
T Consensus 279 ~~~ll~hp~~~ 289 (350)
T cd05573 279 FEEIKSHPFFK 289 (350)
T ss_pred HHHHhcCCCcC
Confidence 99999996553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=324.19 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=197.9
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||++.+.. +++.||+|.++.... ........+.+|+.+++.++|++ ++.+++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~-------i~~~~~~---- 63 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPF-------LTALKYA---- 63 (323)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCC-------CcceeeE----
Confidence 469999999999998754 567899999875321 11234566788999999999988 7766655
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
+...+..|+||||+++++|..++.... .+++..++.++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 64 ---~~~~~~~~lv~E~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 133 (323)
T cd05595 64 ---FQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGH 133 (323)
T ss_pred ---EecCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCC
Confidence 355678999999999999998886532 3889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhh
Q 035572 181 AKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 259 (379)
+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 134 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------- 202 (323)
T cd05595 134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------- 202 (323)
T ss_pred EEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----------
Confidence 99999999865322 222334569999999999998999999999999999999999999997654211
Q ss_pred HHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 260 EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
....+.......|. .+++++.+++.+||+.||++|| ++.++++|....
T Consensus 203 --~~~~~~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 203 --LFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred --HHHHHhcCCCCCCC---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 11111222222232 3457899999999999999998 899999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=328.04 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=204.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+... ....||+|.+...... .....+.+.+|+.+++.++|+| |+++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~-------Iv~~ 96 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE----DFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPF-------CVNL 96 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC----CCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCC-------Ccce
Confidence 45799999999999999999986532 2357999988643211 1334567889999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.| |+||||||+||
T Consensus 97 ~~~~-------~~~~~~~lv~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NI 162 (340)
T PTZ00426 97 YGSF-------KDESYLYLVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENL 162 (340)
T ss_pred EEEE-------EeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHE
Confidence 7764 55678999999999999999997532 3888999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 163 Ll~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----- 235 (340)
T PTZ00426 163 LLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----- 235 (340)
T ss_pred EECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----
Confidence 9999999999999998765332 234479999999999988889999999999999999999999997654211
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
....+.......|.. .+..+.+++.+||+.||++|+ +++++++|....
T Consensus 236 --------~~~~i~~~~~~~p~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~ 288 (340)
T PTZ00426 236 --------IYQKILEGIIYFPKF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG 288 (340)
T ss_pred --------HHHHHhcCCCCCCCC---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence 111122222222322 346788999999999999995 899999996553
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=296.29 Aligned_cols=268 Identities=21% Similarity=0.319 Sum_probs=215.3
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|.+.+.||+|||+-||++.... +++.||+|++.... .+..+...+|++..++++|+| ++
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s-----~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~-------vl 81 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLS-----TGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPN-------VL 81 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccC-----cccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcc-------hH
Confidence 345799999999999999999996433 67889999998654 456788899999999999998 89
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++.++.+... -+.....||+++|...|||.+.++.... +...+++.+++.|+.++++||.+||+..++++||||||.
T Consensus 82 ~l~dh~l~~~--~D~~~~~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~ 158 (302)
T KOG2345|consen 82 RLVDHQLREE--KDGKHEAYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPA 158 (302)
T ss_pred HHHHHHHHhh--ccCceeEEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcc
Confidence 9898877633 2456789999999999999999987764 445599999999999999999999999989999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCc----------ccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESS----------MVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~ 238 (379)
|||+.+.+.++|.|||.+......-. .....-|..|.|||.+. +...+.++|||||||++|.|+.|.
T Consensus 159 NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~ 238 (302)
T KOG2345|consen 159 NILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGE 238 (302)
T ss_pred eeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcC
Confidence 99999999999999999865432110 12224789999999775 345789999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.||...-.... .....+....+..|.... ++..+.+++..||+.||.+||++.+++.+..
T Consensus 239 sPfe~~~~~Gg-----------SlaLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 239 SPFERIYQQGG-----------SLALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred CcchHHhhcCC-----------eEEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 99965322110 111123333444444333 6788999999999999999999999998643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.59 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=204.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
-++|++.+.||+|+||.||++.+.. ++..+|+|.+..+. ......++.+|+++++.++|+| ++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~-------iv~~ 68 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP-----SGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPY-------IVGF 68 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC-----CCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCC-------CCeE
Confidence 4689999999999999999998765 55779999987542 1344577999999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~N 172 (379)
++.+ ..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~N 134 (331)
T cd06649 69 YGAF-------YSDGEISICMEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSN 134 (331)
T ss_pred EEEE-------EECCEEEEEeecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhh
Confidence 7764 34678999999999999999997532 378889999999999999999984 7 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++.++.++|+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .+..
T Consensus 135 il~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~ 212 (331)
T cd06649 135 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEA 212 (331)
T ss_pred EEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 99999999999999998655332 223446999999999999889999999999999999999999999654321 1111
Q ss_pred hhhh-hh--------------------------------h-HHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCC
Q 035572 253 WALP-LI--------------------------------K-EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEEN 298 (379)
Q Consensus 253 ~~~~-~~--------------------------------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 298 (379)
.... .. . ......+..... .......++.++.+|+.+||+.||++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 213 IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP-PKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCC-cCCCCccccHHHHHHHHHHccCCccc
Confidence 0000 00 0 000000111000 00011234678999999999999999
Q ss_pred CCChHHHhccccC
Q 035572 299 RPGIGEILMGCSC 311 (379)
Q Consensus 299 Rps~~e~l~~~~~ 311 (379)
|||++++++|...
T Consensus 292 Rpt~~ell~h~~~ 304 (331)
T cd06649 292 RADLKMLMNHTFI 304 (331)
T ss_pred CCCHHHHhcChHH
Confidence 9999999998544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=324.90 Aligned_cols=275 Identities=22% Similarity=0.262 Sum_probs=204.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+.++|++.+.||+|+||.||+|.+.. .++.||+|.+...... ......+.+|+.+++.++|+| |+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv 83 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTV-----LGINVAVKKLSRPFQN--QTHAKRAYRELVLLKCVNHKN-------II 83 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcC-----CCceeEEEEecccccc--hhHHHHHHHHHHHHHhCCCCC-------Ee
Confidence 456899999999999999999998754 5677999998654222 334567889999999999998 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+... .........|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+
T Consensus 84 ~~~~~~~~~-~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~ 152 (359)
T cd07876 84 SLLNVFTPQ-KSLEEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 152 (359)
T ss_pred eeeeeeccC-CCccccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHH
Confidence 887765321 12233456899999995 577776642 2778888999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|||++.++.+||+|||++.............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 153 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 153 NIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred HEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999976544333444578999999999999999999999999999999999999998765432221
Q ss_pred Hhhhhhh-------h--HHhhhhhccccCCCCc-----------------chHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 252 DWALPLI-------K--EEKLRQVCDSRVGLPT-----------------FMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 252 ~~~~~~~-------~--~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
....... . ..............+. .....+..+.+|+.+||+.||++|||+.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 1110000 0 0000000000000000 011124678999999999999999999999
Q ss_pred hccccC
Q 035572 306 LMGCSC 311 (379)
Q Consensus 306 l~~~~~ 311 (379)
+.|...
T Consensus 313 l~hp~~ 318 (359)
T cd07876 313 LRHPYI 318 (359)
T ss_pred hcCchh
Confidence 999544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=318.13 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=200.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.+.. +++.||+|.++.... ......+.+|+.+++.++|+| |+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------iv~~ 68 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHAN-------IVTL 68 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC-----CCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCC-------EeeE
Confidence 3579999999999999999998765 556799999865422 223456789999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||+. ++|.+++...+ ..+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Ni 134 (288)
T cd07871 69 HDII-------HTERCLTLVFEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNL 134 (288)
T ss_pred EEEE-------cCCCeEEEEEeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHE
Confidence 7764 45678999999995 59999887532 23788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++.++.+||+|||++....... ......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||.+.+....+.
T Consensus 135 l~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~ 214 (288)
T cd07871 135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214 (288)
T ss_pred EECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999986543222 2233468999999998765 568999999999999999999999997765433222
Q ss_pred Hhhhhh--hhHHhhhh---------hccccCCC-C--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPL--IKEEKLRQ---------VCDSRVGL-P--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~--~~~~~~~~---------~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...... -....+.. ...+.... + ......+.++.+|+.+||+.||.+|||++|+++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred HHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 111100 00001111 00000000 0 01123356789999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.46 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=198.9
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+..|+.++..+.|++. ++.+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~------i~~~~~ 68 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPF------LTQLHS 68 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCc------eeeeEE
Confidence 48899999999999999998765 4567999998753211 12345678889999998876541 555554
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||+
T Consensus 69 ~-------~~~~~~~~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill 134 (324)
T cd05587 69 C-------FQTMDRLYFVMEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML 134 (324)
T ss_pred E-------EEcCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE
Confidence 4 355678999999999999999997532 3788899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------ 208 (324)
T cd05587 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------ 208 (324)
T ss_pred cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------
Confidence 9999999999999864322 222334469999999999999999999999999999999999999997654211
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~ 311 (379)
....+.......|. ..++++.+++.+||+.||.+|++. .+++.|...
T Consensus 209 -------~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 209 -------LFQSIMEHNVSYPK---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred -------HHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 11122222222222 345788999999999999999987 788887543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=339.47 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=213.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
.-++++.++|.+|||+.||+|.+... ++.||+|++-.. .+...+.+.+||++|++|. |+| ||.
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~-----~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~n-------IV~ 99 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKG-----GKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKN-------IVS 99 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCC-----CceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCc-------eee
Confidence 35678899999999999999987653 267999998643 3567888999999999998 777 999
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++........-...-.++|.||||+||+|-+++..+... .|++.+++.|++|+++|+++||...+||+|||||-+|
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiEN 176 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIEN 176 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhh
Confidence 9984221111111134678999999999999999986542 2999999999999999999999999999999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-c---------ccccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHHHhCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-S---------MVQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~---------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~ 239 (379)
|||+.+|++||||||.|.-..... . ......|+.|.+||++ .+.++++|+|||+|||+||-|+....
T Consensus 177 vLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 177 VLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred eEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 999999999999999984322111 1 1123479999999954 67789999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
||..... ..|+...+.+|.. +.++..+.+||..||+.||.+||++.+++.+........
T Consensus 257 PFe~sg~-----------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 257 PFEESGK-----------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred CcCcCcc-----------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 9987643 2455666666654 567889999999999999999999999988765544433
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.97 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=203.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.++||+|+||.||++.+.. +++.||+|.+...... .......+.+|+.+++.++|++ ++.+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~-------iv~~~~ 67 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRF-------VVSLAY 67 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-----CCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCC-------Eeeeee
Confidence 58899999999999999998654 5678999998643321 1222456788999999999888 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++||||||+||++
T Consensus 68 ~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~ 135 (285)
T cd05605 68 AY-------ETKDALCLVLTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILL 135 (285)
T ss_pred ee-------cCCCeEEEEEeccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEE
Confidence 53 45678999999999999999886532 234889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||++.............|++.|+|||++.+..++.++||||+||++|+|++|+.||.+..........
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~-- 213 (285)
T cd05605 136 DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-- 213 (285)
T ss_pred CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH--
Confidence 999999999999987654433334457899999999998888999999999999999999999999865432111110
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
...+.... +.....++..+.+++.+||+.||.+|| ++++++.|...
T Consensus 214 -------~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 214 -------ERRVKEDQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred -------HHHhhhcc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 01111111 112234567899999999999999999 89999998443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=326.16 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=201.0
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~ 94 (379)
+|++.+.||+|+||.||++.+... ..+++.||+|.+............+.+.+|+.+++.++ |++ ++.++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-------i~~~~ 71 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF-------LVTLH 71 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCC-------cccEE
Confidence 588999999999999999986432 23678899999865332222344567889999999996 555 66655
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +...+..++||||+++|+|.+++.... .+++.++..++.|++.||.|||++| |+||||||+|||
T Consensus 72 ~~-------~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil 137 (332)
T cd05614 72 YA-------FQTEAKLHLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENIL 137 (332)
T ss_pred EE-------EecCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeE
Confidence 44 456778999999999999999997532 3888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++.++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|+||..||..........
T Consensus 138 i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 217 (332)
T cd05614 138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217 (332)
T ss_pred ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence 9999999999999986543222 22234699999999988765 47889999999999999999999997543221111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
. ....+.......+ ..+++.+.+++.+||+.||++|| +++++++|....
T Consensus 218 ~---------~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 218 E---------VSRRILKCDPPFP---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred H---------HHHHHhcCCCCCC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 1 0111112222222 23457789999999999999999 788999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=338.96 Aligned_cols=272 Identities=23% Similarity=0.322 Sum_probs=210.3
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
.+......++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+.++..+.|++
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~~~h~~---- 92 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVS-----DGEPFAVKVVDMEGMS--EADKNRAQAEVCCLLNCDFFS---- 92 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcC-----CCCEEEEEEEecccCC--HHHHHHHHHHHHHHhcCCCCc----
Confidence 34455667899999999999999999998754 5678999998765432 344567889999999998888
Q ss_pred CceeeeccccccccCCC-ccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 87 NYCVVNFHGTSCRNSGS-VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
++.++..+...... ......+++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ |+|
T Consensus 93 ---iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiH 166 (496)
T PTZ00283 93 ---IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH--MIH 166 (496)
T ss_pred ---EEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--Eec
Confidence 77777654331110 1112247899999999999999976543 2334889999999999999999999999 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCC---CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDE---SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
|||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 167 rDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred CCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998654322 12234579999999999999999999999999999999999999997
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.... ..+. ..+..... +.....+++++.+++.+||+.||.+||++.+++.|..
T Consensus 247 ~~~~-~~~~------------~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 247 GENM-EEVM------------HKTLAGRY--DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred CCCH-HHHH------------HHHhcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 6432 1111 11111111 1112334578999999999999999999999998853
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.61 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=214.0
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKR 84 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 84 (379)
.+.++|....+...+...||+|.||+||+|.+.. .||||.+..+... ++..+.|++|+.++++-+|.|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~pt--~~qlqaFKnEVa~lkkTRH~N-- 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDPT--PEQLQAFKNEVAVLKKTRHEN-- 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCCC--HHHHHHHHHHHHHHhhcchhh--
Confidence 3457888889999999999999999999998754 2999999876654 557899999999999999999
Q ss_pred CCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 85 NPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 85 ~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
|+-+.|++.+ ..+.||+.+|+|-||..+++... ..|...+.+.|+.|+++|+.|||.++ |+
T Consensus 450 -----IlLFMG~~~~--------p~~AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~--II 510 (678)
T KOG0193|consen 450 -----ILLFMGACMN--------PPLAIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN--II 510 (678)
T ss_pred -----heeeehhhcC--------CceeeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh--hh
Confidence 8888888754 44599999999999999998643 34889999999999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCC---CCCcccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSES---DESSMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~ 238 (379)
|||||..|||+.++++|||+|||++.... .........|...|||||++. ..+|++.+||||||+++|||+||.
T Consensus 511 HrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 511 HRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred hhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 99999999999999999999999985432 233445567999999999764 457999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc---chHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT---FMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.||. ....++++. .+...+..+. ....+++++.+|+..||.+++++||.+.+++..
T Consensus 591 lPys-i~~~dqIif-------------mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 591 LPYS-IQNRDQIIF-------------MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred CCcC-CCChhheEE-------------EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 9998 444333322 1222221122 234567899999999999999999999999984
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=329.39 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=201.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|+||.||+|.+.. +++.||||++...... .......+.+|+.+++.++|++ |++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~-------iv~~~ 67 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-----TGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPW-------VVKLY 67 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCC-------CcceE
Confidence 479999999999999999998765 5678999998743211 1233466889999999999888 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl 133 (364)
T cd05599 68 YS-------FQDENYLYLIMEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLL 133 (364)
T ss_pred EE-------EEcCCeEEEEECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeE
Confidence 55 456789999999999999999997532 3889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC---------------------------------------cccccCccccccCCCCCCC
Q 035572 175 FDSKWDAKLADFGLAVSESDES---------------------------------------SMVQPAGTIGYLDPGYTNP 215 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~ 215 (379)
++.++.++|+|||++....... ......||+.|+|||++.+
T Consensus 134 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (364)
T cd05599 134 LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213 (364)
T ss_pred ECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC
Confidence 9999999999999985432110 0012358999999999998
Q ss_pred CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhccc
Q 035572 216 SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVS 293 (379)
Q Consensus 216 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~ 293 (379)
..++.++|||||||++|+|++|..||......... ..+.. .....+.. ...++++.++|.+|+.
T Consensus 214 ~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~-------------~~i~~~~~~~~~~~~-~~~s~~~~~li~~ll~ 279 (364)
T cd05599 214 TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETY-------------RKIINWKETLQFPDE-VPLSPEAKDLIKRLCC 279 (364)
T ss_pred CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHH-------------HHHHcCCCccCCCCC-CCCCHHHHHHHHHHcc
Confidence 89999999999999999999999999765422111 11111 11111111 1245788999999997
Q ss_pred CCCCCCCC---hHHHhccccCc
Q 035572 294 SEEENRPG---IGEILMGCSCF 312 (379)
Q Consensus 294 ~dp~~Rps---~~e~l~~~~~~ 312 (379)
+|.+|++ +.+++.|....
T Consensus 280 -~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 280 -EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred -CHhhcCCCCCHHHHhcCCCcC
Confidence 9999998 99999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.06 Aligned_cols=276 Identities=22% Similarity=0.276 Sum_probs=200.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. .++.||||++.... ....+|+.+++.++|+| +++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~n-------iv~ 123 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID-----TSEKVAIKKVLQDP--------QYKNRELLIMKNLNHIN-------IIF 123 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEecCc--------chHHHHHHHHHhcCCCC-------Ccc
Confidence 34689999999999999999998765 45679999885321 23457999999999998 777
Q ss_pred cccccccc-CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 93 FHGTSCRN-SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~-~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
+++++... .........+++||||++ ++|.+++..... ....+++..++.++.|++.||+|||+.| |+||||||+
T Consensus 124 l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~ 199 (440)
T PTZ00036 124 LKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQ 199 (440)
T ss_pred eeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHH
Confidence 66654321 111122345779999995 688887765332 2334889999999999999999999999 999999999
Q ss_pred ceEEcCCC-CeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 172 NILFDSKW-DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 172 NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|||++.++ .+||+|||+|.............+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......
T Consensus 200 NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 279 (440)
T PTZ00036 200 NLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279 (440)
T ss_pred HEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99998654 799999999976654444445578999999998765 4689999999999999999999999987655443
Q ss_pred HHHhhhhhh--hHHhhhhh-------ccccCCCCc----chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLI--KEEKLRQV-------CDSRVGLPT----FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~--~~~~~~~~-------~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+........ ....+... .-+...... .....+.++.+||.+||+.||.+|||+.|++.|....
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 332211100 00000000 000000000 0112356899999999999999999999999996543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.59 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|++++.||+|+||.||+|.+.. +++.||+|++...... .......+.+|+.+++.++|++ |+++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~-------iv~l~~ 68 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD-----THALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEW-------VVKLYY 68 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCC-------eeeeEE
Confidence 68999999999999999998765 5678999998754321 1234567899999999999888 888776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.| |+||||||+|||+
T Consensus 69 ~~-------~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili 134 (381)
T cd05626 69 SF-------QDKDNLYFVMDYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILI 134 (381)
T ss_pred EE-------ecCCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEE
Confidence 64 55778999999999999999997532 3788889999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCC------------------------------------------------CcccccCccccc
Q 035572 176 DSKWDAKLADFGLAVSESDE------------------------------------------------SSMVQPAGTIGY 207 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~y 207 (379)
+.++.+||+|||++...... .......||+.|
T Consensus 135 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 99999999999987432100 001224699999
Q ss_pred cCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHH
Q 035572 208 LDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHV 287 (379)
Q Consensus 208 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (379)
+|||++.+..++.++|||||||++|||++|..||............. . .......+. ...+++++.++
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~----------~-~~~~~~~~~-~~~~s~~~~dl 282 (381)
T cd05626 215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI----------N-WENTLHIPP-QVKLSPEAVDL 282 (381)
T ss_pred cCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH----------c-cccccCCCC-CCCCCHHHHHH
Confidence 99999988889999999999999999999999998654322111100 0 011111111 11245788899
Q ss_pred HHh--cccCCCCCCCChHHHhccccCc
Q 035572 288 AAR--CVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 288 i~~--~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+.+ |+..+|..||++.+++.|....
T Consensus 283 i~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 283 ITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred HHHHccCcccccCCCCHHHHhcCcccC
Confidence 988 4556666799999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=326.53 Aligned_cols=263 Identities=23% Similarity=0.368 Sum_probs=204.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
..++|++.+.||+|+||.||+|++...+...+.+.||+|.++.... .+....+.+|+.+++.+ +|+| |+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~~h~n-------Iv 105 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH---TDEREALMSELKILSHLGQHKN-------IV 105 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC---HHHHHHHHHHHHHHHhhccCCc-------ee
Confidence 3457999999999999999999986655555677899999975432 23456789999999999 7888 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc----------------------------------------
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA---------------------------------------- 131 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------------------------- 131 (379)
++++.+ ...+..++||||+.+|+|.+++.....
T Consensus 106 ~~~~~~-------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (374)
T cd05106 106 NLLGAC-------THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGS 178 (374)
T ss_pred eEeeEe-------cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccc
Confidence 888764 456789999999999999999875321
Q ss_pred -------------------------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEecc
Q 035572 132 -------------------------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186 (379)
Q Consensus 132 -------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Df 186 (379)
.....+++..++.++.|++.||.|||++| |+||||||+|||+++++.++|+||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~Df 256 (374)
T cd05106 179 DTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDF 256 (374)
T ss_pred ccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeec
Confidence 01123778888999999999999999999 999999999999999999999999
Q ss_pred ccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHh
Q 035572 187 GLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEEK 262 (379)
Q Consensus 187 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (379)
|++........ .....++..|+|||++.+..++.++|||||||++|+|++ |+.||............. .
T Consensus 257 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~--- 329 (374)
T cd05106 257 GLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----K--- 329 (374)
T ss_pred eeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----H---
Confidence 99865433221 112235678999999988899999999999999999997 999997654322111110 0
Q ss_pred hhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 263 LRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. ......+. ..++++.+++.+||+.||.+|||+.++++.
T Consensus 330 --~--~~~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 330 --R--GYQMSRPD---FAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred --c--ccCccCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00111111 235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=325.69 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=202.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+.......+...||+|.++.... ....+.+.+|+.+++.+ +|+| |++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~il~~l~~Hpn-------Iv~ 103 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHIN-------IVN 103 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---cHHHHHHHHHHHHHHHhcCCcc-------eee
Confidence 357999999999999999999865443444677899999874321 23456789999999999 7888 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC----------------------------------------
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---------------------------------------- 132 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---------------------------------------- 132 (379)
+++.+ .+.+..++||||+++|+|.+++......
T Consensus 104 l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (375)
T cd05104 104 LLGAC-------TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS 176 (375)
T ss_pred eeeee-------ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence 88764 4567899999999999999999753210
Q ss_pred ------------------------------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 133 ------------------------------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 133 ------------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
....+++..+..++.|++.||.|||++| ++||||||+|||++.++.+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~k 254 (375)
T cd05104 177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITK 254 (375)
T ss_pred cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEE
Confidence 0123678888999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhh
Q 035572 183 LADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 183 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 258 (379)
|+|||++......... ....++..|+|||+..+..++.++|||||||++|+|++ |..||.............
T Consensus 255 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~---- 330 (375)
T cd05104 255 ICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI---- 330 (375)
T ss_pred EecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH----
Confidence 9999998655433221 12235667999999998899999999999999999998 889987654332222111
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .....+ ...+.++.+|+.+||+.||++|||+.++++..
T Consensus 331 ~~~-------~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 331 KEG-------YRMLSP---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred HhC-------ccCCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 100 011111 12246799999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=326.46 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=196.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||+|+||.||+|.+.. +++.||+|... ...+.+|+.+++.++|+| |++++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~-----~~~~vaiK~~~----------~~~~~~E~~il~~l~Hpn-------Iv~~~ 149 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNK-----TCEHVVIKAGQ----------RGGTATEAHILRAINHPS-------IIQLK 149 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECC-----CCCEEEEechh----------hhhhHHHHHHHHhCCCCC-------CCCEe
Confidence 579999999999999999998765 55679999753 234679999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ......++|||++ +++|..++.... .+++.+++.++.|++.||.|||++| |+||||||+|||
T Consensus 150 ~~~-------~~~~~~~lv~e~~-~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIl 214 (391)
T PHA03212 150 GTF-------TYNKFTCLILPRY-KTDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIF 214 (391)
T ss_pred EEE-------EECCeeEEEEecC-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEE
Confidence 653 4567889999999 578988886532 3788999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC--CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch----
Q 035572 175 FDSKWDAKLADFGLAVSESDE--SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA---- 248 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---- 248 (379)
++.++.++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 999999999999998643221 12234479999999999998899999999999999999999998875432111
Q ss_pred --hHHHhhhhhh----------hHHhhh----hhccc----cCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 249 --SIIDWALPLI----------KEEKLR----QVCDS----RVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 249 --~~~~~~~~~~----------~~~~~~----~~~~~----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
.......... ....+. ..... ....+ ......+.++.+|+.+||+.||++|||++|++
T Consensus 295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 0000000000 000000 00000 00011 11224567899999999999999999999999
Q ss_pred ccccC
Q 035572 307 MGCSC 311 (379)
Q Consensus 307 ~~~~~ 311 (379)
.|...
T Consensus 375 ~hp~f 379 (391)
T PHA03212 375 DFAAF 379 (391)
T ss_pred cChhh
Confidence 98554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.06 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=199.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||.|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+++++.++|++ |++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~-------iv~~~ 67 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-----TGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPW-------VVSLY 67 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCC-------cceEE
Confidence 479999999999999999998765 5678999998643211 1334567889999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+..|+||||++||+|.+++.... .+++..++.++.|++.||+|||+.| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIl 133 (377)
T cd05629 68 YS-------FQDAQYLYLIMEFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNIL 133 (377)
T ss_pred EE-------EEcCCeeEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEE
Confidence 65 456788999999999999999997532 3888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC------------------------------------------------cccccCcccc
Q 035572 175 FDSKWDAKLADFGLAVSESDES------------------------------------------------SMVQPAGTIG 206 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~------------------------------------------------~~~~~~gt~~ 206 (379)
++.++.++|+|||++....... ......||+.
T Consensus 134 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 134 IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred ECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 9999999999999985221100 0012358999
Q ss_pred ccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHH
Q 035572 207 YLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQM 284 (379)
Q Consensus 207 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 284 (379)
|+|||++.+..++.++|||||||++|+|++|..||......... ..+.. .....|. ...++.++
T Consensus 214 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------------~~i~~~~~~~~~p~-~~~~s~~~ 279 (377)
T cd05629 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETY-------------RKIINWRETLYFPD-DIHLSVEA 279 (377)
T ss_pred ccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHH-------------HHHHccCCccCCCC-CCCCCHHH
Confidence 99999999889999999999999999999999999765422111 11111 1111121 11245778
Q ss_pred HHHHHhcccCCCCCC---CChHHHhccccCc
Q 035572 285 LHVAARCVSSEEENR---PGIGEILMGCSCF 312 (379)
Q Consensus 285 ~~li~~~l~~dp~~R---ps~~e~l~~~~~~ 312 (379)
.+++.+||. +|.+| +++.+++.|....
T Consensus 280 ~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 280 EDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred HHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999999998 77765 5999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=322.89 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=196.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+.. +++.||+|.+...... .......+.+|+++++.++|++ |+.++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~-------i~~~~~~---- 63 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPF-------LTALKYS---- 63 (325)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCC-------CCceEEE----
Confidence 468999999999998754 5678999998753221 1234567788999999999887 6665544
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceEEcCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIll~~~~ 179 (379)
+...+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .| |+||||||+|||++.++
T Consensus 64 ---~~~~~~~~lv~E~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~ 133 (325)
T cd05594 64 ---FQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDG 133 (325)
T ss_pred ---EEcCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCC
Confidence 455678999999999999999886532 38899999999999999999997 79 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---------- 203 (325)
T cd05594 134 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---------- 203 (325)
T ss_pred CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----------
Confidence 999999999864322 222334469999999999998899999999999999999999999997653211
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
....+.......|. ..++++.+++.+||+.||++|+ ++.++++|....
T Consensus 204 ---~~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 204 ---LFELILMEEIRFPR---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred ---HHHHHhcCCCCCCC---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 11111222222222 2357899999999999999997 999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=313.06 Aligned_cols=271 Identities=23% Similarity=0.274 Sum_probs=200.2
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh---hccCCCCCceeee
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ---ESNKRNPNYCVVN 92 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~~~~~~~~iv~ 92 (379)
+|++.+.||+|+||.||+|.+.. +++.||+|.++..... ......+.+|+.+++.++ |+| +++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~n-------i~~ 66 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPN-------IVR 66 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCC-------eee
Confidence 58999999999999999998765 5678999988754221 222345677888888774 555 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.... .......++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.| ++||||||+|
T Consensus 67 ~~~~~~~~~--~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~N 138 (288)
T cd07863 67 LMDVCATSR--TDRETKVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPEN 138 (288)
T ss_pred eeeeecccc--CCCCceEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 777653211 233457899999995 68999887532 234889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++.++.+||+|||++.............+|..|+|||++.+..++.++|||||||++|+|++|++||.+......+..
T Consensus 139 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 139 ILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred EEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 99999999999999998765544333445689999999999888899999999999999999999999976544332221
Q ss_pred hhhhhhh---HHhhhhhc-------ccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIK---EEKLRQVC-------DSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~---~~~~~~~~-------~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. .... ...+.... ... .......+.++..+.+++.+||+.||++|||+.|++.|.
T Consensus 219 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 219 IF-DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred HH-HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 11 1000 00000000 000 000011223456789999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=319.50 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=195.5
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.++. +++.||+|.++..... .....+.+..|+.++..+ .|++ ++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~-------iv~~~~~--- 64 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-----SGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPF-------LTQLYCC--- 64 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCc-------hhceeeE---
Confidence 469999999999998764 5678999998743211 123456677888888876 4666 6666654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++| ++||||||+|||++.++
T Consensus 65 ----~~~~~~~~iv~Ey~~~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~ 133 (320)
T cd05590 65 ----FQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEG 133 (320)
T ss_pred ----EEcCCEEEEEEcCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCC
Confidence 456788999999999999999887532 3888999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... +
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~-------- 204 (320)
T cd05590 134 HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-L-------- 204 (320)
T ss_pred cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-H--------
Confidence 999999999865322 222334569999999999998899999999999999999999999997654211 1
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh------HHHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI------GEILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~e~l~~~~~~ 312 (379)
...+.......+. ..+.++.+++.+||+.||.+||++ ++++.|....
T Consensus 205 ----~~~i~~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~ 257 (320)
T cd05590 205 ----FEAILNDEVVYPT---WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257 (320)
T ss_pred ----HHHHhcCCCCCCC---CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence 1122222222232 235788999999999999999998 8899886653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=296.92 Aligned_cols=261 Identities=22% Similarity=0.375 Sum_probs=212.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc----hhhhhcHHHHHHHHHHHHhhh-hccCCCCC
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF----EVLQDNSKKLNNEIRVLSSLQ-ESNKRNPN 87 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~ 87 (379)
....|...+.||+|..++|-++..+. +++.+|+|++..... +......+.-..|+.||+++. ||+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~-----t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~----- 84 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKE-----TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPY----- 84 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcc-----cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCc-----
Confidence 45788999999999999999998766 556688887754322 122344566788999999985 444
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++. ++.+..+++|+|.|+.|.|.+++.+.- .+++...+.+++|++.|+.|||.++ |||||
T Consensus 85 --II~l~D~-------yes~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~--IVHRD 148 (411)
T KOG0599|consen 85 --IIDLQDV-------YESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARN--IVHRD 148 (411)
T ss_pred --EEEeeee-------ccCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhh--hhhcc
Confidence 7776655 788899999999999999999998643 3899999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC------CCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP------SKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|||+|||++++.+++|+|||+|+....+......+|||+|+|||.+.. ..|+..+|+|+.|+++|.++.|.+||
T Consensus 149 LKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 149 LKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred cChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 999999999999999999999999888877777899999999997643 36788999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
-.... .-.+..+....+.. .+.+.+.+....+||++||+.||++|.|++|+|.|....
T Consensus 229 wHRkQ-------------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 229 WHRKQ-------------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred hHHHH-------------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 65321 11122233333221 335677889999999999999999999999999997653
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=318.94 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=196.4
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHH---hhhhccCCCCCceeeec
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS---SLQESNKRNPNYCVVNF 93 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~---~l~~~~~~~~~~~iv~~ 93 (379)
|++.+.||+|+||.||+|.+.. +++.||+|.++..... .....+.+.+|+.++. .++|+| |+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~-------i~~~ 67 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPF-------LVNL 67 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCC-------hhce
Confidence 6789999999999999998764 5577999998743211 1233566777877765 445666 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +...+..|+||||+++++|...+.. ..+++..+..++.|++.||+|||+.| ++||||||+||
T Consensus 68 ~~~-------~~~~~~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Ni 132 (324)
T cd05589 68 FAC-------FQTEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNL 132 (324)
T ss_pred eeE-------EEcCCEEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHe
Confidence 665 4567889999999999999988853 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++..... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--- 209 (324)
T cd05589 133 LLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--- 209 (324)
T ss_pred EECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 999999999999999864322 2223345799999999999988999999999999999999999999976542211
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
...+.......|. .+++.+.+++.+||+.||.+|| ++.++++|...
T Consensus 210 ----------~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 210 ----------FDSIVNDEVRYPR---FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred ----------HHHHHhCCCCCCC---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 1112222222222 2357789999999999999999 68889988644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=318.48 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=196.9
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.+.. +++.||+|.++..... .......+..|..++..+.+++ . ++.+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~----~--i~~~~~ 68 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPP----F--LTQLHS 68 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCC----e--EeeEEE
Confidence 48889999999999999998765 5577999998754221 1233455677888887775432 1 555554
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+.+..|+||||+++|+|.+.+.... .+++.++..++.|++.||+|||++| |+||||||+|||+
T Consensus 69 ~-------~~~~~~~~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill 134 (323)
T cd05616 69 C-------FQTMDRLYFVMEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML 134 (323)
T ss_pred E-------EecCCEEEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEE
Confidence 4 455678999999999999999986532 3888999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|+||+.||...+... +
T Consensus 135 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~---- 209 (323)
T cd05616 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-L---- 209 (323)
T ss_pred CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-H----
Confidence 9999999999999865432 222334579999999999999999999999999999999999999997654211 1
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~ 311 (379)
...+.......|. ..+.++.+++.+||+.||++|++. .+++.|...
T Consensus 210 --------~~~i~~~~~~~p~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~ 260 (323)
T cd05616 210 --------FQSIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260 (323)
T ss_pred --------HHHHHhCCCCCCC---cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence 1122222222232 345788999999999999999985 788877544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.70 Aligned_cols=258 Identities=23% Similarity=0.336 Sum_probs=201.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.++..... .....+.+.+|+.+++.++|++ ++.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~-------iv~ 107 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS-----SKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEW-------IVQ 107 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCC-------cce
Confidence 45789999999999999999998765 5678999998642211 1223455789999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+++..|+||||++||+|.+++... .+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 108 ~~~~-------~~~~~~~~lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~N 172 (370)
T cd05596 108 LHYA-------FQDDKYLYMVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDN 172 (370)
T ss_pred EEEE-------EecCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHH
Confidence 6654 45678899999999999999998642 2778888999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC----CCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS----KLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||++.++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 173 ILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred EEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 999999999999999986654322 22345799999999987643 478899999999999999999999986542
Q ss_pred chhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCF 312 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~ 312 (379)
.. .+..+... ....|. ...++.++.+++.+||+.+|.+ |+++++++.|....
T Consensus 253 ~~-------------~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 253 VG-------------TYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred HH-------------HHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 21 11122211 111121 1134678999999999999988 99999999996554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.92 Aligned_cols=275 Identities=21% Similarity=0.264 Sum_probs=205.4
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. .++.+|+|.+...... ......+.+|+.+++.++|+| |+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv 79 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKN-------II 79 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecC-----CCceEEEEEeCCcccC--hHHHHHHHHHHHHHHHhCCCc-------hh
Confidence 567899999999999999999998654 5577999998754322 334567889999999999998 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+... ..+......|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+
T Consensus 80 ~~~~~~~~~-~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~ 148 (355)
T cd07874 80 SLLNVFTPQ-KSLEEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 148 (355)
T ss_pred ceeeeeecc-ccccccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChH
Confidence 777665321 12334467899999995 577777743 2778888999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|||++.++.+||+|||++.............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 149 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 149 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred HEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999976654444445578999999999998899999999999999999999999997654322221
Q ss_pred Hhhhhhh-------h--HHhhhhhccccC-----CCC------------cchHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 252 DWALPLI-------K--EEKLRQVCDSRV-----GLP------------TFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 252 ~~~~~~~-------~--~~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
....... . ............ ..+ ......+..+.+|+.+||+.||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 1110000 0 000000100000 000 0111224578999999999999999999999
Q ss_pred hccccC
Q 035572 306 LMGCSC 311 (379)
Q Consensus 306 l~~~~~ 311 (379)
++|...
T Consensus 309 l~hp~~ 314 (355)
T cd07874 309 LQHPYI 314 (355)
T ss_pred hcCcch
Confidence 998544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=324.96 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=197.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|.++..... .......+.+|+.++..++|++ |++++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~-------iv~~~ 67 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-----TGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLW-------VVKMF 67 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCC-------cceEE
Confidence 479999999999999999998764 5678999998743211 1234567889999999999887 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+...+|+||||++||+|.+++.+.+ .+++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NIL 133 (363)
T cd05628 68 YS-------FQDKLNLYLIMEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLL 133 (363)
T ss_pred EE-------EecCCeEEEEEcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeE
Confidence 55 456778999999999999999997532 3889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC------------------------------------cccccCccccccCCCCCCCCCC
Q 035572 175 FDSKWDAKLADFGLAVSESDES------------------------------------SMVQPAGTIGYLDPGYTNPSKL 218 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 218 (379)
++.++.+||+|||++....... ......||+.|+|||++.+..+
T Consensus 134 i~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 213 (363)
T cd05628 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213 (363)
T ss_pred ECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC
Confidence 9999999999999986432110 0123469999999999998899
Q ss_pred CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhccc--C
Q 035572 219 SKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVS--S 294 (379)
Q Consensus 219 ~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~--~ 294 (379)
+.++|||||||++|+|++|+.||.+....... ..+.. .....|.. ...+.++.+++.+++. .
T Consensus 214 ~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~-------------~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~~~~ 279 (363)
T cd05628 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETY-------------KKVMNWKETLIFPPE-VPISEKAKDLILRFCCEWE 279 (363)
T ss_pred CCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHcCcCcccCCCc-CCCCHHHHHHHHHHcCChh
Confidence 99999999999999999999999765422111 11111 11111211 1234678888888654 2
Q ss_pred CCCCCCChHHHhccccCcc
Q 035572 295 EEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 295 dp~~Rps~~e~l~~~~~~~ 313 (379)
++..||+++|+++|.....
T Consensus 280 ~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 280 HRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred hcCCCCCHHHHhCCCCCCC
Confidence 3335689999999965543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=322.63 Aligned_cols=275 Identities=21% Similarity=0.249 Sum_probs=204.8
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+.++|++.+.||+|+||.||+|.+.. .++.||||.+...... ......+.+|+.+++.++|+| ++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------ii 86 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKN-------II 86 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECC-----CCcEEEEEEeCccccC--chhHHHHHHHHHHHHhcCCCC-------cc
Confidence 456899999999999999999998765 4567999998754221 334567889999999999998 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+.. ...+......|+||||+ +++|.+.+.. .+++..+..++.|++.||+|||++| |+||||||+
T Consensus 87 ~~~~~~~~-~~~~~~~~~~~lv~e~~-~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~ 155 (364)
T cd07875 87 GLLNVFTP-QKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 155 (364)
T ss_pred ccceeecc-cccccccCeEEEEEeCC-CCCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHH
Confidence 76665432 12233446789999999 4688887743 2778888999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|||++.++.+||+|||++.............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 156 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 156 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred HEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999976654444445578999999999999999999999999999999999999998765433222
Q ss_pred Hhhhhhh------h---HHhhhhhccccCCC-----------------CcchHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 252 DWALPLI------K---EEKLRQVCDSRVGL-----------------PTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 252 ~~~~~~~------~---~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
......- . .............. +.........+.++|.+||+.||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 1110000 0 00000000000000 00011123578999999999999999999999
Q ss_pred hccccC
Q 035572 306 LMGCSC 311 (379)
Q Consensus 306 l~~~~~ 311 (379)
++|...
T Consensus 316 L~hp~~ 321 (364)
T cd07875 316 LQHPYI 321 (364)
T ss_pred hcCccc
Confidence 999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=318.43 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=194.7
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
++||+|+||.||+|.+.. +++.||+|.++.... ......+.+..|.+++..+ +|++ |+.+++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~-------i~~~~~~--- 64 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-----TDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPF-------LTALHCC--- 64 (321)
T ss_pred CccccCCCeEEEEEEECC-----CCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCC-------ccceeeE---
Confidence 469999999999998764 456799999874321 1133456677888888866 4555 6666655
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++++|...+.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~E~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~ 133 (321)
T cd05591 65 ----FQTKDRLFFVMEYVNGGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEG 133 (321)
T ss_pred ----EEcCCeEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCC
Confidence 456778999999999999999987532 3888899999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---------- 203 (321)
T cd05591 134 HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---------- 203 (321)
T ss_pred CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----------
Confidence 999999999865322 222334468999999999998899999999999999999999999998654221
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-------ChHHHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-------GIGEILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~e~l~~~~~ 311 (379)
.+..+.......|.. .+.++.+++.+||+.||++|| ++++++.|...
T Consensus 204 ---~~~~i~~~~~~~p~~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 204 ---LFESILHDDVLYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred ---HHHHHHcCCCCCCCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 111222222222322 347889999999999999999 89999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.06 Aligned_cols=251 Identities=21% Similarity=0.351 Sum_probs=198.3
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
++.||+|+||.||++.+.... .+++.+|+|++...... ......+.+|++++++++|+| |+++++.
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv~~~~~--- 66 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGP--DAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPF-------IVKLHYA--- 66 (318)
T ss_pred CceeeeCCCEEEEEEEEeccC--CCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCC-------cccEEEE---
Confidence 367999999999999764322 36788999998753221 223456788999999999988 7777665
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+++..|+||||+++++|.+++.+. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++
T Consensus 67 ----~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 135 (318)
T cd05582 67 ----FQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEG 135 (318)
T ss_pred ----EEcCCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCC
Confidence 35577899999999999999998653 23889999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 136 ~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------- 205 (318)
T cd05582 136 HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---------- 205 (318)
T ss_pred cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----------
Confidence 9999999998655433 22334578999999999988889999999999999999999999997654211
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~ 311 (379)
....+.......|. ..++.+.+++.+||+.||++||+ +.+++.|...
T Consensus 206 ---~~~~i~~~~~~~p~---~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 206 ---TMTMILKAKLGMPQ---FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred ---HHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 11122222233332 23577899999999999999999 5668887544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=306.84 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=212.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+-|.++.+||+|+||.||+|+++. .+.++|||.++-+ ...+.+.+|+.++.++..+. +|++
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~E-----sG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~y-------VVKY 93 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRE-----SGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKY-------VVKY 93 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhc-----cCcEEEEEecCcc------chHHHHHHHHHHHHHcCCch-------hhhh
Confidence 3568889999999999999998664 7789999998743 45788999999999998777 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++..++ ...+|||||||..||+.+.++.+ ...+++.++..+++..++||+|||... -+|||||..||
T Consensus 94 YGSYFK-------~sDLWIVMEYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNI 160 (502)
T KOG0574|consen 94 YGSYFK-------HSDLWIVMEYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNI 160 (502)
T ss_pred hhhhcc-------CCceEeehhhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccE
Confidence 887544 56799999999889999999864 345999999999999999999999988 89999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|..||+|||.|-...... ..++..||+.|||||+++.-.|+.++||||||++..||..|++||........+.
T Consensus 161 LLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF- 239 (502)
T KOG0574|consen 161 LLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF- 239 (502)
T ss_pred EEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-
Confidence 99999999999999996654432 3566789999999999999999999999999999999999999998765433221
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
-+....++.-..++..+.++.+++++||..+|++|-|+.++++|....
T Consensus 240 ------------MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 240 ------------MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred ------------eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence 111111111113566788999999999999999999999999995543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.81 Aligned_cols=268 Identities=20% Similarity=0.331 Sum_probs=200.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCC-----------CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQT-----------DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
.++|++.+.||+|+||.||+|.+..... ...+..||+|.+..... ......+.+|+.++..++|+|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN---KNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC---HHHHHHHHHHHHHHhhcCCCC
Confidence 3579999999999999999998754321 22456799999875422 334567899999999999988
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc--------------CCCCCCChHhHHHHHHH
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA--------------ATTPQLGWPNRVKIAMQ 148 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~~~~~~~~ 148 (379)
|+++++.+ .+.+..++||||+++++|.+++..... .....+++..+..++.|
T Consensus 81 -------iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 146 (304)
T cd05096 81 -------IIRLLGVC-------VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQ 146 (304)
T ss_pred -------eeEEEEEE-------ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHH
Confidence 88888765 345678999999999999999875421 11234677888999999
Q ss_pred HHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCee
Q 035572 149 ISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVF 225 (379)
Q Consensus 149 i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diw 225 (379)
++.||.|||+.| |+||||||+|||++.++.+||+|||++........ .....++..|+|||++....++.++|||
T Consensus 147 i~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 224 (304)
T cd05096 147 IASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224 (304)
T ss_pred HHHHHHHHHHCC--ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhH
Confidence 999999999999 99999999999999999999999999865433221 1223457889999998888899999999
Q ss_pred hhHHHHHHHHh--CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 226 SYGVVLLEIIS--CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 226 SlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
|||+++|+|++ +..||....+.. .......... ...... .......++..+.+++.+||+.||++|||+.
T Consensus 225 slG~~l~el~~~~~~~p~~~~~~~~-~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 225 AFGVTLWEILMLCKEQPYGELTDEQ-VIENAGEFFR-----DQGRQV--YLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred HHHHHHHHHHHccCCCCCCcCCHHH-HHHHHHHHhh-----hccccc--cccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 99999999987 567777654322 2111111110 000000 0111123357899999999999999999999
Q ss_pred HHhcc
Q 035572 304 EILMG 308 (379)
Q Consensus 304 e~l~~ 308 (379)
++...
T Consensus 297 ~i~~~ 301 (304)
T cd05096 297 DIHAF 301 (304)
T ss_pred HHHHH
Confidence 99753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=318.36 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=191.3
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHH-HHHhhhhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR-VLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.||+|.+....... ......+..|.. +++.++|++ |+++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~-------iv~~~~~--- 64 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-----DGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPF-------LVGLHYS--- 64 (323)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCC-------CCCeeEE---
Confidence 469999999999998764 56789999986432211 222344555554 457788887 7766654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++++|..++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~ 133 (323)
T cd05575 65 ----FQTADKLYFVLDYVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQG 133 (323)
T ss_pred ----EEeCCEEEEEEcCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCC
Confidence 355778999999999999999987532 3888899999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------- 203 (323)
T cd05575 134 HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---------- 203 (323)
T ss_pred cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------
Confidence 999999999865322 222334469999999999999999999999999999999999999997653211
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh----HHHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI----GEILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~e~l~~~~~ 311 (379)
....+.......+. ..+..+.+++.+||+.||.+||++ .+++.|...
T Consensus 204 ---~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 204 ---MYDNILNKPLRLKP---NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred ---HHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 11122222222222 235789999999999999999998 588887554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=326.59 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=198.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++++.||+|+||.||+|.+.. +++.||+|.+..... ........+.+|+.+++.+.|++ |+++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~-----~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~-------iv~~~~ 68 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD-----TKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEW-------VVRLYY 68 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC-----CCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCc-------CCeEEE
Confidence 68999999999999999998765 567899999874321 11334567899999999999888 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+++..|+||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++| |+||||||+|||+
T Consensus 69 ~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl 134 (382)
T cd05625 69 S-------FQDKDNLYFVMDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILI 134 (382)
T ss_pred E-------EEeCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 5 355788999999999999999997532 3788889999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCC------------------------------------------------CcccccCccccc
Q 035572 176 DSKWDAKLADFGLAVSESDE------------------------------------------------SSMVQPAGTIGY 207 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~y 207 (379)
+.+|.+||+|||++...... .......||+.|
T Consensus 135 ~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence 99999999999997421100 001123689999
Q ss_pred cCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHH
Q 035572 208 LDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHV 287 (379)
Q Consensus 208 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (379)
+|||++.+..++.++|||||||++|+|++|+.||...+......... . .......|. ....++++.++
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----------~-~~~~~~~p~-~~~~s~~~~~l 282 (382)
T cd05625 215 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI----------N-WQTSLHIPP-QAKLSPEASDL 282 (382)
T ss_pred CCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH----------c-cCCCcCCCC-cccCCHHHHHH
Confidence 99999998899999999999999999999999998654322111100 0 011111121 12345778899
Q ss_pred HHhcccCCCCCCCC---hHHHhccccCc
Q 035572 288 AARCVSSEEENRPG---IGEILMGCSCF 312 (379)
Q Consensus 288 i~~~l~~dp~~Rps---~~e~l~~~~~~ 312 (379)
+.+|+ .+|.+|++ +++++.|....
T Consensus 283 i~~l~-~~p~~R~~~~~~~ei~~hp~f~ 309 (382)
T cd05625 283 IIKLC-RGPEDRLGKNGADEIKAHPFFK 309 (382)
T ss_pred HHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence 98876 59999997 99999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=318.26 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.+.. .+..+++|.+.... .......+.+|+++++.++|+| |+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~-------iv~~ 68 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP-----SGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPY-------IVGF 68 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC-----CCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCc-------ccce
Confidence 4789999999999999999998764 45678999876532 1334567899999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~N 172 (379)
++.+ .+++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .+ ++|+||||+|
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~N 134 (333)
T cd06650 69 YGAF-------YSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 134 (333)
T ss_pred eEEE-------EECCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhh
Confidence 8764 44678999999999999999997532 37888889999999999999997 48 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++.++.+||+|||++...... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||....... +..
T Consensus 135 ili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~ 212 (333)
T cd06650 135 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE-LEL 212 (333)
T ss_pred EEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH-HHH
Confidence 99999999999999998654322 2233468999999999998889999999999999999999999997543211 100
Q ss_pred hhhh-h------------------------------h-hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC
Q 035572 253 WALP-L------------------------------I-KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300 (379)
Q Consensus 253 ~~~~-~------------------------------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 300 (379)
.... . . .......+...... .......+.++.+|+.+||+.||++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP-KLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCc-cCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 0000 0 0 00000000000000 000112356789999999999999999
Q ss_pred ChHHHhccccCc
Q 035572 301 GIGEILMGCSCF 312 (379)
Q Consensus 301 s~~e~l~~~~~~ 312 (379)
|+.|++.|....
T Consensus 292 t~~ell~h~~~~ 303 (333)
T cd06650 292 DLKQLMVHAFIK 303 (333)
T ss_pred CHHHHhhCHHHh
Confidence 999999986553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=310.70 Aligned_cols=261 Identities=21% Similarity=0.362 Sum_probs=206.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.........+.+++|.+..... ......+.+|+.+++.++|++ +++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~ei~~l~~l~h~~-------i~~~~ 74 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE---PKVQQEFRQEAELMSDLQHPN-------IVCLL 74 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC---HHHHHHHHHHHHHHHhcCCcc-------cceEE
Confidence 47899999999999999999987655455667899999874432 344567899999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCC-----------CCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT-----------PQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
+.+ ...+..+++|||+++++|.+++........ ..+++.++..++.|++.||.|||+.| +
T Consensus 75 ~~~-------~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i 145 (283)
T cd05048 75 GVC-------TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--F 145 (283)
T ss_pred EEE-------cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 764 345678999999999999999976432221 34788889999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 239 (379)
+|+||||+||++++++.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 146 ~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~ 225 (283)
T cd05048 146 VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225 (283)
T ss_pred eccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986543222 1223356889999999888889999999999999999998 999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
||.+.... .+.. .+..... +.....++.++.+|+.+||+.||.+||++.+++++.
T Consensus 226 p~~~~~~~-~~~~------------~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 226 PYYGFSNQ-EVIE------------MIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred CCCCCCHH-HHHH------------HHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99765421 1111 1111111 112234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=326.24 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=219.3
Q ss_pred ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 18 SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 18 ~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
+...+||+|+|-+||+|.|.. ++..||--.++.......+...++|..|+.+|+.|+|+| |++++.+|
T Consensus 43 k~~evLGrGafKtVYka~De~-----~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~N-------Iirfy~SW 110 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE-----EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPN-------IIRFYDSW 110 (632)
T ss_pred ehhhhcccccceeeeeccccc-----cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCc-------eeeeeehe
Confidence 344689999999999999865 444455555544444444566799999999999999999 99999987
Q ss_pred cccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~ 177 (379)
.. ......-+|+|.+..|+|..++++.+. ++.+.+..|++||++||.|||++.+||+|||||-+||||+.
T Consensus 111 ~d-----~~n~~in~iTEL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG 180 (632)
T KOG0584|consen 111 VD-----TDNKTINFITELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG 180 (632)
T ss_pred ec-----CCCceeeeeeecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC
Confidence 65 334678899999999999999987554 78889999999999999999999999999999999999985
Q ss_pred -CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhh
Q 035572 178 -KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 178 -~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 256 (379)
.|.|||+|+|+|........ ....|||.|||||++. ..|+..+||||||++++||+|+..||..-.+++++......
T Consensus 181 ~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 181 NLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred CcCceeecchhHHHHhhcccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 59999999999977754433 3368999999999998 88999999999999999999999999998888888877766
Q ss_pred hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
.+....+..+- .+++.++|.+||.. ...|||+.|+|.|........
T Consensus 259 GiKP~sl~kV~-------------dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 259 GIKPAALSKVK-------------DPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred CCCHHHhhccC-------------CHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 55555555443 26799999999999 999999999999977766544
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=332.19 Aligned_cols=279 Identities=15% Similarity=0.199 Sum_probs=201.5
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
+++...+++|++.++||+|+||.||+|.+.. .++.||||+++.. ......+..|+.+++.+++.+..+.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~- 190 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRK-----RKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADR- 190 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcC-----CCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccC-
Confidence 3444557899999999999999999998764 4578999998632 2234556789999999988764332
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEec
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHR 166 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~ 166 (379)
..++.++.++. .+..+.|+|||++ |++|.+++.+.+ .+++..+..++.|++.||.|||+ .| |+||
T Consensus 191 ~~i~~i~~~~~------~~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHr 256 (467)
T PTZ00284 191 FPLMKIQRYFQ------NETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH--LMHT 256 (467)
T ss_pred cceeeeEEEEE------cCCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--eecC
Confidence 22555555432 2345789999999 889999887532 38889999999999999999998 59 9999
Q ss_pred CCCCCceEEcCCC----------------CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHH
Q 035572 167 DIKSTNILFDSKW----------------DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230 (379)
Q Consensus 167 dlkp~NIll~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 230 (379)
||||+|||++.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||+
T Consensus 257 DlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 334 (467)
T PTZ00284 257 DLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334 (467)
T ss_pred CCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHH
Confidence 9999999998665 499999998754322 2234579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHhhh--hhhhHH-----------hhhhhccc---cCC----------CCcchHHHHHHH
Q 035572 231 LLEIISCRKPIDAARDPASIIDWAL--PLIKEE-----------KLRQVCDS---RVG----------LPTFMEGAIKQM 284 (379)
Q Consensus 231 l~elltg~~p~~~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~---~~~----------~~~~~~~~~~~~ 284 (379)
+|||++|+.||.+.++...+..... ...... .+...... ... .+.......+.+
T Consensus 335 l~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 9999999999987654332211100 000000 00000000 000 000000113568
Q ss_pred HHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 285 LHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 285 ~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.+||.+||++||++|||++|+|.|.....
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 89999999999999999999999966543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.26 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=199.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|++.+.||+|+||.||+|.+.. +++.||+|.+...... .......+.+|+.+++.++|++ |++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~-------iv~~~ 67 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD-----TNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEW-------VVKLY 67 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCC-------cceEE
Confidence 369999999999999999998765 5678999998643211 1233567889999999999888 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nil 133 (376)
T cd05598 68 YS-------FQDKDNLYFVMDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNIL 133 (376)
T ss_pred EE-------EEcCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEE
Confidence 55 456789999999999999999997532 3788888999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC--------------------------------------------CcccccCccccccCC
Q 035572 175 FDSKWDAKLADFGLAVSESDE--------------------------------------------SSMVQPAGTIGYLDP 210 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~~gt~~y~aP 210 (379)
++.++.++|+|||+|...... .......||+.|+||
T Consensus 134 l~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 213 (376)
T cd05598 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213 (376)
T ss_pred ECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence 999999999999997422100 001123699999999
Q ss_pred CCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHh
Q 035572 211 GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAAR 290 (379)
Q Consensus 211 E~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 290 (379)
|++.+..++.++|||||||++|+|++|+.||............ .. .......+. ...+++.+.+++.+
T Consensus 214 E~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----------~~-~~~~~~~~~-~~~~s~~~~~li~~ 281 (376)
T cd05598 214 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV----------IN-WETTLHIPS-QAKLSREASDLILR 281 (376)
T ss_pred HHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH----------hc-cCccccCCC-CCCCCHHHHHHHHH
Confidence 9999899999999999999999999999999876432211110 00 001111111 12345778889999
Q ss_pred cccCCCCCCC---ChHHHhccccCcc
Q 035572 291 CVSSEEENRP---GIGEILMGCSCFF 313 (379)
Q Consensus 291 ~l~~dp~~Rp---s~~e~l~~~~~~~ 313 (379)
|+ .+|.+|+ ++.++++|.....
T Consensus 282 l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 76 5999999 9999999966543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=317.07 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=196.7
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.||+|.++..... .....+.+.+|+.++..+ +|++ |+++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~-------Iv~~~~~--- 64 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-----TRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPF-------LVGLHSC--- 64 (329)
T ss_pred CeEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCC-------CCceEEE---
Confidence 468999999999998765 5677999998754221 123356688999999888 5666 7766655
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||++| ++||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~ 133 (329)
T cd05588 65 ----FQTESRLFFVIEFVSGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEG 133 (329)
T ss_pred ----EEcCCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCC
Confidence 456778999999999999999886532 3899999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++.... .........||+.|+|||++.+..++.++|+|||||++|+|++|+.||........-....
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~---- 209 (329)
T cd05588 134 HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT---- 209 (329)
T ss_pred CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc----
Confidence 99999999986432 2223334579999999999999999999999999999999999999996432111000000
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC------hHHHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG------IGEILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~e~l~~~~~~ 312 (379)
.......+.......|. .++..+.+++.+||+.||.+||+ +++++.|....
T Consensus 210 ~~~~~~~~~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 210 EDYLFQVILEKQIRIPR---SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred hHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 00011122222333333 23467899999999999999997 78999986653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=332.24 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=201.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|.+.+.||+|++|.||+|..... .+..|++|.+.... ......+.+|+.+++.++|+| |++++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~----~~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpn-------iv~~~ 131 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD----PKEKVVAKFVMLND----ERQAAYARSELHCLAACDHFG-------IVKHF 131 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC----CCeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCC-------EeEEE
Confidence 3499999999999999999986542 14567888765432 233456788999999999998 89888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..||||||++||+|.+++..... ....+++.++..++.|++.||.|||+++ |+||||||+|||
T Consensus 132 ~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIl 201 (478)
T PTZ00267 132 DDF-------KSDDKLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIF 201 (478)
T ss_pred EEE-------EECCEEEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEE
Confidence 874 456789999999999999998875432 2334888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +
T Consensus 202 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-~- 279 (478)
T PTZ00267 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-I- 279 (478)
T ss_pred ECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-H-
Confidence 9999999999999997654322 1233469999999999998999999999999999999999999997643211 1
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+..+..... +.....++.++.+++.+||+.||++||++.+++.+
T Consensus 280 -----------~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 280 -----------MQQVLYGKY--DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -----------HHHHHhCCC--CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111111111 11112345789999999999999999999999876
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=318.64 Aligned_cols=267 Identities=21% Similarity=0.342 Sum_probs=205.7
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
..-++|++.+.||.|+||.||+|.+.+.....+++.||+|.++.... ....+.+.+|+.+++++ +|+| +
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~~~~l~~h~n-------i 73 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---ASEYKALMTELKILIHIGHHLN-------V 73 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---HHHHHHHHHHHHHHHhhccCcc-------h
Confidence 34568999999999999999999876655555778999999874321 23356788999999999 6777 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC--------------------------------------
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-------------------------------------- 132 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------------------------- 132 (379)
+++++.+. ..+..++++|||+++++|.+++......
T Consensus 74 v~~~~~~~------~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (337)
T cd05054 74 VNLLGACT------KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGF 147 (337)
T ss_pred hheeeeEe------cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccccc
Confidence 87777653 3456789999999999999998653211
Q ss_pred ------------------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCC
Q 035572 133 ------------------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194 (379)
Q Consensus 133 ------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 194 (379)
....+++..+..++.|++.||+|||++| |+||||||+|||+++++.++|+|||++.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 148 IEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred ccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 0124788899999999999999999999 99999999999999999999999999966432
Q ss_pred CCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhcccc
Q 035572 195 ESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSR 270 (379)
Q Consensus 195 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (379)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.......... ..... .
T Consensus 226 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~---------~~~~~--~ 294 (337)
T cd05054 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR---------LKEGT--R 294 (337)
T ss_pred CcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH---------HhccC--C
Confidence 221 122346778999999998999999999999999999998 99999764322211110 00000 1
Q ss_pred CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 271 VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. .....++++.+++.+||+.+|++||++.|++++..
T Consensus 295 ~~---~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 295 MR---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred CC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 11233567999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=323.27 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=201.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. +++.+|+|.+...... .......+.+|+.+++.++|++ |+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~-------iv 106 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPW-------VV 106 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCC-------Ee
Confidence 345789999999999999999998765 5677999998642211 1233456889999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++. +.+++..|+||||+++|+|.+++... .+++..+..++.|++.||+|||++| |+||||||+
T Consensus 107 ~~~~~-------~~~~~~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~ 171 (370)
T cd05621 107 QLFCA-------FQDDKYLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPD 171 (370)
T ss_pred eEEEE-------EEcCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence 87765 45678899999999999999999642 2788889999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCC----CCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPS----KLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
|||+++++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus 172 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred HEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 99999999999999999976533222 2345799999999987653 37889999999999999999999997654
Q ss_pred CchhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCcc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCFF 313 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~~ 313 (379)
... .+..+... ....|. ....+..+.+++.+||+.+|.+ |+++.|+++|.....
T Consensus 252 ~~~-------------~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 252 LVG-------------TYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHH-------------HHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 211 11122221 122222 1234677889999999866544 899999999966543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=322.22 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=209.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+.++.||.|+||.||.|++.. +..+||||+++..+... ...-.++..|+..|++++||| .|.+-
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~-----n~evVAIKKMsySGKQs-~EKWqDIlKEVrFL~~l~HPn-------tieYk 92 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQS-NEKWQDILKEVRFLRQLRHPN-------TIEYK 92 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccC-----ccceeeeeecccccccc-HHHHHHHHHHHHHHHhccCCC-------ccccc
Confidence 457888999999999999998765 56789999998765432 233467899999999999999 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.+ +...||||||| -||-.+++.-. ..++-+.++..|+.+.+.||+|||+++ .+|||||..|||
T Consensus 93 gCyLr-------e~TaWLVMEYC-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNIL 158 (948)
T KOG0577|consen 93 GCYLR-------EHTAWLVMEYC-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNIL 158 (948)
T ss_pred ceeec-------cchHHHHHHHH-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceE
Confidence 77554 56789999999 67888888753 234888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+++.|.|||+|||.|....+. .+++|||.|||||++ ..+.|+.++||||||++..||...++|..+.+....+.
T Consensus 159 Lse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 159 LSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred ecCCCeeeeccccchhhcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 999999999999998766544 445899999999975 46789999999999999999999999998876554443
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.++. +..+.++ ....+..++.++..||+.-|.+|||.++++.|.....
T Consensus 236 HIAQ------------NesPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 236 HIAQ------------NESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHh------------cCCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 3321 1111111 3455678999999999999999999999999976544
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=309.85 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=196.7
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||+|+||.||+|.+.. +++.+|+|.+...... .....+.+..|+.+++.++|++ ++.+...
T Consensus 1 lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~-------i~~~~~~------ 61 (280)
T cd05608 1 LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRF-------IVSLAYA------ 61 (280)
T ss_pred CCCCCceeEEEEEEcc-----CCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCc-------EeeeeEE------
Confidence 7999999999998765 5678999998754322 1223456788999999999887 7776654
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
+...+..++||||+++|+|.+.+..... ....+++..+..++.|++.||.|||++| |+||||||+||++++++.++
T Consensus 62 -~~~~~~~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~ 137 (280)
T cd05608 62 -FQTKTDLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVR 137 (280)
T ss_pred -EcCCCeEEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEE
Confidence 3456789999999999999988854322 2334889999999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHH
Q 035572 183 LADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEE 261 (379)
Q Consensus 183 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 261 (379)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .
T Consensus 138 l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---------~ 208 (280)
T cd05608 138 ISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---------E 208 (280)
T ss_pred EeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---------H
Confidence 99999986543322 2233468999999999999999999999999999999999999997654321110 1
Q ss_pred hhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 262 KLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
....+...... ....++..+.+++.+||+.||++|| ++++++.|...
T Consensus 209 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 209 LKQRILNDSVT---YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred HHHhhcccCCC---CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 11111222111 1233567899999999999999999 78999998443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=310.32 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=194.7
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
..||+|++|.||+|.+ +++.||||.++..... .....+.+.+|+.+|++++|+| |+++++.+...
T Consensus 26 ~~i~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~n-------Iv~~~g~~~~~ 90 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-------NNKEVIIRTFKKFHKG-HKVLIDITENEIKNLRRIDSNN-------ILKIYGFIIDI 90 (283)
T ss_pred eEEeeCCceEEEEEEE-------CCEEEEEEeccccccc-cHHHHHHHHHHHHHHHhcCCCC-------EEEEeeeEEec
Confidence 6899999999999986 4567999998754321 1223577889999999999998 99999876431
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceEEcCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIll~~~~ 179 (379)
.......++||||+++|+|.+++... ..+++.....++.|++.||.|||+ .+ ++||||||+|||+++++
T Consensus 91 ---~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 91 ---VDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENY 160 (283)
T ss_pred ---ccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCC
Confidence 12345789999999999999999753 238888999999999999999998 48 88999999999999999
Q ss_pred CeEEeccccCccCCCCCcccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhh
Q 035572 180 DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPL 257 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 257 (379)
.+||+|||++....... ....++..|+|||+..+ ..++.++|||||||++|||++|+.||....... +.....
T Consensus 161 ~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~i~-- 235 (283)
T PHA02988 161 KLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDLII-- 235 (283)
T ss_pred cEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH--
Confidence 99999999987554322 23468899999999876 678999999999999999999999998654221 111100
Q ss_pred hhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 258 IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ...+...+ ..++..+.+++.+||+.||++|||+++++...
T Consensus 236 ------~--~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 236 ------N--KNNSLKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred ------h--cCCCCCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 0 01111112 23467899999999999999999999999753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=321.42 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=195.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|+..+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+++++.++|+| |+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 137 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPN-------VVKC 137 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECC-----CCCEEEEEEEecCCc---HHHHHHHHHHHHHHHhCCCCC-------ccee
Confidence 3567888999999999999998764 457799999864321 234577899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+.+++||||+++++|.+.. ...+..+..++.|++.||.|||++| |+||||||+||
T Consensus 138 ~~~-------~~~~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI 199 (353)
T PLN00034 138 HDM-------FDHNGEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNL 199 (353)
T ss_pred eeE-------eccCCeEEEEEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHE
Confidence 765 45677899999999999986532 1456677889999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-----CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|+++++.+||+|||++....... ......||..|+|||++.. ...+.++|||||||++|+|++|+.||......
T Consensus 200 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 279 (353)
T PLN00034 200 LINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279 (353)
T ss_pred EEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 99999999999999986654322 2234579999999998743 23456899999999999999999999743321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
. ....... ...... +.....++.++.+||.+||+.||++|||+.|+++|.....
T Consensus 280 ~-~~~~~~~--------~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 280 D-WASLMCA--------ICMSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred c-HHHHHHH--------HhccCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 1 1100000 000111 1122344578999999999999999999999999854433
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.65 Aligned_cols=276 Identities=21% Similarity=0.297 Sum_probs=203.9
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
...+.++|++.+.||.|+||.||+|.+.. +++.||+|.+...... ......+.+|+.+++.++|+|
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~------- 75 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTR-----LRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHEN------- 75 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECC-----CCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCc-------
Confidence 34567899999999999999999998764 5577999998754222 233466789999999999988
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
|+++++.+... .........|++|+++ +++|.+++.. ..+++..+..++.|++.||.|||++| |+|||||
T Consensus 76 iv~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdik 145 (343)
T cd07878 76 VIGLLDVFTPA-TSIENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLK 145 (343)
T ss_pred hhhhhhhhccc-ccccccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence 77777665321 1122345689999998 8899988753 23889999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 146 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 223 (343)
T cd07878 146 PSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223 (343)
T ss_pred hhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999998765432 233468999999998876 568899999999999999999999997654332
Q ss_pred hHHHhhhh----------hhhHHhhhhhccccCCCCc-----chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 249 SIIDWALP----------LIKEEKLRQVCDSRVGLPT-----FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+...... .+...............+. .....++.+.+|+.+||+.||.+|||+.|++.|...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 224 QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 22111100 0000000011110000010 111234568899999999999999999999998544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=315.53 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=190.5
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHH-HHHhhhhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR-VLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
++||+|+||.||+|.+.. +++.||+|.+....... ......+..|+. +++.++|+| |+++++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~-------iv~~~~~--- 64 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-----DGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPF-------LVGLHYS--- 64 (321)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCC-------ccceeeE---
Confidence 479999999999998764 56789999986432211 222344555554 678888887 7776654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++++|...+... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~ 133 (321)
T cd05603 65 ----FQTAEKLYFVLDYVNGGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQG 133 (321)
T ss_pred ----EEcCCEEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCC
Confidence 35577899999999999999888643 23788889999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~--------- 203 (321)
T cd05603 134 HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-Q--------- 203 (321)
T ss_pred CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-H---------
Confidence 999999999865322 22233456899999999999888999999999999999999999999765321 1
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH----HHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG----EILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----e~l~~~~~ 311 (379)
....+.......+. ..+..+.+++.+||+.||.+||++. ++++|...
T Consensus 204 ---~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 204 ---MYDNILHKPLQLPG---GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred ---HHHHHhcCCCCCCC---CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 11122222222222 2346789999999999999999764 77777544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.22 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=190.5
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.||+|.++..... .....+.+..|..++..+ +|++ |+++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~-------i~~~~~~--- 64 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-----TNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPF-------LTHLFCT--- 64 (316)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCC-------ccceeeE---
Confidence 469999999999998764 5677999998753211 123345556677777654 5666 6666654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+...+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~ 133 (316)
T cd05592 65 ----FQTKEHLFFVMEYLNGGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDG 133 (316)
T ss_pred ----EEcCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCC
Confidence 455678999999999999999987532 3888899999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... +
T Consensus 134 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~-------- 204 (316)
T cd05592 134 HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-L-------- 204 (316)
T ss_pred CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-H--------
Confidence 9999999998654322 22334469999999999998899999999999999999999999998654211 1
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH-HHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG-EILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-e~l~~~~~ 311 (379)
...+.......| ..++.++.+++.+||+.||.+||++. +++.|...
T Consensus 205 ----~~~i~~~~~~~~---~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 205 ----FDSILNDRPHFP---RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred ----HHHHHcCCCCCC---CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence 111112222222 23457789999999999999999975 66676443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.09 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=202.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|.++.... ......+.+.+|+.+++.++|++ ++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~-------i~~~~ 67 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-----TGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPW-------IPQLQ 67 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCC-------Cccee
Confidence 479999999999999999998765 567899999875322 11334567889999999998887 66655
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIl 134 (330)
T cd05601 68 YA-------FQDKDNLYLVMEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVL 134 (330)
T ss_pred eE-------EecCCeEEEEECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheE
Confidence 54 355678999999999999999997642 23889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCC------CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 175 FDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTN------PSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
++.++.+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||.....
T Consensus 135 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 99999999999999966543322 22346899999999876 45678899999999999999999999976543
Q ss_pred chhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.... ..+... ....|. ....+..+.+|+.+||+ +|.+||++++++.|.....
T Consensus 215 ~~~~-------------~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 215 AKTY-------------NNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHH-------------HHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 2211 111111 111111 12345779999999998 9999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=344.19 Aligned_cols=270 Identities=21% Similarity=0.311 Sum_probs=208.7
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.+.....++|++++.||.|+||.||+|.+.. .++.+++|.+...... ......+..|+.+++.|+|++
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~-----tg~~vAlKvIk~~~l~--e~~~~~~~~EI~IL~~L~HPN----- 73 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKR-----TQEFFCWKAISYRGLK--EREKSQLVIEVNVMRELKHKN----- 73 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECC-----CCeEEEEEEEeccccC--HHHHHHHHHHHHHHHHcCCCC-----
Confidence 3444556899999999999999999998765 5678999998754332 344677899999999999988
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC-----CC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND-----PM 162 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----~~ 162 (379)
|+++++.+.. .....+||||||+++++|.++|...... ...+++..++.|+.||+.||.|||+.+ ..
T Consensus 74 --IVrl~d~f~d-----e~~~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 74 --IVRYIDRFLN-----KANQKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred --cCeEEEEEEe-----cCCCEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 8888876542 3346789999999999999999764322 234899999999999999999999843 23
Q ss_pred eEecCCCCCceEEcC-----------------CCCeEEeccccCccCCCCCcccccCccccccCCCCCCC--CCCCCcCC
Q 035572 163 IIHRDIKSTNILFDS-----------------KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP--SKLSKKVD 223 (379)
Q Consensus 163 i~H~dlkp~NIll~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 223 (379)
|+||||||+||||+. .+.+||+|||++.............||+.|+|||++.+ ..++.++|
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD 225 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence 999999999999964 23589999999976654444445579999999998753 45889999
Q ss_pred eehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 224 VFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 224 iwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
||||||++|+|+||..||....+...+.... ......+ ....+.++.+||.+||+.+|.+||++.
T Consensus 226 VWSLG~ILYELLTGk~PF~~~~~~~qli~~l-------------k~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 226 MWALGCIIYELCSGKTPFHKANNFSQLISEL-------------KRGPDLP--IKGKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred HHHHHHHHHHHHHCCCCCCcCCcHHHHHHHH-------------hcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence 9999999999999999997655433222111 1111111 123357899999999999999999999
Q ss_pred HHhccccCc
Q 035572 304 EILMGCSCF 312 (379)
Q Consensus 304 e~l~~~~~~ 312 (379)
|+|.|....
T Consensus 291 QlL~h~~ik 299 (1021)
T PTZ00266 291 QCLGYQIIK 299 (1021)
T ss_pred HHhccHHHh
Confidence 999875543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.04 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=195.0
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.+|+|.+...... .......+.+|+.++.++ +|++ |+++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~-------iv~~~~~--- 64 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-----TERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPF-------LVGLHSC--- 64 (329)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCc-------CCceeeE---
Confidence 469999999999998765 5567999998754221 123355678899888776 6776 7776665
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+...+..|+||||+++++|..++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~E~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~ 133 (329)
T cd05618 65 ----FQTESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEG 133 (329)
T ss_pred ----EEeCCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCC
Confidence 455788999999999999998886532 3889999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~---- 209 (329)
T cd05618 134 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT---- 209 (329)
T ss_pred CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc----
Confidence 999999999865322 222334579999999999999999999999999999999999999996422111000000
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC------hHHHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG------IGEILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~e~l~~~~~ 311 (379)
.......+.......|. ..+..+.+++.+||+.||++||+ +.+++.|...
T Consensus 210 ~~~~~~~i~~~~~~~p~---~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 210 EDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred HHHHHHHHhcCCCCCCC---CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 00111122222233332 33567889999999999999998 4799988654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.59 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=188.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHH-HHHHhhhhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI-RVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.||+|.+....... ......+..|. .+++.++|+| |+++++.
T Consensus 1 ~~lg~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~-------Iv~~~~~--- 64 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPF-------LVGLHFS--- 64 (325)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHHh-hhHHHHHHHHHHHHHHhCCCCC-------CCceeEE---
Confidence 469999999999998765 45679999986432211 11223344444 4567788877 6666654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~ 133 (325)
T cd05602 65 ----FQTADKLYFVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQG 133 (325)
T ss_pred ----EEcCCeEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCC
Confidence 456788999999999999999997532 3778888899999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 134 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------- 204 (325)
T cd05602 134 HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--------- 204 (325)
T ss_pred CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---------
Confidence 999999999865322 2223345799999999999989999999999999999999999999976542211
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH----HHhcccc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG----EILMGCS 310 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----e~l~~~~ 310 (379)
+..+.......+ ...+..+.+++.+||+.||.+||++. ++++|..
T Consensus 205 ----~~~i~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 205 ----YDNILNKPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred ----HHHHHhCCcCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 111111111111 23457889999999999999999887 6666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.12 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=201.5
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|+..+.||+|+||.||+|.+.. +++.+|+|.+...... .......+.+|+.+++.++|++ ++.+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~-------i~~~~~ 67 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRF-------VVSLAY 67 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC-----CCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCC-------eeeeeE
Confidence 47888999999999999998765 5678999988644321 1222355778999999999887 777666
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..++||||+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++||||||+||++
T Consensus 68 ~~-------~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~ 135 (285)
T cd05630 68 AY-------ETKDALCLVLTLMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILL 135 (285)
T ss_pred EE-------ecCCEEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE
Confidence 53 44678999999999999999886532 233888899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||++.............|+..|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~--- 212 (285)
T cd05630 136 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE--- 212 (285)
T ss_pred CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---
Confidence 99999999999998765443333345789999999999988899999999999999999999999976543211100
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccC
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSC 311 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~ 311 (379)
......... ......+++++.+|+.+||+.||++||| ++|+++|...
T Consensus 213 -------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 213 -------VERLVKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred -------HHhhhhhhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 000000000 0111234567899999999999999999 8999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.20 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=195.3
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.||+|.++..... .......+.+|+.++..+ +|++ ++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~-------i~~~~~~--- 64 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-----TDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPF-------LTQLHSC--- 64 (318)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCC-------ccceeeE---
Confidence 469999999999998765 4567999998743211 123456678899998887 4666 7776665
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+...+..|+||||+++++|.+.+.+.. .+++..+..++.|++.||.|||+.| ++||||||+|||+++++
T Consensus 65 ----~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~ 133 (318)
T cd05570 65 ----FQTKDRLFFVMEYVNGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEG 133 (318)
T ss_pred ----EEcCCEEEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCC
Confidence 455678999999999999999887532 3889999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... .
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-~-------- 204 (318)
T cd05570 134 HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-L-------- 204 (318)
T ss_pred cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-H--------
Confidence 9999999998643222 22233468999999999999999999999999999999999999997654211 1
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~~ 312 (379)
...+.......+ ...+..+.+++.+||+.||.+||++ .+++.|....
T Consensus 205 ----~~~i~~~~~~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~ 256 (318)
T cd05570 205 ----FQSILEDEVRYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256 (318)
T ss_pred ----HHHHHcCCCCCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 111122222222 2345789999999999999999999 9999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.87 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=202.6
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
+.++....++|++.+.||+|+||.||+|.++. +++.+|+|.+...... .....+.+.+|+.+++.++|++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~---- 104 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPW---- 104 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCC----
Confidence 34455566899999999999999999998765 5678999998642211 1233456789999999999888
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
++++++. +.+.+..|+||||++||+|.+++... .+++..+..++.|++.||.|||++| |+||
T Consensus 105 ---iv~~~~~-------~~~~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--ivHr 166 (371)
T cd05622 105 ---VVQLFYA-------FQDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG--FIHR 166 (371)
T ss_pred ---CCeEEEE-------EEcCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 7776655 35567899999999999999998642 2788888999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC----CCCCcCCeehhHHHHHHHHhCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS----KLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~p 240 (379)
||||+|||++.++.+||+|||++....... ......||+.|+|||++... .++.++|||||||++|+|++|..|
T Consensus 167 DLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 246 (371)
T cd05622 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (371)
T ss_pred CCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence 999999999999999999999986654322 22345799999999987653 378899999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCF 312 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~ 312 (379)
|...+... .+..+... ....+. ...++..+.+++.+||+.++.+ |+++++++.|....
T Consensus 247 f~~~~~~~-------------~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~ 308 (371)
T cd05622 247 FYADSLVG-------------TYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 308 (371)
T ss_pred CCCCCHHH-------------HHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence 97654211 11122211 111121 2235678999999999844443 78999999996543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.37 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=196.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|+..+.||+|+||.||+|.++. +++.||+|.++..... .....+.+..|+.++..+.|++. ++.++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~------i~~~~~ 68 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPF------LTQLHS 68 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCc------hhheee
Confidence 47888999999999999998765 5678999998743211 12334667888989888865431 444444
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+.+..|+||||++||+|.+++.... .+++.++..++.|++.||.|||++| |+||||||+|||+
T Consensus 69 ~-------~~~~~~~~lv~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill 134 (323)
T cd05615 69 C-------FQTVDRLYFVMEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVML 134 (323)
T ss_pred E-------EecCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE
Confidence 3 455678999999999999999987532 3889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .+
T Consensus 135 ~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~---- 209 (323)
T cd05615 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-EL---- 209 (323)
T ss_pred CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HH----
Confidence 999999999999986543222 223346899999999999888999999999999999999999999765421 11
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~ 311 (379)
...+.......|. ..+.++.+++.+||+.+|.+|++. .++.+|...
T Consensus 210 --------~~~i~~~~~~~p~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f 260 (323)
T cd05615 210 --------FQSIMEHNVSYPK---SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF 260 (323)
T ss_pred --------HHHHHhCCCCCCc---cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence 1122222222222 335778999999999999999984 577777443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=305.31 Aligned_cols=261 Identities=22% Similarity=0.388 Sum_probs=205.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.+.......+.+.|++|.++.... ....+.+.+|+++++.++|++ ++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~-------i~~~ 73 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHEN-------IVKF 73 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---HHHHHHHHHHHHHHHhcCCCC-------chhe
Confidence 457899999999999999999886654445678899999875422 234578999999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc---------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA---------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
++.+ ......++||||+++++|.+++...+. .....+++..+..++.|++.||.|||++| ++
T Consensus 74 ~~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~ 144 (280)
T cd05049 74 YGVC-------TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FV 144 (280)
T ss_pred eeEE-------ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--ee
Confidence 7664 345789999999999999999976432 12234788899999999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 240 (379)
||||||+||+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 145 h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p 224 (280)
T cd05049 145 HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred ccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999986532221 1122345788999999999999999999999999999999 9999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
|....... ... .+..... +......+..+.+++.+||+.||++||++.|+++.
T Consensus 225 ~~~~~~~~-~~~------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 225 WYGLSNEE-VIE------------CITQGRL--LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred CCCCCHHH-HHH------------HHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 97654322 111 1111111 11122345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=306.30 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=202.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
..+++|++.+.||+|+||.||+|.+...........||+|.+..... ......+.+|+.+++.++|+| ++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~-------iv 72 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHH-------VV 72 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCC-------ee
Confidence 35788999999999999999999876543444567899999864321 223466889999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
++++.+ .+....++||||+++++|.+++.+.... ....+++..+..++.|++.||.|||+.| ++|+
T Consensus 73 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~ 143 (277)
T cd05062 73 RLLGVV-------SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHR 143 (277)
T ss_pred eEEEEE-------cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccC
Confidence 887664 4567889999999999999999763321 1223567788899999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPID 242 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~ 242 (379)
||||+||++++++.++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 144 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 144 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred CcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999865432221 112345788999999988889999999999999999999 788987
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...... ... .+..... +......+..+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~-~~~------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 224 GMSNEQ-VLR------------FVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCHHH-HHH------------HHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 653211 111 1111111 11112345679999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=302.20 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=202.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+++|++.+.||.|++|.||+|.+.. .++.+++|.+...... ......+.+.+|+.++++++|+| +++
T Consensus 1 ~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-------i~~ 68 (263)
T cd06625 1 PTNWRRGKLLGQGAFGRVYLCYDVD-----TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER-------IVQ 68 (263)
T ss_pred CCcccccceecCCCceEEEEEEEcC-----CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCC-------eee
Confidence 3679999999999999999998754 4567999988644321 11223567899999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+.+.... .+++..+..++.|++.||.|||+.| ++|+||+|+|
T Consensus 69 ~~~~~-------~~~~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~n 134 (263)
T cd06625 69 YYGCL-------RDDETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGAN 134 (263)
T ss_pred eEEEE-------ccCCeEEEEEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 77764 45679999999999999999997532 3788888999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|++++++.++|+|||++......... ....++..|+|||+..+..++.++||||||+++|+|++|+.||.......
T Consensus 135 ilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 135 ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred EEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 99999999999999998654322111 23457889999999998889999999999999999999999997653322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... ...... .+.....++..+.+++.+||..+|.+|||+.+++.|.
T Consensus 215 ~~~~-------------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 215 AIFK-------------IATQPT-NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHH-------------HhccCC-CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 1111 111101 1112234457899999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.07 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=190.8
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.++. +++.||+|.++..... .......+..|..++..+ .|++ ++.+++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~-------i~~~~~~--- 64 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-----KGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPF-------LTHLYCT--- 64 (316)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCC-------ccCeeEE---
Confidence 479999999999998765 5678999998743211 122345567788887754 5655 6666654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+.+++|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~ 133 (316)
T cd05620 65 ----FQTKEHLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDG 133 (316)
T ss_pred ----EEeCCEEEEEECCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCC
Confidence 45678999999999999999998753 23788899999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .+..
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~~------ 206 (316)
T cd05620 134 HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFE------ 206 (316)
T ss_pred CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHH------
Confidence 999999999864322 22233456999999999999999999999999999999999999999765421 1111
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH-HHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG-EILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-e~l~~~~~ 311 (379)
.+.......+. ..+.++.+++.+||+.||++||++. +++.|...
T Consensus 207 ------~~~~~~~~~~~---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 207 ------SIRVDTPHYPR---WITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred ------HHHhCCCCCCC---CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 11111112222 2357789999999999999999984 77777544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=313.06 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=196.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. .++.+|+|+++..... .....+.+.+|+.++.++. |++ ++.+++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~-------i~~~~~~--- 64 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-----NDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPF-------LVGLHSC--- 64 (327)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCC-------EeeEEEE---
Confidence 479999999999998765 5577999998754221 1234566889999998884 555 7777665
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+.+|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~ 133 (327)
T cd05617 65 ----FQTTSRLFLVIEYVNGGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADG 133 (327)
T ss_pred ----EEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCC
Confidence 355678999999999999999886532 3889999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++.... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+......
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~------ 207 (327)
T cd05617 134 HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT------ 207 (327)
T ss_pred CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc------
Confidence 99999999986532 22233445799999999999999999999999999999999999999965332111000
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh------HHHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI------GEILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~e~l~~~~~~ 312 (379)
.......+.......|. ..+..+.+++.+||+.||.+|+++ ++++.|....
T Consensus 208 ~~~~~~~~~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 208 EDYLFQVILEKPIRIPR---FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred HHHHHHHHHhCCCCCCC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 00111122222222332 234678899999999999999984 6888886543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=305.91 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=200.8
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|+..+.||.|+||.||+|.+.. +++.+|+|.+...... .......+.+|+++++.++|++ ++.+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~-------i~~~~~ 67 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQF-------VVNLAY 67 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC-----CCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcC-------ceeEEE
Confidence 47788999999999999998764 5678999998654321 1223455788999999999887 666555
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +..++..++||||+++++|.+.+...+ ...+++..+..++.|++.||.|||+.| |+||||||+||++
T Consensus 68 ~-------~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili 135 (285)
T cd05632 68 A-------YETKDALCLVLTIMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILL 135 (285)
T ss_pred E-------EecCCEEEEEEEeccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE
Confidence 4 345678999999999999998886532 234899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||++.............|+..|+|||++.+..++.++|+||||+++|+|++|..||....+.......
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~-- 213 (285)
T cd05632 136 DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV-- 213 (285)
T ss_pred CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 999999999999986554333334457899999999998888999999999999999999999999765432211111
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccC
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSC 311 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~ 311 (379)
...+..... ......+.++.+|+.+||+.||++||+ +.+++.|...
T Consensus 214 -------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05632 214 -------DRRVLETEE---VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264 (285)
T ss_pred -------HHhhhcccc---ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence 111111111 112234567899999999999999999 7788887433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=318.58 Aligned_cols=264 Identities=20% Similarity=0.315 Sum_probs=204.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv 91 (379)
..++|++.++||+|+||.||+|.+...........||||.+..... ....+.+.+|+.+++.+. |+| |+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~~l~~l~~Hpn-------Iv 104 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR---SSEKQALMSELKIMTHLGPHLN-------IV 104 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCC-------ee
Confidence 3578999999999999999999886555545567899999875422 233567899999999996 888 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC---------------------------------------
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--------------------------------------- 132 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--------------------------------------- 132 (379)
++++++ .+.+..|+||||+++|+|.+++.+....
T Consensus 105 ~l~~~~-------~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (400)
T cd05105 105 NLLGAC-------TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDY 177 (400)
T ss_pred eEEEEE-------ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccc
Confidence 888775 4467899999999999999998764210
Q ss_pred ----------------------------------------------------CCCCCChHhHHHHHHHHHHHHHHHHcCC
Q 035572 133 ----------------------------------------------------TTPQLGWPNRVKIAMQISRAIQCLHEND 160 (379)
Q Consensus 133 ----------------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 160 (379)
....+++..+..++.|++.||.|||+.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 257 (400)
T cd05105 178 MDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN 257 (400)
T ss_pred cccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 0123777888999999999999999999
Q ss_pred CCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-
Q 035572 161 PMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS- 236 (379)
Q Consensus 161 ~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt- 236 (379)
++||||||+|||+++++.+||+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 258 --ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 258 --CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred --eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999999865432221 222346788999999988889999999999999999997
Q ss_pred CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|..||............ +..... +.....++..+.+++.+||+.||++||++.++.+..
T Consensus 336 g~~P~~~~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 336 GGTPYPGMIVDSTFYNK-------------IKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred CCCCCcccchhHHHHHH-------------HhcCCC-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 99998765322211111 011111 111233457899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.18 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=199.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.++. +++.||+|.++.... ........+.+|+.++..++|++ +++++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~-------iv~~~ 67 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-----TGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAW-------VVKMF 67 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCC-------EeeEE
Confidence 468999999999999999998765 567899999864321 11334567889999999999887 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+.+|+||||++||+|.+++.+.. .+++..+..++.|++.||+|||+.| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIl 133 (360)
T cd05627 68 YS-------FQDKRNLYLIMEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLL 133 (360)
T ss_pred EE-------EEcCCEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEE
Confidence 65 456788999999999999999997532 3888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC------------------------------------cccccCccccccCCCCCCCCCC
Q 035572 175 FDSKWDAKLADFGLAVSESDES------------------------------------SMVQPAGTIGYLDPGYTNPSKL 218 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 218 (379)
++.++.++|+|||++....... ......||+.|+|||++.+..+
T Consensus 134 i~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred ECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 9999999999999985432110 0112469999999999999999
Q ss_pred CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCC
Q 035572 219 SKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEE 296 (379)
Q Consensus 219 ~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp 296 (379)
+.++|||||||++|+|++|+.||......... ..+.. .....|.. ...+.++.+++.+|+. ||
T Consensus 214 ~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~-------------~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~p 278 (360)
T cd05627 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETY-------------RKVMNWKETLVFPPE-VPISEKAKDLILRFCT-DS 278 (360)
T ss_pred CCcceeccccceeeecccCCCCCCCCCHHHHH-------------HHHHcCCCceecCCC-CCCCHHHHHHHHHhcc-Ch
Confidence 99999999999999999999999765432211 11111 11111211 1135678899999774 99
Q ss_pred CCCCC---hHHHhccccCcc
Q 035572 297 ENRPG---IGEILMGCSCFF 313 (379)
Q Consensus 297 ~~Rps---~~e~l~~~~~~~ 313 (379)
.+|++ ++++++|.....
T Consensus 279 ~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 279 ENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred hhcCCCCCHHHHhcCCCCCC
Confidence 99984 789999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=309.72 Aligned_cols=266 Identities=20% Similarity=0.311 Sum_probs=189.4
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
.++||+|+||.||+|.++... ..+.+|+|.+.... ....+.+|+.+++.++|+| |+++++.+..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~---~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~n-------iv~~~~~~~~ 69 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK---DDRDYALKQIEGTG------ISMSACREIALLRELKHPN-------VISLQKVFLS 69 (317)
T ss_pred ccccccCCCeEEEEEEEccCC---CCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCC-------CcceeeeEec
Confidence 468999999999999875432 45779999986432 2345789999999999998 7777766532
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcC----CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA----TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
..+...|++|||+ +++|.+++...... ....+++..++.++.|++.||.|||++| |+||||||+|||+
T Consensus 70 -----~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~ 141 (317)
T cd07868 70 -----HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILV 141 (317)
T ss_pred -----CCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEE
Confidence 2345789999999 57998888643211 1234888899999999999999999999 9999999999999
Q ss_pred ----cCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 176 ----DSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 176 ----~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.....
T Consensus 142 ~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 142 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred ecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 456789999999996553321 1233468999999998876 4589999999999999999999999975432
Q ss_pred chh--------HHHhhhhhhh---HHhhhh-------------hccccCC---CCcch----HHHHHHHHHHHHhcccCC
Q 035572 247 PAS--------IIDWALPLIK---EEKLRQ-------------VCDSRVG---LPTFM----EGAIKQMLHVAARCVSSE 295 (379)
Q Consensus 247 ~~~--------~~~~~~~~~~---~~~~~~-------------~~~~~~~---~~~~~----~~~~~~~~~li~~~l~~d 295 (379)
... .......... ...+.. ....... ..... ......+.+|+.+||+.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 301 (317)
T cd07868 222 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301 (317)
T ss_pred cccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccC
Confidence 110 0000000000 000000 0000000 00000 011245889999999999
Q ss_pred CCCCCChHHHhccc
Q 035572 296 EENRPGIGEILMGC 309 (379)
Q Consensus 296 p~~Rps~~e~l~~~ 309 (379)
|.+|||++|+++|.
T Consensus 302 P~~R~t~~e~l~hp 315 (317)
T cd07868 302 PIKRITSEQAMQDP 315 (317)
T ss_pred cccCCCHHHHhcCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=316.18 Aligned_cols=273 Identities=23% Similarity=0.280 Sum_probs=200.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+++.+|+.+++.++|+| |+++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv~~~~ 66 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-----DGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDN-------VLSALD 66 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-----CCCEEEEEeccccccc--hHHHHHHHHHHHHHHhCCCCC-------cCCHhh
Confidence 47889999999999999998754 5677999998643211 234567889999999999998 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+.... .......|+||||+ +++|.+.+... ..+++..+..++.|++.||.|||+.| ++||||||+|||+
T Consensus 67 ~~~~~~--~~~~~~~~lv~e~~-~~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili 136 (372)
T cd07853 67 ILQPPH--IDPFEEIYVVTELM-QSDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLV 136 (372)
T ss_pred eecCCC--ccccceEEEEeecc-ccCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEE
Confidence 653211 01123789999999 47888888542 24889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 176 DSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+.++.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 137 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 216 (372)
T cd07853 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216 (372)
T ss_pred CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 999999999999986543322 22334678999999988764 478999999999999999999999987654332211
Q ss_pred hhhhhhh-----------HHhhhhhccccCCCCc------chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIK-----------EEKLRQVCDSRVGLPT------FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~-----------~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
. ..... ......+.......+. .....++++.+|+.+||+.||++|||+.|++.|.....
T Consensus 217 i-~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 217 I-TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred H-HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 1 10000 0000111111111111 11223567899999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.69 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=190.9
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHH-HHHhhhhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR-VLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.+|+|++...... .......+..|.. +++.++|+| |+++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~-------iv~~~~~--- 64 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-----DGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPF-------LVGLHYS--- 64 (325)
T ss_pred CceeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCC-------CccEEEE---
Confidence 469999999999998754 5678999998643211 1223345555554 467788887 7776655
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+...+..|+||||+++++|...+.... .+++..+..++.|++.||+|||+.| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~ 133 (325)
T cd05604 65 ----FQTTEKLYFVLDFVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQG 133 (325)
T ss_pred ----EecCCEEEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCC
Confidence 455788999999999999998886532 3889999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+... +
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~-------- 204 (325)
T cd05604 134 HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-M-------- 204 (325)
T ss_pred CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-H--------
Confidence 999999999864322 222334569999999999999999999999999999999999999997653211 1
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH----HHhccccCc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG----EILMGCSCF 312 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----e~l~~~~~~ 312 (379)
...+.......+ +..+..+.+++.+||+.+|.+||++. +++.|....
T Consensus 205 ----~~~~~~~~~~~~---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 205 ----YDNILHKPLVLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred ----HHHHHcCCccCC---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 111122222112 12346788999999999999999874 788875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=303.64 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=191.7
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||+|+||.||++.++. +++.||+|.+....... ......+..|+++++.++|+| ++.+++.
T Consensus 1 lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~-------i~~~~~~------ 61 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-----TGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPF-------IVNLAYA------ 61 (277)
T ss_pred CCCCCceEEEEEEEcc-----CCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCc-------EEEEEEE------
Confidence 7999999999998765 56789999986432211 122345567999999999988 8877665
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
+.++...++||||++|++|.+++.... ...+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++
T Consensus 62 -~~~~~~~~lv~e~~~g~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~ 135 (277)
T cd05607 62 -FESKTHLCLVMSLMNGGDLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCR 135 (277)
T ss_pred -EecCCeEEEEEecCCCCCHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEE
Confidence 355678999999999999998886532 223788888999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHh
Q 035572 183 LADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEK 262 (379)
Q Consensus 183 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (379)
|+|||++.............|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ..
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~---------~~ 206 (277)
T cd05607 136 LSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE---------EL 206 (277)
T ss_pred EeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---------HH
Confidence 999999876554433344578999999999988889999999999999999999999997543211110 11
Q ss_pred hhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 263 LRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
........... ....++.++.+++.+||+.||++||++.|+++
T Consensus 207 ~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 207 KRRTLEDEVKF--EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHhhcccccc--ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 11111111111 11234678999999999999999999965553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.40 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=191.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+.. +++.||+|.++..... .......+..|..++..+ .|++ |+++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~-------iv~~~~~--- 64 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPF-------LTHLYCT--- 64 (316)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCc-------CcceEEE---
Confidence 469999999999998765 5577999998743211 123345567788888764 6776 6666655
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++|+|.+++.... .+++.++..++.|++.||.|||++| ++||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~ 133 (316)
T cd05619 65 ----FQTKENLFFVMEYLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDG 133 (316)
T ss_pred ----EEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCC
Confidence 455678999999999999999997532 3788899999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 258 (379)
.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .+..
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~------ 206 (316)
T cd05619 134 HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQ------ 206 (316)
T ss_pred CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHH------
Confidence 999999999864322 22223446899999999999889999999999999999999999999765321 1111
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH-HHhccccC
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG-EILMGCSC 311 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-e~l~~~~~ 311 (379)
.+.......+ ...+.++.+++.+||+.||++||++. +++.|...
T Consensus 207 ------~i~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05619 207 ------SIRMDNPCYP---RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF 251 (316)
T ss_pred ------HHHhCCCCCC---ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence 1111111112 22456789999999999999999997 78777544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=309.43 Aligned_cols=270 Identities=20% Similarity=0.280 Sum_probs=200.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.++. +++.+|+|.++.... ......+.+|+.+++.++|+| ++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 69 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHAN-------IVTL 69 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC-----CCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCC-------cceE
Confidence 3679999999999999999998764 456799999875432 223456778999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ..++..++||||++ ++|.+++...+ ..+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 70 ~~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Ni 135 (309)
T cd07872 70 HDIV-------HTDKSLTLVFEYLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNL 135 (309)
T ss_pred EEEE-------eeCCeEEEEEeCCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHE
Confidence 7664 45678999999995 58888886532 23788889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++.++.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+......
T Consensus 136 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 215 (309)
T cd07872 136 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215 (309)
T ss_pred EECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999986543322 2233468899999998754 467899999999999999999999997765433221
Q ss_pred Hhhhhh--hhHHhhhhh---------ccccCC---CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 252 DWALPL--IKEEKLRQV---------CDSRVG---LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~--~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
...... -....+..+ ...... .......++.++.+++.+||+.||.+|||+.|++.|....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 216 LIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred HHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 111000 000000000 000000 0001123457789999999999999999999999985443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=302.47 Aligned_cols=255 Identities=19% Similarity=0.307 Sum_probs=199.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+... ......||+|.++.... ......+.+|+.+++.++|+| ++++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~--~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------iv~~ 71 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLP--SKRELPVAIHTLRAGCS---DKQRRGFLAEALTLGQFDHSN-------IVRL 71 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecC--CCceeeEEEEecCCCCC---HHHHHHHHHHHHHHhcCCCCC-------cCeE
Confidence 45799999999999999999987542 22567899999875422 233567899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++| ++||||||+||
T Consensus 72 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~ni 138 (266)
T cd05064 72 EGVI-------TRGNTMMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKV 138 (266)
T ss_pred EEEE-------ecCCCcEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhE
Confidence 7764 4467899999999999999999753 224889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
|++.++.++++|||.+......... ....++..|+|||.+.+..++.++|||||||++|++++ |..||....... .
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~ 217 (266)
T cd05064 139 LVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-V 217 (266)
T ss_pred EEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-H
Confidence 9999999999999987543322211 12235678999999988999999999999999999775 999997654321 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. .+.+. .. ++....++..+.+++.+||+.+|.+||+++++++.
T Consensus 218 ~~------------~~~~~-~~-~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 218 IK------------AVEDG-FR-LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred HH------------HHHCC-CC-CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHH
Confidence 11 11111 11 11123355789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.98 Aligned_cols=270 Identities=24% Similarity=0.340 Sum_probs=207.5
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~ 83 (379)
|+++++..++++|++.+.||.|+||.||+|.+.. +++.+++|.+... ......+.+|+.+++.+ +|+|
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~n- 80 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK-----DGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPN- 80 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCC-
Confidence 5667778889999999999999999999998754 5678999998643 22346778999999998 6777
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
++++++.+.... .......++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.| +
T Consensus 81 ------i~~~~~~~~~~~--~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--i 149 (291)
T cd06639 81 ------VVKFYGMFYKAD--KLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR--I 149 (291)
T ss_pred ------eEEEEEEEEecc--ccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 888888764311 1123578999999999999998875332 2234889999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-----CCCCcCCeehhHHHHHHHHhC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-----KLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg 237 (379)
+|+||||+||+++.++.++|+|||++....... ......++..|+|||.+... .++.++|||||||++|+|++|
T Consensus 150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred eccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 999999999999999999999999986543322 22334688999999987543 368899999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.||........+.. +..............+..+.+++.+||+.+|++||++.++++|.
T Consensus 230 ~~p~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 230 DPPLFDMHPVKTLFK-------------IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred CCCCCCCcHHHHHHH-------------HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 999976543222111 11110000011123446799999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=296.51 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=203.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|++|.||+|.+.. +++.|++|.+...... ......+.+|+.+++.++|+| ++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 66 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-----DKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSY-------IIRYYE 66 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-----CCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCC-------eehhee
Confidence 47888999999999999998765 4577999988654332 345678899999999999988 887777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||||+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili 134 (256)
T cd08529 67 SF-------LDKGKLNIVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFL 134 (256)
T ss_pred ee-------ccCCEEEEEEEeCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE
Confidence 64 44678999999999999999998642 234888899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||++........ .....+++.|+|||+..+..++.++|+||||+++|+|++|+.||...... ...
T Consensus 135 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~--- 210 (256)
T cd08529 135 DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALI--- 210 (256)
T ss_pred eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHH---
Confidence 9999999999999865543322 23346889999999999888999999999999999999999999765421 111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..+..... +.....++..+.+++.+||+.+|++||++.+++.+.
T Consensus 211 ---------~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 211 ---------LKIIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred ---------HHHHcCCC--CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 11111111 112224567899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.50 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=202.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|.+.+.||+|+||.||++.+...........+++|.+.... ....+.+.+|+.+++.++|++ +++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 73 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEH-------IVKFY 73 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCC-------cceEE
Confidence 5789999999999999999987654444466779999986432 234567899999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc--------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA--------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
+.+ ...+..++||||+++++|.+++..... .....+++.++..++.|++.||+|||++| ++||
T Consensus 74 ~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~ 144 (288)
T cd05093 74 GVC-------VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHR 144 (288)
T ss_pred EEE-------ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 764 346789999999999999999975432 12234889999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPID 242 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~ 242 (379)
||||+||++++++.++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 145 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 145 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred ccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865432221 122345778999999998889999999999999999998 999987
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...... ... .+..... +......+.++.+++.+||+.||.+|||+.+++..
T Consensus 225 ~~~~~~-~~~------------~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~ 275 (288)
T cd05093 225 QLSNNE-VIE------------CITQGRV--LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275 (288)
T ss_pred CCCHHH-HHH------------HHHcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 654321 111 1111111 01111234679999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=302.08 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=201.6
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCce
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYC 89 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~ 89 (379)
..+++.|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....+.+|+.+++.+ +|+|
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~------- 64 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRN------- 64 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcC-----CCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCC-------
Confidence 3567889999999999999999998764 45789999986432 3346788999999998 5777
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
++++++.+..... -......|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+++ ++|+|||
T Consensus 65 i~~~~~~~~~~~~-~~~~~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~ 138 (272)
T cd06637 65 IATYYGAFIKKNP-PGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIK 138 (272)
T ss_pred eeeEeeEEeecCC-CCCCcEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCC
Confidence 8888877653211 11235689999999999999999763 2234888999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
|+||++++++.++|+|||++...... .......|+..|+|||++. +..++.++|+|||||++|+|++|..||..
T Consensus 139 ~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 139 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred HHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999999999999998654322 2233446899999999875 34578899999999999999999999965
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
......... ....... ......++..+.+++.+||..||.+|||+.+++.|.
T Consensus 219 ~~~~~~~~~----------~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 219 MHPMRALFL----------IPRNPAP----RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred cCHHHHHHH----------HhcCCCC----CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 432111100 0000000 111123456799999999999999999999999884
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.53 Aligned_cols=270 Identities=23% Similarity=0.371 Sum_probs=206.9
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~ 83 (379)
+.++.+..+.++|++.+.||+|+||.||+|.+.. .++.+++|..... ......+.+|+.+++.+ +|+|
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~- 76 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK-----NGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPN- 76 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECC-----CCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCC-
Confidence 4456677789999999999999999999998765 4567999987542 12245688999999999 5888
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
++++++.+.... ...++..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ +
T Consensus 77 ------i~~~~~~~~~~~--~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i 145 (286)
T cd06638 77 ------VVKFYGMYYKKD--VKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK--T 145 (286)
T ss_pred ------eeeeeeeeeecc--cCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 888887654321 2345679999999999999998865332 2334788889999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-----CCCCCcCCeehhHHHHHHHHhC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg 237 (379)
+||||||+||++++++.++|+|||++....... ......|++.|+|||++.. ..++.++|||||||++|+|++|
T Consensus 146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g 225 (286)
T cd06638 146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225 (286)
T ss_pred cccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence 999999999999999999999999986654322 2233468999999998753 4478899999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.||........+... ..........+ ..++..+.+++.+||+.||++|||+.|++.|.
T Consensus 226 ~~p~~~~~~~~~~~~~----------~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 226 DPPLADLHPMRALFKI----------PRNPPPTLHQP---ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCCCCCchhHHHhhc----------cccCCCcccCC---CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 9999765432211110 00000111111 12346799999999999999999999999884
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.57 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=200.8
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|++|.||++.++. .++.+++|.+...... ....+.+.+|+.++++++|++ ++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-----DGKQYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPN-------IVAYRE 66 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-----CCcEEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCC-------eeeeee
Confidence 58999999999999999998765 4567999998643322 334567899999999999988 777766
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+. ..+..+|++|||+++++|.+++... ....+++.++..++.|++.||++||+.| ++||||||+||++
T Consensus 67 ~~~------~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~ 135 (257)
T cd08223 67 SWE------GEDGLLYIVMGFCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFL 135 (257)
T ss_pred eec------CCCCEEEEEecccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEE
Confidence 532 2345689999999999999999763 2234889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||++....... ......+++.|+|||+..+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---- 211 (257)
T cd08223 136 TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---- 211 (257)
T ss_pred ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----
Confidence 999999999999986553322 223346889999999999888999999999999999999999999754321110
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..+..... +......++.+.+++.+||+.||++||++.+++.|.
T Consensus 212 ---------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 212 ---------YRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred ---------HHHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 01111111 112234567899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=310.65 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=197.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... ......+.+.+|+.++..++|++ |+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~-------i~~~~ 67 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-----TGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRW-------ITNLH 67 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCC-------CCceE
Confidence 479999999999999999998765 557799999864211 11233466889999999998887 66666
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++..|+||||++|++|.+++.+. ...+++..+..++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil 134 (331)
T cd05597 68 YA-------FQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVL 134 (331)
T ss_pred EE-------EecCCeEEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEE
Confidence 54 45678899999999999999999752 223888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCC-----CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 175 FDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
++.++.++|+|||++........ .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 99999999999999865433222 122468999999998763 45788999999999999999999999765321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~ 312 (379)
...... . . .......+......+..+.+++.+||..++++ |+++.+++.|....
T Consensus 215 ~~~~~i----~------~-~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 215 ETYGKI----M------N-HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred HHHHHH----H------c-CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence 111100 0 0 01112223323335678899999988654443 88999999996653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.85 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=199.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||++.++. .++.+|+|.+..... ........+.+|+.++..++|++ ++.++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~-------i~~~~ 67 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQW-------ITTLH 67 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCC-------EeeEE
Confidence 479999999999999999998765 457799999864221 11233455888999999998877 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+..|+||||+++|+|.+++.+.. ..+++..++.++.|++.||.|||+.| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nil 134 (332)
T cd05623 68 YA-------FQDENNLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNIL 134 (332)
T ss_pred EE-------EecCCEEEEEEeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEE
Confidence 55 356788999999999999999997532 23888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 175 FDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
++.++.++|+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999865432222 22346999999999875 346788999999999999999999999765422
Q ss_pred hhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCc
Q 035572 248 ASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~ 312 (379)
... ..+.. .....|.....+++++.+++.+||..++.+ |++++++++|....
T Consensus 215 ~~~-------------~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 215 ETY-------------GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred HHH-------------HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 211 11111 112223333455788999999998665544 78999999996543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=301.50 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=199.2
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|++++.||+|+||.||+|.+.. +++.+|+|.+...... ........+|+.++++++|++ |+++.+.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~-------i~~~~~~ 66 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-----NGQKVAVKIIDKSEIE--EEEREENIREIKILRRLRHPN-------IVQILDV 66 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-----TTEEEEEEEEESTTHH--HHHHHHHHHHHHHHHHHTBTT-------BCHEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-----CCeEEEEEEecccccc--ccccchhhhhhhccccccccc-------ccccccc
Confidence 7889999999999999998765 5568999999876433 233334566999999999888 7776666
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
. .+....++||||+.+++|.+++.... .+++..+..++.|++.||.+||+.| ++|+||||+||+++
T Consensus 67 ~-------~~~~~~~~v~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~ 132 (260)
T PF00069_consen 67 F-------QDDNYLYIVMEYCPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD 132 (260)
T ss_dssp E-------EESSEEEEEEEEETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES
T ss_pred c-------cccccccccccccccccccccccccc-----ccccccccccccccccccccccccc--cccccccccccccc
Confidence 4 34678999999999889999998332 2889999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccC-CCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 177 SKWDAKLADFGLAVSE-SDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
.++.++|+|||.+... ..........++..|+|||+.. +...+.++|+||||+++|+|++|..||........... .
T Consensus 133 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-~ 211 (260)
T PF00069_consen 133 ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-I 211 (260)
T ss_dssp TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh-h
Confidence 9999999999998653 2233344557899999999988 88899999999999999999999999987621111110 0
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .......... ........+.+++.+||+.||++||++.++++|.
T Consensus 212 ~~~-~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 212 EKI-LKRPLPSSSQ-------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp HHH-HHTHHHHHTT-------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred hhc-cccccccccc-------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 000 0000000000 0001127899999999999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=298.77 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=202.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.|++|.+...... .......+.+|+.+++.++|++ +++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 68 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL-----DRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPN-------VIKYL 68 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC-----CCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcc-------eeeee
Confidence 579999999999999999998765 4567999987542211 1344567889999999999988 78777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+.+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||++| ++|+||||+||+
T Consensus 69 ~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil 138 (267)
T cd08228 69 DSF-------IEDNELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVF 138 (267)
T ss_pred eeE-------EECCeEEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEE
Confidence 664 345788999999999999999875432 2234788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch-hHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA-SIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~ 252 (379)
++.++.++|+|||++........ .....+++.|+|||...+..++.++|+||||+++|+|++|+.||....... .+..
T Consensus 139 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 218 (267)
T cd08228 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ 218 (267)
T ss_pred EcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH
Confidence 99999999999999866543222 223468889999999988889999999999999999999999996543221 1111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.+......+......+..+.+++.+||+.+|++||++.++++..
T Consensus 219 -------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 219 -------------KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred -------------HHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 01111111222234567899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=310.51 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=200.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... ........+.+|+.++..+.|++ |+.++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~-------i~~l~ 67 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-----TERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQW-------ITTLH 67 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCC-------EeeEE
Confidence 579999999999999999998764 567799999864211 11233456788999999998887 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+.+..|+||||++||+|.+++.... ..+++..+..++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~lv~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nil 134 (331)
T cd05624 68 YA-------FQDENYLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVL 134 (331)
T ss_pred EE-------EEcCCEEEEEEeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEE
Confidence 65 356788999999999999999997532 23888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCC-----CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 175 FDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 135 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred EcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 99999999999999865543322 123469999999998765 46788999999999999999999999765422
Q ss_pred hhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCc
Q 035572 248 ASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~ 312 (379)
.. +..+.. .+...|.....++.++.+++.+||..++++ |+++++++.|....
T Consensus 215 ~~-------------~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 215 ET-------------YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred HH-------------HHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 11 111111 122233334445678999999999876654 57899999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=302.22 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=200.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||.|+||.||+|.+.. .++.+++|.+.... ....+.+.+|+.+++.++|+| ++.
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~ 73 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKS----EEELEDYMVEIEILATCNHPY-------IVK 73 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECC-----CCceEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCc-------Eee
Confidence 45789999999999999999998764 55679999987542 344677889999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ..++..++||||+++++|..++.+.. ..+++..+..++.|++.+|.|||++| ++||||||+|
T Consensus 74 ~~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~N 140 (292)
T cd06644 74 LLGAF-------YWDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGN 140 (292)
T ss_pred eEEEE-------EeCCeEEEEEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcce
Confidence 77764 34568999999999999988876432 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|+++.++.++|+|||++...... .......++..|+|||++. ...++.++|+|||||++|+|++|..||.....
T Consensus 141 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 141 VLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred EEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 99999999999999988553222 1223346889999999874 34568899999999999999999999976432
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.... ..+.............++.++.+++.+||+.||++||++.+++.|..
T Consensus 221 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 221 MRVL-------------LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred HHHH-------------HHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1111 11111111111112334567899999999999999999999999844
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.44 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=198.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.++||+|+||.||+|.+.. +++.+++|.+..... ......+.+|+.+++++.|+| +++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 65 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL-----TRRILAVKVIPLDIT---VELQKQIMSELEILYKCDSPY-------IIGFY 65 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCC---hHHHHHHHHHHHHHHhCCCCC-------eeeEE
Confidence 468899999999999999998764 557799999864421 334567899999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..++||||+++++|..+. .+++..+..++.|++.||.|||+.| ++|+||||+|||
T Consensus 66 ~~~-------~~~~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 127 (279)
T cd06619 66 GAF-------FVENRISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNML 127 (279)
T ss_pred EEE-------EECCEEEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEE
Confidence 775 3457889999999999996543 1678888899999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||||+++|+|++|..||...........
T Consensus 128 l~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-- 204 (279)
T cd06619 128 VNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-- 204 (279)
T ss_pred ECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc--
Confidence 999999999999998654332 22334789999999999988899999999999999999999999975432211100
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.......+.+.... .......++++.+++.+||+.+|++||++++++.|...
T Consensus 205 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 205 ----PLQLLQCIVDEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred ----hHHHHHHHhccCCC-CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 00111111111100 00112235678999999999999999999999998443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.99 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=197.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.+++|.+.... ......+.+|+.+++.++|++ ++++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~-------ii~~ 71 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH-----TGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCN-------IVAY 71 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC-----CCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCC-------eeee
Confidence 4579999999999999999998754 55789999986432 123456889999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.| |+||||+|+||
T Consensus 72 ~~~~-------~~~~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ni 137 (267)
T cd06646 72 FGSY-------LSREKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANI 137 (267)
T ss_pred eEEE-------EeCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHE
Confidence 7664 34578899999999999999986532 3788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+++.++.++|+|||++....... ......++..|+|||.+. ...++.++|+|||||++|+|++|..||........
T Consensus 138 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 138 LLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred EECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 99999999999999986553222 223346889999999874 34578899999999999999999999865432111
Q ss_pred HHHhhhhhhhHHhhhhhccccCCC--CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGL--PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. .+....... ......++..+.+++.+||+.+|++|||+++++.|.
T Consensus 218 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 LF-------------LMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred he-------------eeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 10 001111110 111223457899999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=303.03 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=204.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|.+.+.||+|+||.||+|.+...........+++|.+.... ....+.+.+|+.+++.++|+| +++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 73 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEH-------IVKFY 73 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCC-------cceEE
Confidence 4688899999999999999987665555567789999986432 233467899999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
+.+ ...+..++||||+++++|.+++..... .....+++..++.++.|++.||+|||++| +
T Consensus 74 ~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 144 (291)
T cd05094 74 GVC-------GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--F 144 (291)
T ss_pred EEE-------ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 764 446789999999999999999976432 11234788999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 239 (379)
+||||||+|||++.++.++|+|||++........ .....++..|+|||++.+..++.++||||||+++|+|+| |..
T Consensus 145 ~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 224 (291)
T cd05094 145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224 (291)
T ss_pred eecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865433221 223356788999999988899999999999999999999 999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
||....... ... .+..... +......+..+.+++.+||+.||++|||+.++++...
T Consensus 225 p~~~~~~~~-~~~------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 225 PWFQLSNTE-VIE------------CITQGRV--LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred CCCCCCHHH-HHH------------HHhCCCC--CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 987654322 111 1111111 1111223567999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.25 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=202.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|+++++||+||.+.||++...+ ...||+|++...... .....-+.+|+..|.+|+... +||+++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~------~~iyalkkv~~~~~D--~qtl~gy~nEI~lL~KLkg~~------~IIqL~ 426 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD------KQIYALKKVVLLEAD--NQTLDGYRNEIALLNKLKGHD------KIIQLY 426 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC------CcchhhhHHHHhhcC--HHHHHHHHHHHHHHHHhcCCc------eEEEEe
Confidence 569999999999999999997543 345888887755443 567888999999999997442 299999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+|- ..++.+|+||||- ..+|..+|++.... .+.-.++.+..||+.++.++|.+| |||.||||.|+|
T Consensus 427 DYE-------v~d~~lYmvmE~G-d~DL~kiL~k~~~~----~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFL 492 (677)
T KOG0596|consen 427 DYE-------VTDGYLYMVMECG-DIDLNKILKKKKSI----DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFL 492 (677)
T ss_pred eee-------ccCceEEEEeecc-cccHHHHHHhccCC----CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEE
Confidence 884 3478999999987 68999999875432 222267889999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCC-----------CCCCcCCeehhHHHHHHHHhCCCC
Q 035572 175 FDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPS-----------KLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~elltg~~p 240 (379)
+- .|.+||+|||+|.......+ ....+||+.||+||.+... ..+.++||||||||||+|+.|+.|
T Consensus 493 lV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP 571 (677)
T KOG0596|consen 493 LV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP 571 (677)
T ss_pred EE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence 86 46899999999977665543 3445899999999976432 256889999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccC--CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRV--GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
|....+ ...++..+.++.. +.|...+ ..++++++..||.+||.+|||+.|+|+|.....
T Consensus 572 f~~~~n------------~~aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 572 FGQIIN------------QIAKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hHHHHH------------HHHHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 976432 2345556666644 3333333 234999999999999999999999999966544
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.05 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=201.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||.|+||.||+|++.. .++.+++|.+..... ...+.+.+|+.+++.+.|+| +++++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~-------v~~~~ 83 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPN-------IVNYL 83 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC-----CCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCC-------EeeEE
Confidence 689999999999999999998654 456799998875432 23467889999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ......|+||||+++++|.+++... .+++.++..++.|++.||.|||+.| ++||||||+||+
T Consensus 84 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nil 148 (296)
T cd06654 84 DSY-------LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNIL 148 (296)
T ss_pred EEE-------EeCCEEEEeecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 764 3456899999999999999998642 2788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus 149 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~ 228 (296)
T cd06654 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (296)
T ss_pred EcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence 9999999999999986543322 223346889999999998888899999999999999999999999765432211110
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
....... ......++..+.+++.+||..+|++||++.+++.|...
T Consensus 229 ------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 229 ------------ATNGTPE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred ------------hcCCCCC-CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 0011101 11123455778999999999999999999999997443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.85 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=197.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+..+. ....+++|.+.... .......+.+|+.++.++ +|+| +++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~-------iv~ 72 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPN-------IIN 72 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCC---ceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCC-------cce
Confidence 457999999999999999999876432 22346777765321 133456788999999999 7777 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHHcCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLHENDP 161 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 161 (379)
+++.+ ...+..|+||||+++++|.+++...... ....+++.+++.++.|++.||+|||++|
T Consensus 73 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g- 144 (303)
T cd05088 73 LLGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 144 (303)
T ss_pred EEEEE-------CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 77764 4567899999999999999999765421 1234788999999999999999999999
Q ss_pred CeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCC
Q 035572 162 MIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240 (379)
Q Consensus 162 ~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 240 (379)
++||||||+|||+++++.++|+|||++.............++..|+|||+..+..++.++|||||||++|+|+| |..|
T Consensus 145 -i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 223 (303)
T cd05088 145 -FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223 (303)
T ss_pred -ccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCC
Confidence 99999999999999999999999999854322111222234678999999888889999999999999999998 9999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|....... ... .+.. ... +......+..+.+++.+||+.+|++||++++++.+..
T Consensus 224 ~~~~~~~~-~~~------------~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 224 YCGMTCAE-LYE------------KLPQ-GYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred cccCChHH-HHH------------HHhc-CCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 97543211 111 0101 000 1111223567899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.66 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=205.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||+|.+.. ++..+++|.+...... ....+++..|+++++.++|++ ++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-----DGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPN-------IVRYYD 66 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-----CCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCc-------cceeee
Confidence 58899999999999999998764 4567999988754332 344577899999999999988 888777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH-----cCCCCeEecCCCC
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH-----ENDPMIIHRDIKS 170 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-----~~~~~i~H~dlkp 170 (379)
.+.. ......+++|||+++++|.+++..... ....+++..++.++.|++.||.||| +.+ ++|+||+|
T Consensus 67 ~~~~-----~~~~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p 138 (265)
T cd08217 67 RIID-----RSNQTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKP 138 (265)
T ss_pred eeec-----CCCCEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCH
Confidence 6432 334678999999999999999976432 2334889999999999999999999 888 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+. ..
T Consensus 139 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~ 217 (265)
T cd08217 139 ANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQ 217 (265)
T ss_pred HHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HH
Confidence 999999999999999999876654332 3344689999999999888899999999999999999999999986542 11
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... +.... .+......+..+.+++.+||+.+|++||++.++++|.
T Consensus 218 ~~~~------------~~~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 218 LASK------------IKEGK--FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred HHHH------------HhcCC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 1111 11111 1122234567899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=302.71 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=203.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|++|.||+|.+.. +++.|++|.+.... ....+.+.+|+.+++.++|+| ++.++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------iv~~~ 82 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA-----TGQEVAIKQINLQK----QPKKELIINEILVMKELKNPN-------IVNFL 82 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC-----CCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCc-------eeeee
Confidence 479999999999999999998754 55679999886432 234567889999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..++|+||+++++|.+++... .+++.++..++.|++.||+|||+.| ++||||||+||+
T Consensus 83 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nil 147 (296)
T cd06655 83 DSF-------LVGDELFVVMEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVL 147 (296)
T ss_pred eeE-------ecCceEEEEEEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 764 4467899999999999999988642 2789999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+........
T Consensus 148 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred ECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999865433222 22346889999999998888999999999999999999999999776532221110
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.............+++.+.+++.+||..||.+||++.+++.|.....
T Consensus 228 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 228 -------------ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -------------HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 00001001112334567899999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.39 Aligned_cols=265 Identities=21% Similarity=0.354 Sum_probs=201.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||.|+||.||+|.+.......+++.||||.++.... ......+.+|+.++..+ +|+| +++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~n-------iv~ 75 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLN-------VVN 75 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---hHHHHHHHHHHHHHHhccCCcc-------Hhh
Confidence 468999999999999999999876555555788999999875321 23356788999999999 4566 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC----------------------------------------
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---------------------------------------- 132 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---------------------------------------- 132 (379)
+++.+. ..+...++||||+++|+|.+++......
T Consensus 76 ~~~~~~------~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (343)
T cd05103 76 LLGACT------KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSAS 149 (343)
T ss_pred hcceee------cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccc
Confidence 777652 3345789999999999999999753210
Q ss_pred ----------------------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 133 ----------------------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 133 ----------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
....+++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~ 227 (343)
T cd05103 150 SGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR 227 (343)
T ss_pred ccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEeccccc
Confidence 0123677888899999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhh
Q 035572 191 SESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQV 266 (379)
Q Consensus 191 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (379)
....... .....++..|+|||++.+..++.++||||||+++|+|++ |..||............. .
T Consensus 228 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------~-- 296 (343)
T cd05103 228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---------K-- 296 (343)
T ss_pred ccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH---------h--
Confidence 5432211 112245678999999988889999999999999999997 999997654322211110 0
Q ss_pred ccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 267 CDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.......+.. .++++.+++.+||+.||.+|||+.+++++..
T Consensus 297 ~~~~~~~~~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 297 EGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred ccCCCCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0111111221 2467899999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=313.35 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=206.3
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccC
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS 101 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~ 101 (379)
+||+|.||+||-|+|..+ ...+|||.++... ....+.+..||.+.++|+|.| ||++.|.+
T Consensus 582 VLGKGTYG~VYA~RD~~t-----qvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkN-------IVrYLGs~---- 641 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT-----QVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKN-------IVRYLGSV---- 641 (1226)
T ss_pred EeecCceeEEEeeccccc-----eeEEEeeeccccc----chhhccHHHHHHHHHHHhhHh-------HHHHhhcc----
Confidence 789999999999988764 4568999987543 345678999999999999999 99999874
Q ss_pred CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc-CCCC
Q 035572 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD-SKWD 180 (379)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~-~~~~ 180 (379)
.+++.+-|.||.++||||.++++.. +.+-.-.+.++.-+..||++||.|||.+. |||||||-+|||++ -.|.
T Consensus 642 ---senGf~kIFMEqVPGGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGv 714 (1226)
T KOG4279|consen 642 ---SENGFFKIFMEQVPGGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGV 714 (1226)
T ss_pred ---CCCCeEEEEeecCCCCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccce
Confidence 5567888999999999999999863 22222367788889999999999999999 99999999999997 5789
Q ss_pred eEEeccccCccCCCCC-cccccCccccccCCCCCCCC--CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhh
Q 035572 181 AKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS--KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPL 257 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 257 (379)
+||+|||.++....-. ...+..||.-|||||++..+ .|+.++|||||||++.||.||++||.....+.......-
T Consensus 715 lKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-- 792 (1226)
T KOG4279|consen 715 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-- 792 (1226)
T ss_pred EEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--
Confidence 9999999997664433 34556899999999988754 588999999999999999999999987776554322211
Q ss_pred hhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 258 IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
+... -|+.+...+.+...+|.+|+.+||..||++.++|.+......
T Consensus 793 --------myKv---HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 793 --------MYKV---HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --------ceec---CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0111 145556777899999999999999999999999988665554
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.77 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=199.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||+|+||.||+|.+...+. .....||+|.++.... ....+++.+|+.+++.+.|+| +++++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~n-------iv~~~ 75 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPH-------VCRLL 75 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCC-------CCeEE
Confidence 469999999999999999998765332 2345589999864321 344577899999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. +..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+.| |+||||||+|||
T Consensus 76 g~~~~--------~~~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nil 141 (316)
T cd05108 76 GICLT--------STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVL 141 (316)
T ss_pred EEEcC--------CCceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheE
Confidence 77532 3568999999999999999753 233788889999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++++.+||+|||++......... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.... .+
T Consensus 142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~ 220 (316)
T cd05108 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI 220 (316)
T ss_pred ecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH
Confidence 999999999999999765433221 12234678999999998899999999999999999998 99999764321 11
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... . .......+ ..++.++.+++.+||..+|.+||++.+++.+...
T Consensus 221 ~~~~---------~--~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 221 SSIL---------E--KGERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred HHHH---------h--CCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1100 0 01111111 2234678999999999999999999999987443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=299.79 Aligned_cols=267 Identities=23% Similarity=0.340 Sum_probs=206.4
Q ss_pred CHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCC
Q 035572 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKR 84 (379)
Q Consensus 6 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~ 84 (379)
++.++....+.|++.+.||.|+||.||+|.+.. .++.+++|..... ......+..|+.+++.+ +|+|
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~-- 74 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRN-- 74 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcC-----CCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCc--
Confidence 566777788999999999999999999998764 4567999987643 23346688999999998 5777
Q ss_pred CCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 85 NPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 85 ~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
++++++.+..... .......|++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++
T Consensus 75 -----i~~~~~~~~~~~~-~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--iv 143 (282)
T cd06636 75 -----IATYYGAFIKKSP-PGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK--VI 143 (282)
T ss_pred -----EEEEeeehhcccc-cCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 8888887653211 123568899999999999999997633 223778888899999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~ 238 (379)
|+||+|+||++++++.++|+|||++...... .......+++.|+|||.+. ...++.++|+|||||++|+|++|.
T Consensus 144 H~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred cCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 9999999999999999999999998654321 2233446899999999875 346788999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.||....+...+.. +... .........++..+.+++.+||+.||.+||++.|++.|.
T Consensus 224 ~p~~~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 224 PPLCDMHPMRALFL-------------IPRN-PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred CCccccCHHhhhhh-------------HhhC-CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 99975432221110 0011 000111223567899999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.49 Aligned_cols=269 Identities=23% Similarity=0.379 Sum_probs=200.0
Q ss_pred cCC-ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESF-SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y-~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
++| ++.+.||+|+||.||++..... ....++.||+|.++.... ......+.+|+++++.++|+| ++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------i~~~ 71 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHEN-------IVKY 71 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccc-cCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 455 8999999999999998765432 233667899999875421 234567889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++.. ......++||||+++++|.+++... .+++..++.++.|++.||.|||++| ++||||||+||
T Consensus 72 ~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Ni 138 (283)
T cd05080 72 KGCCSE-----QGGKGLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNV 138 (283)
T ss_pred EEEEec-----CCCceEEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheE
Confidence 776432 2345689999999999999999642 2899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch-
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA- 248 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~- 248 (379)
|+++++.++|+|||++........ .....++..|+|||...+..++.++||||||+++|+|+||..||.......
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 999999999999999865543221 112245677999999988889999999999999999999999986543211
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
........................ +.....++..+.+++.+||+.+|++|||+++++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 111111100111111111111111 11122345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.82 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=201.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||.|+||.||+|.+.. +++.+++|.+.... ....+.+.+|+++++.++|++ +++
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~ 66 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKE-----TGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPN-------IVG 66 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcC-----CCcEEEEEEEeeCC----HHHHHHHHHHHHHHHhCCCCc-------eeE
Confidence 36789999999999999999998754 45679999986432 334567889999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ..+...|+||||+++++|.+++.+.. ..+++.+++.++.|++.||.|||+.| ++|+||+|+|
T Consensus 67 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~n 133 (280)
T cd06611 67 LYEAY-------FYENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGN 133 (280)
T ss_pred EEEEE-------ecCCeEEEEeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhh
Confidence 88774 44678999999999999999987532 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|+++.++.++|+|||++....... ......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+.
T Consensus 134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred EEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 999999999999999875543222 223346899999999864 34567899999999999999999999976542
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..... .+.............++.++.+++.+||+.+|.+||++.++++|
T Consensus 214 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 MRVLL-------------KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHH-------------HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 22111 11111111011122345688999999999999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.91 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=225.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.+=|.+.+.||+|-|.+|-+|. .-++|..||||++.+.... ......+..|+.-|+.++|+| ||+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLAr-----HVFTGekVAVKviDKTKlD--~~st~hlfqEVRCMKLVQHpN-------iVR 81 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLAR-----HVFTGEKVAVKVIDKTKLD--TLSTGHLFQEVRCMKLVQHPN-------IVR 81 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhh-----hhcccceeEEEEecccccc--hhhhhHHHHHHHHHHHhcCcC-------eee
Confidence 45678899999999999999995 4457888999999887654 344577899999999999998 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.. ++..-.+|||+|.-.+|+|.++|.+. +..+.+..+..++.||+.|+.|+|+.. +|||||||+|
T Consensus 82 LYEV-------iDTQTKlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPEN 148 (864)
T KOG4717|consen 82 LYEV-------IDTQTKLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPEN 148 (864)
T ss_pred eeeh-------hcccceEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcce
Confidence 7754 57788999999999999999999864 344899999999999999999999999 9999999999
Q ss_pred eEEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCC-CcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLS-KKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|.+- .-|-+||.|||++..+.+.....+.+|+..|-|||++.+..|+ +++||||||+|||.|++|++||...++.
T Consensus 149 VVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--- 225 (864)
T KOG4717|consen 149 VVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--- 225 (864)
T ss_pred eEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---
Confidence 9875 5689999999999888777777888999999999999998886 5799999999999999999999988764
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
+.+..+++..+..| ..++.++.+||.+||..||.+|.+.+||+.+........
T Consensus 226 ----------ETLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 226 ----------ETLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred ----------hhhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 44556677777766 456799999999999999999999999999866554433
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.05 Aligned_cols=265 Identities=20% Similarity=0.336 Sum_probs=204.8
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCce
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYC 89 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~ 89 (379)
....++|++.+.||+|+||.||++.............+++|.+..... ......+.+|+.+++.+ +|+|
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~------- 77 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKN------- 77 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCC-------
Confidence 334578999999999999999999887654444667899999875422 23345688999999999 6877
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHc
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHE 158 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~ 158 (379)
++++++.+ ..++..+++|||+++++|.+++..... .....+++..+..++.|++.||.|||+
T Consensus 78 i~~~~~~~-------~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 150 (293)
T cd05053 78 IINLLGVC-------TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150 (293)
T ss_pred eeeEEEEE-------cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 88887764 446789999999999999999975421 123448889999999999999999999
Q ss_pred CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHH
Q 035572 159 NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 159 ~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 235 (379)
.+ |+||||||+|||+++++.++|+|||++........ .....++..|+|||+..+..++.++|||||||++|+|+
T Consensus 151 ~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (293)
T cd05053 151 KK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228 (293)
T ss_pred CC--ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHh
Confidence 99 99999999999999999999999999876543221 12223567899999988888999999999999999999
Q ss_pred h-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 236 S-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 236 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+ |..||....... ... .+.. ... +.....++..+.+|+.+||+.||++|||+.+++++.
T Consensus 229 ~~g~~p~~~~~~~~-~~~------------~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 229 TLGGSPYPGIPVEE-LFK------------LLKE-GYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred cCCCCCCCCCCHHH-HHH------------HHHc-CCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 8 999987543211 111 0101 100 111123356799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.69 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=215.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+.+..+.||+|.||.||+|.............||||.++.... ....++|++|++++..|+|+| ||++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~---~~~~~dF~REaeLla~l~H~n-------IVrL 554 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE---NQARQDFRREAELLAELQHPN-------IVRL 554 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc---HHHHHHHHHHHHHHHhccCCC-------eEEE
Confidence 356677899999999999999887766667788999999986542 346789999999999999999 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC---------CCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT---------TPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
+|.| ..++-+|+|+|||..|||.++|..+.... ++.++..+.+.|+.|||.|+.||-++. +|
T Consensus 555 lGVC-------~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FV 625 (774)
T KOG1026|consen 555 LGVC-------REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FV 625 (774)
T ss_pred EEEE-------ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--cc
Confidence 9887 44788999999999999999998765432 233888899999999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 240 (379)
||||-..|+||.++..|||+|||+++..=..+.+ ....-..+|||||.+..+++|.+||||||||+|||++| |..|
T Consensus 626 HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QP 705 (774)
T KOG1026|consen 626 HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQP 705 (774)
T ss_pred ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCc
Confidence 9999999999999999999999999643222221 22345789999999999999999999999999999999 9999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
|.+..+.+-+ .-+...++ ...++.++.++.+|+.+||+.+|.+||+++||-..
T Consensus 706 y~glSn~EVI-------------e~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 706 YYGLSNQEVI-------------ECIRAGQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred ccccchHHHH-------------HHHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 9887654322 12222222 22345677999999999999999999999998654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=293.42 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=203.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||.+.... +++.+++|.+...... .....++.+|++++++++|+| ++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~-------i~~~~~ 66 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE-----DDSLVVWKEVNLTRLS--EKERRDALNEIVILSLLQHPN-------IIAYYN 66 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC-----CCcEEEEEEEeecccc--hhHHHHHHHHHHHHHhCCCCC-------eeEEEe
Confidence 58999999999999999998654 5677999987654332 344567889999999999888 888887
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..+++|||+++++|.+++.+.. ...+++.++..++.|++.||.|||+.| ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~~~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~ 134 (256)
T cd08221 67 HF-------MDDNTLLIEMEYANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFL 134 (256)
T ss_pred EE-------ecCCeEEEEEEecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEE
Confidence 75 44678999999999999999997642 334888999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++++.+||+|||++....... ......+++.|+|||...+..++.++|+||||+++|+|++|..||.........
T Consensus 135 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---- 210 (256)
T cd08221 135 TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV---- 210 (256)
T ss_pred eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH----
Confidence 999999999999986654333 233446899999999998888899999999999999999999999764322111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..+..... +......+..+.+++.+||..+|.+||++.+++++.
T Consensus 211 ---------~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 ---------VKIVQGNY--TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---------HHHHcCCC--CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111111 111234467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.51 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=197.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.++||+|+||.||+|.+.. ...|++|.+.... ...+.+.+|+.+++.++|+| ++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~~ 66 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN------STKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDK-------LVRL 66 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC------CceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 4689999999999999999998653 2458999876432 23577899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 67 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~ni 134 (261)
T cd05072 67 YAVV-------TKEEPIYIITEYMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANV 134 (261)
T ss_pred EEEE-------cCCCCcEEEEecCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhE
Confidence 7653 45677899999999999999997532 234788889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++........ .....++..|+|||+.....++.++||||||+++|+|+| |..||....... .
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~ 213 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-V 213 (261)
T ss_pred EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-H
Confidence 999999999999999976543221 122245678999999988889999999999999999998 999997643221 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... ... .. .+....++.++.+++.+||..+|++||+++++.+.
T Consensus 214 ~~~~------------~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 257 (261)
T cd05072 214 MSAL------------QRG-YR-MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSV 257 (261)
T ss_pred HHHH------------HcC-CC-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1110 000 01 11122345779999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=298.95 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=201.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+++|++.+.||+|++|.||+|.+...........|++|..+.... ......+.+|+.+++.++|++ ++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~-------i~~~ 74 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---EQDESDFLMEALIMSKFNHQN-------IVRL 74 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 578999999999999999999987644334567899998864322 223456889999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC--CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++.+ .+.+..++||||++|++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 75 ~~~~-------~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~ 145 (277)
T cd05036 75 IGVS-------FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAAR 145 (277)
T ss_pred EEEE-------ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--Eeecccchh
Confidence 8764 3456789999999999999999765421 1234888999999999999999999999 999999999
Q ss_pred ceEEcCCC---CeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 172 NILFDSKW---DAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 172 NIll~~~~---~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
||+++.++ .+||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998654 599999999876532221 112234568999999988889999999999999999997 99999765
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... +.... . ...... ....++..+.+++.+||+.+|++||++.++++|.
T Consensus 226 ~~~~-~~~~~---------~--~~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 226 TNQE-VMEFV---------T--GGGRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CHHH-HHHHH---------H--cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 4321 11100 0 001111 1223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.63 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=197.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.+++|.++... ......+.+|+.+++.++|++ ++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~-------ii~~ 71 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN-----TGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSN-------IVAY 71 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC-----CCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 4589999999999999999998764 45679999986542 223456788999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..|+||||+++++|.+++...+ .+++.++..++.|++.||.|||+.| ++|+||||+||
T Consensus 72 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~ni 137 (267)
T cd06645 72 FGSY-------LRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANI 137 (267)
T ss_pred EEEE-------EeCCEEEEEEeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHE
Confidence 7764 44678999999999999999987532 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+++.++.++|+|||++....... ......|+..|+|||++. ...++.++|+|||||++|+|++|..||........
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~ 217 (267)
T cd06645 138 LLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred EECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh
Confidence 99999999999999986543221 223346899999999864 45688899999999999999999999865442221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... . ....... ......++..+.+++.+||+.+|++||++++++.|.
T Consensus 218 ~~~~~-----~---~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 218 LFLMT-----K---SNFQPPK---LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred HHhhh-----c---cCCCCCc---ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 11000 0 0000000 001112346789999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=298.64 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=204.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.........+.+++|.+..... ......+.+|+.+++.++|++ ++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~-------i~~~ 74 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS---MRERIEFLNEASVMKEFNCHH-------VVRL 74 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC---HHHHHHHHHHHHHHHhCCCCc-------eeEE
Confidence 568999999999999999999987655455668899999864432 233456889999999999888 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC-----CCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-----TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
++.+ ......++||||+++++|.+++....... ...+++..+..++.|++.||.|||+.+ ++||||
T Consensus 75 ~~~~-------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di 145 (277)
T cd05032 75 LGVV-------STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDL 145 (277)
T ss_pred EEEE-------cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccc
Confidence 8774 44578999999999999999997643211 123678889999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
||+||+++.++.++|+|||++........ .....++..|+|||...+..++.++|||||||++|+++| |..||...
T Consensus 146 ~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 146 AARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred ChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999999999999999999865433221 123346789999999888889999999999999999998 99998754
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. ....... . .......| ..++..+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~-~~~~~~~---------~--~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 226 SN-EEVLKFV---------I--DGGHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CH-HHHHHHH---------h--cCCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 32 1111110 0 01111112 2235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.90 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=197.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|++.+.||+|+||.||+|.+.. .++.+++|.+..+. .....+.+|+++++.++|++ +++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~~~ 68 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPN-------LVQLL 68 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec-----CCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCC-------hhheE
Confidence 458889999999999999999765 45679999986432 23567889999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.| ++||||||+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil 136 (263)
T cd05052 69 GVC-------TREPPFYIITEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL 136 (263)
T ss_pred EEE-------cCCCCcEEEEEeCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEE
Confidence 654 44678899999999999999997532 234788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
+++++.++|+|||++......... .....+..|+|||...+..++.++|||||||++|+|++ |..||.+.+. ....
T Consensus 137 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~ 215 (263)
T cd05052 137 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVY 215 (263)
T ss_pred EcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 999999999999998665433221 11234668999999988899999999999999999998 9999876432 1111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. + ..... +.....++.++.+++.+||+.||++||++.++++.
T Consensus 216 ~~------------~-~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 216 EL------------L-EKGYR-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HH------------H-HCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 11 0 01010 11223345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=302.96 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=201.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||++.+.. ++..+++|.+..+.. .....++.+|++++++++|+| |++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 65 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-----SGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPY-------IVGFY 65 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-----CCeEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCC-------CCeEE
Confidence 469999999999999999998664 456799998864321 334567889999999999988 88777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCce
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNI 173 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NI 173 (379)
+.+ .+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||
T Consensus 66 ~~~-------~~~~~~~lv~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~ni 131 (308)
T cd06615 66 GAF-------YSDGEISICMEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNI 131 (308)
T ss_pred EEE-------eeCCEEEEEeeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHE
Confidence 764 4567899999999999999999753 237888999999999999999997 58 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|+++++.++|+|||++...... ......++..|+|||...+..++.++|+||||+++|+|++|+.||...+... ....
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~ 209 (308)
T cd06615 132 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAM 209 (308)
T ss_pred EEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHh
Confidence 9999999999999998654322 2233468999999999988889999999999999999999999996543211 1111
Q ss_pred hhhhhh------------------------HHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 254 ALPLIK------------------------EEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 254 ~~~~~~------------------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...... .......... ....| ...++.++.+++.+||..+|++|||+.+++.|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100000 0000001110 00111 11245679999999999999999999999998
Q ss_pred ccC
Q 035572 309 CSC 311 (379)
Q Consensus 309 ~~~ 311 (379)
...
T Consensus 288 ~~~ 290 (308)
T cd06615 288 PFI 290 (308)
T ss_pred hhh
Confidence 554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=297.58 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=197.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
-|++.+.||.|+||.||+|.+.. .+..+++|.+.... ....+.+.+|+++++.+.|+| ++.+++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------ii~~~~ 69 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE-----TGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPN-------IVKLLD 69 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC-----CCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCC-------eeeEEE
Confidence 37888999999999999998764 55678999886432 234567889999999999988 887777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++||||+++++|..++... ...+++..+..++.|++.||.|||+.| ++||||||+||++
T Consensus 70 ~~-------~~~~~~~~v~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili 136 (282)
T cd06643 70 AF-------YYENNLWILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF 136 (282)
T ss_pred EE-------eeCCEEEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE
Confidence 64 3457889999999999999887642 224889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 176 DSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+.++.++|+|||++...... .......++..|+|||++. +..++.++|+|||||++|+|++|..||........
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 137 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 99999999999998554322 1223346899999999873 44578899999999999999999999976543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..... ........ ....++..+.+++.+||+.||.+||++.+++.|..
T Consensus 217 ~~~~~----------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 217 LLKIA----------KSEPPTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHh----------hcCCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 11110 00011111 11234578999999999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=296.54 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=201.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.+++|.+...... .......+.+|+.+++.++|+| +++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~-------i~~~~ 68 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL-----DGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPN-------VIKYY 68 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC-----CCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCc-------hhhhh
Confidence 578899999999999999998654 4567999987643221 1234567889999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||++| ++|+||||+||+
T Consensus 69 ~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nil 138 (267)
T cd08229 69 ASF-------IEDNELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVF 138 (267)
T ss_pred hee-------EeCCeEEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence 664 446789999999999999999875432 2334889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++........ .....++..|+|||+..+..++.++|+||||+++|+|++|..||.+...... .
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~- 215 (267)
T cd08229 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--S- 215 (267)
T ss_pred EcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--H-
Confidence 99999999999999865543322 2234688999999999888899999999999999999999999975432110 0
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
....+..... .+......+..+.+++.+||+.||.+|||+.++++.
T Consensus 216 --------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 216 --------LCKKIEQCDY-PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred --------HhhhhhcCCC-CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHH
Confidence 0001111111 111223456789999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.87 Aligned_cols=267 Identities=24% Similarity=0.288 Sum_probs=201.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.|++|++...... ....+.+.+|+.+++.++|+| +++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~-------i~~~~ 66 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-----TGQIVAIKKFVESEDD--PVIKKIALREIRMLKQLKHPN-------LVNLI 66 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-----CCcEEEEEEEeecccC--ccccHHHHHHHHHHHhCCCCC-------Eeeee
Confidence 479999999999999999998764 4577999988643211 233466889999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ......++||||+++++|..++... ..+++..+..++.|++.||.|||+.| ++|+||||+||+
T Consensus 67 ~~~-------~~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil 132 (286)
T cd07847 67 EVF-------RRKRKLHLVFEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENIL 132 (286)
T ss_pred eEE-------eeCCEEEEEEeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEE
Confidence 764 4567899999999988888776532 23889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.++|+|||++....... ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+..+......
T Consensus 133 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 133 ITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred EcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999986654433 2233457889999998765 4578899999999999999999999987654433222
Q ss_pred hhh---hhhhH-------Hhh-hhhccccC----CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WAL---PLIKE-------EKL-RQVCDSRV----GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~---~~~~~-------~~~-~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... ..... ..+ ........ .........+..+.+++.+||+.+|++||++.|++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 111 00000 000 00000000 00011234467899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=301.03 Aligned_cols=266 Identities=21% Similarity=0.330 Sum_probs=203.0
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
....++|++.+.||+|+||.||+|..++.........||+|.+..... ......+.+|+.+++.++|++ +
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~-------i 71 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFLNEASVMKGFTCHH-------V 71 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC---HHHHHHHHHHHHHHHhCCCCC-------e
Confidence 345789999999999999999999876543444567899998864421 223456788999999999888 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
+++++.+ .+....++||||+++|+|.+++...... .....++..+..++.|++.||.|||+++ ++|
T Consensus 72 ~~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H 142 (288)
T cd05061 72 VRLLGVV-------SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVH 142 (288)
T ss_pred eeEEEEE-------cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcC
Confidence 8877763 4456789999999999999999764321 1233566788899999999999999999 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCC
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPI 241 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~ 241 (379)
|||||+||++++++.++|+|||++........ .....++..|+|||...+..++.++|+|||||++|+|++ |..||
T Consensus 143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred CCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865432221 122245678999999988889999999999999999998 78898
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.+..... .. ..+.+... +......++.+.+++.+||+.||++|||+.++++...
T Consensus 223 ~~~~~~~-~~------------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 223 QGLSNEQ-VL------------KFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred CCCCHHH-HH------------HHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 7643211 11 11111111 1111233578999999999999999999999987533
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=296.53 Aligned_cols=263 Identities=18% Similarity=0.299 Sum_probs=198.4
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|.+.+.||+|+||.||+|.+.... ....+|+|.++..... ....+.+.+|+.+++.++|+| ++++++.
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~~~~ 68 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPN-------VMRLIGV 68 (272)
T ss_pred CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCcCC--HHHHHHHHHHHHHHHhCCCCC-------cceEEEE
Confidence 457789999999999999876533 2346899988654222 344677899999999999998 8888776
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
+..... .......+++|||+++|+|.+++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 69 ~~~~~~-~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~ 145 (272)
T cd05075 69 CLQTVE-SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCML 145 (272)
T ss_pred EccCCc-ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEE
Confidence 543221 1223467999999999999998854321 22334788999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 176 DSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
++++.++|+|||++........ .....+++.|+|||+..+..++.++||||||+++|+|++ |+.||...... .+.
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~ 224 (272)
T cd05075 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIY 224 (272)
T ss_pred cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Confidence 9999999999999876543221 122246778999999998889999999999999999999 88999764321 111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .+..... +.....++..+.+++.+||+.||++|||+.+++++.
T Consensus 225 ~------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 225 D------------YLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred H------------HHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 1111110 011123456789999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.81 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=203.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|++.+.||.|+||.||+|.+..+......+.||+|.++.... ......+.+|+.+++.++|++ |++++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~-------iv~~~ 74 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPN-------IVCLL 74 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHhcCCCCC-------cCeEE
Confidence 45888999999999999999987655555678899999875432 234567899999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
+.+ .+.+..++++||+.+++|.+++..... .....+++..+..++.|++.||.|||++| +
T Consensus 75 ~~~-------~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i 145 (283)
T cd05091 75 GVV-------TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--V 145 (283)
T ss_pred EEE-------cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--c
Confidence 764 445678999999999999999864211 01223778888999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 239 (379)
+||||||+||++++++.+||+|||++........ .....+++.|+|||...+..++.++|||||||++|||++ |..
T Consensus 146 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 225 (283)
T cd05091 146 VHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225 (283)
T ss_pred cccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999865433221 123346789999999888889999999999999999998 888
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
||.+.... .+. ..+..... ......++..+.+++.+||+.+|++||++++++...
T Consensus 226 p~~~~~~~-~~~------------~~i~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 226 PYCGYSNQ-DVI------------EMIRNRQV--LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred CCCCCCHH-HHH------------HHHHcCCc--CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 88764321 111 11111111 111234557799999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.81 Aligned_cols=264 Identities=18% Similarity=0.318 Sum_probs=201.2
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|++.+.||+|+||.||+|.+.... ...+.+|+|.++.+... ......+.+|+..++.++|++ ++++++.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~--~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------iv~~~~~ 69 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPN-------VMKLIGV 69 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC--CCcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCC-------eeeEEee
Confidence 678899999999999999875422 24577999998754322 334567899999999999988 8887776
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
+... .........+++|||+++++|.+++...... ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 70 ~~~~-~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~ 146 (273)
T cd05035 70 CFEA-SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCML 146 (273)
T ss_pred eccC-CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEE
Confidence 5431 1123345689999999999999998654322 2235888999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 176 DSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
++++.+||+|||++........ .....++..|+|||+..+..++.++|||||||++|||++ |..||....+.. +.
T Consensus 147 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-~~ 225 (273)
T cd05035 147 REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IY 225 (273)
T ss_pred CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 9999999999999865543321 112235678999999988889999999999999999999 889986543221 11
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .+..... +.....++..+.+++.+||+.||.+|||+.|++.+.
T Consensus 226 ~------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 226 D------------YLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred H------------HHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 1111110 111223457899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=295.69 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=200.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.... .....|++|.++.... ......+.+|+.+++.++|+| ++++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~ 70 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGSS---DKQRLDFLTEASIMGQFDHPN-------IIRL 70 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCC-------cceE
Confidence 357999999999999999999886532 2346799999865422 234567889999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||+||
T Consensus 71 ~~~~-------~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~ni 137 (266)
T cd05033 71 EGVV-------TKSRPVMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNI 137 (266)
T ss_pred eEEE-------ecCCceEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceE
Confidence 7653 45678899999999999999997532 24889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++++++.++|+|||++....... .. ....++..|+|||...+..++.++||||||+++|+|++ |..||.......
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~- 216 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD- 216 (266)
T ss_pred EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-
Confidence 99999999999999997664211 11 11234678999999998889999999999999999998 999986543211
Q ss_pred HHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .+... ..+ ....++..+.+++.+||+.+|++||++.+++++.
T Consensus 217 ~~~------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 217 VIK------------AVEDGYRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHH------------HHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111 11111 111 1123457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=284.29 Aligned_cols=277 Identities=22% Similarity=0.372 Sum_probs=215.3
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeeccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFHG 95 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~~ 95 (379)
.+.+..||.|+.|.|++++.+. ++.++|||.++.... ....+++...+.++..-. .+. ||+++|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs-----~~~iiAVK~M~rt~N---kee~kRILmDldvv~~s~dcpy-------IV~c~G 158 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRS-----TGHIIAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPY-------IVQCFG 158 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcc-----cceEEEEEeecccCC---HHHHHHHHHhhhHHhhccCCCe-------eeeeee
Confidence 4556789999999999999876 678899999987643 456788888888887654 233 888888
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNIL 174 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIl 174 (379)
+++. +..+++.||.| +.-++.++.... ..+++..+-.+...+++||.||.. +| |+|||+||+|||
T Consensus 159 yFi~-------n~dV~IcMelM-s~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNIL 224 (391)
T KOG0983|consen 159 YFIT-------NTDVFICMELM-STCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNIL 224 (391)
T ss_pred EEee-------CchHHHHHHHH-HHHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceE
Confidence 8654 56778999998 556666666532 237887788899999999999986 67 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC---CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS---KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+|+.|++|+||||++-........+...|.+.|||||.+... .|+.++||||||++++||.||+.||.+.+..-+.
T Consensus 225 lDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~- 303 (391)
T KOG0983|consen 225 LDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV- 303 (391)
T ss_pred EccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-
Confidence 999999999999999777666666667899999999988654 6889999999999999999999999886543322
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcccccCCCCCCCcccccccC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDHHHHHHHHHVERVRLI 331 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (379)
+..+++..++..+...+.++.+++++..||+.|+.+||...++|+|.......... ...
T Consensus 304 -----------ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~----------~dV 362 (391)
T KOG0983|consen 304 -----------LTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE----------VDV 362 (391)
T ss_pred -----------HHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh----------ccH
Confidence 22333333222223334789999999999999999999999999997654433322 334
Q ss_pred ccchhhccCCcch
Q 035572 332 PLWIMSLWGSTKI 344 (379)
Q Consensus 332 ~~~~~s~~~~~~~ 344 (379)
..|..+.++..+.
T Consensus 363 a~WF~dV~~~~~~ 375 (391)
T KOG0983|consen 363 ASWFKDVMAKTES 375 (391)
T ss_pred HHHHHHHHhcccc
Confidence 5788777776643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=295.56 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=199.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch--hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE--VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+|++.+.||.|+||.||+|.+. +++.+|+|.+...... ........+.+|+.+++.++|+| ++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-------i~~~ 67 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN-------IVQY 67 (265)
T ss_pred CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCC-------EeeE
Confidence 4888999999999999999753 4566999987644221 12234567899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||
T Consensus 68 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ni 133 (265)
T cd06631 68 LGTC-------LDDNTISIFMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNV 133 (265)
T ss_pred eeEe-------ecCCeEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhE
Confidence 8764 44578999999999999999997532 2788888999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-------CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-------SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
++++++.++|+|||++...... .......++..|+|||+..+..++.++|+||||+++|+|++|..||...+.
T Consensus 134 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 134 MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred EECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh
Confidence 9999999999999998643211 112234688999999999988899999999999999999999999976432
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... .+.......+.....++..+.+++.+||+.+|.+||++.+++.|.
T Consensus 214 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 214 LAAMF-------------YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred HHHHH-------------HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 21110 001110111222234557889999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=297.49 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=203.2
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
..+++|++.+.||.|++|.||+|.++. +++.+++|.+.... ...+.+.+|+.+++.+ .|+| +
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~-------i 65 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKK-----TGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPN-------I 65 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECC-----CCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCC-------h
Confidence 467899999999999999999998764 45679999987542 2346789999999999 5787 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+..... .......++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.| ++|+||+|
T Consensus 66 ~~~~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p 141 (275)
T cd06608 66 ATFYGAFIKKNP-PGNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKG 141 (275)
T ss_pred heEEEEEEecCC-CCcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCH
Confidence 887877543211 1335678999999999999999876432 2344889999999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-----CCCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
+||++++++.++|+|||++...... .......++..|+|||++.. ..++.++||||||+++|+|++|..||...
T Consensus 142 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 142 QNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred HHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9999999999999999998654322 22234468999999998653 34678899999999999999999999754
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... .+..............+..+.+++.+||..||++|||+.+++.|.
T Consensus 222 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~ 273 (275)
T cd06608 222 HPMRALF-------------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP 273 (275)
T ss_pred chHHHHH-------------HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence 3222111 111111111111223567899999999999999999999999974
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=293.83 Aligned_cols=253 Identities=24% Similarity=0.419 Sum_probs=202.0
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.+.. +++.+++|.+...... ......+.+|+.+++.++|++ ++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~-------i~~~~~ 66 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-----DQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPN-------IIEYYE 66 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-----CCcEEEEEEEeccccc--cHHHHHHHHHHHHHhhCCCCc-------hhheee
Confidence 58999999999999999998765 5577999998755433 344678999999999999888 776666
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++||||+++++|.+++.... ...+++..+..++.+++.+|+|||++| ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~ 134 (256)
T cd08220 67 NF-------LEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILL 134 (256)
T ss_pred eE-------ecCCEEEEEEecCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 53 45678999999999999999997643 233788899999999999999999999 9999999999999
Q ss_pred cCC-CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSK-WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+++ +.++|+|||++.............++..|+|||...+..++.++|+||||+++|+|++|..||...+.......
T Consensus 135 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~-- 212 (256)
T cd08220 135 DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK-- 212 (256)
T ss_pred cCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH--
Confidence 855 45899999999766544433345688999999999988889999999999999999999999976543221111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+..... ......++..+.+++.+||+.+|.+|||+.|+++|.
T Consensus 213 -----------~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 213 -----------IMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred -----------HHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 111100 111123457899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=293.49 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=202.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.+.. +++.+++|.+.... ....+.+.+|+.+++.++|++ ++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~-------i~~~ 65 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA-----TGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPN-------IVAY 65 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC-----CCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCC-------hhce
Confidence 4689999999999999999998764 44679999987542 224678999999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..|++|||+++++|.+++.... ..+++.++..++.|++.||.|||+++ ++|+||+|+||
T Consensus 66 ~~~~-------~~~~~~~l~~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni 132 (262)
T cd06613 66 FGSY-------LRRDKLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANI 132 (262)
T ss_pred EEEE-------EeCCEEEEEEeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhE
Confidence 7653 45678999999999999999987531 23889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC---CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS---KLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
++++++.++|+|||++....... ......++..|+|||...+. .++.++|+||||+++|+|+||..||........
T Consensus 133 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 133 LLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred EECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999986554322 22334688899999998776 788999999999999999999999976543222
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... . ..............+.++.+++.+||..+|.+|||+.+++.|.
T Consensus 213 ~~~~~-----~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 213 LFLIS-----K------SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred HHHHH-----h------ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 11100 0 0000001112334567899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=310.11 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=187.0
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh---hhccCCCCCceeeeccccccc
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL---QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~~~~~~~~iv~~~~~~~~ 99 (379)
||+|+||.||+|.+.. +++.||+|++....... .........|..++..+ .|++ ++.++..
T Consensus 1 lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~-------i~~~~~~--- 64 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPF-------IVGLKFS--- 64 (330)
T ss_pred CCCCCceEEEEEEECC-----CCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCc-------CcceEEE---
Confidence 7999999999998764 56789999986432211 12234455666666655 3444 5555544
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
+.+.+..|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++| |+||||||+|||++.++
T Consensus 65 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~ 133 (330)
T cd05586 65 ----FQTDSDLYLVTDYMSGGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATG 133 (330)
T ss_pred ----EecCCeEEEEEcCCCCChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCC
Confidence 466788999999999999999987532 3889999999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCC-CCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhh
Q 035572 180 DAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPL 257 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 257 (379)
.++|+|||++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .
T Consensus 134 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~------- 205 (330)
T cd05586 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-M------- 205 (330)
T ss_pred CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-H-------
Confidence 999999999865322 2223345799999999988654 47899999999999999999999997653211 1
Q ss_pred hhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC----ChHHHhccccCc
Q 035572 258 IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP----GIGEILMGCSCF 312 (379)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~e~l~~~~~~ 312 (379)
...+.......+. ..++..+.+++.+||+.||.+|| ++.+++.|....
T Consensus 206 -----~~~i~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 206 -----YRNIAFGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred -----HHHHHcCCCCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 1111111122221 12357788999999999999998 688999986553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.16 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=197.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||+|.+.. +++.+++|.++..... ......+.+|+.+++.++|+| ++++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-----~g~~~~~k~~~~~~~~--~~~~~~~~~ei~~l~~l~h~~-------i~~~~~ 66 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKN-------IVRLYD 66 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-----CCcEEEEEEeeccccc--ccCccchhHHHHHHHhcCCCC-------eeeHHH
Confidence 58899999999999999998765 5567999998754321 233466788999999999988 888777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..++|+||++ ++|.+.+.... ..+++..++.++.|+++||.|||+.| ++||||||+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~ 132 (284)
T cd07839 67 VL-------HSDKKLTLVFEYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLI 132 (284)
T ss_pred Hh-------ccCCceEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE
Confidence 64 45678999999995 68888876432 23889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 176 DSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+.++.++|+|||++...... .......++..|+|||++.+. .++.++|||||||++|+|+||..|+....+.......
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 133 NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 99999999999998654332 222334678999999987664 4688999999999999999999887554443222111
Q ss_pred hhhhhh---HHh---hhhhcccc--------CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIK---EEK---LRQVCDSR--------VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~---~~~---~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...... ... .....+.. .........++.++.+++.+||+.||.+|||+++++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 111000 000 00000000 000011123467889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=292.91 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=194.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||++..+. ...+++|.+.... .....+.+|+.+++.++|+| +++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~------~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~~~ 65 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA------QIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPK-------LVQLY 65 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc------CceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCC-------ceeEE
Confidence 468899999999999999997653 2458999876432 23467889999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++| ++|+||||+||+
T Consensus 66 ~~~-------~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~ 132 (256)
T cd05114 66 GVC-------TQQKPLYIVTEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCL 132 (256)
T ss_pred EEE-------ccCCCEEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEE
Confidence 764 44678899999999999999987532 23788999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
+++++.++|+|||++......... ....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+.... .
T Consensus 133 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-~ 211 (256)
T cd05114 133 VSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-V 211 (256)
T ss_pred EcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-H
Confidence 999999999999998654332221 12235668999999988889999999999999999999 8999976543221 1
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... .. ......+. ..+..+.+++.+||+.+|++||+++++++.
T Consensus 212 ~~i----~~-------~~~~~~~~---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 212 EMI----SR-------GFRLYRPK---LASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred HHH----HC-------CCCCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111 00 01111121 224678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=306.61 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=191.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+|++.+.||+|+||.||+|.+.. .++.||+|..... ....|+.+++.++|+| |+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~valK~~~~~----------~~~~E~~~l~~l~h~~-------iv~~ 122 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKG----------TTLIEAMLLQNVNHPS-------VIRM 122 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC-----CCceEEEEeCCcc----------ccHHHHHHHHhCCCCC-------CcCh
Confidence 4579999999999999999998764 4567999975422 2356999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++|||++ .++|.+++... ...+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 123 ~~~~-------~~~~~~~lv~e~~-~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Ni 188 (357)
T PHA03209 123 KDTL-------VSGAITCMVLPHY-SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENI 188 (357)
T ss_pred hheE-------EeCCeeEEEEEcc-CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHE
Confidence 7764 4467889999999 57898888653 234889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCC-CCCCCch-hHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI-DAARDPA-SII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~-~~~~~~~-~~~ 251 (379)
|++.++.++|+|||++.............||+.|+|||++.+..++.++|||||||++|+|+++..|+ ....... ...
T Consensus 189 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~ 268 (357)
T PHA03209 189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268 (357)
T ss_pred EECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHH
Confidence 99999999999999986544333334456999999999999889999999999999999999865554 3322110 000
Q ss_pred ----HhhhhhhhH-----Hhh---------hhhcc----ccCCCCc----chHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 252 ----DWALPLIKE-----EKL---------RQVCD----SRVGLPT----FMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 252 ----~~~~~~~~~-----~~~---------~~~~~----~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
......+.. ..+ ....+ ....... .....+.++.++|.+||+.||++|||+.|+
T Consensus 269 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~ 348 (357)
T PHA03209 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI 348 (357)
T ss_pred HHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHH
Confidence 000000000 000 00000 0000000 001234567789999999999999999999
Q ss_pred hcccc
Q 035572 306 LMGCS 310 (379)
Q Consensus 306 l~~~~ 310 (379)
++|..
T Consensus 349 l~hp~ 353 (357)
T PHA03209 349 LNYPM 353 (357)
T ss_pred hcCch
Confidence 99854
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=301.77 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=202.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|.+.+.||+|+||.||+|.+...........+|+|.++.... ....+.+.+|+.+++++ +|+| +++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~-------iv~ 103 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHEN-------IVN 103 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCC-------cce
Confidence 457999999999999999999875544445677899999875432 23356789999999999 6888 787
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ...+..++||||+.+++|.+++.... ...+++.++..++.|++.||.|||+++ ++|+||||+|
T Consensus 104 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~N 171 (302)
T cd05055 104 LLGAC-------TIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN 171 (302)
T ss_pred EEEEE-------ecCCceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccce
Confidence 77664 44567899999999999999997532 223789999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
||++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 172 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~ 251 (302)
T cd05055 172 VLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251 (302)
T ss_pred EEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence 9999999999999999865433221 112245778999999988889999999999999999998 999997654322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... ...... +......+..+.+++.+||+.+|++|||+.+++...
T Consensus 252 ~~~~~-------------~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 252 KFYKL-------------IKEGYR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred HHHHH-------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 22111 111100 011122346899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=299.75 Aligned_cols=268 Identities=22% Similarity=0.260 Sum_probs=199.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|++|.||+|.+.. ++..|++|.++..... ......+.+|+.+++.+.|+| ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 66 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-----TGQIVAMKKIRLESEE--EGVPSTAIREISLLKELQHPN-------IVCLQD 66 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-----CCcEEEEEEecccccc--CCchHHHHHHHHHHHhcCCCC-------EeeeEE
Confidence 48889999999999999998764 4567999998654221 233467889999999999888 888887
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+++..|+||||++ ++|.+++.... ....+++..+..++.|++.||.|||+.| ++|+||||+||++
T Consensus 67 ~~-------~~~~~~~~v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~ 134 (285)
T cd07861 67 VL-------MQESRLYLIFEFLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLI 134 (285)
T ss_pred EE-------eeCCeEEEEEecCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE
Confidence 64 45678999999996 68988886532 1234889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+.++.++|+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|+||++||.+..........
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 135 DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999986543221 22333578899999987654 4688999999999999999999999865443322221
Q ss_pred hhhhh-----------hHHhhhhhccccC--CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLI-----------KEEKLRQVCDSRV--GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~-----------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... ....+........ ........+++++.+++.+||+.||++|||+.+++.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~ 283 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence 11000 0000000000000 00001123457889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=299.86 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=200.9
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.+...........+++|.+..... ......+.+|+.+++.++|+| |+++++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~~ 70 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---SSELRDLLSEFNLLKQVNHPH-------VIKLYG 70 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCC-------EeeEEE
Confidence 4788999999999999999876544444557799998875432 233567899999999999988 888776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-------------------CCCCCChHhHHHHHHHHHHHHHHH
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-------------------TTPQLGWPNRVKIAMQISRAIQCL 156 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~L 156 (379)
.+ ...+..+++|||+.+++|.+++...... ....+++.++..++.|++.||.||
T Consensus 71 ~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 143 (290)
T cd05045 71 AC-------SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143 (290)
T ss_pred EE-------ecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH
Confidence 64 4467789999999999999998753211 123477889999999999999999
Q ss_pred HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHH
Q 035572 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233 (379)
Q Consensus 157 H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 233 (379)
|+.+ ++||||||+|||+++++.++|+|||++........ .....++..|+|||...+..++.++||||||+++|+
T Consensus 144 H~~~--ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e 221 (290)
T cd05045 144 AEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 221 (290)
T ss_pred HHCC--eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHH
Confidence 9999 99999999999999999999999999865432221 122345678999999888889999999999999999
Q ss_pred HHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 234 IIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 234 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|++ |..||.+... ..+... ...... +.....++.++.+++.+||+.+|++||++.++++..
T Consensus 222 l~t~g~~p~~~~~~-~~~~~~-------------~~~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 222 IVTLGGNPYPGIAP-ERLFNL-------------LKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHhcCCCCCCCCCH-HHHHHH-------------HhCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 998 9999965432 211111 111111 111223457899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=312.94 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=198.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+|++.+.||.|+||.||+|..... ...+.|++|.+... ....+|+.+++.++|+| |+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~-------iv~~ 151 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGG---------KTPGREIDILKTISHRA-------IINL 151 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEecccc---------ccHHHHHHHHHhcCCCC-------ccce
Confidence 45799999999999999999976532 25677999987532 23468999999999988 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +...+..|+|||++ +++|.+++... ..+++.+++.++.|++.||.|||++| |+||||||+||
T Consensus 152 ~~~-------~~~~~~~~lv~e~~-~~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Ni 216 (392)
T PHA03207 152 IHA-------YRWKSTVCMVMPKY-KCDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENI 216 (392)
T ss_pred eee-------EeeCCEEEEEehhc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHE
Confidence 655 34567899999999 57899888432 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|++.++.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......
T Consensus 217 ll~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred EEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 999999999999999865433221 22346999999999999999999999999999999999999999765432211
Q ss_pred --HHhhhhhhhH--------------Hh---hhhhccccCCCCcch--HHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 --IDWALPLIKE--------------EK---LRQVCDSRVGLPTFM--EGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 --~~~~~~~~~~--------------~~---~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.......... .. +..........+... ...+.++.++|.+||..||++|||+.|++.|.
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000 00 000011111111111 12346788999999999999999999999995
Q ss_pred cC
Q 035572 310 SC 311 (379)
Q Consensus 310 ~~ 311 (379)
..
T Consensus 377 ~f 378 (392)
T PHA03207 377 LF 378 (392)
T ss_pred hh
Confidence 44
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=293.08 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=202.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.... +++.+++|.++.. ...+.+.+|+++++.++|+| ++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~-------i~~~ 63 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE-----TGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPY-------IVKY 63 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC-----CCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCc-------Eeee
Confidence 3679999999999999999998765 4567999998643 12678999999999999888 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+....|+++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 64 ~~~~-------~~~~~~~l~~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni 130 (256)
T cd06612 64 YGSY-------FKNTDLWIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNI 130 (256)
T ss_pred eeee-------ecCCcEEEEEecCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceE
Confidence 7764 4467899999999999999999753 234889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++++++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~ 210 (256)
T cd06612 131 LLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210 (256)
T ss_pred EECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence 99999999999999987654433 22334588999999999888899999999999999999999999976543221111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.............++..+.+++.+||+.||++|||+.+++.|.
T Consensus 211 -------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~ 254 (256)
T cd06612 211 -------------IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254 (256)
T ss_pred -------------hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence 00001111111233457899999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=299.22 Aligned_cols=268 Identities=22% Similarity=0.368 Sum_probs=203.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCC-----------CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQT-----------DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
.++|++.+.||+|+||.||+|.+..... ......+++|.+..... ....+.+.+|+++++.++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhcCCCC
Confidence 4689999999999999999998875332 12456799999875432 244678899999999999988
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC------CCCCChHhHHHHHHHHHHHHHHH
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT------TPQLGWPNRVKIAMQISRAIQCL 156 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~L 156 (379)
++++++.+ ..++..+++|||+.+++|.+++....... ...+++..+..++.|++.||+||
T Consensus 81 -------i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L 146 (296)
T cd05051 81 -------IARLLGVC-------TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL 146 (296)
T ss_pred -------EeEEEEEE-------ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 88888764 34578999999999999999997654221 12488999999999999999999
Q ss_pred HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHH
Q 035572 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233 (379)
Q Consensus 157 H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 233 (379)
|++| ++|+||||+||+++.++.++|+|||++....... ......++..|+|||+..+..++.++|||||||++|+
T Consensus 147 H~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 224 (296)
T cd05051 147 ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224 (296)
T ss_pred HHcC--ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHH
Confidence 9999 9999999999999999999999999986543222 1223356788999999888889999999999999999
Q ss_pred HHh--CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 234 IIS--CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 234 llt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
|++ |..||....+... .......... ...... ......++.++.+++.+||+.||++|||+.++++.
T Consensus 225 l~~~~~~~p~~~~~~~~~-~~~~~~~~~~------~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 225 ILTLCREQPYEHLTDQQV-IENAGHFFRD------DGRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred HHhcCCCCCCCCcChHHH-HHHHHhcccc------cccccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 998 7778865543221 1111100000 000110 11112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=294.80 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=199.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||++.+.. +++.+++|.++.... ....+.+.+|+.+++.++|+| ++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 65 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-----SDQKYAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPN-------IVAFKE 65 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-----CCceEEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCC-------cceEEE
Confidence 58899999999999999998764 456799998864322 234577889999999999988 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+.+..|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++| ++|+||||+||++
T Consensus 66 ~-------~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili 133 (255)
T cd08219 66 S-------FEADGHLYIVMEYCDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFL 133 (255)
T ss_pred E-------EEECCEEEEEEeeCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE
Confidence 5 355788999999999999999887532 234788899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++++.++++|||++........ .....+++.|+|||+..+..++.++|+||||+++|+|++|..||...+....
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----- 208 (255)
T cd08219 134 TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----- 208 (255)
T ss_pred CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----
Confidence 9999999999999865543222 2334688999999999888899999999999999999999999976432111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...+..... +.....++..+.+++.+||+.||++||++.+++..
T Consensus 209 --------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 --------ILKVCQGSY--KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------HHHHhcCCC--CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111111111 11122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=306.20 Aligned_cols=267 Identities=16% Similarity=0.254 Sum_probs=196.0
Q ss_pred ccccccccC--CceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 18 SQSRLIGKG--SHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 18 ~~~~~iG~G--~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+++++||+| +|+.||++.++. +++.||+|.+..+... ....+.+.+|+.+++.++|+| |+++++
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpn-------iv~~~~ 66 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKP-----TGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPN-------IVPYRA 66 (327)
T ss_pred ChhhhccccccceEEEEEEeecc-----cCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCC-------eeeEEE
Confidence 357899999 788999998764 6678999998754322 234567889999999999998 888887
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ..++..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~ 134 (327)
T cd08227 67 TF-------IADNELWVVTSFMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI 134 (327)
T ss_pred EE-------EECCEEEEEEeccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEE
Confidence 64 44678999999999999999997532 223888999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC--------cccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 176 DSKWDAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
+.++.++++||+.+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999999998653322111 1112346788999998875 458899999999999999999999997654
Q ss_pred CchhHHHhhhhhhh---------HHhhh-h---------hcc-----------ccCCCCcchHHHHHHHHHHHHhcccCC
Q 035572 246 DPASIIDWALPLIK---------EEKLR-Q---------VCD-----------SRVGLPTFMEGAIKQMLHVAARCVSSE 295 (379)
Q Consensus 246 ~~~~~~~~~~~~~~---------~~~~~-~---------~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (379)
.............. ..... . ... ...........+++.+.+++.+||+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 294 (327)
T cd08227 215 ATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294 (327)
T ss_pred hhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC
Confidence 32222111110000 00000 0 000 000000112234678999999999999
Q ss_pred CCCCCChHHHhcccc
Q 035572 296 EENRPGIGEILMGCS 310 (379)
Q Consensus 296 p~~Rps~~e~l~~~~ 310 (379)
|++|||++|+++|..
T Consensus 295 P~~Rpt~~ell~~p~ 309 (327)
T cd08227 295 PDARPSASTLLNHSF 309 (327)
T ss_pred chhcCCHHHHhcChh
Confidence 999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=300.52 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=195.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~ 93 (379)
++|++.+.||.|+||.||+|.+...+. ...+++|.++.... ....+.+.+|+.++.++ .|++ ++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~-------iv~~ 68 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL---KMNAAIKMLKEFAS---ENDHRDFAGELEVLCKLGHHPN-------IINL 68 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC---cceeEEEEccccCC---HHHHHHHHHHHHHHHhhcCCCc-------hhhe
Confidence 579999999999999999998765332 23367887763211 23356789999999999 5777 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++.+ ...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||++|
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-- 139 (297)
T cd05089 69 LGAC-------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-- 139 (297)
T ss_pred EEEE-------ccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 7653 4456789999999999999999754311 1124788899999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPI 241 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~ 241 (379)
++||||||+|||+++++.+||+|||++..............+..|+|||+..+..++.++|||||||++|+|++ |..||
T Consensus 140 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf 219 (297)
T cd05089 140 FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219 (297)
T ss_pred cccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999999854322111112233567999999988889999999999999999998 99999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
....... .. ..+... .. +.....++..+.+++.+||+.+|.+||+++++++...
T Consensus 220 ~~~~~~~-~~------------~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 220 CGMTCAE-LY------------EKLPQG-YR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred CCCCHHH-HH------------HHHhcC-CC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7654211 11 111111 10 1111234578999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.25 Aligned_cols=267 Identities=23% Similarity=0.337 Sum_probs=217.7
Q ss_pred HHhcCCcccc-ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCce
Q 035572 12 KATESFSQSR-LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYC 89 (379)
Q Consensus 12 ~~~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~ 89 (379)
.+|+.|++.. +||-|-.|.|-.|..+.+ +..+|+|++.. ..+..+|++..-.. .|+|
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T-----~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~------- 116 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRT-----QEKFALKVLLD---------SPKARREVELHWMASGHPH------- 116 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccc-----hhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCc-------
Confidence 4678888875 889999999999998764 45599999863 24557788776554 3555
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
||.+++.+-. .+....++.+|||.|+||.|.+.+++++. ..+++.++..|+.||..|+.|||+.+ |.|||||
T Consensus 117 iV~IidVyeN---s~~~rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlK 188 (400)
T KOG0604|consen 117 IVSIIDVYEN---SYQGRKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLK 188 (400)
T ss_pred eEEeehhhhh---hccCceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCC
Confidence 7776665433 35667899999999999999999998653 44999999999999999999999999 9999999
Q ss_pred CCceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 170 STNILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 170 p~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|+|+|... |..+||+|||+|+.........+++-|+.|.|||++....|+..+|+||+|+++|-|++|.+||.....
T Consensus 189 pENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 189 PENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred hhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 99999964 567999999999887766677788999999999999999999999999999999999999999966543
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
.. ++.+.-..+....+..|. .+..++....++|+.+|..+|++|.|+.+++.|........
T Consensus 269 ~a---------ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 269 LA---------ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred cc---------CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 11 233334445555555555 57788999999999999999999999999999976655444
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=293.81 Aligned_cols=246 Identities=23% Similarity=0.392 Sum_probs=191.7
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccC
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS 101 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~ 101 (379)
.||+|+||.||+|.+.... .++.+++|.++..... ....+.+.+|+.+++.+.|++ ++++++.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~~~~~---- 65 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK---SEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPY-------IVRMIGIC---- 65 (257)
T ss_pred cCCCcCCcceEEeEEecCC---CceEEEEEEccCCCCc--HHHHHHHHHHHHHHHhCCCCC-------cceEEEEE----
Confidence 6899999999999765322 5678999998754322 345677899999999999988 77777653
Q ss_pred CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCe
Q 035572 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181 (379)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~ 181 (379)
..+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++| ++||||||+||++++++.+
T Consensus 66 ----~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~ 134 (257)
T cd05116 66 ----EAESWMLVMELAELGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYA 134 (257)
T ss_pred ----cCCCcEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeE
Confidence 2356799999999999999996532 3888999999999999999999999 9999999999999999999
Q ss_pred EEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhh
Q 035572 182 KLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 182 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 256 (379)
+|+|||++........ .....++..|+|||.+....++.++|+|||||++|||++ |..||...... .+....
T Consensus 135 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i-- 211 (257)
T cd05116 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMI-- 211 (257)
T ss_pred EECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH--
Confidence 9999999866543322 112234578999999888889999999999999999998 99999765321 111111
Q ss_pred hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. ..... ....+++++.+++.+||+.||++||++++|....
T Consensus 212 -------~~--~~~~~---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 212 -------ES--GERME---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred -------HC--CCCCC---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 00 00111 1223457899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=296.38 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=202.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|++|.||+|.+.. +++.+++|.+..... ......+.+|+.+++.++|+| +++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 65 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-----TNQVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPY-------ITKYY 65 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-----CCeEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCC-------eeeee
Confidence 478999999999999999998764 567899999875421 233467889999999999988 78777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .++...++|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 66 ~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~ 130 (274)
T cd06609 66 GSF-------LKGSKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANIL 130 (274)
T ss_pred EEE-------EECCeEEEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEE
Confidence 664 3457899999999999999999753 4889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+++++.++|+|||++...... .......++..|+|||+..+..++.++|+||||+++|+|+||+.||...+... ...
T Consensus 131 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~~- 208 (274)
T cd06609 131 LSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLF- 208 (274)
T ss_pred ECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-HHH-
Confidence 999999999999998665543 22334468889999999988889999999999999999999999997654211 110
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHH-HHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEG-AIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+..... +..... ++..+.+++.+||..+|++|||+++++.|...
T Consensus 209 -----------~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 209 -----------LIPKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred -----------HhhhcCC--CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 0000000 111111 56789999999999999999999999998433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=302.21 Aligned_cols=266 Identities=20% Similarity=0.299 Sum_probs=189.0
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
..+||+|+||.||+|...+.. .++.||+|.+.... ....+.+|+.+++.++|+| ++++++.+..
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~---~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~n-------iv~~~~~~~~ 69 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTG------ISMSACREIALLRELKHPN-------VIALQKVFLS 69 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC---ccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCC-------eeeEEEEEec
Confidence 468999999999999875432 55779999986432 2345789999999999998 8888776543
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhc----CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA----ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
..+...++||||+ +++|.+++..... .....+++..+..++.|++.||.|||+.| |+||||||+|||+
T Consensus 70 -----~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~ 141 (317)
T cd07867 70 -----HSDRKVWLLFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILV 141 (317)
T ss_pred -----cCCCeEEEEEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEE
Confidence 3456789999999 5688888754321 12234788889999999999999999999 9999999999999
Q ss_pred ----cCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 176 ----DSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 176 ----~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||....+
T Consensus 142 ~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~ 221 (317)
T cd07867 142 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred ccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence 466789999999996553322 1223468999999998876 4578999999999999999999999975432
Q ss_pred chh--------HHHhhhhhhh---HHhhhh-------------hccccCCCCcc-------hHHHHHHHHHHHHhcccCC
Q 035572 247 PAS--------IIDWALPLIK---EEKLRQ-------------VCDSRVGLPTF-------MEGAIKQMLHVAARCVSSE 295 (379)
Q Consensus 247 ~~~--------~~~~~~~~~~---~~~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~d 295 (379)
... ........+. ...+.. ........+.. .......+.+|+.+||+.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 301 (317)
T cd07867 222 DIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301 (317)
T ss_pred cccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccC
Confidence 110 0000000000 000000 00000000000 0011346889999999999
Q ss_pred CCCCCChHHHhccc
Q 035572 296 EENRPGIGEILMGC 309 (379)
Q Consensus 296 p~~Rps~~e~l~~~ 309 (379)
|.+|||+.|+++|.
T Consensus 302 P~~R~t~~e~l~hp 315 (317)
T cd07867 302 PTKRITSEQALQDP 315 (317)
T ss_pred cccccCHHHHhcCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=302.42 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=204.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|++|.||+|.+.. +++.+++|.+....... ....+.+.+|+++++.+.|++ +++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~-------i~~~~ 67 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPF-------LPTLY 67 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-----CCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCC-------chhhe
Confidence 478999999999999999998765 56789999987653321 234567899999999999887 77776
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+....|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+.| ++|+||||+||+
T Consensus 68 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 135 (316)
T cd05574 68 ASF-------QTETYLCLVMDYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENIL 135 (316)
T ss_pred eee-------ecCCEEEEEEEecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeE
Confidence 553 4567899999999999999998753 2234889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC------------------------------cccccCccccccCCCCCCCCCCCCcCCe
Q 035572 175 FDSKWDAKLADFGLAVSESDES------------------------------SMVQPAGTIGYLDPGYTNPSKLSKKVDV 224 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 224 (379)
++.++.++|+|||++....... ......|+..|+|||+..+..++.++||
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 215 (316)
T cd05574 136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW 215 (316)
T ss_pred EcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHH
Confidence 9999999999999975432211 0112357889999999988889999999
Q ss_pred ehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC---
Q 035572 225 FSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG--- 301 (379)
Q Consensus 225 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps--- 301 (379)
||||+++|+|++|..||...+.... +..+.......+.. ...+..+.+++.+||..||++|||
T Consensus 216 ~slG~ll~~l~~g~~pf~~~~~~~~-------------~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 216 WTLGILLYEMLYGTTPFKGSNRDET-------------FSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred HHHHHHHHHHhhCCCCCCCCchHHH-------------HHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchh
Confidence 9999999999999999976643221 12222222222221 125688999999999999999999
Q ss_pred -hHHHhcccc
Q 035572 302 -IGEILMGCS 310 (379)
Q Consensus 302 -~~e~l~~~~ 310 (379)
+++++.|..
T Consensus 282 ~~~~ll~~~~ 291 (316)
T cd05574 282 GAAEIKQHPF 291 (316)
T ss_pred hHHHHHcCch
Confidence 999999853
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.19 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=199.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+|++.+.||+|+||.||+|.+.. +++.|++|.+...... ......+.+.+|+.+++.+.|++ ++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-------i~~~ 69 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-----TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER-------IVQY 69 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-----CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCC-------eeeE
Confidence 578999999999999999998764 5678999987643211 11234568899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. .....++++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+||
T Consensus 70 ~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~ni 137 (265)
T cd06652 70 YGCLRD-----PMERTLSIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANI 137 (265)
T ss_pred EeEecc-----CCCceEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHE
Confidence 775422 12356889999999999999987532 2778888999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC----CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDE----SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........
T Consensus 138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 9999999999999998654321 112234588999999999888899999999999999999999999975432211
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+. ...... ..+......+..+.+++.+|+. +|++||++++++.|..
T Consensus 218 ~~-------------~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 218 IF-------------KIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred HH-------------HHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 11 111111 1122234456788899999995 9999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.17 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=202.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|+||.||+|.+.. +++.+++|.++..... .....+.+.+|+++++.++|++ ++.++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~-------i~~~~ 68 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-----DGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPN-------VIKYL 68 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-----CCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCC-------eeeee
Confidence 689999999999999999998764 5577999988643221 1334678899999999999887 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..++||||+++++|.+++..... ....+++..+..++.+++.||.|||+.| ++||||+|+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil 138 (267)
T cd08224 69 ASF-------IENNELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVF 138 (267)
T ss_pred eee-------ecCCeEEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEE
Confidence 764 345788999999999999999875432 2334888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++....... ......++..|+|||...+..++.++|+||||+++|+|++|+.||....... ...
T Consensus 139 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~ 216 (267)
T cd08224 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSL 216 (267)
T ss_pred ECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH--HHH
Confidence 9999999999999986543322 2233468899999999988889999999999999999999999996543211 000
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...+.. ....+......+..+.+++.+||..+|++|||+.++++..
T Consensus 217 ---------~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 217 ---------CKKIEK-CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred ---------Hhhhhc-CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 000111 1111111224567899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.13 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=197.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.++||+|+||.||+|.+.. +++.||+|+++.... ......+++.+|+.+++.++|+| +++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~-----tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPN-------IVkl~ 68 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV-----CSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPG-------IVPVY 68 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC-----CCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcC-------cCeEE
Confidence 689999999999999999998765 467799999875321 11334567999999999999988 77776
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
+.+ .+++..|+||||++|++|.+++...... .....++..+..++.|++.||+|||+.| |+||||
T Consensus 69 ~v~-------~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDL 139 (932)
T PRK13184 69 SIC-------SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDL 139 (932)
T ss_pred EEE-------eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Confidence 653 4567899999999999999998753211 1123556778899999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCC-------------------CcccccCccccccCCCCCCCCCCCCcCCeehhHH
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDE-------------------SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 229 (379)
||+|||++.++.++|+|||++...... .......||+.|+|||+..+..++.++|||||||
T Consensus 140 KPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV 219 (932)
T PRK13184 140 KPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219 (932)
T ss_pred chheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence 999999999999999999998654110 0111236899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 230 VLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 230 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++|+|+||+.||.......... .......... .....+++.+.+++.+||+.||++||+..+.+.+
T Consensus 220 ILyELLTG~~PF~~~~~~ki~~------------~~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 220 ILYQMLTLSFPYRRKKGRKISY------------RDVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHHHCCCCCCCcchhhhhh------------hhhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999997643211100 0000000000 1123455778999999999999999876665544
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.33 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=198.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
-+|++.+.||+|+||.||+|.+.. +++.|++|.+...... ........+.+|+.+++.++|+| ++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-------i~~~ 69 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-----TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER-------IVQY 69 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-----CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCC-------eeeE
Confidence 378999999999999999998765 4567999988654321 11234567899999999999988 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ......+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||
T Consensus 70 ~~~~~~-----~~~~~~~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~ni 137 (266)
T cd06651 70 YGCLRD-----RAEKTLTIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANI 137 (266)
T ss_pred EEEEEc-----CCCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHE
Confidence 765422 22467889999999999999997532 2788888999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC----CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDE----SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||........
T Consensus 138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 9999999999999998654321 111223588899999999988899999999999999999999999976532221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+. ...... ..+......++.+.+++ +||..+|++||+++|++.|..
T Consensus 218 ~~-------------~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 218 IF-------------KIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred HH-------------HHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 11 111110 11222233456677787 688899999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.64 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=203.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. .++.+++|.+...... .....+.+.+|+++++++.|+| +++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 67 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPF-------LVNLY 67 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCC-------cccee
Confidence 478999999999999999998765 4577999998643221 1234577899999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+.+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||+
T Consensus 68 ~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nil 133 (290)
T cd05580 68 GSF-------QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLL 133 (290)
T ss_pred eEE-------EcCCeEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEE
Confidence 653 4567899999999999999999764 23888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.++.++|+|||++...... .....+++.|+|||.+.+...+.++||||||+++|+|++|..||...+. .
T Consensus 134 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~------ 204 (290)
T cd05580 134 LDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-I------ 204 (290)
T ss_pred ECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-H------
Confidence 999999999999998765443 2334689999999998888889999999999999999999999976541 1
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
.....+.......+.. .+..+.+++.+||+.||.+|+ ++++++.|...
T Consensus 205 ------~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 205 ------QIYEKILEGKVRFPSF---FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred ------HHHHHHhcCCccCCcc---CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 1111122222223322 357889999999999999999 89999998543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=301.20 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=201.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.+.. +++.|++|.+.... ....+.+.+|+.+++.++|+| ++++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~-------i~~~ 81 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA-----TGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPN-------IVNY 81 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC-----CCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 3789999999999999999998654 45679999986433 223467889999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ..++..|+||||+++++|.+++.+. .+++..+..++.|++.||.|||+.| ++||||||+||
T Consensus 82 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Ni 146 (297)
T cd06656 82 LDSY-------LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNI 146 (297)
T ss_pred EEEE-------ecCCEEEEeecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence 7764 4467899999999999999998642 2788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.++|+|||++....... ......+++.|+|||...+..++.++|+||||+++|++++|..||...+....+..
T Consensus 147 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred EECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 99999999999999986543322 22334688999999999888899999999999999999999999976543221110
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...............+..+.+++.+||+.+|++||++.+++.|..
T Consensus 227 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 227 -------------IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred -------------eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 000001111122334567889999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.77 Aligned_cols=275 Identities=21% Similarity=0.261 Sum_probs=204.3
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+.+++.++|+| ++
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv 78 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTV-----TGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHKN-------II 78 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECC-----CCCEEEEEecCccccC--hhHHHHHHHHHHHHHhcCCCC-------Cc
Confidence 567899999999999999999998765 5567999998643221 234466788999999999988 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+... ..+.+....|+||||+ +++|.+.+... ++...+..++.|++.||+|||++| ++||||||+
T Consensus 79 ~~~~~~~~~-~~~~~~~~~~lv~e~~-~~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~ 147 (353)
T cd07850 79 GLLNVFTPQ-KSLEEFQDVYLVMELM-DANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 147 (353)
T ss_pred ceeeeeccC-CCccccCcEEEEEecc-CCCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHH
Confidence 777654321 1233446789999999 56888887531 778888999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||+++.++.++|+|||++.............++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......
T Consensus 148 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 148 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred HEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999999976554433344468899999999998899999999999999999999999997654322211
Q ss_pred Hhhhhhhh---------HHhhhhhccccCC--------------CCc----chHHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 252 DWALPLIK---------EEKLRQVCDSRVG--------------LPT----FMEGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 252 ~~~~~~~~---------~~~~~~~~~~~~~--------------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
........ ............. .+. .....+..+.+++.+||+.||++|||+.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 11000000 0000000000000 000 01134567899999999999999999999
Q ss_pred HhccccC
Q 035572 305 ILMGCSC 311 (379)
Q Consensus 305 ~l~~~~~ 311 (379)
+|.|...
T Consensus 308 iL~~~~~ 314 (353)
T cd07850 308 ALQHPYI 314 (353)
T ss_pred HhcChhH
Confidence 9998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.45 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=201.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|+..+.||+|+||.||++.............+++|.+.... ......+.+|+++++.++|+| ++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~~ 72 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQH-------IVRF 72 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----HHHHHHHHHHHHHHhcCCCCC-------CceE
Confidence 35788899999999999999987654444567789999876432 344568999999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC----------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA----------TTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
++.+ .+.+..+++|||+++++|.+++...... ....+++..+..++.|++.||+|||+.| +
T Consensus 73 ~~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i 143 (280)
T cd05092 73 YGVC-------TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--F 143 (280)
T ss_pred EEEE-------ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 7653 4456789999999999999999764311 1134788999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 239 (379)
+||||||+|||+++++.++|+|||++........ .....+++.|+|||...+..++.++|||||||++|+|++ |.+
T Consensus 144 ~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 223 (280)
T cd05092 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223 (280)
T ss_pred ecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999865432221 122235678999999998899999999999999999998 999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
||......... ..+..... +.....+++.+.+++.+||+.||.+||++.+++..
T Consensus 224 p~~~~~~~~~~-------------~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~ 277 (280)
T cd05092 224 PWYQLSNTEAI-------------ECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277 (280)
T ss_pred CCccCCHHHHH-------------HHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 98654432211 11111110 11112345779999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=294.04 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=199.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh-----hhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-----LQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
+|.+...||.|++|.||+|.+.. .++.+++|.+....... .....+.+.+|+.+++.++|++ +
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-------i 68 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS-----SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN-------I 68 (267)
T ss_pred CccccceeecCCCeEEEEEEecC-----CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCC-------e
Confidence 57889999999999999998754 45679999886543221 1123467899999999999988 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+ .+.+..++||||+++++|.+++...+ .+++..+..++.|++.||+|||+.| ++||||+|
T Consensus 69 ~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p 134 (267)
T cd06628 69 VQYLGSS-------LDADHLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKG 134 (267)
T ss_pred eeEEEEE-------EeCCccEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCH
Confidence 8877764 44678899999999999999997532 2788889999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCC-------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDES-------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
+||++++++.++|+|||++....... ......++..|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 135 ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999986553211 11123578899999999888899999999999999999999999986
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
......+. .+... ..+......+..+.+++.+||+.||.+||++.++++|.
T Consensus 215 ~~~~~~~~-------------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 265 (267)
T cd06628 215 CTQLQAIF-------------KIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265 (267)
T ss_pred ccHHHHHH-------------HHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence 54322111 11011 01122233457899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.27 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=196.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|++|.||+|.+.. .+.|++|.++... ...+.+.+|+.+++.++|+| ++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~------~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~~ 66 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN------TTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPK-------LIQL 66 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC------CeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCC-------ccce
Confidence 5679999999999999999998643 3569999987542 23567889999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||+++++|.+++.... ...+++..+..++.|++.||.+||+.| ++||||||+||
T Consensus 67 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Ni 134 (261)
T cd05068 67 YAVC-------TLEEPIYIVTELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNV 134 (261)
T ss_pred eEEE-------ecCCCeeeeeecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceE
Confidence 7653 44678899999999999999997632 234889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
++++++.++|+|||++......... .....+..|+|||+..+..++.++||||||+++|+|+| |+.||.+..... .
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~ 213 (261)
T cd05068 135 LVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-V 213 (261)
T ss_pred EEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-H
Confidence 9999999999999998665432211 11123457999999998899999999999999999999 999997654221 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. .+ ..... .......+..+.+++.+||+.+|++||++++++..
T Consensus 214 ~~------------~~-~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~ 257 (261)
T cd05068 214 LQ------------QV-DQGYR-MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWK 257 (261)
T ss_pred HH------------HH-HcCCC-CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11 01 01111 11122345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.48 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=200.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||+|.+.... ...++.+++|.+..... ......+.+|+.+++.++|+| +++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------iv~~~ 73 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDINN---PQQWGEFQQEASLMAELHHPN-------IVCLL 73 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCC-------eeeEE
Confidence 56889999999999999999864322 22567899999874322 233467899999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC------------CCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA------------TTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
+.+ ...+..|+||||+++++|.+++...... ....+++..+..++.|++.||.|||++|
T Consensus 74 ~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 144 (283)
T cd05090 74 GVV-------TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-- 144 (283)
T ss_pred EEE-------ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 764 4457889999999999999998643210 1223778888999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CR 238 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~ 238 (379)
++||||||+|||+++++.++|+|||++....... ......++..|+|||+..+..++.++|+||||+++|+|++ |.
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~ 224 (283)
T cd05090 145 FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224 (283)
T ss_pred eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999986543322 1222345678999999988889999999999999999998 99
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.||.+... ..+.... ..... +.....++..+.+++.+||+.||++||++.+++++.
T Consensus 225 ~p~~~~~~-~~~~~~~-------------~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 225 QPYYGFSN-QEVIEMV-------------RKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred CCCCCCCH-HHHHHHH-------------HcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 99976532 1111111 00000 111223457899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=310.66 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=205.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|.++..||.|+||.||+|+.+. +.-.-|-|++.... ....+++.-||+||..+.||+ ||++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetks----eEELEDylVEIeILa~CdHP~-------ivkL 94 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETKS----EEELEDYLVEIEILAECDHPV-------IVKL 94 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhcccc----hhHHhhhhhhhhhhhcCCChH-------HHHH
Confidence 4568889999999999999998654 44455667765443 456788999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ --.+.++|..|||.||-....+-.-+ ..+.+.++.-+++|++.||.|||+++ |+|||||..||
T Consensus 95 l~ay-------y~enkLwiliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNi 161 (1187)
T KOG0579|consen 95 LSAY-------YFENKLWILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNI 161 (1187)
T ss_pred HHHH-------hccCceEEEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccce
Confidence 8764 33688999999999999988876532 34899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccC-ccCCCCCcccccCccccccCCCCC-----CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLA-VSESDESSMVQPAGTIGYLDPGYT-----NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a-~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|++-+|.++|+|||.+ +.........+..|||+|||||+. ...+|+.++||||||++|.||..+.+|....+..
T Consensus 162 L~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 162 LLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred EEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 9999999999999987 334444455677999999999965 4568999999999999999999999997766543
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.-++. +....++..-.+...+..+.|++.+||..||+.||++.++++|..
T Consensus 242 RVllK-------------iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 242 RVLLK-------------IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHHHH-------------HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 33322 222222222234556789999999999999999999999999943
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=308.92 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=208.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++-.+.++||+|+||.||+|..+......... ||||....+. .........+.+|++++++++|+| ||.+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~-VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~N-------VVr~ 226 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVP-VAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPN-------VVRF 226 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeee-eEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCC-------EEEE
Confidence 456667799999999999999988643321222 8999987522 233566888999999999999999 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+|.. ....-++||||+|.||+|.++|++... .++..++..++.+.+.||+|||+++ ++||||-..|+
T Consensus 227 yGVa-------~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNc 293 (474)
T KOG0194|consen 227 YGVA-------VLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNC 293 (474)
T ss_pred EEEE-------cCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHh
Confidence 9875 456789999999999999999987432 4889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCccc-ccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMV-QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
|++.++.+||+|||+++......... ...-...|+|||.+....++.++|||||||++||+++ |..||.+....+.
T Consensus 294 L~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-- 371 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-- 371 (474)
T ss_pred eecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--
Confidence 99999999999999987664222211 2235689999999999999999999999999999999 8999988754321
Q ss_pred HhhhhhhhHHhhhhh--ccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 252 DWALPLIKEEKLRQV--CDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
...+ ...+...|. ..+..+..++.+|+..+|++||++.++.+......
T Consensus 372 -----------~~kI~~~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 372 -----------KAKIVKNGYRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred -----------HHHHHhcCccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1111 122333333 33577889999999999999999999987654443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.39 Aligned_cols=268 Identities=19% Similarity=0.297 Sum_probs=199.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.+.. +++.||+|.++.... ......+.+|+.+++.++|+| |+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------I~~~ 69 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL-----TDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHAN-------IVTL 69 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC-----CCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCC-------cceE
Confidence 3579999999999999999998764 456799999864432 223456788999999999988 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||+||
T Consensus 70 ~~~~-------~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Ni 135 (301)
T cd07873 70 HDII-------HTEKSLTLVFEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNL 135 (301)
T ss_pred EEEE-------ecCCeEEEEEeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHE
Confidence 7764 45678999999995 69999887532 23788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|+||++||...+......
T Consensus 136 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~ 215 (301)
T cd07873 136 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215 (301)
T ss_pred EECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999986543222 2233467899999998764 457889999999999999999999997654322211
Q ss_pred Hhhhhhh---hHHhhhhhccc----cCCCCc--------chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLI---KEEKLRQVCDS----RVGLPT--------FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~---~~~~~~~~~~~----~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. .... ....+..+... ....+. ....+++.+.+||.+||+.||.+|||++|+++|...
T Consensus 216 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 216 FI-FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred HH-HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 11 0000 00111111000 000011 112345678999999999999999999999998554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.17 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=194.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.++||+|+||.||+|.+... ..|++|.++... ...+.+.+|+++++.++|++ ++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~------~~valK~~~~~~-----~~~~~~~~E~~~l~~l~~~~-------i~~~ 66 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEK-------LVQL 66 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC------ceEEEEecccCc-----cCHHHHHHHHHHHHhCCCCC-------cceE
Confidence 46799999999999999999987542 238999987532 22467899999999999887 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ..+..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 67 ~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Ni 133 (262)
T cd05071 67 YAVV--------SEEPIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANI 133 (262)
T ss_pred EEEE--------CCCCcEEEEEcCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccE
Confidence 6543 234579999999999999999753 2234788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
++++++.++|+|||.+......... ....++..|+|||+..+..++.++||||||+++|+|+| |..||....+.. .
T Consensus 134 ll~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~ 212 (262)
T cd05071 134 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-V 212 (262)
T ss_pred EEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-H
Confidence 9999999999999998655433221 22346678999999988889999999999999999999 888987654221 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. .+... .. .......+..+.+++.+|++.||++||++.++++-
T Consensus 213 ~~------------~~~~~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 213 LD------------QVERG-YR-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HH------------HHhcC-CC-CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 11 11110 01 11123456789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=310.11 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=205.2
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCc
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNY 88 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~ 88 (379)
+....++|.+.+.||+|+||.||+|.+.........+.||+|+++.... ....+.+.+|+.+|..+. |+|
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~~H~n------ 102 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR---SSEKQALMSELKIMSHLGPHLN------ 102 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC---hhHHHHHHHHHHHHHhcCCCCC------
Confidence 4455678999999999999999999986544444667899999975432 233457889999999997 887
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-------------------------------------
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA------------------------------------- 131 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------- 131 (379)
|+.+++.+ ...+..++||||+.+|+|.+++.....
T Consensus 103 -iv~~~~~~-------~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (401)
T cd05107 103 -IVNLLGAC-------TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES 174 (401)
T ss_pred -eEEEEEEE-------ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence 88888775 345689999999999999999975421
Q ss_pred --------------------------------------------------------CCCCCCChHhHHHHHHHHHHHHHH
Q 035572 132 --------------------------------------------------------ATTPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 132 --------------------------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
.....+++..++.++.|++.||.|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 254 (401)
T cd05107 175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF 254 (401)
T ss_pred CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 011236677788899999999999
Q ss_pred HHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHH
Q 035572 156 LHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLL 232 (379)
Q Consensus 156 LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 232 (379)
||+.+ ++||||||+|||+++++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|
T Consensus 255 LH~~~--ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 255 LASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332 (401)
T ss_pred HhcCC--cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence 99999 9999999999999999999999999986543221 112235678899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 233 EIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 233 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
||++ |..||.............. . ......| ..++.++.+++.+||..+|.+||++++++...
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~---------~--~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIK---------R--GYRMAKP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHH---------c--CCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 8999876543221111100 0 0111112 22457899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.84 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=190.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+.. +++.+++|.+.... ..+....+.+|+++++.+.|+| ++++++.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~-----~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~-------i~~~~~~~--- 62 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-----DNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPN-------IVRLIGVC--- 62 (252)
T ss_pred CccCcccCccEEEEEEec-----CCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCC-------cceEEEEE---
Confidence 469999999999998765 45779999876432 1344577899999999999988 78777664
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
......++||||+++++|.+++... ...+++.++..++.|++.||.|||++| ++||||||+||+++.++.
T Consensus 63 ----~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~ 132 (252)
T cd05084 63 ----TQKQPIYIVMELVQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNV 132 (252)
T ss_pred ----cCCCCeEEEEeeccCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCc
Confidence 3457889999999999999999642 234788999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhh
Q 035572 181 AKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 256 (379)
++|+|||++......... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 133 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~---- 207 (252)
T cd05084 133 LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TRE---- 207 (252)
T ss_pred EEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHH----
Confidence 999999998654322111 11123457999999998889999999999999999998 888886543211 000
Q ss_pred hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... ..... .....+..+.+++.+||+.+|++|||+.++++.
T Consensus 208 -----~~~~--~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 208 -----AIEQ--GVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred -----HHHc--CCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 01111 122345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.61 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=195.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHH-HHhhhhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV-LSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~~~~~~~~iv~~ 93 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|.++..... ....++..|+.+ ++.+.|+| ++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~-------iv~~ 65 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-----TGTIMAVKRIRATVNS---QEQKRLLMDLDISMRSVDCPY-------TVTF 65 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-----CCcEEEEEEEecCCCc---HHHHHHHHHHHHHHHHcCCCC-------eeee
Confidence 478999999999999999998764 5678999998754322 223455556665 55566777 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~N 172 (379)
++.+ ..++..|+||||++ ++|.+++...... ...+++..+..++.|++.||+|||++ + ++||||||+|
T Consensus 66 ~~~~-------~~~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~n 134 (283)
T cd06617 66 YGAL-------FREGDVWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSN 134 (283)
T ss_pred eEEE-------ecCCcEEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHH
Confidence 7764 34678999999995 7998888764322 24589999999999999999999997 8 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC----CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP----SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|+++.++.+||+|||++.............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......
T Consensus 135 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (283)
T cd06617 135 VLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214 (283)
T ss_pred EEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH
Confidence 9999999999999999866543333333468899999998765 456889999999999999999999996543221
Q ss_pred hHHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 249 SIIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... ...... ....+ ...++.++.+++.+||..+|.+||++.+++.|...
T Consensus 215 ~~~------------~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 215 QQL------------KQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred HHH------------HHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 111 111111 11111 12345789999999999999999999999998433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=290.97 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=194.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +..+++|.++.... ..+.+.+|+.+++.++|++ ++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~-------i~~~ 66 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG------NTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDK-------LVQL 66 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC------CceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCc-------eEEE
Confidence 4689999999999999999997653 23489998875422 2467899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .....+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 67 ~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Ni 133 (260)
T cd05070 67 YAVV--------SEEPIYIVTEYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANI 133 (260)
T ss_pred EeEE--------CCCCcEEEEEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceE
Confidence 7653 234579999999999999999753 2234788999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
++++++.++|+|||++......... ....++..|+|||...+..++.++||||||+++|+|++ |..||...+... .
T Consensus 134 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~ 212 (260)
T cd05070 134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-V 212 (260)
T ss_pred EEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-H
Confidence 9999999999999998655432211 12235668999999888889999999999999999999 899997643221 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
... +.. ... ++.....+..+.+++.+||..+|.+|||+.++.+
T Consensus 213 ~~~------------~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 213 LEQ------------VER-GYR-MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHH------------HHc-CCC-CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 111 111 001 1112334578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.93 Aligned_cols=266 Identities=22% Similarity=0.299 Sum_probs=200.5
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||+|.+.. +++.|++|.+...... ......+.+|+.+++.++|+| ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~-------i~~~~~ 66 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLE--GGIPNQALREIKALQACQHPY-------VVKLLD 66 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-----CCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCC-------Ccceee
Confidence 58999999999999999998765 4567999998754322 234567899999999999888 777666
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ......++||||+ +++|.+++.... ..+++.+++.++.|++.||.|||+.| ++|+||||+||++
T Consensus 67 ~~-------~~~~~~~~v~e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~ 132 (286)
T cd07832 67 VF-------PHGSGFVLVMEYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI 132 (286)
T ss_pred EE-------ecCCeeEEEeccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEE
Confidence 53 4467899999999 999999987532 34889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 176 DSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+.++.++|+|||++....... ......++..|+|||++.+. .++.++||||+|+++|+|++|.+||.+..+...+..
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 133 SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 999999999999986654432 23344689999999987654 468899999999999999999888866543322211
Q ss_pred hhhhhhhHH---h---------hhhhccc---cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 253 WALPLIKEE---K---------LRQVCDS---RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~~~---~---------~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
........ . +..+... ...........+..+.+++.+||+.+|++|||+++++.|..
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 213 -VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred -HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 11100000 0 0000000 00001111234578999999999999999999999999843
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=290.07 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=201.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh--hhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV--LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+|+..+.||.|++|.||+|.+.. +++.+++|.++...... .....+.+.+|+.+++.++|++ ++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-------iv~~ 68 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH-------IIRM 68 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-----CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCc-------eehh
Confidence 58889999999999999998654 45679999987543211 1224578999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||++| ++|+||+|+||
T Consensus 69 ~~~~-------~~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~ni 134 (268)
T cd06630 69 LGAT-------CEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANL 134 (268)
T ss_pred hcee-------ccCCeEEEEEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 8764 55678999999999999999997532 3788899999999999999999999 99999999999
Q ss_pred EEcCCC-CeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKW-DAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~-~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+++.++ .++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 998775 599999999865543211 12235788999999998888999999999999999999999999654321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..... ...... ....+......++++.+++.+||+.+|.+||++.+++.|..
T Consensus 215 ~~~~~----------~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 215 NHLAL----------IFKIAS-ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred chHHH----------HHHHhc-cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 11100 001100 11112233455688999999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.56 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=196.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.-++|++.++||+|+||.||+|..+ .++.+++|.+.... ....++.+|+.+++.++|++ +++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~-------i~~ 65 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPR-------LVR 65 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcC-------eee
Confidence 4578999999999999999999864 34569999987543 23467899999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ..+..+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+.| ++||||||+|
T Consensus 66 ~~~~~--------~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~n 132 (260)
T cd05067 66 LYAVV--------TQEPIYIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAAN 132 (260)
T ss_pred EEEEE--------ccCCcEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHh
Confidence 77653 2356899999999999999987532 234888899999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
|++++++.++|+|||++........ .....++..|+|||+.....++.++||||||+++|++++ |+.||....+...
T Consensus 133 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 212 (260)
T cd05067 133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212 (260)
T ss_pred EEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 9999999999999999865542221 112245678999999988889999999999999999999 9999976543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... .. ......+ ...+.++.+++.+||+.+|++||++++++..
T Consensus 213 -~~~~---------~~--~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05067 213 -IQNL---------ER--GYRMPRP---DNCPEELYELMRLCWKEKPEERPTFEYLRSV 256 (260)
T ss_pred -HHHH---------Hc--CCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1110 00 0111111 2235679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=313.47 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=192.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|.+.+.||+|+||.||+|.+.. .++.|++|... ...+.+|++++++++|+| |++++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~----------~~~~~~E~~iL~~L~Hpn-------Iv~l~ 226 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGW----------YASSVHEARLLRRLSHPA-------VLALL 226 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEeccc----------ccCHHHHHHHHHHCCCCC-------CCcEE
Confidence 479999999999999999998765 45679999643 123568999999999998 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..++|||++ .++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+|||
T Consensus 227 ~~~-------~~~~~~~lv~e~~-~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NIL 292 (461)
T PHA03211 227 DVR-------VVGGLTCLVLPKY-RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVL 292 (461)
T ss_pred EEE-------EECCEEEEEEEcc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEE
Confidence 664 3457889999999 578988886532 24899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc----
Q 035572 175 FDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP---- 247 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---- 247 (379)
++.++.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..|+......
T Consensus 293 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 293 VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred ECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 99999999999999865432211 12346999999999999999999999999999999999988765432211
Q ss_pred ---hhHHHhhhhhhh-HH------------hhhhh----ccccCCCCcc--hHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 248 ---ASIIDWALPLIK-EE------------KLRQV----CDSRVGLPTF--MEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 248 ---~~~~~~~~~~~~-~~------------~~~~~----~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
..+......... .. .+... .......+.+ ....+..+.+||.+||+.||++|||+.|+
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 111111110000 00 00000 0000000100 11234578999999999999999999999
Q ss_pred hccccC
Q 035572 306 LMGCSC 311 (379)
Q Consensus 306 l~~~~~ 311 (379)
|+|...
T Consensus 453 L~hp~f 458 (461)
T PHA03211 453 LRLPLF 458 (461)
T ss_pred hhCccc
Confidence 998543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.56 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=194.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||++... +..+++|..+.. ...+.+.+|+.+++.++|++ ++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~-------i~~~ 64 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN-------LVQL 64 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-------CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 457999999999999999999653 355899987643 23467899999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ +..++..++||||+++++|.+++.+.. ...+++..+..++.|++.||+|||++| ++||||||+||
T Consensus 65 ~~~~------~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~ni 133 (256)
T cd05082 65 LGVI------VEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNV 133 (256)
T ss_pred EEEE------EcCCCceEEEEECCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheE
Confidence 7654 234567899999999999999997632 234788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~ 252 (379)
++++++.+||+|||++....... ....++..|+|||+..+..++.++|||||||++|+|++ |+.||..... ..+..
T Consensus 134 l~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~ 210 (256)
T cd05082 134 LVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVP 210 (256)
T ss_pred EEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHH
Confidence 99999999999999986543322 22345678999999988889999999999999999998 9999875431 11111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. . . ... +.....+++.+.+++.+||+.+|++|||+.+++++
T Consensus 211 ~~----~-----~--~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 211 RV----E-----K--GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred HH----h-----c--CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 10 0 0 001 11123345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.72 Aligned_cols=247 Identities=22% Similarity=0.373 Sum_probs=194.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||+|.+.. ...+|+|.+..... ..+.+.+|+.+++.++|+| +++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~-------i~~~~ 65 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEK-------LVQLY 65 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCC-------eeeEE
Confidence 568899999999999999997643 23499998874422 2466899999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.| ++|+||||+||+
T Consensus 66 ~~~-------~~~~~~~lv~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nil 132 (256)
T cd05113 66 GVC-------TKQRPIYIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCL 132 (256)
T ss_pred EEE-------ccCCCcEEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEE
Confidence 764 34567899999999999999997532 24889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
+++++.+||+|||++......... ....++..|+|||...+..++.++||||||+++|+|++ |..||....... ..
T Consensus 133 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~ 211 (256)
T cd05113 133 VDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-TV 211 (256)
T ss_pred EcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HH
Confidence 999999999999998654333221 12235678999999988889999999999999999999 999997654321 11
Q ss_pred HhhhhhhhHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. .+.. .....+ ...+..+.+++.+||+.+|.+||++.+++..
T Consensus 212 ~------------~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 212 E------------KVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred H------------HHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1 1111 111111 1235789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.98 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=199.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|+||.||+|.+.. .++.+++|.+..... ......+.+|+.++++++|+| +++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~~~~~~-------i~~~~ 65 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP-----TGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPY-------IVDFY 65 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC-----CCcEEEEEEeecccC---HHHHHHHHHHHHHHHhcCCCc-------HHhhh
Confidence 468999999999999999998754 457799998864321 233567899999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCce
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNI 173 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NI 173 (379)
+.+ ...+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+ ++|+||||+||
T Consensus 66 ~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~ni 134 (286)
T cd06622 66 GAF-------FIEGAVYMCMEYMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNV 134 (286)
T ss_pred hhe-------ecCCeEEEEEeecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHE
Confidence 663 45678999999999999999887531 12248899999999999999999996 58 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC------CCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS------KLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 135 LVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred EECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 9999999999999998654322 22334688899999987544 3478999999999999999999999754321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
. ... ....+.... .+.....++.++.+++.+||+.+|.+||++.+++.|..
T Consensus 214 ~-~~~---------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 214 N-IFA---------QLSAIVDGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred h-HHH---------HHHHHhhcC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 1 110 111111111 11222346688999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=290.55 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=202.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|+||.||+|.... .+..+++|++...... ...+.+.+|+.+++.++|++ +++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~-------i~~~~ 65 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-----NNEKVAIKRIDLEKCQ---TSVDELRKEVQAMSQCNHPN-------VVKYY 65 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-----CCcEEEEEEeccCCcc---hHHHHHHHHHHHHHhcCCCC-------EEEEE
Confidence 479999999999999999998654 4567999998654322 25678999999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ......++|||++++++|.+++..... ...+++..+..++.|++.||.+||+.| ++|+||+|+||+
T Consensus 66 ~~~-------~~~~~~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~ 134 (267)
T cd06610 66 TSF-------VVGDELWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNIL 134 (267)
T ss_pred EEE-------eeCCEEEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEE
Confidence 653 456789999999999999999976422 234888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
+++++.++|+|||++........ .....++..|+|||++... .++.++|+||||+++|+|++|+.||.......
T Consensus 135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 135 LGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred EcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 99999999999999855433221 1233588999999987766 78999999999999999999999997654322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... ...............+..+.+++.+||..||++||++.+++.|.
T Consensus 215 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p 265 (267)
T cd06610 215 VLMLTLQ----------NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265 (267)
T ss_pred hHHHHhc----------CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence 1111110 01111111111235567899999999999999999999999984
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=294.41 Aligned_cols=269 Identities=22% Similarity=0.374 Sum_probs=198.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|++.+.||+|+||.||+|..... ....++.|++|.++.... ......+.+|+.+++.++|+| +++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 72 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHEN-------IVKYK 72 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccC-CCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCC-------eeeee
Confidence 4589999999999999999976532 233677899999875432 234567999999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. .+....++||||++|++|.+++.+.. ..+++.++..++.|++.||+|||++| ++||||||+||+
T Consensus 73 ~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil 141 (284)
T cd05079 73 GICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVL 141 (284)
T ss_pred eEEec-----CCCCceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEE
Confidence 76532 22467899999999999999996532 23789999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.++|+|||++........ .....++..|+|||+..+..++.++||||||+++|+|+|++.|+...... .
T Consensus 142 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~--~ 219 (284)
T cd05079 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL--F 219 (284)
T ss_pred EcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch--h
Confidence 99999999999999865533221 12335677899999988888999999999999999999987765322110 0
Q ss_pred HHhhhh----hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALP----LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.....+ ............. .. .+....++..+.+|+.+||+.+|++|||+.+++...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEG-KR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred hhhcccccccccHHHHHHHHHcC-cc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 000000 0000000001010 01 111223567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=295.29 Aligned_cols=267 Identities=20% Similarity=0.339 Sum_probs=198.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCC---------CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCC
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQT---------DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRN 85 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~ 85 (379)
.+|++.+.||+|+||.||+|.+..... ......||+|.++.... ......+.+|+++++.++|++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~--- 78 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPN--- 78 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCC---
Confidence 589999999999999999998754211 11334689999875421 334567899999999999988
Q ss_pred CCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-------CCCCCChHhHHHHHHHHHHHHHHHHc
Q 035572 86 PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-------TTPQLGWPNRVKIAMQISRAIQCLHE 158 (379)
Q Consensus 86 ~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~ 158 (379)
++++++.+ ...+..++||||+.+++|.+++...... ....+++..+..++.|++.||+|||+
T Consensus 79 ----i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 147 (295)
T cd05097 79 ----IIRLLGVC-------VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS 147 (295)
T ss_pred ----cCeEEEEE-------cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh
Confidence 77777764 3457889999999999999999653211 11236788889999999999999999
Q ss_pred CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHH
Q 035572 159 NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 159 ~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 235 (379)
+| ++|+||||+||++++++.+||+|||++........ .....++..|+|||+..+..++.++|+||||+++|+|+
T Consensus 148 ~~--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~ 225 (295)
T cd05097 148 LN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225 (295)
T ss_pred cC--eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHH
Confidence 99 99999999999999999999999999865432221 12234577899999988888999999999999999999
Q ss_pred h--CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 236 S--CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 236 t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+ |..||....... .......... ....... .......+..+.+++.+||+.||++|||++++++.
T Consensus 226 ~~~~~~p~~~~~~~~-~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 226 TLCKEQPYSLLSDEQ-VIENTGEFFR-----NQGRQIY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred HcCCCCCCcccChHH-HHHHHHHhhh-----hcccccc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8 667877654322 1111111000 0000000 00111234689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=295.70 Aligned_cols=267 Identities=19% Similarity=0.333 Sum_probs=198.5
Q ss_pred cCCccccccccCCceeEEEEEecCCC-----------CCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccC
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQ-----------TDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
++|++.+.||+|+||.||++.+.... .......+|+|.++.... ......+.+|+.+++.++|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~E~~~l~~l~~~~- 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN---KNARNDFLKEIKIMSRLKDPN- 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCC-
Confidence 57999999999999999998654321 122356799999874421 334568899999999999988
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC------CCCCChHhHHHHHHHHHHHHHHHH
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT------TPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
++++++++ ...+..++||||+++++|.+++....... ...+++.++..++.|++.||+|||
T Consensus 81 ------i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 147 (296)
T cd05095 81 ------IIRLLAVC-------ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147 (296)
T ss_pred ------cceEEEEE-------ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 88877764 34567899999999999999997643211 123677889999999999999999
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHH
Q 035572 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 234 (379)
+.| ++|+||||+|||+++++.++|+|||++........ .....++..|++||...++.++.++|+|||||++|||
T Consensus 148 ~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el 225 (296)
T cd05095 148 SLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225 (296)
T ss_pred HCC--eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHH
Confidence 999 99999999999999999999999999865433221 1222346789999988888899999999999999999
Q ss_pred Hh--CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 235 IS--CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 235 lt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++ |..||........ ........... ......+.+ ..+++.+.+++.+||+.||++||++.++++.
T Consensus 226 ~~~~~~~p~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 226 LTLCKEQPYSQLSDEQV-IENTGEFFRDQ----GRQVYLPKP---ALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred HHhCCCCCccccChHHH-HHHHHHHHhhc----cccccCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 98 7788865543221 11111100000 000011111 2234789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=293.45 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=203.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|+..+.||.|++|.||+|.+.. .++.+++|.+..... .....++.+|+++++.++|+| |++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------iv~~~ 65 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDPN---PDLQKQILRELEINKSCKSPY-------IVKYY 65 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-----CCeEEEEEEEecCCc---hHHHHHHHHHHHHHHhCCCCC-------eeeee
Confidence 478899999999999999999765 557799999875422 244677899999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. ...+.+++||||+++++|.+++..... ....++...+..++.|++.||.|||+.| ++|+||+|+||+
T Consensus 66 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil 137 (287)
T cd06621 66 GAFLD-----ESSSSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNIL 137 (287)
T ss_pred eEEEc-----cCCCeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 76532 234578999999999999998875432 3344788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc----hhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP----ASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~----~~~ 250 (379)
++.++.++|+|||++........ ....++..|+|||...+..++.++|+||||+++|+|++|..||...... ...
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (287)
T cd06621 138 LTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216 (287)
T ss_pred EecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence 99999999999999865433221 2335788999999998888999999999999999999999999766321 111
Q ss_pred HHhhhhhhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..+. ......... .+......++.+.+++.+||+.+|.+|||+.|++.|..
T Consensus 217 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 217 LSYI---------VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred HHHH---------hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 1110 000000000 01111224578999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.46 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=215.5
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
+..++-+++-..+||.|.||.||-|+..+ +|...|+|.++..... ......+.+|..++..++|+|
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~-----tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpN------- 1295 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLD-----TGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPN------- 1295 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCC-----ccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCcc-------
Confidence 45567789999999999999999998765 6778999998866544 666788999999999999999
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
+|+++|. -.+.+.++|.||||++|+|.++++..+. .++.....+..|++.|++|||++| |||||||
T Consensus 1296 lV~YyGV-------EvHRekv~IFMEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK 1361 (1509)
T KOG4645|consen 1296 LVRYYGV-------EVHREKVYIFMEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIK 1361 (1509)
T ss_pred ccccCce-------eecHHHHHHHHHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcC--ceecCCC
Confidence 7777755 3456789999999999999999986432 555566778899999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCC---CCCcCCeehhHHHHHHHHhCCCCC
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSK---LSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|.||+++.+|.+|++|||.|....... ......||+.|||||++.+.. -..+.|||||||+..||+||+.||
T Consensus 1362 ~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1362 PANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred ccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence 999999999999999999996543322 234457999999999987543 466899999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
...++..++.-+.... .. |+.+...+.+-.++|.+||+.||++|.++.|+++|.....
T Consensus 1442 ~~~dne~aIMy~V~~g-----------h~---Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1442 AELDNEWAIMYHVAAG-----------HK---PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hhccchhHHHhHHhcc-----------CC---CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9888766655443321 11 4444557889999999999999999999999999866544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=293.80 Aligned_cols=267 Identities=20% Similarity=0.276 Sum_probs=198.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|++|.||+|.+.. +++.|++|.+...... ......+.+|++++++++|+| ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i~~~~~ 66 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPN-------IVKLLD 66 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-----CCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCC-------Ccchhh
Confidence 58899999999999999998764 4567999988754322 334467899999999999988 888777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
++ .+.+..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~~v~e~~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill 133 (284)
T cd07860 67 VI-------HTENKLYLVFEFLH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI 133 (284)
T ss_pred hc-------ccCCcEEEEeeccc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence 64 45678999999995 68999887532 234889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCC-CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 176 DSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++++.++|+|||++...... .......++..|+|||++.+.. ++.++||||||+++|+|+||+.||....+.......
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 134 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999998654322 1222335788999999876544 588999999999999999999999765543322221
Q ss_pred hhhhhh-----------HHhhhhhcccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIK-----------EEKLRQVCDSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~-----------~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....-. ........... .........+++++.++|.+||+.||.+|||+++++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 110000 00000000000 000001122456788999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=290.55 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||++.+.. .++.|++|.+...... ....+.+.+|+.+++.++|++ ++++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-----DGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPN-------IVQYQE 66 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-----CCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCC-------eeeeEe
Confidence 58999999999999999998764 4567999988643222 234567899999999999988 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++||||+.+++|.+.+.... ...+++.++..++.|++.||.|||++| ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~ 134 (256)
T cd08218 67 SF-------EENGNLYIVMDYCEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL 134 (256)
T ss_pred ee-------cCCCeEEEEEecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE
Confidence 63 55678999999999999999987532 223788899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||++........ .....+++.|+|||+..+..++.++|+||||+++|+|++|..||...+....
T Consensus 135 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----- 209 (256)
T cd08218 135 TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL----- 209 (256)
T ss_pred cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-----
Confidence 9999999999999865533222 2233588899999999888899999999999999999999999975432211
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...+..... +......+.++.+++.+||+.+|.+||++.++++|.
T Consensus 210 --------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 210 --------VLKIIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred --------HHHHhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 111111111 111223457899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=293.44 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=199.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
...+|++.+.||.|+||.||+|.+.. ++.+++|.+.... ......+.+|+.+++.++|++ +++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~-------i~~ 66 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN------RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKH-------LIS 66 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC------CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcc-------hhh
Confidence 45679999999999999999998764 3559999987543 223567899999999999887 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+++.+.. ...+++..+..++.|++.||.|||++| ++|+||+|+|
T Consensus 67 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~n 134 (261)
T cd05148 67 LFAVC-------SVGEPVYIITELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARN 134 (261)
T ss_pred eeeeE-------ecCCCeEEEEeecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcce
Confidence 66653 45678899999999999999997632 234788999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
|++++++.++|+|||++........ .....++..|+|||......++.++||||||+++|+|++ |+.||....... .
T Consensus 135 ilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~ 213 (261)
T cd05148 135 ILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-V 213 (261)
T ss_pred EEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-H
Confidence 9999999999999999866543221 223346778999999888889999999999999999998 899997654221 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. .+.. ... +.....++..+.+++.+||+.||.+|||+.++++.
T Consensus 214 ~~------------~~~~-~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~ 257 (261)
T cd05148 214 YD------------QITA-GYR-MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREE 257 (261)
T ss_pred HH------------HHHh-CCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 11 1111 111 11123445789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.17 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=203.8
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||+|.+.. +++.+++|.+...... .....+.+.+|++++++++|+| ++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 67 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-----TKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPF-------LVNLWY 67 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-----CCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCC-------hHHHHH
Confidence 58999999999999999998764 4567999998754321 1234678999999999999988 777665
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. +.+.+..++|+||++|++|.+++... ..+++.++..++.|+++||.|||++| ++|+||+|+||++
T Consensus 68 ~-------~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~ 133 (258)
T cd05578 68 S-------FQDEENMYLVVDLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILL 133 (258)
T ss_pred h-------hcCCCeEEEEEeCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE
Confidence 5 35677899999999999999999753 23888899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||++.............++..|+|||+..+..++.++|+||||+++|+|++|..||....... ....
T Consensus 134 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~- 210 (258)
T cd05578 134 DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQI- 210 (258)
T ss_pred cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHH-
Confidence 9999999999999876654433444568899999999988889999999999999999999999998664321 0000
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh--HHHhccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI--GEILMGC 309 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~e~l~~~ 309 (379)
........ +......+..+.+++.+||+.||.+||++ +|++.|.
T Consensus 211 -------~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 211 -------RAKQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred -------HHHhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 00111011 11222345789999999999999999999 9998874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.65 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=196.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++.++||.|+||.||+|.+...... ....||+|.+..... ......+.+|+.+++.+.|++ ++.+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~~~~~~-------i~~~ 74 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-VKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGSPY-------VCRL 74 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-cceEEEEEEecCCCC---HHHHHHHHHHHHHHHhcCCCC-------CceE
Confidence 35789999999999999999987653322 234589999875432 334567889999999999887 6666
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+. ....+++|||+++|+|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+||
T Consensus 75 ~~~~~--------~~~~~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Ni 140 (279)
T cd05109 75 LGICL--------TSTVQLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNV 140 (279)
T ss_pred EEEEc--------CCCcEEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceE
Confidence 66542 24578999999999999999753 234889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
|+++++.+||+|||++........ .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..
T Consensus 141 l~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~ 219 (279)
T cd05109 141 LVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-RE 219 (279)
T ss_pred EEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HH
Confidence 999999999999999876543222 112235678999999988889999999999999999998 8999875432 11
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+... +..... +.....++.++.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~-------------~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 220 IPDL-------------LEKGER-LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHH-------------HHCCCc-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 111111 11122345789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=305.52 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=219.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.-...|.+...||+|.|+.|.+|++.. ++..||||.+.+.... ....+.+.+|+++|..|.||| ||
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~-----t~~~VaiK~idkt~ln--~~~~~k~~rev~imk~l~HPn-------Iv 118 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHIL-----TGTEVAIKIIDKTQLN--PSKRQKLGREVDIMKSLNHPN-------IV 118 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecC-----CCceEEEEEehhcccC--hHHHHHHHHHHHHHHhcCCcc-------ee
Confidence 345789999999999999999998776 4566999999876544 455566999999999999998 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
+++.. .+....+|+||||+.+|.+.+++.+.+. ..+.+++.++.|+.++++|||+++ |||||||++
T Consensus 119 kl~~v-------~~t~~~lylV~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~e 184 (596)
T KOG0586|consen 119 KLFSV-------IETEATLYLVMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAE 184 (596)
T ss_pred eeeee-------eeecceeEEEEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc--eeccccchh
Confidence 87765 4667899999999999999999986543 556888999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||||+.+.++||+|||++..+.......+.+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-
T Consensus 185 NilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---- 260 (596)
T KOG0586|consen 185 NILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---- 260 (596)
T ss_pred hcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----
Confidence 99999999999999999988887777788899999999999998877 5789999999999999999999987641
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.+.-...+...+.+|.++. .++.++|+++|..+|.+|++.+++..|.....
T Consensus 261 ---------k~Lr~rvl~gk~rIp~~ms---~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 261 ---------KELRPRVLRGKYRIPFYMS---CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred ---------ccccchheeeeecccceee---chhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 1222334445555666554 67889999999999999999999999855444
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.76 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=194.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||+|+||.||+|.++. ...+++|.+.... .....+.+|+.+++.++|++ +++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~------~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~-------i~~~~ 65 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG------KIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPN-------LVQLY 65 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC------CccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCC-------EEEEE
Confidence 358899999999999999997642 2358999876432 22456888999999999888 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ...+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.| ++||||||+||+
T Consensus 66 ~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~ 132 (256)
T cd05059 66 GVC-------TKQRPIFIVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCL 132 (256)
T ss_pred EEE-------cCCCceEEEEecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEE
Confidence 663 45578899999999999999997532 24889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
+++++.+||+|||++......... ....++..|+|||...+..++.++|+||||+++|+|++ |..||....+.. ..
T Consensus 133 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~ 211 (256)
T cd05059 133 VGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VV 211 (256)
T ss_pred ECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HH
Confidence 999999999999998655332211 11124457999999988889999999999999999999 899997654321 11
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. ..... ....+ ..++..+.+++.+||..+|++|||+.++++.
T Consensus 212 ~~---------~~~~~--~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 212 ES---------VSAGY--RLYRP---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HH---------HHcCC--cCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 11 00000 11111 2245789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=294.62 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=202.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||++.+.. .++.+++|.+..... ....+.+.+|+++++.++|++ ++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------i~~~ 68 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP-----TGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPY-------IVSF 68 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC-----CCcEEEEEEEEecCc---chHHHHHHHHHHHHHHcCCCC-------cceE
Confidence 3578999999999999999998754 457799998764321 334678899999999999988 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~N 172 (379)
++.+ ......++||||+++++|.+++...+ .+++..+..++.+++.+|.|||+ .+ ++||||+|+|
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~n 134 (284)
T cd06620 69 YGAF-------LNENNICMCMEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSN 134 (284)
T ss_pred eeeE-------ecCCEEEEEEecCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHH
Confidence 7764 44578999999999999999987532 38889999999999999999997 68 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++++++.++|+|||++...... ......++..|+|||++.+..++.++|+|||||++|++++|+.||...........
T Consensus 135 il~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~ 213 (284)
T cd06620 135 ILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213 (284)
T ss_pred EEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh
Confidence 99999999999999998544222 12234689999999998888899999999999999999999999986543211000
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... .+. .....+...... ......++..+.+++.+||+.||++|||+.|+++|...
T Consensus 214 ~~~-~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 214 DPM-GIL-DLLQQIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred hhh-HHH-HHHHHHhhccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 000 000 011111111111 11112356789999999999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=294.82 Aligned_cols=267 Identities=23% Similarity=0.290 Sum_probs=200.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.++. +++.|++|.+...... ....+.+.+|+++++.++|+| +++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~ 66 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-----TGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHEN-------IVNLK 66 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-----CCcEEEEehhhhhccc--ccchhHHHHHHHHHHhcCCCC-------eeehh
Confidence 479999999999999999998765 4567999988653221 344578999999999999888 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ..++..++||||++++.+..+..+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 67 ~~~-------~~~~~~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~ 132 (288)
T cd07833 67 EAF-------RRKGRLYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENIL 132 (288)
T ss_pred heE-------EECCEEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeE
Confidence 764 346789999999987666655543 223788999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+++++.++|+|||++....... ......++..|+|||+..+. .++.++|+||||+++|+|++|+.||........+.
T Consensus 133 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 133 VSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred ECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999986654433 23345678999999998877 78999999999999999999999997654332221
Q ss_pred Hhhhhh--hhHHhhhhh-ccc--------cCCCCc-----chHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPL--IKEEKLRQV-CDS--------RVGLPT-----FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~--~~~~~~~~~-~~~--------~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...... ......... .+. ....+. ....++.++.+++.+||..+|++||++++++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred HHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 110000 000000000 000 000000 1112367899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=292.45 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=195.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||+|.+...+.. ....+++|.+.... .......+..|+.+++.+.|+| +++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~-------iv~~~ 75 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY-------IVRLL 75 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-eeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCC-------cceEE
Confidence 4688899999999999999987653321 22357888875321 1234467888888999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++. ....++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||
T Consensus 76 ~~~~--------~~~~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nil 141 (279)
T cd05111 76 GICP--------GASLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNIL 141 (279)
T ss_pred EEEC--------CCccEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEE
Confidence 7642 345789999999999999997532 23889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++++.+||+|||++....... ......++..|+|||+..+..++.++||||||+++||+++ |..||.+.... ..
T Consensus 142 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~ 220 (279)
T cd05111 142 LKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EV 220 (279)
T ss_pred EcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH
Confidence 9999999999999996543322 1223356778999999988889999999999999999998 99999765321 11
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... . . ......+. .++.++.+++.+||..||++|||+.|+++..
T Consensus 221 ~~~~----~-----~--~~~~~~~~---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 221 PDLL----E-----K--GERLAQPQ---ICTIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred HHHH----H-----C--CCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1110 0 0 01111111 2345788999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=288.42 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=201.2
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.+.. +++.+++|.++..... ....+.+.+|+.+++.++|++ ++++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~-------i~~~~~ 66 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-----TGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPN-------LVKYYG 66 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-----CCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCC-------hhheee
Confidence 58999999999999999998654 4567999998765432 346788999999999999887 777666
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.. ...+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~ 132 (264)
T cd06626 67 VE-------VHREKVYIFMEYCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL 132 (264)
T ss_pred eE-------ecCCEEEEEEecCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence 53 4467899999999999999999753 23778888999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcc-----cccCccccccCCCCCCCCC---CCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 176 DSKWDAKLADFGLAVSESDESSM-----VQPAGTIGYLDPGYTNPSK---LSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
++++.++|+|||++......... ....++..|+|||++.+.. ++.++||||||+++|++++|+.||...++.
T Consensus 133 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~ 212 (264)
T cd06626 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212 (264)
T ss_pred CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence 99999999999998665433221 1246788999999988766 889999999999999999999999765432
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... ........|. ...++..+.+++.+||+.+|.+||++.+++.|.
T Consensus 213 ~~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~ 262 (264)
T cd06626 213 FQIMFHV-----------GAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262 (264)
T ss_pred HHHHHHH-----------hcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 2211110 0011111222 123357788999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=288.88 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=189.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+... .....+++|.++.... ......+.+|+.+++.++|+| ++++++.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~---~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~~~~--- 64 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG---YTPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSN-------LLQCLGQC--- 64 (269)
T ss_pred CcccccCCceEEEEEEcCC---CCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCC-------EeeEEEEE---
Confidence 4689999999999987532 2456799998875432 223457889999999999988 88887764
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+....++||||+++++|.+++...........++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 65 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~ 138 (269)
T cd05087 65 ----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLT 138 (269)
T ss_pred ----cCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCc
Confidence 34567899999999999999997654333334667778889999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCc---ccccCccccccCCCCCCCC-------CCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 181 AKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPS-------KLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++|+|||++........ .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||........
T Consensus 139 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred EEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 99999999865433221 1223567889999987542 35789999999999999996 9999976543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..... .. .......+......+..+.+++.+|+ .+|++|||+++++..
T Consensus 219 ~~~~~-----~~-----~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 219 LTYTV-----RE-----QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred HHHHh-----hc-----ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 11100 00 01111112222233467889999998 689999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=289.83 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=200.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+|+..+.||+|++|.||+|++.. +++.|++|.+...... ......+.+.+|+.+++.++|++ +++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-------i~~~~ 68 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD-----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-------IVQYL 68 (258)
T ss_pred CccccceeeecCCceEEEEEEcC-----CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCC-------chhee
Confidence 58888999999999999998754 4567999987643221 12334577999999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+....+++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.| ++|+||+|+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~ 134 (258)
T cd06632 69 GTE-------REEDNLYIFLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANIL 134 (258)
T ss_pred eeE-------ecCCeEEEEEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 653 45678999999999999999997532 3788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCC-CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.+||+|||++.............++..|+|||...... ++.++|+||||+++|+|++|+.||............
T Consensus 135 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 214 (258)
T cd06632 135 VDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI 214 (258)
T ss_pred ECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH
Confidence 9999999999999986654433334456899999999887666 899999999999999999999999765421111110
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. ....+.....+++.+.+++.+||+.+|.+||++.+++.|.
T Consensus 215 -------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 215 -------------GR-SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred -------------Hh-cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 00 0011222233457889999999999999999999999884
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=298.10 Aligned_cols=266 Identities=20% Similarity=0.339 Sum_probs=202.3
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCC--CCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCC
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTD--GDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPN 87 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~ 87 (379)
....++|.+.+.||+|+||.||+|.+...... .....+|+|.+..... ......+.+|+.+++.+ +|++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~----- 85 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKN----- 85 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---hHHHHHHHHHHHHHHHhcCCCC-----
Confidence 34457899999999999999999987543221 2346799999875421 23356788999999999 6777
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHH
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCL 156 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~L 156 (379)
++++++.+ ...+..|+||||+++++|.+++...... ....+++.+++.++.|++.||+||
T Consensus 86 --i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 86 --IINLLGAC-------TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred --EeeEEEEE-------ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 88877764 4457899999999999999999864321 123488889999999999999999
Q ss_pred HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHH
Q 035572 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233 (379)
Q Consensus 157 H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 233 (379)
|++| ++||||||+||++++++.++|+|||++........ .....++..|+|||+..+..++.++|+|||||++|+
T Consensus 157 H~~g--i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 234 (307)
T cd05098 157 ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234 (307)
T ss_pred HHCC--cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHH
Confidence 9999 99999999999999999999999999865533221 111234568999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 234 IIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 234 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|++ |..||.... ...+.... .. .... ......+.++.+++.+||..+|++|||+.+++.+..
T Consensus 235 l~~~g~~p~~~~~-~~~~~~~~----~~-------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 235 IFTLGGSPYPGVP-VEELFKLL----KE-------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred HHcCCCCCCCcCC-HHHHHHHH----Hc-------CCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 998 888886532 12111110 00 0111 112234578999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.90 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=199.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+..+.||.|+||.||+|.+.. .++.|++|.+..... ....+.+.+|+.+++.++|+| +++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 68 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPY-------ITRYY 68 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC-----CCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCc-------cHhhh
Confidence 457788999999999999998754 456799999874432 234567899999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ..++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++| ++|+||+|+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~ 133 (277)
T cd06642 69 GSY-------LKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVL 133 (277)
T ss_pred ccc-------ccCCceEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEE
Confidence 664 456789999999999999998853 23788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+++++.++|+|||++........ .....++..|+|||++.+..++.++|+||||+++|+|++|+.||......... .
T Consensus 134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~- 211 (277)
T cd06642 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-F- 211 (277)
T ss_pred EeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-h-
Confidence 99999999999999866543322 22335888999999999888999999999999999999999998654321110 0
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.+.... .+.....++.++.+++.+||+.+|++||++.+++.|.
T Consensus 212 -----------~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 212 -----------LIPKNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred -----------hhhcCC--CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 011110 1122234457899999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=285.61 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=208.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+++|..+++||+|.||.|-+|..+. +++.+|+|+++++-.- ..+....-..|-++|+..+||- +..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKa-----t~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPF--------Lt~ 232 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKA-----TGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPF--------LTS 232 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecc-----cCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcH--------HHH
Confidence 4789999999999999999997655 7789999999876443 2455666778889999888763 222
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
..| +|+..+.+|.||||+.||.|.-.+.+.. .+++...+-+...|+.||.|||+++ ||.||||.+|+
T Consensus 233 LKY------sFQt~drlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENL 299 (516)
T KOG0690|consen 233 LKY------SFQTQDRLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENL 299 (516)
T ss_pred hhh------hhccCceEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhh
Confidence 322 3788999999999999999999887533 3888888899999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|+|.+|++||+|||+++-.. ......+.+|||.|+|||++....|+.++|.|.+|+++|||++|+.||...+.
T Consensus 300 lLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------ 373 (516)
T KOG0690|consen 300 LLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------ 373 (516)
T ss_pred eeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch------
Confidence 99999999999999996543 34456778999999999999999999999999999999999999999976542
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCcc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~~ 313 (379)
+..+.-++-..+..|. ..+++...|+..+|..||.+|. .+.|+..|.....
T Consensus 374 -------~kLFeLIl~ed~kFPr---~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 374 -------EKLFELILMEDLKFPR---TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred -------hHHHHHHHhhhccCCc---cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 2222223333333343 4457889999999999999996 5778887755443
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=295.82 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=198.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||++.+.. .++.|++|.+...... .......+.+|+.+++.++|+| +++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~-------i~~~~ 67 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-----TRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPF-------VVSMF 67 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-----CCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCC-------eeeeE
Confidence 478999999999999999998765 4567999988654221 1234567889999999999887 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ..++..++||||++|++|.+++...+ .+++..+..++.|++.||.|||+.| ++||||||+||+
T Consensus 68 ~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIl 133 (305)
T cd05609 68 CSF-------ETKRHLCMVMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLL 133 (305)
T ss_pred EEE-------ecCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEE
Confidence 653 45678999999999999999997532 3788889999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC----------------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC
Q 035572 175 FDSKWDAKLADFGLAVSESDES----------------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 238 (379)
++.++.++|+|||++....... ......++..|+|||.+....++.++|+||||+++|+|++|.
T Consensus 134 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~ 213 (305)
T cd05609 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213 (305)
T ss_pred ECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999885321100 011235788999999988888999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC---hHHHhccccC
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG---IGEILMGCSC 311 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~~~~ 311 (379)
.||.+... ..+ ...........+......+..+.+++.+||+.||++||+ +.++++|...
T Consensus 214 ~pf~~~~~-~~~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 214 VPFFGDTP-EEL------------FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred CCCCCCCH-HHH------------HHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 99975432 111 111111111112212234577999999999999999998 6788887443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=288.82 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=194.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|++|.||+|.+... ..+++|.+.... ...+.+.+|+.+++.+.|++ ++.+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~-------i~~~ 66 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT------TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDK-------LVPL 66 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC------ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 36799999999999999999987542 248999876432 23467889999999999988 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ..+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||||+||
T Consensus 67 ~~~~--------~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Ni 133 (260)
T cd05069 67 YAVV--------SEEPIYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANI 133 (260)
T ss_pred EEEE--------cCCCcEEEEEcCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceE
Confidence 6553 2346799999999999999997532 233788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
++++++.++|+|||++........ .....++..|+|||+..+..++.++||||||+++|+|+| |..||....+....
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 213 (260)
T cd05069 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213 (260)
T ss_pred EEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999865533221 122346678999999988889999999999999999999 99999765432211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. +... .. +......+..+.+++.+||..||++||+++++++-
T Consensus 214 -~~------------~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 256 (260)
T cd05069 214 -EQ------------VERG-YR-MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSF 256 (260)
T ss_pred -HH------------HHcC-CC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11 1111 00 11123446789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.90 Aligned_cols=269 Identities=26% Similarity=0.409 Sum_probs=198.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|...... ...++.|++|.+.... ....+.+.+|+++++.++|+| ++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------iv~~ 70 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDN-------IVKY 70 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCC-------eeEE
Confidence 357899999999999999999764322 2356789999986442 334567899999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. .+....++||||+++++|.+++.... ..+++..+..++.|++.||+|||++| ++||||||+||
T Consensus 71 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~ni 139 (284)
T cd05081 71 KGVCYS-----AGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNI 139 (284)
T ss_pred EEEEcc-----CCCCceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhE
Confidence 776532 33457899999999999999997532 23788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
++++++.++|+|||++......... ....++..|+|||+..+..++.++||||||+++|||++|..|+......
T Consensus 140 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-- 217 (284)
T cd05081 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-- 217 (284)
T ss_pred EECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--
Confidence 9999999999999998765432221 1112445699999998888999999999999999999988776433210
Q ss_pred HHHhhhhh----hhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPL----IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
........ .....+..........+ ....++..+.+++.+||+.+|++|||+.+++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00000000 00000111111111111 122345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=296.56 Aligned_cols=252 Identities=31% Similarity=0.518 Sum_probs=192.7
Q ss_pred ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 18 SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 18 ~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
.+.+.||.|.||.||+|.+.. ........|+||.++.... ....+.+.+|++.+++++|+| |+++++.+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~---~~~~~~~~~e~~~l~~l~h~n-------i~~~~g~~ 70 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSS---EEEEEEFLNEIQILRKLRHPN-------IVKLYGFC 70 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSS---HHHHHHHHHHHHHHHTHSBTT-------BE-EEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccc---cccceeeeecccccccccccc-------cccccccc
Confidence 356789999999999999884 3344678899999964321 334788999999999999998 99999887
Q ss_pred cccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~ 177 (379)
. ..+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+++||++++
T Consensus 71 ~-------~~~~~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~ 138 (259)
T PF07714_consen 71 I-------ENEPLFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDS 138 (259)
T ss_dssp E-------SSSSEEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEET
T ss_pred c-------cccccccccccccccccccccccc---cccccccccccccccccccccccccccc--ccccccccccccccc
Confidence 5 345689999999999999999874 2334899999999999999999999999 999999999999999
Q ss_pred CCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHh
Q 035572 178 KWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDW 253 (379)
Q Consensus 178 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 253 (379)
++.+||+|||++........ .........|+|||.+.+..++.++||||||+++||+++ |+.||...+. ..+...
T Consensus 139 ~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~ 217 (259)
T PF07714_consen 139 NGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEK 217 (259)
T ss_dssp TTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence 99999999999866532221 223357789999999888889999999999999999999 7899876632 221111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
+.+... +.....++..+.+++.+||+.||++|||+.++++
T Consensus 218 ------------~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 218 ------------LKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------------HHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------------cccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 1112234577899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.03 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=202.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|+..+.||.|+||.||+|.+.. .+..+++|.+..... ......+.+|+.+++.+.|++ +++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 68 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPY-------VTKYY 68 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-----CCEEEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCC-------EeeEE
Confidence 468889999999999999998764 456799998875432 234578899999999999888 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil 133 (277)
T cd06640 69 GSY-------LKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVL 133 (277)
T ss_pred EEE-------EECCEEEEEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEE
Confidence 764 4467899999999999999998642 2788888999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++........ .....++..|+|||+..+..++.++|+||||+++|+|++|..||.........
T Consensus 134 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--- 210 (277)
T cd06640 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--- 210 (277)
T ss_pred EcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---
Confidence 99999999999999865543222 22335788999999998888999999999999999999999999765321110
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..+ . ....+.....++..+.+++.+||+.+|++||++.+++.|..
T Consensus 211 ----------~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 211 ----------FLI-P-KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred ----------hhh-h-cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 000 0 01113334456788999999999999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=295.75 Aligned_cols=267 Identities=25% Similarity=0.314 Sum_probs=198.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. .++.+++|.+...... ....+.+.+|+++++.++|++ +++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 66 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-----TGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHEN-------LVNLI 66 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-----CCCEEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcc-------hhhHH
Confidence 479999999999999999998764 4577999987654322 234567889999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..++||||+++++|..+.... ..+++.++..++.|++.||+|||+.| ++|+||+|+||+
T Consensus 67 ~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~ 132 (286)
T cd07846 67 EVF-------RRKKRLYLVFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENIL 132 (286)
T ss_pred Hhc-------ccCCeEEEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEE
Confidence 663 5577899999999998888876532 23889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+++++.++|+|||++....... ......++..|+|||+..+ ..++.++||||||+++|+|++|++||...........
T Consensus 133 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 133 VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred ECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 9999999999999986543322 2233457899999998765 3467899999999999999999999975543221111
Q ss_pred hhh--hhhhHHhhh---------hhccccCCC----CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WAL--PLIKEEKLR---------QVCDSRVGL----PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~--~~~~~~~~~---------~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... ....+.... ......... ....+.++..+.+++.+||+.+|++||++.+++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 100 000000000 000000000 001123467899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.36 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=198.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|.....||.|+||.||++.+.. .++.|++|.+.... ....+.+.+|+.+++.++|+| ++++
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------ii~~ 84 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH-----TGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHEN-------VVDM 84 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC-----CCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCc-------HHHH
Confidence 3556667889999999999998654 45779999876432 234567899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||+++++|.+++... .+++.++..++.|++.||.|||++| ++||||||+||
T Consensus 85 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Ni 149 (292)
T cd06658 85 YNSY-------LVGDELWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSI 149 (292)
T ss_pred HHhe-------ecCCeEEEEEeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHE
Confidence 7664 4467899999999999999988531 2788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++++++.++|+|||++....... ......++..|+|||...+..++.++|+||||+++|+|++|..||...........
T Consensus 150 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred EEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999986543222 12334688999999999888899999999999999999999999976543221110
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.......... .....+..+.+++.+||..||.+|||++++++|...
T Consensus 230 ----------~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 275 (292)
T cd06658 230 ----------IRDNLPPRVK---DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275 (292)
T ss_pred ----------HHhcCCCccc---cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 1111111111 112345678899999999999999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=289.69 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=198.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.... .....+++|.++.... ....+.+.+|+.+++.++|+| ++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~ 70 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPN-------IIHL 70 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCC-------cceE
Confidence 357899999999999999999875432 2445799999864322 234568899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||
T Consensus 71 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~ni 137 (267)
T cd05066 71 EGVV-------TKSKPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNI 137 (267)
T ss_pred EEEE-------ecCCccEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcE
Confidence 7764 45678899999999999999997532 24788999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
|++.++.++|+|||++......... ....++..|+|||++.+..++.++|+||||+++|++++ |..||.......
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~ 217 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence 9999999999999998765432211 11123568999999998889999999999999999887 999997654221
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... +.+. .. ++....+++.+.+++.+||+.+|.+||++.++++.
T Consensus 218 -~~~~------------~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 218 -VIKA------------IEEG-YR-LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred -HHHH------------HhCC-Cc-CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 1111 1111 01 11122345788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=293.64 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=200.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+...........+++|.+..... ......+.+|+.+++.+.|++ ++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~-------iv~~ 73 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDHPN-------IVKL 73 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC---HHHHHHHHHHHHHHHhcCCCc-------hheE
Confidence 467999999999999999999876433334667899999875422 234567899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------------CCCCCCChHhHHHHHHHHHHHHHHH
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------------ATTPQLGWPNRVKIAMQISRAIQCL 156 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------~~~~~~~~~~~~~~~~~i~~~l~~L 156 (379)
++.+ ..++..++||||+++++|.+++..... .....+++.++..++.|++.||.||
T Consensus 74 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l 146 (288)
T cd05050 74 LGVC-------AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL 146 (288)
T ss_pred EEEE-------cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 7654 445678999999999999999975321 1122377888899999999999999
Q ss_pred HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHH
Q 035572 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233 (379)
Q Consensus 157 H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 233 (379)
|+++ ++||||||+||++++++.++|+|||++........ ......+..|+|||...+..++.++|||||||++|+
T Consensus 147 H~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 224 (288)
T cd05050 147 SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224 (288)
T ss_pred HhCC--eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHH
Confidence 9999 99999999999999999999999999864432211 112235677999999888889999999999999999
Q ss_pred HHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 234 IIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 234 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
|++ |..||.+.... .. ...+.+... ......++.++.+++.+||+.+|.+|||+.|+++-
T Consensus 225 l~~~~~~p~~~~~~~-~~------------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 225 IFSYGMQPYYGMAHE-EV------------IYYVRDGNV--LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred HHhCCCCCCCCCCHH-HH------------HHHHhcCCC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 998 88888654321 11 111111111 11112345789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=286.99 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=198.7
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+.... .....+++|.+...... ...+.+.+|+++++.++|++ ++++++.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~-------i~~~~~~~--- 65 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPN-------VVRLLGVC--- 65 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCC-------hheeeeee---
Confidence 47999999999999987531 23677999998765332 24678999999999999887 77777654
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcC----CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA----TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
......++||||+++++|.+++...... ....+++..+..++.|++.||.|||++| ++|+||+|+||+++
T Consensus 66 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~ 139 (262)
T cd00192 66 ----TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG 139 (262)
T ss_pred ----cCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC
Confidence 3467899999999999999999864211 1244899999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHH
Q 035572 177 SKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIID 252 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~ 252 (379)
+++.++|+|||.+....... ......++..|+|||......++.++||||||+++|+|++ |..||..... ..+..
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~ 218 (262)
T cd00192 140 EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLE 218 (262)
T ss_pred CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHH
Confidence 99999999999997654432 1233457889999999888889999999999999999999 6999977632 11111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. .. ..... ....++.++.+++.+||+.+|.+|||+.+++.+
T Consensus 219 ~~---------~~--~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 219 YL---------RK--GYRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HH---------Hc--CCCCC---CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11 00 11111 123346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=290.57 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=202.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|+..+.||.|++|.||+|.++. +++.+++|.+..... .....++.+|+++++.+.|+| +++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~-------i~~~~ 65 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEIN---EAIQKQILRELDILHKCNSPY-------IVGFY 65 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC-----CCcEEEEEEEecccC---hHHHHHHHHHHHHHHHCCCCc-------hhhhh
Confidence 468889999999999999998764 557799999875432 244577899999999999888 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCce
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNI 173 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NI 173 (379)
+.+ ...+..++++||+++++|.+++.... ..+++..+..++.|++.||.|||+ .| ++|+||||+||
T Consensus 66 ~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni 132 (265)
T cd06605 66 GAF-------YNNGDISICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNI 132 (265)
T ss_pred eee-------ecCCEEEEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHE
Confidence 654 34578999999999999999997632 348888999999999999999999 99 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch-hHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA-SIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~ 252 (379)
++++++.++|+|||.+.......... ..++..|+|||+..+..++.++|+||||+++|+|++|..||...+... ....
T Consensus 133 ~~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (265)
T cd06605 133 LVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211 (265)
T ss_pred EECCCCCEEEeecccchhhHHHHhhc-ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH
Confidence 99999999999999986543322222 578899999999988899999999999999999999999997653211 1111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchH-HHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFME-GAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
....+..... +.... .++.++.++|.+||..||++|||+.+++.|...
T Consensus 212 ---------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 212 ---------LLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ---------HHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 1111111111 11111 256789999999999999999999999988443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.62 Aligned_cols=261 Identities=20% Similarity=0.411 Sum_probs=203.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|+||.||+|..+........+.+++|.+..... ....+.+.+|+.++++++|++ +++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 74 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD---ENLQSEFRRELDMFRKLSHKN-------VVRLL 74 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc---hHHHHHHHHHHHHHHhcCCcc-------eeeeE
Confidence 68999999999999999999987766666778899998864321 234577899999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC----CCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT----TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+.+ .+.+..++||||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ ++||||||
T Consensus 75 ~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp 145 (275)
T cd05046 75 GLC-------REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAA 145 (275)
T ss_pred EEE-------CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCcc
Confidence 664 44567899999999999999997643211 124889999999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
+||+++.++.++++|||++....... ......++..|+|||...+...+.++||||||+++|+|++ |..||....+.
T Consensus 146 ~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~ 225 (275)
T cd05046 146 RNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225 (275)
T ss_pred ceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH
Confidence 99999999999999999985432221 1223356778999999888888999999999999999999 88898654322
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. .... ........+ ....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus 226 ~-~~~~------------~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 226 E-VLNR------------LQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred H-HHHH------------HHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1 1111 110111101 112334689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=288.17 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=195.8
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|++|.||+|.+... ......+++|.++..... ...+.+.+|+.++++++|+| ++++++.+.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~-------iv~~~~~~~-- 66 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHEN-------LIRLYGVVL-- 66 (257)
T ss_pred CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCC-------ccceeEEEc--
Confidence 4689999999999988652 224457999999865432 45678999999999999988 777776642
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
+ ...++||||+++++|.+.+.+... ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.
T Consensus 67 -----~-~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~ 135 (257)
T cd05040 67 -----T-HPLMMVTELAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDK 135 (257)
T ss_pred -----C-CeEEEEEEecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCE
Confidence 2 678999999999999999986432 34889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhh
Q 035572 181 AKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 255 (379)
+||+|||++........ .....++..|+|||+.....++.++|||||||++|+|++ |..||....... .....
T Consensus 136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~- 213 (257)
T cd05040 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKI- 213 (257)
T ss_pred EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-
Confidence 99999999866543211 122357789999999988889999999999999999999 999997553221 11110
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.. ...... .....+..+.+++.+||+.+|++||++.++++.
T Consensus 214 --------~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 214 --------DK-EGERLE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred --------Hh-cCCcCC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 00 011111 112345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.70 Aligned_cols=273 Identities=22% Similarity=0.306 Sum_probs=200.1
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
++++|++.+.||+|+||.||+|.+.. +++.||+|.++.... .....++.+|+.+++.++|+| +++
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------iv~ 67 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP-----TGVKVAIKKISPFEH---QTFCQRTLREIKILRRFKHEN-------IIG 67 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC-----CCCeEEEEEeccccc---chhHHHHHHHHHHHHhCCCCC-------cCc
Confidence 36899999999999999999998764 557799999864221 234567889999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ..+......|+|+||+ +++|.+.+... .+++..+..++.|++.||.|||+.| ++||||||+|
T Consensus 68 ~~~~~~~--~~~~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~N 136 (336)
T cd07849 68 ILDIIRP--PSFESFNDVYIVQELM-ETDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSN 136 (336)
T ss_pred hhheeec--ccccccceEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHH
Confidence 7765432 1133445789999999 46888877532 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..
T Consensus 137 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 137 LLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred EEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999986543322 1123468899999997644 56889999999999999999999999765422
Q ss_pred hhHHHhhhhhhh---HHhhhhh-----------ccccC--CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLIK---EEKLRQV-----------CDSRV--GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~~---~~~~~~~-----------~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..... ...... .+....+ ..... ......+..+..+.+++.+||+.||++|||+.+++.|...
T Consensus 217 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 217 HQLNL-ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred HHHHH-HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 11111 100000 0000000 00000 0011122346779999999999999999999999999554
Q ss_pred c
Q 035572 312 F 312 (379)
Q Consensus 312 ~ 312 (379)
.
T Consensus 296 ~ 296 (336)
T cd07849 296 E 296 (336)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=289.14 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=198.0
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
...++++.....||+|+||.||+|.+.. ++..|++|.+.... ....+.+.+|+.+++.++|+| +
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i 67 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLS-----TQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRN-------I 67 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecC-----CCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCC-------e
Confidence 3456677777899999999999998764 45679999876543 234567899999999999988 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+ ..++..++|+||+++++|.+++..... ....+...+..++.|++.||+|||+.| |+||||||
T Consensus 68 v~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p 136 (268)
T cd06624 68 VQYLGSD-------SENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKG 136 (268)
T ss_pred eeeeeee-------ccCCEEEEEEecCCCCCHHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence 8888764 445789999999999999999975321 111267788889999999999999999 99999999
Q ss_pred CceEEcC-CCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCC--CCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 171 TNILFDS-KWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSK--LSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 171 ~NIll~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+||+++. ++.++|+|||++....... ......++..|+|||++.+.. ++.++|+||||+++|+|++|+.||.....
T Consensus 137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999975 6789999999986543222 222335889999999876543 78899999999999999999999975433
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
........ ...... +......+.++.+++.+||+.+|.+|||+.+++.|.
T Consensus 217 ~~~~~~~~----------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 217 PQAAMFKV----------GMFKIH---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred hhhhHhhh----------hhhccC---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 22111000 000111 112233457899999999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.01 Aligned_cols=276 Identities=20% Similarity=0.256 Sum_probs=198.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh-ccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-SNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~~~~~~~iv~~ 93 (379)
++|++.+.||+|+||.||+|.+.. +++.|++|.++..... ......+.+|+.+++.+.+ +| ++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~-------i~~~ 66 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-----TGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIY-------IVRL 66 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-----CCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCC-------ccce
Confidence 479999999999999999998764 5678999987654221 2344678899999999964 56 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.... .......|+||||++ ++|.+++..........+++..+..++.|++.||.|||+.| ++||||+|+||
T Consensus 67 ~~~~~~~~--~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~ni 141 (295)
T cd07837 67 LDVEHVEE--KNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNL 141 (295)
T ss_pred eeeEeecC--CCCCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHE
Confidence 65542211 012234899999996 58999887654332345899999999999999999999999 99999999999
Q ss_pred EEcC-CCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDS-KWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~-~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+++. ++.++|+|||++...... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+..+....
T Consensus 142 l~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 221 (295)
T cd07837 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221 (295)
T ss_pred EEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 9998 889999999998654322 22223357889999997754 45789999999999999999999999876544333
Q ss_pred HHhhhhhhh--HHhhhh---------hcccc-CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIK--EEKLRQ---------VCDSR-VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~--~~~~~~---------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
......... ...... ..... .......+..+..+.++|.+||+.||.+||++.|++.|.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~ 292 (295)
T cd07837 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292 (295)
T ss_pred HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence 221110000 000000 00000 000011123567899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=293.39 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=197.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~ 93 (379)
++|+..+.||+|+||.||++.+.. .++.+|+|.+...... .....+.+|+.++.++. |+| ++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~-------iv~~ 68 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP-----SGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPY-------IVKF 68 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC-----CCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCC-------Eeee
Confidence 356677899999999999998764 4578999998754322 34567889999999996 777 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~N 172 (379)
++.+ ..++..+++|||+ +++|.++...........+++..+..++.|++.||+|||+. + ++||||||+|
T Consensus 69 ~~~~-------~~~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~N 138 (288)
T cd06616 69 YGAL-------FREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSN 138 (288)
T ss_pred eeEE-------ecCCcEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHH
Confidence 8764 3457889999999 56776655432112234488999999999999999999974 8 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC---CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS---KLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|+++.++.++|+|||++.............++..|+|||++.+. .++.++||||||+++|+|++|+.||.......
T Consensus 139 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~- 217 (288)
T cd06616 139 ILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF- 217 (288)
T ss_pred EEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-
Confidence 99999999999999998655443333344688999999988766 68899999999999999999999997543111
Q ss_pred HHHhhhhhhhHHhhhhhcccc-CCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSR-VGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.......... ... +.....++.++.+|+.+||+.||++|||+++++.|...
T Consensus 218 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 218 -----------DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred -----------HHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0111111110 001 11113356789999999999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=295.29 Aligned_cols=264 Identities=18% Similarity=0.337 Sum_probs=201.4
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCC--CCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCc
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQ--TDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNY 88 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~ 88 (379)
...++|.+.+.||+|+||.||+|...... .......+++|....... ......+.+|+.+++.+ +|+|
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~------ 82 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKN------ 82 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCC------
Confidence 34578999999999999999999764321 222456799999864321 23457789999999999 7877
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
++++++.+ ...+..++||||+++++|.+++.+.... ....+++.++..++.|++.||.|||
T Consensus 83 -i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 154 (304)
T cd05101 83 -IINLLGAC-------TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA 154 (304)
T ss_pred -chheeEEE-------ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 77767653 4467889999999999999999864321 1234788889999999999999999
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHH
Q 035572 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 234 (379)
++| ++||||||+||++++++.++|+|||++........ .....+++.|+|||+..+..++.++||||||+++|+|
T Consensus 155 ~~g--ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 155 SQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred HCC--eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999 99999999999999999999999999876543221 1223456789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 235 IS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 235 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
++ |..||.... ...+.... . . ..... ....++..+.+++.+||+.+|.+|||+.++++..
T Consensus 233 ~~~g~~p~~~~~-~~~~~~~~----~-----~--~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 233 FTLGGSPYPGIP-VEELFKLL----K-----E--GHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HcCCCCCcccCC-HHHHHHHH----H-----c--CCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 98 788886543 11111110 0 0 01111 1123457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=292.52 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=201.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||++.+.. .++.+++|.+.... ....+.+.+|+.+++.++|+| ++++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~-------i~~~ 81 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-----TGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPN-------IVNY 81 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-----CCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCC-------eeeh
Confidence 4689999999999999999998654 45679999886432 233567899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..|+|+||+++++|.+++.+. .+++.++..++.|++.||.|||++| ++|+||+|+||
T Consensus 82 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Ni 146 (293)
T cd06647 82 LDSY-------LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 146 (293)
T ss_pred hhee-------eeCCcEEEEEecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHE
Confidence 7764 4467899999999999999998642 2778899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+++.++.++|+|||++....... ......+++.|+|||.+....++.++|+||||+++|++++|+.||...+.......
T Consensus 147 li~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred EEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 99999999999999885543322 22334688899999998888889999999999999999999999976543221110
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
. ....... .......+..+.+++.+||..+|++||++.+++.|...
T Consensus 227 ~------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 227 I------------ATNGTPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred h------------hcCCCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 0 0001111 11122345679999999999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=289.05 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=189.5
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||+|+||.||+|.+..++ ....+++|..+.... ....+.+.+|+.++.++ .|+| ++++++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~-------iv~~~~~~-- 65 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPN-------IINLLGAC-- 65 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC---CeeEEEEEEccccCC---HHHHHHHHHHHHHHHhhccCCC-------eeeEEEEE--
Confidence 46899999999999876532 223578888763211 23456788999999999 6777 88877764
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
...+..++||||+++++|.+++...... ....+++.++..++.|++.||+|||+.| ++||||
T Consensus 66 -----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~di 138 (270)
T cd05047 66 -----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDL 138 (270)
T ss_pred -----ecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--Eeeccc
Confidence 4456789999999999999999764321 1234788999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
||+||++++++.++|+|||++..............+..|+|||+.....++.++||||||+++|+|++ |..||...+..
T Consensus 139 kp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~ 218 (270)
T cd05047 139 AARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 218 (270)
T ss_pred ccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH
Confidence 99999999999999999999853322111122234667999999988889999999999999999997 99999654321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. ..... .. ......+ ...+.++.+++.+||+.||.+|||+.+++..
T Consensus 219 ~-~~~~~---------~~--~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 219 E-LYEKL---------PQ--GYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred H-HHHHH---------hC--CCCCCCC---CcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1 11100 00 0111111 2234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=297.21 Aligned_cols=272 Identities=23% Similarity=0.280 Sum_probs=199.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.++..... ......+.+|+.++++++|++ ++++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i~~~ 71 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT-----SGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPN-------IVEL 71 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC-----CCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCC-------Ccce
Confidence 4689999999999999999998764 5567999998654321 222345678999999999988 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ...+..++||||+. ++|.+++.... ..+++.++..++.|++.||.|||+.| ++||||||+||
T Consensus 72 ~~~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ni 139 (309)
T cd07845 72 KEVVVG-----KHLDSIFLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNL 139 (309)
T ss_pred EEEEec-----CCCCeEEEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 766432 22356899999995 68998887532 34889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++++++.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...++...+.
T Consensus 140 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~ 219 (309)
T cd07845 140 LLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219 (309)
T ss_pred EECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999987654332 2222346788999998765 457899999999999999999999998665433222
Q ss_pred Hhhhhhhh---HHhh---hh-----hcc-ccCCCC---cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 252 DWALPLIK---EEKL---RQ-----VCD-SRVGLP---TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~---~~~~---~~-----~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.... ... ...+ .. ... ...... ......++.+.++|.+||+.||++|||+.+++.|....
T Consensus 220 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 220 LIIQ-LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred HHHH-hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 1111 000 0000 00 000 000000 01122467889999999999999999999999985554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=286.26 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=197.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|... ++.+++|.+.... ...+++.+|+.+++.++|+| ++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~-------i~~~ 65 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPN-------LVQL 65 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-------CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcc-------eeee
Confidence 467999999999999999999753 4669999987542 24678999999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++| ++|+||||+||
T Consensus 66 ~~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Ni 133 (256)
T cd05039 66 LGVV-------LQGNPLYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNV 133 (256)
T ss_pred EEEE-------cCCCCeEEEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceE
Confidence 7764 33678899999999999999997643 124889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~ 252 (379)
+++.++.++|+|||.+........ ....+..|+|||+.....++.++|+||||+++|++++ |..||..... ..+..
T Consensus 134 li~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~ 210 (256)
T cd05039 134 LVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVP 210 (256)
T ss_pred EEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHH
Confidence 999999999999999876633222 2345678999999988889999999999999999997 9999865431 11111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... . +.....+ ...++.+.+++.+||..+|++|||+.+++..
T Consensus 211 ~~~---------~--~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 211 HVE---------K--GYRMEAP---EGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHh---------c--CCCCCCc---cCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 110 0 0111111 2345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=286.62 Aligned_cols=246 Identities=22% Similarity=0.385 Sum_probs=190.3
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccC
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS 101 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~ 101 (379)
.||+|+||.||+|.+.... .+..||+|.+..... ....+.+.+|+.++++++|+| ++++++.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------ii~~~~~~---- 64 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPY-------IVRMIGVC---- 64 (257)
T ss_pred ccCCCCcccEEEEEEecCC---CceeEEEEEcccccC---hHHHHHHHHHHHHHHhcCCCC-------eEEEEEEE----
Confidence 3899999999999875322 345699999875421 334567999999999999988 88887753
Q ss_pred CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCe
Q 035572 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181 (379)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~ 181 (379)
..+..++||||+++++|.+++... ...+++..+..++.|++.||.|||++| ++||||||+||+++.++.+
T Consensus 65 ----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~ 134 (257)
T cd05115 65 ----EAEALMLVMEMASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYA 134 (257)
T ss_pred ----cCCCeEEEEEeCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcE
Confidence 134689999999999999998742 234889999999999999999999999 9999999999999999999
Q ss_pred EEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhh
Q 035572 182 KLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 182 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 256 (379)
||+|||++........ .....++..|+|||......++.++||||||+++|++++ |..||....... +...
T Consensus 135 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~--- 210 (257)
T cd05115 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSF--- 210 (257)
T ss_pred EeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHH---
Confidence 9999999865433221 111233578999999888889999999999999999996 999997654321 1111
Q ss_pred hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.... . +.....+++++.+++.+||+.+|++||++.++.+..
T Consensus 211 ---------~~~~~-~-~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 211 ---------IEQGK-R-LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred ---------HHCCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00100 0 111223457899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=299.74 Aligned_cols=274 Identities=19% Similarity=0.279 Sum_probs=203.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||.|+||.||+|.+.. +++.|++|++...... ....+.+.+|+.+++.++|+| +++
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------iv~ 68 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTR-----SGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKHDN-------IIA 68 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEecccccc--ccchHHHHHHHHHHHhcCCCC-------ccC
Confidence 35789999999999999999998765 4567999998754321 344677889999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+... .......++||||+ +++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 69 ~~~~~~~~---~~~~~~~~lv~e~~-~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~N 137 (334)
T cd07855 69 IRDILRPP---GADFKDVYVVMDLM-ESDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSN 137 (334)
T ss_pred HHHhcccc---CCCCceEEEEEehh-hhhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence 77654321 12346789999999 56999988642 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|++++++.+||+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 138 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred EEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 9999999999999999865432221 123468899999998755 4588999999999999999999999976544
Q ss_pred chhHHHhhhh----------hhhHHhhhhh---ccccCCC--CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 247 PASIIDWALP----------LIKEEKLRQV---CDSRVGL--PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 247 ~~~~~~~~~~----------~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...+...... .......... ....... .......+..+.+++.+||+.+|++||++.+++.|...
T Consensus 218 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 3222111100 0000001111 1111111 11123456889999999999999999999999998444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=293.02 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=196.7
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
++++|.+.+.||+|+||.||+|.+.. +++.+++|.+..... ......+.+|+.+++.++|+| +++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~n-------i~~ 67 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHAN-------IVL 67 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcC-----CCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCC-------EeE
Confidence 46789999999999999999998765 456799999865422 233456788999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+++..|+||||+ +++|.+.+... ...+++..+..++.|++.||.|||+.| ++|+||||+|
T Consensus 68 ~~~~~-------~~~~~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~N 133 (291)
T cd07870 68 LHDII-------HTKETLTFVFEYM-HTDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQN 133 (291)
T ss_pred EEEEE-------ecCCeEEEEEecc-cCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHH
Confidence 77764 4467899999999 57887776542 223677888899999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|+++.++.++|+|||++....... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||....+....
T Consensus 134 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 134 LLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred EEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 999999999999999986543222 22334578999999988653 5788999999999999999999999866543222
Q ss_pred HHhhhhhhh---HHh------hhhhcccc--CCCCcch------HHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIK---EEK------LRQVCDSR--VGLPTFM------EGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~---~~~------~~~~~~~~--~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
......... ... ........ ...+... ...+..+.+++.+|+..||++|||+.|++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~ 289 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence 111110000 000 00000000 0000000 01146788999999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=287.77 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=204.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||.|++|.||+|.+.. +++.+++|.+...... .....+.+|+.++..++|++ +++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~-------i~~~~ 65 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-----TGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPY-------VVKCY 65 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCC-------eeeEE
Confidence 368899999999999999998765 5677999998754321 44678999999999999888 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCce
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNI 173 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NI 173 (379)
+.+ ...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||
T Consensus 66 ~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni 131 (264)
T cd06623 66 GAF-------YKEGEISIVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNL 131 (264)
T ss_pred EEE-------ccCCeEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHE
Confidence 764 3457899999999999999999754 238899999999999999999999 99 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc-cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC--chhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM-VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD--PASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~ 250 (379)
+++.++.++|+|||++......... ....++..|+|||...+..++.++|+||||+++|+|++|..||..... ....
T Consensus 132 ~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 132 LINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred EECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 9999999999999998665443322 244688999999999988899999999999999999999999977652 1111
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHH-HHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEG-AIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
. ..+..... +..... ++..+.+++.+||..+|++||++.++++|..
T Consensus 212 ~------------~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 212 M------------QAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred H------------HHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 1 11111111 111222 5678999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=287.97 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=197.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|++.+.||+|+||.||+|.+..... ....|++|.+..... ......+.+|+.+++.+.|+| +++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~n-------i~~~~ 71 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK--REIFVAIKTLKSGYT---EKQRRDFLSEASIMGQFDHPN-------IIHLE 71 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC--CceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCcC-------cceEE
Confidence 358899999999999999998765332 345799999875321 344678999999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .++...++||||+++++|.+++... ...+++.+++.++.|++.||+|||++| ++|+||||+||+
T Consensus 72 ~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nil 138 (269)
T cd05065 72 GVV-------TKSRPVMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNIL 138 (269)
T ss_pred EEE-------CCCCceEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEE
Confidence 663 4567889999999999999999753 234889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc---cccC---ccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM---VQPA---GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~---~~~~---gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
++.++.++|+|||++......... .... .+..|+|||++.+..++.++|||||||++||+++ |..||......
T Consensus 139 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 139 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred EcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 999999999999998654332211 1111 2457999999998899999999999999999886 99999765321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. ..... .. ....+. ...++..+.+++.+||+.+|.+||++.+++..
T Consensus 219 ~-~~~~i---------~~--~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 219 D-VINAI---------EQ--DYRLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred H-HHHHH---------Hc--CCcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 11110 00 111111 12345778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.43 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=198.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|.....||.|+||.||+|.+.. .++.|++|.+.... ....+.+.+|+.+++.+.|+| +++++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~-------i~~~~ 84 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKH-----SGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQN-------VVEMY 84 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcC-----CCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCc-------hhhhh
Confidence 456667789999999999998754 45679999986432 233567889999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ..++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++| ++||||||+||+
T Consensus 85 ~~~-------~~~~~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nil 149 (297)
T cd06659 85 KSY-------LVGEELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSIL 149 (297)
T ss_pred hhe-------eeCCeEEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeE
Confidence 653 446789999999999999998753 23788999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++....... ......++..|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~- 228 (297)
T cd06659 150 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR- 228 (297)
T ss_pred EccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 9999999999999986443222 22334689999999999888899999999999999999999999976543221111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+..............+..+.+++.+||+.+|.+||+++++++|...
T Consensus 229 ------------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 229 ------------LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred ------------HhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 1011111111122345678999999999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=295.53 Aligned_cols=264 Identities=19% Similarity=0.333 Sum_probs=200.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCC--CCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCce
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQ--TDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYC 89 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~ 89 (379)
..++|.+.+.||+|+||.||+|...... .......+++|.++.... ......+.+|+.+++.+ +|+|
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~------- 79 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKN------- 79 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCC-------
Confidence 3468999999999999999999764321 123456799999874322 23356788999999999 5887
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHc
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHE 158 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~ 158 (379)
|+++++.+ .+.+..++||||+++++|.+++..... .....+++.++..++.|++.||.|||+
T Consensus 80 iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 152 (314)
T cd05099 80 IINLLGVC-------TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152 (314)
T ss_pred eeeEEEEE-------ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 88887764 345678999999999999999976432 112348888999999999999999999
Q ss_pred CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHH
Q 035572 159 NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 159 ~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 235 (379)
+| ++||||||+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 153 ~g--i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 230 (314)
T cd05099 153 RR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230 (314)
T ss_pred CC--eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHH
Confidence 99 99999999999999999999999999965543221 11223456799999988888999999999999999999
Q ss_pred h-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 236 S-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 236 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+ |..||..... ..+... +.... . ......++.++.+++.+||+.+|++|||+.++++...
T Consensus 231 ~~g~~p~~~~~~-~~~~~~------------~~~~~-~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 231 TLGGSPYPGIPV-EELFKL------------LREGH-R-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred hCCCCCCCCCCH-HHHHHH------------HHcCC-C-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9 8899865432 111111 01110 0 1112233567889999999999999999999997644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.92 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=192.6
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+.... .....+++|.+...... ...+.+.+|+.+++.+.|++ ++++++.+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~--~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~-------iv~~~~~~~-- 66 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS--GKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPC-------IVRLIGVCK-- 66 (257)
T ss_pred CccCccCceeEEEeEeeccC--CCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCC-------eeeEEEEEc--
Confidence 47999999999999875432 24467999998755332 34567899999999999888 888877532
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.
T Consensus 67 ------~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~ 133 (257)
T cd05060 67 ------GEPLMLVMELAPLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQ 133 (257)
T ss_pred ------CCceEEEEEeCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCc
Confidence 346799999999999999997532 4889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhh
Q 035572 181 AKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 255 (379)
++|+|||++......... ....++..|+|||...+..++.++||||||+++|+|++ |..||...+.. .......
T Consensus 134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~ 212 (257)
T cd05060 134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE 212 (257)
T ss_pred EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH
Confidence 999999998655333221 11123467999999988899999999999999999998 99999765432 2211110
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. .... ....++..+.+++.+||..+|++||++.++++..
T Consensus 213 ----~~-------~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 213 ----SG-------ERLP---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred ----cC-------CcCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 00 0111 1123457899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=293.11 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=196.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|++|.||+|.++. +++.|++|.+..... ......+.+|+.+++.++|+| ++++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------i~~~ 68 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL-----TGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHAN-------IVTL 68 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC-----CCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcc-------eeeE
Confidence 3689999999999999999998754 457799999875421 122345678999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~ni 134 (291)
T cd07844 69 HDII-------HTKKTLTLVFEYLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNL 134 (291)
T ss_pred EEEE-------ecCCeEEEEEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHE
Confidence 7663 45678999999996 59999887532 24788999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+++.++.++|+|||++....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||..........
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 214 (291)
T cd07844 135 LISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214 (291)
T ss_pred EEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence 99999999999999986543221 1222356889999998765 457889999999999999999999997655332221
Q ss_pred Hhhhhhhh---HHhhhhhc------cccCC--CCcc----hHHHH--HHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIK---EEKLRQVC------DSRVG--LPTF----MEGAI--KQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~---~~~~~~~~------~~~~~--~~~~----~~~~~--~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
........ ...+.... ..... .+.. ..... ..+.+++.+||+.+|++|||+.+++.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred HHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 11111000 00000000 00000 0000 01112 6788999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=297.52 Aligned_cols=265 Identities=19% Similarity=0.323 Sum_probs=201.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCC--CCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTD--GDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
..+|++.+.||+|+||.||+|.+...... .....+++|.+..... ....+.+.+|+.+++++ +|+| |
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~-------i 80 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT---DKDLSDLVSEMEMMKMIGKHKN-------I 80 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC---HHHHHHHHHHHHHHHhhcCCCC-------e
Confidence 45799999999999999999987543222 2334689998764321 23457789999999999 6887 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
+++++.+ ...+..+++|||+++++|.+++..... .....+++.++..++.|++.||.|||++
T Consensus 81 v~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 153 (334)
T cd05100 81 INLLGAC-------TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ 153 (334)
T ss_pred eeeeEEE-------ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 8877764 345678999999999999999976431 1234478888999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
| ++||||||+|||+++++.++|+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++
T Consensus 154 g--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 154 K--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred C--eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence 9 99999999999999999999999999865533221 122234568999999988889999999999999999998
Q ss_pred -CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 237 -CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 237 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
|..||..... ..... .+..... +.....++.++.+++.+||+.+|++||++.+++.+....
T Consensus 232 ~g~~p~~~~~~-~~~~~------------~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 232 LGGSPYPGIPV-EELFK------------LLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred cCCCCCCCCCH-HHHHH------------HHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 8899865432 11111 1111100 111123356899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.26 Aligned_cols=256 Identities=20% Similarity=0.360 Sum_probs=198.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+.+|+..+.||+|+||.||+|.+..... ....+++|.+..... ....+.+..|+++++.++|+| ++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~ 71 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR--KEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHN-------IIRL 71 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC--CceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCC-------eeEE
Confidence 4578889999999999999999865322 345799999865421 233567899999999999888 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
.+.+ .+.+..++||||+++++|.+++... ...+++.++..++.|++.||+|||+.| ++|+||||+||
T Consensus 72 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Ni 138 (268)
T cd05063 72 EGVV-------TKFKPAMIITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNI 138 (268)
T ss_pred EEEE-------ccCCCcEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhE
Confidence 7664 4567889999999999999999752 234888999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
++++++.++|+|||++......... .....+..|+|||++....++.++|||||||++|+|++ |..||.......
T Consensus 139 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~ 218 (268)
T cd05063 139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218 (268)
T ss_pred EEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 9999999999999998655332211 11123457999999988889999999999999999998 999997543211
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .+.. ... .+.....+.++.+++.+||+.+|++||++.++++..
T Consensus 219 -~~~------------~i~~-~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 219 -VMK------------AIND-GFR-LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred -HHH------------HHhc-CCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111 1111 111 111223457899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=321.34 Aligned_cols=266 Identities=22% Similarity=0.414 Sum_probs=213.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++-+..+.||+|.||.||.|...+.......-.||+|.++.... .....+|.+|+.+|+.+.|+| ||.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~---~~~~~~Fl~Ea~~m~~f~HpN-------iv~l 760 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS---EQEVSDFLKEALLMSKFDHPN-------IVSL 760 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCcc-------eeeE
Confidence 356677889999999999999988765544456699999875432 456788999999999999999 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC--CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
+|.++. ....+|++|||+||+|..+|++.... ....++..+.+.++.||++|+.||++++ +|||||...
T Consensus 761 iGv~l~-------~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaR 831 (1025)
T KOG1095|consen 761 IGVCLD-------SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAAR 831 (1025)
T ss_pred EEeecC-------CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhh
Confidence 998754 57889999999999999999975322 1445888999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
|+||+....+||+|||+|+..-....+ ....-...|||||.+..+.++.++|||||||++||++| |..||...++.
T Consensus 832 NCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 832 NCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred heeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 999999999999999999743222221 11234568999999999999999999999999999999 99999877654
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
+-+... ..+.++..|.. ++..+.+++..||+.+|++||++..+++......
T Consensus 912 ~v~~~~------------~~ggRL~~P~~---CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 912 EVLLDV------------LEGGRLDPPSY---CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHHHHH------------HhCCccCCCCC---CChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 322211 12334444543 4577889999999999999999999998544433
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=295.93 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=209.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|..-++||+||||.||-|+.++ +|+.+|.|++.+.... .........+|-.+|.++..+- ||.+-
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvra-----TGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~F-------iVsla 251 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRA-----TGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPF-------IVSLA 251 (591)
T ss_pred cceeeeEEEecccccceeEEEEec-----chhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCc-------EEEEe
Confidence 568888999999999999998766 7788999887643221 1222345678999999887553 55533
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
..|++.+.+|+||..|+||+|.-.|...+ ++.+++..++-++.+|+.||++||..+ ||+|||||+|||
T Consensus 252 -------YAfeTkd~LClVLtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNIL 319 (591)
T KOG0986|consen 252 -------YAFETKDALCLVLTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENIL 319 (591)
T ss_pred -------eeecCCCceEEEEEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhhee
Confidence 33788999999999999999998887743 456999999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+|+.|+++|+|+|+|...+........+||.+|||||++.++.|+...|.|||||++|+|+.|+.||.....-..
T Consensus 320 LDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----- 394 (591)
T KOG0986|consen 320 LDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----- 394 (591)
T ss_pred eccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----
Confidence 999999999999999988887777777999999999999999999999999999999999999999976542110
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCcc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCFF 313 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~~ 313 (379)
.++.-..+...... +....++++.++...+|+.||.+|. .++++-+|.....
T Consensus 395 ----~eEvdrr~~~~~~e---y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 395 ----REEVDRRTLEDPEE---YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred ----HHHHHHHHhcchhh---cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 11111122222222 2355678899999999999999996 5567777765544
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=292.55 Aligned_cols=268 Identities=20% Similarity=0.273 Sum_probs=199.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|+||.||+|.++. +++.+++|.++..... ......+.+|+.++++++|+| +++++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~n-------i~~~~ 70 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK-----TGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPN-------IVTVK 70 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC-----CCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCC-------EEEEE
Confidence 579999999999999999998764 4567999998754322 233456788999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. .+.+..|+||||+. ++|.+++.... ..+++.+++.++.|++.||+|||+.| ++|+||||+||+
T Consensus 71 ~~~~~-----~~~~~~~lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nil 138 (293)
T cd07843 71 EVVVG-----SNLDKIYMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLL 138 (293)
T ss_pred EEEEe-----cCCCcEEEEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEE
Confidence 77532 22378999999995 69999887532 24899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........
T Consensus 139 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (293)
T cd07843 139 LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218 (293)
T ss_pred ECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999999999998665443 222334578899999987654 468899999999999999999999976554322211
Q ss_pred hhhhhhh---HHhhh---hhc--------cccC-CCCcchHH--HHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIK---EEKLR---QVC--------DSRV-GLPTFMEG--AIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~---~~~~~---~~~--------~~~~-~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. .... ...+. ... .... ........ .++.+.+++.+||+.||++|||+.|++.|.
T Consensus 219 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~ 291 (293)
T cd07843 219 IF-KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291 (293)
T ss_pred HH-HHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence 11 0000 00000 000 0000 00001111 357789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.01 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=188.6
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|..... .....+++|.+..... ......+.+|+.+++.++|+| |+++++.+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~n-------ii~~~~~~--- 64 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG---MSKARVVVKELRASAT---PDEQLLFLQEVQPYRELNHPN-------VLQCLGQC--- 64 (269)
T ss_pred CcCCccCCceEEEEEEecC---CCCeEEEEeecCccCC---hHHHHHHHHHHHHHHhCCCCC-------cceEEEEE---
Confidence 3689999999999975432 2456789998764321 233467889999999999988 88888764
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+....++||||+++|+|.+++...........++.....++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 65 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~ 138 (269)
T cd05042 65 ----IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLS 138 (269)
T ss_pred ----CCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCc
Confidence 34578899999999999999998754333334567788899999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCc---ccccCccccccCCCCCC-------CCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 181 AKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTN-------PSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
+||+|||++........ .....++..|+|||+.. ...++.++|||||||++|+|++ |..||....+...
T Consensus 139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (269)
T cd05042 139 VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV 218 (269)
T ss_pred EEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 99999999855332211 12234567899999764 3456889999999999999999 7888876543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+.... .........+......+..+.+++..|+ .||++|||++++++.
T Consensus 219 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 219 LKQVV----------REQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred HHHHh----------hccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 11100 0011111122223345577788888998 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=293.86 Aligned_cols=271 Identities=23% Similarity=0.275 Sum_probs=201.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+|++.+.||.|+||.||+|.+.. +++.|++|.++..... ........+..|+++++.++|+| +++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-------i~~~~ 68 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-----TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN-------IIGLL 68 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-----CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCC-------Chhhh
Confidence 58889999999999999998765 4567999998754322 01223456788999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+.+..++||||+ +++|.+++.... ..+++..+..++.|+++||.|||++| ++|+||+|+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil 134 (298)
T cd07841 69 DVF-------GHKSNINLVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLL 134 (298)
T ss_pred hee-------ecCCEEEEEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEE
Confidence 664 4467899999999 999999997532 24889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||....+...+..
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 135 IASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred EcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 9999999999999986654332 2223356888999998754 4578899999999999999999888876554332211
Q ss_pred hhhhhhh---HHhh------hhhcccc----CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIK---EEKL------RQVCDSR----VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~---~~~~------~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.. .... .... ....... ..........+..+.+++.+||+.||++|||+.|++.|.....
T Consensus 215 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 215 IF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred HH-HHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 11 0000 0000 0000000 0001112334678999999999999999999999999854433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=290.24 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=197.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. .++.|++|.+...... .....+.+.+|+.+++.++|+| ++++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~n-------iv~~ 80 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPN-------TIEY 80 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcC-----CCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCC-------EEEE
Confidence 4679999999999999999998754 4577999988643221 1334567889999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.| ++|+||+|+||
T Consensus 81 ~~~~-------~~~~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nI 146 (307)
T cd06607 81 KGCY-------LREHTAWLVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNI 146 (307)
T ss_pred EEEE-------EeCCeEEEEHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccE
Confidence 8775 34577899999995 68878776422 23889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++++++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++|+|+||..||...+.....
T Consensus 147 l~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~ 223 (307)
T cd06607 147 LLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (307)
T ss_pred EECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence 9999999999999998655332 2346888999999863 456888999999999999999999999765422211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... ...... ......++..+.+++.+||+.+|++||++.+++.|.
T Consensus 224 ~~~------------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 224 YHI------------AQNDSP--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHH------------hcCCCC--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 100 000111 111233567899999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=298.81 Aligned_cols=274 Identities=21% Similarity=0.307 Sum_probs=201.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+..+|++.+.||.|+||.||+|.+.. +++.|++|.+...... ......+.+|+.+++.++|+| +++
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------i~~ 68 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE-----TNEKVAIKKIANAFDN--RIDAKRTLREIKLLRHLDHEN-------VIA 68 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC-----CCCeEEEEEecccccc--cchhHHHHHHHHHHHhcCCCC-------ccc
Confidence 35689999999999999999998654 5678999998653211 233566789999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.... .......|+||||+ +++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|
T Consensus 69 ~~~~~~~~~--~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~N 138 (337)
T cd07858 69 IKDIMPPPH--REAFNDVYIVYELM-DTDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSN 138 (337)
T ss_pred hHHheeccc--ccccCcEEEEEeCC-CCCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHH
Confidence 777653211 12234689999999 57999888643 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|+++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 139 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 139 LLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred EEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 99999999999999999765433 22334468899999997654 46889999999999999999999999765321111
Q ss_pred HHhhhhh-----------hhHHhhhhhc---ccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPL-----------IKEEKLRQVC---DSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~-----------~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
. ..... .......... ... .......+.+++.+.+++.+||+.+|++|||++++++|...
T Consensus 219 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 219 K-LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred H-HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 0 00000 0000000000 000 00011123456789999999999999999999999999544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.64 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=195.7
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||++.+.. ...+++|.+... ....+.+.+|+.+++.++|++ ++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~-------i~ 64 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDK-------LV 64 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC------CccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCC-------cc
Confidence 346789999999999999999997543 234899987643 223567899999999999988 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+. . ...+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 65 ~~~~~~~-------~-~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ 131 (260)
T cd05073 65 KLHAVVT-------K-EPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAA 131 (260)
T ss_pred eEEEEEc-------C-CCeEEEEEeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcc
Confidence 7776642 2 56799999999999999997632 234788889999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
||+++.++.++|+|||++........ .....++..|+|||++....++.++|+||||+++|+++| |..||...+...
T Consensus 132 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~ 211 (260)
T cd05073 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211 (260)
T ss_pred eEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865433221 112245678999999988889999999999999999999 999997654322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..... ..... .......+.++.+++.+||+.+|++||++.++++.
T Consensus 212 -~~~~~-------------~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05073 212 -VIRAL-------------ERGYR-MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSV 256 (260)
T ss_pred -HHHHH-------------hCCCC-CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11110 01111 11112345789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=277.69 Aligned_cols=275 Identities=19% Similarity=0.289 Sum_probs=218.9
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRN 85 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~ 85 (379)
|+|..++| .+.||+|+|+.|--|+... +++.||||++.+.. .-...++.+|++++.+.+ |+|
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~-----t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~n--- 137 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQ-----TGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKN--- 137 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeec-----cchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCcc---
Confidence 56666666 5789999999999997544 66779999997652 345788999999999997 445
Q ss_pred CCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 86 PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 86 ~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
|++++++ |+++...|||||.|.||+|.+.|.++.. |++.++..++.+|+.||.+||.+| |.|
T Consensus 138 ----ilqLief-------FEdd~~FYLVfEKm~GGplLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~kg--IAH 199 (463)
T KOG0607|consen 138 ----ILQLIEF-------FEDDTRFYLVFEKMRGGPLLSHIQKRKH-----FNEREASRVVKDIASALDFLHTKG--IAH 199 (463)
T ss_pred ----HHHHHHH-------hcccceEEEEEecccCchHHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhcC--ccc
Confidence 7777765 6889999999999999999999987553 999999999999999999999999 999
Q ss_pred cCCCCCceEEcCCCC---eEEeccccCccCCC--------CCcccccCccccccCCCCCC-----CCCCCCcCCeehhHH
Q 035572 166 RDIKSTNILFDSKWD---AKLADFGLAVSESD--------ESSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGV 229 (379)
Q Consensus 166 ~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~ 229 (379)
|||||+|||...... +||+||.++..... .....+++|+..|||||+.. ...|+.++|.||||+
T Consensus 200 RDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGv 279 (463)
T KOG0607|consen 200 RDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGV 279 (463)
T ss_pred ccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHH
Confidence 999999999975544 79999988632211 11234567999999999653 235889999999999
Q ss_pred HHHHHHhCCCCCCCCCCch--hHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 230 VLLEIISCRKPIDAARDPA--SIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 230 il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
|+|-|++|.+||.+....+ ..-........+..+..+.+..+..|+ .+..++.+..++++.+|..|+.+|.++.+++
T Consensus 280 IlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 280 ILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 9999999999998765421 111122233445566677777787777 5778889999999999999999999999999
Q ss_pred ccccCccccc
Q 035572 307 MGCSCFFVDH 316 (379)
Q Consensus 307 ~~~~~~~~~~ 316 (379)
.|........
T Consensus 360 nhPw~~~~~~ 369 (463)
T KOG0607|consen 360 NHPWVQRCAP 369 (463)
T ss_pred CCccccccch
Confidence 9876655443
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=286.57 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=197.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch------hhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE------VLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
+|.+.+.||.|+||.||+|.+.. +++.+++|.++..... ......+.+.+|+.+++.++|++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------- 69 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-----TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN------- 69 (272)
T ss_pred ceeecceecccCceEEEEEeecC-----CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCC-------
Confidence 58889999999999999998654 4567999987543211 11223457889999999999888
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
++++++.+ ...+..++||||+.+++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||+
T Consensus 70 i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~ 135 (272)
T cd06629 70 IVQYLGFE-------TTEEYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLK 135 (272)
T ss_pred cceEEEEe-------ccCCceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCC
Confidence 77777653 45678999999999999999997642 3888889999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCC--CCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSK--LSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
|+||+++.++.++|+|||++....... ......++..|+|||...... ++.++|+||||+++|++++|..||...
T Consensus 136 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 136 ADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred hhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999999986543221 122345889999999876554 789999999999999999999999654
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.......... . .......+ .....++..+.+++.+||..+|++||+++++++|.
T Consensus 216 ~~~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 216 EAIAAMFKLG----------N-KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred chHHHHHHhh----------c-cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 3222111100 0 00011111 12234567899999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=314.18 Aligned_cols=284 Identities=20% Similarity=0.252 Sum_probs=191.7
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCC----------ceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhc
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGD----------HKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 81 (379)
...++|++++.||+|+||.||+|..+....... ++..+.+.+... ..........+.+|+.+|+.++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR-VKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHH-hhcchHHHHHHHHHHHHHHhCCCC
Confidence 446799999999999999999987654221100 011111111100 011123456789999999999998
Q ss_pred cCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCC
Q 035572 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDP 161 (379)
Q Consensus 82 ~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 161 (379)
| |+++++++ ...+..|+|++++ +++|.+++...............++.++.|++.||.|||++|
T Consensus 224 n-------Iv~l~~~~-------~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g- 287 (501)
T PHA03210 224 N-------ILKIEEIL-------RSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK- 287 (501)
T ss_pred C-------cCcEeEEE-------EECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 8 77777653 5567889999999 568888775433222222445677889999999999999999
Q ss_pred CeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCC
Q 035572 162 MIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 162 ~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 239 (379)
|+||||||+|||++.++.+||+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 288 -IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 288 -LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred -eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999976543322 223479999999999999999999999999999999999875
Q ss_pred C-CCCCCCc--hhHHHhhhhh--hhH------Hhhhhhcc------ccCCCCcch--HHHHHHHHHHHHhcccCCCCCCC
Q 035572 240 P-IDAARDP--ASIIDWALPL--IKE------EKLRQVCD------SRVGLPTFM--EGAIKQMLHVAARCVSSEEENRP 300 (379)
Q Consensus 240 p-~~~~~~~--~~~~~~~~~~--~~~------~~~~~~~~------~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp 300 (379)
+ +...... ..+....... ... ..+...+. .....+... ...+.++.+++.+||++||.+||
T Consensus 367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 4 4332211 1111111000 000 00000000 000011111 11245678889999999999999
Q ss_pred ChHHHhccccCcc
Q 035572 301 GIGEILMGCSCFF 313 (379)
Q Consensus 301 s~~e~l~~~~~~~ 313 (379)
|+.|++.|.....
T Consensus 447 sa~elL~hp~f~~ 459 (501)
T PHA03210 447 GAAELLALPLFSA 459 (501)
T ss_pred CHHHHhhChhhhc
Confidence 9999999866533
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=286.70 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=197.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.-++|.+.+.||+|+||.||+|.+.. .+.+++|.+.... ...+.+.+|+.+++.++|++ +++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~------~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~ 65 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG------TTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDK-------LVQ 65 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC------CceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCC-------Eee
Confidence 35789999999999999999998653 2458999987543 23567899999999999888 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ......++||||+++++|.+++.... ...+++.++..++.|++.||.|||++| ++|+||||+|
T Consensus 66 ~~~~~-------~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~n 133 (261)
T cd05034 66 LYAVC-------SEEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARN 133 (261)
T ss_pred eeeee-------ecCCceEEEEeccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchhe
Confidence 77653 44578899999999999999997632 234889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
|++++++.++|+|||++........ ......+..|+|||...+..++.++|+||||+++|++++ |+.||.+......
T Consensus 134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 213 (261)
T cd05034 134 ILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV 213 (261)
T ss_pred EEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999866543211 112234578999999988889999999999999999999 9999976542211
Q ss_pred HHHhhhhhhhHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+ .. +.. .....+ ...+..+.+++.+||+.+|.+||+++++.+-
T Consensus 214 ~-~~------------~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 214 L-EQ------------VERGYRMPRP---PNCPEELYDLMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred H-HH------------HHcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 1 11 111 011111 2235679999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.39 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=203.9
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||++.++. +++.+++|.+...... ......+.+|+++++.++|++ ++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-----DNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPN-------IISYKE 66 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-----CCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCC-------chhhhh
Confidence 58899999999999999998654 4567999998654322 334567789999999999887 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+....++||||+++++|.+++.+... ....+++..+..++.|++.||.|||+.| ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~ 136 (256)
T cd08530 67 AF-------LDGNKLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILL 136 (256)
T ss_pred hh-------ccCCEEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE
Confidence 54 345789999999999999999977443 2344888899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||++...... ......++..|+|||...+..++.++|+||||+++|+|++|+.||...+... +.
T Consensus 137 ~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~---- 210 (256)
T cd08530 137 VANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LR---- 210 (256)
T ss_pred ecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----
Confidence 99999999999998766544 2233468899999999988889999999999999999999999997654211 10
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..+.... .+......+.++.+++.+||+.+|++||++.++++|.
T Consensus 211 --------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 211 --------YKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred --------HHHhcCC--CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 0111111 1222235668899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.19 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=195.7
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||.|+||.||+|.+.. +++.+++|.+...... .......+.+|+++++.++|++ ++.+++.
T Consensus 1 lg~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~-------i~~~~~~------ 61 (277)
T cd05577 1 LGKGGFGEVCACQVKA-----TGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRF-------IVSLAYA------ 61 (277)
T ss_pred CCCCCceeEEEEEEcC-----CCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCC-------EeeeeeE------
Confidence 6999999999998665 5677999998653221 1233556778999999999887 7776655
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
+...+..|+||||+++++|.+++..... ..+++.++..++.|++.||.|||+.| ++||||+|+||++++++.++
T Consensus 62 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~ 135 (277)
T cd05577 62 -FETKDDLCLVMTLMNGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVR 135 (277)
T ss_pred -EecCCeEEEEEecCCCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEE
Confidence 3456789999999999999999976432 34889999999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHh
Q 035572 183 LADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEK 262 (379)
Q Consensus 183 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (379)
|+|||++.............++..|+|||+..+..++.++|+||||+++|+|++|+.||.......... ..
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------~~ 206 (277)
T cd05577 136 ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---------EL 206 (277)
T ss_pred EccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---------HH
Confidence 999999866544333344468889999999988889999999999999999999999997654311110 00
Q ss_pred hhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 263 LRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
...........+ ...++.+.+++.+||+.||.+|| ++.+++.|...
T Consensus 207 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 207 KRRTLEMAVEYP---DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HhccccccccCC---ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 111111111112 23367899999999999999999 88889987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.37 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=198.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|.+.+.||.|+||.||+|.+.... .....+++|....... ....+.+.+|+.+++.+.|+| +++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~-------i~~~~ 73 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPH-------IVKLI 73 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCc-------hhcee
Confidence 56889999999999999999876432 2345689998764421 234568899999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+. .+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.| ++|+||||+||+
T Consensus 74 ~~~~--------~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nil 139 (270)
T cd05056 74 GVIT--------ENPVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVL 139 (270)
T ss_pred EEEc--------CCCcEEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEE
Confidence 7642 24578999999999999999753 224889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
++.++.++|+|||++......... ....++..|+|||.+....++.++||||||+++|++++ |..||..........
T Consensus 140 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 140 VSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred EecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 999999999999998655433221 12234568999999888889999999999999999996 999997664322111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. . .......+ ..++..+.+++.+|+..+|.+|||+.+++...
T Consensus 220 ~~----------~--~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 220 RI----------E--NGERLPMP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred HH----------H--cCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 10 0 01111112 23457899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.46 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=188.1
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+.... .....+|+|.+..... ....+.+.+|+.+++.++|+| ++++++.+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------iv~~~~~~~-- 66 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITD---LEEVEQFLKEGIIMKDFSHPN-------VLSLLGICL-- 66 (262)
T ss_pred CcccccCCceEEEEEEecCC--CceEEEEEEecCccCC---HHHHHHHHHHHHHHccCCCCC-------cceEEEEee--
Confidence 46899999999999875422 2456799998753221 233567889999999999988 777777542
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
..++..++||||+.+++|.+++.... ...++..+..++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 67 ----~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~ 136 (262)
T cd05058 67 ----PSEGSPLVVLPYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFT 136 (262)
T ss_pred ----cCCCCcEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCc
Confidence 23456789999999999999997532 23567778889999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCC-----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC-CCCCCCCCCchhHHHhh
Q 035572 181 AKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKPIDAARDPASIIDWA 254 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~~~~~~~~~ 254 (379)
+||+|||++....... ......++..|+|||...+..++.++||||||+++|+|++| .+||.... ...+...
T Consensus 137 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~- 214 (262)
T cd05058 137 VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-SFDITVY- 214 (262)
T ss_pred EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH-
Confidence 9999999986543221 11122457789999999888899999999999999999995 56665432 1111111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+..... +......+..+.+++.+||..+|++||++.+++...
T Consensus 215 -----------~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 215 -----------LLQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred -----------HhcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111110 111122346799999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=284.99 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=199.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc-hhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF-EVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+|++.+.||+|+||.||+|.+.. +++.+++|.+..... .........+.+|+.+++.++|++ ++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~-------i~~~ 69 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-----TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR-------IVQY 69 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-----CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCC-------cceE
Confidence 579999999999999999998764 567899998754321 112344568899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ......+++|||+++++|.+++.... .+++..+..++.|++.||.|||++| ++|+||||+||
T Consensus 70 ~~~~~~-----~~~~~~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni 137 (264)
T cd06653 70 YGCLRD-----PEEKKLSIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANI 137 (264)
T ss_pred EEEEEc-----CCCCEEEEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHE
Confidence 776432 22356889999999999999997532 2778889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC----CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDE----SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+++.++.++|+|||++...... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||........
T Consensus 138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 9999999999999998654321 111234588999999999888889999999999999999999999976432221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+. ++.... ..+......+..+.+++.+||+ +|..||++.+++.|.
T Consensus 218 ~~-------------~~~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 218 IF-------------KIATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred HH-------------HHHcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 11 111111 1122234456789999999999 579999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.84 Aligned_cols=284 Identities=20% Similarity=0.263 Sum_probs=209.0
Q ss_pred CCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
+.....++..++++|++.+.||+|+||.||+|.+.. +++.||+|++...... ....+.+.+|+.++++++|+|
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~ 77 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHEN 77 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcC-----CCeEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCc
Confidence 455677888899999999999999999999998754 5678999998753221 223566889999999999998
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
|+++++.+.. ...+......|++++++ +++|.+++... .+++..+..++.|++.||+|||+.|
T Consensus 78 -------iv~~~~~~~~-~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~-- 140 (345)
T cd07877 78 -------VIGLLDVFTP-ARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD-- 140 (345)
T ss_pred -------ccceeeeeee-cccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 7777765432 11233445678999988 88998888531 3889999999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
++||||||+||++++++.++|+|||++...... .....++..|+|||...+ ..++.++|||||||++|+|++|+.||
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999998654322 233468899999998765 56788999999999999999999999
Q ss_pred CCCCCchhHHHhhh----------hhhh---HHhhhhhccccCC--CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 242 DAARDPASIIDWAL----------PLIK---EEKLRQVCDSRVG--LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 242 ~~~~~~~~~~~~~~----------~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
...+.......... ..+. ...+......... ........++.+.+++.+||+.||.+||++.+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 75543221111000 0000 0000000010000 0001112356789999999999999999999999
Q ss_pred ccccCc
Q 035572 307 MGCSCF 312 (379)
Q Consensus 307 ~~~~~~ 312 (379)
.|....
T Consensus 299 ~h~~f~ 304 (345)
T cd07877 299 AHAYFA 304 (345)
T ss_pred cChhhh
Confidence 995443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.45 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=198.1
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|++.+.||.|++|.||+|.+.. +++.|++|++...... ......+.+|+++++.++|++ ++++++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~-------iv~~~~~ 66 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-----TGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPN-------IVRLLDV 66 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-----CCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCC-------ccCHhhe
Confidence 6788999999999999998765 5577999998754322 234467889999999999888 7777766
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+ .+.+..|++|||+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++
T Consensus 67 ~-------~~~~~~~iv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~ 133 (283)
T cd07835 67 V-------HSENKLYLVFEFL-DLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID 133 (283)
T ss_pred e-------ccCCeEEEEEecc-CcCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc
Confidence 4 4468899999999 579999987533 134889999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 177 SKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
.++.++|+|||++...... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...++........
T Consensus 134 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 134 REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998654322 122333568899999987654 56889999999999999999999997654432222211
Q ss_pred hhhhh--HH---------hhhh-hccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIK--EE---------KLRQ-VCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~--~~---------~~~~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... .. .... .... ...........+..+.+++.+||+.||++|||++|++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred HHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 00000 00 0000 0000 0001111223457899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=288.63 Aligned_cols=262 Identities=19% Similarity=0.300 Sum_probs=202.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.... ......|++|.+.... .......+.+|+.+++.+.|+| +++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~n-------i~~ 72 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQN-------ILP 72 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCC-------CCe
Confidence 3578999999999999999999876522 2235779999886432 1344677899999999999998 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC---CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
+++++. .++...++++||+++++|.+++...... ....+++.++..++.|++.||+|||+++ ++|||||
T Consensus 73 ~~~~~~------~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~ 144 (280)
T cd05043 73 ILHVCI------EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIA 144 (280)
T ss_pred EEEEEe------cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccC
Confidence 777642 3356789999999999999999764321 1134889999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCC
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAAR 245 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~ 245 (379)
|+||++++++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|++++ |+.||...+
T Consensus 145 p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 145 ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred HhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 9999999999999999999975433221 122346778999999988889999999999999999999 999997653
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. ..+..... .....+ ....++.++.+++.+||+.||++|||+.+++..
T Consensus 225 ~-~~~~~~~~-------------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 272 (280)
T cd05043 225 P-FEMAAYLK-------------DGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQC 272 (280)
T ss_pred H-HHHHHHHH-------------cCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 2 22211110 011111 112245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.75 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=199.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.++. .++.+++|.+...... ....+.+.+|+.+++.++|+| ++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~~~h~~-------i~~~~~ 66 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-----DSEHCVIKEIDLTKMP--VKEKEASKKEVILLAKMKHPN-------IVTFFA 66 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-----CCceEEEEEeeHhhcc--chhhHHHHHHHHHHHhCCCCC-------hhhhhh
Confidence 58899999999999999998765 4566899998654322 234567889999999999888 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+....++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~ 134 (257)
T cd08225 67 SF-------QENGRLFIVMEYCDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFL 134 (257)
T ss_pred ee-------ccCCeEEEEEecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE
Confidence 53 45678999999999999999997532 234788999999999999999999999 9999999999999
Q ss_pred cCCCC-eEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 176 DSKWD-AKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 176 ~~~~~-~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++++. ++|+|||.+........ .....|++.|+|||+..+..++.++|+||||+++|+|++|..||...+.....
T Consensus 135 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--- 211 (257)
T cd08225 135 SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV--- 211 (257)
T ss_pred cCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---
Confidence 98754 69999999865543322 22346889999999988888999999999999999999999999754321111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
........ +......+.++.+++.+||..+|++|||+.+++.|.
T Consensus 212 ----------~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 212 ----------LKICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred ----------HHHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 11111111 111123456799999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=284.09 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=198.0
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||.|++|.||+|.+.. .++.+++|.+...... .....+.+.+|+.+++.++|+| ++++++.+
T Consensus 1 lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~~~~~----- 62 (262)
T cd05572 1 LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPF-------IVKLYRTF----- 62 (262)
T ss_pred CCCCCceEEEEEEECC-----CCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCC-------EeeeeeeE-----
Confidence 7999999999998764 5677999998754321 1234577999999999999988 78777653
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
.++...+++|||+++++|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++
T Consensus 63 --~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~ 133 (262)
T cd05572 63 --KDKKYIYMLMEYCLGGELWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVK 133 (262)
T ss_pred --EcCCccEEEEecCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEE
Confidence 45678999999999999999997532 2788899999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHh
Q 035572 183 LADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEK 262 (379)
Q Consensus 183 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (379)
|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 134 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~ 202 (262)
T cd05572 134 LVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----------MEI 202 (262)
T ss_pred EeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----------HHH
Confidence 999999876654433334468899999999888889999999999999999999999997664211 011
Q ss_pred hhhhc--cccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccC
Q 035572 263 LRQVC--DSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSC 311 (379)
Q Consensus 263 ~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~ 311 (379)
...+. ......|. ..+.++.+++.+||+.+|++||+ +.|+++|...
T Consensus 203 ~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 203 YNDILKGNGKLEFPN---YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred HHHHhccCCCCCCCc---ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 11111 11122222 22578999999999999999999 9999998543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=287.00 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=204.1
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
..+++|++.+.||.|++|.||+|.+.. .+..+++|.+..... ..+.+.+|+++++.++|+| ++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~-------i~ 78 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA-----TGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPN-------IV 78 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc-----CCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCC-------ee
Confidence 356789999999999999999998764 456799999874321 4567889999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+. ..+..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|+
T Consensus 79 ~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ 145 (286)
T cd06614 79 DYYDSYL-------VGDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSD 145 (286)
T ss_pred EEEEEEE-------ECCEEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChh
Confidence 8887643 3578999999999999999998643 24889999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||+++.++.++|+|||++....... ......++..|+|||+..+..++.++|+||||+++|+|++|..||.........
T Consensus 146 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred hEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999875443221 222335788999999988888999999999999999999999999765332111
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. +.............++..+.+++.+||+.+|.+||++.+++.|...
T Consensus 226 ~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 226 FL-------------ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred HH-------------HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 11 1111111111122356789999999999999999999999997444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.73 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=196.2
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh---hccCCCCCceeee
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ---ESNKRNPNYCVVN 92 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~~~~~~~~iv~ 92 (379)
.|++.+.||.|+||.||+|.+.. .++.+++|.++.... ......+.+|+.+++.++ |++ +++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~-------vi~ 66 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-----TGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPN-------ITK 66 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCC-------eee
Confidence 48889999999999999998754 557899998864321 344567889999999997 555 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .++...++||||+++++|.+++... .+++..+..++.|++.||.|||+.| ++|+||+|+|
T Consensus 67 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~n 131 (277)
T cd06917 67 YYGSY-------LKGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAAN 131 (277)
T ss_pred Eeeee-------eeCCEEEEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHH
Confidence 77764 4467899999999999999998642 3888999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|++++++.++|+|||++....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 132 ILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred EEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 999999999999999986654332 2233468899999998764 45688999999999999999999999765321111
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcch-HHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFM-EGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .+... ..+... ...+.++.+++.+||+.||++||++.+++.|.
T Consensus 212 ~-------------~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 212 M-------------LIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred h-------------ccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 0 00000 001111 12457899999999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=288.08 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=197.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|...+.||.|++|.||++.+.. .++.+++|.+.... ....+.+.+|+.+++.+.|++ ++.+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~-------vv~~~~ 83 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS-----TGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPN-------IVEMYS 83 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC-----CCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCC-------hheEEE
Confidence 56667899999999999998654 45679999875332 233466889999999999888 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++++||+++++|.+++.. ..+++..+..++.|++.||+|||++| ++||||+|+||++
T Consensus 84 ~~-------~~~~~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~ 148 (285)
T cd06648 84 SY-------LVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILL 148 (285)
T ss_pred EE-------EcCCeEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEE
Confidence 64 346788999999999999999875 12788899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||.+....... ......|++.|+|||...+..++.++|+||||+++|+|++|+.||...+..... .
T Consensus 149 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-~-- 225 (285)
T cd06648 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-K-- 225 (285)
T ss_pred cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-H--
Confidence 999999999999875443222 222346899999999998888999999999999999999999999764321111 1
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+.............++..+.+++.+||+.+|++||++.+++.|...
T Consensus 226 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 226 ----------RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred ----------HHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence 01111000111112245789999999999999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.20 Aligned_cols=276 Identities=22% Similarity=0.258 Sum_probs=196.3
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+.++++++|++ +++
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------iv~ 75 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKK-----TKQIVALKKVLMENEK--EGFPITALREIKILQLLKHEN-------VVN 75 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECC-----CCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCC-------ccc
Confidence 34689999999999999999998664 5678999988644221 223445678999999999998 777
Q ss_pred ccccccccCCC-ccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 93 FHGTSCRNSGS-VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
+++.+...... .......++||||+ +++|.+.+.... ..+++.++..++.|++.||.|||++| ++|+||||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~ 148 (310)
T cd07865 76 LIEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAA 148 (310)
T ss_pred eEEEEecccccccCCCceEEEEEcCC-CcCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 77665432111 12345679999999 568888886532 23889999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
||+++.++.++|+|||++........ .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 149 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred HEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865432211 1233578899999987654 46889999999999999999999997654
Q ss_pred CchhHHH--hhhhhhhHHhhhhhcc----ccCCCCcc----------hHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 246 DPASIID--WALPLIKEEKLRQVCD----SRVGLPTF----------MEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 246 ~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... ..........+..... .....+.. ....+..+.++|.+||..||.+|||++++++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 229 EQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred HHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 3221111 0000000000000000 00000000 001135678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=286.69 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=199.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+-|++.+.||.|+||.||+|.+.. .++.+|+|....... ....+.+.+|+.+++.++|+| +++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~-----~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------iv~~~ 68 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPY-------VTKYY 68 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC-----CCcEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCC-------EeEEE
Confidence 347788999999999999998654 457799998764322 234567899999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ ..++..++||||+.+++|.+++... .+++..+..++.|++.++.+||+.| ++|+||+|+||+
T Consensus 69 ~~~-------~~~~~~~lv~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~ 133 (277)
T cd06641 69 GSY-------LKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVL 133 (277)
T ss_pred EEE-------EeCCeEEEEEEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEE
Confidence 764 4567899999999999999998631 3788999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++........ .....++..|+|||...+...+.++|+|||||++|+|++|..||....... ...
T Consensus 134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~- 211 (277)
T cd06641 134 LSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-VLF- 211 (277)
T ss_pred ECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-HHH-
Confidence 99999999999999865433221 223468889999999988888999999999999999999999997543211 100
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.+... ..+.....++.++.+++.+||+.+|.+||++.+++.|..
T Consensus 212 -----------~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 212 -----------LIPKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255 (277)
T ss_pred -----------HHhcC--CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 01011 112222344578999999999999999999999999843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=284.17 Aligned_cols=259 Identities=21% Similarity=0.362 Sum_probs=199.2
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch------hhhhcHHHHHHHHHHHHh-hhhccCCCCCc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE------VLQDNSKKLNNEIRVLSS-LQESNKRNPNY 88 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~-l~~~~~~~~~~ 88 (379)
+|++.+.||.|+||.||+|.+... .++.+++|.+...... .......++.+|+.++.. ++|+|
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~------ 70 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN------ 70 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCC------
Confidence 588899999999999999987651 3467999987543211 112334567788888865 67777
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRD 167 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~d 167 (379)
++++++.+ .+++..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+ ++|+|
T Consensus 71 -i~~~~~~~-------~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~d 139 (269)
T cd08528 71 -IVRYYKTF-------LENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRD 139 (269)
T ss_pred -eeeEEeeE-------ccCCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecC
Confidence 88877764 456789999999999999999865332 23348888999999999999999996 78 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|+|+||+++.++.++|+|||++.............++..|+|||...+..++.++|+||||+++|+|++|+.||......
T Consensus 140 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 140 LTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred CCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 99999999999999999999997655443334456899999999999888999999999999999999999999754322
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... ..+...... +......++.+.+++.+||+.||++||++.|+..+.
T Consensus 220 ~~~-------------~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 220 SLA-------------TKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred HHH-------------HHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 111 011111111 111123457899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.22 Aligned_cols=280 Identities=22% Similarity=0.283 Sum_probs=202.7
Q ss_pred CCHHHHHHH----hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh
Q 035572 5 FDYEELVKA----TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80 (379)
Q Consensus 5 ~~~~~~~~~----~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 80 (379)
|+.+++... .++|.+.+.||.|+||.||+|++.. +++.||+|.+...... ......+.+|+.+++.++|
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h 73 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKR-----TGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQH 73 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCC-----CCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCC
Confidence 556666655 4899999999999999999998754 5567999998653221 2334668899999999999
Q ss_pred ccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC
Q 035572 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND 160 (379)
Q Consensus 81 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 160 (379)
+| ++++++.+... .........++|+||+. .+|.+... ..+++..+..++.|++.||+|||+.|
T Consensus 74 ~n-------iv~~~~~~~~~-~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ 137 (342)
T cd07879 74 EN-------VIGLLDVFTSA-VSGDEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG 137 (342)
T ss_pred CC-------ccchhheeccc-ccCCCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 98 77777765321 11223356799999994 57776652 13888999999999999999999999
Q ss_pred CCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCC
Q 035572 161 PMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 161 ~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~ 239 (379)
++||||||+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.
T Consensus 138 --i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~ 213 (342)
T cd07879 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213 (342)
T ss_pred --cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998654322 223467889999998765 468899999999999999999999
Q ss_pred CCCCCCCchhHHHhhhh----------hhhHHhhhhhccc--cC---CCCcchHHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 240 PIDAARDPASIIDWALP----------LIKEEKLRQVCDS--RV---GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
||.+.+....+...... ............. .. ......+..+..+.+++.+||+.||.+||++++
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e 293 (342)
T cd07879 214 LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE 293 (342)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99865432221111100 0000000000000 00 000111234567899999999999999999999
Q ss_pred HhccccC
Q 035572 305 ILMGCSC 311 (379)
Q Consensus 305 ~l~~~~~ 311 (379)
++.|...
T Consensus 294 ~l~h~~f 300 (342)
T cd07879 294 ALEHPYF 300 (342)
T ss_pred HhcCcch
Confidence 9998544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=283.31 Aligned_cols=244 Identities=20% Similarity=0.340 Sum_probs=184.8
Q ss_pred cccccCCceeEEEEEecCCCC-------CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 21 RLIGKGSHGSVYKAILEDHQT-------DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+.||+|+||.||+|....... ......+++|.+.... ......+.+|+.+++.++|+| ++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~-------iv~~ 69 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKH-------IVLL 69 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 468999999999998543221 1233468889876432 234567889999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ ..+...++||||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 70 ~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Ni 136 (262)
T cd05077 70 YGVC-------VRDVENIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNI 136 (262)
T ss_pred EEEE-------ecCCCCEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccE
Confidence 8875 3456789999999999999888642 223888899999999999999999999 99999999999
Q ss_pred EEcCCCC-------eEEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHH-hCCCCCCCC
Q 035572 174 LFDSKWD-------AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEII-SCRKPIDAA 244 (379)
Q Consensus 174 ll~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~p~~~~ 244 (379)
|++.++. ++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||...
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9986654 899999998654322 2335788999999876 566899999999999999998 588887654
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... .. .......... ...+.++.+|+.+||+.||++||++.+++.+
T Consensus 214 ~~~~-~~-------------~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 214 TLAE-KE-------------RFYEGQCMLV---TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred chhH-HH-------------HHHhcCccCC---CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 2111 00 0000111111 1123678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=287.58 Aligned_cols=244 Identities=20% Similarity=0.347 Sum_probs=185.5
Q ss_pred cccccCCceeEEEEEecCCCC--CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQT--DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSC 98 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~ 98 (379)
+.||.|+||.||+|....... ......+++|.+.... ....+.+.+|+.+++.+.|+| ++.+++.+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~-------iv~~~~~~- 68 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKH-------LVLNYGVC- 68 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCC-------hhheeeEE-
Confidence 469999999999998764332 1234568888875332 234567889999999999988 77777764
Q ss_pred ccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCC
Q 035572 99 RNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~ 178 (379)
..+...++||||+.+|+|.+++...+ ..+++..+..++.|++.||+|||+.| |+||||||+||+++.+
T Consensus 69 ------~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~ 136 (258)
T cd05078 69 ------VCGDESIMVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIRE 136 (258)
T ss_pred ------EeCCCcEEEEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecc
Confidence 34567899999999999999997533 24788899999999999999999999 9999999999999876
Q ss_pred CC--------eEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCC-CCCCCCCCch
Q 035572 179 WD--------AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCR-KPIDAARDPA 248 (379)
Q Consensus 179 ~~--------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~-~p~~~~~~~~ 248 (379)
+. ++++|||++...... ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||.......
T Consensus 137 ~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 137 EDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred cccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 65 699999988654332 22367889999998876 45789999999999999999985 5654432211
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... ........|. ....++.+++.+||+.||++|||++++++.
T Consensus 214 -~~~-------------~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 214 -KLQ-------------FYEDRHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -HHH-------------HHHccccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 100 0111111222 123678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=282.81 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=185.6
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHH-HhhhhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL-SSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||.|+||.||+|.+.. .++.||+|.++...... ......+..|..++ ....|+| ++++++.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~-----~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~-------i~~~~~~~-- 66 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-----TGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPY-------VAKLYYSF-- 66 (260)
T ss_pred ccCCcCCCeeEEEEEecC-----CCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCC-------eeeeeeeE--
Confidence 579999999999998754 45679999987543221 11223344454443 3445666 77777654
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
...+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++
T Consensus 67 -----~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~ 134 (260)
T cd05611 67 -----QSKDYLYLVMEYLNGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTG 134 (260)
T ss_pred -----EcCCeEEEEEeccCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCC
Confidence 45678999999999999999997532 3788899999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhh
Q 035572 180 DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 259 (379)
.++|+|||++..... .....++..|+|||...+..++.++||||||+++|+|++|..||...+..... .
T Consensus 135 ~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~------- 203 (260)
T cd05611 135 HLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-D------- 203 (260)
T ss_pred cEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-H-------
Confidence 999999999865433 22336888999999998888899999999999999999999999765432111 1
Q ss_pred HHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCCh---HHHhccc
Q 035572 260 EEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGI---GEILMGC 309 (379)
Q Consensus 260 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~---~e~l~~~ 309 (379)
.+.......+ .....+++.+.+++.+||+.+|++||++ .|++.|.
T Consensus 204 -----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 204 -----NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred -----HHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 1111111111 1122456789999999999999999955 6888874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=283.67 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=191.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||++.. .++.+++|.++.. ...+.+.+|+.+++.++|++ +++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~-------i~~~~ 65 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKN-------LVRLL 65 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-------CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCC-------cCeEE
Confidence 5699999999999999999853 4456999998643 23467889999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+. .+..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+.| ++||||||+||+
T Consensus 66 ~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nil 132 (254)
T cd05083 66 GVIL--------HNGLYIVMELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNIL 132 (254)
T ss_pred EEEc--------CCCcEEEEECCCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEE
Confidence 6542 234799999999999999997632 234788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 253 (379)
++.++.++|+|||++....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... ....
T Consensus 133 i~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~ 209 (254)
T cd05083 133 VSEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKEC 209 (254)
T ss_pred EcCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-HHHH
Confidence 9999999999999986543221 12234678999999988889999999999999999998 999997653211 1110
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... ..... ....++..+.+++.+||+.+|++||++++++..
T Consensus 210 ---------~~~--~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 210 ---------VEK--GYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred ---------HhC--CCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01111 123345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=287.27 Aligned_cols=264 Identities=22% Similarity=0.251 Sum_probs=193.5
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeeccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFHG 95 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~~ 95 (379)
|++.+.||+|+||.||+|.+.. +++.+++|.++..... .......+|+.+++++. |+| ++++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~-------i~~~~~ 65 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-----TGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPN-------ILRLIE 65 (282)
T ss_pred CceEeeccccccceEEEEEEcC-----CCcEEEEEEehhccCC---chhhhHHHHHHHHhhcCCCCC-------ccceEE
Confidence 6788999999999999998764 5577999998753221 12233457888888886 777 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+.. ...+..++||||++ ++|.+.+.... ..+++.++..++.|++.||.|||+.| ++||||+|+||++
T Consensus 66 ~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l 133 (282)
T cd07831 66 VLFD-----RKTGRLALVFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI 133 (282)
T ss_pred EEec-----CCCCcEEEEEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE
Confidence 6532 12368899999995 68888886532 34889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+. +.++|+|||++.............++..|+|||++. +..++.++|||||||++|+|++|..||...+..... ...
T Consensus 134 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~-~~~ 211 (282)
T cd07831 134 KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI-AKI 211 (282)
T ss_pred cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH-HHH
Confidence 99 999999999997654443334446889999999654 455788999999999999999999999765432221 111
Q ss_pred hhhhhH--Hhhhhhcc----ccCCCC--------cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKE--EKLRQVCD----SRVGLP--------TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~--~~~~~~~~----~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...... ..+..... .....+ ......+.++.+++.+||+.+|++||++++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 111000 00000000 000001 11224568899999999999999999999999984
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=284.94 Aligned_cols=271 Identities=23% Similarity=0.271 Sum_probs=198.7
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh---hccCCCCCceeeec
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ---ESNKRNPNYCVVNF 93 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~~~~~~~~iv~~ 93 (379)
|++.+.||.|+||.||+|.++. +++.+++|.++..... ......+.+|+.+++.++ |++ ++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~-------i~~~ 66 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-----TGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPN-------IVRL 66 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-----CCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCC-------cceE
Confidence 6788999999999999998764 4567999998754321 223456778888888775 666 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.... .......+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 67 ~~~~~~~~--~~~~~~~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~ni 138 (287)
T cd07838 67 LDVCHGPR--TDRELKLTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNI 138 (287)
T ss_pred EEEEeecc--CCCCceeEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhE
Confidence 77654311 012234899999995 68999887532 224889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++++++.++|+|||++.............++..|+|||+..+..++.++|+|||||++|+|++|.+||........+...
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 139 LVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred EEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 99999999999999986654443333445788999999998888999999999999999999999999865543322221
Q ss_pred hhhhhhHHhhh---------hhcccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIKEEKLR---------QVCDSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~~~~~~---------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
........... ...... ..........+..+.+++.+||+.||.+||++.+++.|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 11000000000 000000 000111234567889999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=283.89 Aligned_cols=274 Identities=20% Similarity=0.253 Sum_probs=207.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
..+.+|+++..+|+|.||.|-.+.+..+ ...||+|+++. .....+...-|+++|.++.+...... ..++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~-----~~~vAlKIik~-----V~kYreAa~iEi~vLqki~~~DP~g~-~rcv 154 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRET-----KEHVALKIIKN-----VDKYREAALIEIEVLQKINESDPNGK-FRCV 154 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCC-----CceehHHHHHH-----HHHHhhHHHHHHHHHHHHHhcCCCCc-eEEE
Confidence 3488999999999999999999998763 56799999873 24556778889999999965432221 1234
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.+ .++|+-.++.|||+|.+ |-|+.+++...+ ...++...++.+++|+++++++||+.+ ++|.||||+
T Consensus 155 ~m-------~~wFdyrghiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPE 221 (415)
T KOG0671|consen 155 QM-------RDWFDYRGHICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPE 221 (415)
T ss_pred ee-------ehhhhccCceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChh
Confidence 33 34577789999999999 889999998744 344888999999999999999999999 999999999
Q ss_pred ceEEcC--------------------CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHH
Q 035572 172 NILFDS--------------------KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231 (379)
Q Consensus 172 NIll~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 231 (379)
|||+.+ +..++|+|||.|+...... ...+.|..|.|||++.+-+++.++||||+||||
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 999922 2458999999997765443 344789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHH--hhhhhhhHHhhhhh------ccccCCC---------------Ccc-------hHHHH
Q 035572 232 LEIISCRKPIDAARDPASIID--WALPLIKEEKLRQV------CDSRVGL---------------PTF-------MEGAI 281 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~------~~~~~~~---------------~~~-------~~~~~ 281 (379)
+|+.||...|.+.++.+++.. .+..-+........ ...++.+ +.. .....
T Consensus 300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 999999999998886664421 11111111111110 0001110 110 12334
Q ss_pred HHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 282 KQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 282 ~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+.||+.+||.+||.+|+|+.|+|.|...
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcCHHh
Confidence 579999999999999999999999998544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=279.34 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=201.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|.+.+.||.|++|.||++.+.. +++.+++|++..... .....+.+|+.+++.++|++ ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 64 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-----TGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPN-------IVKYYG 64 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-----CCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCC-------EeEEEE
Confidence 37888999999999999998764 456799999875432 34678999999999999887 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ......++++||+++++|.+++.... ..+++..+..++.|++.+|.+||+.| ++||||+|+||++
T Consensus 65 ~~-------~~~~~~~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i 131 (253)
T cd05122 65 SY-------LKKDELWIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILL 131 (253)
T ss_pred EE-------ecCCeEEEEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEE
Confidence 64 44578999999999999999997632 34899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++++.++|+|||.+.............++..|+|||...+..++.++|+||||+++|+|++|+.||...+........
T Consensus 132 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-- 209 (253)
T cd05122 132 TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-- 209 (253)
T ss_pred ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--
Confidence 999999999999987665443234457899999999988888999999999999999999999999765422211110
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. ......+ ....++..+.+++.+||+.||++|||+.+++.|.
T Consensus 210 --------~~--~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 210 --------AT--NGPPGLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred --------Hh--cCCCCcC-cccccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 00 0000001 1111257799999999999999999999999883
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=285.80 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=186.0
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccC
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS 101 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~ 101 (379)
.||+|+||.||++.+.. +++.+|+|.+....... ......+.+|..+++.+.+.+ +|+ ++.+++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~--i~~~~~~----- 65 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGD--CPF--IVCMTYA----- 65 (279)
T ss_pred CcccCCCeEEEEEEECC-----CCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCC--CCc--EeEEEEE-----
Confidence 48999999999998754 56789999886543221 112233455555555543221 111 6665554
Q ss_pred CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCe
Q 035572 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181 (379)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~ 181 (379)
+...+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 66 --~~~~~~~~lv~e~~~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~ 136 (279)
T cd05633 66 --FHTPDKLCFILDLMNGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHV 136 (279)
T ss_pred --EecCCeEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCE
Confidence 345678999999999999999987532 3899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhH
Q 035572 182 KLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKE 260 (379)
Q Consensus 182 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 260 (379)
+|+|||++....... .....|+..|+|||... +..++.++||||+||++|+|++|..||.......... ...
T Consensus 137 ~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~ 209 (279)
T cd05633 137 RISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDR 209 (279)
T ss_pred EEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH------HHH
Confidence 999999986543322 22346899999999876 4568899999999999999999999997653321100 000
Q ss_pred HhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCcc
Q 035572 261 EKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCFF 313 (379)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~~ 313 (379)
........ .....+.++.+++.+||+.||.+|| +++++++|.....
T Consensus 210 ----~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 210 ----MTLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred ----HhhcCCcC---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 00011111 1233457899999999999999999 6999999865433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=285.46 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=199.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++..+. .....+++|....... ......+.+|+.+++.++|+| ++++
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~ 74 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPH-------VVRL 74 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCC-------cceE
Confidence 3578999999999999999999876432 2345699998875432 344577889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ...++||||+++|+|.+++... ...+++..+..++.|++.||+|||++| ++||||||+||
T Consensus 75 ~~~~~~--------~~~~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~ni 140 (279)
T cd05057 75 LGICLS--------SQVQLITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNV 140 (279)
T ss_pred EEEEec--------CceEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceE
Confidence 776532 5789999999999999999753 223889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCccc---ccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMV---QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++++++.++|+|||++.......... ...++..|+|||......++.++|+||||+++|++++ |+.||..... ..
T Consensus 141 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~ 219 (279)
T cd05057 141 LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VE 219 (279)
T ss_pred EEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HH
Confidence 99999999999999986654332211 1223568999999888889999999999999999998 9999976532 11
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+.... .. ......+. ..+..+.+++.+||..||.+||++.+++....
T Consensus 220 ~~~~~---------~~--~~~~~~~~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 220 IPDLL---------EK--GERLPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred HHHHH---------hC--CCCCCCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11110 00 11111121 23467889999999999999999999987533
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=283.24 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=194.8
Q ss_pred CHHHHHHHhcCCcccccc--ccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhcc
Q 035572 6 DYEELVKATESFSQSRLI--GKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESN 82 (379)
Q Consensus 6 ~~~~~~~~~~~y~~~~~i--G~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 82 (379)
+..+.....++|++.+.+ |.|+||.||++..+. +++.+++|.+...... . .|+.....+ .|++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~-------~--~e~~~~~~~~~h~~ 70 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP-----TQKLFVQKIIKAKNFN-------A--IEPMVHQLMKDNPN 70 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcC-----CCcEEEEEEEehhhcc-------h--hhHHHHHHhhcCCC
Confidence 455666777899998887 999999999998654 5577999998643211 1 122222222 3555
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++++++.+ ...+..++||||+++++|.+++.... .+++.++..++.|+++||.|||+.|
T Consensus 71 -------iv~~~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~-- 129 (267)
T PHA03390 71 -------FIKLYYSV-------TTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN-- 129 (267)
T ss_pred -------EEEEEEEE-------ecCCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 77777664 44678999999999999999997532 4899999999999999999999999
Q ss_pred eEecCCCCCceEEcCCC-CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 163 IIHRDIKSTNILFDSKW-DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
++||||||+||+++.++ .++|+|||++....... ...++..|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 130 i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~ 206 (267)
T PHA03390 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206 (267)
T ss_pred eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999888 99999999986554322 236889999999999889999999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-hHHHhcccc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-IGEILMGCS 310 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~e~l~~~~ 310 (379)
....+.. . . ...+....... .......++.+.+++.+||+.+|.+||+ ++++++|..
T Consensus 207 ~~~~~~~-~-~-------~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 207 KEDEDEE-L-D-------LESLLKRQQKK---LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred CCCCcch-h-h-------HHHHHHhhccc---CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 7543221 0 0 00111111111 1222356688999999999999999996 599999843
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=280.05 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=203.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|+||.||++.+.. +++.+++|++...... ......+.+|+++++.++|+| ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------~~~~~~ 66 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-----DGKLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPN-------IIKYYE 66 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-----CCcEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCC-------hhheEE
Confidence 58899999999999999998754 4577999998754322 345677899999999999888 666665
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++|+||+++++|.+.+..... ....+++..+..++.+++.||.+||+.| ++|+||+|+||++
T Consensus 67 ~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~ 136 (258)
T cd08215 67 SF-------EEKGKLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFL 136 (258)
T ss_pred EE-------ecCCEEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEE
Confidence 53 345789999999999999999987532 2345899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++++.++|+|||++....... ......+++.|+|||...+..++.++|+||+|+++|+|++|..||....... +..
T Consensus 137 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~-- 213 (258)
T cd08215 137 TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LAL-- 213 (258)
T ss_pred cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-HHH--
Confidence 999999999999986654433 2233468899999999888889999999999999999999999997654211 111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... +......+..+.+++.+||..+|++|||+.+++.|.
T Consensus 214 ----------~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 256 (258)
T cd08215 214 ----------KILKGQY--PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256 (258)
T ss_pred ----------HHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence 1111111 111223457899999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=291.34 Aligned_cols=275 Identities=20% Similarity=0.260 Sum_probs=198.8
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||+|.+... ..++.||+|.+..... ........+.+|+.+++.++|++ ++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 69 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHEN-------VVSLVE 69 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCC-------ccceEE
Confidence 588999999999999999987652 2467899999876431 11334567789999999999988 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+.. ...+..++||||++ ++|.+.+..........+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 70 ~~~~-----~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~ 141 (316)
T cd07842 70 VFLE-----HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILV 141 (316)
T ss_pred EEeC-----CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEE
Confidence 6532 22368999999995 57888776544333335888999999999999999999999 9999999999999
Q ss_pred cC----CCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 176 DS----KWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 176 ~~----~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+. ++.+||+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++|++||.+...
T Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 142 MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99 89999999999865433221 223357889999997765 4578899999999999999999999976543
Q ss_pred chh--------HHHhhhhhhh---H---------Hhhhhh--ccccCCCC--cchH------HHHHHHHHHHHhcccCCC
Q 035572 247 PAS--------IIDWALPLIK---E---------EKLRQV--CDSRVGLP--TFME------GAIKQMLHVAARCVSSEE 296 (379)
Q Consensus 247 ~~~--------~~~~~~~~~~---~---------~~~~~~--~~~~~~~~--~~~~------~~~~~~~~li~~~l~~dp 296 (379)
... ........+. . ..+... .......+ .... ..+..+.+++.+||+.||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 301 (316)
T cd07842 222 KIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301 (316)
T ss_pred cccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCc
Confidence 220 0000000000 0 000000 00000001 0000 234578999999999999
Q ss_pred CCCCChHHHhccc
Q 035572 297 ENRPGIGEILMGC 309 (379)
Q Consensus 297 ~~Rps~~e~l~~~ 309 (379)
++|||+.|++.|.
T Consensus 302 ~~Rps~~eil~~~ 314 (316)
T cd07842 302 TKRITAEEALEHP 314 (316)
T ss_pred ccCcCHHHHhcCC
Confidence 9999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=287.13 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=197.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~ 94 (379)
+|++.+.||.|+||.||+|.+.... .+++.||+|.++...........+.+.+|+.+++.+. |++ |+.++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-------i~~~~ 71 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF-------LVTLH 71 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCC-------hhcee
Confidence 5889999999999999999865322 2567899999875433222344577889999999995 555 66555
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +..+...|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++||||+|+|||
T Consensus 72 ~~-------~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil 137 (290)
T cd05613 72 YA-------FQTDTKLHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENIL 137 (290)
T ss_pred eE-------eecCCeEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeE
Confidence 44 455678899999999999999997532 3788888999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC--CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS--KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.++|+|||++....... ......++..|+|||..... .++.++||||||+++|+|++|..||.........
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 217 (290)
T cd05613 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217 (290)
T ss_pred ECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence 9999999999999986543322 12234688999999987653 4678999999999999999999999754322111
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
... ...........+ ...++.+.+++.+||+.||.+|| ++.+++.|...
T Consensus 218 ~~~---------~~~~~~~~~~~~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 271 (290)
T cd05613 218 AEI---------SRRILKSEPPYP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271 (290)
T ss_pred HHH---------HHHhhccCCCCC---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence 111 111111111112 23457789999999999999997 88999988544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=279.49 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=189.0
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
++||.|+||.||+|... .++.+++|.+..... ......+.+|+.+++.++|+| ++++++.+
T Consensus 1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~~~~--- 61 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPN-------IVKLIGVC--- 61 (250)
T ss_pred CccCCCCCceEEEEEec------CCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCC-------cCeEEEEE---
Confidence 46899999999999753 345699998864421 233457889999999999988 77777654
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
...+..++||||+++++|.+++.... ..+++..+..++.|++.+|.|+|++| ++||||||+||+++.++.
T Consensus 62 ----~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~ 131 (250)
T cd05085 62 ----TQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNV 131 (250)
T ss_pred ----ecCCccEEEEECCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCe
Confidence 34567899999999999999986532 23788999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCcc--cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhh
Q 035572 181 AKLADFGLAVSESDESSM--VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPL 257 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 257 (379)
++|+|||++......... ....++..|+|||+..+..++.++||||||+++|++++ |..||........ ...
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-~~~---- 206 (250)
T cd05085 132 LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-REQ---- 206 (250)
T ss_pred EEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHH----
Confidence 999999998654332211 12234678999999988889999999999999999998 9999976532211 110
Q ss_pred hhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 258 IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... .....+ ..++..+.+++.+||+.+|++||++.++++.
T Consensus 207 -----~~~~--~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 207 -----VEKG--YRMSCP---QKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -----HHcC--CCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 0000 011111 2245789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=280.34 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=193.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...|++.+.||.|+||.||+|.+.. +..+++|.+..... ....+.+|+++++.+.|++ ++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~-------i~~~ 64 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE------KRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPK-------LVQL 64 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC------CCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 3578899999999999999998752 34589998864422 2456889999999999887 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ......++||||+++++|.+++.... ..+++..+..++.|++.+|++||+.+ ++|+||||+||
T Consensus 65 ~~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni 131 (256)
T cd05112 65 YGVC-------TERSPICLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNC 131 (256)
T ss_pred EEEE-------ccCCceEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceE
Confidence 7653 44568899999999999999987532 23788889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++........ .....++..|+|||...+..++.++|+||||+++|+|++ |..||....... .
T Consensus 132 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~ 210 (256)
T cd05112 132 LVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-V 210 (256)
T ss_pred EEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-H
Confidence 999999999999999865432211 112235678999999988889999999999999999998 999997543211 1
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... ... ......+.. .+..+.+++.+||+.+|++|||+.+++++
T Consensus 211 ~~~---------~~~--~~~~~~~~~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 211 VET---------INA--GFRLYKPRL---ASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHH---------HhC--CCCCCCCCC---CCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 110 000 001111211 24679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=285.41 Aligned_cols=243 Identities=21% Similarity=0.368 Sum_probs=184.2
Q ss_pred ccccCCceeEEEEEecCCC-------------------CCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 22 LIGKGSHGSVYKAILEDHQ-------------------TDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
.||+|+||.||+|...... .......|++|.+.... ......+.+|+.+++.++|+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 6999999999999854321 11123468899886432 233467888999999999988
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++++++++. +....++||||+++++|..++... ...+++..+..++.|++.||+|||+.+
T Consensus 78 -------iv~~~~~~~-------~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 137 (274)
T cd05076 78 -------LAFVHGVCV-------RGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN-- 137 (274)
T ss_pred -------eeeEEEEEE-------eCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC--
Confidence 898888753 356789999999999999998642 234788999999999999999999999
Q ss_pred eEecCCCCCceEEcCCC-------CeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHH
Q 035572 163 IIHRDIKSTNILFDSKW-------DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el 234 (379)
|+||||||+|||+++++ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|++
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999997643 3799999987543222 22357888999998765 5689999999999999999
Q ss_pred H-hCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 235 I-SCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 235 l-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+ +|..||........ .. ........+. ...+.+.+++.+||+.+|++|||+.+++++
T Consensus 215 ~~~g~~p~~~~~~~~~-~~-------------~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 215 CFDGEVPLKERTPSEK-ER-------------FYEKKHRLPE---PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhCCCCCccccChHHH-HH-------------HHHhccCCCC---CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5 69999876532211 11 0111111121 123568999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=290.74 Aligned_cols=274 Identities=24% Similarity=0.284 Sum_probs=197.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||.|+||.||+|.+.. +++.+++|.+...... ......+.+|+++++.++|++ ++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~ 72 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK-----TGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPN-------VVPL 72 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCC-------ccch
Confidence 6899999999999999999998765 4567999988643221 222345678999999999988 7777
Q ss_pred cccccccCCC-ccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGS-VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.+...... ......+++||||+. ++|.+.+... ...+++.++..++.|+++||.|||+.| ++|+||||+|
T Consensus 73 ~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~n 145 (311)
T cd07866 73 IDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAAN 145 (311)
T ss_pred hhheecccccccccCceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 7765432221 234557899999994 6787777642 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc------------ccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS------------MVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~ 239 (379)
|++++++.++|+|||++........ .....+++.|+|||...+ ..++.++||||||+++|+|++|++
T Consensus 146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 9999999999999999865432211 112246788999997754 457899999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhh---HHh---h---hhhc--cccCCCCc----chHHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 240 PIDAARDPASIIDWALPLIK---EEK---L---RQVC--DSRVGLPT----FMEGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~---~~~---~---~~~~--~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
||.+........... .... ... . .... ......+. ......+.+.+++.+||+.||++|||+.+
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 226 ILQGKSDIDQLHLIF-KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred CCCCCCHHHHHHHHH-HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 997655432221110 0000 000 0 0000 00000011 11223467899999999999999999999
Q ss_pred Hhccc
Q 035572 305 ILMGC 309 (379)
Q Consensus 305 ~l~~~ 309 (379)
++.|.
T Consensus 305 ll~~~ 309 (311)
T cd07866 305 ALEHP 309 (311)
T ss_pred HhcCC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=279.24 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=205.2
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|...+.||+|++|.||+|.+.. +++.+++|.+...... ....+.+.+|+.++++++|++ ++++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-----TGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPN-------IVRYYG 66 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-----CCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCC-------EeeEEE
Confidence 47888999999999999998764 5567999998755432 345788999999999999888 888776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+... .....++++||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||+|+||++
T Consensus 67 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i 134 (260)
T cd06606 67 SERDE-----EKNTLNIFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV 134 (260)
T ss_pred EEecC-----CCCeEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence 65321 1278899999999999999997643 4899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 176 DSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+.++.++|+|||.+........ .....++..|+|||...+...+.++||||||+++|+|++|..||....+......
T Consensus 135 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (260)
T cd06606 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214 (260)
T ss_pred cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 9999999999999876654432 3445789999999999888899999999999999999999999987652221111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.+.. ....+......+..+.+++.+||+.+|++||++.+++.|.
T Consensus 215 ------------~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 215 ------------KIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred ------------hccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 1111 0011222233467899999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=292.56 Aligned_cols=272 Identities=23% Similarity=0.296 Sum_probs=200.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
.+.++|++.+.||.|+||.||+|.+.. .++.+++|++...... ......+.+|+.+++++ +|+| +
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~n-------i 69 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRR-----TKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPN-------I 69 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcC-----CCeEEEEEeeccccCc--chhhhhhhHHHHHHHHhcCCCC-------c
Confidence 457889999999999999999998764 4567999987543211 23345677899999999 8888 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++++.. .+....|+||||+. ++|.+++... .+++..+..++.|++.||.|||+.| |+||||||
T Consensus 70 ~~~~~~~~~-----~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p 135 (337)
T cd07852 70 VKLLNVIKA-----ENDKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKP 135 (337)
T ss_pred cceeeeecc-----CCCceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 888876432 23456899999995 6999988642 3788888999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCC------cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDES------SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+
T Consensus 136 ~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 136 SNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred HHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999986543322 1223458899999997654 5578899999999999999999999976
Q ss_pred CCCchhHHHhhhh--------------hhhHHhhhhhcccc-CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 244 ARDPASIIDWALP--------------LIKEEKLRQVCDSR-VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 244 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..+.......... ......+..+.... ..........+.++.+++.+||+.||++|||+.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 5443221111000 00000111111111 11111122246789999999999999999999999998
Q ss_pred ccC
Q 035572 309 CSC 311 (379)
Q Consensus 309 ~~~ 311 (379)
...
T Consensus 296 ~~~ 298 (337)
T cd07852 296 PYV 298 (337)
T ss_pred hhh
Confidence 533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=290.99 Aligned_cols=264 Identities=19% Similarity=0.245 Sum_probs=193.9
Q ss_pred ccccccC--CceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 20 SRLIGKG--SHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 20 ~~~iG~G--~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
...||+| +||.||+|.+.. .++.||+|.+...... ....+.+.+|+.+++.++|+| |+++++.+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~n-------iv~~~~~~ 68 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTP-----TGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPN-------IMTSWTVF 68 (328)
T ss_pred HHHhCCcccCceeEEEEEEcC-----CCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCC-------cceEeeeE
Confidence 3567776 999999998654 5678999998754332 234578899999999999988 88877764
Q ss_pred cccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~ 177 (379)
..++..++||||+.+++|.+++.... ...+++..+..++.|++.||+|||+.| ++||||||+|||++.
T Consensus 69 -------~~~~~~~~v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~ 136 (328)
T cd08226 69 -------TTGSWLWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISG 136 (328)
T ss_pred -------ecCCceEEEEecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeC
Confidence 45678999999999999999987643 223888889999999999999999999 999999999999999
Q ss_pred CCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCC--CCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 178 KWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPS--KLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 178 ~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
++.++++||+.+........ .....++..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 216 (328)
T cd08226 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216 (328)
T ss_pred CCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH
Confidence 99999999986532211110 0112356679999998763 4788999999999999999999999776543
Q ss_pred hhHHHhhhhhh---------h--H----------------Hhhh-----hhccccCCCCcchHHHHHHHHHHHHhcccCC
Q 035572 248 ASIIDWALPLI---------K--E----------------EKLR-----QVCDSRVGLPTFMEGAIKQMLHVAARCVSSE 295 (379)
Q Consensus 248 ~~~~~~~~~~~---------~--~----------------~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (379)
........... . . .... ........ ......++..+.+|+++||+.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~d 295 (328)
T cd08226 217 QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQD 295 (328)
T ss_pred HHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCC
Confidence 32222111000 0 0 0000 00000000 1123446788999999999999
Q ss_pred CCCCCChHHHhcccc
Q 035572 296 EENRPGIGEILMGCS 310 (379)
Q Consensus 296 p~~Rps~~e~l~~~~ 310 (379)
|++|||+.|+++|..
T Consensus 296 P~~Rpta~e~l~~~~ 310 (328)
T cd08226 296 PEKRPSASSLLSHAF 310 (328)
T ss_pred cccCCCHHHHhhCHH
Confidence 999999999999844
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=282.12 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=194.6
Q ss_pred cccccCCceeEEEEEecCCCC-CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQT-DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
+.||.|+||.||+|.+..... ....+.+++|.+..... ......+.+|+.+++.++|++ |+++++.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~~~~~-- 68 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPN-------IVKLLGVC-- 68 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCC-------eeeEeeee--
Confidence 468999999999998765432 12346789998764321 234567889999999999988 88888764
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcC--CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~ 177 (379)
...+..++||||+++++|.+++.+.... ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 69 -----~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~ 141 (269)
T cd05044 69 -----LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSE 141 (269)
T ss_pred -----cCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEec
Confidence 3456789999999999999999764322 2234788899999999999999999999 999999999999998
Q ss_pred CC-----CeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 178 KW-----DAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 178 ~~-----~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
++ .++|+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||....+..
T Consensus 142 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~ 221 (269)
T cd05044 142 KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221 (269)
T ss_pred CCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH
Confidence 77 899999999865432211 122345788999999998899999999999999999998 999997543221
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..... . ..... ......+..+.+++.+||+.+|.+||+++++++.
T Consensus 222 -~~~~~----~-------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 222 -VLQHV----T-------AGGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred -HHHHH----h-------cCCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11100 0 01111 1223446789999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=287.48 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=196.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||.|++|.||+|.+.. +++.|++|.+...... ......+.+|+++++.++|+| +++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~~ 67 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV-----TNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGN-------IVRLQ 67 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC-----CCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCC-------EeeEE
Confidence 579999999999999999998754 5577999998654321 234467889999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+....|+||||+ +++|.+.+.... ...+++..+..++.|++.||+|||+++ ++|+||+|+||+
T Consensus 68 ~~~-------~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nil 134 (294)
T PLN00009 68 DVV-------HSEKRLYLVFEYL-DLDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLL 134 (294)
T ss_pred EEE-------ecCCeEEEEEecc-cccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEE
Confidence 774 4567899999999 468888876532 222577788899999999999999999 999999999999
Q ss_pred EcC-CCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDS-KWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~-~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++. ++.+||+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||........+.
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~ 214 (294)
T PLN00009 135 IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214 (294)
T ss_pred EECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 985 567999999998654322 22233467899999998765 457889999999999999999999997654433222
Q ss_pred HhhhhhhhHH---hhh------hhccccCC-CCc----chHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEE---KLR------QVCDSRVG-LPT----FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~---~~~------~~~~~~~~-~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... ...... .+. ........ .+. .....+..+.+++.+||+.+|++||++.+++.|.
T Consensus 215 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 215 KIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred HHH-HHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111 000000 000 00000000 000 1123456789999999999999999999999974
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=286.41 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=194.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
-++|++.+.||.|+||.||+|.+.. +++.||||.++.... ......+..|+.++.... |++ +++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~-------i~~ 78 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK-----TGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPY-------IVK 78 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC-----CCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCc-------hHh
Confidence 4679999999999999999998764 467799999875432 233456677777776664 666 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~ 171 (379)
+++++ .+....|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .| ++||||+|+
T Consensus 79 ~~~~~-------~~~~~~~~v~e~~-~~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~ 144 (296)
T cd06618 79 CYGYF-------ITDSDVFICMELM-STCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPS 144 (296)
T ss_pred hheee-------ecCCeEEEEeecc-CcCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHH
Confidence 77764 4467899999999 568888776532 248888999999999999999997 58 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCC----CCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSK----LSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||++++++.++|+|||++.............++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......
T Consensus 145 nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 224 (296)
T cd06618 145 NILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224 (296)
T ss_pred HEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence 9999999999999999986654433333446788999999887553 788999999999999999999999754322
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.... ..+.............++.++.+++.+||+.||.+||++++++.|..
T Consensus 225 ~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 225 FEVL------------TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HHHH------------HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1111 11111111101111134577999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=286.16 Aligned_cols=272 Identities=24% Similarity=0.399 Sum_probs=201.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||+|.....+ ...++.+|+|.++..... ...+.+.+|+++++.+.|++ +++++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~-------i~~~~ 72 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHEN-------IVKYK 72 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCC-------hheEE
Confidence 46888899999999999999876532 236788999998754321 34678999999999999988 77776
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++.. ......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.| ++|+||||+||+
T Consensus 73 ~~~~~-----~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil 141 (284)
T cd05038 73 GVCEK-----PGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNIL 141 (284)
T ss_pred eeeec-----CCCCceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEE
Confidence 65422 23567899999999999999997532 24888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.++|+|||++......... ....++..|+|||...+..++.++||||||+++|+|+||..|+.........
T Consensus 142 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 221 (284)
T cd05038 142 VESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR 221 (284)
T ss_pred EcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc
Confidence 999999999999998765422211 1123556799999988888999999999999999999999998654221100
Q ss_pred -HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 -IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
................+......+ ....++.++.+++.+||+.+|++|||+.|+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 222 MIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred ccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 000000000011111111111111 1223447799999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.02 Aligned_cols=274 Identities=21% Similarity=0.301 Sum_probs=200.0
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
-...++|++.+.||.|+||.||+|.+.. +++.||+|.+...... ......+.+|+.+++.++|+| |
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i 76 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRR-----TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMKHEN-------V 76 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECC-----CCcEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCC-------c
Confidence 3457899999999999999999998654 5677999988643211 233567889999999999988 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+.... ........++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||
T Consensus 77 v~~~~~~~~~~-~~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp 146 (343)
T cd07880 77 IGLLDVFTPDL-SLDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKP 146 (343)
T ss_pred cceeeeecCCc-cccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 77776643211 111223569999999 8899988853 23889999999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+||+++.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+....
T Consensus 147 ~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 224 (343)
T cd07880 147 GNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224 (343)
T ss_pred HHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999998654332 223367889999998765 4578899999999999999999999986543222
Q ss_pred HHHhhhh----------hhhHHhhhhhccc--cCC---CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALP----------LIKEEKLRQVCDS--RVG---LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~----------~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
....... .+........... ... .......+++.+.+++.+||+.||++|||+.+++.|..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 1111000 0000000000000 000 00111234567899999999999999999999999843
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.36 Aligned_cols=264 Identities=21% Similarity=0.397 Sum_probs=197.5
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|.+.+.||+|+||.||+|.+... ...++.+|+|.+..+... ....+++.+|+.+++.++|++ ++++++.
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i~~~~~~ 69 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPN-------VIKLIGV 69 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCC-------cceEEEE
Confidence 67789999999999999987642 235678999998754322 334567889999999999988 8888876
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
+..... .......++++||+.+++|.+++...... ....+++..+..++.|++.||+|||+.| |+||||||+||++
T Consensus 70 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili 146 (273)
T cd05074 70 SLRSRA-KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCML 146 (273)
T ss_pred EccCCC-CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEE
Confidence 543111 00112457899999999999887543211 2234788889999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 176 DSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
++++.++|+|||++........ .....+++.|++||......++.++|||||||++|+|++ |++||..... ..+.
T Consensus 147 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~ 225 (273)
T cd05074 147 NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIY 225 (273)
T ss_pred cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHH
Confidence 9999999999999875533221 122345678999999888889999999999999999999 8899875432 1111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... . ......+ ...+..+.+++.+||+.+|++|||+.+++...
T Consensus 226 ~~~~---------~--~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 226 NYLI---------K--GNRLKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred HHHH---------c--CCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1100 0 0111111 23356899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.59 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=197.6
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
+++.+.||.|+||.||+|.+..... .....+++|.+..... ....+.+..|+.+++.+.|++ ++++++.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~-------i~~~~~~ 69 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDAD---EQQIEEFLREARIMRKLDHPN-------IVKLLGV 69 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCC---hHHHHHHHHHHHHHHhcCCCc-------hheEEEE
Confidence 4678999999999999999876332 2457899999875432 125678999999999998887 7777765
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+ .+.+..+++|||+++++|.+++..... ..+++..+..++.|++.||++||+.+ ++|+||+|+||+++
T Consensus 70 ~-------~~~~~~~~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~ 137 (258)
T smart00219 70 C-------TEEEPLMIVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG 137 (258)
T ss_pred E-------cCCCeeEEEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc
Confidence 4 345789999999999999999976332 11789999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCCccc--ccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHh
Q 035572 177 SKWDAKLADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDW 253 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 253 (379)
+++.++|+|||++.......... ...++..|+|||...+..++.++|+||||+++|+|++ |..||....... ....
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-~~~~ 216 (258)
T smart00219 138 ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-VLEY 216 (258)
T ss_pred cCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence 99999999999986654432221 1236789999999888889999999999999999998 888887643211 1111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+..... +......+.++.+++.+||..||++|||+.++++.
T Consensus 217 ------------~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 217 ------------LKKGYR--LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred ------------HhcCCC--CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 111100 11122256789999999999999999999999863
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=284.48 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|++|.||+|.+.. +++.|++|.++.... ......+.+|+.+++.++|+| ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------i~~~~~ 65 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-----TGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHEN-------IVRLHD 65 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-----CCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCC-------Eeeeee
Confidence 58999999999999999998764 567899999875432 234567788999999999888 888777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..++||||++ ++|.+++..... ...+++..+..++.|++.||.|||+.| ++||||||+||++
T Consensus 66 ~~-------~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~ 133 (284)
T cd07836 66 VI-------HTENKLMLVFEYMD-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLI 133 (284)
T ss_pred eE-------eeCCcEEEEEecCC-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE
Confidence 64 44678899999996 589888875432 234899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+........
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 134 NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999986543321 22234578899999987654 5688999999999999999999999876543322211
Q ss_pred hhhh--hhHHhhhhhc---cccCCCC--------cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPL--IKEEKLRQVC---DSRVGLP--------TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~--~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... -....+..+. ......+ ...+..+..+.+++.+||+.||.+||++.++++|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 214 FRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred HHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 1000 0000000000 0000000 01123457789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.57 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=213.0
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
+++.-.+.|.++++||+|+||.|.+++.+. ++++||.|++++-.. ........|..|-.+|..-..+.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~-----t~~VYAMK~lnK~eM-lKr~~tA~F~EERDimv~~ns~W------ 136 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKS-----TEKVYAMKILNKWEM-LKRAETACFREERDIMVFGNSEW------ 136 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeec-----cccchhHHHhhHHHH-hhchhHHHHHHHhHHHHcCCcHH------
Confidence 445556899999999999999999998765 678899999975211 11233567888999998766555
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++|-. |+++.++|+||||++||+|-.++.+.. .+++..++-|+..|+-||..||+.| +|||||
T Consensus 137 -iv~LhyA-------FQD~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDi 201 (1317)
T KOG0612|consen 137 -IVQLHYA-------FQDERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDI 201 (1317)
T ss_pred -HHHHHHH-------hcCccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccC
Confidence 7776654 799999999999999999999998643 4899999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCC----C-CCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTN----P-SKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
||+|||+|..|++||+|||.+..+...+. ....+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||
T Consensus 202 KPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 202 KPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred CcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 99999999999999999999977665543 35568999999999763 3 57899999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCC---hHHHhccccCccccc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPG---IGEILMGCSCFFVDH 316 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~~~~~~~~~ 316 (379)
.... + -+.+.+|++. .+.+|. ...++.++.+||.+.+. +|+.|.. ++++-.|........
T Consensus 282 Yads----l---------veTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 282 YADS----L---------VETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hHHH----H---------HHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 7542 1 2233444443 455552 33488999999998775 6778887 999999876655433
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=279.79 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=185.6
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|...... ....+++|.+..... ....+.+.+|+.+++.++|+| ++++++.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~~-------iv~~~~~~--- 64 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT---GVARVVVKELKANAS---SKEQNEFLQQGDPYRILQHPN-------ILQCLGQC--- 64 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC---CcceEEEEEecCCCC---hHHHHHHHHHHHHHhccCCcc-------hhheEEEe---
Confidence 36999999999999754322 344567777654321 234578999999999999988 88888764
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+....|+||||+++|+|.+++.+.... ....+...+..++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 65 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~ 137 (268)
T cd05086 65 ----VEAIPYLLVFEYCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLT 137 (268)
T ss_pred ----cCCCccEEEEecCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCcc
Confidence 3456789999999999999999864322 233666777889999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCC---cccccCccccccCCCCCCC-------CCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 181 AKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNP-------SKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++|+|||++....... ......++..|+|||+... ..++.++||||||+++|+|++ |..||....+...
T Consensus 138 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 217 (268)
T cd05086 138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV 217 (268)
T ss_pred EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999985432211 1223467889999998743 245789999999999999997 5678865443221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+... .. +......+ +......+..+.+++..|+ .+|++||+++++++.
T Consensus 218 ~~~~----~~-~~~~~~~~-----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 218 LNHV----IK-DQQVKLFK-----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred HHHH----Hh-hcccccCC-----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 1111 11 11111111 2222234567888999999 679999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=288.48 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=196.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|+..+.||+|+||.||+|.+...+.. ....+++|.+..... ......+.+|+.+++.+.|+| ++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~n-------iv~~ 74 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-VKIPVAIKILNETTG---PKANVEFMDEALIMASMDHPH-------LVRL 74 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-ceeeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCC-------cccE
Confidence 35688899999999999999988654332 234689998864422 233456889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ...++++||+++|+|.+++... ...+++..+..++.|++.||.|||++| ++|+||||+||
T Consensus 75 ~~~~~~--------~~~~~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Ni 140 (303)
T cd05110 75 LGVCLS--------PTIQLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNV 140 (303)
T ss_pred EEEEcC--------CCceeeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC--eecccccccee
Confidence 776532 3467999999999999998753 223788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
+++.++.+||+|||++........ .....++..|+|||+..+..++.++||||||+++|+|++ |..||.+... ..
T Consensus 141 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~ 219 (303)
T cd05110 141 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-RE 219 (303)
T ss_pred eecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH
Confidence 999999999999999975543221 122345778999999988889999999999999999997 8999976431 11
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..... . .......+ ..++..+.+++.+||..+|++||++.++++...
T Consensus 220 ~~~~~----------~-~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 220 IPDLL----------E-KGERLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred HHHHH----------H-CCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11110 0 01111111 223467899999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.02 Aligned_cols=265 Identities=25% Similarity=0.305 Sum_probs=200.5
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|++.+.||.|++|.||+|.+.. +++.+++|.+...... ......+.+|+.+++.++|++ ++++++.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~~ 66 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-----TGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPN-------IIKLLDV 66 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-----CCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCC-------cchHHHh
Confidence 6788999999999999998654 5677999998754322 234578889999999999887 7777776
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+ ......++||||++ ++|.+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 67 ~-------~~~~~~~~v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~ 132 (283)
T cd05118 67 F-------RHKGDLYLVFEFMD-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN 132 (283)
T ss_pred h-------ccCCCEEEEEeccC-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC
Confidence 4 44588999999995 58988887632 24889999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 177 SKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+++.++|+|||.+....... ......++..|+|||...+. .++.++|+||||+++|+|+||+.||...+....+....
T Consensus 133 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999986654433 22334688899999988766 78999999999999999999999997655433221111
Q ss_pred hhhhh--HHhhhhhc-----------c-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIK--EEKLRQVC-----------D-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~--~~~~~~~~-----------~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... ........ . .........+.++..+.+++.+||+.||.+||++.+++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 00000 00000000 0 00111112334678899999999999999999999999884
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=293.82 Aligned_cols=274 Identities=21% Similarity=0.324 Sum_probs=198.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+|++.+.||.|+||.||+|.+.. +++.|++|.+.... ....+.+.+|+++++.++|+| ++++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~-----~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~-------i~~~ 67 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD-----CDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDN-------IVKV 67 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC-----CCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCc-------chhh
Confidence 4789999999999999999998764 56779999886543 234567889999999999988 7776
Q ss_pred cccccccC-------CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 94 HGTSCRNS-------GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 94 ~~~~~~~~-------~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
++.+.... ..+.+....|+||||++ ++|.+++... .+++..+..++.|++.||.|||+.| ++||
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~ 138 (342)
T cd07854 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN--VLHR 138 (342)
T ss_pred HhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 66543211 12333457899999995 6898887531 3888999999999999999999999 9999
Q ss_pred CCCCCceEEc-CCCCeEEeccccCccCCCCC----cccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 167 DIKSTNILFD-SKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 167 dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||||+||+++ +++.++|+|||++....... ......++..|+|||.+. +..++.++|||||||++|+|++|+.|
T Consensus 139 dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 218 (342)
T cd07854 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218 (342)
T ss_pred CCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999997 45678999999986543221 112235788999999654 45678899999999999999999999
Q ss_pred CCCCCCchhHHHhhhh--hhhH----H---hhhhh-----ccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 241 IDAARDPASIIDWALP--LIKE----E---KLRQV-----CDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~--~~~~----~---~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
|....+.......... .... . ..... ..............+.++.+++.+||+.||.+|||+.+++
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 9766543322111100 0000 0 00000 0000000111123457789999999999999999999999
Q ss_pred ccccCc
Q 035572 307 MGCSCF 312 (379)
Q Consensus 307 ~~~~~~ 312 (379)
.|....
T Consensus 299 ~h~~~~ 304 (342)
T cd07854 299 MHPYMS 304 (342)
T ss_pred CCCccc
Confidence 985553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=291.72 Aligned_cols=273 Identities=21% Similarity=0.259 Sum_probs=202.3
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
++..++++|++.+.||.|+||.||+|.+.. +++.+++|.+...... ....+.+.+|+.+++.++|+|
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn------ 70 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQL-----TGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHEN------ 70 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECC-----CCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCC------
Confidence 445578999999999999999999998765 5677999987643221 234567889999999999988
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
++++++.+. ......+++|||+ +++|.+++... .++...+..++.|+++||.|||+.+ ++||||
T Consensus 71 -iv~~~~~~~------~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl 134 (328)
T cd07856 71 -IISLSDIFI------SPLEDIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDL 134 (328)
T ss_pred -eeeEeeeEe------cCCCcEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence 888777653 2345789999999 67998888531 2777888899999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+|+||++++++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 135 ~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 135 KPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred CHHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999998654322 223357889999998765 56899999999999999999999999765421
Q ss_pred hhHHHhhh-----------hhhhHHh--hhhhccccCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 248 ASIIDWAL-----------PLIKEEK--LRQVCDSRVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~-----------~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
........ ....... +..........+ .....++..+.+++.+||+.+|++||++++++.|....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 11110000 0000000 000000000111 11123457899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.29 Aligned_cols=244 Identities=24% Similarity=0.405 Sum_probs=190.2
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
++||.|+||.||+|.+.+ ++.|++|.++..... .....+.+|+++++++.|++ ++.+++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~-------i~~~~~~~--- 61 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPN-------IVKLIGVC--- 61 (251)
T ss_pred CccccCCCceEEEEEEeC------CCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCC-------eEEEEEEE---
Confidence 479999999999998653 456999988754321 34567899999999999888 77777664
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+....++||||+++++|.+++.... ..+++..+..++.+++.+|.|||+++ ++||||+|+||+++.++.
T Consensus 62 ----~~~~~~~~v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~ 131 (251)
T cd05041 62 ----VQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNV 131 (251)
T ss_pred ----ecCCCeEEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCc
Confidence 45678899999999999999997532 23788889999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhh
Q 035572 181 AKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 256 (379)
++|+|||++......... .....+..|+|||.+.+..++.++|+||||+++|+|+| |..||......... .
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~---- 206 (251)
T cd05041 132 LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-E---- 206 (251)
T ss_pred EEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-H----
Confidence 999999998654322111 11234567999999988889999999999999999999 88888665321110 0
Q ss_pred hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.... ..... .....+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 207 -----~~~~--~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 207 -----RIES--GYRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred -----HHhc--CCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0000 01111 122345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=290.04 Aligned_cols=270 Identities=23% Similarity=0.312 Sum_probs=201.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|++|.||+|.+.. .++.+++|.+..... .....+.+.+|+.+++.++|++ ++++++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-----TGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHEN-------IIGLLD 66 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-----CCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcc-------hhhhhh
Confidence 58999999999999999998654 467799998875422 1344678999999999999888 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+..... ......|++|||++ ++|.+++.+.. .+++..+..++.|++.||++||+.| ++||||||+|||+
T Consensus 67 ~~~~~~~--~~~~~~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili 136 (330)
T cd07834 67 ILRPPSP--EDFNDVYIVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILV 136 (330)
T ss_pred hhcccCc--ccccceEEEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 6543111 22347899999995 68998886432 4889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 176 DSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+.++.++|+|||++....... ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.........
T Consensus 137 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~ 216 (330)
T cd07834 137 NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL 216 (330)
T ss_pred cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence 999999999999987654432 22334678899999998877 7899999999999999999999999776532211
Q ss_pred HHhhhhhhh---HH--------hhhhhcc---cc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIK---EE--------KLRQVCD---SR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~---~~--------~~~~~~~---~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
... ..... .. .....+. .. ..........+..+.+++.+||+.+|.+||++.+++.|..
T Consensus 217 ~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 217 NLI-VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred HHH-HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 111 00000 00 0000000 00 0001111234678999999999999999999999999843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=253.20 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=208.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|.-.++||+|.||+||+|..+. +.++||+|+++.+... ........+||.+|+.++|.| ||+++
T Consensus 2 ~~ydkmekigegtygtvfkarn~~-----t~eivalkrvrldddd--egvpssalreicllkelkhkn-------ivrl~ 67 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE-----THEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKN-------IVRLH 67 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC-----ccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcc-------eeehh
Confidence 457778999999999999996543 7788999999876543 455677899999999999999 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.. -.++.+-+|+||| ..+|..+..+.+ ..++...++.++.|++.||.++|+++ +.||||||+|.|
T Consensus 68 dvl-------hsdkkltlvfe~c-dqdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnll 133 (292)
T KOG0662|consen 68 DVL-------HSDKKLTLVFEFC-DQDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLL 133 (292)
T ss_pred hhh-------ccCceeEEeHHHh-hHHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEE
Confidence 764 4578899999999 789999887643 34888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCC-CCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
++.+|.+|++|||+++-+...- .....+-|..|.||.++-+.. |+...|+||.||++.|+.. |++.|.+.+..+++.
T Consensus 134 in~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred eccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 9999999999999997665443 334457899999999887654 7889999999999999987 777787776655554
Q ss_pred Hhhhhh--hhHHhhhh---hccccC----CCCcchHH----HHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPL--IKEEKLRQ---VCDSRV----GLPTFMEG----AIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~--~~~~~~~~---~~~~~~----~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...... ..+..+.. ..+... +.-..+.. ....-+++++++|.-+|.+|++++++++|...
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 433221 11222221 112111 00011222 23346799999999999999999999998654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=280.61 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=185.7
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccC
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS 101 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~ 101 (379)
.||+|+||.||+|.+.. +++.||+|.+....... ......+..|..+++.+++.+ +|+ ++.+++.
T Consensus 1 ~ig~g~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~--i~~~~~~----- 65 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGD--CPF--IVCMSYA----- 65 (278)
T ss_pred CcccCCCeEEEEEEEec-----CCCEEEEEEeecccccc-chhHHHHHHHHHHHHHHHhCC--CCc--Eeeeeee-----
Confidence 48999999999998754 56789999987543221 111223445555555443321 111 6665554
Q ss_pred CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCe
Q 035572 102 GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181 (379)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~ 181 (379)
+.+.+..++||||+.|++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 66 --~~~~~~~~~v~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~ 136 (278)
T cd05606 66 --FHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHV 136 (278)
T ss_pred --eecCCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCE
Confidence 45677899999999999999988643 23899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhH
Q 035572 182 KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKE 260 (379)
Q Consensus 182 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 260 (379)
+|+|||++....... .....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||..........
T Consensus 137 kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--------- 206 (278)
T cd05606 137 RISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------- 206 (278)
T ss_pred EEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---------
Confidence 999999986543222 2334689999999988644 68899999999999999999999997653221100
Q ss_pred HhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 261 EKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
............+ ...+..+.+++.+||..+|.+|| ++.++++|...
T Consensus 207 -~~~~~~~~~~~~~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 207 -IDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred -HHHHhhccCCCCC---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 0000111111122 22357899999999999999999 99999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=285.56 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=194.9
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|....+||+|+||.||++.... +++.+++|.+.... ......+.+|+.+++.++|+| ++++++.
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------iv~~~~~ 85 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS-----SGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHEN-------VVEMYNS 85 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC-----CCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcc-------hhheeeE
Confidence 3445689999999999998764 56789999875432 234567899999999999888 7777765
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+ ...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+.| ++|+||+|+||+++
T Consensus 86 ~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~ 150 (292)
T cd06657 86 Y-------LVGDELWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT 150 (292)
T ss_pred E-------EeCCEEEEEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC
Confidence 3 4567899999999999999987532 2788899999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 177 SKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
.++.++|+|||++....... ......+++.|+|||...+..++.++|+||+|+++|+|++|..||.+....... ..
T Consensus 151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~-- 227 (292)
T cd06657 151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KM-- 227 (292)
T ss_pred CCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH--
Confidence 99999999999886543322 122346889999999988888899999999999999999999999765322111 00
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
......... .....++..+.+++.+||+.+|.+||++.+++.|..
T Consensus 228 -------~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 228 -------IRDNLPPKL---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred -------HHhhCCccc---CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 000111111 011234567889999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=283.01 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=201.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~ 93 (379)
++|++.+.||.|+||.||+|.+.. +++.|++|++...... .....+.+.+|+.++++++ |+| ++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~-------i~~~ 67 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-----TNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPG-------IIKL 67 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-----CCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCC-------chhH
Confidence 479999999999999999998765 5677999998653221 1233467889999999998 777 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..++||||+++++|.+++.+.. .+++..+..++.|++.||.+||+.| ++|+||+|+||
T Consensus 68 ~~~-------~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni 133 (280)
T cd05581 68 YYT-------FQDEENLYFVLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENI 133 (280)
T ss_pred HHH-------hcCCceEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHe
Confidence 765 355678999999999999999997643 3899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC---------------------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES---------------------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLL 232 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 232 (379)
+++.++.++|+|||++....... ......++..|+|||+..+..++.++|+||||++++
T Consensus 134 ~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 213 (280)
T cd05581 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIY 213 (280)
T ss_pred EECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHH
Confidence 99999999999999986543322 112235788999999988888999999999999999
Q ss_pred HHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh----HHHhcc
Q 035572 233 EIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI----GEILMG 308 (379)
Q Consensus 233 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~e~l~~ 308 (379)
++++|+.||........ +..........+ ...++.+.+++.+||+.+|.+||++ ++++.|
T Consensus 214 ~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 214 QMLTGKPPFRGSNEYLT-------------FQKILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHhCCCCCCCccHHHH-------------HHHHHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 99999999986642111 111111222222 2335789999999999999999999 999988
Q ss_pred c
Q 035572 309 C 309 (379)
Q Consensus 309 ~ 309 (379)
.
T Consensus 278 ~ 278 (280)
T cd05581 278 P 278 (280)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=281.77 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=197.0
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeeccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFHG 95 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~~ 95 (379)
|++.+.||.|++|.||+|.+.. .++.|++|++...... .......+|+..++.++ |++ ++++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~-------i~~~~~ 65 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-----TGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPN-------IVKLKE 65 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-----CCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCC-------chhHHH
Confidence 6788999999999999998765 4567999998643221 12234567899999998 887 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+++..++||||+ +++|.+.+.... ...+++..+..++.|++.+|.|||++| ++|+||+|+||++
T Consensus 66 ~~-------~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i 132 (283)
T cd07830 66 VF-------RENDELYFVFEYM-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLV 132 (283)
T ss_pred Hh-------hcCCcEEEEEecC-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE
Confidence 64 4467899999999 889999887643 234899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++++.++|+|||++.............++..|+|||++. ...++.++|+||||+++|+|++|++||.............
T Consensus 133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 133 SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC 212 (283)
T ss_pred cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence 999999999999987665444444456889999999774 4557899999999999999999999997665433221110
Q ss_pred hh-------hhhH-HhhhhhccccCC------CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LP-------LIKE-EKLRQVCDSRVG------LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~-------~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. .+.. .......+.... ........+..+.+++.+||+.||++|||+.|++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 00 0000 000000000000 0011112246799999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=286.00 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=196.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+..+.||+|+||.||+|.+.. ++..+++|.+...... .......+.+|+++++.++|+| +++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~-----~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------iv~~~ 91 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPN-------SIEYK 91 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCC-------EEEEE
Confidence 348889999999999999998754 4567999998654221 1334567889999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .++...++||||+. |+|.+.+... ...+++.++..++.|++.||.|||++| ++||||+|+||+
T Consensus 92 ~~~-------~~~~~~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil 157 (317)
T cd06635 92 GCY-------LREHTAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNIL 157 (317)
T ss_pred EEE-------eeCCeEEEEEeCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEE
Confidence 775 34567899999995 5888877542 223889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++.++.++|+|||++...... ....+++.|+|||++ ....++.++|+|||||++|+|++|..||........+.
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 234 (317)
T cd06635 158 LTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 234 (317)
T ss_pred ECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 999999999999988654332 234688999999986 34568899999999999999999999987653222111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
. +...... +......+..+.+++.+||+.+|.+||++.+++.|...
T Consensus 235 ~-------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 235 H-------------IAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred H-------------HHhccCC-CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1 1111110 11122345679999999999999999999999998444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=277.06 Aligned_cols=242 Identities=21% Similarity=0.392 Sum_probs=186.6
Q ss_pred cccccCCceeEEEEEecCCCC-----CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQT-----DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+.||+|+||.||+|.+..... ......+++|.+.... .....+.+|+.+++.++|++ ++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 68 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKH-------LVKLYG 68 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcc-------hhheee
Confidence 479999999999999876431 1223457788765432 22678899999999999988 787777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+.. +..++||||+++++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+|||+
T Consensus 69 ~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill 134 (259)
T cd05037 69 VCVR--------DENIMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILV 134 (259)
T ss_pred EEec--------CCcEEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEE
Confidence 6532 456999999999999999986431 4888999999999999999999999 9999999999999
Q ss_pred cCCC-------CeEEeccccCccCCCCCcccccCccccccCCCCCCCC--CCCCcCCeehhHHHHHHHHh-CCCCCCCCC
Q 035572 176 DSKW-------DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS--KLSKKVDVFSYGVVLLEIIS-CRKPIDAAR 245 (379)
Q Consensus 176 ~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~p~~~~~ 245 (379)
+.++ .++|+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||....
T Consensus 135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 135 ARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 9887 799999999876543 2223567889999998776 78999999999999999999 577776553
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... .... +. .......+. ...+.+++.+||..+|.+|||+.++++.
T Consensus 212 ~~~-~~~~---------~~--~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 212 SSE-KERF---------YQ--DQHRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred chh-HHHH---------Hh--cCCCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 211 1110 00 111111111 1678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=278.99 Aligned_cols=247 Identities=28% Similarity=0.378 Sum_probs=195.1
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||.|+||.||+|.+.. +++.+++|.+...... .....+.+.+|+.+++.++|+| ++++++.
T Consensus 1 lg~g~~~~vy~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~-------i~~~~~~------ 61 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-----TGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPY-------VVKLYYS------ 61 (265)
T ss_pred CCCCCceEEEEEEECC-----CCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcc-------hhHHHHh------
Confidence 6899999999998764 4678999998754322 1345678899999999999888 7776655
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
+.+....|++|||+++++|.+++.+.+ .+++..+..++.|++.||.|||+.| ++|+||+|+||++++++.++
T Consensus 62 -~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~ 133 (265)
T cd05579 62 -FQGKKNLYLVMEYLPGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLK 133 (265)
T ss_pred -eecCcEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEE
Confidence 355788999999999999999997633 3889999999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCC---------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 183 LADFGLAVSESDES---------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 183 l~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|+|||++....... ......++..|+|||.......+.++|+||||+++|++++|..||.......
T Consensus 134 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----- 208 (265)
T cd05579 134 LTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----- 208 (265)
T ss_pred EEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 99999986543221 1223357889999999888888999999999999999999999997654211
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh---HHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI---GEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~e~l~~~~ 310 (379)
....+.......+... ..+..+.+++.+||+.+|.+|||+ .+++.|..
T Consensus 209 --------~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 209 --------IFQNILNGKIEWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred --------HHHHHhcCCcCCCccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 1111111122222211 135789999999999999999999 99998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=285.10 Aligned_cols=277 Identities=23% Similarity=0.300 Sum_probs=201.7
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
....++|++.+.||.|+||.||+|.+.. .++.|++|.++..... ......+.+|+.+++.++|+| +
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~-------i 68 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKD-----TGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRN-------I 68 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECC-----CCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCC-------e
Confidence 4567899999999999999999999764 4567999998754321 233456788999999999988 8
Q ss_pred eeccccccccCC---CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 91 VNFHGTSCRNSG---SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 91 v~~~~~~~~~~~---~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
+++++.+....+ ...+....++|+||+++ +|.+.+... ...+++..+..++.|++.||+|||+.| |+|+|
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~d 141 (302)
T cd07864 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRD 141 (302)
T ss_pred eeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence 888877654221 12234589999999964 787777642 224889999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
|+|+||++++++.+||+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...
T Consensus 142 l~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 142 IKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986554332 1122346788999997754 45788999999999999999999999765
Q ss_pred CCchhHHHhhhhhhh---HHhhhhhcc--------ccC----CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 245 RDPASIIDWALPLIK---EEKLRQVCD--------SRV----GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~---~~~~~~~~~--------~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.+...+.... .... ...+..+.. ... .........+..+.+++.+||+.||.+||++.+++.|.
T Consensus 222 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 300 (302)
T cd07864 222 QELAQLELIS-RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300 (302)
T ss_pred ChHHHHHHHH-HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 4332221111 0000 000000000 000 00001122457899999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=261.27 Aligned_cols=264 Identities=18% Similarity=0.255 Sum_probs=211.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
.++|++.+++|+|.|+.||.|.... +...++||.++ +...+.+.+|+.||+.|. ++| |+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~-----~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~N-------Ii~ 97 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINIT-----NNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPN-------IIK 97 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccC-----CCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCC-------eee
Confidence 4789999999999999999997554 44558899987 556788999999999997 777 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+.+.... .......|++||+++.+...+... ++...++.+++++++||.|+|+.| |.|||+||.|
T Consensus 98 L~DiV~D-----p~SktpaLiFE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhN 162 (338)
T KOG0668|consen 98 LLDIVKD-----PESKTPSLIFEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHN 162 (338)
T ss_pred hhhhhcC-----ccccCchhHhhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcC--cccccCCcce
Confidence 8877543 345677899999999998888754 777888999999999999999999 9999999999
Q ss_pred eEEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCC-CCCchh
Q 035572 173 ILFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDA-ARDPAS 249 (379)
Q Consensus 173 Ill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~-~~~~~~ 249 (379)
++++ ....++|+|||+|.+..+....+.++.+..|-.||.+.. ..|+..-|+|||||++..|+..+.||.. .++.++
T Consensus 163 vmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ 242 (338)
T KOG0668|consen 163 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 242 (338)
T ss_pred eeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH
Confidence 9999 456799999999999888888888889999999997654 4578899999999999999998888754 455667
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchH---------------------HHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFME---------------------GAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++..+.-+-.++...-+......+++... -++++++|++.++|..|..+|+|+.|++.|
T Consensus 243 LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 76655433333222222222222222211 134889999999999999999999999998
Q ss_pred ccC
Q 035572 309 CSC 311 (379)
Q Consensus 309 ~~~ 311 (379)
...
T Consensus 323 pyF 325 (338)
T KOG0668|consen 323 PYF 325 (338)
T ss_pred chH
Confidence 544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.40 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=201.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||.|++|.||+|.+.. .++.+++|.+...... ....+.+.+|+++++.++|++ ++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~-------i~~~~~ 66 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-----TGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPN-------IVKYIG 66 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-----CCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCC-------ccEEEE
Confidence 58899999999999999998754 4567999998765432 345678999999999999887 666665
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+.+..+++|||+++++|.+++... ..+++..+..++.|++.||.+||+.| ++||||+|+||++
T Consensus 67 ~~-------~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i 132 (254)
T cd06627 67 SI-------ETSDSLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILT 132 (254)
T ss_pred EE-------EeCCEEEEEEecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE
Confidence 53 3457889999999999999999754 23889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+.++.++|+|||++........ .....++..|+|||...+..++.++|+||+|+++|+|++|+.||....+.......
T Consensus 133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~- 211 (254)
T cd06627 133 TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI- 211 (254)
T ss_pred CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-
Confidence 9999999999999866543332 23346889999999988888899999999999999999999999765422111110
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... +......+..+.+++.+||..+|++|||+.+++.+.
T Consensus 212 -----------~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 212 -----------VQDDH---PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred -----------hccCC---CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 00111 112223457899999999999999999999999873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.39 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=194.9
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~ 94 (379)
+|++.+.||.|++|.||++.+.... ..++.+++|.++...........+.+.+|+.+++.++ |++ ++.++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~-------i~~~~ 71 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF-------LVTLH 71 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcc-------hhhhh
Confidence 4888999999999999999865432 3567899999875432222344567889999999995 666 55555
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +..+...++||||+.+++|.+.+... ..+++..+..++.|++.+|.|||+.+ ++||||+|+||+
T Consensus 72 ~~-------~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil 137 (288)
T cd05583 72 YA-------FQTDTKLHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENIL 137 (288)
T ss_pred ee-------eecCCEEEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeE
Confidence 44 45567899999999999999998643 23788899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCC--CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSK--LSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.++|+|||++........ .....++..|+|||...+.. .+.++|+||||+++|+|++|..||.........
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 217 (288)
T cd05583 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217 (288)
T ss_pred ECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence 99999999999999865433222 12235889999999887654 788999999999999999999999643322111
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH---HHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG---EILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---e~l~~~ 309 (379)
... ...........+ ...+..+.+++.+||+.||++|||+. +++.|.
T Consensus 218 ~~~---------~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 218 SEI---------SRRILKSKPPFP---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHH---------HHHHHccCCCCC---cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 110 111111122222 22456789999999999999999964 556663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=288.22 Aligned_cols=273 Identities=19% Similarity=0.253 Sum_probs=196.0
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~ 94 (379)
+|++.+.||+|+||.||++.+.... .++.||+|.++..... ....+.+.+|+.+++.++ |+| +++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~-------iv~~~ 68 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKN-------ITCLY 68 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCC-------hheee
Confidence 5888999999999999999876531 2567999998643211 234567889999999995 777 77766
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+..... .......|+++||+ +++|.+.+... ..+++..++.++.|++.||.|||+.| ++||||||+|||
T Consensus 69 ~~~~~~---~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nil 137 (332)
T cd07857 69 DMDIVF---PGNFNELYLYEELM-EADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLL 137 (332)
T ss_pred eeeeec---cccCCcEEEEEecc-cCCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeE
Confidence 653221 12345688999999 57999988642 23889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 175 FDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
+++++.++|+|||++....... ......|+..|+|||+..+ ..++.++||||||+++|+|++|.+||...+...
T Consensus 138 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~ 217 (332)
T cd07857 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD 217 (332)
T ss_pred EcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH
Confidence 9999999999999986543221 1223468999999997655 568899999999999999999999997654322
Q ss_pred hHHHhhhh----------hhhHHhhhhh---ccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 249 SIIDWALP----------LIKEEKLRQV---CDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~----------~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+...... .+........ ... ....+......+..+.+++.+||+.||.+|||+.+++.|...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 11110000 0000000000 000 000111112235689999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.20 Aligned_cols=282 Identities=21% Similarity=0.261 Sum_probs=207.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|+....||+|.||.||+|+..++... -.+.+|+|.++.+... ........+|+.+++.++|+| ++.+.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~n-------vi~Lv 93 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPN-------VISLV 93 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCc-------chhHH
Confidence 4799999999999999999986654432 2467999999866332 233456789999999999999 66666
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
..+. ..+..+++++||.+ -+|...|+.........++...+..+++||+.|+.|||++= |+||||||.|||
T Consensus 94 ~Vfl------~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIl 164 (438)
T KOG0666|consen 94 KVFL------SHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANIL 164 (438)
T ss_pred HHHh------ccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEE
Confidence 5543 23689999999996 59999998766666677999999999999999999999999 999999999999
Q ss_pred EcCC----CCeEEeccccCccCCCCC----cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 175 FDSK----WDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 175 l~~~----~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
+..+ |.+||+|||+++.....- .....+-|..|.|||.+.+. .||.+.|+|+.|||+.||+|-.+.|.+..
T Consensus 165 vmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 165 VMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred EeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9877 999999999997664432 22334679999999987765 58999999999999999999988886532
Q ss_pred C------c---hhHHHhhhhhhhHHhhhhh------c-------c------ccCCCCcch---HHHHHHHHHHHHhcccC
Q 035572 246 D------P---ASIIDWALPLIKEEKLRQV------C-------D------SRVGLPTFM---EGAIKQMLHVAARCVSS 294 (379)
Q Consensus 246 ~------~---~~~~~~~~~~~~~~~~~~~------~-------~------~~~~~~~~~---~~~~~~~~~li~~~l~~ 294 (379)
. + +++.+ +..++.......+ . + ....+..+. ..-++...+|+.++|++
T Consensus 245 ~k~~~~~Pfq~dQl~r-If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y 323 (438)
T KOG0666|consen 245 EKIKTKNPFQHDQLDR-IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY 323 (438)
T ss_pred hhcccCCCchHHHHHH-HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc
Confidence 1 1 11111 1111111000000 0 0 000011110 01134588999999999
Q ss_pred CCCCCCChHHHhccccCccccc
Q 035572 295 EEENRPGIGEILMGCSCFFVDH 316 (379)
Q Consensus 295 dp~~Rps~~e~l~~~~~~~~~~ 316 (379)
||.+|.|++++++|........
T Consensus 324 DP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 324 DPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred CchhhccHHHHhcccccccCCC
Confidence 9999999999999977665533
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.14 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=197.9
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|++.+.||.|+||.||+|.+.. .++.+++|.+.... ........+.+|+.+++.++|++ ++++++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~-------i~~~~~~ 66 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-----TGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPN-------IVRLKEI 66 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-----CCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCC-------eeeheee
Confidence 6788999999999999998765 45779999997543 11334567889999999999888 8888877
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+... ..+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++
T Consensus 67 ~~~~-----~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~ 134 (287)
T cd07840 67 VTSK-----GKGSIYMVFEYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN 134 (287)
T ss_pred EecC-----CCCcEEEEecccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc
Confidence 5321 1378999999995 59998886532 34889999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 177 SKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+++.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~ 214 (287)
T cd07840 135 NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214 (287)
T ss_pred CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999986654432 1233457888999997654 45789999999999999999999999766543222111
Q ss_pred hhhhhh---HHhh--------hhhccccCCCCc----chHH-HHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 254 ALPLIK---EEKL--------RQVCDSRVGLPT----FMEG-AIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 254 ~~~~~~---~~~~--------~~~~~~~~~~~~----~~~~-~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .... ...+ ..........+. .... ++..+.+++.+||+.+|.+||++.+++.|.
T Consensus 215 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 215 F-ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred H-HHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 1 1000 0000 000000000010 1111 267899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=277.11 Aligned_cols=257 Identities=20% Similarity=0.320 Sum_probs=195.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|.+.+.||+|+||.||++.+..... .....++|.+...... ......+.+|+.+++.++|+| ++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~~~ 69 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVA--EERLKVLKEIPVGELN--PNETVQANQEAQLLSKLDHPA-------IVKFHA 69 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCC--cceEEEeccccccccC--cchHHHHHHHHHHHHhCCCCc-------HHHHHH
Confidence 58899999999999999998765322 2233344443322221 233456778999999999988 777776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ .+....++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.| ++|+||+|+||++
T Consensus 70 ~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili 139 (260)
T cd08222 70 SF-------LERDAFCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFL 139 (260)
T ss_pred HH-------hcCCceEEEEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEe
Confidence 64 445678999999999999999876432 2334899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 176 DSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++ +.++|+|||++....... ......+++.|+|||...+..++.++|+||||+++|+|++|..||.........
T Consensus 140 ~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---- 214 (260)
T cd08222 140 KN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV---- 214 (260)
T ss_pred ec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH----
Confidence 75 579999999986543322 223346888999999988888899999999999999999999999654321110
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..+... ..+.....++.++.+++.+||+.+|++||++.+++.|.
T Consensus 215 ---------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 258 (260)
T cd08222 215 ---------LRIVEG--PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP 258 (260)
T ss_pred ---------HHHHcC--CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence 111111 11222345668899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=289.81 Aligned_cols=275 Identities=22% Similarity=0.315 Sum_probs=201.9
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
..+.++|++.+.||+|++|.||+|.+.. +++.|++|.+...... ......+.+|+.+++.+.|+| +
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i 76 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTK-----TGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHEN-------V 76 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECC-----CCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCC-------H
Confidence 3457899999999999999999998765 4567999988643211 234566788999999999988 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+.+++.+..... .......++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||+|
T Consensus 77 v~~~~~~~~~~~-~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp 146 (343)
T cd07851 77 IGLLDVFTPASS-LEDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKP 146 (343)
T ss_pred HHHHHHhhcccc-ccccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence 777765432111 12234589999999 7899998864 23899999999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+||++++++.++|+|||++...... .....++..|+|||...+ ..++.++||||||+++|+|++|+.||........
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~ 224 (343)
T cd07851 147 SNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224 (343)
T ss_pred HHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9999999999999999998665432 233467889999997754 4678899999999999999999999976543322
Q ss_pred HHHhhhhhhh---HHhhh--------hhccc-c-CC---CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLIK---EEKLR--------QVCDS-R-VG---LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~~---~~~~~--------~~~~~-~-~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+... ..... ..... ..... . .. ........+..+.+++.+||+.||++|||+.+++.|....
T Consensus 225 ~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 225 LKRI-MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHH-HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 1111 00000 00000 00000 0 00 0011122367899999999999999999999999985443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=283.29 Aligned_cols=265 Identities=17% Similarity=0.218 Sum_probs=190.3
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccc
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSC 98 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~ 98 (379)
+.+.+|.| |.||.+.... +++.||+|+++..... ....+.+.+|+.+++.++|+| ++++++.+
T Consensus 6 i~~~~~~~--~~v~~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~-------i~~~~~~~- 68 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKP-----TNTLVAVKKINLDSCS--KEDLKLLQQEIITSRQLQHPN-------ILPYVTSF- 68 (314)
T ss_pred hhHhhcCC--ceEEEEEecC-----CCCEEEEEEEeccccc--hhHHHHHHHHHHHHHhcCCcc-------hhhhhhee-
Confidence 34444444 4455554433 5678999998754322 345678999999999999988 77777653
Q ss_pred ccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCC
Q 035572 99 RNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~ 178 (379)
.+.+..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.+
T Consensus 69 ------~~~~~~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~ 137 (314)
T cd08216 69 ------IVDSELYVVSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD 137 (314)
T ss_pred ------ecCCeEEEEEeccCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC
Confidence 45678899999999999999998642 223788889999999999999999999 9999999999999999
Q ss_pred CCeEEeccccCccCCCCC--------cccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 179 WDAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 179 ~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
+.++|+|||.+....... ......++..|+|||++.. ..++.++|+|||||++|+|++|..||.......
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred CceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999885432211 1223357788999998765 357889999999999999999999998654433
Q ss_pred hHHHhhhhhh----hHHhhhhh-----------cc---ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 249 SIIDWALPLI----KEEKLRQV-----------CD---SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 249 ~~~~~~~~~~----~~~~~~~~-----------~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.......... ........ .. ............+.++.+++.+||+.||++|||+++++.|..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 218 MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 2222111000 00000000 00 000001122345678999999999999999999999999854
Q ss_pred C
Q 035572 311 C 311 (379)
Q Consensus 311 ~ 311 (379)
.
T Consensus 298 ~ 298 (314)
T cd08216 298 F 298 (314)
T ss_pred H
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=309.75 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=200.2
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.-...|+.+++||+||||.||+++.+ .+++.||||+++... ......++.+|+..|.+|+|+| ||
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNK-----lDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpN-------VV 540 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNK-----LDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPN-------VV 540 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeec-----ccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcc-------ee
Confidence 44567899999999999999999654 488899999998764 2566788999999999999999 66
Q ss_pred eccccccccCC----------------------------------------------------C----------------
Q 035572 92 NFHGTSCRNSG----------------------------------------------------S---------------- 103 (379)
Q Consensus 92 ~~~~~~~~~~~----------------------------------------------------~---------------- 103 (379)
+|+..|+.... .
T Consensus 541 RYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~ 620 (1351)
T KOG1035|consen 541 RYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEEN 620 (1351)
T ss_pred eeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccc
Confidence 65554443000 0
Q ss_pred ---------------c----------------------c-------CCCceEEEEeccCCCCHHHHHHhhhcCCCCCCCh
Q 035572 104 ---------------V----------------------D-------GNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139 (379)
Q Consensus 104 ---------------~----------------------~-------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 139 (379)
. . ....+||-||||+...|.+++.+..... ..
T Consensus 621 ~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~ 696 (1351)
T KOG1035|consen 621 DDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QR 696 (1351)
T ss_pred ccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hh
Confidence 0 0 0035788999998877777776533110 35
Q ss_pred HhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCC-------------------CCCcccc
Q 035572 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES-------------------DESSMVQ 200 (379)
Q Consensus 140 ~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~ 200 (379)
...+.++++|++||.|+|+.| ++||||||.|||+++++.|||+|||+|.... .....+.
T Consensus 697 d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts 774 (1351)
T KOG1035|consen 697 DEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS 774 (1351)
T ss_pred HHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence 677899999999999999999 9999999999999999999999999996511 0112344
Q ss_pred cCccccccCCCCCCCCC---CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCC-cc
Q 035572 201 PAGTIGYLDPGYTNPSK---LSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLP-TF 276 (379)
Q Consensus 201 ~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 276 (379)
.+||.-|+|||++.+.. |+.|+|+||||++++||+ .||....+... .+.++-+..++.+ .+
T Consensus 775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~------------iL~~LR~g~iP~~~~f 839 (1351)
T KOG1035|consen 775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERAS------------ILTNLRKGSIPEPADF 839 (1351)
T ss_pred ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHH------------HHHhcccCCCCCCccc
Confidence 57999999999887654 999999999999999998 46766543222 2223333333333 22
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 277 MEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 277 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+....+.-..+|+.||+.||.+|||+.|+|.+....
T Consensus 840 ~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 840 FDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 334445677899999999999999999999987665
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.04 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=211.7
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
.++||+|-||+||-|..++ +|+-||||++.+..+. .....++.+|+.||+.+.||. ||.+.-.
T Consensus 569 devLGSGQFG~VYgg~hRk-----tGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPG-------iV~le~M--- 631 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK-----TGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPG-------IVNLECM--- 631 (888)
T ss_pred HhhccCCcceeeecceecc-----cCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCC-------eeEEEEe---
Confidence 3799999999999998776 6677999999887776 344488999999999999998 7776544
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC--
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS-- 177 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~-- 177 (379)
++..+.+|+|||.+ .|++.++|-.+. ..++++....-++.||+.||.|||-.+ |+|+||||+|||+..
T Consensus 632 ----~ET~ervFVVMEKl-~GDMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~ 701 (888)
T KOG4236|consen 632 ----FETPERVFVVMEKL-HGDMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASAS 701 (888)
T ss_pred ----ecCCceEEEEehhh-cchHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCC
Confidence 57889999999999 677777776543 345888888899999999999999999 999999999999964
Q ss_pred -CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhh
Q 035572 178 -KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 178 -~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 256 (379)
...+||||||+|+.....+...+.+||+.|+|||++.+..|...-|+||.|+|+|--++|..||....+-.+-+
T Consensus 702 ~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI----- 776 (888)
T KOG4236|consen 702 PFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI----- 776 (888)
T ss_pred CCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-----
Confidence 45799999999999988888888899999999999999999999999999999999999999997654322111
Q ss_pred hhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 257 LIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.+..+- .|..+.+++++.++||..+|+..=++|.|.+..+.|.....
T Consensus 777 ----------QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 777 ----------QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ----------hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 111111 24567888999999999999999999999999999866544
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=296.66 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=200.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|..-+.||.|+||.||+|+.+. +|+.||||.++... .....++..+|+++|++|+|+| ||++.+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke-----tG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~N-------IVk~f~ 78 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE-----TGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPN-------IVKLFD 78 (732)
T ss_pred ceeehhhhcCCccceeeeecccc-----cccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchh-------hhhhcc
Confidence 45566899999999999997543 77889999998654 2456788999999999999999 888776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.--.... ........+|||||.||||...+++... ...+++.+.+.++.++..||.|||++| |+||||||.||++
T Consensus 79 iee~~~~-~~~~~~~vlvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl 153 (732)
T KOG4250|consen 79 IEETKFL-GLVTRLPVLVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVL 153 (732)
T ss_pred cCCcccc-CcccccceEEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEE
Confidence 5322111 1124567899999999999999987543 334999999999999999999999999 9999999999999
Q ss_pred c--CCC--CeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh-
Q 035572 176 D--SKW--DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS- 249 (379)
Q Consensus 176 ~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~- 249 (379)
- .+| ..||+|||.|+.........+..||..|++||.+.. ..|+..+|.|||||++|+.+||..||.....+..
T Consensus 154 ~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~ 233 (732)
T KOG4250|consen 154 QIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN 233 (732)
T ss_pred eecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc
Confidence 4 333 379999999999988888888899999999999985 8899999999999999999999999976654421
Q ss_pred --HHHhhhhhhhHHhhhhh-------ccc--cCCCCc-chHHHHHHHHHHHHhcccCCCCCCC
Q 035572 250 --IIDWALPLIKEEKLRQV-------CDS--RVGLPT-FMEGAIKQMLHVAARCVSSEEENRP 300 (379)
Q Consensus 250 --~~~~~~~~~~~~~~~~~-------~~~--~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp 300 (379)
+.......-..+..... +.. .++.|- ..+.....+...+..+|..+|++|-
T Consensus 234 ~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 234 KEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred chhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11111000000000000 001 111111 2344455677888899999999998
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=280.29 Aligned_cols=267 Identities=15% Similarity=0.204 Sum_probs=180.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhc-------HHHHHHHHHHHHhhhhccCCC
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN-------SKKLNNEIRVLSSLQESNKRN 85 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~~ 85 (379)
..++|++.++||+|+||.||+|.+.... ...+.+++|............. ......+...+..+.|++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~--- 84 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG--- 84 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC---
Confidence 3478999999999999999999876532 1245567776433221100000 001112222333344444
Q ss_pred CCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 86 PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 86 ~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
++.+++..... .......+++++++ ..++.+.+.... ..++..+..++.|++.||+|||+.+ ++|
T Consensus 85 ----i~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--iiH 149 (294)
T PHA02882 85 ----IPKYYGCGSFK---RCRMYYRFILLEKL-VENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG--ISH 149 (294)
T ss_pred ----CCcEEEeeeEe---cCCceEEEEEEehh-ccCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 55544432110 01112457888988 567877775422 2567778899999999999999999 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCC--------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 237 (379)
|||||+|||++.++.++|+|||+|....... ......||+.|+|||+..+..++.++|||||||++|+|++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999986543211 11223699999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
..||............... .....+.......+ ..++.+.+++..|++.+|++||+++++++
T Consensus 230 ~~P~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKC----DFIKRLHEGKIKIK----NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CCCCCccccchHHHHHhHH----HHHHHhhhhhhccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999876443332221111 11122222222112 23477999999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=281.56 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=193.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|...+.||+|+||.||+|.+.. .++.+++|.+...... .......+.+|+.+++.++|++ +++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 87 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSH-----TNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPN-------TIEYK 87 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECC-----CCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCC-------CccEE
Confidence 347777889999999999998654 5678999998654321 1233467889999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+....|+||||+ .++|.+.+.... ..+++.++..++.|++.+|.|||+.| ++|+||+|+||+
T Consensus 88 ~~~-------~~~~~~~lv~e~~-~~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nil 153 (313)
T cd06633 88 GCY-------LKEHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNIL 153 (313)
T ss_pred EEE-------EeCCEEEEEEecC-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEE
Confidence 664 4467889999999 468888876422 23888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++.++.++|+|||++..... .....++..|+|||++. ...++.++||||||+++|+|++|..||...+......
T Consensus 154 i~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 154 LTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred ECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999998854322 22346889999999874 4568889999999999999999999997654322111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. ...... .......+..+.+++.+||+.+|.+||++.+++.|..
T Consensus 231 ~~-------------~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 231 HI-------------AQNDSP-TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred HH-------------HhcCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 10 000000 0111223467899999999999999999999998843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=283.70 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=195.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...|+..+.||.|+||.||+|.+.. .++.+++|.+...... ......++.+|+.+++.++|++ ++++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~ 80 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPN-------TIQY 80 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcC-----CCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCC-------cccE
Confidence 4568889999999999999998764 4567999988643221 1233467889999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++. ..+..++||||+. ++|.+.+.... ..+++.++..++.|++.||.|||+.+ ++||||+|+||
T Consensus 81 ~~~~~-------~~~~~~lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~ni 146 (308)
T cd06634 81 RGCYL-------REHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 146 (308)
T ss_pred EEEEE-------cCCeeEEEEEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhE
Confidence 76643 3578899999995 68888775422 23788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+.....
T Consensus 147 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 223 (308)
T cd06634 147 LLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (308)
T ss_pred EECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence 9999999999999998654332 2336888999999763 356788999999999999999999998664322111
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. +...... ......++..+.+++.+||+.+|++||++.+++.|...
T Consensus 224 ~~-------------~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 224 YH-------------IAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HH-------------HhhcCCC-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 11 1111110 11122456779999999999999999999999998443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=286.80 Aligned_cols=273 Identities=21% Similarity=0.227 Sum_probs=197.3
Q ss_pred hcCCcc-ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhh----------hcHHHHHHHHHHHHhhhhcc
Q 035572 14 TESFSQ-SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ----------DNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 14 ~~~y~~-~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~~~ 82 (379)
.++|.. .+.||.|+||.||+|.+.. .++.||+|.++........ .....+.+|+++++.++|++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTL-----TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECC-----CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 567864 5779999999999998764 4567999988654321100 01125789999999999988
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++++++.+ ...+..++||||+. ++|.+++... ..+++.....++.|++.||+|||+.|
T Consensus 82 -------iv~~~~~~-------~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~-- 139 (335)
T PTZ00024 82 -------IMGLVDVY-------VEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY-- 139 (335)
T ss_pred -------eeeeeEEE-------ecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 88877764 44678999999995 7999998642 23888999999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCC---------------CcccccCccccccCCCCCCCC-CCCCcCCeeh
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDE---------------SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFS 226 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 226 (379)
++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+. .++.++|+||
T Consensus 140 i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred eecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 999999999999999999999999998654311 111223468889999988654 4688999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh--hHHhhhhh------ccccCCCCc----chHHHHHHHHHHHHhcccC
Q 035572 227 YGVVLLEIISCRKPIDAARDPASIIDWALPLI--KEEKLRQV------CDSRVGLPT----FMEGAIKQMLHVAARCVSS 294 (379)
Q Consensus 227 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~li~~~l~~ 294 (379)
|||++|+|++|..||...++...+........ ....+... .......+. .....+..+.+++.+||+.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 99999999999999987654332221111000 00000000 000000011 1122356789999999999
Q ss_pred CCCCCCChHHHhccccCcc
Q 035572 295 EEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 295 dp~~Rps~~e~l~~~~~~~ 313 (379)
+|++|||+++++.|.....
T Consensus 300 ~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 300 NPLERISAKEALKHEYFKS 318 (335)
T ss_pred CchhccCHHHHhcCcccCC
Confidence 9999999999999865543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=270.30 Aligned_cols=244 Identities=28% Similarity=0.383 Sum_probs=195.4
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||.|+||.||++.+.. .++.+++|.+...... .......+.+|+.+++.++|++ ++++++.
T Consensus 1 lg~G~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~~~~------ 61 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-----TGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPF-------IVKLHYA------ 61 (250)
T ss_pred CCCCCceEEEEEEECC-----CCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCc-------HHHHHHH------
Confidence 6999999999998754 4567999998754322 1234668899999999999887 7776655
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
+.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 62 -~~~~~~~~~v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~ 133 (250)
T cd05123 62 -FQTEEKLYLVLEYAPGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIK 133 (250)
T ss_pred -eecCCeeEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEE
Confidence 456788999999999999999997532 3788999999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHH
Q 035572 183 LADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEE 261 (379)
Q Consensus 183 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 261 (379)
|+|||++...... .......++..|+|||...+...+.++|+||||+++|++++|..||...+. ...
T Consensus 134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~----------- 201 (250)
T cd05123 134 LTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEI----------- 201 (250)
T ss_pred EeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHH-----------
Confidence 9999998665433 223344688999999999888889999999999999999999999976542 111
Q ss_pred hhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh---HHHhccc
Q 035572 262 KLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI---GEILMGC 309 (379)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~e~l~~~ 309 (379)
...+.......+.. .+..+.+++.+||..||++||++ .+++.|.
T Consensus 202 -~~~~~~~~~~~~~~---~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~ 248 (250)
T cd05123 202 -YEKILKDPLRFPEF---LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHP 248 (250)
T ss_pred -HHHHhcCCCCCCCC---CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCC
Confidence 11112222222322 25778999999999999999999 8888874
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.07 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=198.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv 91 (379)
.++.|.+...+|.|+|+.|-.+.+.. +.+..++|++.... ....+|+.++...+ |+| ++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~-----t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~n-------iv 379 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP-----TDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPN-------IV 379 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc-----cccchhheeccccc--------cccccccchhhhhcCCCc-------ce
Confidence 36789999999999999999998766 44568999987542 22346676666554 555 66
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++. +.+..+.|+|||.+.|+-|.+.+.... .+. .++..|+++|+.++.|||++| ++||||||+
T Consensus 380 ~~~~v-------~~~~~~~~~v~e~l~g~ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~ 444 (612)
T KOG0603|consen 380 KSHDV-------YEDGKEIYLVMELLDGGELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPG 444 (612)
T ss_pred eecce-------ecCCceeeeeehhccccHHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChh
Confidence 66654 677899999999999998888886432 233 677889999999999999999 999999999
Q ss_pred ceEE-cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILF-DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|||+ ++.|+++|+|||.+...... ..+++-|..|.|||+.....|++++|+||||++||+||+|+.||....+...+
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei 522 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI 522 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH
Confidence 9999 58899999999999776554 44557899999999999999999999999999999999999999876543222
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. +...+.+...++..+.+|+.+||++||.+||++.++..|...
T Consensus 523 ~~-----------------~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 523 HT-----------------RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HH-----------------hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 21 112233446678899999999999999999999999999665
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=280.67 Aligned_cols=274 Identities=26% Similarity=0.354 Sum_probs=214.3
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc---hhhhhcHHHHHHHHHHHHhhhhccC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF---EVLQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
|.|-..+.++|-++++||+|||+.||+|.|.. ..+.||+|+-..... +......+...+|..|.+.|.|+.
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~-----EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpR- 528 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT-----EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPR- 528 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccc-----hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcce-
Confidence 34455667899999999999999999998765 557799987543211 122344566789999999999988
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
||++++++- -+.+.+|-|+|||+|.+|.-+|+.... +++.+++.|+.||+.||.||....+||
T Consensus 529 ------IVKlYDyfs------lDtdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPI 591 (775)
T KOG1151|consen 529 ------IVKLYDYFS------LDTDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPI 591 (775)
T ss_pred ------eeeeeeeee------eccccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCe
Confidence 999998863 356778999999999999999986443 899999999999999999999999999
Q ss_pred EecCCCCCceEEc---CCCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCC----CCCCCCcCCeehhH
Q 035572 164 IHRDIKSTNILFD---SKWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTN----PSKLSKKVDVFSYG 228 (379)
Q Consensus 164 ~H~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG 228 (379)
+|-||||.|||+- .-|.+||.|||+++.+...+. .....||..|+|||.+. +..++.++||||+|
T Consensus 592 IHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvG 671 (775)
T KOG1151|consen 592 IHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVG 671 (775)
T ss_pred eeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeee
Confidence 9999999999995 347899999999987755432 34557999999999653 34578999999999
Q ss_pred HHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 229 VVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 229 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+|+|..+.|+.||........+... ..+.+.. ....|. -+.++.+..++|++||++.-+.|....++..+
T Consensus 672 VIFyQClYGrKPFGhnqsQQdILqe-------NTIlkAt--EVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 672 VIFYQCLYGRKPFGHNQSQQDILQE-------NTILKAT--EVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhhhhhhccCCCCCCchhHHHHHhh-------hchhcce--eccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 9999999999999876554443321 1111111 122222 23466889999999999999999999999887
Q ss_pred ccCcc
Q 035572 309 CSCFF 313 (379)
Q Consensus 309 ~~~~~ 313 (379)
.....
T Consensus 742 pyllP 746 (775)
T KOG1151|consen 742 PYLLP 746 (775)
T ss_pred ccccc
Confidence 55543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.62 Aligned_cols=265 Identities=23% Similarity=0.273 Sum_probs=198.2
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|+..+.||+|++|.||+|.... +++.+++|.+..... .....+.+..|+.+++.++|++ ++++++.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~-------i~~~~~~ 66 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-----TGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPN-------IVKLLDV 66 (282)
T ss_pred CeeehcccccCcceEEEeeecC-----CCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCC-------HHHHHhh
Confidence 6778899999999999998765 467799999876431 1344567889999999999887 7777776
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+ .+.+..++||||++ ++|.+++.... ..+++..+..++.|++.||++||++| ++||||+|+||+++
T Consensus 67 ~-------~~~~~~~~v~e~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~ 132 (282)
T cd07829 67 I-------HTERKLYLVFEYCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN 132 (282)
T ss_pred h-------hcCCceEEEecCcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc
Confidence 4 34578999999996 69999998642 23889999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 177 SKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
+++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||||+++|++++|+.||........+....
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 133 RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 99999999999986654332 22233567889999987766 78999999999999999999999997655332221111
Q ss_pred hhhh--hHHhhhhhc-----cccCC------CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLI--KEEKLRQVC-----DSRVG------LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~--~~~~~~~~~-----~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... ....+.... +.... .....+..+..+.+++.+||+.||++||++.+++.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 0000 000000000 00000 0001122357899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=270.07 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=202.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~ 93 (379)
++.+.+..||.|+||+|++..++. .++..|||+++.... ....+++..|.+...+-. .++ ||++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~-----sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~-------IVkf 128 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKP-----SGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPN-------IVKF 128 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCc-----cCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcH-------HHHH
Confidence 345567899999999999997654 778999999986543 355678888887765543 333 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~N 172 (379)
+|.+++ ++..||.||.| ..||..+...--......+++...-.|....+.||.||.. .. |+|||+||+|
T Consensus 129 yGa~F~-------EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSN 198 (361)
T KOG1006|consen 129 YGALFS-------EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSN 198 (361)
T ss_pred hhhhhc-------CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhh
Confidence 888754 56789999999 7899888765544556668888888888899999999986 47 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC--CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS--KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++..|.+||||||++-.....-..+...|...|||||.+.+. .|+.+||+||||++|||+.||+.|+..-++.
T Consensus 199 ILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--- 275 (361)
T KOG1006|consen 199 ILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--- 275 (361)
T ss_pred eEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---
Confidence 99999999999999998665444444455799999999987644 5899999999999999999999999764321
Q ss_pred HHhhhhhhhHHhhhhhccccCC---CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVG---LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
-+.+..++...++ .+...-..+..+..++.-||..|...||...++..+......
T Consensus 276 ---------feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 276 ---------FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ---------HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 1112222222211 111223467889999999999999999999999987655443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=285.14 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=208.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+...+.++||.|-||.||+|+..+...+ ..--||||..+.+.. .+..+.|..|+.+|+.+.||+ |++++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kg-e~iaVAvKtCK~d~t---~d~tekflqEa~iMrnfdHph-------IikLI 457 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKG-ERIAVAVKTCKTDCT---PDDTEKFLQEASIMRNFDHPH-------IIKLI 457 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccC-cceeeeeehhccCCC---hhhHHHHHHHHHHHHhCCCcc-------hhhee
Confidence 3445567999999999999999876433 333489999875422 456899999999999999998 99999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
|.|.. ...|||||.++-|.|..+++.. ...++..+...+++||+.+|+|||+.. +|||||-..|||
T Consensus 458 Gv~~e--------~P~WivmEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiL 523 (974)
T KOG4257|consen 458 GVCVE--------QPMWIVMELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNIL 523 (974)
T ss_pred eeeec--------cceeEEEecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhhee
Confidence 88753 6789999999999999999863 344888889999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCccccc--CccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQP--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
+.....+||+|||+++.......+... .-..-|||||-++-.+++.+||||-||+++||++. |..||.+-.+.+-+.
T Consensus 524 VsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 524 VSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred ecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 999999999999999888776654333 34667999999999999999999999999999988 999999876654332
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... ...+++. ++.+++.+..|..+||.+||.+||.+.++...
T Consensus 604 ~iE------------nGeRlP~---P~nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 604 HIE------------NGERLPC---PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred Eec------------CCCCCCC---CCCCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 111 1223333 34567889999999999999999999887543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.85 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=126.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.++||.|+||.||+|.+.. .++.||+|+++..... .......+.+|+.++..++|++ |+.+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~-------Iv~~ 69 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN-----NSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPF-------IVHL 69 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCC-------cCeE
Confidence 4689999999999999999998764 5677999998754321 1334577899999999999888 7776
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+..+ ...+..|+||||+.|++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 70 ~~~~-------~~~~~~~lVmEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NI 135 (669)
T cd05610 70 YYSL-------QSANNVYLVMEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNM 135 (669)
T ss_pred EEEE-------EECCEEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHE
Confidence 6543 45678999999999999999997532 3788889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCc
Q 035572 174 LFDSKWDAKLADFGLAV 190 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~ 190 (379)
|++.++.++|+|||++.
T Consensus 136 Ll~~~g~vkL~DFGls~ 152 (669)
T cd05610 136 LISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEcCCCCEEEEeCCCCc
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.91 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=217.4
Q ss_pred CHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh-ccCC
Q 035572 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-SNKR 84 (379)
Q Consensus 6 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~~ 84 (379)
.++.+.-.++.|++.+.||.|.+|.||++..++ ++...|+|+.... .+..+.++.|..+|+.+.+ +|
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~-----~~~~aa~kI~~~~-----~d~deEiE~eynil~~~~~hpn-- 77 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVK-----TGQLAAIKIMDPT-----EDEEEEIELEYNMLKKYSHHPN-- 77 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeee-----cCceeeeEeecCC-----ccccHHHHHHHHHHHhccCCCC--
Confidence 345556668899999999999999999998665 5566788877654 3556788999999999864 44
Q ss_pred CCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 85 NPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 85 ~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
++.+++++...-- ..++++|||||||.|||..++++... ..++.|..+..|++.++.||.+||.+. ++
T Consensus 78 -----v~~fyg~~~k~~~--~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk--vi 145 (953)
T KOG0587|consen 78 -----VATFYGAFIKKDP--GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK--VI 145 (953)
T ss_pred -----cceEEEEEEEecC--CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc--ee
Confidence 7777777654322 45789999999999999999998754 556999999999999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCC-----CCCCcCCeehhHHHHHHHHhCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPS-----KLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~ 238 (379)
|||||-.|||++.++.|||+|||++.... ......+..||+.|||||++... .|+.++|+||||++..||.-|.
T Consensus 146 HRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~ 225 (953)
T KOG0587|consen 146 HRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA 225 (953)
T ss_pred eecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence 99999999999999999999999985543 33455677899999999987643 4678999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+|+....... .+-.+.....+-...+...++++.++|+.||..|-++||++.++|.|....
T Consensus 226 PPl~DmHPmr-------------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 226 PPLCDMHPMR-------------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CCccCcchhh-------------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 9987765422 222222222221223567789999999999999999999999999997665
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=274.41 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=198.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|..+.+||.|+||.|.+|..+. +.+.+|||+++++-.-. .+..+--..|-++|.....+. +++++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQ-dDDvectm~EKrvLAL~~kpp------FL~qlH 416 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPP------FLVQLH 416 (683)
T ss_pred cccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeee-cCcccceehhhhheecCCCCc------hHHHHH
Confidence 467889999999999999996544 56789999998764332 233444556777776654332 255555
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
. .|+.-+.+|.||||+.||+|--.+++.+. +.++.+.-++..|+-||-+||++| |++||||.+|||
T Consensus 417 S-------cFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvm 482 (683)
T KOG0696|consen 417 S-------CFQTMDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVM 482 (683)
T ss_pred H-------HhhhhhheeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceE
Confidence 4 46888999999999999999999987665 666778889999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.+|++||+|||+++... ...+..+.+|||.|+|||++...+|+..+|.||+|++||||+.|++||++.+.
T Consensus 483 Ld~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------- 555 (683)
T KOG0696|consen 483 LDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------- 555 (683)
T ss_pred eccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-------
Confidence 9999999999999996543 33455667999999999999999999999999999999999999999998863
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI 302 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 302 (379)
++.+..+.+.....|. ..+.+..+++...|...|.+|...
T Consensus 556 ------~elF~aI~ehnvsyPK---slSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 556 ------DELFQAIMEHNVSYPK---SLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ------HHHHHHHHHccCcCcc---cccHHHHHHHHHHhhcCCccccCC
Confidence 3344555555555454 445889999999999999999643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.72 Aligned_cols=257 Identities=22% Similarity=0.423 Sum_probs=195.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|...+.||+|+||.||+|.+.. .++.||+|.+.... .....|++++++++|+| |+++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~--------~~~~~~~~~l~~l~Hpn-------Iv~~ 748 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK-----NGMQFVVKEINDVN--------SIPSSEIADMGKLQHPN-------IVKL 748 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC-----CCcEEEEEEccCCc--------cccHHHHHHHhhCCCCC-------cceE
Confidence 4567888999999999999998754 55779999886322 11235688999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH---cCCCCeEecCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH---ENDPMIIHRDIKS 170 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~~i~H~dlkp 170 (379)
++++ .+.+..|+||||+++|+|.++++. +++..+..++.|++.||+||| +.+ |+||||||
T Consensus 749 ~~~~-------~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp 811 (968)
T PLN00113 749 IGLC-------RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSP 811 (968)
T ss_pred EEEE-------EcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCH
Confidence 8875 345678999999999999999963 789999999999999999999 456 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC-chh
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD-PAS 249 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~ 249 (379)
+||+++.++..++. ||.+...... ....+|+.|+|||+..+..++.++|||||||++|||+||+.||..... ...
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~ 887 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887 (968)
T ss_pred HhEEECCCCceEEE-eccccccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence 99999988888775 6654332211 223688999999999999999999999999999999999999954322 223
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+..+............+.++..... ........++.+++.+||+.||++|||+.|+++....
T Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 3333322222222333333332211 1223455678899999999999999999999987543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=297.46 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=211.2
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
...+.++||.|.||.||+|..+... .....||||.++... .+.....|..|+.||-++.||| |+.+.|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPN-------IIrLEG 697 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPN-------IIRLEG 697 (996)
T ss_pred heEEEEEEecccccceecccccCCC--CcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCc-------EEEEEE
Confidence 4567899999999999999988644 355789999997543 2456788999999999999999 888776
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ....-++||+|||++|+|+.+|+... .+|+..+...+++.|+.|+.||-..+ +|||||...|||+
T Consensus 698 VV-------Tks~PvMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILV 764 (996)
T KOG0196|consen 698 VV-------TKSKPVMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILV 764 (996)
T ss_pred EE-------ecCceeEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheee
Confidence 64 55678899999999999999999743 44889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCCc--ccccCc--cccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 176 DSKWDAKLADFGLAVSESDESS--MVQPAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+.+-..|++|||+++...+... ..+..| ...|.|||.+...+++.+|||||+|+++||.++ |..||-...+.+-+
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 9999999999999987654431 222222 468999999999999999999999999999988 99999876543322
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
+.+...+.+|+. -+++..+.+|+..||+.|-.+||.+.+|+.+.....
T Consensus 845 --------------kaIe~gyRLPpP-mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 845 --------------KAIEQGYRLPPP-MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred --------------HHHHhccCCCCC-CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 222333333332 356789999999999999999999999998765544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.18 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=206.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+...+.++||+|+||+|++|.+.. ...+...||||.++..... .....|.+|+.+|.+|+|++ ++++|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~--psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~h-------liRLy 177 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQ--PSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPH-------LIRLY 177 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccC--CCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcc-------eeEEe
Confidence 456677899999999999999976 3346677999999866433 26789999999999999998 99999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
|.+. +....+|||+++.|||.+.|++ .....|.......++.||+.|+.||.+++ +|||||-..|+|
T Consensus 178 GvVl--------~qp~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNll 244 (1039)
T KOG0199|consen 178 GVVL--------DQPAMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLL 244 (1039)
T ss_pred eeec--------cchhhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhhe
Confidence 8753 2678899999999999999987 34445777888899999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcc----cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSM----VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
+.....+||+|||+.+........ ....-...|+|||.++...++.++|+|+|||++|||+| |..||.+....+.
T Consensus 245 lasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 245 LASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred ecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 998889999999999776544332 22235678999999999999999999999999999999 9999987643221
Q ss_pred HHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 250 IIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
+ +.++ .++.. .+.++.++.+++.+||..+|.+|||+..|.+
T Consensus 325 L--------------~~iD~~erLpR---Pk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 325 L--------------KNIDAGERLPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred H--------------HhccccccCCC---CCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 1 1122 22332 3456789999999999999999999999863
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=281.90 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=204.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+...+.++||+|-||.|.+|.... +..||||.++.... ......|.+||++|.+|+||| |+.+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPN-------IveL 600 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPN-------IVEL 600 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCC-------eeEE
Confidence 3567788999999999999997542 46799999986543 345688999999999999999 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
.+.|.. ++.+++++||+++|+|.+++.+..... +.......|+.||+.|++||.+.+ +|||||.+.|+
T Consensus 601 vGVC~~-------DePicmI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNc 668 (807)
T KOG1094|consen 601 LGVCVQ-------DDPLCMITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNC 668 (807)
T ss_pred Eeeeec-------CCchHHHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhc--hhhccccccce
Confidence 998754 678999999999999999998754322 334445679999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh--CCCCCCCCCCch
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS--CRKPIDAARDPA 248 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~p~~~~~~~~ 248 (379)
|+++++++||+|||+++..-..... ...+-...|||||.+..++++.+||+|+||+++||+++ ...||....+.+
T Consensus 669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 9999999999999999754333221 22356789999999888999999999999999999876 778998776543
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ++....+...+.... .+..+..++..+.+++.+||..|-.+||+++++..+.
T Consensus 749 v-ven~~~~~~~~~~~~-------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 749 V-VENAGEFFRDQGRQV-------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred H-HHhhhhhcCCCCcce-------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 2 222222222111111 1222344567889999999999999999999987653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.75 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=207.3
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
+.|..-.......++||-|.||.||.|+++.. .-.||||.++.+ ....+.|..|+.+|+.++|+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky-----slTvAVKtLKED-----tMeveEFLkEAAvMKeikHpN----- 324 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPN----- 324 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeecc-----ceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCcc-----
Confidence 44444445566678999999999999999873 356999998754 455789999999999999999
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
+|++++.| ..+.-+|||+|||..|+|.++|++... ..++.-..+.++.||.+|++||..++ ++|||
T Consensus 325 --LVqLLGVC-------T~EpPFYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRD 390 (1157)
T KOG4278|consen 325 --LVQLLGVC-------THEPPFYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKN--FIHRD 390 (1157)
T ss_pred --HHHHhhhh-------ccCCCeEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhh
Confidence 99999886 446788999999999999999998543 33666667889999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCccccc--CccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQP--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
|-..|+|+.++..+|++|||+++.+......... .-..-|.|||-+..+.++.++|||+||++|||+.| |-.||.+.
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 9999999999999999999999988655433221 23567999999999999999999999999999999 88999876
Q ss_pred CCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+-. ....++. .+... .++|++.+.+|++.||++.|..||++.|+-+.
T Consensus 471 dlS--------------qVY~LLEkgyRM~~---PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 471 DLS--------------QVYGLLEKGYRMDG---PEGCPPKVYELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred cHH--------------HHHHHHhccccccC---CCCCCHHHHHHHHHHhcCCcccCccHHHHHHH
Confidence 421 1122222 22222 35677899999999999999999999988654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.07 Aligned_cols=280 Identities=19% Similarity=0.188 Sum_probs=175.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+..+.. ..+..||+|++.... ..|+.+...+++..... +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~-----------~~e~~~~e~l~~~~~~~----~~~ 193 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYG-----------AVEIWMNERVRRACPNS----CAD 193 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccc-----------hhHHHHHHHHHhhchhh----HHH
Confidence 56799999999999999999999876422 236779999875321 11222222232221000 111
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC---------------CCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---------------TTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
+...+..... .......++||||+.+++|.+++...... .........+..++.|++.||.|||
T Consensus 194 ~~~~~~~~~~-~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH 272 (566)
T PLN03225 194 FVYGFLEPVS-SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH 272 (566)
T ss_pred HHHhhhcccc-cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH
Confidence 1111111011 24567899999999999999998753210 0001123345679999999999999
Q ss_pred cCCCCeEecCCCCCceEEcC-CCCeEEeccccCccCCCC--CcccccCccccccCCCCCCCC------------------
Q 035572 158 ENDPMIIHRDIKSTNILFDS-KWDAKLADFGLAVSESDE--SSMVQPAGTIGYLDPGYTNPS------------------ 216 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~------------------ 216 (379)
+++ |+||||||+|||++. ++.+||+|||+|...... .......+++.|+|||.+...
T Consensus 273 ~~g--IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~ 350 (566)
T PLN03225 273 STG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 350 (566)
T ss_pred HCC--EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccch
Confidence 999 999999999999985 689999999999654322 222345789999999954322
Q ss_pred ----CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhh-hhhHHhhhhhccccCCCCc------chHHHHHHHH
Q 035572 217 ----KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP-LIKEEKLRQVCDSRVGLPT------FMEGAIKQML 285 (379)
Q Consensus 217 ----~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 285 (379)
.++.++|||||||++|||+++..|+... .......... ......+......... +. ..........
T Consensus 351 l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 351 LWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRAS-PDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred hccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccc-hhhhhhhhhccccchHHH
Confidence 2345679999999999999976654321 1111110000 0000111111111100 00 0011123456
Q ss_pred HHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 286 HVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 286 ~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
+|+.+||+.||++|||+.++++|......
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 89999999999999999999999766543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.54 Aligned_cols=227 Identities=17% Similarity=0.228 Sum_probs=175.2
Q ss_pred CCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCcc
Q 035572 26 GSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVD 105 (379)
Q Consensus 26 G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~ 105 (379)
|.+|.||++.+.. +++.+|+|.++... ...+|...+....|+| ++++++.+ .
T Consensus 4 g~~~~v~~~~~~~-----~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~-------i~~~~~~~-------~ 55 (237)
T cd05576 4 GVIDKVLLVMDTR-----TQQTFILKGLRKSS---------EYSRERLTIIPHCVPN-------MVCLHKYI-------V 55 (237)
T ss_pred cccceEEEEEEcc-----CCcEEEEEeecchh---------hhhhHHHHHHhcCCCc-------eeehhhhe-------e
Confidence 8999999998765 55679999987532 1233444444444555 77777653 4
Q ss_pred CCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEec
Q 035572 106 GNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185 (379)
Q Consensus 106 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~D 185 (379)
+.+..++||||++|++|.+++.+.. .+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++++|
T Consensus 56 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~d 128 (237)
T cd05576 56 SEDSVFLVLQHAEGGKLWSHISKFL-----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTY 128 (237)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEec
Confidence 5678999999999999999997542 2889999999999999999999999 99999999999999999999999
Q ss_pred cccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhh
Q 035572 186 FGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQ 265 (379)
Q Consensus 186 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (379)
||.+...... .....++..|+|||...+..++.++|+||+|+++|+|++|..|+....... ..
T Consensus 129 f~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~ 191 (237)
T cd05576 129 FSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NT 191 (237)
T ss_pred ccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------cc
Confidence 9987554332 222356778999999988889999999999999999999998875432100 00
Q ss_pred hccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccc
Q 035572 266 VCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGC 309 (379)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~ 309 (379)
......| ..+++.+.+++.+||+.||.+||++ ++++.|.
T Consensus 192 --~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 192 --HTTLNIP---EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred --ccccCCc---ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence 0011112 2235778999999999999999996 7888774
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=258.73 Aligned_cols=279 Identities=20% Similarity=0.253 Sum_probs=203.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+-..+||+|.||.||+|..+. .++.||+|++-.+... ........+|+++|..|+|+| +++++
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n-----~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHen-------v~nli 82 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN-----TGKKVALKKVLMENEK--EGFPITALREIKILQLLKHEN-------VVNLI 82 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC-----ccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchh-------HHHHH
Confidence 467778899999999999997554 5566888887543211 334566789999999999999 66666
Q ss_pred ccccccCCC-ccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 95 GTSCRNSGS-VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 95 ~~~~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
..|-..... ..+...+|+||.+|+ .+|..++... ..+++..++..++.++..||.|+|... |+|||+||.|+
T Consensus 83 Eic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNv 155 (376)
T KOG0669|consen 83 EICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANV 155 (376)
T ss_pred HHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhE
Confidence 555432221 233456899999995 6999999753 345899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||+.+|.+||+|||+++..+... ..+.++-|..|.+||.+.+ ..|+++.|||..||++.+|+|+.+-+.+..+.
T Consensus 156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 99999999999999996554332 2344467999999996654 56899999999999999999999988877665
Q ss_pred hhHHH--hhhhhhhHHhhh--------hhcccc-CCCCc--chHHH------HHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 248 ASIID--WALPLIKEEKLR--------QVCDSR-VGLPT--FMEGA------IKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 248 ~~~~~--~~~~~~~~~~~~--------~~~~~~-~~~~~--~~~~~------~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.++.. ....-+..+.+. +.+... ++-.. ..+.. .++..+|+..+|..||.+|+++++++.|
T Consensus 236 qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 236 QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 54322 211111111111 111111 10000 01111 2378899999999999999999999999
Q ss_pred ccCccc
Q 035572 309 CSCFFV 314 (379)
Q Consensus 309 ~~~~~~ 314 (379)
......
T Consensus 316 ~~F~kd 321 (376)
T KOG0669|consen 316 DFFWKD 321 (376)
T ss_pred hhhhcC
Confidence 665443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=277.99 Aligned_cols=292 Identities=16% Similarity=0.220 Sum_probs=192.7
Q ss_pred HhcCCccccccccCCceeEEEEEecCCC-----------CCCCceEEEEEeccCCCchhhh----------hcHHHHHHH
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQ-----------TDGDHKILAIKRASTNGFEVLQ----------DNSKKLNNE 71 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~E 71 (379)
..++|++.++||+|+||.||+|.+.... ....++.||||++......... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999763322 1234567999998654221111 112234457
Q ss_pred HHHHHhhhhccCCCCCceeeeccccccccC-CCccCCCceEEEEeccCCCCHHHHHHhhhcC------------------
Q 035572 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNS-GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA------------------ 132 (379)
Q Consensus 72 ~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~-~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------ 132 (379)
+.++.+++|.+..... ++.+.+++.... +.....+..+|||||+++++|.+++......
T Consensus 223 ~~~l~~l~~~~l~~~~--~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 223 AYMCAKIKRNPIAAAS--CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHhhcccchhhh--hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 7778888776533322 455555543311 1112346789999999999999998743210
Q ss_pred -CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCccc--ccCccccccC
Q 035572 133 -TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV--QPAGTIGYLD 209 (379)
Q Consensus 133 -~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~a 209 (379)
....+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++.......... ...+|+.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1122466788899999999999999999 9999999999999999999999999986543322221 2245889999
Q ss_pred CCCCCCCC----------------------CCCcCCeehhHHHHHHHHhCCC-CCCCCCCchhHHHhhhhhhhHHhhhhh
Q 035572 210 PGYTNPSK----------------------LSKKVDVFSYGVVLLEIISCRK-PIDAARDPASIIDWALPLIKEEKLRQV 266 (379)
Q Consensus 210 PE~~~~~~----------------------~~~~~DiwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (379)
||.+.... ...++|+||+||++|+|++|.. ||............... ....+...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~--~~~~~r~~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN--DLNRWRMY 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc--hHHHHHhh
Confidence 99765322 1234799999999999999875 66543211110000000 00011111
Q ss_pred ccccCCCCcchHHHHHHHHHHHHhcccCCC---CCCCChHHHhccccC
Q 035572 267 CDSRVGLPTFMEGAIKQMLHVAARCVSSEE---ENRPGIGEILMGCSC 311 (379)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~e~l~~~~~ 311 (379)
.......+ .+...+....+|+.+||..+| .+|+|++|+|+|...
T Consensus 457 ~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 457 KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 11222222 233456789999999999866 689999999999544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=277.60 Aligned_cols=258 Identities=18% Similarity=0.249 Sum_probs=210.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++++.+..||-||||.|=++...... ..+|+|.+++.... .....+.+..|-.||...+.+. ||+++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~-----~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~f-------IvrLY 486 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQK-----ATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDF-------IVRLY 486 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccc-----hHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchH-------HHHHH
Confidence 46777889999999999988765422 25889988876542 3445667889999999887554 66655
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
.. |.+...+|+.||-|-||.|...+++++. |...+++-++..+++|++|||++| |++|||||+|.+
T Consensus 487 rT-------frd~kyvYmLmEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENll 552 (732)
T KOG0614|consen 487 RT-------FRDSKYVYMLMEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLL 552 (732)
T ss_pred HH-------hccchhhhhhHHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhhee
Confidence 44 6888999999999999999999987664 888888999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.+|-+||.|||+|+.........+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||++.++.... +.+
T Consensus 553 Ld~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-n~I 631 (732)
T KOG0614|consen 553 LDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-NLI 631 (732)
T ss_pred eccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-HHH
Confidence 9999999999999999998888889999999999999999999999999999999999999999999988653321 111
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCcc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCFF 313 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~~ 313 (379)
.. .+..-.++..+++...+|+.++-..+|.+|.. +.+|-.|.....
T Consensus 632 Lk-------------Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 632 LK-------------GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred Hh-------------hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 11 11112233556688999999999999999986 677777754433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=270.68 Aligned_cols=282 Identities=18% Similarity=0.165 Sum_probs=213.4
Q ss_pred CHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCC
Q 035572 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRN 85 (379)
Q Consensus 6 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~ 85 (379)
.+....-+-.+|.+....|.|-||+|-+|.+.. .+..||||+++... ...+.=..|+++|++|+......
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~-----r~~~vAiKIIRnNE-----~M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA-----RGQEVAIKIIRNNE-----VMHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccC-----CCCeeEEEEeecch-----HHhhhhhHHHHHHHHhhccCchh
Confidence 344445566799999999999999999998765 34479999998653 33455678999999998654322
Q ss_pred CCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 86 PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 86 ~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
.. +|+++...|...+++|||+|-+ ..+|.++|++.+. ...+...+++.|+.|++.||..|-.+| |+|
T Consensus 493 k~--------Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~--vlH 559 (752)
T KOG0670|consen 493 KF--------HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG--VLH 559 (752)
T ss_pred hh--------HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC--eee
Confidence 22 2333344467789999999999 7999999998764 445888899999999999999999999 999
Q ss_pred cCCCCCceEEcCC-CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 166 RDIKSTNILFDSK-WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 166 ~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
.||||+|||+++. ..+||||||.|-..+.... +.+.-+..|.|||++.|-+|+...|+||+||+||||.||+..|.+.
T Consensus 560 aDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 560 ADIKPDNILVNESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccCccceEeccCcceeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 9999999999854 5689999999866544322 2345678999999999999999999999999999999999999887
Q ss_pred CCchhHHHhh--h-----hhhhH-------------------------------------HhhhhhccccCCCCcchHHH
Q 035572 245 RDPASIIDWA--L-----PLIKE-------------------------------------EKLRQVCDSRVGLPTFMEGA 280 (379)
Q Consensus 245 ~~~~~~~~~~--~-----~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~~ 280 (379)
.+..-+--.. . .++.. ..+...+-.....|......
T Consensus 639 TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~ 718 (752)
T KOG0670|consen 639 TNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKI 718 (752)
T ss_pred CcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHH
Confidence 6654321000 0 00000 11111111222234444556
Q ss_pred HHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 281 IKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 281 ~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..++.+|+.+||..||++|.|..++|.|...
T Consensus 719 ~~~~rdLLdkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 719 VQQLRDLLDKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred HHHHHHHHHHHhccChhhcCCHHHHhcCCcc
Confidence 6789999999999999999999999999654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=256.48 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=189.0
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHH--HhhhhccCCCCCc
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL--SSLQESNKRNPNY 88 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l--~~l~~~~~~~~~~ 88 (379)
.++.....+.+.||+|.||.||+|.++. .-||||++...+ .+...+|.+|. ..|+|+|
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHEN------ 266 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHEN------ 266 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccC-------CceEEEEecccc-------hhhhhhHHHHHHHHHhccch------
Confidence 4567889999999999999999998864 449999997543 23344555555 5679999
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-----CC-CC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-----ND-PM 162 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-----~~-~~ 162 (379)
|+.+++.-....+.+ -+++||++|.+.|||.|+|... .++......++..+++||++||. +| +.
T Consensus 267 -ILgFIaaD~~~~gs~---TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 267 -ILGFIAADNKDNGSW---TQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred -hhhhhhccccCCCce---EEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 888887654433322 4789999999999999999752 38888999999999999999994 33 44
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCC------CCCcCCeehhHHHH
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSK------LSKKVDVFSYGVVL 231 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il 231 (379)
|.|||||..|||+..+|...|+|+|+|....... ..+..+||.+|||||++...- .-..+||||||.++
T Consensus 337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 9999999999999999999999999996654432 235568999999999886432 12368999999999
Q ss_pred HHHHh----------CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc--chHHHHHHHHHHHHhcccCCCCCC
Q 035572 232 LEIIS----------CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT--FMEGAIKQMLHVAARCVSSEEENR 299 (379)
Q Consensus 232 ~ellt----------g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R 299 (379)
||++. -++||..--+.+.-.+...+ ....+. .++.+|. ....+...+..+++.||..||.-|
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrk----VVCv~~--~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRK----VVCVQK--LRPNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhc----ceeecc--cCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 99984 24566543322211111111 111111 2222333 233556789999999999999999
Q ss_pred CChHHH
Q 035572 300 PGIGEI 305 (379)
Q Consensus 300 ps~~e~ 305 (379)
.|+--+
T Consensus 491 ltALri 496 (513)
T KOG2052|consen 491 LTALRI 496 (513)
T ss_pred hHHHHH
Confidence 987654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=258.22 Aligned_cols=262 Identities=28% Similarity=0.471 Sum_probs=186.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHh--hhhccCCCCCceeee
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSS--LQESNKRNPNYCVVN 92 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~~~~~~~~~~iv~ 92 (379)
+..++.++||+|.||.||+|... ++.||||+++. ...+.+.+|-.|.+. ++|+| |++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-------~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~n-------Il~ 268 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-------NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHEN-------ILQ 268 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-------CceeEEEecCH-------HHHHHHHhHHHHHhccCccchh-------HHH
Confidence 45677889999999999999764 47799999973 445667777776655 46766 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-------CCCeEe
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-------DPMIIH 165 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-------~~~i~H 165 (379)
+++.--+.. .....++||++|.+.|||.++|...- ++|.+..+++..|++||+|||+. .++|+|
T Consensus 269 Fi~~ekr~t---~~~~eywLVt~fh~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 269 FIGAEKRGT---ADRMEYWLVTEFHPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred hhchhccCC---ccccceeEEeeeccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 887643321 22568999999999999999997632 99999999999999999999963 245999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCC-C-----CCcCCeehhHHHHHHHHh
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSK-L-----SKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwSlG~il~ellt 236 (379)
||||.+|||+..|++..|+|||+|........ ....+||.+|||||++++.- + -.+.||||+|.++|||++
T Consensus 340 RDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 340 RDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred ccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999966544322 23357999999999987542 1 136899999999999998
Q ss_pred CCCCCCC-CCCchhH-----HH--hhhhhhhHHhhhhhccccCCCCcchH--HHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 237 CRKPIDA-ARDPASI-----ID--WALPLIKEEKLRQVCDSRVGLPTFME--GAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 237 g~~p~~~-~~~~~~~-----~~--~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
...-+.. .-+.-++ +. -....+..-...+ ..++.+|..+. .....+.+.+..||+.||+.|.|+.=+.
T Consensus 420 RC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~k--K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 420 RCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRK--KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhh--ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 6655431 1111000 00 0000011111111 12233333221 2345688999999999999999998665
Q ss_pred cc
Q 035572 307 MG 308 (379)
Q Consensus 307 ~~ 308 (379)
+.
T Consensus 498 eR 499 (534)
T KOG3653|consen 498 ER 499 (534)
T ss_pred HH
Confidence 54
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=247.58 Aligned_cols=242 Identities=29% Similarity=0.385 Sum_probs=191.5
Q ss_pred CceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccC
Q 035572 27 SHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDG 106 (379)
Q Consensus 27 ~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 106 (379)
+||.||+|.+.. +++.+++|++...... ...+.+.+|++.+++++|++ ++++++.+ ..
T Consensus 1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~-------i~~~~~~~-------~~ 58 (244)
T smart00220 1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPN-------IVRLYDVF-------ED 58 (244)
T ss_pred CceEEEEEEECC-----CCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCc-------HHHHHhhe-------ee
Confidence 589999998764 4577999998754321 11678999999999998887 77777664 33
Q ss_pred CCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEecc
Q 035572 107 NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186 (379)
Q Consensus 107 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Df 186 (379)
....++++||+++++|.+++..... +++..+..++.+++.++.+||+.+ ++|+||+|+||++++++.++|+||
T Consensus 59 ~~~~~l~~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~ 131 (244)
T smart00220 59 EDKLYLVMEYCDGGDLFDLLKKRGR-----LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADF 131 (244)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccc
Confidence 4788999999998899999975321 788899999999999999999999 999999999999999999999999
Q ss_pred ccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhh
Q 035572 187 GLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQV 266 (379)
Q Consensus 187 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (379)
|.+.............++..|++||......++.++||||||+++|++++|..||....+...+....
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~------------ 199 (244)
T smart00220 132 GLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI------------ 199 (244)
T ss_pred cceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH------------
Confidence 99977655444445578899999999888888999999999999999999999997643333222211
Q ss_pred ccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 267 CDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.............++..+.+++.+||..+|++||++.++++|.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 200 GKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHP 242 (244)
T ss_pred hccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCC
Confidence 1111111111111457899999999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.87 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=209.3
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCC--CceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCC
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDG--DHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNP 86 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~ 86 (379)
++...++.++.+.||+|.||.|++|......... ....||||.++.... ....+.+..|+++|+.+. |+|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~n---- 363 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPN---- 363 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcc----
Confidence 4444566677789999999999999876544332 367899999875532 356788999999999996 666
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhh---------cCCCC--CCChHhHHHHHHHHHHHHHH
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA---------AATTP--QLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~--~~~~~~~~~~~~~i~~~l~~ 155 (379)
++.+.+.|.. .+.+++|+||++.|+|.++++..+ ..... .++......+++||+.|++|
T Consensus 364 ---iv~llG~~t~-------~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~ 433 (609)
T KOG0200|consen 364 ---IVNLLGACTQ-------DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEY 433 (609)
T ss_pred ---hhhheeeecc-------CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHH
Confidence 8888887643 678999999999999999999876 11222 28888999999999999999
Q ss_pred HHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccc--cCc--cccccCCCCCCCCCCCCcCCeehhHHHH
Q 035572 156 LHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ--PAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVL 231 (379)
Q Consensus 156 LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il 231 (379)
|++.. ++||||-..|||++++..+||+|||+|+.......... ..+ ...|||||.+....++.++||||||+++
T Consensus 434 L~~~~--~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 434 LASVP--CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred HhhCC--ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 99999 99999999999999999999999999976544433321 122 3459999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 232 LEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 232 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
||++| |..||.+......+..... ...+...| ..++.++.+++..||+.+|++||++.++.....
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~-----------~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLK-----------EGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHh-----------cCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 99999 9999976432222221111 11222333 334688999999999999999999999988655
Q ss_pred C
Q 035572 311 C 311 (379)
Q Consensus 311 ~ 311 (379)
.
T Consensus 578 ~ 578 (609)
T KOG0200|consen 578 K 578 (609)
T ss_pred H
Confidence 5
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.54 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=188.7
Q ss_pred CccccccccCCce-eEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecc
Q 035572 17 FSQSRLIGKGSHG-SVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFH 94 (379)
Q Consensus 17 y~~~~~iG~G~~g-~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~ 94 (379)
|.-.+.+|.|+-| .||+|... ++.||||++- .+......+|+..|+.-. |+| ||+++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-------~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~N-------viRyy 569 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-------GREVAVKRLL-------EEFFDFAQREIQLLQESDEHPN-------VIRYY 569 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-------CceehHHHHh-------hHhHHHHHHHHHHHHhccCCCc-------eEEEE
Confidence 3445688999987 67999874 4679999986 345567889999998774 555 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. -.+.+..||+.|.| ..+|.++++... .......-...+.++.|+++||++||+.+ ||||||||+|||
T Consensus 570 c~-------E~d~qF~YIalELC-~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNIL 638 (903)
T KOG1027|consen 570 CS-------EQDRQFLYIALELC-ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNIL 638 (903)
T ss_pred ee-------ccCCceEEEEehHh-hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEE
Confidence 55 46788999999999 689999998741 11111111345788999999999999999 999999999999
Q ss_pred EcC---C--CCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC-CCCCCCC
Q 035572 175 FDS---K--WDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKPIDAA 244 (379)
Q Consensus 175 l~~---~--~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~ 244 (379)
|+. + ..++|+|||+++....... .....||-+|+|||++.....+.++|||||||++|+.++| ..||...
T Consensus 639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 975 3 4589999999977654432 3445799999999999988888899999999999999995 8999765
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
-..+ .+++.....+.........+..+||.+|+.++|..||++.++|.|......
T Consensus 719 ~~R~---------------~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 719 LERQ---------------ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHhh---------------hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 3221 122222211111111001178999999999999999999999999765443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=246.24 Aligned_cols=276 Identities=21% Similarity=0.257 Sum_probs=202.1
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+.+..+.||.|+||.||.+.|.. +++.|+.|++..-.- .-...+++.+|+++|..++|.| ++...+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPR-----dgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdN-------VLSaLD 119 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPR-----SGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDN-------VLSLLD 119 (449)
T ss_pred cCCCCCcccccceeEEEeccCCC-----CccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhcccc-------HHHHHH
Confidence 45667899999999999998765 678899999864321 1344688999999999999999 544444
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
..-.-.- +--..+|+++|.| ..+|...+-+ ...++..-+.-+++||+.||.|||+.+ |.||||||.|+|+
T Consensus 120 ILQPph~--dfFqEiYV~TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLV 189 (449)
T KOG0664|consen 120 ILQPANP--SFFQELYVLTELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLV 189 (449)
T ss_pred hcCCCCc--hHHHHHHHHHHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEe
Confidence 3221110 0113578899999 6789888853 344777788889999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 176 DSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+.|..+||||||+++...... ..+..+-|..|.|||++.+. .|+.+.||||.||++.|++..+..|...+.-+++.-
T Consensus 190 NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 190 NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM 269 (449)
T ss_pred ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence 999999999999998765543 23445689999999988775 589999999999999999988888876654443321
Q ss_pred hhhhhhhHHh-----------hhhhccccCCCCcc--------hHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIKEEK-----------LRQVCDSRVGLPTF--------MEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~~~~-----------~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
+..++.... -.-+++.....|.. ...-..+..+++..++.+||++|.+..+++.|.....
T Consensus 270 -ItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 270 -IIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred -HHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 112221111 11122222222221 1122346788999999999999999999999876654
Q ss_pred ccc
Q 035572 314 VDH 316 (379)
Q Consensus 314 ~~~ 316 (379)
...
T Consensus 349 ~R~ 351 (449)
T KOG0664|consen 349 GRL 351 (449)
T ss_pred cce
Confidence 433
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=264.13 Aligned_cols=204 Identities=25% Similarity=0.381 Sum_probs=169.8
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
-|..++.||=|+||.|.++...+ +..+||.|.+++.+. .......-.+.|-.||....... ||+++-
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvD-----T~~lYAmKTLrKaDV-l~rnQvaHVKAERDILAEADn~W-------VVrLyy 696 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVD-----TRALYAMKTLRKADV-LMRNQVAHVKAERDILAEADNEW-------VVRLYY 696 (1034)
T ss_pred ceEEEeeecccccceeEEEeecc-----hhhHHHHhhhHHHHH-HhhhhhhhhhhhhhhHhhcCCcc-------eEEEEE
Confidence 47778899999999999997655 457899999886532 22344566788999999887665 777664
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
. |++++.+|+||+|++||++-.+|-+.+- |.+..++-++..+.+|+++.|..| ++||||||+||||
T Consensus 697 S-------FQDkdnLYFVMdYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILI 762 (1034)
T KOG0608|consen 697 S-------FQDKDNLYFVMDYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI 762 (1034)
T ss_pred E-------eccCCceEEEEeccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEE
Confidence 3 7899999999999999999999987654 888899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCC---------CCC----------------------------------cccccCccccccCCCC
Q 035572 176 DSKWDAKLADFGLAVSES---------DES----------------------------------SMVQPAGTIGYLDPGY 212 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~---------~~~----------------------------------~~~~~~gt~~y~aPE~ 212 (379)
|.+|++||.|||++.-+. ..+ .....+||+.|+|||+
T Consensus 763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 999999999999984221 000 0112249999999999
Q ss_pred CCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 213 TNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 213 ~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+....++..+|.||.|+|||||+.|++||.....
T Consensus 843 l~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 843 LARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 9999999999999999999999999999976543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=245.33 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=193.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|.++++||+|+|..|-++..++ +.+++|+|+++++-... .+..+-...|-.+..+.. | ++++|.+|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~-----t~qiyamkvvkkel~nd-dedidwvqtek~vfe~as--n----~pflvglh 317 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKK-----TDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQAS--N----NPFLVGLH 317 (593)
T ss_pred ccceeeeeecCcchhhhhheehcc-----cceeeehhhHHHHhcCC-cccchhHHhhHHHHHhcc--C----CCeEEehh
Confidence 578899999999999999998776 55789999998654321 223344566666666553 1 12255555
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.|+.+..++.|.||++||+|--..+++.. ++++-++-+-..|..||.|||++| |+.||||.+|+|
T Consensus 318 -------scfqtesrlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvl 383 (593)
T KOG0695|consen 318 -------SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVL 383 (593)
T ss_pred -------hhhcccceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceE
Confidence 447889999999999999999777765443 788888889999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCcc-CCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCC--CCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA--ARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~--~~~~~~~~ 251 (379)
++..|++||.|+|+++. ..+.....+.+|||.|.|||++.+..|+..+|.|+||++++||+.|+.||+- .++++...
T Consensus 384 ldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt 463 (593)
T KOG0695|consen 384 LDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT 463 (593)
T ss_pred EccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch
Confidence 99999999999999964 3455667788999999999999999999999999999999999999999963 23322111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 300 (379)
. .-.+.-++.....+|..+. -....++...|..||.+|.
T Consensus 464 e-------dylfqvilekqiriprsls---vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 464 E-------DYLFQVILEKQIRIPRSLS---VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred h-------HHHHHHHhhhcccccceee---hhhHHHHHHhhcCCcHHhc
Confidence 0 1112223344445555443 4566788899999999995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.19 Aligned_cols=209 Identities=26% Similarity=0.380 Sum_probs=164.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+....+..||+|++|.|=+.++. .++.+.|+|+++.. ......+++.+|+.+..+.- +-..+|.+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~-----~sg~imAvKri~~t---vn~q~q~r~L~dldi~~r~~------~CPf~V~F 110 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHI-----QSGTIMAVKRIRAT---VNSQEQKRLLMDLDIIMRTV------DCPFTVHF 110 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeec-----cCCeEEEEeeehhh---cChHHHHHHHHhhhhhccCC------CCCeEEEe
Confidence 344555778999999999887644 47889999999754 22445666777777665443 22337777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~N 172 (379)
++.. -....++|.||.| ..||..+..+--. ....+++..+-+|+..+..||.|||++ . ++|||+||+|
T Consensus 111 yGa~-------~regdvwIcME~M-~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsN 179 (282)
T KOG0984|consen 111 YGAL-------FREGDVWICMELM-DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSN 179 (282)
T ss_pred ehhh-------hccccEEEeHHHh-hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcce
Confidence 7654 4467899999999 7899887765443 444588888899999999999999986 7 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC----CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP----SKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||++.+|.+|+||||++-...+.-..+...|...|||||.+.+ ..|+.+|||||||+++.||.+++.||..-..+
T Consensus 180 iLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 180 ILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred EEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 9999999999999999866654433344578999999997754 36899999999999999999999999776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=246.37 Aligned_cols=142 Identities=22% Similarity=0.354 Sum_probs=118.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCC-CCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRN-PNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~-~~~~iv~~ 93 (379)
.+|-+.++||=|-|++||+|.|.- ..+.||+|+.+.. +...+....||.+|++++...... -..+||++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq-----~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ-----NKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc-----CCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999999764 5678999998732 456777899999999998554222 22459999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~N 172 (379)
++++.-. -..+.++|+|+|++ |.+|..+|..... ..++...++.|++|++.||.|||. .| |+|.||||+|
T Consensus 148 lD~Fkhs---GpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPEN 218 (590)
T KOG1290|consen 148 LDHFKHS---GPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPEN 218 (590)
T ss_pred eccceec---CCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcce
Confidence 9886431 35678999999999 8999999987543 348899999999999999999997 58 9999999999
Q ss_pred eEE
Q 035572 173 ILF 175 (379)
Q Consensus 173 Ill 175 (379)
||+
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.15 Aligned_cols=274 Identities=21% Similarity=0.277 Sum_probs=206.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
+...+|.-+..+|.|.- .|.-|.|.- .++.|++|++..+ +. .....++..+|...+..+.|+| ++
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v-----~~~~v~ikk~~~p-f~-n~~~akra~rel~l~~~v~~~n-------ii 78 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQV-----LGRPVAIKKLSRP-FQ-NQTHAKRAYRELKLMKCVNHKN-------II 78 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhh-----ccCceehhhhcCc-cc-cCccchhhhhhhhhhhhhcccc-------ee
Confidence 44678999999999998 677775543 5677999998766 22 2455678899999999999999 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.++..+.... ..+.-...|+|||+| ..+|.+.+.- .++-.++..+++|+++|+.|||+.| |+||||||+
T Consensus 79 ~l~n~ftP~~-~l~~~~e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPs 147 (369)
T KOG0665|consen 79 SLLNVFTPQK-TLEEFQEVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPS 147 (369)
T ss_pred eeeeccCccc-cHHHHHhHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcc
Confidence 7776654422 234456789999999 7899998862 1677788999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++..++.+||.|||+|+.....-..+..+.|..|.|||++-+..+.+.+||||+||++.||++|..-|.+.+--++..
T Consensus 148 nivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 148 NIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred cceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 99999999999999999987766645566689999999999998889999999999999999999999998654322221
Q ss_pred Hhhh--------------h----hhh-HHhhhhhccccCCCCc-ch-------HHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 252 DWAL--------------P----LIK-EEKLRQVCDSRVGLPT-FM-------EGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 252 ~~~~--------------~----~~~-~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
.... + ... ...... ..-....|+ .+ .-....+.+++.+||..||++|.++++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d 306 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD 306 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence 1100 0 000 000000 000000011 00 112346889999999999999999999
Q ss_pred HhccccCc
Q 035572 305 ILMGCSCF 312 (379)
Q Consensus 305 ~l~~~~~~ 312 (379)
+|.|....
T Consensus 307 aL~HPY~~ 314 (369)
T KOG0665|consen 307 ALRHPYIK 314 (369)
T ss_pred HhcCCeee
Confidence 99997665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=246.66 Aligned_cols=272 Identities=24% Similarity=0.359 Sum_probs=201.0
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
+..+.+.|.++++||.|.|++||+|.+... ....+.||+|.+... ....++.+|+++|..+...+.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~n------ 96 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDN------ 96 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccc------cCchHHHHHHHHHHHhccchh------
Confidence 344567899999999999999999988752 335678999998754 345789999999999975431
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
|+++.+. +..+++..+|+||++..+..+++.. ++..++..+++.++.||.++|.+| |+|||||
T Consensus 97 i~~~~~~-------~rnnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiK 159 (418)
T KOG1167|consen 97 IIKLNGC-------FRNNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIK 159 (418)
T ss_pred hhcchhh-------hccCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCC
Confidence 4444433 5667899999999999999999975 788899999999999999999999 9999999
Q ss_pred CCceEEc-CCCCeEEeccccCccC-----------------CC-CC---------------------------cccccCc
Q 035572 170 STNILFD-SKWDAKLADFGLAVSE-----------------SD-ES---------------------------SMVQPAG 203 (379)
Q Consensus 170 p~NIll~-~~~~~kl~Dfg~a~~~-----------------~~-~~---------------------------~~~~~~g 203 (379)
|+|+|.+ ..+.-.|.|||+|... .. .+ ......|
T Consensus 160 psNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAG 239 (418)
T KOG1167|consen 160 PSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAG 239 (418)
T ss_pred ccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCC
Confidence 9999998 5677899999998510 00 00 0112349
Q ss_pred cccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhh-----------------
Q 035572 204 TIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQ----------------- 265 (379)
Q Consensus 204 t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 265 (379)
|++|.|||++. ....+.++||||.|++++.+++++.||....+..........+.....+.+
T Consensus 240 T~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~ 319 (418)
T KOG1167|consen 240 TPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIP 319 (418)
T ss_pred CCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccccc
Confidence 99999999765 455789999999999999999999999766554333222211111111000
Q ss_pred -----------h-cccc-------CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 266 -----------V-CDSR-------VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 266 -----------~-~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
. +... ..........+..+.+|+.+||..||.+|.|++++|+|....
T Consensus 320 ~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 320 TIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 0 0000 000111122344789999999999999999999999997665
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=265.95 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=202.5
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
.+..++||+|+||.||+|.+-..+.. ..-+||+|++..... ......+..|+.+|.++.|+| ++++++.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~-vKipVaiKvl~~~t~---~~~s~e~LdeAl~masldHpn-------l~RLLgv 766 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGEN-VKIPVAIKVLIEFTS---PKASIELLDEALRMASLDHPN-------LLRLLGV 766 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCce-ecceeEEEEeeccCC---chhhHHHHHHHHHHhcCCCch-------HHHHhhh
Confidence 34467999999999999999876443 345789999875432 455788999999999999999 9998988
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+.. ..+.||++|+++|.|.++++..+ ..+..+..+.|.+||++|+.|||.+. ++||||-..|||+.
T Consensus 767 c~~--------s~~qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk 832 (1177)
T KOG1025|consen 767 CML--------STLQLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK 832 (1177)
T ss_pred ccc--------chHHHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec
Confidence 753 34889999999999999998733 34888899999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCCcccc-c--CccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHH
Q 035572 177 SKWDAKLADFGLAVSESDESSMVQ-P--AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIID 252 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~ 252 (379)
.-..+||.|||+++.......... . .-.+.|||-|.+....++.++|||||||++||++| |..|+++...
T Consensus 833 sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------ 906 (1177)
T KOG1025|consen 833 SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------ 906 (1177)
T ss_pred CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------
Confidence 999999999999987765543222 2 23567899999999999999999999999999999 9999987642
Q ss_pred hhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 253 WALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+.+.+++.. ++.-| +-++-++..++.+||..|+..||+++++.....
T Consensus 907 --------~eI~dlle~geRLsqP---piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 907 --------EEIPDLLEKGERLSQP---PICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred --------HHhhHHHhccccCCCC---CCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 122222222 22223 334577889999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-33 Score=258.86 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=206.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|+.+..+|.|.||.||+|+++. .+++.|+|+++.+. .+...-+..|+-+++..+|+| |+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~-----s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~n-------iv 75 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR-----SGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPN-------IV 75 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc-----cCchhhheeeeccC----CccccccccceeeeecCCCcC-------hH
Confidence 345789999999999999999998765 67788999988764 355677889999999999999 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.+++...+ .+.++++||||.||+|.+..+-. ..+++.++..+++..++||+|||+.| =+|||||-.
T Consensus 76 ay~gsylr-------~dklwicMEycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGa 141 (829)
T KOG0576|consen 76 AYFGSYLR-------RDKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGA 141 (829)
T ss_pred HHHhhhhh-------hcCcEEEEEecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhcCC--ccccccccc
Confidence 88877544 67899999999999999988643 33888899999999999999999999 899999999
Q ss_pred ceEEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|||+++.|.+|++|||.+-.... -.......||+.|||||+. ..+.|...+|||++|++..|+-.-++|-......
T Consensus 142 nilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 142 NILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 99999999999999998744432 2234556899999999964 4567899999999999999999888886544332
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCc--chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPT--FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
. .+.-.....+..|. .....++.+.++++.||..+|.+||+++.+|.|......
T Consensus 222 r-------------~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 R-------------ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred H-------------HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 2 11111112222111 122345779999999999999999999999998665443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=244.55 Aligned_cols=203 Identities=25% Similarity=0.378 Sum_probs=171.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcH----HHHHHHHHHHHhhh---hccCCCC
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS----KKLNNEIRVLSSLQ---ESNKRNP 86 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~E~~~l~~l~---~~~~~~~ 86 (379)
...|..++.+|.|+||.|++|+++. +...|+||.+.++..-+..+.. ..+--||+||..|+ |+|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~-----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N---- 630 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKE-----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN---- 630 (772)
T ss_pred cccceeeeeccccccceEEEeeecc-----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc----
Confidence 3568999999999999999999876 4577999999876554433333 34678999999998 444
Q ss_pred CceeeeccccccccCCCccCCCceEEEEecc-CCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFM-PNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
|+++.+. |++++.+||+||-. +|.+|.++|+. .+.+++.++..|+.|++.|+++||+.| |+|
T Consensus 631 ---IlKlLdf-------FEddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~--ivh 693 (772)
T KOG1152|consen 631 ---ILKLLDF-------FEDDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG--IVH 693 (772)
T ss_pred ---hhhhhhe-------eecCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC--cee
Confidence 7776665 78899999999964 45799999974 445999999999999999999999999 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
||||-+||.++.+|.+||+|||.|-.... +......||..|.|||++.+.+| +..-|||++|++||.++....||.+
T Consensus 694 rdikdenvivd~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 694 RDIKDENVIVDSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cccccccEEEecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999999865543 34456789999999999999987 5568999999999999999998853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-29 Score=215.69 Aligned_cols=211 Identities=34% Similarity=0.501 Sum_probs=176.8
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCC
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSG 102 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~ 102 (379)
||.|++|.||++.+.. .++.+++|.+....... ..+.+.+|+..++.++|++ ++++++.+
T Consensus 1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~-------i~~~~~~~----- 60 (215)
T cd00180 1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPN-------IVKLYGVF----- 60 (215)
T ss_pred CCcCCceEEEEEEecC-----CCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCC-------eeeEeeee-----
Confidence 6899999999998754 45679999987543211 3477999999999999866 77777664
Q ss_pred CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC-CCCe
Q 035572 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS-KWDA 181 (379)
Q Consensus 103 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~-~~~~ 181 (379)
......+++||++.+++|.+++.... ..++...+..++.+++.++.+||+.| ++|+||+|.||+++. ++.+
T Consensus 61 --~~~~~~~~~~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~ 132 (215)
T cd00180 61 --EDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKV 132 (215)
T ss_pred --ecCCeEEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcE
Confidence 33478899999998899999997532 23788899999999999999999999 999999999999998 8999
Q ss_pred EEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhh
Q 035572 182 KLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259 (379)
Q Consensus 182 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 259 (379)
+|+|||.+....... ......+...|++||..... ..+.++|+|++|++++++
T Consensus 133 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------- 187 (215)
T cd00180 133 KLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------- 187 (215)
T ss_pred EEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------
Confidence 999999986654432 12334688899999988876 788999999999999999
Q ss_pred HHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 260 EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..+.+++.+|++.+|.+||++.+++.+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=226.97 Aligned_cols=268 Identities=21% Similarity=0.297 Sum_probs=207.3
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.+|..-..+++...++-+|.||.||.|+++...+-.+.+.|-+|.++.... +-....+..|.-.+..+.|+|
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS---~iQv~~~L~es~lly~~sH~n----- 348 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS---QIQVNLLLQESMLLYGASHPN----- 348 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc---HHHHHHHHHHHHHHhcCcCCC-----
Confidence 455556678999999999999999999988766655667788888765432 344677889999999998888
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC---CCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT---TPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
++...+.+. ++....++++.++.-|+|..++...++.. ...++..+...++.|++.|++|||++| ++
T Consensus 349 --ll~V~~V~i------e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--Vi 418 (563)
T KOG1024|consen 349 --LLSVLGVSI------EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VI 418 (563)
T ss_pred --ccceeEEEe------eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cc
Confidence 666665543 45678899999998899999998544322 233666777889999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 240 (379)
|.||-..|.+|++.-.+||+|=.+++..-+.+. .........||+||.+....|+.++|+||||+++|||+| |+.|
T Consensus 419 HkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~P 498 (563)
T KOG1024|consen 419 HKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLP 498 (563)
T ss_pred cchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999866544332 122235678999999999999999999999999999999 9999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+...++ .+...... ...++..| -.++.++..++..||..+|++||+.+|++.-
T Consensus 499 yaeIDP-fEm~~ylk-----------dGyRlaQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 499 YAEIDP-FEMEHYLK-----------DGYRLAQP---FNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred ccccCH-HHHHHHHh-----------ccceecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 876543 22111111 11222222 2456889999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=213.99 Aligned_cols=199 Identities=30% Similarity=0.451 Sum_probs=165.5
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|.+.+.||.|++|.||++.... .++.+++|.+...... ...+.+.+|++.++.++|++ ++.+++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~-------i~~~~~~ 65 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPN-------IVKLYGV 65 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCC-------hhhheee
Confidence 5678999999999999998764 4567999998754321 24678899999999998777 6666665
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+ ......++++|++.+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++
T Consensus 66 ~-------~~~~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~ 132 (225)
T smart00221 66 F-------EDPEPLYLVMEYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG 132 (225)
T ss_pred e-------ecCCceEEEEeccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence 3 335788999999999999999976331 1678889999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCC--cccccCccccccCCCCC-CCCCCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 177 SKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYT-NPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
.++.++|+|||.+....... ......++..|++||.. ....++.++|+||||+++++|++|+.||..
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 133 MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999999999987665432 23344678899999988 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=258.14 Aligned_cols=181 Identities=17% Similarity=0.186 Sum_probs=132.2
Q ss_pred CCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCC--------
Q 035572 107 NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-------- 178 (379)
Q Consensus 107 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~-------- 178 (379)
...++.+||++ +++|.+++... ...+++.+++.+++||+.||+|||++| |+||||||+||||+..
T Consensus 52 ~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~ 124 (793)
T PLN00181 52 DDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIES 124 (793)
T ss_pred cchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeec
Confidence 34677889988 77999999742 234889999999999999999999999 9999999999999643
Q ss_pred -----------CCeEEeccccCccCCCCC-----------------cccccCccccccCCCCCCCCCCCCcCCeehhHHH
Q 035572 179 -----------WDAKLADFGLAVSESDES-----------------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230 (379)
Q Consensus 179 -----------~~~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 230 (379)
+.+|++|||+++...... ......||+.|||||++.+..++.++|||||||+
T Consensus 125 ~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGvi 204 (793)
T PLN00181 125 ASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVL 204 (793)
T ss_pred cccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHH
Confidence 455666666664321100 0011357889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 231 LLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 231 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+|||++|.+|+..... .... + ..... +.......+...+++.+||+.+|.+||++.|+++|..
T Consensus 205 L~ELl~~~~~~~~~~~---~~~~----~----~~~~~------~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 205 LFELFCPVSSREEKSR---TMSS----L----RHRVL------PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHhhCCCchhhHHH---HHHH----H----HHhhc------ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence 9999999888653211 0000 0 00011 1111112345678889999999999999999999865
Q ss_pred C
Q 035572 311 C 311 (379)
Q Consensus 311 ~ 311 (379)
.
T Consensus 268 ~ 268 (793)
T PLN00181 268 I 268 (793)
T ss_pred h
Confidence 4
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=212.19 Aligned_cols=252 Identities=19% Similarity=0.329 Sum_probs=183.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...+.|.+.+.||+|.||.+-+|.++. +...+++|-++.+ ....++|.+|..---.|.++. .|+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~-----s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~------hIi 84 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQ-----SKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQ------HII 84 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccC-----CceEEEeeccCcc-----hhhHHHHHHHhccceeeccch------hhh
Confidence 345789999999999999999998765 4456899988755 455677888776544444221 155
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.-++.- |+..+.++.++||++-|+|.+-+...+ +.+.....++.|+++|+.|+|+.+ +||||||.+
T Consensus 85 ~tY~va------Fqt~d~YvF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~e 150 (378)
T KOG1345|consen 85 DTYEVA------FQTSDAYVFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAE 150 (378)
T ss_pred HHHHHH------hhcCceEEEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccc
Confidence 544432 667778899999999999999886533 778888999999999999999999 999999999
Q ss_pred ceEEc--CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC---C--CCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 172 NILFD--SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP---S--KLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 172 NIll~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
|||+- +.-.+||||||+++.....- ....-+..|.+||.... + ...+.+|||.||+++|.++||..||...
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred eEEEecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 99994 34579999999986553322 12235667889985432 2 2467899999999999999999999743
Q ss_pred CCchh-HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 245 RDPAS-IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 245 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
...+. ..++ ..+.. +.....|..+...++.+..+..+-|..+|++|=-..+
T Consensus 229 ~~~d~~Y~~~-------~~w~~--rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 229 SIMDKPYWEW-------EQWLK--RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred hccCchHHHH-------HHHhc--ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 21111 1111 11111 1122346666677788999999999999999943333
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=206.30 Aligned_cols=166 Identities=22% Similarity=0.271 Sum_probs=126.6
Q ss_pred CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCccc
Q 035572 120 GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199 (379)
Q Consensus 120 ~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 199 (379)
|||.+++.+.+ ..+++.+++.++.|++.||.|||+++ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997532 24899999999999999999999987 999999999999999 99986654322
Q ss_pred ccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHH
Q 035572 200 QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEG 279 (379)
Q Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (379)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.............. ................
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 134 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL--------NGMPADDPRDRSNLES 134 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH--------HHhccCCccccccHHH
Confidence 2688999999999999999999999999999999999999976543222211111 0111110000112233
Q ss_pred HHH--HHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 280 AIK--QMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 280 ~~~--~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... .+.+++.+||+.||.+||++.|++.|...
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 333 69999999999999999999999998543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=192.00 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=188.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.-+|+++++||+|+||.+|.|.. -.++.+||||.-+. ....-++..|....+.|.+... .| -|-+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~N-----l~nne~VAIKfEPr------kS~APQLrdEYr~YKlL~g~~G-IP---~vYY 91 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKN-----LYNNEPVAIKFEPR------KSEAPQLRDEYRTYKLLGGTEG-IP---QVYY 91 (449)
T ss_pred cccceeccccccCcceeeecccc-----cccCceEEEEeccc------cCCcchHHHHHHHHHHHcCCCC-CC---ceee
Confidence 45799999999999999999964 34788999997553 3445678899999999874321 11 1212
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
. -.++.+-.||||.+ |.||++++. ++...|+..++..++.|++.-++|+|++. ++.|||||+|+
T Consensus 92 F---------GqeG~~NiLVidLL-GPSLEDLFD----~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNF 155 (449)
T KOG1165|consen 92 F---------GQEGKYNILVIDLL-GPSLEDLFD----LCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNF 155 (449)
T ss_pred e---------ccccchhhhhhhhh-CcCHHHHHH----HhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccce
Confidence 2 24456678999999 999999997 45667999999999999999999999999 99999999999
Q ss_pred EEcCC-----CCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 174 LFDSK-----WDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 174 ll~~~-----~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||... ..+.|+|||+|+...+..+ .....||..||+--...+...+.+-|+=|||-++++.|-|..|
T Consensus 156 LIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 156 LIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred eecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 99743 3489999999977655433 2233699999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
|.+...+.- .+.+.+|-+..-..| ....+.+.++...+.-.-..+-.+-|..+
T Consensus 236 WQGLKA~tn----------K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 236 WQGLKADTN----------KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred cccccCcch----------HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 998765431 223333333222112 23445566777766666666666667655
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=202.37 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=185.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|++.+.||+|+||.||.|.+.... .+.+|+|....... .. ...+..|..++..+...+ ..++ +..++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~---~~-~~~l~~E~~vl~~l~~~~-~~~~--~~~~~~ 87 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELG---SK-PSVLKIEIQVLKKLEKKN-GPSH--FPKLLD 87 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEeccc---CC-CccchhHHHHHHHHhhhc-CCCC--CCEEEE
Confidence 8999999999999999999876533 45688888664321 11 126889999999998511 0011 222222
Q ss_pred cccccCCCc-cCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 96 TSCRNSGSV-DGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 96 ~~~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
. . ......|+||+.+ |.+|.++..... ...++..++..++.|++.+|.+||+.| ++||||||+|++
T Consensus 88 ~-------G~~~~~~~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~ 154 (322)
T KOG1164|consen 88 H-------GRSTEDFNFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFV 154 (322)
T ss_pred e-------ccCCCceeEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHee
Confidence 2 2 3566789999999 999999886543 455999999999999999999999999 999999999999
Q ss_pred EcCC-----CCeEEeccccCc--cCCCCC--------c-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC
Q 035572 175 FDSK-----WDAKLADFGLAV--SESDES--------S-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 175 l~~~-----~~~kl~Dfg~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 238 (379)
+... ..+.|.|||+++ ...... . .....||..|+++....+...+.+.|+||++.++.+++.|.
T Consensus 155 ~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 155 VGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred ecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 9854 369999999997 321111 1 12235999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.||............ ........... .....+..+.++...+-..+...+|....+...
T Consensus 235 LPW~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 235 LPWEALEMTDLKSKF-----EKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred CCCccccccchHHHH-----HHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 999776543321111 11111111110 111123456666666667899999999888665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=205.60 Aligned_cols=183 Identities=17% Similarity=0.183 Sum_probs=134.2
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNKRN 85 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~ 85 (379)
-+....+.++|.+.+.||+|+||.||+|++... .+..+|||++...... ........+.+|+++|+.++|++
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~--- 82 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGD----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIG--- 82 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCC----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCC---
Confidence 345567788999999999999999999986542 3455899986532110 01223567999999999999887
Q ss_pred CCceeee-ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 86 PNYCVVN-FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 86 ~~~~iv~-~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
++. ++. .+..|+||||++|++|.. +.. .. ...++.|++++|.|||++| |+
T Consensus 83 ----iv~~l~~-----------~~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g--Ii 133 (365)
T PRK09188 83 ----VVPQLLA-----------TGKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG--IT 133 (365)
T ss_pred ----CCcEEEE-----------cCCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC--Ce
Confidence 332 221 135699999999999963 210 11 1467899999999999999 99
Q ss_pred ecCC-CCCceEEcCCCCeEEeccccCccCCCCCcc---------cccCccccccCCCCCCCCCC------CCcCCee
Q 035572 165 HRDI-KSTNILFDSKWDAKLADFGLAVSESDESSM---------VQPAGTIGYLDPGYTNPSKL------SKKVDVF 225 (379)
Q Consensus 165 H~dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~------~~~~Diw 225 (379)
|||| ||+|||++.++.++|+|||+|......+.. ....+++.|+|||++..... +..+|-|
T Consensus 134 HrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 134 HNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999 999999999999999999999765443311 23357888999998875532 3346666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-26 Score=223.31 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=188.3
Q ss_pred cCC-ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESF-SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y-~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+.| ...+++|.|++|.|+.+...........+.+.+| .... +...+....+..|..+-..|.|++ ++..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~--~s~~~~~~~i~sE~~i~~~l~h~~-------~~e~ 386 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPT--ESERKYNYNITSEFCIGSSLSHPN-------IIET 386 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cCCc--ccHHHHhhhhhhheeecccccCCc-------hhhh
Confidence 335 4567899999998888876654444344444433 2111 111233333778888888898887 4333
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
...+. +....+-+||||++ +|..++.... .+...++-.++.|++.||+|+|+.| |.|||+||+|+
T Consensus 387 l~~~~-------~~~~~~~~mE~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enl 451 (601)
T KOG0590|consen 387 LDIVQ-------EIDGILQSMEYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENL 451 (601)
T ss_pred HHHHh-------hcccchhhhhcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccE
Confidence 33322 22333334999998 9999997642 3777788899999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCCCCC-cCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSKLSK-KVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+++.+|.+||+|||.+....... ......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......
T Consensus 452 l~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 452 LVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred EEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 99999999999999985543332 223457999999999999999876 589999999999999999999766433
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... .............+.......++...+.++.+||+.||.+|.|+++|++....
T Consensus 532 ~~~~-------~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 532 DNSF-------KTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ccch-------hhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 2110 00001111111112222455667889999999999999999999999997433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=184.06 Aligned_cols=261 Identities=25% Similarity=0.305 Sum_probs=193.8
Q ss_pred CCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
.+.+.+++-. ..+|.++++||.|+||.+|.|.... .+..||||.-+.. ....++..|..+.+.|++..
T Consensus 4 ~~~s~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~-----~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~ 71 (341)
T KOG1163|consen 4 NSGSLEELIV-GGKYKLVRKIGSGSFGDIYLGISIT-----SGEEVAIKLESSK------AKHPQLLYESKVYRILQGGV 71 (341)
T ss_pred cccchhhhee-ccceEEEEeecCCchhheeeeeecc-----CCceEEEEeeccc------CCCcchhHHHHHHHHhccCC
Confidence 3445555443 5789999999999999999998654 5677999986532 23456788999999998642
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
..|+ + . ....+...-.+||+.+ |.||++++.- +...++..+++-++.|++.-++|+|.++
T Consensus 72 -GiP~--i---~-------~y~~e~~ynvlVMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~-- 131 (341)
T KOG1163|consen 72 -GIPH--I---R-------HYGTEKDYNVLVMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRN-- 131 (341)
T ss_pred -CCch--h---h-------hhccccccceeeeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhc--
Confidence 1111 1 1 1134567778999999 9999999984 4455999999999999999999999999
Q ss_pred eEecCCCCCceEEcC---CCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHH
Q 035572 163 IIHRDIKSTNILFDS---KWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231 (379)
Q Consensus 163 i~H~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 231 (379)
++||||||+|.|..- -..+.++|||+|+...+..+ .....||..|.+--..-+...+.+-|+=|+|.++
T Consensus 132 fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 132 FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 999999999999963 24689999999965433221 2234699999888777777778899999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc--chHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT--FMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
.++..|..||.+..... ..+++..+.......+. ...+.|.++.-.+.-|-..--++-|...-+
T Consensus 212 mYfnrG~LPWQglka~t----------k~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAAT----------KKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred eeeecCCCcccccchhh----------HHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 99999999999876543 23333344333332222 345566778888888888877777876544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-23 Score=189.84 Aligned_cols=259 Identities=29% Similarity=0.379 Sum_probs=191.4
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhc-cCCCCCceeeeccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES-NKRNPNYCVVNFHG 95 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~~~iv~~~~ 95 (379)
|.+...||.|+||.||++.+. +.+++|.+....... ......+.+|+.+++.+.++ + ++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~-------i~~~~~ 65 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPN-------IVKLYD 65 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcc-------eeeEEE
Confidence 778899999999999999865 558889887653321 12477899999999999877 4 555555
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ......+++++++.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||++
T Consensus 66 ~~-------~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~ 134 (384)
T COG0515 66 FF-------QDEGSLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILL 134 (384)
T ss_pred EE-------ecCCEEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee
Confidence 43 3334479999999999999777643211 24888899999999999999999999 9999999999999
Q ss_pred cCCC-CeEEeccccCccCCCCC-------cccccCccccccCCCCCCC---CCCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 176 DSKW-DAKLADFGLAVSESDES-------SMVQPAGTIGYLDPGYTNP---SKLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 176 ~~~~-~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
+..+ .++++|||++....... ......+|..|++||...+ ...+...|+||+|++++++++|..||...
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9888 79999999986444332 2345579999999998887 57888999999999999999999997665
Q ss_pred CCc---hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 245 RDP---ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 245 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
... ......... .... ....... ..........+.+++.+|+..+|..|.+..+...+
T Consensus 215 ~~~~~~~~~~~~~~~----~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 215 KNSSATSQTLKIILE----LPTP-SLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CccccHHHHHHHHHh----cCCc-ccccccC-ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 531 111111100 0000 0000000 00001223578899999999999999999988876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=177.33 Aligned_cols=181 Identities=12% Similarity=0.106 Sum_probs=128.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHH------HHHHHHHHHhhhhccCCCC
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK------LNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~E~~~l~~l~~~~~~~~ 86 (379)
+.++|++.+++|.|+||.||++.+ . +..+++|.++.+.... +..... +.+|+..+.++.|++...|
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~------~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-D------YGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-C------CCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 468999999999999999999643 2 2349999987543221 222222 6899999999999985544
Q ss_pred Cceeeecccc-ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 87 NYCVVNFHGT-SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 87 ~~~iv~~~~~-~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
. .+ +......+.-.+..+|||||++|.+|.++.. ++. ....+++.+|..+|..| ++|
T Consensus 101 ~-------d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g--i~H 158 (232)
T PRK10359 101 N-------DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG--MVS 158 (232)
T ss_pred e-------EeeeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC--Ccc
Confidence 3 22 1111111223467899999999999988742 322 34669999999999999 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHH
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 235 (379)
||++|+||+++.+| ++|+|||............. +.....+..++|+||||+++..+.
T Consensus 159 ~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeCCC-EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence 99999999999988 99999998754422111110 223344667899999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-24 Score=188.13 Aligned_cols=250 Identities=19% Similarity=0.309 Sum_probs=155.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh----------ccCC
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE----------SNKR 84 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----------~~~~ 84 (379)
.++...+.||.|+++.||.+++.. +++.+++|...... .......+.+.+|.-....+.+ -...
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~-----t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVE-----TGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred eEEEEccccccCCceEEEEEEEcc-----CCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence 356677899999999999999876 66789999987665 3445567777777765555332 1111
Q ss_pred CCCceeeecccc--ccccCCCccCCC-----ceEEEEeccCCCCHHHHHHhhhcCC--CCCCChHhHHHHHHHHHHHHHH
Q 035572 85 NPNYCVVNFHGT--SCRNSGSVDGNS-----NKLLVMEFMPNGSLYDLLHNAAAAT--TPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 85 ~~~~~iv~~~~~--~~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
.|. -++.+.+. +... -.+.. ..+++|+-+ .+||.+++..-.... ...+....+..+..|+++.+++
T Consensus 86 ~P~-d~~~i~~~~~~~~~---~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~ 160 (288)
T PF14531_consen 86 VPL-DLLRIPGKPPFFER---GPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVAN 160 (288)
T ss_dssp --S-EEEEETTS-SEEEE---CETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred eee-EEEEEcCCCcceec---CCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHH
Confidence 111 02222211 0000 00011 347789988 679988876422111 1123344455667899999999
Q ss_pred HHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC--------CCCCCcCCeehh
Q 035572 156 LHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP--------SKLSKKVDVFSY 227 (379)
Q Consensus 156 LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSl 227 (379)
||+.| ++|+||+|+|++++.+|.+.|+||+........... ...+..|.|||.... -.++.+.|.|+|
T Consensus 161 Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 161 LHSYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp HHHTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred Hhhcc--eEecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 99999 999999999999999999999999876554432222 345578899985532 246888999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCC
Q 035572 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299 (379)
Q Consensus 228 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 299 (379)
|+++|.|++|+.||......... .+ .+-. .. +.+..+.+||.++|++||++|
T Consensus 237 G~~ly~lWC~~lPf~~~~~~~~~-~~-----------~f~~-------C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 237 GITLYSLWCGRLPFGLSSPEADP-EW-----------DFSR-------CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHSS-STCCCGGGSTS-GG-----------GGTT-------SS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCCCCCCccccc-cc-----------cchh-------cC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999865321110 00 1111 11 456789999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=170.08 Aligned_cols=143 Identities=20% Similarity=0.254 Sum_probs=105.9
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhh----------------------cHHHHHHHHHHHHh
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD----------------------NSKKLNNEIRVLSS 77 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~E~~~l~~ 77 (379)
...||+|+||.||+|.+. +++.||+|+++....+.... .......|+.++..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999999753 46779999987542110000 01233559999999
Q ss_pred hhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHH-
Q 035572 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCL- 156 (379)
Q Consensus 78 l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L- 156 (379)
+.+++...|. ++. ....+|||||++|+++....... ..++..++..++.|++.+|.++
T Consensus 76 l~~~~v~~p~--~~~--------------~~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~ 134 (190)
T cd05147 76 LVTAGIPCPE--PIL--------------LKSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILY 134 (190)
T ss_pred HHHCCCCCCc--EEE--------------ecCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9887643332 211 11238999999887776543221 2378889999999999999999
Q ss_pred HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 157 H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
|+.| |+||||||+|||++ ++.++|+|||+|...
T Consensus 135 H~~g--iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 135 QDCR--LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HhCC--cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 7999 99999999999998 478999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=197.10 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=186.9
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecccccccc
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~~~~~~~ 100 (379)
++|.|+||.||++.-- ....++..++.|...+......... ....|..++...+ ++. ++.++..
T Consensus 1 vlg~g~~gkvfLvrk~--~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f-------~v~lhya---- 65 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA--GGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPF-------LVKLHYA---- 65 (612)
T ss_pred CCCcCCCcchHHHHHh--ccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCc-------eeeeeee----
Confidence 4799999999987533 3345788899999876654332222 5566777777776 333 6666654
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
++.+...++++++..||+|...+.+. ..+.+.....+...++-+++++|+.+ ++|||+|++||+++.+|+
T Consensus 66 ---fqt~~kl~l~ld~~rgg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Gh 135 (612)
T KOG0603|consen 66 ---FQTDGKLYLILDFLRGGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGH 135 (612)
T ss_pred ---eccccchhHhhhhcccchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCc
Confidence 67789999999999999999988643 34777788889999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhH
Q 035572 181 AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKE 260 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 260 (379)
+++.|||+++........ +||..|||||+++ ....++|.||||+++++|+||..||..
T Consensus 136 i~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------- 193 (612)
T KOG0603|consen 136 IKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------- 193 (612)
T ss_pred cccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------------
Confidence 999999998765443332 8999999999988 567789999999999999999999986
Q ss_pred HhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccCcc
Q 035572 261 EKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSCFF 313 (379)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~~~ 313 (379)
.....+....+..| ...+..+.+++..++..+|.+|.-. .|+.+|.....
T Consensus 194 ~~~~~Il~~~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 194 DTMKRILKAELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHHHHhhhccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 11223333344444 4445778888899999999999755 56666654433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-23 Score=203.24 Aligned_cols=249 Identities=20% Similarity=0.226 Sum_probs=173.8
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|...+.||++.|=.|++|.++. | .|+||++-+..-...-....+-..|++ ...+++|| ++.+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn-------~lPfqk 88 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPN-------CLPFQK 88 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCc-------ccchHH
Confidence 67788999999999999997643 2 278888755432222222334444555 55566665 443332
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
+...+.-.|||-+|. ..+|.|.+. ..+.+..-+.+-|+.|++.||..+|..| |+|||||.+|||+
T Consensus 89 -------~~~t~kAAylvRqyv-khnLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILi 153 (1431)
T KOG1240|consen 89 -------VLVTDKAAYLVRQYV-KHNLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILI 153 (1431)
T ss_pred -------HHHhhHHHHHHHHHH-hhhhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEE
Confidence 235566778888999 569999995 4555778888899999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCcc--CCCCC------cccccCccccccCCCCCCCC----------C-CCCcCCeehhHHHHHHHHh
Q 035572 176 DSKWDAKLADFGLAVS--ESDES------SMVQPAGTIGYLDPGYTNPS----------K-LSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~--~~~~~------~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt 236 (379)
+.-+.+.|+||..-+. .+.+. ...+.....+|+|||.+... + .+++-||||+||++.|+++
T Consensus 154 TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 154 TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 9999999999986532 11111 12333456689999965431 2 5778899999999999998
Q ss_pred -CCCCCCCCCCchhHHHhhhh--hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 237 -CRKPIDAARDPASIIDWALP--LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 237 -g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|++||.-. ++.++... ...+..+.++- ...++.++..|++.||.+|.++++.|+....
T Consensus 234 Eg~PlF~LS----QL~aYr~~~~~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 234 EGRPLFTLS----QLLAYRSGNADDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCCCcccHH----HHHhHhccCccCHHHHHHhCc-------------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 89998532 11111000 00111111111 1368899999999999999999999987443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=174.33 Aligned_cols=246 Identities=20% Similarity=0.372 Sum_probs=183.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
...+..+|.....|..|+|.+..+. +++|++.-.... ....++|..|.-.|+.+.||| |+.+.+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-------ivakil~vr~~t--~risrdfneefp~lrifshpn-------ilpvlg 254 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-------IVAKILNVREVT--ARISRDFNEEFPALRIFSHPN-------ILPVLG 254 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-------hhhhhhhhhhcc--hhhcchhhhhCcceeeecCCc-------hhhhhh
Confidence 3445667888999999999886533 566666544333 455678999999999999998 777777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.| ....++.++..||+-|||..+++.. ..-..+..++.+++.+++.|++|||+..+.|.---|+...+++
T Consensus 255 ac-------nsppnlv~isq~mp~gslynvlhe~---t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi 324 (448)
T KOG0195|consen 255 AC-------NSPPNLVIISQYMPFGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI 324 (448)
T ss_pred hc-------cCCCCceEeeeeccchHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe
Confidence 75 4568899999999999999999874 3333667788999999999999999988766667899999999
Q ss_pred cCCCCeEEe--ccccCccCCCCCcccccCccccccCCCCCCCCCC---CCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 176 DSKWDAKLA--DFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL---SKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 176 ~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|++.+.+|+ |--++... ....-.+.||+||.++..+- -.++|+|||++++||+.|...||....+.+--
T Consensus 325 dedltarismad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg 398 (448)
T KOG0195|consen 325 DEDLTARISMADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG 398 (448)
T ss_pred cchhhhheecccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh
Confidence 999887765 32222111 12245789999998876553 24689999999999999999999876543321
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
...+.. .-+ +..+++.+..+..|+.-|+..||.+||.++.++-
T Consensus 399 mkiale-----------glr---v~ippgis~hm~klm~icmnedpgkrpkfdmivp 441 (448)
T KOG0195|consen 399 MKIALE-----------GLR---VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVP 441 (448)
T ss_pred hhhhhc-----------ccc---ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehh
Confidence 111111 112 2233566789999999999999999999987763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=178.05 Aligned_cols=180 Identities=20% Similarity=0.266 Sum_probs=134.8
Q ss_pred cCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc--CCC--C
Q 035572 105 DGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD--SKW--D 180 (379)
Q Consensus 105 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~--~~~--~ 180 (379)
.++..+|+||... ..+|.+++-.+ ..+....+-++.|+++|+.|||++| |.|||+|.+|||+. +|+ .
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~~------~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~ 383 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWTR------HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQ 383 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhcC------CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcE
Confidence 4457889999988 57999999542 2667788889999999999999999 99999999999994 333 4
Q ss_pred eEEeccccCccC-------CCCCcccccCccccccCCCCCCCCCC------CCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 181 AKLADFGLAVSE-------SDESSMVQPAGTIGYLDPGYTNPSKL------SKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 181 ~kl~Dfg~a~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+.|+|||.+.-. +..+......|+...||||+....+- -.++|.|+.|.+.||+++...||.+....
T Consensus 384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem 463 (598)
T KOG4158|consen 384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM 463 (598)
T ss_pred EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh
Confidence 789999987322 22233444568889999998764332 24899999999999999999999763221
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
. +.... -..-.+|...+.+++.+++++...|+.||.+|+++.-+..
T Consensus 464 ~---------L~~r~-----Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 464 L---------LDTRT-----YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred e---------echhh-----hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1 00111 1122235566677889999999999999999999875543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=162.09 Aligned_cols=144 Identities=23% Similarity=0.257 Sum_probs=107.1
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh----------------------hhcHHHHHHHHHHHH
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL----------------------QDNSKKLNNEIRVLS 76 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~ 76 (379)
+...||+|++|.||+|.+. +++.||||+++....... ......+.+|...+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05145 1 INGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK 74 (190)
T ss_pred CCceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999999754 467799999886521100 001233468999999
Q ss_pred hhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHH-HHhhhcCCCCCCChHhHHHHHHHHHHHHHH
Q 035572 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL-LHNAAAATTPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 77 ~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
++.+++...|.. +. . ...++||||++|+++... +.. ..++..+...++.|++.++.+
T Consensus 75 ~l~~~~i~~p~~--~~---~-----------~~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~ 132 (190)
T cd05145 75 RLYEAGVPVPEP--IL---L-----------KKNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRR 132 (190)
T ss_pred HHHhCCCCCceE--EE---e-----------cCCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHH
Confidence 999887433331 11 0 123899999988755443 322 126777889999999999999
Q ss_pred HHc-CCCCeEecCCCCCceEEcCCCCeEEeccccCccCC
Q 035572 156 LHE-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193 (379)
Q Consensus 156 LH~-~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 193 (379)
+|+ .| |+||||||+|||++ ++.++|+|||++....
T Consensus 133 lH~~~g--ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 133 LYQEAG--LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHhCC--EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999 99 99999999999999 7899999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=163.38 Aligned_cols=190 Identities=15% Similarity=0.110 Sum_probs=130.8
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
+.+...|++|+||+||.+.. .+..++.+.+.....-...-....+.+|+++|++|.|.. . +.+++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~-~-----vP~ll~~ 70 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLP-R-----TPRLLHW 70 (218)
T ss_pred cccceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCC-C-----CCEEEEE
Confidence 34578999999999997743 334467666654332111111236889999999997532 1 2222221
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCceEE
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI-KSTNILF 175 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl-kp~NIll 175 (379)
+..+++|||++|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||+
T Consensus 71 -----------~~~~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv 125 (218)
T PRK12274 71 -----------DGRHLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLV 125 (218)
T ss_pred -----------cCEEEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEE
Confidence 346999999999998754421 01357789999999999999 999999 7999999
Q ss_pred cCCCCeEEeccccCccCCCCCcc--------------cccCccccccCCCCCCC-CCCC-CcCCeehhHHHHHHHHhCCC
Q 035572 176 DSKWDAKLADFGLAVSESDESSM--------------VQPAGTIGYLDPGYTNP-SKLS-KKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~--------------~~~~gt~~y~aPE~~~~-~~~~-~~~DiwSlG~il~elltg~~ 239 (379)
+.+|.++|+|||+|......... .-...++.|++|+-..- ...+ .+.+.++.|+-+|.++|++.
T Consensus 126 ~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~ 205 (218)
T PRK12274 126 QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV 205 (218)
T ss_pred cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC
Confidence 99999999999999755443310 00124666677753211 1223 45677899999999999999
Q ss_pred CCCCC
Q 035572 240 PIDAA 244 (379)
Q Consensus 240 p~~~~ 244 (379)
|+.+.
T Consensus 206 ~~~~~ 210 (218)
T PRK12274 206 LHWED 210 (218)
T ss_pred Ccccc
Confidence 87544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=188.69 Aligned_cols=196 Identities=24% Similarity=0.306 Sum_probs=149.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|.|.+.||+|+||.||+|... +++.||+|+-+... ...|.--.+++.+|+ +-.. + .+..+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~-------~WEfYI~~q~~~RLk-~~~~-~--~~~~~ 759 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPN-------PWEFYICLQVMERLK-PQML-P--SIMHI 759 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCC-------ceeeeehHHHHHhhc-hhhh-c--chHHH
Confidence 467999999999999999999754 37889999976432 122222233344443 1100 0 02222
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+.. ..-.+..+||+||.+.|+|.+++. ....+++.....+..|++..++.||..+ |||+||||+|.
T Consensus 760 ~~a-------~~~~~~S~lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNf 825 (974)
T KOG1166|consen 760 SSA-------HVFQNASVLVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNF 825 (974)
T ss_pred HHH-------HccCCcceeeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCccee
Confidence 222 223466789999999999999998 3344888888999999999999999999 99999999999
Q ss_pred EEc-------CCCCeEEeccccCccC---CCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 174 LFD-------SKWDAKLADFGLAVSE---SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 174 ll~-------~~~~~kl~Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||. ++.-++|+|||-+..+ .+........+|-.+-.+|+..|.+++..+|.|.|+.+++-||.|+.-
T Consensus 826 ll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 826 LLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 994 2345899999998544 344455566789999999999999999999999999999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-21 Score=178.40 Aligned_cols=175 Identities=25% Similarity=0.437 Sum_probs=133.2
Q ss_pred CCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEecc
Q 035572 107 NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186 (379)
Q Consensus 107 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Df 186 (379)
...+||.|++|+..+|.+++..+.... ..++.....++.|++.|+.| +| .+|+|+||.||++..+..+||+||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e--~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGE--ERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCccc--ccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhh
Confidence 457899999999999999997554322 35667788999999999999 88 999999999999999999999999
Q ss_pred ccCccCCCCC-------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhh
Q 035572 187 GLAVSESDES-------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 187 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 258 (379)
|+........ ..+...||..||+||.+.+..|+.++||||||++|+|++. -..++....
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------------- 467 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------------- 467 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-------------
Confidence 9986665444 3455679999999999999999999999999999999997 333332211
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
.+..+.+..++ |....+ -+.-..|+.++|...|.+||++.+.-
T Consensus 468 ---t~~d~r~g~ip-~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 468 ---TLTDIRDGIIP-PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ---hhhhhhcCCCC-hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence 11122222221 222222 24456889999999999999555443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=149.33 Aligned_cols=143 Identities=20% Similarity=0.302 Sum_probs=101.8
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
+.-.++||+|+||.||. ++. +.. .+||++.... ....+.+.+|+.+++.+.|.+..+|+ |+++++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~-----~~~-k~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~n--Ivr~yg~ 69 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPE-----DAQ-RCIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSG--IPRYYGT 69 (210)
T ss_pred cCCcceecCCCceEEEE--CCC-----CcC-eEEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcc--cceeeEE
Confidence 34467899999999995 332 222 3688876532 12356799999999999765444444 8888877
Q ss_pred ccccCCCccCCCceE-EEEec--cCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHH-HHHHcCCCCeEecCCCCCc
Q 035572 97 SCRNSGSVDGNSNKL-LVMEF--MPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAI-QCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~-lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~LH~~~~~i~H~dlkp~N 172 (379)
+.... ..+.++ +|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|
T Consensus 70 ~et~~----g~g~v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~N 135 (210)
T PRK10345 70 VETDC----GTGYVYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQN 135 (210)
T ss_pred EEeCC----CCeEEEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHH
Confidence 53211 112434 78999 5579999999652 14444 35678888777 9999999 9999999999
Q ss_pred eEEcCC----CCeEEeccc
Q 035572 173 ILFDSK----WDAKLADFG 187 (379)
Q Consensus 173 Ill~~~----~~~kl~Dfg 187 (379)
||++.. +.++|+||+
T Consensus 136 ILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEeccCCCCCcEEEEECC
Confidence 999743 379999954
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-20 Score=180.76 Aligned_cols=212 Identities=26% Similarity=0.380 Sum_probs=150.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+|..++.|..|+||.||.+.++.++ +.+|.|. .+.. -|++. |+.+
T Consensus 82 e~df~~IklisngAygavylvrh~~tr-----qrfa~ki-Nkq~---------------lilRn------------ilt~ 128 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETR-----QRFAMKI-NKQN---------------LILRN------------ILTF 128 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccc-----cchhhcc-cccc---------------hhhhc------------cccc
Confidence 468899999999999999999876533 4577743 2211 01110 1111
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
- +..+.| |+=...++..+. ++. +++.+++|||+.| |+|||+||+|.
T Consensus 129 a-------------~npfvv------gDc~tllk~~g~-----lPv--------dmvla~Eylh~yg--ivhrdlkpdnl 174 (1205)
T KOG0606|consen 129 A-------------GNPFVV------GDCATLLKNIGP-----LPV--------DMVLAVEYLHSYG--IVHRDLKPDNL 174 (1205)
T ss_pred c-------------CCccee------chhhhhcccCCC-----Ccc--------hhhHHhHhhccCC--eecCCCCCCcc
Confidence 1 222333 344444443221 221 3488999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC----------------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC
Q 035572 174 LFDSKWDAKLADFGLAVSESDES----------------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 237 (379)
+|+.-|++|+.|||+++..-... .....+||+.|.|||++....|+..+|.|++|+++|+.+-|
T Consensus 175 lIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVg 254 (1205)
T KOG0606|consen 175 LITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 254 (1205)
T ss_pred eeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhee
Confidence 99999999999999974321110 12334799999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
..||.+... ++.+..++.....+|+.....++++++++.++|+.+|..|.-....
T Consensus 255 cvpffGdtp-------------eelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 255 CVPFFGDTP-------------EELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred eeeccCCCH-------------HHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 999987642 3333344444444566666677899999999999999999644433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=153.19 Aligned_cols=149 Identities=21% Similarity=0.209 Sum_probs=108.9
Q ss_pred CCccccccccCCceeEEEEE-ecCCCCCCCceEEEEEeccCCCchh--------------------hhhcHHHHHHHHHH
Q 035572 16 SFSQSRLIGKGSHGSVYKAI-LEDHQTDGDHKILAIKRASTNGFEV--------------------LQDNSKKLNNEIRV 74 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~-~~~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~~E~~~ 74 (379)
-|++.+.||.|++|.||+|. +.. +++.||+|.++...... .......+.+|+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG-----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC-----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 48899999999999999997 322 56789999987543210 00012346789999
Q ss_pred HHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHH
Q 035572 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQ 154 (379)
Q Consensus 75 l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 154 (379)
+..+.+.....|. + +. ....++||||++|.+|...... ...+...+...++.|++.+|.
T Consensus 104 L~~L~~~~i~~p~--~---~~-----------~~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~ 162 (237)
T smart00090 104 LQRLYEAGVPVPK--P---IA-----------WRRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMR 162 (237)
T ss_pred HHHHHhcCCCCCe--e---eE-----------ecCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHH
Confidence 9999764322221 1 11 1234899999988888765422 122555667889999999999
Q ss_pred HHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 155 CLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 155 ~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
+||+.|. ++||||||+||+++ ++.++|+|||.+...
T Consensus 163 ~LH~~g~-iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 163 KLYKEGE-LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred HHHhcCC-EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999864 99999999999999 889999999987644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-17 Score=143.65 Aligned_cols=149 Identities=24% Similarity=0.223 Sum_probs=108.8
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh------------------hhcHHHHHHH
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL------------------QDNSKKLNNE 71 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~~E 71 (379)
+...--.|.+.+.||.|+||.||+|... +++.|+||+++....... ........+|
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 83 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKE 83 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHH
Confidence 3333345999999999999999999753 456799998764321100 0112246788
Q ss_pred HHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHH
Q 035572 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISR 151 (379)
Q Consensus 72 ~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~ 151 (379)
+.++..+.+.+...+ ...+ ....++||||++|++|.+.... .....++.+++.
T Consensus 84 ~~~l~~l~~~~i~v~-----~~~~-----------~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~ 136 (198)
T cd05144 84 FAALKALYEEGFPVP-----KPID-----------WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILE 136 (198)
T ss_pred HHHHHHHHHcCCCCC-----ceee-----------cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHH
Confidence 999999977642111 1111 1345899999999998765421 234578899999
Q ss_pred HHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCC
Q 035572 152 AIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193 (379)
Q Consensus 152 ~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 193 (379)
++.++|+.| ++||||+|+||++++++.++|+|||++....
T Consensus 137 ~l~~lh~~g--i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 137 EIVKAYKHG--IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHCC--CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999 9999999999999999999999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=161.38 Aligned_cols=210 Identities=26% Similarity=0.383 Sum_probs=150.1
Q ss_pred HhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHH
Q 035572 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 76 ~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
+.+.|.| +.++.+.++. +...++|.+||..|+|.+.+... ...+++.-...++++++.||.|
T Consensus 2 ~~l~h~n-------~~~f~g~~~~-------~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~y 63 (484)
T KOG1023|consen 2 RQLDHDN-------LNKFIGASVD-------GPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAY 63 (484)
T ss_pred cccchhh-------hhhheeeEec-------CCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHH
Confidence 4566666 6666766543 47899999999999999999862 2337777778899999999999
Q ss_pred HHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCC---CcccccCccccccCCCCCCCC-------CCCCcCCee
Q 035572 156 LHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE---SSMVQPAGTIGYLDPGYTNPS-------KLSKKVDVF 225 (379)
Q Consensus 156 LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Diw 225 (379)
||.... -+|+.+++.|.+++..-.+||+|||+....... .......-..-|.|||.+... ..+.+.|||
T Consensus 64 lh~s~i-~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiY 142 (484)
T KOG1023|consen 64 LHNSPI-GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIY 142 (484)
T ss_pred HhcCcc-eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCee
Confidence 998762 399999999999999999999999998555321 111122345678999987653 146679999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcch--HHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 226 SYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFM--EGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 226 SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
|||++++|+++...||............... +. . .......|... ....+++..++.+||..+|.+||+++
T Consensus 143 s~~ii~~ei~~r~~~~~~~~~~~~~~eii~~-~~-----~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 143 SFGIIMYEILFRSGPFDLRNLVEDPDEIILR-VK-----K-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred hHHHHHHHHHhccCccccccccCChHHHHHH-HH-----h-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 9999999999999999775433221111111 01 1 11111112211 14445799999999999999999999
Q ss_pred HHhccccC
Q 035572 304 EILMGCSC 311 (379)
Q Consensus 304 e~l~~~~~ 311 (379)
++-.....
T Consensus 216 ~i~~~~~~ 223 (484)
T KOG1023|consen 216 QIRSKLLT 223 (484)
T ss_pred HHHhhhhh
Confidence 98765333
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=142.35 Aligned_cols=139 Identities=24% Similarity=0.397 Sum_probs=105.7
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh----hhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV----LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
++.||+|++|.||+|.+. +..+++|......... ......++.+|+.++..+.+++...|. ++
T Consensus 1 ~~~l~~G~~~~vy~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~--~~---- 67 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFL-------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPA--VY---- 67 (211)
T ss_pred CcccccCceEEEEEEeeC-------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCe--EE----
Confidence 367999999999999752 3347888755332110 011235688999999999987754443 11
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
+.+....++||||++|++|.+.+... .. ....++.+++.+|.++|+.| ++|+|++|.|||+
T Consensus 68 --------~~~~~~~~lv~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~ 128 (211)
T PRK14879 68 --------FVDPENFIIVMEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMIL 128 (211)
T ss_pred --------EEeCCCCEEEEEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEE
Confidence 11235678999999999999998642 12 67789999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCcc
Q 035572 176 DSKWDAKLADFGLAVS 191 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~ 191 (379)
+ ++.++|+|||.+..
T Consensus 129 ~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 129 S-GGKIYLIDFGLAEF 143 (211)
T ss_pred E-CCCEEEEECCcccC
Confidence 9 78899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.7e-17 Score=139.01 Aligned_cols=134 Identities=26% Similarity=0.390 Sum_probs=101.4
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh----hhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV----LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
.||+|+||.||+|.. .+..+++|......... ......++.+|+++++.+++++...|. +..
T Consensus 1 ~ig~G~~~~vy~~~~-------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~--~~~----- 66 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPV--VYD----- 66 (199)
T ss_pred CCCCCceEEEEEeec-------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCE--EEE-----
Confidence 489999999999974 23458888854332110 112246788999999999987643332 111
Q ss_pred cccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~ 177 (379)
...+..++||||++|++|.+.+.... . .++.+++.+|.+||+.| ++|+|++|.||+++
T Consensus 67 -------~~~~~~~lv~e~~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~- 124 (199)
T TIGR03724 67 -------VDPDNKTIVMEYIEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR- 124 (199)
T ss_pred -------EECCCCEEEEEEECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-
Confidence 12345689999999999999875421 0 68899999999999999 99999999999999
Q ss_pred CCCeEEeccccCcc
Q 035572 178 KWDAKLADFGLAVS 191 (379)
Q Consensus 178 ~~~~kl~Dfg~a~~ 191 (379)
++.++++|||++..
T Consensus 125 ~~~~~liDfg~a~~ 138 (199)
T TIGR03724 125 DDKLYLIDFGLGKY 138 (199)
T ss_pred CCcEEEEECCCCcC
Confidence 78999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=162.55 Aligned_cols=144 Identities=22% Similarity=0.344 Sum_probs=104.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch----hhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE----VLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.....|...+.||+|+||.||++.+.... +++|+....... ......+++.+|+++++.+++++...|.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 33455677899999999999999765421 222221111000 0112346789999999999987733221
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
.+. .+....++||||++|++|.+++. ....++.+++.+|.+||+.| ++|||
T Consensus 403 -------~~~-------~~~~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g--iiHrD 453 (535)
T PRK09605 403 -------IYD-------VDPEEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG--IVHGD 453 (535)
T ss_pred -------EEE-------EeCCCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC--CccCC
Confidence 111 12345689999999999999885 23578999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
|||+|||+ +++.++|+|||++...
T Consensus 454 lkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 454 LTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999 5778999999998553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-18 Score=168.34 Aligned_cols=263 Identities=24% Similarity=0.289 Sum_probs=194.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
...|.+.+.||.|+|+.|-.+..... ....+++|.+.....+ ......+..|..+-..+. |.| ++.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~----~~~~~a~~~~s~~~~~--~~~~~~i~~e~~~~~~~s~h~n-------~~~ 85 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRD----PESSSATKPISIPPKS--EDSSEHIDTETDIQKKLSKHSN-------TVH 85 (601)
T ss_pred cccccccccccccccchhhhhhhcCC----CcceeeccCCCCCCCc--cchhhhcCcccccccccccccc-------ccc
Confidence 45789999999999999988864332 3455777777654321 344556666777777776 555 555
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH-cCCCCeEecCCCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH-ENDPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~~~i~H~dlkp~ 171 (379)
+.+. ..+.+..+++++|..|+++.+.+... .....+...+..++.|+..++.|+| ..+ +.|+|+||+
T Consensus 86 ~~~~-------~~~~~~~~~~~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~ 153 (601)
T KOG0590|consen 86 MIEP-------SSSPRSYLLSLSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPS 153 (601)
T ss_pred cCCc-------cCCCcccccccCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCc
Confidence 4544 46678889999999999999988311 1113556677889999999999999 889 999999999
Q ss_pred ceEEcCCC-CeEEeccccCccCCC-CC---cccccCc-cccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 172 NILFDSKW-DAKLADFGLAVSESD-ES---SMVQPAG-TIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 172 NIll~~~~-~~kl~Dfg~a~~~~~-~~---~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
|.+++..+ .++++|||+|..... .+ ......| ++.|+|||...+. ...+..|+||.|+++..+++|..|+...
T Consensus 154 n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 154 NSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 99999999 999999999966544 22 2344568 9999999988874 4577899999999999999999999776
Q ss_pred CCchhHHHhhhhhhhHHhhhhhcccc-CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSR-VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
..... .+....... ......+........+++.+++..+|.+|.+.+++-.+.....
T Consensus 234 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDG------------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccc------------cceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 53321 111111111 1012234455577889999999999999999999988766655
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.3e-16 Score=132.01 Aligned_cols=143 Identities=24% Similarity=0.259 Sum_probs=95.7
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcH--------------------HHHHHHHHHHHhh
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--------------------KKLNNEIRVLSSL 78 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~E~~~l~~l 78 (379)
+.+.||+|+||.||+|.+. ++..||||+++........... .....|...+..+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 74 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL 74 (187)
T ss_pred CCcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence 3578999999999999764 3567999988754321111000 0114566666666
Q ss_pred hhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHH-HHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 79 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
.+.....|. .++ ....++||||++++++.. .+.... .. ..+..++.+++.++.++|
T Consensus 75 ~~~~~~~~~-----~~~-----------~~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh 131 (187)
T cd05119 75 YEAGVPVPK-----PID-----------LNRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLY 131 (187)
T ss_pred HHcCCCCCc-----eEe-----------cCCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHh
Confidence 544311111 011 124589999998854321 121110 11 456789999999999999
Q ss_pred c-CCCCeEecCCCCCceEEcCCCCeEEeccccCccCC
Q 035572 158 E-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193 (379)
Q Consensus 158 ~-~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 193 (379)
+ .+ ++|+||||+||+++ ++.++|+|||.+....
T Consensus 132 ~~~~--ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 132 REAG--LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hccC--cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 9 99 99999999999999 8899999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5e-16 Score=135.94 Aligned_cols=214 Identities=21% Similarity=0.281 Sum_probs=151.9
Q ss_pred HHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHH
Q 035572 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRA 152 (379)
Q Consensus 73 ~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~ 152 (379)
..|-++-|.| +|++|.++-..- +++.....++.|||+.|+|.++|++..... ..+......+|+.||+.|
T Consensus 119 dnllqlvHsn-------lvkfH~yw~d~K--~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 119 DNLLQLVHSN-------LVKFHKYWTDKK--YEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHH-------HHHHHHhhcccc--cccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhh
Confidence 3455666777 899998875422 345677889999999999999999876533 347777888999999999
Q ss_pred HHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCcc-CC----CCCcccccCccccccCCCCCCCCCCCCcCCeehh
Q 035572 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-ES----DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSY 227 (379)
Q Consensus 153 l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~-~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 227 (379)
|.|||+..++|+|+++..+.|++..+|-+|++--.-... .. .........+.++|.+||.-.....+.++|||+|
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 999999999999999999999999999888763221100 00 0001122347789999998887788899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 228 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
|+...+|.-+..--...... ...+......+-. .. .--++++..|++..|..||++.+++
T Consensus 269 gmcAlemailEiq~tnseS~---------~~~ee~ia~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 269 GMCALEMAILEIQSTNSESK---------VEVEENIANVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred hHHHHHHHHheeccCCCcce---------eehhhhhhhheeeccC----------ccccCcCcccccCCCCCCcchhhhh
Confidence 99999998876542222110 0111122221111 11 1123667799999999999999999
Q ss_pred ccccCcccc
Q 035572 307 MGCSCFFVD 315 (379)
Q Consensus 307 ~~~~~~~~~ 315 (379)
.|.......
T Consensus 330 fHpllfeVh 338 (458)
T KOG1266|consen 330 FHPLLFEVH 338 (458)
T ss_pred cCceeeecc
Confidence 997665443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.8e-15 Score=131.24 Aligned_cols=145 Identities=19% Similarity=0.222 Sum_probs=101.4
Q ss_pred cccc-cCCceeEEEEEecCCCCCCCceEEEEEeccCCCc---------hhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 21 RLIG-KGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF---------EVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 21 ~~iG-~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
..|| .||.|+||.+... +..+++|.+..... ........++.+|+.++..|++.++..|...-
T Consensus 37 ~~lg~~~g~gtv~~v~~~-------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeC-------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 4677 8888999988653 34588888753221 00112346788999999999988754443211
Q ss_pred eeccccccccCCCccCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
..... . ......++|||+++| .+|.+++... .++. ..+.+++.+|.+||+.| |+|||||
T Consensus 110 ~~~~~-----~---~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH~~G--I~HrDlk 169 (239)
T PRK01723 110 ARVVR-----H---GLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFHDAG--VYHADLN 169 (239)
T ss_pred eeeee-----c---CcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHHHCC--CCCCCCC
Confidence 11000 0 001123699999997 6999988541 1333 34678999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccC
Q 035572 170 STNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
|.|||++.++.++|+|||.+...
T Consensus 170 p~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 170 AHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred chhEEEcCCCCEEEEECCCcccC
Confidence 99999998889999999987553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-14 Score=118.68 Aligned_cols=135 Identities=20% Similarity=0.242 Sum_probs=103.1
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccc
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSC 98 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~ 98 (379)
+.+.||.|.++.||++.... +.+++|....... ...+.+|+.+++.+++.+.. +.+++..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~-----~p~~~~~-- 61 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK------GADREREVAILQLLARKGLP-----VPKVLAS-- 61 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCC-----CCeEEEE--
Confidence 46789999999999998643 4589999864321 46789999999999875211 2222222
Q ss_pred ccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC---CCCeEecCCCCCceEE
Q 035572 99 RNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN---DPMIIHRDIKSTNILF 175 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~~~i~H~dlkp~NIll 175 (379)
....+..+++|||++|+++..+ +......++.+++.+|+++|.. + ++|+|++|.||++
T Consensus 62 -----~~~~~~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~--i~H~Dl~~~Nil~ 122 (155)
T cd05120 62 -----GESDGWSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLV--LCHGDLHPGNILV 122 (155)
T ss_pred -----cCCCCccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceE--EEecCCCcceEEE
Confidence 2334678999999988777543 2334567888999999999984 6 9999999999999
Q ss_pred cCCCCeEEeccccCccC
Q 035572 176 DSKWDAKLADFGLAVSE 192 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~ 192 (379)
++++.++++|||.+...
T Consensus 123 ~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 123 DDGKILGIIDWEYAGYG 139 (155)
T ss_pred ECCcEEEEEecccccCC
Confidence 99889999999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.3e-14 Score=133.16 Aligned_cols=155 Identities=24% Similarity=0.260 Sum_probs=102.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhh------------------------------
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD------------------------------ 63 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~------------------------------ 63 (379)
+..|. .+.||+|++|.||+|+.+ +++.||||+.+.........
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e 189 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKE 189 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHH
Confidence 34444 368999999999999875 45679999987542110000
Q ss_pred cH------HHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCC
Q 035572 64 NS------KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137 (379)
Q Consensus 64 ~~------~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 137 (379)
.. -.+.+|+..+.+++......+...+-..+. +.....+|||||++|++|.+....... ..
T Consensus 190 ~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~---------~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~ 256 (437)
T TIGR01982 190 FEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYW---------DRTSERVLTMEWIDGIPLSDIAALDEA----GL 256 (437)
T ss_pred HHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh---------hhcCCceEEEEeECCcccccHHHHHhc----CC
Confidence 00 025556666666654332233322222221 113456999999999999887653211 12
Q ss_pred ChHhHHHHHHHHHH-HHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCC
Q 035572 138 GWPNRVKIAMQISR-AIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193 (379)
Q Consensus 138 ~~~~~~~~~~~i~~-~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 193 (379)
....++..++. .+..+|..| ++|+|++|.||+++.++.++++|||++....
T Consensus 257 ---~~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 257 ---DRKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CHHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 23456666665 578889999 9999999999999999999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.9e-15 Score=138.59 Aligned_cols=256 Identities=23% Similarity=0.240 Sum_probs=181.2
Q ss_pred cCCcccccccc--CCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 15 ESFSQSRLIGK--GSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 15 ~~y~~~~~iG~--G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..+.+..-+|. |.+|.||.+.... ..++..+|+|+-...... +....+-.+|..... ++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~--p~~~~~k~~~~~s~~-------------~i~ 175 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSP--PLDSKRKLREFLSHH-------------KID 175 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCC--ccccccccchhhccc-------------ccC
Confidence 45677888999 9999999997633 236677899884432211 111122223333332 333
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHH----HHHHHHcCCCCeEecCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISR----AIQCLHENDPMIIHRDI 168 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~LH~~~~~i~H~dl 168 (379)
.+...++.+..+++.+..|+-+|++ +.+|.++..... ..++....+..+.+... ||.++|+.+ ++|-|+
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~ 248 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDL 248 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCCCc--cccccc
Confidence 3444455556678899999999999 788888887533 33566677788888888 999999999 999999
Q ss_pred CCCceEEcCC-CCeEEeccccCccCCCCCcc------cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 169 KSTNILFDSK-WDAKLADFGLAVSESDESSM------VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 169 kp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
||.||++..+ ...+++|||+.......... ....|...|++||..+ ..++...|||++|.++.+..++..+.
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999998 88999999998666554421 1225788899999877 56788999999999999999887766
Q ss_pred CCCC--CchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 242 DAAR--DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.... ...++ +..+....+...-+.++...+..|++.+|..|++.+.+..+.....
T Consensus 328 ~~g~~~~W~~~-----------------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 328 SVGKNSSWSQL-----------------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCCCCCCcccc-----------------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 5442 11111 1111112233334456666899999999999999999998766654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.7e-13 Score=131.29 Aligned_cols=159 Identities=20% Similarity=0.171 Sum_probs=97.4
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch------------------------------h
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE------------------------------V 60 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~------------------------------~ 60 (379)
...+..|+. +.||+|++|.||+|+.++ +++.||||+.++.... .
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 344567887 899999999999999865 3677999999754211 0
Q ss_pred hhhcHHH------HHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHH--HhhhcC
Q 035572 61 LQDNSKK------LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAA 132 (379)
Q Consensus 61 ~~~~~~~------~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~~ 132 (379)
..+..+. +.+|+..+.+++......+...+-..+ .+-....+|||||+.|+++.+.- ...+.
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~---------~d~st~~VLvmE~i~G~~l~d~~~l~~~g~- 259 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVY---------WDYCSETVMVMERMYGIPVSDVAALRAAGT- 259 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceee---------cccCCCceEEEeeecCccHHhHHHHHhcCC-
Confidence 0011222 445555555555332111111111111 11235678999999999998743 22110
Q ss_pred CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC----CeEEeccccCccCCC
Q 035572 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW----DAKLADFGLAVSESD 194 (379)
Q Consensus 133 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 194 (379)
....+....+..++.|+ ...| ++|+|++|.||+++.+| .++++|||++...+.
T Consensus 260 d~~~la~~~v~~~~~Qi-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 260 DMKLLAERGVEVFFTQV-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CHHHHHHHHHHHHHHHH-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 00112223333344444 3588 99999999999999887 999999999865543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-13 Score=133.85 Aligned_cols=251 Identities=20% Similarity=0.209 Sum_probs=175.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..+.+.+.+-+-+|+++.++.+.-... +...+.|.......-. ....+. ..+..|.. |..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~s-----gh~~~~~v~~~ap~i~-~~~~~s---------~r~~s~~~-----i~p 861 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGS-----GHTRPSKVHGLAPKIR-TNDYES---------IRSKSNIL-----ITP 861 (1205)
T ss_pred CCccceecccccCCCCcccccCCcccc-----ccccchhhhccchhhc-cccccc---------cCCccCcc-----ccC
Confidence 456788888899999999998854432 2334444332111000 000011 11111111 111
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
.++..+.....+......+||++|+.+++|...++..+. .+....+.+...+.+++++||+.. +.|+|++|.|
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~ 934 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDS 934 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccccch--hhcccccccc
Confidence 233333333335567889999999999999999986542 444555678888999999999998 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCC------C--------------------------CcccccCccccccCCCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESD------E--------------------------SSMVQPAGTIGYLDPGYTNPSKLSK 220 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~------~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (379)
++...+|..+++|||....... . .......+|+.|.+||...+.....
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 9999999999999984311000 0 0012235899999999999999999
Q ss_pred cCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC
Q 035572 221 KVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300 (379)
Q Consensus 221 ~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 300 (379)
.+|.|++|+++++.++|.+||.... .+..+..+......+|.-....+.++.+++.+.+..+|.+|.
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~t-------------pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAET-------------PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcc-------------hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhcc
Confidence 9999999999999999999998764 344455666666666666666678899999999999999999
Q ss_pred ChH
Q 035572 301 GIG 303 (379)
Q Consensus 301 s~~ 303 (379)
.+.
T Consensus 1082 ~a~ 1084 (1205)
T KOG0606|consen 1082 GAK 1084 (1205)
T ss_pred Ccc
Confidence 887
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.9e-13 Score=128.05 Aligned_cols=254 Identities=20% Similarity=0.177 Sum_probs=169.6
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.....|..+..||.|.|+.||.+..+ ...+..|++|.+...... ......-..|+.+...+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r----~~~~~~Y~~ke~~~~l~~--~~~di~sl~ev~l~~~l~------------ 323 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKR----PEGDCIYAAKELLNGLAT--FASDIFSLGEVILEAILG------------ 323 (524)
T ss_pred eecCCcceeEEccCCccccceeeeec----CCCCceEeChhhhccccc--hHhhhcchhhhhHhhHhh------------
Confidence 34567889999999999999998632 235677999987654322 111122234444444443
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.+....+....+....+.|+=-|||+++++...+.- ...+.+...+.+..|++.++.++|+.. ++|+|+||+
T Consensus 324 -~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~ps 395 (524)
T KOG0601|consen 324 -SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPS 395 (524)
T ss_pred -cccccCCCCCCccccccccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh--hhccccccc
Confidence 122222223345566778899999999998777632 223677778899999999999999999 999999999
Q ss_pred ceEEcCC-CCeEEeccccCccCCCCCcccccCccccc-cCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 172 NILFDSK-WDAKLADFGLAVSESDESSMVQPAGTIGY-LDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 172 NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||++..+ +..+++|||.......... .....+..| .+|.......+..++|++|||..+.+..++..--......
T Consensus 396 ni~i~~~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-- 472 (524)
T KOG0601|consen 396 NILISNDGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-- 472 (524)
T ss_pred ceeeccchhhhhccccccccccceecc-cccccccccccchhhccccccccccccccccccccccccCcccCcccccc--
Confidence 9999876 7789999998865322111 111233333 3555666677888999999999999999886543322211
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+....... .......+..+...++..++..||.+.++..|...
T Consensus 473 --------------~~i~~~~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 --------------LTIRSGDTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --------------eeeecccccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111111111 11223667888889999999999999998877543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-12 Score=106.17 Aligned_cols=148 Identities=20% Similarity=0.226 Sum_probs=101.0
Q ss_pred ccccccCCceeEEEEEecCCC-CCCCceEEEEEeccCCCch------------------hhhhcHHHHH----HHHHHHH
Q 035572 20 SRLIGKGSHGSVYKAILEDHQ-TDGDHKILAIKRASTNGFE------------------VLQDNSKKLN----NEIRVLS 76 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~-~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~----~E~~~l~ 76 (379)
...||.|-=+.||.|...+.. ....+..+|||..+....+ ......+.+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457999999999999754310 0113467899987642111 0011123344 8999999
Q ss_pred hhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHH-HHHhhhcCCCCCCChHhHHHHHHHHHHHHHH
Q 035572 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAAATTPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 77 ~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
++...+...|.. +.+ ...+|||||+.+..+.. .+.+ ..++..+...+..+++.+|..
T Consensus 82 rl~~~Gv~vP~p--i~~--------------~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~ 139 (197)
T cd05146 82 RMQKAGIPCPEV--VVL--------------KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQ 139 (197)
T ss_pred HHHHcCCCCCeE--EEe--------------cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHH
Confidence 999877655552 211 34589999996644322 2221 124445566788999999999
Q ss_pred H-HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 156 L-HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 156 L-H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
+ |..| |+|+||++.|||++ ++.+.|+|||.+...
T Consensus 140 l~H~~g--lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 140 LYKECN--LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHhCC--eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9 8999 99999999999997 468999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.3e-12 Score=105.99 Aligned_cols=130 Identities=17% Similarity=0.179 Sum_probs=92.6
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
.+.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.+. .|. ++. .
T Consensus 3 ~~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~-~P~--~~~---~--- 61 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGI-GPK--LYY---F--- 61 (170)
T ss_pred eeecCCcccCceEEEEEC-------CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCC-CCc--eEE---E---
Confidence 467889999999998753 45699998764321 12346789999999976542 222 221 1
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCC---CeEecCCCCCceEEc
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDP---MIIHRDIKSTNILFD 176 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---~i~H~dlkp~NIll~ 176 (379)
.....++||||++|.++.+.- .. ...++.+++.+|+.||+.+. .++|+|++|.||+++
T Consensus 62 ------~~~~~~lv~e~i~G~~l~~~~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~ 122 (170)
T cd05151 62 ------DPETGVLITEFIEGSELLTED----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD 122 (170)
T ss_pred ------eCCCCeEEEEecCCCcccccc----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence 112358999999998875430 11 12466799999999999871 149999999999999
Q ss_pred CCCCeEEeccccCc
Q 035572 177 SKWDAKLADFGLAV 190 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~ 190 (379)
++.++++|||.+.
T Consensus 123 -~~~~~liDf~~a~ 135 (170)
T cd05151 123 -DGRLWLIDWEYAG 135 (170)
T ss_pred -CCeEEEEeccccc
Confidence 6689999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.4e-11 Score=115.49 Aligned_cols=162 Identities=17% Similarity=0.251 Sum_probs=119.7
Q ss_pred CceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHH
Q 035572 44 DHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123 (379)
Q Consensus 44 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~ 123 (379)
++.++.|...+.... .......+-++.|+.++||+ |++++.. ++.++..|||+|.+ ..|.
T Consensus 36 ~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~-------Il~yL~t-------~e~~~~~ylvTErV--~Pl~ 95 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPN-------ILSYLDT-------TEEEGTLYLVTERV--RPLE 95 (690)
T ss_pred cCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCch-------hhhhhhh-------hcccCceEEEeecc--ccHH
Confidence 445566665543321 23456778899999999998 8887766 46678999999998 4888
Q ss_pred HHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc-cccc
Q 035572 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS-MVQP 201 (379)
Q Consensus 124 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 201 (379)
.++++ ++.......+.||+.||.|||. .+ ++|++|.-+.|+++..|..||++|.++........ ....
T Consensus 96 ~~lk~--------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~ 165 (690)
T KOG1243|consen 96 TVLKE--------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL 165 (690)
T ss_pred HHHHH--------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc
Confidence 89987 3345566788999999999985 66 99999999999999999999999988744332221 1111
Q ss_pred CccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC
Q 035572 202 AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 202 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 237 (379)
..--.|..|+...... ...|.|.|||++++++.|
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 2334466676544333 456999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-11 Score=97.29 Aligned_cols=136 Identities=24% Similarity=0.370 Sum_probs=97.6
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch---hh-hhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE---VL-QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~---~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
..+++|+=+.+|.+.+.+ ..+.+|.-..+... .+ .-...+-.+|+.++..++......|. +.
T Consensus 2 ~~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~--v~----- 67 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPI--VY----- 67 (204)
T ss_pred chhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCe--EE-----
Confidence 467899999999986532 12444432221111 11 12246678999999999876644443 11
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
..+.+...|+|||++|..|.+.+... ...++..+-.-+.-||..| |+|+||.++||++.
T Consensus 68 -------dvD~~~~~I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~ 126 (204)
T COG3642 68 -------DVDPDNGLIVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILS 126 (204)
T ss_pred -------EEcCCCCEEEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEe
Confidence 13456778999999999999899753 1357778888899999999 99999999999998
Q ss_pred CCCCeEEeccccCccC
Q 035572 177 SKWDAKLADFGLAVSE 192 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~ 192 (379)
+++ +.++|||++...
T Consensus 127 ~~~-i~~IDfGLg~~s 141 (204)
T COG3642 127 GGR-IYFIDFGLGEFS 141 (204)
T ss_pred CCc-EEEEECCccccc
Confidence 664 999999998643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.3e-11 Score=95.46 Aligned_cols=147 Identities=24% Similarity=0.335 Sum_probs=104.4
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEe-----ccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKR-----ASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~-----~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...+|-+|+-+.|+++.+. ++...||. .+.+..+ .+-..++..+|++.|.+++--.+..|..+
T Consensus 11 ~l~likQGAEArv~~~~~~-------Ge~~iIK~Rf~K~YRHP~LD-~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~---- 78 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-------GEAAIIKERFSKRYRHPALD-QKLTRKRTKQEARLLAKCRALGIPAPRLI---- 78 (229)
T ss_pred cceeeeccceeeEeeeccC-------CceeEEeecccccccchHHH-HHHHHHHHHHHHHHHHHHHHhCCCCceEE----
Confidence 5678899999999999764 33344444 3333322 13446788999999999987665555422
Q ss_pred cccccccCCCccCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+.+...-.|+|||++| .++.+++....... ........++..+-+.+.-||.++ |+|+||..+|
T Consensus 79 ----------~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSN 143 (229)
T KOG3087|consen 79 ----------FIDTYGGQIYMEFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHDND--IIHGDLTTSN 143 (229)
T ss_pred ----------EEecCCCeEEEEeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhhCC--eecccccccc
Confidence 2234456899999965 48888887643211 222233688999999999999999 9999999999
Q ss_pred eEEcCCCC---eEEeccccCccC
Q 035572 173 ILFDSKWD---AKLADFGLAVSE 192 (379)
Q Consensus 173 Ill~~~~~---~kl~Dfg~a~~~ 192 (379)
|++..++. +.++|||++...
T Consensus 144 ill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 144 ILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eEEecCCCcCceEEEeecchhcc
Confidence 99975543 489999997443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.7e-10 Score=93.90 Aligned_cols=132 Identities=28% Similarity=0.322 Sum_probs=82.6
Q ss_pred eEEEEEecCCCCCCCceEEEEEeccCCCch----------------------hhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 30 SVYKAILEDHQTDGDHKILAIKRASTNGFE----------------------VLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 30 ~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.||.|... .+..+|+|..+....+ ..........+|.+.|.++...+...|.
T Consensus 1 ~Vy~~~~~------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~ 74 (188)
T PF01163_consen 1 DVYHAIDP------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK 74 (188)
T ss_dssp EEEEEEEC------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred CEEEEECC------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence 48888754 4457999987542110 1112235678999999999877655554
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccC--CCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHH-HHcCCCCeE
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMP--NGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQC-LHENDPMII 164 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-LH~~~~~i~ 164 (379)
++.+. ..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+
T Consensus 75 --p~~~~--------------~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g--iv 129 (188)
T PF01163_consen 75 --PYDYN--------------RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG--IV 129 (188)
T ss_dssp --EEEEE--------------TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT--EE
T ss_pred --EEEEe--------------CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC--ce
Confidence 22222 3479999998 65554444321 1134456788888885555 57999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSES 193 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 193 (379)
|+||++.|||++++ .+.++|||.+....
T Consensus 130 HGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 130 HGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ecCCChhhEEeecc-eEEEEecCcceecC
Confidence 99999999999987 89999999875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-10 Score=102.06 Aligned_cols=193 Identities=13% Similarity=0.176 Sum_probs=127.3
Q ss_pred eEEEEeccCCCC-HHHHHHh-hhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccc
Q 035572 110 KLLVMEFMPNGS-LYDLLHN-AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187 (379)
Q Consensus 110 ~~lv~e~~~~~s-L~~~l~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg 187 (379)
.-+.|+.+.|.. +..+++. .....-+.+.|.-....++.++.+.+.||.+| .+-+|++++|+|+++++.+.|.|=.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence 668888887742 3333321 11123455889999999999999999999999 9999999999999999999999854
Q ss_pred cCccCCCCCcccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhC-CCCCCCCCC----c---hhHHHhh
Q 035572 188 LAVSESDESSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISC-RKPIDAARD----P---ASIIDWA 254 (379)
Q Consensus 188 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~----~---~~~~~~~ 254 (379)
.-............+|...|.+||... +-.-+..+|.|.||+++++++.| +.||.+... + +..+..-
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 322223333345567999999999654 34557789999999999999885 999976431 1 1111100
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCC--CCCCCChHHHh
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSE--EENRPGIGEIL 306 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d--p~~Rps~~e~l 306 (379)
.-............ .+....+.-.++++..+..+|+..- +.-|||++.=+
T Consensus 243 ~f~ya~~~~~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 243 RFAYASDQRRGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred eeeechhccCCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 00000000000111 1111234556788999999998753 67899987443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.3e-09 Score=92.82 Aligned_cols=151 Identities=18% Similarity=0.161 Sum_probs=101.1
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh-hh------hcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-LQ------DNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
+.+-......|++... .++.|.||+........ .. .-...+.+|...+..|...++..|. .|-+
T Consensus 28 e~v~~~~~rrvvr~~~-------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~--pVa~ 98 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMT--GVAF 98 (268)
T ss_pred cEEecCCCceEEEEEE-------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCC--eeEE
Confidence 3344334444666543 44679999775433110 00 1112478999999999888876665 2222
Q ss_pred cccccccCCCccCCCceEEEEeccCCC-CHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
. .. .........+||||++++. +|.+++.... ....+......++.+++..+..||..| |+|+|+++.|
T Consensus 99 ~---e~--~~~~~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~N 168 (268)
T PRK15123 99 G---ER--GSNPATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICH 168 (268)
T ss_pred E---Ee--cCCCccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhh
Confidence 1 10 0001124568999999875 8999986422 122455677789999999999999999 9999999999
Q ss_pred eEEcC-------CCCeEEeccccCc
Q 035572 173 ILFDS-------KWDAKLADFGLAV 190 (379)
Q Consensus 173 Ill~~-------~~~~kl~Dfg~a~ 190 (379)
||++. +..+.++||+.+.
T Consensus 169 iLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 169 FLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EEEeccccCCCCCceEEEEECCccc
Confidence 99975 4678999999774
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=94.04 Aligned_cols=148 Identities=23% Similarity=0.335 Sum_probs=99.3
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
.+.|+.|..+.||++...+ ++.+++|....... ......+.+|+++++.+.+.+...|. ++.+...
T Consensus 3 ~~~l~~G~~n~~~~v~~~~------g~~~ilK~~~~~~~---~~~~~~~~~E~~~~~~l~~~~~~vp~--~~~~~~~--- 68 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG------GRRLVLRRPPPGAL---LPSAHDVAREYRVLRALAGTGVPVPK--VLALCED--- 68 (223)
T ss_pred ceecCCCccceEEEEEecC------CcceEEEeCCCccc---CcccccHHHHHHHHHHhhCCCCCCCC--EEEECCC---
Confidence 3678999999999997532 35699998764321 12356789999999999875432232 2221110
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC-------------------
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND------------------- 160 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------------- 160 (379)
-...+..++||||++|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 69 ----~~~~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 138 (223)
T cd05154 69 ----PSVLGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQ 138 (223)
T ss_pred ----CCccCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHH
Confidence 0112356899999999887665421 12455556666777777777777421
Q ss_pred -----------------------------------CCeEecCCCCCceEEcC--CCCeEEeccccCcc
Q 035572 161 -----------------------------------PMIIHRDIKSTNILFDS--KWDAKLADFGLAVS 191 (379)
Q Consensus 161 -----------------------------------~~i~H~dlkp~NIll~~--~~~~kl~Dfg~a~~ 191 (379)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 139 VARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 12799999999999998 56689999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.2e-11 Score=115.27 Aligned_cols=151 Identities=19% Similarity=0.316 Sum_probs=104.7
Q ss_pred HHHHHHHHHHcC-CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc----------ccccCccccccCCCCCCCC
Q 035572 148 QISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS----------MVQPAGTIGYLDPGYTNPS 216 (379)
Q Consensus 148 ~i~~~l~~LH~~-~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~ 216 (379)
+++.|+.|+|.. + +||++|.|++|.++.+|.+||+.|+.+........ .....-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 455899999975 6 99999999999999999999999998754333111 0111246689999999988
Q ss_pred CCCCcCCeehhHHHHHHHHhCCCC-CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCC
Q 035572 217 KLSKKVDVFSYGVVLLEIISCRKP-IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSE 295 (379)
Q Consensus 217 ~~~~~~DiwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (379)
..+.++|+||+|+++|.+..|..+ +...+... ..... ....+. ........++.++++-+.+++..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~---------~~~~~~--~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFS---------RNLLNA--GAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhh---------hccccc--ccccccccCcHHHHHHHHHHhcCC
Confidence 889999999999999999955444 43332111 10000 000000 001112455688999999999999
Q ss_pred CCCCCChHHHhccccCc
Q 035572 296 EENRPGIGEILMGCSCF 312 (379)
Q Consensus 296 p~~Rps~~e~l~~~~~~ 312 (379)
+.-||++.++..-....
T Consensus 253 ~~~rp~~~~l~~~~ff~ 269 (700)
T KOG2137|consen 253 SAVRPTLDLLLSIPFFS 269 (700)
T ss_pred cccCcchhhhhcccccC
Confidence 99999888887654443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-08 Score=85.60 Aligned_cols=147 Identities=19% Similarity=0.189 Sum_probs=105.1
Q ss_pred cccCCceeEEEEEecCCCCCCCceEEEEEeccCCC-chhh-hhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNG-FEVL-QDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 23 iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~-~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
-|+||.+.|+..... ++.+-+|+-...- .+.. +.....|.+|...+..|...+...|. ++ +.+ ..+
T Consensus 26 ~~rgG~SgV~r~~~~-------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~--pv-f~~-~~k- 93 (216)
T PRK09902 26 YRRNGMSGVQCVERN-------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPK--IV-FGE-AVK- 93 (216)
T ss_pred cCCCCcceEEEEEeC-------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCc--cc-eee-eec-
Confidence 467999999997643 2358888765211 1111 34567899999999999988765554 22 111 111
Q ss_pred CCCccCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
....-.-+||+|-+.| .||.+++.+.. ..+.+......++.+++..+.-||..| +.|+|+.+.||+++.+|
T Consensus 94 ---~~~~~rA~LVTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g 165 (216)
T PRK09902 94 ---IEGEWRALLVTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEG 165 (216)
T ss_pred ---cCCceEEEEEEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCC
Confidence 1113456899998854 68999886532 223566677899999999999999999 99999999999998666
Q ss_pred C--eEEeccccC
Q 035572 180 D--AKLADFGLA 189 (379)
Q Consensus 180 ~--~kl~Dfg~a 189 (379)
. ++++||.-+
T Consensus 166 ~~~v~lIDlEk~ 177 (216)
T PRK09902 166 KAEAGFLDLEKS 177 (216)
T ss_pred CeeEEEEEhhcc
Confidence 7 999999755
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.5e-09 Score=90.65 Aligned_cols=140 Identities=24% Similarity=0.232 Sum_probs=98.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCC------------------CchhhhhcHHHHHHHHHHHHh
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTN------------------GFEVLQDNSKKLNNEIRVLSS 77 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~~~~~~E~~~l~~ 77 (379)
-+.+++.||-|-=|.||.|.+. .+..++||.=+.. ..+..........+|.++|.+
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~ 165 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR 165 (304)
T ss_pred HHhhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence 3567789999999999999865 4566888864321 111112234557899999999
Q ss_pred hhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 78 l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
|......-|.+ -+-+...+|||+++|-.|...- +.....-.++..|+.-+..+-
T Consensus 166 L~~~G~~VP~P----------------~~~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~ 219 (304)
T COG0478 166 LYPEGVKVPKP----------------IAWNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY 219 (304)
T ss_pred hhhcCCCCCCc----------------cccccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH
Confidence 97653222221 1235678999999886654432 123334566777777777777
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
..| ++|+|+++-||+++++|.+.++||--+
T Consensus 220 ~~G--iVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 220 RRG--IVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred HcC--ccccCCchheEEEecCCCEEEEeCccc
Confidence 889 999999999999999999999999544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.6e-08 Score=84.35 Aligned_cols=148 Identities=24% Similarity=0.259 Sum_probs=101.6
Q ss_pred ceeEEEEEecCCCCCCCceEEEEEeccCCCch---hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCc
Q 035572 28 HGSVYKAILEDHQTDGDHKILAIKRASTNGFE---VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSV 104 (379)
Q Consensus 28 ~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~ 104 (379)
-+.++.+.... ....++.+-+|........ .......+..+|...+..|...++..|.+ +-+.. ...+
T Consensus 17 R~~~~~~~~~~--~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~p--va~~~---~r~~-- 87 (206)
T PF06293_consen 17 RRGGWFGVQRV--VDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEP--VAYGE---RRKG-- 87 (206)
T ss_pred CceEEEEEEcc--ccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcE--EEEEE---EcCC--
Confidence 44555555443 2335667777764322111 01134567899999999999887666653 22211 1011
Q ss_pred cCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC---C
Q 035572 105 DGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW---D 180 (379)
Q Consensus 105 ~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~---~ 180 (379)
.....++|+|++++ .+|.+++..... .+......++.+++..+.-||..| |+|+|+++.|||++.++ .
T Consensus 88 -~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~ 159 (206)
T PF06293_consen 88 -GGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYR 159 (206)
T ss_pred -CceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCcee
Confidence 11456899999987 489999975322 445567789999999999999999 99999999999999876 7
Q ss_pred eEEeccccCccC
Q 035572 181 AKLADFGLAVSE 192 (379)
Q Consensus 181 ~kl~Dfg~a~~~ 192 (379)
+.++||+-+...
T Consensus 160 ~~lIDld~~~~~ 171 (206)
T PF06293_consen 160 FYLIDLDRMRFR 171 (206)
T ss_pred EEEEcchhceeC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.4e-07 Score=88.54 Aligned_cols=223 Identities=17% Similarity=0.192 Sum_probs=146.3
Q ss_pred ceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCC
Q 035572 28 HGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGN 107 (379)
Q Consensus 28 ~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 107 (379)
....|+|... .+|..|++|++..... ........-+++++++.|.| +|.++..+.- . --++
T Consensus 289 ~~Ttyk~~s~-----~DG~~YvLkRlhg~r~----~~~nk~t~lve~wkkl~h~N-------vV~frevf~t--~-tF~D 349 (655)
T KOG3741|consen 289 SITTYKATSN-----VDGNAYVLKRLHGDRD----QSTNKDTSLVEAWKKLCHTN-------VVPFREVFLT--Y-TFGD 349 (655)
T ss_pred cceeEeeeec-----cCCceeeeeeeccccc----cCcccchHHHHHHHHhccCc-------eeehhhhhhh--h-ccCc
Confidence 3567888744 4778899999843211 11222345578899999999 9998887651 1 1235
Q ss_pred CceEEEEeccCC-CCHHHHHHhhhcC----------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 108 SNKLLVMEFMPN-GSLYDLLHNAAAA----------TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 108 ~~~~lv~e~~~~-~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
..+++|++|.++ ++|.++....... .+...++..++.++.|+..||.++|+.| +.-+-|.|.+||++
T Consensus 350 ~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 350 LSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVT 427 (655)
T ss_pred ceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEee
Confidence 678999999987 6888876543222 2233677889999999999999999999 99999999999999
Q ss_pred CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhh
Q 035572 177 SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256 (379)
Q Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 256 (379)
++..++|+..|......... . |.++. -.+-|.=-||.+++.|.||..--...+...+..
T Consensus 428 G~~RIriS~C~i~Dvl~~d~-----------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~----- 486 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDP-----------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH----- 486 (655)
T ss_pred CcceEEEecccceeeecCCC-----------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH-----
Confidence 88888888777654433221 0 11111 124588889999999999965422222111110
Q ss_pred hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ......++.++++++.-....++++ -++.+++.+.
T Consensus 487 ------~----------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 ------L----------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ------H----------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0 1112334566667777777777765 4556665543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.5e-07 Score=80.09 Aligned_cols=147 Identities=16% Similarity=0.170 Sum_probs=92.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcH-----HHHHHHHHHHHhhhhccCCCCCc
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
..+|++.+++-.....-|.+-.. +++.+.+|..+.+......... ....+++..+..++..+...+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 46788888888877777776543 4566999987754322111111 12345555556665444222211
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
. +-.... -.+.-....+++|||++|..|.+... ++. .+...+.+++.-||+.| ++|+|.
T Consensus 103 ~----yl~~ek--k~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G--~~HGD~ 161 (229)
T PF06176_consen 103 P----YLAAEK--KIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG--FYHGDP 161 (229)
T ss_pred c----eeeeee--eeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC--CccCCC
Confidence 0 000000 00112245578999999988877643 222 34556788899999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccC
Q 035572 169 KSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a 189 (379)
.|.|++++++ .++++||+..
T Consensus 162 hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 162 HPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred CcCcEEEECC-cEEEEECccc
Confidence 9999999865 4999999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.4e-07 Score=77.63 Aligned_cols=159 Identities=24% Similarity=0.275 Sum_probs=106.4
Q ss_pred CCCHHHHHHHhcCCccccccc---cCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhh---------------hcH
Q 035572 4 NFDYEELVKATESFSQSRLIG---KGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ---------------DNS 65 (379)
Q Consensus 4 ~~~~~~~~~~~~~y~~~~~iG---~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~---------------~~~ 65 (379)
..+++.|..+..+..+....| .|--+.||+|.. ..+..+|+|+.+.....-.. ...
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r 107 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR 107 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence 345677888888888877665 566678999863 24567999998643221000 011
Q ss_pred -----HHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChH
Q 035572 66 -----KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140 (379)
Q Consensus 66 -----~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 140 (379)
.=..+|...|+++.......|.++.. ..-.|||||+.. . . ..........+...
T Consensus 108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~----------------~~nVLvMEfIg~-~-g---~pAP~LkDv~~e~~ 166 (268)
T COG1718 108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAF----------------RNNVLVMEFIGD-D-G---LPAPRLKDVPLELE 166 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCCCCceee----------------cCCeEEEEeccC-C-C---CCCCCcccCCcCch
Confidence 11367888888888776555543222 234799999943 3 1 11111222223344
Q ss_pred hHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 141 NRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 141 ~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
++..+..++++.+.-|-. .+ +||+||+.-|||+. ++.+.|+|||-|...
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECcccccc
Confidence 577788899999998877 88 99999999999999 778999999977544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=9e-08 Score=92.54 Aligned_cols=157 Identities=20% Similarity=0.236 Sum_probs=97.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh------------------------------h
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL------------------------------Q 62 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~ 62 (379)
.+..|.. +.|+.++-|.||+|+.++ |+.||||+.++.-.+.. .
T Consensus 124 ~F~eF~~-~PiAsASIaQVH~A~L~s------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~ 196 (517)
T COG0661 124 LFSEFEP-EPIASASIAQVHRAVLKS------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVD 196 (517)
T ss_pred HHHHcCC-CchhhhhHhhheeEEecC------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHH
Confidence 3344442 789999999999999874 66799999875322100 0
Q ss_pred hcH------HHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCC
Q 035572 63 DNS------KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136 (379)
Q Consensus 63 ~~~------~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 136 (379)
+.. =++.+|+..+.++++.....+...|-+.+ ++-.....|+|||+.|..+.+...-.. ..
T Consensus 197 e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~---------we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g 263 (517)
T COG0661 197 EFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVY---------WEYTTRRVLTMEWIDGIKISDIAALKS----AG 263 (517)
T ss_pred HHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceee---------hhccCCcEEEEEeeCCEecccHHHHHh----cC
Confidence 001 12456666677776554433432222211 122467789999999988888743211 11
Q ss_pred CChHhHHHHHHHHHH-HHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCC
Q 035572 137 LGWPNRVKIAMQISR-AIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194 (379)
Q Consensus 137 ~~~~~~~~~~~~i~~-~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 194 (379)
++... ++..++. -+..+=..| ++|.|..|.||+++.+|.+.+.|||+......
T Consensus 264 ~d~k~---ia~~~~~~f~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 264 IDRKE---LAELLVRAFLRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CCHHH---HHHHHHHHHHHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33222 2222222 122223378 99999999999999999999999999755543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.3e-07 Score=77.24 Aligned_cols=142 Identities=12% Similarity=0.163 Sum_probs=79.8
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
..||.|..+.||+.. +..+++|..+.. .....+.+|.++++.+...+...|. ++.+.
T Consensus 7 ~~i~~G~t~~~y~~~---------~~~~VlR~~~~~------~~~~~i~~E~~~l~~l~~~glpvP~--~~~~~------ 63 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---------TGKWMLKLYNPG------FDKETIKREFDASRKVFSLGIPTPH--PFDLV------ 63 (226)
T ss_pred eeecCCCCcceeEec---------CCCEEEEeCCCC------CCHHHHHHHHHHHHHHHHcCCCCCc--eEEEE------
Confidence 578999999999841 123778887532 2345678999999999865543333 22211
Q ss_pred CCCccCCCceEEEEeccCCCC-HHHHHH--------------h----hhcCCCCCCChHhHHH-HHH----------HHH
Q 035572 101 SGSVDGNSNKLLVMEFMPNGS-LYDLLH--------------N----AAAATTPQLGWPNRVK-IAM----------QIS 150 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~s-L~~~l~--------------~----~~~~~~~~~~~~~~~~-~~~----------~i~ 150 (379)
++.+...+|||+++|.+ +...+. + --.............. +.. .+.
T Consensus 64 ----~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~ 139 (226)
T TIGR02172 64 ----EDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYK 139 (226)
T ss_pred ----ecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHH
Confidence 23445678999998863 221111 0 0000001111111111 000 001
Q ss_pred H-HHHHH--HcCCCCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 151 R-AIQCL--HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 151 ~-~l~~L--H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
. ...+| +.....++|+|+.|.||++++++ +.++||+.+.
T Consensus 140 ~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 140 EKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 1 11222 22222389999999999999888 9999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.5e-06 Score=66.89 Aligned_cols=132 Identities=19% Similarity=0.252 Sum_probs=90.0
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
-++.+.||+|.+|.||++.+. +..+++|+-+.+ .....+..|+++|..+...+.. |. +. ++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-------~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~-p~--vy-~y-- 84 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-------GGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVT-PE--VY-FY-- 84 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-------CceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCC-ce--EE-Ee--
Confidence 345678999999999999764 346899987654 3357789999999999865421 11 11 11
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC-CCceEE
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK-STNILF 175 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk-p~NIll 175 (379)
+.-++.|||+.|-+|.+.... .+ ..-+..++..---|-..| |-|+.|. |...++
T Consensus 85 -----------g~~~i~me~i~G~~L~~~~~~--------~~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vl 139 (201)
T COG2112 85 -----------GEDFIRMEYIDGRPLGKLEIG--------GD----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVL 139 (201)
T ss_pred -----------chhhhhhhhhcCcchhhhhhc--------cc----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEE
Confidence 233566999988898877642 11 233345666655566778 9999987 444444
Q ss_pred cCCCCeEEeccccCccC
Q 035572 176 DSKWDAKLADFGLAVSE 192 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~ 192 (379)
..++.+.|+||..|...
T Consensus 140 v~~~~~~iIDFd~At~k 156 (201)
T COG2112 140 VNDRDVYIIDFDSATFK 156 (201)
T ss_pred ecCCcEEEEEccchhhc
Confidence 44558999999988643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.1e-06 Score=71.54 Aligned_cols=83 Identities=30% Similarity=0.414 Sum_probs=55.7
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+.......|. ++... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~~-------~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~--~~~~~-~~-- 63 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-------GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPR--VLAFD-TS-- 63 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-------SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS----EEEEE-EE--
T ss_pred CccCCCCCeeeEEEEEECC-------cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCce--EEeec-cc--
Confidence 4678999999999997543 35999986532 3457788999999999876542232 33211 00
Q ss_pred cCCCccCCCceEEEEeccCCCCHHH
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYD 124 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~ 124 (379)
-......+++|++++|.++..
T Consensus 64 ----~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 64 ----DEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp ----TEETSEEEEEEEEESSEEHHH
T ss_pred ----ccccccceEEEEEeccccccc
Confidence 112234799999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.5e-05 Score=65.93 Aligned_cols=142 Identities=25% Similarity=0.395 Sum_probs=98.0
Q ss_pred hcCCccccccccCCc-eeEEEEEecCCCCCCCceEEEEEeccC---CCch--------------hhhhcHHHHHHHHHHH
Q 035572 14 TESFSQSRLIGKGSH-GSVYKAILEDHQTDGDHKILAIKRAST---NGFE--------------VLQDNSKKLNNEIRVL 75 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~-g~V~~a~~~~~~~~~~~~~vavK~~~~---~~~~--------------~~~~~~~~~~~E~~~l 75 (379)
+..++.++.||.|.- |.||++.. .++.+|+|..+. .... ........|..|.+..
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I-------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf 108 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI-------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF 108 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE-------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence 378999999999999 99999976 456799999321 1110 0012345689999999
Q ss_pred HhhhhccCCCCCceeeeccccccccC-----------CCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHH
Q 035572 76 SSLQESNKRNPNYCVVNFHGTSCRNS-----------GSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVK 144 (379)
Q Consensus 76 ~~l~~~~~~~~~~~iv~~~~~~~~~~-----------~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 144 (379)
.+|+..+... +.-+++||++.-.. ..........||.||+.... .+. ..
T Consensus 109 gRLke~~~e~--~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~ 168 (207)
T PF13095_consen 109 GRLKEAGREG--LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IR 168 (207)
T ss_pred HHHHhccccC--ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hh
Confidence 9998766322 22478888764321 11123345568888886543 021 23
Q ss_pred HHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 145 IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 145 ~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
-+.+|.+-+..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 4567888899999999 999999999986 4599999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.4e-05 Score=68.35 Aligned_cols=77 Identities=19% Similarity=0.248 Sum_probs=47.9
Q ss_pred ccccCCc-eeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 22 LIGKGSH-GSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 22 ~iG~G~~-g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
.|-.|.. ..||+.... +..+.+|...... ...+.+|+++++.+... ...|. ++..
T Consensus 5 ~~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~-~~vP~--v~~~------- 60 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-------NPGLYLKIAPSGP-------TYELEREAERLRWLAGK-LPVPE--VIDY------- 60 (244)
T ss_pred ecCCCCCcCeEEEEcCC-------CCcEEEEecCCCc-------ccchHHHHHHHHHHHhc-CCCCe--EEEE-------
Confidence 3444555 788998532 1348888875321 34577899999999754 33332 2221
Q ss_pred CCCccCCCceEEEEeccCCCCHHHH
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDL 125 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~ 125 (379)
....+..++|||+++|.+|...
T Consensus 61 ---~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 61 ---GSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ---EecCCccEEEEEeeCCccHhHh
Confidence 1223467899999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.7e-07 Score=87.74 Aligned_cols=194 Identities=21% Similarity=0.157 Sum_probs=136.2
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
+.-+.-|...+-+++|+++.+++.+... .+.+..+.+... ....-++++|.+++|+| + .
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRpta------eklL~h~fvs~~---------l~~rl~~eLLdK~n~P~---~---~ 296 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTA------EKLLQHPFVSQT---------LSRRLAIELLDKVNNPN---P---V 296 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCCh------hhheeceeeccc---------hhhHHHHHHHHHccCCC---C---c
Confidence 3344556667778999999999986543 334556665432 33456788999999887 2 2
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCC-CHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
+.+. +..+.++..+++|+++.++ +-..... ..+-.+..-+...+.+.-..+++++|+.- =+|+|
T Consensus 297 v~~~-------~d~~~E~~~~i~~~i~s~~rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d-- 361 (829)
T KOG0576|consen 297 VRYL-------EDYDGEDYLWIPMRICSTGRSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD-- 361 (829)
T ss_pred cccc-------ccCCcccccchhhhhhcCCccccccCC----hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc--
Confidence 2222 2356678889999999766 2111111 01111333344456667778999999875 58888
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
||+..+ +..+..||+...............+++.++|||+...+.+....|.|++|.-..++.-|.+|-..
T Consensus 362 --~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 362 --NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred --cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 877765 57999999998777666566667899999999999999999999999999888888878777543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=5e-05 Score=66.88 Aligned_cols=27 Identities=26% Similarity=0.412 Sum_probs=23.7
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
++|+|+.|.||++++++..-|+||+.+
T Consensus 166 l~HGD~~~~Nvlv~~~~i~giIDw~~a 192 (235)
T cd05155 166 WFHGDLAPGNLLVQDGRLSAVIDFGCL 192 (235)
T ss_pred EEeCCCCCCcEEEECCCEEEEEeCccc
Confidence 899999999999987655679999876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.7e-05 Score=81.53 Aligned_cols=211 Identities=13% Similarity=0.149 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHH
Q 035572 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVK 144 (379)
Q Consensus 65 ~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 144 (379)
....+.|...+....|+| ++.+..+-.... +. +-...+..+++..-++.+.+..-+ ..+..+.+.
T Consensus 226 i~~~E~e~~~l~k~~~~n-------~~~~~~~~le~~--~~-g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~ 290 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDN-------LGGYFVYGLERL--FR-GIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRI 290 (1351)
T ss_pred HHHHHHHHHHHHhhcccc-------ccceeEEeehhh--cc-hHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHH
Confidence 344566777788888887 444444432211 00 012334567888888888887543 277788889
Q ss_pred HHHHHHHHHHHHHcCCCCeEecCCCCC---ceEEcCCCCeEEe--ccccCccCCCCCcccccCccccccCCCCCCCCCCC
Q 035572 145 IAMQISRAIQCLHENDPMIIHRDIKST---NILFDSKWDAKLA--DFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLS 219 (379)
Q Consensus 145 ~~~~i~~~l~~LH~~~~~i~H~dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (379)
+..++.+||.++|+.. ..|.-|..+ +--.+..+.+.++ ||+.+..............+..+.+||........
T Consensus 291 ~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~ 368 (1351)
T KOG1035|consen 291 LHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAK 368 (1351)
T ss_pred HHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccch
Confidence 9999999999999986 666666555 4444566667766 88887766655444444556677788876655554
Q ss_pred C--cCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCC
Q 035572 220 K--KVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297 (379)
Q Consensus 220 ~--~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 297 (379)
. ..|+|++|.....+..|..+-...-... ... +... .....+...+|+..+++
T Consensus 369 ~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~----------------~~l------~~~~---~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 369 KSRLTDLWCLGLLLLQLSQGEDISEKSAVPV----------------SLL------DVLS---TSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhhHHHHHHHHHhhhhhcCcccccccchh----------------hhh------cccc---chhhhhhhhhhcchhhh
Confidence 4 4799999999999998766532221100 000 0000 11577888899999999
Q ss_pred CCCChHHHhccccCcccccC
Q 035572 298 NRPGIGEILMGCSCFFVDHH 317 (379)
Q Consensus 298 ~Rps~~e~l~~~~~~~~~~~ 317 (379)
+|+++.+++.|.........
T Consensus 424 ~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred hccchhhhhhchhccccccc
Confidence 99999999999776655443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00036 Score=63.66 Aligned_cols=160 Identities=19% Similarity=0.237 Sum_probs=88.8
Q ss_pred HHHHHhcCCcc-----ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccC
Q 035572 9 ELVKATESFSQ-----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 9 ~~~~~~~~y~~-----~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
++..+-+.|.+ .+.|..|....+|+.... +..+++|.... .....+..|+.++..|.+.+.
T Consensus 3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~-------~~~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~ 68 (296)
T cd05153 3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTD-------SGRYVLTLFEK-------VSAEELPFFLALLDHLAERGL 68 (296)
T ss_pred HHHHHHHHcCCCchhheecccCccccceEEEEeC-------CCcEEEEEcCC-------CChHhccHHHHHHHHHHHCCC
Confidence 45555555654 456677877899987532 12488888753 224567889999999976553
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHH-----------HH---HhhhcC-CC-----CCCChHhHH
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-----------LL---HNAAAA-TT-----PQLGWPNRV 143 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~-----------~l---~~~~~~-~~-----~~~~~~~~~ 143 (379)
..|.. +...-+.. ....++..++|++|++|.++.. .+ +..... .. ....|....
T Consensus 69 ~vp~~-i~~~~g~~-----~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~ 142 (296)
T cd05153 69 PVPRP-IADRDGEY-----LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIREL 142 (296)
T ss_pred CCCcc-ccCCCCcE-----eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHH
Confidence 22221 11111111 1123456789999998866421 11 110000 00 001111100
Q ss_pred ----------HHHHHHHHHHHHHHc-------CCCCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 144 ----------KIAMQISRAIQCLHE-------NDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 144 ----------~~~~~i~~~l~~LH~-------~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
.....+..++.++.. .+ ++|+|+.|.||++++++.+.|+||+.+.
T Consensus 143 ~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~--l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 143 GKDLLPLLSAEDRALLADELARQDAFDPSDLPRG--VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc--CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 011112333444432 34 9999999999999988777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00023 Score=64.92 Aligned_cols=84 Identities=17% Similarity=0.125 Sum_probs=52.2
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeeccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFHG 95 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~~ 95 (379)
-.-.+.||.|..+.||+....+ ++ +.+|..+. ......+.+|+..|+.|.... ...|. ++....
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~------~~-~~~k~~~~------~~~~~~~~~Ea~~L~~L~~~~~vpVP~--V~~~~~ 80 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ------GN-PMPLMARS------FSTPGVAQQEAWKLSMLARSGTVRMPT--VYGVMT 80 (297)
T ss_pred hheeeecCCccceeEEEEEcCC------CC-EEEEEecc------cccchHHHHHHHHHHHHccCCCCCcCc--EEEEec
Confidence 3345689999999999985432 22 56676431 012357899999999997542 23333 332111
Q ss_pred cccccCCCccCCCceEEEEeccCCCCH
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSL 122 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL 122 (379)
. ....+..+||||+++|.++
T Consensus 81 ~-------~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 81 H-------EQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred c-------CCcCCCeEEEEeccCCEec
Confidence 1 1223568999999988754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.1e-05 Score=70.44 Aligned_cols=151 Identities=21% Similarity=0.247 Sum_probs=102.7
Q ss_pred CCHHHHHHHhc---CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCC--c----------------hhhhh
Q 035572 5 FDYEELVKATE---SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNG--F----------------EVLQD 63 (379)
Q Consensus 5 ~~~~~~~~~~~---~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~--~----------------~~~~~ 63 (379)
|+|=-|+++.. -+.+++.||=|.-+.||.+.+. .++++++|.=+... + ++..-
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyL 152 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYL 152 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhh
Confidence 44545555554 4678899999999999999765 34556666532110 1 11111
Q ss_pred cHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHH
Q 035572 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRV 143 (379)
Q Consensus 64 ~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 143 (379)
..-...+|...|+.|.......|. .-+.+..++|||++.|-.|.+.-+- . ...
T Consensus 153 SRlaa~kEfafmkaL~e~gfpVPk----------------piD~~RH~Vvmelv~g~Pl~~v~~v----~-------d~~ 205 (465)
T KOG2268|consen 153 SRLAATKEFAFMKALYERGFPVPK----------------PIDHNRHCVVMELVDGYPLRQVRHV----E-------DPP 205 (465)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCC----------------cccccceeeHHHhhcccceeeeeec----C-------ChH
Confidence 123356888899998765422222 1234677999999998888765532 1 123
Q ss_pred HHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 144 KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 144 ~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
.+...+..-+.-|..+| ++|+|.+-=||++++++.++++||--+.
T Consensus 206 ~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 206 TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred HHHHHHHHHHHHHHHcC--ceecccchheeEEecCCCEEEeechHhh
Confidence 56666777778888899 9999999999999999999999996543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00041 Score=72.37 Aligned_cols=87 Identities=13% Similarity=0.235 Sum_probs=52.3
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeeecccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVNFHGTSC 98 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~~~~~~~ 98 (379)
++.++.|.++.+|+....... ....+++|+.+.... ......+.+|+++++.+. +.+...|. ++ .++.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~---~~~~~VLR~~p~~~~---~~~~~~~~rE~~~l~~L~~~~~vpVP~--v~---~~~~ 111 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG---SVKRYVLRKKPPGKL---LQSAHAVEREYQVLRALGEHTDVPVPK--VY---CLCT 111 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC---cceeEEEEeCCCCcc---CccHHHHHHHHHHHHHHhhcCCCCCCc--EE---EEec
Confidence 577889999999998654321 123477777653321 122457889999999996 45433333 22 1111
Q ss_pred ccCCCccCCCceEEEEeccCCCC
Q 035572 99 RNSGSVDGNSNKLLVMEFMPNGS 121 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~s 121 (379)
. ....+..|+||||++|..
T Consensus 112 d----~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 112 D----ASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred C----CCcCCCceEEEEecCCcc
Confidence 0 011245789999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00015 Score=70.40 Aligned_cols=151 Identities=20% Similarity=0.210 Sum_probs=86.5
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh---------------------------hhhcHH------
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV---------------------------LQDNSK------ 66 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------~~~~~~------ 66 (379)
.+.||.-+.|.||+|+.++ ++.||||+-+..-... ..+..+
T Consensus 166 ~~piaaASlaQVhrA~L~~------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL 239 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL 239 (538)
T ss_pred cchhhhcchhheEEEEecC------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence 3689999999999998874 5669999976431110 000011
Q ss_pred HHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHH--HHhhhcCCCCCCChHhHHH
Q 035572 67 KLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL--LHNAAAATTPQLGWPNRVK 144 (379)
Q Consensus 67 ~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~~~~~~ 144 (379)
+|.+|++..+++++.-.......-|. .+-+. ++-.....|+||||+|..+.+. +.+.+ ++...
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~-VP~Vy-----~~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~--- 304 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVL-VPKVY-----WDLSTKRVLTMEYVDGIKINDLDAIDKRG------ISPHD--- 304 (538)
T ss_pred chHHHHHhHHHHHHHHHhccccccee-CCeeh-----hhcCcceEEEEEecCCccCCCHHHHHHcC------CCHHH---
Confidence 24445555544443211111000000 11111 1223577899999999766554 33322 44433
Q ss_pred HHHHHHHHHH-HHHcCCCCeEecCCCCCceEEcC----CCCeEEeccccCccCC
Q 035572 145 IAMQISRAIQ-CLHENDPMIIHRDIKSTNILFDS----KWDAKLADFGLAVSES 193 (379)
Q Consensus 145 ~~~~i~~~l~-~LH~~~~~i~H~dlkp~NIll~~----~~~~kl~Dfg~a~~~~ 193 (379)
++..+.++.. -+-..| ++|+|=.|.||++.. ++.+.+-|||+....+
T Consensus 305 i~~~l~~~~~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 305 ILNKLVEAYLEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHHHHHHHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3333333222 223467 999999999999983 6789999999975543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00055 Score=63.25 Aligned_cols=165 Identities=15% Similarity=0.201 Sum_probs=88.8
Q ss_pred CCHHHHHHHhcCCcc-----ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh
Q 035572 5 FDYEELVKATESFSQ-----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~-----~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 79 (379)
.+.+++...-+.|.+ .+.|+.|....+|+..... ..+++|+.. . ...+.+..|+.+++.|.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-------g~~vLK~~~-~------~~~~~l~~~~~~l~~L~ 72 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-------GEYVLTLFE-R------LTAEDLPFFLGLMQHLA 72 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-------CcEEEEEec-c------CChHHhHHHHHHHHHHH
Confidence 456677777677865 2456667777899875322 238888764 1 12345566788888887
Q ss_pred hccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCH-----------HHHHHh---hhcC-C-----CCCCCh
Q 035572 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL-----------YDLLHN---AAAA-T-----TPQLGW 139 (379)
Q Consensus 80 ~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL-----------~~~l~~---~~~~-~-----~~~~~~ 139 (379)
..+...|.. +...-+..+ ....+..+++++|++|..+ .+.+.+ .... . ...+.+
T Consensus 73 ~~glpvP~~-i~~~~G~~~-----~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~ 146 (319)
T PRK05231 73 ARGVPVPAP-VARRDGAAL-----GELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAW 146 (319)
T ss_pred HCCCCCCcc-eeCCCCCEe-----eeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHH
Confidence 655433331 111112111 1224567899999988643 111111 0000 0 000111
Q ss_pred -HhHH------------HHHHH-HHHHHHHHH-------cCCCCeEecCCCCCceEEcCCCCeEEeccccCcc
Q 035572 140 -PNRV------------KIAMQ-ISRAIQCLH-------ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191 (379)
Q Consensus 140 -~~~~------------~~~~~-i~~~l~~LH-------~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~ 191 (379)
.... ..+.+ +...++.+. ..+ ++|+|+.|.||+++++...-|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~--liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 147 WRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPALPRG--VIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccCCcc--cCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 01111 111222322 135 99999999999998765568999987643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00086 Score=61.61 Aligned_cols=162 Identities=19% Similarity=0.248 Sum_probs=89.5
Q ss_pred CHHHHHHHhcCCccc-----cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh
Q 035572 6 DYEELVKATESFSQS-----RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80 (379)
Q Consensus 6 ~~~~~~~~~~~y~~~-----~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 80 (379)
+-++|....+.|.+. +.++.|.-..+|+.... .+ .+.+|..... ...+.+..|++++..|..
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~------~~-~~vLK~~~~~------~~~~~i~~e~~~l~~L~~ 74 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD------VG-RYILTLYEKR------VKAEELPFFLALTTHLAA 74 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC------CC-cEEEEEecCC------CCHHHHHHHHHHHHHHHH
Confidence 446677776777653 45667777899987532 22 3778876432 123556788889998876
Q ss_pred ccCCCCCceeeec-cccccccCCCccCCCceEEEEeccCCCCHH-----------HHH---HhhhcCC-CC------CCC
Q 035572 81 SNKRNPNYCVVNF-HGTSCRNSGSVDGNSNKLLVMEFMPNGSLY-----------DLL---HNAAAAT-TP------QLG 138 (379)
Q Consensus 81 ~~~~~~~~~iv~~-~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~-----------~~l---~~~~~~~-~~------~~~ 138 (379)
.....|. ++.. -+..+ ....+..+++++|++|.++. ..+ +.....- .. .-.
T Consensus 75 ~g~pvp~--~i~t~~g~~~-----~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~ 147 (307)
T TIGR00938 75 RGLPVPK--PVKSRDGRQL-----STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEA 147 (307)
T ss_pred CCCCCCc--cccCCCCCee-----hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHH
Confidence 5432222 2211 11111 12245679999999885431 111 1111000 00 001
Q ss_pred hHhHH------------HHHHHHHHHHHHHHc-------CCCCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 139 WPNRV------------KIAMQISRAIQCLHE-------NDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 139 ~~~~~------------~~~~~i~~~l~~LH~-------~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
|.... .....+...++++.. .+ ++|+|+.+.||++++++...|+||+.+
T Consensus 148 w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~--l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 148 WHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRG--VIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCc--cCCCCCCcCcEEEECCceEEEeecccc
Confidence 11000 011123334555532 45 999999999999998876789999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00039 Score=59.13 Aligned_cols=141 Identities=23% Similarity=0.319 Sum_probs=90.5
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch------------hhhhcHHHHHHHHHHHHhhh-hccCCC
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE------------VLQDNSKKLNNEIRVLSSLQ-ESNKRN 85 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~~E~~~l~~l~-~~~~~~ 85 (379)
-...||.|+.-.||.- +.. ....||+....... ......++..+|+.-...+. ..+...
T Consensus 5 ~~~~i~~G~~R~cy~H--P~d------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~ 76 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDD------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW 76 (199)
T ss_pred CCcccccCCCceEEEC--CCC------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence 3568999999999964 221 22688888754400 00123577889999888887 444222
Q ss_pred CCceeeeccccccccCCCccCCCceEEEEeccCC------CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 86 PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPN------GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 86 ~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
.+ +-+++ |..+++...-+|+|.+.+ .+|.+++.+.. ++. .+...+-.-..||-.+
T Consensus 77 ~~--i~r~~-------G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~----~~~~~L~~f~~~l~~~ 137 (199)
T PF10707_consen 77 SH--IPRFY-------GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE----ELRQALDEFKRYLLDH 137 (199)
T ss_pred cc--cccEe-------EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH----HHHHHHHHHHHHHHHc
Confidence 22 34444 446778888999998654 46888885421 443 3333444555677778
Q ss_pred CCCeEecCCCCCceEEcCC--C--CeEEec-ccc
Q 035572 160 DPMIIHRDIKSTNILFDSK--W--DAKLAD-FGL 188 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~--~--~~kl~D-fg~ 188 (379)
+ |+.+|++|.||++..+ + .+.|+| ||.
T Consensus 138 ~--Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 138 H--IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred C--CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 8 9999999999999633 2 467777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=6.6e-05 Score=63.49 Aligned_cols=104 Identities=27% Similarity=0.367 Sum_probs=75.8
Q ss_pred HHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHH
Q 035572 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQ 148 (379)
Q Consensus 69 ~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~ 148 (379)
..|.-+++.+++..+ +.+++|+| ..++|.||...+++....... ..-...+|..+..++.+
T Consensus 7 ~~E~lll~~l~~~~~------~pk~lG~C-----------G~~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~ 67 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEP------FPKLLGSC-----------GRFYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQ 67 (188)
T ss_pred ccHHHHHHHcCCCCC------CCCeeeEC-----------CCEEEEEeecCcccccccccc--ccccccCHHHHHHHHHH
Confidence 357888888876431 66667765 237899999766554210000 00012789999999999
Q ss_pred HHHHHHHHHcC--CCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 149 ISRAIQCLHEN--DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 149 i~~~l~~LH~~--~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
+++.+.+++.. |. +.-.|++|+|+-++++|.+|++|...+...
T Consensus 68 lL~~l~~l~~~~~~~-~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 68 LLELLEELDHGPLGF-FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHHhcCCCCc-EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999873 33 888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00034 Score=63.94 Aligned_cols=140 Identities=22% Similarity=0.267 Sum_probs=96.4
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch----------------------hhhhcHHHHHHHHHHHHh
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE----------------------VLQDNSKKLNNEIRVLSS 77 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~E~~~l~~ 77 (379)
-.+|..|--+.||.|.-. +|..+|||+.+..... ......-=.+.|+..|.+
T Consensus 149 nGCiSTGKEANVYHat~~------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR 222 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR 222 (520)
T ss_pred ccccccCccceeEeeecC------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence 347788999999999644 4555999987642211 000111124789999999
Q ss_pred hhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 78 l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
+....+..|-+++++.| .|||+|+....... ...+...++...+..+-.+++.-+.-|-
T Consensus 223 l~~aGIP~PePIlLk~h----------------VLVM~FlGrdgw~a-----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY 281 (520)
T KOG2270|consen 223 LNNAGIPCPEPILLKNH----------------VLVMEFLGRDGWAA-----PKLKDASLSTSKARELYQQCVRIMRRLY 281 (520)
T ss_pred HHhcCCCCCCceeeecc----------------eEeeeeccCCCCcC-----cccccccCChHHHHHHHHHHHHHHHHHH
Confidence 99888777776666544 79999994322111 0123344666677777788888888775
Q ss_pred -cCCCCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 158 -ENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 158 -~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
.++ +||.||+--|+|+- +|.+.|+|.+-+
T Consensus 282 ~~c~--LVHADLSEfN~Lyh-dG~lyiIDVSQS 311 (520)
T KOG2270|consen 282 QKCR--LVHADLSEFNLLYH-DGKLYIIDVSQS 311 (520)
T ss_pred HHhc--eeccchhhhhheEE-CCEEEEEEcccc
Confidence 467 99999999999986 568999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00084 Score=59.01 Aligned_cols=27 Identities=33% Similarity=0.578 Sum_probs=24.7
Q ss_pred eEecCCCCCceEEcC-CCCeEEeccccC
Q 035572 163 IIHRDIKSTNILFDS-KWDAKLADFGLA 189 (379)
Q Consensus 163 i~H~dlkp~NIll~~-~~~~kl~Dfg~a 189 (379)
++|+|+.+.|||+++ ++.+.++||..|
T Consensus 172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 172 FCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred EEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 999999999999997 578999999766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0017 Score=61.28 Aligned_cols=83 Identities=18% Similarity=0.098 Sum_probs=51.2
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc---hhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF---EVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
.+.||.|.+..||++.+.+. .+.+.||....... +.++...++...|.+.|+.+....... +-.++.
T Consensus 31 ~~elggGn~N~VyrV~~~~g-----~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~----VPkV~~- 100 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEG-----GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDL----VPKVYH- 100 (401)
T ss_pred eeEcCCCceEEEEEEEeCCC-----CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCC----CCeEEE-
Confidence 36789999999999986532 13589998652211 111335678889999999876321100 111111
Q ss_pred ccccCCCccCCCceEEEEeccCCC
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNG 120 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~ 120 (379)
.+.+..++||||+++.
T Consensus 101 --------~D~~~~~lVME~L~~~ 116 (401)
T PRK09550 101 --------YDEELAVTVMEDLSDH 116 (401)
T ss_pred --------ECCCCCEEEEecCCCc
Confidence 1335678999999763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0032 Score=56.82 Aligned_cols=29 Identities=28% Similarity=0.424 Sum_probs=24.3
Q ss_pred eEecCCCCCceEEcCCCC-eEEeccccCcc
Q 035572 163 IIHRDIKSTNILFDSKWD-AKLADFGLAVS 191 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~-~kl~Dfg~a~~ 191 (379)
++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 899999999999997555 46999997644
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0052 Score=54.79 Aligned_cols=140 Identities=16% Similarity=0.167 Sum_probs=74.5
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccC
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNS 101 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~ 101 (379)
.+..|-.+.+|+... .++.+++|....... ...-...+|..+++.+...+. .|. ++..
T Consensus 3 ~~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~-~P~--~i~~-------- 60 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-------PGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGL-APK--PILV-------- 60 (256)
T ss_pred cCCCcCcCCeEEEEe-------CCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCC-CCc--eEEE--------
Confidence 345677789998752 334588887543211 110135789999999976542 232 2211
Q ss_pred CCccCCCceEEEEeccCCCCHHH--------------HHHhhhcC--CCCCCChHh-HHHHHHHH---------HHHHHH
Q 035572 102 GSVDGNSNKLLVMEFMPNGSLYD--------------LLHNAAAA--TTPQLGWPN-RVKIAMQI---------SRAIQC 155 (379)
Q Consensus 102 ~~~~~~~~~~lv~e~~~~~sL~~--------------~l~~~~~~--~~~~~~~~~-~~~~~~~i---------~~~l~~ 155 (379)
..-++||||++|..+.. .+.+--.. ....++... +..+..++ ...+..
T Consensus 61 ------~~~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 134 (256)
T TIGR02721 61 ------NEHWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQ 134 (256)
T ss_pred ------eCCEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHH
Confidence 11268999998865431 11111001 111122211 11111111 111222
Q ss_pred HHcC------CCCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 156 LHEN------DPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 156 LH~~------~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
+-.. ...++|+|+.|.||++++++ +.++||..|.
T Consensus 135 ~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 135 FRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred HHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 2111 11289999999999999877 7899998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=2.3e-05 Score=82.59 Aligned_cols=211 Identities=13% Similarity=0.060 Sum_probs=133.2
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhh-hcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-DNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
..+++.|++.--+|.|.+ +++.+.+... --+.+|+.+.-.++... -..+....|...++...|.+
T Consensus 1225 ~s~~e~~EV~l~i~~~~~---~R~k~Lr~ki----d~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~------- 1290 (2724)
T KOG1826|consen 1225 FSAMEHSEVNLGISNHFH---FRNKWLRSKI----DWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYL------- 1290 (2724)
T ss_pred HHHhhhhheeeeccccee---eccchHhhhh----ceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhcee-------
Confidence 344556665544554443 4454433221 12455655433332211 12233445555555666665
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHH-HHHHHHHHcC---CCCeEe
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQI-SRAIQCLHEN---DPMIIH 165 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~~---~~~i~H 165 (379)
+......+.. .+....+.+++|+.+|.+.+.+-+......+ +...- ....+++ .....-+|+. |.-.+|
T Consensus 1291 ~~~~p~rI~p-----s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~-ld~~~-v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1291 TEVDPLRIPP-----SESTEEYIRSLYVEFGKLFSIIIKGLEESPD-LDRSP-VHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred eecccccCCC-----CCChHHHHHHHHHHHhHHHHHHHhccccCCc-chhch-HHHHHHHHHhccchhhhcccCCccchh
Confidence 3333333322 3345678999999999999999875432222 22222 2233333 5556666643 233789
Q ss_pred cCCCCCceEEcCCCCeEEeccccCc-cCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAV-SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
++||+-|.+|..+-.++++++|+.+ ..+.........+++.|+.|+..+.-.++.++|+|+.|+-+|...-|..+|.
T Consensus 1364 ~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999999998 4444445555678889999998888888889999999999999988877763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0036 Score=57.33 Aligned_cols=27 Identities=33% Similarity=0.433 Sum_probs=24.8
Q ss_pred eEecCCCCCceEEcCC----CCeEEeccccC
Q 035572 163 IIHRDIKSTNILFDSK----WDAKLADFGLA 189 (379)
Q Consensus 163 i~H~dlkp~NIll~~~----~~~kl~Dfg~a 189 (379)
++|+|+.|.|||++++ +.+.++||..|
T Consensus 181 lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 181 FCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred EEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 8999999999999974 88999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0011 Score=63.19 Aligned_cols=173 Identities=22% Similarity=0.248 Sum_probs=94.1
Q ss_pred HHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHH
Q 035572 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVK 144 (379)
Q Consensus 65 ~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 144 (379)
..++.....+++.++|++ .-++...... ......+|||++ +.||++.+..+. ...
T Consensus 26 s~~ilgr~~~lktl~~~~-------l~~yl~~~r~------~~~r~IVV~e~~-~~Sled~~~~~~-l~~---------- 80 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDN-------LCQYLDFSRG------KHERVIVVMEHY-TMSLEDILKTGN-LKD---------- 80 (725)
T ss_pred HHHHhhhhHHHHhhcCcc-------ceeeEeeecC------ccceEEEEehhh-ccchHHHHHhcc-cch----------
Confidence 456777888999999887 4444443322 223488999999 899999997532 110
Q ss_pred HHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCe
Q 035572 145 IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDV 224 (379)
Q Consensus 145 ~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 224 (379)
.+++ .++ +.| .||+ +.+| .++... | .+..+++||
T Consensus 81 -----~s~~----~~~--~~~-----~~~~-------~~td-~~~t~~-----------------~-----~~~~pKsdV 114 (725)
T KOG1093|consen 81 -----ESLL----AHG--VLH-----LNII-------YITD-HFLTKY-----------------P-----SPIGPKSDV 114 (725)
T ss_pred -----hhhc----ccc--cce-----ehhh-------hccc-cccccC-----------------C-----CCCCcchhh
Confidence 0111 223 322 2332 2222 000000 1 111149999
Q ss_pred ehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 225 FSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 225 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
||+|.++.++.-|..-+..............-............. ......+...+.++...|+...|..||...+
T Consensus 115 wsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e----~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 115 WSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAME----HLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred hhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH----HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 999999999998877665433222111100000000000000000 0122344567889999999999999998887
Q ss_pred HhccccCc
Q 035572 305 ILMGCSCF 312 (379)
Q Consensus 305 ~l~~~~~~ 312 (379)
..++....
T Consensus 191 ~~k~~i~~ 198 (725)
T KOG1093|consen 191 LSKRCSFT 198 (725)
T ss_pred HhcCccHH
Confidence 77765443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.018 Score=52.58 Aligned_cols=31 Identities=23% Similarity=0.438 Sum_probs=27.8
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSES 193 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 193 (379)
++|+|+.+.||+++.++-+-+.||+++....
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 9999999999999988889999999986543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.036 Score=50.88 Aligned_cols=26 Identities=27% Similarity=0.437 Sum_probs=23.5
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
++|+|+.+.||+++. +.+.|+||+.+
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECccc
Confidence 999999999999987 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.02 Score=52.64 Aligned_cols=29 Identities=17% Similarity=0.381 Sum_probs=26.4
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCcc
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVS 191 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~ 191 (379)
++|+|+.+.|+|+++++.+.++||..+..
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 99999999999999998999999987644
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.015 Score=53.90 Aligned_cols=80 Identities=18% Similarity=0.137 Sum_probs=48.3
Q ss_pred ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc---hhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccc
Q 035572 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF---EVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSC 98 (379)
Q Consensus 22 ~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~ 98 (379)
.||.|....||++.+.. .++-|.||....--. +.++-...+..-|...|+....-- |. .+-+++
T Consensus 2 EigdGnlN~VfrV~~~~-----g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~---P~-~vP~vy---- 68 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE-----GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHV---PH-LVPRIF---- 68 (370)
T ss_pred cCCCCceEEEEEEEcCC-----CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccC---cc-ccCeEE----
Confidence 47999999999998532 124589998653211 123455677788888887765321 11 011112
Q ss_pred ccCCCccCCCceEEEEeccCC
Q 035572 99 RNSGSVDGNSNKLLVMEFMPN 119 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~ 119 (379)
.-+.....+|||+++.
T Consensus 69 -----~~D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 69 -----HFDTEMAVTVMEDLSH 84 (370)
T ss_pred -----EEccccceehHhhCcc
Confidence 1234566799999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.02 Score=53.43 Aligned_cols=28 Identities=25% Similarity=0.461 Sum_probs=24.7
Q ss_pred eEecCCCCCceEEcC-CCCeEEeccccCc
Q 035572 163 IIHRDIKSTNILFDS-KWDAKLADFGLAV 190 (379)
Q Consensus 163 i~H~dlkp~NIll~~-~~~~kl~Dfg~a~ 190 (379)
++|+|+++.|||+++ ++.+.++||..+.
T Consensus 202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 202 FCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred EEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 899999999999986 4689999998763
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.039 Score=50.91 Aligned_cols=147 Identities=22% Similarity=0.329 Sum_probs=85.8
Q ss_pred CceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccC
Q 035572 27 SHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDG 106 (379)
Q Consensus 27 ~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 106 (379)
.-..+|+....+ ++ +++|..+.. .....+..|+..+..|....+..+.. +...-|..... +..
T Consensus 37 ~eN~~f~~~~~~------g~-~iLki~~~~------~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~---~~~ 99 (331)
T COG2334 37 EENSNFRVQTED------GR-YILKIYRPG------WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEA---LSG 99 (331)
T ss_pred ccCceEEEEecC------CC-eEEEEecCC------CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhh---ccC
Confidence 456788886543 22 588887643 34577889999999998776544443 33333333221 122
Q ss_pred CCceEEEEeccCCCCHHH-----HH----------Hhhhc-CC------CCCCChH-------------hHHHHHHHHHH
Q 035572 107 NSNKLLVMEFMPNGSLYD-----LL----------HNAAA-AT------TPQLGWP-------------NRVKIAMQISR 151 (379)
Q Consensus 107 ~~~~~lv~e~~~~~sL~~-----~l----------~~~~~-~~------~~~~~~~-------------~~~~~~~~i~~ 151 (379)
....+-+++|++|..+.. .+ +.... .+ .....|. .......++..
T Consensus 100 ~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~ 179 (331)
T COG2334 100 GPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLA 179 (331)
T ss_pred CceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHH
Confidence 247788999999877762 11 11000 00 0012221 00113334444
Q ss_pred HHHHHHcC--------CCCeEecCCCCCceEEcCCCC-eEEeccccCc
Q 035572 152 AIQCLHEN--------DPMIIHRDIKSTNILFDSKWD-AKLADFGLAV 190 (379)
Q Consensus 152 ~l~~LH~~--------~~~i~H~dlkp~NIll~~~~~-~kl~Dfg~a~ 190 (379)
.+..+.+. +..++|+|+.|.||+++.+.. ..++||+-+.
T Consensus 180 ~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 180 ALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 55555432 112899999999999998874 8899998653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.007 Score=54.76 Aligned_cols=77 Identities=22% Similarity=0.330 Sum_probs=42.8
Q ss_pred ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeecccc
Q 035572 18 SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFHGT 96 (379)
Q Consensus 18 ~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~~~ 96 (379)
+-.+.|+.|.-..+|+... .++.+.||.-. ......|..|.+-|+.|...+ ...|. ++. .
T Consensus 20 ~~~~~v~GG~i~~a~~~~~-------~~~~~FvK~~~-------~~~~~~f~~Ea~gL~~L~~~~~~~vP~--vi~---~ 80 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDT-------DGGSYFVKVNS-------ESGRDMFEGEAEGLKALAEANPIRVPK--VIA---W 80 (288)
T ss_dssp -EEEEE--SSSSEEEEEET-------TS-EEEEEEEE-------GGGCCHHHHHHHHHHHHCHTTTSBS----EEE---E
T ss_pred eeeEecCCCChhheEEEEC-------CCccEEEEecC-------hhhHHHHHHHHHHHHHHHhcCCCCCCe--EEE---E
Confidence 4456788888899998752 44568999865 233567899999999995433 22222 111 1
Q ss_pred ccccCCCccCCCceEEEEeccCCC
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNG 120 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~ 120 (379)
....+..||||||++.+
T Consensus 81 -------G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 81 -------GEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp -------EE-SSCCEEEEE-----
T ss_pred -------EeecCCceEEEEeecCC
Confidence 12234459999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.028 Score=48.13 Aligned_cols=103 Identities=17% Similarity=0.170 Sum_probs=67.0
Q ss_pred EEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHH
Q 035572 47 ILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL 126 (379)
Q Consensus 47 ~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l 126 (379)
+..+|+++..++. -...-+.++.+++.++.. |+++.- +....+-++.|+|-...
T Consensus 87 ~L~lKKi~slp~~---~~~~~y~nky~v~ArmhG---------ilrL~N---------Dn~~~yGvIlE~Cy~~~----- 140 (308)
T PF07387_consen 87 PLFLKKIRSLPCC---INDALYFNKYRVFARMHG---------ILRLKN---------DNNYKYGVILERCYKIK----- 140 (308)
T ss_pred hhhhhhccCCCcc---cchhhhhhhhhHHHHhhh---------eeEeec---------CCCceeEEEEeeccCcc-----
Confidence 3566666544332 133456788888888843 555441 23456678999983211
Q ss_pred HhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEecccc
Q 035572 127 HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL 188 (379)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~ 188 (379)
... ..++.-=+++|.-.|+.....+|||-.|+||+-|..|.+||.|-+.
T Consensus 141 ----------i~~---~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 141 ----------INF---SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ----------cch---hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 100 1222223567788896544599999999999999999999999864
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.074 Score=50.36 Aligned_cols=80 Identities=15% Similarity=0.109 Sum_probs=46.5
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh---hhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV---LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
.+.||.|....||+..+.. +.+.||+........ ++-...+-..|...|+.+...... + +-+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~~-------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~-~---VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSS-------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPD-H---VPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcCC-------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCC-C---CCeEEEE
Confidence 5678999999999986521 238899876322211 112455666677777776532110 0 1222222
Q ss_pred ccccCCCccCCCceEEEEeccCC
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPN 119 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~ 119 (379)
+.+..+++||++++
T Consensus 106 ---------ded~~vlvME~L~~ 119 (418)
T PLN02756 106 ---------DRTMALIGMRYLEP 119 (418)
T ss_pred ---------CCCCCEEEEeecCC
Confidence 23556889999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.062 Score=49.84 Aligned_cols=27 Identities=22% Similarity=0.418 Sum_probs=24.2
Q ss_pred eEecCCCCCceEEcC-CCCeEEeccccC
Q 035572 163 IIHRDIKSTNILFDS-KWDAKLADFGLA 189 (379)
Q Consensus 163 i~H~dlkp~NIll~~-~~~~kl~Dfg~a 189 (379)
++|+|+.+.|||+++ ++.++++||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 899999999999974 578999999876
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.012 Score=54.12 Aligned_cols=75 Identities=16% Similarity=0.114 Sum_probs=57.4
Q ss_pred CCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEec
Q 035572 106 GNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185 (379)
Q Consensus 106 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~D 185 (379)
+.-..|++|++- |++|.-.-. ..+.++..++++.+..++-+... .+.=|||+.-.||||+ +|++.|+|
T Consensus 297 e~~y~yl~~kdh-gt~is~ik~---------~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIKA---------DRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred CceEEEEEEecC-Cceeeeeec---------ccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEE
Confidence 345667888887 666633221 45678888999988887777654 2388999999999999 99999999
Q ss_pred cccCccC
Q 035572 186 FGLAVSE 192 (379)
Q Consensus 186 fg~a~~~ 192 (379)
|-+++..
T Consensus 365 fklsRl~ 371 (488)
T COG5072 365 FKLSRLS 371 (488)
T ss_pred eeeeecc
Confidence 9998744
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.26 Score=52.77 Aligned_cols=171 Identities=20% Similarity=0.308 Sum_probs=87.8
Q ss_pred CCCHHHHHHH-hcCCccc---cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh
Q 035572 4 NFDYEELVKA-TESFSQS---RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79 (379)
Q Consensus 4 ~~~~~~~~~~-~~~y~~~---~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 79 (379)
.++.+++..+ -+.|-+. +.|+ |..-.+|+.... +++.+++|+.+.. .....+..|...|..|.
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~------~g~~yVLKi~~~~------~~~~~~~~q~~~L~hL~ 76 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTD------DGADYILKIVNPS------EPRVESDFQTAALDHLA 76 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeC------CCCeEEEEEcCCc------cchhHHHHHHHHHHHHH
Confidence 3455555333 2344442 4554 456778887543 3445999998743 12345566777888776
Q ss_pred hc--cCCCCCceeeecc-ccccccCCCccCCCceEEEEeccCCCCHHHH-------HHhhh-----------cCC----C
Q 035572 80 ES--NKRNPNYCVVNFH-GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL-------LHNAA-----------AAT----T 134 (379)
Q Consensus 80 ~~--~~~~~~~~iv~~~-~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~-------l~~~~-----------~~~----~ 134 (379)
.. ....|. ++... +...............+.+++|++|..|.+. +.+-+ ... .
T Consensus 77 ~~~~glpvP~--~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~ 154 (1013)
T PRK06148 77 AVAPDLPVPR--LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGAL 154 (1013)
T ss_pred hhCCCCCcCe--eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcc
Confidence 54 222222 33222 2221111101112256778999998776541 11000 000 0
Q ss_pred CCCChH-----------------hHHHHHHHHHHHHH-----HHHc--CCCCeEecCCCCCceEEcCCC--CeE-Eeccc
Q 035572 135 PQLGWP-----------------NRVKIAMQISRAIQ-----CLHE--NDPMIIHRDIKSTNILFDSKW--DAK-LADFG 187 (379)
Q Consensus 135 ~~~~~~-----------------~~~~~~~~i~~~l~-----~LH~--~~~~i~H~dlkp~NIll~~~~--~~k-l~Dfg 187 (379)
..+.|. ..+.++.+++.... .+.+ .+ ++|+|+++.|||++.++ .+. |+|||
T Consensus 155 r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~--vIHgDln~~NiLv~~~~~~~isGiIDFg 232 (1013)
T PRK06148 155 RDLDWDLRHAGRARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQ--VIHNDANDYNILVDADDGERISGLIDFG 232 (1013)
T ss_pred cccccccccchhhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcc--eECCCCCcccEEEcCCCCcceEEEEECc
Confidence 112221 11222333333222 1222 45 99999999999999775 555 99999
Q ss_pred cCcc
Q 035572 188 LAVS 191 (379)
Q Consensus 188 ~a~~ 191 (379)
-+..
T Consensus 233 Da~~ 236 (1013)
T PRK06148 233 DAVH 236 (1013)
T ss_pred cccc
Confidence 8744
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.031 Score=52.58 Aligned_cols=82 Identities=20% Similarity=0.245 Sum_probs=51.5
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCC--chhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNG--FEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
.+.||.|.-.-||++.+.. .++-|.||....-- .+.++-..++..-|.+.|+.+..-. |.. +-+++
T Consensus 34 ~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~---P~~-VP~vy--- 101 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELA---PGL-VPKVY--- 101 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhC---CCc-CCeEE---
Confidence 4688999999999998632 12448888864321 1234566788889999999775421 110 11111
Q ss_pred cccCCCccCCCceEEEEeccCC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPN 119 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~ 119 (379)
+-+.....+|||+++.
T Consensus 102 ------~~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 102 ------LFDSVMNCCVMEDLSD 117 (409)
T ss_pred ------EECcHHhhHHHHhCcc
Confidence 1345566789999854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.38 Score=44.54 Aligned_cols=78 Identities=13% Similarity=0.069 Sum_probs=45.7
Q ss_pred CCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCcc
Q 035572 26 GSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVD 105 (379)
Q Consensus 26 G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~ 105 (379)
+.-..||+.... +++.+++|..+... .....+..|++.+..|.......+.. +...+..+ ..
T Consensus 36 s~eN~vy~v~~~------~~~~~vlKv~r~~~-----~~~~~i~~E~~~l~~L~~~gipv~~p--~~~~G~~~-----~~ 97 (325)
T PRK11768 36 SYENRVYQFGDE------DGRRVVAKFYRPER-----WSDAQILEEHAFALELAEAEIPVVAP--LAFNGQTL-----HE 97 (325)
T ss_pred cccceEEEEecC------CCCEEEEEEcCccc-----CCHHHHHHHHHHHHHHHHCCCCCCCC--ccCCCCEE-----EE
Confidence 344678988543 33458889875321 24567888999999997654322221 12222211 12
Q ss_pred CCCceEEEEeccCCCC
Q 035572 106 GNSNKLLVMEFMPNGS 121 (379)
Q Consensus 106 ~~~~~~lv~e~~~~~s 121 (379)
-++..+.++++++|..
T Consensus 98 ~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 98 HQGFRFALFPRRGGRA 113 (325)
T ss_pred ECCEEEEEEeeeCCCC
Confidence 2356788999998753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.23 Score=42.95 Aligned_cols=60 Identities=22% Similarity=0.303 Sum_probs=41.6
Q ss_pred ceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHH
Q 035572 45 HKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123 (379)
Q Consensus 45 ~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~ 123 (379)
...+.||+-. ......|..|+.-|+.|...| +..|..+. +-.+..+.|+||||++-+.+.
T Consensus 39 ~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~------------~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIA------------VGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEE------------ecCCCCeeEEEEeeccCCCCC
Confidence 3558888754 344577899999999998777 44343211 124567899999999876654
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.036 Score=52.88 Aligned_cols=28 Identities=32% Similarity=0.589 Sum_probs=22.2
Q ss_pred CeEecCCCCCceEEcCCCC-----eEEeccccC
Q 035572 162 MIIHRDIKSTNILFDSKWD-----AKLADFGLA 189 (379)
Q Consensus 162 ~i~H~dlkp~NIll~~~~~-----~kl~Dfg~a 189 (379)
.++||||...|||++.++. ..|+||-.+
T Consensus 269 VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~v 301 (414)
T PF07914_consen 269 VLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCV 301 (414)
T ss_pred ceecCCccHHheeeecCCchhHHHHHHHHHHHh
Confidence 4999999999999987433 468888654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.26 Score=46.61 Aligned_cols=26 Identities=35% Similarity=0.384 Sum_probs=22.5
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
++|.|+-+.||+.+++ .+.++||..|
T Consensus 229 fCHNDL~~gNIL~~~~-~l~lID~EYA 254 (383)
T PTZ00384 229 FCHNDLFFTNILDFNQ-GIYFIDFDFA 254 (383)
T ss_pred eeeccCCcccEEecCC-CEEEEEeccc
Confidence 8999999999998654 6999999765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.17 Score=47.42 Aligned_cols=61 Identities=16% Similarity=0.169 Sum_probs=41.8
Q ss_pred CceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceEEc
Q 035572 108 SNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 108 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIll~ 176 (379)
....++-+|..|.++..++...+ .++.....++.-.++|+-.+-- .+ ++|.|+.|.||++-
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 34457778999999999886432 3333445555555555554433 46 99999999999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 379 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 5e-85
Identities = 99/309 (32%), Positives = 157/309 (50%), Gaps = 32/309 (10%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F EL A+++FS ++G+G G VYK L D G ++A+KR Q
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----G--TLVAVKRLKEER---TQGG 70
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
+ E+ ++S N ++ G C + +LLV +M NGS+
Sbjct: 71 ELQFQTEVEMISMAVHRN-------LLRLRG-FC-----MTPT-ERLLVYPYMANGSVAS 116
Query: 125 LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTNILFDSKWDAKL 183
L + P L WP R +IA+ +R + LH++ DP IIHRD+K+ NIL D +++A +
Sbjct: 117 CLRERPESQ-PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 184 ADFGLAVSESDESSMV--QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
DFGLA + + V GTIG++ P Y + K S+K DVF YGV+LLE+I+ ++
Sbjct: 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 242 DAARDP----ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
D AR ++DW L+KE+KL + D + + + ++Q++ VA C S
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPM 294
Query: 298 NRPGIGEIL 306
RP + E++
Sbjct: 295 ERPKMSEVV 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 7e-84
Identities = 89/315 (28%), Positives = 152/315 (48%), Gaps = 49/315 (15%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
+L +AT +F LIG G G VYK +L D +A+KR + Q
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA------KVALKRRTPES---SQGI 79
Query: 65 SKKLNNEIRVLSSLQESNKRNPN------YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMP 118
++ EI LS R+P+ +C D + +L+ ++M
Sbjct: 80 -EEFETEIETLSFC-----RHPHLVSLIGFC---------------DERNEMILIYKYME 118
Query: 119 NGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
NG+L L+ + T + W R++I + +R + LH IIHRD+KS NIL D
Sbjct: 119 NGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDEN 175
Query: 179 WDAKLADFGLA--VSESDE---SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233
+ K+ DFG++ +E D+ S++V GT+GY+DP Y +L++K DV+S+GVVL E
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVV--KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 234 IISCRKPIDAARDP--ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARC 291
++ R I + ++ +WA+ +L Q+ D + ++++ A +C
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKC 292
Query: 292 VSSEEENRPGIGEIL 306
++ E+RP +G++L
Sbjct: 293 LALSSEDRPSMGDVL 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-78
Identities = 97/316 (30%), Positives = 154/316 (48%), Gaps = 46/316 (14%)
Query: 5 FDYEELVKATESFSQ------SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF 58
F + EL T +F + +G+G G VYK + + +A+K+ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-------TTVAVKKLAAM-- 65
Query: 59 EVLQDNSKKLN----NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVM 114
+ +++L EI+V++ Q + N +V G S DG+ + LV
Sbjct: 66 --VDITTEELKQQFDQEIKVMAKCQ-----HEN--LVELLGFSS------DGD-DLCLVY 109
Query: 115 EFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174
+MPNGSL D L TP L W R KIA + I LHEN IHRDIKS NIL
Sbjct: 110 VYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANIL 165
Query: 175 FDSKWDAKLADFGLA-VSESDESSMV--QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
D + AK++DFGLA SE +++ + GT Y+ P +++ K D++S+GVVL
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVL 224
Query: 232 LEIISCRKPIDAARDPASIIDWALPLIKEEK-LRQVCDSRVGLPTFMEGAIKQMLHVAAR 290
LEII+ +D R+P ++D + EEK + D ++ +++ M VA++
Sbjct: 225 LEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQ 282
Query: 291 CVSSEEENRPGIGEIL 306
C+ ++ RP I ++
Sbjct: 283 CLHEKKNKRPDIKKVQ 298
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-59
Identities = 67/326 (20%), Positives = 118/326 (36%), Gaps = 51/326 (15%)
Query: 4 NFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD 63
+ E L + + +G G V+KA L ++ +A+K F +
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-------LNEYVAVKI-----FPIQDK 60
Query: 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
S + E+ L + ++ N ++ F G + + + + L+ F GSL
Sbjct: 61 QSWQNEYEVYSLPGM-----KHEN--ILQFIG-AEKRGT--SVDVDLWLITAFHEKGSLS 110
Query: 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN--------DPMIIHRDIKSTNILF 175
D L + W IA ++R + LHE+ P I HRDIKS N+L
Sbjct: 111 DFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 176 DSKWDAKLADFGLAV---SESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSY 227
+ A +ADFGLA+ + GT Y+ P ++D+++
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 228 GVVLLEIISCRKPIDAARDPASI--IDWALPLIKEEKLRQVCDSRVGLPTFME-----GA 280
G+VL E+ S D D + + E +++V + P +
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 281 IKQMLHVAARCVSSEEENRPGIGEIL 306
+ + C + E R G +
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVG 310
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-56
Identities = 86/303 (28%), Positives = 133/303 (43%), Gaps = 55/303 (18%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
DY+E+ ++G+G+ G V KA K +AIK+ + +
Sbjct: 6 DYKEIEV-------EEVVGRGAFGVVCKAKWRA-------KDVAIKQIES------ESER 45
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
K E+R LS + +PN +V +G +C N LVME+ GSLY++
Sbjct: 46 KAFIVELRQLSRV-----NHPN--IVKLYG-ACLN--------PVCLVMEYAEGGSLYNV 89
Query: 126 LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM-IIHRDIKSTNILFDSKWD-AKL 183
LH A P + + +Q S+ + LH P +IHRD+K N+L + K+
Sbjct: 90 LHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
Query: 184 ADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
DFG A + M G+ ++ P S S+K DVFS+G++L E+I+ RKP D
Sbjct: 148 CDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303
PA I WA+ R P ++ K + + RC S + RP +
Sbjct: 206 IGGPAFRIMWAV----HNGTR---------PPLIKNLPKPIESLMTRCWSKDPSQRPSME 252
Query: 304 EIL 306
EI+
Sbjct: 253 EIV 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-54
Identities = 75/313 (23%), Positives = 127/313 (40%), Gaps = 60/313 (19%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
E+ + IGKG G V+K L ++ +AIK E +
Sbjct: 17 ADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSV-----VAIKSLILGDSEGETEMI 64
Query: 66 KKLN---NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL 122
+K E+ ++S+L +PN +V +G N +VMEF+P G L
Sbjct: 65 EKFQEFQREVFIMSNL-----NHPN--IVKLYG-LMHN--------PPRMVMEFVPCGDL 108
Query: 123 YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD-- 180
Y L + + W ++++ + I+ I+ + +P I+HRD++S NI S +
Sbjct: 109 YHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 181 ---AKLADFGLAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLE 233
AK+ADFGL S+ S+ G ++ P ++K D +S+ ++L
Sbjct: 165 PVCAKVADFGL--SQQSVHSVSGLLGNFQWMAPETIGAEEESY--TEKADTYSFAMILYT 220
Query: 234 IISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVS 293
I++ P D I+EE LR PT E ++ +V C S
Sbjct: 221 ILTGEGPFDEYSYGKIKFINM---IREEGLR---------PTIPEDCPPRLRNVIELCWS 268
Query: 294 SEEENRPGIGEIL 306
+ + RP I+
Sbjct: 269 GDPKKRPHFSYIV 281
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-53
Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 47/302 (15%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
+ +L + IG GS G+V++A +A+K F +
Sbjct: 35 PWCDLNIKEK-------IGAGSFGTVHRAEWHG-------SDVAVKILMEQDFH--AERV 78
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
+ E+ ++ L R+PN +V F G + N +V E++ GSLY L
Sbjct: 79 NEFLREVAIMKRL-----RHPN--IVLFMG-AVTQP------PNLSIVTEYLSRGSLYRL 124
Query: 126 LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
LH + QL R+ +A +++ + LH +P I+HR++KS N+L D K+ K+ D
Sbjct: 125 LHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 186 FGLA-VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
FGL+ + S S AGT ++ P ++K DV+S+GV+L E+ + ++P
Sbjct: 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-N 241
Query: 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304
+PA ++ + R Q+ + C ++E RP
Sbjct: 242 LNPAQVVAAVG----FKCKR---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFAT 288
Query: 305 IL 306
I+
Sbjct: 289 IM 290
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-50
Identities = 57/307 (18%), Positives = 113/307 (36%), Gaps = 58/307 (18%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
D+++L T+ + + G ++K + + +K + S
Sbjct: 8 DFKQLNFLTK-------LNENHSGELWKGRWQG-------NDIVVKVLKVRDWS--TRKS 51
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
+ N E L +PN V+ G +C++ + + L+ +MP GSLY++
Sbjct: 52 RDFNEECPRLRIF-----SHPN--VLPVLG-ACQSPPA----PHPTLITHWMPYGSLYNV 99
Query: 126 LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
LH T + VK A+ ++R + LH +P+I + S +++ D A+++
Sbjct: 100 LHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156
Query: 186 FGLAVSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
+ S M ++ P + D++S+ V+L E+++
Sbjct: 157 ADVKFSFQSPGRM----YAPAWVAPEALQKKPE---DTNRRSADMWSFAVLLWELVTREV 209
Query: 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299
P A I + E LR PT G + + C++ + R
Sbjct: 210 PF-ADLSNMEIGMK----VALEGLR---------PTIPPGISPHVSKLMKICMNEDPAKR 255
Query: 300 PGIGEIL 306
P I+
Sbjct: 256 PKFDMIV 262
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-50
Identities = 77/310 (24%), Positives = 119/310 (38%), Gaps = 58/310 (18%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
D+ EL +IG G G VY+A +A+K A + E +
Sbjct: 5 DFAELT-------LEEIIGIGGFGKVYRAFWIG-------DEVAVKAARHDPDEDISQTI 50
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
+ + E ++ + L ++PN ++ G C N LVMEF G L +
Sbjct: 51 ENVRQEAKLFAML-----KHPN--IIALRG-VCLKE------PNLCLVMEFARGGPLNRV 96
Query: 126 LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM-IIHRDIKSTNILFDSK------ 178
L ++ V A+QI+R + LH+ + IIHRD+KS+NIL K
Sbjct: 97 LSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150
Query: 179 --WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
K+ DFGLA + M AG ++ P S SK DV+SYGV+L E+++
Sbjct: 151 SNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209
Query: 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEE 296
P D ++ KL + + C + +
Sbjct: 210 GEVPFR-GIDGLAVAYGVA----MNKLA---------LPIPSTCPEPFAKLMEDCWNPDP 255
Query: 297 ENRPGIGEIL 306
+RP IL
Sbjct: 256 HSRPSFTNIL 265
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 76/362 (20%), Positives = 127/362 (35%), Gaps = 73/362 (20%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
E ++ LIG+G +G+VYK L D + +A+K S +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-------DERPVAVKVFSF------ANR 49
Query: 65 SKKLN-NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
+N I + + + N + F R + DG LLVME+ PNGSL
Sbjct: 50 QNFINEKNIYRVPLM-----EHDN--IARFIVGDER--VTADGRMEYLLVMEYYPNGSLX 100
Query: 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND-------PMIIHRDIKSTNILFD 176
L W + ++A ++R + LH P I HRD+ S N+L
Sbjct: 101 KYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154
Query: 177 SKWDAKLADFGLAV---------SESDESSMVQPAGTIGYLDP-------GYTNPSKLSK 220
+ ++DFGL++ ++++ + GTI Y+ P + K
Sbjct: 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214
Query: 221 KVDVFSYGVVLLEIISCRKPIDAARDPASI----IDWALPLIKEEKLRQVCDSRVGLPTF 276
+VD+++ G++ EI + E ++ + P F
Sbjct: 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF 274
Query: 277 ME------GAIKQMLHVAARCVSSEEENRP---GIGEILMGC--------SCFFVDHHHH 319
E A++ + C + E R E + S HHHH
Sbjct: 275 PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334
Query: 320 HH 321
HH
Sbjct: 335 HH 336
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-47
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 47/292 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG GS G+VYK H +A+K + + NE+ VL
Sbjct: 30 QRIGSGSFGTVYKGKW--------HGDVAVKMLNVTAPT--PQQLQAFKNEVGVLRKT-- 77
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
R+ N ++ F G +V ++ SLY LH + +
Sbjct: 78 ---RHVN--ILLFMG-YSTAP-------QLAIVTQWCEGSSLYHHLHAS----ETKFEMK 120
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSESDESS 197
+ IA Q +R + LH IIHRD+KS NI K+ DFGLA S
Sbjct: 121 KLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 198 MVQPAGTIGYLDP---GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
Q +G+I ++ P + + S + DV+++G+VL E+++ + P + II
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-EM 237
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ L K+M + A C+ + + RP IL
Sbjct: 238 V----GRGSL-----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 66/316 (20%), Positives = 118/316 (37%), Gaps = 67/316 (21%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
+E+L LIGKG G VY G+ +AI+ +D
Sbjct: 31 PFEQLE-------IGELIGKGRFGQVYHGRW-----HGE---VAIRLIDIERDN--EDQL 73
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
K E+ R+ N VV F G +C + + ++ +LY +
Sbjct: 74 KAFKREVMAYRQT-----RHEN--VVLFMG-ACMSPP------HLAIITSLCKGRTLYSV 119
Query: 126 LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ +A L +IA +I + + LH I+H+D+KS N+ +D + D
Sbjct: 120 VRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITD 172
Query: 186 FGLA------VSESDESSMVQPAGTIGYLDP---------GYTNPSKLSKKVDVFSYGVV 230
FGL + E + G + +L P + SK DVF+ G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 231 LLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAAR 290
E+ + P + +II W + ++ S++G+ K++ +
Sbjct: 233 WYELHAREWPFK-TQPAEAII-WQM----GTGMKPNL-SQIGMG-------KEISDILLF 278
Query: 291 CVSSEEENRPGIGEIL 306
C + E+E RP +++
Sbjct: 279 CWAFEQEERPTFTKLM 294
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 67/310 (21%), Positives = 114/310 (36%), Gaps = 53/310 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+GKG +G V++ + + +A+K F + S E+ L
Sbjct: 14 ECVGKGRYGEVWRGSWQG-------ENVAVKI-----FSSRDEKSWFRETELYNTVML-- 59
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
R+ N ++ F + + S ++ L+ + GSLYD L L
Sbjct: 60 ---RHEN--ILGFIASDMTSRHS---STQLWLITHYHEMGSLYDYLQL------TTLDTV 105
Query: 141 NRVKIAMQISRAIQCLHEN------DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ ++I + I+ + LH P I HRD+KS NIL +AD GLAV S
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 195 ESSMVQPA-----GTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
++ + GT Y+ P + K+VD++++G+VL E+
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225
Query: 244 ARD---PASIIDWALPLIKEEKLRQVCD--SRVGLPT--FMEGAIKQMLHVAARCVSSEE 296
D P + P E+ + VC R +P F + + + + C
Sbjct: 226 VEDYKPPFYDVVPNDPSF-EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 297 ENRPGIGEIL 306
R I
Sbjct: 285 SARLTALRIK 294
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-45
Identities = 67/310 (21%), Positives = 113/310 (36%), Gaps = 53/310 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IGKG +G V+ + +A+K F ++ S EI +
Sbjct: 43 KQIGKGRYGEVWMGKWRG-------EKVAVKV-----FFTTEEASWFRETEIYQTVLM-- 88
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
R+ N ++ F + +GS + L+ ++ NGSLYD L + L
Sbjct: 89 ---RHEN--ILGFIAADIKGTGS---WTQLYLITDYHENGSLYDYLKS------TTLDAK 134
Query: 141 NRVKIAMQISRAIQCLHEND------PMIIHRDIKSTNILFDSKWDAKLADFGLAV---- 190
+ +K+A + LH P I HRD+KS NIL +AD GLAV
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
Query: 191 -SESDESSMVQPAGTIGYLDP----GYTNPSKL--SKKVDVFSYGVVLLEIISCRKPIDA 243
+ + GT Y+ P N + D++S+G++L E+
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254
Query: 244 ARD---PASIIDWALPLIKEEKLRQVC--DSRVGLPT--FMEGAIKQMLHVAARCVSSEE 296
+ P + + P E+ VC R P + ++QM + C +
Sbjct: 255 VEEYQLPYHDLVPSDPSY-EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 297 ENRPGIGEIL 306
+R +
Sbjct: 314 ASRLTALRVK 323
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-44
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 53/309 (17%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
IGKG G V++ + +A+K F ++ S EI L
Sbjct: 49 SIGKGRFGEVWRGKWRG-------EEVAVKI-----FSSREERSWFREAEIYQTVML--- 93
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
R+ N ++ F +++G+ + LV ++ +GSL+D L+ +
Sbjct: 94 --RHEN--ILGFIAADNKDNGT---WTQLWLVSDYHEHGSLFDYLNR------YTVTVEG 140
Query: 142 RVKIAMQISRAIQCLHEND------PMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+K+A+ + + LH P I HRD+KS NIL +AD GLAV
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 196 SSMVQPA-----GTIGYLDP----GYTNPSKL--SKKVDVFSYGVVLLEIISCRKPIDAA 244
+ + A GT Y+ P N K+ D+++ G+V EI
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 245 RD---PASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEG--AIKQMLHVAARCVSSEEE 297
D P + + P + EE + VC+ R +P + A++ M + C +
Sbjct: 261 EDYQLPYYDLVPSDPSV-EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 298 NRPGIGEIL 306
R I
Sbjct: 320 ARLTALRIK 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 68/317 (21%), Positives = 111/317 (35%), Gaps = 64/317 (20%)
Query: 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
F +L+ ++GKG G K +++ +K ++
Sbjct: 7 FRPSDLIH-------GEVLGKGCFGQAIKVTHR-----ETGEVMVMKELI----RFDEET 50
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
+ E++V+ L +PN V+ F G + + E++ G+L
Sbjct: 51 QRTFLKEVKVMRCL-----EHPN--VLKFIG-VLYKDKRL------NFITEYIKGGTLRG 96
Query: 125 LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
++ + Q W RV A I+ + LH + IIHRD+ S N L + +A
Sbjct: 97 IIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVA 150
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDPGYTNPS---------------KLSKKVDVFSYGV 229
DFGLA DE + + ++ D +KVDVFS+G+
Sbjct: 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI 210
Query: 230 VLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAA 289
VL EII DP D+ LP + L P +
Sbjct: 211 VLCEIIGRVNA-----DP----DY-LPRTMDFGLNVRGFLDRYCP---PNCPPSFFPITV 257
Query: 290 RCVSSEEENRPGIGEIL 306
RC + E RP ++
Sbjct: 258 RCCDLDPEKRPSFVKLE 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 69/317 (21%), Positives = 132/317 (41%), Gaps = 78/317 (24%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
D++E+ LIG G G V+KA H+ DG K IKR ++ N+
Sbjct: 12 DFKEI----------ELIGSGGFGQVFKAK---HRIDG--KTYVIKR--------VKYNN 48
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHG--------TSCRNSGSVDGNSNKL-LVMEF 116
+K E++ L+ L + N +V+++G + S + L + MEF
Sbjct: 49 EKAEREVKALAKL-----DHVN--IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEF 101
Query: 117 MPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176
G+L + + +++ QI++ + +H +I+RD+K +NI
Sbjct: 102 CDKGTLEQWIEKRRGEKLDK---VLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV 156
Query: 177 SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVV 230
K+ DFGL S ++ + GT+ Y+ P Y K+VD+++ G++
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY------GKEVDLYALGLI 210
Query: 231 LLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAA 289
L E++ C + ++ + D + I ++K + + ++++L
Sbjct: 211 LAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTL--------------LQKLLSK-- 254
Query: 290 RCVSSEEENRPGIGEIL 306
+ E+RP EIL
Sbjct: 255 -----KPEDRPNTSEIL 266
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 42/289 (14%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
IG+GS +VYK + +A ++ + ++ E +L LQ
Sbjct: 33 EIGRGSFKTVYKGL---DTETT--VEVAWCELQDR--KLTKSERQRFKEEAEMLKGLQ-- 83
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPN 141
+PN +V F+ S ++ LV E M +G+L L +
Sbjct: 84 ---HPN--IVRFYD-SWESTVKGKKCIV--LVTELMTSGTLKTYLKR-----FKVMKIKV 130
Query: 142 RVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLA--VSESDESSM 198
QI + +Q LH P IIHRD+K NI K+ D GLA S ++
Sbjct: 131 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 190
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258
+ GT ++ P K + VDV+++G+ +LE+ + P ++ A I +
Sbjct: 191 I---GTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246
Query: 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307
K +V +K+++ C+ ++ R I ++L
Sbjct: 247 KPASFDKVAIP----------EVKEIIE---GCIRQNKDERYSIKDLLN 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 76/315 (24%), Positives = 135/315 (42%), Gaps = 49/315 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E + IG GS+G K ++DG KIL K + + L +E+ +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIR---RKSDG--KILVWKELDYGSMT--EAEKQMLVSEVNL 58
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
L L ++PN +V ++ +D + L +VME+ G L ++
Sbjct: 59 LREL-----KHPN--IVRYYDRI------IDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 134 TP---QLGWPNRVKIAMQISRAIQCLHE---NDPMIIHRDIKSTNILFDSKWDAKLADFG 187
+ ++ Q++ A++ H ++HRD+K N+ D K + KL DFG
Sbjct: 106 QYLDEEFVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161
Query: 188 LAVSESDESSMVQ-PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246
LA + ++S + GT Y+ P N ++K D++S G +L E+ + P A
Sbjct: 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFS 220
Query: 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ I+E K R++ + I +ML++ ++ +RP + EIL
Sbjct: 221 QKELAG----KIREGKFRRIPY---RYSDELNEIITRMLNL-------KDYHRPSVEEIL 266
Query: 307 MGCSCFFVDHHHHHH 321
+ ++HHHHHH
Sbjct: 267 E--NPLILEHHHHHH 279
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 60/325 (18%), Positives = 111/325 (34%), Gaps = 76/325 (23%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
D+E + + +G+G G V++A ++ D AIKR +
Sbjct: 6 DFEPI----------QCLGRGGFGVVFEAK---NKVDD--CNYAIKRIRLPN---RELAR 47
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHG-----TSCRNSGSVDGNSNKLLVMEFMPNG 120
+K+ E++ L+ L +P +V + + + M+
Sbjct: 48 EKVMREVKALAKL-----EHPG--IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKE 100
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180
+L D ++ + + I +QI+ A++ LH ++HRD+K +NI F
Sbjct: 101 NLKDWMNGRCTIEERE--RSVCLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDV 156
Query: 181 AKLADFGLA-------------VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKK 221
K+ DFGL + GT Y+ P Y S K
Sbjct: 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY------SHK 210
Query: 222 VDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAI 281
VD+FS G++L E++ P + + ++ K + + +
Sbjct: 211 VDIFSLGLILFELLY---PFSTQMERVRTLT----DVRNLKFPPLFTQK---YPCEYVMV 260
Query: 282 KQMLHVAARCVSSEEENRPGIGEIL 306
+ ML RP I+
Sbjct: 261 QDMLSP-------SPMERPEAINII 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 63/323 (19%), Positives = 120/323 (37%), Gaps = 75/323 (23%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
F + ++G+G+ G V KA + D + AIK+ ++ + +E+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKAR---NALDS--RYYAIKKIRHT-----EEKLSTILSEVM 54
Query: 74 VLSSLQESNKRNPNYCVVNFHG-----TSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLH 127
+L+SL + VV ++ + + + L + ME+ NG+LYDL+H
Sbjct: 55 LLASL-----NHQY--VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107
Query: 128 NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
+ W ++ QI A+ +H IIHRD+K NI D + K+ DFG
Sbjct: 108 SENLNQQRDEYW----RLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFG 161
Query: 188 LAVSESDESSMVQPAGTIGYLD----------PGYTNP------SKLSKKVDVFSYGVVL 231
LA + +++ Y ++K+D++S G++
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
Query: 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGA--------IKQ 283
E+I P + +I L+++ + P + I+
Sbjct: 222 FEMI---YPFSTGMERVNI------------LKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266
Query: 284 MLHVAARCVSSEEENRPGIGEIL 306
++ + RPG +L
Sbjct: 267 LIDH-------DPNKRPGARTLL 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 64/318 (20%), Positives = 118/318 (37%), Gaps = 62/318 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG+G VY+A DG +A+K+ + EI +L L
Sbjct: 38 KKIGRGQFSEVYRAA---CLLDG--VPVALKKVQIFDLMDAKA-RADCIKEIDLLKQL-- 89
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP---QL 137
+PN V+ ++ S ++ +V+E G L ++ + +
Sbjct: 90 ---NHPN--VIKYYA-------SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS 197
W K +Q+ A++ +H ++HRDIK N+ + KL D GL S +++
Sbjct: 138 VW----KYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191
Query: 198 MVQ-PAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA-ARDPAS 249
GT Y+ P GY K D++S G +L E+ + + P + S
Sbjct: 192 AAHSLVGTPYYMSPERIHENGYNF------KSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL--- 306
+ I++ + + + ++ + E RP + +
Sbjct: 246 LC----KKIEQCDYPPLPSDH--YSEELRQLVNMCINP-------DPEKRPDVTYVYDVA 292
Query: 307 ---MGCSCFFVDHHHHHH 321
C+ ++HHHHHH
Sbjct: 293 KRMHACTASSLEHHHHHH 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 53/306 (17%), Positives = 101/306 (33%), Gaps = 50/306 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + + +G+G V + D A+KR + + + + E +
Sbjct: 29 KHYLFIQKLGEGGFSYVDLV-----EGLHDGHFYALKRILCHEQQDRE----EAQREADM 79
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+PN ++ R G L++ F G+L++ +
Sbjct: 80 HRLF-----NHPN--ILRLVAYCLRERG---AKHEAWLLLPFFKRGTLWNEI-ERLKDKG 128
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
L + + + I R ++ +H HRD+K TNIL + L D G
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186
Query: 195 ESSMVQPA----------GTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ A TI Y P ++ + ++ DV+S G VL ++ P
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH-CVIDERTDVWSLGCVLYAMMFGEGP 245
Query: 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300
D ++ L + +L R + + + M+ V + RP
Sbjct: 246 YDMVFQKGD----SVALAVQNQLSIPQSPRH--SSALWQLLNSMMTV-------DPHQRP 292
Query: 301 GIGEIL 306
I +L
Sbjct: 293 HIPLLL 298
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 62/301 (20%), Positives = 98/301 (32%), Gaps = 63/301 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+SF + +G GS+G V+K + DG ++ A+KR S + F +D ++KL E+
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVR---SKEDG--RLYAVKR-SMSPFRGPKDRARKLA-EVGS 109
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ ++P V + + L E SL A+
Sbjct: 110 HEKV----GQHPC--CVRLEQ-------AWEEGGILYLQTELC-GPSLQQHCEAWGASLP 155
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
W A+ LH ++H D+K NI + KL DFGL V
Sbjct: 156 EAQVW----GYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209
Query: 195 ESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
+ G Y+ P Y DVFS G+ +LE+ +
Sbjct: 210 AGAGEVQEGDPRYMAPELLQGSYG------TAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 250 IIDWALPLIKEEK----LRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
+ LP LR V + ML + + R +
Sbjct: 264 LRQGYLPPEFTAGLSSELRSV--------------LVMMLEP-------DPKLRATAEAL 302
Query: 306 L 306
L
Sbjct: 303 L 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 61/312 (19%), Positives = 122/312 (39%), Gaps = 60/312 (19%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ 62
EN ++ + E + + + IG+GS G DG + IK + +
Sbjct: 16 ENLYFQSM----EKYVRLQKIGEGSFGKAILVK---STEDG--RQYVIKEINISRMS--S 64
Query: 63 DNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSL 122
++ E+ VL+++ ++PN +V + S + N + +VM++ G L
Sbjct: 65 KEREESRREVAVLANM-----KHPN--IVQYRE-------SFEENGSLYIVMDYCEGGDL 110
Query: 123 YDLLHNAAAATTPQLGWPNRV-KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
+ ++ + +++ +QI A++ +H+ I+HRDIKS NI
Sbjct: 111 FKRINAQKGVLFQE----DQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTV 164
Query: 182 KLADFGLAVSESDESSMVQ-PAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEI 234
+L DFG+A + + + GT YL P Y N K D+++ G VL E+
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN------KSDIWALGCVLYEL 218
Query: 235 ISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSS 294
+ + + A +++ I + ++ ++ +
Sbjct: 219 CTLKHAFE-AGSMKNLVL----KIISGSFPP-------VSLHYSYDLRSLVS---QLFKR 263
Query: 295 EEENRPGIGEIL 306
+RP + IL
Sbjct: 264 NPRDRPSVNSIL 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 57/323 (17%), Positives = 102/323 (31%), Gaps = 84/323 (26%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
T F + IG G GSV+K + + DG I AIKR S D L E+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV---KRLDG--CIYAIKR-SKKPLAGSVDEQNALR-EVY 62
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+ L + + VV + + + + + E+ GSL D +
Sbjct: 63 AHAVLGQH----SH--VVRYFSAWAED--------DHMLIQNEYCNGGSLADAISENYRI 108
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD---------------- 176
+ + +Q+ R ++ +H ++H DIK +NI
Sbjct: 109 MSY-FKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165
Query: 177 ---SKWDAKLADFGLAVSESDESSMVQPAGTIGYL-------DPGYTNPSKLSKKVDVFS 226
+K K+ D G S G +L + + K D+F+
Sbjct: 166 WASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQENYTHL------PKADIFA 216
Query: 227 YGVVLLEIISCRKPIDAARDPASIIDWALPLIKE---EKLRQVCDSRVGLPTFMEGAIKQ 283
+ ++ I LP I + ++ ++ +K
Sbjct: 217 LALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTEL--------------LKV 262
Query: 284 MLHVAARCVSSEEENRPGIGEIL 306
M+H + E RP ++
Sbjct: 263 MIHP-------DPERRPSAMALV 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 64/311 (20%), Positives = 113/311 (36%), Gaps = 69/311 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R++ +G VY+A G + A+KR +N E + + E+ + L
Sbjct: 34 RVLAEGGFAFVYEAQ---DVGSG--REYALKRLLSNEEEKNR----AIIQEVCFMKKL-- 82
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---TTPQL 137
+PN +V F + D + L++ + G L + L + + +
Sbjct: 83 --SGHPN--IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS 197
+KI Q RA+Q +H P IIHRD+K N+L ++ KL DFG A + S
Sbjct: 139 -----LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 198 MVQPAGTIGYLD--------PGYTNP------SKL--SKKVDVFSYGVVLLEIISCRKPI 241
A ++ P Y P S +K D+++ G +L + + P
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
Query: 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTF------MEGAIKQMLHVAARCVSSE 295
+ + ++ + + +P I+ ML V
Sbjct: 254 E-----------------DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNP------ 290
Query: 296 EENRPGIGEIL 306
E R I E++
Sbjct: 291 -EERLSIAEVV 300
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 63/321 (19%), Positives = 115/321 (35%), Gaps = 62/321 (19%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ 62
EN ++ + +S + IG G V++ + ++ +I AIK + +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL---NEK---KQIYAIKYVNLEEAD--N 67
Query: 63 DNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGS 121
NEI L+ L + + ++ + + + +VME N
Sbjct: 68 QTLDSYRNEIAYLNKL-----QQHSDKIIRLYD--------YEITDQYIYMVMECG-NID 113
Query: 122 LYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
L L + R + A+ +H++ I+H D+K N L
Sbjct: 114 LNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-ML 165
Query: 182 KLADFGLAVSESDESSMVQ---PAGTIGYLDP-----------GYTNPSKLSKKVDVFSY 227
KL DFG+A +++ V GT+ Y+ P + SK+S K DV+S
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSR--VGLPTFMEGAIKQML 285
G +L + + P + KL + D + P E ++ +L
Sbjct: 226 GCILYYMTYGKTPFQQIINQI------------SKLHAIIDPNHEIEFPDIPEKDLQDVL 273
Query: 286 HVAARCVSSEEENRPGIGEIL 306
C+ + + R I E+L
Sbjct: 274 K---CCLKRDPKQRISIPELL 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 61/309 (19%), Positives = 110/309 (35%), Gaps = 62/309 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+S + IG G V++ + ++ +I AIK + + NEI
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL---NEK---KQIYAIKYVNLEEAD--NQTLDSYRNEIAY 60
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
L+ L + + ++ + + + +VME N L L
Sbjct: 61 LNKL-----QQHSDKIIRLYD--------YEITDQYIYMVMEC-GNIDLNSWLKKKK--- 103
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
+ R + A+ +H++ I+H D+K N L KL DFG+A
Sbjct: 104 --SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 158
Query: 194 DESSMVQ---PAGTIGYLDP-----------GYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
+++ V GT+ Y+ P + SK+S K DV+S G +L + +
Sbjct: 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
Query: 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSR--VGLPTFMEGAIKQMLHVAARCVSSEEE 297
P + KL + D + P E ++ +L C+ + +
Sbjct: 219 PFQQIINQI------------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPK 263
Query: 298 NRPGIGEIL 306
R I E+L
Sbjct: 264 QRISIPELL 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 47/237 (19%), Positives = 85/237 (35%), Gaps = 45/237 (18%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
SF ++G G+ G++ D + +A+KR +L + + E+++L
Sbjct: 25 SFCPKDVLGHGAEGTIVYR----GMFDN--RDVAVKR-------ILPECFSFADREVQLL 71
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
+PN V+ + T + + +E +L + + A
Sbjct: 72 RES----DEHPN--VIRYFCT-------EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG 117
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD-----AKLADFGLAV 190
+ + Q + + LH + I+HRD+K NIL A ++DFGL
Sbjct: 118 ----LEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 191 SESDESS----MVQPAGTIGYLDP---GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ GT G++ P + VD+FS G V +IS
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 63/267 (23%), Positives = 107/267 (40%), Gaps = 31/267 (11%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ F + +G G+ G V+K H+ G ++A K ++ ++ E++V
Sbjct: 33 DDFEKISELGAGNGGVVFKVS---HKPSG--LVMARKLIHLEIKPAIR---NQIIRELQV 84
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L +V F+G + + + ME M GSL +L A
Sbjct: 85 LHECNSPY-------IVGFYG-------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
LG K+++ + + + L E I+HRD+K +NIL +S+ + KL DFG VS
Sbjct: 131 QILG-----KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFG--VSGQL 182
Query: 195 ESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253
SM GT Y+ P + S + D++S G+ L+E+ R PI + +
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 254 ALPLIKEEKLRQVCDSRVGLPTFMEGA 280
+ + G P G
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGM 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 62/303 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG G V++ + ++ +I AIK + + NEI L+ L
Sbjct: 62 KQIGSGGSSKVFQVL---NEK---KQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKL-- 111
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+ + ++ + + + +VME N L L +
Sbjct: 112 ---QQHSDKIIRLYD--------YEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDP 154
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
R + A+ +H++ I+H D+K N L KL DFG+A +++ V
Sbjct: 155 WERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 211
Query: 200 Q---PAGTIGYLDP-----------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
G + Y+ P + SK+S K DV+S G +L + + P
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 246 DPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303
+ KL + D + P E ++ +L C+ + + R I
Sbjct: 272 NQI------------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 316
Query: 304 EIL 306
E+L
Sbjct: 317 ELL 319
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 48/239 (20%)
Query: 12 KATESFSQ----SRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDN 64
+T F + ++G+G V + I H+ KI+ + + E +Q+
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCI---HKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
+ E+ +L + +PN ++ T + N+ LV + M G L+D
Sbjct: 67 REATLKEVDILRKV----SGHPN--IIQLKDT-------YETNTFFFLVFDLMKKGELFD 113
Query: 125 LLHN------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
L KI + I LH+ I+HRD+K NIL D
Sbjct: 114 YLTEKVTLSEKETR-----------KIMRALLEVICALHKL--NIVHRDLKPENILLDDD 160
Query: 179 WDAKLADFGLAVSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVL 231
+ KL DFG + + + GT YL P N K+VD++S GV++
Sbjct: 161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 45/233 (19%)
Query: 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78
++GKG++G VY ++ +AIK S+ L+ EI + L
Sbjct: 26 DRVVLGKGTYGIVYAGR---DLSNQV--RIAIKEIPERD----SRYSQPLHEEIALHKHL 76
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQL 137
+ N +V + G+ N + + ME +P GSL LL + +
Sbjct: 77 KHKN-------IVQYLGSFSEN--------GFIKIFMEQVPGGSLSALLRSKWGPL--KD 119
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW-DAKLADFGLAVSESDES 196
QI ++ LH+N I+HRDIK N+L ++ K++DFG + + +
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 197 SMVQP-AGTIGYLDP--------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ GT+ Y+ P GY K D++S G ++E+ + + P
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGY------GKAADIWSLGCTIIEMATGKPP 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 40/318 (12%), Positives = 84/318 (26%), Gaps = 42/318 (13%)
Query: 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL 68
L + + G V+ D + + A+K + + ++L
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVR--DVERL---EDFALKVFTMGAENSRSE-LERL 109
Query: 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGN---------------SNKLLV 113
+ + L +P ++ +V +N LL+
Sbjct: 110 HEATFAAARLL---GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 114 MEFMPNGSLYDLLH--NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171
M + L L + G + Q+ R L ++H
Sbjct: 167 MPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPD 223
Query: 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL--SKKVDVFSYGV 229
N+ L D + + Y + N S + ++ + G+
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVGTRGPAS--SVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 230 VLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVC-DSRVGLPTFMEGAIKQMLHVA 288
+ + C P W P ++ + S LP F++ I + L+
Sbjct: 282 SIYRVW-CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF- 339
Query: 289 ARCVSSEEENRPGIGEIL 306
+ R E +
Sbjct: 340 ------DRRRRLLPLEAM 351
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 63/252 (25%), Positives = 102/252 (40%), Gaps = 54/252 (21%)
Query: 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ 62
+ D L F L+G G++G VYK H G ++ AIK +V
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGR---HVKTG--QLAAIKV-----MDVTG 61
Query: 63 DNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGS 121
D +++ EI +L + N + ++G + + G ++L LVMEF GS
Sbjct: 62 DEEEEIKQEINMLKKY----SHHRN--IATYYGAFIK--KNPPGMDDQLWLVMEFCGAGS 113
Query: 122 LYDLLHNAAAATTPQLGWPNRVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
+ DL+ N T + IA +I R + LH++ +IHRDIK N+L
Sbjct: 114 VTDLIKNTKGNTLKE------EWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN 165
Query: 179 WDAKLADFGLAVSESDE----SSMVQPAGT-----------IGYLDPGYTNPSKLSKKVD 223
+ KL DFG++ ++ + GT D Y K D
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIACDENPDATYDF------KSD 216
Query: 224 VFSYGVVLLEII 235
++S G+ +E+
Sbjct: 217 LWSLGITAIEMA 228
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 59/249 (23%), Positives = 90/249 (36%), Gaps = 36/249 (14%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+ S ++G+G+ +V++ H+ G + AIK + E VL
Sbjct: 11 WLLSDILGQGATANVFRGR---HKKTG--DLFAIKVFNN---ISFLRPVDVQMREFEVLK 62
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
L + N +V +K+L+MEF P GSLY +L +
Sbjct: 63 KL-----NHKN--IVKLFAIE-----EETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYG 108
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA----KLADFGLAVSE 192
L + + + + L EN I+HR+IK NI+ D KL DFG A
Sbjct: 109 LPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 193 SDESSMVQPAGTIGYLDP--------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
D+ V GT YL P + K VD++S GV + P
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 245 RDPASIIDW 253
P +
Sbjct: 227 EGPRRNKEV 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 46/244 (18%), Positives = 82/244 (33%), Gaps = 62/244 (25%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ +G+GS G V++ + G A+K +V + + E+
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMK---DKQTG--FQCAVK-------KVRLEVFRV--EELV 102
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+ L +P +V +G + + ME + GSL L+
Sbjct: 103 ACAGL-----SSPR--IVPLYGAVREG--------PWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLA-- 189
+ Q ++ LH I+H D+K+ N+L S A L DFG A
Sbjct: 148 PEDRAL-----YYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 190 -------VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
S + GT ++ P KVD++S ++L +++
Sbjct: 201 LQPDGLGKSLLTGDYIP---GTETHMAPEVVMGKPC------DAKVDIWSSCCMMLHMLN 251
Query: 237 CRKP 240
P
Sbjct: 252 GCHP 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 40/227 (17%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ +++ IG+G+ G+VY A+ D T + +AI++ + Q + + NEI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM--DVATG---QEVAIRQMNLQQ----QPKKELIINEIL 69
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
V+ +NPN +VN+ + ++L +VME++ GSL D++
Sbjct: 70 VMREN-----KNPN--IVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTETCM- 113
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
Q+ + + +A++ LH N +IHRDIKS NIL KL DFG
Sbjct: 114 DEGQIA-----AVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 193 SDE----SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
+ E S+MV GT ++ P KVD++S G++ +E+I
Sbjct: 167 TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 56/252 (22%), Positives = 106/252 (42%), Gaps = 48/252 (19%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
M+E+ + + +IG G+ V A + +AIKR + E
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAY--CAPKK---EKVAIKRIN---LEK 52
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPN 119
Q + +L EI+ +S +PN +V+++ + +L LVM+ +
Sbjct: 53 CQTSMDELLKEIQAMSQC-----HHPN--IVSYYTSFVVKD--------ELWLVMKLLSG 97
Query: 120 GSLYDLLHNAAAATTPQLGWPNRVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFD 176
GS+ D++ + A + G + IA ++ ++ LH+N IHRD+K+ NIL
Sbjct: 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG 155
Query: 177 SKWDAKLADFGLAVSESDESSMVQPA------GTIGYLDP-------GYTNPSKLSKKVD 223
++ADFG++ + + + GT ++ P GY K D
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF------KAD 209
Query: 224 VFSYGVVLLEII 235
++S+G+ +E+
Sbjct: 210 IWSFGITAIELA 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 59/249 (23%), Positives = 90/249 (36%), Gaps = 36/249 (14%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+ S ++G+G+ +V++ H+ G + AIK + E VL
Sbjct: 11 WLLSDILGQGATANVFRGR---HKKTG--DLFAIKVFNN---ISFLRPVDVQMREFEVLK 62
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
L + N +V +K+L+MEF P GSLY +L +
Sbjct: 63 KL-----NHKN--IVKLFAIE-----EETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYG 108
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA----KLADFGLAVSE 192
L + + + + L EN I+HR+IK NI+ D KL DFG A
Sbjct: 109 LPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 193 SDESSMVQPAGTIGYLDP--------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
D+ V GT YL P + K VD++S GV + P
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 245 RDPASIIDW 253
P +
Sbjct: 227 EGPRRNKEV 235
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
IG+GS G V A + + + +A+K Q + L NE+
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAR--EKHSG---RQVAVKMMDLRK----QQRRELLFNEVV 94
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
++ Q + N VV + + +L ++MEF+ G+L D++
Sbjct: 95 IMRDYQ-----HFN--VVEMYKSYLVG--------EELWVLMEFLQGGALTDIVSQVRL- 138
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
Q+ + + +A+ LH +IHRDIKS +IL KL+DFG
Sbjct: 139 NEEQIA-----TVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 193 SDE----SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
S + S+V GT ++ P + S + +VD++S G++++E++
Sbjct: 192 SKDVPKRKSLV---GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 64/357 (17%), Positives = 121/357 (33%), Gaps = 95/357 (26%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
D+E + + +G+G G V++A ++ D AIKR +
Sbjct: 7 DFEPI----------QCMGRGGFGVVFEAK---NKVDD--CNYAIKRIR---LPNRELAR 48
Query: 66 KKLNNEIRVLSSLQESN--------------KRNPNYCVVNFHGTSCRNSGSVDGNSNKL 111
+K+ E++ L+ L+ K + S S +
Sbjct: 49 EKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108
Query: 112 -----------------------------LVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
+ M+ +L D ++ + +
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE--HGVC 166
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSESDESSMV 199
+ I +QI+ A++ LH ++HRD+K +NI F K+ DFGL + +E +++
Sbjct: 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 200 QPA----------GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
P GT Y+ P + + S KVD+FS G++L E++ +
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVR 281
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
II ++ K + + P ++ ML RP +I+
Sbjct: 282 IIT----DVRNLKFPLLFTQKY--PQEHM-MVQDMLSP-------SPTERPEATDII 324
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 45/226 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+IG+G V + + H+ G KI+ A E L++ + E +L
Sbjct: 100 DVIGRGVSSVVRRCV---HRATGHEFAVKIME-VTAERLSPEQLEEVREATRRETHILRQ 155
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAA 131
+ +P+ ++ + + +S LV + M G L+D L
Sbjct: 156 V----AGHPH--IITLIDS-------YESSSFMFLVFDLMRKGELFDYLTEKVALSEKET 202
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
I + A+ LH N I+HRD+K NIL D +L+DFG +
Sbjct: 203 R-----------SIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 192 ESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVL 231
+ + GT GYL P K+VD+++ GV+L
Sbjct: 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 65/321 (20%), Positives = 114/321 (35%), Gaps = 74/321 (23%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+++G GS G+V G + +A+KR +L D EI++L+
Sbjct: 17 VVSEKILGYGSSGTVVFQ----GSFQG--RPVAVKR-------MLIDFCDIALMEIKLLT 63
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATT 134
+PN V+ ++ + + + +E N +L DL+ N +
Sbjct: 64 ES----DDHPN--VIRYYCS-------ETTDRFLYIALELC-NLNLQDLVESKNVSDENL 109
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-------------WDA 181
N + + QI+ + LH IIHRD+K NIL +
Sbjct: 110 KLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 182 KLADFGLAV-----SESDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGV 229
++DFGL S +++ P+GT G+ P +L++ +D+FS G
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 230 VLLEIISC-RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGA---IKQML 285
V I+S + P S I + + + A I QM+
Sbjct: 228 VFYYILSKGKHPFGDKYSRES-------NIIRGIFSLDEMKCLHDRSLIAEATDLISQMI 280
Query: 286 HVAARCVSSEEENRPGIGEIL 306
+ RP ++L
Sbjct: 281 DH-------DPLKRPTAMKVL 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 39/242 (16%), Positives = 83/242 (34%), Gaps = 34/242 (14%)
Query: 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK 67
E ++ L+G+G+ VY+A D + + +K N +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK-------VQKPANPWE 110
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH 127
+++ L+ S + + F+ +GSV LV E G+L + ++
Sbjct: 111 FYIGTQLMERLKPSMQHM----FMKFYSAHLFQNGSV-------LVGELYSYGTLLNAIN 159
Query: 128 NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA------ 181
+ + AM++ I+ +H+ + IIH DIK N + + +
Sbjct: 160 LYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 182 -----KLADFGLAV---SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233
L D G ++ + T G+ + + ++D F +
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277
Query: 234 II 235
++
Sbjct: 278 ML 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G++G V K H G +I+A+KR Q K+L ++ + +
Sbjct: 15 LGRGAYGVVEKMR---HVPSG--QIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDC- 65
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP----QLG 138
P V F+G ++ + + ME M + SL LG
Sbjct: 66 ---PF--TVTFYG-------ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG 112
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
KIA+ I +A++ LH +IHRD+K +N+L ++ K+ DFG +S +
Sbjct: 113 -----KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFG--ISGYLVDDV 164
Query: 199 VQP--AGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
+ AG Y+ P N S K D++S G+ ++E+ R P D+ P
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 61/234 (26%), Positives = 90/234 (38%), Gaps = 31/234 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G G G V + I HQ G+ +AIK+ E+ N ++ EI+++ L
Sbjct: 20 ERLGTGGFGYVLRWI---HQDTGE--QVAIKQCRQ---ELSPKNRERWCLEIQIMKKL-- 69
Query: 81 SNKRNPN----YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
+PN V + N LL ME+ G L L+
Sbjct: 70 ---NHPNVVSAREVP-------DGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCG 117
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAVSES 193
L + IS A++ LHEN IIHRD+K NI+ K+ D G A
Sbjct: 118 LKEGPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 194 DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247
+ GT+ YL P K + VD +S+G + E I+ +P P
Sbjct: 176 QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
IG+G++GSV K + H+ G +I+A+KR + E K+L ++ V+ +
Sbjct: 30 IGRGAYGSVNKMV---HKPSG--QIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSSDC- 80
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
P +V F+G + G + ME M + S + +
Sbjct: 81 ---PY--IVQFYG-ALFREGDC------WICMELM-STSFDKFYKYVYSVLDDVIPEEIL 127
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ-- 200
KI + +A+ L EN IIHRDIK +NIL D + KL DFG +S S+ +
Sbjct: 128 GKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFG--ISGQLVDSIAKTR 184
Query: 201 PAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256
AG Y+ P + + DV+S G+ L E+ + R P S+ D L
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP---KWNSVFD-QLT 240
Query: 257 LIKEE 261
+ +
Sbjct: 241 QVVKG 245
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 59/244 (24%), Positives = 94/244 (38%), Gaps = 57/244 (23%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
E + +G G+ G VYKA ++ G + A K T E L+D EI
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAK---NKETG--ALAAAKVIETKSEEELED----YIVEIE 68
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+L++ +V G + KL +++EF P G++ ++
Sbjct: 69 ILATCDHPY-------IVKLLGAYYHD--------GKLWIMIEFCPGGAVDAIMLELDRG 113
Query: 133 TT-PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG---- 187
T PQ+ + Q+ A+ LH IIHRD+K+ N+L + D +LADFG
Sbjct: 114 LTEPQIQV-----VCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166
Query: 188 LAVSESDESSMVQPAGT-----------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ S + GT D Y K D++S G+ L+E+
Sbjct: 167 NLKTLQKRDSFI---GTPYWMAPEVVMCETMKDTPYDY------KADIWSLGITLIEMAQ 217
Query: 237 CRKP 240
P
Sbjct: 218 IEPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 42/228 (18%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
E F +G+GS+GSVYKAI H+ G +I+AIK+ ++ + +++ EI
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAI---HKETG--QIVAIKQVP------VESDLQEIIKEIS 76
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
++ +P+ VV ++G+ +N L +VME+ GS+ D++
Sbjct: 77 IMQQC-----DSPH--VVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 133 TT-PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
T ++ I + ++ LH IHRDIK+ NIL +++ AKLADFG+A
Sbjct: 122 LTEDEIAT-----ILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174
Query: 192 ESDE----SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
+D ++++ GT ++ P + D++S G+ +E+
Sbjct: 175 LTDTMAKRNTVI---GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 63/248 (25%), Positives = 96/248 (38%), Gaps = 47/248 (18%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
S+ +G G+ G V A + +I++ KR G D + + EI +L
Sbjct: 140 SKTLGSGACGEVKLAF---ERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILK 195
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL------LHNAA 130
L +P ++ D + +V+E M G L+D L A
Sbjct: 196 KL-----NHPC--IIKIKNF-------FD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT 240
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFG 187
Q+ A+Q LHEN IIHRD+K N+L S+ + K+ DFG
Sbjct: 241 CK-----------LYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 188 LAVSESDESSMVQPAGTIGYLDP---GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
+ + S M GT YL P + ++ VD +S GV+L +S P
Sbjct: 288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347
Query: 245 RDPASIID 252
R S+ D
Sbjct: 348 RTQVSLKD 355
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 49/233 (21%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ FS R IG GS G+VY A D + +++AIK+ S +G + + + + E+R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFAR--DVRNS---EVVAIKKMSYSGKQS-NEKWQDIIKEVR 106
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
L L+ N + + G R + LVME+ GS DLL
Sbjct: 107 FLQKLRHPN-------TIQYRGCYLRE--------HTAWLVMEYCL-GSASDLLEVHKKP 150
Query: 133 TT-PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
++ + + + LH ++ +IHRD+K+ NIL KL DFG A
Sbjct: 151 LQEVEIAA-----VTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 192 ESDESSMVQPAGT---------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
+ +S V GT + + Y KVDV+S G+ +E+
Sbjct: 204 MAPANSFV---GTPYWMAPEVILAMDEGQYDG------KVDVWSLGITCIELA 247
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
E F++ IGKGS G V+K I K++AIK E +D + + EI
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGI---DNRTQ--KVVAIKIID---LEEAEDEIEDIQQEIT 72
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
VLS +P V ++G+ +++ KL ++ME++ GS DLL
Sbjct: 73 VLSQC-----DSPY--VTKYYGSYLKDT--------KLWIIMEYLGGGSALDLLEPGPL- 116
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG----L 188
Q+ I +I + + LH IHRDIK+ N+L + KLADFG L
Sbjct: 117 DETQIAT-----ILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169
Query: 189 AVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235
++ ++ V GT ++ P S K D++S G+ +E+
Sbjct: 170 TDTQIKRNTFV---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 32/226 (14%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G G+ G V+K + G ++A+K+ ++ +K++ ++ V+ +
Sbjct: 33 MGSGTCGQVWKMR---FRKTG--HVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDC- 83
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR 142
P +V G + + V + ME M + LG
Sbjct: 84 ---PY--IVQCFG-TFITNTDV------FIAMELMGTCAEKLKKRMQGPIPERILG---- 127
Query: 143 VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPA 202
K+ + I +A+ L E +IHRD+K +NIL D + KL DFG++ D+ + + A
Sbjct: 128 -KMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 203 GTIGY-----LDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
G Y +DP + DV+S G+ L+E+ + + P
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-24
Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 47/222 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
L+GKGS VY+A G K++ K G +++ NE+++
Sbjct: 17 NLLGKGSFAGVYRAE---SIHTGLEVAIKMIDKKAMYKAGMV------QRVQNEVKIHCQ 67
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L ++P+ ++ + +SN + LV+E NG + L N +
Sbjct: 68 L-----KHPS--ILELYN--------YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN 112
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
QI + LH + I+HRD+ +N+L + K+ADFGLA
Sbjct: 113 EAR----HFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 197 SMVQPA-GTIGYLDP------GYTNPSKLSKKVDVFSYGVVL 231
GT Y+ P + + DV+S G +
Sbjct: 167 EKHYTLCGTPNYISPEIATRSAH------GLESDVWSLGCMF 202
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 47/227 (20%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
S+ +G G+ G V A + KI++ KR G D + + EI +L
Sbjct: 15 SKTLGSGACGEVKLAF---ERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILK 70
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD------LLHNAA 130
L +P ++ D + +V+E M G L+D L A
Sbjct: 71 KL-----NHPC--IIKIKNF-------FD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT 115
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFG 187
Q+ A+Q LHEN IIHRD+K N+L S+ + K+ DFG
Sbjct: 116 CK-----------LYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 188 LAVSESDESSMVQPAGTIGYLDP---GYTNPSKLSKKVDVFSYGVVL 231
+ + S M GT YL P + ++ VD +S GV+L
Sbjct: 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 72/301 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
R +GKG ++ + KI+ +K++ EI + S
Sbjct: 21 RFLGKGGFAKCFEIS---DADTKEVFAGKIVPKSLLLKPHQR------EKMSMEISIHRS 71
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L + + VV FHG +++ + +V+E SL +L A T P+
Sbjct: 72 L-----AHQH--VVGFHG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 116
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDE 195
R QI Q LH N +IHRD+K N+ + + K+ DFGLA E D
Sbjct: 117 A----R-YYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169
Query: 196 SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
GT Y+ P G+ S +VDV+S G ++ ++ + P + +
Sbjct: 170 ERKKVLCGTPNYIAPEVLSKKGH------SFEVDVWSIGCIMYTLLVGKPPFETSCLK-- 221
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFM-EGA---IKQMLHVAARCVSSEEENRPGIGEI 305
E ++ + +P + A I++ML + RP I E+
Sbjct: 222 -----------ETYLRIKKNEYSIPKHINPVAASLIQKMLQT-------DPTARPTINEL 263
Query: 306 L 306
L
Sbjct: 264 L 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 46/232 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
R +GKG G+VY A + K+L + G E +L E+ + S
Sbjct: 15 RPLGKGKFGNVYLAR---EKQSKFILALKVLFKAQLEKAGVE------HQLRREVEIQSH 65
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH------NAAA 131
L R+PN ++ +G + L++E+ P G++Y L
Sbjct: 66 L-----RHPN--ILRLYGY-------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
A +++ A+ H +IHRDIK N+L S + K+ADFG +V
Sbjct: 112 A-----------TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV- 157
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ S GT+ YL P +KVD++S GV+ E + + P +A
Sbjct: 158 HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 47/231 (20%)
Query: 14 TESFSQ----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN 69
+ FS +GKG+ V + + H+T G A K +T ++ + +KL
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCV---HKTTG--LEFAAKIINTK--KLSARDFQKLE 53
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN- 128
E R+ LQ N +V H + + S LV + + G L++ +
Sbjct: 54 REARICRKLQHPN-------IVRLHDS-------IQEESFHYLVFDLVTGGELFEDIVAR 99
Query: 129 -----AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-- 181
A A+ QI +I H N I+HR++K N+L SK
Sbjct: 100 EFYSEADAS-----------HCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAA 146
Query: 182 -KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
KLADFGLA+ +D + AGT GYL P SK VD+++ GV+L
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-23
Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 72/301 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
R +GKG ++ + KI+ +K++ EI + S
Sbjct: 47 RFLGKGGFAKCFEIS---DADTKEVFAGKIVPKSLLLKPHQR------EKMSMEISIHRS 97
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L + + VV FHG +++ + +V+E SL +L A T P+
Sbjct: 98 L-----AHQH--VVGFHG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 142
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDE 195
R QI Q LH N +IHRD+K N+ + + K+ DFGLA E D
Sbjct: 143 A----R-YYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
Query: 196 SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
GT Y+ P G+ S +VDV+S G ++ ++ + P + +
Sbjct: 196 ERKKVLCGTPNYIAPEVLSKKGH------SFEVDVWSIGCIMYTLLVGKPPFETSCLK-- 247
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFM-EGA---IKQMLHVAARCVSSEEENRPGIGEI 305
E ++ + +P + A I++ML + RP I E+
Sbjct: 248 -----------ETYLRIKKNEYSIPKHINPVAASLIQKMLQT-------DPTARPTINEL 289
Query: 306 L 306
L
Sbjct: 290 L 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 54/247 (21%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+E + + + +G G++G V + AIK V ++ KL E+
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCR---DKVTH--VERAIKIIRKT--SVSTSSNSKLLEEVA 88
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN----- 128
VL L N ++ + + N LVME G L+D + +
Sbjct: 89 VLKLLDHPN-------IMKLYDF-------FEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 129 -AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLA 184
AA I Q+ + LH+++ I+HRD+K N+L +SK K+
Sbjct: 135 EVDAA-----------VIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIV 181
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVLLEIISCRK 239
DFGL+ ++ M + GT Y+ P Y +K DV+S GV+L +++
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY------DEKCDVWSIGVILFILLAGYP 235
Query: 240 PIDAARD 246
P D
Sbjct: 236 PFGGQTD 242
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 60/229 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
R +GKG G+VY A + + K+L + G E +L EI + S
Sbjct: 20 RPLGKGKFGNVYLAR---EKQNKFIMALKVLFKSQLEKEGVE------HQLRREIEIQSH 70
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNA------A 130
L R+PN ++ + + ++ L++EF P G LY L
Sbjct: 71 L-----RHPN--ILRMYN--------YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR 115
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+A +++ A+ HE +IHRDIK N+L K + K+ADFG +V
Sbjct: 116 SA-----------TFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSV 162
Query: 191 SESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLE 233
+ GT+ YL P + +KVD++ GV+ E
Sbjct: 163 -HAPSLRRRTMCGTLDYLPPEMIEGKTHD------EKVDLWCAGVLCYE 204
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 53/232 (22%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
++ + R++GKGS G V + G + A+K S + + + + L E++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCK---DKITG--QECAVKVISKRQVKQ-KTDKESLLREVQ 78
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN----- 128
+L L N ++ + + LV E G L+D + +
Sbjct: 79 LLKQLDHPN-------IMKLYEF-------FEDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 129 -AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLA 184
AA +I Q+ I +H+N I+HRD+K N+L +SK ++
Sbjct: 125 EVDAA-----------RIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRII 171
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVL 231
DFGL+ M GT Y+ P Y +K DV+S GV+L
Sbjct: 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY------DEKCDVWSTGVIL 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 38/312 (12%), Positives = 91/312 (29%), Gaps = 58/312 (18%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
++G+ + +A Q G + + + K++ E+ L L+
Sbjct: 79 TVLGQEDPYAYLEAT---DQETG--ESFEVHVPYFTE-RPPSNAIKQMKEEVLRLRLLRG 132
Query: 81 SNKRNPNYCVVNF-------------HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH 127
+ + F R ++ + M +L
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGE 191
Query: 128 N--AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ ++T L R+++ +Q+ R + LH ++H ++ +I+ D + L
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTG 249
Query: 186 FGLAVSESDESSMVQPAGTIGYLDP-----------GYTNPSKLSKKVDVFSYGVVLLEI 234
F V + + G+ P + ++ D ++ G+V+ I
Sbjct: 250 FEHLVRDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 235 ISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSS 294
C +W + S +P + ++ L
Sbjct: 307 W-CADLPITKDAALGGSEW------------IFRSCKNIPQPVRALLEGFLRYPK----- 348
Query: 295 EEENRPGIGEIL 306
E+R + +
Sbjct: 349 --EDRLLPLQAM 358
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 54/232 (23%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
E ++ ++GKGS G V K + + A+K + ++ + E+
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCK---DRITQ--QEYAVKVINKA--SAKNKDTSTILREVE 73
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN----- 128
+L L N ++ ++ +S+ +V E G L+D +
Sbjct: 74 LLKKLDHPN-------IMKLFEI-------LEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 129 -AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLA 184
AA +I Q+ I +H+++ I+HRD+K NIL +SK K+
Sbjct: 120 EHDAA-----------RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKII 166
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVL 231
DFGL+ + M GT Y+ P Y +K DV+S GV+L
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 45/235 (19%), Positives = 82/235 (34%), Gaps = 53/235 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK-------------RASTNGFEVLQDNSKK 67
R + +G + D+K A+K S N ++
Sbjct: 37 RTLNQGKFNKIILCE---K----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
NE+++++ + +N + G + N +++ ++ E+M N S+
Sbjct: 90 FKNELQIITDI-----KNEY--CLTCEG--------IITNYDEVYIIYEYMENDSILKFD 134
Query: 127 HNA---AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
T + I + + +H I HRD+K +NIL D KL
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKL 193
Query: 184 ADFGLAVSESDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVL 231
+DFG + D + GT ++ P Y KVD++S G+ L
Sbjct: 194 SDFGESEYMVD-KKIKGSRGTYEFMPPEFFSNESSYNGA-----KVDIWSLGICL 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +GKG+ GSV D D +++A+K + ST +++ + EI +L SL
Sbjct: 16 QQLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHST------EEHLRDFEREIEILKSL 68
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
++ N +V + G G N L+ME++P GSL D L ++
Sbjct: 69 -----QHDN--IVKYKGVCYS-----AGRRNLKLIMEYLPYGSLRDYLQKHK----ERID 112
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDES 196
++ QI + ++ L IHRD+ + NIL +++ K+ DFGL + + E
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
Query: 197 SMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
V+ G I + P SK S DV+S+GVVL E+ +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 41/238 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNS--KKLNNEIRVLS 76
RL+G+G G VY+A ED + +I+A+K + D ++ E R
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRE---RIVALKLMSE-----TLSSDPVFRTRMQREARTAG 89
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
LQE P+ VV H + G +DG + M + L +L
Sbjct: 90 RLQE-----PH--VVPIH-----DFGEIDGQL--YVDMRLINGVDLAAMLRRQGP----- 130
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
L P V I QI A+ H HRD+K NIL + A L DFG+A + + +
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASA-TTDE 187
Query: 197 SMVQPA---GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251
+ Q GT+ Y+ P + S + + D+++ VL E ++ P D S++
Sbjct: 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG--DQLSVM 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 36/254 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS----KKLNNEIRVLS 76
+GKG+ GSV D D ++A+K LQ + + EI++L
Sbjct: 29 SQLGKGNFGSVELCRY-DPLGDNTGALVAVK--------QLQHSGPDQQRDFQREIQILK 79
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
+L + +V + G S G + LVME++P+G L D L +
Sbjct: 80 AL-----HSDF--IVKYRGVS-----YGPGRQSLRLVMEYLPSGCLRDFLQRHR----AR 123
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA---VSES 193
L + + QI + ++ L +HRD+ + NIL +S+ K+ADFGLA +
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
Query: 194 DESSMVQPAGT-IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251
D + +P + I + P + + S++ DV+S+GVVL E+ + C K + + ++
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 252 DWALPLIKEEKLRQ 265
+ +L +
Sbjct: 242 GCERDVPALSRLLE 255
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 48/238 (20%), Positives = 83/238 (34%), Gaps = 48/238 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E IG+G+ G V+ L D+ ++A+K + D K E R+
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLR-----ADNTLVAVKSCRET---LPPDLKAKFLQEARI 165
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L +PN +V G C + +VME + G L
Sbjct: 166 LKQY-----SHPN--IVRLIGV-CTQKQPI------YIVMELVQGGDFLTFLRTEG---- 207
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSES 193
+L +++ + ++ L IHRD+ + N L K K++DFG++
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 194 DESSMVQPAG----------TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
+ + Y + S + DV+S+G++L E S P
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASP 315
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 40/237 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNS--KKLNNEIRVLS 76
+G G +VY A ED + +AIK + K+ E+ S
Sbjct: 17 DKLGGGGMSTVYLA--EDTILN---IKVAIKAIFI-----PPREKEETLKRFEREVHNSS 66
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
L + N +V+ D LVME++ +L + + +
Sbjct: 67 QLS-----HQN--IVSMIDV-----DEEDDCY--YLVMEYIEGPTLSEYIESHGP----- 107
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
L + QI I+ H+ I+HRDIK NIL DS K+ DFG+A + E+
Sbjct: 108 LSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSET 164
Query: 197 SMVQPA---GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250
S+ Q GT+ Y P + D++S G+VL E++ P + SI
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-TAVSI 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +GKG+ GSV D D +++A+K + ST +++ + EI +L SL
Sbjct: 47 QQLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHST------EEHLRDFEREIEILKSL 99
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
++ N +V + G G N L+ME++P GSL D L ++
Sbjct: 100 -----QHDN--IVKYKGVCYS-----AGRRNLKLIMEYLPYGSLRDYLQKHK----ERID 143
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDES 196
++ QI + ++ L IHRD+ + NIL +++ K+ DFGL + + E
Sbjct: 144 HIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 197 SMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
V+ G I + P SK S DV+S+GVVL E+ +
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-22
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 54/225 (24%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
++GKGS G V K + + A+K + ++ + E+ +L L
Sbjct: 28 CMLGKGSFGEVLKCK---DRITQ--QEYAVKVINKA--SAKNKDTSTILREVELLKKLDH 80
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAAATT 134
N ++ ++ +S+ +V E G L+D + AA
Sbjct: 81 PN-------IMKLFEI-------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-- 124
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAVS 191
+I Q+ I +H+++ I+HRD+K NIL +SK K+ DFGL+
Sbjct: 125 ---------RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 192 ESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVL 231
+ M GT Y+ P Y +K DV+S GV+L
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 8 EELVKATESFSQS----RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD 63
E ++ A+ FS + +GKG+ V + + H+T G A K +T
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCV---HKTTG--LEFAAKIINTKKLS--AR 70
Query: 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
+ +KL E R+ LQ N +V H + + S LV + + G L+
Sbjct: 71 DFQKLEREARICRKLQHPN-------IVRLHDS-------IQEESFHYLVFDLVTGGELF 116
Query: 124 DLLHN------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177
+ + A A+ QI +I H N I+HR++K N+L S
Sbjct: 117 EDIVAREFYSEADAS-----------HCIQQILESIAYCHSNG--IVHRNLKPENLLLAS 163
Query: 178 KWDA---KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
K KLADFGLA+ +D + AGT GYL P SK VD+++ GV+L
Sbjct: 164 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 5e-22
Identities = 37/314 (11%), Positives = 94/314 (29%), Gaps = 55/314 (17%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
+ ++G+ + +A D +T + + + K++ E+ L
Sbjct: 80 LVRGTVLGQEDPYAYLEA--TDQET---GESFEVHVPYF-TERPPSNAIKQMKEEVLRLR 133
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGN---------------SNKLLVMEFMPNGS 121
L+ +N V+ + ++ + M +
Sbjct: 134 LLRGI--KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSN 190
Query: 122 LYDLLH--NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179
L + ++T L R+++ +Q+ R + LH ++H ++ +I+ D +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRG 248
Query: 180 DAKLADFGLAVSESDESSMV--QPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVLL 232
L F V + + + G +P+ ++ D ++ G+ +
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 233 EIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCV 292
I C + +W S +P + ++ L
Sbjct: 309 WIW-CADLPNTDDAALGGSEWIFR------------SCKNIPQPVRALLEGFLRYPK--- 352
Query: 293 SSEEENRPGIGEIL 306
E+R + +
Sbjct: 353 ----EDRLLPLQAM 362
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 39/233 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNS--KKLNNEIRVLS 76
++G G V+ A D + + +A+K RA ++ +D S + E + +
Sbjct: 18 EILGFGGMSEVHLA--RDLRDH---RDVAVKVLRA-----DLARDPSFYLRFRREAQNAA 67
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL--LVMEFMPNGSLYDLLHNAAAATT 134
+L +P +V + ++G + + L +VME++ +L D++H
Sbjct: 68 ALN-----HPA--IVAVY-----DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--- 112
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ +++ +A+ H+N IIHRD+K NI+ + K+ DFG+A + +D
Sbjct: 113 --MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 195 ES-SMVQPA---GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
S+ Q A GT YL P + + DV+S G VL E+++ P
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 60/255 (23%), Positives = 98/255 (38%), Gaps = 55/255 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLN 69
+ R +G+G G V + DG +++A+K L+ ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVK--------ALKADAGPQHRSGWK 81
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
EI +L +L + + ++ + G G ++ LVME++P GSL D L
Sbjct: 82 QEIDILRTL-----YHEH--IIKYKGCC-----EDAGAASLQLVMEYVPLGSLRDYLPR- 128
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+G + A QI + LH IHRD+ + N+L D+ K+ DFGLA
Sbjct: 129 -----HSIGLAQLLLFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 190 --VSESDESSMVQPAG----------TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS- 236
V E E V+ G + K DV+S+GV L E+++
Sbjct: 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTH 233
Query: 237 CRKPIDAARDPASII 251
C +I
Sbjct: 234 CDSSQSPPTKFLELI 248
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 41/229 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
+ +G G +G VY+ + + + +A+K L++++ ++ E
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLT-----VAVK--------TLKEDTMEVEEFLKE 266
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNA 129
V+ + ++PN +V G C ++ EFM G+L D L N
Sbjct: 267 AAVMKEI-----KHPN--LVQLLGV-CTREPPF------YIITEFMTYGNLLDYLRECNR 312
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+ L + +A QIS A++ L + + IHR++ + N L K+ADFGL+
Sbjct: 313 QEVSAVVL-----LYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLS 365
Query: 190 VSESDESSMVQPAGTIGY--LDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ ++ P +K S K DV+++GV+L EI +
Sbjct: 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 59/249 (23%), Positives = 96/249 (38%), Gaps = 65/249 (26%)
Query: 10 LVKATESFSQ----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIK---------RASTN 56
+ K + R +G G++G V + AIK ++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCK---EKNGH--SEKAIKVIKKSQFDKGRYSD 81
Query: 57 GFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEF 116
+ ++ +++ NEI +L SL +PN ++ + LV EF
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLD-----HPN--IIKLFDV-------FEDKKYFYLVTEF 127
Query: 117 MPNGSLYDLLHN------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170
G L++ + N AA I QI I LH+++ I+HRDIK
Sbjct: 128 YEGGELFEQIINRHKFDECDAA-----------NIMKQILSGICYLHKHN--IVHRDIKP 174
Query: 171 TNILFDSKWDA---KLADFGLAVSESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKV 222
NIL ++K K+ DFGL+ S + + GT Y+ P Y +K
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYN------EKC 228
Query: 223 DVFSYGVVL 231
DV+S GV++
Sbjct: 229 DVWSCGVIM 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 39/242 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVL 75
R +G+G G V D + D + +A+K L+ S L EI +L
Sbjct: 27 RDLGEGHFGKVELCRY-DPEGDNTGEQVAVK--------SLKPESGGNHIADLKKEIEIL 77
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAAATT 134
+L + N +V + G DG + L+MEF+P+GSL + L N
Sbjct: 78 RNL-----YHEN--IVKYKGICTE-----DGGNGIKLIMEFLPSGSLKEYLPKNKNKINL 125
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSES 193
Q +K A+QI + + L +HRD+ + N+L +S+ K+ DFGL E+
Sbjct: 126 KQQ-----LKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 194 DESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249
D+ + + P SK DV+S+GV L E+++ C
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238
Query: 250 II 251
+I
Sbjct: 239 MI 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 47/223 (21%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79
S+++G G +G V + ++ + A+K +LQD K E+ +
Sbjct: 67 SQVLGLGINGKVLQIF---NKRTQ--EKFALK--------MLQD-CPKARREVELHWRAS 112
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN--------AAA 131
+ P+ +V N G L+VME + G L+ + + A
Sbjct: 113 ----QCPH--IVRIVDV-YENL--YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGL 188
+ +I I AIQ LH + I HRD+K N+L+ SK KL DFG
Sbjct: 164 S-----------EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 189 AVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
A + +S+ P T Y+ P P K K D++S GV++
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 33/230 (14%)
Query: 10 LVKATESFSQ-----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN 64
++ E+F+ S+ +G+G V + I ++ G + A K QD
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCI---SKSTG--QEYAAKFLKKR--RRGQDC 71
Query: 65 SKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD 124
++ +EI VL + P V+N H + S +L++E+ G ++
Sbjct: 72 RAEILHEIAVLELAKS----CPR--VINLHEV-------YENTSEIILILEYAAGGEIFS 118
Query: 125 LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--- 181
L + + +++ QI + LH+N+ I+H D+K NIL S +
Sbjct: 119 LC---LPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDI 173
Query: 182 KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
K+ DFG++ + + GT YL P N ++ D+++ G++
Sbjct: 174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 43/249 (17%), Positives = 81/249 (32%), Gaps = 58/249 (23%)
Query: 14 TESFSQSRLIGKG--SHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE 71
+ +IGKG +V A ++ G + + ++R N + L E
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLAR---YKPTG--EYVTVRR--INLEACSNEMVTFLQGE 76
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAA 130
+ V +PN +V + T ++ +L +V FM GS DL+
Sbjct: 77 LHVSKLF-----NHPN--IVPYRATFIADN--------ELWVVTSFMAYGSAKDLICTHF 121
Query: 131 AATTPQLGWPNRVKIAM---QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
+ + IA + +A+ +H +HR +K+++IL L+
Sbjct: 122 MDGMNE------LAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLR 173
Query: 188 LAVSESDESSM--------VQPAGT--------IGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+S + GY K D++S G+
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA------KSDIYSVGITA 227
Query: 232 LEIISCRKP 240
E+ + P
Sbjct: 228 CELANGHVP 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 47/231 (20%), Positives = 84/231 (36%), Gaps = 46/231 (19%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNN 70
+ + +G G V K ++ G K + +++ + V ++ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVCRE---EIER 64
Query: 71 EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL----- 125
E+ +L + +PN ++ H + ++ +L++E + G L+D
Sbjct: 65 EVSILRQVL-----HPN--IITLHDV-------YENRTDVVLILELVSGGELFDFLAQKE 110
Query: 126 -LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--- 181
L A QI + LH I H D+K NI+ K
Sbjct: 111 SLSEEEAT-----------SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPH 157
Query: 182 -KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
KL DFGLA D GT ++ P N L + D++S GV+
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 38/240 (15%)
Query: 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE 71
K + F R+ G+G+ G+V + T +AIK+ V+QD + N E
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGK--EKSTG---MSVAIKK-------VIQDPRFR-NRE 66
Query: 72 IRVLSSLQESNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH 127
++++ L + N +V F+ R+ + N +VME++P+ +L+
Sbjct: 67 LQIMQDLAVLHHPN----IVQLQSYFYTLGERDRRDIYLN----VVMEYVPD-TLHRCCR 117
Query: 128 NAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFD-SKWDAKLAD 185
N P +K+ + Q+ R+I CLH + HRDIK N+L + + KL D
Sbjct: 118 NYYRRQVAPP--PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 186 FGLAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
FG A S V + Y P G + + VD++S G + E++ +PI
Sbjct: 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY---TTAVDIWSVGCIFAEMML-GEPI 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-21
Identities = 47/231 (20%), Positives = 83/231 (35%), Gaps = 46/231 (19%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNN 70
+ + +G G V K ++ G K + +++ + V ++ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVSRE---EIER 64
Query: 71 EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL----- 125
E+ +L + + N V+ H + ++ +L++E + G L+D
Sbjct: 65 EVSILRQVL-----HHN--VITLHDV-------YENRTDVVLILELVSGGELFDFLAQKE 110
Query: 126 -LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--- 181
L A QI + LH I H D+K NI+ K
Sbjct: 111 SLSEEEAT-----------SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPH 157
Query: 182 -KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
KL DFGLA D GT ++ P N L + D++S GV+
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 38/230 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R++GKG GSV +A L+ DG +A+K + + ++ E +
Sbjct: 29 RMLGKGEFGSVREAQLKQE--DGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEF-- 82
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAAATTPQLGW 139
+P+ V G S + ++++ FM +G L+ LL + L
Sbjct: 83 ---DHPH--VAKLVGV-SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESS 197
V+ + I+ ++ L + IHRD+ + N + +ADFGL+ + D
Sbjct: 137 QTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 198 MVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
G L D YT S DV+++GV + EI++
Sbjct: 195 ----QGCASKLPVKWLALESLADNLYTVHS------DVWAFGVTMWEIMT 234
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 45/239 (18%), Positives = 88/239 (36%), Gaps = 54/239 (22%)
Query: 8 EELVKATESFSQ----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD 63
++L + + F+ IG GS+ + I H+ A+K ++
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCI---HKATN--MEFAVK--------IIDK 57
Query: 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
+ + EI +L ++PN ++ D +V E M G L
Sbjct: 58 SKRDPTEEIEILLRYG----QHPN--IITLKDV-------YDDGKYVYVVTELMKGGELL 104
Query: 124 DLLHN------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177
D + A+ + I++ ++ LH ++HRD+K +NIL+
Sbjct: 105 DKILRQKFFSEREAS-----------AVLFTITKTVEYLHAQG--VVHRDLKPSNILYVD 151
Query: 178 KWDA----KLADFGLAVS-ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+ ++ DFG A ++ ++ P T ++ P D++S GV+L
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
++G G+ V+ + G K+ A+K + L NEI VL ++
Sbjct: 15 EVLGSGAFSEVFLVK---QRLTG--KLFALKCIKKS----PAFRDSSLENEIAVLKKIK- 64
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAAATT 134
+ N +V + ++ LVM+ + G L+D + A+
Sbjct: 65 ----HEN--IVTLEDI-------YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-- 109
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAVS 191
+ Q+ A++ LHEN I+HRD+K N+L+ + + + DFGL+
Sbjct: 110 ---------LVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
E M GT GY+ P SK VD +S GV+
Sbjct: 159 E-QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 35/220 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+IGKG V + I ++ G KI+ + + +++ +D L E +
Sbjct: 30 EVIGKGPFSVVRRCI---NRETGQQFAVKIVDVAKFTSSPGLSTED----LKREASICHM 82
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
L+ + +V T + +V EFM L +
Sbjct: 83 LKHPH-------IVELLET-------YSSDGMLYMVFEFMDGADLCFEI---VKRADAGF 125
Query: 138 GWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAVSE 192
+ V QI A++ H+N+ IIHRD+K +L SK ++ KL FG+A+
Sbjct: 126 VYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 193 SDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+ GT ++ P K VDV+ GV+L
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 51/225 (22%), Positives = 83/225 (36%), Gaps = 56/225 (24%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
IG+GS G V A+ + + K I + + + EI ++ SL
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKK--IPKYFVEDVD-------RFKQEIEIMKSLDH 65
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAAATT 134
N ++ + T + N++ LVME G L++ + + + AA
Sbjct: 66 PN-------IIRLYET-------FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-- 109
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAVS 191
+I + A+ H+ + HRD+K N LF + KL DFGLA
Sbjct: 110 ---------RIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 192 ESDESSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVL 231
M GT Y+ P Y + D +S GV++
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLEGLY------GPECDEWSAGVMM 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 46/224 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+G G V K + G K + +R S++ V ++ ++ E+ +L
Sbjct: 11 EELGSGQFAIVRKCR---QKGTGKEYAAKFIKKRRLSSSRRGVSRE---EIEREVNILRE 64
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAA 131
++ +PN ++ H + ++ +L++E + G L+D L A
Sbjct: 65 IR-----HPN--IITLHDI-------FENKTDVVLILELVSGGELFDFLAEKESLTEDEA 110
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA----KLADFG 187
+ QI + LH I H D+K NI+ K KL DFG
Sbjct: 111 T-----------QFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157
Query: 188 LAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+A + GT ++ P N L + D++S GV+
Sbjct: 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 57/235 (24%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ F R +G G+ G V+ E+ + + I I + + Q +++ EI
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLV--EERSSGLERVIKTINKDRS------QVPMEQIEAEIE 72
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN----- 128
VL SL +PN ++ + N +VME G L + + +
Sbjct: 73 VLKSLD-----HPN--IIKIFEV-------FEDYHNMYIVMETCEGGELLERIVSAQARG 118
Query: 129 -----AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-- 181
A ++ Q+ A+ H ++H+D+K NILF
Sbjct: 119 KALSEGYVA-----------ELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSP 165
Query: 182 -KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP----SKLSKKVDVFSYGVVL 231
K+ DFGLA + AGT Y P ++ K D++S GVV+
Sbjct: 166 IKIIDFGLAELFKSDEHSTNAAGT-----ALYMAPEVFKRDVTFKCDIWSAGVVM 215
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+IG+G G VY L D+ DG A+K T+ EV + E ++
Sbjct: 31 EVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDF 83
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+PN V++ G R+ GS L+V+ +M +G L + + N T
Sbjct: 84 -----SHPN--VLSLLGICLRSEGSP------LVVLPYMKHGDLRNFIRNE----THNPT 126
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+ + +Q+++ ++ L +HRD+ + N + D K+ K+ADFGLA D+
Sbjct: 127 VKDLIGFGLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 199 VQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
T L +T S DV+S+GV+L E+++
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKS------DVWSFGVLLWELMT 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 56/258 (21%), Positives = 82/258 (31%), Gaps = 70/258 (27%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
IG+GS+G V AI KI+ + + +++ E+R++
Sbjct: 32 GAIGQGSYGVVRVAI---ENQTRAIRAIKIMNKNKIRQIN----PKDVERIKTEVRLMKK 84
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
L N + + + LVME G L D L+ +T +
Sbjct: 85 LHHPN-------IARLYEV-------YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 138 GWPNRV-----------------------------------KIAMQISRAIQCLHENDPM 162
I QI A+ LH
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-- 188
Query: 163 IIHRDIKSTNILFDSKWDA--KLADFGLAV-----SESDESSMVQPAGTIGYLDP--GYT 213
I HRDIK N LF + KL DFGL+ + + M AGT ++ P T
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 214 NPSKLSKKVDVFSYGVVL 231
K D +S GV+L
Sbjct: 249 TNESYGPKCDAWSAGVLL 266
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 48/221 (21%)
Query: 22 LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES 81
++G G +G V + H+ G + A+K +L D S K E+
Sbjct: 36 VLGLGVNGKVLECF---HRRTG--QKCALK--------LLYD-SPKARQEVDHHWQAS-- 79
Query: 82 NKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN--------AAAAT 133
P+ +V N G L++ME M G L+ + AA
Sbjct: 80 --GGPH--IVCILDV-YENMH--HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA- 131
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAV 190
+I I AIQ LH ++ I HRD+K N+L+ SK KL DFG A
Sbjct: 132 ----------EIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 191 SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
E+ ++++ P T Y+ P P K K D++S GV++
Sbjct: 180 -ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 47/220 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G+G+ VY+ T + + +K+ + K + EI VL L
Sbjct: 59 SELGRGATSIVYRCK--QKGTQKPYALKVLKKTV---------DKKIVRTEIGVLLRLS- 106
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAAATT 134
+PN ++ + + LV+E + G L+D + AA
Sbjct: 107 ----HPN--IIKLKEI-------FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-- 151
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLAVS 191
QI A+ LHEN I+HRD+K N+L+ + K+ADFGL+
Sbjct: 152 ---------DAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+ M GT GY P +VD++S G++
Sbjct: 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 62/230 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+GKG+ V + + G I I + + +KL E R+
Sbjct: 17 EELGKGAFSVVRRCV---KVLAGQEYAAMI--INTKKLSARDH-----QKLEREARICRL 66
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------AAA 131
L+ +PN +V H + + + L+ + + G L++ + A A
Sbjct: 67 LK-----HPN--IVRLHDS-------ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA 112
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGL 188
+ QI A+ H+ ++HR++K N+L SK KLADFGL
Sbjct: 113 S-----------HCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGL 159
Query: 189 AVS-ESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVL 231
A+ E ++ + AGT GYL P Y K VD+++ GV+L
Sbjct: 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY------GKPVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 51/250 (20%), Positives = 86/250 (34%), Gaps = 66/250 (26%)
Query: 13 ATESFS---------QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD 63
+T+SFS Q ++G+G+H V I + + A+K
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCI---NLITS--QEYAVKIIEKQPGH---- 52
Query: 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
++ E+ +L Q + N V+ + LV E M GS+
Sbjct: 53 IRSRVFREVEMLYQCQG----HRN--VLELIEF-------FEEEDRFYLVFEKMRGGSIL 99
Query: 124 DLLHN------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177
+H A+ + ++ A+ LH I HRD+K NIL +
Sbjct: 100 SHIHKRRHFNELEAS-----------VVVQDVASALDFLHNKG--IAHRDLKPENILCEH 146
Query: 178 KWDA---KLADFGLAV--------SESDESSMVQPAGTIGY-----LDPGYTNPSKLSKK 221
K+ DF L S ++ P G+ Y ++ S K+
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 222 VDVFSYGVVL 231
D++S GV+L
Sbjct: 207 CDLWSLGVIL 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 43/227 (18%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ + +G G+ G V++ + + G ++ K +T + + NEI
Sbjct: 50 YDYYDILEELGSGAFGVVHRCV---EKATG--RVFVAKFINTPYPL----DKYTVKNEIS 100
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-------LL 126
+++ L +P ++N H + +L++EF+ G L+D +
Sbjct: 101 IMNQLH-----HPK--LINLHDA-------FEDKYEMVLILEFLSGGELFDRIAAEDYKM 146
Query: 127 HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLA 184
A Q ++ +HE+ I+H DIK NI+ ++K + K+
Sbjct: 147 SEAEVI-----------NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKII 193
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
DFGLA + + + T + P + + D+++ GV+
Sbjct: 194 DFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 44/232 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--KKLNNEI 72
+ + IGKG G V ++ +A+K +++++ + E
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK-------VAVK--------CIKNDATAQAFLAEA 237
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAA 130
V++ L R+ N +V G G + +V E+M GSL D L +
Sbjct: 238 SVMTQL-----RHSN--LVQLLGVIVEEKGGL------YIVTEYMAKGSLVDYLRSRGRS 284
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
L +K ++ + A++ L N+ +HRD+ + N+L AK++DFGL
Sbjct: 285 VLGGDCL-----LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 191 SESDESSMVQ-PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
S + P + + P K S K DV+S+G++L EI S R P
Sbjct: 338 EASSTQDTGKLP---VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 37/227 (16%), Positives = 82/227 (36%), Gaps = 46/227 (20%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
E + + +G+G G V++ + + K K G + + EI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCV---ETSSK--KTYMAKFVKVKGTDQ-----VLVKKEIS 53
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-------LL 126
+L+ + + N +++ H + + +++ EF+ +++ L
Sbjct: 54 ILNIAR-----HRN--ILHLHES-------FESMEELVMIFEFISGLDIFERINTSAFEL 99
Query: 127 HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLA 184
+ Q+ A+Q LH ++ I H DI+ NI++ ++ + K+
Sbjct: 100 NEREIV-----------SYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKII 146
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+FG A + Y P +S D++S G ++
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 52/241 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
R +G+GS G VY+ + + D +AIK + + E + NE V+
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-----IEFLNEASVMKEF 85
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAATTPQ 136
+ VV G L++ME M G L L A A P
Sbjct: 86 -----NCHH--VVRLLGV-VSQGQPT------LVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 137 LGWPNR---VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VS 191
L P+ +++A +I+ + L+ N +HRD+ + N + + K+ DFG+ +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 192 ESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239
E+D G G L D +T S DV+S+GVVL EI + +
Sbjct: 190 ETDYYRK----GGKGLLPVRWMSPESLKDGVFTTYS------DVWSFGVVLWEIATLAEQ 239
Query: 240 P 240
P
Sbjct: 240 P 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 45/225 (20%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
+ S++ ++G G G V+K G LA K T G + +++ NEI V+
Sbjct: 90 TVSKTEILGGGRFGQVHKCE---ETATG--LKLAAKIIKTRG----MKDKEEVKNEISVM 140
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-------LLHN 128
+ L + N ++ + + ++ +LVME++ G L+D L
Sbjct: 141 NQL-----DHAN--LIQLYDA-------FESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 129 AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLADF 186
QI I+ +H+ I+H D+K NIL ++ K+ DF
Sbjct: 187 LDTI-----------LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDF 233
Query: 187 GLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
GLA + GT +L P N +S D++S GV+
Sbjct: 234 GLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 48/227 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + + +G+GS K + H+ + A+K S Q EI
Sbjct: 11 DLDLKDKPLGEGSFSICRKCV---HKKSN--QAFAVKIISKRMEANTQ-------KEITA 58
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------ 128
L + +PN +V H + LVME + G L++ +
Sbjct: 59 LKLCEG----HPN--IVKLHEV-------FHDQLHTFLVMELLNGGELFERIKKKKHFSE 105
Query: 129 AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLAD 185
A+ I ++ A+ +H+ ++HRD+K N+LF + D K+ D
Sbjct: 106 TEAS-----------YIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIID 152
Query: 186 FGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
FG A + ++ + P T+ Y P N + + D++S GV+L
Sbjct: 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 53/242 (21%), Positives = 93/242 (38%), Gaps = 55/242 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +G+G+ G V +A + +A+K + E + L +E+++L +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-----RALMSELKILIHI 87
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL-----------H 127
+ N VVN G + G + ++++EF G+L L
Sbjct: 88 ----GHHLN--VVNLLGACTKPGGPL------MVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 128 NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
L + + + Q+++ ++ L IHRD+ + NIL K K+ DFG
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 188 LA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEI 234
LA + + + L D YT S DV+S+GV+L EI
Sbjct: 194 LARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQS------DVWSFGVLLWEI 243
Query: 235 IS 236
S
Sbjct: 244 FS 245
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-20
Identities = 69/337 (20%), Positives = 115/337 (34%), Gaps = 66/337 (19%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+G G+ G V+ A+ + K + K + K+ EI +LS
Sbjct: 30 SPLGSGAFGFVWTAV---DKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGS-LYDLLHNAAAATTP 135
+ + N ++ + N LVME +G L+ + P
Sbjct: 86 V-----EHAN--IIKVL--------DIFENQGFFQLVMEKHGSGLDLFAFI-----DRHP 125
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+L P I Q+ A+ L IIHRDIK NI+ + KL DFG A
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 196 SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD--- 246
GTI Y P Y P +++++S GV L ++ P +
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFEENPFCELEETVE 238
Query: 247 -----PASIIDWALPLIKE------EK---LRQVCDSR-----VGLPTFMEGAIKQMLHV 287
P + + L+ E+ L ++ V L + + ++
Sbjct: 239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP 298
Query: 288 AARCVS--SEEENRPGIGEILMGCSCFFVDHHHHHHH 322
+ +S S E + ++ + HHHHHH
Sbjct: 299 ESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHHHHH 335
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 54/229 (23%), Positives = 88/229 (38%), Gaps = 43/229 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
ES +G+G G V+ +AIK L+ + + E
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR------VAIK--------TLKPGTMSPEAFLQE 229
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNA 129
+V+ L R+ +V + V +V E+M GSL D L
Sbjct: 230 AQVMKKL-----RHEK--LVQLYA--------VVSEEPIYIVTEYMSKGSLLDFLKGETG 274
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
PQL V +A QI+ + + + +HRD+++ NIL K+ADFGLA
Sbjct: 275 KYLRLPQL-----VDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 327
Query: 190 VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
D + I + P + + K DV+S+G++L E+ +
Sbjct: 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 54/229 (23%), Positives = 88/229 (38%), Gaps = 43/229 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
ES +G+G G V+ +AIK L+ + + E
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR------VAIK--------TLKPGTMSPEAFLQE 312
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNA 129
+V+ L R+ +V + V +V E+M GSL D L
Sbjct: 313 AQVMKKL-----RHEK--LVQLYA--------VVSEEPIYIVTEYMSKGSLLDFLKGETG 357
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
PQL V +A QI+ + + + +HRD+++ NIL K+ADFGLA
Sbjct: 358 KYLRLPQL-----VDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 410
Query: 190 VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
D + I + P + + K DV+S+G++L E+ +
Sbjct: 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 46/231 (19%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNN 70
+ + +G G V K ++ G K + +R ++ V ++ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCR---EKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIER 63
Query: 71 EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD------ 124
E+ +L +Q +PN V+ H + ++ +L++E + G L+D
Sbjct: 64 EVSILKEIQ-----HPN--VITLHEV-------YENKTDVILILELVAGGELFDFLAEKE 109
Query: 125 LLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--- 181
L A + QI + LH I H D+K NI+ +
Sbjct: 110 SLTEEEAT-----------EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPR 156
Query: 182 -KLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
K+ DFGLA + GT ++ P N L + D++S GV+
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 49/231 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+IG+G G VY L D+ DG A+K T+ EV + E ++
Sbjct: 95 EVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDF 147
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+PN V++ G R+ GS L+V+ +M +G L + + N T
Sbjct: 148 -----SHPN--VLSLLGICLRSEGSP------LVVLPYMKHGDLRNFIRN----ETHNPT 190
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDES 196
+ + +Q+++ ++ L +HRD+ + N + D K+ K+ADFGLA + + +
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248
Query: 197 SMVQPAGT-----------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
S+ G + K + K DV+S+GV+L E+++
Sbjct: 249 SVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMT 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 50/235 (21%), Positives = 90/235 (38%), Gaps = 57/235 (24%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
R+IGKG G VY D + AIK T +V + E ++ L
Sbjct: 27 RVIGKGHFGVVYHGEYID--QAQNRIQCAIKSLSRITEMQQV-----EAFLREGLLMRGL 79
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+PN V+ G G +++ +M +G L + +
Sbjct: 80 -----NHPN--VLALIGIMLPPEGLP------HVLLPYMCHGDLLQFIRSPQ----RNPT 122
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDES 196
+ + +Q++R ++ L E +HRD+ + N + D + K+ADFGLA + + +
Sbjct: 123 VKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE-- 178
Query: 197 SMVQPAGTIGYLDPGYTNPSKL---------------SKKVDVFSYGVVLLEIIS 236
Y ++L + K DV+S+GV+L E+++
Sbjct: 179 ----------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 39/230 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+++G+G GSV + L+ DG +A+K + Q ++ +E +
Sbjct: 40 KILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDF-- 93
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAAATTPQLGW 139
+PN V+ G C S G ++++ FM G L+ LL++ +
Sbjct: 94 ---SHPN--VIRLLGV-CIEMSSQ-GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESS 197
+K + I+ ++ L +HRD+ + N + +ADFGL+ + D
Sbjct: 147 QTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 198 MVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
G I + D YT+ S DV+++GV + EI +
Sbjct: 205 ----QGRIAKMPVKWIAIESLADRVYTSKS------DVWAFGVTMWEIAT 244
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 41/230 (17%), Positives = 75/230 (32%), Gaps = 50/230 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
I G G +Y A D +G + +K S + + E + L+ +
Sbjct: 86 GCIAHGGLGWIYLA--LDRNVNGRP--VVLKGLVHSGD-----AEAQAMAMAERQFLAEV 136
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL---LVMEFMPNGSLYDLLHNAAAATTP 135
+P+ +V N +VME++ SL
Sbjct: 137 V-----HPS--IVQIF-----NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------- 177
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+L + ++I A+ LH +++ D+K NI+ + KL D G +
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234
Query: 196 SSMVQPAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ GT G+ P G T + D+++ G L +
Sbjct: 235 GYLY---GTPGFQAPEIVRTGPTVAT------DIYTVGRTLAALTLDLPT 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 52/235 (22%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLN 69
F + +++G G+ G+VYK + + AIK L++ + K++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIK--------ELREATSPKANKEIL 65
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
+E V++S+ NP+ V G ++ L+ + MP G L D +
Sbjct: 66 DEAYVMASV-----DNPH--VCRLLGICLTST--------VQLITQLMPFGCLLDYVREH 110
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+G + +QI++ + L + ++HRD+ + N+L + K+ DFGLA
Sbjct: 111 K----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 190 VSESDESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
E G I ++ + + DV+SYGV + E+++ KP
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 53/239 (22%), Positives = 83/239 (34%), Gaps = 57/239 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVL 75
R +G G+ G VY+ + D +A+K L + E ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--------TLPEVCSEQDELDFLMEALII 87
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAAT 133
S + N +V G S ++ME M G L L +
Sbjct: 88 SKF-----NHQN--IVRCIGV-SLQSLPR------FILMELMAGGDLKSFLRETRPRPSQ 133
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD---AKLADFGLA- 189
L + + +A I+ Q L EN IHRDI + N L AK+ DFG+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 190 -VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + G L + +T+ + D +S+GV+L EI S
Sbjct: 192 DIYRASYYRK----GGCAMLPVKWMPPEAFMEGIFTSKT------DTWSFGVLLWEIFS 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 52/239 (21%), Positives = 83/239 (34%), Gaps = 57/239 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVL 75
R +G G+ G VY+ + D +A+K L + E ++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--------TLPEVCSEQDELDFLMEALII 128
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAAAAT 133
S + N +V G S +++E M G L L +
Sbjct: 129 SKF-----NHQN--IVRCIGV-SLQSLPR------FILLELMAGGDLKSFLRETRPRPSQ 174
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD---AKLADFGLA- 189
L + + +A I+ Q L EN IHRDI + N L AK+ DFG+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 190 -VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ + G L + +T+ + D +S+GV+L EI S
Sbjct: 233 DIYRAGYYRK----GGCAMLPVKWMPPEAFMEGIFTSKT------DTWSFGVLLWEIFS 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 68/297 (22%), Positives = 114/297 (38%), Gaps = 65/297 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IGKG+ V A H G +AIK + ++ + +KL E+R++ L
Sbjct: 21 KTIGKGNFAKVKLAR---HILTGRE--VAIK--IIDKTQLNPTSLQKLFREVRIMKIL-- 71
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+PN +V V L L+ME+ G ++D L ++
Sbjct: 72 ---NHPN--IVKLF--------EVIETEKTLYLIMEYASGGEVFDYLVAHG-----RMKE 113
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV 199
QI A+Q H+ I+HRD+K+ N+L D+ + K+ADFG + + +
Sbjct: 114 KEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171
Query: 200 QPAGTIGY------LDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253
G Y Y P +VDV+S GV+L ++S P D
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGP-----EVDVWSLGVILYTLVSGSLPFDGQNLK------ 220
Query: 254 ALPLIKEEKLRQVCDSRVGLPTFM----EGAIKQMLHVAARCVSSEEENRPGIGEIL 306
E +V + +P +M E +K+ L + R + +I+
Sbjct: 221 -------ELRERVLRGKYRIPFYMSTDCENLLKRFLVL-------NPIKRGTLEQIM 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 54/240 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +G G+ G V +A + +A+K +++ + E + L +E++++S L
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-----EALMSELKIMSHL 106
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN---------A 129
++ N +VN G +C + G V L++ E+ G L + L A
Sbjct: 107 ----GQHEN--IVNLLG-ACTHGGPV------LVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
A + + + Q+++ + L IHRD+ + N+L + AK+ DFGLA
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 190 --VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
+ L D YT S DV+SYG++L EI S
Sbjct: 212 RDIMNDSNYI----VKGNARLPVKWMAPESIFDCVYTVQS------DVWSYGILLWEIFS 261
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-18
Identities = 66/247 (26%), Positives = 92/247 (37%), Gaps = 51/247 (20%)
Query: 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN- 70
AT + IG G++G+VYKA D + +A+K V N
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKAR--DPHSG---HFVALKS-------VRVPNGGGGGGG 53
Query: 71 -------EIRVLSSLQESNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKLLVMEFMPN 119
E+ +L L+ N VV + V LV E +
Sbjct: 54 LPISTVREVALLRRLEAFEHPN----VVRLMDVCATSRTDREIKV------TLVFEHVDQ 103
Query: 120 GSLYDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
L L A P +K M Q R + LH N I+HRD+K NIL S
Sbjct: 104 -DLRTYLDKAPPPGLP----AETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSG 156
Query: 179 WDAKLADFGLAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEI 234
KLADFGLA S + ++ T+ Y P S + VD++S G + E+
Sbjct: 157 GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAEM 212
Query: 235 ISCRKPI 241
RKP+
Sbjct: 213 FR-RKPL 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 49/233 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
+ +G G +G VY+ + + + +A+K L++++ ++ E
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLT-----VAVK--------TLKEDTMEVEEFLKE 59
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNA 129
V+ + ++PN +V G C ++ EFM G+L D L N
Sbjct: 60 AAVMKEI-----KHPN--LVQLLGV-CTREPPF------YIITEFMTYGNLLDYLRECNR 105
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+ L + +A QIS A++ L + + IHRD+ + N L K+ADFGL+
Sbjct: 106 QEVSAVVL-----LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS 158
Query: 190 -VSESDESSMVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEIIS 236
+ D + A +T P +K S K DV+++GV+L EI +
Sbjct: 159 RLMTGDTYT----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 42/188 (22%)
Query: 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN 70
+ ++ F Q +G G++ +VYK + + T +A+K KL++
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGL--NKTTG---VYVALKEV-------------KLDS 42
Query: 71 E-------IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSL 122
E IR +S ++E N +V + V NKL LV EFM N L
Sbjct: 43 EEGTPSTAIREISLMKELKHEN----IVRLY--------DVIHTENKLTLVFEFMDN-DL 89
Query: 123 YDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
+ + TP+ N VK Q+ + + HEN I+HRD+K N+L + +
Sbjct: 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQL 147
Query: 182 KLADFGLA 189
KL DFGLA
Sbjct: 148 KLGDFGLA 155
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 60/264 (22%), Positives = 101/264 (38%), Gaps = 54/264 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIR 73
+ F R IGKGS G V Q + K+ A+K N + ++ N + + E++
Sbjct: 15 DHFEILRAIGKGSFGKVCIV-----QKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQ 67
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
++ L +P +VN + + + +V++ + G L L
Sbjct: 68 IMQGL-----EHP--FLVNLWYSF--------QDEEDMFMVVDLLLGGDLRYHLQQNVHF 112
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
VK+ ++ A+ L IIHRD+K NIL D + DF +A
Sbjct: 113 KEE------TVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 192 ESDESSMVQPAGTIGYLDP---------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP-- 240
E+ + AGT Y+ P GY S VD +S GV E++ R+P
Sbjct: 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGY------SFAVDWWSLGVTAYELLRGRRPYH 218
Query: 241 IDAARDPASIIDWALPLIKEEKLR 264
I ++ I+ + +
Sbjct: 219 IRSSTSSKEIVH----TFETTVVT 238
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 31/220 (14%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ + +G G+ G V++ + G A K T + + EI+
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVT---ERATG--NNFAAKFVMTPHESDKET----VRKEIQ 206
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
+S L+ +P +VN H + ++ +++ EFM G L++ + A
Sbjct: 207 TMSVLR-----HPT--LVNLHDA-------FEDDNEMVMIYEFMSGGELFEKV----ADE 248
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLADFGLAVS 191
++ V+ Q+ + + +HEN+ +H D+K NI+F +K KL DFGL
Sbjct: 249 HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
+ S+ GT + P + D++S GV+
Sbjct: 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 55/232 (23%), Positives = 87/232 (37%), Gaps = 35/232 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
E R IG+G G V++ I + +AIK + T+ +K E
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSP--ENPAMAVAIKTCKNCTS-----DSVREKFLQEA 442
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAA 131
+ +P+ +V G V + ++ME G L L +
Sbjct: 443 LTMRQF-----DHPH--IVKLIG--------VITENPVWIIMELCTLGELRSFLQVRKFS 487
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
L + A Q+S A+ L +HRDI + N+L S KL DFGL+
Sbjct: 488 LDLASL-----ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
Query: 192 ESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
D + G I ++ P N + + DV+ +GV + EI+ KP
Sbjct: 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 52/244 (21%), Positives = 100/244 (40%), Gaps = 58/244 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKIL--AIK--RASTNGFEVLQDNSKKLNNEIRVLS 76
+ +G+G+ G V A D + + A+K + ++ L +E+ ++
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-----SDLVSEMEMMK 95
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL---------- 126
+ ++ N ++N G +C G + +++E+ G+L + L
Sbjct: 96 MI----GKHKN--IINLLG-ACTQDGPL------YVIVEYASKGNLREYLRARRPPGMEY 142
Query: 127 -HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
++ Q+ + + V Q++R ++ L IHRD+ + N+L K+AD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIAD 200
Query: 186 FGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLL 232
FGLA ++ D T G L D YT+ S DV+S+GV++
Sbjct: 201 FGLARDINNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQS------DVWSFGVLMW 250
Query: 233 EIIS 236
EI +
Sbjct: 251 EIFT 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 70/329 (21%), Positives = 128/329 (38%), Gaps = 66/329 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKIL--AIK--RASTNGFEVLQDNSKKLNN 70
E + +G+G+ ++K + + G +K + ++ S+
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH------RNYSESFFE 61
Query: 71 EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA 130
++S L + + +V +G C +LV EF+ GSL L
Sbjct: 62 AASMMSKL-----SHKH--LVLNYGV-CVCGDEN------ILVQEFVKFGSLDTYLKKNK 107
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD--------AK 182
+ ++++A Q++ A+ L EN +IH ++ + NIL + D K
Sbjct: 108 ----NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIK 161
Query: 183 LADFGLAVSESDESSMVQPAGTIGYLDP-GYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
L+D G++++ + + + I ++ P NP L+ D +S+G L EI S KP
Sbjct: 162 LSDPGISITVLPKDILQER---IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQ-MLHVAARCVSSEEENR 299
+ AL + KL+ + R LP + + C+ E ++R
Sbjct: 219 L-----------SALDS--QRKLQFY-EDRHQLPAPKAAELANLIN----NCMDYEPDHR 260
Query: 300 PGIGEILMGCSCFF----VDHHHHHHHHH 324
P I+ + F V HHHHHH
Sbjct: 261 PSFRAIIRDLNSLFTPDLVPRGSHHHHHH 289
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 50/241 (20%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
++ ++IG G G VYK +L+ + + AIK +A + E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKAGYT-----EKQRVDFLGEA 97
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++ + N ++ G + +++ E+M NG+L L
Sbjct: 98 GIMGQF-----SHHN--IIRLEGV-ISKYKPM------MIITEYMENGALDKFLREKD-- 141
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VS 191
+ V + I+ ++ L + +HRD+ + NIL +S K++DFGL+ V
Sbjct: 142 --GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 192 ESDESSMVQPAGT-----------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RK 239
E D + +G I Y K + DV+S+G+V+ E+++ +
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGER 249
Query: 240 P 240
P
Sbjct: 250 P 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 55/250 (22%), Positives = 89/250 (35%), Gaps = 58/250 (23%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
S + +G G+ G V +A +A+K + S + E + L +E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALMSEL 77
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+VLS L + N +VN G +C G L++ E+ G L + L +
Sbjct: 78 KVLSYL----GNHMN--IVNLLG-ACTIGGPT------LVITEYCCYGDLLNFLRRKRDS 124
Query: 133 TTPQLGWPNR-------------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179
P + + Q+++ + L IHRD+ + NIL
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGR 182
Query: 180 DAKLADFGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFS 226
K+ DFGLA + L + YT S DV+S
Sbjct: 183 ITKICDFGLARDIKNDSNYV----VKGNARLPVKWMAPESIFNCVYTFES------DVWS 232
Query: 227 YGVVLLEIIS 236
YG+ L E+ S
Sbjct: 233 YGIFLWELFS 242
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 45/233 (19%), Positives = 78/233 (33%), Gaps = 33/233 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRAST--NGFEVLQDNSKKLNNEI 72
+ +G GS G V + G +A+K + E+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEW--DAPSGKTVSVAVK---CLKPDVLSQPEAMDDFIREV 72
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+ SL + N ++ +G V +V E P GSL D L
Sbjct: 73 NAMHSL-----DHRN--LIRLYG--------VVLTPPMKMVTELAPLGSLLDRLRKHQ-- 115
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VS 191
+ A+Q++ + L IHRD+ + N+L ++ K+ DFGL
Sbjct: 116 --GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 192 ESDESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
++ V + P S D + +GV L E+ + ++P
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 44/234 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
ES + +G G G V+ A H +A+K ++ S + E
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK------VAVK--------TMKPGSMSVEAFLAE 233
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNA 129
V+ +L ++ +V H V ++ EFM GSL D L
Sbjct: 234 ANVMKTL-----QHDK--LVKLHA--------VVTKEPIYIITEFMAKGSLLDFLKSDEG 278
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+ P+L + + QI+ + + + + IHRD+++ NIL + K+ADFGLA
Sbjct: 279 SKQPLPKL-----IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLA 331
Query: 190 VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240
D + I + P N + K DV+S+G++L+EI++ R P
Sbjct: 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 3e-18
Identities = 55/252 (21%), Positives = 102/252 (40%), Gaps = 76/252 (30%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--- 71
+ + + IG+G++G+V+KA + +T +I+A+KR +L+++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK--NRETH---EIVALKRV-------------RLDDDDEG 43
Query: 72 -----IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
+R + L+E +N +V H V + KL LV EF L
Sbjct: 44 VPSSALREICLLKELKHKN----IVRLH--------DVLHSDKKLTLVFEFCDQ-DLKKY 90
Query: 126 LHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
+ P++ VK + Q+ + + H ++HRD+K N+L + + KLA
Sbjct: 91 FDSCNGDLDPEI-----VKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLA 143
Query: 185 DFGLAVSESDESSMVQPAGTIGYLDPGYTN---------PSKL------SKKVDVFSYGV 229
+FGLA + P Y+ P L S +D++S G
Sbjct: 144 NFGLARAFGI------PVRC-------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190
Query: 230 VLLEIISCRKPI 241
+ E+ + +P+
Sbjct: 191 IFAELANAGRPL 202
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 48/235 (20%)
Query: 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ + +G G+ G+V K Q K +A+K + +L E V+ L
Sbjct: 21 EDKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQL 75
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
NP +V G + + +LVME G L L +
Sbjct: 76 -----DNPY--IVRMIG--------ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 119
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDESS 197
+++ Q+S ++ L E++ +HRD+ + N+L ++ AK++DFGL+ +DE+
Sbjct: 120 ----IELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 198 MVQPAGT-----------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
I Y K S K DV+S+GV++ E S +KP
Sbjct: 174 YKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 32/253 (12%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL-NNEIR 73
+F Q R++GKG G V Q K+ A K+ + + + + NE +
Sbjct: 184 NTFRQYRVLGKGGFGEVCAC-----QVRATGKMYACKKLEKK--RIKKRKGEAMALNEKQ 236
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+L + + VV+ + + L LV+ M G L +++ A
Sbjct: 237 ILEKV-----NSR--FVVSLA--YAYET------KDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
P+ R A +I ++ LH I++RD+K NIL D +++D GLAV
Sbjct: 282 GFPE----ARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251
+ ++ GT+GY+ P + + D ++ G +L E+I+ + P R
Sbjct: 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ-QRKKKIKR 394
Query: 252 DWALPLIKEEKLR 264
+ L+KE
Sbjct: 395 EEVERLVKEVPEE 407
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--KKLNNEI 72
+ + IGKG G V ++ +A+K +++++ + E
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK-------VAVK--------CIKNDATAQAFLAEA 65
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNAA 130
V++ L R+ N +V G G + +V E+M GSL D L +
Sbjct: 66 SVMTQL-----RHSN--LVQLLGVIVEEKGGL------YIVTEYMAKGSLVDYLRSRGRS 112
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA- 189
L +K ++ + A++ L N+ +HRD+ + N+L AK++DFGL
Sbjct: 113 VLGGDCL-----LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK 165
Query: 190 -VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
S + ++ + P + + P K S K DV+S+G++L EI S
Sbjct: 166 EASSTQDTGKL-P---VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 52/243 (21%), Positives = 92/243 (37%), Gaps = 61/243 (25%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK----LNNEIRVLS 76
+G+G+ G V+ A + + D ++A+K L++ S+ E +L+
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVK--------ALKEASESARQDFQREAELLT 98
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL---------- 126
L ++ + +V F G C + L+V E+M +G L L
Sbjct: 99 ML-----QHQH--IVRFFGV-CTEGRPL------LMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 127 HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186
LG + +A Q++ + L +HRD+ + N L K+ DF
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDF 202
Query: 187 GLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLE 233
G++ + +D + G L +T S DV+S+GVVL E
Sbjct: 203 GMSRDIYSTDYYRV----GGRTMLPIRWMPPESILYRKFTTES------DVWSFGVVLWE 252
Query: 234 IIS 236
I +
Sbjct: 253 IFT 255
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 46/239 (19%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
S++ +++IG GS G VY+A L D +++AIK+ VLQD K N E++
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKK-------VLQDKRFK-NRELQ 99
Query: 74 VLSSLQESNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHN 128
++ L N +V F+ S + L LV++++P ++Y + +
Sbjct: 100 IMRKLDHCN-------IVRLRYFFY------SSGEKKDEVYLNLVLDYVPE-TVYRVARH 145
Query: 129 AAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-KLADF 186
+ A VK+ M Q+ R++ +H I HRDIK N+L D KL DF
Sbjct: 146 YSRAKQTLP--VIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 187 GLAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
G A V + Y P G T+ + +DV+S G VL E++ +PI
Sbjct: 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATD---YTSSIDVWSAGCVLAELLL-GQPI 256
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 67/243 (27%), Positives = 103/243 (42%), Gaps = 64/243 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVL 75
+IG+G+ G V KA ++ DG AIKR +++ + + E+ VL
Sbjct: 31 DVIGEGNFGQVLKARIKK---DGLRMDAAIKR--------MKEYASKDDHRDFAGELEVL 79
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--------- 126
L +PN ++N G C + G + L +E+ P+G+L D L
Sbjct: 80 CKL----GHHPN--IINLLGA-CEHRGYL------YLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 127 --HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
A +T L + A ++R + L + IHRD+ + NIL + AK+A
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIA 184
Query: 185 DFGLAVSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLE 233
DFGL+ + V T+G L YT S DV+SYGV+L E
Sbjct: 185 DFGLSRGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNS------DVWSYGVLLWE 233
Query: 234 IIS 236
I+S
Sbjct: 234 IVS 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 62/244 (25%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK----LNNEIRVLS 76
R +G+G+ G V+ A + D ++A+K L+D + E +L+
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVK--------ALKDPTLAARKDFQREAELLT 72
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL---------- 126
+LQ + +V F+G C + + ++V E+M +G L L
Sbjct: 73 NLQHEH-------IVKFYGV-CGDGDPL------IMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 127 -HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+LG + IA QI+ + L +HRD+ + N L + K+ D
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGD 176
Query: 186 FGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLL 232
FG++ V +D + G L +T S DV+S+GV+L
Sbjct: 177 FGMSRDVYSTDYYRV----GGHTMLPIRWMPPESIMYRKFTTES------DVWSFGVILW 226
Query: 233 EIIS 236
EI +
Sbjct: 227 EIFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 52/244 (21%), Positives = 99/244 (40%), Gaps = 58/244 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKIL--AIK--RASTNGFEVLQDNSKKLNNEIRVLS 76
+ +G+G G V A D + + A+K + ++ L +E+ ++
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-----SDLVSEMEMMK 141
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL---------- 126
+ ++ N ++N G +C G + +++E+ G+L + L
Sbjct: 142 MI----GKHKN--IINLLG-ACTQDGPL------YVIVEYASKGNLREYLRARRPPGMEY 188
Query: 127 -HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
++ Q+ + + V Q++R ++ L IHRD+ + N+L K+AD
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIAD 246
Query: 186 FGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLL 232
FGLA ++ D T G L D YT+ S DV+S+GV++
Sbjct: 247 FGLARDINNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQS------DVWSFGVLMW 296
Query: 233 EIIS 236
EI +
Sbjct: 297 EIFT 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 38/230 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---- 70
F + +++G G+ G+VYK + + AIK L++ + N
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIK--------ELREATSPKANKEIL 65
Query: 71 -EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
E V++S+ NP+ V G ++ L+ + MP G L D +
Sbjct: 66 DEAYVMASV-----DNPH--VCRLLGICLTST--------VQLITQLMPFGCLLDYVREH 110
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
+G + +QI++ + L + ++HRD+ + N+L + K+ DFGLA
Sbjct: 111 K----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 190 VSESDESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
E G I ++ + + DV+SYGV + E+++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 56/244 (22%), Positives = 101/244 (41%), Gaps = 58/244 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKIL--AIK--RASTNGFEVLQDNSKKLNNEIRVLS 76
+ +G+G+ G V A D +++ A+K ++ ++ L +E+ ++
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-----SDLISEMEMMK 129
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL---------- 126
+ ++ N ++N G C G + +++E+ G+L + L
Sbjct: 130 MI----GKHKN--IINLLGA-CTQDGPL------YVIVEYASKGNLREYLQARRPPGLEY 176
Query: 127 -HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+N + QL + V A Q++R ++ L IHRD+ + N+L K+AD
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIAD 234
Query: 186 FGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLL 232
FGLA + D T G L D YT+ S DV+S+GV+L
Sbjct: 235 FGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQS------DVWSFGVLLW 284
Query: 233 EIIS 236
EI +
Sbjct: 285 EIFT 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 51/235 (21%), Positives = 83/235 (35%), Gaps = 50/235 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
E R IG+G G V++ I + +AIK + T+ +K E
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSP--ENPALAVAIKTCKNCTS-----DSVREKFLQEA 67
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYD-LLHNAAA 131
+ +P+ +V G V + ++ME G L L +
Sbjct: 68 LTMRQF-----DHPH--IVKLIG--------VITENPVWIIMELCTLGELRSFLQVRKYS 112
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
L + A Q+S A+ L +HRDI + N+L S KL DFGL+
Sbjct: 113 LDLASL-----ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
Query: 192 ESDESSMVQPAG----------TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
D + G +I + + + DV+ +GV + EI+
Sbjct: 166 MEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILM 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 49/247 (19%), Positives = 91/247 (36%), Gaps = 58/247 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+G+ G VYK L + +AIK + G ++ +E + + L
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-----EEFRHEAMLRARL 69
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL-----------H 127
++PN VV G + ++ + +G L++ L
Sbjct: 70 -----QHPN--VVCLLGV-VTKDQPL------SMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 128 NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
+ L P+ V + QI+ ++ L + ++H+D+ + N+L K + K++D G
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLG 173
Query: 188 LA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSYGVVLLEI 234
L V +D L ++ S D++SYGVVL E+
Sbjct: 174 LFREVYAADYYK----LLGNSLLPIRWMAPEAIMYGKFSIDS------DIWSYGVVLWEV 223
Query: 235 IS-CRKP 240
S +P
Sbjct: 224 FSYGLQP 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 49/239 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
E +R++G+G G VY+ + +H G+ +A+K + DN +K +E
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNH--KGEKINVAVKTCKKDCT-----LDNKEKFMSEA 64
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++ +L +P+ +V G + ++ME P G L L
Sbjct: 65 VIMKNL-----DHPH--IVKLIG--------IIEEEPTWIIMELYPYGELGHYLERNK-- 107
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
L V ++QI +A+ L + +HRDI NIL S KL DFGL+
Sbjct: 108 --NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYI 163
Query: 193 SDESSMVQPAG----------TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
DE +I + + + DV+ + V + EI+S ++P
Sbjct: 164 EDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 33/228 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
+ S +++G G G V L +AIK + + + E
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRL--KLPSKKEISVAIKTLKVGYT-----EKQRRDFLGEA 97
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++ +PN ++ G S V ++V E+M NGSL L
Sbjct: 98 SIMGQF-----DHPN--IIRLEGV-VTKSKPV------MIVTEYMENGSLDSFLRKHD-- 141
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VS 191
Q V + I+ ++ L + +HRD+ + NIL +S K++DFGL V
Sbjct: 142 --AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197
Query: 192 ESDESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236
E D + G I + P K + DV+SYG+VL E++S
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 51/241 (21%), Positives = 87/241 (36%), Gaps = 50/241 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
++IG G G V L +AIK +A + + +E
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRL--RVPGQRDVPVAIKALKAGY-----TERQRRDFLSEA 101
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++ +PN ++ G ++V E+M NGSL L
Sbjct: 102 SIMGQF-----DHPN--IIRLEGV-VTRGRLA------MIVTEYMENGSLDTFLRTHD-- 145
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VS 191
Q V + + ++ L + +HRD+ + N+L DS K++DFGL+ V
Sbjct: 146 --GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 192 ESDESSMVQPAGT-----------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RK 239
E D + G I + S DV+S+GVV+ E+++ +
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGER 253
Query: 240 P 240
P
Sbjct: 254 P 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 44/236 (18%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL-NNEIR 73
FS R+IG+G G VY + K+ A+K + + L NE
Sbjct: 189 NDFSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKK--RIKMKQGETLALNERI 241
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+LS + S P +V +KL +++ M G L+ L
Sbjct: 242 MLSLV--STGDCP--FIVCMSYAF--------HTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ ++ A +I ++ +H +++RD+K NIL D +++D GLA
Sbjct: 290 SEA------DMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC- 340
Query: 192 ESDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ + GT GY+ P Y D FS G +L +++ P
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYD------SSADWFSLGCMLFKLLRGHSP 390
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 56/245 (22%), Positives = 91/245 (37%), Gaps = 67/245 (27%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KIL-----------------AIKRASTNGFEV 60
IGKGS+G V A ++ D + K+L R + G
Sbjct: 19 DEIGKGSYGVVKLAY---NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPN----YCVVNFHGTSCRNSGSVDGNSNKL-LVME 115
+ +++ EI +L L +PN V++ D N + L +V E
Sbjct: 76 PRGPIEQVYQEIAILKKL-----DHPNVVKLVEVLD------------DPNEDHLYMVFE 118
Query: 116 FMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175
+ G + ++ L + + I+ LH IIHRDIK +N+L
Sbjct: 119 LVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKPSNLLV 170
Query: 176 DSKWDAKLADFGL-AVSESDESSMVQPAGTIGYLDPGYTNPSKLS--------KKVDVFS 226
K+ADFG+ + ++ + GT P + P LS K +DV++
Sbjct: 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGT-----PAFMAPESLSETRKIFSGKALDVWA 225
Query: 227 YGVVL 231
GV L
Sbjct: 226 MGVTL 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 61/248 (24%), Positives = 98/248 (39%), Gaps = 55/248 (22%)
Query: 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE 71
+A + + IG+G++G V+KA D + G + +A+KR ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKAR--DLKNGG--RFVALKRV-------------RVQTG 50
Query: 72 --------IRVLSSLQE-SNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKLLVMEFMP 118
IR ++ L+ +PN VV + + LV E +
Sbjct: 51 EEGMPLSTIREVAVLRHLETFEHPN--VVRLFDVCTVSRTDRETKL------TLVFEHVD 102
Query: 119 NGSLYDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDS 177
L L P +K M Q+ R + LH + ++HRD+K NIL S
Sbjct: 103 Q-DLTTYLDKVPEPGVP----TETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTS 155
Query: 178 KWDAKLADFGLAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLE 233
KLADFGLA S + ++ T+ Y P S + VD++S G + E
Sbjct: 156 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIFAE 211
Query: 234 IISCRKPI 241
+ RKP+
Sbjct: 212 MFR-RKPL 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 55/242 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+ +G+G++G V A+ ++ + KI+ +KR D + + EI +
Sbjct: 13 QTLGEGAYGEVQLAV---NRVTEEAVAVKIVDMKR--------AVDCPENIKKEICINKM 61
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L + N VV F+G N L +E+ G L+D +
Sbjct: 62 L-----NHEN--VVKFYG--------HRREGNIQYLFLEYCSGGELFDRIEPDI-----G 101
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
+ P+ + Q+ + LH I HRDIK N+L D + + K++DFGL +
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGL-------A 152
Query: 197 SMVQPAGTIGYLD-----PGYTNPSKLSKK------VDVFSYGVVLLEIISCRKPIDAAR 245
++ + L+ Y P L ++ VDV+S G+VL +++ P D
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
Query: 246 DP 247
D
Sbjct: 213 DS 214
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 42/182 (23%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---- 70
E + + IG+GS+G V+K + T +I+AIK+ L+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR--NRDTG---QIVAIKK-------FLESEDDPVIKKIAL 50
Query: 71 -EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHN 128
EIR+L L+ N +VN V +L LV E+ + ++ L
Sbjct: 51 REIRMLKQLKHPN-------LVNLL--------EVFRRKRRLHLVFEYCDH-TVLHELDR 94
Query: 129 AAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
+ + VK Q +A+ H+++ IHRD+K NIL KL DFG
Sbjct: 95 -----YQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFG 147
Query: 188 LA 189
A
Sbjct: 148 FA 149
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 65/250 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ +G+G G V KA + + +A+K + + + E+ + L +E VL +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-----RDLLSEFNVLKQV 83
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL------------ 126
+P+ V+ +G +C G + LL++E+ GSL L
Sbjct: 84 N-----HPH--VIKLYG-ACSQDGPL------LLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 127 -------HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179
+ L + + A QIS+ +Q L E ++HRD+ + NIL
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGR 187
Query: 180 DAKLADFGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFS 226
K++DFGL+ V E D + G + D YT S DV+S
Sbjct: 188 KMKISDFGLSRDVYEEDSYV----KRSQGRIPVKWMAIESLFDHIYTTQS------DVWS 237
Query: 227 YGVVLLEIIS 236
+GV+L EI++
Sbjct: 238 FGVLLWEIVT 247
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 49/235 (20%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---- 70
+ +++G G G+V+K + + IK V++D S + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIK--------VIEDKSGRQSFQAVT 63
Query: 71 -EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
+ + SL + + +V G +S LV +++P GSL D +
Sbjct: 64 DHMLAIGSL-----DHAH--IVRLLGLCPGSS--------LQLVTQYLPLGSLLDHVRQH 108
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
LG + +QI++ + L E+ ++HR++ + N+L S ++ADFG+A
Sbjct: 109 R----GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVA 162
Query: 190 -VSESDESSMVQPAGT--IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
+ D+ ++ I ++ + K + + DV+SYGV + E+++ +P
Sbjct: 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 48/251 (19%)
Query: 6 DYEELVKATESFSQSRL------IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE 59
D EEL + L +G G+ GSV + + + +AIK
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY---RMRKKQIDVAIK-------- 369
Query: 60 VLQDNSKKLNN-----EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVM 114
VL+ ++K + E +++ L NP +V G V +LVM
Sbjct: 370 VLKQGTEKADTEEMMREAQIMHQL-----DNPY--IVRLIG--------VCQAEALMLVM 414
Query: 115 EFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174
E G L+ L ++ N ++ Q+S ++ L E + +HR++ + N+L
Sbjct: 415 EMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVL 468
Query: 175 FDSKWDAKLADFGLA-VSESDESSMVQPAGT---IGYLDPGYTNPSKLSKKVDVFSYGVV 230
++ AK++DFGL+ +D+S + + + P N K S + DV+SYGV
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 231 LLEIISC-RKP 240
+ E +S +KP
Sbjct: 529 MWEALSYGQKP 539
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 55/242 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+ +G+G++G V A+ ++ + KI+ +KR D + + EI +
Sbjct: 13 QTLGEGAYGEVQLAV---NRVTEEAVAVKIVDMKR--------AVDCPENIKKEICINKM 61
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L + N VV F+G N L +E+ G L+D +
Sbjct: 62 L-----NHEN--VVKFYG--------HRREGNIQYLFLEYCSGGELFDRIEPDI-----G 101
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
+ P+ + Q+ + LH I HRDIK N+L D + + K++DFGL +
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGL-------A 152
Query: 197 SMVQPAGTIGYLD-----PGYTNPSKLSKK------VDVFSYGVVLLEIISCRKPIDAAR 245
++ + L+ Y P L ++ VDV+S G+VL +++ P D
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
Query: 246 DP 247
D
Sbjct: 213 DS 214
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 3e-17
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 47/185 (25%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--- 71
E+F + IG+G++G VYKA + T +++A+K+ +L+ E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKAR--NKLTG---EVVALKKI-------------RLDTETEG 44
Query: 72 -----IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
IR +S L+E N N +V V NKL LV EF+ L
Sbjct: 45 VPSTAIREISLLKELNHPN----IVKLL--------DVIHTENKLYLVFEFLHQ-DLKKF 91
Query: 126 LHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
+ +A P +K + Q+ + + H + ++HRD+K N+L +++ KLA
Sbjct: 92 MDASALTGIP----LPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLA 145
Query: 185 DFGLA 189
DFGLA
Sbjct: 146 DFGLA 150
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 57/255 (22%), Positives = 103/255 (40%), Gaps = 33/255 (12%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIR 73
+ F R++G+G G V+ Q K+ A K+ + + + + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFAC-----QMKATGKLYACKKLNKK--RLKKRKGYQGAMVEKK 237
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+L+ + + +V+ + + L LVM M G D+ ++
Sbjct: 238 ILAKV-----HSR--FIVSLA--YAFETKT------DLCLVMTIMNGG---DIRYHIYNV 279
Query: 133 TTPQLGWP-NRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
G+ R QI ++ LH+ + II+RD+K N+L D + +++D GLAV
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 191 SESDESSMVQP-AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
+ + AGT G++ P + VD F+ GV L E+I+ R P AR
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR-ARGEKV 396
Query: 250 IIDWALPLIKEEKLR 264
+ E+ +
Sbjct: 397 ENKELKQRVLEQAVT 411
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 61/261 (23%), Positives = 95/261 (36%), Gaps = 75/261 (28%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
YE+L K IG+G+ G V+KA +T + +A+K+
Sbjct: 18 KYEKLAK----------IGQGTFGEVFKAR--HRKTG---QKVALKKV------------ 50
Query: 66 KKLNNE--------IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEF 116
+ NE +R + LQ N VVN + + + LV +F
Sbjct: 51 -LMENEKEGFPITALREIKILQLLKHEN----VVNLIEICRTKASPYNRCKGSIYLVFDF 105
Query: 117 MPNGSLYDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILF 175
+ L LL N T +K M + + +H N I+HRD+K+ N+L
Sbjct: 106 CEH-DLAGLLSNVLVKFTLSE-----IKRVMQMLLNGLYYIHRN--KILHRDMKAANVLI 157
Query: 176 DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN---------PSKL------SK 220
KLADFGLA + + YTN P L
Sbjct: 158 TRDGVLKLADFGLA------RAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGP 208
Query: 221 KVDVFSYGVVLLEIISCRKPI 241
+D++ G ++ E+ + R PI
Sbjct: 209 PIDLWGAGCIMAEMWT-RSPI 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 45/238 (18%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+++ ++IG GS G V++A + +AIK+ VLQD K N E++
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAK------LVESDEVAIKK-------VLQDKRFK-NRELQ 84
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
++ ++ N VV+ + S + L LV+E++P ++Y + A
Sbjct: 85 IMRIVKHPN-------VVDLK--AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL 134
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-KLADFGLAV 190
+ +K+ M Q+ R++ +H I HRDIK N+L D KL DFG A
Sbjct: 135 KQT-MP-MLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 191 SESDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
V + Y P YT +D++S G V+ E++ +P+
Sbjct: 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTN------IDIWSTGCVMAELMQ-GQPL 241
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 46/236 (19%), Positives = 91/236 (38%), Gaps = 48/236 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
E + + +G G G V + +A+K ++++ S + E
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD------VAVK--------MIKEGSMSEDEFFQE 53
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
+ + L +P +V F+G C + +V E++ NG L + L +
Sbjct: 54 AQTMMKL-----SHPK--LVKFYGV-CSKEYPI------YIVTEYISNGCLLNYLRSHG- 98
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
L +++ + + L + IHRD+ + N L D K++DFG+
Sbjct: 99 ---KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
Query: 192 ESDESSMVQPAGTIGYLDP-GYTNP-----SKLSKKVDVFSYGVVLLEIISC-RKP 240
D+ + P ++ P K S K DV+++G+++ E+ S + P
Sbjct: 154 VLDDQYVSSVGTKF----PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 51/249 (20%), Positives = 91/249 (36%), Gaps = 63/249 (25%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+++G G+ G V A G +A+K + + E + L +E+++++ L
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-----EALMSELKMMTQL 105
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ N +VN G +C SG + L+ E+ G L + L + +
Sbjct: 106 ----GSHEN--IVNLLG-ACTLSGPI------YLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 139 WPNR------------------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180
+ A Q+++ ++ L +HRD+ + N+L
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKV 210
Query: 181 AKLADFGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVDVFSY 227
K+ DFGLA + L + YT S DV+SY
Sbjct: 211 VKICDFGLARDIMSDSNYV----VRGNARLPVKWMAPESLFEGIYTIKS------DVWSY 260
Query: 228 GVVLLEIIS 236
G++L EI S
Sbjct: 261 GILLWEIFS 269
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 42/182 (23%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---- 70
E + L+G+GS+G V K + T +I+AIK+ L+ + K+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCR--NKDTG---RIVAIKK-------FLESDDDKMVKKIAM 72
Query: 71 -EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHN 128
EI++L L+ N +VN V + LV EF+ + ++ D L
Sbjct: 73 REIKLLKQLRHEN-------LVNLL--------EVCKKKKRWYLVFEFVDH-TILDDLEL 116
Query: 129 AAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
Q+ V+ + QI I H ++ IIHRDIK NIL KL DFG
Sbjct: 117 FPNGLDYQV-----VQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 188 LA 189
A
Sbjct: 170 FA 171
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 50/237 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
+ + IG G G V+ + +AIK +++ + + E
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK------VAIK--------TIREGAMSEEDFIEE 53
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH-NAA 130
V+ L +P +V +G C + LV EFM +G L D L
Sbjct: 54 AEVMMKL-----SHPK--LVQLYGV-CLEQAPI------CLVTEFMEHGCLSDYLRTQRG 99
Query: 131 AATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
L + + + + + L E +IHRD+ + N L K++DFG+
Sbjct: 100 LFAAETL-----LGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTR 152
Query: 191 SESDESSMVQPAGTIGYLDP-GYTNP-----SKLSKKVDVFSYGVVLLEIISC-RKP 240
D+ P + +P S+ S K DV+S+GV++ E+ S + P
Sbjct: 153 FVLDDQYTSSTGTKF----PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 54/237 (22%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIR 73
E F +++G+GS +V A + + AIK ++++N + E
Sbjct: 30 EDFKFGKILGEGSFSTVVLA-----RELATSREYAIKILEKR--HIIKENKVPYVTRERD 82
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
V+S L +P V + T + KL + + NG L + +
Sbjct: 83 VMSRL-----DHPF--FVKLYFTF--------QDDEKLYFGLSYAKNGELLKYIRKIGSF 127
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-- 189
+ +I A++ LH IIHRD+K NIL + ++ DFG A
Sbjct: 128 DET------CTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 190 -VSESDE---SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
ES + +S V GT Y+ P K D+++ G ++ ++++
Sbjct: 180 LSPESKQARANSFV---GTAQYVSPELLTEKSAC------KSSDLWALGCIIYQLVA 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
++ +S + +G GS G V + D ++ K A+K+ VLQD K N E+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVF--DIESG---KRFALKK-------VLQDPRYK-NRELD 52
Query: 74 VLSSLQESN-------------KRNPNYCVVNFHGTSCRNSGSVDGNSNKL--------- 111
++ L N + + H + V+ + +
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 112 --LVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDI 168
++ME++P+ +L+ +L + + + N + I + Q+ RA+ +H I HRDI
Sbjct: 113 LNVIMEYVPD-TLHKVLKSFIRSGRS-IP-MNLISIYIYQLFRAVGFIHSLG--ICHRDI 167
Query: 169 KSTNILFDSKWDA-KLADFGLAVSESDESSMVQPAGTIGYLDP----GYTNPSKLSKKVD 223
K N+L +SK + KL DFG A V + Y P G T + +D
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY---TPSID 224
Query: 224 VFSYGVVLLEIISCRKPI 241
++S G V E+I KP+
Sbjct: 225 LWSIGCVFGELIL-GKPL 241
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 45/185 (24%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN---- 70
+ + + +G+G +VYKA D T+ +I+AIK+ + + + +
Sbjct: 10 KRYEKLDFLGEGQFATVYKAR--DKNTN---QIVAIKK-------IKLGHRSEAKDGINR 57
Query: 71 ----EIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
EI++L L N ++ G+ + + LV +FM L +
Sbjct: 58 TALREIKLLQELSHPN-------IIGLLD--------AFGHKSNISLVFDFMET-DLEVI 101
Query: 126 LHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
+ + + TP +K M + ++ LH++ I+HRD+K N+L D KLA
Sbjct: 102 IKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLA 154
Query: 185 DFGLA 189
DFGLA
Sbjct: 155 DFGLA 159
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 34/176 (19%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82
+G+G++G VYKA +D + D K A+K+ G S EI +L L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDD---KDYALKQIEGTGI------SMSACREIALLREL---- 75
Query: 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGWP- 140
++PN V++ + K+ L+ ++ + L+ ++ A+ +
Sbjct: 76 -KHPN--VISLQKVF------LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 141 --NRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA----KLADFGLA 189
VK + QI I LH N ++HRD+K NIL + K+AD G A
Sbjct: 126 PRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 7e-17
Identities = 45/185 (24%), Positives = 71/185 (38%), Gaps = 49/185 (26%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--- 71
E + IG+G++G VYKA + + A+K+ +L E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ------NNYGETFALKKI-------------RLEKEDEG 42
Query: 72 -----IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
IR +S L+E N +V + V +L LV E + L L
Sbjct: 43 IPSTTIREISILKELKHSN----IVKLY--------DVIHTKKRLVLVFEHLDQ-DLKKL 89
Query: 126 LHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
L K + Q+ I H+ ++HRD+K N+L + + + K+A
Sbjct: 90 LDVCEGGLESVT-----AKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIA 142
Query: 185 DFGLA 189
DFGLA
Sbjct: 143 DFGLA 147
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 48/236 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
+ + + +G G G V +AIK ++++ S + E
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD------VAIK--------MIKEGSMSEDEFIEE 69
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
+V+ +L + +V +G C + ++ E+M NG L + L
Sbjct: 70 AKVMMNL-----SHEK--LVQLYGV-CTKQRPI------FIITEYMANGCLLNYLREMR- 114
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ +++ + A++ L +HRD+ + N L + + K++DFGL+
Sbjct: 115 ---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 192 ESDESSMVQPAGTIGYLDP-GYTNP-----SKLSKKVDVFSYGVVLLEIISC-RKP 240
D+ P ++ P SK S K D++++GV++ EI S + P
Sbjct: 170 VLDDEYTSSVGSKF----PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 8e-17
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 49/185 (26%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--- 71
E + + +G+G++G VYKA +I+A+KR +L+ E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK---DSQG---RIVALKRI-------------RLDAEDEG 61
Query: 72 -----IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
IR +S L+E + N +V+ V + L LV EFM L +
Sbjct: 62 IPSTAIREISLLKELHHPN----IVSLI--------DVIHSERCLTLVFEFMEK-DLKKV 108
Query: 126 LHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
L +KI + Q+ R + H++ I+HRD+K N+L +S KLA
Sbjct: 109 LDENKTGLQDSQ-----IKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLA 161
Query: 185 DFGLA 189
DFGLA
Sbjct: 162 DFGLA 166
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 58/236 (24%)
Query: 23 IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN-----EIRVLSS 77
+G G+ GSV + + + +AIK VL+ ++K + E +++
Sbjct: 18 LGCGNFGSVRQGVY---RMRKKQIDVAIK--------VLKQGTEKADTEEMMREAQIMHQ 66
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137
L NP +V G V +LVME G L+ L ++
Sbjct: 67 L-----DNPY--IVRLIG--------VCQAEALMLVMEMAGGGPLHKFLVGKR----EEI 107
Query: 138 GWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-VSESDES 196
N ++ Q+S ++ L E + +HRD+ + N+L ++ AK++DFGL+ +D+S
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
Query: 197 SMVQPAGT-----------IGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKP 240
+ I + K S + DV+SYGV + E +S +KP
Sbjct: 166 YYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 55/253 (21%), Positives = 91/253 (35%), Gaps = 71/253 (28%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-----KKLNNEIRVL 75
R IG+G+ G V++A ++A+K +L++ + E ++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--------MLKEEASADMQADFQREAALM 104
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--------- 126
+ NPN +V G C + L+ E+M G L + L
Sbjct: 105 AEF-----DNPN--IVKLLGV-CAVGKPM------CLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 127 ----------HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176
++ P L ++ IA Q++ + L E +HRD+ + N L
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVG 208
Query: 177 SKWDAKLADFGLA--VSESDESSMVQPAGTIGYL-----------DPGYTNPSKLSKKVD 223
K+ADFGL+ + +D + YT S D
Sbjct: 209 ENMVVKIADFGLSRNIYSADYYKA----DGNDAIPIRWMPPESIFYNRYTTES------D 258
Query: 224 VFSYGVVLLEIIS 236
V++YGVVL EI S
Sbjct: 259 VWAYGVVLWEIFS 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 51/233 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS---KKLNNE 71
E+ +G G G V+ H +A+K L+ S E
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK------VAVK--------SLKQGSMSPDAFLAE 58
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL--HNA 129
++ L ++ +V + + ++ E+M NGSL D L +
Sbjct: 59 ANLMKQL-----QHQR--LVRLYAVVTQEP--------IYIITEYMENGSLVDFLKTPSG 103
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
T +L + +A QI+ + + E + IHRD+++ NIL K+ADFGLA
Sbjct: 104 IKLTINKL-----LDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 190 VSESDESSMVQPAGTIGYLDP-GYTNP-----SKLSKKVDVFSYGVVLLEIIS 236
D + P +T P + K DV+S+G++L EI++
Sbjct: 157 RLIEDNEYTAREGAKF----PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 47/184 (25%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--- 71
E++ + +G+G++ +VYK + TD ++A+K +L +E
Sbjct: 2 ETYIKLDKLGEGTYATVYKG--KSKLTD---NLVALKEI-------------RLEHEEGA 43
Query: 72 ----IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
IR +S L++ N +V H + L LV E++ L L
Sbjct: 44 PCTAIREVSLLKDLKHAN----IVTLH--------DIIHTEKSLTLVFEYLDK-DLKQYL 90
Query: 127 HNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ VK+ + Q+ R + H ++HRD+K N+L + + + KLAD
Sbjct: 91 DDCGNIINMHN-----VKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLAD 143
Query: 186 FGLA 189
FGLA
Sbjct: 144 FGLA 147
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 46/221 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+G G+ G V HQ G KIL ++ + D K+ EI+ L
Sbjct: 17 DTLGVGTFGKVKIGE---HQLTGHKVAVKILNRQKIRS------LDVVGKIKREIQNLKL 67
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
R+P+ ++ + V +VME++ G L+D + +
Sbjct: 68 F-----RHPH--IIKLY--------QVISTPTDFFMVMEYVSGGELFDYI-----CKHGR 107
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
+ ++ QI A+ H + M++HRD+K N+L D+ +AK+ADFGL+ SD
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKK------VDVFSYGVVL 231
+ G+ P Y P +S + VD++S GV+L
Sbjct: 166 FLRTSCGS-----PNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-16
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 54/190 (28%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE--- 71
+ + + +G+G++G VYKAI D T+ + +AIKR +L +E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAI--DTVTN---ETVAIKRI-------------RLEHEEEG 75
Query: 72 -----IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
IR +S L+E RN ++ SV ++++L L+ E+ N L
Sbjct: 76 VPGTAIREVSLLKELQHRN----IIELK--------SVIHHNHRLHLIFEYAEN-DLKKY 122
Query: 126 LHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--- 181
+ P + +K + Q+ + H +HRD+K N+L +
Sbjct: 123 MDK-----NPDVS-MRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETP 174
Query: 182 --KLADFGLA 189
K+ DFGLA
Sbjct: 175 VLKIGDFGLA 184
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 52/259 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIR 73
+ F R +G GS G V+ ++ + + A+K V++ + N+E
Sbjct: 6 QDFQILRTLGTGSFGRVHLI-----RSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERL 58
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+LS + +P ++ GT ++ ++ ++M+++ G L+ LL +
Sbjct: 59 MLSIV-----THP--FIIRMWGTFQ--------DAQQIFMIMDYIEGGELFSLLRKSQRF 103
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
P K A ++ A++ LH D II+RD+K NIL D K+ DFG A
Sbjct: 104 PNP------VAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY 155
Query: 192 ESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
D + + GT Y+ P Y K +D +S+G+++ E+++ P
Sbjct: 156 VPDVTYTL--CGTPDYIAPEVVSTKPYN------KSIDWWSFGILIYEMLAGYTPFY-DS 206
Query: 246 DPASIIDWALPLIKEEKLR 264
+ + I +LR
Sbjct: 207 NTMKTYE----KILNAELR 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 52/259 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKK-LNNEIR 73
+ F + + +G GS G V + A+K +V++ + NE R
Sbjct: 41 DQFDRIKTLGTGSFGRVMLV-----KHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKR 93
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+L ++ P +V + +++ L +VME++ G ++ L
Sbjct: 94 ILQAV-----NFP--FLVKLEFSFK--------DNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ P + A QI + LH D +I+RD+K N+L D + ++ DFG A
Sbjct: 139 SEP------HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 192 ESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
+ + GT L P GY K VD ++ GV++ E+ + P A
Sbjct: 191 VKGRTWTL--CGTPEALAPEIILSKGYN------KAVDWWALGVLIYEMAAGYPPFF-AD 241
Query: 246 DPASIIDWALPLIKEEKLR 264
P I + I K+R
Sbjct: 242 QPIQIYE----KIVSGKVR 256
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 52/231 (22%), Positives = 81/231 (35%), Gaps = 41/231 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN-SKKLNNEIR 73
+ F ++IG+G+ V + QT ++ A+K N +++L+ E
Sbjct: 61 DDFEILKVIGRGAFSEVAVV--KMKQTG---QVYAMK--IMNKWDMLKRGEVSCFREERD 113
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
VL + + H + + LVME+ G L LL
Sbjct: 114 VLVNG-----DRR--WITQLHF-------AFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 134 TPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
+ +I AI +H +HRDIK NIL D +LADFG + +
Sbjct: 160 PA-----EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCL-K 211
Query: 193 SDESSMVQ---PAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLE 233
V+ GT YL P G + D ++ GV E
Sbjct: 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 6e-15
Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 57/264 (21%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEI 72
F +++G+GS G V+ + ++ A+K + +T + + + E
Sbjct: 24 SQFELLKVLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKAT----LKVRDRVRTKMER 77
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAA 131
+L + +P +V H + KL L+++F+ G L+ L
Sbjct: 78 DILVEV-----NHP--FIVKLH--YAFQTEG------KLYLILDFLRGGDLFTRLSKEVM 122
Query: 132 ATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA- 189
T VK +++ A+ LH II+RD+K NIL D + KL DFGL+
Sbjct: 123 FTEE------DVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 190 --VSESDE-SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ + S GT+ Y+ P G+T + D +S+GV++ E+++ P
Sbjct: 175 ESIDHEKKAYSFC---GTVEYMAPEVVNRRGHT------QSADWWSFGVLMFEMLTGTLP 225
Query: 241 IDAARDPASIIDWALPLIKEEKLR 264
+D + +I + KL
Sbjct: 226 FQ-GKDRKETMT----MILKAKLG 244
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 57/302 (18%), Positives = 96/302 (31%), Gaps = 74/302 (24%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
L+G G GSVY I +D K + R S G N ++ E+ +L
Sbjct: 49 PLLGSGGFGSVYSGI---RVSDNLPVAIKHVEKDRISDWG---ELPNGTRVPMEVVLLKK 102
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEF-MPNGSLYDLLHNAAAATTP 135
+ + V+ + L++E P L+D + A
Sbjct: 103 V---SSGFSG--VIRLLD--------WFERPDSFVLILERPEPVQDLFDFITERGALQEE 149
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS-KWDAKLADFGLAVSESD 194
Q+ A++ H ++HRDIK NIL D + + KL DFG +
Sbjct: 150 L-----ARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLK 201
Query: 195 ESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248
++ GT Y P Y V+S G++L +++ P +
Sbjct: 202 DTVYTDFDGTRVYSPPEWIRYHRYHGR-----SAAVWSLGILLYDMVCGDIPFEHD---- 252
Query: 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFM-EGA---IKQMLHVAARCVSSEEENRPGIGE 304
++ +V + I+ L + +RP E
Sbjct: 253 ---------------EEIIRGQVFFRQRVSSECQHLIRWCLALRP-------SDRPTFEE 290
Query: 305 IL 306
I
Sbjct: 291 IQ 292
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+G G+ G V H+ G KIL ++ + D K+ EI+ L
Sbjct: 22 DTLGVGTFGKVKVGK---HELTGHKVAVKILNRQKIRSL------DVVGKIRREIQNLKL 72
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
R+P+ ++ + V + + +VME++ G L+D + +
Sbjct: 73 F-----RHPH--IIKLY--------QVISTPSDIFMVMEYVSGGELFDYI-----CKNGR 112
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
L ++ QI + H + M++HRD+K N+L D+ +AK+ADFGL+ SD
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKK------VDVFSYGVVL 231
+ G+ P Y P +S + VD++S GV+L
Sbjct: 171 FLRTSCGS-----PNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 62/268 (23%), Positives = 102/268 (38%), Gaps = 67/268 (25%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI-- 72
F +L+GKG+ G V + T + A+K +L+ +E+
Sbjct: 5 NDFDYLKLLGKGTFGKVILV--REKATG---RYYAMK--------ILRKEVIIAKDEVAH 51
Query: 73 -----RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
RVL + R+P + + ++L VME+ G L+ L
Sbjct: 52 TVTESRVLQNT-----RHP--FLTALK--YAFQT------HDRLCFVMEYANGGELFFHL 96
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
T R + +I A++ LH D +++RDIK N++ D K+ D
Sbjct: 97 SRERVFTEE------RARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITD 148
Query: 186 FGLA---VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
FGL +S+ GT YL P Y + VD + GVV+ E++
Sbjct: 149 FGLCKEGISDGATMKTF--CGTPEYLAPEVLEDNDYG------RAVDWWGLGVVMYEMMC 200
Query: 237 CRKPIDAARDPASIIDWALPLIKEEKLR 264
R P +D + + LI E++R
Sbjct: 201 GRLPFY-NQDHERLFE----LILMEEIR 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 59/270 (21%), Positives = 102/270 (37%), Gaps = 67/270 (24%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--------QDNSK 66
E F R++GKG +G V++ KI A+K VL ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQV--RKVTGANTGKIFAMK--------VLKKAMIVRNAKDTA 66
Query: 67 KLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDL 125
E +L + ++P +V+ + KL L++E++ G L+
Sbjct: 67 HTKAERNILEEV-----KHP--FIVDLI--YAFQT------GGKLYLILEYLSGGELFMQ 111
Query: 126 LHNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA 184
L +IS A+ LH+ II+RD+K NI+ + + KL
Sbjct: 112 LEREGIFMED------TACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLT 163
Query: 185 DFGLA---VSESDE-SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEI 234
DFGL + + + GTI Y+ P G+ + VD +S G ++ ++
Sbjct: 164 DFGLCKESIHDGTVTHTFC---GTIEYMAPEILMRSGHN------RAVDWWSLGALMYDM 214
Query: 235 ISCRKPIDAARDPASIIDWALPLIKEEKLR 264
++ P + ID I + KL
Sbjct: 215 LTGAPPFT-GENRKKTID----KILKCKLN 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 44/230 (19%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN-SKKLNNEIR 73
E + ++IG+G+ G V + K+ A+K + FE+++ + S E
Sbjct: 69 EDYEVVKVIGRGAFGEVQLV-----RHKSTRKVYAMK--LLSKFEMIKRSDSAFFWEERD 121
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
+++ +P VV + L +VME+MP G L +L+ N
Sbjct: 122 IMAFA-----NSP--WVVQLFYAF--------QDDRYLYMVMEYMPGGDLVNLMSNY--- 163
Query: 133 TTPQLGWPN-RVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
P + ++ A+ +H IHRD+K N+L D KLADFG +
Sbjct: 164 -----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 191 SESDESSMVQ---PAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLE 233
+ ++ MV+ GT Y+ P ++ D +S GV L E
Sbjct: 217 -KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 42/236 (17%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ + + IG G+ G V A D D + +AIK+ S F+ +K+ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAY--DAVLD---RNVAIKKLS-RPFQNQTH-AKRAYRELV 113
Query: 74 VLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++ + + N ++N +++ + LVME M +L ++
Sbjct: 114 LMKCV-----NHKNIISLLNVF----TPQKTLEEFQDVYLVMELMDA-NLCQVIQ----- 158
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
R+ + Q+ I+ LH IIHRD+K +NI+ S K+ DFGLA +
Sbjct: 159 ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 192 ESDESSMVQPAGTIGY------LDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
M T Y L GY + VD++S G ++ E++ K +
Sbjct: 214 AGTSFMMTPYVVTRYYRAPEVILGMGYK------ENVDIWSVGCIMGEMVR-HKIL 262
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 55/240 (22%), Positives = 82/240 (34%), Gaps = 52/240 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+ IG G+ G + + K I+R + + EI S
Sbjct: 26 KDIGSGNFGVARLMR---DKLTKELVAVKY--IERG--------AAIDENVQREIINHRS 72
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L R+PN +V F V L ++ME+ G LY+ + NA +
Sbjct: 73 L-----RHPN--IVRFK--------EVILTPTHLAIIMEYASGGELYERICNAG-----R 112
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLADFGLAVSESD 194
Q+ + H I HRD+K N L D K+ DFG + S
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKK------VDVFSYGVVLLEIISCRKPIDAARDPA 248
S GT P Y P L ++ DV+S GV L ++ P + +P
Sbjct: 171 HSQPKSTVGT-----PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 50/224 (22%), Positives = 80/224 (35%), Gaps = 72/224 (32%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+++G G +G V + ++ + A+K +LQD K E+ +
Sbjct: 24 QVLGLGINGKVLQIF---NKRTQ--EKFALK--------MLQD-CPKARREVELHWRAS- 68
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN--------AAAA 132
+ P+ +V N G L+VME + G L+ + + A+
Sbjct: 69 ---QCPH--IVRIVDV-YENL--YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA---KLADFGLA 189
+I I AIQ LH + I HRD+K N+L+ SK KL DFG A
Sbjct: 121 -----------EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
Query: 190 --VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231
Y K D++S GV++
Sbjct: 168 KET-----------------TGEKY------DKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 56/230 (24%), Positives = 86/230 (37%), Gaps = 41/230 (17%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN-SKKLNNEIR 73
E F ++IG+G+ G V + D K+ A+K N +E+L+ + E
Sbjct: 74 EDFEILKVIGRGAFGEVAVV--KLKNAD---KVFAMK--ILNKWEMLKRAETACFREERD 126
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
VL + + + H + N L LVM++ G L LL
Sbjct: 127 VLVNG-----DSK--WITTLHYAF--------QDDNNLYLVMDYYVGGDLLTLLSKFEDR 171
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ ++ AI +H+ +HRDIK NIL D +LADFG
Sbjct: 172 LPE-----EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSC-L 223
Query: 192 ESDESSMVQ---PAGTIGYLDP-----GYTNPSKLSKKVDVFSYGVVLLE 233
+ E VQ GT Y+ P + + D +S GV + E
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 54/262 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-------DNSKK 67
E F +++GKGS G V+ A + ++ AIK L+ D+ +
Sbjct: 17 EDFILHKMLGKGSFGKVFLA-----EFKKTNQFFAIK--------ALKKDVVLMDDDVEC 63
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
E RVL +P + + T L VME++ G L +
Sbjct: 64 TMVEKRVL----SLAWEHP--FLTHMFCTFQ--------TKENLFFVMEYLNGGDLMYHI 109
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ R A +I +Q LH I++RD+K NIL D K+AD
Sbjct: 110 QSCHKFDLS------RATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIAD 161
Query: 186 FGLA---VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242
FG+ + +++ GT Y+ P K + VD +S+GV+L E++ + P
Sbjct: 162 FGMCKENMLGDAKTNTF--CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219
Query: 243 AARDPASIIDWALPLIKEEKLR 264
+D + I+ +
Sbjct: 220 -GQDEEELFH----SIRMDNPF 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 30/230 (13%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ + + IG G+ G V A D + +AIK+ S F+ +K+ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAY--DAIL---ERNVAIKKLS-RPFQNQTH-AKRAYRELV 76
Query: 74 VLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
++ + + N ++N S++ + +VME M +L ++
Sbjct: 77 LMKCV-----NHKNIIGLLNVF----TPQKSLEEFQDVYIVMELMDA-NLCQVIQ----- 121
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
R+ + Q+ I+ LH IIHRD+K +NI+ S K+ DFGLA +
Sbjct: 122 ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
M T Y P + VD++S G ++ E+I +
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVL 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 47/245 (19%), Positives = 85/245 (34%), Gaps = 64/245 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
L+G+GS+G V + + A+K + + + EI++L L
Sbjct: 11 DLLGEGSYGKVKEVL---DSETLCR--RAVKILKKKKLRRIPNGEANVKKEIQLLRRL-- 63
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSV--DGNSNKL-LVMEFMPNGS--LYDLLHNAAAATTP 135
R+ N V+ V + K+ +VME+ G + D +
Sbjct: 64 ---RHKN--VIQLV--------DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE------- 103
Query: 136 QLGWPNRVKIAM------QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
R + Q+ ++ LH I+H+DIK N+L + K++ G+
Sbjct: 104 -----KRFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGV- 155
Query: 190 VSESDESSMVQPAGTIGYLD-----PGYTNPSKLS-------KKVDVFSYGVVLLEIISC 237
+ + P P + P + KVD++S GV L I +
Sbjct: 156 ------AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
Query: 238 RKPID 242
P +
Sbjct: 210 LYPFE 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 63/307 (20%), Positives = 103/307 (33%), Gaps = 82/307 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
L+GKG G+V+ TD K++ R +S E+ +L
Sbjct: 37 PLLGKGGFGTVFAGH---RLTDRLQVAIKVIPRNRVLGWS---PLSDSVTCPLEVALLWK 90
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEF-MPNGSLYDLLHNAAAATTPQ 136
+ +P V+ + +LV+E +P L+D +
Sbjct: 91 VGAGGG-HPG--VIRLLDW-------FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW-DAKLADFGLAVSESDE 195
+R Q+ AIQ H ++HRDIK NIL D + AKL DFG
Sbjct: 141 ----SR-CFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGS------- 186
Query: 196 SSMVQP------AGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+++ GT Y P Y V+S G++L +++ P +
Sbjct: 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIPFER 241
Query: 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFM-EGA---IKQMLHVAARCVSSEEENR 299
++ I E +L P + I++ L +R
Sbjct: 242 DQE-----------ILEAELH--------FPAHVSPDCCALIRRCLAPKP-------SSR 275
Query: 300 PGIGEIL 306
P + EIL
Sbjct: 276 PSLEEIL 282
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 49/238 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKR--------ASTNGFEVLQDNSKKLNNEI 72
R I GS+G+V + D + +AIKR + N K++ EI
Sbjct: 28 RFISSGSYGAVCAGV------DSEGIPVAIKRVFNTVSDGRTVNILSDSFL-CKRVLREI 80
Query: 73 RVLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
R+L+ +PN + + LV E M L ++H+
Sbjct: 81 RLLNHF-----HHPNILGLRDIF-----VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 132 ATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190
+PQ ++ M I + LHE ++HRD+ NIL D + DF LA
Sbjct: 130 VISPQ-----HIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 191 SESDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
++ +++ Y P G+T K VD++S G V+ E+ + RK +
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFT------KLVDMWSAGCVMAEMFN-RKAL 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 68/269 (25%), Positives = 107/269 (39%), Gaps = 68/269 (25%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-------DNSKK 67
F ++IGKGS G V A + + A+K VLQ K
Sbjct: 38 SDFHFLKVIGKGSFGKVLLA-----RHKAEEVFYAVK--------VLQKKAILKKKEEKH 84
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
+ +E VL N ++P +V H + ++KL V++++ G L+ L
Sbjct: 85 IMSERNVL----LKNVKHP--FLVGLH--FSFQT------ADKLYFVLDYINGGELFYHL 130
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
P R + A +I+ A+ LH + I++RD+K NIL DS+ L D
Sbjct: 131 QRERCFLEP------RARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTD 182
Query: 186 FGLA---VSESDE-SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEII 235
FGL + + S+ GT YL P Y + VD + G VL E++
Sbjct: 183 FGLCKENIEHNSTTSTFC---GTPEYLAPEVLHKQPYD------RTVDWWCLGAVLYEML 233
Query: 236 SCRKPIDAARDPASIIDWALPLIKEEKLR 264
P +R+ A + D I + L+
Sbjct: 234 YGLPPFY-SRNTAEMYD----NILNKPLQ 257
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 47/232 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77
+G+GS G V A H K ++ + + ++ EI L
Sbjct: 15 ETLGEGSFGKVKLAT---HYKTQQKVALKFISRQLLKKSDMH------MRVEREISYLKL 65
Query: 78 LQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQ 136
L R+P+ ++ + V + +V+E+ G L+D + +
Sbjct: 66 L-----RHPH--IIKLY--------DVITTPTDIVMVIEYA-GGELFDYI-----VEKKR 104
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
+ + QI AI+ H + I+HRD+K N+L D + K+ADFGL+ +D +
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKK------VDVFSYGVVLLEIISCRKPID 242
+ G+ P Y P ++ K VDV+S G+VL ++ R P D
Sbjct: 163 FLKTSCGS-----PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 58/260 (22%), Positives = 100/260 (38%), Gaps = 50/260 (19%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI-- 72
F +L+GKG+ G V + + A+K +L+ +E+
Sbjct: 148 NEFEYLKLLGKGTFGKVILV-----KEKATGRYYAMK--------ILKKEVIVAKDEVAH 194
Query: 73 -----RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
RVL + R+P + + ++L VME+ G L+ L
Sbjct: 195 TLTENRVLQNS-----RHP--FLTALK--YSFQT------HDRLCFVMEYANGGELFFHL 239
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ R + +I A+ LH +++RD+K N++ D K+ D
Sbjct: 240 SRERVFSED------RARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITD 292
Query: 186 FGLAVSE-SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244
FGL D ++M GT YL P + + VD + GVV+ E++ R P
Sbjct: 293 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-N 351
Query: 245 RDPASIIDWALPLIKEEKLR 264
+D + + LI E++R
Sbjct: 352 QDHEKLFE----LILMEEIR 367
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 65/289 (22%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-------DNSKK 67
+ F R+IG+GS+ V + +I A+K V++ ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLV-----RLKKTDRIYAMK--------VVKKELVNDDEDIDW 55
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
+ E V E +P +V H SC + S +L V+E++ G L +
Sbjct: 56 VQTEKHVF----EQASNHP--FLVGLH--SCFQTES------RLFFVIEYVNGGDLMFHM 101
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ + +IS A+ LHE II+RD+K N+L DS+ KL D
Sbjct: 102 QRQRKLPEE------HARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTD 153
Query: 186 FGLA---VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
+G+ + D +S GT Y+ P Y VD ++ GV++ E+++
Sbjct: 154 YGMCKEGLRPGDTTSTF--CGTPNYIAPEILRGEDYG------FSVDWWALGVLMFEMMA 205
Query: 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQML 285
R P D + ++ + + + ++ +P + +L
Sbjct: 206 GRSPFDIVGSSDNPDQNT----EDYLFQVILEKQIRIPRSLSVKAASVL 250
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 32/184 (17%), Positives = 68/184 (36%), Gaps = 38/184 (20%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
IG+G G +Y A + ++ G +K + ++ L E++ +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS--------DNGPLFTELKFYQRAAK 92
Query: 81 SNKRNPNYCVVNFHGT---SCRNSGSVDGNSNK--LLVMEFMPNG-SLYDLLHNAAAATT 134
+ SG D N ++M+ G L +
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYE------- 143
Query: 135 PQLGWPNR-------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK--LAD 185
+ ++++++I ++ +HE++ +H DIK++N+L + K + L D
Sbjct: 144 ----ANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
Query: 186 FGLA 189
+GLA
Sbjct: 198 YGLA 201
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 63/245 (25%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI-- 72
++F R++GKGS G V A + + A+K VL+ + ++++
Sbjct: 23 DNFEFIRVLGKGSFGKVMLA-----RVKETGDLYAVK--------VLKKDVILQDDDVEC 69
Query: 73 -----RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
R+L + +P + C + +L VMEF+ G L +
Sbjct: 70 TMTEKRIL----SLARNHP--FLTQLF--CCFQTPD------RLFFVMEFVNGGDLMFHI 115
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ R + A +I A+ LH+ II+RD+K N+L D + KLAD
Sbjct: 116 QKSRRFDEA------RARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLAD 167
Query: 186 FGLA---VSESDE-SSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEII 235
FG+ + ++ GT Y+ P Y VD ++ GV+L E++
Sbjct: 168 FGMCKEGICNGVTTATFC---GTPDYIAPEILQEMLYG------PAVDWWAMGVLLYEML 218
Query: 236 SCRKP 240
P
Sbjct: 219 CGHAP 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 62/233 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN---NEIRVLSS 77
++IGKGS G V KA DH+ H+ +A+K ++++ + EIR+L
Sbjct: 103 KVIGKGSFGQVVKAY--DHKV---HQHVALK--------MVRNEKRFHRQAAEEIRILEH 149
Query: 78 LQESNKRNPNYCV-----VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
L++ +K N + F C + E + + +LY+L+
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHIC-------------MTFELL-SMNLYELIKK---- 191
Query: 133 TTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILF--DSKWDAKLADFGL 188
G+ + K A I + + LH+N IIH D+K NIL + K+ DFG
Sbjct: 192 -NKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 189 AVSESDE-SSMVQ------PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234
+ E + +Q P +G Y P +D++S G +L E+
Sbjct: 249 SCYEHQRVYTYIQSRFYRAPEVILGA---RYGMP------IDMWSLGCILAEL 292
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 68/279 (24%), Positives = 109/279 (39%), Gaps = 77/279 (27%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-----DNSKKL- 68
E+F +++G G++G V+ K+ A+K VL+ +K
Sbjct: 54 ENFELLKVLGTGAYGKVFLV--RKISGHDTGKLYAMK--------VLKKATIVQKAKTTE 103
Query: 69 --NNEIRVLSSLQESNKRNPNYCVVNFHG---TSCRNSGSVDGNSNKL-LVMEFMPNGSL 122
E +VL E +++P +V H T KL L+++++ G L
Sbjct: 104 HTRTERQVL----EHIRQSP--FLVTLHYAFQTE-----------TKLHLILDYINGGEL 146
Query: 123 YDLLHNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
+ L T V+I +I A++ LH+ II+RDIK NIL DS
Sbjct: 147 FTHLSQRERFTEH------EVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHV 198
Query: 182 KLADFGLA---VSESDE--SSMVQPAGTIGYLDP--------GYTNPSKLSKKVDVFSYG 228
L DFGL+ V++ E GTI Y+ P G+ K VD +S G
Sbjct: 199 VLTDFGLSKEFVADETERAYDFC---GTIEYMAPDIVRGGDSGHD------KAVDWWSLG 249
Query: 229 VVLLEIISCRKP---IDAARDPASIIDWALPLIKEEKLR 264
V++ E+++ P A I I + +
Sbjct: 250 VLMYELLTGASPFTVDGEKNSQAEISR----RILKSEPP 284
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 60/289 (20%), Positives = 112/289 (38%), Gaps = 65/289 (22%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-------DNSKK 67
+ F R+IG+GS+ V + +I A++ V++ ++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLV-----RLKKTDRIYAMR--------VVKKELVNDDEDIDW 98
Query: 68 LNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
+ E V E +P +V H SC + S +L V+E++ G L +
Sbjct: 99 VQTEKHVF----EQASNHP--FLVGLH--SCFQTES------RLFFVIEYVNGGDLMFHM 144
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
+ + +IS A+ LHE II+RD+K N+L DS+ KL D
Sbjct: 145 QRQRKLPEE------HARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTD 196
Query: 186 FGLA---VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
+G+ + D +S GT Y+ P Y VD ++ GV++ E+++
Sbjct: 197 YGMCKEGLRPGDTTSTF--CGTPNYIAPEILRGEDYG------FSVDWWALGVLMFEMMA 248
Query: 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQML 285
R P D + ++ + + + ++ +P + +L
Sbjct: 249 GRSPFDIVGSSDNPDQNT----EDYLFQVILEKQIRIPRSLSVKAASVL 293
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 57/268 (21%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI-- 72
F+ ++GKGS G V + + G ++ A+K +L+ + ++++
Sbjct: 20 TDFNFLMVLGKGSFGKVMLS-----ERKGTDELYAVK--------ILKKDVVIQDDDVEC 66
Query: 73 -----RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLL 126
RVL + P + H SC + +L VME++ G L +
Sbjct: 67 TMVEKRVL----ALPGKPP--FLTQLH--SCFQTMD------RLYFVMEYVNGGDLMYHI 112
Query: 127 HNAAAATTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
P A +I+ + L II+RD+K N++ DS+ K+AD
Sbjct: 113 QQVGRFKEP------HAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIAD 164
Query: 186 FGLA---VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIIS 236
FG+ + + + GT Y+ P Y K VD +++GV+L E+++
Sbjct: 165 FGMCKENIWDGVTTKTF--CGTPDYIAPEIIAYQPYG------KSVDWWAFGVLLYEMLA 216
Query: 237 CRKPIDAARDPASIIDWALPLIKEEKLR 264
+ P + D + I E +
Sbjct: 217 GQAPFE-GEDEDELFQ----SIMEHNVA 239
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 60/232 (25%), Positives = 89/232 (38%), Gaps = 60/232 (25%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN---NEIRVLSS 77
LIGKGS G V KA D + +AIK ++++ LN E+R+L
Sbjct: 60 SLIGKGSFGQVVKAY--DRVE---QEWVAIK--------IIKNKKAFLNQAQIEVRLLEL 106
Query: 78 LQESNKRNPNYCV-----VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+ + + Y V F C LV E + + +LYDLL N
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLC-------------LVFEML-SYNLYDLLRN---- 148
Query: 133 TTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILF--DSKWDAKLADFGL 188
T G + K A Q+ A+ L + IIH D+K NIL + K+ DFG
Sbjct: 149 -TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207
Query: 189 AVSESDE-SSMVQ------PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233
+ +Q P +G Y +D++S G +L+E
Sbjct: 208 SCQLGQRIYQYIQSRFYRSPEVLLGM---PYDLA------IDMWSLGCILVE 250
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 55/259 (21%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
M + Y F L+G+G++G V A T +I+AIK+ F+
Sbjct: 1 MPKRIVYNISSD----FQLKSLLGEGAYGVVCSAT--HKPT---GEIVAIKK--IEPFDK 49
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKLLVMEF 116
+ + EI++L + N ++ S N V ++ E
Sbjct: 50 PLF-ALRTLREIKILKHFKHEN-------IITIFNIQRPDSFENFNEV------YIIQEL 95
Query: 117 MPNGSLYDLLHNAAAATTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILF 175
M DL H + Q+ + ++ + Q RA++ LH ++ +IHRD+K +N+L
Sbjct: 96 MQ----TDL-HRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLI 145
Query: 176 DSKWDAKLADFGLA-VSESDESSMVQPAGTIGYLDPGY--T----------NPSKLSKKV 222
+S D K+ DFGLA + + + +P G + + T +K S+ +
Sbjct: 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAM 204
Query: 223 DVFSYGVVLLEIISCRKPI 241
DV+S G +L E+ R+PI
Sbjct: 205 DVWSCGCILAELFL-RRPI 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS-KKLNNEIR 73
F+ ++GKGS G V + + G ++ A+K + V+QD+ + E R
Sbjct: 341 TDFNFLMVLGKGSFGKVMLS-----ERKGTDELYAVKILKKD--VVIQDDDVECTMVEKR 393
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAA 132
VL + P + H ++L VME++ G L +
Sbjct: 394 VL----ALPGKPP--FLTQLHSCF--------QTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 133 TTPQLGWPNRVKI-AMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-- 189
P A +I+ + L II+RD+K N++ DS+ K+ADFG+
Sbjct: 440 KEP------HAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491
Query: 190 -VSESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ + + GT Y+ P Y K VD +++GV+L E+++ + P
Sbjct: 492 NIWDGVTTKTF--CGTPDYIAPEIIAYQPYG------KSVDWWAFGVLLYEMLAGQAP 541
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 48/231 (20%), Positives = 102/231 (44%), Gaps = 33/231 (14%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+++ +G G++GSV AI D ++ + +AIK+ S F+ +K+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAI--DKRS---GEKVAIKKLS-RPFQSEIF-AKRAYRELL 75
Query: 74 VLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+L + ++ N +++ + S+ + LVM FM L ++
Sbjct: 76 LLKHM-----QHENVIGLLDVF----TPASSLRNFYDFYLVMPFMQT-DLQKIMG----- 120
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+++ + Q+ + ++ +H ++HRD+K N+ + + K+ DFGLA
Sbjct: 121 ---LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 192 ESDESSMVQPAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
E M T Y P + ++ VD++S G ++ E+++ K +
Sbjct: 176 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTL 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 36/280 (12%), Positives = 74/280 (26%), Gaps = 64/280 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
G ++A D D + +A+ G D ++ + LS + +
Sbjct: 37 IFHGGVPPLQFWQA--LDTALD---RQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDK 90
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
V V + L+V E++ GSL ++ +
Sbjct: 91 PG-------VARVLDV-------VHTRAGGLVVAEWIRGGSLQEVADTS-------PSPV 129
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
++ ++ A H + + + D LA +++
Sbjct: 130 GAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATM-PDANPQD--- 183
Query: 201 PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKE 260
D+ G L ++ R P+ A + +
Sbjct: 184 ----------------------DIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTA 219
Query: 261 EKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300
+ + D +P + VAAR V + R
Sbjct: 220 GQPIEPADIDRDIPFQISA-------VAARSVQGDGGIRS 252
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 32/184 (17%), Positives = 62/184 (33%), Gaps = 41/184 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG G G +Y A +K + L +E++ + +
Sbjct: 43 KKIGSGGFGLIYLA--FPTNKPEKDARHVVKVEYQE--------NGPLFSELKFYQRVAK 92
Query: 81 SNKRNPNYCVVNFHGT---SCRNSGSVDGNSNK--LLVMEFMPNG-SLYDLLHNAAAATT 134
+ SG + +VME + G L +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ------ 144
Query: 135 PQLGWPNR-------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK--LAD 185
N +++ +++ ++ +HEN+ +H DIK+ N+L K + LAD
Sbjct: 145 ------NGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLAD 196
Query: 186 FGLA 189
+GL+
Sbjct: 197 YGLS 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 51/240 (21%), Positives = 96/240 (40%), Gaps = 51/240 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ +G G +G V+ A+ D+ D K +AIK+ Q K EI+++ L
Sbjct: 17 KPLGCGGNGLVFSAV--DNDCD---KRVAIKKIV---LTDPQS-VKHALREIKIIRRL-- 65
Query: 81 SNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKL----LVMEFMPNGSLYDLLHNAAAATTP 135
+ N V G S G+ +L +V E+M L ++L
Sbjct: 66 ---DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE------QG 115
Query: 136 QLGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW-DAKLADFGLAVSES 193
L + Q+ R ++ +H + ++HRD+K N+ +++ K+ DFGLA
Sbjct: 116 PLL-EEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 194 DESSMVQPAGTIGYLDPGYT------------NPSKLSKKVDVFSYGVVLLEIISCRKPI 241
S G+L +P+ +K +D+++ G + E+++ K +
Sbjct: 173 PHYS------HKGHL-SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTL 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 44/237 (18%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ + +G G++G+V A+ D +T +AIK+ F+ +K+ E+R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAV--DGRT---GAKVAIKKLY-RPFQSELF-AKRAYRELR 76
Query: 74 VLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+L + R+ N +++ ++D ++ LVM FM L L+ +
Sbjct: 77 LLKHM-----RHENVIGLLDVF----TPDETLDDFTDFYLVMPFMGT-DLGKLMKH---- 122
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+ +R++ + Q+ + ++ +H IIHRD+K N+ + + K+ DFGLA
Sbjct: 123 ---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 192 ESDESSMVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
E M T Y P YT + VD++S G ++ E+I+ K +
Sbjct: 178 ADSE--MTGYVVTRWYRAPEVILNWMRYT------QTVDIWSVGCIMAEMIT-GKTL 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 44/249 (17%), Positives = 86/249 (34%), Gaps = 72/249 (28%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
R +G G +V+ A D + +A+K R E +D EI++L +
Sbjct: 25 RKLGWGHFSTVWLAK--DMVN---NTHVAMKIVRGDKVYTEAAED-------EIKLLQRV 72
Query: 79 QESNKRNPN----YCVVN------FHGTS----CRNSGSVDGNSNKLLVMEFMPNGSLYD 124
+++ + ++ G + +V E + +L
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV-------------MVFEVL-GENLLA 118
Query: 125 LLHNAAAATTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFD------ 176
L+ G P +I+ Q+ + +H IIH DIK N+L +
Sbjct: 119 LIKK-----YEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPE 172
Query: 177 SKWDAKLADFGLAVSESDE-SSMVQ------PAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229
+ K+AD G A + ++ +Q P +G + D++S
Sbjct: 173 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA---PWGCG------ADIWSTAC 223
Query: 230 VLLEIISCR 238
++ E+I+
Sbjct: 224 LIFELITGD 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 28/207 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
LIG GS+G V +A D +++AIK+ FE L D K++ EI +L+ L
Sbjct: 59 HLIGTGSYGHVCEAY--DKLE---KRVVAIKKI-LRVFEDLID-CKRILREIAILNRLNH 111
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+ VV ++L +V+E + L TP
Sbjct: 112 DH-------VVKVLDIVIPKDVE---KFDELYVVLEIADS-DFKKLFR------TPVYLT 154
Query: 140 PNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
+K + + ++ +H I+HRD+K N L + K+ DFGLA + +
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVF 225
D +K +
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQ 239
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 30/186 (16%), Positives = 62/186 (33%), Gaps = 42/186 (22%)
Query: 21 RLIGKGSHGSVYKAI---LEDHQTDGDHKILAIKRASTNG---FEVLQDNSKKLNNEIRV 74
+ + G +Y+A + + ++K + +G E ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAAT 133
L P + G G LV+ + G SL L
Sbjct: 108 WKKLY----STPLLAIPTCMG-----FGVHQDKYR-FLVLPSL--GRSLQSALD------ 149
Query: 134 TPQLGWPNR--------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK--L 183
+ +++A ++ A++ LHEN+ +H ++ + NI D + ++ L
Sbjct: 150 -----VSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTL 202
Query: 184 ADFGLA 189
A +G A
Sbjct: 203 AGYGFA 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 55/231 (23%), Positives = 107/231 (46%), Gaps = 32/231 (13%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
E + +G G++GSV A D +T +A+K+ S F+ + +K+ E+R
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF--DTKT---GLRVAVKKLS-RPFQSIIH-AKRTYRELR 80
Query: 74 VLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+L + ++ N +++ + S++ ++ LV M L +++
Sbjct: 81 LLKHM-----KHENVIGLLDVF----TPARSLEEFNDVYLVTHLMGA-DLNNIVKC---- 126
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
Q + V+ + QI R ++ +H D IIHRD+K +N+ + + K+ DFGLA
Sbjct: 127 ---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 192 ESDESSMVQPAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+DE M T Y P N ++ VD++S G ++ E+++ + +
Sbjct: 182 TADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTL 229
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 57/249 (22%), Positives = 96/249 (38%), Gaps = 78/249 (31%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN---NEIRVLSS 77
+G+G+ G V + I DH+ G + +A+K ++++ + +EI+VL
Sbjct: 20 DTLGEGAFGKVVECI--DHKAGG--RHVAVK--------IVKNVDRYCEAARSEIQVLEH 67
Query: 78 LQESNKRNPNYCV-----VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
L ++ + CV HG C +V E + S YD +
Sbjct: 68 LNTTDPNSTFRCVQMLEWFEHHGHIC-------------IVFELL-GLSTYDFIKE---- 109
Query: 133 TTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS------------- 177
L + K+A QI +++ LH N + H D+K NILF
Sbjct: 110 -NGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKR 166
Query: 178 ------KWDAKLADFGLAVSESD-ESSMVQ------PAGTIGYLDPGYTNPSKLSKKVDV 224
D K+ DFG A + + S++V P + G++ P DV
Sbjct: 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILAL---GWSQP------CDV 217
Query: 225 FSYGVVLLE 233
+S G +L+E
Sbjct: 218 WSIGCILIE 226
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 3e-11
Identities = 35/207 (16%), Positives = 58/207 (28%), Gaps = 45/207 (21%)
Query: 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK----RASTNGFEVLQDNSKKL 68
TE + IG+G G V++ I DH +AIK Q +++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 69 NNEIRVLSSLQESNKRNPNYCVVNFHGT--------------------------SCRNSG 102
EI + L + N F G S +
Sbjct: 71 LPEIIISKELSLLSGEVCNRTE-GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 103 SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162
+ +V+EF G + + I Q++ ++ + E
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASL-AVAEASLR 182
Query: 163 IIHRDIKSTNILFDSKWDAKLADFGLA 189
HRD+ N+L KL
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNG 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 42/182 (23%), Positives = 69/182 (37%), Gaps = 52/182 (28%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R IG+GS G +++ + ++ +AIK FE + ++ +L +E R L
Sbjct: 16 RRIGEGSFGVIFEGT--NLLN---NQQVAIK------FEPRRSDAPQLRDEYRTYKLLAG 64
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAATTPQLGW 139
V + G +G N +LV++ + G SL DLL
Sbjct: 65 C----TGIPNVYYFGQ--------EGLHN-VLVIDLL--GPSLEDLLD-----------L 98
Query: 140 PNR-------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK-----LADFG 187
R A Q+ +Q +HE +++RDIK N L + DFG
Sbjct: 99 CGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156
Query: 188 LA 189
+
Sbjct: 157 MV 158
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 59/245 (24%), Positives = 108/245 (44%), Gaps = 53/245 (21%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ +GKG++G V+K+I D +T +++A+K+ + F+ D +++ EI +L+ L
Sbjct: 15 KKLGKGAYGIVWKSI--DRRT---GEVVAVKKI-FDAFQNSTD-AQRTFREIMILTEL-- 65
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ N +VN N D + + LV ++M DL H A + P
Sbjct: 66 --SGHEN--IVNL-----LNVLRADNDRDVYLVFDYME----TDL-HAVIRA---NILEP 108
Query: 141 NRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSESDESS 197
+ + Q+ + I+ LH ++HRD+K +NIL +++ K+ADFGL+ +
Sbjct: 109 VHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 198 MVQPAGTIGYLDPGYTNPSKL---------------------SKKVDVFSYGVVLLEIIS 236
P + + L +K +D++S G +L EI+
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 237 CRKPI 241
KPI
Sbjct: 227 -GKPI 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 50/180 (27%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R IG GS G +Y D + +AIK E ++ +L+ E ++ +Q
Sbjct: 15 RKIGSGSFGDIYLGT--DIAA---GEEVAIK------LECVKTKHPQLHIESKIYKMMQG 63
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAATTPQLGW 139
+ + G +G+ N ++VME + G SL DL + +
Sbjct: 64 G----VGIPTIRWCGA--------EGDYN-VMVMELL--GPSLEDLFN-----------F 97
Query: 140 PNR-------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK---LADFGLA 189
+R + +A Q+ I+ +H + IHRD+K N L + DFGLA
Sbjct: 98 CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 39/182 (21%), Positives = 68/182 (37%), Gaps = 52/182 (28%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG G+ G + + T ++ +AIK E ++ + +L+ E R L
Sbjct: 15 KKIGCGNFGELRLGK--NLYT---NEYVAIK------LEPMKSRAPQLHLEYRFYKQLGS 63
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAATTPQLGW 139
V + G G N +V+E + G SL DL
Sbjct: 64 G----DGIPQVYYFGP--------CGKYN-AMVLELL--GPSLEDLFD-----------L 97
Query: 140 PNR-------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK-----LADFG 187
+R + IA+Q+ ++ +H + +I+RD+K N L + + DF
Sbjct: 98 CDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155
Query: 188 LA 189
LA
Sbjct: 156 LA 157
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 56/250 (22%), Positives = 93/250 (37%), Gaps = 80/250 (32%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNN----EIRVLS 76
+G+G+ G V + + DH +A+K +++ N K EI VL
Sbjct: 25 GNLGEGTFGKVVECL--DHARG--KSQVALK--------IIR-NVGKYREAARLEINVLK 71
Query: 77 SLQESNKRNPNYCV-----VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
++E +K N CV NFHG C + E + + ++ L
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMC-------------IAFELL-GKNTFEFLKE--- 114
Query: 132 ATTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA-------- 181
+P +A Q+ A++ LHEN + H D+K NILF +
Sbjct: 115 --NNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 182 -----------KLADFGLAVSESDE-SSMVQ------PAGTIGYLDPGYTNPSKLSKKVD 223
++ADFG A + + +++V P + G+ P D
Sbjct: 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILEL---GWAQP------CD 221
Query: 224 VFSYGVVLLE 233
V+S G +L E
Sbjct: 222 VWSIGCILFE 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 46/231 (19%), Positives = 86/231 (37%), Gaps = 51/231 (22%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R +G+G + V++AI + + + + +K + KK+ EI++L +L+
Sbjct: 42 RKLGRGKYSEVFEAI--NITNN---EKVVVKI-------LKPVKKKKIKREIKILENLRG 89
Query: 81 SNKRNPN----YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
PN +V + LV E + N L
Sbjct: 90 G----PNIITLADIV-----------KDPVSRTPALVFEHVNNTDFKQLY--------QT 126
Query: 137 LGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKW-DAKLADFGLAVSESD 194
L ++ M +I +A+ H I+HRD+K N++ D + +L D+GLA
Sbjct: 127 LT-DYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 195 ESSMVQPAGTIGYLDP----GYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241
+ + P Y +D++S G +L +I ++P
Sbjct: 184 GQEYNVRVASRYFKGPELLVDY---QMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 57/249 (22%), Positives = 94/249 (37%), Gaps = 58/249 (23%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
LIG+GS+G VY A D T+ K +AIK+ FE L D K++ EI +L+ L
Sbjct: 32 HLIGRGSYGYVYLAY--DKNTE---KNVAIKKV-NRMFEDLID-CKRILREITILNRL-- 82
Query: 81 SNKRNPNYCVVN----FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
++ ++ + +V+E + L L TP
Sbjct: 83 ---KSDY--IIRLYDLIIPDDLLKFDEL------YIVLEIADS-DLKKLFK------TPI 124
Query: 137 LGWPNRVK-IAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE 195
+K I + +HE+ IIHRD+K N L + K+ DFGLA + + E
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 196 SSMVQPAGTIGYLDPGYTNPSKL------------------------SKKVDVFSYGVVL 231
+PG N + +K +D++S G +
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 232 LEIISCRKP 240
E+++ +
Sbjct: 243 AELLNMLQS 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 57/246 (23%), Positives = 106/246 (43%), Gaps = 48/246 (19%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
++ IG+G++G V A D+ +AIK+ + FE ++ EI+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAY--DNLNK---VRVAIKK--ISPFEHQTY-CQRTLREIK 77
Query: 74 VLSSLQESNKRNPN-YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+L R+ N + + + +++ + +V + M LY LL
Sbjct: 78 ILLRF-----RHENIIGINDII-----RAPTIEQMKDVYIVQDLMET-DLYKLLK----- 121
Query: 133 TTPQLGWPNRVKIAM-QISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
T L + + + QI R ++ +H + ++HRD+K +N+L ++ D K+ DFGLA
Sbjct: 122 -TQHLS-NDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 192 ESDESS----MVQPAGTIGYLDP-------GYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
+ + + T Y P GYT K +D++S G +L E++S +P
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT------KSIDIWSVGCILAEMLS-NRP 230
Query: 241 IDAARD 246
I +
Sbjct: 231 IFPGKH 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 45/273 (16%), Positives = 81/273 (29%), Gaps = 55/273 (20%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEV------------ 60
+ + +G+G+ G V +A + +A+K + E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 61 --------------------------------LQDNSKKLNNEIRVLSSLQESNKRNPNY 88
L + NE + ++ +Y
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQ 148
R S+ + S + L + + + Q
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 149 ISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYL 208
+++ ++ L IHRD+ + NIL K K+ DFGLA + V L
Sbjct: 202 VAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARL 257
Query: 209 DPGYTNPSKLSKKV-----DVFSYGVVLLEIIS 236
+ P + +V DV+S+GV+L EI S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 37/194 (19%), Positives = 64/194 (32%), Gaps = 51/194 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNN----EIRV 74
R +G G+ G V K A+K R N KK E +
Sbjct: 41 RKMGDGTFGRVLLCQ--HIDN---KKYYAVKVVR-----------NIKKYTRSAKIEADI 84
Query: 75 LSSLQESNKRNPNYCV-----VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
L +Q + N N V ++ C L+ E + SLY+++
Sbjct: 85 LKKIQNDDINN-NNIVKYHGKFMYYDHMC-------------LIFEPL-GPSLYEIITR- 128
Query: 130 AAATTPQLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFG 187
G+ ++I +A+ L + + H D+K NIL D + K
Sbjct: 129 ----NNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV 182
Query: 188 LAVSESDESSMVQP 201
V++ + + +
Sbjct: 183 RRVTDGKKIQIYRT 196
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 48/179 (26%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R IG GS G +Y + QT ++ +AIK E ++ +L E ++ LQ
Sbjct: 13 RKIGSGSFGEIYLGT--NIQT---NEEVAIK------LENVKTKHPQLLYESKIYRILQG 61
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
V + G +G+ N +LVM+ + SL DL + +
Sbjct: 62 G----TGIPNVRWFGV--------EGDYN-VLVMDLLGP-SLEDLFN-----------FC 96
Query: 141 NR-------VKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK---LADFGLA 189
+R + +A Q+ ++ +H +HRDIK N L A + DFGLA
Sbjct: 97 SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 53/280 (18%), Positives = 89/280 (31%), Gaps = 84/280 (30%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
R +G G +V+ + D Q K +A+K +++ + E D EIR+L S+
Sbjct: 43 RKLGWGHFSTVWLS--WDIQG---KKFVAMKVVKSAEHYTETALD-------EIRLLKSV 90
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNK--LLVMEFMPNG-SLYDLLHNAAAATTP 135
+ S+ +PN +V + + G + +V E + G L + +
Sbjct: 91 RNSDPNDPNREMV----VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIK-----SN 139
Query: 136 QLGWPNRV--KIAMQISRAIQCLHENDPMIIHRDIKSTNILF------------------ 175
G P KI Q+ + + LH IIH DIK NIL
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 176 -------------------------------DSKWDAKLADFGLAVSESDE-SSMVQPAG 203
K K+AD G A + +Q
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT-- 256
Query: 204 TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
Y S + D++S + E+ + +
Sbjct: 257 -RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 379 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.57 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.92 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=425.12 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=211.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||+|.++. +++.||||++.... ....+.+.+|+.+|+.++|+| ||+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~Hpn-------IV~l~ 137 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHEN-------VVEMY 137 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGG----CSSGGGGHHHHHHHHHCCCTT-------BCCEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC-----CCCEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCC-------CCcEE
Confidence 569999999999999999998765 56789999997543 234566889999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++.+|||||||+||+|.+++.+. .+++.+++.++.||+.||+|||++| |+||||||+|||
T Consensus 138 ~~~-------~~~~~~~ivmEy~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NIL 202 (346)
T 4fih_A 138 NSY-------LVGDELWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSIL 202 (346)
T ss_dssp EEE-------EETTEEEEEECCCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred EEE-------EECCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEE
Confidence 764 5678999999999999999999752 2899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.+|.+||+|||+|...... ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+... ..
T Consensus 203 l~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~-- 279 (346)
T 4fih_A 203 LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AM-- 279 (346)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH--
T ss_pred ECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HH--
Confidence 999999999999999766443 33456689999999999999999999999999999999999999998654222 11
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+..........+..+++++.+||.+||+.||++|||++|+++|...
T Consensus 280 ----------~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 280 ----------KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp ----------HHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ----------HHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 111111111122344567899999999999999999999999999544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=430.60 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=207.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|+++. +++.||||++...... ....+++.+|+.+|++|+|+| ||++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~Hpn-------IV~~ 88 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE-----DGRQYVIKEINISRMS--SKEREESRREVAVLANMKHPN-------IVQY 88 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT-----TCCEEEEEEEECTTSC--HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred ccceEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHCC--HHHHHHHHHHHHHHHHCCCCC-------CCcE
Confidence 4789999999999999999998765 5678999999765433 345678999999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++.+|||||||+||+|.+++...+ ...+++.+++.|+.||+.||+|||++| |+||||||+||
T Consensus 89 ~~~~-------~~~~~~yiVmEy~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NI 156 (350)
T 4b9d_A 89 RESF-------EENGSLYIVMDYCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNI 156 (350)
T ss_dssp EEEE-------EETTEEEEEEECCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGE
T ss_pred EEEE-------EECCEEEEEEeCCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHE
Confidence 8764 56789999999999999999997643 233788899999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|.+||+|||+|+...... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+... +
T Consensus 157 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~-- 233 (350)
T 4b9d_A 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-L-- 233 (350)
T ss_dssp EECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H--
T ss_pred EECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-H--
Confidence 99999999999999997764432 2234579999999999999999999999999999999999999998754222 1
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+..+..... +.....+++++.+||.+||+.||++|||++|+++|...
T Consensus 234 ----------~~~i~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 234 ----------VLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp ----------HHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ----------HHHHHcCCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 111222211 12223456889999999999999999999999998544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=410.72 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=194.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.++. +++.||+|+++..... .....+++.+|+.+|+.++|+| ||+++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~Hpn-------Iv~~~ 79 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT-----TGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPH-------IIKLY 79 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT-----TCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTT-------BCCEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCC-------CCeEE
Confidence 689999999999999999998654 5678999999765332 2345678999999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++.+|+||||| +|+|.+++.+.+ .+++.+++.++.|++.||+|||++| |+||||||+|||
T Consensus 80 ~~-------~~~~~~~~ivmEy~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NIL 144 (275)
T 3hyh_A 80 DV-------IKSKDEIIMVIEYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLL 144 (275)
T ss_dssp EE-------EECSSEEEEEEECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEE
T ss_pred EE-------EEECCEEEEEEeCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeE
Confidence 76 46678999999999 789999997643 3999999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+++++.+||+|||+|+.........+..||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+. ..+
T Consensus 145 l~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~--- 220 (275)
T 3hyh_A 145 LDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVL--- 220 (275)
T ss_dssp ECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH---
T ss_pred ECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHH---
Confidence 99999999999999987666555566789999999999988876 5799999999999999999999976532 111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+..+.......|. .+++++.+|+.+||+.||++|||++|+++|..
T Consensus 221 ---------~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 221 ---------FKNISNGVYTLPK---FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp ---------HHHHHHTCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred ---------HHHHHcCCCCCCC---CCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 1222223333333 34578999999999999999999999999853
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=419.69 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=210.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|+++. +++.||+|++.+.... .....+.+.+|+++|++++|+| ||+++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~-----~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~Hpn-------Iv~l~ 98 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPF-------FVKLY 98 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred cccEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCC-------CCeEE
Confidence 579999999999999999998765 5678999999754321 2345678999999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +++++.+|||||||+||+|.+++.+.+. +++.+++.++.||+.||+|||++| |+||||||+|||
T Consensus 99 ~~-------~~~~~~~yivmEy~~gG~L~~~i~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNIL 164 (311)
T 4aw0_A 99 FT-------FQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENIL 164 (311)
T ss_dssp EE-------EECSSEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred EE-------EEeCCEEEEEEecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeE
Confidence 76 5678899999999999999999986542 899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC---CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDE---SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++.+|.+||+|||+|+..... ....+.+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+.. .
T Consensus 165 l~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~-- 241 (311)
T 4aw0_A 165 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-L-- 241 (311)
T ss_dssp ECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H--
T ss_pred EcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H--
Confidence 999999999999999765432 2344568999999999999999999999999999999999999999865421 1
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.+..+....+..|. .+++++.+||.+||+.||++|||++|++.|
T Consensus 242 ----------~~~~i~~~~~~~p~---~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 242 ----------IFAKIIKLEYDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ----------HHHHHHHTCCCCCT---TCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ----------HHHHHHcCCCCCCc---ccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 12222333333343 345789999999999999999999997544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-58 Score=412.92 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=207.4
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+++.+|+.+|++|+||| ||++++.
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~Hpn-------IV~~~~~ 93 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPN-------IVRFYDS 93 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHTCCCTT-------BCCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCC-------CCcEEEE
Confidence 3677889999999999998765 5677999998754332 345678999999999999999 9998887
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~ 176 (379)
+... ....+.+|||||||+||+|.+++.+.+ .+++..++.++.|++.||+|||++|++|+||||||+|||++
T Consensus 94 ~~~~---~~~~~~~~lvmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~ 165 (290)
T 3fpq_A 94 WEST---VKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp EEEE---ETTEEEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES
T ss_pred Eeec---cCCCcEEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE
Confidence 5321 123457899999999999999998643 38999999999999999999999887799999999999998
Q ss_pred -CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 177 -SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 177 -~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
.+|.+||+|||+|+.... ....+.+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+..+...+....
T Consensus 166 ~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i- 242 (290)
T 3fpq_A 166 GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV- 242 (290)
T ss_dssp STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-
T ss_pred CCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH-
Confidence 479999999999976443 33445689999999999875 69999999999999999999999998765544332221
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
......+......++++.+||.+||+.||++|||++|+++|..
T Consensus 243 ------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 243 ------------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp ------------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ------------HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1111112223334578999999999999999999999999854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=428.01 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=210.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|++.+.||+|+||.||+|.++. +++.||||++.... ....+.+.+|+.+|+.++|+| ||+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~Hpn-------IV~l~ 214 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHEN-------VVEMY 214 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEESTT----CSSGGGHHHHHHHHHHCCCTT-------BCCEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECC-----CCCEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCC-------CCceE
Confidence 579999999999999999998765 56789999997543 234567899999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++.+|||||||+||+|.+++... .+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 215 ~~~-------~~~~~~~iVmEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NIL 279 (423)
T 4fie_A 215 NSY-------LVGDELWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSIL 279 (423)
T ss_dssp EEE-------EETTEEEEEEECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEE
T ss_pred EEE-------EECCEEEEEEeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEE
Confidence 774 5578999999999999999999652 2899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|+.+|.+||+|||+|...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+ .
T Consensus 280 l~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-~- 357 (423)
T 4fie_A 280 LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-K- 357 (423)
T ss_dssp ECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-H-
T ss_pred EcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-H-
Confidence 999999999999999765443 3345668999999999999999999999999999999999999999865422211 1
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+.............+++++.+||.+||+.||++|||+.|+++|...
T Consensus 358 -----------~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 358 -----------MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp -----------HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -----------HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 11111111112233456889999999999999999999999999544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-58 Score=414.52 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=205.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|.+..+ ..+++.||+|.++..... .....++.+|+.+|++++|+| ||+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~Hpn-------Iv~l~ 92 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHPF-------IVKLH 92 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEE--EEECC------CCCCCCCCTT-------EECEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcC--hHHHHHHHHHHHHHHHCCCCC-------CCeEE
Confidence 6799999999999999999987543 236788999999765432 233457889999999999998 99988
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++.+|||||||+||+|.+++.+.+ .+++.+++.++.|++.||+|||++| |+||||||+|||
T Consensus 93 ~~-------~~~~~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NIL 158 (304)
T 3ubd_A 93 YA-------FQTEGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENIL 158 (304)
T ss_dssp EE-------EEETTEEEEEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEE
T ss_pred EE-------EEECCEEEEEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeE
Confidence 76 456789999999999999999998654 3899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.+|.+||+|||+|+.... .....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...
T Consensus 159 l~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----- 233 (304)
T 3ubd_A 159 LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----- 233 (304)
T ss_dssp ECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred EcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-----
Confidence 99999999999999976433 233455689999999999999999999999999999999999999998654221
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~ 311 (379)
.+..+.......|. .+++++.+||.+||+.||++|||+ +|+++|...
T Consensus 234 --------~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 234 --------TMTMILKAKLGMPQ---FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp --------HHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred --------HHHHHHcCCCCCCC---cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 12222233333333 346889999999999999999984 799998543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=416.05 Aligned_cols=249 Identities=19% Similarity=0.212 Sum_probs=202.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++.++||+|+||.||+|+++. +++.||||+++.+.. ..+|+.+++.++||| ||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~-----~g~~vAiK~i~~~~~---------~~~E~~il~~l~Hpn-------IV~l 115 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ-----TGFQCAVKKVRLEVF---------RVEELVACAGLSSPR-------IVPL 115 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC---------CTHHHHTTTTCCCTT-------BCCE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC-----CCCEEEEEEECHHHh---------HHHHHHHHHhCCCCC-------CCcE
Confidence 3568888999999999999998765 567899999975432 247999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++.+|||||||+||+|.+++.+.+ .+++..++.++.|++.||+|||++| |+||||||+||
T Consensus 116 ~~~~-------~~~~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NI 181 (336)
T 4g3f_A 116 YGAV-------REGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNV 181 (336)
T ss_dssp EEEE-------EETTEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGE
T ss_pred EEEE-------EECCEEEEEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHE
Confidence 8764 56788999999999999999998654 2899999999999999999999999 99999999999
Q ss_pred EEcCCC-CeEEeccccCccCCCCCc------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 174 LFDSKW-DAKLADFGLAVSESDESS------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 174 ll~~~~-~~kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|++.+| .+||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+...
T Consensus 182 Ll~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp EECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred EEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 999887 599999999976543321 2234799999999999999999999999999999999999999987654
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
....... ...........+.+++.+.++|.+||+.||++|||+.|+++|..
T Consensus 262 ~~~~~~i-------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 262 GPLCLKI-------------ASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp SCCHHHH-------------HHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH-------------HcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 3322111 11111111223345688999999999999999999999998743
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-57 Score=410.19 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=207.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|.+.+.||+|+||.||+|.+.......++..||||+++... ....+.|.+|+++|++++|+| ||+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~Hpn-------IV~l~ 81 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEH-------IVKFY 81 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC----HHHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC----hHHHHHHHHHHHHHHhCCCCC-------CccEE
Confidence 5789999999999999999998765555578899999997543 344678999999999999999 99999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc--------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA--------ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
+++ .+++..|||||||++|+|.+++...+. .....+++.++..++.|++.||+|||+++ |+||
T Consensus 82 g~~-------~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHR 152 (299)
T 4asz_A 82 GVC-------VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHR 152 (299)
T ss_dssp EEE-------CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEE-------eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 875 446789999999999999999986431 23445999999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPID 242 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~ 242 (379)
||||+|||+++++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 153 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 153 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999975433322 223368999999999999999999999999999999999 999998
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+..+. ++.... .. ......| ..+++++.+|+.+||+.||++|||+++++..
T Consensus 233 ~~~~~-~~~~~i----~~-------~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~ 283 (299)
T 4asz_A 233 QLSNN-EVIECI----TQ-------GRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTL 283 (299)
T ss_dssp TSCHH-HHHHHH----HH-------TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHH-HHHHHH----Hc-------CCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 76432 221111 11 1112222 3456789999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=403.96 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=202.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. .||||.++..... ....+.|.+|+.++++++|+| ||+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~--~~~~~~f~~E~~il~~l~HpN-------IV~ 96 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPT--PEQFQAFRNEVAVLRKTRHVN-------ILL 96 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCC--HHHHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCC--HHHHHHHHHHHHHHHhCCCCC-------Eee
Confidence 34678899999999999999997532 3899998754332 455678999999999999999 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++. ++.+|||||||+||+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|
T Consensus 97 l~g~~~--------~~~~~iVmEy~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~N 162 (307)
T 3omv_A 97 FMGYMT--------KDNLAIVTQWCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNN 162 (307)
T ss_dssp EEEEEC--------SSSCEEEEECCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSS
T ss_pred EEEEEE--------CCeEEEEEEcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHH
Confidence 888642 35689999999999999999753 234999999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||+++++.+||+|||+|+...... ......||+.|||||++. ..+++.++|||||||++|||+||+.||.+.++
T Consensus 163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999997654322 234457999999999875 34689999999999999999999999987665
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...+...... ... ....+.....+++++.+|+.+||+.||++|||+.|++++.
T Consensus 243 ~~~~~~~~~~--------~~~--~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 243 RDQIIFMVGR--------GYA--SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHHHT--------TCC--CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHHhc--------CCC--CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 4333221110 001 1111223345668899999999999999999999998763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=415.76 Aligned_cols=273 Identities=21% Similarity=0.332 Sum_probs=222.1
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh-ccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-SNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~ 83 (379)
|+.+.|....++|++.+.||+|+||.||+|.+.......+++.||||.+..... ....+.+.+|+.+|.++.| +|
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~---~~~~~~~~~E~~il~~l~hhpn- 129 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLN- 129 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT-
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---hHHHHHHHHHHHHHHHcCCCCc-
Confidence 344566667789999999999999999999998877777889999999975432 3446789999999999976 56
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHH
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRA 152 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~ 152 (379)
||++++.|. .+++.+|||||||++|+|.++|+..... ....+++..+..++.|++.|
T Consensus 130 ------IV~l~g~~~------~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~g 197 (353)
T 4ase_A 130 ------VVNLLGACT------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 197 (353)
T ss_dssp ------BCCEEEEEC------CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHH
T ss_pred ------EEEEEEEEE------ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHH
Confidence 899888763 3346789999999999999999865421 13448899999999999999
Q ss_pred HHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHH
Q 035572 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229 (379)
Q Consensus 153 l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 229 (379)
|+|||+++ |+||||||+|||+++++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||
T Consensus 198 l~yLH~~~--iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv 275 (353)
T 4ase_A 198 MEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 275 (353)
T ss_dssp HHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHhHhhCC--eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHH
Confidence 99999999 99999999999999999999999999976543322 23446899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 230 VLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 230 il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++|||+| |+.||.+......+..... . ..++..|. .+++++.+++.+||+.||++|||+.|+++|
T Consensus 276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~----~-------g~~~~~p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 276 LLWEIFSLGASPYPGVKIDEEFCRRLK----E-------GTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHH----H-------TCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHH----c-------CCCCCCCc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999998 9999987654443322211 1 11222232 345789999999999999999999999987
Q ss_pred c
Q 035572 309 C 309 (379)
Q Consensus 309 ~ 309 (379)
.
T Consensus 342 L 342 (353)
T 4ase_A 342 L 342 (353)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=408.42 Aligned_cols=261 Identities=21% Similarity=0.364 Sum_probs=204.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|.+.++||+|+||.||+|.++......+++.||||+++... ....+.|.+|+++|++++|+| ||+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~Hpn-------IV~l~ 109 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTMLQHQH-------IVRFF 109 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS----HHHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCC-------CCcEE
Confidence 4677889999999999999998765455578899999997543 345678999999999999999 99999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC----------CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA----------TTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~ 164 (379)
+++ .+.+.+|||||||++|+|.+++.+.... ....+++.+++.++.|++.||+|||+++ |+
T Consensus 110 g~~-------~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--ii 180 (329)
T 4aoj_A 110 GVC-------TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FV 180 (329)
T ss_dssp EEE-------CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EEE-------EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--ee
Confidence 875 4467899999999999999999864321 2234899999999999999999999999 99
Q ss_pred ecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCC
Q 035572 165 HRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKP 240 (379)
Q Consensus 165 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 240 (379)
||||||+|||+++++.+||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 181 HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC
Confidence 99999999999999999999999997653332 2234579999999999999999999999999999999999 9999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|.+..+.. +.... .. ..++..| ..+++++.+|+.+||+.||++|||++|++++..
T Consensus 261 f~~~~~~~-~~~~i----~~-------g~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 261 WYQLSNTE-AIDCI----TQ-------GRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp TCSSCHHH-HHHHH----HH-------TCCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCHHH-HHHHH----Hc-------CCCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 98764322 11111 10 1122223 345678999999999999999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=405.81 Aligned_cols=261 Identities=20% Similarity=0.323 Sum_probs=207.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+++++.+.||+|+||.||+|.+.......+++.||||+++.... ....+.|.+|+.++++++|+| ||+++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~---~~~~~~f~~E~~il~~l~HpN-------IV~l~ 95 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE---GPLREEFRHEAMLRARLQHPN-------VVCLL 95 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC---C-CHHHHHHHHHHHHHCCCTT-------BCCEE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC---hHHHHHHHHHHHHHHhCCCCC-------CCCcc
Confidence 56788899999999999999986655555778999999975422 345678999999999999999 99999
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC-----------CCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-----------TPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
+++ .+++.++||||||++|||.++|....... ...+++.++..++.|++.||+|||+++ |
T Consensus 96 g~~-------~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--i 166 (308)
T 4gt4_A 96 GVV-------TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--V 166 (308)
T ss_dssp EEE-------CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred eEE-------EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--C
Confidence 875 34678899999999999999997643211 234899999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRK 239 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 239 (379)
+||||||+|||+++++.+||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus 167 iHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp CCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCC
Confidence 999999999999999999999999997543322 2334579999999999999999999999999999999998 899
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
||.+..+. ++... +.. ...+.| ..+++.+.+|+.+||+.||++|||+.||+++..
T Consensus 247 Pf~~~~~~-~~~~~------------i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 247 PYCGYSNQ-DVVEM------------IRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp TTTTCCHH-HHHHH------------HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHH-HHHHH------------HHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99876432 22111 111 122222 345678999999999999999999999998743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=395.63 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=196.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|.++. +++.||||+++.... ....+++.+|+.+|++|+||| ||+++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~---~~~~~~~~~E~~il~~l~Hpn-------IV~~~ 69 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPNR---ELAREKVMREVKALAKLEHPG-------IVRYF 69 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT-----TCCEEEEEEEEECSS---HHHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCC-------CCeEE
Confidence 469999999999999999998765 567899999875432 344578999999999999999 99988
Q ss_pred ccccccCC-----CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 95 GTSCRNSG-----SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 95 ~~~~~~~~-----~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
+.+..... .......+|+|||||+||+|.+++...... ...++..++.++.|++.||+|||++| |+|||||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlK 145 (299)
T 4g31_A 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLK 145 (299)
T ss_dssp EEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCC
T ss_pred EEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCc
Confidence 87653211 112334579999999999999999864321 22455668899999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCCc-------------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDESS-------------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
|+|||++.+|.+||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 146 p~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp GGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred HHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 9999999999999999999976543211 223469999999999999999999999999999999996
Q ss_pred CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
||....+.. ..+..+. ....|+.....++.+.+|+.+||+.||++|||+.|+++|..
T Consensus 226 ---Pf~~~~~~~------------~~~~~~~--~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 226 ---PFSTQMERV------------RTLTDVR--NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp ---CCSSHHHHH------------HHHHHHH--TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---CCCCccHHH------------HHHHHHh--cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 775421110 0111111 12234555666778899999999999999999999999844
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=403.45 Aligned_cols=276 Identities=21% Similarity=0.287 Sum_probs=211.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|.++. +++.||||+++..... ....+++.+|+.+|+.++|+| ||++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~-----t~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hpn-------Iv~l 118 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRL-----TGQQVAIKKIPNAFDV--VTNAKRTLRELKILKHFKHDN-------IIAI 118 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEETTTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred CCCeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEECccccc--hHHHHHHHHHHHHHHhcCCCC-------cceE
Confidence 3689999999999999999998765 6678999999755332 344577899999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ...+.+.+.+||||||| +|+|.+++.+. ..+++..++.+++||+.||.|||++| |+||||||+||
T Consensus 119 ~~~~~~-~~~~~~~~~~~ivmE~~-~g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NI 189 (398)
T 4b99_A 119 KDILRP-TVPYGEFKSVYVVLDLM-ESDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNL 189 (398)
T ss_dssp EEECCC-SSCTTTCCCEEEEEECC-SEEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred eeeeec-ccccccCCEEEEEEeCC-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCcccc
Confidence 876543 23356678999999999 57899999753 34999999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-----CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-----SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|++.+|.+||+|||+|+..... ....+.+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..
T Consensus 190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999999765332 233456899999999987765 5699999999999999999999999876544
Q ss_pred hhHHHhhhhhh----------hHHhhh---hhccccCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 248 ASIIDWALPLI----------KEEKLR---QVCDSRVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~----------~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
..+........ ...... .........+ ...+..++++.+||.+||+.||++|||++|+|+|....
T Consensus 270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 33322111000 000000 0011111101 01123467899999999999999999999999996553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=396.65 Aligned_cols=271 Identities=20% Similarity=0.335 Sum_probs=204.7
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCC
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPN 87 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~ 87 (379)
.+..+.++|++.+.||+|+||.||+|.++. ...+++.||+|.+... ....++.+|+++|+.+ .|+|
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~n----- 81 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQL--QVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDN----- 81 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEB--TTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTT-----
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcc--cCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCC-----
Confidence 334567899999999999999999998753 2236788999998643 2346788999999998 4677
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++. +.+.+++|+|||||+||+|.+++.. +++.+++.++.|++.||+|||++| |+|||
T Consensus 82 --Iv~l~~~-------~~~~~~~~lvmE~~~g~~L~~~~~~--------l~~~~~~~~~~qll~al~ylH~~g--IiHRD 142 (361)
T 4f9c_A 82 --VMGVKYC-------FRKNDHVVIAMPYLEHESFLDILNS--------LSFQEVREYMLNLFKALKRIHQFG--IVHRD 142 (361)
T ss_dssp --BCCCSEE-------EEETTEEEEEEECCCCCCHHHHHTT--------CCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred --CceEEEE-------EEECCEEEEEEeCCCcccHHHHHcC--------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCc
Confidence 7777655 4667899999999999999999853 899999999999999999999999 99999
Q ss_pred CCCCceEEcCC-CCeEEeccccCccCCCCC-----------------------------cccccCccccccCCCCCCCC-
Q 035572 168 IKSTNILFDSK-WDAKLADFGLAVSESDES-----------------------------SMVQPAGTIGYLDPGYTNPS- 216 (379)
Q Consensus 168 lkp~NIll~~~-~~~kl~Dfg~a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~- 216 (379)
|||+|||++.+ +.+||+|||+|+...... .....+||+.|+|||++.+.
T Consensus 143 iKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 143 VKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred CCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99999999876 899999999996443211 12334799999999988765
Q ss_pred CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhh--------------------------hhcccc
Q 035572 217 KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLR--------------------------QVCDSR 270 (379)
Q Consensus 217 ~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~ 270 (379)
.++.++||||+||++|+|+||+.||....+..+....+.......... .+....
T Consensus 223 ~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 302 (361)
T 4f9c_A 223 NQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---
T ss_pred CCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccc
Confidence 589999999999999999999999977665443332222211110000 000000
Q ss_pred CCC-------------CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 271 VGL-------------PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 271 ~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... ...+..+++++.+||.+||+.||++|||++|+|+|...
T Consensus 303 ~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred ccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 000 01122345789999999999999999999999999543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=386.43 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=193.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.+ .++.||||+++... ......+.|+..+.+++|+| ||++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-------~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpN-------Iv~l 62 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHEN-------ILGF 62 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-------TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTT-------BCCE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCC-------CCcE
Confidence 45788999999999999999986 34679999986432 12233445666677889998 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC--------CCCeEe
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN--------DPMIIH 165 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~~~i~H 165 (379)
++++.... .....+|||||||++|+|.++++.. .+++..+..++.|++.||+|||++ + |+|
T Consensus 63 ~g~~~~~~---~~~~~~~lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiH 131 (303)
T 3hmm_A 63 IAADNKDN---GTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAH 131 (303)
T ss_dssp EEEEEEEC---SSSEEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EEC
T ss_pred EEEEEecC---CCceEEEEEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--Eee
Confidence 98875311 1123689999999999999999753 288999999999999999999987 6 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCC------CCCCcCCeehhHHHHHHH
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPS------KLSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el 234 (379)
|||||+|||++.++.+||+|||+|+....... .....||+.|||||++.+. .++.++|||||||++|||
T Consensus 132 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 99999999999999999999999976543221 2234799999999988654 367899999999999999
Q ss_pred HhCCCCCCCCCCchhHHHhhh-h-hhhHHhhhhhccc--cCCCCcc--hHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 235 ISCRKPIDAARDPASIIDWAL-P-LIKEEKLRQVCDS--RVGLPTF--MEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 235 ltg~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+||.+||....+...-..... . ...+.....+... ++..|.. ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 212 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999888754432211000000 0 0001111111221 1222322 23466789999999999999999999999876
Q ss_pred c
Q 035572 309 C 309 (379)
Q Consensus 309 ~ 309 (379)
.
T Consensus 292 L 292 (303)
T 3hmm_A 292 L 292 (303)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=406.36 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=215.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.+.... ....+.+.+|+.+|+.|+|+| ||++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~-----tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpn-------Iv~l 219 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPT-------LVNL 219 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTT-------BCCE
T ss_pred ccccEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 4789999999999999999998765 66789999987543 233577899999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+.+|||||||+||+|.+++... ...+++.+++.++.||+.||.|||++| |+||||||+||
T Consensus 220 ~~~-------~~~~~~~~iv~E~~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Ni 286 (573)
T 3uto_A 220 HDA-------FEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENI 286 (573)
T ss_dssp EEE-------EECSSEEEEEEECCCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred EEE-------EEECCEEEEEEeecCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhc
Confidence 876 46788999999999999999999642 224899999999999999999999999 99999999999
Q ss_pred EEcCC--CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSK--WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++.+ +.+||+|||+|............+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+....
T Consensus 287 ll~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-- 364 (573)
T 3uto_A 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-- 364 (573)
T ss_dssp EESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--
T ss_pred cccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--
Confidence 99854 89999999999887766666667899999999999999999999999999999999999999987653221
Q ss_pred HhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+..+....... +..+..+++++.+||.+||+.||.+|||+.|+++|....
T Consensus 365 -----------~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 365 -----------LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp -----------HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred -----------HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 22222222222 223445678899999999999999999999999996544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=399.44 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=204.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHH---HHHHHhhhhccCCCCCceee
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE---IRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E---~~~l~~l~~~~~~~~~~~iv 91 (379)
++|+++++||+|+||.||+|.++. +++.||+|++.+..... ......+.+| +.+++.++||| ||
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~-----tg~~~AiK~i~K~~i~~-~~~~~~~~~E~~~l~ll~~~~HP~-------IV 255 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPF-------IV 255 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHSSSCCTT-------BC
T ss_pred HHeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEeHHHcch-hhhHHHHHHHHHHHHHHhhCCCCC-------Ee
Confidence 679999999999999999998765 67889999997543221 2223344455 44555556666 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++. +.+.+.+|||||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++| |+||||||+
T Consensus 256 ~l~~~-------f~~~~~lylVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPe 321 (689)
T 3v5w_A 256 CMSYA-------FHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 321 (689)
T ss_dssp CEEEE-------EECSSEEEEEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGG
T ss_pred EEEEE-------EEECCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchH
Confidence 77765 577899999999999999999998654 3999999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|||++.+|.+||+|||+|+...... ..+.+||+.|||||++. +..|+.++|+|||||++|||++|++||.+.......
T Consensus 322 NILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~ 400 (689)
T 3v5w_A 322 NILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400 (689)
T ss_dssp GEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH
T ss_pred HeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999999997665433 34568999999999886 457999999999999999999999999764322110
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~~ 313 (379)
.....+.......|. .+++++.+||.+||+.||.+|++ ++|+++|.....
T Consensus 401 ----------~i~~~i~~~~~~~p~---~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 401 ----------EIDRMTLTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp ----------HHHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred ----------HHHHhhcCCCCCCCc---cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 111122222333333 34688999999999999999998 799999976654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=361.18 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=212.8
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+++.+|+.+++.++|+| |+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn-------Iv 77 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHIL-----TGREVAIKIIDKTQLN--PTSLQKLFREVRIMKILNHPN-------IV 77 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTT-------BC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhcCC--HHHHHHHHHHHHHHHhCCCCC-------Ee
Confidence 345799999999999999999998764 5678999998754332 345678899999999999988 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+
T Consensus 78 ~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~ 143 (328)
T 3fe3_A 78 KLFEVI-------ETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAE 143 (328)
T ss_dssp CEEEEE-------ECSSEEEEEECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eEEEEE-------EECCEEEEEEECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHH
Confidence 777663 55788999999999999999997643 2889999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCC-CcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLS-KKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|||++.++.+||+|||++.............||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...
T Consensus 144 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 221 (328)
T 3fe3_A 144 NLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-- 221 (328)
T ss_dssp GEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred HEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999999999999776665555667899999999998877765 78999999999999999999998654211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
....+.......|.. .++++.+|+.+||+.||.+|||++|+++|....
T Consensus 222 -----------~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 222 -----------LRERVLRGKYRIPFY---MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp -----------HHHHHHHCCCCCCTT---SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred -----------HHHHHHhCCCCCCCC---CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 111222233333332 357899999999999999999999999996554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=359.78 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=213.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
+.++|++.+.||+|+||.||+|.++. +++.||+|.+........ ....+.+.+|+.+++.++|+| |
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-------I 77 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN-------I 77 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTT-------B
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC-----CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcC-------C
Confidence 46789999999999999999998765 567899999876543211 123578999999999999988 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++. +.+.+..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++| |+||||||
T Consensus 78 v~l~~~-------~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp 143 (361)
T 2yab_A 78 ITLHDV-------YENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKP 143 (361)
T ss_dssp CCEEEE-------EECSSEEEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred CcEEEE-------EEeCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence 877766 35678899999999999999999653 24899999999999999999999999 99999999
Q ss_pred CceEEcCCC----CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 171 TNILFDSKW----DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 171 ~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+|||++.++ .+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp GGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999998776 7999999999776655555556899999999999988999999999999999999999999977542
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.. .+..+.......+ ..+..++..+.+||.+||..||++|||+.|+++|....
T Consensus 224 ~~-------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 224 QE-------------TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp HH-------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred HH-------------HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 21 1122222222222 22345567899999999999999999999999996654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=351.22 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=207.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| |+++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hp~-------iv~~ 82 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPN-------IVNY 82 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT-----TCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhceeeeeeeccCCCeEEEEEEECC-----CCcEEEEEEeeccc----ccHHHHHHHHHHHHhcCCCCC-------CCeE
Confidence 4689999999999999999998654 56789999986432 334577899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..++||||++|++|.+++... .+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 83 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Ni 147 (297)
T 3fxz_A 83 LDSY-------LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147 (297)
T ss_dssp EEEE-------EETTEEEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred eEEE-------EECCEEEEEEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHE
Confidence 7764 4467899999999999999999753 2889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 148 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987654433 33445799999999999989999999999999999999999999976543222111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. ...... ......++..+.+++.+||+.||++|||++|+++|...
T Consensus 228 ~~----------~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 228 IA----------TNGTPE---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp HH----------HHCSCC---CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HH----------hCCCCC---CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 10 001111 11233456789999999999999999999999998443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=352.09 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=209.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.++.... ........+.+|+.+++.++|++ |+++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~-------iv~l 70 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPF-------LTAL 70 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTT-------BCCE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhCCCCc-------Ccce
Confidence 4689999999999999999998764 567899999874321 12345678899999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++| |+||||||+||
T Consensus 71 ~~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NI 136 (337)
T 1o6l_A 71 KYA-------FQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENL 136 (337)
T ss_dssp EEE-------EECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred EEE-------EEeCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHE
Confidence 765 456788999999999999999997643 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|.+||+|||++..... ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 137 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---- 212 (337)
T 1o6l_A 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---- 212 (337)
T ss_dssp EECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----
T ss_pred EECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999999975432 333445679999999999999999999999999999999999999997653211
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
....+.......|. .+++++.++|.+||+.||++|| +++|+++|....
T Consensus 213 ---------~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 213 ---------LFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ---------HHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ---------HHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 11122222222332 3457899999999999999999 999999997654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=359.07 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=212.1
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
....++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+.+++.++|+| |
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~~~~E~~il~~l~hpn-------I 90 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPN-------I 90 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCC--HHHHHHHHHHHHHHHHCCCTT-------B
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCC-------C
Confidence 3456789999999999999999998764 5678999999765433 344577999999999999988 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+ .+.+..|+||||++|++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||
T Consensus 91 v~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp 156 (362)
T 2bdw_A 91 VRLHDSI-------QEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKP 156 (362)
T ss_dssp CCEEEEE-------ECSSEEEEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSG
T ss_pred CeEEEEE-------EeCCEEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCch
Confidence 8877764 5578899999999999999999643 34899999999999999999999999 99999999
Q ss_pred CceEEcCC---CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 171 TNILFDSK---WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 171 ~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+|||++.+ +.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 157 ~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 236 (362)
T 2bdw_A 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236 (362)
T ss_dssp GGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999865 459999999997766555455568999999999999889999999999999999999999999765421
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
. + ...+.......+ ..+..+++++.+|+.+||+.||++|||+.++++|...
T Consensus 237 ~-~------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 237 R-L------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp H-H------------HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred H-H------------HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 1 1 111111111111 2334566889999999999999999999999998543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=353.56 Aligned_cols=258 Identities=18% Similarity=0.285 Sum_probs=212.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....+.+|+.+++.++|+| |++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpn-------Iv~ 65 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRN-------ILH 65 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTT-------BCC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECC-----CCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCC-------CCe
Confidence 46899999999999999999998765 56789999987442 33567899999999999988 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||++|++|.+++... ...+++.++..++.|++.||.|||++| |+||||||+|
T Consensus 66 ~~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~N 132 (321)
T 1tki_A 66 LHESF-------ESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPEN 132 (321)
T ss_dssp EEEEE-------EETTEEEEEECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EeEEE-------ecCCEEEEEEEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHH
Confidence 77764 4567899999999999999999642 234899999999999999999999999 9999999999
Q ss_pred eEEcC--CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDS--KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++. ++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 133 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~- 211 (321)
T 1tki_A 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI- 211 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-
T ss_pred EEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-
Confidence 99986 789999999999877655555556799999999999988889999999999999999999999987543221
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
...+.......+. .+..++.++.+++.+||+.||.+|||+.|+++|.....
T Consensus 212 ------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 212 ------------IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 1122222222221 23345678999999999999999999999999966543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=364.05 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=211.0
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. +++.+|+|.+...... ....+.+.+|+.+++.++|+| |+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~-----~~~~~a~K~i~~~~~~--~~~~~~~~~E~~il~~l~hpn-------Iv 73 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLS--ARDHQKLEREARICRLLKHPN-------IV 73 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT-----TTEEEEEEEEESCSCH--HHHHHHHHHHHHHHHHCCBTT-------BC
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC-----CCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCcC-------CC
Confidence 457899999999999999999998765 6678999998765543 344677999999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++. +.+.+..|+||||++||+|.+.+.... .+++..+..++.|++.||.|||++| |+||||||+
T Consensus 74 ~l~~~-------~~~~~~~~lv~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~ 139 (444)
T 3soa_A 74 RLHDS-------ISEEGHHYLIFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPE 139 (444)
T ss_dssp CEEEE-------EECSSEEEEEECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSST
T ss_pred eEEEE-------EEECCEEEEEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence 87776 456789999999999999999998643 3899999999999999999999999 999999999
Q ss_pred ceEEc---CCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFD---SKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~---~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|||++ .++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~ 219 (444)
T 3soa_A 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219 (444)
T ss_dssp TEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence 99998 46789999999997654433 234457999999999999989999999999999999999999999765422
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.. ...+.......+ ..+..+++++.+|+.+||+.||++|||+.|+++|....
T Consensus 220 ~~-------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 220 RL-------------YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp HH-------------HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred HH-------------HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 11 111111211111 12344568899999999999999999999999996553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=353.78 Aligned_cols=282 Identities=33% Similarity=0.603 Sum_probs=223.7
Q ss_pred CCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
..|++.++..++++|++.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.+++.++|+|
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~ 88 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRN 88 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTT
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCC
Confidence 46899999999999999999999999999999643 356799999875432 223346899999999999888
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC---
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN--- 159 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 159 (379)
|+++++++ .+.+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||++
T Consensus 89 -------iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 153 (326)
T 3uim_A 89 -------LLRLRGFC-------MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDP 153 (326)
T ss_dssp -------BCCCCEEE-------CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred -------ccceEEEE-------ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 88777764 456788999999999999999987543 333489999999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 237 (379)
| |+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 154 ~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 154 K--IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp C--EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred C--eEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 9 9999999999999999999999999997654332 23334599999999998888899999999999999999999
Q ss_pred CCCCCC----CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 238 RKPIDA----ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 238 ~~p~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.||.. .........+..............+.... +......+..+.+++.+||+.||.+|||+.|++++...
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 999962 22222233333333333333333333332 33456778899999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=347.91 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=213.8
Q ss_pred CCCCHHHHHHHhcC----------CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHH
Q 035572 3 ENFDYEELVKATES----------FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72 (379)
Q Consensus 3 ~~~~~~~~~~~~~~----------y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~ 72 (379)
..|+++++..+++. |...+.||+|+||.||+|.+.. +++.||||.+.... ....+.+.+|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~-----~g~~vavK~~~~~~----~~~~~~~~~E~ 93 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH-----SGRQVAVKMMDLRK----QQRRELLFNEV 93 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTT----CCSHHHHHHHH
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC-----CCcEEEEEEEeccc----hhHHHHHHHHH
Confidence 46899999999875 7888899999999999998764 56789999987543 34467789999
Q ss_pred HHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHH
Q 035572 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRA 152 (379)
Q Consensus 73 ~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~ 152 (379)
.+++.++|+| |+++++.+ ...+..++||||+++++|.+++.. ..+++..+..++.|++.|
T Consensus 94 ~~l~~l~h~n-------iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~ 153 (321)
T 2c30_A 94 VIMRDYQHFN-------VVEMYKSY-------LVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQA 153 (321)
T ss_dssp HHHTTCCCTT-------BCCEEEEE-------EETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCC-------cceEEEEE-------EECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHH
Confidence 9999999988 77777664 345789999999999999999864 238999999999999999
Q ss_pred HHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHH
Q 035572 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231 (379)
Q Consensus 153 l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 231 (379)
|.|||+.| |+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++
T Consensus 154 L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il 231 (321)
T 2c30_A 154 LAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231 (321)
T ss_dssp HHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHH
Confidence 99999999 9999999999999999999999999986654332 23445799999999999989999999999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|+|++|+.||......... . .+.............+++.+.+++.+||+.||++|||+.++++|...
T Consensus 232 ~el~~g~~pf~~~~~~~~~-~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 232 IEMVDGEPPYFSDSPVQAM-K------------RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp HHHHHSSCTTTTSCHHHHH-H------------HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHhCCCCCCCCCHHHHH-H------------HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 9999999999765422111 1 11111111111223345789999999999999999999999998443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=350.19 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=210.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+.+|+.+++.++|+| |
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-------i 76 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN-------V 76 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTT-------B
T ss_pred cccceEeceEEeeCCCeEEEEEEECC-----CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCC-------C
Confidence 35689999999999999999998765 567899999875432211 124678999999999999988 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+ .+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||
T Consensus 77 v~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp 142 (326)
T 2y0a_A 77 ITLHEVY-------ENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKP 142 (326)
T ss_dssp CCEEEEE-------ECSSEEEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred CcEEEEE-------EeCCEEEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCH
Confidence 7777664 5567899999999999999999643 34899999999999999999999999 99999999
Q ss_pred CceEEcCCC----CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 171 TNILFDSKW----DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 171 ~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+|||++.++ .+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 143 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 999999877 7999999999776554444556799999999999988999999999999999999999999976542
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...+ ..+.......+ ......+..+.+++.+||+.||++|||+.|+++|...
T Consensus 223 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 223 QETL-------------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp HHHH-------------HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHH-------------HHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 2211 11111111111 1223456789999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=348.84 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=210.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.++|+| |+++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~-------Iv~l 80 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND-----TKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPF-------LVNL 80 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 4789999999999999999998765 5678999998643221 2345678899999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||+.||+|.+++... ..+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 81 ~~~-------~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NI 146 (384)
T 4fr4_A 81 WYS-------FQDEEDMFMVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNI 146 (384)
T ss_dssp EEE-------EECSSEEEEEECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred EEE-------EEeCCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHe
Confidence 765 45678899999999999999999753 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC---CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP---SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|++.+|.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 147 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~ 226 (384)
T 4fr4_A 147 LLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226 (384)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH
T ss_pred EECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH
Confidence 999999999999999987765555566789999999998863 45899999999999999999999999754332110
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-hHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-IGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~e~l~~~~~~~ 313 (379)
.....+.......| ..++..+.+||.+||+.||.+||+ +++++.|.....
T Consensus 227 ----------~~~~~~~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 227 ----------EIVHTFETTVVTYP---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ----------HHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ----------HHHHHHhhcccCCC---CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 11111111222222 234578999999999999999998 888888766543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=355.53 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=205.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|+++.... ......+.+.+|+.+++.+ +|++ |++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AvK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~-------Iv~ 88 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE-----TGDLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPF-------LTQ 88 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHH-HHHTTHHHHHHHHHHHHHTTTCTT-------BCC
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC-----CCCEEEEEEEEHHHh-cchhHHHHHHHHHHHHHhccCCCc-------eee
Confidence 4789999999999999999998765 567899999875322 1234567788999999988 5776 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+..|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 89 l~~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~N 154 (353)
T 3txo_A 89 LFCC-------FQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDN 154 (353)
T ss_dssp EEEE-------EECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGG
T ss_pred EEEE-------EEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHH
Confidence 7765 456788999999999999999998653 2899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+||+|||+|..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 155 ILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--- 231 (353)
T 3txo_A 155 VLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--- 231 (353)
T ss_dssp EEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred EEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---
Confidence 9999999999999999975432 233445579999999999988889999999999999999999999998654221
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh------HHHhccccCcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI------GEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~e~l~~~~~~~ 313 (379)
.+..+.......|.. .++++.+++.+||+.||++||++ +++++|.....
T Consensus 232 ----------~~~~i~~~~~~~p~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 232 ----------LFEAILNDEVVYPTW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp ----------HHHHHHHCCCCCCTT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred ----------HHHHHHcCCCCCCCC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 222223333333332 34779999999999999999999 89999876644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=351.70 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=208.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .......+.+|+.+++.++|+| |+++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpn-------Iv~l 74 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK-----TQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPH-------IIKL 74 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTT-------BCCE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 4789999999999999999998765 5677999998643211 1334568999999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+ +|+|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+||
T Consensus 75 ~~~~-------~~~~~~~lv~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NI 139 (336)
T 3h4j_B 75 YDVI-------TTPTDIVMVIEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENL 139 (336)
T ss_dssp EEEE-------ECSSEEEEEECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTE
T ss_pred EEEE-------EeCCEEEEEEECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhE
Confidence 7664 5567899999999 789999987643 3899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|+++++.+||+|||++.............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......
T Consensus 140 ll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---- 215 (336)
T 3h4j_B 140 LLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---- 215 (336)
T ss_dssp EECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----
T ss_pred EEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----
Confidence 999999999999999987766555566689999999999988776 689999999999999999999997654221
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
....+.......|. ..++++.+|+.+||+.||.+|||++|+++|....
T Consensus 216 ---------~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 216 ---------LFKKVNSCVYVMPD---FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp ---------CBCCCCSSCCCCCT---TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred ---------HHHHHHcCCCCCcc---cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 11111122222232 3457899999999999999999999999996543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=354.31 Aligned_cols=266 Identities=21% Similarity=0.311 Sum_probs=208.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.++||+|+||.||+|.++. +++.||+|+++..... .....+.+.+|..++.++ +|++ |++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~-------Iv~ 117 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPF-------LVG 117 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTT-------BCC
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCC-------cCe
Confidence 3689999999999999999998765 5678999998754322 123345688999999887 6777 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|
T Consensus 118 l~~~-------~~~~~~~~lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~N 183 (396)
T 4dc2_A 118 LHSC-------FQTESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDN 183 (396)
T ss_dssp EEEE-------EECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGG
T ss_pred eEEE-------EEECCEEEEEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHH
Confidence 7765 456789999999999999999998643 2899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccC-CCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSE-SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+||+|||+|... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 184 ILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~ 263 (396)
T 4dc2_A 184 VLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263 (396)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----
T ss_pred EEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc
Confidence 99999999999999999753 33334455689999999999999999999999999999999999999997543221110
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh------HHHhccccCcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI------GEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~e~l~~~~~~~ 313 (379)
... .......+.......|.. +++++.+||.+||+.||++||++ +|+++|.....
T Consensus 264 ~~~----~~~~~~~i~~~~~~~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 264 QNT----EDYLFQVILEKQIRIPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp -CC----HHHHHHHHHHCCCCCCTT---SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred hhh----HHHHHHHHhccccCCCCc---CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 000 011122233333333432 45789999999999999999995 79999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=352.31 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=208.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh-hhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.+....... .....+.+.+|+.+++.++|+| |++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-------Iv~ 90 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH-------IVE 90 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCC-------CCc
Confidence 5689999999999999999998765 56789999986432111 0124678999999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..|+||||++|++|.+.+...... ...+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 91 ~~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~N 160 (351)
T 3c0i_A 91 LLETY-------SSDGMLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHC 160 (351)
T ss_dssp EEEEE-------EETTEEEEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred EEEEE-------EeCCEEEEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHH
Confidence 77764 4567899999999999999988765432 334889999999999999999999999 9999999999
Q ss_pred eEEcCCCC---eEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWD---AKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~---~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
||++.++. +||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .
T Consensus 161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~ 238 (351)
T 3c0i_A 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--E 238 (351)
T ss_dssp EEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H
T ss_pred eEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H
Confidence 99986654 99999999976654332 344579999999999998899999999999999999999999997642 1
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+ ...+.......+ ..+..++.++.+|+.+||+.||++|||+.|+++|...
T Consensus 239 ~~------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 239 RL------------FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp HH------------HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HH------------HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 11 111111222111 2233456789999999999999999999999998544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=344.37 Aligned_cols=276 Identities=24% Similarity=0.330 Sum_probs=214.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.++||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++.++|+| |+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 72 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKN-------IVKL 72 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC-----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCC-------cceE
Confidence 4789999999999999999998765 567899999874322 344677889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ......++||||+++++|.+++..... ...+++.+++.++.|++.||+|||++| |+||||||+||
T Consensus 73 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NI 143 (319)
T 4euu_A 73 FAIEEE-----TTTRHKVLIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNI 143 (319)
T ss_dssp EEEEEC-----TTTCCEEEEEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred EEEeec-----CCCceEEEEEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHE
Confidence 776432 234578999999999999999987543 223899999999999999999999999 99999999999
Q ss_pred EE----cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC--------CCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 174 LF----DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN--------PSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 174 ll----~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|+ +.++.+||+|||++.............||+.|+|||++. +..++.++|||||||++|+|++|+.||
T Consensus 144 ll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 223 (319)
T 4euu_A 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (319)
T ss_dssp EEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred EEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99 777889999999998766655555667999999999765 577899999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhh---hh----------hccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 242 DAARDPASIIDWALPLIKEEKL---RQ----------VCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...................... .. ..............++..+.+++.+||+.||++|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp ECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 7655443332222222111100 00 0000011112346778899999999999999999999999999
Q ss_pred ccCcc
Q 035572 309 CSCFF 313 (379)
Q Consensus 309 ~~~~~ 313 (379)
.....
T Consensus 304 ~~d~~ 308 (319)
T 4euu_A 304 TSDIL 308 (319)
T ss_dssp HHHHT
T ss_pred cHHHh
Confidence 66543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.05 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=209.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.++.... ......+.+.+|+.+++.++|+| |+++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~-------Iv~~ 71 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPF-------IIRM 71 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTT-------BCCE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhhCCCCC-------CceE
Confidence 3689999999999999999998764 567899999874321 12345677889999999999888 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||++||+|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 72 ~~~-------~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NI 137 (318)
T 1fot_A 72 WGT-------FQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENI 137 (318)
T ss_dssp EEE-------EECSSEEEEEECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGE
T ss_pred eEE-------EEeCCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheE
Confidence 766 456788999999999999999998643 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.+|.+||+|||++...... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 138 ll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----- 210 (318)
T 1fot_A 138 LLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----- 210 (318)
T ss_dssp EECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----
T ss_pred EEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999999999999765432 234579999999999999999999999999999999999999997654211
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
.+..+.......|. ..+.++.+++.+||+.||++|| +++++++|....
T Consensus 211 --------~~~~i~~~~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 211 --------TYEKILNAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp --------HHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred --------HHHHHHhCCCCCCC---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 12222223333332 2357899999999999999999 999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=350.12 Aligned_cols=279 Identities=30% Similarity=0.570 Sum_probs=218.2
Q ss_pred CCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccC
Q 035572 4 NFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 4 ~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
.+++.++..++++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.+++.++|+|
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~- 96 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPH- 96 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTT-
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCC-
Confidence 4566667778899999999999999999999853 35679999987543 334678999999999999888
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
|+++++++ .+.+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||++| |
T Consensus 97 ------iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i 160 (321)
T 2qkw_B 97 ------LVSLIGFC-------DERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA--I 160 (321)
T ss_dssp ------BCCEEEEC-------CCTTCCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ------EeeEEEEE-------cCCCeEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC--e
Confidence 88777764 456789999999999999999865432 2334899999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 161 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp ECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred ecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCc
Confidence 999999999999999999999999996543221 22334589999999998888899999999999999999999999
Q ss_pred CCCCCCch--hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 241 IDAARDPA--SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 241 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|....... ....+.........+....+.... .......+..+.+++.+||+.||++|||+.|++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccCcHHHHHHHHHhhhccccccHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 97654322 222222211122222223332222 2234677889999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=348.99 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=208.2
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCc
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNY 88 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~ 88 (379)
.....++|++.+.||+|+||.||+|.++. +++.||+|.++.... ......+.+..|..++..+ +|++
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~------ 79 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPF------ 79 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTT------
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhHHh-hhhhhHHHHHHHHHHHHhcCCCCC------
Confidence 34456899999999999999999998764 568899999875321 1134467788999999887 7777
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++++. +.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||+|||++| |+||||
T Consensus 80 -iv~l~~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDl 144 (345)
T 1xjd_A 80 -LTHMFCT-------FQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDL 144 (345)
T ss_dssp -BCCEEEE-------EECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCC
T ss_pred -CCcEEEE-------EEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCC
Confidence 7777765 456788999999999999999998643 2899999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||+|||++.+|.+||+|||++..... ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..
T Consensus 145 kp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 145 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999999975432 22344567999999999999999999999999999999999999999765421
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH-HHhccccCc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG-EILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-e~l~~~~~~ 312 (379)
. + +..+.......|. .+++++.++|.+||+.||++||++. ++++|....
T Consensus 225 ~-~------------~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~ 274 (345)
T 1xjd_A 225 E-L------------FHSIRMDNPFYPR---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274 (345)
T ss_dssp H-H------------HHHHHHCCCCCCT---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred H-H------------HHHHHhCCCCCCc---ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence 1 1 1112222222232 2457899999999999999999998 888886554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=357.99 Aligned_cols=275 Identities=20% Similarity=0.234 Sum_probs=205.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|.+.. +++.||||++..... .....+++.+|+.+++.++|+| |+++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpn-------Iv~l 126 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKN-------IISL 126 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTT-------BCCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 5789999999999999999998765 567899999875422 2445678899999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+... ..+++....|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 127 ~~~~~~~-~~~~~~~~~~lv~E~~~-~~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NI 195 (464)
T 3ttj_A 127 LNVFTPQ-KTLEEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 195 (464)
T ss_dssp SEEECSC-CSTTTCCEEEEEEECCS-EEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred EEEEccC-CccccCCeEEEEEeCCC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhE
Confidence 8775431 22344567899999995 567777742 2889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+...
T Consensus 196 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i 275 (464)
T 3ttj_A 196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275 (464)
T ss_dssp EECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999998766555555668999999999999999999999999999999999999999876543332221
Q ss_pred hhhhhh---------HHhhhhhccccCC-----------------CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 254 ALPLIK---------EEKLRQVCDSRVG-----------------LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 254 ~~~~~~---------~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
...... ............. ........++++.+||.+||+.||++|||++|+++
T Consensus 276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110000 0001111111000 00111223678999999999999999999999999
Q ss_pred cccCcc
Q 035572 308 GCSCFF 313 (379)
Q Consensus 308 ~~~~~~ 313 (379)
|.....
T Consensus 356 Hp~~~~ 361 (464)
T 3ttj_A 356 HPYINV 361 (464)
T ss_dssp STTTGG
T ss_pred Chhhhh
Confidence 976653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=352.87 Aligned_cols=259 Identities=18% Similarity=0.293 Sum_probs=210.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ......+.+|+.+++.++|+| |++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpn-------Iv~ 112 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPK-------LIN 112 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTT-------BCC
T ss_pred cccceEEEEEEecCCCEEEEEEEECC-----CCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcC-------CCe
Confidence 35789999999999999999998765 56789999987543 223467899999999999988 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||++|++|.+++... ...+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 113 ~~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~N 179 (387)
T 1kob_A 113 LHDAF-------EDKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 179 (387)
T ss_dssp EEEEE-------ECSSEEEEEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEEE-------EeCCEEEEEEEcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHH
Confidence 77764 5578899999999999999998742 234899999999999999999999999 9999999999
Q ss_pred eEEcC--CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDS--KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++. ++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+
T Consensus 180 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 259 (387)
T 1kob_A 180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259 (387)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred eEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99974 5779999999998766555555567999999999999999999999999999999999999999875432211
Q ss_pred HHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.. +....... +.....+++++.++|.+||+.||++|||+.|+++|.....
T Consensus 260 ~~-------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 260 QN-------------VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HH-------------HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HH-------------HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 11 11111111 1223345678999999999999999999999999966543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=346.27 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=200.3
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
.+++....++|++.+.||+|+||.||+|.+ .++.||+|.+...... ....+.+.+|+.++++++|+|
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~---- 95 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-------HGSDVAVKILMEQDFH--AERVNEFLREVAIMKRLRHPN---- 95 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECCCCCS--HHHHHHHHHHHHHHHHCCCTT----
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-------CCCcEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCC----
Confidence 344444567999999999999999999975 3466999998765433 344678899999999999988
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++.+ .+.+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||++|.+|+||
T Consensus 96 ---iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~ 163 (309)
T 3p86_A 96 ---IVLFMGAV-------TQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163 (309)
T ss_dssp ---BCCEEEEE-------CSTTCCEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCT
T ss_pred ---EeeEEEEE-------EECCceEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECC
Confidence 78777764 456789999999999999999976431 112888999999999999999999998779999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 164 Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp TCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999996544332 2334579999999999999999999999999999999999999998654
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
........ .........+ ..+++.+.+++.+||+.||.+|||+.++++..
T Consensus 244 ~~~~~~~~-----------~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 244 PAQVVAAV-----------GFKCKRLEIP---RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp HHHHHHHH-----------HHSCCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHH-----------HhcCCCCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 32211100 0011122222 33457899999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=347.63 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=207.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.++..... .....+.+.+|..++..+ +|++ |++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~-------iv~ 85 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPF-------LTQ 85 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTT-------BCC
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCE-------Eee
Confidence 4789999999999999999998764 5688999998753221 234567788999999887 5555 676
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+..|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 86 l~~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~N 151 (353)
T 2i0e_A 86 LHSC-------FQTMDRLYFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDN 151 (353)
T ss_dssp EEEE-------EECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGG
T ss_pred EEEE-------EEcCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHH
Confidence 6655 456789999999999999999998643 2899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+||+|||++..... ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.. .
T Consensus 152 Ill~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~-- 228 (353)
T 2i0e_A 152 VMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-E-- 228 (353)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H--
T ss_pred EEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-H--
Confidence 9999999999999999975432 23344567999999999999999999999999999999999999999765421 1
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~ 312 (379)
.+..+.......|. .+++++.+||.+||+.||.+||+ ++++++|....
T Consensus 229 ----------~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 229 ----------LFQSIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp ----------HHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred ----------HHHHHHhCCCCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 12222223333332 34578999999999999999995 68999986553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=343.74 Aligned_cols=266 Identities=21% Similarity=0.313 Sum_probs=208.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.+...... .....+.+.+|+.+++.+ +|++ |++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~-------iv~ 74 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPF-------LVG 74 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGSC-SHHHHHHHHHHHHHHHHTTTCTT-------BCC
T ss_pred hhheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEhHHhc-chHHHHHHHHHHHHHHhcCCCCc-------cCe
Confidence 3689999999999999999998765 5688999999754321 133456788999999988 7777 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+..|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 75 l~~~-------~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~N 140 (345)
T 3a8x_A 75 LHSC-------FQTESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDN 140 (345)
T ss_dssp EEEE-------EECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGG
T ss_pred EEEE-------EEeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHH
Confidence 7766 456788999999999999999997643 2899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+||+|||++.... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 141 Ill~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 141 VLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp EEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred EEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 999999999999999997533 2333445689999999999999999999999999999999999999997543221100
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh------HHHhccccCcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI------GEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~e~l~~~~~~~ 313 (379)
... .......+.......|. .++.++.++|.+||+.||++||++ .+++.|.....
T Consensus 221 ~~~----~~~~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 221 QNT----EDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp --C----HHHHHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred ccc----HHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 000 01111222223333333 345789999999999999999996 79999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=342.37 Aligned_cols=270 Identities=23% Similarity=0.293 Sum_probs=203.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+. .++.||+|++...... ......+.+|+.+++.++|+| |++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~-------iv~ 83 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHPN-------IVS 83 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEeccccc--chhhHHHHHHHHHHHHcCCCC-------Eee
Confidence 4589999999999999999999874 3567999998754322 334577899999999999988 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||++ ++|.+.+... ...+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 84 ~~~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~N 149 (311)
T 3niz_A 84 LIDVI-------HSERCLTLVFEFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQN 149 (311)
T ss_dssp EEEEE-------CCSSCEEEEEECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred eeeEE-------ccCCEEEEEEcCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHh
Confidence 77764 55678999999996 5888888753 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+...+
T Consensus 150 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 229 (311)
T 3niz_A 150 LLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229 (311)
T ss_dssp EEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred EEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999765432 23344578999999998765 56899999999999999999999999876655433
Q ss_pred HHhhhhhhh--HHh---------hhhhccccCC---CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIK--EEK---------LRQVCDSRVG---LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~--~~~---------~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
......... ... +......... .....+.+++++.+|+.+||+.||++|||++|+++|...
T Consensus 230 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 222110000 000 0000000000 001112345688999999999999999999999998543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=346.70 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=208.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.++|++ |+++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~-------iv~~ 106 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPF-------LVKL 106 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTT-------BCCE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 3689999999999999999998765 5678999998643221 2345678899999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 107 ~~~-------~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NI 172 (350)
T 1rdq_E 107 EFS-------FKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172 (350)
T ss_dssp EEE-------EECSSEEEEEEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred EEE-------EEcCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceE
Confidence 665 456788999999999999999998643 2899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.+|.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 173 ll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----- 245 (350)
T 1rdq_E 173 LIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----- 245 (350)
T ss_dssp EECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred EECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----
Confidence 9999999999999999765432 234579999999999998999999999999999999999999997653211
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCF 312 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~ 312 (379)
....+.......|. .++.++.++|.+||+.||.+||+ ++++++|....
T Consensus 246 --------~~~~i~~~~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 246 --------IYEKIVSGKVRFPS---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp --------HHHHHHHCCCCCCT---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred --------HHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 11222222333332 34578999999999999999998 99999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=343.92 Aligned_cols=260 Identities=21% Similarity=0.326 Sum_probs=199.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+... ..+++.||+|++..............+.+|+.+++.++|+| |+++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-------iv~~ 86 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF-------IVDL 86 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTT-------BCCE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCC-------ccce
Confidence 47899999999999999999987532 23678899999986543222344567889999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ ...+..|+||||++|++|.+++...+ .+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 87 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Ni 152 (327)
T 3a62_A 87 IYAF-------QTGGKLYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENI 152 (327)
T ss_dssp EEEE-------ECSSCEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTE
T ss_pred eEEE-------EcCCEEEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHe
Confidence 7663 55678999999999999999997643 2888999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 153 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--- 229 (327)
T 3a62_A 153 MLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--- 229 (327)
T ss_dssp EECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred EECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---
Confidence 9999999999999998654322 223445799999999999888999999999999999999999999986542211
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
...+.......|. .++.++.+++.+||+.||++|| ++.|+++|....
T Consensus 230 ----------~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 230 ----------IDKILKCKLNLPP---YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp ----------HHHHHHTCCCCCT---TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred ----------HHHHHhCCCCCCC---CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 1122222223332 2357899999999999999999 888999986653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=336.40 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=209.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+.+++.++|+| |++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~ 69 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPN-------IVR 69 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCC--HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC-----CCceEEEEEeecccCC--HHHHHHHHHHHHHHHHcCCCC-------cCe
Confidence 46899999999999999999998765 5677999998754332 344577899999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+.+.... .+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 70 ~~~~~-------~~~~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~N 135 (284)
T 3kk8_A 70 LHDSI-------QEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPEN 135 (284)
T ss_dssp EEEEE-------ECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGG
T ss_pred EEEEE-------EcCCEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHH
Confidence 77664 45678899999999999999987643 2889999999999999999999999 9999999999
Q ss_pred eEEcCCCC---eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILFDSKWD---AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|+++.++. +||+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 136 il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 215 (284)
T 3kk8_A 136 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215 (284)
T ss_dssp EEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH
Confidence 99986655 999999999776655555556899999999999999999999999999999999999999976542221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. .+.......+ .....+++++.+++.+||+.||++|||+.|+++|...
T Consensus 216 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 216 YA-------------QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp HH-------------HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred HH-------------HHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 11 1111111111 1223456789999999999999999999999998443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=348.70 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=204.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++|+| |+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpn-------Iv~~ 70 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHEN-------VVKF 70 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC----------CHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhhceeeeEEecCCCEEEEEEEECC-----CCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 6899999999999999999998765 567799999865432 233467889999999999988 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+.+..|+||||+++++|.+++... ..+++..++.++.|++.||+|||++| |+||||||+||
T Consensus 71 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NI 136 (323)
T 3tki_A 71 YGHR-------REGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136 (323)
T ss_dssp EEEE-------ECSSEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred EEEE-------ecCCeEEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHE
Confidence 7763 5577899999999999999998643 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....+...
T Consensus 137 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp EECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred EEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 99999999999999996543222 2334579999999999877665 7789999999999999999999987654322
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.... ....... ......++..+.+|+.+||+.||++|||+.|+++|.....
T Consensus 217 ~~~~------------~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 217 EYSD------------WKEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHH------------HHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHH------------Hhccccc-CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 1111 0111111 1123345678899999999999999999999999866543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=351.06 Aligned_cols=273 Identities=21% Similarity=0.313 Sum_probs=197.6
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCce
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYC 89 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~ 89 (379)
..+.++|++.+.||+|+||.||+|.+.. +++.||+|++...... ....+++.+|+.+++.+. |+|
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~h~n------- 70 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRR-----TGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHEN------- 70 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETT-----TCCEEEEEEECC--CC--HHHHHHHHHHHHHHHHTTTCTT-------
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECC-----CCCEEEEEEecccccC--hHHHHHHHHHHHHHHhccCCCC-------
Confidence 3567899999999999999999998765 5678999998644222 345677889999999997 888
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
|+++++.+.. .+....|+||||++ ++|.+++... .+++..+..++.|++.||+|||+.| |+|||||
T Consensus 71 iv~l~~~~~~-----~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlk 136 (388)
T 3oz6_A 71 IVNLLNVLRA-----DNDRDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMK 136 (388)
T ss_dssp BCCEEEEEEC-----TTSSCEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred CCeeeeEEec-----CCCCEEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCC
Confidence 8887776532 23457899999995 7999999752 3888999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCC----------------------CcccccCccccccCCCCCCC-CCCCCcCCeeh
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDE----------------------SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFS 226 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 226 (379)
|+|||++.++.+||+|||+|+..... .......||+.|+|||++.+ ..++.++||||
T Consensus 137 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp GGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 99999999999999999999654321 11233579999999998876 67899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhH---Hhhhhh---------------cc-ccCCCCcchH---------
Q 035572 227 YGVVLLEIISCRKPIDAARDPASIIDWALPLIKE---EKLRQV---------------CD-SRVGLPTFME--------- 278 (379)
Q Consensus 227 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~---------------~~-~~~~~~~~~~--------- 278 (379)
|||++|+|++|++||.+.+....+.... ..... ..+..+ .. ..........
T Consensus 217 lG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (388)
T 3oz6_A 217 LGCILGEILCGKPIFPGSSTMNQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295 (388)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccc
Confidence 9999999999999998765443332221 11000 000000 00 0000000111
Q ss_pred ----HHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 279 ----GAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 279 ----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.+++++.+|+.+||+.||++|||++|+++|....
T Consensus 296 ~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333 (388)
T ss_dssp CTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTT
T ss_pred cccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHH
Confidence 2356899999999999999999999999996543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=351.71 Aligned_cols=274 Identities=21% Similarity=0.334 Sum_probs=217.2
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~ 83 (379)
|+...+....++|++.+.||+|+||.||+|.+.......+++.||||.++.... ....+.+.+|+.++..+ +|+|
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpn- 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLN- 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT-
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC---HHHHHHHHHHHHHHHhhcCCcc-
Confidence 556677777899999999999999999999987665666889999999975432 33457799999999999 6677
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC------------------------------
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT------------------------------ 133 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~------------------------------ 133 (379)
|+++++.+. ..+...++||||+++|+|.+++.......
T Consensus 88 ------iv~~~~~~~------~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (359)
T 3vhe_A 88 ------VVNLLGACT------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155 (359)
T ss_dssp ------BCCEEEEEC------STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------
T ss_pred ------eeeeeeeee------cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccc
Confidence 888887753 23456899999999999999998653210
Q ss_pred -------------------------------CCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 134 -------------------------------TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 134 -------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
...+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~k 233 (359)
T 3vhe_A 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVK 233 (359)
T ss_dssp ----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEE
T ss_pred cCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEE
Confidence 122888899999999999999999999 99999999999999999999
Q ss_pred EeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhh
Q 035572 183 LADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWALPLI 258 (379)
Q Consensus 183 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 258 (379)
|+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+............
T Consensus 234 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 310 (359)
T 3vhe_A 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--- 310 (359)
T ss_dssp ECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH---
T ss_pred EEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH---
Confidence 99999997553322 2233468899999999988889999999999999999998 9999987654332222111
Q ss_pred hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
. ......+ ..+++++.+++.+||+.||.+|||+.|+++|..
T Consensus 311 ------~--~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 311 ------E--GTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp ------H--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------c--CCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 0 1111112 223578999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=349.36 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=195.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ...+.+.+|+.+++.++|+| |+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpn-------iv~~ 81 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL-----TKELVAVKYIERGA-----AIDENVQREIINHRSLRHPN-------IVRF 81 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT-----TCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCC-------CCcE
Confidence 4789999999999999999998765 56789999987542 23467889999999999988 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++|+|.+++...+ .+++..++.++.|++.||+|||++| |+||||||+||
T Consensus 82 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Ni 147 (361)
T 3uc3_A 82 KEVI-------LTPTHLAIIMEYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENT 147 (361)
T ss_dssp EEEE-------ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGE
T ss_pred EEEE-------eeCCEEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence 7764 45678999999999999999997643 2899999999999999999999999 99999999999
Q ss_pred EEcCCCC--eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCc-CCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWD--AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKK-VDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|++.++. +||+|||++.............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.......
T Consensus 148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (361)
T 3uc3_A 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227 (361)
T ss_dssp EECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence 9987765 99999999975544444455679999999999877777655 89999999999999999999876544332
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... ..+.......+. ...+++.+.+||.+||+.||++|||+.|+++|...
T Consensus 228 ~~~~---------~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 228 RKTI---------QRILSVKYSIPD-DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHHH---------HHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHH---------HHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 2211 112222222221 11235789999999999999999999999999654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.27 Aligned_cols=280 Identities=21% Similarity=0.267 Sum_probs=210.4
Q ss_pred CCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccC
Q 035572 4 NFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 4 ~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
.|++.+...+.++|++.+.||+|+||.||+|.+.. +++.||||++... ......+..|+.+++.+++...
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~ 93 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID-----NKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDI 93 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCST
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC-----CCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCC
Confidence 56777777788999999999999999999998765 5678999998743 3345677889999999983222
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
.+|+ |+++++.+ ...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++| |
T Consensus 94 ~h~~--iv~~~~~~-------~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--i 158 (360)
T 3llt_A 94 NNNN--IVKYHGKF-------MYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS--L 158 (360)
T ss_dssp TGGG--BCCEEEEE-------EETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred CCCC--eeccccee-------eECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 2222 77777664 4467899999999 999999998643 234889999999999999999999999 9
Q ss_pred EecCCCCCceEEcC-------------------------CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC
Q 035572 164 IHRDIKSTNILFDS-------------------------KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL 218 (379)
Q Consensus 164 ~H~dlkp~NIll~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 218 (379)
+||||||+|||++. ++.+||+|||++...... .....||+.|+|||++.+..+
T Consensus 159 vHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp ECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCC
T ss_pred eeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCC
Confidence 99999999999975 789999999999765432 234579999999999999999
Q ss_pred CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh--hhhhHHhhhhhcc-----------ccCCCC-----------
Q 035572 219 SKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL--PLIKEEKLRQVCD-----------SRVGLP----------- 274 (379)
Q Consensus 219 ~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-----------~~~~~~----------- 274 (379)
+.++|||||||++|+|++|+.||........+..... ............. .....|
T Consensus 237 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 316 (360)
T 3llt_A 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316 (360)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHH
T ss_pred CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhh
Confidence 9999999999999999999999987653322211100 0000000000000 000000
Q ss_pred ------cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 275 ------TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 275 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
......++.+.+|+.+||+.||++|||+.|+|+|..
T Consensus 317 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred hhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 001111267889999999999999999999999853
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=348.25 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=192.3
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+.++|++.+.||+|+||.||+|.+.. +++.||+|.+... ...+.+.+|+.+++.++|+| |+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~n-------iv 111 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKG-----TQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPN-------II 111 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEC----------------CHHHHHCCCTT-------BC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECC-----CCcEEEEEEeccc------hhHHHHHHHHHHHHhCCCCC-------Cc
Confidence 356789999999999999999998765 4577999998743 23466889999999999988 78
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..++||||+++++|.+++... ..+++.++..++.|++.||.|||+.| |+||||||+
T Consensus 112 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 177 (349)
T 2w4o_A 112 KLKEIF-------ETPTEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPE 177 (349)
T ss_dssp CEEEEE-------ECSSEEEEEECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred ceeeeE-------ecCCeEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcc
Confidence 777764 4567899999999999999999653 23899999999999999999999999 999999999
Q ss_pred ceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 172 NILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 172 NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|||++. ++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 178 NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp GEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred cEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 999975 88999999999976654444445679999999999998899999999999999999999999997665433
Q ss_pred hHHHhhhhhhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.... .+...... .+.....++.++.+|+.+||+.||++|||+.|+++|..
T Consensus 258 ~~~~------------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 258 FMFR------------RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp HHHH------------HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHH------------HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 2211 11111111 12223445678999999999999999999999999843
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=346.66 Aligned_cols=250 Identities=21% Similarity=0.256 Sum_probs=195.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~ 93 (379)
++|++.++||+|+||.||+|.+.. +++.||||++...... .....+...|+..+..+ +|+| |+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~~~~~~~h~~-------iv~l 122 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKE-----DGRLYAVKRSMSPFRG--PKDRARKLAEVGSHEKVGQHPC-------CVRL 122 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-----TSCEEEEEEESSSCCS--HHHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hheeeeheeccCCCeEEEEEEECC-----CCeEEEEEEecccccC--hHHHHHHHHHHHHHHHhcCCCc-------EEEE
Confidence 789999999999999999998764 5678999987654322 23334555666666555 6777 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+.+..|+||||+ +++|.+++...+ ..+++..++.++.|++.||+|||+.| |+||||||+||
T Consensus 123 ~~~~-------~~~~~~~lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI 188 (311)
T 3p1a_A 123 EQAW-------EEGGILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANI 188 (311)
T ss_dssp EEEE-------EETTEEEEEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred EEEE-------EeCCEEEEEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHE
Confidence 7664 4578899999999 789999987643 24899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..|+......
T Consensus 189 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~------ 261 (311)
T 3p1a_A 189 FLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW------ 261 (311)
T ss_dssp EECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH------
T ss_pred EECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence 999999999999999977665555555679999999998875 7899999999999999999997776543211
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..+... ...+.....+++++.+++.+||+.||++|||+.|+++|..
T Consensus 262 ----------~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 262 ----------QQLRQG-YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp ----------HHHTTT-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ----------HHHhcc-CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 111111 1112233345678999999999999999999999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=341.35 Aligned_cols=260 Identities=21% Similarity=0.297 Sum_probs=210.3
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+.+|+.+++.++|+| |
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-------i 77 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN-------V 77 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTT-------B
T ss_pred hhccEEEeeEeeecCCEEEEEEEECC-----CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCC-------c
Confidence 46789999999999999999998765 567899999875433211 124678999999999999988 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+ .+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||
T Consensus 78 v~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp 143 (321)
T 2a2a_A 78 ITLHDVY-------ENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKP 143 (321)
T ss_dssp CCEEEEE-------ECSSEEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred ceEEEEE-------ecCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCh
Confidence 7777664 4567899999999999999999753 23889999999999999999999999 99999999
Q ss_pred CceEEcCCC----CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 171 TNILFDSKW----DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 171 ~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+|||++.++ .++|+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 144 ~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp GGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999887 7999999999776555444556799999999999988999999999999999999999999976542
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...+ ..+.......+. .....+..+.+++.+||+.||++|||+.|+++|...
T Consensus 224 ~~~~-------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 224 QETL-------------ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp HHHH-------------HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred HHHH-------------HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 2211 111111111121 223445789999999999999999999999998543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=338.62 Aligned_cols=269 Identities=21% Similarity=0.305 Sum_probs=204.4
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+.+++.++|+| |++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 67 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKN-------IVRLH 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC-----CCceEEEEeeeccCCc--CCcchHHHHHHHHHhcCCCCC-------EeeEE
Confidence 689999999999999999998765 5678999999765432 344577899999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..++||||++ ++|.+.+... ...+++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil 133 (292)
T 3o0g_A 68 DVL-------HSDKKLTLVFEFCD-QDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLL 133 (292)
T ss_dssp EEE-------EETTEEEEEEECCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred eEE-------EeCCEEEEEEecCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 764 45678999999995 5777766542 234899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCC-CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....+......
T Consensus 134 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~ 213 (292)
T 3o0g_A 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp ECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred EcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 999999999999999765432 2334457899999999887665 79999999999999999998888655544433322
Q ss_pred hhhhhhhHH---hhh---hhccc--------cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEE---KLR---QVCDS--------RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~---~~~---~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
......... .+. ...+. ...........+..+.+|+.+||+.||++|||++|+++|...
T Consensus 214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 221111000 000 00000 000111122356789999999999999999999999998543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=351.11 Aligned_cols=273 Identities=16% Similarity=0.234 Sum_probs=207.6
Q ss_pred hcCCccccccccC--CceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 14 TESFSQSRLIGKG--SHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~~~iG~G--~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.++|++.+.||+| +||.||+|.+.. +++.||||++...... ....+.+.+|+.+++.++|+| |+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv 89 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINLEACS--NEMVTFLQGELHVSKLFNHPN-------IV 89 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT-----TCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTT-------BC
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC-----CCCEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCC-------CC
Confidence 5789999999999 999999998765 5678999999765432 345678899999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..|+||||+++++|.+++.... ...+++..+..++.|++.||+|||++| |+||||||+
T Consensus 90 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~ 157 (389)
T 3gni_B 90 PYRATF-------IADNELWVVTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKAS 157 (389)
T ss_dssp CEEEEE-------EETTEEEEEEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred cEeEEE-------EECCEEEEEEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 887764 45678999999999999999998642 234899999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCC--------CcccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDE--------SSMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|||++.++.+||+|||.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 158 NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp GEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999988543211 11223478999999998877 57899999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhH---------Hh-------------hhhhcc--------ccCCCCcchHHHHHHHHHHHHhc
Q 035572 242 DAARDPASIIDWALPLIKE---------EK-------------LRQVCD--------SRVGLPTFMEGAIKQMLHVAARC 291 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~---------~~-------------~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~ 291 (379)
.+......+.......... .. ...... ...........+++.+.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 8765544333221110000 00 000000 00000112234567899999999
Q ss_pred ccCCCCCCCChHHHhccccCc
Q 035572 292 VSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 292 l~~dp~~Rps~~e~l~~~~~~ 312 (379)
|+.||++|||+.|+++|....
T Consensus 318 L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 318 LQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp TCSCTTTSCCHHHHTTSGGGG
T ss_pred hhcCcccCCCHHHHhcCHHHH
Confidence 999999999999999986554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.40 Aligned_cols=270 Identities=22% Similarity=0.304 Sum_probs=212.0
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
+.++...+++|++.++||+|+||.||+|.++. +++.||+|++...... .......+.+|+.++..++|++
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~~~~E~~il~~~~hp~---- 135 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEML-KRAETACFREERDVLVNGDSKW---- 135 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHH-HTTTTCCHHHHHHHHHHSCTTT----
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcC-----CCcEEEEEEEEHHHhh-hHHHHHHHHHHHHHHHhCCCCC----
Confidence 34444556899999999999999999998765 5688999998643211 1222344889999999999888
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++. +.+.+.+|+||||++||+|.+++... ...+++..++.++.|++.||.|||+.| |+||
T Consensus 136 ---Iv~l~~~-------~~~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHr 199 (437)
T 4aw2_A 136 ---ITTLHYA-------FQDDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHR 199 (437)
T ss_dssp ---BCCEEEE-------EECSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred ---EEEEEEE-------EeeCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEec
Confidence 7777766 45678899999999999999999752 234899999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~ 239 (379)
||||+|||++.+|.+||+|||+|........ .....||+.|+|||++. ...++.++|||||||++|||++|+.
T Consensus 200 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 9999999999999999999999966544332 23357999999999876 5678999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCcc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCFF 313 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~~ 313 (379)
||.+.+......... .. ......|.....+++++.+||.+||..+|++ ||+++|+++|.....
T Consensus 280 Pf~~~~~~~~~~~i~----~~-------~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 280 PFYAESLVETYGKIM----NH-------KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp TTCCSSHHHHHHHHH----TH-------HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCCCCChhHHHHhhh----hc-------cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 998654322111110 00 0112223333345678999999999998888 999999999977654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=356.56 Aligned_cols=276 Identities=19% Similarity=0.262 Sum_probs=193.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+++.+|+.+|+.++|+| |+++
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv~l 117 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL-----EKRVVAIKKILRVFED--LIDCKRILREIAILNRLNHDH-------VVKV 117 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC-----CCcEEEEEEechhhcC--HHHHHHHHHHHHHHHhCCCCC-------CCce
Confidence 4789999999999999999998765 5678999998654222 344678999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ........+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+||
T Consensus 118 ~~~~~~--~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NI 187 (458)
T 3rp9_A 118 LDIVIP--KDVEKFDELYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANC 187 (458)
T ss_dssp EEECCC--SCTTTCCCEEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred EEEEec--CCcccCceEEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhE
Confidence 877643 1234457899999998 68999999753 34899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC----------------------------cccccCccccccCCCCC-CCCCCCCcCCe
Q 035572 174 LFDSKWDAKLADFGLAVSESDES----------------------------SMVQPAGTIGYLDPGYT-NPSKLSKKVDV 224 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Di 224 (379)
|++.++.+||+|||+|+...... ......||+.|+|||++ ....++.++||
T Consensus 188 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di 267 (458)
T 3rp9_A 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267 (458)
T ss_dssp EECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHH
T ss_pred EECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHH
Confidence 99999999999999997653221 12334689999999965 56779999999
Q ss_pred ehhHHHHHHHHh-----------CCCCCCCCCCc-------------------hhHHHhhhhhhh---H-----------
Q 035572 225 FSYGVVLLEIIS-----------CRKPIDAARDP-------------------ASIIDWALPLIK---E----------- 260 (379)
Q Consensus 225 wSlG~il~ellt-----------g~~p~~~~~~~-------------------~~~~~~~~~~~~---~----------- 260 (379)
|||||++|||++ |+++|.+.+.. ......+...+. .
T Consensus 268 wSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 347 (458)
T 3rp9_A 268 WSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347 (458)
T ss_dssp HHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHH
T ss_pred HHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHH
Confidence 999999999999 66666553310 000000000000 0
Q ss_pred Hhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 261 EKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 261 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
..+...... ........+..++++.+||.+||+.||++|||++|+++|.....
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp HHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 000001100 01111122344678999999999999999999999999966544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=332.19 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=207.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. ++..+++|.+.... ....+.+.+|+.+++.++|+| |++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~----~~~~~~~~~E~~~l~~l~h~~-------i~~ 70 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKYF----VEDVDRFKQEIEIMKSLDHPN-------IIR 70 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGG----CSCHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCC-----CCcEEEEEeehhhc----cchHHHHHHHHHHHHhCCCCC-------Eee
Confidence 46789999999999999999998765 45679999986432 234678999999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 71 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~N 136 (277)
T 3f3z_A 71 LYETF-------EDNTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPEN 136 (277)
T ss_dssp EEEEE-------ECSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred EEEEE-------ecCCeEEEEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHH
Confidence 77664 45678999999999999999997643 2889999999999999999999999 9999999999
Q ss_pred eEE---cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILF---DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||+ +.++.++|+|||++.............+|+.|+|||++.+. ++.++||||||+++|+|++|+.||....+...
T Consensus 137 il~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 215 (277)
T 3f3z_A 137 FLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215 (277)
T ss_dssp EEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999 78889999999999776655555566899999999988754 89999999999999999999999987543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ..+.......+. ....+++.+.+++.+||+.||++|||+.++++|.
T Consensus 216 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 216 M-------------LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp H-------------HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred H-------------HHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1 111122222222 1224567899999999999999999999999983
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=339.04 Aligned_cols=264 Identities=19% Similarity=0.257 Sum_probs=207.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.. ...+.+.+|+.+++.++ |+| |++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~~~~~-------i~~ 95 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKP-------VKKKKIKREIKILENLRGGPN-------IIT 95 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECS-------CCHHHHHHHHHHHHHHTTSTT-------BCC
T ss_pred CCceEEEEEecccCCeEEEEEEECC-----CCcEEEEEEecc-------cchHHHHHHHHHHHHcCCCCC-------EEE
Confidence 3689999999999999999998765 567899999863 33577899999999997 777 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ......++||||+++++|.+++.. +++..++.++.|++.||+|||++| |+||||||+|
T Consensus 96 ~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~N 160 (330)
T 3nsz_A 96 LADIVKD-----PVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHN 160 (330)
T ss_dssp EEEEEEC-----TTTCCEEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred eeeeecc-----CCCCceEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHH
Confidence 7766432 225678999999999999998854 888999999999999999999999 9999999999
Q ss_pred eEEcCCC-CeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKW-DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++.++ .+||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+....
T Consensus 161 il~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 240 (330)
T 3nsz_A 161 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240 (330)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred EEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH
Confidence 9999766 899999999977665555556689999999998776 67899999999999999999999999766554333
Q ss_pred HHhhhhhhhHHhhhhhcc-ccCCCC---------------------cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCD-SRVGLP---------------------TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~-~~~~~~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
................+. .....+ .....+++++.+||.+||+.||++|||++|+++|
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 322222222221111111 111111 1112246889999999999999999999999998
Q ss_pred ccC
Q 035572 309 CSC 311 (379)
Q Consensus 309 ~~~ 311 (379)
...
T Consensus 321 p~f 323 (330)
T 3nsz_A 321 PYF 323 (330)
T ss_dssp GGG
T ss_pred ccH
Confidence 544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=357.83 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=209.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.+.. +++.||||.+...... ..+....+.+|+.+++.++|+| |+++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~Hpn-------Iv~l 81 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL-----TGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPH-------IIKL 81 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT-----TCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTT-------BCCE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 4689999999999999999998764 5678999998643221 1234678999999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..|+||||++|++|.+++.+. ..+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 82 ~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NI 147 (476)
T 2y94_A 82 YQVI-------STPSDIFMVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENV 147 (476)
T ss_dssp EEEE-------ECSSEEEEEEECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGE
T ss_pred EEEE-------EECCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHE
Confidence 7664 5567899999999999999999643 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++.............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........
T Consensus 148 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--- 224 (476)
T 2y94_A 148 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--- 224 (476)
T ss_dssp EECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---
T ss_pred EEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---
Confidence 999999999999999987665555556689999999999887765 6799999999999999999999986543221
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...+.......|. .+++++.+|+.+||+.||.+|||+.|+++|...
T Consensus 225 ----------~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 225 ----------FKKICDGIFYTPQ---YLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp ----------HHHHHTTCCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ----------HHHHhcCCcCCCc---cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 1122222222232 234779999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=333.64 Aligned_cols=279 Identities=32% Similarity=0.546 Sum_probs=218.8
Q ss_pred CCCCHHHHHHHhcCCccc------cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHH
Q 035572 3 ENFDYEELVKATESFSQS------RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~------~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 76 (379)
..|++.++..++++|... +.||+|+||.||+|.+ .++.||+|.+............+.+.+|+.+++
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 469999999999999877 8999999999999975 345699999875432222345678999999999
Q ss_pred hhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHH
Q 035572 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCL 156 (379)
Q Consensus 77 ~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 156 (379)
.++|+| |+++++++ .+.+..++||||+++++|.+++..... ...+++..+..++.|++.||.||
T Consensus 86 ~l~h~~-------i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~l 149 (307)
T 2nru_A 86 KCQHEN-------LVELLGFS-------SDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFL 149 (307)
T ss_dssp HCCCTT-------BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCC-------eEEEEEEE-------ecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHH
Confidence 999988 78777764 456789999999999999999986432 23489999999999999999999
Q ss_pred HcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHH
Q 035572 157 HENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233 (379)
Q Consensus 157 H~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 233 (379)
|++| ++||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+
T Consensus 150 H~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~ 226 (307)
T 2nru_A 150 HENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLE 226 (307)
T ss_dssp HHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHH
T ss_pred hcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHH
Confidence 9999 99999999999999999999999999865543221 233468999999998775 58899999999999999
Q ss_pred HHhCCCCCCCCCCchhHHHhhhhhh-hHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 234 IISCRKPIDAARDPASIIDWALPLI-KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 234 lltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|++|..||........+........ ....+...++... +......+..+.+++.+||+.||.+|||+.+++++.
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 227 IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999987654432222111100 0111222233222 233456678899999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=335.65 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=199.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ....+.+.+|+.+++.++|+| |++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~-------iv~ 84 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPN-------IIK 84 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred hhhheeecceeccCCCeEEEEEEEcc-----CCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCch-------HHh
Confidence 35789999999999999999998765 567799999875421 344688999999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+.+...... ...+++..+..++.|++.||.|||+.| |+||||||+|
T Consensus 85 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~N 154 (285)
T 3is5_A 85 IFEVF-------EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPEN 154 (285)
T ss_dssp EEEEE-------ECSSEEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGG
T ss_pred HHHhe-------ecCCeEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHH
Confidence 77664 4567899999999999999999765422 234899999999999999999999999 9999999999
Q ss_pred eEE---cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILF---DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||+ +.++.+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||.+......
T Consensus 155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~ 233 (285)
T 3is5_A 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233 (285)
T ss_dssp EEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999 456789999999997665554455567999999999876 5688999999999999999999999976542111
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. .........+......++.+.+++.+||+.||++|||+.|+++|..
T Consensus 234 -~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 234 -QQ------------KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp -HH------------HHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred -Hh------------hhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 10 0000111111111123578899999999999999999999999854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=355.84 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=209.0
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.++....++|++.+.||+|+||.||+|.++. +++.||+|+++..... .....+.+.+|+.++..++|++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~-----~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~----- 122 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ-----TGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRW----- 122 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTT-----
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCC-----
Confidence 3444456899999999999999999998764 5678999998643211 1233456889999999999887
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++. +.+.+.+|+||||++||+|.+++.+.+ ..+++..++.++.|++.||.|||++| |+|||
T Consensus 123 --Iv~l~~~-------~~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrD 187 (412)
T 2vd5_A 123 --ITQLHFA-------FQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRD 187 (412)
T ss_dssp --BCCEEEE-------EECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred --eeeEEEE-------EeeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecc
Confidence 7777765 456788999999999999999998643 23899999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCC-------CCCCCCcCCeehhHHHHHHHHhCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTN-------PSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~ 238 (379)
|||+|||++.+|.+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 188 LKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 999999999999999999999976544332 23357999999999876 456899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhcc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCC---CChHHHhccccCcc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENR---PGIGEILMGCSCFF 313 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~e~l~~~~~~~ 313 (379)
.||.+.+...... .+.. .....|.....+++++.+||.+||. +|.+| |+++|+++|.....
T Consensus 268 ~Pf~~~~~~~~~~-------------~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 268 TPFYADSTAETYG-------------KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CTTCCSSHHHHHH-------------HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHH-------------HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 9997654322111 1111 1112232233456889999999999 99998 59999999977644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=345.60 Aligned_cols=263 Identities=18% Similarity=0.355 Sum_probs=208.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCC--CCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQ--TDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
.++|++.+.||+|+||.||+|.+.... ....+..||+|.++.... ....+.+.+|+.+++.+ +|+| |
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpn-------I 149 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKN-------I 149 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB---HHHHHHHHHHHHHHHHSCCCTT-------B
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC---HHHHHHHHHHHHHHHHhcCCCC-------E
Confidence 468999999999999999999875432 223577899999975432 34467899999999999 7888 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
+++++.+ .+.+..|+||||+++|+|.+++..... .....+++.+++.++.|++.||.|||++
T Consensus 150 v~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 222 (370)
T 2psq_A 150 INLLGAC-------TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 222 (370)
T ss_dssp CCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeEEEEE-------ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 8888764 456789999999999999999987532 1234588999999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
| |+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus 223 ~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 223 K--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp T--EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 9 9999999999999999999999999997554322 2233457889999999988899999999999999999999
Q ss_pred -CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 237 -CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 237 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|..||.+.... .+.... .. ......+ ..++..+.+++.+||+.||++|||+.|++++..
T Consensus 301 ~g~~p~~~~~~~-~~~~~~---------~~--~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 301 LGGSPYPGIPVE-ELFKLL---------KE--GHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp TSCCSSTTCCGG-GHHHHH---------HT--TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCCHH-HHHHHH---------hc--CCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999765422 111111 00 0111112 234578999999999999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=357.33 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=208.7
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
++....++|++.+.||+|+||.||+|.++. +++.||+|++...... .....+.+.+|+.+++.++|++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~-~~~~~~~~~~E~~il~~l~hp~------ 130 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPW------ 130 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTCCCSTHHHHHHHHHHCCCTT------
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECC-----CCcEEEEEEEehhhhh-hhHHHHHHHHHHHHHHhCCCCC------
Confidence 344456899999999999999999998765 5678999998643211 1233455889999999999888
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++++. +.+.+.+|+||||++||+|.+++... .+++..++.++.|++.||.|||++| |+||||
T Consensus 131 -Iv~l~~~-------~~~~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDL 194 (410)
T 3v8s_A 131 -VVQLFYA-------FQDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG--FIHRDV 194 (410)
T ss_dssp -BCCEEEE-------EECSSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred -CCeEEEE-------EEECCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccC
Confidence 8877766 45678899999999999999999752 2889999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCC----CCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSK----LSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
||+|||++.+|.+||+|||+|........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 195 Kp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 99999999999999999999976654432 23557999999999887654 7899999999999999999999998
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCC--CCChHHHhccccCcc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEEN--RPGIGEILMGCSCFF 313 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~e~l~~~~~~~ 313 (379)
+.+..... ..+... ....|. ...+++++.+||.+||+.+|.+ ||+++|+++|.....
T Consensus 275 ~~~~~~~~-------------~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 275 ADSLVGTY-------------SKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp CSSHHHHH-------------HHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred CCChhhHH-------------HHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 65422211 111110 011111 1224578999999999999998 999999999977654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=339.16 Aligned_cols=279 Identities=23% Similarity=0.237 Sum_probs=205.8
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhh---hccCCCCC
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQ---ESNKRNPN 87 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~---~~~~~~~~ 87 (379)
.++++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ........+.+|+.+++.++ |+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~n----- 75 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN----- 75 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT-----TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTT-----
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCC-----
Confidence 457899999999999999999998654 5678999998643221 11223456788999888887 777
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++.+.... .......++||||+. ++|.+++.... ...+++..++.++.|++.||+|||++| |+|||
T Consensus 76 --iv~~~~~~~~~~--~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~D 145 (308)
T 3g33_A 76 --VVRLMDVCATSR--TDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRD 145 (308)
T ss_dssp --BCCEEEEEEECC--SSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred --eEEeeeeeeccC--CCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCC
Confidence 787777653311 011225899999995 69999998632 233899999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|||+|||++.++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 146 LKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp CCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999997766555555668999999999998889999999999999999999999999876543
Q ss_pred hhHHHhhhhhhhH---Hhhhh-------hccccCC--CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLIKE---EKLRQ-------VCDSRVG--LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~~~---~~~~~-------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+..... .... ..+.. ....... .....+.++..+.+|+.+||+.||++|||+.|+++|...
T Consensus 226 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 226 DQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp HHHHHHHH-HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred HHHHHHHH-HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 32222111 0000 00000 0000000 000112345789999999999999999999999998544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=339.50 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=202.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| |+++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~hp~-------iv~~ 72 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD----EETQRTFLKEVKVMRCLEHPN-------VLKF 72 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEESCCC----HHHHHHHHHHHHHHTTCCCTT-------BCCE
T ss_pred hhHeeccceecCCCCEEEEEEEECC-----CCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCcC-------cccE
Confidence 4689999999999999999998765 56789999875432 455678999999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+++..++||||+++++|.+++... ...+++.++..++.|++.||+|||++| |+||||||+||
T Consensus 73 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Ni 139 (310)
T 3s95_A 73 IGVL-------YKDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNC 139 (310)
T ss_dssp EEEE-------EETTEEEEEEECCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSE
T ss_pred EEEE-------ecCCeeEEEEEecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeE
Confidence 7764 3467899999999999999999863 234899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcc---------------cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSM---------------VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 238 (379)
|++.++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 140 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 219 (310)
T 3s95_A 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219 (310)
T ss_dssp EECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred EECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCC
Confidence 9999999999999999655332211 1446999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.||............. ......... ...+++.+.+++.+||+.||++|||+.++++..
T Consensus 220 ~~~~~~~~~~~~~~~~----~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 220 NADPDYLPRTMDFGLN----VRGFLDRYC---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp CSSTTTSCBCTTSSBC----HHHHHHHTC---------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcchhhhHHHHhhh----hhccccccC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9987543322110000 001111111 112235688999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=356.16 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=206.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..... .......+.+|+.+++.++|+| |++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpn-------iv~ 85 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPN-------IMK 85 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT-----TCCEEEEEEEEHHHH--BCSCHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEecccc--cchHHHHHHHHHHHHHhCCCCC-------cCe
Confidence 46789999999999999999998764 567899999864321 1344678999999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ .+.+..|+||||+++++|.+.+.... .+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 86 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~N 151 (486)
T 3mwu_A 86 LFEIL-------EDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPEN 151 (486)
T ss_dssp EEEEE-------ECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEEE-------EcCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHH
Confidence 77663 55788999999999999999997643 3899999999999999999999999 9999999999
Q ss_pred eEEc---CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILFD---SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||++ .++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......
T Consensus 152 il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 230 (486)
T 3mwu_A 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230 (486)
T ss_dssp EEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9995 456799999999977665555556689999999999875 589999999999999999999999977543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+ ..+....... .+.+..+++++.+||.+||+.||.+|||+.++++|...
T Consensus 231 ~-------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 231 L-------------KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp H-------------HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred H-------------HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 1 1111111111 12334567889999999999999999999999998543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.52 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=203.3
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||||+++.... ....+.+.+|+.+++.++|+| |++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpn-------iv~ 68 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPNR---ELAREKVMREVKALAKLEHPG-------IVR 68 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT-----TCCEEEEEEEECCST---TTHHHHHHHHHHHHTSCCCTT-------BCC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC-----CCcEEEEEEeecCCc---hhHHHHHHHHHHHHHhCCCCC-------Eee
Confidence 45789999999999999999998764 567899999875432 345678999999999999998 787
Q ss_pred ccccccccCC--------------------------------------------------CccCCCceEEEEeccCCCCH
Q 035572 93 FHGTSCRNSG--------------------------------------------------SVDGNSNKLLVMEFMPNGSL 122 (379)
Q Consensus 93 ~~~~~~~~~~--------------------------------------------------~~~~~~~~~lv~e~~~~~sL 122 (379)
+++.+..... ........++||||+++++|
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 148 (332)
T 3qd2_B 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148 (332)
T ss_dssp EEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCH
T ss_pred EEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCH
Confidence 7776543211 01223358999999999999
Q ss_pred HHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC------
Q 035572 123 YDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES------ 196 (379)
Q Consensus 123 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------ 196 (379)
.+++..... ....++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~ 224 (332)
T 3qd2_B 149 KDWMNRRCS--LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224 (332)
T ss_dssp HHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------
T ss_pred HHHHhcccC--ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc
Confidence 999986542 222556678899999999999999999 9999999999999999999999999997654432
Q ss_pred -------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccc
Q 035572 197 -------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDS 269 (379)
Q Consensus 197 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (379)
......||+.|+|||++.+..++.++|||||||++|+|++|..|+.... ........
T Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------------~~~~~~~~- 288 (332)
T 3qd2_B 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------------RIITDVRN- 288 (332)
T ss_dssp -------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------------HHHHHHHT-
T ss_pred ccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------------HHHHHhhc-
Confidence 2233469999999999998899999999999999999999876642210 01111111
Q ss_pred cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 270 RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...+......++.+.+++.+||+.||++|||+.|+++|..
T Consensus 289 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 289 -LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp -TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred -cCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 1234455666788999999999999999999999999854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=340.53 Aligned_cols=274 Identities=20% Similarity=0.286 Sum_probs=203.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+++.+|+.+++.++|+| |++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn-------Iv~ 88 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHEN-------VIG 88 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTT-------BCC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECC-----CCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCcC-------CCC
Confidence 35789999999999999999998764 5678999998654322 344678899999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+... +...+....|+||||+ +++|.+++... .+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 89 l~~~~~~~-~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~N 158 (367)
T 1cm8_A 89 LLDVFTPD-ETLDDFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGN 158 (367)
T ss_dssp CSEEECSC-SSTTTCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred ceeeEecC-CccccCceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHH
Confidence 77765431 1123345679999999 89999999752 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 159 Ill~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~ 236 (367)
T 1cm8_A 159 LAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236 (367)
T ss_dssp EEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999765432 334578999999998766 678999999999999999999999998765433322
Q ss_pred Hhhhhhh--hH-----------Hhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 252 DWALPLI--KE-----------EKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~--~~-----------~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
....... .. ..+...... ...........++.+.+|+.+||+.||++|||+.|+++|....
T Consensus 237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 2111000 00 000000100 0111112234567899999999999999999999999996553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=340.64 Aligned_cols=259 Identities=19% Similarity=0.346 Sum_probs=186.2
Q ss_pred hcCCccc---cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCce
Q 035572 14 TESFSQS---RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYC 89 (379)
Q Consensus 14 ~~~y~~~---~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~ 89 (379)
.++|++. +.||+|+||.||+|.+.. +++.||+|.+.. .....+.+|+.+++.+. |+|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~n------- 67 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKK-----SNQAFAVKIISK-------RMEANTQKEITALKLCEGHPN------- 67 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETT-----TCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTT-------
T ss_pred hhccccccCCCccccCCCeEEEEEEECC-----CCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCC-------
Confidence 4566665 789999999999998765 567899999863 34567889999999997 777
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
|+++++.+ .+....|+||||+++++|.+++.... .+++.++..++.|++.||+|||++| |+|||||
T Consensus 68 iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlk 133 (325)
T 3kn6_A 68 IVKLHEVF-------HDQLHTFLVMELLNGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLK 133 (325)
T ss_dssp BCCEEEEE-------ECSSEEEEEECCCCSCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred eeEEEEEE-------EcCCEEEEEEEccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCC
Confidence 88877764 56788999999999999999997632 3899999999999999999999999 9999999
Q ss_pred CCceEEcCCC---CeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 170 STNILFDSKW---DAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 170 p~NIll~~~~---~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
|+|||++.++ .+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 134 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp GGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred HHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 9999998665 79999999997654332 2344578999999999999999999999999999999999999997654
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...... ........+.......+ ..+..+++++.+|+.+||+.||.+|||++|+++|...
T Consensus 214 ~~~~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 214 RSLTCT------SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp ----CC------CHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred cccccc------cHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 321000 00111222233332222 2334567889999999999999999999999998544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=337.34 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=197.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh----------------------hhcHHHHHHH
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL----------------------QDNSKKLNNE 71 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~E 71 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+.+|
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN-----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT-----TTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 4789999999999999999998764 567899999875432110 1124568999
Q ss_pred HHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHH
Q 035572 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISR 151 (379)
Q Consensus 72 ~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~ 151 (379)
+.+++.++|+| |+++++.+.. ...+..|+||||+++++|.+++. ...+++..+..++.|++.
T Consensus 87 ~~~l~~l~h~~-------iv~~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~ 148 (298)
T 2zv2_A 87 IAILKKLDHPN-------VVKLVEVLDD-----PNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIK 148 (298)
T ss_dssp HHHHHTCCCTT-------BCCEEEEEEC-----SSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCC-------CCeEEEEEEc-----CCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHH
Confidence 99999999988 8887776532 23568899999999999987543 234899999999999999
Q ss_pred HHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCC---CCCcCCeehh
Q 035572 152 AIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSK---LSKKVDVFSY 227 (379)
Q Consensus 152 ~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSl 227 (379)
||.|||++| |+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||
T Consensus 149 ~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 226 (298)
T 2zv2_A 149 GIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226 (298)
T ss_dssp HHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred HHHHHHHCC--eeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence 999999999 9999999999999999999999999997654432 234457999999999987665 3778999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 228 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
||++|+|++|+.||....... +. ..+.......+. ...+++.+.+++.+||+.||++|||+.|+++
T Consensus 227 G~~l~~l~~g~~pf~~~~~~~-~~------------~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 227 GVTLYCFVFGQCPFMDERIMC-LH------------SKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH-HH------------HHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCccHHH-HH------------HHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999999999997653211 10 011111111111 1234577999999999999999999999999
Q ss_pred cc
Q 035572 308 GC 309 (379)
Q Consensus 308 ~~ 309 (379)
|.
T Consensus 293 hp 294 (298)
T 2zv2_A 293 HP 294 (298)
T ss_dssp CH
T ss_pred Cc
Confidence 84
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=346.66 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=198.6
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| |+++++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpn-------Iv~~~~~~-- 155 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHAN-------LIQLYDAF-- 155 (373)
T ss_dssp EEECC-----CEEEEEETT-----TCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTT-------BCCEEEEE--
T ss_pred ceEEecCcCEEEEEEEEcC-----CCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCC-------CCeEEEEE--
Confidence 5689999999999998765 56789999987543 234577999999999999988 88877764
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE--cC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF--DS 177 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll--~~ 177 (379)
.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.| |+||||||+|||+ +.
T Consensus 156 -----~~~~~~~lv~E~~~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 224 (373)
T 2x4f_A 156 -----ESKNDIVLVMEYVDGGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRD 224 (373)
T ss_dssp -----ECSSEEEEEEECCTTCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETT
T ss_pred -----EECCEEEEEEeCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCC
Confidence 45678999999999999999887532 23889999999999999999999999 9999999999999 56
Q ss_pred CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhh
Q 035572 178 KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPL 257 (379)
Q Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 257 (379)
++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+...+..
T Consensus 225 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~----- 299 (373)
T 2x4f_A 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----- 299 (373)
T ss_dssp TTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----
T ss_pred CCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----
Confidence 788999999999876655555556799999999999988899999999999999999999999987653322211
Q ss_pred hhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 258 IKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 258 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+....... +.....+++++.+||.+||+.||.+|||+.|+++|..
T Consensus 300 --------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 300 --------ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp --------HHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred --------HHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 11111111 2223445688999999999999999999999999843
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=337.07 Aligned_cols=272 Identities=20% Similarity=0.280 Sum_probs=193.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++|+| |+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~-------iv~~ 68 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-----TGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHEN-------IVRL 68 (317)
T ss_dssp ---------------CEEEEEECSS-----SCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTT-------BCCE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-----CCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCC-------cceE
Confidence 5789999999999999999998654 567899999875432 334577889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC-CCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.+ .+++..++||||++ ++|.+++....... ...+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~N 138 (317)
T 2pmi_A 69 YDVI-------HTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQN 138 (317)
T ss_dssp EEEE-------CCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEE-------EECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHH
Confidence 7764 55678999999996 69999998654322 234889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+...+
T Consensus 139 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 218 (317)
T 2pmi_A 139 LLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218 (317)
T ss_dssp EEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999765432 23344578999999998876 46899999999999999999999999876543322
Q ss_pred HHhhhhhhhH---Hh---hhhhccccCCC----Cc---------chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKE---EK---LRQVCDSRVGL----PT---------FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~---~~---~~~~~~~~~~~----~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... ..... .. ........... +. ....++.++.+|+.+||+.||++|||+.|+++|...
T Consensus 219 ~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 219 KLIF-DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp HHHH-HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred HHHH-HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 1111 10000 00 00000000000 00 011235689999999999999999999999998544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=336.21 Aligned_cols=267 Identities=21% Similarity=0.305 Sum_probs=200.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+. .++.||+|.+...... ....+.+.+|+.+++.++|+| |++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 66 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKED--EGIPSTTIREISILKELKHSN-------IVKLY 66 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTT-------BCCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCC-------Eeeee
Confidence 68999999999999999999863 4567999998765432 344578899999999999988 88777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+.+..++||||++ ++|.+++... ...+++..+..++.|++.||+|||++| |+||||||+|||
T Consensus 67 ~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 132 (288)
T 1ob3_A 67 DVI-------HTKKRLVLVFEHLD-QDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLL 132 (288)
T ss_dssp EEE-------ECSSCEEEEEECCS-EEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred eEE-------ccCCeEEEEEEecC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence 764 45678999999995 5999999753 234889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (288)
T 1ob3_A 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (288)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999998654322 223344789999999988654 589999999999999999999999987654333222
Q ss_pred hhhhhhh--HHhhhh---h--cccc------CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 253 WALPLIK--EEKLRQ---V--CDSR------VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~--~~~~~~---~--~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
....... ...+.. . .+.. .........+++++.+|+.+||+.||++|||++|+++|..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 1110000 000000 0 0000 0001112335678999999999999999999999999854
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=349.43 Aligned_cols=277 Identities=19% Similarity=0.252 Sum_probs=201.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+++.+|+.+|+.++|+| |++
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------Iv~ 89 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKN-----TEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSDY-------IIR 89 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSTTTS--HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeCchhcC--hHHHHHHHHHHHHHHHcCCCC-------cce
Confidence 36899999999999999999998765 5678999999754222 345678999999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ..+...+..|+||||+ +++|.+++... ..+++..++.+++||+.||.|||++| |+||||||+|
T Consensus 90 l~~~~~~--~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~N 159 (432)
T 3n9x_A 90 LYDLIIP--DDLLKFDELYIVLEIA-DSDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPAN 159 (432)
T ss_dssp EEEECCC--SCTTTCCCEEEEEECC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEEEec--CCCCcCCeEEEEEecC-CcCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHH
Confidence 7776543 1123336799999999 57999999753 33899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-----------------------cccccCccccccCCCCC-CCCCCCCcCCeehhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-----------------------SMVQPAGTIGYLDPGYT-NPSKLSKKVDVFSYG 228 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG 228 (379)
||++.++.+||+|||++....... ......||+.|+|||++ ....++.++||||||
T Consensus 160 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG 239 (432)
T 3n9x_A 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239 (432)
T ss_dssp EEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred eEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHH
Confidence 999999999999999997653321 12455799999999974 666799999999999
Q ss_pred HHHHHHHhCCCCC-----------CCCCCc----------------hhHHHhhhhhhh-----------HHhhh---hhc
Q 035572 229 VVLLEIISCRKPI-----------DAARDP----------------ASIIDWALPLIK-----------EEKLR---QVC 267 (379)
Q Consensus 229 ~il~elltg~~p~-----------~~~~~~----------------~~~~~~~~~~~~-----------~~~~~---~~~ 267 (379)
|++|||++|..|| .+.+.. ..........+. ..... ...
T Consensus 240 ~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 319 (432)
T 3n9x_A 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319 (432)
T ss_dssp HHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred HHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC
Confidence 9999999854443 332210 000000000000 00000 011
Q ss_pred cccCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 268 DSRVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 268 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
......+ ...+.+++++.+||.+||+.||++|||++|+++|.....
T Consensus 320 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 1111100 011335678999999999999999999999999966544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=356.95 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=205.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++++.||+|+||.||+|.+.. ++..||+|.+...... ......+.+|+.+++.++|+| |++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn-------iv~ 100 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPN-------IMK 100 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETT-----TCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTT-------BCC
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECC-----CCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCC-------CCe
Confidence 45689999999999999999998765 5577999998765432 334678899999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ .+....|+||||+++|+|.+.+.... .+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 101 ~~~~~-------~~~~~~~lv~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~N 166 (494)
T 3lij_A 101 LYDFF-------EDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPEN 166 (494)
T ss_dssp EEEEE-------ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred EEEEE-------EeCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhh
Confidence 77764 55778999999999999999987653 2889999999999999999999999 9999999999
Q ss_pred eEEcCC---CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILFDSK---WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||++.. +.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+......
T Consensus 167 il~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp EEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999754 559999999997766555555668999999999886 5689999999999999999999999987543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
...+....... ...+..+++.+.+|+.+||+.||.+|||+.|+++|....
T Consensus 246 -------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 246 -------------LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp -------------HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred -------------HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 11111111111 223345668899999999999999999999999985543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=357.52 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=197.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ........+.+|+.+++.++|+| |+.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~-------iv~l 213 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPF-------LTAL 213 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHH-C-------------CCCCCSCTT-------SCCE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC-----CCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCe-------EeeE
Confidence 4689999999999999999998765 567899999864321 11334567789999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~N 172 (379)
++.+ .+.+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||+ .| |+||||||+|
T Consensus 214 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~N 279 (446)
T 4ejn_A 214 KYSF-------QTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 279 (446)
T ss_dssp EEEE-------EETTEEEEEECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGG
T ss_pred EEEE-------eeCCEEEEEEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHH
Confidence 7664 45678999999999999999997643 38999999999999999999998 89 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.++.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... +
T Consensus 280 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~- 357 (446)
T 4ejn_A 280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-L- 357 (446)
T ss_dssp EEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H-
T ss_pred EEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-H-
Confidence 9999999999999999975432 233445679999999999998999999999999999999999999997654211 1
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
...+.......|. .+++++.+||.+||+.||.+|| +++|+++|....
T Consensus 358 -----------~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 358 -----------FELILMEEIRFPR---TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp -----------HHHHHHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred -----------HHHHHhCCCCCCc---cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 1112222222232 2457899999999999999999 999999996553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.39 Aligned_cols=271 Identities=20% Similarity=0.329 Sum_probs=212.1
Q ss_pred CCCCHHHHHHHhcCCccc-cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh-
Q 035572 3 ENFDYEELVKATESFSQS-RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE- 80 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~- 80 (379)
.+..|.......++|.+. +.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+.+++.+.+
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~ 88 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS-----TGQEYAAKFLKKRRRG--QDCRAEILHEIAVLELAKSC 88 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESEETT--EECHHHHHHHHHHHHHTTTC
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC-----CCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHhccCC
Confidence 455566777888899998 899999999999998765 5678999998754322 3456789999999999965
Q ss_pred ccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC
Q 035572 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND 160 (379)
Q Consensus 81 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 160 (379)
++ |+++++. +.+.+..++||||+++++|.+++... ....+++..++.++.|++.||+|||++|
T Consensus 89 ~~-------iv~~~~~-------~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g 151 (327)
T 3lm5_A 89 PR-------VINLHEV-------YENTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN 151 (327)
T ss_dssp TT-------BCCEEEE-------EECSSEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CC-------EEEEEEE-------EEeCCeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 55 7776665 35678899999999999999988542 2244899999999999999999999999
Q ss_pred CCeEecCCCCCceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC
Q 035572 161 PMIIHRDIKSTNILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 161 ~~i~H~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 237 (379)
|+||||||+|||++. ++.+||+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 152 --ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp --EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999987 789999999999776555444556799999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+.||...+....... +...... .......+++.+.+++.+||+.||++|||++++++|....
T Consensus 230 ~~pf~~~~~~~~~~~-------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 230 TSPFVGEDNQETYLN-------------ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp SCSSCCSSHHHHHHH-------------HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred CCCCCCCCchHHHHH-------------HHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 999977643222111 1111111 1122234567899999999999999999999999985543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.82 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=196.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHH-HHhhhhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV-LSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|++....... ......+.+|..+ ++.++|++ |++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~-------Iv~ 103 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA-----EEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPF-------LVG 103 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT-----TCCEEEEEEEEGGGBC--------------CCBCCCCCTT-------BCC
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCC-------CCC
Confidence 4689999999999999999998765 56789999987543321 2234556667766 46677777 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+..|+||||++||+|.+++.+.+ .+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 104 l~~~-------~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~N 169 (373)
T 2r5t_A 104 LHFS-------FQTADKLYFVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPEN 169 (373)
T ss_dssp EEEE-------EECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGG
T ss_pred EEEE-------EEeCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHH
Confidence 7665 456789999999999999999998643 2889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+||+|||++.... .........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+...
T Consensus 170 Ill~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--- 246 (373)
T 2r5t_A 170 ILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--- 246 (373)
T ss_dssp EEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---
T ss_pred EEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---
Confidence 999999999999999997532 2333445689999999999999999999999999999999999999997653211
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh----HHHhccccCc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI----GEILMGCSCF 312 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~e~l~~~~~~ 312 (379)
.+..+.......+. .++..+.+||.+||+.||.+||++ .+++.|....
T Consensus 247 ----------~~~~i~~~~~~~~~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 247 ----------MYDNILNKPLQLKP---NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp ----------HHHHHHHSCCCCCS---SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred ----------HHHHHHhcccCCCC---CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 12222222333332 235789999999999999999997 5788876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=351.14 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=197.4
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh----hhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV----LQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
....++|.+.+.||+|+||.||+|.+.. +++.||+|.+....... .......+.+|+.+|++++|+|
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn---- 201 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC---- 201 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT----
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC-----CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC----
Confidence 3457899999999999999999998765 56789999987543211 1122335889999999999988
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++++ ..+..|+||||+++++|.+++... ..+++..+..++.|++.||+|||++| |+||
T Consensus 202 ---iv~l~~~~--------~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHr 263 (419)
T 3i6u_A 202 ---IIKIKNFF--------DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG--IIHR 263 (419)
T ss_dssp ---BCCCCEEE--------ESSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred ---EeeEEEEE--------ecCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence 88777764 234589999999999999888642 34899999999999999999999999 9999
Q ss_pred CCCCCceEEcCCC---CeEEeccccCccCCCCCcccccCccccccCCCCCCC---CCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 167 DIKSTNILFDSKW---DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP---SKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 167 dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||||+|||++.++ .+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999997544 599999999987765555556689999999998753 5678899999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|........+.... ...... .+.....++..+.+++.+||+.||++|||++|+++|..
T Consensus 344 f~~~~~~~~~~~~i------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 344 FSEHRTQVSLKDQI------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp SCCCSSSCCHHHHH------------HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCcchHHHHHHH------------hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 98655433322211 111111 12233345678999999999999999999999999843
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=333.84 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=198.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. .++.||+|.+...... .....+++.+|+.+++.++|+| |+++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~-------iv~~ 76 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI-----LNIKVAIKAIFIPPRE-KEETLKRFEREVHNSSQLSHQN-------IVSM 76 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT-----TCSEEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCBTT-------BCCE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC-----CCCeEEEEEeccCccc-cHHHHHHHHHHHHHHhcCCCCC-------CceE
Confidence 5789999999999999999998764 5677999998644322 2345678999999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||++|++|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 77 ~~~-------~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Ni 142 (294)
T 4eqm_A 77 IDV-------DEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNI 142 (294)
T ss_dssp EEE-------EECSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred EEe-------eeeCCeEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence 766 356788999999999999999998653 3899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++.++.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+........
T Consensus 143 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 222 (294)
T 4eqm_A 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222 (294)
T ss_dssp EECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH
T ss_pred EECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999997654332 2233469999999999998899999999999999999999999998764322111
Q ss_pred HhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCC-ChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRP-GIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~e~l~~ 308 (379)
.. +....... ......+++.+.+++.+||+.||.+|| +++++...
T Consensus 223 ~~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 223 KH------------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp HH------------HSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHH
T ss_pred HH------------hhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHH
Confidence 11 11111000 011223457899999999999999999 55555443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=355.57 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=207.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh---------hhhcHHHHHHHHHHHHhhhhccC
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV---------LQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
+.++|++++.||+|+||.||+|.+.. +++.||+|.+....... .....+.+.+|+.+++.++|+|
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn- 107 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN- 107 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT-
T ss_pred cccceEEEeEecccCCeEEEEEEECC-----CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC-
Confidence 56899999999999999999998765 55679999987543221 1134678999999999999988
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
|+++++.+ .+....|+||||++||+|.+.+.... .+++..++.++.|++.||.|||++| |
T Consensus 108 ------iv~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i 167 (504)
T 3q5i_A 108 ------IIKLFDVF-------EDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN--I 167 (504)
T ss_dssp ------BCCEEEEE-------ECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ------CCeEEEEE-------EcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 88877764 56788999999999999999997643 2899999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCC---CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 164 IHRDIKSTNILFDSKW---DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
+||||||+|||++.++ .+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCC
Confidence 9999999999998775 69999999998766555555668999999999887 4689999999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
|.+...... +..+.......+ ..+..+++++.+|+.+||+.||.+|||+.|+++|....
T Consensus 247 f~~~~~~~~-------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 247 FGGQNDQDI-------------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp SCCSSHHHH-------------HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCCCHHHH-------------HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 987543221 111112222111 12344568899999999999999999999999995543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=360.41 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=212.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.+...... .......+.+|+.+|+.++|++ |+++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~-------Iv~l 249 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRF-------VVSL 249 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCC-------EeeE
Confidence 4679999999999999999998765 5678999998643221 1334567889999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||++||+|.+++...+ ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 250 ~~~-------~~~~~~l~lVmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNI 317 (576)
T 2acx_A 250 AYA-------YETKDALCLVLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENI 317 (576)
T ss_dssp EEE-------EECSSEEEEEECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred EEE-------EeeCCEEEEEEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheE
Confidence 765 456788999999999999999997632 234899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.+|.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 318 Lld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~- 396 (576)
T 2acx_A 318 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE- 396 (576)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH-
T ss_pred EEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH-
Confidence 9999999999999999876655555556899999999999988999999999999999999999999987543221111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCcc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCFF 313 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~~ 313 (379)
....+.......+ ..+++++.+||.+||+.||.+|| +++|+++|.....
T Consensus 397 --------i~~~i~~~~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 397 --------VERLVKEVPEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp --------HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred --------HHHHhhcccccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 0111111112222 33457899999999999999999 7899999966543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=329.94 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=202.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. .++.||+|.+...... .......+.+|+.+++.++|+| |++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~ 73 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPN-------ILR 73 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc-----CCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCC-------Ccc
Confidence 35789999999999999999998765 5567999998643221 1334677899999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ .+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.| |+||||||+|
T Consensus 74 ~~~~~-------~~~~~~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~N 139 (279)
T 3fdn_A 74 LYGYF-------HDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPEN 139 (279)
T ss_dssp EEEEE-------ECSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGG
T ss_pred hhheE-------ecCCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHh
Confidence 77764 45678999999999999999997643 2889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++.++.++|+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 140 ili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--- 215 (279)
T 3fdn_A 140 LLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--- 215 (279)
T ss_dssp EEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---
T ss_pred EEEcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---
Confidence 999999999999999985543322 2345799999999999988999999999999999999999999976532111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...+.......+. .++..+.+++.+||+.||++|||+.|+++|.
T Consensus 216 ----------~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 216 ----------YKRISRVEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----------HHHHHHTCCCCCT---TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----------HHHHHhCCCCCCC---cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1111112222222 2347789999999999999999999999983
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=347.62 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=194.9
Q ss_pred hcCCccc-cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 14 TESFSQS-RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
.++|.+. ++||+|+||.||+|.+.. +++.||||.+.. ...+.+|+.++.++ +|+| |+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~-----~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~-------iv 118 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQD---------CPKARREVELHWRASQCPH-------IV 118 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTT-------BC
T ss_pred cccceeccceeeeccCeEEEEEEECC-----CCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCC-------cc
Confidence 4567776 789999999999998765 567899999852 24567888887544 6777 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+.. .+.+...+|+||||++||+|.+++.... ...+++..++.++.|++.||.|||++| |+||||||+
T Consensus 119 ~l~~~~~~---~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 190 (400)
T 1nxk_A 119 RIVDVYEN---LYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 190 (400)
T ss_dssp CEEEEEEE---EETTEEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred eEeEEEee---cccCCcEEEEEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcc
Confidence 77765422 1234567899999999999999998632 234899999999999999999999999 999999999
Q ss_pred ceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 172 NILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 172 NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|||++. ++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 270 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 999997 78999999999977655444556689999999999999999999999999999999999999997654321
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
... .....+.......+ ..+..++.++.+||.+||+.||++|||+.|+++|....
T Consensus 271 ~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 271 ISP---------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp SCC---------SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ccH---------HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 100 00001111111111 12234567899999999999999999999999996543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.80 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=205.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.......+++.||||.++.... ......+.+|+.+++.++|+| |+++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpn-------Iv~~ 139 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQN-------IVRC 139 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC---hhhHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 367999999999999999999977655555788999999874322 344567889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC--CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++.+ .+....++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||++| |+||||||+
T Consensus 140 ~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 210 (367)
T 3l9p_A 140 IGVS-------LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAAR 210 (367)
T ss_dssp EEEE-------CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred EEEE-------ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChh
Confidence 7764 4567789999999999999999876432 2234889999999999999999999999 999999999
Q ss_pred ceEEcCCC---CeEEeccccCccCCC---CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 172 NILFDSKW---DAKLADFGLAVSESD---ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 172 NIll~~~~---~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
|||++.++ .+||+|||++..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 211 NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 211 NCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999555 599999999864321 122233468999999999988889999999999999999998 99999765
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... +.. .+... .... ...++..+.+|+.+||+.||++|||+.+++++...
T Consensus 291 ~~~~-~~~------------~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 291 SNQE-VLE------------FVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CHHH-HHH------------HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHH-HHH------------HHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 4221 111 11111 1111 22345779999999999999999999999987544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=329.04 Aligned_cols=258 Identities=19% Similarity=0.320 Sum_probs=204.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+.+|+.+++.++|+| |+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-------i~ 71 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG-----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN-------II 71 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTT-------BC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC-----CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCC-------ee
Confidence 4689999999999999999998765 457799999875533211 124678999999999999888 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++| ++||||||+
T Consensus 72 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ 137 (283)
T 3bhy_A 72 TLHDIF-------ENKTDVVLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPE 137 (283)
T ss_dssp CEEEEE-------ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred ehhhee-------cCCCeEEEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChH
Confidence 777664 45678999999999999999997643 3899999999999999999999999 999999999
Q ss_pred ceEEcCCC----CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSKW----DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||+++.++ .++|+|||++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 138 Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 217 (283)
T 3bhy_A 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217 (283)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH
Confidence 99998876 79999999997765544445557999999999999889999999999999999999999999765422
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
... ..+.......+ ......+..+.+++.+||+.||++|||+.++++|..
T Consensus 218 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 218 ETL-------------TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp HHH-------------HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred HHH-------------HHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 111 11111111111 122344578999999999999999999999999843
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=338.51 Aligned_cols=270 Identities=24% Similarity=0.262 Sum_probs=201.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+.+++.++|+| |+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i~~~ 67 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD-----TGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPN-------LVNL 67 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC-----CCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhCCCCC-------ccch
Confidence 5789999999999999999998765 5678999998655332 344677889999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 68 ~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Ni 133 (311)
T 4agu_A 68 LEVF-------RRKRRLHLVFEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENI 133 (311)
T ss_dssp EEEE-------EETTEEEEEEECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred hhee-------ecCCeEEEEEEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhE
Confidence 7764 4567899999999999999988643 23889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+..+.....
T Consensus 134 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (311)
T 4agu_A 134 LITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213 (311)
T ss_dssp EECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999997654322 2344579999999998765 568999999999999999999999998765443322
Q ss_pred Hhhhh---hhhH--Hhhh--h-hccccCCCCc-------chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALP---LIKE--EKLR--Q-VCDSRVGLPT-------FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~---~~~~--~~~~--~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..... .... ..+. . ........+. ..+.++..+.+++.+||+.||++|||++|+++|...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 11100 0000 0000 0 0000000000 112356779999999999999999999999998544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.64 Aligned_cols=281 Identities=20% Similarity=0.255 Sum_probs=203.4
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-------hhhhcHHHHHHHHHHHHhhh
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-------VLQDNSKKLNNEIRVLSSLQ 79 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~ 79 (379)
+.++..+.++|++.+.||+|+||.||+|.+. .++.||||++...... ......+.+.+|+.+++.++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 87 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC
Confidence 5678889999999999999999999999864 3577999998653221 11222478999999999999
Q ss_pred hccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 80 ~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
|+| |+++++.+.... -......|+||||++ |+|.+.+... ...+++..+..++.|++.||.|||++
T Consensus 88 h~~-------iv~~~~~~~~~~--~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~ 153 (362)
T 3pg1_A 88 HPN-------ILGLRDIFVHFE--EPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEA 153 (362)
T ss_dssp CTT-------BCCCSEEEEECC--TTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcC-------ccceeeeEEecc--CCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 988 888777754321 133457899999995 7998988743 23489999999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCC
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~ 238 (379)
| |+||||||+|||++.++.+||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 154 ~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 154 G--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp T--CCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred c--CEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence 9 99999999999999999999999999976555555555679999999998776 67899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhh-----------HHhhhhhcccc-CCCCc-----chHHHHHHHHHHHHhcccCCCCCCCC
Q 035572 239 KPIDAARDPASIIDWALPLIK-----------EEKLRQVCDSR-VGLPT-----FMEGAIKQMLHVAARCVSSEEENRPG 301 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps 301 (379)
.||.+......+.... .... ........... ...+. .....++.+.+|+.+||+.||.+|||
T Consensus 232 ~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 232 ALFRGSTFYNQLNKIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp CSCCCSSHHHHHHHHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCHHHHHHHHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 9998765333222111 0000 00001111000 00010 11233577999999999999999999
Q ss_pred hHHHhcccc
Q 035572 302 IGEILMGCS 310 (379)
Q Consensus 302 ~~e~l~~~~ 310 (379)
+.|+++|..
T Consensus 311 ~~ell~hp~ 319 (362)
T 3pg1_A 311 TEQALRHPY 319 (362)
T ss_dssp HHHHHTSGG
T ss_pred HHHHHcCch
Confidence 999999843
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.83 Aligned_cols=263 Identities=21% Similarity=0.364 Sum_probs=208.2
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch----hhhhcHHHHHHHHHHHHhh-hhccC
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE----VLQDNSKKLNNEIRVLSSL-QESNK 83 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l-~~~~~ 83 (379)
......++|++.+.||+|+||.||+|.+.. +++.||||+++..... ......+.+.+|+.+++.+ +|+|
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~- 161 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRA-----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH- 161 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT-
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECC-----CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC-
Confidence 345566889999999999999999998764 5678999998654321 1123356789999999999 6887
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
|+.+++++ ......|+||||++|++|.+++.... .+++..+..++.|++.||.|||+.| +
T Consensus 162 ------iv~~~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g--i 221 (365)
T 2y7j_A 162 ------IITLIDSY-------ESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN--I 221 (365)
T ss_dssp ------BCCEEEEE-------EBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ------EeEEEEEE-------eeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 77766653 44678999999999999999997643 3899999999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC------CCCCCCcCCeehhHHHHHHHHhC
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN------PSKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg 237 (379)
+|+||||+|||++.++.++|+|||++.............||+.|+|||++. ...++.++|||||||++|+|++|
T Consensus 222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g 301 (365)
T 2y7j_A 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301 (365)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence 999999999999999999999999997766555555668999999999764 33588999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+.||........ ...+.......+ ..+...+..+.+++.+||+.||++|||+.++++|..
T Consensus 302 ~~pf~~~~~~~~-------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 302 SPPFWHRRQILM-------------LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp SCSSCCSSHHHH-------------HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCCCCHHHH-------------HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 999976532111 111111111111 112234577999999999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=338.33 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=203.0
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+...+ ..+..||||.+..... ....+.+.+|+.+++.++|+| |+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 115 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGYT---ERQRRDFLSEASIMGQFDHPN-------IIRL 115 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTCC---HHHHHHHHHHHHHHTTCCCTT-------BCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 357899999999999999999986533 2566799999875422 344678999999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+.+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.| |+||||||+||
T Consensus 116 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NI 182 (325)
T 3kul_A 116 EGVV-------TRGRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNV 182 (325)
T ss_dssp EEEE-------CGGGCCEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred EEEE-------EeCCccEEEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceE
Confidence 7764 4467889999999999999999753 234899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
|++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 183 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 262 (325)
T 3kul_A 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262 (325)
T ss_dssp EECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred EECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999976543321 122346788999999988889999999999999999999 999997654322
Q ss_pred hHHHhhhhhhhHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 249 SIIDWALPLIKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. . .+.. .... ....++..+.+++.+||+.||++|||+.++++...
T Consensus 263 ~~-~------------~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 263 VI-S------------SVEEGYRLP---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp HH-H------------HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-H------------HHHcCCCCC---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 1 1111 1111 12234578999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.99 Aligned_cols=273 Identities=25% Similarity=0.298 Sum_probs=207.8
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch-hhhhcHHHHHHHHHHHHhhhhccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE-VLQDNSKKLNNEIRVLSSLQESNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~ 83 (379)
+.-.++..+.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ......+.+.+|+.+++.++|+|
T Consensus 16 ~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn- 89 (345)
T 3hko_A 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQ-----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN- 89 (345)
T ss_dssp CCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTT-
T ss_pred ccCchhhhhhhheeecceeeecCCeEEEEEEECC-----CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCC-
Confidence 3445667888999999999999999999998764 5678999998643211 12345678999999999999888
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-------------------------------
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA------------------------------- 132 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------------------- 132 (379)
|+++++++ .+.+..++||||++||+|.+++......
T Consensus 90 ------iv~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (345)
T 3hko_A 90 ------IARLYEVY-------EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156 (345)
T ss_dssp ------BCCEEEEE-------ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--
T ss_pred ------cceeehhh-------ccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccc
Confidence 88877764 5567899999999999999998532111
Q ss_pred ----CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC--CeEEeccccCccCCCCC-----ccccc
Q 035572 133 ----TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW--DAKLADFGLAVSESDES-----SMVQP 201 (379)
Q Consensus 133 ----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~-----~~~~~ 201 (379)
....+++..++.++.|++.||+|||+.| |+||||||+|||++.++ .+||+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 234 (345)
T 3hko_A 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234 (345)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCcccccccccc
Confidence 0111356678889999999999999999 99999999999998776 89999999996542211 12345
Q ss_pred CccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCC-CcchH
Q 035572 202 AGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGL-PTFME 278 (379)
Q Consensus 202 ~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 278 (379)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ .+....... .....
T Consensus 235 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-------------~~~~~~~~~~~~~~~ 301 (345)
T 3hko_A 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS-------------QVLNKKLCFENPNYN 301 (345)
T ss_dssp CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------HHHHCCCCTTSGGGG
T ss_pred CCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH-------------HHHhcccccCCcccc
Confidence 79999999998765 678999999999999999999999998765332221 111111111 22233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 279 GAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 279 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+++.+.+++.+||+.||.+|||+.++++|...
T Consensus 302 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 456789999999999999999999999998543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=341.34 Aligned_cols=256 Identities=20% Similarity=0.339 Sum_probs=202.1
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
..++|++.+.||+|+||.||+|.++. +++.||+|.+..... ...+|++++.++ +|+| |+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~-------iv 79 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA-----TNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPN-------II 79 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTT-------BC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCC-------cC
Confidence 46789999999999999999998765 567899999875421 235788888888 6777 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++. +.+.+..|+||||++||+|.+.+...+ .+++..+..++.|++.||.|||++| |+||||||+
T Consensus 80 ~~~~~-------~~~~~~~~lv~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~ 145 (342)
T 2qr7_A 80 TLKDV-------YDDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPS 145 (342)
T ss_dssp CEEEE-------EECSSEEEEEECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred eEEEE-------EEcCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHH
Confidence 77766 456789999999999999999997532 3899999999999999999999999 999999999
Q ss_pred ceEEcCC----CCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 172 NILFDSK----WDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 172 NIll~~~----~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|||+.++ +.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....+
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 9998533 34999999999765433 233456799999999998877789999999999999999999999976432
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
... ......+.......+ ..+..++.++.+|+.+||+.||++|||+.++++|....
T Consensus 226 ~~~----------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 226 DTP----------EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp SCH----------HHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CCH----------HHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 110 011111111122111 12344568899999999999999999999999996653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=357.38 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=210.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... .....+.+.+|+.++++++|+| |++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpn-------iv~ 90 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPN-------IMK 90 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC-----CCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCC-------CCc
Confidence 45789999999999999999998764 5678999998654322 1344678999999999999988 787
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ .+.+..|+||||+.+++|.+.+... ..+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 91 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~N 156 (484)
T 3nyv_A 91 LYEFF-------EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPEN 156 (484)
T ss_dssp EEEEE-------ECSSEEEEEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred EEEEE-------EeCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHH
Confidence 77664 5578899999999999999999753 23899999999999999999999999 9999999999
Q ss_pred eEE---cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILF---DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......
T Consensus 157 il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 235 (484)
T 3nyv_A 157 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235 (484)
T ss_dssp EEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999 5678999999999977665555555679999999998875 689999999999999999999999987643221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+ ..+....... .+.+..+++.+.+||.+||+.||.+|||+.|+++|....
T Consensus 236 ~-------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 236 L-------------KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp H-------------HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred H-------------HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 1 1111111111 123345678899999999999999999999999996543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.08 Aligned_cols=273 Identities=21% Similarity=0.248 Sum_probs=198.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||.+...... ....+.+.+|+.+++.++|+| |+++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn-------iv~~ 89 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKN-------IIGL 89 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheeEeeeeEecCCEEEEEEEECC-----CCceEEEEEeccccCC--hHHHHHHHHHHHHHHhcCCCC-------ccce
Confidence 5789999999999999999998764 5678999998754322 344677899999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+... +...+....|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 90 ~~~~~~~-~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NI 158 (371)
T 2xrw_A 90 LNVFTPQ-KSLEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 158 (371)
T ss_dssp EEEECSC-CSTTTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred EEeeccc-cccccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHE
Confidence 7765431 22334458899999995 688888852 2888999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+...
T Consensus 159 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 238 (371)
T 2xrw_A 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238 (371)
T ss_dssp EECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999997665444444567999999999999889999999999999999999999999876543322211
Q ss_pred hhhhh-------h--HHhhhhhccccC----------------C-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 254 ALPLI-------K--EEKLRQVCDSRV----------------G-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 254 ~~~~~-------~--~~~~~~~~~~~~----------------~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
..... . ............ + ........+.++.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 10000 0 000000000000 0 01112344678999999999999999999999999
Q ss_pred cccC
Q 035572 308 GCSC 311 (379)
Q Consensus 308 ~~~~ 311 (379)
|...
T Consensus 319 hp~~ 322 (371)
T 2xrw_A 319 HPYI 322 (371)
T ss_dssp SHHH
T ss_pred Ccch
Confidence 9543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=339.65 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=199.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.++||+|+||.||+|.+. ++.||||++... ........+|+.+++.++|+| |+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpn-------iv~~ 83 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHEN-------ILQF 83 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTT-------BCCE
T ss_pred hhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCC-------chhh
Confidence 578999999999999999999764 467999998643 233455677999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC----------CCCe
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN----------DPMI 163 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----------~~~i 163 (379)
++.+.... ......++||||+++|+|.+++... .+++..+..++.|++.||.|||+. | |
T Consensus 84 ~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--i 152 (322)
T 3soc_A 84 IGAEKRGT---SVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--I 152 (322)
T ss_dssp EEEEEEEC---SSSEEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--E
T ss_pred cceeccCC---CCCceEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--E
Confidence 87754311 1134579999999999999999752 289999999999999999999999 9 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCC-----CCCCcCCeehhHHHHHHHH
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPS-----KLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell 235 (379)
+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 153 vH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~ 232 (322)
T 3soc_A 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232 (322)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence 9999999999999999999999999965443222 2334799999999988763 4567889999999999999
Q ss_pred hCCCCCCCCCCchhH--HHhhhhhhhHHhhhh-hccc--cCCCCc--chHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 236 SCRKPIDAARDPASI--IDWALPLIKEEKLRQ-VCDS--RVGLPT--FMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 236 tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~--~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
||+.||.+..+.... ............... .... ....+. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 233 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp TTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999875442211 000000000011111 1111 111111 123456779999999999999999999999976
Q ss_pred c
Q 035572 309 C 309 (379)
Q Consensus 309 ~ 309 (379)
.
T Consensus 313 L 313 (322)
T 3soc_A 313 I 313 (322)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=339.31 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=206.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh----hhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL----QDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+.+|+.+++.++|+|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------ 90 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE-----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN------ 90 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT-----TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTT------
T ss_pred cccceEEEeEEEecCCEEEEEEEECC-----CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCC------
Confidence 35789999999999999999998765 568899999876532110 113446778999999999888
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCC-CHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG-SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++++ .+.+..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||++| |+|||
T Consensus 91 -Iv~~~~~~-------~~~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~D 155 (335)
T 3dls_A 91 -IIKVLDIF-------ENQGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRD 155 (335)
T ss_dssp -BCCEEEEE-------ECSSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred -EeeEEEEE-------eeCCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEec
Confidence 78777764 5578899999999766 999999753 23899999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|||+|||++.++.+||+|||++.............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 156 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 235 (335)
T 3dls_A 156 IKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235 (335)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG
T ss_pred cCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH
Confidence 999999999999999999999987665555555679999999999888776 7899999999999999999999975321
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
........+.. +++++.+|+.+||+.||++|||+.++++|....
T Consensus 236 -------------------~~~~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 236 -------------------TVEAAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp -------------------GTTTCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred -------------------HHhhccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 11111111221 347799999999999999999999999996553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=326.72 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=186.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.++|+| +++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~ 75 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIH-----TGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPS-------ILE 75 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTT-------BCC
T ss_pred ccccceeeeeecCCCceEEEEEEEcc-----CCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCC-------eEe
Confidence 35789999999999999999998754 5678999998643211 1234578999999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ .+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||++| ++||||||+|
T Consensus 76 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~N 142 (278)
T 3cok_A 76 LYNYF-------EDSNYVYLVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSN 142 (278)
T ss_dssp EEEEE-------ECSSEEEEEEECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGG
T ss_pred EEEEE-------ccCCeEEEEEecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence 77664 4567899999999999999999753 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|+++.++.++|+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 143 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~- 221 (278)
T 3cok_A 143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL- 221 (278)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred EEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-
Confidence 999999999999999997654322 223456899999999999888999999999999999999999999765432211
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+.......+. .++.++.+++.+||+.||++|||++++++|...
T Consensus 222 ------------~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 222 ------------NKVVLADYEMPS---FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp --------------CCSSCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred ------------HHHhhcccCCcc---ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 111111222222 235788999999999999999999999998543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.56 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=205.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
..|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+.+|+.+++.++|+| |++++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~va~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------iv~~~ 91 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPN-------IVRFY 91 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecC-----CceEEEEEEecchhhC--HHHHHHHHHHHHHHHhCCCCC-------eeeee
Confidence 358888999999999999998765 5577999998754332 345678999999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+... ..+....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|.+++||||||+|||
T Consensus 92 ~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil 163 (290)
T 1t4h_A 92 DSWEST---VKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp EEEEEE---SSSCEEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred eeeccc---cCCCceEEEEEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEE
Confidence 765321 234567899999999999999997643 288999999999999999999998766999999999999
Q ss_pred Ec-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||....+.......
T Consensus 164 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 241 (290)
T 1t4h_A 164 ITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred EECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH
Confidence 98 7899999999999654433 233457999999999887 45899999999999999999999999876554333221
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. ............++++.+++.+||+.||.+|||+.++++|..
T Consensus 242 ~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 242 VT-------------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp HT-------------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred Hh-------------ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 11 111111222233467999999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=355.84 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=211.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|++...... .......+.+|+.+++.++|++ |+++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~-------Iv~l 250 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA-----TGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRF-------IVSL 250 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCC-------EeeE
Confidence 3689999999999999999998764 5678999998653221 1234577899999999999887 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+.+|+||||++||+|.+++..... ....+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 251 ~~~-------~~~~~~l~lVmE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NI 320 (543)
T 3c4z_A 251 AYA-------FETKTDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENV 320 (543)
T ss_dssp EEE-------EECSSEEEEEECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred EEE-------EeeCCEEEEEEEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHE
Confidence 665 3557889999999999999999976432 2334899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 321 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~ 400 (543)
T 3c4z_A 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400 (543)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH
T ss_pred EEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH
Confidence 999999999999999976554333 3345899999999999999999999999999999999999999987543221111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCcc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~~ 313 (379)
....+.......| ..+++.+.+||.+||+.||++||+ +++++.|.....
T Consensus 401 ---------~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 401 ---------LKQRVLEQAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp ---------HHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred ---------HHHHHhhcccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 1111222222223 234578999999999999999996 488998866543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=362.94 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=210.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
.++|++++.||+|+||.||+|.++. +++.||||+++.... ......+.+..|..++..+. |++ |+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~l~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~-------i~~ 406 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPF-------LTQ 406 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESS-----SCCEEEEEEEEHHHH-HHTTTTHHHHHHHHHHTCTTCCTT-------BCC
T ss_pred ccceEEEEEEccCCCEEEEEEEECC-----CCcEEEEEEEecccc-ccHHHHHHHHHHHHHHHhccCCCe-------EEE
Confidence 4689999999999999999998765 567899999875322 12345677889999999884 444 666
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.. +.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|
T Consensus 407 l~~~-------~~~~~~~~lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~N 472 (674)
T 3pfq_A 407 LHSC-------FQTMDRLYFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDN 472 (674)
T ss_dssp EEEE-------CBCSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTT
T ss_pred EEEE-------EEeCCEEEEEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhh
Confidence 6654 566789999999999999999998653 2899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCC-CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSES-DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+||+|||++.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 473 ILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----- 547 (674)
T 3pfq_A 473 VMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----- 547 (674)
T ss_dssp EEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred EEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----
Confidence 999999999999999997533 23334556899999999999999999999999999999999999999987542
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCCh-----HHHhccccCcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI-----GEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~~~~~~ 313 (379)
...+..+.......|. .+++++.+||.+||+.||++||++ +|+++|.....
T Consensus 548 --------~~~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 548 --------DELFQSIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp --------HHHHHHHHSSCCCCCT---TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred --------HHHHHHHHhCCCCCCc---cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 1222333344444443 345789999999999999999998 89999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=339.77 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=209.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.......+++.||+|.++.... ....+.+.+|+.+++.++|+| |++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~-------iv~ 114 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPN-------IVK 114 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCC-------EEE
Confidence 4579999999999999999999987655445778999999975432 345678999999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC-------------------CCCCChHhHHHHHHHHHHHH
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-------------------TPQLGWPNRVKIAMQISRAI 153 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l 153 (379)
+++.+ .+.+..++||||+++++|.+++....... ...+++.+++.++.|++.||
T Consensus 115 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 187 (343)
T 1luf_A 115 LLGVC-------AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187 (343)
T ss_dssp EEEEE-------CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEEE-------ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHH
Confidence 77764 44678999999999999999998743211 14589999999999999999
Q ss_pred HHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHH
Q 035572 154 QCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230 (379)
Q Consensus 154 ~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 230 (379)
.|||++| |+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||++
T Consensus 188 ~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 265 (343)
T 1luf_A 188 AYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265 (343)
T ss_dssp HHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHhCC--eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHH
Confidence 9999999 9999999999999999999999999986543221 2233468899999999888889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 231 LLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 231 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+|+|+| |..||.+..... +. ..+..... +.....++..+.+++.+||+.||++|||+.+++++.
T Consensus 266 l~el~t~g~~p~~~~~~~~-~~------------~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 266 LWEIFSYGLQPYYGMAHEE-VI------------YYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHHHHTTTCCTTTTSCHHH-HH------------HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCcCCCCChHH-HH------------HHHhCCCc--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 999999 999997654211 11 11111111 111223457899999999999999999999999875
Q ss_pred cC
Q 035572 310 SC 311 (379)
Q Consensus 310 ~~ 311 (379)
..
T Consensus 331 ~~ 332 (343)
T 1luf_A 331 QR 332 (343)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=340.94 Aligned_cols=267 Identities=19% Similarity=0.337 Sum_probs=211.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCC--CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCce
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQT--DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYC 89 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~ 89 (379)
..++|++.+.||+|+||.||+|.+..... ...+..||+|++..... ....+++.+|+++++.+ +|+|
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpn------- 136 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKN------- 136 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT-------
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC---HHHHHHHHHHHHHHHHhcCCch-------
Confidence 35789999999999999999999765332 23567899999875432 34467899999999999 8888
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHHc
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLHE 158 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~ 158 (379)
|+++++.+ .+.+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+
T Consensus 137 Iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 137 IINLLGAC-------TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhheeee-------ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 88877764 4567899999999999999999875421 12348999999999999999999999
Q ss_pred CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHH
Q 035572 159 NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 159 ~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 235 (379)
.| |+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 210 ~~--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 210 KK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp TT--CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred CC--EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999997654332 223346788999999998889999999999999999999
Q ss_pred h-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 236 S-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 236 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
+ |..||..... ..+.... ... .....+ ..++.++.+++.+||+.||++|||+.|++++.....
T Consensus 288 t~g~~p~~~~~~-~~~~~~~---------~~~--~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 288 TLGGSPYPGVPV-EELFKLL---------KEG--HRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp TTSCCSSTTCCH-HHHHHHH---------HTT--CCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCH-HHHHHHH---------HcC--CCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9 9999976542 1111111 000 011112 234578999999999999999999999999865443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=339.17 Aligned_cols=267 Identities=21% Similarity=0.325 Sum_probs=208.7
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
...++|++.+.||+|+||.||+|.+........+..||+|.+..... ....+.+.+|+.+++.+ +|+| |
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~-------i 111 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHEN-------I 111 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTT-------B
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC---HHHHHHHHHHHHHHHhhcCCCC-------e
Confidence 34578999999999999999999986555555778999999975421 34567899999999999 7888 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC------------------CCCCCChHhHHHHHHHHHHH
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA------------------TTPQLGWPNRVKIAMQISRA 152 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~~~~~~~~i~~~ 152 (379)
+++++.+ ...+..++||||+++|+|.+++...... ....+++..++.++.|++.|
T Consensus 112 v~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 184 (344)
T 1rjb_A 112 VNLLGAC-------TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184 (344)
T ss_dssp CCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHH
T ss_pred eeEEEEE-------eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHH
Confidence 8777764 4467899999999999999999864321 01237889999999999999
Q ss_pred HHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHH
Q 035572 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229 (379)
Q Consensus 153 l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 229 (379)
|.|||++| |+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+
T Consensus 185 L~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 262 (344)
T 1rjb_A 185 MEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262 (344)
T ss_dssp HHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHhCC--cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHH
Confidence 99999999 99999999999999999999999999965533322 22335788999999988888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 230 VLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 230 il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++|+|+| |..||.+............ .. .....+ ..+++.+.+++.+||+.||.+|||+.+++++
T Consensus 263 il~el~t~g~~p~~~~~~~~~~~~~~~---------~~--~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 263 LLWEIFSLGVNPYPGIPVDANFYKLIQ---------NG--FKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHH---------TT--CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCcccCCcHHHHHHHHh---------cC--CCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9999998 9999987654332222111 00 011111 2235789999999999999999999999987
Q ss_pred ccC
Q 035572 309 CSC 311 (379)
Q Consensus 309 ~~~ 311 (379)
...
T Consensus 329 l~~ 331 (344)
T 1rjb_A 329 LGC 331 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=325.68 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=206.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.++|+| ++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~ 79 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ-----NKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPN-------ILRM 79 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC-----CCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCC-------EeeE
Confidence 4689999999999999999998764 5678999998643211 1234578999999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+.+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++| ++||||||+||
T Consensus 80 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Ni 145 (284)
T 2vgo_A 80 YNYF-------HDRKRIYLMLEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENL 145 (284)
T ss_dssp EEEE-------ECSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGE
T ss_pred EEEE-------EcCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHE
Confidence 7664 45678999999999999999998643 2889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+++.++.++|+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 146 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---- 220 (284)
T 2vgo_A 146 LMGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---- 220 (284)
T ss_dssp EECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----
T ss_pred EEcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----
Confidence 99999999999999986554322 2345799999999999988999999999999999999999999976542211
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...+.......+. .++..+.+++.+||+.||.+|||++++++|...
T Consensus 221 ---------~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 221 ---------HRRIVNVDLKFPP---FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp ---------HHHHHTTCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred ---------HHHHhccccCCCC---cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 1111222222222 235788999999999999999999999998443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=344.38 Aligned_cols=273 Identities=22% Similarity=0.293 Sum_probs=204.7
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+..+|++.+.||+|+||.||+|.+.. +++.||||.++.. ......+.+|+.+++.+++....+ +..++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~-~~~iv~ 163 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK-----VHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDN-TMNVIH 163 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT-----TTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTS-CSCBCC
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC-----CCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccC-CcCEEE
Confidence 34679999999999999999998765 5678999999753 334567889999999998764221 111666
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 164 ~~~~-------~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~N 230 (429)
T 3kvw_A 164 MLEN-------FTFRNHICMTFELL-SMNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPEN 230 (429)
T ss_dssp EEEE-------EEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGG
T ss_pred EEee-------cccCCeEEEEEecc-CCCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence 5554 45568899999999 579999998643 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCC--eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWD--AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++.++. +||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+
T Consensus 231 ILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l 308 (429)
T 3kvw_A 231 ILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308 (429)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99998887 999999999665432 23457999999999999889999999999999999999999999876544333
Q ss_pred HHhhhhh--hhHHhh------hhhcccc------------------------------CCCCcchH-----HHHHHHHHH
Q 035572 251 IDWALPL--IKEEKL------RQVCDSR------------------------------VGLPTFME-----GAIKQMLHV 287 (379)
Q Consensus 251 ~~~~~~~--~~~~~~------~~~~~~~------------------------------~~~~~~~~-----~~~~~~~~l 287 (379)
....... .....+ ....+.. ......+. ..++.+.+|
T Consensus 309 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dl 388 (429)
T 3kvw_A 309 ACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388 (429)
T ss_dssp HHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHH
T ss_pred HHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHH
Confidence 2211100 000000 0000000 00000111 114678999
Q ss_pred HHhcccCCCCCCCChHHHhccccC
Q 035572 288 AARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 288 i~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|.+||+.||++|||++|+|+|...
T Consensus 389 i~~~L~~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 389 LKQCLEWDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHCCCChhhCCCHHHHhCChhh
Confidence 999999999999999999999443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=340.16 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=201.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||+|.++..... .......+.+|+.+++.++|+| |++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~-------iv~ 76 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLR-----DHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA-------IVA 76 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTT-------BCC
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECC-----CCceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCC-------cce
Confidence 35789999999999999999998754 5678999999764322 2344577899999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.... ......|+||||++|++|.+++...+ .+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 77 ~~~~~~~~~---~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~N 146 (311)
T 3ork_A 77 VYDTGEAET---PAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPAN 146 (311)
T ss_dssp EEEEEEEEE---TTEEEEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGG
T ss_pred EEEeeeccC---CCCcccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHH
Confidence 777643211 11124599999999999999997643 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
||++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.....
T Consensus 147 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 226 (311)
T 3ork_A 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226 (311)
T ss_dssp EEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999996554322 1223468999999999998899999999999999999999999997654322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
..... ..............++.++.+++.+||+.||++||++.+++.+.....
T Consensus 227 ~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 227 VAYQH------------VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHH------------HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHH------------hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 11111 001111101112235678999999999999999999999998765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=331.30 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=197.1
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHh--hhhccCCCCCcee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSS--LQESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~~~~~~~~~~i 90 (379)
..++|++.+.||+|+||.||+|.+ +++.||||++.. .....+.+|.+++.. ++|+| |
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~n-------i 64 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-------QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHEN-------I 64 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTT-------B
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-------CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcC-------e
Confidence 367999999999999999999976 356799999863 234556677777776 77887 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH--------cCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH--------ENDPM 162 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~~~ 162 (379)
+++++.+... .......++||||+++|+|.++++. ..+++..+..++.|++.||+||| +.|
T Consensus 65 v~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-- 133 (301)
T 3q4u_A 65 LGFIASDMTS---RHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-- 133 (301)
T ss_dssp CCEEEEEEEE---ETTEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--
T ss_pred eeEEEeeccc---cCCCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--
Confidence 7777765331 2334678999999999999999953 23899999999999999999999 889
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCC------CCCCcCCeehhHHHH
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPS------KLSKKVDVFSYGVVL 231 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il 231 (379)
|+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++
T Consensus 134 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 99999999999999999999999999965433322 2234799999999988766 455789999999999
Q ss_pred HHHHhC----------CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc--chHHHHHHHHHHHHhcccCCCCCC
Q 035572 232 LEIISC----------RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT--FMEGAIKQMLHVAARCVSSEEENR 299 (379)
Q Consensus 232 ~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R 299 (379)
|+|+|| ..||............... ...........+. .....++.+.+++.+||+.||++|
T Consensus 214 ~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 287 (301)
T 3q4u_A 214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287 (301)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhhhcCccccccccccccccCCCCcchhhhhH------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence 999999 8888654332211111100 0111111222222 234577899999999999999999
Q ss_pred CChHHHhcc
Q 035572 300 PGIGEILMG 308 (379)
Q Consensus 300 ps~~e~l~~ 308 (379)
||+.++++.
T Consensus 288 ps~~~i~~~ 296 (301)
T 3q4u_A 288 LTALRIKKT 296 (301)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=333.27 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=210.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
..++|++.+.||+|+||.||+|.+........++.||+|.+..... ....+.+.+|+.+++++ +|+| |+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~-------i~ 90 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMN-------IV 90 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT-------BC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh---HHHHHHHHHHHHHHhhcccCCC-------ee
Confidence 3578999999999999999999876544555788999999975432 23457899999999999 8888 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-------------CCCCCChHhHHHHHHHHHHHHHHHHc
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-------------TTPQLGWPNRVKIAMQISRAIQCLHE 158 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~LH~ 158 (379)
++++.+ .+.+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+
T Consensus 91 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 163 (313)
T 1t46_A 91 NLLGAC-------TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163 (313)
T ss_dssp CEEEEE-------CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEE-------ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 777764 4567889999999999999999875421 12248899999999999999999999
Q ss_pred CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHH
Q 035572 159 NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 159 ~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 235 (379)
+| ++||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 164 ~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 164 KN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp TT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CC--eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 99 99999999999999999999999999976544332 22335788999999988888999999999999999999
Q ss_pred h-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 236 S-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 236 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
| |+.||.............. .... . .....++..+.+++.+||+.||.+|||+.+++++..
T Consensus 242 t~g~~p~~~~~~~~~~~~~~~---------~~~~--~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 242 SLGSSPYPGMPVDSKFYKMIK---------EGFR--M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp TTTCCSSTTCCSSHHHHHHHH---------HTCC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCCCcccchhHHHHHhc---------cCCC--C---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 9 9999987654332221110 1111 1 111234578999999999999999999999998743
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.80 Aligned_cols=257 Identities=13% Similarity=0.179 Sum_probs=194.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHH---HHhhhhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV---LSSLQESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~---l~~l~~~~~~~~~~~i 90 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... .....+.+.+|+.+ ++.++|+| |
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpn-------i 138 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQK-------Q 138 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C-----CCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHH-------H
T ss_pred CceEEEcceeecCCCEEEEEEEECC-----CCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHH-------H
Confidence 4779999999999999999998754 5678999998743221 13446789999954 45556777 8
Q ss_pred eeccccccccCCCccCCC-----------------ceEEEEeccCCCCHHHHHHhhhcCCC--CCCChHhHHHHHHHHHH
Q 035572 91 VNFHGTSCRNSGSVDGNS-----------------NKLLVMEFMPNGSLYDLLHNAAAATT--PQLGWPNRVKIAMQISR 151 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~ 151 (379)
+++++.+....+++.+.+ ..|+||||+ +|+|.+++...+.... ..+++..+..++.|++.
T Consensus 139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~ 217 (377)
T 3byv_A 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217 (377)
T ss_dssp HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence 888866654444444332 388999999 7899999987654222 12334778889999999
Q ss_pred HHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-----------CCCC
Q 035572 152 AIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-----------KLSK 220 (379)
Q Consensus 152 ~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ 220 (379)
||+|||++| |+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.
T Consensus 218 aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 218 LLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 999999999 99999999999999999999999999976433 2334467 999999998877 7999
Q ss_pred cCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC
Q 035572 221 KVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300 (379)
Q Consensus 221 ~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 300 (379)
++|||||||++|+|++|+.||........ ...+.... ..+++++.+|+.+||+.||++||
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGG-------------SEWIFRSC-------KNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CC-------------SGGGGSSC-------CCCCHHHHHHHHHHTCSSGGGCC
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccc-------------hhhhhhhc-------cCCCHHHHHHHHHHcCCCchhCC
Confidence 99999999999999999999976542211 11111111 12246799999999999999999
Q ss_pred ChHHHhccc
Q 035572 301 GIGEILMGC 309 (379)
Q Consensus 301 s~~e~l~~~ 309 (379)
|+.++++|.
T Consensus 353 t~~e~l~hp 361 (377)
T 3byv_A 353 LPLQAMETP 361 (377)
T ss_dssp CHHHHHTSH
T ss_pred CHHHHhhCh
Confidence 999999983
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=325.56 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=200.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh---hhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL---QDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+.+|+.+++.++|+| |
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-------i 85 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK-----DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN-------I 85 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT-----TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTT-------B
T ss_pred hccceehhccccCCceeEEEEEEcC-----CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCC-------c
Confidence 4789999999999999999998765 567799999875433211 122378999999999999988 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+. ...++||||+++++|.+.+... ...+++..+..++.|++.||+|||++|.+|+||||||
T Consensus 86 ~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp 152 (287)
T 4f0f_A 86 VKLYGLMH---------NPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS 152 (287)
T ss_dssp CCEEEEET---------TTTEEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG
T ss_pred hhhheeec---------CCCeEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc
Confidence 88777642 2237999999999999988753 2348999999999999999999999887799999999
Q ss_pred CceEEcCCCC-----eEEeccccCccCCCCCcccccCccccccCCCCC--CCCCCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 171 TNILFDSKWD-----AKLADFGLAVSESDESSMVQPAGTIGYLDPGYT--NPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 171 ~NIll~~~~~-----~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
+|||++.++. +||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||..
T Consensus 153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 153 PNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp GGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999988776 99999999875433 23345799999999988 445578899999999999999999999976
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
......... ........ .+.....+++.+.+++.+||+.||++|||+.++++..
T Consensus 231 ~~~~~~~~~-----------~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 231 YSYGKIKFI-----------NMIREEGL-RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CCCCHHHHH-----------HHHHHSCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccHHHHH-----------HHHhccCC-CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 554321100 00000111 1122234467899999999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=336.75 Aligned_cols=269 Identities=19% Similarity=0.278 Sum_probs=196.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+|+.+++.++|+| |++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~-------iv~~~ 66 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL-----TDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHAN-------IVTLH 66 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECC---------CCCCCCCHHHHSCCCCTT-------BCCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC-----CCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCC-------CCeee
Confidence 689999999999999999998764 5678999998754321 22224557999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+.+..++||||++ ++|.+++...+ ..+++..+..++.|++.||.|||+.| |+||||||+|||
T Consensus 67 ~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl 132 (324)
T 3mtl_A 67 DII-------HTEKSLTLVFEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLL 132 (324)
T ss_dssp EEE-------ECSSCEEEEEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEE
T ss_pred eEE-------eeCCEEEEEecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEE
Confidence 664 45678999999995 69999987642 34889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..
T Consensus 133 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (324)
T 3mtl_A 133 INERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212 (324)
T ss_dssp ECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999986554322 2334578999999998765 5689999999999999999999999987654332211
Q ss_pred hhhhhhh------------HHhhhhhccccCCCC---cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLIK------------EEKLRQVCDSRVGLP---TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~~------------~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.. .... ............... .....+++++.+|+.+||+.||++|||++|+++|.....
T Consensus 213 i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 213 IF-RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HH-HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred HH-HHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 11 1000 000000000000000 011234578899999999999999999999999965543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=326.50 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=207.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. .++.+|+|.+...... .....+.+.+|+.+++.++|+| |+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------iv~~ 80 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQH-------VVGF 80 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-----CCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCC-------Eeee
Confidence 4689999999999999999998765 5577999998644221 1344677899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+.+..++||||+++++|.+++.... .+++.++..++.|++.||.|||++| ++||||||+||
T Consensus 81 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Ni 146 (294)
T 2rku_A 81 HGFF-------EDNDFVFVVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNL 146 (294)
T ss_dssp EEEE-------ECSSEEEEEEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred eeee-------ccCCEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhE
Confidence 7764 45678999999999999999987643 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+++.++.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 147 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 223 (294)
T 2rku_A 147 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--- 223 (294)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---
T ss_pred EEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 9999999999999999765432 223345799999999999888899999999999999999999999976542211
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...+.......+. .+++.+.+++.+||+.||++|||++++++|...
T Consensus 224 ----------~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 224 ----------YLRIKKNEYSIPK---HINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ----------HHHHHTTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ----------HHHHhhccCCCcc---ccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 1111222222232 234678999999999999999999999998544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=329.18 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=203.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| |++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~ 70 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL-----TGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHEN-------IVT 70 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECC----------HHHHHHHHHHHCCCTT-------BCC
T ss_pred hhccceeeeeccCCCCceEEEEEECC-----CCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCC-------eee
Confidence 46789999999999999999998764 56789999987542 223467889999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.| ++||||||+|
T Consensus 71 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~N 136 (304)
T 2jam_A 71 LEDIY-------ESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPEN 136 (304)
T ss_dssp EEEEE-------ECSSEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGG
T ss_pred hhhhc-------ccCCEEEEEEEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHH
Confidence 77653 45678999999999999999997643 2889999999999999999999999 9999999999
Q ss_pred eEE---cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILF---DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++ +.++.++|+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 137 Il~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 214 (304)
T 2jam_A 137 LLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK- 214 (304)
T ss_dssp CEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred EEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-
Confidence 999 77889999999998655432 2233468999999999999999999999999999999999999997654221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+. ..+....... ......++..+.+++.+||+.||++|||+.++++|...
T Consensus 215 ~~------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 215 LF------------EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp HH------------HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred HH------------HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 11 1111111111 11223456789999999999999999999999998554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.19 Aligned_cols=268 Identities=19% Similarity=0.286 Sum_probs=200.3
Q ss_pred hcCCccc-cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 14 TESFSQS-RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
.+.|++. +.||+|+||.||+|.+.. +++.||||.+.... ....+.+.+|+.++.++ +|+| |+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~-------i~ 74 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI-----TSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRN-------VL 74 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS-----SCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTT-------BC
T ss_pred ceeEEecCceecCCceEEEEEEEEcC-----CCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCC-------ee
Confidence 5689885 789999999999998654 56789999987542 34467889999999985 5777 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++| |+||||||+
T Consensus 75 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~ 140 (316)
T 2ac3_A 75 ELIEFF-------EEEDRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPE 140 (316)
T ss_dssp CEEEEE-------EETTEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred eEEEEE-------eeCCEEEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHH
Confidence 777764 45678999999999999999998643 3889999999999999999999999 999999999
Q ss_pred ceEEcCCCC---eEEeccccCccCCCCC--------cccccCccccccCCCCCCC-----CCCCCcCCeehhHHHHHHHH
Q 035572 172 NILFDSKWD---AKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNP-----SKLSKKVDVFSYGVVLLEII 235 (379)
Q Consensus 172 NIll~~~~~---~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell 235 (379)
|||++.++. +||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999997766 9999999986543211 1223459999999998764 45789999999999999999
Q ss_pred hCCCCCCCCCCchhH--HHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 236 SCRKPIDAARDPASI--IDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 236 tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+|+.||.+....... ...............+.......+. ....++..+.+|+.+||+.||++|||+.|+++|...
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 999999765432100 0000000011112222222333232 123456789999999999999999999999998554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=341.23 Aligned_cols=273 Identities=22% Similarity=0.294 Sum_probs=191.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+++.+|+.+++.++|+| |+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpn-------Iv~~ 93 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHEN-------VIGL 93 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT-----TTEEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC-----CCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 5799999999999999999998764 5678999998754322 344678899999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+... .........|+|||++ +++|.+++.. ..+++..+..++.|++.||.|||+.| |+||||||+||
T Consensus 94 ~~~~~~~-~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NI 163 (367)
T 2fst_X 94 LDVFTPA-RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNL 163 (367)
T ss_dssp SEEECSC-SSGGGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred EEEEecC-CccccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhE
Confidence 7765431 1233456789999999 8999998864 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 164 ll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~ 241 (367)
T 2fst_X 164 AVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241 (367)
T ss_dssp EECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999999765432 234579999999998776 6789999999999999999999999987654333222
Q ss_pred hhhhh----------hhHHhhhhhcc---ccC--CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 253 WALPL----------IKEEKLRQVCD---SRV--GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~----------~~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
..... +.......... ... .........++.+.+||.+||+.||++|||+.|+++|....
T Consensus 242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 11100 00000111111 100 00111223457899999999999999999999999996554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.54 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=190.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.++...++.++|+| +++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~-------iv~ 70 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP-----SGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPF-------TVT 70 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEC---CH--HHHHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC-----CCeEEEEEEeecccCc--HHHHHHHHHHHHHHHhCCCCe-------EEE
Confidence 35789999999999999999998764 5688999998754322 233444555566678888877 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~ 171 (379)
+++.+ .+.+..++||||++ ++|.+++..... ....+++..++.++.|++.||.|||++ | ++||||||+
T Consensus 71 ~~~~~-------~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~ 139 (290)
T 3fme_A 71 FYGAL-------FREGDVWICMELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPS 139 (290)
T ss_dssp EEEEE-------ECSSSEEEEEECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGG
T ss_pred Eeeee-------eccCCEEEEEehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHH
Confidence 77764 45678999999995 699888876433 233489999999999999999999998 9 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC----CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT----NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||+++.++.+||+|||++.............||+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (290)
T 3fme_A 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219 (290)
T ss_dssp GCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH
T ss_pred HEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch
Confidence 999999999999999999776555444555799999999985 5667899999999999999999999999764433
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...... ....... ......+++++.+++.+||+.||++|||+.|+++|..
T Consensus 220 ~~~~~~------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 220 FQQLKQ------------VVEEPSP-QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp HHHHHH------------HHHSCCC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHH------------HhccCCC-CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 221111 1111110 1112234578999999999999999999999999843
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=334.04 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=209.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+........++.||+|.+..... ....+.+.+|+.+++.++|+| |++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~-------iv~ 90 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS---PSELRDLLSEFNVLKQVNHPH-------VIK 90 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCc-------eee
Confidence 3578999999999999999999986655555778999999975432 344678999999999999888 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-------------------CCCCCChHhHHHHHHHHHHHH
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-------------------TTPQLGWPNRVKIAMQISRAI 153 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l 153 (379)
+++.+ .+.+..++||||+++++|.+++...... ....+++.+++.++.|++.||
T Consensus 91 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 163 (314)
T 2ivs_A 91 LYGAC-------SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGM 163 (314)
T ss_dssp EEEEE-------CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHH
T ss_pred EEEEE-------ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHH
Confidence 77764 4567899999999999999999875431 123378899999999999999
Q ss_pred HHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHH
Q 035572 154 QCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230 (379)
Q Consensus 154 ~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 230 (379)
.|||++| |+||||||+|||++.++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||++
T Consensus 164 ~~lH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 164 QYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241 (314)
T ss_dssp HHHHHTT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHH
T ss_pred HHHHHCC--CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHH
Confidence 9999999 99999999999999999999999999976543322 223357889999999888889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 231 LLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 231 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+|+|++ |..||.+..... +.... .. ... +.....+++.+.+++.+||+.||++|||+.+++++.
T Consensus 242 l~el~t~g~~p~~~~~~~~-~~~~~---------~~--~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPPER-LFNLL---------KT--GHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp HHHHHTTSCCSSTTCCGGG-HHHHH---------HT--TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHh---------hc--CCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999 999997654321 11111 00 001 111233457899999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=343.26 Aligned_cols=279 Identities=19% Similarity=0.237 Sum_probs=204.6
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
+....++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+|+.+++.++|+|
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~--------~~~~~E~~il~~l~hpn------- 61 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIE-----SGKRFALKKVLQDP--------RYKNRELDIMKVLDHVN------- 61 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETT-----TCCEEEEEEEECCT--------TSCCHHHHHHTTCCCTT-------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEecCc--------chHHHHHHHHHHcCCCC-------
Confidence 34567899999999999999999998765 56789999986432 12347999999999998
Q ss_pred eeeccccccccCCC-------------------------------ccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCC
Q 035572 90 VVNFHGTSCRNSGS-------------------------------VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138 (379)
Q Consensus 90 iv~~~~~~~~~~~~-------------------------------~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 138 (379)
|+++++++...... ..+....++||||++ ++|.+.+..... ....++
T Consensus 62 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~ 139 (383)
T 3eb0_A 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIP 139 (383)
T ss_dssp BCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCC
T ss_pred ccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCC
Confidence 77777765432110 034456889999996 698888876443 233489
Q ss_pred hHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-
Q 035572 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS- 216 (379)
Q Consensus 139 ~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~- 216 (379)
+..++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++.............+|+.|+|||++.+.
T Consensus 140 ~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 217 (383)
T 3eb0_A 140 MNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT 217 (383)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCC
Confidence 9999999999999999999999 99999999999997 6889999999999876555555566899999999987764
Q ss_pred CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhhhhh--hHHhhhhhcc-------ccCCCCc----chHHHHHH
Q 035572 217 KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI--KEEKLRQVCD-------SRVGLPT----FMEGAIKQ 283 (379)
Q Consensus 217 ~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-------~~~~~~~----~~~~~~~~ 283 (379)
.++.++|||||||++|+|++|+.||.+......+........ ....+..... ....... .....+++
T Consensus 218 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (383)
T 3eb0_A 218 EYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL 297 (383)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHH
T ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHH
Confidence 489999999999999999999999987655443333221100 0001111000 0000000 11224567
Q ss_pred HHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 284 MLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 284 ~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+.+|+.+||+.||++|||+.|+++|....
T Consensus 298 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 298 AIDLLEQILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSGGGH
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCHHHH
Confidence 99999999999999999999999995543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=324.49 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=197.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+.+|+.+++.++|+| |++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~-------i~~ 75 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQL-----TGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPH-------IIK 75 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred eeccEEEEeeecCCCCeEEEEEEECC-----CCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCC-------EeE
Confidence 35789999999999999999998764 567799999864321 12345678999999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++| ++|+||||+|
T Consensus 76 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~N 141 (276)
T 2h6d_A 76 LYQVI-------STPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPEN 141 (276)
T ss_dssp EEEEE-------ECSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGG
T ss_pred EEEEE-------ecCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhh
Confidence 77664 45678999999999999999997643 2889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|+++.++.++|+|||++.............+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ..
T Consensus 142 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~ 220 (276)
T 2h6d_A 142 VLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LF 220 (276)
T ss_dssp EEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred EEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HH
Confidence 9999999999999999977655444445579999999999887765 689999999999999999999997653211 11
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..+.......+. .++..+.+++.+||+.||++|||+.++++|..
T Consensus 221 ------------~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 221 ------------KKIRGGVFYIPE---YLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ------------HHHHHCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ------------HHhhcCcccCch---hcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 111111112222 23467899999999999999999999999843
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=335.69 Aligned_cols=274 Identities=21% Similarity=0.335 Sum_probs=215.1
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~ 83 (379)
++...+....++|++.+.||+|+||.||+|.+.......+++.||+|.+..... ....+.+.+|+.+++.+ +|+|
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~- 92 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLN- 92 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT-
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC---cHHHHHHHHHHHHHHhcccCCC-
Confidence 445566666789999999999999999999977655556889999999975432 33456789999999999 5677
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC-----------CCCCChHhHHHHHHHHHHH
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-----------TPQLGWPNRVKIAMQISRA 152 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~ 152 (379)
|+++++.+. ..+...++||||+++++|.+++....... ...+++..++.++.|++.|
T Consensus 93 ------iv~~~~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 160 (316)
T 2xir_A 93 ------VVNLLGACT------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160 (316)
T ss_dssp ------BCCEEEEEC------CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHH
T ss_pred ------eeeEEEEEe------cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHH
Confidence 888777653 23456899999999999999998643210 1227888999999999999
Q ss_pred HHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHH
Q 035572 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229 (379)
Q Consensus 153 l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 229 (379)
|.|||++| |+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+
T Consensus 161 l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 238 (316)
T 2xir_A 161 MEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238 (316)
T ss_dssp HHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHhCC--cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHH
Confidence 99999999 99999999999999999999999999976543322 22345788999999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 230 VLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 230 il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++|+|+| |..||.+............ . ......+ ...++.+.+++.+||+.||.+|||+.+++++
T Consensus 239 il~~l~t~g~~p~~~~~~~~~~~~~~~---------~--~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 239 LLWEIFSLGASPYPGVKIDEEFCRRLK---------E--GTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTTSCCSSTTCCCSHHHHHHHH---------H--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCcccchhHHHHHHhc---------c--CccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999998 9999987654333222111 0 0111112 2235789999999999999999999999987
Q ss_pred cc
Q 035572 309 CS 310 (379)
Q Consensus 309 ~~ 310 (379)
..
T Consensus 305 L~ 306 (316)
T 2xir_A 305 LG 306 (316)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=337.97 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=201.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++.+.||+|+||.||+|.+.. +++.||||++...... .....+.+.+|+.+++.++|+| |+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpn-------iv~~ 119 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPN-------TIQY 119 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheeeeeEEccCCCEEEEEEEEcc-----CCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 3569999999999999999998654 6678999998754322 1334577899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+. |+|.+.+.... ..+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 120 ~~~~-------~~~~~~~lv~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 185 (348)
T 1u5q_A 120 RGCY-------LREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 185 (348)
T ss_dssp EEEE-------EETTEEEEEEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGE
T ss_pred EEEE-------EECCeEEEEEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHE
Confidence 7764 34678999999995 78988886532 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|++.++.+||+|||++...... ....||+.|+|||++ ....++.++|||||||++|+|++|+.||........+
T Consensus 186 ll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 262 (348)
T 1u5q_A 186 LLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262 (348)
T ss_dssp EEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999999765432 334799999999976 3567899999999999999999999999765432221
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
... ...... ......++..+.+++.+||+.||++|||++++++|..
T Consensus 263 ~~~-------------~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 263 YHI-------------AQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHH-------------HHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHH-------------HhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 111 111100 1111233577899999999999999999999999843
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=338.20 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=195.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh--ccCCCCCceee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE--SNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~~~~~~~~iv 91 (379)
.++|++.+.||+|+||.||+|.+. .++.||+|++...... ....+.+.+|+.+++.++| +| |+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~-------iv 72 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDK-------II 72 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTT-------BC
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeeccccc--hHHHHHHHHHHHHHHhhhhcCCc-------eE
Confidence 467999999999999999999763 3567999998755332 3456789999999999987 44 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++++ .+.+..|+|||+. +++|.+++.... .+++.++..++.|++.||.|||++| |+||||||+
T Consensus 73 ~~~~~~-------~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~ 137 (343)
T 3dbq_A 73 RLYDYE-------ITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 137 (343)
T ss_dssp CEEEEE-------ECSSEEEEEECCC-SEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred EEeeeE-------eeCCEEEEEEeCC-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcc
Confidence 777664 4567899999955 899999998632 3889999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCC-----------CCCCCcCCeehhHHHHHHHHhC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNP-----------SKLSKKVDVFSYGVVLLEIISC 237 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg 237 (379)
|||++ ++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 138 NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 138 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp GEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred eEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 99997 57899999999976543322 234579999999998753 6788899999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhhHHhhhhhccc--cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDS--RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+.||....+.... +..+.+. ....+.. .+..+.+++.+||+.||.+|||+.|+++|....
T Consensus 217 ~~pf~~~~~~~~~------------~~~~~~~~~~~~~~~~---~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 217 KTPFQQIINQISK------------LHAIIDPNHEIEFPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp SCTTTTCCSHHHH------------HHHHHCTTSCCCCCCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCcchhhhhHHHH------------HHHHhcCCcccCCccc---CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 9999765432111 1111111 1112222 236789999999999999999999999996554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.01 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=201.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ...+.+.+|+.++++++|+| |+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~-------i~~~ 70 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPK-------LVQL 70 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred hhhceeeheecCCCccEEEEEEecC------CCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 4789999999999999999998753 4569999997543 23467999999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.| ++||||||+||
T Consensus 71 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Ni 137 (269)
T 4hcu_A 71 YGVC-------LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNC 137 (269)
T ss_dssp EEEE-------CSSSSEEEEEECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred EEEE-------ecCCceEEEEEeCCCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheE
Confidence 7664 4567899999999999999999753 234889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... .
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~ 216 (269)
T 4hcu_A 138 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-V 216 (269)
T ss_dssp EECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-H
T ss_pred EEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-H
Confidence 99999999999999997554322 1223357788999999988889999999999999999999 999997654221 1
Q ss_pred HHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. .+... ....+ ...+..+.+++.+||+.||++|||+.+++++..
T Consensus 217 ~~------------~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 217 VE------------DISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp HH------------HHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH------------HHhcCccCCCC---CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 11 11111 11112 223577999999999999999999999998743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.01 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=195.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh--ccCCCCCceeee
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE--SNKRNPNYCVVN 92 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~~~~~~~~iv~ 92 (379)
++|++.+.||+|+||.||+|.+. .++.||||.+...... ....+.+.+|+.+++.++| +| |++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~~~~~~-------iv~ 120 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDK-------IIR 120 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTT-------BCC
T ss_pred CceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEeccccc--HHHHHHHHHHHHHHHHcccCCCe-------EEE
Confidence 45999999999999999999754 3567999998765332 3456789999999999985 44 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ ...+..|+|||+ .+++|.+++.... .+++.++..++.||+.||.|||++| |+||||||+|
T Consensus 121 ~~~~~-------~~~~~~~lv~E~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~N 185 (390)
T 2zmd_A 121 LYDYE-------ITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPAN 185 (390)
T ss_dssp EEEEE-------ECSSEEEEEEEC-CSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGG
T ss_pred EEEEE-------ecCCEEEEEEec-CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHH
Confidence 77664 446779999995 5899999998643 3888899999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCC-----------CCCCCcCCeehhHHHHHHHHhCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNP-----------SKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~ 238 (379)
||++ ++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 186 Ill~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 186 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp EEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 9996 5789999999997654332 1234579999999998754 36888999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhcccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.||....+.... +..+.+.. ...+... +..+.+|+.+||+.||++|||+.|+++|....
T Consensus 265 ~Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 265 TPFQQIINQISK------------LHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp CTTTTCCCHHHH------------HHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CcchhhhHHHHH------------HHHHhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 999765432211 11222221 1122222 46789999999999999999999999996543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=322.31 Aligned_cols=251 Identities=21% Similarity=0.349 Sum_probs=202.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++|+| |+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~-------i~~~ 68 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG------QYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPK-------LVKF 68 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheeeeeeeccCCCceEEEEEecC------ceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 5789999999999999999997653 4559999987543 23467899999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.| ++||||||+||
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Ni 135 (268)
T 3sxs_A 69 YGVC-------SKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNC 135 (268)
T ss_dssp EEEE-------CSSSSEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGE
T ss_pred EEEE-------ccCCceEEEEEccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceE
Confidence 7664 456789999999999999999986532 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.........
T Consensus 136 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 215 (268)
T 3sxs_A 136 LVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215 (268)
T ss_dssp EECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred EECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH
Confidence 999999999999999976544332 223356778999999988889999999999999999999 99999765432211
Q ss_pred HHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. +... ....+ ...++.+.+++.+||+.||.+|||+.+++++...
T Consensus 216 ~~-------------~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 216 LK-------------VSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261 (268)
T ss_dssp HH-------------HHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred HH-------------HHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 1111 11112 2234679999999999999999999999987544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=338.07 Aligned_cols=268 Identities=26% Similarity=0.319 Sum_probs=201.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+.+++.++|+| |+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~ 89 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD-----TGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLRHEN-------LVNL 89 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT-----TCCEEEEEEEESCSSC--HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC-----CCceEEEEEEecCCCc--hHHHHHHHHHHHHHhhCCCCC-------EeeE
Confidence 5789999999999999999998765 5678999998654322 344567889999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+||
T Consensus 90 ~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Ni 155 (331)
T 4aaa_A 90 LEVC-------KKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENI 155 (331)
T ss_dssp EEEE-------EETTEEEEEEECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred EEEe-------ecCCEEEEEEecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheE
Confidence 7664 4567899999999998888887542 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++.++.+||+|||++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..+...+.
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 235 (331)
T 4aaa_A 156 LVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235 (331)
T ss_dssp EECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999999665432 223445799999999988765 68999999999999999999999998765443332
Q ss_pred Hhhhhh---h-------hH-HhhhhhccccCCC----CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPL---I-------KE-EKLRQVCDSRVGL----PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~---~-------~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...... . .. ............. ....+.++..+.+|+.+||+.||++|||+.|+++|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 211100 0 00 0000000000000 001123467899999999999999999999999983
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=339.60 Aligned_cols=276 Identities=20% Similarity=0.228 Sum_probs=204.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC-ceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN-YCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~-~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... ....+.+.+|+.+++.++|.+..+++ ..|++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ-----GKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC-----CCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 4789999999999999999998764 5688999998743 34467789999999999876543332 22666
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~ 171 (379)
+++.+... .......|+||||+ +++|.+.+.... ...+++..++.++.||+.||.|||++ | |+||||||+
T Consensus 106 ~~~~~~~~---~~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~ 176 (397)
T 1wak_A 106 LLDDFKIS---GVNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPE 176 (397)
T ss_dssp EEEEEEEE---ETTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGG
T ss_pred eecceeec---CCCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHH
Confidence 66554210 01456889999999 677777776532 23489999999999999999999998 9 999999999
Q ss_pred ceEEcCCC-------------------------------------------------CeEEeccccCccCCCCCcccccC
Q 035572 172 NILFDSKW-------------------------------------------------DAKLADFGLAVSESDESSMVQPA 202 (379)
Q Consensus 172 NIll~~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~ 202 (379)
|||++.++ .+||+|||++...... .....
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~ 254 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDI 254 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCC
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCC
Confidence 99999775 7999999999765432 23447
Q ss_pred ccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh-----HHHhhhhhhh---HH-----hhh-hhcc
Q 035572 203 GTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS-----IIDWALPLIK---EE-----KLR-QVCD 268 (379)
Q Consensus 203 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~---~~-----~~~-~~~~ 268 (379)
||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......... .. ... ....
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 99999999999988899999999999999999999999976543221 1111100000 00 000 0000
Q ss_pred cc--------C----------CCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 269 SR--------V----------GLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 269 ~~--------~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. . .........+..+.+||.+||+.||++|||+.|+++|..
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 00 0 000123556788999999999999999999999999843
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=333.04 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=207.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.+.. +++.+|+|.+...... .....+.+.+|+.+++.++|+| |+++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~-------iv~~ 106 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQH-------VVGF 106 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 4689999999999999999998765 5578999998643221 1344677899999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++ .+.+..|+||||+++++|.+++.... .+++.+++.++.|++.||.|||++| |+||||||+||
T Consensus 107 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 172 (335)
T 2owb_A 107 HGFF-------EDNDFVFVVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNL 172 (335)
T ss_dssp EEEE-------ECSSEEEEEECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred EEEE-------ecCCeEEEEEecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhE
Confidence 7764 45678999999999999999987643 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 173 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 250 (335)
T 2owb_A 173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-- 250 (335)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--
T ss_pred EEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--
Confidence 9999999999999999765432 2234457999999999998888999999999999999999999999765422111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
..+.......+. .++..+.+++.+||+.||++|||+.|+++|....
T Consensus 251 -----------~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 251 -----------LRIKKNEYSIPK---HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp -----------HHHHHTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred -----------HHHhcCCCCCCc---cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 111111222222 2346789999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=333.54 Aligned_cols=270 Identities=23% Similarity=0.389 Sum_probs=201.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+... ...+++.||+|++.... ....+.+.+|+.+++.++|+| |+++
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~-------iv~~ 76 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPL-QDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDN-------IVKY 76 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTT-CSSCCEEEEEEEESCCC----HHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred HHHhhhhheeeccCCEEEEEEEEecc-cCCCCcEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 47899999999999999999986432 22367899999987543 344578999999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. .+....++||||+++++|.+++..... .+++..+..++.|++.||.|||+.| |+||||||+||
T Consensus 77 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Ni 145 (295)
T 3ugc_A 77 KGVCYS-----AGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNI 145 (295)
T ss_dssp EEEECH-----HHHTSCEEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred EEEEec-----CCCCceEEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhE
Confidence 776532 233568999999999999999986432 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|+||..||..... .
T Consensus 146 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~ 223 (295)
T 3ugc_A 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--E 223 (295)
T ss_dssp EEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--H
T ss_pred EEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--H
Confidence 99999999999999997654332 12233577889999999888899999999999999999999999865321 1
Q ss_pred HHHhhhh----hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALP----LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....... ................ ......+++++.+++.+||+.||++|||+.|+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 224 FMRMIGNDKQGQMIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHCTTCCTHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhhhcCccccchhHHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 0000000 0000011111111111 112234457899999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=336.50 Aligned_cols=273 Identities=20% Similarity=0.295 Sum_probs=206.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++.++|+| |++
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------iv~ 89 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNL-----NKVRVAIKKISPFEH---QTYCQRTLREIKILLRFRHEN-------IIG 89 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCTTC---HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECC-----CCeEEEEEEeccccC---cHHHHHHHHHHHHHHhcCCCC-------Ccc
Confidence 45799999999999999999998764 567899999874321 344578899999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. .........|+||||++ ++|.+++... .+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 90 ~~~~~~~--~~~~~~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~N 158 (364)
T 3qyz_A 90 INDIIRA--PTIEQMKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSN 158 (364)
T ss_dssp CCEEECC--SSTTTCCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred ceeEEec--CCccccceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHh
Confidence 7776532 11234467899999995 6999999652 2899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||++.++.+||+|||++........ .....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+....
T Consensus 159 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred EEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 9999999999999999976543221 23457999999999754 455899999999999999999999999876544
Q ss_pred hhHHHhhhhhh--hH-----------HhhhhhccccCC--CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLI--KE-----------EKLRQVCDSRVG--LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~--~~-----------~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..+........ .. ............ .......+++++.+|+.+||+.||++|||+.|+++|...
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 43322211000 00 000000111110 011123345789999999999999999999999999554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=341.40 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=203.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+... ..+++.||||+++...........+.+.+|+.+++.++ |++ |+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-------iv~ 123 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF-------LVT 123 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTT-------BCC
T ss_pred ccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCc-------eeE
Confidence 36899999999999999999987542 23678899999875432222334566788999999995 666 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 124 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~N 189 (355)
T 1vzo_A 124 LHYAF-------QTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLEN 189 (355)
T ss_dssp EEEEE-------EETTEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGG
T ss_pred EEEEE-------eeCceEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHH
Confidence 66653 45678999999999999999998643 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 190 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 269 (355)
T 1vzo_A 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269 (355)
T ss_dssp EEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred EEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc
Confidence 999999999999999996543322 2233479999999998875 347889999999999999999999997654332
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
...... ..+.......+ ..++..+.+||.+||+.||++|| +++|+++|...
T Consensus 270 ~~~~~~---------~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 270 SQAEIS---------RRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CHHHHH---------HHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred hHHHHH---------HHHhccCCCCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 221111 11111111222 23457789999999999999999 99999998554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=327.79 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=194.7
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.... ..+..||+|....... ....+.+.+|+.+++.++|+| |++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------iv~ 80 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPH-------IVK 80 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTS---HHHHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCc-------cce
Confidence 4678999999999999999999986533 2567899999875422 345678999999999999988 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 81 ~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~N 146 (281)
T 1mp8_A 81 LIGVI--------TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 146 (281)
T ss_dssp EEEEE--------CSSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEEE--------ccCccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHH
Confidence 77764 2357899999999999999997532 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+......
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 147 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp EEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH
Confidence 9999999999999999976543322 223356789999999988889999999999999999997 9999987643321
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ... .. ..... ....+++.+.+++.+||+.||++|||+.+++++.
T Consensus 227 ~-~~i---------~~--~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 227 I-GRI---------EN--GERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp H-HHH---------HT--TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-HHH---------Hc--CCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 110 00 01111 1233457899999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.09 Aligned_cols=274 Identities=19% Similarity=0.284 Sum_probs=206.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. ..++.||+|.+... ....+.+.+|+.+++.++|++... +..+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~-~~~i~~ 81 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHK----AGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNS-TFRCVQ 81 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTC-TTCBCC
T ss_pred ccCceEEEEEEecCCCeEEEEEEecC----CCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCC-ceeeEe
Confidence 45799999999999999999998732 25678999998743 234577899999999999986332 112444
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 82 ~~~~-------~~~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~N 148 (339)
T 1z57_A 82 MLEW-------FEHHGHICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPEN 148 (339)
T ss_dssp EEEE-------EEETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred eecc-------cccCCcEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHH
Confidence 4444 45678999999999 899999998643 234889999999999999999999999 9999999999
Q ss_pred eEEcC-------------------CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHH
Q 035572 173 ILFDS-------------------KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233 (379)
Q Consensus 173 Ill~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 233 (379)
||++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 149 il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226 (339)
T ss_dssp EEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred EEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence 99987 668999999999765432 234479999999999998899999999999999999
Q ss_pred HHhCCCCCCCCCCchhHHHhh--hhhhhHHhhh--------------------------hhccccCCCCcchHHHHHHHH
Q 035572 234 IISCRKPIDAARDPASIIDWA--LPLIKEEKLR--------------------------QVCDSRVGLPTFMEGAIKQML 285 (379)
Q Consensus 234 lltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~ 285 (379)
|++|..||...+......... .......... ................++.+.
T Consensus 227 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 227 YYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 999999998765432211110 0000000000 000000000111234568899
Q ss_pred HHHHhcccCCCCCCCChHHHhccccC
Q 035572 286 HVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 286 ~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+|+.+||+.||.+|||+.|+++|...
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~hp~f 332 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALKHPFF 332 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSGGG
T ss_pred HHHHHHhCcCcccccCHHHHhcCHHH
Confidence 99999999999999999999998543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=342.19 Aligned_cols=266 Identities=12% Similarity=0.082 Sum_probs=189.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh--hccCCCCCceeee
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ--ESNKRNPNYCVVN 92 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~~~~~~~~iv~ 92 (379)
.+|++.+.||+|+||.||+|.+.. +++.||+|++...... .....+.+.+|+.+++.|+ |+| +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~-------iv~ 128 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE-----RLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPE-------EAR 128 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC--------------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC-----CCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChh-------hhh
Confidence 459999999999999999998765 5678999999875432 2345677889977777776 666 555
Q ss_pred ccccccccCCCccC-----------------CCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhH------HHHHHHH
Q 035572 93 FHGTSCRNSGSVDG-----------------NSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNR------VKIAMQI 149 (379)
Q Consensus 93 ~~~~~~~~~~~~~~-----------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~------~~~~~~i 149 (379)
++..+....+++.. ....|+||||++ ++|.+++...+.. +++..+ ..++.|+
T Consensus 129 ~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi 203 (371)
T 3q60_A 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQL 203 (371)
T ss_dssp ---CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHH
T ss_pred hceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHH
Confidence 44332200011110 144899999997 8999999875432 344455 6777999
Q ss_pred HHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC--CCCCCcCCeehh
Q 035572 150 SRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP--SKLSKKVDVFSY 227 (379)
Q Consensus 150 ~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSl 227 (379)
+.||+|||++| |+||||||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||
T Consensus 204 ~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 204 IRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHHHHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHHHHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 99999999999 9999999999999999999999999997654322 13467799999999987 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 228 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
||++|+|++|+.||......... . ................+ ....+++.+.+|+.+||+.||++|||+.++++
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKG-S-----WKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTT-C-----CCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCCcCccccc-c-----hhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999999999876422100 0 00000000011111111 11244678999999999999999999999999
Q ss_pred cc
Q 035572 308 GC 309 (379)
Q Consensus 308 ~~ 309 (379)
|.
T Consensus 353 hp 354 (371)
T 3q60_A 353 TP 354 (371)
T ss_dssp SH
T ss_pred CH
Confidence 84
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.65 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=190.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+. ++.+|+|.+............+.+.+|+.+++.++|+| |+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-------i~~~ 71 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN-------IIAL 71 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCC-------EeeE
Confidence 468999999999999999999863 46699999876544433455678999999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC-eEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM-IIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-i~H~dlkp~N 172 (379)
++.+ .+.+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|.. ++||||||+|
T Consensus 72 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N 138 (271)
T 3dtc_A 72 RGVC-------LKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138 (271)
T ss_dssp EEEE-------CCC--CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred EEEE-------ecCCceEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence 7764 456789999999999999999853 2389999999999999999999998833 7899999999
Q ss_pred eEEcC--------CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 173 ILFDS--------KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 173 Ill~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
||++. ++.++|+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 139 ILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp EEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred EEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99985 67899999999976543322 2447999999999998888999999999999999999999999875
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
........ ....... ......+++.+.+++.+||+.||.+|||+.|++++.
T Consensus 218 ~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 218 DGLAVAYG-------------VAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CHHHHHHH-------------HHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHh-------------hhcCCCC-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 43221111 1111111 111233457899999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=324.88 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=208.7
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc-----hhhhhcHHHHHHHHHHHHhhh-hccCCC
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF-----EVLQDNSKKLNNEIRVLSSLQ-ESNKRN 85 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~-~~~~~~ 85 (379)
...++|++.+.||+|+||.||+|.+.. +++.||+|.+..... .......+.+.+|+.+++++. |+|
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~--- 85 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN--- 85 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT---
T ss_pred chhhccceeeeecCCCceEEEEEEEcC-----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC---
Confidence 446899999999999999999998765 567899999875431 111234567899999999996 877
Q ss_pred CCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEe
Q 035572 86 PNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIH 165 (379)
Q Consensus 86 ~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H 165 (379)
|+++++.+ ...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++| ++|
T Consensus 86 ----i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H 147 (298)
T 1phk_A 86 ----IIQLKDTY-------ETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN--IVH 147 (298)
T ss_dssp ----BCCEEEEE-------ECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ----Eeeeeeee-------ccCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 77777664 55678999999999999999998643 3889999999999999999999999 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC------CCCCCCcCCeehhHHHHHHHHhCCC
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN------PSKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~ 239 (379)
|||||+||+++.++.++|+|||++.............+|+.|+|||++. ...++.++||||||+++|+|++|+.
T Consensus 148 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence 9999999999999999999999997765555555567999999999763 4568899999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
||......... ..+....... ......++..+.+++.+||+.||++|||+.++++|...
T Consensus 228 p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 228 PFWHRKQMLML-------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp SSCCSSHHHHH-------------HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred CCcCccHHHHH-------------HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 99765421111 1111111111 11234456789999999999999999999999998544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=336.11 Aligned_cols=275 Identities=21% Similarity=0.343 Sum_probs=216.0
Q ss_pred CCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
+.|..+++....++|++.+.||+|+||.||+|.+........++.||+|.+..... ......+.+|+.+++.++|+|
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTT
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCC
Confidence 34566677778899999999999999999999876433344678899999975432 234567899999999999888
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----CCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----TTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
|+++++.+ .+.+..++||||+++++|.+++...... ....+++..++.++.|++.||.|||
T Consensus 90 -------i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 155 (322)
T 1p4o_A 90 -------VVRLLGVV-------SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 155 (322)
T ss_dssp -------BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred -------EeeeEEEE-------ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 77777764 4567889999999999999999864321 1233788999999999999999999
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHH
Q 035572 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 234 (379)
++| |+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|
T Consensus 156 ~~~--i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 233 (322)
T 1p4o_A 156 ANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233 (322)
T ss_dssp HTT--CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HCC--CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 999 99999999999999999999999999865433221 2233578899999998888899999999999999999
Q ss_pred Hh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 235 IS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 235 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
++ |..||....... ... .+..... +.....++..+.+++.+||+.||.+|||+.+++++...
T Consensus 234 ~~~g~~p~~~~~~~~-~~~------------~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 234 ATLAEQPYQGLSNEQ-VLR------------FVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp HHTSCCTTTTSCHHH-HHH------------HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HhcCCCccccCCHHH-HHH------------HHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 99 899997654221 111 1111111 11122345789999999999999999999999998544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=324.86 Aligned_cols=254 Identities=18% Similarity=0.309 Sum_probs=202.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+. ++.||+|.+...... ....+.+.+|+.++++++|+| |+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~ 72 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDWS--TRKSRDFNEECPRLRIFSHPN-------VLPV 72 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTCC--HHHHHHHHHHGGGGCCCSCTT-------EECE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCc-------hhhe
Confidence 578999999999999999999863 466999998865433 344577999999999999988 8988
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|.+++||||||+||
T Consensus 73 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Ni 144 (271)
T 3kmu_A 73 LGACQS-----PPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSV 144 (271)
T ss_dssp EEEECT-----TTSSSCEEEEECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGE
T ss_pred EEEEcc-----CCCCCeEeeecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceE
Confidence 887532 22378899999999999999998632 2248999999999999999999999887799999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCC---cCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSK---KVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++..... ....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||.........
T Consensus 145 l~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 220 (271)
T 3kmu_A 145 MIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG 220 (271)
T ss_dssp EECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH
T ss_pred EEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH
Confidence 999999999999988755332 2346899999999887665554 799999999999999999999865432211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... ... ... +.....+++.+.+++.+||+.||++|||++++++..
T Consensus 221 ~~~---------~~~--~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 221 MKV---------ALE--GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp HHH---------HHS--CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHH---------Hhc--CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111 000 111 112233457899999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.86 Aligned_cols=277 Identities=20% Similarity=0.247 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+.+++.++|+| |+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~ 81 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENEK--EGFPITALREIKILQLLKHEN-------VVNL 81 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT-----TCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred ccceeEEEEEecCCCcEEEEEEECC-----CCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCC-------cccH
Confidence 4789999999999999999998764 5678999998765432 344567889999999999988 7777
Q ss_pred cccccccCCC-ccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGS-VDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.+...... ....+..|+||||++ ++|.+.+... ...+++.+++.++.|++.||+|||++| |+||||||+|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~N 154 (351)
T 3mi9_A 82 IEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAAN 154 (351)
T ss_dssp EEEEEEC--------CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred hheeeccccccccCCceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHH
Confidence 7765432211 122567899999995 5888888653 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC-----CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE-----SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 155 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 155 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999654321 22334578999999998765 4579999999999999999999999987653
Q ss_pred chhHHHhhhh--hhhHHhhhhh--------ccccCCC-CcchHH-----HHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 247 PASIIDWALP--LIKEEKLRQV--------CDSRVGL-PTFMEG-----AIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 247 ~~~~~~~~~~--~~~~~~~~~~--------~~~~~~~-~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.......... ......+... ....... ...... .++.+.+|+.+||+.||++|||++|+++|..
T Consensus 235 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 3222111100 0000000000 0000000 000011 1466899999999999999999999999955
Q ss_pred C
Q 035572 311 C 311 (379)
Q Consensus 311 ~ 311 (379)
.
T Consensus 315 f 315 (351)
T 3mi9_A 315 F 315 (351)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=325.43 Aligned_cols=262 Identities=19% Similarity=0.280 Sum_probs=201.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
+..++|++.+.||+|+||.||+|.+.. +++.||+|.+............+.+.+|+.+++.++|+| |+
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-------i~ 69 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSE-----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN-------VI 69 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTT-----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTT-------BC
T ss_pred ccccceeEeeEEecCCCeEEEEEEECC-----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCC-------ee
Confidence 356899999999999999999998654 567899999875433222345678999999999999988 78
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+.. .+.+..++||||++++ |.+++... ....+++..+..++.|++.||.|||++| ++||||||+
T Consensus 70 ~~~~~~~~-----~~~~~~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~ 138 (305)
T 2wtk_C 70 QLVDVLYN-----EEKQKMYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPG 138 (305)
T ss_dssp CEEEEEEC-----C---CEEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred EEEEEEEc-----CCCCeEEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcc
Confidence 77776532 3456889999999655 88887753 2345899999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCC---CcccccCccccccCCCCCCCCC--CCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDE---SSMVQPAGTIGYLDPGYTNPSK--LSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|||++.++.++|+|||++...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 139 NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218 (305)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence 999999999999999999665322 2233456999999999887644 37799999999999999999999976532
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.. . ...+.......+. .+++.+.+++.+||+.||.+|||+.|+++|....
T Consensus 219 ~~-~------------~~~i~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 268 (305)
T 2wtk_C 219 YK-L------------FENIGKGSYAIPG---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268 (305)
T ss_dssp HH-H------------HHHHHHCCCCCCS---SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred HH-H------------HHHHhcCCCCCCC---ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 11 1 1111111222222 2347789999999999999999999999985543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=332.31 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=202.4
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch----hhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE----VLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.+.++|++.+.||+|+||.||+|.+.. +++.||||.+...... ........+.+|+.+++.++|+|
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~----- 76 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC----- 76 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTT-----
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcC-----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCC-----
Confidence 456789999999999999999998765 5678999998754321 11223456889999999999988
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++.+. .+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+|||
T Consensus 77 --i~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~d 139 (322)
T 2ycf_A 77 --IIKIKNFFD--------AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRD 139 (322)
T ss_dssp --BCCEEEEEE--------SSSEEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred --CceEeeEEc--------CCceEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccC
Confidence 777776642 23489999999999999998642 34899999999999999999999999 99999
Q ss_pred CCCCceEEcCCCC---eEEeccccCccCCCCCcccccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 168 IKSTNILFDSKWD---AKLADFGLAVSESDESSMVQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 168 lkp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|||+|||++.++. +||+|||++.............||+.|+|||++ ....++.++|||||||++|+|++|..||
T Consensus 140 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp CSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999987654 999999999776544333445689999999985 4567899999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCC-CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVG-LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
........+..... ..... .+.....++..+.+++.+||+.||++|||+.++++|....
T Consensus 220 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 220 SEHRTQVSLKDQIT------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp CSTTCSSCHHHHHH------------HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred cccchHHHHHHHHH------------hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 87654433222111 01111 1222334567899999999999999999999999986543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=336.06 Aligned_cols=266 Identities=21% Similarity=0.331 Sum_probs=211.1
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCce
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYC 89 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~ 89 (379)
....++|++.+.||+|+||.||+|.+...+.....+.||+|.+..... ....+.+.+|+.+++.+ +|+|
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~------- 111 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH---ADEKEALMSELKIMSHLGQHEN------- 111 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT-------
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC---hHHHHHHHHHHHHHHhhcCCCC-------
Confidence 334578999999999999999999998777666778999999875432 34467899999999999 7888
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC---------CCCCCChHhHHHHHHHHHHHHHHHHcCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---------TTPQLGWPNRVKIAMQISRAIQCLHEND 160 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 160 (379)
|+++++.+ .+.+..++||||+++|+|.+++...... ....+++..+..++.|++.||.|||++|
T Consensus 112 iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 184 (333)
T 2i1m_A 112 IVNLLGAC-------THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184 (333)
T ss_dssp BCCEEEEE-------CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeeEEEEE-------ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 88777764 4567899999999999999999865421 1234789999999999999999999999
Q ss_pred CCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-
Q 035572 161 PMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS- 236 (379)
Q Consensus 161 ~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt- 236 (379)
|+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|+|
T Consensus 185 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 185 --CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp --EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999965433222 223357889999999888889999999999999999998
Q ss_pred CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|..||.+............ ... ....+ ...+..+.+++.+||+.||.+|||+.+++++.
T Consensus 263 g~~p~~~~~~~~~~~~~~~---------~~~--~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 263 GLNPYPGILVNSKFYKLVK---------DGY--QMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp SCCSSTTCCSSHHHHHHHH---------HTC--CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCcccchhHHHHHHHh---------cCC--CCCCC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 9999987654332221110 000 11111 12347799999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.63 Aligned_cols=273 Identities=24% Similarity=0.342 Sum_probs=209.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.++||+|+||.||+|.+.. +++.||||++..... ....+.+.+|+++++.++|+| |+++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpn-------Iv~~ 72 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKN-------IVKL 72 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC-----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCC-------CCeE
Confidence 4689999999999999999998765 567899999874322 344677889999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ......++||||+++++|.+++...... ..+++..++.++.|++.||+|||++| |+||||||+||
T Consensus 73 ~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 143 (396)
T 4eut_A 73 FAIEEE-----TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNI 143 (396)
T ss_dssp EEEEEC-----TTTCCEEEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred EEeecc-----CCCCeeEEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHE
Confidence 776432 2344789999999999999999865432 23899999999999999999999999 99999999999
Q ss_pred EE----cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC--------CCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 174 LF----DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP--------SKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 174 ll----~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|+ +.++.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 144 ll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf 223 (396)
T 4eut_A 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (396)
T ss_dssp EEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred EEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99 7777899999999977665555555679999999998754 45778999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHh---hhh----------hccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 242 DAARDPASIIDWALPLIKEEK---LRQ----------VCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..................... ... ..............++..+.+++.+||+.||++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 765443322221111111000 000 0000011112336778899999999999999999999999776
Q ss_pred cc
Q 035572 309 CS 310 (379)
Q Consensus 309 ~~ 310 (379)
..
T Consensus 304 l~ 305 (396)
T 4eut_A 304 TS 305 (396)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=336.70 Aligned_cols=272 Identities=19% Similarity=0.238 Sum_probs=195.3
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
....++|++.+.||+|+||.||+|.+.. +++.||+|+++..... ....+.+.+|+.+++.++|+| |
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------i 95 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTV-----TNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRN-------I 95 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECCCCC----------CHHHHHHGGGCCCTT-------B
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECC-----CCceEEEEEEcccccc--cccchhHHHHHHHHHHcCCCC-------c
Confidence 3456799999999999999999998765 5678999999765432 344567789999999999988 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+ .+.+..++||||++ ++|.+++.... .+++..++.++.|++.||.|||++| |+||||||
T Consensus 96 v~~~~~~-------~~~~~~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp 160 (329)
T 3gbz_A 96 IELKSVI-------HHNHRLHLIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKP 160 (329)
T ss_dssp CCEEEEE-------EETTEEEEEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred ceEEEEE-------ecCCEEEEEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCH
Confidence 7777664 45678999999996 69999997643 3889999999999999999999999 99999999
Q ss_pred CceEEc-----CCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCC
Q 035572 171 TNILFD-----SKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDA 243 (379)
Q Consensus 171 ~NIll~-----~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~ 243 (379)
+|||++ .++.+||+|||++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 999994 4455999999999654322 223444689999999988764 489999999999999999999999987
Q ss_pred CCCchhHHHhhhhhh--hHHh---hhhhccccCCCCc---------chHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 244 ARDPASIIDWALPLI--KEEK---LRQVCDSRVGLPT---------FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
......+........ .... ...........+. ....++.++.+|+.+||+.||++|||++|+++|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 654333222111000 0000 0000000000000 0111457889999999999999999999999985
Q ss_pred cC
Q 035572 310 SC 311 (379)
Q Consensus 310 ~~ 311 (379)
..
T Consensus 321 ~f 322 (329)
T 3gbz_A 321 YF 322 (329)
T ss_dssp GG
T ss_pred cc
Confidence 44
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=331.66 Aligned_cols=286 Identities=21% Similarity=0.199 Sum_probs=200.8
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
-+......++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+..+++..++.++|+|
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~n---- 80 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKS-----TGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPN---- 80 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETT-----TCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTT----
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCC----
Confidence 35566778999999999999999999998765 56789999886432 23445678888889999988
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH--cCCCCeE
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH--ENDPMII 164 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~~i~ 164 (379)
|+++++++.............++||||++ ++|.+.+..... ....+++..+..++.|++.||.||| ++| |+
T Consensus 81 ---iv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--iv 153 (360)
T 3e3p_A 81 ---IVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VC 153 (360)
T ss_dssp ---BCCEEEEEEEECSSCTTCEEEEEEEECCS-CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CB
T ss_pred ---cccHHHhhhccccccccceeEEEEeeccc-ccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC--ee
Confidence 88888776543322233344889999996 566666554322 3334888999999999999999999 889 99
Q ss_pred ecCCCCCceEEcC-CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 165 HRDIKSTNILFDS-KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 165 H~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
||||||+|||++. ++.+||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 9999999999996 899999999999877665555566799999999987654 48999999999999999999999998
Q ss_pred CCCCchhHHHhhhhh--hhHHhhhhhccccC----------C----CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 243 AARDPASIIDWALPL--IKEEKLRQVCDSRV----------G----LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
+.+....+....... .....+........ . .+......++++.+|+.+||+.||.+|||+.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 765433332221100 00011111100000 0 0001112467899999999999999999999999
Q ss_pred ccccCcc
Q 035572 307 MGCSCFF 313 (379)
Q Consensus 307 ~~~~~~~ 313 (379)
+|.....
T Consensus 314 ~hp~f~~ 320 (360)
T 3e3p_A 314 CHPYFDE 320 (360)
T ss_dssp TSGGGGG
T ss_pred cCccccc
Confidence 9954433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.31 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=204.7
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++|+| |++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~ 69 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHEN-------VVK 69 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred eecceEEEEEeecCCCcEEEEEEECC-----CCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCC-------cee
Confidence 46789999999999999999998764 557799999864322 234578899999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 70 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~N 135 (276)
T 2yex_A 70 FYGHR-------REGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPEN 135 (276)
T ss_dssp EEEEE-------EETTEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred eeeEE-------EcCCEEEEEEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHH
Confidence 77664 4467889999999999999988643 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|+++.++.++|+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.......
T Consensus 136 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred EEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999999986543221 2334578999999999887665 778999999999999999999998765432
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...... ...... ......++..+.+++.+||+.||++|||+.|+++|..
T Consensus 216 ~~~~~~------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 216 QEYSDW------------KEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp HHHHHH------------HTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHh------------hhcccc-cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 211110 011111 1112344678999999999999999999999999844
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=336.60 Aligned_cols=279 Identities=22% Similarity=0.228 Sum_probs=205.5
Q ss_pred CHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc-CC
Q 035572 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN-KR 84 (379)
Q Consensus 6 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-~~ 84 (379)
.+.......++|++.+.||+|+||.||+|.+.. +++.||||+++.. ......+.+|+.+++.+++++ ..
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~ 114 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV-----EQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEM 114 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGG
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcC-----CCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhccccc
Confidence 334445567899999999999999999998764 5678999998743 234567889999999997543 21
Q ss_pred CCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc--CCCC
Q 035572 85 NPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE--NDPM 162 (379)
Q Consensus 85 ~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~~ 162 (379)
++. ++.+.+. +...+..|+||||+ +++|.+++.... ...+++..++.++.|++.||.|||+ .|
T Consensus 115 ~~~--iv~~~~~-------~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~-- 179 (382)
T 2vx3_A 115 KYY--IVHLKRH-------FMFRNHLCLVFEML-SYNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELS-- 179 (382)
T ss_dssp GGG--BCCEEEE-------EEETTEEEEEEECC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTC--
T ss_pred cee--EEEeeee-------eccCCceEEEEecC-CCCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCC--
Confidence 111 4444443 45568899999999 569999998643 2348999999999999999999995 57
Q ss_pred eEecCCCCCceEEc--CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 163 IIHRDIKSTNILFD--SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 163 i~H~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
|+||||||+|||++ .++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|+||+.|
T Consensus 180 ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999995 4788999999999766432 2345799999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHhhhhh--hhHHhh----------hhhccc------------cC------------------------C
Q 035572 241 IDAARDPASIIDWALPL--IKEEKL----------RQVCDS------------RV------------------------G 272 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~--~~~~~~----------~~~~~~------------~~------------------------~ 272 (379)
|.+.+....+....... ...... ..+.+. .. +
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 98765433322211100 000000 000000 00 0
Q ss_pred CCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 273 LPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.........+++.+||.+||+.||++|||+.|+|+|...
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccc
Confidence 000112234689999999999999999999999998543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.51 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=206.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.|++|.+...... ....+.+.+|+.+++.++|+| |+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~~ 70 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPN-------IVRY 70 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheeeehhccCCCCcEEEEEEECC-----CCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhcCCCC-------CCeE
Confidence 5789999999999999999998764 5678999998765432 345678999999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC---CCeEecCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND---PMIIHRDIKS 170 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~~i~H~dlkp 170 (379)
++.+.. ......++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.| .+++||||||
T Consensus 71 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p 144 (279)
T 2w5a_A 71 YDRIID-----RTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 144 (279)
T ss_dssp EEEEEE-----GGGTEEEEEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSG
T ss_pred EEEEec-----CCCceEEEEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccch
Confidence 776532 3356789999999999999999875542 334899999999999999999999876 3399999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCc-ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESS-MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+||+++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .
T Consensus 145 ~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~ 223 (279)
T 2w5a_A 145 ANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-E 223 (279)
T ss_dssp GGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred hhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-H
Confidence 999999999999999999866543322 22346899999999998888999999999999999999999999765421 1
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
+... +..... +.....++.++.+++.+||+.||++|||+.|+++|.....
T Consensus 224 ~~~~------------i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 224 LAGK------------IREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHHH------------HHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred HHHH------------Hhhccc--ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1111 111111 1111234578999999999999999999999999865443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=338.75 Aligned_cols=276 Identities=15% Similarity=0.230 Sum_probs=200.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh-------hhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL-------QDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
.++|++.+.||+|+||.||+|.+..++....++.||+|.+........ ......+..|+..++.++|+|
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~---- 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG---- 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC----
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC----
Confidence 458999999999999999999998766555678899999865421100 000112223333444445555
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++.+... .......|+||||+ |++|.+++... ...+++..++.++.|++.||+|||++| |+||
T Consensus 110 ---iv~~~~~~~~~---~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHr 176 (364)
T 3op5_A 110 ---VPKYWGSGLHD---KNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHE--YVHG 176 (364)
T ss_dssp ---SCCEEEEEEEE---ETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred ---CCeEEeeeeec---cCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEe
Confidence 77777765431 11235689999999 99999999863 234899999999999999999999999 9999
Q ss_pred CCCCCceEEc--CCCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 167 DIKSTNILFD--SKWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 167 dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
||||+|||++ .++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus 177 Dlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 256 (364)
T 3op5_A 177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256 (364)
T ss_dssp CCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999 889999999999965433221 123359999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|+.||.+............... ......+.+..... ..++.++.+++..||+.||.+||++.++++....
T Consensus 257 g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 257 GHLPWEDNLKDPKYVRDSKIRY-RENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp SCCTTGGGTTCHHHHHHHHHHH-HHCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCCCccccccCHHHHHHHHHHh-hhhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 9999986544433322221111 11122222211110 1224789999999999999999999999876443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=326.37 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=193.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. .+|+|.+...... ....+.+.+|+.+++.++|+| ++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~ 84 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVN-------ILL 84 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCC--HHHHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCc-------EEE
Confidence 35789999999999999999997532 3899998755432 445678999999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++++. .....++||||+++++|.+++... ...+++..+..++.|++.||.|||+.| |+||||||+|
T Consensus 85 ~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~N 150 (289)
T 3og7_A 85 FMGYS--------TAPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNN 150 (289)
T ss_dssp EEEEE--------CSSSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred EEeec--------cCCccEEEEEecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccce
Confidence 66642 346789999999999999999643 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC---CcccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE---SSMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||++.++.++|+|||++...... .......||+.|+|||++. +..++.++||||||+++|+|++|+.||....+
T Consensus 151 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp EEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred EEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 99999999999999998654321 2223446999999999876 56788899999999999999999999987665
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...+...... ... ..........+++.+.+++.+||+.||++|||+.++++..
T Consensus 231 ~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 231 RDQIIEMVGR--------GSL--SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp HHHHHHHHHH--------TSC--CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhcc--------ccc--CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 4433222111 000 1111122234567899999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=341.90 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=202.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||||.++.... ....+.+.+|+.+++.++|+| |++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpn-------iv~ 176 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRA-----DNTLVAVKSCRETLP---PDLKAKFLQEARILKQYSHPN-------IVR 176 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEECCTTSC---HHHHTTTTHHHHHHTTCCCTT-------BCC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEec-----CCeEEEEEEccccCC---HHHHHHHHHHHHHHHhCCCCC-------EEE
Confidence 45789999999999999999998764 457799999874421 234557889999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+.+..|+||||+++|+|.+++...+. .+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 177 ~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~N 243 (377)
T 3cbl_A 177 LIGVC-------TQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARN 243 (377)
T ss_dssp EEEEE-------CSSSSCEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred EEEEE-------ecCCCcEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHH
Confidence 88764 446788999999999999999986432 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcc---cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSM---VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
||++.++.+||+|||++......... ....+++.|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 244 il~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~ 323 (377)
T 3cbl_A 244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323 (377)
T ss_dssp EEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH
T ss_pred EEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999754332211 12235778999999988889999999999999999998 999997754321
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... ... ......| ..++..+.+++.+||+.||++|||+.++++..
T Consensus 324 -~~~~---------~~~--~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 324 -TREF---------VEK--GGRLPCP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp -HHHH---------HHT--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHH---------HHc--CCCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 1110 000 1112222 23457899999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.20 Aligned_cols=256 Identities=17% Similarity=0.206 Sum_probs=198.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||.+.... ..+.+.+|+.+++.+ +|++ |+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~h~~-------i~~ 69 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY-----TNEYVAIKLEPMKS------RAPQLHLEYRFYKQLGSGDG-------IPQ 69 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT-----TTEEEEEEEEETTC------SSCCHHHHHHHHHHHCSCTT-------SCC
T ss_pred cCCeEEEEEeeccCCceEEEEEECC-----CCcEEEEEEecccc------chHHHHHHHHHHHHhhCCCC-------CCE
Confidence 5789999999999999999998654 56889999986432 234588999999999 7777 666
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ ...+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.| |+||||||+|
T Consensus 70 ~~~~~-------~~~~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~N 135 (330)
T 2izr_A 70 VYYFG-------PCGKYNAMVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPEN 135 (330)
T ss_dssp EEEEE-------EETTEEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEEE-------ecCCccEEEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHH
Confidence 66553 4467889999999 99999999863 234999999999999999999999999 9999999999
Q ss_pred eEEcCCCC-----eEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCC
Q 035572 173 ILFDSKWD-----AKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 173 Ill~~~~~-----~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 239 (379)
||++.++. +||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 136 ill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 215 (330)
T 2izr_A 136 FLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSL 215 (330)
T ss_dssp EEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCC
Confidence 99998887 99999999976433221 234579999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
||.+...... ....... ....... .........+ ++.+++.+||+.||.+||+++++++...
T Consensus 216 Pf~~~~~~~~-~~~~~~i-~~~~~~~------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 216 PWQGLKADTL-KERYQKI-GDTKRAT------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp TTTTCCCSSH-HHHHHHH-HHHHHHS------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CccccccccH-HHHHHHH-HhhhccC------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 9987643221 1111100 0000000 0000111123 8999999999999999999999987544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.47 Aligned_cols=258 Identities=22% Similarity=0.384 Sum_probs=198.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+...+... ...|++|.+.... .....+.+.+|+.++++++|+| |+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~-------iv~~ 82 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREAT---SPKANKEILDEAYVMASVDNPH-------VCRL 82 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----C-CEEEEEEEC----------CHHHHHHHHHHHHHCCBTT-------BCCE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceE-EEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCC-------EeEE
Confidence 368999999999999999999987644332 3347899886432 2345678999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++.. +..++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 83 ~~~~~~--------~~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NI 148 (327)
T 3poz_A 83 LGICLT--------STVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNV 148 (327)
T ss_dssp EEEEES--------SSEEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred EEEEec--------CCeEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheE
Confidence 877532 35789999999999999998632 34899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.+.....
T Consensus 149 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 227 (327)
T 3poz_A 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 227 (327)
T ss_dssp EEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred EECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-
Confidence 999999999999999965543322 223356889999999988899999999999999999999 999997654321
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.... .. ......+ ..++..+.+++.+||+.||++|||+.+++++...
T Consensus 228 ~~~~~---------~~--~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 228 ISSIL---------EK--GERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp HHHHH---------HT--TCCCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred HHHHH---------Hc--CCCCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11110 00 0111112 2345689999999999999999999999987443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.28 Aligned_cols=271 Identities=18% Similarity=0.311 Sum_probs=190.7
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
+....++|++.+.||+|+||.||+|.+...+. ....||+|.+...... ....+.+.+|+.+++.++|+|
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~------- 86 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPH------- 86 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTT-------
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCC--cceeEEEEEecccccC--HHHHHHHHHHHHHHHHCCCCc-------
Confidence 33446789999999999999999998765322 2347999998754322 344678999999999999988
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCC-CCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT-TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++++.+..... .......++||||+++++|.+++....... ...+++..+..++.|++.||.|||++| |+||||
T Consensus 87 iv~~~~~~~~~~~-~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Di 163 (323)
T 3qup_A 87 VAKLVGVSLRSRA-KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDL 163 (323)
T ss_dssp BCCCCEEEECC--------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eehhhceeecccc-ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCC
Confidence 8887877543111 111123499999999999999997654322 224889999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
||+|||+++++.+||+|||++........ .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.
T Consensus 164 kp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 164 AARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp SGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999976543322 223357789999999988889999999999999999999 99999876
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...... . .+..... +.....++.++.+++.+||+.||++|||+.++++..
T Consensus 244 ~~~~~~-~------------~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 244 ENAEIY-N------------YLIGGNR--LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp CGGGHH-H------------HHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ChHHHH-H------------HHhcCCC--CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 532211 1 1111110 111223457899999999999999999977776543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=325.91 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=198.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.|++|.+.... ....+.+.+|+.+++.++|+| |++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------i~~ 80 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKS----EEELEDYIVEIEILATCDHPY-------IVK 80 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT-----TCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred CccceeecceeccCCCeEEEEEEEcC-----CCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCC-------Eee
Confidence 45789999999999999999998764 56789999987542 345678999999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++||||||+|
T Consensus 81 ~~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~N 147 (302)
T 2j7t_A 81 LLGAY-------YHDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGN 147 (302)
T ss_dssp EEEEE-------ECC-CEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGG
T ss_pred eeeee-------eeCCeEEEEEEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHH
Confidence 77764 44678999999999999999987532 23899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCC-----CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYT-----NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
|+++.++.+||+|||++...... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp EEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999999999987432111 112234689999999987 467789999999999999999999999986543
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...... +.............++..+.+++.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 228 MRVLLK-------------IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHH-------------HHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHH-------------HhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 221111 1111111111223445789999999999999999999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=327.13 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=200.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+..+..+ +|+| |+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~-------iv 74 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL-----DGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSH-------VV 74 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTT-------BC
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC-----CCceEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCC-------ee
Confidence 46789999999999999999998764 5678999998754322 33457788999999999 7887 78
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..++||||+++++|.+++....... ..+++..++.++.|++.||.|||++| |+||||||+
T Consensus 75 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~ 144 (289)
T 1x8b_A 75 RYFSAW-------AEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPS 144 (289)
T ss_dssp CEEEEE-------EETTEEEEEEECCTTCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred eeeeee-------ecCCeEEEEEEecCCCcHHHHHHhhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHH
Confidence 777764 45678999999999999999998754322 33899999999999999999999999 999999999
Q ss_pred ceEEcCC-------------------CCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHH
Q 035572 172 NILFDSK-------------------WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVL 231 (379)
Q Consensus 172 NIll~~~-------------------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 231 (379)
|||++.+ ..++|+|||++....... ...||+.|+|||++.+. .++.++|||||||++
T Consensus 145 NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTV 221 (289)
T ss_dssp GEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHH
T ss_pred HEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHH
Confidence 9999844 479999999987664432 23699999999988765 567899999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|+|++|.+|+....... .+..... +.....+++.+.+++.+||+.||++|||+.++++|...
T Consensus 222 ~~l~~~~~~~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 222 VCAAGAEPLPRNGDQWH----------------EIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp HHHTTCCCCCSSSHHHH----------------HHHTTCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred HHHhcCCCCCcchhHHH----------------HHHcCCC--CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 99999998775432110 1111111 11122345789999999999999999999999998543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=338.20 Aligned_cols=255 Identities=14% Similarity=0.163 Sum_probs=196.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.......+++.||+|++... ....+.+|+.+++.+++..+. + ++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~--~--iv~ 131 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQH--M--FMK 131 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGG--G--BCC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhh--h--hhh
Confidence 35679999999999999999998665555567889999998743 356788889999888732211 1 666
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ...+..|+||||+++|+|.+++..........+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 132 ~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~N 202 (365)
T 3e7e_A 132 FYSAH-------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDN 202 (365)
T ss_dssp EEEEE-------ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGG
T ss_pred hheee-------ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHH
Confidence 66553 45678899999999999999998766555566999999999999999999999999 9999999999
Q ss_pred eEEcC-----------CCCeEEeccccCccCC---CCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC
Q 035572 173 ILFDS-----------KWDAKLADFGLAVSES---DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 173 Ill~~-----------~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 238 (379)
||++. ++.+||+|||+|.... .........||+.|+|||++.+..++.++|||||||++|+|+||+
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99988 8999999999996432 223344557999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
.||....+.... ........ ..+..+.+++..||+.+|.+|++..+.+.
T Consensus 283 ~pf~~~~~~~~~----------------~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 283 YMKVKNEGGECK----------------PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CCCEEEETTEEE----------------ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred CccccCCCCcee----------------echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 999654321100 01111101 11456788999999999999976555444
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=335.09 Aligned_cols=274 Identities=23% Similarity=0.345 Sum_probs=207.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+... ....++.||+|.+.... ....+.+.+|+.+++.++|+| |+.++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~-------i~~~~ 90 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPL-GDNTGALVAVKQLQHSG----PDQQRDFQREIQILKALHSDF-------IVKYR 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTT-SSSCSEEEEEEEESSCC----HHHHHHHHHHHHHHHTCCCTT-------BCCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccC-CCCcceEEEEEEeccCC----HHHHHHHHHHHHHHHhcCCCc-------eeEEE
Confidence 6899999999999999999986432 22367889999987543 344577999999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. .+....++||||+++++|.+++..... .+++..++.++.|++.||+|||+.| |+||||||+|||
T Consensus 91 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl 159 (327)
T 3lxl_A 91 GVSYG-----PGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNIL 159 (327)
T ss_dssp EEEEC-----SSSCEEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred EEEec-----CCCceEEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEE
Confidence 76532 345778999999999999999986432 2889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 160 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 239 (327)
T 3lxl_A 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239 (327)
T ss_dssp EEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred ECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh
Confidence 99999999999999976543322 23345888899999998888999999999999999999999998653211000
Q ss_pred HH-hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 251 ID-WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 251 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.. .................... +.....+++.+.+++.+||+.||++|||+.+++++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 240 MMGCERDVPALSRLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HCC----CCHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hcccccccccHHHHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 00000000111111111111 112234467899999999999999999999999875443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=333.96 Aligned_cols=278 Identities=22% Similarity=0.277 Sum_probs=199.5
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh-hhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-LQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
+....++|++.+.||+|+||.||+|.+.. +++.||+|.+....... .....+.+.+|+.+++.++|+|
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------ 73 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN------ 73 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTT------
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCC------
Confidence 34557899999999999999999998754 56789999987543221 1122357889999999999988
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++++.+ .+.+..++||||++ ++|.+++... ...+++..+..++.|++.||.|||++| |+||||
T Consensus 74 -iv~~~~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl 138 (346)
T 1ua2_A 74 -IIGLLDAF-------GHKSNISLVFDFME-TDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDL 138 (346)
T ss_dssp -BCCEEEEE-------CCTTCCEEEEECCS-EEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCC
T ss_pred -CCeEEEEE-------eeCCceEEEEEcCC-CCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCC
Confidence 77777764 45678999999996 5899988753 234888899999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||+|||++.++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+..+
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 139 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp CGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999999997654332 33445799999999988654 578999999999999999999999987654
Q ss_pred chhHHHhhhhhhh--HHhhhhhcc--------ccCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 247 PASIIDWALPLIK--EEKLRQVCD--------SRVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 247 ~~~~~~~~~~~~~--~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
...+......... ...+..... .....+ .....++.++.+||.+||+.||++|||+.|+++|.....
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 3332221110000 000000000 000000 011334578999999999999999999999999976543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=324.89 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=199.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv 91 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ..+.+.+|+.+++.+ +|++ ++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~-------i~ 69 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTG-------IP 69 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTT-------CC
T ss_pred cccceEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCC-------CC
Confidence 35789999999999999999998754 56789999986432 234578999999999 5555 44
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
+++++ +......++||||+ +++|.+++...+ ..+++..+..++.|++.||+|||++| |+||||||+
T Consensus 70 ~~~~~-------~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~ 135 (298)
T 1csn_A 70 NVYYF-------GQEGLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD 135 (298)
T ss_dssp CEEEE-------EEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGG
T ss_pred eEEee-------cCCCceeEEEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHH
Confidence 44443 34567899999999 999999998632 23899999999999999999999999 999999999
Q ss_pred ceEEcCCCC-----eEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC
Q 035572 172 NILFDSKWD-----AKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 172 NIll~~~~~-----~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 238 (379)
|||++.++. +||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 136 NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence 999987766 99999999966543321 23446999999999999989999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.||............ .. +..... ....+.....+++++.+++.+||+.||++|||++++++....
T Consensus 216 ~pf~~~~~~~~~~~~-~~-~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 216 LPWQGLKAATNKQKY-ER-IGEKKQ------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp CTTSSCCSCCHHHHH-HH-HHHHHH------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCcchhhccccHHHH-HH-HHhhcc------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 999875433211110 00 000000 000011122345789999999999999999999999876443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=332.07 Aligned_cols=273 Identities=22% Similarity=0.287 Sum_probs=205.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||||.+..... ......+.+|+.+++.++|+| |++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~ 73 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKP-----TGEIVAIKKIEPFDK---PLFALRTLREIKILKHFKHEN-------IIT 73 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCSS---HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECC-----CCcEEEEEeeccccc---chHHHHHHHHHHHHHhCcCCC-------cCC
Confidence 46899999999999999999998764 567899999864321 344567889999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ..+......++||||+. ++|.+++... .+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 74 ~~~~~~~--~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~N 142 (353)
T 2b9h_A 74 IFNIQRP--DSFENFNEVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSN 142 (353)
T ss_dssp EEEECCC--SCSTTCCCEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGG
T ss_pred eeeeecc--cccCccceEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence 7766432 22445678999999995 7999998752 3899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-----------cccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-----------SMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||++.++.+||+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|+.|
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999996553221 112346899999999764 46789999999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhh----------------HHhhhhhcccc-CCCCcchHHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 241 IDAARDPASIIDWALPLIK----------------EEKLRQVCDSR-VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
|.+.+....+.... .... ........... .........+++++.+|+.+||+.||++|||+.
T Consensus 223 f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 223 FPGRDYRHQLLLIF-GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp CCCSSHHHHHHHHH-HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcHHHHHHHH-HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 98765332221111 0000 00000000000 000011234567899999999999999999999
Q ss_pred HHhccccCc
Q 035572 304 EILMGCSCF 312 (379)
Q Consensus 304 e~l~~~~~~ 312 (379)
|+++|....
T Consensus 302 ell~hp~~~ 310 (353)
T 2b9h_A 302 EALEHPYLQ 310 (353)
T ss_dssp HHHTSGGGT
T ss_pred HHhcCcccc
Confidence 999986553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=339.91 Aligned_cols=278 Identities=19% Similarity=0.287 Sum_probs=190.3
Q ss_pred HhcCCcc-ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 13 ATESFSQ-SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~-~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
+.+.|++ .++||+|+||.||+|.+++.. .++.||+|.+.... ....+.+|+.+|+.++|+| |+
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpn-------iv 81 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGK---DDKDYALKQIEGTG------ISMSACREIALLRELKHPN-------VI 81 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSS---CCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTT-------BC
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCC---CCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCC-------ee
Confidence 3456777 458999999999999876432 56779999997543 2356889999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC----CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA----TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
++++.+.. ......|+||||+ +++|.+++...... ....+++..++.++.|++.||.|||++| |+|||
T Consensus 82 ~~~~~~~~-----~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~D 153 (405)
T 3rgf_A 82 SLQKVFLS-----HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRD 153 (405)
T ss_dssp CCCEEEEE-----TTTTEEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCC
T ss_pred eEeeEEec-----CCCCeEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCC
Confidence 87777532 3467899999999 56898888754321 1223889999999999999999999999 99999
Q ss_pred CCCCceEE----cCCCCeEEeccccCccCCCC----CcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCC
Q 035572 168 IKSTNILF----DSKWDAKLADFGLAVSESDE----SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCR 238 (379)
Q Consensus 168 lkp~NIll----~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~ 238 (379)
|||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 99999999 67789999999999765432 122345789999999988764 5899999999999999999999
Q ss_pred CCCCCCCCch--------hHHHhhhhhhhH----------------HhhhhhccccCCCCcchH-------HHHHHHHHH
Q 035572 239 KPIDAARDPA--------SIIDWALPLIKE----------------EKLRQVCDSRVGLPTFME-------GAIKQMLHV 287 (379)
Q Consensus 239 ~p~~~~~~~~--------~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~-------~~~~~~~~l 287 (379)
.||.+..... .........+.. .................. ..+..+.+|
T Consensus 234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 313 (405)
T 3rgf_A 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313 (405)
T ss_dssp CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence 9997654321 111110000000 000000000000000000 014578899
Q ss_pred HHhcccCCCCCCCChHHHhccccCccc
Q 035572 288 AARCVSSEEENRPGIGEILMGCSCFFV 314 (379)
Q Consensus 288 i~~~l~~dp~~Rps~~e~l~~~~~~~~ 314 (379)
|.+||+.||.+|||++|+|+|......
T Consensus 314 l~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 314 LQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred HHHHccCCcccCCCHHHHhcChhhccC
Confidence 999999999999999999999776543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=329.05 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=208.5
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
++++....++|++.+.||+|+||.||+|.+.. .++.||+|.+.... ...+.+.+|+.+++.++|+|
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~---- 70 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPN---- 70 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGG-----GTEEEEEEEECSCS-----THHHHHHHHHHHHHHCCCTT----
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecC-----CCEEEEEEecCcCH-----HHHHHHHHHHHHHHhCCCCC----
Confidence 34555567899999999999999999998765 56789999987542 34577899999999999888
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++++ .+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||++| ++||
T Consensus 71 ---i~~~~~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~ 135 (288)
T 3kfa_A 71 ---LVQLLGVC-------TREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN--FIHR 135 (288)
T ss_dssp ---BCCEEEEE-------CSSSSEEEEEECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCS
T ss_pred ---EeeEEEEE-------ccCCCEEEEEEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCC
Confidence 77777664 4567899999999999999999763 2344899999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDA 243 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~ 243 (379)
||||+||+++.++.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 136 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976554332 223356789999999988889999999999999999999 9999976
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.+... ..... ... ... .....+++.+.+++.+||+.||.+|||+.++++..
T Consensus 216 ~~~~~-~~~~~---------~~~--~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 216 IDLSQ-VYELL---------EKD--YRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CCGGG-HHHHH---------HTT--CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHH-HHHHH---------hcc--CCC---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 54322 11111 111 011 11233457899999999999999999999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=343.44 Aligned_cols=274 Identities=22% Similarity=0.293 Sum_probs=203.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||+|+||.||+|.+.. +++.||||++.... ....+|+++++.++|+| |++++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~--------~~~~~E~~il~~l~hpn-------iv~l~ 113 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDK--------RFKNRELQIMRKLDHCN-------IVRLR 113 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECCT--------TSCCHHHHHHHTCCCTT-------BCCEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC-----CCcEEEEEEecccc--------hhHHHHHHHHHHcCCCC-------cccee
Confidence 369999999999999999998765 56789999986432 22347999999999998 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++..... ..+...+++||||++ ++|.+.+..... ....+++..++.++.|++.||.|||++| |+||||||+|||
T Consensus 114 ~~~~~~~~-~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIL 188 (420)
T 1j1b_A 114 YFFYSSGE-KKDEVYLNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLL 188 (420)
T ss_dssp EEEEEEET-TTTEEEEEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEE
T ss_pred eEEeccCC-CCcceeEEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEE
Confidence 76543111 122335679999995 577777765432 2334899999999999999999999999 999999999999
Q ss_pred EcCC-CCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSK-WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.+ +.+||+|||+++............+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..
T Consensus 189 l~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~ 268 (420)
T 1j1b_A 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268 (420)
T ss_dssp EETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9955 56899999999776554444556899999999987654 789999999999999999999999987654443333
Q ss_pred hhhhhh--hHHhhhhhcc--ccCCCCc---------chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 253 WALPLI--KEEKLRQVCD--SRVGLPT---------FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 253 ~~~~~~--~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
.....- ....+..... .....+. .....++++.+||.+||+.||.+|||+.|+++|.....
T Consensus 269 i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 221100 0011111110 0011111 01223578999999999999999999999999977644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=321.79 Aligned_cols=255 Identities=20% Similarity=0.340 Sum_probs=200.8
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
.+....++|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++|+|
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~------ 80 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEK------ 80 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTT------
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCC------
Confidence 33444678999999999999999999765 34569999997543 23467899999999999888
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++++.+ .+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||
T Consensus 81 -i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~di 146 (283)
T 3gen_A 81 -LVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDL 146 (283)
T ss_dssp -BCCEEEEE-------CSSSSEEEEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSC
T ss_pred -EeeEEEEE-------ecCCCeEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCC
Confidence 77777664 45678999999999999999997632 23899999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCC
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAAR 245 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~ 245 (379)
||+||+++.++.++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||....
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp SGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999997554322 1223356788999999988889999999999999999998 999998754
Q ss_pred CchhHHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...... .+... ....+ ...++.+.+++.+||+.||.+|||+.+++++..
T Consensus 227 ~~~~~~-------------~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 227 NSETAE-------------HIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp HHHHHH-------------HHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHH-------------HHhcccCCCCC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 322111 11111 11111 223467999999999999999999999998743
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=327.02 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=195.4
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+|+.+++.++|++. +
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~-------i 67 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVG-------I 67 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTT-------C
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC-----CCceEEEEeecccc------cchHHHHHHHHHHHhcCCCC-------C
Confidence 457899999999999999999998754 56789999865432 23457899999999998873 2
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
..+..+ ....+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++| |+||||||+
T Consensus 68 ~~~~~~------~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~ 134 (296)
T 4hgt_A 68 PTIRWC------GAEGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD 134 (296)
T ss_dssp CCEEEE------EEETTEEEEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred Ceeeee------cCCCCceEEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence 223222 23467889999999 999999997532 23899999999999999999999999 999999999
Q ss_pred ceEE---cCCCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 172 NILF---DSKWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 172 NIll---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
|||+ +.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 135 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 214 (296)
T 4hgt_A 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214 (296)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 9999 7889999999999965543321 2345799999999999999999999999999999999999999
Q ss_pred CCCCCCchh--HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 241 IDAARDPAS--IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 241 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|........ ..... ....... ..+.....+++++.+++.+||+.||++|||++++++....
T Consensus 215 f~~~~~~~~~~~~~~~----~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 215 WQGLKAATKRQKYERI----SEKKMST------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp TSSCCCSSSSSHHHHH----HHHHHHS------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred Ccccchhhhhhhhhhh----hcccccc------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 987543321 11110 0000000 0011112335789999999999999999999999986443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=331.99 Aligned_cols=269 Identities=23% Similarity=0.358 Sum_probs=201.4
Q ss_pred CCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhcc
Q 035572 4 NFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESN 82 (379)
Q Consensus 4 ~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 82 (379)
.++++.+....++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ...+.+.+|+.+++.+ +|+|
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~ 82 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRN 82 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTT
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECC-----CCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCC
Confidence 45566666778999999999999999999998764 55789999986542 3357789999999999 6877
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
|+++++.+..... ....+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|
T Consensus 83 -------i~~~~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 149 (326)
T 2x7f_A 83 -------IATYYGAFIKKNP-PGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK-- 149 (326)
T ss_dssp -------BCCEEEEEEECC---CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred -------eeeeeeEEeeccC-ccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 7777777543111 112568899999999999999998643 224889999999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHh
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ellt 236 (379)
|+||||||+|||++.++.+||+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 150 ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 229 (326)
T 2x7f_A 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229 (326)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH
T ss_pred ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh
Confidence 9999999999999999999999999986654322 233447999999999876 5678899999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|..||............ ........ ....++..+.+++.+||+.||.+|||+.++++|.
T Consensus 230 g~~p~~~~~~~~~~~~~----------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 230 GAPPLCDMHPMRALFLI----------PRNPAPRL----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp SSCTTTTSCHHHHHHHH----------HHSCCCCC----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred CCCCCCCCcHHHHHHHh----------hcCccccC----CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 99999765432211100 00001111 1122347899999999999999999999999983
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=324.70 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=199.4
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. +++.||+|.+... ...+.+.+|+.+++.++|+| ++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~-------i~ 87 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE-----TGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPH-------VV 87 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT-----TCCEEEEEEEETT------SCCHHHHHHHHHHHTCCCTT-------BC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC-----CCCEEEEEecCch------HHHHHHHHHHHHHHhCCCCC-------Cc
Confidence 345789999999999999999998764 5678999998753 23567899999999999888 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ ...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||+
T Consensus 88 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~ 154 (314)
T 3com_A 88 KYYGSY-------FKNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAG 154 (314)
T ss_dssp CEEEEE-------EETTEEEEEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred cEEEEE-------EeCCEEEEEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHH
Confidence 777764 34578899999999999999997432 23899999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||+++.++.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 234 (314)
T 3com_A 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234 (314)
T ss_dssp GEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred HEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999999996654332 233457999999999999889999999999999999999999999765432211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. .......... ....++..+.+++.+||+.||.+|||+.++++|..
T Consensus 235 ~~----------~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 235 FM----------IPTNPPPTFR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp HH----------HHHSCCCCCS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred HH----------HhcCCCcccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 10 0011111111 12234578999999999999999999999999843
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=337.86 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=204.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++|+| |+++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 96 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPY-------IVGF 96 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECCCC---HHHHHHHHHHHGGGGGCCCTT-------BCCE
T ss_pred cccceeeeeecCCCCeEEEEEEECC-----CCcEEEEEEeccccC---HHHHHHHHHHHHHHHHCCCCC-------EEEE
Confidence 4689999999999999999998764 567899999875422 345678999999999999888 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~N 172 (379)
++.+ .+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. | |+||||||+|
T Consensus 97 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~N 162 (360)
T 3eqc_A 97 YGAF-------YSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 162 (360)
T ss_dssp EEEE-------EETTEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGG
T ss_pred eEEE-------EECCEEEEEEECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHH
Confidence 7764 34678999999999999999998653 288999999999999999999995 9 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++.++.++|+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 163 il~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 163 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred EEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999998544221 22334799999999999999999999999999999999999999976542211000
Q ss_pred hhhhh-----------------------------hhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 253 WALPL-----------------------------IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 253 ~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
..... ........+...... ......++.++.+|+.+||+.||++|||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 320 (360)
T 3eqc_A 242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLK 320 (360)
T ss_dssp HC------------------------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred hcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence 00000 000001111111110 111122457899999999999999999999
Q ss_pred HHhccccCc
Q 035572 304 EILMGCSCF 312 (379)
Q Consensus 304 e~l~~~~~~ 312 (379)
|+++|....
T Consensus 321 ell~hp~~~ 329 (360)
T 3eqc_A 321 QLMVHAFIK 329 (360)
T ss_dssp HHHTSHHHH
T ss_pred HHhhChHhh
Confidence 999985543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=337.37 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=192.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+... ...+..||||.++.... ....+.+.+|+.++++++|+| |++++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n-------iv~~~ 112 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLP--SKKEISVAIKTLKVGYT---EKQRRDFLGEASIMGQFDHPN-------IIRLE 112 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCT--TSCBCCEEEEECCTTCC---HHHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecC--CCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhCCCCC-------CCeEE
Confidence 5899999999999999999987532 22567799999875422 344678999999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++ .+.+..++||||+++++|.+++... ...+++.++..++.|++.||+|||++| |+||||||+|||
T Consensus 113 ~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 179 (373)
T 2qol_A 113 GVV-------TKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNIL 179 (373)
T ss_dssp EEE-------CSSSSCEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred EEE-------eeCCceEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEE
Confidence 764 4467899999999999999999753 234899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++.++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 180 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~- 258 (373)
T 2qol_A 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD- 258 (373)
T ss_dssp ECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-
T ss_pred EcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999976543221 112235778999999988899999999999999999998 999997654221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.... .. ......+ ..++..+.+++.+||+.||++||++.++++....
T Consensus 259 ~~~~i---------~~--~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 259 VIKAV---------DE--GYRLPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp HHHHH---------HT--TEECCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH---------Hc--CCCCCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 11110 00 0111111 2345789999999999999999999999876443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=325.96 Aligned_cols=275 Identities=19% Similarity=0.256 Sum_probs=204.0
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.+.++|++.+.||+|+||.||+|.+... .++.||+|.++.. ....+.+.+|+.+++.++|++..+.. .++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~-~~~ 85 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHAR----GKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKF-LCV 85 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCS-CBC
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCC----CceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCce-eEE
Confidence 3468999999999999999999987642 2367999998743 23457788999999999988743322 133
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
.+.+. +...+..++||||+ +++|.+.+.... ...+++..++.++.|++.||.|||++| |+||||||+
T Consensus 86 ~~~~~-------~~~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~ 152 (355)
T 2eu9_A 86 LMSDW-------FNFHGHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPE 152 (355)
T ss_dssp CEEEE-------EEETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGG
T ss_pred Eeeee-------eeeCCeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence 33333 45567899999999 778888776532 234899999999999999999999999 999999999
Q ss_pred ceEE-------------------cCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHH
Q 035572 172 NILF-------------------DSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLL 232 (379)
Q Consensus 172 NIll-------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 232 (379)
|||+ +.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 153 NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 230 (355)
T 2eu9_A 153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230 (355)
T ss_dssp GEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHH
Confidence 9999 56789999999999764432 23447999999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCCchhHHHhhh--hhhhHHhhh--------------------------hhccccCCCCcchHHHHHHH
Q 035572 233 EIISCRKPIDAARDPASIIDWAL--PLIKEEKLR--------------------------QVCDSRVGLPTFMEGAIKQM 284 (379)
Q Consensus 233 elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~ 284 (379)
+|++|+.||........+..... ......... ................+.++
T Consensus 231 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 310 (355)
T 2eu9_A 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310 (355)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHH
Confidence 99999999987654332211100 000000000 00000000001122346789
Q ss_pred HHHHHhcccCCCCCCCChHHHhccccC
Q 035572 285 LHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 285 ~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+|+.+||+.||++|||+.|+++|...
T Consensus 311 ~~li~~~L~~dP~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 311 FDLMRRMLEFDPAQRITLAEALLHPFF 337 (355)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSGGG
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 999999999999999999999998443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=322.25 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=202.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.... ..+..||+|.+..... ....+.+.+|+.+++.++|+| |++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------i~~ 77 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDCT---LDNKEKFMSEAVIMKNLDHPH-------IVK 77 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTSC---HHHHHHHHHHHHHHHHHCCTT-------BCC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEecccccC---chHHHHHHHHHHHHHhCCCCC-------cce
Confidence 4678999999999999999999876432 2567799999875432 345678999999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+. .+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 78 ~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~N 143 (281)
T 3cc6_A 78 LIGIIE--------EEPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRN 143 (281)
T ss_dssp EEEEEC--------SSSCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGG
T ss_pred EEEEEc--------CCCCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccce
Confidence 777632 345699999999999999997643 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
|+++.++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||........
T Consensus 144 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 144 ILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp EEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred EEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence 9999999999999999876543322 233457889999999988889999999999999999998 9999976543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .. ... ......+ ..+++.+.+++.+||+.||++|||+.+++.+.
T Consensus 224 ~-~~---------~~~--~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 224 I-GV---------LEK--GDRLPKP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp H-HH---------HHH--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-HH---------Hhc--CCCCCCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 1 11 000 0111112 22457799999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.78 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=203.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++|++ ++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------i~~~ 85 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPY-------VTKY 85 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC-----CCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCC-------EeEE
Confidence 4679999999999999999998754 567899999875432 345678999999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||
T Consensus 86 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Ni 150 (303)
T 3a7i_A 86 YGSY-------LKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANV 150 (303)
T ss_dssp EEEE-------EETTEEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred EEEE-------ecCCeEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheE
Confidence 7764 345789999999999999999863 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
+++.++.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .
T Consensus 151 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~ 229 (303)
T 3a7i_A 151 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-F 229 (303)
T ss_dssp EECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-H
T ss_pred EECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-H
Confidence 99999999999999996654332 233457999999999999899999999999999999999999999765422111 1
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .... .. +.....++..+.+++.+||+.||++|||+.++++|.
T Consensus 230 ~---------~~~~--~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 230 L---------IPKN--NP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp H---------HHHS--CC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred H---------hhcC--CC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 0 0000 01 111223357799999999999999999999999983
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.48 Aligned_cols=251 Identities=31% Similarity=0.520 Sum_probs=194.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.++++++|+| |+++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~-------iv~~ 66 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE------SERKAFIVELRQLSRVNHPN-------IVKL 66 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST------THHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCC-------cCeE
Confidence 468999999999999999999763 466999998643 34577899999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc---CCCCeEecCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE---NDPMIIHRDIKS 170 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~~i~H~dlkp 170 (379)
++.+. +..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+ +| |+||||||
T Consensus 67 ~~~~~---------~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp 133 (307)
T 2eva_A 67 YGACL---------NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKP 133 (307)
T ss_dssp EEBCT---------TTTEEEEECCTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSG
T ss_pred EEEEc---------CCcEEEEEcCCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCCh
Confidence 77642 347999999999999999986432 2237888899999999999999999 78 99999999
Q ss_pred CceEEcCCCC-eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 171 TNILFDSKWD-AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 171 ~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+|||++.++. +||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 134 ~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 134 PNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp GGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred hHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 9999998886 799999998654332 2234699999999999988999999999999999999999999976543321
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
...+. ...... +.....++..+.+++.+||+.||++|||+++++++....
T Consensus 212 ~~~~~----------~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 212 RIMWA----------VHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp HHHHH----------HHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----------HhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11100 000111 122234457899999999999999999999999875443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.17 Aligned_cols=272 Identities=19% Similarity=0.254 Sum_probs=201.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+.+++.++|+| |+++
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~n-------iv~~ 106 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHEN-------VIGL 106 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC-----CCCEEEEEEecccccc--hhHHHHHHHHHHHHHhcCCCC-------chhh
Confidence 5789999999999999999998765 5678999999754322 344678899999999999988 8877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+..... .......|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 107 ~~~~~~~~~-~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI 175 (371)
T 4exu_A 107 LDVFTPASS-LRNFYDFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNL 175 (371)
T ss_dssp SEEECSCSS-STTCCCCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred hhheeccCC-cccceeEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHe
Confidence 776543111 122234599999995 788887732 2899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 176 ll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 253 (371)
T 4exu_A 176 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 253 (371)
T ss_dssp EECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999999755432 234478999999998776 6789999999999999999999999987654332222
Q ss_pred hhhhh--------------hhHHhhhhhcccc-CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 253 WALPL--------------IKEEKLRQVCDSR-VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~--------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
..... ............. .........+++.+.+|+.+||+.||++|||+.|+++|....
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 11100 0000000110000 000111223467899999999999999999999999995543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=324.82 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=193.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.++|+| |++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~-------iv~ 98 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTV-----RERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPH-------VVP 98 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECGGGGGG-SHHHHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcC-----CCeEEEEEecCccccc-CHHHHHHHHHHHHHHhhcCCCC-------eeE
Confidence 35789999999999999999998764 5678999998754221 2334578999999999999988 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++ ...+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 99 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~N 164 (309)
T 2h34_A 99 IHDFG-------EIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPEN 164 (309)
T ss_dssp EEEEE-------EETTEEEEEEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred EEEEE-------eeCCeEEEEEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHH
Confidence 77764 44678999999999999999998643 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~ 243 (309)
T 2h34_A 165 ILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VM 243 (309)
T ss_dssp EEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HH
T ss_pred EEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HH
Confidence 999999999999999986554332 223446899999999999899999999999999999999999999764311 10
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-ChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-GIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~e~l~~~ 309 (379)
.. .... ...........++..+.+++.+||+.||++|| ++++++...
T Consensus 244 ~~---------~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 244 GA---------HINQ---AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HH---------HHHS---CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HH---------Hhcc---CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 00 0000 00111112234457799999999999999999 888888653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=324.86 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=199.1
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ..+.+.+|+.+++.++|++. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~-------i~ 68 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVG-------IP 68 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEESCS------SCCHHHHHHHHHHHHTTSTT-------CC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC-----CCcEEEEEEecCCc------chhHHHHHHHHHHHhhcCCC-------CC
Confidence 46799999999999999999998754 56789999986532 23468899999999998773 22
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
.+..+ ....+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 69 ~~~~~------~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~N 135 (296)
T 3uzp_A 69 TIRWC------GAEGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDN 135 (296)
T ss_dssp CEEEE------EEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGG
T ss_pred ccccc------cCCCCceEEEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHH
Confidence 22221 23456789999999 999999997532 24899999999999999999999999 9999999999
Q ss_pred eEE---cCCCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 173 ILF---DSKWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 173 Ill---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
||+ +.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 136 Il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 999 4788999999999966543322 23457999999999999989999999999999999999999999
Q ss_pred CCCCCch--hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 242 DAARDPA--SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
....... ....... ...... ..+.....+++++.+++.+||+.||++|||+.++++....
T Consensus 216 ~~~~~~~~~~~~~~~~----~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 216 QGLKAATKRQKYERIS----EKKMST------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp SSCCCSSSSSHHHHHH----HHHHHS------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CCcCchhhhhhhhhhc----ccccCC------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 8754322 1111110 000000 0011112345789999999999999999999999886443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=322.16 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=204.6
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+.++++++|+| |+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~ 84 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPN-------IM 84 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTT-------BC
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcC-----CCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCC-------cc
Confidence 446799999999999999999998764 5577999998654322 345678999999999999888 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..++||||+++++|.+.+.... .+++..+..++.|++.||.|||++| ++||||||+
T Consensus 85 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~ 150 (287)
T 2wei_A 85 KLFEIL-------EDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE 150 (287)
T ss_dssp CEEEEE-------ECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred EEEEEE-------eCCCeEEEEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChh
Confidence 777664 45678999999999999999987643 3889999999999999999999999 999999999
Q ss_pred ceEEcCC---CCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 172 NILFDSK---WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 172 NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
||+++.+ +.+||+|||++.............+|+.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (287)
T 2wei_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (287)
T ss_dssp GEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999754 4699999999876655444444568999999998875 48999999999999999999999997654221
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.. .+....... ......++.++.+++.+||+.||++|||+.++++|.
T Consensus 230 -~~~------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 230 -ILK------------RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp -HHH------------HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -HHH------------HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 111 111111111 112234567899999999999999999999999984
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=327.55 Aligned_cols=270 Identities=22% Similarity=0.377 Sum_probs=202.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+... ...+++.||+|.+.... .....+.+.+|+.+++.++|+| |++++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~-------i~~~~ 89 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHEN-------IVKYK 89 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-SSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTT-------BCCEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-cCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCC-------eeeee
Confidence 5699999999999999999985432 23477899999987543 2345678999999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. ......++||||+++++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 90 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil 158 (302)
T 4e5w_A 90 GICTE-----DGGNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVL 158 (302)
T ss_dssp EEEEC--------CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred eEEec-----CCCceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEE
Confidence 76532 23367899999999999999996543 23899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.++|+|||++........ .....+|..|+|||++.+..++.++||||||+++|+|++|..|+..... ..
T Consensus 159 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~ 236 (302)
T 4e5w_A 159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--LF 236 (302)
T ss_dssp EEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HH
T ss_pred EcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--HH
Confidence 99999999999999976544332 2334688889999999888899999999999999999999998643211 00
Q ss_pred HHhhhh---hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALP---LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.....+ ................ ......+++.+.+++.+||+.||.+|||+.++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 237 LKMIGPTHGQMTVTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHCSCCGGGHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred hhccCCcccccCHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 000000 0011111111111111 112233457899999999999999999999999753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=324.18 Aligned_cols=269 Identities=17% Similarity=0.317 Sum_probs=199.3
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|.+.+.||+|+||.||+|.+... ...+..||+|.+...... ....+.+.+|+.+++.++|+| |+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------iv 99 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHPN-------VI 99 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CCC--HHHHHHHHHHHHHHHTCCCTT-------BC
T ss_pred cCHHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEeccccc--hhHHHHHHHHHHHHhcCCCCC-------ee
Confidence 3457899999999999999999987643 235678999998755332 344577999999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
++++++..... ......++||||+++++|.+++..... .....+++..++.++.|++.||.|||++| |+||||||
T Consensus 100 ~~~~~~~~~~~--~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp 175 (313)
T 3brb_A 100 RLLGVCIEMSS--QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAA 175 (313)
T ss_dssp CCCEEEEC---------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSG
T ss_pred eeeEEEeeccc--cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCc
Confidence 88877643211 112356999999999999999965332 12345899999999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCC
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARD 246 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~ 246 (379)
+|||++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 176 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999999999999996554322 1223357889999999988889999999999999999999 8999976543
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
... ... +.... .+.....++..+.+++.+||+.||.+|||+.+++.+..
T Consensus 256 ~~~-~~~------------~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 256 HEM-YDY------------LLHGH--RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp GGH-HHH------------HHTTC--CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-HHH------------HHcCC--CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 221 111 11110 01122334578999999999999999999999998743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=330.03 Aligned_cols=270 Identities=23% Similarity=0.370 Sum_probs=204.7
Q ss_pred cCC-ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESF-SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y-~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
++| ++++.||+|+||.||+|..... ...+++.||+|++..... ....+.+.+|+.+++.++|+| |+++
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 98 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAG---PQHRSGWKQEIDILRTLYHEH-------IIKY 98 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSC-C--CCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccC-CCCCCcEEEEEEeccccC---hHHHHHHHHHHHHHHhCCCcc-------hhhE
Confidence 455 9999999999999999976543 334788999999975432 344677999999999999988 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++.. ......++||||+++++|.+++... .+++..++.++.|++.||.|||+.| |+||||||+||
T Consensus 99 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Ni 165 (318)
T 3lxp_A 99 KGCCED-----AGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNV 165 (318)
T ss_dssp EEEEEE-----TTTTEEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred EEEEec-----CCCceEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheE
Confidence 776532 2346789999999999999999653 2889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||++........ .....+|..|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~ 245 (318)
T 3lxp_A 166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245 (318)
T ss_dssp EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh
Confidence 999999999999999976654322 2334688889999999888899999999999999999999999865321100
Q ss_pred -HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 -IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
....................... +.....++.++.+++.+||+.||++|||+.++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 246 ELIGIAQGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHCSCCHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhcccccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000000111111222221111 112234567899999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.61 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=200.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCC--CCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTD--GDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
.++|++.+.||+|+||.||+|.+...+.. .....|++|.+.... ....+.+.+|+.+++.++|+| |+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~-------iv 75 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKH-------LV 75 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTT-------BC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCC-------Ee
Confidence 46899999999999999999988754321 123679999986432 345678999999999999988 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+ .+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++| |+||||||+
T Consensus 76 ~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~ 142 (289)
T 4fvq_A 76 LNYGVC-------VCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAK 142 (289)
T ss_dssp CEEEEE-------CCTTCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred EEEEEE-------EeCCCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcc
Confidence 777764 45678899999999999999998643 23888999999999999999999999 999999999
Q ss_pred ceEEcCCCC--------eEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 172 NILFDSKWD--------AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 172 NIll~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
|||++.++. +||+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+.
T Consensus 143 NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 143 NILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp GEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 999998877 999999998655332 22358899999998877 678999999999999999999655544
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
...+....... .......+.. .+.++.+++.+||+.||++|||+.+++++.....
T Consensus 220 ~~~~~~~~~~~-------------~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 220 SALDSQRKLQF-------------YEDRHQLPAP---KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTSCHHHHHHH-------------HHTTCCCCCC---SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred cccchHHHHHH-------------hhccCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 33332211111 0111111111 1356889999999999999999999999865544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=331.00 Aligned_cols=257 Identities=21% Similarity=0.347 Sum_probs=199.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+..++... ...|++|.+..... ......+.+|+.+++.++|+| |++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~-------iv~~~ 81 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESI-KIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAH-------IVRLL 81 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSC-CEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTT-------BCCEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceE-EEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCC-------cCeEE
Confidence 58999999999999999999987644332 33478888754321 233456788999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++ ..+..++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++| |+||||||+|||
T Consensus 82 ~~~--------~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil 147 (325)
T 3kex_A 82 GLC--------PGSSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVL 147 (325)
T ss_dssp EEE--------CBSSEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEE
T ss_pred EEE--------cCCccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEE
Confidence 764 2457899999999999999997642 23888899999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
++.++.+||+|||++....... ......+|..|+|||++.+..++.++|||||||++|+|+| |+.||.+......
T Consensus 148 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~- 226 (325)
T 3kex_A 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV- 226 (325)
T ss_dssp ESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-
T ss_pred ECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-
Confidence 9999999999999997654332 2234467889999999988889999999999999999999 9999987543221
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... .. ......+ ..++.++.+++.+||+.||.+|||+.+++++...
T Consensus 227 ~~~~---------~~--~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~ 273 (325)
T 3kex_A 227 PDLL---------EK--GERLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273 (325)
T ss_dssp HHHH---------HT--TCBCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred HHHH---------Hc--CCCCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1110 00 0111111 1234578899999999999999999999998544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=324.69 Aligned_cols=268 Identities=22% Similarity=0.325 Sum_probs=198.1
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh--hhcc
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL--QESN 82 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~~~~ 82 (379)
++......+.++|++.+.||+|+||.||+|.+. ++.||||++... ......+|.+++..+ +|+|
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~ 92 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHEN 92 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTT
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCC
Confidence 344444556789999999999999999999763 567999998532 234455666666555 7777
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC---
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN--- 159 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 159 (379)
|+++++.+.... ......++||||+++|+|.+++... .+++..+..++.|++.||.|||+.
T Consensus 93 -------i~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~ 156 (337)
T 3mdy_A 93 -------ILGFIAADIKGT---GSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFS 156 (337)
T ss_dssp -------BCCEEEEEEESC---GGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred -------eeeEEEEEccCC---CCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 777777654311 1126789999999999999999653 288999999999999999999998
Q ss_pred -----CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCCCCCCc------CC
Q 035572 160 -----DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPSKLSKK------VD 223 (379)
Q Consensus 160 -----~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~D 223 (379)
| |+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+...+.. +|
T Consensus 157 ~~~~~~--ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 234 (337)
T 3mdy_A 157 TQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234 (337)
T ss_dssp TTCBCC--EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHH
T ss_pred hccCCC--EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccc
Confidence 8 99999999999999999999999999965433222 124479999999999887766665 99
Q ss_pred eehhHHHHHHHHhC----------CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc--chHHHHHHHHHHHHhc
Q 035572 224 VFSYGVVLLEIISC----------RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT--FMEGAIKQMLHVAARC 291 (379)
Q Consensus 224 iwSlG~il~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~ 291 (379)
||||||++|+|+|| +.||............. .. ...........+. ....++..+.+++.+|
T Consensus 235 iwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 308 (337)
T 3mdy_A 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM----RE--IVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308 (337)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH----HH--HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhh----HH--HHhhhccCccccccchhhHHHHHHHHHHHHh
Confidence 99999999999999 66665433222111110 00 0011111111222 2346788999999999
Q ss_pred ccCCCCCCCChHHHhcccc
Q 035572 292 VSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 292 l~~dp~~Rps~~e~l~~~~ 310 (379)
|+.||++|||+.+++++..
T Consensus 309 l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 309 WAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp SCSSGGGSCCHHHHHHHHH
T ss_pred hhhChhhCCCHHHHHHHHH
Confidence 9999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.86 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=200.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+. ++.||||.++... ..+.+.+|+.++++++|+| |++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~n-------iv~ 250 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSN-------LVQ 250 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTT-------BCC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCC-------EEE
Confidence 3578999999999999999999764 4579999997542 4577999999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+. ...+..|+||||+++|+|.+++...+ ...+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 251 ~~~~~~------~~~~~~~iv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~N 319 (450)
T 1k9a_A 251 LLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARN 319 (450)
T ss_dssp EEEEEE------CTTSCEEEEEECCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGG
T ss_pred EEEEEE------cCCCceEEEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhh
Confidence 887753 23457899999999999999998643 223788899999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
||++.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.........
T Consensus 320 ill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~- 396 (450)
T 1k9a_A 320 VLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV- 396 (450)
T ss_dssp EEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-
T ss_pred EEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 999999999999999997543322 22367889999999988899999999999999999998 99999876433211
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .. ..+...| ..+++.+.+++.+||+.||++|||+.+++...
T Consensus 397 ~~i---------~~--~~~~~~p---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 397 PRV---------EK--GYKMDAP---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp HHH---------HT--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHH---------Hc--CCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 110 00 1112222 34457899999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=339.20 Aligned_cols=274 Identities=20% Similarity=0.266 Sum_probs=200.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
..+|++.+.||+|+||.||+|.+.. .++ +|+|++.... ....+|+.+++.++|+| |+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~-----~~~-~aikk~~~~~--------~~~~~E~~il~~l~h~n-------iv~l 97 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE-----SDE-VAIKKVLQDK--------RFKNRELQIMRIVKHPN-------VVDL 97 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT-----TEE-EEEEEEECCT--------TSCCHHHHHHHTCCCTT-------BCCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC-----CCe-EEEEEEecCc--------chHHHHHHHHHhCCCCC-------cceE
Confidence 3579999999999999999998764 233 7888775432 11247999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++..... ..+....++||||+++ ++.+.+...... ...+++..++.++.|++.||+|||++| |+||||||+||
T Consensus 98 ~~~~~~~~~-~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Ni 172 (394)
T 4e7w_A 98 KAFFYSNGD-KKDEVFLNLVLEYVPE-TVYRASRHYAKL-KQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNL 172 (394)
T ss_dssp EEEEEEESS-SSSCEEEEEEEECCSE-EHHHHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred EEEEEecCC-CCCceEEEEEeeccCc-cHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHE
Confidence 777643211 1233457899999965 555555433322 334899999999999999999999999 99999999999
Q ss_pred EEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|++ .++.+||+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 173 ll~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~ 252 (394)
T 4e7w_A 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252 (394)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999 7999999999999776555555566899999999987654 58999999999999999999999998776444333
Q ss_pred Hhhhhhh--hHHhhhh----hccccCC--CCcc-----hHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 252 DWALPLI--KEEKLRQ----VCDSRVG--LPTF-----MEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 252 ~~~~~~~--~~~~~~~----~~~~~~~--~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
....... ....+.. ......+ .+.. ....++++.+|+.+||+.||.+|||+.|+++|.....
T Consensus 253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 3221100 0000111 0000000 0001 1124578999999999999999999999999976654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=346.59 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=205.7
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
.+.+....++|++.+.||+|+||.||+|.+.. +..||||.++... ...+.+.+|+.+++.++|+|
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~---- 244 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDK---- 244 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT------TEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTT----
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECC------ccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCC----
Confidence 34455567889999999999999999998753 4569999987542 34678999999999999988
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++.+. .+..++||||+++|+|.+++...... .+++..+..++.|++.||+|||++| |+||
T Consensus 245 ---iv~l~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--ivHr 308 (454)
T 1qcf_A 245 ---LVKLHAVVT--------KEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRN--YIHR 308 (454)
T ss_dssp ---BCCEEEEEC--------SSSCEEEECCCTTCBHHHHHHSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred ---EeeEEEEEe--------CCccEEEEeecCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCC
Confidence 888776642 45789999999999999999864321 2788899999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDA 243 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~ 243 (379)
||||+|||++.++.+||+|||++........ .....++..|+|||++....++.++|||||||++|||+| |+.||.+
T Consensus 309 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp SCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976543211 122346789999999988889999999999999999999 9999986
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..... +.... .. ......| ..+++++.+++.+||+.||++|||+++++.....
T Consensus 389 ~~~~~-~~~~i---------~~--~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 389 MSNPE-VIRAL---------ER--GYRMPRP---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp CCHHH-HHHHH---------HH--TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCHHH-HHHHH---------Hc--CCCCCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 54322 11110 00 1111112 2345789999999999999999999999876443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.86 Aligned_cols=264 Identities=18% Similarity=0.333 Sum_probs=205.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCC--CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQT--DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
.++|++.+.||+|+||.||+|.+..... ...+..||+|.+..... ....+.+.+|+.+++.+ +|+| |
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~-------i 103 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKN-------I 103 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC---HHHHHHHHHHHHHHHHHCCCTT-------B
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc---HHHHHHHHHHHHHHHHhhcCCC-------E
Confidence 5789999999999999999999864322 23567899999975432 34467899999999999 7887 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
+++++.+ .+.+..++||||+++++|.+++...... ....+++..++.++.|++.||.|||++
T Consensus 104 v~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (334)
T 2pvf_A 104 INLLGAC-------TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176 (334)
T ss_dssp CCEEEEE-------CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeEEEEE-------ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 8777764 4567899999999999999999865421 123488999999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
| |+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++
T Consensus 177 ~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 177 K--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp T--EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred C--eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 9 99999999999999999999999999976544322 223357889999999888889999999999999999999
Q ss_pred -CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 237 -CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 237 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|..||.+... ..+.... . .. .... ....++..+.+++.+||+.||.+|||+.+++++...
T Consensus 255 ~g~~p~~~~~~-~~~~~~~----~-----~~--~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 255 LGGSPYPGIPV-EELFKLL----K-----EG--HRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp TSCCSSTTCCH-HHHHHHH----H-----HT--CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcCcCCH-HHHHHHH----h-----cC--CCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999976532 1111110 0 00 0111 112345789999999999999999999999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=321.98 Aligned_cols=257 Identities=23% Similarity=0.394 Sum_probs=198.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
.+|++.+.||+|+||.||+|.+.... .....+++|.+..... ....+.+.+|+.++++++|+| |++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 92 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPN-------VLSLL 92 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCS---HHHHHHHHHHHHHHHTCCCTT-------BCCCC
T ss_pred eehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCCC---HHHHHHHHHHHHHHHhCCCCC-------Eeeee
Confidence 57899999999999999999876433 2456789999875322 344678999999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+. ..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||++| ++||||||+|||
T Consensus 93 ~~~~------~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil 160 (298)
T 3f66_A 93 GICL------RSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCM 160 (298)
T ss_dssp EEEC------CSSSCCEEEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred eEEE------cCCCceEEEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEE
Confidence 7642 3456789999999999999999752 234789999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 175 FDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
+++++.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 240 (298)
T 3f66_A 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240 (298)
T ss_dssp ECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred ECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 9999999999999997554322 1233457889999999988889999999999999999999 556665544322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...... .......+ ..++..+.+++.+||+.||++|||+.++++...
T Consensus 241 -~~~~~~-----------~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 241 -ITVYLL-----------QGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp -HHHHHH-----------TTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHh-----------cCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111110 01111112 223467999999999999999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=346.11 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=206.1
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCce
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYC 89 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 89 (379)
+....++|++.+.||+|+||.||+|.+.. .+..||||.+.... ...+.+.+|+.++++++|+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpn------- 277 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPN------- 277 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGG-----GTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTT-------
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcC-----CCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCC-------
Confidence 34446789999999999999999998864 45779999997542 34678999999999999988
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIK 169 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlk 169 (379)
|+++++.+ .+.+..|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||++| |+|||||
T Consensus 278 iv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlk 345 (495)
T 1opk_A 278 LVQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLA 345 (495)
T ss_dssp BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EeeEEEEE-------ecCCcEEEEEEccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence 88888764 44678999999999999999998632 234889999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCC
Q 035572 170 STNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARD 246 (379)
Q Consensus 170 p~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~ 246 (379)
|+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||.+.+.
T Consensus 346 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp GGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999976543322 222346789999999988889999999999999999999 9999987543
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. +.... .. ..+...+ ..++..+.+|+.+||+.||++|||+.++++..
T Consensus 426 ~~-~~~~~---------~~--~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 426 SQ-VYELL---------EK--DYRMERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp GG-HHHHH---------HT--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH-HHHHH---------Hc--CCCCCCC---CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 21 11111 00 1111112 23457899999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.82 Aligned_cols=279 Identities=23% Similarity=0.279 Sum_probs=207.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh---hhccCCCCCc
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL---QESNKRNPNY 88 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~~~~~~~ 88 (379)
.+.++|++.+.||+|+||.||+|.+.. ..++.||+|.+...... ......+.+|+.+++.+ +|+|
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~------ 75 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPN------ 75 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTT------
T ss_pred CchhceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCC------
Confidence 456899999999999999999998742 14678999998654322 22234567888888887 5776
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|+++++.+... ........++||||+. ++|.+++.... ...+++..++.++.|++.||.|||++| |+||||
T Consensus 76 -i~~~~~~~~~~--~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dl 146 (326)
T 1blx_A 76 -VVRLFDVCTVS--RTDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDL 146 (326)
T ss_dssp -BCCEEEEEEEE--ECSSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCC
T ss_pred -eEeeeeeeeec--ccCCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccC
Confidence 77777765311 0124567899999996 79999998632 334889999999999999999999999 999999
Q ss_pred CCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 169 KSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 169 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
||+||+++.++.+||+|||++.............+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.....
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (326)
T 1blx_A 147 KPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226 (326)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999999999976654444455679999999999988899999999999999999999999998765433
Q ss_pred hHHHhhhhhh--hHHhhhhh-------cc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 249 SIIDWALPLI--KEEKLRQV-------CD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~~~--~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+........ ....+... .. ...........++..+.+|+.+||+.||++|||+.++++|...
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 2221110000 00000000 00 0000111123456789999999999999999999999998554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.43 Aligned_cols=273 Identities=19% Similarity=0.307 Sum_probs=197.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| ++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------iv~~ 73 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND-----CDKRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDN-------IVKV 73 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT-----TTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred CCceeEEEEeccCCCeEEEEEEECC-----CCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCC-------eeEE
Confidence 5789999999999999999998764 56789999987542 344678899999999999988 7777
Q ss_pred ccccccc-------CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 94 HGTSCRN-------SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 94 ~~~~~~~-------~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
++.+... .+.+.+.+..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++| |+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~ 144 (320)
T 2i6l_A 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN--VLHR 144 (320)
T ss_dssp EEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCC
T ss_pred EEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC--EecC
Confidence 7654321 123355678999999996 699999863 23889999999999999999999999 9999
Q ss_pred CCCCCceEEc-CCCCeEEeccccCccCCCC----CcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 167 DIKSTNILFD-SKWDAKLADFGLAVSESDE----SSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 167 dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||||+|||++ +++.+||+|||++...... .......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999999997 5679999999999765322 12233467999999997654 6789999999999999999999999
Q ss_pred CCCCCCchhHHHhhhh--hhhHHhhhh------------hccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 241 IDAARDPASIIDWALP--LIKEEKLRQ------------VCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
|.+............. ......... ..............++.++.+++.+||+.||++|||++|++
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 225 FAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp SCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence 9876543322111100 000000000 00011111111223567899999999999999999999999
Q ss_pred ccccC
Q 035572 307 MGCSC 311 (379)
Q Consensus 307 ~~~~~ 311 (379)
+|...
T Consensus 305 ~hp~~ 309 (320)
T 2i6l_A 305 SHPYM 309 (320)
T ss_dssp TSHHH
T ss_pred CCccc
Confidence 98443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=318.99 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=200.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|.+.++||+|+||.||+|.+.... .....+|+|.+..... ....+.+.+|+.+++.++|+| |+++++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~~ 89 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRITE---MQQVEAFLREGLLMRGLNHPN-------VLALIG 89 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCCS---HHHHHHHHHHHHHHHTCCCTT-------BCCCCE
T ss_pred EEccCceeccCCCceEEEEEEecCC--Cceeeeeeeecccccc---HHHHHHHHHHHHHHHhCCCCC-------eeeEEE
Confidence 4666799999999999999876533 2556799999875322 344678899999999999988 888787
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
++. ..+...++||||+.+++|.+++... ...+++..+..++.|++.||+|||++| ++||||||+|||+
T Consensus 90 ~~~------~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili 157 (298)
T 3pls_A 90 IML------PPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML 157 (298)
T ss_dssp EEC------CSSSCCEEEECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred EEe------cCCCCcEEEEecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE
Confidence 653 2334459999999999999999752 334889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 176 DSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+.++.+||+|||++....... ......+++.|+|||...+..++.++||||||+++|+|++|..|+....+....
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~ 237 (298)
T 3pls_A 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237 (298)
T ss_dssp CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH
T ss_pred cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH
Confidence 999999999999996543321 223346889999999999999999999999999999999966655444443332
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...... ......+ ..++..+.+++.+||+.||.+|||+.++++....
T Consensus 238 ~~~~~~-----------~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 238 THFLAQ-----------GRRLPQP---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp HHHHHT-----------TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhc-----------CCCCCCC---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 221110 0111111 2335789999999999999999999999986443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=329.17 Aligned_cols=279 Identities=21% Similarity=0.299 Sum_probs=187.4
Q ss_pred CCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
++=+..-+....++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++|+|
T Consensus 3 ~~s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~ 74 (303)
T 2vwi_A 3 EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAP-----KKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPN 74 (303)
T ss_dssp ----------CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC-------------------CCCCCCCTT
T ss_pred CcccccccccchhhhhhhheeccccceEEEEEEECC-----CCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCC
Confidence 333344445557899999999999999999998654 456799999875432 234567889999999999888
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC---CCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA---TTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
|+++++.+ ...+..++||||+++++|.+++...... ....+++..+..++.|++.||.|||++
T Consensus 75 -------i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 75 -------IVSYYTSF-------VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp -------BCCEEEEE-------ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred -------EeeEEEEE-------eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 77777664 4457899999999999999999753221 233488999999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC------cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHH
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES------SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLL 232 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ 232 (379)
| ++||||||+||+++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 141 ~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 218 (303)
T 2vwi_A 141 G--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218 (303)
T ss_dssp T--CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHH
T ss_pred C--CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHH
Confidence 9 9999999999999999999999999986543221 1233468999999998765 46889999999999999
Q ss_pred HHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 233 EIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 233 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+|++|+.||............... . ..........+.....++..+.+++.+||+.||.+|||+.++++|...
T Consensus 219 ~l~~g~~pf~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 219 ELATGAAPYHKYPPMKVLMLTLQN-----D-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp HHHHSSCTTTTSCGGGHHHHHHTS-----S-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred HHHhCCCCCccCchhhHHHHHhcc-----C-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 999999999876543222111000 0 000000000011122345789999999999999999999999998443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=323.20 Aligned_cols=263 Identities=20% Similarity=0.307 Sum_probs=194.9
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .......+.+|+.+++.++|+| |++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~-------i~~ 96 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL-----DGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPN-------VIK 96 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT-----TCCEEEEEEECTTSSC-CHHHHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred cccceEEEEeecCCCCceEEEEEEcC-----CCceEEEEeeehhhcc-CHHHHHHHHHHHHHHHhCCCCC-------Eee
Confidence 35689999999999999999998764 5678999998753221 1345677899999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ...+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.| ++||||||+|
T Consensus 97 ~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~N 166 (310)
T 2wqm_A 97 YYASF-------IEDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPAN 166 (310)
T ss_dssp EEEEE-------EETTEEEEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGG
T ss_pred EEEEE-------EcCCcEEEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHH
Confidence 77664 3467899999999999999999765432 334889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch-hH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA-SI 250 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~ 250 (379)
|+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+..... .+
T Consensus 167 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 246 (310)
T 2wqm_A 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246 (310)
T ss_dssp EEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH
T ss_pred EEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH
Confidence 999999999999999986654332 2233468999999999988899999999999999999999999997643221 11
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. .+...... +.....++.++.+++.+||+.||++|||+.+++++...
T Consensus 247 ~~------------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 247 CK------------KIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp HH------------HHHTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH------------HhhcccCC-CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11 11111111 11113345789999999999999999999999986433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.23 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=194.3
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|++.+.||+|+||.||+|.+.... .....||+|.+..... ....+++.+|+.+++.++|+| |+++++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~hpn-------Iv~~~~ 157 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPN-------VLSLLG 157 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCSC---SHHHHHHHHHHTTSTTCCCTT-------BCCCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCC-------cceEEE
Confidence 4677899999999999999875422 2456799999864321 345678999999999999988 888887
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
++. ..++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||++| |+||||||+|||+
T Consensus 158 ~~~------~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll 225 (373)
T 3c1x_A 158 ICL------RSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML 225 (373)
T ss_dssp EEC------CCSSCCEEEEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred EEE------cCCCCeEEEEECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEE
Confidence 653 3456789999999999999999753 234788899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 176 DSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
+.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||........
T Consensus 226 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~ 305 (373)
T 3c1x_A 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305 (373)
T ss_dssp CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH
T ss_pred CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH
Confidence 999999999999996543322 1123357889999999988899999999999999999999 7788876543321
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
. .... .......+ ..++..+.+++.+||+.||++|||+.+++++....
T Consensus 306 ~-~~~~-----------~~~~~~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 306 T-VYLL-----------QGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp H-HHHH-----------TTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HHHH-----------cCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1100 01111112 23357799999999999999999999999875543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.45 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=199.6
Q ss_pred hcCCcccc-ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 14 TESFSQSR-LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.++|++.+ .||+|+||.||+|.+... ..++.||+|.+...... ....+.+.+|+.+++.++|+| |++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~-------i~~ 82 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPY-------IVR 82 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred chhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCC-------EEE
Confidence 46888888 999999999999976432 26788999998754322 344678999999999999888 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 83 ~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~N 147 (291)
T 1xbb_A 83 MIGIC--------EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARN 147 (291)
T ss_dssp EEEEE--------ESSSEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred EEEEE--------CCCCcEEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcce
Confidence 77764 2467899999999999999997632 3889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
|+++.++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 227 (291)
T 1xbb_A 148 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227 (291)
T ss_dssp EEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999976544322 122346789999999888888999999999999999999 99999865422
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. +.... .. ..... ....+++.+.+++.+||+.||.+|||+.++++..
T Consensus 228 ~-~~~~~---------~~--~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 228 E-VTAML---------EK--GERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp H-HHHHH---------HT--TCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred H-HHHHH---------Hc--CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 11110 00 01111 1233457899999999999999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=329.15 Aligned_cols=274 Identities=18% Similarity=0.221 Sum_probs=197.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh-------hhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL-------QDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
.++|++.+.||+|+||.||+|.+.... ..+..+|+|.......... ......+.+|+..++.++|+|
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n---- 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG---- 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC----
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC----
Confidence 368999999999999999999987532 2567799999875432110 112344677888888888888
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++.+... +.+....|+||||+ +++|.+++...+ .+++..++.++.|++.||+|||++| |+||
T Consensus 110 ---i~~~~~~~~~~---~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 175 (345)
T 2v62_A 110 ---IPLFYGSGLTE---FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE--YVHG 175 (345)
T ss_dssp ---CCCEEEEEEEE---SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred ---cceeecccccc---cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCC
Confidence 77777765431 23467899999999 999999997654 3899999999999999999999999 9999
Q ss_pred CCCCCceEEcCCC--CeEEeccccCccCCCCC--------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 167 DIKSTNILFDSKW--DAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 167 dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 176 Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp CCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999998777 99999999996553221 1234479999999999998889999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 237 CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
|+.||.................... .......... ...++.++.+++.+||+.||++|||++++++.....
T Consensus 256 g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 256 GKLPWEQNLKDPVAVQTAKTNLLDE-LPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp SSCTTGGGTTCHHHHHHHHHHHHHT-TTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred CCCCccccccccHHHHHHHHhhccc-ccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 9999965433222111111110000 0000000000 002346899999999999999999999999875543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.21 Aligned_cols=258 Identities=22% Similarity=0.384 Sum_probs=198.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+...+... ...|++|.+.... .....+.+.+|+.+++.++|+| |+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~-------iv~~ 82 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREAT---SPKANKEILDEAYVMASVDNPH-------VCRL 82 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSC-CEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTT-------BCCC
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceE-EEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCC-------eeEE
Confidence 368999999999999999999987654433 2346888876432 1345688999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++.. +..++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 83 ~~~~~~--------~~~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI 148 (327)
T 3lzb_A 83 LGICLT--------STVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNV 148 (327)
T ss_dssp CEEEES--------SSEEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred EEEEec--------CCceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHE
Confidence 876532 35889999999999999998632 34889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 149 l~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~- 227 (327)
T 3lzb_A 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 227 (327)
T ss_dssp EEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred EEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-
Confidence 999999999999999976543322 223356889999999988899999999999999999999 999997654322
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.... .. ......+ ..++.++.+++.+||+.||.+|||+.|+++....
T Consensus 228 ~~~~~---------~~--~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 228 ISSIL---------EK--GERLPQP---PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp HHHHH---------HT--TCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH---------Hc--CCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11110 00 1111112 2345679999999999999999999999986443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.93 Aligned_cols=257 Identities=21% Similarity=0.375 Sum_probs=197.5
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.... ...+..||+|.+..... ......+.+|+.+++.++|+| |++++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 112 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHN-------IIRLE 112 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTT-------BCCEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCC-------CCcEE
Confidence 46777899999999999999876533 22456799999875432 334567899999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||
T Consensus 113 ~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl 179 (333)
T 1mqb_A 113 GVI-------SKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNIL 179 (333)
T ss_dssp EEE-------CSSSSEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred EEE-------ecCCCcEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEE
Confidence 764 4567899999999999999999763 234899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 180 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~- 258 (333)
T 1mqb_A 180 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE- 258 (333)
T ss_dssp ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred ECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 99999999999999966543221 122346789999999988889999999999999999999 999997654211
Q ss_pred HHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.. .+... .... ...++..+.+++.+||+.||++||++.+++++...
T Consensus 259 ~~~------------~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 259 VMK------------AINDGFRLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp HHH------------HHHTTCCCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHH------------HHHCCCcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 11111 1111 12345789999999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=329.01 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=199.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~ 93 (379)
++|++.+.||+|+||.||+|.+..++ ....+++|.+.... .....+.+.+|+.+++++ +|+| |+++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~-------iv~~ 91 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPN-------IINL 91 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTT-------BCCE
T ss_pred HHccceeeeecCCCceEEEEEEccCC---cccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCc-------hhhh
Confidence 68999999999999999999876522 11235899886432 134456789999999999 7877 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----------CCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----------ATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++.+ .+.+..|+||||+++++|.+++..... .....+++..++.++.|++.||.|||++|
T Consensus 92 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 162 (327)
T 1fvr_A 92 LGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-- 162 (327)
T ss_dssp EEEE-------EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ceee-------eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 7764 456789999999999999999986431 12234899999999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPI 241 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~ 241 (379)
|+||||||+|||++.++.+||+|||++.............+++.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 163 ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 163 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp EECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999999865443333334467889999999888888999999999999999998 99999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.+..... +.. .+... ... ....+++.+.+++.+||+.||.+|||+.+++.+....
T Consensus 243 ~~~~~~~-~~~------------~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 243 CGMTCAE-LYE------------KLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp TTCCHHH-HHH------------HGGGTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcHHH-HHH------------HhhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7654211 111 11111 111 1123457899999999999999999999999875543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.30 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=203.4
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
-+++....++|++.+.||+|+||.||+|.+. .++.||+|.+.... ...+.+.+|+.+++.++|+|
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~---- 69 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQR---- 69 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTT----
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcC----
Confidence 3445556789999999999999999999864 34569999987542 23578999999999999988
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
++++++.+. .+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++| ++||
T Consensus 70 ---i~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~ 133 (279)
T 1qpc_A 70 ---LVRLYAVVT--------QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN--YIHR 133 (279)
T ss_dssp ---BCCEEEEEC--------SSSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred ---cceEEEEEc--------CCCcEEEEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 777776542 3568999999999999999975432 13889999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDA 243 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~ 243 (379)
||||+||++++++.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+
T Consensus 134 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999976544322 223357789999999888889999999999999999999 9999976
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... ..... .. ..... ....++..+.+++.+||+.||++|||++++++..
T Consensus 214 ~~~~~-~~~~~---------~~--~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 214 MTNPE-VIQNL---------ER--GYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp CCHHH-HHHHH---------HT--TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHH-HHHHH---------hc--ccCCC---CcccccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 54322 11110 00 00111 1123457899999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=323.46 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=201.4
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.+.. +++.||+|.+.... +.+.+|+.+++.++|+| ++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~-------i~ 67 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRI-----DGKTYVIKRVKYNN--------EKAEREVKALAKLDHVN-------IV 67 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETT-----TCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTT-------BC
T ss_pred hhccccceeeeeccCCceEEEEEEEcC-----CCeEEEEEEecccc--------HHHHHHHHHHHhCCCCC-------EE
Confidence 456789999999999999999998764 56789999986432 34678999999999988 77
Q ss_pred ecccccccc---------CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 92 NFHGTSCRN---------SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 92 ~~~~~~~~~---------~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++++.+... ..........++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-- 142 (284)
T 2a19_B 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSKK-- 142 (284)
T ss_dssp CEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 666654220 0011234568999999999999999986432 23889999999999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
|+||||||+|||++.++.++|+|||++.............+|+.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 143 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred eeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999999999999999999999977665555555679999999999988889999999999999999999998874
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
... .....+..... + ..++..+.+++.+||+.||.+|||+.|++++..
T Consensus 223 ~~~---------------~~~~~~~~~~~--~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 223 ETS---------------KFFTDLRDGII--S---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp HHH---------------HHHHHHHTTCC--C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hHH---------------HHHHHhhcccc--c---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 311 00111111111 1 123467889999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.50 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=198.6
Q ss_pred CCCCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh--
Q 035572 3 ENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-- 80 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-- 80 (379)
++|++..+....++|++.+.||+|+||.||+|.+. .++.||+|.+...... ....+.+.+|+.+++.++|
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~ 87 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHS 87 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHHGGGC
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEecccccc--ccchHHHHHHHHHHHhccccC
Confidence 45666666667789999999999999999999864 3567999998755332 3456789999999999986
Q ss_pred ccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC
Q 035572 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND 160 (379)
Q Consensus 81 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 160 (379)
++ ++++++++ .+.+..++|||+ .+++|.+++.... .+++..+..++.|++.||.|||++|
T Consensus 88 ~~-------iv~~~~~~-------~~~~~~~lv~e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ 147 (313)
T 3cek_A 88 DK-------IIRLYDYE-------ITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 147 (313)
T ss_dssp TT-------BCCEEEEE-------ECSSEEEEEECC-CSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred Cc-------eEEEEEEe-------ecCCEEEEEEec-CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44 77777654 456789999995 4899999998643 3889999999999999999999999
Q ss_pred CCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCC-----------CCCCCcCCeeh
Q 035572 161 PMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNP-----------SKLSKKVDVFS 226 (379)
Q Consensus 161 ~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwS 226 (379)
|+||||||+|||+++ +.+||+|||++........ .....||+.|+|||++.+ ..++.++||||
T Consensus 148 --ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~s 224 (313)
T 3cek_A 148 --IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224 (313)
T ss_dssp --CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHH
T ss_pred --ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHH
Confidence 999999999999964 7999999999976543322 233468999999998765 46788999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhcccc--CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHH
Q 035572 227 YGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSR--VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304 (379)
Q Consensus 227 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 304 (379)
||+++|+|++|+.||....+.... .....+.. ...+.. .+..+.+++.+||+.||++|||+.|
T Consensus 225 lG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~e 289 (313)
T 3cek_A 225 LGCILYYMTYGKTPFQQIINQISK------------LHAIIDPNHEIEFPDI---PEKDLQDVLKCCLKRDPKQRISIPE 289 (313)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHH------------HHHHHCTTSCCCCCCC---SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHhCCCchhhHHHHHHH------------HHHHHhcccccCCccc---chHHHHHHHHHHccCCcccCcCHHH
Confidence 999999999999999765432211 11111111 111221 2467899999999999999999999
Q ss_pred HhccccC
Q 035572 305 ILMGCSC 311 (379)
Q Consensus 305 ~l~~~~~ 311 (379)
+++|...
T Consensus 290 ll~h~~~ 296 (313)
T 3cek_A 290 LLAHPYV 296 (313)
T ss_dssp HHTSHHH
T ss_pred HhcCccc
Confidence 9998443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=314.10 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=200.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+. .++.||+|.+.... ...+.+.+|+.+++.++|+| ++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~-------i~~~ 68 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPK-------LVQL 68 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred hhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 578999999999999999999875 34569999997543 23467899999999999888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++| ++||||||+||
T Consensus 69 ~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Ni 135 (267)
T 3t9t_A 69 YGVC-------LEQAPICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNC 135 (267)
T ss_dssp EEEE-------CSSSSCEEEECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGE
T ss_pred EEEE-------ccCCCeEEEEeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheE
Confidence 7764 44678999999999999999997632 24889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++.++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||....... .
T Consensus 136 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~ 214 (267)
T 3t9t_A 136 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-V 214 (267)
T ss_dssp EECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-H
T ss_pred EECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-H
Confidence 99999999999999986653321 1223357889999999988889999999999999999999 899997654221 1
Q ss_pred HHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 251 IDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.. .+... ....+ ...+..+.+++.+||+.||++|||+.+++++..
T Consensus 215 ~~------------~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 215 VE------------DISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp HH------------HHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH------------HHhcCCcCCCC---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 11111 11111 223577999999999999999999999998643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=318.69 Aligned_cols=257 Identities=22% Similarity=0.367 Sum_probs=203.4
Q ss_pred hcCCcccc-ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 14 TESFSQSR-LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.++|.+.+ .||+|+||.||+|.+.... .+..||+|.+..... ....+.+.+|+.+++.++|+| |++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------i~~ 74 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPY-------IVR 74 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred HHHhhhhhccccccCceeEEEeEeccCC---CcceEEEEecCCccc---hhHHHHHHHHHHHHHhCCCCC-------EeE
Confidence 46788877 9999999999999875432 567899999976422 345678999999999999888 787
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ ..+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.| ++||||||+|
T Consensus 75 ~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~N 140 (287)
T 1u59_A 75 LIGVC--------QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 140 (287)
T ss_dssp EEEEE--------ESSSEEEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred EEEEe--------cCCCcEEEEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchhe
Confidence 77764 235689999999999999999642 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
|+++.++.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 220 (287)
T 1u59_A 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220 (287)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999976543322 223356899999999888889999999999999999998 99999776532
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
.. .... .. ..... ....+++.+.+++.+||+.||++||++.+++++....
T Consensus 221 ~~-~~~i---------~~--~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 221 EV-MAFI---------EQ--GKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HH-HHHH---------HT--TCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-HHHH---------hc--CCcCC---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21 1110 00 01111 2234457899999999999999999999999875443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=325.84 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=199.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.......+++.||+|.+..... .....++.+|+.+++.++|+| |+++
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~-------iv~~ 98 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQN-------IVRC 98 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc---hhhHHHHHHHHHHHhhCCCCC-------CCeE
Confidence 579999999999999999999876544445778899999974422 344567899999999999888 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC--CCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA--TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++.+ .+.+..|+||||+++++|.+++...... ....+++..++.++.|++.||.|||++| |+||||||+
T Consensus 99 ~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~ 169 (327)
T 2yfx_A 99 IGVS-------LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAAR 169 (327)
T ss_dssp EEEE-------CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred EEEE-------cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHh
Confidence 7764 4467789999999999999999875422 1234888999999999999999999999 999999999
Q ss_pred ceEEcC---CCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 172 NILFDS---KWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 172 NIll~~---~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
|||++. +..++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 170 NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred HEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 999984 4469999999985432221 2233467899999999888889999999999999999998 99999765
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... .+... +..... +.....++..+.+++.+||+.||.+|||+.+++++...
T Consensus 250 ~~~-~~~~~------------~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 250 SNQ-EVLEF------------VTSGGR--MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp CHH-HHHHH------------HHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHH-HHHHH------------HhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 321 11111 111100 11122345789999999999999999999999987443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.49 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=190.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHH--HHhhhhccCCCCCceee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV--LSSLQESNKRNPNYCVV 91 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~--l~~l~~~~~~~~~~~iv 91 (379)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.++ +..++|+| |+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~-------i~ 70 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-------DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDN-------IA 70 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTT-------BC
T ss_pred hHHhheeeecccCCCeEEEEEEE-------CCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcc-------hh
Confidence 57899999999999999999965 4577999998632 23344445544 44578877 66
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC---------CCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN---------DPM 162 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---------~~~ 162 (379)
++++.+... ........++||||+++|+|.+++.... .++..+..++.|++.||.|||+. |
T Consensus 71 ~~~~~~~~~--~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-- 140 (336)
T 3g2f_A 71 RFIVGDERV--TADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-- 140 (336)
T ss_dssp CEEEEEEEE--CTTSCEEEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--
T ss_pred hheeccccc--ccCCCceEEEEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccc--
Confidence 666533221 1234557799999999999999997532 57888999999999999999999 9
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCC---------cccccCccccccCCCCCCC-------CCCCCcCCeeh
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---------SMVQPAGTIGYLDPGYTNP-------SKLSKKVDVFS 226 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwS 226 (379)
|+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||
T Consensus 141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws 220 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220 (336)
T ss_dssp EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence 9999999999999999999999999996553321 1223469999999998876 35667899999
Q ss_pred hHHHHHHHHhCCCCCCCCCCchhHHHh----hhhhhhHHhhh---hhccccCCCCc---chHHHHHHHHHHHHhcccCCC
Q 035572 227 YGVVLLEIISCRKPIDAARDPASIIDW----ALPLIKEEKLR---QVCDSRVGLPT---FMEGAIKQMLHVAARCVSSEE 296 (379)
Q Consensus 227 lG~il~elltg~~p~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp 296 (379)
|||++|+|++|..||............ ........... .........+. ....+++.+.+|+.+||+.||
T Consensus 221 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (336)
T 3g2f_A 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300 (336)
T ss_dssp HHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCCh
Confidence 999999999998776544322111000 00000000000 01111112222 123467789999999999999
Q ss_pred CCCCChHHHhcccc
Q 035572 297 ENRPGIGEILMGCS 310 (379)
Q Consensus 297 ~~Rps~~e~l~~~~ 310 (379)
++|||+.|+++...
T Consensus 301 ~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 301 EARLTAQXAEERMA 314 (336)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCcchHHHHHHHH
Confidence 99999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=319.43 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=197.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
.|....+||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| |+++++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~-------iv~~~~ 86 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS-----NQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKN-------IVQYLG 86 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT-----TCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTT-------BCCEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECC-----CCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCC-------EeeEee
Confidence 45555699999999999998765 55779999987543 334577999999999999988 787777
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
.+ ...+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||++| ++||||||+||++
T Consensus 87 ~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~ 155 (295)
T 2clq_A 87 SF-------SENGFIKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLI 155 (295)
T ss_dssp EE-------EETTEEEEEEECCSEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred EE-------EeCCcEEEEEEeCCCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEE
Confidence 64 44678999999999999999998643 2233678888999999999999999999 9999999999999
Q ss_pred cC-CCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCC--CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 176 DS-KWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSK--LSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 176 ~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
+. ++.++|+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..........
T Consensus 156 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 235 (295)
T 2clq_A 156 NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235 (295)
T ss_dssp ETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH
T ss_pred ECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH
Confidence 87 8999999999997654322 233457999999999886543 7889999999999999999999997654332111
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... ...... +.....++.++.+++.+||+.||++|||+.+++.|...
T Consensus 236 ~~~----------~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 236 FKV----------GMFKVH---PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp HHH----------HHHCCC---CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred Hhh----------cccccc---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 100 001111 11223345789999999999999999999999998443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.59 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=188.0
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv 91 (379)
...+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.+. |+| |+
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~~h~~-------iv 89 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG-----SGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPN-------IV 89 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEESS----HHHHHHHHHHHHHHHHHTTSTT-------BC
T ss_pred cCceEEEEEEEccCCceEEEEEEECC-----CCcEEEEEEecCCc----hHHHHHHHHHHHHHHHhccCCC-------hh
Confidence 34689999999999999999998765 56789999885432 344577899999999996 888 77
Q ss_pred eccccccccCC-CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 92 NFHGTSCRNSG-SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 92 ~~~~~~~~~~~-~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
++++.+..... ........++||||+ +|+|.+++..... ...+++..++.++.|++.||.|||+.|.+|+||||||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp 166 (337)
T 3ll6_A 90 QFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166 (337)
T ss_dssp CEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCG
T ss_pred hccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCc
Confidence 77776532111 124456789999999 5899999976432 2348999999999999999999999876699999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCcc-------------cccCccccccCCCCC---CCCCCCCcCCeehhHHHHHHH
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESSM-------------VQPAGTIGYLDPGYT---NPSKLSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~el 234 (379)
+|||++.++.+||+|||++......... ....+|+.|+|||++ .+..++.++|||||||++|+|
T Consensus 167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 9999999999999999999765433211 134589999999988 566788999999999999999
Q ss_pred HhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 235 ISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 235 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
++|+.||......... ......+ .....+..+.+++.+||+.||.+|||+.|++++.....
T Consensus 247 ~~g~~p~~~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 247 CFRQHPFEDGAKLRIV-----------------NGKYSIP-PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp HHSSCCC-----------------------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCCCcchhHHHhh-----------------cCcccCC-cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999754321110 0000001 01112345889999999999999999999999855443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=324.87 Aligned_cols=263 Identities=18% Similarity=0.280 Sum_probs=200.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+| |+++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~-------iv~~ 91 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH-----DGHFYALKRILCHE----QQDREEAQREADMHRLFNHPN-------ILRL 91 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEESS----HHHHHHHHHHHHHHHTCCCTT-------BCCC
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC-----CCcEEEEEEEecCC----HHHHHHHHHHHHHHhhcCCCC-------eeeE
Confidence 4689999999999999999998754 56789999886432 345678899999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++... .......++||||+++++|.+++..... ....+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 92 ~~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NI 165 (317)
T 2buj_A 92 VAYCLRE---RGAKHEAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNI 165 (317)
T ss_dssp CEEEEEE---ETTEEEEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred EEEEEec---cCCCceeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHE
Confidence 8775421 1234578999999999999999987543 2344899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc----------ccccCccccccCCCCCCCCC---CCCcCCeehhHHHHHHHHhCCCC
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS----------MVQPAGTIGYLDPGYTNPSK---LSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~p 240 (379)
|++.++.++|+|||++........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.|
T Consensus 166 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp EECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999865432111 11234799999999887654 68899999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|........... ..... ....+ ....++..+.+++.+||+.||.+|||+.+++++...
T Consensus 246 ~~~~~~~~~~~~--------~~~~~----~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 246 YDMVFQKGDSVA--------LAVQN----QLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp THHHHHTTSCHH--------HHHHC----C--CC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhcccchhh--------HHhhc----cCCCC-ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 954211100000 00000 11111 112345789999999999999999999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=323.24 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=181.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHH-HHHhhhhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR-VLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... .....++..|+. +++.++|+| |++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~h~n-------iv~ 85 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP-----SGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPY-------IVQ 85 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT-----TTEEEEEEEEECCCC---HHHHHHHHHHHHHHHSSCCCTT-------BCC
T ss_pred HHHhhehheeccCCCEEEEEEEEcC-----CCCEEEEEEeecccC---chHHHHHHHHHHHHHHcCCCCc-------Eee
Confidence 4789999999999999999998764 567899999875432 233445556665 677778887 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKST 171 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~ 171 (379)
+++.+ ...+..++||||++ ++|.+++..........+++..+..++.|++.||.|||+. | |+||||||+
T Consensus 86 ~~~~~-------~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~ 155 (327)
T 3aln_A 86 FYGAL-------FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPS 155 (327)
T ss_dssp EEEEE-------ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGG
T ss_pred eeeEE-------EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHH
Confidence 77764 44678999999996 5998888754433445589999999999999999999998 9 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC----CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT----NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|||++.++.+||+|||++.............||+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 156 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (327)
T 3aln_A 156 NILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235 (327)
T ss_dssp GEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---
T ss_pred HEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH
Confidence 999999999999999999766554444445799999999998 4567899999999999999999999999764321
Q ss_pred hhHHHhhhhhhhHHhhhhhcccc-CCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSR-VGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
... ...+.... ...+ .....+++.+.+++.+||+.||++|||+.++++|..
T Consensus 236 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 236 FDQ------------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp ----------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHH------------HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 111 11111111 1111 111234578999999999999999999999999843
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.63 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=202.5
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHh--hhhcc
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSS--LQESN 82 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~~~ 82 (379)
.++.....+.++|++.+.||+|+||.||+|.+ .++.||+|.+.. .....+.+|++++.. ++|+|
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~n 97 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHEN 97 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTT
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-------cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCc
Confidence 34445566778999999999999999999976 356799999863 234667889999988 67877
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHH-----
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLH----- 157 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----- 157 (379)
|+++++.+.... ......++||||+++|+|.+++... .+++..++.++.|++.||.|||
T Consensus 98 -------i~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~ 161 (342)
T 1b6c_B 98 -------ILGFIAADNKDN---GTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVG 161 (342)
T ss_dssp -------BCCEEEEEECCC---SSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred -------EEEEEeeecccC---CccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 777777653211 1113789999999999999999752 2889999999999999999999
Q ss_pred ---cCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCC------CCCCcCC
Q 035572 158 ---ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPS------KLSKKVD 223 (379)
Q Consensus 158 ---~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~D 223 (379)
+.| |+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+. .++.++|
T Consensus 162 ~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 239 (342)
T 1b6c_B 162 TQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239 (342)
T ss_dssp TTCBCE--EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHH
T ss_pred hcccCC--eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCccc
Confidence 889 9999999999999999999999999996554332 12344799999999988765 2346899
Q ss_pred eehhHHHHHHHHhC----------CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc--chHHHHHHHHHHHHhc
Q 035572 224 VFSYGVVLLEIISC----------RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT--FMEGAIKQMLHVAARC 291 (379)
Q Consensus 224 iwSlG~il~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~ 291 (379)
||||||++|+|+|| ..||............... ....... ....+. ....++..+.+++.+|
T Consensus 240 i~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~c 313 (342)
T 1b6c_B 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK----VVCEQKL--RPNIPNRWQSCEALRVMAKIMREC 313 (342)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH----HHTTSCC--CCCCCGGGGTSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHH----HHHHHHh--CCCCcccccchhHHHHHHHHHHHH
Confidence 99999999999999 7788655332211111100 0001111 111222 1235678899999999
Q ss_pred ccCCCCCCCChHHHhcccc
Q 035572 292 VSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 292 l~~dp~~Rps~~e~l~~~~ 310 (379)
|+.||++|||+.+++++..
T Consensus 314 l~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 314 WYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCSSGGGSCCHHHHHHHHH
T ss_pred hccChhhCCCHHHHHHHHH
Confidence 9999999999999998744
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.87 Aligned_cols=271 Identities=20% Similarity=0.271 Sum_probs=201.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|.+.. +++.||||.+...... ....+++.+|+.+++.++|+| |+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~-------iv~~ 88 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHEN-------VIGL 88 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEESSTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC-----CCCEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCC-------cccH
Confidence 4789999999999999999998764 5678999998754322 344678899999999999988 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.... ........|+||||+. ++|.+++.. .+++..+..++.|++.||.|||++| |+||||||+||
T Consensus 89 ~~~~~~~~-~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NI 157 (353)
T 3coi_A 89 LDVFTPAS-SLRNFYDFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNL 157 (353)
T ss_dssp SEEECSCS-SGGGCCCCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGE
T ss_pred hheEeccc-ccccceeEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence 77653311 1112235699999995 688777632 2899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 158 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 235 (353)
T 3coi_A 158 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235 (353)
T ss_dssp EECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH
T ss_pred eECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999998765432 233478999999998776 6789999999999999999999999987653322211
Q ss_pred hhhhh----------h----hHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPL----------I----KEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~----------~----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..... + .......+.. ...........+++.+.+++.+||+.||++|||+.++++|...
T Consensus 236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 11000 0 0000000000 0111122233456889999999999999999999999998554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.98 Aligned_cols=270 Identities=16% Similarity=0.194 Sum_probs=199.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCC---CceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDG---DHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
.++|++.+.||+|+||.||+|.+..+.... .++.||+|.+... +.+.+|+.+++.++|+| +
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~n-------i 104 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPL-------Q 104 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHH-------H
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccc-------h
Confidence 368999999999999999999987532111 3677999998632 35789999999999988 5
Q ss_pred eeccccc--------cccCCCc-cCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCC
Q 035572 91 VNFHGTS--------CRNSGSV-DGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDP 161 (379)
Q Consensus 91 v~~~~~~--------~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 161 (379)
+++++.+ ....+.. .+++..|+||||+ +++|.+++.... ...+++.+++.++.|++.||.|||++|
T Consensus 105 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~- 179 (352)
T 2jii_A 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE- 179 (352)
T ss_dssp HHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5533221 1111222 2367889999999 999999998642 233899999999999999999999999
Q ss_pred CeEecCCCCCceEEcCCC--CeEEeccccCccCCCCC--------cccccCccccccCCCCCCCCCCCCcCCeehhHHHH
Q 035572 162 MIIHRDIKSTNILFDSKW--DAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231 (379)
Q Consensus 162 ~i~H~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 231 (379)
|+||||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 180 -ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 180 -YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp -CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 99999999999999988 89999999996554322 11334799999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCch-hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 232 LEIISCRKPIDAARDPA-SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
|+|++|+.||....... .+...... +................++..+.+++.+||+.||++|||++++++...
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQK------FVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHH------HHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHh------ccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 99999999998765322 22111110 011000000000011223578999999999999999999999988644
Q ss_pred C
Q 035572 311 C 311 (379)
Q Consensus 311 ~ 311 (379)
.
T Consensus 333 ~ 333 (352)
T 2jii_A 333 A 333 (352)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=320.23 Aligned_cols=261 Identities=25% Similarity=0.447 Sum_probs=195.3
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+... ....+.+.+|+.+++.++|+| +++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~-------i~~ 66 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL-----DSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQY-------VVR 66 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTT-------BCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC-----CCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchH-------HHH
Confidence 46789999999999999999998764 5678999998632 344578899999999999988 777
Q ss_pred cccccccc------CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 93 FHGTSCRN------SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 93 ~~~~~~~~------~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
+++.+... .+.....+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++| ++||
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~ 140 (303)
T 1zy4_A 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG--IIHR 140 (303)
T ss_dssp EEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred HHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence 77765432 122345678999999999999999998532 23778889999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCC---------------CcccccCccccccCCCCCCCC-CCCCcCCeehhHHH
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDE---------------SSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVV 230 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~i 230 (379)
||||+|||++.++.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||+
T Consensus 141 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 220 (303)
T 1zy4_A 141 DLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHH
T ss_pred cCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHH
Confidence 99999999999999999999998655321 112334689999999988754 68999999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 231 LLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 231 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+|+|++ ||....+.... ...+.......+ ......+..+.+++.+||+.||.+|||+.++++|.
T Consensus 221 l~~l~~---p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 221 FFEMIY---PFSTGMERVNI------------LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHS---CCSSHHHHHHH------------HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHHHHh---ccCCchhHHHH------------HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 999998 55432211111 111111111111 12234456789999999999999999999999984
Q ss_pred cC
Q 035572 310 SC 311 (379)
Q Consensus 310 ~~ 311 (379)
..
T Consensus 286 ~~ 287 (303)
T 1zy4_A 286 WL 287 (303)
T ss_dssp CS
T ss_pred Cc
Confidence 43
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=324.20 Aligned_cols=274 Identities=16% Similarity=0.232 Sum_probs=199.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCC------CCC
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKR------NPN 87 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~------~~~ 87 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+... ....+.+.+|+.+++.+++.+.. +++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC-----CCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3689999999999999999998764 5678999998743 23456788999999999843210 111
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEec
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHR 166 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~ 166 (379)
|+++++++... -......++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ | |+||
T Consensus 88 --i~~~~~~~~~~---~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~ 156 (373)
T 1q8y_A 88 --ILKLLDHFNHK---GPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHT 156 (373)
T ss_dssp --BCCCCEEEEEE---ETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECS
T ss_pred --HHHHHHHhhcc---CCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEec
Confidence 67766664321 01223789999999 999999998643 23388999999999999999999998 9 9999
Q ss_pred CCCCCceEEc------CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 167 DIKSTNILFD------SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 167 dlkp~NIll~------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
||||+|||++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 157 Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 157 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred CCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 9999999994 3447999999999765432 2334799999999999988999999999999999999999999
Q ss_pred CCCCCCch-----hHHHhhhhhhh---HHhh---------------------------hhhccccCCCCcchHHHHHHHH
Q 035572 241 IDAARDPA-----SIIDWALPLIK---EEKL---------------------------RQVCDSRVGLPTFMEGAIKQML 285 (379)
Q Consensus 241 ~~~~~~~~-----~~~~~~~~~~~---~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~ 285 (379)
|....... ........... .... ........ .....++.++.
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 311 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY---KFSKDEAKEIS 311 (373)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT---CCCHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc---cCCcchHHHHH
Confidence 97654211 11110000000 0000 00000011 12246678999
Q ss_pred HHHHhcccCCCCCCCChHHHhccccCcc
Q 035572 286 HVAARCVSSEEENRPGIGEILMGCSCFF 313 (379)
Q Consensus 286 ~li~~~l~~dp~~Rps~~e~l~~~~~~~ 313 (379)
+||.+||+.||++|||+.|+++|.....
T Consensus 312 ~li~~~L~~dP~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred HHHHHHhccCccccCCHHHHhhChhhhc
Confidence 9999999999999999999999966544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.22 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=199.9
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
+.+....++|++.+.||+|+||.||+|.+.. ...||||.++... ...+.+.+|+.+++.++|+|
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~----- 240 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEK----- 240 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTT-----
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCC-----
Confidence 3444456789999999999999999998753 2459999997543 23567999999999999988
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++.+. .+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++| |+|||
T Consensus 241 --iv~~~~~~~--------~~~~~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrD 305 (452)
T 1fmk_A 241 --LVQLYAVVS--------EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 305 (452)
T ss_dssp --BCCEEEEEC--------SSSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred --EeeEEEEEc--------CCceEEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence 888777642 2568999999999999999975432 23889999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAA 244 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~ 244 (379)
|||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|+| |+.||.+.
T Consensus 306 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997654322 1223356789999999888889999999999999999999 99999765
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... ..... . ...+...+ ..++..+.+++.+||+.||++|||+++++.....
T Consensus 386 ~~~~-~~~~i---------~--~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~ 437 (452)
T 1fmk_A 386 VNRE-VLDQV---------E--RGYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437 (452)
T ss_dssp CHHH-HHHHH---------H--TTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CHHH-HHHHH---------H--cCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 4321 11110 0 01112222 2345789999999999999999999999976443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=317.73 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=192.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++|+| +++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~-------iv~ 78 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN-------LVQ 78 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTT-------BCC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCC-------Eee
Confidence 3578999999999999999999753 467999998743 24577899999999999988 787
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+. ...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++| ++||||||+|
T Consensus 79 ~~~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~N 147 (278)
T 1byg_A 79 LLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARN 147 (278)
T ss_dssp EEEEEC------CC--CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEEEE------cCCCceEEEEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcce
Confidence 777642 334578999999999999999986532 12788889999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
|+++.++.++|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|+| |+.||....... ..
T Consensus 148 il~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~ 224 (278)
T 1byg_A 148 VLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV 224 (278)
T ss_dssp EEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HH
T ss_pred EEEeCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 999999999999999986544322 23367889999999988889999999999999999998 999997654221 11
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. .+... .. +.....+++.+.+++.+||+.||++|||+.++++..
T Consensus 225 ~------------~~~~~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 225 P------------RVEKG-YK-MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp H------------HHTTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H------------HHhcC-CC-CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 1 11111 00 111233457899999999999999999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=326.90 Aligned_cols=257 Identities=18% Similarity=0.285 Sum_probs=202.7
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhh-------------hcHHHHHHHHHHHHhhhh
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQ-------------DNSKKLNNEIRVLSSLQE 80 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 80 (379)
.++|++.+.||+|+||.||+|.+ +++.||+|.+......... ...+.+.+|+.+++.++|
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 47899999999999999999986 4578999998643211000 011889999999999998
Q ss_pred ccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHH------HHhhhcCCCCCCChHhHHHHHHHHHHHHH
Q 035572 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL------LHNAAAATTPQLGWPNRVKIAMQISRAIQ 154 (379)
Q Consensus 81 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 154 (379)
+| |+++++.+ .+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.
T Consensus 103 ~~-------i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~ 165 (348)
T 2pml_X 103 EY-------CLTCEGII-------TNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFS 165 (348)
T ss_dssp TT-------BCCCSEEE-------ESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHH
T ss_pred CC-------cceEEEEE-------eeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHH
Confidence 88 77777764 456789999999999999998 4431 1345899999999999999999
Q ss_pred HHHc-CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCC-cCCeehhHHHH
Q 035572 155 CLHE-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSK-KVDVFSYGVVL 231 (379)
Q Consensus 155 ~LH~-~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il 231 (379)
|||+ .| ++||||||+||+++.++.++|+|||++...... ......+|+.|+|||++.+. .++. ++||||||+++
T Consensus 166 ~lH~~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 242 (348)
T 2pml_X 166 YIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242 (348)
T ss_dssp HHHHTSC--EECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHH
T ss_pred HHhccCC--EeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHH
Confidence 9999 99 999999999999999999999999999765433 33445799999999998877 5666 99999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc----------------chHHHHHHHHHHHHhcccCC
Q 035572 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT----------------FMEGAIKQMLHVAARCVSSE 295 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~d 295 (379)
|+|++|+.||............. .......+. ....++..+.+++.+||+.|
T Consensus 243 ~~l~~g~~pf~~~~~~~~~~~~i------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 310 (348)
T 2pml_X 243 YVMFYNVVPFSLKISLVELFNNI------------RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310 (348)
T ss_dssp HHHHHSSCSSCCSSCSHHHHHHH------------TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHH------------hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCC
Confidence 99999999998766533322221 111111110 01334578999999999999
Q ss_pred CCCCCChHHHhccc
Q 035572 296 EENRPGIGEILMGC 309 (379)
Q Consensus 296 p~~Rps~~e~l~~~ 309 (379)
|.+|||+.|+++|.
T Consensus 311 P~~Rps~~e~l~hp 324 (348)
T 2pml_X 311 PAERITSEDALKHE 324 (348)
T ss_dssp GGGSCCHHHHHTSG
T ss_pred hhhCCCHHHHhcCc
Confidence 99999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=318.49 Aligned_cols=258 Identities=20% Similarity=0.310 Sum_probs=193.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.... .....||+|.++..... .....+.+.+|+.+++.++|+| |+++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~-------i~~~ 86 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRN-------LIRL 86 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCC-------cccE
Confidence 468999999999999999999865322 24457999998754321 1345678999999999999888 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. ...++||||+++++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||
T Consensus 87 ~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Ni 152 (291)
T 1u46_A 87 YGVVLT--------PPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNL 152 (291)
T ss_dssp EEEECS--------SSCEEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred EEEEcc--------CCceeeEecccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheE
Confidence 776432 348999999999999999986432 3889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCch
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPA 248 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~ 248 (379)
+++.++.+||+|||++........ .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 153 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 232 (291)
T 1u46_A 153 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232 (291)
T ss_dssp EEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH
Confidence 999999999999999976544322 223357889999999888888999999999999999999 999997654221
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ...+...... +.....++..+.+++.+||+.||++|||+.+++++.
T Consensus 233 -~------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 233 -I------------LHKIDKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp -H------------HHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -H------------HHHHHccCCC-CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 1 1111111111 112234457899999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=318.98 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=182.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.++..+++.++|+| |+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~-------i~~~ 89 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPY-------IVQC 89 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT-----TCCEEEEEEEETTSCH--HHHHHHHHHHHHHHHTTTCTT-------BCCE
T ss_pred hccccccceeeecCCeeEEEEEEec-----CCeEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCc-------eeeE
Confidence 4689999999999999999998764 5678999999765432 233344555666788888887 8887
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN-DPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~i~H~dlkp~N 172 (379)
++++ .+.+..++||||+ ++.+..+..... ..+++..+..++.|++.||.|||+. | ++||||||+|
T Consensus 90 ~~~~-------~~~~~~~lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~N 155 (318)
T 2dyl_A 90 FGTF-------ITNTDVFIAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSN 155 (318)
T ss_dssp EEEE-------ECSSEEEEEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGG
T ss_pred EEEE-------ecCCcEEEEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHH
Confidence 7764 4467899999999 666766665422 2388999999999999999999995 9 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC-----CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-----PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||++.++.+||+|||++.............+|+.|+|||++. ...++.++||||||+++|+|++|+.||......
T Consensus 156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp EEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999997655444444557999999999874 456889999999999999999999999865443
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
....... .............+++++.+++.+||+.||.+|||+.++++|...
T Consensus 236 ~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 236 FEVLTKV------------LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp HHHHHHH------------HHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred HHHHHHH------------hccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 2221111 111111111112245789999999999999999999999998543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.97 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=198.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.++||+|+||.||+|.+.. +++.||||++.... ....+.+|+.+++.++|++... .+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~------~~~~~~~E~~il~~L~~~~~i~----~i~~ 70 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKT------KHPQLLYESKIYRILQGGTGIP----NVRW 70 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT-----TCCEEEEEEEETTC------SSCCHHHHHHHHHHTTTSTTCC----CEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC-----CCcEEEEEEecccc------ccHHHHHHHHHHHHhcCCCCCC----eEEE
Confidence 5789999999999999999998764 56789999876432 2345789999999999865322 1211
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+ ....+..+|||||+ +++|.+++.... ..+++.+++.++.||+.||.|||++| |+||||||+||
T Consensus 71 ~---------~~~~~~~~lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NI 134 (483)
T 3sv0_A 71 F---------GVEGDYNVLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNF 134 (483)
T ss_dssp E---------EEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred E---------EeeCCEEEEEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceE
Confidence 1 23456889999999 999999997532 24999999999999999999999999 99999999999
Q ss_pred EE---cCCCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 174 LF---DSKWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 174 ll---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
|+ +.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99 5889999999999976543322 124579999999999999999999999999999999999999998
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
+.......... ..+......... ......++.++.+++.+||+.||++||++.++++....
T Consensus 215 ~~~~~~~~~~~--~~i~~~~~~~~~------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 215 GLKAGTKKQKY--EKISEKKVATSI------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp SCCCSSHHHHH--HHHHHHHHHSCH------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccchhHHHHH--HHHhhccccccH------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 76543221111 001111111100 11112335789999999999999999999998875433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=342.20 Aligned_cols=278 Identities=22% Similarity=0.248 Sum_probs=206.1
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+.. +++.||||.++.... ....+.+.+|+.+++.++|+| |++
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~-----tg~~VAVKvi~~~~~---~~~~~~~~~Ei~iL~~L~Hpn-------IV~ 76 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQD-----TGEQVAIKQCRQELS---PKNRERWCLEIQIMKKLNHPN-------VVS 76 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTT-----TTCCEEECCCCSCCC---HHHHHHHHHHHHHHHHCCBTT-------BCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCC-------CCc
Confidence 35899999999999999999997654 567799999875422 345678999999999999998 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ...+...+..++||||++|++|.+++..... ...+++..++.++.|++.||+|||+.| |+||||||+|
T Consensus 77 l~~v~~~-~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~N 151 (676)
T 3qa8_A 77 AREVPDG-LQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPEN 151 (676)
T ss_dssp EEECCTT-TCCCCTTSSCCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTT
T ss_pred eeeeecc-cccccCCCeEEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHH
Confidence 7766432 2224457788999999999999999986432 224888999999999999999999999 9999999999
Q ss_pred eEEcCCCC---eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILFDSKWD---AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|+++.++. ++|+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 152 ILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~ 231 (676)
T 3qa8_A 152 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231 (676)
T ss_dssp EEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred eEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence 99997765 899999999877665555566899999999999999999999999999999999999999976532211
Q ss_pred HHHhhhhhhhHH-hhhhhc------cccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEE-KLRQVC------DSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~-~~~~~~------~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+........... ...... ....+.+ .....++..+.+++.+||+.||++|||+.+++.|..
T Consensus 232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 100000000000 000000 0111111 133456789999999999999999999999888765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=319.50 Aligned_cols=268 Identities=23% Similarity=0.393 Sum_probs=201.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+... ...+++.||+|.+.... ....+.+.+|+.+++.++|+| |++++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~-------iv~~~ 108 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPL-QDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDN-------IVKYK 108 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTT-SSSCCEEEEEEEESSCC----SHHHHHHHHHHHHHHTCCCTT-------BCCEE
T ss_pred HHceeeeeeccCCCeEEEEEEeccc-cCCCceEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCC-------eeeEE
Confidence 5699999999999999999986432 22367899999987542 344678999999999999888 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+.. .+....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.| |+||||||+|||
T Consensus 109 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIl 177 (326)
T 2w1i_A 109 GVCYS-----AGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNIL 177 (326)
T ss_dssp EEECC---------CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred EEEEe-----cCCCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEE
Confidence 76432 23457899999999999999998632 23889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|+||..||..... ..
T Consensus 178 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~ 255 (326)
T 2w1i_A 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF 255 (326)
T ss_dssp EEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH
T ss_pred EcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH
Confidence 99999999999999976544332 2233577889999998888889999999999999999999999864310 01
Q ss_pred HHhhhh----hhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALP----LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
...... ......+...+..... +.....++.++.+++.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 256 MRMIGNDKQGQMIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHhhccccchhhhHHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000000 0000011111111111 11123345789999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.00 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=173.9
Q ss_pred HhcCCcccc-ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 13 ATESFSQSR-LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 13 ~~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
+.++|++.+ +||+|+||.||+|.+.. +++.||+|++... ..........++.+.|+| ++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~-------i~ 85 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRR-----TGQKCALKLLYDS--------PKARQEVDHHWQASGGPH-------IV 85 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTT-------BC
T ss_pred ccceeEecceeeeeCCCeEEEEEEECC-----CCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCC-------hH
Confidence 468899965 69999999999998765 5678999998642 122223333456667777 66
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+... .......++||||++||+|.+++.... ...+++.+++.++.|++.||.|||++| |+||||||+
T Consensus 86 ~~~~~~~~~---~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~ 157 (336)
T 3fhr_A 86 CILDVYENM---HHGKRCLLIIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPE 157 (336)
T ss_dssp CEEEEEEEE---ETTEEEEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred HHHHHHhhc---cCCCceEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 666654321 122456899999999999999998643 234899999999999999999999999 999999999
Q ss_pred ceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 172 NILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 172 NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
|||++. ++.+||+|||++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred HEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 999976 455999999999765432 2234578999999999988889999999999999999999999997654322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... ....+.......+ .....++.++.+|+.+||+.||++|||+.|+++|...
T Consensus 237 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 237 ISPG---------MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp -----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hhhh---------HHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 1000 0001111111111 1223456789999999999999999999999998543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=345.90 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=194.1
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+... ..++.||||.++..... ....+.+.+|+.+++.++|+| |+++++++.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~hpn-------Iv~l~~~~~-- 440 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPY-------IVRMIGICE-- 440 (635)
T ss_dssp EEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGGGC--GGGHHHHHHHHHHHHHCCCTT-------BCCEEEEEE--
T ss_pred CEeccCCCEEEEEEEEcCC---CcceEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCC-------EeeEEEEEe--
Confidence 4799999999999976542 25688999998754322 344678999999999999988 888887642
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 441 ------~~~~~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~ 507 (635)
T 4fl3_A 441 ------AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHY 507 (635)
T ss_dssp ------SSSEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTE
T ss_pred ------cCCEEEEEEccCCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCC
Confidence 346899999999999999997532 3889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhh
Q 035572 181 AKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 255 (379)
+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..... +....
T Consensus 508 ~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~~i- 585 (635)
T 4fl3_A 508 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAML- 585 (635)
T ss_dssp EEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH-
T ss_pred EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-
Confidence 99999999976543321 222356789999999988899999999999999999998 999998764321 11110
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. ......+ ..++.++.+|+.+||+.||++|||+.++++..
T Consensus 586 --------~~--~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 586 --------EK--GERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp --------HT--TCCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred --------Hc--CCCCCCC---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 00 1111112 33457899999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=342.09 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=197.1
Q ss_pred CCcccc-ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 16 SFSQSR-LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~-~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++.+.+ .||+|+||.||+|.+.... .+..||||.++.... ....+.+.+|+.+|+.++|+| |++++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~hpn-------iv~l~ 402 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPY-------IVRLI 402 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCCS---STTHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCC-------EeeEE
Confidence 334444 7999999999999876432 457799999975421 345688999999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++. .+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++| |+||||||+|||
T Consensus 403 ~~~~--------~~~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIL 468 (613)
T 2ozo_A 403 GVCQ--------AEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVL 468 (613)
T ss_dssp EEEE--------SSSEEEEEECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred EEec--------cCCeEEEEEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEE
Confidence 7652 24689999999999999999642 334899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 469 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~- 547 (613)
T 2ozo_A 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE- 547 (613)
T ss_dssp EEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-
T ss_pred EcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-
Confidence 99999999999999976543221 122245689999999988899999999999999999998 999998765432
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
+.... . . ..+...+ ..+++++.+++.+||+.||++||++.++++...
T Consensus 548 ~~~~i----~-----~--~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 594 (613)
T 2ozo_A 548 VMAFI----E-----Q--GKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594 (613)
T ss_dssp HHHHH----H-----T--TCCCCCC---TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHH----H-----c--CCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111 0 0 1112222 234578999999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=318.94 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=199.0
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhhhh--ccC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSLQE--SNK 83 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~--~~~ 83 (379)
.......++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ......+.+|+.+++.+++ ++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~- 109 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG- 109 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETT-----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS-
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC-
Confidence 4445567899999999999999999998764 568899999875432210 0123557789999999975 44
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
++++++.+ ...+..++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+.|
T Consensus 110 ------i~~~~~~~-------~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~-- 169 (320)
T 3a99_A 110 ------VIRLLDWF-------ERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG-- 169 (320)
T ss_dssp ------BCCEEEEE-------ECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ------ceEEEEEE-------ecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 77766653 556789999999976 89999998643 3889999999999999999999999
Q ss_pred eEecCCCCCceEEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCC
Q 035572 163 IIHRDIKSTNILFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 163 i~H~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p 240 (379)
|+||||||+|||++ +++.+||+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.|
T Consensus 170 ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 99999999999999 7889999999999765433 2334579999999998876665 6789999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|.... .. . ......+ ..+++++.+++.+||+.||++|||++++++|...
T Consensus 249 f~~~~---~~------------~----~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 249 FEHDE---EI------------I----RGQVFFR---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp CCSHH---HH------------H----HCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCChh---hh------------h----ccccccc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 96531 00 0 0111111 1234679999999999999999999999998543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.92 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=204.4
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
.+.+....++|++.+.||+|+||.||+|.+.. ...||||.++... ...+.+.+|+.+|+.++|+|
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpn---- 323 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEK---- 323 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTT----
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCC----
Confidence 34444556789999999999999999998753 2459999987543 23567999999999999988
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++.+. .+..||||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++| |+||
T Consensus 324 ---iv~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHr 387 (535)
T 2h8h_A 324 ---LVQLYAVVS--------EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHR 387 (535)
T ss_dssp ---BCCEEEEEC--------SSSCEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred ---EeeEEEEEe--------eccceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCC
Confidence 888777642 2568999999999999999975432 23889999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDA 243 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~ 243 (379)
||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 388 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654321 1122356789999999888889999999999999999999 9999976
Q ss_pred CCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..... +.... .. ..+...+ ..++..+.+|+.+||+.||++|||+++++.....
T Consensus 468 ~~~~~-~~~~i---------~~--~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 468 MVNRE-VLDQV---------ER--GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520 (535)
T ss_dssp CCHHH-HHHHH---------HT--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCHHH-HHHHH---------Hc--CCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 54221 11110 00 1111212 2345789999999999999999999999976443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.53 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=185.8
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~ 93 (379)
+.|.+.+.||+|+||.||.+... +++.||||++.. +..+.+.+|+.+++.+ +|+| |+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~------~g~~vAvK~~~~-------~~~~~~~~E~~~l~~l~~Hpn-------Iv~~ 74 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF------QGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPN-------VIRY 74 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES------SSSEEEEEEEEG-------GGHHHHHHHHHHHHHHTTSTT-------BCCE
T ss_pred heeeccCeEeeCCCeEEEEEEEE------CCeEEEEEEEcH-------HHHHHHHHHHHHHHhccCCCC-------cCeE
Confidence 34555688999999999865322 567899999863 2345678999999887 7888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCC--CCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP--QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++. +.+.+..|+||||+ +|+|.+++......... ..++..++.++.|++.||+|||++| |+||||||+
T Consensus 75 ~~~-------~~~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~ 144 (434)
T 2rio_A 75 YCS-------ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQ 144 (434)
T ss_dssp EEE-------EECSSEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred EEE-------EecCCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChH
Confidence 655 35578899999999 57999999865432111 1133456789999999999999999 999999999
Q ss_pred ceEEcCC-------------CCeEEeccccCccCCCCCc-----ccccCccccccCCCCCCC-------CCCCCcCCeeh
Q 035572 172 NILFDSK-------------WDAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNP-------SKLSKKVDVFS 226 (379)
Q Consensus 172 NIll~~~-------------~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwS 226 (379)
|||++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++||||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999754 4799999999976544321 233479999999998765 56899999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 227 YGVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 227 lG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
|||++|+|+| |+.||........ . ..................++.++.+++.+||+.||.+|||+.++
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~~--~---------i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRES--N---------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHHH--H---------HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCchhhHH--H---------HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 9999999999 9999976433211 0 00111111100111234667899999999999999999999999
Q ss_pred hccccCc
Q 035572 306 LMGCSCF 312 (379)
Q Consensus 306 l~~~~~~ 312 (379)
++|....
T Consensus 294 l~hp~f~ 300 (434)
T 2rio_A 294 LRHPLFW 300 (434)
T ss_dssp HTSGGGS
T ss_pred HhCCccC
Confidence 9987653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.72 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=201.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
..++|++.+.||+|+||.||+|.+..... .+..||+|.+..... ....+.+.+|+.+++.++|+| |++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~Hpn-------Iv~ 455 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPEN--PAMAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPH-------IVK 455 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSS--CCEEEEEEECSSTTC---HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCC--ccEEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCC-------CCe
Confidence 45789999999999999999999865332 567899999875322 344578999999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+. ++..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 456 l~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~N 521 (656)
T 2j0j_A 456 LIGVIT--------ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 521 (656)
T ss_dssp EEEEEC--------SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEEEe--------cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHh
Confidence 887642 356899999999999999997532 23889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 522 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 601 (656)
T 2j0j_A 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601 (656)
T ss_dssp EEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999976544322 223356789999999988889999999999999999997 9999986543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
. ... .. ......+ ..+++.+.+++.+||+.||++|||+.++++..
T Consensus 602 ~-~~i---------~~--~~~~~~~---~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 602 I-GRI---------EN--GERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp H-HHH---------HH--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-HHH---------Hc--CCCCCCC---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1 110 00 1111112 23457899999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=313.57 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=192.3
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhh----hhccC
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSL----QESNK 83 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l----~~~~~ 83 (379)
.....++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ......+.+|+.+++.+ +|+|
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~- 99 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLT-----DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG- 99 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTT-----TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS-
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEcc-----CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC-
Confidence 44567899999999999999999998654 567899999975432110 01234467899999999 6777
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEec-cCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEF-MPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
|+++++++ ...+..++|||+ +.+++|.+++.... .+++..++.++.|++.||.|||++|
T Consensus 100 ------i~~~~~~~-------~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-- 159 (312)
T 2iwi_A 100 ------VIRLLDWF-------ETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG-- 159 (312)
T ss_dssp ------BCCEEEEC------------CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred ------eeeEEEEE-------ecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 77777653 456788999999 78999999998643 2899999999999999999999999
Q ss_pred eEecCCCCCceEEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCC
Q 035572 163 IIHRDIKSTNILFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 163 i~H~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p 240 (379)
|+||||||+||+++ .++.+||+|||++....... .....||..|+|||++.+..+ +.++||||||+++|+|++|+.|
T Consensus 160 i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 238 (312)
T 2iwi_A 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238 (312)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCC
Confidence 99999999999999 88999999999997665432 334569999999998876665 4589999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
|.... .+ .......+ ..++..+.+++.+||+.||++|||+.|+++|....
T Consensus 239 f~~~~---~~----------------~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 239 FERDQ---EI----------------LEAELHFP---AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp CCSHH---HH----------------HHTCCCCC---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred CCChH---HH----------------hhhccCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 96531 00 01111112 22357789999999999999999999999985543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=318.73 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
..++....++|++.+.||+|+||.||+|.+.. .+++|.+...... ....+.+.+|+.+++.++|+|
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~---- 90 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDN--EDQLKAFKREVMAYRQTRHEN---- 90 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCC--CCCCCCCCTTGGGGTTCCCTT----
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCC--HHHHHHHHHHHHHHhcCCCCC----
Confidence 34445556899999999999999999998643 2899998754322 334456789999999999888
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
|+++++.+ .+.+..++||||+++++|.+++... ...+++..+..++.|++.||+|||++| ++||
T Consensus 91 ---iv~~~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~ 154 (319)
T 2y4i_B 91 ---VVLFMGAC-------MSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHK 154 (319)
T ss_dssp ---BCCCCEEE-------ECSSCEEEECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCC
T ss_pred ---EeEEEEEE-------ecCCceEEEeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccc
Confidence 77777764 4467899999999999999999752 234889999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCC------CcccccCccccccCCCCCCC---------CCCCCcCCeehhHHHH
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDE------SSMVQPAGTIGYLDPGYTNP---------SKLSKKVDVFSYGVVL 231 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il 231 (379)
||||+|||++ ++.++|+|||++...... .......||+.|+|||++.+ ..++.++||||||+++
T Consensus 155 dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp CCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred CCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 9999999998 679999999998543211 12233468999999997764 4578899999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 232 LEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 232 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
|+|++|+.||....... .... ......... ....++.++.+++.+||+.||++|||+.++++....
T Consensus 234 ~el~~g~~p~~~~~~~~-~~~~---------~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 299 (319)
T 2y4i_B 234 YELHAREWPFKTQPAEA-IIWQ---------MGTGMKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299 (319)
T ss_dssp HHHHHSSCSSSSCCHHH-HHHH---------HHTTCCCCC----CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCHHH-HHHH---------hccCCCCCC----CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 99999999997654221 1110 000011111 111234678999999999999999999999987554
Q ss_pred cc
Q 035572 312 FF 313 (379)
Q Consensus 312 ~~ 313 (379)
..
T Consensus 300 l~ 301 (319)
T 2y4i_B 300 LP 301 (319)
T ss_dssp C-
T ss_pred HH
Confidence 33
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=323.42 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=185.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~ 93 (379)
.+|++.++||+|+||.|+.... .+++.||||++..+.. ..+.+|+.+|+.+ +|+| |+++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~------~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~Hpn-------Iv~l 83 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM------FDNRDVAVKRILPECF-------SFADREVQLLRESDEHPN-------VIRY 83 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE------SSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTT-------BCCE
T ss_pred EEEecCCeeecCcCEEEEEEEE------eCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCC-------cCeE
Confidence 4699999999999999654322 1457799999875322 2356899999999 6888 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+..|+||||+ +|+|.+++.... .......+..++.|++.||.|||++| |+||||||+||
T Consensus 84 ~~~-------~~~~~~~~lv~E~~-~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NI 149 (432)
T 3p23_A 84 FCT-------EKDRQFQYIAIELC-AATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNI 149 (432)
T ss_dssp EEE-------EEETTEEEEEEECC-SEEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSE
T ss_pred EEE-------EecCCEEEEEEECC-CCCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHE
Confidence 765 35567899999999 579999998643 22445567899999999999999999 99999999999
Q ss_pred EEcC-----CCCeEEeccccCccCCCCC----cccccCccccccCCCCCC---CCCCCCcCCeehhHHHHHHHHh-CCCC
Q 035572 174 LFDS-----KWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTN---PSKLSKKVDVFSYGVVLLEIIS-CRKP 240 (379)
Q Consensus 174 ll~~-----~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-g~~p 240 (379)
|++. ...+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++ |..|
T Consensus 150 ll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~p 229 (432)
T 3p23_A 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229 (432)
T ss_dssp EECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBT
T ss_pred EEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9953 2357899999997654332 233457999999999887 4567889999999999999999 9999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
|.......... . ...............+..+.+|+.+||+.||.+|||+.++++|....
T Consensus 230 f~~~~~~~~~~-----------~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 230 FGKSLQRQANI-----------L--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp TBSTTTHHHHH-----------H--TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred cchhhHHHHHH-----------H--hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 96543211100 0 00111111112234567789999999999999999999999997654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.73 Aligned_cols=262 Identities=14% Similarity=0.163 Sum_probs=188.0
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccC----------C
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNK----------R 84 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~----------~ 84 (379)
.+|...++||+|+||.||+|.+.. +++.||||++...... .....+.+.+|+.+++.++|... .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred eeEEEecccccCCCEEEEEEEecC-----CCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 458888999999999999998765 5568999998743322 23446789999999999987210 0
Q ss_pred CCCceeeeccccccccCCCcc-----CCCceEEEEeccCCCCHHHHHHhhhc--CCCCCCChHhHHHHHHHHHHHHHHHH
Q 035572 85 NPNYCVVNFHGTSCRNSGSVD-----GNSNKLLVMEFMPNGSLYDLLHNAAA--ATTPQLGWPNRVKIAMQISRAIQCLH 157 (379)
Q Consensus 85 ~~~~~iv~~~~~~~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH 157 (379)
.+. .++...+. ........ .....+++|+++ +++|.++++.... .....+++..+..++.|++.||+|||
T Consensus 152 ~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 152 FPF-DLVKDPQK-KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp CCC-EEEECCC----------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cch-hhcccCCC-CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 000 01111110 00000011 123567888877 7899999963211 12233777888999999999999999
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCC----------CCCCCCCcCCeehh
Q 035572 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYT----------NPSKLSKKVDVFSY 227 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSl 227 (379)
++| |+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++|||||
T Consensus 229 ~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 229 HYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp HTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred hCC--cccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999 999999999999999999999999998765433 334467 999999988 66678899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 228 GVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 228 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
||++|+|++|+.||....... ....+..... .+++.+.+|+.+||+.||++|||+.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~-------------~~~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALG-------------GSEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGS-------------CSGGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhh-------------hHHHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999997653211 1111122111 12367999999999999999999999998
Q ss_pred ccc
Q 035572 308 GCS 310 (379)
Q Consensus 308 ~~~ 310 (379)
|..
T Consensus 364 ~~~ 366 (413)
T 3dzo_A 364 TPE 366 (413)
T ss_dssp SHH
T ss_pred CHH
Confidence 744
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.85 Aligned_cols=256 Identities=16% Similarity=0.200 Sum_probs=192.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch----hhhhcHHHHHHHHHHHHhhh---------h
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE----VLQDNSKKLNNEIRVLSSLQ---------E 80 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~---------~ 80 (379)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ......+.+.+|+.+++.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred cccchheeeecccCceEEEEEEe-------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 47899999999999999999986 3478999999765321 12334588999999999997 5
Q ss_pred ccCCCCCceeeec----------cccccccCCCcc-------------CCCceEEEEeccCCCCHHHHHHhhhcCCCCCC
Q 035572 81 SNKRNPNYCVVNF----------HGTSCRNSGSVD-------------GNSNKLLVMEFMPNGSLYDLLHNAAAATTPQL 137 (379)
Q Consensus 81 ~~~~~~~~~iv~~----------~~~~~~~~~~~~-------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 137 (379)
+| ++++ |+++++..+.+. +.+..|+||||+++|++.+.+.+ ..+
T Consensus 92 ~n-------iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~ 158 (336)
T 2vuw_A 92 EG-------FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLS 158 (336)
T ss_dssp CC-------BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCC
T ss_pred Cc-------hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCC
Confidence 44 4333 333333333333 37899999999999976666632 238
Q ss_pred ChHhHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCceEEcCCC--------------------CeEEeccccCccCCCCC
Q 035572 138 GWPNRVKIAMQISRAIQCLH-ENDPMIIHRDIKSTNILFDSKW--------------------DAKLADFGLAVSESDES 196 (379)
Q Consensus 138 ~~~~~~~~~~~i~~~l~~LH-~~~~~i~H~dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~ 196 (379)
++..++.++.|++.||+||| ++| |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 159 ~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~- 235 (336)
T 2vuw_A 159 SLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG- 235 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-
T ss_pred CHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-
Confidence 89999999999999999999 899 99999999999999887 8999999999765432
Q ss_pred cccccCccccccCCCCCCCCCCCCcCCeehhHHH-HHHHHhCCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCc
Q 035572 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV-LLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPT 275 (379)
Q Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (379)
...||+.|+|||++.+.. +.++|||||+++ .+++++|..||.... +. ..................+.
T Consensus 236 ---~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~ 303 (336)
T 2vuw_A 236 ---IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WL-HYLTDKMLKQMTFKTKCNTP 303 (336)
T ss_dssp ---EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HH-HHHHHHHHHTCCCSSCCCSH
T ss_pred ---cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-------hh-hHHHHhhhhhhccCcccchh
Confidence 337999999999998766 889999998777 778889999984310 00 00011111111222222334
Q ss_pred chHHHHHHHHHHHHhcccCCCCCCCChHHHh-ccc
Q 035572 276 FMEGAIKQMLHVAARCVSSEEENRPGIGEIL-MGC 309 (379)
Q Consensus 276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l-~~~ 309 (379)
....+++++.+||.+||++| |++|++ +|.
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 56678999999999999977 999999 884
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=298.10 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=181.4
Q ss_pred HhcCCccc-cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHH-HhhhhccCCCCCcee
Q 035572 13 ATESFSQS-RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL-SSLQESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~-~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~~~~~~~~~~~i 90 (379)
..++|.+. +.||+|+||.||+|.+.. +++.||+|.+.. ...+.+|+.++ +.++|+| |
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~-------i 73 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQD---------CPKARREVELHWRASQCPH-------I 73 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTT-------B
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC-----CCcEEEEEEecc---------cHHHHHHHHHHHHhccCCC-------c
Confidence 35678887 789999999999998765 567899999853 24567889888 5557777 7
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+... .......++||||+++++|.+++.... ...+++..++.++.|++.||.|||++| |+||||||
T Consensus 74 ~~~~~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp 145 (299)
T 3m2w_A 74 VRIVDVYENL---YAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKP 145 (299)
T ss_dssp CCEEEEEEEE---ETTEEEEEEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred hhHHhhhhhh---cCCCceEEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence 7777664321 233567899999999999999998742 234899999999999999999999999 99999999
Q ss_pred CceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 171 TNILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 171 ~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+|||++. ++.++|+|||++.... +..++.++|||||||++|+|++|+.||......
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred HHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 9999997 7889999999885432 245678999999999999999999999765321
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
... ......+.......+. ....+++++.+++.+||+.||++|||+.|+++|...
T Consensus 205 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 205 AIS---------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp ------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hhh---------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 100 0000111111111111 123456889999999999999999999999998443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=296.19 Aligned_cols=232 Identities=15% Similarity=0.121 Sum_probs=180.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.++..++|+| |+++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~-------iv~~ 96 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA-----LDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPG-------VARV 96 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT-----TTEEEEEEESCTTCCS-CHHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC-----CCceEEEEEECccccc-CHHHHHHHHHHHHHHhcCCCCC-------ccee
Confidence 4689999999999999999998764 5678999999765322 1334578999999999999988 7877
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..|+||||++|++|.+++... ....++..++.|++.||+|||++| |+||||||+||
T Consensus 97 ~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NI 160 (286)
T 3uqc_A 97 LDVV-------HTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRV 160 (286)
T ss_dssp EEEE-------EETTEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGE
T ss_pred eEEE-------EECCcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccE
Confidence 7764 4467899999999999999999531 355578889999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.+|.+||+++| |++ +++.++|||||||++|+|+||+.||.+.+....+...
T Consensus 161 ll~~~g~~kl~~~~-------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~ 214 (286)
T 3uqc_A 161 RVSIDGDVVLAYPA-------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214 (286)
T ss_dssp EEETTSCEEECSCC-------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC
T ss_pred EEcCCCCEEEEecc-------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH
Confidence 99999999998553 232 3678999999999999999999999876432211000
Q ss_pred hhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..........+ .....+++++.+++.+||+.||++| |+.|+++....
T Consensus 215 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 215 ----------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp ----------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred ----------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 00001111100 1123456789999999999999999 99999987544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.65 Aligned_cols=245 Identities=16% Similarity=0.203 Sum_probs=191.4
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+... +++.||||.+..... ......+.+|+.+++.++|+| |++
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~-------iv~ 143 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNV----NGRPVVLKGLVHSGD---AEAQAMAMAERQFLAEVVHPS-------IVQ 143 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGG----TTEEEEEEESCSSCC---HHHHHHHHHHHGGGGGCCCTT-------BCC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCC----CCcEEEEEEeCccCC---HHHHHHHHHHHHHHHhcCCCC-------cCe
Confidence 347899999999999999999987531 457899999875422 344567899999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++++..... ......||||||++|++|.+++.. .+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 144 ~~~~~~~~~~--~~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~N 212 (681)
T 2pzi_A 144 IFNFVEHTDR--HGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPEN 212 (681)
T ss_dssp EEEEEEEECT--TSCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred EeeeEeecCC--CCCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHH
Confidence 8877543111 111226999999999999887753 3899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++.+ .+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....
T Consensus 213 Ill~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----- 282 (681)
T 2pzi_A 213 IMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----- 282 (681)
T ss_dssp EEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----
T ss_pred eEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----
Confidence 999975 8999999999766443 344799999999988754 488999999999999999999888653110
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
...........++.+.++|.+||+.||++||+..+.+.+.
T Consensus 283 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 283 -----------------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp -----------------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred -----------------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 0001112233457899999999999999999887777654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=264.67 Aligned_cols=172 Identities=20% Similarity=0.147 Sum_probs=122.2
Q ss_pred CceEEEEEeccCCCc------hhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeeeccccccccCCCccCCCceEEEEec
Q 035572 44 DHKILAIKRASTNGF------EVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEF 116 (379)
Q Consensus 44 ~~~~vavK~~~~~~~------~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~ 116 (379)
.++.+++|.+..... ...+...+.|.+|+++|+++ .|+| |++++++ +++++..||||||
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~-------i~~~~~~-------~ed~~~~yLVMEy 323 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFD-------APAVLAH-------GENAQSGWLVMEK 323 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCC-------CCCEEEE-------EECSSEEEEEEEC
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCC-------eeEEEEE-------EEECCEEEEEEec
Confidence 456799999875421 12234457799999999999 4555 6666665 5788999999999
Q ss_pred cCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC
Q 035572 117 MPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196 (379)
Q Consensus 117 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 196 (379)
++|++|.++|.+.+. ++. ..|+.||+.||+|+|++| |+||||||+|||++++|.+||+|||+|+......
T Consensus 324 v~G~~L~d~i~~~~~-----l~~---~~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 324 LPGRLLSDMLAAGEE-----IDR---EKILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp CCSEEHHHHHHTTCC-----CCH---HHHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred CCCCcHHHHHHhCCC-----CCH---HHHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999986432 544 358899999999999999 9999999999999999999999999997654432
Q ss_pred -cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 197 -SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
...+.+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 3345579999999999875 467789999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=237.22 Aligned_cols=187 Identities=20% Similarity=0.244 Sum_probs=139.0
Q ss_pred ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch----hhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 18 SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE----VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 18 ~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
...+.||+|+||.||+|.. .++.+++|........ ......+++.+|++++++++|+| |+.+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-------Iv~~ 404 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFG-------IPAP 404 (540)
T ss_dssp ---------CCEEEEEEEC-------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGT-------CCCC
T ss_pred CCCCEEeeCCCEEEEEEEE-------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCC-------cCce
Confidence 4467899999999999943 3345788875433221 11223566899999999999999 5533
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
..+.. ..+..|+||||++|++|.+++.. +..++.|++.||.|||++| |+||||||+||
T Consensus 405 ~~~~~-------~~~~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NI 462 (540)
T 3en9_A 405 YIFDV-------DLDNKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNF 462 (540)
T ss_dssp CEEEE-------ETTTTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSE
T ss_pred EEEEE-------eCCccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHE
Confidence 32221 24566999999999999999964 3479999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc--------ccccCccccccCCCCCCC--CCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS--------MVQPAGTIGYLDPGYTNP--SKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
|++. .+||+|||+++....... .....||+.|||||++.. ..|+..+|+||..+-..+...++.+|.
T Consensus 463 Ll~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 463 IFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9998 999999999987654322 124479999999999876 567888999999999988888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-25 Score=198.72 Aligned_cols=154 Identities=18% Similarity=0.206 Sum_probs=114.0
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--------------hhcHHHHHHHHHHH
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--------------QDNSKKLNNEIRVL 75 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~~E~~~l 75 (379)
+......|++.+.||+|+||.||+|.+ . +++.||+|.++....... ......+.+|+.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 334445667779999999999999987 3 567899999864321100 01356789999999
Q ss_pred HhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHH
Q 035572 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 76 ~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
+.++| .+ +..+.+ .+..|+||||++|++|.+ +. . .....++.|++.||.|
T Consensus 159 ~~l~~---~~----v~~~~~-----------~~~~~lvmE~~~g~~L~~-l~---------~--~~~~~i~~qi~~~l~~ 208 (282)
T 1zar_A 159 QKLQG---LA----VPKVYA-----------WEGNAVLMELIDAKELYR-VR---------V--ENPDEVLDMILEEVAK 208 (282)
T ss_dssp HHTTT---SS----SCCEEE-----------EETTEEEEECCCCEEGGG-CC---------C--SCHHHHHHHHHHHHHH
T ss_pred HhccC---CC----cCeEEe-----------ccceEEEEEecCCCcHHH-cc---------h--hhHHHHHHHHHHHHHH
Confidence 99982 11 222111 245699999999999988 42 1 2345799999999999
Q ss_pred HHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC
Q 035572 156 LHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN 214 (379)
Q Consensus 156 LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 214 (379)
||++| |+||||||+|||++ ++.+||+|||+|.. +..++|||++.
T Consensus 209 lH~~g--iiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 209 FYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp HHHTT--EECSCCSTTSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred HHHCC--CEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 99999 99999999999999 99999999999853 33456777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-21 Score=171.59 Aligned_cols=143 Identities=22% Similarity=0.262 Sum_probs=107.2
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceE--EEEEeccCCCchhh--------------------hhcHHHHHHHHHH
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKI--LAIKRASTNGFEVL--------------------QDNSKKLNNEIRV 74 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~--vavK~~~~~~~~~~--------------------~~~~~~~~~E~~~ 74 (379)
|++.+.||+|+||.||+|.+.. +++. ||||+++....... ......+.+|+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~-----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF-----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE-----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC-----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 6788999999999999998732 4567 99998754321100 0112468999999
Q ss_pred HHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCC-C----CHHHHHHhhhcCCCCCCChHhHHHHHHHH
Q 035572 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPN-G----SLYDLLHNAAAATTPQLGWPNRVKIAMQI 149 (379)
Q Consensus 75 l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~~~~~~i 149 (379)
|..+.|++...|. ++.. +..+|||||+.+ | +|.+.... .++..+..++.|+
T Consensus 124 l~~l~~~~i~~p~--~~~~--------------~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi 179 (258)
T 1zth_A 124 LERAKEAGVSVPQ--PYTY--------------MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDV 179 (258)
T ss_dssp HHHHHHTTCCCCC--EEEE--------------ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHH
T ss_pred HHHHHhCCCCCCe--EEEc--------------CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHH
Confidence 9999988754443 2211 245899999932 3 77776532 2345678899999
Q ss_pred HHHHHHHH-cCCCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 150 SRAIQCLH-ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 150 ~~~l~~LH-~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
+.+|.||| +.| |+||||||+|||+++ .++|+|||+|...
T Consensus 180 ~~~l~~lH~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 180 VENVKRLYQEAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHTSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999 999 999999999999998 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=160.03 Aligned_cols=148 Identities=19% Similarity=0.203 Sum_probs=103.1
Q ss_pred HHHHhcC---CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh----------h--------hcHHHH
Q 035572 10 LVKATES---FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL----------Q--------DNSKKL 68 (379)
Q Consensus 10 ~~~~~~~---y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~----------~--------~~~~~~ 68 (379)
|.+..++ |++.+.||.|++|.||+|.+. .++.||||+++....+.. . ...-..
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A 160 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAA 160 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHH
Confidence 3444444 999999999999999999864 467899998764311100 0 000112
Q ss_pred HHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHH
Q 035572 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQ 148 (379)
Q Consensus 69 ~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~ 148 (379)
.+|...|.++.+.+...|..+ . ....+|||||++|++|.++. ..+....++.|
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~--~--------------~~~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~q 213 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPI--A--------------QSRHTIVMSLVDALPMRQVS-----------SVPDPASLYAD 213 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEE--E--------------EETTEEEEECCSCEEGGGCC-----------CCSCHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCeee--e--------------ccCceEEEEecCCccHhhhc-----------ccHHHHHHHHH
Confidence 467778888866553322211 0 12347999999988875432 12244678899
Q ss_pred HHHHHHHHHcCCCCeEecCCCCCceEEcCCCC----------eEEeccccCccC
Q 035572 149 ISRAIQCLHENDPMIIHRDIKSTNILFDSKWD----------AKLADFGLAVSE 192 (379)
Q Consensus 149 i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~----------~kl~Dfg~a~~~ 192 (379)
++.+|.+||++| ||||||||.|||++++|. +.|+||+-+...
T Consensus 214 ll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 214 LIALILRLAKHG--LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp HHHHHHHHHHTT--EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999999 999999999999987763 899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=2.4e-12 Score=114.24 Aligned_cols=145 Identities=19% Similarity=0.159 Sum_probs=105.7
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
.+....++|++...++.|+.+.||++... +..+++|..+... ......+.+|+.+++.+.. ....|.
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-------~~~~vlK~~~~~~----~~~~~~~~~E~~~l~~l~~-~~~vP~- 74 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRY----KGTTYDVEREKDMMLWLEG-KLPVPK- 74 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-------SCEEEEEEECGGG----TTSTTCHHHHHHHHHHHTT-TSCCCC-
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-------CCcEEEEeCCccc----CCCHHHHHHHHHHHHHHhc-CCCCCe-
Confidence 34556678999999999999999998632 3569999986421 1223468999999999965 222222
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc----------
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE---------- 158 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---------- 158 (379)
++. + ..+.+..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 75 -v~~---~-------~~~~~~~~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~ 133 (263)
T 3tm0_A 75 -VLH---F-------ERHDGWSNLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTN 133 (263)
T ss_dssp -EEE---E-------EEETTEEEEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBC
T ss_pred -EEE---E-------EecCCceEEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcc
Confidence 222 2 123467899999999999987631 122345788899999999998
Q ss_pred -------------------------------------------------CCCCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 159 -------------------------------------------------NDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 159 -------------------------------------------------~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
.. ++|+|++|.|||+++++.+.|+||+.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~--l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 134 SLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV--FSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE--EECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred hHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce--EECCCCCcCcEEEECCcEEEEEEchhc
Confidence 23 899999999999987655679999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.3e-10 Score=102.68 Aligned_cols=142 Identities=18% Similarity=0.204 Sum_probs=94.3
Q ss_pred HHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 11 VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 11 ~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
.....+|.+....+.|..+.||++... +++.+++|..... ....+.+|+.+++.+.+.+...|. +
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~--~ 80 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAA--V 80 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCC--E
T ss_pred HHhcCCCceEecccCCCCceEEEEecC------CCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCe--E
Confidence 334556776555456667999998542 2345899987532 124578999999999765422222 2
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC----------
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND---------- 160 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------- 160 (379)
+.. ....+..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 81 ---~~~-------~~~~~~~~~v~e~i~G~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~ 137 (264)
T 1nd4_A 81 ---LDV-------VTEAGRDWLLLGEVPGQDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQA 137 (264)
T ss_dssp ---EEE-------EECSSCEEEEEECCSSEETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCH
T ss_pred ---EEe-------ccCCCCCEEEEEecCCcccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 221 23345689999999998873 210 11 2356677777777777642
Q ss_pred ----------------------------------------------CCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 161 ----------------------------------------------PMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 161 ----------------------------------------------~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
..++|+|++|.|||+++++.+.|+|||.+.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 138 KHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 019999999999999877666799999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=4e-10 Score=104.61 Aligned_cols=149 Identities=16% Similarity=0.275 Sum_probs=99.3
Q ss_pred ccccccccCCceeEEEEEecCCCCCCCceEEEEEecc--CCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 18 SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRAS--TNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 18 ~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
...+.|+.|.++.||+.... +..+++|+.. .... ......+.+|+.+++.|...+...|. ++.+..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-------~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~--~~~~~~ 108 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-------GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAK--MYALCE 108 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-------SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCC--EEEEEC
T ss_pred ceEEEcCCcccceEEEEEEC-------CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCc--EEEECC
Confidence 34678899999999998643 2358888875 3211 12245788999999999865433333 222111
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcC----------------
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEN---------------- 159 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---------------- 159 (379)
. -...+..|+||||++|..+.+.. ...++..+...++.+++..|..||+.
T Consensus 109 ~-------~~~~g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~ 174 (359)
T 3dxp_A 109 D-------ESVIGRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY 174 (359)
T ss_dssp C-------TTTTSSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred C-------CCccCCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence 0 01124579999999987764311 11267777888999999999999972
Q ss_pred ----------------------------------------CCCeEecCCCCCceEEcCCCC--eEEeccccCccC
Q 035572 160 ----------------------------------------DPMIIHRDIKSTNILFDSKWD--AKLADFGLAVSE 192 (379)
Q Consensus 160 ----------------------------------------~~~i~H~dlkp~NIll~~~~~--~kl~Dfg~a~~~ 192 (379)
...++|+|++|.|||++.++. +.|+||+.+...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 123999999999999997653 689999987543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.2e-10 Score=102.78 Aligned_cols=188 Identities=22% Similarity=0.264 Sum_probs=116.1
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhc-cCCCCCceeeecccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES-NKRNPNYCVVNFHGTSC 98 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~~~iv~~~~~~~ 98 (379)
.+.++.|....||+.. ..+++|..+. ......+.+|+.+|+.+... ....|. ++.....
T Consensus 25 i~~~~~G~~n~v~~v~----------~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~--~~~~~~~-- 84 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----------RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPE--VVFTGMP-- 84 (304)
T ss_dssp CCEEEECSSEEEEEST----------TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCC--EEEECCC--
T ss_pred eEecCCCCcceEEEEC----------CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCc--eEeecCC--
Confidence 4678999999999862 2288888542 13457799999999998543 322232 2211100
Q ss_pred ccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC------------------
Q 035572 99 RNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND------------------ 160 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------------ 160 (379)
-......|+||++++|.+|.+.... .++..+...++.+++..|..||+..
T Consensus 85 -----~~~~~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~ 152 (304)
T 3sg8_A 85 -----SETYQMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINE 152 (304)
T ss_dssp -----CSSCSCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHH
T ss_pred -----CCCCCcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHH
Confidence 0111245899999999888653321 1566677778888888888888511
Q ss_pred --------------------------------------CCeEecCCCCCceEEcC--CCCeEEeccccCccCCCCCcccc
Q 035572 161 --------------------------------------PMIIHRDIKSTNILFDS--KWDAKLADFGLAVSESDESSMVQ 200 (379)
Q Consensus 161 --------------------------------------~~i~H~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~ 200 (379)
..++|+|++|.||++++ ++.+.|+||+.+...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~ 232 (304)
T 3sg8_A 153 DNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS 232 (304)
T ss_dssp HHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT
T ss_pred HHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH
Confidence 12899999999999997 45678999998754322110000
Q ss_pred c------Cc-------cccc--cC-CCCCCCCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 201 P------AG-------TIGY--LD-PGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 201 ~------~g-------t~~y--~a-PE~~~~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
. .+ -..| .. |+... ......+.|+++.++|.+.+|..+|
T Consensus 233 ~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 233 LMEDDEEYGMEFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCCTTTSCCHHHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHhhccccCHHHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 0011 00 11100 0112258899999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.5e-06 Score=76.83 Aligned_cols=135 Identities=17% Similarity=0.241 Sum_probs=90.5
Q ss_pred ccccCCce-eEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 22 LIGKGSHG-SVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 22 ~iG~G~~g-~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
.+..|..| .||+..... .+..+.+|+.+. .....+.+|..+|+.|.. ....|. ++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~-----~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~-~vPVP~--v~~~------- 88 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP-----NAPELFLKHGKG-------SVANDVTDEMVRLNWLTA-FMPLPT--IKHF------- 88 (272)
T ss_dssp EEECSSSSCEEEEEECCT-----TCCCEEEEEEET-------HHHHHHHHHHHHHHHHTT-TSCCCC--EEEE-------
T ss_pred EccCCCcCCeEEEEEecC-----CCeEEEEEECCC-------CCHhHHHHHHHHHHHhcc-CCCcCe--EEEE-------
Confidence 34445554 689876443 334588888652 335678899999999964 222222 3221
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCC-------------------
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDP------------------- 161 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~------------------- 161 (379)
..+.+..|+|||+++|.++.+..... ......+..++...|..||+...
T Consensus 89 ---~~~~~~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~ 156 (272)
T 4gkh_A 89 ---IRTPDDAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSR 156 (272)
T ss_dssp ---EEETTEEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHH
T ss_pred ---EEECCeEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHH
Confidence 23456789999999999888776431 22334566677777777775310
Q ss_pred -------------------------------------CeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 162 -------------------------------------MIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 162 -------------------------------------~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 157 MNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17999999999999987767799998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.7e-06 Score=78.25 Aligned_cols=138 Identities=19% Similarity=0.209 Sum_probs=86.5
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeecccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFHGTSC 98 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~~~~~ 98 (379)
.+.++.|....||+. . ..+++|..+. ......+.+|..+|+.|.+.. ...|. ++.+..
T Consensus 24 v~~l~~G~~n~v~~v---g-------~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~--~~~~~~--- 82 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---N-------GDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQ--YVYIGK--- 82 (306)
T ss_dssp EEEEEECSSEEEEEE---T-------TTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCC--EEEEEE---
T ss_pred eeecCCCcceeEEEE---C-------CEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCC--eEeecc---
Confidence 356788888899987 1 2278887431 234578999999999997642 22222 221110
Q ss_pred ccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC------------------
Q 035572 99 RNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND------------------ 160 (379)
Q Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------------ 160 (379)
...+..++|||+++|.+|.+..-. .++..+...++.++...|..||+..
T Consensus 83 ------~~~g~~~~v~e~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~ 149 (306)
T 3tdw_A 83 ------RSDGNPFVGYRKVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKI 149 (306)
T ss_dssp ------CTTSCEEEEEECCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHH
T ss_pred ------cCCCceEEEEeccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHH
Confidence 124567899999999888763211 0233334444444444444444321
Q ss_pred ----------------------------------------CCeEecCCCCCceEEcC---CCCe-EEeccccCcc
Q 035572 161 ----------------------------------------PMIIHRDIKSTNILFDS---KWDA-KLADFGLAVS 191 (379)
Q Consensus 161 ----------------------------------------~~i~H~dlkp~NIll~~---~~~~-kl~Dfg~a~~ 191 (379)
..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 150 LLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 12799999999999987 4554 7999997644
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.2e-05 Score=71.64 Aligned_cols=80 Identities=16% Similarity=0.195 Sum_probs=44.8
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc-ccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH-GTSCR 99 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~-~~~~~ 99 (379)
+.|+.|..+.||+.... . ..+++|..... ...+..|..+++.|...+...|. ++... +..
T Consensus 38 ~~l~gG~~n~~~~v~~~------~-~~~vlk~~~~~--------~~~~~~e~~~l~~L~~~g~~vp~--~~~~~~g~~-- 98 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD------S-GAVCLKRIHRP--------EKKALFSIFAQDYLAKKGMNVPG--ILPNKKGSL-- 98 (346)
T ss_dssp EECC----CEEEEEEET------T-EEEEEEEECSC--------HHHHHHHHHHHHHHHHHTCSSCC--BCCCTTSCS--
T ss_pred eeccccccCcEEEEEeC------C-CCEEEEecCCC--------HHHHHHHHHHHHHHHHcCCCCCc--eeecCCCCE--
Confidence 45666778899998642 2 23889988631 24556788888888765532222 22111 110
Q ss_pred cCCCccCCCceEEEEeccCCCCH
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSL 122 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL 122 (379)
.....+..+++|+|++|.++
T Consensus 99 ---~~~~~~~~~~l~~~i~G~~~ 118 (346)
T 2q83_A 99 ---YSKHGSFLFVVYDWIEGRPF 118 (346)
T ss_dssp ---CEEETTEEEEEEECCCCBCC
T ss_pred ---EEEECCEEEEEEEeecCccC
Confidence 01234578999999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.1e-06 Score=76.07 Aligned_cols=94 Identities=14% Similarity=0.089 Sum_probs=51.8
Q ss_pred cccc-ccCCceeEEEEEecCCCCCC-CceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhc-cCCCCCceeeecccc
Q 035572 20 SRLI-GKGSHGSVYKAILEDHQTDG-DHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES-NKRNPNYCVVNFHGT 96 (379)
Q Consensus 20 ~~~i-G~G~~g~V~~a~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~~~iv~~~~~ 96 (379)
.+.| +.|....+|+........+. .+..+++|........ .......+.+|+.+++.|... ....|. ++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~-~~~~~~~~~~E~~~l~~L~~~~~vpvP~--v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV-PVFPTYRLDHQFEVIRLVGELTDVPVPR--VRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC-CSSSCCCHHHHHHHHHHHHHHCCSCCCC--EEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc-ccCchhHHHHHHHHHHHHhhcCCCCCCc--EEEEccC
Confidence 4667 78888999987543000000 1456888886532100 000124678999999999765 433333 2221110
Q ss_pred ccccCCCccCCCceEEEEeccCCCCHH
Q 035572 97 SCRNSGSVDGNSNKLLVMEFMPNGSLY 123 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~sL~ 123 (379)
+ ...+..|+||||++|..+.
T Consensus 102 -----~--~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 -----G--DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp -----S--TTTSSCEEEEECCCCBCCC
T ss_pred -----C--CccCCceEEEEecCCCChh
Confidence 0 0013568999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.1e-05 Score=75.64 Aligned_cols=82 Identities=21% Similarity=0.171 Sum_probs=47.8
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc---hhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeeccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF---EVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFHG 95 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~~ 95 (379)
.+.||.|..+.||++.... .++.+++|....... ........++..|.++++.+.... ...|. + +.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~-----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~--~---~~ 104 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPR--V---FY 104 (397)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCC--E---EE
T ss_pred EEECCCCceEEEEEEEECC-----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCe--E---EE
Confidence 5689999999999996542 235689998653211 000123456788999999886421 11111 1 11
Q ss_pred cccccCCCccCCCceEEEEeccCCC
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNG 120 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~ 120 (379)
.+.+..++|||+++|.
T Consensus 105 ---------~d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 105 ---------SDTEMAVTVMEDLSHL 120 (397)
T ss_dssp ---------EETTTTEEEECCCTTS
T ss_pred ---------EcCCccEEEEEeCCCc
Confidence 1123468999999763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00035 Score=63.09 Aligned_cols=166 Identities=17% Similarity=0.196 Sum_probs=91.4
Q ss_pred CCCCHHHHHHHhcCCccc-----cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHh
Q 035572 3 ENFDYEELVKATESFSQS-----RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSS 77 (379)
Q Consensus 3 ~~~~~~~~~~~~~~y~~~-----~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 77 (379)
..++-+++..+-..|.+. +.|+.|....+|+..... ..+++|..... .....+..|+.+++.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-------g~~vlk~~~~~------~~~~~l~~e~~~l~~ 71 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-------DPLILTLYEKR------VEKNDLPFFLGLMQH 71 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-------CCEEEEEECC---------CCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-------ccEEEEEeCCC------CCHHHHHHHHHHHHH
Confidence 356778888888888762 346668888999986432 13788987642 123456789999999
Q ss_pred hhhccCCCCCceeeecc-ccccccCCCccCCCceEEEEeccCCCCHH-----------HH---HHhhh-cCCCCC---CC
Q 035572 78 LQESNKRNPNYCVVNFH-GTSCRNSGSVDGNSNKLLVMEFMPNGSLY-----------DL---LHNAA-AATTPQ---LG 138 (379)
Q Consensus 78 l~~~~~~~~~~~iv~~~-~~~~~~~~~~~~~~~~~lv~e~~~~~sL~-----------~~---l~~~~-~~~~~~---~~ 138 (379)
|...+...|. ++... +..+ ....+..+++|+|++|..+. .. ++... ....+. ..
T Consensus 72 L~~~g~~vP~--~~~~~~g~~~-----~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~ 144 (322)
T 2ppq_A 72 LAAKGLSCPL--PLPRKDGELL-----GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALS 144 (322)
T ss_dssp HHHTTCCCCC--BCCBTTCCSC-----EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTS
T ss_pred HHHCCCCCCc--ccCCCCCCEE-----EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccC
Confidence 9866533333 22111 1100 11235678999999885431 11 11111 001110 01
Q ss_pred ---hHhHHH------------HHHHHHHHHHHHHc-------CCCCeEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 139 ---WPNRVK------------IAMQISRAIQCLHE-------NDPMIIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 139 ---~~~~~~------------~~~~i~~~l~~LH~-------~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
|..... +...+...++.+.. .+ ++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 145 ~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~--liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 145 VDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAG--VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEE--EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcc--cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 111000 00113344555542 24 9999999999999887656899998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.75 E-value=8.6e-05 Score=62.32 Aligned_cols=101 Identities=14% Similarity=0.063 Sum_probs=65.8
Q ss_pred CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcc
Q 035572 120 GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198 (379)
Q Consensus 120 ~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 198 (379)
-||.+.|...+ .+++++++++++.|.+.+|.-+-. .. -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc--------
Confidence 48999998754 349999999999999999887722 12 11223457899999999888764 1110
Q ss_pred cccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCC
Q 035572 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK 239 (379)
Q Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 239 (379)
.....+.|||... ...+.+.=|||||+++|..+--..
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1233456888753 344567789999999999986333
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00035 Score=62.15 Aligned_cols=80 Identities=19% Similarity=0.191 Sum_probs=53.6
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeecc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFH 94 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~ 94 (379)
...-++.+|.|..+.||+.... +++.|.+|+.+... ......+..|+..|+.|.... ...|. ++.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~------DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~--v~~-- 81 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA------DGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQ--VAG-- 81 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET------TSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCC--EEE--
T ss_pred CeEEEEecCCCCCeEEEEEEEC------CCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcce--EEe--
Confidence 4556778999999999999764 45669999865432 223456889999999996432 22222 221
Q ss_pred ccccccCCCccCCCceEEEEeccCCCC
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGS 121 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~s 121 (379)
. +.-++||||++++.
T Consensus 82 -~-----------~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 82 -W-----------DDRTLAMEWVDERP 96 (288)
T ss_dssp -E-----------ETTEEEEECCCCCC
T ss_pred -c-----------cCceEEEEeecccC
Confidence 1 23489999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00034 Score=63.05 Aligned_cols=78 Identities=12% Similarity=0.149 Sum_probs=52.7
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhc-cCCCCCceeeeccccc
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQES-NKRNPNYCVVNFHGTS 97 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~~~iv~~~~~~ 97 (379)
-.+.|+.|....+|+... .+..+++|.... .....+..|...|+.|... ....|. ++. .
T Consensus 40 ~~~~l~gG~~n~~y~v~~-------~~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~--vl~---~- 99 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-------EVQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPL--VYG---I- 99 (312)
T ss_dssp EEEEECCSSSSEEEEEES-------SSCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCC--EEE---E-
T ss_pred eeEEeCCccceeeeEEEE-------CCCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcce--EEE---E-
Confidence 346789999999999863 234588888652 2356789999999999764 222232 221 1
Q ss_pred cccCCCccCCCceEEEEeccCCCCH
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSL 122 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL 122 (379)
....+..++||||++|..+
T Consensus 100 ------~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 100 ------GNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp ------EECSSEEEEEEECCCCCCC
T ss_pred ------eecCCceEEEEEeccCCCC
Confidence 1223678999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00036 Score=65.70 Aligned_cols=32 Identities=13% Similarity=0.300 Sum_probs=27.3
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEeccccCccC
Q 035572 158 ENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192 (379)
Q Consensus 158 ~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~ 192 (379)
... ++|+|++|.|||++.++ +.++||+.+...
T Consensus 231 ~~~--liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQA--LIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCE--EECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCe--EEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 445 99999999999998776 999999987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0014 Score=59.31 Aligned_cols=97 Identities=12% Similarity=0.096 Sum_probs=56.0
Q ss_pred CHHHHHHHhcCCcc-----ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh
Q 035572 6 DYEELVKATESFSQ-----SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80 (379)
Q Consensus 6 ~~~~~~~~~~~y~~-----~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 80 (379)
+-+.+..+-+.|.+ ...++ |....||+.... .++.+++|..+... .....+..|..+++.|..
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~ 79 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE------DRRRFVVKFYRPER-----WTADQILEEHQFALQLVN 79 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT------TCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC------CCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHH
Confidence 34455555555543 23466 777899987432 23458999876321 234677889999999976
Q ss_pred ccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCC
Q 035572 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGS 121 (379)
Q Consensus 81 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~s 121 (379)
.....|. ++...+. ......+..+++|++++|..
T Consensus 80 ~g~~vp~--~~~~~g~-----~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 80 DEVPVAA--PVAFNGQ-----TLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp TTCSBCC--CCCBTTB-----SCEEETTEEEEEEECCCCEE
T ss_pred cCCeecc--eeecCCc-----EEEEECCEEEEEEEecCCCC
Confidence 5432222 1111111 11122456789999998743
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.001 Score=59.49 Aligned_cols=75 Identities=12% Similarity=0.200 Sum_probs=46.2
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGT 96 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~ 96 (379)
+.-.+.|+.|....+|+. . .+++|...... ...-...+|+.+++.+...+.. |. ++..
T Consensus 20 ~~~i~~l~gG~tN~~~~~--~---------~~vlR~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~-P~--~~~~--- 77 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA--G---------DLCLRIPGKGT-----EEYINRANEAVAAREAAKAGVS-PE--VLHV--- 77 (301)
T ss_dssp CCSCEEEESCSSEEEEEE--T---------TEEEEEECC---------CCCHHHHHHHHHHHHHTTSS-CC--EEEE---
T ss_pred ccceeEcCCcccccccee--e---------eEEEECCCCCc-----cceeCHHHHHHHHHHHHHcCCC-Cc--eEEE---
Confidence 333678888999999998 1 18888875321 1111235799999999866543 43 2211
Q ss_pred ccccCCCccCCCceEEEEecc-CCCCH
Q 035572 97 SCRNSGSVDGNSNKLLVMEFM-PNGSL 122 (379)
Q Consensus 97 ~~~~~~~~~~~~~~~lv~e~~-~~~sL 122 (379)
+.+.-++++||+ +|.+|
T Consensus 78 ---------~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 78 ---------DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp ---------CTTTCCEEEECCTTCEEC
T ss_pred ---------ECCCCEEEEeecCCCccC
Confidence 123347899999 66444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0014 Score=59.46 Aligned_cols=30 Identities=27% Similarity=0.386 Sum_probs=26.0
Q ss_pred eEecCCCCCceEEcCC----CCeEEeccccCccC
Q 035572 163 IIHRDIKSTNILFDSK----WDAKLADFGLAVSE 192 (379)
Q Consensus 163 i~H~dlkp~NIll~~~----~~~kl~Dfg~a~~~ 192 (379)
++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 9999999999999874 67899999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0047 Score=57.08 Aligned_cols=149 Identities=17% Similarity=0.207 Sum_probs=79.9
Q ss_pred ccccccCCceeEEEEEecCCCC--CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQT--DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
++.|..|-...+|++....... ...++.+.+|+.... ......+.+|..+++.|...+. .|. ++. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv-~P~--ll~---~- 122 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSL-GPQ--LYG---V- 122 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTS-SCC--EEE---E-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCC-CCe--EEE---E-
Confidence 3566668888899987542110 113456888885321 1234566799999999987653 233 221 1
Q ss_pred cccCCCccCCCceEEEEeccCCCCHH--------------HHHHhhhcC---CCCCCC--hHhHHHHHHHHHH-------
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSLY--------------DLLHNAAAA---TTPQLG--WPNRVKIAMQISR------- 151 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL~--------------~~l~~~~~~---~~~~~~--~~~~~~~~~~i~~------- 151 (379)
+++ .+||||++|..|. +.+.+--.. ...... +.++..+..++..
T Consensus 123 ------~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~ 192 (379)
T 3feg_A 123 ------FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLP 192 (379)
T ss_dssp ------ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCC
T ss_pred ------cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccc
Confidence 111 2899999875432 111111001 011121 3444455444321
Q ss_pred ------------HHHHH----HcCCC--CeEecCCCCCceEEcCC----CCeEEeccccCc
Q 035572 152 ------------AIQCL----HENDP--MIIHRDIKSTNILFDSK----WDAKLADFGLAV 190 (379)
Q Consensus 152 ------------~l~~L----H~~~~--~i~H~dlkp~NIll~~~----~~~kl~Dfg~a~ 190 (379)
.+..| ...+. .++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 193 ~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 193 EMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp SCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22333 22221 29999999999999876 789999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0054 Score=57.82 Aligned_cols=57 Identities=12% Similarity=0.152 Sum_probs=36.5
Q ss_pred ccccccCCceeEEEEEecCCCC--CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQT--DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
.+.|+.|-...||++....... ...++.+.+|+.... .....+.+|..+++.|...+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~------~~~~~li~E~~~l~~L~~~g 136 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERH 136 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTT
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC------CcHHHHHHHHHHHHHHHhCC
Confidence 4567778889999997643111 012356888887421 11145568999999998665
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.004 Score=57.36 Aligned_cols=27 Identities=30% Similarity=0.493 Sum_probs=23.1
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
++|+|+.+.|||+++++ +.|+||..+.
T Consensus 214 l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 214 FCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 99999999999998654 8999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.03 Score=50.81 Aligned_cols=29 Identities=21% Similarity=0.354 Sum_probs=25.9
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCcc
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVS 191 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~ 191 (379)
++|+|+.+.||++++++.+.|+||+.+..
T Consensus 208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 208 LCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 99999999999999878899999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.045 Score=51.90 Aligned_cols=53 Identities=13% Similarity=0.105 Sum_probs=31.9
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhcc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
++.|+.|-...+|++.... .++.+.+|+..... . ... .-.+|..+++.|...+
T Consensus 113 i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~-~---~~i-dR~~E~~vl~~L~~~g 165 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT-D---EII-NREREKKISCILYNKN 165 (458)
T ss_dssp EEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C-C---SCS-CHHHHHHHHHHHTTSS
T ss_pred EEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh-h---hhc-CHHHHHHHHHHHHhcC
Confidence 3567778888999987542 23557888764321 1 111 1268999999997655
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.31 Score=45.51 Aligned_cols=27 Identities=19% Similarity=0.537 Sum_probs=24.4
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCc
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAV 190 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~ 190 (379)
++|+|+.+.||+ +.++.+.++||..|.
T Consensus 264 ~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 264 FAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred EECCCCCcccee-cCCCcEEEEecccCC
Confidence 899999999999 778899999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.87 E-value=0.37 Score=44.67 Aligned_cols=29 Identities=31% Similarity=0.410 Sum_probs=24.4
Q ss_pred eEecCCCCCceEE------cCCCCeEEeccccCcc
Q 035572 163 IIHRDIKSTNILF------DSKWDAKLADFGLAVS 191 (379)
Q Consensus 163 i~H~dlkp~NIll------~~~~~~kl~Dfg~a~~ 191 (379)
++|+|+.+.|||+ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999987743
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.92 E-value=1.8 Score=36.19 Aligned_cols=103 Identities=10% Similarity=0.136 Sum_probs=67.8
Q ss_pred cCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHH-HHHcCCCCeEecCCCCCceEEcCCCCeE
Q 035572 105 DGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQ-CLHENDPMIIHRDIKSTNILFDSKWDAK 182 (379)
Q Consensus 105 ~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~LH~~~~~i~H~dlkp~NIll~~~~~~k 182 (379)
.+++.+.+.++.-++ .++. .++. ++..++++++.+|+.... ++++ -+|--|.|+||+++.++.++
T Consensus 58 ~~eD~~~i~y~~~~~~~~f~-~i~~--------~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f~~~~~p~ 124 (219)
T 4ano_A 58 VSEDEVKVVIKPPSSFLTFA-AIRK--------TTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMFNRALEPF 124 (219)
T ss_dssp ECSSEEEEEEECCTTCEEHH-HHHT--------SCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEECTTCCEE
T ss_pred EeCCEEEEEEEcCcccCcHH-HHHh--------cCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEEeCCCcEE
Confidence 455667777776533 3454 4443 778888988888887666 4433 56778899999999999999
Q ss_pred EeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCee-hhHHHHHHHHhCCCCCC
Q 035572 183 LADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVF-SYGVVLLEIISCRKPID 242 (379)
Q Consensus 183 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw-SlG~il~elltg~~p~~ 242 (379)
+.-.|+-..+ +|.-.. ..|.| ++=|++..++.++..|.
T Consensus 125 i~hRGi~~~l----------------pP~e~~------ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 125 FLHVGVKESL----------------PPDEWD------DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ESCCEETTTB----------------SSCSCC------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEcCCcccC----------------CCCCCC------HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9987763222 332211 12333 46677777887776663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 379 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 8e-50
Identities = 69/298 (23%), Positives = 114/298 (38%), Gaps = 47/298 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + IG GS G+VYK H +A+K + + NE+ V
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW--------HGDVAVKMLNVTAPT--PQQLQAFKNEVGV 57
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L R+ N ++ F G +V ++ SLY LH
Sbjct: 58 LRKT-----RHVN--ILLFMG--------YSTAPQLAIVTQWCEGSSLYHHLHIIE---- 98
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV---S 191
+ + IA Q ++ + LH IIHRD+KS NI K+ DFGLA
Sbjct: 99 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156
Query: 192 ESDESSMVQPAGTIGYLDPGY---TNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248
S Q +G+I ++ P + + S + DV+++G+VL E+++ + P +
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR- 215
Query: 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
D + ++ L L K M + A C+ + + RP +IL
Sbjct: 216 ---DQIIFMVGRGYLSPD------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-47
Identities = 66/326 (20%), Positives = 134/326 (41%), Gaps = 52/326 (15%)
Query: 8 EELVKATESFSQSRL-IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSK 66
++L ++ + + +G G+ GSV + + ++ +AIK + +++
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGV---YRMRKKQIDVAIKVLKQ---GTEKADTE 54
Query: 67 KLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLL 126
++ E +++ L NP +V G V +LVME G L+ L
Sbjct: 55 EMMREAQIMHQL-----DNPY--IVRLIG--------VCQAEALMLVMEMAGGGPLHKFL 99
Query: 127 HNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADF 186
++ N ++ Q+S ++ L E + +HRD+ + N+L ++ AK++DF
Sbjct: 100 VG----KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDF 153
Query: 187 GLA----VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242
GL+ +S ++ + + P N K S + DV+SYGV + E +S +
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213
Query: 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGI 302
++ + I++ K ++ + + C + E+RP
Sbjct: 214 KKMKGPEVMAF----IEQGK----------RMECPPECPPELYALMSDCWIYKWEDRPDF 259
Query: 303 GEIL-MGCSCFF-----VDHHHHHHH 322
+ +C++ V+ HHHHHH
Sbjct: 260 LTVEQRMRACYYSLASKVEGHHHHHH 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 3e-47
Identities = 66/317 (20%), Positives = 120/317 (37%), Gaps = 54/317 (17%)
Query: 5 FDYEELVKATESFSQS---------RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRAST 55
F +E+ +A F++ ++IG G G V L+ +AIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKL--PGKREIFVAIKTLKS 64
Query: 56 NGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVME 115
+ + +E ++ +PN V++ G V ++ +++ E
Sbjct: 65 ---GYTEKQRRDFLSEASIMGQF-----DHPN--VIHLEG-------VVTKSTPVMIITE 107
Query: 116 FMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175
FM NGSL L T V + I+ ++ L D +HRD+ + NIL
Sbjct: 108 FMENGSLDSFLRQNDGQFT----VIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILV 161
Query: 176 DSKWDAKLADFGLAVSESDESSM------VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229
+S K++DFGL+ D++S + I + P K + DV+SYG+
Sbjct: 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGI 221
Query: 230 VLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAA 289
V+ E++S + +I+ D R+ P + +
Sbjct: 222 VMWEVMSYGERPYWDMTNQDVINAIEQ-----------DYRLPPP---MDCPSALHQLML 267
Query: 290 RCVSSEEENRPGIGEIL 306
C + +RP G+I+
Sbjct: 268 DCWQKDRNHRPKFGQIV 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-47
Identities = 62/287 (21%), Positives = 108/287 (37%), Gaps = 38/287 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
IG+GS +VYK + + +A ++ + ++ E +L LQ
Sbjct: 15 IEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDR--KLTKSERQRFKEEAEMLKGLQH 67
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
N V F+ + +V G +LV E M +G+L L +
Sbjct: 68 PNI-------VRFYDSW---ESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIK 112
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLAVSESDESSMV 199
QI + +Q LH P IIHRD+K NI K+ D GLA + +
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK- 171
Query: 200 QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIK 259
GT ++ P K + VDV+++G+ +LE+ + P ++ A I +K
Sbjct: 172 AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230
Query: 260 EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+V ++ + C+ ++ R I ++L
Sbjct: 231 PASFDKVAI-------------PEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-46
Identities = 58/301 (19%), Positives = 108/301 (35%), Gaps = 47/301 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E+ +G G G V+ H +A+K + E +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT------KVAVKSLKQG-----SMSPDAFLAEANL 61
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ L ++ +V + V ++ E+M NGSL D L +
Sbjct: 62 MKQL-----QHQR--LVRLYA--------VVTQEPIYIITEYMENGSLVDFLKTPSG--- 103
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSE 192
+L + +A QI+ + + E + IHRD+++ NIL K+ADFGLA + +
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
++ ++ I + P N + K DV+S+G++L EI++ + +I
Sbjct: 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312
R + +++ + C E+RP + F
Sbjct: 222 NLE--------------RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 313 F 313
F
Sbjct: 268 F 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-46
Identities = 60/325 (18%), Positives = 109/325 (33%), Gaps = 55/325 (16%)
Query: 4 NFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD 63
N L + R IG+G+ G V++A ++A+K E D
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASAD 58
Query: 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
E +++ + + G L+ E+M G L
Sbjct: 59 MQADFQREAALMAEFD--------------NPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 124 DLLHN-------------------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMII 164
+ L + ++ P L ++ IA Q++ + L E +
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162
Query: 165 HRDIKSTNILFDSKWDAKLADFGLAV---SESDESSMVQPAGTIGYLDPGYTNPSKLSKK 221
HRD+ + N L K+ADFGL+ S + A I ++ P ++ + +
Sbjct: 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222
Query: 222 VDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAI 281
DV++YGVVL EI S +I + +++ + E
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY----VRDGN----------ILACPENCP 268
Query: 282 KQMLHVAARCVSSEEENRPGIGEIL 306
++ ++ C S +RP I
Sbjct: 269 LELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 5e-46
Identities = 71/303 (23%), Positives = 114/303 (37%), Gaps = 46/303 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+IG+G+ G V KA + DG AIKR +D+ + E+ V
Sbjct: 10 NDIKFQDVIGEGNFGQVLKAR---IKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEV 63
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------ 128
L L +PN ++N G + + L +E+ P+G+L D L
Sbjct: 64 LCKL----GHHPN--IINLLG-------ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 110
Query: 129 -----AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
A +T L + A ++R + L + IHRD+ + NIL + AK+
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKI 168
Query: 184 ADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
ADFGL+ + + ++ N S + DV+SYGV+L EI+S
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228
Query: 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303
A + EKL Q ++ + +C + RP
Sbjct: 229 GMTCAELY---------EKLPQGYR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 304 EIL 306
+IL
Sbjct: 275 QIL 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-44
Identities = 62/308 (20%), Positives = 122/308 (39%), Gaps = 45/308 (14%)
Query: 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78
+ + +G G+ G+V K + + K +A+K + +L E V+ L
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVV---KTVAVKILKNEAND--PALKDELLAEANVMQQL 65
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
NP +V G + +LVME G L L +
Sbjct: 66 -----DNPY--IVRMIGICEAE--------SWMLVMEMAELGPLNKYLQQ-----NRHVK 105
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDE--- 195
N +++ Q+S ++ L E++ +HRD+ + N+L ++ AK++DFGL+ + +
Sbjct: 106 DKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 196 -SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
+ + + P N K S K DV+S+GV++ E S + + +
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-- 221
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCFFV 314
++++ + G ++M + C + + ENRPG + + ++
Sbjct: 222 --MLEKGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
Query: 315 DHHHHHHH 322
D + HH
Sbjct: 270 DVVNEGHH 277
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-44
Identities = 59/318 (18%), Positives = 116/318 (36%), Gaps = 54/318 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E+ +++G G+ G V A G +A+K + + L +E+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE---KADSSEREALMSELKM 93
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------ 128
++ L + N +VN G +C SG + L+ E+ G L + L +
Sbjct: 94 MTQLG----SHEN--IVNLLG-ACTLSGPI------YLIFEYCCYGDLLNYLRSKREKFS 140
Query: 129 ------------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD 176
L + + + A Q+++ ++ L +HRD+ + N+L
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT 198
Query: 177 SKWDAKLADFGLA---VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLE 233
K+ DFGLA +S+S+ + ++ P + K DV+SYG++L E
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 234 IISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVS 293
I S D + + + A +++ + C +
Sbjct: 259 IFSLGVNPYPGIPV----DANFYKLIQNGFK---------MDQPFYATEEIYIIMQSCWA 305
Query: 294 SEEENRPGIGEIL--MGC 309
+ RP + +GC
Sbjct: 306 FDSRKRPSFPNLTSFLGC 323
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-44
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72
+ F + +G G+ G V+K + ++A K E+ ++ E+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIH---LEIKPAIRNQIIREL 55
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA 132
+VL +P +V F+G + + + ME M GSL +L A
Sbjct: 56 QVLHEC-----NSPY--IVGFYG-------AFYSDGEISICMEHMDGGSLDQVLKKAG-- 99
Query: 133 TTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSE 192
++ K+++ + + + L E I+HRD+K +NIL +S+ + KL DFG++
Sbjct: 100 ---RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
D + GT Y+ P + S + D++S G+ L+E+ R PI
Sbjct: 156 IDSMAN-SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-44
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 41/297 (13%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E + IG GS+G K + D KIL K + + L +E+ +
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSMT--EAEKQMLVSEVNL 56
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAAT 133
L L ++PN +V ++ +D + L +VME+ G L ++
Sbjct: 57 LREL-----KHPN--IVRYYDRI------IDRTNTTLYIVMEYCEGGDLASVITKGTKER 103
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHE---NDPMIIHRDIKSTNILFDSKWDAKLADFGLA- 189
L +++ Q++ A++ H ++HRD+K N+ D K + KL DFGLA
Sbjct: 104 QY-LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162
Query: 190 VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
+ D S GT Y+ P N ++K D++S G +L E+ + P A
Sbjct: 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--- 219
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+E ++ + + ++ + R ++ ++ +RP + EIL
Sbjct: 220 ----------KELAGKIREGK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-44
Identities = 60/292 (20%), Positives = 102/292 (34%), Gaps = 47/292 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + IGKG G V +A+K ++ E V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKN------DATAQAFLAEASV 53
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
++ L R+ N +V G G + +V E+M GSL D L +
Sbjct: 54 MTQL-----RHSN--LVQLLGVIVEEKGGL------YIVTEYMAKGSLVDYLRSRGR--- 97
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
LG +K ++ + A++ L N+ +HRD+ + N+L AK++DFGL S
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
+ + + P K S K DV+S+G++L EI S + ++
Sbjct: 156 TQDTGK--LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
K +G + V C + RP ++
Sbjct: 214 EKGYK--------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-43
Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 47/294 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
ES +G+G G V+ +AIK + + E +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPG-----TMSPEAFLQEAQV 65
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ L+ +V + +V E+M GSL D L T
Sbjct: 66 MKKLRHEK-------LVQLYAVVSEE--------PIYIVTEYMSKGSLLDFLKGE---TG 107
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSE 192
L P V +A QI+ + + +HRD+++ NIL K+ADFGLA + +
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIED 165
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
++ ++ I + P + + K DV+S+G++L E+ + + ++D
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ + + + +C E E RP +
Sbjct: 226 QVERGYR--------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-43
Identities = 62/309 (20%), Positives = 110/309 (35%), Gaps = 51/309 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
IGKG G V++ + +A+K S+ ++ S EI L+
Sbjct: 9 ESIGKGRFGEVWRGKW-------RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRH 56
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
N ++ F +++G+ + LV ++ +GSL+D L+ +
Sbjct: 57 EN-------ILGFIAADNKDNGTW---TQLWLVSDYHEHGSLFDYLNR------YTVTVE 100
Query: 141 NRVKIAMQISRAIQCLHEN------DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+K+A+ + + LH P I HRD+KS NIL +AD GLAV
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160
Query: 195 ESSMVQPA-----GTIGYLDPGY------TNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
+ + A GT Y+ P + K+ D+++ G+V EI
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 244 ARDP------ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
D D ++ +++ Q + A++ M + C +
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
Query: 298 NRPGIGEIL 306
R I
Sbjct: 281 ARLTALRIK 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-43
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 44/292 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F R +GKG G+VY A + ILA+K E +L E+ +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEK-AGVEHQLRREVEI 59
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
S L+ N ++ +G ++ V L++E+ P G++Y L
Sbjct: 60 QSHLRHPN-------ILRLYG-YFHDATRV------YLILEYAPLGTVYRELQK-----L 100
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ +++ A+ H +IHRDIK N+L S + K+ADFG +V +
Sbjct: 101 SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV-HAP 157
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
S GT+ YL P +KVD++S GV+ E + + P +A
Sbjct: 158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------- 209
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+E +++ P F+ + ++ +R + RP + E+L
Sbjct: 210 -----QETYKRISRVEFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVL 253
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-42
Identities = 60/308 (19%), Positives = 108/308 (35%), Gaps = 47/308 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
S + +G G+ G V +A +A+K + + L +E++V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKV 79
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN------ 128
LS L + N +VN G + L++ E+ G L + L
Sbjct: 80 LSYL----GNHMN--IVNLLG-------ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 129 -------AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
L + + + Q+++ + L + IHRD+ + NIL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT 184
Query: 182 KLADFGLAVSESDESSMV---QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238
K+ DFGLA ++S+ V + ++ P + + DV+SYG+ L E+ S
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEEN 298
S + +E R E A +M + C ++
Sbjct: 245 SSPYPGMPVDSKFYK----MIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 299 RPGIGEIL 306
RP +I+
Sbjct: 292 RPTFKQIV 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 3e-42
Identities = 63/303 (20%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 6 DYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS 65
+Y++ + +G G +G VY+ + + +A+K + EV
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTMEV----- 57
Query: 66 KKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDL 125
++ E V+ + ++PN +V G ++ EFM G+L D
Sbjct: 58 EEFLKEAAVMKEI-----KHPN--LVQLLG-------VCTREPPFYIITEFMTYGNLLDY 103
Query: 126 LHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLAD 185
L ++ + +A QIS A++ L + + IHRD+ + N L K+AD
Sbjct: 104 LREC---NRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVAD 158
Query: 186 FGLA--VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
FGL+ ++ ++ I + P +K S K DV+++GV+L EI +
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218
Query: 244 ARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303
D + + + + E+ R EG +++ + C +RP
Sbjct: 219 GIDLSQVYE-----LLEKDYR---------MERPEGCPEKVYELMRACWQWNPSDRPSFA 264
Query: 304 EIL 306
EI
Sbjct: 265 EIH 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-42
Identities = 58/292 (19%), Positives = 113/292 (38%), Gaps = 43/292 (14%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79
+ +IG+G G VY L D+ DG A+K + + E ++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFS 86
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
N V++ G + + L+V+ +M +G L + + N T
Sbjct: 87 HPN-------VLSLLGIC------LRSEGSPLVVLPYMKHGDLRNFIRN----ETHNPTV 129
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES--- 196
+ + +Q+++ ++ L +HRD+ + N + D K+ K+ADFGLA D+
Sbjct: 130 KDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187
Query: 197 --SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
+ + ++ K + K DV+S+GV+L E+++ P + I +
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY- 246
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
L++ + E + V +C + E RP E++
Sbjct: 247 --LLQGRR-----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 4e-42
Identities = 50/294 (17%), Positives = 104/294 (35%), Gaps = 47/294 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + + +G G G V +AIK + + E +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMIKEG-----SMSEDEFIEEAKV 52
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ +L + +V +G ++ E+M NG L + L
Sbjct: 53 MMNL-----SHEK--LVQLYG-------VCTKQRPIFIITEYMANGCLLNYLRE----MR 94
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSE 192
+ +++ + A++ L +HRD+ + N L + + K++DFGL+ V +
Sbjct: 95 HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
+ +S V + + P SK S K D++++GV++ EI S K + +
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
++ A +++ + C + + RP +L
Sbjct: 213 HIAQGLR--------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 6e-42
Identities = 56/294 (19%), Positives = 100/294 (34%), Gaps = 47/294 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + IG G G V+ + +AIK + + E V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREG-----AMSEEDFIEEAEV 53
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ L +P +V +G + LV EFM +G L D L
Sbjct: 54 MMKL-----SHPK--LVQLYGVCLEQA-------PICLVFEFMEHGCLSDYLRTQRGLFA 99
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL--AVSE 192
+ + + + + L E +IHRD+ + N L K++DFG+ V +
Sbjct: 100 ----AETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
+S + + P + S+ S K DV+S+GV++ E+ S K R + +++
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ A + + C E+RP +L
Sbjct: 214 DISTGFR--------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 50/296 (16%), Positives = 102/296 (34%), Gaps = 42/296 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
++ ++IG G G VYK +L+ + + AIK + E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKA---GYTEKQRVDFLGEAGI 62
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ N ++ G + +++ E+M NG+L L
Sbjct: 63 MGQFSHHN-------IIRLEGVISKYK-------PMMIITEYMENGALDKFLRE----KD 104
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ V + I+ ++ L +HRD+ + NIL +S K++DFGL+ D
Sbjct: 105 GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162
Query: 195 ES----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250
+ + I + P + K + DV+S+G+V+ E+++ + +
Sbjct: 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
Query: 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ + + + +C E RP +I+
Sbjct: 223 MKAINDGFR--------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 1e-40
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 49/297 (16%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ FS R IG GS G+VY A + +++AIK+ S +G + + + + E+R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQ-SNEKWQDIIKEVR 67
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
L L R+PN + + G LVME+ + L +
Sbjct: 68 FLQKL-----RHPN--TIQYRG-------CYLREHTAWLVMEYCLGSASDLLEVHK---- 109
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSES 193
L + + + LH ++ +IHRD+K+ NIL KL DFG A +
Sbjct: 110 -KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 194 DESSMVQPAGTIGYLDPGY---TNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250
+S V GT ++ P + + KVDV+S G+ +E+ + P+
Sbjct: 167 PANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---- 219
Query: 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAI-KQMLHVAARCVSSEEENRPGIGEIL 306
L + + P G + + C+ ++RP +L
Sbjct: 220 ---------MSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 52/290 (17%), Positives = 95/290 (32%), Gaps = 41/290 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G GS G V + G +A+K + + E+ + SL
Sbjct: 14 EKLGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSL-- 68
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ N ++ +G +V E P GSL D L
Sbjct: 69 ---DHRN--LIRLYGVVL--------TPPMKMVTELAPLGSLLDRLRK----HQGHFLLG 111
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMV- 199
+ A+Q++ + L IHRD+ + N+L ++ K+ DFGL +
Sbjct: 112 TLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 200 ---QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256
+ P S D + +GV L E+ + + + + I+
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK--- 226
Query: 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I +E R E + + +V +C + + E+RP +
Sbjct: 227 -IDKEGER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-40
Identities = 59/314 (18%), Positives = 107/314 (34%), Gaps = 41/314 (13%)
Query: 1 MAENFDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
A+ + +E A E + SR +G+GS G VY+ + + D +AIK +
Sbjct: 6 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AA 62
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
+ NE V+ R G V L++ME M G
Sbjct: 63 SMRERIEFLNEASVMKEFN--------------CHHVVRLLGVVSQGQPTLVIMELMTRG 108
Query: 121 SLYDLLHN-----AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175
L L + A +++A +I+ + L+ N +HRD+ + N +
Sbjct: 109 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV 166
Query: 176 DSKWDAKLADFGL---AVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLL 232
+ K+ DFG+ + + ++ P + DV+S+GVVL
Sbjct: 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226
Query: 233 EIISCRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCV 292
EI + + ++ + + GL + + + C
Sbjct: 227 EIATLAEQPYQGLSNEQVLRFVM--------------EGGLLDKPDNCPDMLFELMRMCW 272
Query: 293 SSEEENRPGIGEIL 306
+ RP EI+
Sbjct: 273 QYNPKMRPSFLEII 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-39
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 48/297 (16%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E + + +G+G++G V A+ + +A+K + D + + EI +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVD---MKRAVDCPENIKKEICI 56
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L N VV F+G + + L +E+ G L+D +
Sbjct: 57 NKMLNHEN-------VVKFYGHRREGN-------IQYLFLEYCSGGELFDRIEP-----D 97
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV---S 191
+ P+ + Q+ + LH I HRDIK N+L D + + K++DFGLA
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155
Query: 192 ESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250
+ E + + GT+ Y+ P + ++ VDV+S G+VL +++ P D D
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
Query: 251 I-DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
DW +++ + + L + ++L R I +I
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLAL-------LHKILVE-------NPSARITIPDIK 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-39
Identities = 65/309 (21%), Positives = 110/309 (35%), Gaps = 51/309 (16%)
Query: 7 YEEL---VKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD 63
YE + + + + +G G+ G VYKA ++ + A K T E L+D
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKSEEELED 55
Query: 64 NSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY 123
EI +L+S +PN +V + +N +++EF G++
Sbjct: 56 ----YMVEIDILASC-----DHPN--IVKLLD-------AFYYENNLWILIEFCAGGAVD 97
Query: 124 DLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
++ L + Q A+ LH+N IIHRD+K+ NILF D KL
Sbjct: 98 AVMLE----LERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKL 151
Query: 184 ADFGLA-VSESDESSMVQPAGTIGYLDPGY-----TNPSKLSKKVDVFSYGVVLLEIISC 237
ADFG++ + GT ++ P + K DV+S G+ L+E+
Sbjct: 152 ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
Query: 238 RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEE 297
P L ++ S +C+ +
Sbjct: 212 EPPHHELNP-------------MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVD 258
Query: 298 NRPGIGEIL 306
R ++L
Sbjct: 259 ARWTTSQLL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (350), Expect = 3e-39
Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 44/301 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDH---KILAIKRASTNGFEVLQDNSKKLNNE 71
E++ ++G+G V + I H+ KI+ + + E +Q+ + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCI---HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
+ +L + H + + + N+ LV + M G L+D L
Sbjct: 60 VDILRKVSG-------------HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--- 103
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
L KI + I LH+ + I+HRD+K NIL D + KL DFG +
Sbjct: 104 --KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159
Query: 192 ESDESSMVQPAGTIGYLDP------GYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
+ + GT YL P N K+VD++S GV++ +++ P R
Sbjct: 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HR 218
Query: 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
++ +I + ++ + + L V + + R E
Sbjct: 219 KQMLMLR----MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV-------QPQKRYTAEEA 267
Query: 306 L 306
L
Sbjct: 268 L 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 57/294 (19%), Positives = 97/294 (32%), Gaps = 42/294 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E R IG+G G V++ I + +AIK +K E
Sbjct: 7 ERIELGRCIGEGQFGDVHQGI--YMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 61
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
+ +P+ +V G N ++ME G L L
Sbjct: 62 MRQF-----DHPH--IVKLIGVITEN--------PVWIIMELCTLGELRSFLQV----RK 102
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSE 192
L + + A Q+S A+ L +HRDI + N+L S KL DFGL+ + +
Sbjct: 103 YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
S + I ++ P N + + DV+ +GV + EI+ +I
Sbjct: 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I+ + + + +C + + RP E+
Sbjct: 221 R----IENGE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (348), Expect = 3e-38
Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G G+ G V++ + G A K T + + + + EI+ +S L
Sbjct: 32 EELGTGAFGVVHRVT---ERATG--NNFAAKFVMTP----HESDKETVRKEIQTMSVL-- 80
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
R+P +VN H + + ++ +++ EFM G L++ + + ++
Sbjct: 81 ---RHPT--LVNLHD-------AFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSED 124
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD--AKLADFGLAVSESDESSM 198
V+ Q+ + + +HEN+ +H D+K NI+F +K KL DFGL + S+
Sbjct: 125 EAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258
GT + P + D++S GV+ ++S P D L +
Sbjct: 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNV 237
Query: 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
K + G+ + I+++L + R I + L
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLA-------DPNTRMTIHQAL 278
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-38
Identities = 65/325 (20%), Positives = 124/325 (38%), Gaps = 43/325 (13%)
Query: 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKL 68
++K TE F + +++G G+ G+VYK + + AIK +K++
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSP---KANKEI 58
Query: 69 NNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHN 128
+E V++S+ NP+ C + S L+ + MP G L D +
Sbjct: 59 LDEAYVMASV-----DNPHVCRLLGICL----------TSTVQLITQLMPFGCLLDYVRE 103
Query: 129 AAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGL 188
+G + +QI++ + L + ++HRD+ + N+L + K+ DFGL
Sbjct: 104 ----HKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGL 157
Query: 189 AV---SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245
A +E E I ++ + + DV+SYGV + E+++
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217
Query: 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
+ I I E+ R + + +C + ++RP E+
Sbjct: 218 PASEISS-----ILEKGER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263
Query: 306 LMGCSCFFVDHHHHHHHHHVERVRL 330
++ S D + ER+ L
Sbjct: 264 IIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-38
Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 45/294 (15%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
+ +++ IG+G+ G+VY A+ + +AI++ + Q + + NEI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQ----QPKKELIINEIL 69
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
V+ +NPN +VN+ S +VME++ GSL D++
Sbjct: 70 VMREN-----KNPN--IVNYLD-------SYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-E 192
+ + + +A++ LH N +IHRDIKS NIL KL DFG
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
++S GT ++ P KVD++S G++ +E+I P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------ 221
Query: 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
L + + E RC+ + E R E+L
Sbjct: 222 -------LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 3e-37
Identities = 53/288 (18%), Positives = 111/288 (38%), Gaps = 43/288 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G G+ G V++ + + ++ K +T + + NEI +++ L
Sbjct: 35 EELGSGAFGVVHRCVEKA-----TGRVFVAKFINTP----YPLDKYTVKNEISIMNQL-- 83
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+P ++N H + + + +L++EF+ G L+D + ++
Sbjct: 84 ---HHPK--LINLHD-AFEDKYEM------VLILEFLSGGELFDRIAA----EDYKMSEA 127
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLADFGLAVSESDESSM 198
+ Q ++ +HE+ I+H DIK NI+ ++K + K+ DFGLA + + +
Sbjct: 128 EVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258
T + P + + D+++ GV+ ++S P D L +
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNV 240
Query: 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
K D+ + + IK +L E R + + L
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQK-------EPRKRLTVHDAL 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-37
Identities = 58/306 (18%), Positives = 108/306 (35%), Gaps = 44/306 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + +G+G+ G V +A + +A+K + L +E+++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKI 69
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L + VVN G + G + ++++EF G+L L +
Sbjct: 70 LIHIGHHL------NVVNLLGACTKPGGPL------MVIVEFCKFGNLSTYLRSKRNEFV 117
Query: 135 PQ-----------LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKL 183
P L + + + Q+++ ++ L IHRD+ + NIL K K+
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKI 175
Query: 184 ADFGLAVSESDESSMVQ---PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
DFGLA + V+ + ++ P + + DV+S+GV+L EI S
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP 300
I + +KE + +M C E RP
Sbjct: 236 PY---PGVKIDEEFCRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRP 282
Query: 301 GIGEIL 306
E++
Sbjct: 283 TFSELV 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 53/298 (17%), Positives = 99/298 (33%), Gaps = 46/298 (15%)
Query: 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE 71
K E F +++G+GS +V A + AIK ++ + E
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIK-ENKVPYVTRE 58
Query: 72 IRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA 131
V+S L +P V + + + + + NG L +
Sbjct: 59 RDVMSRL-----DHPF--FVKLYF-------TFQDDEKLYFGLSYAKNGELLKYIRK--- 101
Query: 132 ATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS 191
+I A++ LH IIHRD+K NIL + ++ DFG A
Sbjct: 102 --IGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKV 157
Query: 192 ESDESSMVQ---PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248
S ES + GT Y+ P K D+++ G ++ ++++ P A +
Sbjct: 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-- 215
Query: 249 SIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+++ P + ++ + + + R G E+
Sbjct: 216 -----------YLIFQKIIKLEYDFPEKFFPKARDLV---EKLLVLDATKRLGCEEME 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 5e-36
Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 44/289 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
++G G+ V A + K++AIK + + L+ + NEI VL +
Sbjct: 15 DVLGTGAFSEVILAEDKR-----TQKLVAIKCIAK---KALEGKEGSMENEIAVLHKI-- 64
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
++PN +V + + L+M+ + G L+D +
Sbjct: 65 ---KHPN--IVALDD-------IYESGGHLYLIMQLVSGGELFDRIVE-----KGFYTER 107
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD---AKLADFGLAVSESDESS 197
+ ++ Q+ A++ LH+ I+HRD+K N+L+ S + ++DFGL+ E S
Sbjct: 108 DASRLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
Query: 198 MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPL 257
+ GT GY+ P SK VD +S GV+ ++ P D
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----LFEQ 220
Query: 258 IKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I + + + + I+ ++ + E R + L
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEK-------DPEKRFTCEQAL 262
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-36
Identities = 65/290 (22%), Positives = 110/290 (37%), Gaps = 39/290 (13%)
Query: 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ 79
S+++G G +G V + + +T + A+K +LQD K E+ +
Sbjct: 17 SQVLGLGINGKVLQIF--NKRTQ---EKFALK--------MLQD-CPKARREVELHWRAS 62
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
+ P+ +V G L+VME + G L+ + +
Sbjct: 63 ----QCPH--IVRIVDVY---ENLYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTE 110
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD---AKLADFGLAVSESDES 196
+I I AIQ LH + I HRD+K N+L+ SK KL DFG A + +
Sbjct: 111 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256
S+ P T Y+ P P K K D++S GV++ ++ P + +I
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKT 227
Query: 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
I+ + + ++ I+ +L E R I E +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT-------EPTQRMTITEFM 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-36
Identities = 52/308 (16%), Positives = 107/308 (34%), Gaps = 48/308 (15%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILE--DHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEI 72
+ + +G+G+ G V A D +A+K + + + + L +E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEM 69
Query: 73 RVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLH----- 127
++ + ++ N + T + +++E+ G+L + L
Sbjct: 70 EMMKMIG----KHKNIINLLGACTQ---------DGPLYVIVEYASKGNLREYLQARRPP 116
Query: 128 ------NAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA 181
N + QL + V A Q++R ++ L IHRD+ + N+L
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVM 174
Query: 182 KLADFGLAVSESDESSMVQ---PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238
K+ADFGLA + + ++ P + + DV+S+GV+L EI +
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
Query: 239 KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEEN 298
+ L+KE ++ + C +
Sbjct: 235 GSPYPGVPVEELFK----LLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQ 280
Query: 299 RPGIGEIL 306
RP +++
Sbjct: 281 RPTFKQLV 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 49/288 (17%), Positives = 105/288 (36%), Gaps = 44/288 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+G+G G V++ + K K G + + EI +L+
Sbjct: 11 EDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG-----TDQVLVKKEISILNIA-- 58
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
R+ N +++ H S + +++ EF+ +++ ++ +A +L
Sbjct: 59 ---RHRN--ILHLHE-------SFESMEELVMIFEFISGLDIFERINTSA----FELNER 102
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA--KLADFGLAVSESDESSM 198
V Q+ A+Q LH ++ I H DI+ NI++ ++ + K+ +FG A +
Sbjct: 103 EIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 199 VQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLI 258
Y P +S D++S G ++ ++S P A + + I
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENI 215
Query: 259 KEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
+ ++ + + ++L E ++R E L
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVK-------ERKSRMTASEAL 256
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-34
Identities = 68/308 (22%), Positives = 113/308 (36%), Gaps = 29/308 (9%)
Query: 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLN 69
L +A + + IG+G++G V+KA D + G + +A+KR E +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKAR--DLKNGG--RFVALKRVRVQTGE--EGMPLSTI 55
Query: 70 NEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNA 129
E+ VL L+ N VV D + LV E + L
Sbjct: 56 REVAVLRHLETFEHPN----VVRLFD--VCTVSRTDRETKLTLVFEHVDQDLTTYLDKV- 108
Query: 130 AAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189
P + + Q+ R + LH + ++HRD+K NIL S KLADFGLA
Sbjct: 109 ---PEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 163
Query: 190 VSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
S + ++ T+ Y P S + VD++S G + E+ + + D
Sbjct: 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223
Query: 250 I--IDWALPLIKEEKLRQVCD---------SRVGLPTFMEGAIKQMLHVAARCVSSEEEN 298
+ I + L EE + S + F+ + + +C++
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
Query: 299 RPGIGEIL 306
R L
Sbjct: 284 RISAYSAL 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-33
Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 43/294 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E F +++GKGS G V+ A + ++ AIK + + D+ + E RV
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVL-MDDDVECTMVEKRV 55
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
LS +P + + + N VME++ G L + +
Sbjct: 56 LSLAW----EHPF--LTHMFC-------TFQTKENLFFVMEYLNGGDLMYHIQSC----- 97
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV-SES 193
+ A +I +Q LH I++RD+K NIL D K+ADFG+ +
Sbjct: 98 HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155
Query: 194 DESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253
++ GT Y+ P K + VD +S+GV+L E++ + P +
Sbjct: 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------- 208
Query: 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307
EE + P ++E K +L + E E R G+ +
Sbjct: 209 ------EELFHSIRMDNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (306), Expect = 6e-33
Identities = 56/298 (18%), Positives = 109/298 (36%), Gaps = 39/298 (13%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
++ + ++G G V+ A D + H+ +A+K + + E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLA--RDLRL---HRDVAVKVLRAD-LARDPSFYLRFRREAQ 59
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
++L +P +V + T + +VME++ +L D++H
Sbjct: 60 NAAAL-----NHPA--IVAVYDTGEAET---PAGPLPYIVMEYVDGVTLRDIVHT----- 104
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV--- 190
+ +++ +A+ H+N IIHRD+K NI+ + K+ DFG+A
Sbjct: 105 EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 162
Query: 191 -SESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
S + + GT YL P + + DV+S G VL E+++ P
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-- 220
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307
+ V + + EG + V + ++ ENR +
Sbjct: 221 ----------SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-32
Identities = 64/306 (20%), Positives = 111/306 (36%), Gaps = 40/306 (13%)
Query: 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVL 75
S++ +++IG GS G VY+A L D +++AIK + + + N E++++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIK--------KVLQDKRFKNRELQIM 67
Query: 76 SSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTP 135
L N +V +SG LV++++P H + A T
Sbjct: 68 RKLDHCN-------IVRLRY-FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT- 118
Query: 136 QLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK-WDAKLADFGLAVSESD 194
L Q+ R++ +H I HRDIK N+L D KL DFG A
Sbjct: 119 -LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 195 ESSMVQPAGTIGYLDPGY-TNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI--I 251
V + Y P + + +DV+S G VL E++ + + I
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 252 DWALPLIKEEKLRQVCDSRVGLP-----------TFMEGAIKQMLHVAARCVSSEEENRP 300
L E++R++ + F + + + +R + R
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 301 GIGEIL 306
E
Sbjct: 296 TPLEAC 301
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (306), Expect = 3e-32
Identities = 54/288 (18%), Positives = 93/288 (32%), Gaps = 37/288 (12%)
Query: 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS 76
FS R+IG+G G VY D K+ A+K ++ Q + LN E +LS
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALN-ERIMLS 59
Query: 77 SLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQ 136
+ + +V + +++ M G L+ L
Sbjct: 60 LVSTGDCPF----IVCMSY-------AFHTPDKLSFILDLMNGGDLHYHLSQ-----HGV 103
Query: 137 LGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES 196
+ A +I ++ +H +++RD+K NIL D +++D GLA S +
Sbjct: 104 FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256
D FS G +L +++ P +
Sbjct: 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------- 213
Query: 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304
K E R V LP ++ +L + + R G
Sbjct: 214 --KHEIDRMTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 6e-31
Identities = 52/292 (17%), Positives = 96/292 (32%), Gaps = 44/292 (15%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNS--KKLNNEIRVLSSL 78
+G G V K + A K + + + + E+ +L +
Sbjct: 16 EELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
++PN V+ H + ++ +L++E + G L+D L L
Sbjct: 71 -----QHPN--VITLHE-------VYENKTDVILILELVAGGELFDFLAE-----KESLT 111
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDA----KLADFGLAVSESD 194
+ QI + LH I H D+K NI+ + K+ DFGLA
Sbjct: 112 EEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254
+ GT ++ P N L + D++S GV+ ++S P
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----T 224
Query: 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
L + + + I+++L + + R I + L
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK-------DPKKRMTIQDSL 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-30
Identities = 59/301 (19%), Positives = 103/301 (34%), Gaps = 41/301 (13%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDN-SKKLNNEIRVLSSLQ 79
+G+G +VYKA ++ ++I+AIK+ +D ++ EI++L L
Sbjct: 4 DFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58
Query: 80 ESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGW 139
N ++ + SN LV +FM + N + L
Sbjct: 59 HPN-------IIGLLD-------AFGHKSNISLVFDFMETDLEVIIKDN-----SLVLTP 99
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-ESDESSM 198
+ + + ++ LH++ I+HRD+K N+L D KLADFGLA S S +
Sbjct: 100 SHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157
Query: 199 VQPAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEIISCRKP------------IDAAR 245
T Y P VD+++ G +L E++ I
Sbjct: 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
Query: 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
+ W + + + L A +L + R +
Sbjct: 218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
Query: 306 L 306
L
Sbjct: 278 L 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (282), Expect = 4e-29
Identities = 57/281 (20%), Positives = 113/281 (40%), Gaps = 45/281 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R +G GS G V+ + + A+K L+ + N+E +LS +
Sbjct: 10 RTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIV-- 61
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+P ++ G + ++M+++ G L+ LL + + P
Sbjct: 62 ---THPF--IIRMWG-------TFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNP 104
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
A ++ A++ LH II+RD+K NIL D K+ DFG A D + +
Sbjct: 105 VAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL- 161
Query: 201 PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALPLIKE 260
GT Y+ P + +K +D +S+G+++ E+++ P +
Sbjct: 162 -CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------------M 207
Query: 261 EKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG 301
+ ++ ++ + P F +K +L +R ++ + R G
Sbjct: 208 KTYEKILNAELRFPPFFNEDVKDLL---SRLITRDLSQRLG 245
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-28
Identities = 56/290 (19%), Positives = 96/290 (33%), Gaps = 50/290 (17%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQD--NSKKLNNEIRVLSSL 78
L+G G GSVY I D+ +AIK + + N ++ E+ +L +
Sbjct: 10 PLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
+ V+ R V L++E L
Sbjct: 65 -----SSGFSGVIRLLDWFERPDSFV-------LILERPEPVQDLFDFITE----RGALQ 108
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFD-SKWDAKLADFGLAVSESDESS 197
Q+ A++ H ++HRDIK NIL D ++ + KL DFG D +
Sbjct: 109 EELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TV 165
Query: 198 MVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWALP 256
GT Y P + + + V+S G++L +++ P + +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------- 218
Query: 257 LIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
G F + + H+ C++ +RP EI
Sbjct: 219 ---------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 60/313 (19%), Positives = 115/313 (36%), Gaps = 46/313 (14%)
Query: 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73
++ IG+G++G V A + +AIK+ S Q ++ EI+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNV-----NKVRVAIKKISPFE---HQTYCQRTLREIK 58
Query: 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAAT 133
+L + N ++ + + +++ + LV M LY LL
Sbjct: 59 ILLRFRHEN-------IIGIND--IIRAPTIEQMKDVYLVTHLM-GADLYKLLKT----- 103
Query: 134 TPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAV--- 190
L + QI R ++ +H + ++HRD+K +N+L ++ D K+ DFGLA
Sbjct: 104 -QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160
Query: 191 -SESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKP-------- 240
+ + T Y P SK +K +D++S G +L E++S R
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 241 -------IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVS 293
I + + + L ++V A + L + + ++
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 294 SEEENRPGIGEIL 306
R + + L
Sbjct: 281 FNPHKRIEVEQAL 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-27
Identities = 51/309 (16%), Positives = 102/309 (33%), Gaps = 44/309 (14%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
IG+G+ G V+KA + +A+K+ + + EI++L L+
Sbjct: 16 AKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENEK--EGFPITALREIKILQLLKH 68
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKL-LVMEFMPNGSLYDLLHNAAAATTPQLGW 139
N VVN + + + LV +F + L + +
Sbjct: 69 EN-------VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTL 116
Query: 140 PNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA-----VSESD 194
++ + + +H N I+HRD+K+ N+L KLADFGLA S
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 195 ESSMVQPAGTIGYL-DPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD------- 246
+ T+ Y +D++ G ++ E+ + + +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 247 -------PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIK--QMLHVAARCVSSEEE 297
+ EKL V + + ++ ++ L + + + +
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 298 NRPGIGEIL 306
R + L
Sbjct: 295 QRIDSDDAL 303
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 6e-27
Identities = 49/254 (19%), Positives = 94/254 (37%), Gaps = 38/254 (14%)
Query: 3 ENFDYEELVKATES---FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE 59
E +DYE V + + R +G+G + V++AI +++ + +K
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKI------- 67
Query: 60 VLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPN 119
+ KK+ EI++L +L + PN ++ + LV E + N
Sbjct: 68 LKPVKKKKIKREIKILENL----RGGPN--IITLAD-----IVKDPVSRTPALVFEHVNN 116
Query: 120 GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK- 178
L L + +I +A+ H I+HRD+K N++ D +
Sbjct: 117 TDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEH 166
Query: 179 WDAKLADFGLAVSESDESSMVQPAGTIGYLDPG-YTNPSKLSKKVDVFSYGVVLLEIISC 237
+L D+GLA + + P + +D++S G +L +I
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
Query: 238 RKPIDAARDPASII 251
++P D +
Sbjct: 227 KEPFFHGHDNYDQL 240
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 105 bits (263), Expect = 1e-26
Identities = 51/307 (16%), Positives = 101/307 (32%), Gaps = 44/307 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E + IG+G++G VYKA + + A+K+ + + EI +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKA------QNNYGETFALKKIRLEKED--EGIPSTTIREISI 53
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L L+ SN +V + +LV E + L
Sbjct: 54 LKELKHSN-------IVKLYDVIHTKK-------RLVLVFEHLDQDLKKLLDVC-----E 94
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSE 192
L +Q+ I H+ ++HRD+K N+L + + + K+ADFGLA
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGI 152
Query: 193 SDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP------------ 240
+ K S +D++S G + E+++
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 241 -IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299
P S + + + + +F++G + + + ++ + + R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 300 PGIGEIL 306
+ L
Sbjct: 273 ITAKQAL 279
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-26
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 28/221 (12%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+L+GKG+ G V + + A+K +D E RVL +
Sbjct: 11 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNT-- 62
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
R+P + + + + VME+ G L+ L T + +
Sbjct: 63 ---RHPFLTALKYAFQT---------HDRLCFVMEYANGGELFFHLSRERVFTEERARF- 109
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVS-ESDESSMV 199
+I A++ LH D +++RDIK N++ D K+ DFGL SD ++M
Sbjct: 110 ----YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 200 QPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
GT YL P + + VD + GVV+ E++ R P
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-26
Identities = 51/307 (16%), Positives = 103/307 (33%), Gaps = 42/307 (13%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E+F + IG+G++G VYKA + +++A+K+ + + EI +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTET--EGVPSTAIREISL 54
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L L N +V + + LV EF+ + +
Sbjct: 55 LKELNHPN-------IVKLLD-------VIHTENKLYLVFEFLHQDLKKFMDAS----AL 96
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ P Q+ + + H + ++HRD+K N+L +++ KLADFGLA +
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154
Query: 195 ESSMVQPAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP------------ 240
S VD++S G + E+++ R
Sbjct: 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 241 -IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENR 299
P ++ + + + K +R + + + ++ + + R
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274
Query: 300 PGIGEIL 306
L
Sbjct: 275 ISAKAAL 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-25
Identities = 65/294 (22%), Positives = 111/294 (37%), Gaps = 38/294 (12%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
E+F +++G G++G V+ G K+ A+K ++ E +V
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTG--KLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L +++S +V H + L+++++ G L+ L
Sbjct: 82 LEHIRQSP------FLVTLHYA-------FQTETKLHLILDYINGGELFTHLSQ-----R 123
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLA--VSE 192
+ +I A++ LH+ II+RDIK NIL DS L DFGL+
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181
Query: 193 SDESSMVQPAGTIGYL--DPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250
+ GTI Y+ D S K VD +S GV++ E+++ P + S
Sbjct: 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241
Query: 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGE 304
E R++ S P M K ++ R + + + R G G
Sbjct: 242 ---------AEISRRILKSEPPYPQEMSALAKDLI---QRLLMKDPKKRLGCGP 283
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (252), Expect = 4e-25
Identities = 46/300 (15%), Positives = 94/300 (31%), Gaps = 56/300 (18%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R IG+GS G +++ + + + +AIK + ++ +L +E R L
Sbjct: 11 RRIGEGSFGVIFEGT---NLLNN--QQVAIKFEP------RRSDAPQLRDEYRTYKLLAG 59
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ N + + +LV++ + L +
Sbjct: 60 CT------GIPNVYYF-------GQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVK 101
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD-----AKLADFGLAVSESDE 195
A Q+ +Q +HE +++RDIK N L + DFG+ D
Sbjct: 102 TVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159
Query: 196 SS--------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS--CRKPIDAAR 245
+ +GT Y+ + S++ D+ + G V + + A
Sbjct: 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219
Query: 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305
+ + LR++C G P ++ + + P +
Sbjct: 220 TNKQKYERIGEKKQSTPLRELCA---GFP-------EEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (251), Expect = 5e-25
Identities = 50/297 (16%), Positives = 89/297 (29%), Gaps = 50/297 (16%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R IG GS G +Y D + +AIK E ++ +L+ E ++ +Q
Sbjct: 13 RKIGSGSFGDIYLGT--DIAAG---EEVAIKL------ECVKTKHPQLHIESKIYKMMQG 61
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ ++VME + + +
Sbjct: 62 GV------GIPTIRW-------CGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLK 103
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLA---DFGLAVSESDESS 197
+ +A Q+ I+ +H + IHRD+K N L L DFGLA D +
Sbjct: 104 TVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 198 MVQP--------AGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249
GT Y + S++ D+ S G VL+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS--------LPW 213
Query: 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306
A ++ + + +G + C S +++P +
Sbjct: 214 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-25
Identities = 55/323 (17%), Positives = 121/323 (37%), Gaps = 44/323 (13%)
Query: 3 ENFDYEELVKATESFSQS----RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF 58
F +E+ K + +G G++G+V A+ D +T +AIK+
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV--DGRTG---AKVAIKKLYRPFQ 56
Query: 59 EVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMP 118
+ +K+ E+R+L ++ N V+ ++D ++ LVM FM
Sbjct: 57 S--ELFAKRAYRELRLLKHMRHEN-------VIGLLD-VFTPDETLDDFTDFYLVMPFMG 106
Query: 119 NGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSK 178
+ H +LG + Q+ + ++ +H + HRD+K N+ +
Sbjct: 107 TDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNED 157
Query: 179 WDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR 238
+ K+ DFGLA ++D N + ++ VD++S G ++ E+I+ +
Sbjct: 158 CELKILDFGLAR-QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
Query: 239 KPIDAARDPA----------SIIDWALPLIKEEKLRQVCDS-----RVGLPTFMEGAIKQ 283
+ + + ++ ++ + + + + A
Sbjct: 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276
Query: 284 MLHVAARCVSSEEENRPGIGEIL 306
+++ + + + E R GE L
Sbjct: 277 AVNLLEKMLVLDAEQRVTAGEAL 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-25
Identities = 53/319 (16%), Positives = 104/319 (32%), Gaps = 46/319 (14%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ + + IG+G++G+V+KA + H+I+A+KR + + + EI +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDDD--EGVPSSALREICL 54
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L L+ N +V H + + LV EF
Sbjct: 55 LKELKHKN-------IVRLHD-------VLHSDKKLTLVFEFCDQDLKKYFDSC-----N 95
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
L Q+ + + H + ++HRD+K N+L + + KLA+FGLA +
Sbjct: 96 GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
Query: 195 ESSMVQPAG--TIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252
S +D++S G + E+ + +P+ D +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 253 --------------WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEEN 298
++ + + K + + L + + +
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 299 RPGIGEILMGCSCFFVDHH 317
R E L +F D
Sbjct: 274 RISAEEAL--QHPYFSDFC 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRV 74
+ F + + +G GS G V ++ A+K L+ + NE R+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQ-IEHTLNEKRI 94
Query: 75 LSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATT 134
L ++ +V + NS N +VME++ G ++ L
Sbjct: 95 LQAVNFPF-------LVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRR-----I 135
Query: 135 PQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESD 194
+ P+ A QI + LH D +I+RD+K N+L D + ++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 195 ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253
+ + GT L P +K VD ++ GV++ E+ + P A P I +
Sbjct: 194 RTWTLC--GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEK 249
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 2e-23
Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 25/220 (11%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
+ IG G+ G V A D D + +AIK+ S Q ++K+ E+ ++ +
Sbjct: 23 KPIGSGAQGIVCAAY--DAVLD---RNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVN- 74
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
+ +++ +++ + LVME M +
Sbjct: 75 ------HKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHE 119
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQ 200
+ Q+ I+ LH IIHRD+K +NI+ S K+ DFGLA + M
Sbjct: 120 RMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 201 PAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
T Y P + VD++S G ++ E++ +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 3e-23
Identities = 63/332 (18%), Positives = 123/332 (37%), Gaps = 46/332 (13%)
Query: 5 FDYEELVKA----TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV 60
F +EL K E + +G G++GSV A D +T +A+K+ S
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTG---LRVAVKKLSRPFQS- 57
Query: 61 LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNG 120
++K+ E+R+L ++ N V+ + N + ++ +
Sbjct: 58 -IIHAKRTYRELRLLKHMKHEN-------VIGLLDVFTPARSLEEFND--VYLVTHLMGA 107
Query: 121 SLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180
L +++ +L + + QI R ++ +H IIHRD+K +N+ + +
Sbjct: 108 DLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCE 159
Query: 181 AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240
K+ DFGLA +D+ A N ++ VD++S G ++ E+++ R
Sbjct: 160 LKILDFGLAR-HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
Query: 241 IDAA----------RDPASIIDWALPLIKEEKLRQVCDS-----RVGLPTFMEGAIKQML 285
R + L I E R S ++ GA +
Sbjct: 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278
Query: 286 HVAARCVSSEEENRPGIGEILMGCSCFFVDHH 317
+ + + + + R + L +F +H
Sbjct: 279 DLLEKMLVLDSDKRITAAQAL--AHAYFAQYH 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.5 bits (197), Expect = 2e-17
Identities = 38/227 (16%), Positives = 82/227 (36%), Gaps = 18/227 (7%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE 80
R +G G +V+ A ++ +A+K + + ++ +EI++L + +
Sbjct: 19 RKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVND 68
Query: 81 SNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWP 140
++ + N H + + G + +VM F G L L +
Sbjct: 69 ADNTKEDSMGAN-HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY- 126
Query: 141 NRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS----KWDAKLADFGLAVSESDES 196
+I+ Q+ + +H IIH DIK N+L + + ++ L + +
Sbjct: 127 -VKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 197 SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDA 243
T Y P + D++S ++ E+I+ +
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 7e-14
Identities = 30/220 (13%), Positives = 65/220 (29%), Gaps = 41/220 (18%)
Query: 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIK--RASTNGFEVLQDNSKKLNNEIRVLSSL 78
+L+G+G +V+ +K + F+ +++ + VL+
Sbjct: 6 KLMGEGKESAVFNC------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA-- 57
Query: 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLG 138
R+ V ++ME + LY ++
Sbjct: 58 ----IRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY------------RVR 101
Query: 139 WPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSM 198
N ++ I + + I+H D+ N+L + + DF +V +E
Sbjct: 102 VENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR 158
Query: 199 VQPAGTIGYLDPGYTNPS-----KLSKKVDVFSYGVVLLE 233
L+ N + D+ S +L+
Sbjct: 159 -------EILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 379 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=399.09 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=209.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.++. +++.||+|++...... .....+.+.+|+.+++.++|+| |++++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpn-------Iv~~~ 72 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPN-------ILRLY 72 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTT-------BCCEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC-----CCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCC-------CCeEE
Confidence 479999999999999999998765 5678999998643221 2345678899999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++ .+++..|+|||||++|+|.+++...+. +++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 73 ~~~-------~~~~~~~ivmEy~~~g~L~~~l~~~~~-----l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nil 138 (263)
T d2j4za1 73 GYF-------HDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLL 138 (263)
T ss_dssp EEE-------ECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEE
T ss_pred EEE-------EECCEEEEEEeecCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccce
Confidence 764 567889999999999999999986432 899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.++.+||+|||+|....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 139 l~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------ 211 (263)
T d2j4za1 139 LGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------ 211 (263)
T ss_dssp ECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------
T ss_pred ecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------
Confidence 9999999999999997665432 344579999999999999999999999999999999999999997653211
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.+..+.......|. .+++++.+|+.+||+.||++|||++|+++|.
T Consensus 212 -------~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 212 -------TYKRISRVEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp -------HHHHHHTTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred -------HHHHHHcCCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 12222333333333 3457899999999999999999999999984
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=402.90 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=208.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.++. +++.||||.+.... ....+.+.+|+.+++.++|+| |++++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~Hpn-------Iv~~~ 83 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPN-------IVNYL 83 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT-----TCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTT-------BCCEE
T ss_pred cccEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEeccc----ChHHHHHHHHHHHHHhCCCCC-------EeeEe
Confidence 579999999999999999998764 56789999987543 234578999999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..|+|||||+||+|.+++.+. .+++.+++.++.|++.||+|||++| |+||||||+|||
T Consensus 84 ~~~-------~~~~~~~ivmEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NIL 148 (293)
T d1yhwa1 84 DSY-------LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNIL 148 (293)
T ss_dssp EEE-------EETTEEEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred EEE-------EECCEEEEEEEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeE
Confidence 764 5578899999999999999988652 2899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
++.+|.+||+|||+|...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+....+...
T Consensus 149 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp ECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 999999999999999765433 3345567999999999999999999999999999999999999999765432222111
Q ss_pred hhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 254 ALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.............+++++.+||.+||+.||++|||++|+++|..
T Consensus 229 -------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 229 -------------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp -------------HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred -------------HhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 11111111223445688999999999999999999999999843
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=403.00 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=205.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|+++. +++.||||+++.... .+..+.+.+|+.++++++|+| |+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~Hpn-------Iv~~ 68 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHEN-------VVKF 68 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC----------CHHHHHHHHHTCCCTT-------BCCE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 4689999999999999999998765 567899999875432 234567899999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++..|+|||||+||+|.+++.+.+ .+++.+++.++.|++.||+|||++| |+||||||+||
T Consensus 69 ~~~~-------~~~~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NI 134 (271)
T d1nvra_ 69 YGHR-------REGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 134 (271)
T ss_dssp EEEE-------EETTEEEEEEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred eeee-------ccCceeEEEEeccCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHE
Confidence 8774 55788999999999999999996432 3899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|+++++.+||+|||+|....... ......||+.|||||++.+..+ +.++|||||||++|+|+||+.||....+...
T Consensus 135 Ll~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp EECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred EECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999999999997653322 2345579999999999887776 5789999999999999999999987654332
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..... ..... .......+++++.+|+.+||+.||++|||++|+++|..
T Consensus 215 ~~~~~------------~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 215 EYSDW------------KEKKT-YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp HHHHH------------HTTCT-TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHH------------hcCCC-CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 21111 11111 12223445678999999999999999999999999854
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=401.17 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=199.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. +++.||+|.+...... ....+.+.+|++++++++|+| |+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~Hpn-------Iv~~ 68 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPN-------IVRY 68 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCTTSC--HHHHHHHHHHHHHTTSCCCTT-------BCCE
T ss_pred chhCEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEChhhCC--HHHHHHHHHHHHHHHHCCCCC-------EeeE
Confidence 3689999999999999999998765 5678999999765443 344678999999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC---CCeEecCCCC
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND---PMIIHRDIKS 170 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~~i~H~dlkp 170 (379)
++.+.. ..++.+|+|||||+||+|.+++.+.... ...+++..++.++.|++.||.|||+.| .+|+||||||
T Consensus 69 ~~~~~~-----~~~~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp 142 (269)
T d2java1 69 YDRIID-----RTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 142 (269)
T ss_dssp EEEEEC---------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCG
T ss_pred EEEEEe-----CCCCEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCch
Confidence 887642 3356789999999999999999765432 234999999999999999999999854 2399999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
+|||++.++.+||+|||+|....... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+. .+
T Consensus 143 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-~~ 221 (269)
T d2java1 143 ANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KE 221 (269)
T ss_dssp GGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HH
T ss_pred hhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-HH
Confidence 99999999999999999997654433 33456799999999999999999999999999999999999999976542 11
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+.. .+..... +.....+++++.+|+.+||+.||++|||++|+++|.
T Consensus 222 ~~~------------~i~~~~~--~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 222 LAG------------KIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp HHH------------HHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHH------------HHHcCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 111 1111111 111223457899999999999999999999999984
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=392.30 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=207.1
Q ss_pred cCC-ccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 15 ESF-SQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y-~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
++| ++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+.+|+++|++++|+| ||++
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~-----~~~~va~K~i~~~~~~--~~~~~~~~~E~~il~~l~Hpn-------Iv~~ 73 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPN-------IVRF 73 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTT-------BCCE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCC-------eeeE
Confidence 344 677899999999999998765 5567999998754332 344678999999999999999 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+... ......+|+||||+++|+|.+++.+.. .+++..++.++.|++.||+|||+++.+|+||||||+||
T Consensus 74 ~~~~~~~---~~~~~~~~ivmE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 74 YDSWEST---VKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145 (270)
T ss_dssp EEEEEEE---SSSCEEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred EEEEeec---cccCCEEEEEEeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhc
Confidence 8875321 233567899999999999999998643 28999999999999999999999887799999999999
Q ss_pred EEc-CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFD-SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++ +++.+||+|||+|...... ......||+.|||||++.+ +++.++|||||||++|+|++|+.||....+...+..
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~ 223 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 223 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred eeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH
Confidence 997 5789999999999765433 3345589999999999875 599999999999999999999999987654443322
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.. . .....+......++++.+|+.+||+.||++|||++|+++|.
T Consensus 224 ~i------------~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 224 RV------------T-SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp HH------------T-TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HH------------H-cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 21 1 11111223334457899999999999999999999999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=399.98 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=207.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.+.|++++.||+|+||.||+|.++. +++.||||.++... ....+.+.+|+++|++++|+| ||++
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~Hpn-------Iv~l 74 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPN-------IVKL 74 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTT-------BCCE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECC-----CCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCC-------CCeE
Confidence 3579999999999999999998765 56789999987543 344567899999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++..|+|||||+||+|.+++.+.. ..+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 75 ~~~~-------~~~~~~~lvmEy~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NI 141 (288)
T d2jfla1 75 LDAF-------YYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNI 141 (288)
T ss_dssp EEEE-------EETTEEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred EEEE-------eeCCeEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhhe
Confidence 8764 45788999999999999999987532 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCC-----CCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYT-----NPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
|++.++.+||+|||+|...... .......||+.|+|||++ .+..++.++|||||||++|+|+||+.||.+.+..
T Consensus 142 ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp EECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred eECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 9999999999999999654332 123345799999999976 3456889999999999999999999999876543
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..+.. +.............+++++.+||.+||+.||++|||++|+++|.
T Consensus 222 ~~~~~-------------i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 222 RVLLK-------------IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp GHHHH-------------HHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred HHHHH-------------HHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 32211 11121111222345568899999999999999999999999983
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-56 Score=402.02 Aligned_cols=257 Identities=22% Similarity=0.362 Sum_probs=194.8
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.+.|++.+.||+|+||.||+|.++. +++.||||.+...... ...+.+.+|+.+|+.++|+| |++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~Hpn-------Iv~ 71 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKR-----TQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPN-------IVA 71 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETT-----TCCEEEEEEEEC-------------CHHHHHHHTCCCTT-------BCC
T ss_pred CccceEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCC-------CCc
Confidence 35789999999999999999998765 5678999999765432 33467889999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+++.+|||||||+||+|.+++.+. ..+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 72 l~~~-------~~~~~~~~lvmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~N 137 (307)
T d1a06a_ 72 LDDI-------YESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPEN 137 (307)
T ss_dssp EEEE-------EECSSEEEEEECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred EEEE-------EEECCEEEEEEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccc
Confidence 8876 46678999999999999999999753 23999999999999999999999999 9999999999
Q ss_pred eEEc---CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 173 ILFD---SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 173 Ill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
||+. +++.+||+|||+|.............||+.|||||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 138 il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~- 216 (307)
T d1a06a_ 138 LLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK- 216 (307)
T ss_dssp EEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred eeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-
Confidence 9995 578999999999987665555556689999999999999999999999999999999999999997654221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
....+.......+ .....+++++.+|+.+||+.||++|||++|+++|...
T Consensus 217 ------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 217 ------------LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp ------------HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ------------HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 1112222222212 2334566889999999999999999999999998544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=396.37 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=206.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|.++. +++.||||++..... ......+.+.+|++++++++|+| |+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~Hpn-------Iv~l 73 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPF-------FVKL 73 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTT-------BCCE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHc-cCHHHHHHHHHHHHHHHHcCCCC-------eeEE
Confidence 4679999999999999999998765 567899999864322 12345678999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+++.+|+|||||+||+|.+++...+. +++..++.++.|++.||+|||++| |+||||||+||
T Consensus 74 ~~~-------~~~~~~~~ivmEy~~gg~L~~~~~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NI 139 (288)
T d1uu3a_ 74 YFT-------FQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENI 139 (288)
T ss_dssp EEE-------EECSSEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred EEE-------EEECCEEEEEEEccCCCCHHHhhhccCC-----CCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcccc
Confidence 776 4567899999999999999999886543 899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|+++++.+||+|||+|....... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...
T Consensus 140 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-- 217 (288)
T d1uu3a_ 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-- 217 (288)
T ss_dssp EECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred ccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--
Confidence 99999999999999997654322 2334579999999999999999999999999999999999999998654211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.+..+.......|. .+++++.+||.+||+.||++|||++|++.+
T Consensus 218 -----------~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 218 -----------IFQKIIKLEYDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -----------HHHHHHTTCCCCCT---TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -----------HHHHHHcCCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 12222333333332 345789999999999999999999997654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=392.89 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=215.1
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh--hhhcHHHHHHHHHHHHhhhhccCCCCCcee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV--LQDNSKKLNNEIRVLSSLQESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~i 90 (379)
+.++|++++.||+|+||.||+|.++. +++.||||+++...... .....+.+.+|+.+|++++|+| |
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~Hpn-------I 75 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN-------V 75 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTT-------B
T ss_pred cccCEEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCC-------C
Confidence 35789999999999999999998765 56789999987553321 1234678999999999999988 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
|++++. +.+.+..|||||||+||+|.+++...+ .+++..++.++.|++.||+|||++| |+||||||
T Consensus 76 v~~~~~-------~~~~~~~~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp 141 (293)
T d1jksa_ 76 ITLHEV-------YENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKP 141 (293)
T ss_dssp CCEEEE-------EECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred CcEEEE-------EEECCEEEEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc--eeeccccc
Confidence 888876 466789999999999999999998653 3899999999999999999999999 99999999
Q ss_pred CceEEcCCC----CeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 171 TNILFDSKW----DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 171 ~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
+|||++.++ .+||+|||+|.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 142 ~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence 999998776 4999999999877665555666899999999999999999999999999999999999999986542
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.. .+..+.......+. ....+++.+.+||.+||+.||++|||++|+++|...
T Consensus 222 ~~-------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 222 QE-------------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp HH-------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred HH-------------HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 22 11222222222222 234456789999999999999999999999998543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=403.94 Aligned_cols=267 Identities=21% Similarity=0.310 Sum_probs=207.6
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|.+.. +++.||+|.++.... ....+++.+|+.+|+.++|+| ||++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~Hpn-------Iv~l 69 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPY-------IVGF 69 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT-----TTEEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTT-------BCCE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEChhhC---HHHHHHHHHHHHHHHhCCCCC-------CCcE
Confidence 5789999999999999999998765 568899999875432 344578999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCc
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~dlkp~N 172 (379)
++.+ .+++.+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ +| |+||||||+|
T Consensus 70 ~~~~-------~~~~~~~iVmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~N 135 (322)
T d1s9ja_ 70 YGAF-------YSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 135 (322)
T ss_dssp EEEE-------ECSSEEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGG
T ss_pred EEEE-------EECCEEEEEEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHH
Confidence 8774 56788999999999999999998653 28999999999999999999997 59 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
||++++|.+||+|||+|...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......
T Consensus 136 ILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~ 214 (322)
T d1s9ja_ 136 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214 (322)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH
T ss_pred eeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99999999999999999754332 22345899999999999999999999999999999999999999987654321111
Q ss_pred hhhhhhh-----------------------------HHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH
Q 035572 253 WALPLIK-----------------------------EEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG 303 (379)
Q Consensus 253 ~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 303 (379)
....... ............+ .......+.++.+|+.+||+.||++|||++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp C------------------------------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 0000000 0000000100000 001112357899999999999999999999
Q ss_pred HHhccccC
Q 035572 304 EILMGCSC 311 (379)
Q Consensus 304 e~l~~~~~ 311 (379)
|+++|...
T Consensus 294 e~L~Hpf~ 301 (322)
T d1s9ja_ 294 QLMVHAFI 301 (322)
T ss_dssp HHHTSHHH
T ss_pred HHhhCHhh
Confidence 99998443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-54 Score=401.63 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=214.5
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.++. +++.||||++.... ....+.+.+|+.+|++++|+| ||+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~-----~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~Hpn-------Iv~ 87 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPT-------LVN 87 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTT-------BCC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCC-------CCc
Confidence 35789999999999999999998765 56889999997553 234577899999999999998 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+ .+++..|+|||||+||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 88 ~~~~~-------~~~~~~~ivmE~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~N 154 (350)
T d1koaa2 88 LHDAF-------EDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPEN 154 (350)
T ss_dssp EEEEE-------EETTEEEEEECCCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEEE-------EECCEEEEEEEcCCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhH
Confidence 88764 5678999999999999999999642 223899999999999999999999999 9999999999
Q ss_pred eEEc--CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFD--SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++ .++.+||+|||+|.............||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 155 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~- 233 (350)
T d1koaa2 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET- 233 (350)
T ss_dssp EEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred eeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-
Confidence 9996 4688999999999887766666667899999999999999999999999999999999999999986543221
Q ss_pred HHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+..+....... +.....+++++.+||.+||+.||++|||++|+++|....
T Consensus 234 ------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 234 ------------LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp ------------HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred ------------HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11222222221 223345678899999999999999999999999996543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-54 Score=401.71 Aligned_cols=258 Identities=18% Similarity=0.306 Sum_probs=214.6
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++++.||+|+||.||+|.+.. +++.||||+++... ....+.+.+|+.+|++++|+| ||+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~Hpn-------Iv~ 90 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPK-------LIN 90 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTT-------BCC
T ss_pred cccceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCC-------CCc
Confidence 35789999999999999999998765 56789999987543 233567889999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+++.+|+|||||+||+|.+.+... ...+++.+++.++.||+.||.|||++| |+||||||+|
T Consensus 91 ~~~~-------~~~~~~~~ivmE~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~N 157 (352)
T d1koba_ 91 LHDA-------FEDKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 157 (352)
T ss_dssp EEEE-------EECSSEEEEEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEE-------EEECCEEEEEEEcCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccccccc
Confidence 8876 46678999999999999999887642 234899999999999999999999999 9999999999
Q ss_pred eEEc--CCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFD--SKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++ .++.+||+|||+|.............||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+....
T Consensus 158 ILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~- 236 (352)
T d1koba_ 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET- 236 (352)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-
T ss_pred ccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9998 6789999999999887766666667899999999999999999999999999999999999999987543221
Q ss_pred HHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccCc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+..+.......+ .....+++++.+||.+||+.||++|||++|+++|....
T Consensus 237 ------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~ 287 (352)
T d1koba_ 237 ------------LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287 (352)
T ss_dssp ------------HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred ------------HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 112222222212 23345678899999999999999999999999996543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=390.60 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=201.9
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|..+ ..||||+++..... ....+.|.+|+.++++++|+| ||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l~Hpn-------Iv 67 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVN-------IL 67 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSCC--TTHHHHHHHHHHHHTTCCCTT-------BC
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCC-------Ee
Confidence 34678999999999999999999743 23999999765433 455688999999999999999 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++++ ..+.+++|||||++|+|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+
T Consensus 68 ~~~~~~--------~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~ 133 (276)
T d1uwha_ 68 LFMGYS--------TAPQLAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSN 133 (276)
T ss_dssp CEEEEE--------CSSSCEEEEECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eeeEEE--------eccEEEEEEecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHH
Confidence 888764 235689999999999999999753 234899999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCC---CCCCCcCCeehhHHHHHHHHhCCCCCCCCC
Q 035572 172 NILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNP---SKLSKKVDVFSYGVVLLEIISCRKPIDAAR 245 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~ 245 (379)
|||++.++.+||+|||+|....... ......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+..
T Consensus 134 NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp GEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred HEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999997654322 2344579999999998754 357899999999999999999999998766
Q ss_pred CchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 246 DPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+...+...... ... ....+.....+++++.+|+.+||+.||++|||++|++++.
T Consensus 214 ~~~~~~~~~~~--------~~~--~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 214 NRDQIIFMVGR--------GYL--SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CHHHHHHHHHH--------TSC--CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHhc--------CCC--CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 54433222111 000 0111122334567899999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-54 Score=394.48 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=204.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+.++.||+|+||.||+|++.. +++.||||.++..... .....+.+.+|+.+|++++|+| ||+++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~Hpn-------Iv~~~ 81 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPN-------TIQYR 81 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEECCSSC-HHHHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC-----CCcEEEEEEEchhhcc-CHHHHHHHHHHHHHHHHCCCCC-------EeeEE
Confidence 459999999999999999998765 5678999998765432 1344577999999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..|+|||||.+|+|..++...+ .+++..++.++.|++.||.|||++| |+||||||+|||
T Consensus 82 ~~~-------~~~~~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NIL 147 (309)
T d1u5ra_ 82 GCY-------LREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNIL 147 (309)
T ss_dssp EEE-------EETTEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEE
T ss_pred EEE-------EECCEEEEEEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEE
Confidence 774 45678999999999999977765432 3899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC---CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP---SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
++.++.+||+|||+|...... ....||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+......+.
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 148 LSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp EETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999999999765433 34579999999998753 468999999999999999999999998654322211
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.+...... +.....+++++.+|+.+||+.||++|||++|+++|..
T Consensus 225 -------------~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 225 -------------HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp -------------HHHHSCCC-CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -------------HHHhCCCC-CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 11111111 1112234578999999999999999999999999843
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=392.26 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=213.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|.++. +++.||+|+++..... .....+.+.+|+.+|+.++|+| |+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~-------Iv~l 70 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPF-------LTAL 70 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTT-------BCCE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCC-------EEEE
Confidence 3679999999999999999998765 6678999999754322 2345678999999999999988 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+.+.+|+|||||+||+|.+++.+.+. +++..++.++.|++.||+|||++| |+||||||+||
T Consensus 71 ~~~-------~~~~~~~~iv~ey~~gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NI 136 (337)
T d1o6la_ 71 KYA-------FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENL 136 (337)
T ss_dssp EEE-------EECSSEEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred Eee-------eccccccccceeccCCCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHe
Confidence 866 4678899999999999999999987543 889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCC-CCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESD-ESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|++.+|.+||+|||+|+.... .......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.. .
T Consensus 137 Ll~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-~--- 212 (337)
T d1o6la_ 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-R--- 212 (337)
T ss_dssp EECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-H---
T ss_pred EecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-H---
Confidence 999999999999999976543 33445568999999999999999999999999999999999999999876421 1
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCF 312 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~ 312 (379)
....+.......|. .+++++.+||.+||+.||.+||+ ++|+++|....
T Consensus 213 ---------~~~~i~~~~~~~p~---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 213 ---------LFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ---------HHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ---------HHHHHhcCCCCCCc---cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 11222223333333 34678999999999999999995 89999986543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-55 Score=392.26 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=210.4
Q ss_pred HHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCC
Q 035572 7 YEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNP 86 (379)
Q Consensus 7 ~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 86 (379)
|++|+...++|++.+.||+|+||.||+|.++. +++.||||+++... ...+++.+|+.+|++++|+|
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~Hpn---- 74 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPN---- 74 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGG-----GTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTT----
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECC-----CCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCC----
Confidence 34455556789999999999999999999865 56789999987543 34578999999999999998
Q ss_pred CceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEec
Q 035572 87 NYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHR 166 (379)
Q Consensus 87 ~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~ 166 (379)
||++++.+ .+++..++|||||++|+|.+++... ....+++..++.++.|++.||+|||++| |+||
T Consensus 75 ---Iv~~~~~~-------~~~~~~~iv~E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHr 139 (287)
T d1opja_ 75 ---LVQLLGVC-------TREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN--FIHR 139 (287)
T ss_dssp ---BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred ---EecCCccE-------eeCCeeEEEeecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC--cccC
Confidence 88888875 4567899999999999999999763 2344899999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCC
Q 035572 167 DIKSTNILFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAA 244 (379)
Q Consensus 167 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 244 (379)
||||+|||+++++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 140 DlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999977654332 22335889999999999899999999999999999999977776555
Q ss_pred CCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 245 RDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
.+...+...... +.... ....+++++.+|+.+||+.||++|||++|+++.
T Consensus 220 ~~~~~~~~~i~~-----------~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 220 IDLSQVYELLEK-----------DYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp CCHHHHHHHHHT-----------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhc-----------CCCCC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 443333221110 11122 223446789999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-54 Score=390.09 Aligned_cols=267 Identities=23% Similarity=0.381 Sum_probs=203.3
Q ss_pred CCCCHHHHHHHh---------cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHH
Q 035572 3 ENFDYEELVKAT---------ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIR 73 (379)
Q Consensus 3 ~~~~~~~~~~~~---------~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~ 73 (379)
+-|+|+++..++ ++|++.++||+|+||.||+|.++.+.. ....||||.+..... ....+.+.+|+.
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~E~~ 79 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK--REIFVAIKTLKSGYT---EKQRRDFLSEAS 79 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCC---HHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEECcccC---HHHHHHHHHHHH
Confidence 457788887776 456677899999999999998865332 345799999875432 344578999999
Q ss_pred HHHhhhhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHH
Q 035572 74 VLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAI 153 (379)
Q Consensus 74 ~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l 153 (379)
+|++++|+| ||++++++ .+++..++|||||++|+|.+++... ...+++.++..++.|++.||
T Consensus 80 ~l~~l~Hpn-------Iv~l~g~~-------~~~~~~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl 141 (299)
T d1jpaa_ 80 IMGQFDHPN-------VIHLEGVV-------TKSTPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGM 141 (299)
T ss_dssp HHTTCCCTT-------BCCEEEEE-------CSSSSCEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCC-------CccEEEEE-------eeCCEEEEEEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHH
Confidence 999999999 89888875 4467899999999999999988753 23489999999999999999
Q ss_pred HHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc------ccccCccccccCCCCCCCCCCCCcCCeehh
Q 035572 154 QCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS------MVQPAGTIGYLDPGYTNPSKLSKKVDVFSY 227 (379)
Q Consensus 154 ~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 227 (379)
.|||+++ |+||||||+|||++.++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||
T Consensus 142 ~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~ 219 (299)
T d1jpaa_ 142 KYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY 219 (299)
T ss_dssp HHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred HHHhhCC--CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccc
Confidence 9999999 99999999999999999999999999976543322 112357899999999998999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHh
Q 035572 228 GVVLLEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEIL 306 (379)
Q Consensus 228 G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 306 (379)
||++|||+| |+.||.+.... .+..... ...+.+. ...++.++.+|+.+||+.||++|||+.|++
T Consensus 220 Gvvl~el~t~g~~Pf~~~~~~-~~~~~i~-----------~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~ 284 (299)
T d1jpaa_ 220 GIVMWEVMSYGERPYWDMTNQ-DVINAIE-----------QDYRLPP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284 (299)
T ss_dssp HHHHHHHHTTSCCTTTTCCHH-HHHHHHH-----------TTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHH-HHHHHHH-----------cCCCCCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 999999998 89999765432 1111110 0112222 234567899999999999999999999998
Q ss_pred ccc
Q 035572 307 MGC 309 (379)
Q Consensus 307 ~~~ 309 (379)
++.
T Consensus 285 ~~L 287 (299)
T d1jpaa_ 285 NTL 287 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=394.69 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=210.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.+.||+|+||.||+|.+...........||+|.+..... ......+.+|+.+++++ +|+| ||+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~Hpn-------Iv~ 105 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHEN-------IVN 105 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---HHHHHHHHHHHHHHHHhcCCCc-------EeE
Confidence 468999999999999999999988766666677899999875432 34467889999999998 7888 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC------------------CCCCCChHhHHHHHHHHHHHHH
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA------------------TTPQLGWPNRVKIAMQISRAIQ 154 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~ 154 (379)
+++.+ .+.+..|+|||||++|+|.+++...... ....+++..++.++.|+++||+
T Consensus 106 l~~~~-------~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 106 LLGAC-------TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp EEEEE-------CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred EEEEE-------eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 88774 5577899999999999999999865321 1234889999999999999999
Q ss_pred HHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHH
Q 035572 155 CLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVL 231 (379)
Q Consensus 155 ~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 231 (379)
|||+++ |+||||||+|||++.++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||++
T Consensus 179 yLH~~~--IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 179 FLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHhCC--eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 999999 99999999999999999999999999976544332 2344689999999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 232 LEIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 232 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|||+| |+.||.+......+...... ..++..| ..+++++.+|+.+||+.||++|||++|+++|.
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~-----------~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQN-----------GFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHT-----------TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc-----------CCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99998 89999876554433222110 1112222 33457899999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-53 Score=379.05 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=211.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh-----hhhcHHHHHHHHHHHHhhh-hccCCCCC
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-----LQDNSKKLNNEIRVLSSLQ-ESNKRNPN 87 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~-~~~~~~~~ 87 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||+++...... .....+++.+|+.++++++ |+|
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn----- 71 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN----- 71 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT-----
T ss_pred cccCEEceEEecCcCeEEEEEEECC-----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCC-----
Confidence 5789999999999999999998754 57889999987654321 1233467899999999997 888
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecC
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRD 167 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~d 167 (379)
|+++++. +.+++..|||||||+||+|.+++...+. +++.+++.++.||+.||+|||++| |+|||
T Consensus 72 --Iv~~~~~-------~~~~~~~~ivmE~~~~g~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~~lH~~~--ivHrD 135 (277)
T d1phka_ 72 --IIQLKDT-------YETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICALHKLN--IVHRD 135 (277)
T ss_dssp --BCCEEEE-------EECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred --eEEEEee-------cccCcceEEEEEcCCCchHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHcC--Ccccc
Confidence 8887776 4678899999999999999999986542 899999999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC------CCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 168 IKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN------PSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 168 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|||+|||++.++.+||+|||++.............||+.|+|||++. ...++.++||||+||++|+|++|+.||
T Consensus 136 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 136 LKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 99999999999999999999998776655556678999999999764 345788999999999999999999999
Q ss_pred CCCCCchhHHHhhhhhhhHHhhhhhccccCCC-CcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 242 DAARDPASIIDWALPLIKEEKLRQVCDSRVGL-PTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.+...... ...+....... ......+++++.+|+.+||+.||++|||++|+++|..
T Consensus 216 ~~~~~~~~-------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 216 WHRKQMLM-------------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CCSSHHHH-------------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCHHHH-------------HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 87642221 11122222111 2234456789999999999999999999999999853
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-53 Score=385.89 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=209.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|.++. +++.||||+++.... ......+.+.+|+.+++.++||| |++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~Hpn-------Iv~~~ 70 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPF-------IIRMW 70 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTT-------BCCEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHhccCcC-------hhhee
Confidence 579999999999999999998765 567899999874322 12345678999999999999998 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..|+|||||+||+|..++..... +++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 71 ~~~-------~~~~~~~ivmE~~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIL 136 (316)
T d1fota_ 71 GTF-------QDAQQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENIL 136 (316)
T ss_dssp EEE-------ECSSEEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEE
T ss_pred eeE-------eeCCeeeeEeeecCCcccccccccccc-----ccccHHHHHHHHHHHhhhhhccCc--EEccccCchhee
Confidence 764 567899999999999999999976432 788889999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.+|.+||+|||+|...... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...
T Consensus 137 l~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------ 208 (316)
T d1fota_ 137 LDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------ 208 (316)
T ss_dssp ECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------
T ss_pred EcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------
Confidence 999999999999999776543 234589999999999999999999999999999999999999998654221
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
....+.......|. .+++++.+++.+||+.||.+|| |++++++|....
T Consensus 209 -------~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 209 -------TYEKILNAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp -------HHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred -------HHHHHHcCCCCCCC---CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence 12222223333332 3457899999999999999996 999999996543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=389.04 Aligned_cols=256 Identities=18% Similarity=0.301 Sum_probs=213.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++++.||+|+||.||+|.++. +++.||+|.++... .....+.+|+++|+.++|+| |++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~-----~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~Hpn-------Iv~ 65 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRN-------ILH 65 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTT-------BCC
T ss_pred CccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCC-------CCe
Confidence 46899999999999999999998765 56789999998653 23456889999999999988 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++. +.+.+.+|||||||+||+|.+++...+ ..+++.+++.++.||+.||+|||++| |+||||||+|
T Consensus 66 ~~~~-------~~~~~~~~lvmE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~N 132 (321)
T d1tkia_ 66 LHES-------FESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPEN 132 (321)
T ss_dssp EEEE-------EEETTEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEE-------EEECCEEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccc
Confidence 8876 456789999999999999999997532 23899999999999999999999999 9999999999
Q ss_pred eEEcC--CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDS--KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++. .+.+||+|||++.............+|+.|+|||...+..++.++|||||||++|+|++|..||.+.+...
T Consensus 133 Ill~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-- 210 (321)
T d1tkia_ 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-- 210 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--
T ss_pred eeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99984 45899999999987766555566689999999999999999999999999999999999999998764321
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.+..+.......+. .+..+++++.+||.+||+.||++|||++|+++|...
T Consensus 211 -----------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 211 -----------IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp -----------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -----------HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 22223333333232 233456889999999999999999999999998643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=378.53 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=193.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.+ ++.||||+++... ...+.+.+|++++++++|+| |+++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~Hpn-------Iv~~ 65 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPK-------LVQL 65 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT------TEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC------CCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCC-------cccc
Confidence 3579999999999999999998753 4569999997543 33577999999999999998 9998
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||
T Consensus 66 ~g~~-------~~~~~~~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Ni 132 (263)
T d1sm2a_ 66 YGVC-------LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNC 132 (263)
T ss_dssp EEEE-------CSSSSCEEEEECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGE
T ss_pred ccee-------ccCCceEEEEEecCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhhe
Confidence 8875 3467899999999999999998753 234889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhC-CCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISC-RKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~~~~~ 250 (379)
|+++++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+|+ .+||.. .+...+
T Consensus 133 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~ 211 (263)
T d1sm2a_ 133 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEV 211 (263)
T ss_dssp EECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHH
T ss_pred eecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHH
Confidence 999999999999999976544322 2334689999999999999999999999999999999995 555543 333322
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
..... . ..+...| ..+++++.+|+.+||+.||++|||++|++++.
T Consensus 212 ~~~i~---------~--~~~~~~p---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 212 VEDIS---------T--GFRLYKP---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHH---------H--TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHH---------h--cCCCCCc---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 22111 0 1111222 23357899999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=383.48 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=202.5
Q ss_pred HHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceee
Q 035572 12 KATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 12 ~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv 91 (379)
...++|++.+.||+|+||.||+|.++ .++.||||+++... ...+.+.+|+.++++++|+| ||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~Hpn-------Iv 71 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQR-------LV 71 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTT-------BC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCC-------Ee
Confidence 34678999999999999999999875 34569999987542 34577999999999999998 88
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++.+. ++..++||||+++|+|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 72 ~~~g~~~--------~~~~~iv~Ey~~~g~L~~~~~~~~~~---~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~ 138 (272)
T d1qpca_ 72 RLYAVVT--------QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA 138 (272)
T ss_dssp CEEEEEC--------SSSCEEEEECCTTCBHHHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred EEEeeec--------cCCeEEEEEeCCCCcHHHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchh
Confidence 8887642 35679999999999999988654432 3899999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 172 NILFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|||+++++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+....+...
T Consensus 139 NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred heeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999997765433 22345789999999999888899999999999999999996665544443333
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+..... . ..+...| ..+++++.+|+.+||+.||++|||++++++.
T Consensus 219 ~~~~i~---------~--~~~~~~p---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~ 263 (272)
T d1qpca_ 219 VIQNLE---------R--GYRMVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263 (272)
T ss_dssp HHHHHH---------T--TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH---------h--cCCCCCc---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 222111 0 1112222 3345789999999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-52 Score=386.85 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=209.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|.++. +++.||||++..... ......+.+.+|+.+|+.++|+| |++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~-----~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpn-------Iv~~~ 107 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPF-------LVKLE 107 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHHcCCCc-------Eeecc
Confidence 679999999999999999998765 567899999864322 12345678999999999999988 88877
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+....++||||+.||+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 108 ~~-------~~~~~~~~~v~e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NIL 173 (350)
T d1rdqe_ 108 FS-------FKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLL 173 (350)
T ss_dssp EE-------EECSSEEEEEEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred cc-------cccccccccccccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcc
Confidence 66 456788999999999999999997654 3899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 175 FDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
++.+|.+||+|||+|+..... .....||+.|||||++.+..++.++|||||||++|+|+||+.||.+.+...
T Consensus 174 l~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------ 245 (350)
T d1rdqe_ 174 IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------ 245 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred cCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------
Confidence 999999999999999776533 334579999999999999999999999999999999999999997653211
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccCc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSCF 312 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~~ 312 (379)
.+..+.......| ..+++++.+||.+||+.||.+|+ |++++++|....
T Consensus 246 -------~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~ 298 (350)
T d1rdqe_ 246 -------IYEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp -------HHHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred -------HHHHHhcCCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence 1122222222223 23457899999999999999994 999999996653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=384.86 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=207.0
Q ss_pred HhcCCcccc-ccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 13 ATESFSQSR-LIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 13 ~~~~y~~~~-~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
+.++|++.. .||+|+||.||+|.+.. +++.||||+++. ...+.+|+.++.++ +|+| |
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpn-------I 67 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQD---------CPKARREVELHWRASQCPH-------I 67 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTT-------B
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC-----CCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCC-------C
Confidence 357899875 69999999999998765 567899999863 24577899987655 7888 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+.. .......+|+|||||+||+|.+++.+.+ ...+++.+++.++.|++.||+|||++| |+||||||
T Consensus 68 v~l~~~~~~---~~~~~~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp 139 (335)
T d2ozaa1 68 VRIVDVYEN---LYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKP 139 (335)
T ss_dssp CCEEEEEEE---EETTEEEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred CeEEEEEee---cccCCCEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccc
Confidence 887776421 1233567899999999999999997632 234999999999999999999999999 99999999
Q ss_pred CceEEcC---CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 171 TNILFDS---KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 171 ~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
+|||++. ++.+||+|||+|.............||+.|+|||++.+..++.++|||||||++|+|+||+.||.+....
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred cccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 9999985 5679999999998776666666778999999999999999999999999999999999999999765432
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCc-chHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPT-FMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
..... ....+.......|. ....+++++.+||.+||+.||++|||+.|+++|..
T Consensus 220 ~~~~~---------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 220 AISPG---------MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp -----------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred HHHHH---------HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 21111 11122222222232 34567789999999999999999999999999843
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-53 Score=382.64 Aligned_cols=273 Identities=21% Similarity=0.336 Sum_probs=206.5
Q ss_pred CCHHHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh-ccC
Q 035572 5 FDYEELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-SNK 83 (379)
Q Consensus 5 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~ 83 (379)
|+...|....++|++.+.||+|+||.||+|.+.......+++.||||+++.... ....+.+.+|..++.++.| +|
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~e~~~l~~~~~h~~- 78 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLN- 78 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C---HHHHHHHHHHHHHHHHHCCCTT-
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---cHHHHHHHHHHHHHHhhcCCCe-
Confidence 344555555688999999999999999999998877777889999999875432 3445678888888888854 44
Q ss_pred CCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHH
Q 035572 84 RNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRA 152 (379)
Q Consensus 84 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~ 152 (379)
|+.+++.+ ..+++.+++|||||++|+|.+++...... ....+++..++.++.|++.|
T Consensus 79 ------iv~~~~~~------~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~g 146 (299)
T d1ywna1 79 ------VVNLLGAC------TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146 (299)
T ss_dssp ------BCCEEEEE------CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHH
T ss_pred ------EEEeeeee------ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHH
Confidence 66666654 24456789999999999999999865421 12348899999999999999
Q ss_pred HHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHH
Q 035572 153 IQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGV 229 (379)
Q Consensus 153 l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 229 (379)
|.|||+++ |+||||||+|||+++++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||
T Consensus 147 l~ylH~~~--ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv 224 (299)
T d1ywna1 147 MEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224 (299)
T ss_dssp HHHHHHTT--CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHhCC--CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHH
Confidence 99999999 9999999999999999999999999997544332 233457999999999999999999999999999
Q ss_pred HHHHHHhC-CCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 230 VLLEIISC-RKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 230 il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
++|||+|| .+||.+......+..... . ...+..| ..+++++.+++.+||+.||++|||++|+++|
T Consensus 225 il~ellt~~~~p~~~~~~~~~~~~~~~----~-------~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 225 LLWEIFSLGASPYPGVKIDEEFCRRLK----E-------GTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTTSCCSSTTCCCSHHHHHHHH----H-------TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHh----c-------CCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999986 567876554433222111 0 1112222 2345789999999999999999999999987
Q ss_pred c
Q 035572 309 C 309 (379)
Q Consensus 309 ~ 309 (379)
.
T Consensus 291 L 291 (299)
T d1ywna1 291 L 291 (299)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=377.85 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=202.6
Q ss_pred hcCCccccc-cccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 14 TESFSQSRL-IGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~-iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
.++|.+.+. ||+|+||.||+|.++... .+..||||.++.... ....+++.+|+++|++++|+| ||+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vAvK~l~~~~~---~~~~~~~~~E~~il~~l~Hpn-------Iv~ 73 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPY-------IVR 73 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCC---CcEEEEEEEEChhcC---HHHHHHHHHHHHHHHhCCCCC-------Eee
Confidence 357778885 999999999999876533 456799999875432 345678999999999999998 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+. .+..|+|||||++|+|.+++... ...+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 74 l~g~~~--------~~~~~lvmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~N 139 (285)
T d1u59a_ 74 LIGVCQ--------AEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 139 (285)
T ss_dssp EEEEEE--------SSSEEEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred Eeeeec--------cCeEEEEEEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhh
Confidence 888642 24689999999999999998642 234899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~ 247 (379)
||++.++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 140 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred eeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976544322 233468999999999988899999999999999999998 99999876543
Q ss_pred hhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 248 ASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
. +.... . . ..++..| +.+++++.+|+.+||+.||++|||+.++++.
T Consensus 220 ~-~~~~i----~-----~--~~~~~~p---~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~ 265 (285)
T d1u59a_ 220 E-VMAFI----E-----Q--GKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQR 265 (285)
T ss_dssp H-HHHHH----H-----T--TCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred H-HHHHH----H-----c--CCCCCCC---CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 2 11111 0 0 1122222 3456789999999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=377.08 Aligned_cols=245 Identities=25% Similarity=0.432 Sum_probs=195.1
Q ss_pred cccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 21 RLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 21 ~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
+.||+|+||.||+|.+...+ .++.||||+++..... ....+++.+|+.+|++++|+| ||++++.+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~Hpn-------Iv~~~g~~~-- 78 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPY-------IVRMIGICE-- 78 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTT-------BCCEEEEEE--
T ss_pred CCcccCCCeEEEEEEEccCC---cCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCC-------CceEEEEec--
Confidence 47999999999999875432 6788999999754322 445678999999999999999 888888642
Q ss_pred CCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCCC
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKWD 180 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~ 180 (379)
.+..+|||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 79 ------~~~~~lvmE~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~ 145 (277)
T d1xbba_ 79 ------AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHY 145 (277)
T ss_dssp ------SSSEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTE
T ss_pred ------cCCEEEEEEcCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCc
Confidence 246799999999999999997533 3899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHHhhh
Q 035572 181 AKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 181 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 255 (379)
+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ++....
T Consensus 146 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i- 223 (277)
T d1xbba_ 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAML- 223 (277)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH-
T ss_pred ccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHH-
Confidence 99999999976543322 223468999999999988899999999999999999998 89999875422 211111
Q ss_pred hhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 256 PLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
. . ..++..| ..+++++.+|+.+||+.||++|||+++++.
T Consensus 224 ---~-----~--~~~~~~p---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 224 ---E-----K--GERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp ---H-----T--TCCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---H-----c--CCCCCCC---cccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0 0 1122222 345678999999999999999999999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=381.23 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=206.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHH-hhhhccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLS-SLQESNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~~~~~~~~iv~~ 93 (379)
++|++++.||+|+||.||+|.++. +++.||||+++..... .....+.+.+|+.++. .++|+| |+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~-----t~~~vAvK~i~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~-------Iv~~ 68 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPF-------LTHM 68 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTT-------BCCE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC-----CCCEEEEEEEchhhcc-ChHHHHHHHHHHHHHHHhCCCCc-------EEEE
Confidence 689999999999999999998765 6788999999753221 2344566777777765 688888 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +.+++..|+||||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+||
T Consensus 69 ~~~-------~~~~~~~yivmEy~~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~Ni 134 (320)
T d1xjda_ 69 FCT-------FQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNI 134 (320)
T ss_dssp EEE-------EECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred EEE-------EccCCceeEEEeecCCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccce
Confidence 876 4667899999999999999999986543 889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
|+++++.+||+|||+|...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.. .+.
T Consensus 135 L~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~- 212 (320)
T d1xjda_ 135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELF- 212 (320)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH-
T ss_pred eecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHH-
Confidence 9999999999999999765433 3344457999999999999999999999999999999999999999865422 111
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChH-HHhccccC
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIG-EILMGCSC 311 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-e~l~~~~~ 311 (379)
..+....+..| ..+++++.+||.+||+.||++|||+. ++++|...
T Consensus 213 -----------~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 213 -----------HSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp -----------HHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -----------HHHHcCCCCCC---ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 11112222223 33467899999999999999999996 78888544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=366.64 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=205.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.++||+|+||.||+|.++ +++.||||.++... ...+.+.+|+.++++++|+| |++++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~Hpn-------Iv~~~ 65 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEK-------LVQLY 65 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTT-------BCCEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCc-------eeeEE
Confidence 68999999999999999999864 34679999987653 33567999999999999998 99998
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++.+++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++| |+||||||+|||
T Consensus 66 g~~-------~~~~~~~iv~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nil 132 (258)
T d1k2pa_ 66 GVC-------TKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL 132 (258)
T ss_dssp EEE-------CCSSSEEEEEECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEE
T ss_pred EEE-------eeCCceEEEEEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEE
Confidence 875 45678999999999999999987543 23888999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc--ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS--MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASII 251 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~ 251 (379)
+++++.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ++.
T Consensus 133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~ 211 (258)
T d1k2pa_ 133 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETA 211 (258)
T ss_dssp ECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHH
T ss_pred EcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-HHH
Confidence 99999999999999975543322 233568999999999998999999999999999999998 89999876532 221
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... .. ..+...| ...++++.+|+.+||+.||++|||++++++|.
T Consensus 212 ~~i---------~~--~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 212 EHI---------AQ--GLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHH---------HT--TCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHH---------Hh--CCCCCCc---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 111 11 1122222 23457899999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-51 Score=382.94 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=202.2
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHH---HHHHHhhhhccCCCCCceee
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNE---IRVLSSLQESNKRNPNYCVV 91 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E---~~~l~~l~~~~~~~~~~~iv 91 (379)
++|++.++||+|+||.||+|.+.. +++.||||++....... ......+.+| +.+++.++|+| |+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~-----t~~~vAiK~i~~~~~~~-~~~~~~~~~e~~~~~~l~~~~hpn-------Iv 70 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPF-------IV 70 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHHHHSSSCCTT-------BC
T ss_pred HhCeeeeEEecCCCeEEEEEEECC-----CCCEEEEEEEchHHcch-hhHHHHHHHHHHHHHHHhcCCCCc-------EE
Confidence 689999999999999999998765 56789999986432221 2223444555 55555556666 77
Q ss_pred eccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 035572 92 NFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKST 171 (379)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~ 171 (379)
++++. +.+.+.+|+|||||+||+|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+
T Consensus 71 ~l~~~-------~~~~~~~~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~ 136 (364)
T d1omwa3 71 CMSYA-------FHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136 (364)
T ss_dssp CEEEE-------EECSSEEEEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred EEEEE-------EEECCEEEEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccc
Confidence 77765 466789999999999999999998643 2788999999999999999999999 999999999
Q ss_pred ceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 172 NILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 172 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
|||++.+|.+||+|||+|....... .....||+.|+|||++. +..++.++|||||||++|+|+||+.||.+.......
T Consensus 137 NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 215 (364)
T d1omwa3 137 NILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215 (364)
T ss_dssp GEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH
T ss_pred eeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999997665433 33457999999999876 456899999999999999999999999865432211
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCC-----hHHHhccccCcc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPG-----IGEILMGCSCFF 313 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~e~l~~~~~~~ 313 (379)
.............+ ..+++++.+||.+||+.||++||| ++|+++|.....
T Consensus 216 ----------~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 216 ----------EIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ----------HHHHHSSSCCCCCC---SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ----------HHHHhcccCCCCCC---CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 11112222222223 234578999999999999999999 799999976543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=373.01 Aligned_cols=258 Identities=20% Similarity=0.333 Sum_probs=198.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
++.|++.++||+|+||.||+|.++.... .....||||.++.... ......+.+|+.++++++|+| ||++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~H~n-------Iv~~ 74 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHN-------IIRL 74 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECcccC---hHHHHHHHHHHHHHHhcCCCC-------Eeee
Confidence 4579999999999999999998875332 2446799999875432 234567899999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+ .+.+..++||||+.+++|.+.+.... ..+++.++..++.|++.||+|||+++ |+||||||+||
T Consensus 75 ~g~~-------~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NI 141 (283)
T d1mqba_ 75 EGVI-------SKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNI 141 (283)
T ss_dssp EEEE-------CSSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred eEEE-------ecCCceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceE
Confidence 8875 44678999999999999999887532 34899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+....+..+
T Consensus 142 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~ 221 (283)
T d1mqba_ 142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221 (283)
T ss_dssp EECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH
Confidence 99999999999999997654322 12234689999999999999999999999999999999997666554444333
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
+...... ..+.+ ....++..+.+|+.+||+.||++|||+.|+++..
T Consensus 222 ~~~~i~~-----------~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 222 VMKAIND-----------GFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp HHHHHHT-----------TCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHhc-----------cCCCC---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 3221110 01112 2233557899999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-52 Score=372.80 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=199.3
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++.+.||+|+||.||+|.+.. +++.||||.++..... .....+++.+|+.+++.++|+| |++
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~~l~~~~hpn-------iv~ 71 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLR-----LHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA-------IVA 71 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTTT-CHHHHHHHHHHHHHHHTCCCTT-------BCC
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhcCCCC-------CCc
Confidence 35789999999999999999998765 5688999999765332 2345678999999999999998 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+... .......|+||||++|++|.+++...+. +++.+++.++.|++.||+|||++| |+||||||+|
T Consensus 72 ~~~~~~~~---~~~~~~~~lvmE~~~g~~L~~~~~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~N 141 (277)
T d1o6ya_ 72 VYDTGEAE---TPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPAN 141 (277)
T ss_dssp EEEEEEEE---CSSSEEEEEEEECCCEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred ccceeeec---cCCCceEEEEEECCCCCEehhhhcccCC-----CCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcc
Confidence 77765321 0112358999999999999999876542 899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCch
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPA 248 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 248 (379)
||++.++..+++|||.+....... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...
T Consensus 142 Ill~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 142 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp EEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 999999999999999885443222 2344579999999999999999999999999999999999999998654322
Q ss_pred hHHHhhhhhhhHHhhhhhccccCCCC-cchHHHHHHHHHHHHhcccCCCCCCC-ChHHHhcc
Q 035572 249 SIIDWALPLIKEEKLRQVCDSRVGLP-TFMEGAIKQMLHVAARCVSSEEENRP-GIGEILMG 308 (379)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~e~l~~ 308 (379)
.. ..++......+ .....+++++.++|.+||+.||.+|| |+++++..
T Consensus 222 ~~-------------~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~ 270 (277)
T d1o6ya_ 222 VA-------------YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270 (277)
T ss_dssp HH-------------HHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HH-------------HHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence 11 11111111111 12234568899999999999999999 67776643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=368.95 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=196.3
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+...+ ..+..||||.++.... ....+.+.+|+.++++++|+| |+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~~---~~~~~~~~~E~~~l~~l~Hpn-------Iv~l 73 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPH-------IVKL 73 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTS---HHHHHHHHHHHHHHHTCCCTT-------BCCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 578999999999999999999876533 2556799999865432 344678999999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++. ++..|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 74 ~~~~~--------~~~~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NI 139 (273)
T d1mp8a_ 74 IGVIT--------ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNV 139 (273)
T ss_dssp EEEEC--------SSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred EEEEe--------cCeEEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhhe
Confidence 88752 357899999999999999886532 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
+++.++.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||....... +
T Consensus 140 ll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~ 218 (273)
T d1mp8a_ 140 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-V 218 (273)
T ss_dssp EEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-H
T ss_pred eecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-H
Confidence 99999999999999997654332 2234468999999999998999999999999999999998 899997764322 2
Q ss_pred HHhhhhhhhHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
... +.. ...+ ....+++++.+||.+||+.||++|||++|++++.
T Consensus 219 ~~~------------i~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 219 IGR------------IENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp HHH------------HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHH------------HHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 111 111 1122 2234567899999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=369.50 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=197.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++. .+.||||+++... ...+.|.+|+.++++++|+| ||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~------~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~n-------Iv~~ 77 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEK-------LVQL 77 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC------CCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCC-------EeEE
Confidence 5789999999999999999998753 3459999997543 33577999999999999998 8998
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++. ++..++||||+++|+|..++..... ..+++.+++.++.|++.||+|||++| |+||||||+||
T Consensus 78 ~g~~~--------~~~~~lv~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NI 144 (285)
T d1fmka3 78 YAVVS--------EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANI 144 (285)
T ss_dssp EEEEC--------SSSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred EEEEe--------cCCeEEEEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEE
Confidence 88752 3467999999999999999876432 23899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
|+++++++||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+........+.
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999997654332 2334568999999999999999999999999999999999766665544433332
Q ss_pred HhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 252 DWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
..... ....+ ....+++++.+++.+||+.||++|||++++++.
T Consensus 225 ~~i~~-----------~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 267 (285)
T d1fmka3 225 DQVER-----------GYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 267 (285)
T ss_dssp HHHHT-----------TCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHh-----------cCCCC---CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22110 11112 223445789999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=374.67 Aligned_cols=277 Identities=22% Similarity=0.259 Sum_probs=207.4
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh---hhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL---QESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~~~~~~~~i 90 (379)
.++|++++.||+|+||.||+|.+..+ .++.||||+++..... ......+.+|+.+|+.| +|+| |
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~----~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~Hpn-------I 72 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPN-------V 72 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTT-------B
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC----CCEEEEEEEEehhhcc--chHHHHHHHHHHHHHHHhhcCCCC-------c
Confidence 47899999999999999999987542 3567999998754322 23344567888888877 4666 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKS 170 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp 170 (379)
+++++.+.... .......+++|||+.++++...... ....+++..++.++.|++.||+|||++| |+||||||
T Consensus 73 v~~~~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp 144 (305)
T d1blxa_ 73 VRLFDVCTVSR--TDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKP 144 (305)
T ss_dssp CCEEEEEEEEE--CSSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred ceeeeeecccc--cccCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCc
Confidence 88887754211 2345678999999977666544432 3344889999999999999999999999 99999999
Q ss_pred CceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 171 TNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 171 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
+|||++.++.+||+|||++.............||+.|+|||++.+..++.++||||+||++|||+||+.||.+.++...+
T Consensus 145 ~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 224 (305)
T d1blxa_ 145 QNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224 (305)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999997766666666778999999999999999999999999999999999999999876543332
Q ss_pred HHhhhhhh--hHHhhhh---------hccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 251 IDWALPLI--KEEKLRQ---------VCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 251 ~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
........ ....+.. ........+......++.+.+||.+||+.||++|||++|+++|...
T Consensus 225 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 22111000 0000000 0000111111223446789999999999999999999999999543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-51 Score=373.60 Aligned_cols=266 Identities=23% Similarity=0.359 Sum_probs=210.0
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
+|+-..++|++.+.||+|+||.||+|.++......+++.||||+++.... ....+++.+|+.+|++++|+|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~il~~l~h~n------ 77 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPN------ 77 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTT------
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC---hHHHHHHHHHHHHHHhcCCCC------
Confidence 34445678999999999999999999987655566788999999875432 345678999999999999998
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-------------------CCCCCCChHhHHHHHHHH
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-------------------ATTPQLGWPNRVKIAMQI 149 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~~~~~~~i 149 (379)
++.+++.+ ...+..++||||+++|+|.+++..... .....+++..+..++.|+
T Consensus 78 -iv~~~~~~-------~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 78 -IVKLLGVC-------AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp -BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred -cccceeee-------ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 88888775 446789999999999999999975321 122348889999999999
Q ss_pred HHHHHHHHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeeh
Q 035572 150 SRAIQCLHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFS 226 (379)
Q Consensus 150 ~~~l~~LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 226 (379)
+.||+|||+++ |+||||||+|||++.++.+||+|||+|....... ......+|+.|+|||.+.+..++.++||||
T Consensus 150 ~~gl~ylH~~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS 227 (301)
T d1lufa_ 150 AAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227 (301)
T ss_dssp HHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHhhhcccCC--eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhcc
Confidence 99999999999 9999999999999999999999999996543322 233457899999999999999999999999
Q ss_pred hHHHHHHHHhCC-CCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHH
Q 035572 227 YGVVLLEIISCR-KPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEI 305 (379)
Q Consensus 227 lG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 305 (379)
|||++|||++|. +||.+..+ .++... +..... +.....+++++.+|+.+||+.||++|||+.|+
T Consensus 228 ~Gvvl~ell~~~~~p~~~~~~-~e~~~~------------v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 228 YGVVLWEIFSYGLQPYYGMAH-EEVIYY------------VRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHHHHHHHTTTCCTTTTSCH-HHHHHH------------HHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chhhHHHHHccCCCCCCCCCH-HHHHHH------------HHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999986 56665432 222221 111111 12223445789999999999999999999999
Q ss_pred hcc
Q 035572 306 LMG 308 (379)
Q Consensus 306 l~~ 308 (379)
++.
T Consensus 293 ~~~ 295 (301)
T d1lufa_ 293 HRI 295 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=371.48 Aligned_cols=270 Identities=21% Similarity=0.296 Sum_probs=202.6
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|.+.. +++.||||+++..... ....+.+.+|+++|++++|+| |++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~-------Iv~~~ 67 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPN-------IVKLL 67 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCc-------EEEec
Confidence 689999999999999999999865 5678999999754322 345678999999999999988 88888
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+ .+++..|+||||+. +++.+.+... ....+++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~~-------~~~~~~~iv~e~~~-~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl 134 (298)
T d1gz8a_ 68 DVI-------HTENKLYLVFEFLH-QDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLL 134 (298)
T ss_dssp EEE-------EETTEEEEEEECCS-EEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred ccc-------ccccceeEEEeecC-Cchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchhee
Confidence 764 56789999999995 5665655442 2334999999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCC-CcccccCccccccCCCCCCCCC-CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDE-SSMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||+|...... .......||+.|+|||+..... ++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 135 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 135 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214 (298)
T ss_dssp ECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH
Confidence 999999999999999665433 3344557999999999766555 57899999999999999999999987654332222
Q ss_pred hhhhhh--hH---HhhhhhccccCCCC--------cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 253 WALPLI--KE---EKLRQVCDSRVGLP--------TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 253 ~~~~~~--~~---~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
...... .+ .......+.....+ .....+++++.+|+.+||+.||++|||++|+++|...
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 111000 00 00000101000000 0112345789999999999999999999999998443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=371.91 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=196.5
Q ss_pred cccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchh-hhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 19 QSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEV-LQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 19 ~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
.+++||+|+||.||+|.++. +++.||||+++...... .....+.+.+|+.+++.++|+| ||++++.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-------Iv~~~~~- 68 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN-------IIGLLDA- 68 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTT-------BCCEEEE-
T ss_pred cceEeccCcCeEEEEEEECC-----CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCC-------EeEEEee-
Confidence 46889999999999998764 56789999997543321 1223467899999999999988 8888876
Q ss_pred cccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDS 177 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~ 177 (379)
+.+++..|+||||+.++++..+.. ....+++..+..++.||+.||+|||++| |+||||||+|||++.
T Consensus 69 ------~~~~~~~~ivmE~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~ 135 (299)
T d1ua2a_ 69 ------FGHKSNISLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDE 135 (299)
T ss_dssp ------ECCTTCCEEEEECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred ------eccCCceeehhhhhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecC
Confidence 456788999999998776665553 2334888999999999999999999999 999999999999999
Q ss_pred CCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhhh
Q 035572 178 KWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWAL 255 (379)
Q Consensus 178 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 255 (379)
++.+||+|||+|....... ......||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.+..+.+.+....
T Consensus 136 ~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~- 214 (299)
T d1ua2a_ 136 NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF- 214 (299)
T ss_dssp TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred CCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH-
Confidence 9999999999997654433 3344579999999998764 467999999999999999999999998765443322211
Q ss_pred hhhhH---Hhhhhhc------c-ccC-CCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 256 PLIKE---EKLRQVC------D-SRV-GLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 256 ~~~~~---~~~~~~~------~-~~~-~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
..... ..+.... . ... ..+ ......++++.+|+.+||+.||++|||++|+|+|...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred HhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 11000 0000000 0 000 000 0112345789999999999999999999999999544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=368.58 Aligned_cols=272 Identities=21% Similarity=0.306 Sum_probs=203.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
+.++|++++.||+|+||.||+|.++. +++.||||+++..... ....+.+.+|+.+|+.++|+| +|+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpn-------iv~ 81 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHEN-------VIG 81 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTT-------BCC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEchhhcC--hHHHHHHHHHHHHHHhcCCCC-------eeE
Confidence 46899999999999999999998765 5678999999754322 345678999999999999998 888
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. .+.......+|+||||+ +.+|..+++.. .+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 82 l~~~~~~-~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~N 151 (346)
T d1cm8a_ 82 LLDVFTP-DETLDDFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGN 151 (346)
T ss_dssp CSEEECS-CSSTTTCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEEecc-CccccccceEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcch
Confidence 8877543 22334456789999999 78888877542 3999999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.++.+|++|||+|...... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+.
T Consensus 152 IL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 152 LAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp EEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hhcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence 99999999999999999766433 344579999999998765 457899999999999999999999998765433222
Q ss_pred Hhhhhh--------------hhHHhhhhhcc-ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 252 DWALPL--------------IKEEKLRQVCD-SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 252 ~~~~~~--------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
...... ........... ............++.+.+||.+||+.||++|||++|+|+|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 111100 00000000100 011111122345678999999999999999999999999843
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=362.59 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=194.8
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.++ ++.||||+++.+ ...+.+.+|++++++++|+| |+++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~Hpn-------Iv~~ 65 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN-------LVQL 65 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTT-------BCCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCC-------EeeE
Confidence 467899999999999999999874 356999999753 23477999999999999998 9999
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++++. ++.+.+|+||||+++|+|.+++.+.... .+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 66 ~g~~~------~~~~~~~lv~ey~~~g~L~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Ni 134 (262)
T d1byga_ 66 LGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNV 134 (262)
T ss_dssp EEEEC------CC--CCEEEECCCTTEEHHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred EEEEE------ecCCcEEEEEeccCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHhhccccccCc--eeccccchHhh
Confidence 98763 3446689999999999999999764321 2889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhHHH
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASIID 252 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~ 252 (379)
|++.++.+||+|||++...... .....+|..|+|||++.+..++.++|||||||++|||+| |++||.... ..++..
T Consensus 135 l~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-~~~~~~ 211 (262)
T d1byga_ 135 LVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVP 211 (262)
T ss_dssp EECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHH
T ss_pred eecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-HHHHHH
Confidence 9999999999999999765432 233468999999999988899999999999999999998 788877653 233322
Q ss_pred hhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 253 WALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... ..+...+ ..+++++.+|+.+||+.||++|||+.+++++.
T Consensus 212 ~i~~-----------~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 212 RVEK-----------GYKMDAP---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHTT-----------TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHc-----------CCCCCCC---ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 2110 1122222 33457899999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=363.65 Aligned_cols=255 Identities=20% Similarity=0.316 Sum_probs=194.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++.+.||+|+||.||+|.+.... .....||||.+...... .....+.+.+|+.+|++++|+| |++++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~n-------Iv~~~ 77 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRN-------LIRLY 77 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTT-------BCCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCC-------EEEEE
Confidence 67999999999999999999875422 24457999998754332 2344678999999999999999 89988
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+.+. ++..++||||+++|+|.+.+..... .+++..++.++.|++.||.|||++| |+||||||+|||
T Consensus 78 g~~~--------~~~~~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIl 143 (273)
T d1u46a_ 78 GVVL--------TPPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLL 143 (273)
T ss_dssp EEEC--------SSSCEEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred EEEe--------ecchheeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhc
Confidence 8753 2467999999999999998876432 2899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchh
Q 035572 175 FDSKWDAKLADFGLAVSESDESS----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPAS 249 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~ 249 (379)
++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |+.||.+.+....
T Consensus 144 l~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~ 223 (273)
T d1u46a_ 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223 (273)
T ss_dssp EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred cccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH
Confidence 99999999999999976544332 223357889999999999999999999999999999998 8999986543221
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
...+...... ++....+++++.+|+.+||+.||++|||++|+++
T Consensus 224 -------------~~~i~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 224 -------------LHKIDKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------HHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------HHHHHhCCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1122222211 2223345678999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=370.28 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=199.9
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
+.|+++++||+|+||.||+|.+..++.. ....||+|.++... .....+.+.+|+.++++++|+| ||+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~Hpn-------Iv~l~ 77 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPH-------VCRLL 77 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTT-------BCCEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-EEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCC-------EeeEE
Confidence 4699999999999999999998764433 23458999886432 2345678999999999999998 99998
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+++.. +..+++|||+.+++|.+.+... ...+++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 78 g~~~~--------~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIl 143 (317)
T d1xkka_ 78 GICLT--------STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVL 143 (317)
T ss_dssp EEEES--------SSEEEEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred EEEec--------CCeeEEEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcce
Confidence 87632 4678999999999999988763 334899999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh-CCCCCCCCCCchhH
Q 035572 175 FDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS-CRKPIDAARDPASI 250 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~ 250 (379)
++.++.+||+|||+|........ .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.... .+
T Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~ 222 (317)
T d1xkka_ 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI 222 (317)
T ss_dssp EEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GH
T ss_pred eCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HH
Confidence 99999999999999976543322 233468999999999998999999999999999999998 78898765422 22
Q ss_pred HHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 251 IDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
.... .. ..++..| ..+++++.+|+.+||+.||++|||+.|++.+.
T Consensus 223 ~~~i----~~-------~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 223 SSIL----EK-------GERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHH----HH-------TCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHH----Hc-------CCCCCCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1111 00 1122222 33457899999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-50 Score=365.82 Aligned_cols=267 Identities=20% Similarity=0.278 Sum_probs=201.1
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|.++ +++.||||+++..... ....+++.+|+.+|++++|+| |++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpn-------Iv~~~ 66 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKED--EGIPSTTIREISILKELKHSN-------IVKLY 66 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTT-------BCCEE
T ss_pred CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCc-------EEeee
Confidence 68999999999999999999874 4567999999765433 455688999999999999988 88777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+++..+++||++.++.+..+... ...+++..+..++.|++.||+|||+.| |+||||||+|||
T Consensus 67 ~~-------~~~~~~~~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIl 132 (286)
T d1ob3a_ 67 DV-------IHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLL 132 (286)
T ss_dssp EE-------EECSSCEEEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred ee-------cccCCceeEEEEeehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceee
Confidence 66 4567889999999976666555543 234999999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCC-CCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNP-SKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||+|....... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.++...+..
T Consensus 133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~ 212 (286)
T d1ob3a_ 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (286)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999999996654332 2344468999999998765 4568999999999999999999999987654333222
Q ss_pred hhhhhhh--HHh---hhhh------cc--ccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 253 WALPLIK--EEK---LRQV------CD--SRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~--~~~---~~~~------~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
....... ... .... .. ............++.+.+|+.+||+.||++|||++|+++|..
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1110000 000 0000 00 011111123345678999999999999999999999999843
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=364.80 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=197.9
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhh--hhcHHHHHHHHHHHHhhh--hccCCCCCce
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVL--QDNSKKLNNEIRVLSSLQ--ESNKRNPNYC 89 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~~~~~~~~~~ 89 (379)
.++|++.+.||+|+||.||+|++.. +++.||||.+........ .....++.+|+.++++++ |+|
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~n------- 70 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG------- 70 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS-------
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCC-------
Confidence 4689999999999999999998765 567899999875432211 112344678999999997 555
Q ss_pred eeeccccccccCCCccCCCceEEEEeccCC-CCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 035572 90 VVNFHGTSCRNSGSVDGNSNKLLVMEFMPN-GSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDI 168 (379)
Q Consensus 90 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dl 168 (379)
|++++++ +.+.+..|+||||+.+ +++.+++.... .+++.+++.++.|++.||+|||++| |+||||
T Consensus 71 Iv~~~~~-------~~~~~~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDi 136 (273)
T d1xwsa_ 71 VIRLLDW-------FERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDI 136 (273)
T ss_dssp BCCEEEE-------EECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred ccEEEEE-------EeeCCeEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccccC
Confidence 7777766 4667899999999976 68888887643 2899999999999999999999999 999999
Q ss_pred CCCceEEcC-CCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCC-CCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 169 KSTNILFDS-KWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKL-SKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 169 kp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||+|||++. ++.+||+|||+|...... ......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....
T Consensus 137 Kp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~- 214 (273)
T d1xwsa_ 137 KDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 214 (273)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred cccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-
Confidence 999999985 578999999999765433 3345679999999999877665 567999999999999999999997531
Q ss_pred chhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 247 PASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
. +.......+. .+++++.+||.+||+.||++|||++|+++|..
T Consensus 215 --~----------------i~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 215 --E----------------IIRGQVFFRQ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp --H----------------HHHCCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred --H----------------HhhcccCCCC---CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 1 1111112222 23578999999999999999999999999843
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=369.75 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=202.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~iv~ 92 (379)
.++|++.++||+|+||.||+|.++.++ ....||||.++.... .+..+.+.+|+++|+++ +|+| |++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~~Hpn-------Iv~ 75 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPN-------IIN 75 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTT-------BCC
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCC---eEEEEEEEEECcccC---hHHHHHHHHHHHHHHhccCCCC-------Eee
Confidence 368999999999999999999986532 233578888753321 33456799999999998 6888 999
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhh-----------cCCCCCCChHhHHHHHHHHHHHHHHHHcCCC
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAA-----------AATTPQLGWPNRVKIAMQISRAIQCLHENDP 161 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 161 (379)
+++++ .+.+..++||||+++|+|.+++.... ......+++..+..++.|++.||.|||+++
T Consensus 76 ~~~~~-------~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~- 147 (309)
T d1fvra_ 76 LLGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 147 (309)
T ss_dssp EEEEE-------EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEEE-------ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-
Confidence 88875 34678999999999999999997542 122345899999999999999999999999
Q ss_pred CeEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCC-C
Q 035572 162 MIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRK-P 240 (379)
Q Consensus 162 ~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~-p 240 (379)
|+||||||+|||++.++.+||+|||+|.............||..|+|||.+.+..++.++|||||||++|||++|.. |
T Consensus 148 -iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p 226 (309)
T d1fvra_ 148 -FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226 (309)
T ss_dssp -EECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -ccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCC
Confidence 99999999999999999999999999976655544455579999999999998999999999999999999999764 5
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|.+. +...+...... ..++.. ...+++++.+||.+||+.||++|||++|++++.
T Consensus 227 ~~~~-~~~~~~~~i~~-----------~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 227 YCGM-TCAELYEKLPQ-----------GYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp TTTC-CHHHHHHHGGG-----------TCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC-CHHHHHHHHHh-----------cCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6543 33332222110 112222 234457899999999999999999999999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=366.35 Aligned_cols=266 Identities=22% Similarity=0.331 Sum_probs=211.2
Q ss_pred HHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCc
Q 035572 10 LVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNY 88 (379)
Q Consensus 10 ~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~ 88 (379)
|....++|++.++||+|+||.||+|.+.......+++.||||+++.... ......+.+|+.+++.+ +|+|
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~~~~~l~~Hpn------ 88 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMN------ 88 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTT------
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC---HHHHHHHHHHHHHHHhccCCCC------
Confidence 3334589999999999999999999987665667889999999976532 34456789999999999 5888
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-------------CCCCCChHhHHHHHHHHHHHHHH
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-------------TTPQLGWPNRVKIAMQISRAIQC 155 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~ 155 (379)
||++++.+ .+.+..++|||||++|+|.+++...... ....+++..+..++.||+.||+|
T Consensus 89 -Iv~~~g~~-------~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~ 160 (311)
T d1t46a_ 89 -IVNLLGAC-------TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (311)
T ss_dssp -BCCEEEEE-------CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred -EEEEEEEE-------eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 88888875 4567899999999999999999865421 22348899999999999999999
Q ss_pred HHcCCCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHH
Q 035572 156 LHENDPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLL 232 (379)
Q Consensus 156 LH~~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 232 (379)
||+++ ++||||||+|||++.++.++++|||+++....... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 161 LH~~~--ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 161 LASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp HHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHhCC--eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence 99999 99999999999999999999999999976544322 23346899999999999899999999999999999
Q ss_pred HHHh-CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 233 EIIS-CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 233 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
||+| |.+||........+..... . ..+...+ ...+..+.+||.+||+.||++|||++++++.
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~---------~--~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIK---------E--GFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHH---------H--TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHh---------c--CCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999 5555655443332222110 0 1111112 2345789999999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=361.78 Aligned_cols=262 Identities=19% Similarity=0.342 Sum_probs=203.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCC--CCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh-hhccCCCCCcee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQT--DGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL-QESNKRNPNYCV 90 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~i 90 (379)
.++|++.+.||+|+||.||+|.+..... ..++..||||+++.... ......+.+|...+.++ +|+| |
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~e~~~l~~~~~Hpn-------I 81 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKN-------I 81 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---HHHHHHHHHHHHHHHHHCCCTT-------B
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---hHHHHHHHHHHHHHHHhcCCCe-------E
Confidence 5789999999999999999998765443 23457899999976532 34467788999999888 6888 8
Q ss_pred eeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcC-----------CCCCCChHhHHHHHHHHHHHHHHHHcC
Q 035572 91 VNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAA-----------TTPQLGWPNRVKIAMQISRAIQCLHEN 159 (379)
Q Consensus 91 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 159 (379)
|++++.+ .+++..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||++
T Consensus 82 v~~~~~~-------~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~ 154 (299)
T d1fgka_ 82 INLLGAC-------TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 154 (299)
T ss_dssp CCEEEEE-------CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Eeccccc-------ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC
Confidence 8888775 4567899999999999999999865421 234589999999999999999999999
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEeccccCccCCCCC---cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHh
Q 035572 160 DPMIIHRDIKSTNILFDSKWDAKLADFGLAVSESDES---SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIIS 236 (379)
Q Consensus 160 ~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 236 (379)
+ |+||||||+|||++.++.+||+|||++....... ......+|+.|+|||.+.+..++.++|||||||++|||++
T Consensus 155 ~--ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 155 K--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp T--CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence 9 9999999999999999999999999997654432 2233578999999999998999999999999999999998
Q ss_pred -CCCCCCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 237 -CRKPIDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 237 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
|.+||.+... ..+.... . ....+..| ..+++.+.+|+.+||+.||++|||+.|+++..
T Consensus 233 ~g~~p~~~~~~-~~~~~~i---------~--~~~~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 233 LGGSPYPGVPV-EELFKLL---------K--EGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp TSCCSSTTCCH-HHHHHHH---------H--TTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCCH-HHHHHHH---------H--cCCCCCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 7888875442 2211111 0 01122222 33457899999999999999999999999853
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-49 Score=364.61 Aligned_cols=264 Identities=19% Similarity=0.251 Sum_probs=204.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhh-hccCCCCCceeee
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQ-ESNKRNPNYCVVN 92 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~iv~ 92 (379)
.++|+++++||+|+||.||+|++.. +++.||||+++.. ..+++.+|+.+|+.++ |+| |++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpn-------Iv~ 94 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPV-------KKKKIKREIKILENLRGGPN-------IIT 94 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTT-------BCC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCC-------CcE
Confidence 3689999999999999999998764 6788999998742 3567899999999996 777 887
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ......++|||||.+++|.+..+ .+++.+++.++.||+.||.|||++| |+||||||+|
T Consensus 95 ~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~N 159 (328)
T d3bqca1 95 LADIVKD-----PVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHN 159 (328)
T ss_dssp EEEEEEC-----TTTCSEEEEEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred EEEEEEe-----cCCCceeEEEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccc
Confidence 7776432 34567999999999999876542 2899999999999999999999999 9999999999
Q ss_pred eEEcCCC-CeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhH
Q 035572 173 ILFDSKW-DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASI 250 (379)
Q Consensus 173 Ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~ 250 (379)
||++.++ .+||+|||+|.............+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....+....
T Consensus 160 ILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~ 239 (328)
T d3bqca1 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239 (328)
T ss_dssp EEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred eEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH
Confidence 9998654 6999999999877665556667899999999986654 5799999999999999999999999877654332
Q ss_pred HHhhhhhhhHHhh---------------hhhccc-------cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 251 IDWALPLIKEEKL---------------RQVCDS-------RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 251 ~~~~~~~~~~~~~---------------~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
............. ...... ..........+++++.+||.+||+.||++|||++|+|+|
T Consensus 240 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2221111111000 000000 001111223456789999999999999999999999998
Q ss_pred ccC
Q 035572 309 CSC 311 (379)
Q Consensus 309 ~~~ 311 (379)
...
T Consensus 320 p~F 322 (328)
T d3bqca1 320 PYF 322 (328)
T ss_dssp GGG
T ss_pred ccc
Confidence 543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=365.14 Aligned_cols=272 Identities=21% Similarity=0.315 Sum_probs=199.2
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
++++|++++.||+|+||.||+|+++. +++.||||+++.... ....+++.+|+.+|++++|++ +++
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~hp~-------iv~ 70 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNV-----NKVRVAIKKISPFEH---QTYCQRTLREIKILLRFRHEN-------IIG 70 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETT-----TCSEEEEEEECCTTC---HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECC-----CCcEEEEEEEehhcC---hHHHHHHHHHHHHHHHcCCCC-------CCc
Confidence 36789999999999999999998765 567899999975432 344678899999999999998 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+... .+......|++|+ +.+|+|.+++... .+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 71 ~~~~~~~~--~~~~~~~~~l~~~-~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~N 139 (345)
T d1pmea_ 71 INDIIRAP--TIEQMKDVYLVTH-LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSN 139 (345)
T ss_dssp CCEEECCS--STTTCCCEEEEEE-CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EEEEEeec--cccccceEEEEEe-ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcce
Confidence 77665331 1233344556555 5599999999752 3899999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC----cccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCc
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES----SMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDP 247 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 247 (379)
||++.++.+||+|||+|....... ......||+.|+|||++. +..++.++||||+||++|+|++|+.||.+....
T Consensus 140 ILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~ 219 (345)
T d1pmea_ 140 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219 (345)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence 999999999999999996543322 234457999999999874 456788999999999999999999999876533
Q ss_pred hhHHHhhhhh-------------hhHHhhhhhccccCCCC--cchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 248 ASIIDWALPL-------------IKEEKLRQVCDSRVGLP--TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 248 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
.......... ................+ ......++++.+|+.+||+.||.+|||++|+++|..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 2221111000 00000000111111111 112234567999999999999999999999999854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=362.07 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=197.7
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCR 99 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~ 99 (379)
.++||+|+||.||+|.+..+.. ....||||.++... .....+++.+|+++|++++|+| |+++++++.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~Hpn-------Iv~~~g~~~- 98 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPN-------VLSLLGICL- 98 (311)
T ss_dssp EEEEEEETTEEEEEEEECC------CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCCCTT-------BCCCCEEEE-
T ss_pred ceEEeecCCeEEEEEEEECCCC--EEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCC-------EeEEeEEEE-
Confidence 5689999999999999875332 34568999987432 2445688999999999999999 999888764
Q ss_pred cCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEEcCCC
Q 035572 100 NSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILFDSKW 179 (379)
Q Consensus 100 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll~~~~ 179 (379)
..++..++|||||++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 99 -----~~~~~~~lv~E~~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~ 167 (311)
T d1r0pa_ 99 -----RSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF 167 (311)
T ss_dssp -----ETTTEEEEEEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTC
T ss_pred -----ecCCceEEEEEEeecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCC
Confidence 3356789999999999999998753 334778889999999999999999999 99999999999999999
Q ss_pred CeEEeccccCccCCCCCc-----ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHhh
Q 035572 180 DAKLADFGLAVSESDESS-----MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDWA 254 (379)
Q Consensus 180 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 254 (379)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||+||..||....+..++....
T Consensus 168 ~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i 247 (311)
T d1r0pa_ 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247 (311)
T ss_dssp CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH
T ss_pred CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 999999999976543321 223468999999999998999999999999999999999888876544333222211
Q ss_pred hhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 255 LPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
. ...++..| ..+++++.+|+.+||+.||++|||+.|++++..
T Consensus 248 ~-----------~g~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 248 L-----------QGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp H-----------TTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-----------cCCCCCCc---ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1 01122222 234578999999999999999999999998843
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=362.91 Aligned_cols=273 Identities=20% Similarity=0.244 Sum_probs=200.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|+++++||+|+||.||+|++.. +++.||||+++..... .....++.+|+.++++++|+| |+++
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~-----t~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpn-------Iv~~ 81 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKN-------IISL 81 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT-----TTEEEEEEEEESTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC-----CCCEEEEEEEChhhcC--HHHHHHHHHHHHHHHhcCCCC-------eeEE
Confidence 4789999999999999999998765 5688999999765433 445677999999999999998 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++.+.. .+..+....+|+||||+.+ ++.+.+.. .+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 82 ~~~f~~-~~~~~~~~~~~iv~Ey~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Ni 150 (355)
T d2b1pa1 82 LNVFTP-QKTLEEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 150 (355)
T ss_dssp SEEECS-CCSTTTCCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred EEEEec-ccccccCceeEEEEeccch-HHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCcccc
Confidence 877543 3334567899999999955 55555532 2899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 174 LFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
|++.++.++++|||++.............+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.++.......
T Consensus 151 l~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp EECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 99999999999999987776666666668999999999999999999999999999999999999999876543322211
Q ss_pred hhhhhh---------HHhhhhhcccc-----------------CCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 254 ALPLIK---------EEKLRQVCDSR-----------------VGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 254 ~~~~~~---------~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
...... ........... ..........++++.+||.+||+.||++|||++|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 00000000000 0111123456788999999999999999999999999
Q ss_pred cccC
Q 035572 308 GCSC 311 (379)
Q Consensus 308 ~~~~ 311 (379)
|...
T Consensus 311 Hpw~ 314 (355)
T d2b1pa1 311 HPYI 314 (355)
T ss_dssp STTT
T ss_pred Cccc
Confidence 9443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=365.69 Aligned_cols=271 Identities=23% Similarity=0.311 Sum_probs=201.7
Q ss_pred CCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccc
Q 035572 16 SFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHG 95 (379)
Q Consensus 16 ~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~ 95 (379)
+|+.+++||+|+||.||+|++.. +++.||||++..+.. ...+|+.+|++++|+| |+++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~n-------iv~~~~ 80 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKR--------FKNRELQIMRKLDHCN-------IVRLRY 80 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTT-------BCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECC-----CCCEEEEEEECccch--------HHHHHHHHHHhcCCCC-------CCcEEE
Confidence 68999999999999999999875 567899999875432 2347999999999998 888887
Q ss_pred cccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceEE
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNILF 175 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIll 175 (379)
++... +...+...+|+|||||+++ +.+.+..... ....+++..++.++.|++.||+|||++| |+||||||+|||+
T Consensus 81 ~~~~~-~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl 155 (350)
T d1q5ka_ 81 FFYSS-GEKKDEVYLNLVLDYVPET-VYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL 155 (350)
T ss_dssp EEEEC---CCSCCEEEEEEECCSEE-HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE
T ss_pred EEEec-CccCCceEEEEEEeccCCc-cHHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEE
Confidence 76432 1123456789999999654 4444443222 3334999999999999999999999999 9999999999999
Q ss_pred cCCC-CeEEeccccCccCCCCCcccccCccccccCCCCCC-CCCCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHHh
Q 035572 176 DSKW-DAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTN-PSKLSKKVDVFSYGVVLLEIISCRKPIDAARDPASIIDW 253 (379)
Q Consensus 176 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 253 (379)
+.++ .+||+|||++.............||+.|+|||.+. ...++.++||||+||++|||++|+.||........+...
T Consensus 156 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i 235 (350)
T d1q5ka_ 156 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235 (350)
T ss_dssp CTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred ecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH
Confidence 9765 89999999998776666666678999999999765 457899999999999999999999999876544333222
Q ss_pred hhhh--hhHHhhhhhc----cccCC---C-C---cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 254 ALPL--IKEEKLRQVC----DSRVG---L-P---TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 254 ~~~~--~~~~~~~~~~----~~~~~---~-~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
.... .....+.... ..... . + ......++++.+|+.+||+.||++|||+.|+++|...
T Consensus 236 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1100 0001111110 00000 0 0 0112345789999999999999999999999999654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=358.48 Aligned_cols=277 Identities=19% Similarity=0.216 Sum_probs=197.1
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|++.. +++.||||++..+... .....++.+|+.+|+.++|+| ++++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~n-------ii~~ 74 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENEK--EGFPITALREIKILQLLKHEN-------VVNL 74 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTT-------BCCE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCC-------ccce
Confidence 4799999999999999999998764 5678999998765432 455678899999999999998 6666
Q ss_pred cccccccCC-CccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 94 HGTSCRNSG-SVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 94 ~~~~~~~~~-~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
++.+..... .....+..|+||||+.++.+..... ....+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~N 147 (318)
T d3blha1 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAAN 147 (318)
T ss_dssp EEEEEC----------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred EeeeecccccccccCceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchh
Confidence 666543222 1234568999999997665544432 2334889999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCC
Q 035572 173 ILFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARD 246 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~ 246 (379)
||++.++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.++
T Consensus 148 ILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 999999999999999996543221 22334799999999987654 689999999999999999999999987554
Q ss_pred chhHHHhhhhh--hhHHh--------hhhhccccCCCCcchH------HHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 247 PASIIDWALPL--IKEEK--------LRQVCDSRVGLPTFME------GAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 247 ~~~~~~~~~~~--~~~~~--------~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
........... ..... ...........+.... ..++.+.+||.+||+.||++|||++|++.|..
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 33221111000 00000 0000000001111111 12457889999999999999999999999965
Q ss_pred C
Q 035572 311 C 311 (379)
Q Consensus 311 ~ 311 (379)
.
T Consensus 308 f 308 (318)
T d3blha1 308 F 308 (318)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=361.21 Aligned_cols=266 Identities=22% Similarity=0.365 Sum_probs=210.7
Q ss_pred HHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCc
Q 035572 9 ELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNY 88 (379)
Q Consensus 9 ~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 88 (379)
+|....++|++.+.||+|+||.||+|.+........+..||||+++.... ......+.+|+.++++++|+|
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~---~~~~~~~~~E~~il~~l~h~n------ 84 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHH------ 84 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTT------
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC---hHHHHHHHHHHHHHHHcCCCC------
Confidence 34444689999999999999999999986544444567899999975432 344567899999999999998
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhc-----CCCCCCChHhHHHHHHHHHHHHHHHHcCCCCe
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAA-----ATTPQLGWPNRVKIAMQISRAIQCLHENDPMI 163 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i 163 (379)
|+++++.+ ...+..++||||+++|+|.+++..... .....+++..+..++.|++.||.|||+++ |
T Consensus 85 -Iv~~~~~~-------~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--i 154 (308)
T d1p4oa_ 85 -VVRLLGVV-------SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--F 154 (308)
T ss_dssp -BCCEEEEE-------CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred -EeeeeeEE-------ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--e
Confidence 88888875 446789999999999999999875432 12233688899999999999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEeccccCccCCCCCc---ccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCC-C
Q 035572 164 IHRDIKSTNILFDSKWDAKLADFGLAVSESDESS---MVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCR-K 239 (379)
Q Consensus 164 ~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~ 239 (379)
+||||||+|||+++++++||+|||+|+....... .....+|+.|+|||.+.+..++.++|||||||++|||+||. +
T Consensus 155 vHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~ 234 (308)
T d1p4oa_ 155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234 (308)
T ss_dssp BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred eeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCC
Confidence 9999999999999999999999999975543322 23346899999999999999999999999999999999985 6
Q ss_pred CCCCCCCchhHHHhhhhhhhHHhhhhhccc-cCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhccc
Q 035572 240 PIDAARDPASIIDWALPLIKEEKLRQVCDS-RVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGC 309 (379)
Q Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~ 309 (379)
||.+... ..+.. .+.+. ....| ..+++.+.+++.+||+.||++|||+++++++.
T Consensus 235 p~~~~~~-~~~~~------------~i~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 235 PYQGLSN-EQVLR------------FVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp TTTTSCH-HHHHH------------HHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCH-HHHHH------------HHHhCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 7765432 22211 11121 22222 33457899999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=361.39 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=206.7
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhh-ccCCCCCceeeec
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQE-SNKRNPNYCVVNF 93 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~~~~~~~iv~~ 93 (379)
++|++++.||+|+||.||+|.+...+ .+++.||||.++...........+.+.+|++++++++| +| |+++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pn-------Iv~~ 94 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH--DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF-------LVTL 94 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST--TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTT-------BCCE
T ss_pred hceEEEEEEecCCCeEEEEEEECccC--CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCe-------EEEe
Confidence 67999999999999999999876532 36789999998755433223456778999999999988 45 7777
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
++. +++....++||||+.+|+|.+++...+. +++..+..++.|++.||.|||++| |+||||||+||
T Consensus 95 ~~~-------~~~~~~~~~v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Ni 160 (322)
T d1vzoa_ 95 HYA-------FQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENI 160 (322)
T ss_dssp EEE-------EEETTEEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred eee-------eccCCceeeeeecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccce
Confidence 665 4567899999999999999999986543 778889999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeccccCccCCCCC--cccccCccccccCCCCCCCC--CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchh
Q 035572 174 LFDSKWDAKLADFGLAVSESDES--SMVQPAGTIGYLDPGYTNPS--KLSKKVDVFSYGVVLLEIISCRKPIDAARDPAS 249 (379)
Q Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 249 (379)
|++.++.+||+|||+|....... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+......
T Consensus 161 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp EECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred eecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999996553322 23455799999999987654 468899999999999999999999987654432
Q ss_pred HHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCC-----ChHHHhccccC
Q 035572 250 IIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRP-----GIGEILMGCSC 311 (379)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~~~~ 311 (379)
..... ..........| ..+++++.+|+.+||++||++|| |++|+++|...
T Consensus 241 ~~~i~---------~~~~~~~~~~~---~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 241 QAEIS---------RRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp HHHHH---------HHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHH---------HhcccCCCCCc---ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 22211 11111122222 23568899999999999999999 48999998543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=353.18 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=208.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFH 94 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~ 94 (379)
++|++++.||+|+||.||+|++.. +++.||||+++..... .....++.+|+.+|+.++|+| |++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~n-------iv~~~ 67 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKN-------IVRLH 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTT-------BCCEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC-----CCcEEEEEEEehhhCC--hHHHHHHHHHHHHHHhcCcCC-------EEeec
Confidence 689999999999999999998765 5678999998765432 455788999999999999988 77777
Q ss_pred ccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCceE
Q 035572 95 GTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNIL 174 (379)
Q Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NIl 174 (379)
+. +.+....++||+++.+++|..++...+ .+++..++.++.|++.||+|||++| |+||||||+|||
T Consensus 68 ~~-------~~~~~~~~iv~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIl 133 (292)
T d1unla_ 68 DV-------LHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLL 133 (292)
T ss_dssp EE-------EECSSEEEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred cc-------cccccceeEEeeecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccc
Confidence 66 456788999999999999888876432 3889999999999999999999999 999999999999
Q ss_pred EcCCCCeEEeccccCccCCCCC-cccccCccccccCCCCCCCCC-CCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHHH
Q 035572 175 FDSKWDAKLADFGLAVSESDES-SMVQPAGTIGYLDPGYTNPSK-LSKKVDVFSYGVVLLEIISCRKPIDAARDPASIID 252 (379)
Q Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 252 (379)
++.++.+||+|||.|....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||....+......
T Consensus 134 i~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp ECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred cccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 9999999999999997665433 333446788899999876554 68999999999999999999999866655444333
Q ss_pred hhhhhhhHH---hh---hhh--------ccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhcccc
Q 035572 253 WALPLIKEE---KL---RQV--------CDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCS 310 (379)
Q Consensus 253 ~~~~~~~~~---~~---~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~ 310 (379)
......... .. ... ..............++.+.+|+.+||+.||++|||++|+|+|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 221111100 00 000 00111112223345678999999999999999999999999953
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=354.90 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=191.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|.+.+.||+|+||.||+|++ .++.||||+++.+. ......+.|+..+.+++|+| |+++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-------~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~Hpn-------Iv~~ 62 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHEN-------ILGF 62 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-------TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTT-------BCCE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCc-------Ccce
Confidence 45788899999999999999985 35679999986432 11222344555556788888 8888
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc--------CCCCeEe
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE--------NDPMIIH 165 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--------~~~~i~H 165 (379)
++.+.... .....+|+||||+++|+|.+++++. .+++..+..++.|++.||+|||+ .| |+|
T Consensus 63 ~~~~~~~~---~~~~~~~lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvH 131 (303)
T d1vjya_ 63 IAADNKDN---GTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAH 131 (303)
T ss_dssp EEEEEEEC---SSSEEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EEC
T ss_pred EEEEEeCC---CcceEEEEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eec
Confidence 88875421 1223689999999999999999753 28899999999999999999997 47 999
Q ss_pred cCCCCCceEEcCCCCeEEeccccCccCCCCC-----cccccCccccccCCCCCCCCC------CCCcCCeehhHHHHHHH
Q 035572 166 RDIKSTNILFDSKWDAKLADFGLAVSESDES-----SMVQPAGTIGYLDPGYTNPSK------LSKKVDVFSYGVVLLEI 234 (379)
Q Consensus 166 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~el 234 (379)
|||||+|||+++++.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 132 rDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred cccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence 9999999999999999999999996553322 223457999999999877543 57789999999999999
Q ss_pred HhCCCCCCCCCCchhHHHhh-h-hhhhHHhhhhhcccc--CCCCcc--hHHHHHHHHHHHHhcccCCCCCCCChHHHhcc
Q 035572 235 ISCRKPIDAARDPASIIDWA-L-PLIKEEKLRQVCDSR--VGLPTF--MEGAIKQMLHVAARCVSSEEENRPGIGEILMG 308 (379)
Q Consensus 235 ltg~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 308 (379)
+||..||............. . ............... +..+.. .......+.+|+.+||+.||++|||+.|++++
T Consensus 212 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99998875433221100000 0 000011111111111 122222 23455679999999999999999999999876
Q ss_pred c
Q 035572 309 C 309 (379)
Q Consensus 309 ~ 309 (379)
.
T Consensus 292 L 292 (303)
T d1vjya_ 292 L 292 (303)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=358.11 Aligned_cols=273 Identities=21% Similarity=0.287 Sum_probs=199.3
Q ss_pred HhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeee
Q 035572 13 ATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVN 92 (379)
Q Consensus 13 ~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~ 92 (379)
++++|++++.||+|+||.||+|++.. +++.||||+++..... ....+++.+|+.+|+.++|+| +++
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~h~~-------iv~ 81 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHEN-------VIG 81 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT-----TTEEEEEEECSCTTSS--HHHHHHHHHHHHHHHHCCCTT-------BCC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECchhcC--hHHHHHHHHHHHHHHhcCCCC-------eee
Confidence 46899999999999999999998765 6788999999865432 344567899999999999998 777
Q ss_pred ccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q 035572 93 FHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTN 172 (379)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~N 172 (379)
+++.+.. ...+++. ..+++|+|+.||+|.+++... .+++.+++.++.||+.||+|||++| |+||||||+|
T Consensus 82 ~~~~~~~-~~~~~~~-~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~N 151 (348)
T d2gfsa1 82 LLDVFTP-ARSLEEF-NDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN 151 (348)
T ss_dssp CSEEECS-CSSTTTC-CCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGG
T ss_pred EEEEEee-ccccccC-ceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcc
Confidence 6665432 1122333 345556667799999998532 3999999999999999999999999 9999999999
Q ss_pred eEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCC-CCCCcCCeehhHHHHHHHHhCCCCCCCCCCchhHH
Q 035572 173 ILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPS-KLSKKVDVFSYGVVLLEIISCRKPIDAARDPASII 251 (379)
Q Consensus 173 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 251 (379)
||++.+|.+|++|||++..... ......||+.|+|||...+. .++.++|||||||++|+|++|+.||.+.+......
T Consensus 152 ILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~ 229 (348)
T d2gfsa1 152 LAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229 (348)
T ss_dssp EEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccccccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999999865533 23345799999999976554 56889999999999999999999998765332221
Q ss_pred Hhhhhhh----------hHHhhhhhccccCCCC-----cchHHHHHHHHHHHHhcccCCCCCCCChHHHhccccC
Q 035572 252 DWALPLI----------KEEKLRQVCDSRVGLP-----TFMEGAIKQMLHVAARCVSSEEENRPGIGEILMGCSC 311 (379)
Q Consensus 252 ~~~~~~~----------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~~~~ 311 (379)
....... ...............+ ......++++.+||.+||+.||++|||++|+++|...
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 1110000 0000000000000001 1112346789999999999999999999999999544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-47 Score=346.36 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=191.2
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++.+.||+|+||.||+|.+.. +++.||||.+..+. ....+.+|+++++.++|++ ++..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~------~~~~~~~E~~i~~~l~~~~-------~i~~ 67 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGV-------GIPT 67 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEESCT------TSCCHHHHHHHHHHSTTST-------TCCC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC-----CCCEEEEEEEchhc------cCHHHHHHHHHHHHccCCC-------cccE
Confidence 4689999999999999999998765 56789999876532 2245789999999999876 2222
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
...+ ..+.+..++||||+ +++|.+.+... ...+++..+..++.|++.||+|||++| |+||||||+||
T Consensus 68 ~~~~------~~~~~~~~ivme~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NI 134 (299)
T d1ckia_ 68 IRWC------GAEGDYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNF 134 (299)
T ss_dssp EEEE------EEETTEEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred EEEE------EecCCEEEEEEEEc-CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhc
Confidence 2222 34567889999999 77887777642 234899999999999999999999999 99999999999
Q ss_pred EEc---CCCCeEEeccccCccCCCCC--------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCCC
Q 035572 174 LFD---SKWDAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPID 242 (379)
Q Consensus 174 ll~---~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 242 (379)
|++ .+..++|+|||+|....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 135 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp EECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 986 34579999999997654322 1234479999999999999999999999999999999999999997
Q ss_pred CCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 243 AARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
............. ....... .+.+.....+++++.+++.+||+.||++||+++++.+
T Consensus 215 ~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 215 GLKAATKRQKYER--ISEKKMS------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp CCC-------HHH--HHHHHHH------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred ccchHHHHHHHHH--hhcccCC------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7654332211100 0000000 0001112334578999999999999999999987644
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-46 Score=336.40 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=194.5
Q ss_pred hcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeec
Q 035572 14 TESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNF 93 (379)
Q Consensus 14 ~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~ 93 (379)
.++|++++.||+|+||.||+|++.. +++.||||.++... ....+.+|+++++.++|.++ ++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~------i~~~ 66 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTG------IPNV 66 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTT------CCCE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEcccc------CcHHHHHHHHHHHHhcCCCC------CCEE
Confidence 4789999999999999999998764 56889999876432 22457789999999987432 3333
Q ss_pred cccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCCeEecCCCCCce
Q 035572 94 HGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPMIIHRDIKSTNI 173 (379)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~i~H~dlkp~NI 173 (379)
+.+ +..+...++||||+ +++|.+++...+ ..++..++..++.|++.||+|||++| |+||||||+||
T Consensus 67 ~~~-------~~~~~~~~~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Ni 132 (293)
T d1csna_ 67 YYF-------GQEGLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNF 132 (293)
T ss_dssp EEE-------EEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGE
T ss_pred EEE-------eecCCccEEEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccce
Confidence 333 34567889999999 899999987633 24899999999999999999999999 99999999999
Q ss_pred EEcC-----CCCeEEeccccCccCCCCC--------cccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCC
Q 035572 174 LFDS-----KWDAKLADFGLAVSESDES--------SMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKP 240 (379)
Q Consensus 174 ll~~-----~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 240 (379)
|++. ++.+||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+||+.|
T Consensus 133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCc
Confidence 9974 5789999999997643221 22344799999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHhhhhhhhHHhhhhhccccCCCCcchHHHHHHHHHHHHhcccCCCCCCCChHHHhc
Q 035572 241 IDAARDPASIIDWALPLIKEEKLRQVCDSRVGLPTFMEGAIKQMLHVAARCVSSEEENRPGIGEILM 307 (379)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 307 (379)
|.+............ +...... ...+.....+++++.+++..|+..+|++||+.+.+.+
T Consensus 213 f~~~~~~~~~~~~~~--i~~~~~~------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 213 WQGLKAATNKQKYER--IGEKKQS------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp TSSCCSCCHHHHHHH--HHHHHHH------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCccchhHHHHHHH--HHhccCC------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 987654432221110 0000000 0001111234578999999999999999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-42 Score=322.93 Aligned_cols=275 Identities=17% Similarity=0.204 Sum_probs=193.3
Q ss_pred cCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCC------CCCc
Q 035572 15 ESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKR------NPNY 88 (379)
Q Consensus 15 ~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~------~~~~ 88 (379)
++|+++++||+|+||.||+|++.. +++.||||+++.+. ...+.+.+|+.+++.+.|++.. +++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~-----~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~- 81 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH- 81 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT-
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCc-
Confidence 369999999999999999998765 56789999997542 3346788999999999887632 122
Q ss_pred eeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHc-CCCCeEecC
Q 035572 89 CVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHE-NDPMIIHRD 167 (379)
Q Consensus 89 ~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~i~H~d 167 (379)
|+++++++. .......+++|+++..+......... .....+++..+..++.|++.||+|||+ .| |+|||
T Consensus 82 -iv~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrD 151 (362)
T d1q8ya_ 82 -ILKLLDHFN-----HKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTD 151 (362)
T ss_dssp -BCCCCEEEE-----EEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSC
T ss_pred -eEEEEEEee-----eccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC--ccccc
Confidence 555554432 13345666777766554433333222 244458899999999999999999997 89 99999
Q ss_pred CCCCceEEcCCCC------eEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHHHHHHHhCCCCC
Q 035572 168 IKSTNILFDSKWD------AKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVVLLEIISCRKPI 241 (379)
Q Consensus 168 lkp~NIll~~~~~------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~ 241 (379)
|||+|||++.++. ++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||
T Consensus 152 lKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred CChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 9999999986553 999999998765432 23457999999999998889999999999999999999999999
Q ss_pred CCCCCchh-----HHHhhhhhh---hHHhh------hhhcc------c--cC----------CCCcchHHHHHHHHHHHH
Q 035572 242 DAARDPAS-----IIDWALPLI---KEEKL------RQVCD------S--RV----------GLPTFMEGAIKQMLHVAA 289 (379)
Q Consensus 242 ~~~~~~~~-----~~~~~~~~~---~~~~~------~~~~~------~--~~----------~~~~~~~~~~~~~~~li~ 289 (379)
........ ........+ ..... ....+ . .. .........++++.+||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 75432110 000000000 00000 00000 0 00 001123567789999999
Q ss_pred hcccCCCCCCCChHHHhccccCc
Q 035572 290 RCVSSEEENRPGIGEILMGCSCF 312 (379)
Q Consensus 290 ~~l~~dp~~Rps~~e~l~~~~~~ 312 (379)
+||++||.+|||++|+|+|....
T Consensus 310 ~mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGT
T ss_pred HHCCCChhHCcCHHHHhcCcccC
Confidence 99999999999999999996543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=3.8e-23 Score=173.43 Aligned_cols=173 Identities=18% Similarity=0.182 Sum_probs=113.7
Q ss_pred CccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCch--------------hhhhcHHHHHHHHHHHHhhhhcc
Q 035572 17 FSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFE--------------VLQDNSKKLNNEIRVLSSLQESN 82 (379)
Q Consensus 17 y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~~~~ 82 (379)
+.+.+.||+|+||.||+|.+. +++.||||.++....+ ..........+|...+.++.+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 457899999999999999864 4577999987532111 00111234567888888887665
Q ss_pred CCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCCCC
Q 035572 83 KRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHENDPM 162 (379)
Q Consensus 83 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 162 (379)
+...++. ...+++|||+++..+.+ ++...+..++.|++.+|.|||++|
T Consensus 76 -------v~~~~~~-----------~~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g-- 123 (191)
T d1zara2 76 -------VPKVYAW-----------EGNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG-- 123 (191)
T ss_dssp -------SCCEEEE-----------ETTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT--
T ss_pred -------cceEEEe-----------cCCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC--
Confidence 3322221 12379999998755422 445566789999999999999999
Q ss_pred eEecCCCCCceEEcCCCCeEEeccccCccCCCCCcccccCccccccCCCCCCCCCCCCcCCeehhHHH
Q 035572 163 IIHRDIKSTNILFDSKWDAKLADFGLAVSESDESSMVQPAGTIGYLDPGYTNPSKLSKKVDVFSYGVV 230 (379)
Q Consensus 163 i~H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 230 (379)
|+||||||+|||+++++ ++|+|||+|..........-.......+ .+.+ ...|+.++|+||+.--
T Consensus 124 iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 124 IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNI-ITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp EECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHHHHHHHHHHH-HHHH-HHHHCCCCCHHHHHHH
T ss_pred EEEccCChhheeeeCCC-EEEEECCCcccCCCCCcHHHHHHHHHHH-HHHH-cCCCCCcccHHHHHHH
Confidence 99999999999999764 8999999986654322110000000000 0111 2456788999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=5.7e-08 Score=83.56 Aligned_cols=148 Identities=19% Similarity=0.192 Sum_probs=96.5
Q ss_pred HHHHHHhcCCccccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCC
Q 035572 8 EELVKATESFSQSRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPN 87 (379)
Q Consensus 8 ~~~~~~~~~y~~~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 87 (379)
.++.+..+.|++.+..+.++.+.||+... .++.+.+|+..... ......+.+|...++.+... ...|.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~----~~~~~~~~~E~~~l~~l~~~-vpvP~ 74 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRY----KGTTYDVEREKDMMLWLEGK-LPVPK 74 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGG----TTSTTCHHHHHHHHHHHTTT-SCCCC
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCc----ccchhhHHHHHHHHHHHhcc-CCCCc
Confidence 46788889999888766566678998752 23347788765332 22344578899999888532 22222
Q ss_pred ceeeeccccccccCCCccCCCceEEEEeccCCCCHHHHHHhhhcCCCCCCChHhHHHHHHHHHHHHHHHHcCC-------
Q 035572 88 YCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLYDLLHNAAAATTPQLGWPNRVKIAMQISRAIQCLHEND------- 160 (379)
Q Consensus 88 ~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------- 160 (379)
++.. ..+++..++||++++|.++.+.... ......++.++...+..||+..
T Consensus 75 --vl~~----------~~~~~~~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~ 132 (263)
T d1j7la_ 75 --VLHF----------ERHDGWSNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYT 132 (263)
T ss_dssp --EEEE----------EEETTEEEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCB
T ss_pred --EEEE----------EecCCceEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccC
Confidence 3321 2345678999999999887654421 1112334555556666666421
Q ss_pred --------------------------------------------------CCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 161 --------------------------------------------------PMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 161 --------------------------------------------------~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
..++|+|+.|.|||+++++..-|+||+.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 133 NSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred cchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 01789999999999998766679999865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=5.3e-06 Score=70.42 Aligned_cols=76 Identities=18% Similarity=0.254 Sum_probs=47.6
Q ss_pred ccccCCc-eeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeecccccccc
Q 035572 22 LIGKGSH-GSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRN 100 (379)
Q Consensus 22 ~iG~G~~-g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~ 100 (379)
.+..|.. +.||+.... .+..+.+|..+.. ....+..|...++.+.......|. ++.
T Consensus 17 ~~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~-------~~~~l~~E~~~l~~L~~~gvpvP~--v~~-------- 73 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAA--VLD-------- 73 (255)
T ss_dssp ECSCTTSSCEEEEEECT------TSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCC--EEE--------
T ss_pred EcCCcccCCeEEEEEeC------CCCEEEEEeCCcc-------CHhHHHHHHHHHHHHHhcCCCCCc--eee--------
Confidence 3444543 678988643 2344788876533 234578899999999766533333 221
Q ss_pred CCCccCCCceEEEEeccCCCCH
Q 035572 101 SGSVDGNSNKLLVMEFMPNGSL 122 (379)
Q Consensus 101 ~~~~~~~~~~~lv~e~~~~~sL 122 (379)
...+++..++||++++|.++
T Consensus 74 --~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 74 --VVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp --EEECSSCEEEEEECCSSEET
T ss_pred --ecccccceEEEEEeeecccc
Confidence 12345678999999988554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.96 E-value=2.4e-05 Score=70.90 Aligned_cols=83 Identities=20% Similarity=0.169 Sum_probs=47.6
Q ss_pred ccccccCCceeEEEEEecCCCCCCCceEEEEEeccCCCc---hhhhhcHHHHHHHHHHHHhhhhcc-CCCCCceeeeccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTDGDHKILAIKRASTNGF---EVLQDNSKKLNNEIRVLSSLQESN-KRNPNYCVVNFHG 95 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~~~iv~~~~ 95 (379)
.+.||.|....||+..+.+ .++.+++|....... +..+....+...|...|+.+.... ...|. + +.
T Consensus 31 ~~eig~G~~N~vfrV~~~~-----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~--v---~~ 100 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPR--V---FY 100 (392)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCC--E---EE
T ss_pred EEEeCCCceEeEEEEEeCC-----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcce--E---EE
Confidence 4578999999999997543 345688887543111 011223456678999998775321 11111 1 11
Q ss_pred cccccCCCccCCCceEEEEeccCCCC
Q 035572 96 TSCRNSGSVDGNSNKLLVMEFMPNGS 121 (379)
Q Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~~s 121 (379)
.+.+..++|||++.+..
T Consensus 101 ---------~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 101 ---------SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp ---------EETTTTEEEECCCTTSE
T ss_pred ---------EcCCCCEEEEeccCCcc
Confidence 12345689999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.30 E-value=0.0019 Score=55.98 Aligned_cols=165 Identities=14% Similarity=0.090 Sum_probs=92.2
Q ss_pred CCCHHHHHHHhcCCccccccc-----cCCceeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhh
Q 035572 4 NFDYEELVKATESFSQSRLIG-----KGSHGSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSL 78 (379)
Q Consensus 4 ~~~~~~~~~~~~~y~~~~~iG-----~G~~g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 78 (379)
..+-+++..+.++|.+.+... .|---+.|+..... ..+++|+.... ...+.+..|+.++..|
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-------g~yVLri~~~~------~~~~~l~~~~~~l~~L 68 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-------DPLILTLYEKR------VEKNDLPFFLGLMQHL 68 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-------CCEEEEEECC---------CCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-------CcEEEEEcCCC------CCHHHHHHHHHHHHhh
Confidence 457789999999998865543 45446779886432 22899987532 1235677889999999
Q ss_pred hhccCCCCCceeeeccccccccCCCccCCCceEEEEeccCCCCHH--------------HHHHhhhcCCC-C---C----
Q 035572 79 QESNKRNPNYCVVNFHGTSCRNSGSVDGNSNKLLVMEFMPNGSLY--------------DLLHNAAAATT-P---Q---- 136 (379)
Q Consensus 79 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~--------------~~l~~~~~~~~-~---~---- 136 (379)
...+...|.+ +...-+... ..-......++.++.+.... ..+........ . .
T Consensus 69 ~~~g~pvp~p-i~~~~g~~~-----~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 142 (316)
T d2ppqa1 69 AAKGLSCPLP-LPRKDGELL-----GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVD 142 (316)
T ss_dssp HHTTCCCCCB-CCBTTCCSC-----EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHH
T ss_pred hhcccccccc-ceecCCCcc-----eeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchh
Confidence 8877554443 222222221 12234566677776653221 01110000000 0 0
Q ss_pred --------------CChHhHHHHHHHHHHHHHHHHc----CCCCeEecCCCCCceEEcCCCCeEEeccccC
Q 035572 137 --------------LGWPNRVKIAMQISRAIQCLHE----NDPMIIHRDIKSTNILFDSKWDAKLADFGLA 189 (379)
Q Consensus 137 --------------~~~~~~~~~~~~i~~~l~~LH~----~~~~i~H~dlkp~NIll~~~~~~kl~Dfg~a 189 (379)
.........+......+..... .| ++|+|+.++||+++++...-|.||+.+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~g--iIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 143 GWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAG--VIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEE--EECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred hcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccccc--cccCCcchhhhhcccccceeEeccccc
Confidence 0011122233333333443332 34 999999999999998877789999876
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.0018 Score=56.49 Aligned_cols=74 Identities=15% Similarity=0.139 Sum_probs=47.8
Q ss_pred eeEEEEEecCCCCCCCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccccccCCCccCCC
Q 035572 29 GSVYKAILEDHQTDGDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTSCRNSGSVDGNS 108 (379)
Q Consensus 29 g~V~~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 108 (379)
-.||++... ++..+++|..+.. ....+++..|...+..|...+...+.. +..-+ ...+...+
T Consensus 36 N~vy~v~~~------dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p--~~~~g-----~~~~~~~~ 97 (325)
T d1zyla1 36 NRVYQFQDE------DRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAP--VAFNG-----QTLLNHQG 97 (325)
T ss_dssp SEEEEECCT------TCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCC--CCBTT-----BSCEEETT
T ss_pred ceeEEEEcC------CCCEEEEEEeCCC-----CCCHHHHHHHHHHHHHHHhcCCCCCCc--eecCC-----Ceeeeeee
Confidence 479998654 4556999997643 234677889999999998765433321 11111 12234567
Q ss_pred ceEEEEeccCCC
Q 035572 109 NKLLVMEFMPNG 120 (379)
Q Consensus 109 ~~~lv~e~~~~~ 120 (379)
..+.++++++|.
T Consensus 98 ~~~~l~~~~~G~ 109 (325)
T d1zyla1 98 FYFAVFPSVGGR 109 (325)
T ss_dssp EEEEEEECCCCE
T ss_pred EEEEEEeecCCc
Confidence 788999999763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.005 Score=55.08 Aligned_cols=79 Identities=14% Similarity=0.214 Sum_probs=47.4
Q ss_pred ccccccCCceeEEEEEecCCCCC--CCceEEEEEeccCCCchhhhhcHHHHHHHHHHHHhhhhccCCCCCceeeeccccc
Q 035572 20 SRLIGKGSHGSVYKAILEDHQTD--GDHKILAIKRASTNGFEVLQDNSKKLNNEIRVLSSLQESNKRNPNYCVVNFHGTS 97 (379)
Q Consensus 20 ~~~iG~G~~g~V~~a~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~iv~~~~~~ 97 (379)
++.|+.|-.-.+|++........ ...+.|.+++.... .......+|..+++.+...+. .|. ++ +.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~------~~~idr~~E~~i~~~ls~~gl-~Pk--ll---~~- 113 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERHL-GPK--LY---GI- 113 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTTS-SSC--EE---EE-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc------chhhHHHHHHHHHHHHHhCCC-CCe--EE---EE-
Confidence 46787788889999876543211 13345667765421 123345689999999976553 222 22 11
Q ss_pred cccCCCccCCCceEEEEeccCCCC
Q 035572 98 CRNSGSVDGNSNKLLVMEFMPNGS 121 (379)
Q Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~s 121 (379)
+. -.+||||++|..
T Consensus 114 ------~~----~g~I~efi~g~~ 127 (395)
T d1nw1a_ 114 ------FS----GGRLEEYIPSRP 127 (395)
T ss_dssp ------ET----TEEEECCCCEEE
T ss_pred ------cC----CceEEEEecccc
Confidence 11 168999998743
|